,Unnamed: 0,label,doc_id,seeds,word_pos,text
0,903,conspiracy,C011fa,vaccine,"On_IN this_DT Thursday_NNP night_NN edition_NN of_IN the_DT broadcast_NN ,_, James_NNP goes_VBZ over_IN the_DT latest_JJS headlines_NNS and_CC takes_VBZ your_PRP$ calls_NNS ._. In_IN the_DT second_JJ half_NN of_IN the_DT broadcast_NN we_PRP ’re_VBP joined_VBN by_IN James_NNP Evan_NNP Pilato_NNP of_IN FoodWorldOrder.com_NNP to_TO talk_VB about_IN the_DT news_NN in_IN the_DT land_NN of_IN food_NN ,_, health_NN and_CC the_DT environment_NN ._. These_DT 6_CD Corporations_NNS Control_NN 90_CD %_NN Of_IN The_DT Media_NN In_IN America_NNP Chart_NN :_: How_WRB the_DT Bilderbergers_NNPS are_VBP Connected_VBN to_IN Everything_NN Benefits_NNS may_MD be_VB linked_VBN to_IN kids_NNS ’_POS jabs_NNS Get_VB Internet_NN Access_NN When_WRB Your_PRP$ Government_NN Shuts_VBZ It_PRP Down_RB #_NN What_WP Happens_VBZ When_WRB Schools_NNS Care_VBP About_IN Healthy_JJ Lunches_NNS ?_. #_NN What_WP Happens_VBZ When_WRB Schools_NNS Care_VBP About_IN Healthy_JJ Lunches_NNS ?_. Farm_NN Bill_NNP Jackpot_NN :_: How_WRB Much_JJ Do_VBP Corporations_NNS Benefit_VB from_IN SNAP_NN ?_. #_NN BingeAndPurge_NN :_: Hemp_NN For_IN Victory_NN ,_, Expired_JJ ,_, Epidemic_NN and_CC more_JJR","On this NNP NN NN of the NN , NNP VBZ over the JJS NNS and VBZ your NNS . In the JJ NN of the NN we VBP VBN by NNP NNP NNP of NNP to VB about the NN in the NN of NN , NN and the NN . These 6 NNS NN 90 NN Of The NN In NNP NN : How the NNPS VBP VBN to NN NNS may VB VBN to NNS ’ NNS VB NN NN When Your NN VBZ It RB NN What VBZ When NNS VBP About JJ NNS ? NN What VBZ When NNS VBP About JJ NNS ? NN NNP NN : How JJ VBP NNS VB from NN ? NN NN : NN For NN , JJ , NN and JJR"
1,921,mainstream,M09cf5,vaccine.autism,"Despite_IN concerns_NNS by_IN some_DT parents_NNS that_IN their_PRP$ children_NNS receive_VBP “_`` too_RB many_JJ vaccines_NNS too_RB soon_RB ,_, ”_'' a_DT new_JJ study_NN finds_VBZ that_IN many_JJ shots_NNS ,_, even_RB on_IN the_DT same_JJ day_NN ,_, do_VBP not_RB increase_VB the_DT risk_NN of_IN autism_NN ._. In_IN the_DT first_JJ six_CD months_NNS of_IN life_NN ,_, children_NNS receive_VBP as_RB many_JJ as_IN 19_CD vaccine_NN doses_NNS of_IN six_CD different_JJ vaccines_NNS ,_, and_CC by_IN the_DT time_NN they_PRP are_VBP 6_CD years_NNS old_JJ ,_, a_DT total_NN of_IN 25_CD doses_NNS from_IN 10_CD vaccines_NNS ._. MORE_JJR FROM_IN MY_PRP$ HEALTH_NN NEWS_NN DAILY_JJ :_: •_NFP Beyond_IN Vaccines_NNS :_: 5_CD Things_NNS that_WDT Might_MD Really_RB Cause_VB Autism_NN •_SYM 10_CD Medical_JJ Myths_NNS that_WDT Just_RB Wo_MD n't_RB Go_VB Away_RB In_IN a_DT 2011_CD survey_NN ,_, about_RB a_DT third_NN of_IN parents_NNS expressed_VBD concerns_NNS that_IN their_PRP$ child_NN received_VBD too_RB many_JJ vaccines_NNS before_IN age_NN 2_CD ,_, and_CC too_RB many_JJ vaccines_NNS on_IN a_DT single_JJ day_NN ._. Previous_JJ studies_NNS have_VBP found_VBN no_DT link_NN between_IN the_DT number_NN of_IN vaccines_NNS a_DT child_NN receives_VBZ and_CC their_PRP$ risk_NN of_IN several_JJ neurological_JJ conditions_NNS (_-LRB- though_IN these_DT studies_NNS did_VBD not_RB specifically_RB consider_VB autism_NN )_-RRB- ._. The_DT new_JJ study_NN went_VBD a_DT step_NN further_RBR by_IN looking_VBG at_IN the_DT link_NN between_IN a_DT child_NN 's_POS total_JJ exposure_NN to_IN antigens_NNS —_: the_DT proteins_NNS in_IN vaccines_NNS that_WDT stimulate_VBP the_DT body_NN 's_POS immune_NN system_NN —_: and_CC his_PRP$ or_CC her_PRP$ risk_NN of_IN autism_NN ._. The_DT researchers_NNS looked_VBD at_IN total_JJ antigen_NN exposure_NN rather_RB than_IN the_DT total_JJ number_NN of_IN vaccines_NNS kids_NNS received_VBN because_IN ,_, at_IN the_DT root_NN of_IN parents_NNS '_POS concerns_NNS is_VBZ the_DT idea_NN that_IN ""_`` somehow_RB they_PRP provide_VBP too_RB much_JJ immunological_JJ stimulation_NN ,_, more_RBR so_RB than_IN a_DT young_JJ child_NN 's_POS immune_JJ system_NN can_MD handle_VB ,_, ""_'' said_VBD study_NN researcher_NN Dr._NNP Frank_NNP DeStefano_NNP ,_, of_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. (_-LRB- The_DT sheer_JJ number_NN of_IN vaccines_NNS would_MD not_RB be_VB as_RB good_JJ a_DT measure_NN of_IN immunological_JJ response_NN because_IN vaccines_NNS contain_VBP different_JJ numbers_NNS of_IN antigens_NNS ,_, and_CC some_DT protect_VBP against_IN more_JJR than_IN one_CD disease_NN ,_, DeStefano_NNP said_VBD ._. )_-RRB- DeStefano_NNP and_CC colleagues_NNS analyzed_VBD information_NN from_IN about_RB 250_CD children_NNS with_IN autism_NN and_CC 750_CD children_NNS without_IN autism_NN ,_, born_VBN between_IN 1994_CD and_CC 1999_CD ._. Children_NNS with_IN autism_NN were_VBD exposed_VBN to_IN about_RB same_JJ total_JJ number_NN of_IN antigens_NNS as_IN children_NNS without_IN autism_NN at_IN ages_NNS 3_CD months_NNS ,_, 7_CD months_NNS and_CC 2_CD years_NNS ._. There_EX was_VBD also_RB no_DT difference_NN between_IN the_DT two_CD groups_NNS in_IN terms_NNS of_IN the_DT total_JJ number_NN of_IN antigens_NNS they_PRP were_VBD exposed_VBN to_IN on_IN a_DT single_JJ day_NN ._. ""_`` Parental_JJ concerns_NNS that_WDT their_PRP$ children_NNS are_VBP receiving_VBG too_RB many_JJ vaccines_NNS in_IN the_DT first_JJ two_CD years_NNS of_IN life_NN ,_, or_CC too_RB many_JJ vaccines_NNS at_IN a_DT single_JJ doctor_NN visit_NN are_VBP not_RB supported_VBN in_IN terms_NNS of_IN an_DT increased_VBN risk_NN of_IN autism_NN ,_, ""_'' the_DT researchers_NNS write_VBP in_IN the_DT March_NNP 29_CD issue_NN of_IN the_DT Journal_NNP of_IN Pediatrics_NNP ._. Kids_NNS are_VBP exposed_VBN to_IN many_JJ viruses_NNS and_CC other_JJ pathogens_NNS that_WDT stimulate_VBP their_PRP$ immune_JJ systems_NNS in_IN the_DT same_JJ way_NN vaccines_NNS do_VBP ,_, and_CC it's_VBZ been_VBN estimated_VBN that_IN kids_NNS could_MD theoretically_RB receive_VB thousands_NNS of_IN vaccines_NNS at_IN once_RB ,_, the_DT researchers_NNS said_VBD ._. Although_IN children_NNS today_NN receive_VBP more_JJR vaccines_NNS than_IN children_NNS in_IN the_DT mid-90s_NNS ,_, the_DT vaccines_NNS used_VBN today_NN contain_VBP fewer_JJR antigens_NNS ._. So_RB while_IN children_NNS in_IN the_DT mid-90s_NNS were_VBD exposed_VBN to_IN between_RB 3,000_CD and_CC 15,250_CD antigens_NNS in_IN the_DT first_JJ two_CD years_NNS of_IN life_NN ,_, children_NNS today_NN are_VBP exposed_VBN to_IN about_RB 315_CD antigens_NNS ,_, the_DT researchers_NNS said_VBD ._. Copyright_NN 2013_CD MyHealthNewsDaily_NNP ,_, a_DT TechMediaNetwork_NNP company_NN ._. All_DT rights_NNS reserved_VBN ._. This_DT material_NN may_MD not_RB be_VB published_VBN ,_, broadcast_VBN ,_, rewritten_VBN or_CC redistributed_VBN ._.","Despite NNS by some NNS that their NNS VBP “ RB JJ NNS RB RB , ” a JJ NN VBZ that JJ NNS , RB on the JJ NN , VBP RB VB the NN of NN . In the JJ six NNS of NN , NNS VBP RB JJ as 19 NN NNS of six JJ NNS , and by the NN they VBP 6 NNS JJ , a NN of 25 NNS from 10 NNS . JJR FROM MY NN NN JJ : • Beyond NNS : 5 NNS that Might RB VB NN • 10 JJ NNS that RB Wo RB VB RB In a 2011 NN , RB a NN of NNS VBD NNS that their NN VBD RB JJ NNS before NN 2 , and RB JJ NNS on a JJ NN . JJ NNS VBP VBN no NN between the NN of NNS a NN VBZ and their NN of JJ JJ NNS ( though these NNS VBD RB RB VB NN ) . The JJ NN VBD a NN RBR by VBG at the NN between a NN 's JJ NN to NNS — the NNS in NNS that VBP the NN 's NN NN — and his or her NN of NN . The NNS VBD at JJ NN NN RB than the JJ NN of NNS NNS VBN because , at the NN of NNS ' NNS VBZ the NN that "" RB they VBP RB JJ JJ NN , RBR RB than a JJ NN 's JJ NN can VB , "" VBD NN NN NNP NNP NNP , of the NNPS for NNP NNP and NNP . ( The JJ NN of NNS would RB VB RB JJ a NN of JJ NN because NNS VBP JJ NNS of NNS , and some VBP against JJR than one NN , NNP VBD . ) NNP and NNS VBD NN from RB 250 NNS with NN and 750 NNS without NN , VBN between 1994 and 1999 . NNS with NN VBD VBN to RB JJ JJ NN of NNS as NNS without NN at NNS 3 NNS , 7 NNS and 2 NNS . There VBD RB no NN between the two NNS in NNS of the JJ NN of NNS they VBD VBN to on a JJ NN . "" JJ NNS that their NNS VBP VBG RB JJ NNS in the JJ two NNS of NN , or RB JJ NNS at a JJ NN NN VBP RB VBN in NNS of an VBN NN of NN , "" the NNS VBP in the NNP 29 NN of the NNP of NNP . NNS VBP VBN to JJ NNS and JJ NNS that VBP their JJ NNS in the JJ NN NNS VBP , and VBZ VBN VBN that NNS could RB VB NNS of NNS at RB , the NNS VBD . Although NNS NN VBP JJR NNS than NNS in the NNS , the NNS VBN NN VBP JJR NNS . RB while NNS in the NNS VBD VBN to RB 3,000 and 15,250 NNS in the JJ two NNS of NN , NNS NN VBP VBN to RB 315 NNS , the NNS VBD . NN 2013 NNP , a NNP NN . All NNS VBN . This NN may RB VB VBN , VBN , VBN or VBN ."
2,534,mainstream,M08f39,cancer; coronavirus; covid.19; drug.companies; population.control; vaccine.covid,"On_IN April_NNP 30_CD ,_, the_DT nation_NN reported_VBD just_RB four_CD cases_NNS ,_, all_DT of_IN them_PRP travellers_NNS arriving_VBG from_IN abroad_RB ,_, marking_VBG the_DT first_JJ day_NN with_IN zero_CD local_JJ infections_NNS in_IN two_CD and_CC a_DT half_NN months_NNS ._. As_IN case_NN numbers_NNS have_VBP continued_VBN to_TO fall_VB ,_, the_DT government_NN has_VBZ cautiously_RB relaxed_VBN its_PRP$ guidelines_NNS ,_, while_IN signaling_VBG a_DT shift_NN to_IN ""_`` everyday_JJ quarantine_NN ""_'' measures_NNS ,_, such_JJ as_IN wearing_VBG masks_NNS and_CC temperature_NN checks_NNS at_IN schools_NNS ._. People_NNS 's_POS attitudes_NNS have_VBP also_RB relaxed_VBN ,_, leading_VBG some_DT officials_NNS to_TO worry_VB about_IN complacency_NN and_CC a_DT second_JJ wave_NN of_IN infections_NNS ._. The_DT nightclub_NN outbreak_NN may_MD heighten_VB those_DT fears_NNS ,_, but_CC the_DT government_NN has_VBZ already_RB responded_VBN aggressively_RB ,_, tracing_VBG and_CC testing_VBG thousands_NNS of_IN people_NNS in_IN a_DT matter_NN of_IN days_NNS ._. Last_JJ mile_NN is_VBZ the_DT toughest_JJS Though_IN testing_NN companies_NNS were_VBD quick_JJ to_TO respond_VB to_IN the_DT demand_NN ,_, rolling_VBG out_RP the_DT kits_NNS presented_VBD difficulties_NNS ._. Through_IN February_NNP ,_, demand_NN for_IN tests_NNS was_VBD still_RB outpacing_VBG supply_NN ,_, and_CC there_EX were_VBD only_RB enough_JJ kits_NNS to_TO distribute_VB to_IN a_DT select_JJ number_NN of_IN hospitals_NNS ._. Furthermore_RB ,_, hospitals_NNS struggled_VBD to_TO administer_VB the_DT tests_NNS to_IN potentially_RB contagious_JJ patients_NNS safely_RB and_CC quickly_RB —_: testing_NN areas_NNS needed_VBN to_TO be_VB sanitised_VBN after_IN each_DT patient_NN ,_, long_JJ queues_NNS meant_VBD the_DT virus_NN could_MD spread_VB while_IN people_NNS waited_VBD in_IN line_NN ,_, and_CC health_NN workers_NNS were_VBD running_VBG low_JJ on_IN protective_JJ gear_NN ._. At_IN Yangji_NNP Hospital_NNP ,_, this_DT also_RB led_VBD to_IN exhausted_VBN staff_NN ,_, says_VBZ hospital_NN director_NN Sang_NNP Il_NNP Kim_NNP ._. ""_`` Even_RB when_WRB we_PRP did_VBD have_VB kits_NNS ,_, the_DT waiting_NN times_NNS were_VBD just_RB too_RB long_JJ for_IN everybody_NN to_TO get_VB tested_VBN ,_, so_IN they_PRP would_MD have_VB to_TO go_VB to_IN other_JJ hospitals_NNS ,_, ""_'' adds_VBZ Yoona_NNP Chung_NNP ,_, a_DT doctor_NN in_IN the_DT hospital_NN 's_POS surgery_NN department_NN ._. According_VBG to_IN Yangji's_NNP data_NNS ,_, the_DT hospital_NN was_VBD conducting_VBG roughly_RB 10_CD tests_NNS a_DT day_NN by_IN late_JJ February_NNP —_: but_CC many_JJ more_JJR were_VBD being_VBG turned_VBN away_RB due_IN to_IN the_DT wait_NN ._. Other_JJ hospitals_NNS in_IN Korea_NNP started_VBD experimenting_VBG with_IN drive_NN -_HYPH through_IN testing_NN centres_NNS ,_, where_WRB patients_NNS could_MD get_VB tested_VBN without_IN leaving_VBG their_PRP$ cars_NNS ._. But_CC Yangji_NNP Hospital_NNP is_VBZ near_IN a_DT subway_NN station_NN in_IN a_DT crowded_JJ neighbourhood_NN in_IN southern_JJ Seoul_NNP ;_, for_IN many_JJ of_IN its_PRP$ patients_NNS ,_, cars_NNS are_VBP n't_RB an_DT option_NN ._. So_RB ,_, Kim_NNP devised_VBD the_DT walk_NN -_HYPH in_IN booths_NNS ,_, which_WDT went_VBD into_IN pilot_NN operation_NN on_IN March_NNP 10_CD ._. Within_IN days_NNS ,_, the_DT number_NN of_IN tests_NNS administered_VBN in_IN a_DT day_NN had_VBD tripled_VBN ._. By_IN the_DT end_NN of_IN the_DT month_NN ,_, the_DT hospital_NN could_MD handle_VB more_JJR than_IN 90_CD patients_NNS a_DT day_NN ._. Hospitals_NNS elsewhere_RB in_IN Korea_NNP and_CC around_IN the_DT world_NN quickly_RB adopted_VBD their_PRP$ own_JJ variations_NNS on_IN the_DT concept_NN ._. A_DT hospital_NN in_IN Busan_NNP had_VBD a_DT similar_JJ idea_NN independently_RB but_CC others_NNS have_VBP had_VBN help_NN from_IN Kim_NNP ._.","On NNP 30 , the NN VBD RB four NNS , all of them NNS VBG from RB , VBG the JJ NN with zero JJ NNS in two and a NN NNS . As NN NNS VBP VBN to VB , the NN VBZ RB VBN its NNS , while VBG a NN to "" JJ NN "" NNS , JJ as VBG NNS and NN NNS at NNS . NNS 's NNS VBP RB VBN , VBG some NNS to VB about NN and a JJ NN of NNS . The NN NN may VB those NNS , but the NN VBZ RB VBN RB , VBG and VBG NNS of NNS in a NN of NNS . JJ NN VBZ the JJS Though NN NNS VBD JJ to VB to the NN , VBG out the NNS VBD NNS . Through NNP , NN for NNS VBD RB VBG NN , and there VBD RB JJ NNS to VB to a JJ NN of NNS . RB , NNS VBD to VB the NNS to RB JJ NNS RB and RB — NN NNS VBN to VB VBN after each NN , JJ NNS VBD the NN could VB while NNS VBD in NN , and NN NNS VBD VBG JJ on JJ NN . At NNP NNP , this RB VBD to VBN NN , VBZ NN NN NNP NNP NNP . "" RB when we VBD VB NNS , the NN NNS VBD RB RB JJ for NN to VB VBN , so they would VB to VB to JJ NNS , "" VBZ NNP NNP , a NN in the NN 's NN NN . VBG to NNP NNS , the NN VBD VBG RB 10 NNS a NN by JJ NNP — but JJ JJR VBD VBG VBN RB due to the NN . JJ NNS in NNP VBD VBG with NN - through NN NNS , where NNS could VB VBN without VBG their NNS . But NNP NNP VBZ near a NN NN in a JJ NN in JJ NNP ; for JJ of its NNS , NNS VBP RB an NN . RB , NNP VBD the NN - in NNS , which VBD into NN NN on NNP 10 . Within NNS , the NN of NNS VBN in a NN VBD VBN . By the NN of the NN , the NN could VB JJR than 90 NNS a NN . NNS RB in NNP and around the NN RB VBD their JJ NNS on the NN . A NN in NNP VBD a JJ NN RB but NNS VBP VBN NN from NNP ."
3,538,conspiracy,C0086a,vaccine,"The_DT FBI_NNP disproved_VBD its_PRP$ main_JJ theory_NN about_IN how_WRB the_DT anthrax_NN spores_NNS were_VBD weaponized_VBN ._. The_DT investigation_NN of_IN the_DT 2001_CD anthrax_NN attacks_NNS ended_VBD as_RB far_RB as_IN the_DT public_NN knew_VBD on_IN July_NNP 29_CD ,_, 2008_CD ,_, with_IN the_DT death_NN of_IN Bruce_NNP Ivins_NNP ,_, a_DT senior_JJ biodefense_NN researcher_NN at_IN the_DT U.S._NNP Army_NNP Medical_NNP Research_NNP Institute_NNP of_IN Infectious_NNP Diseases_NNPS (_-LRB- USAMRIID_NNP )_-RRB- in_IN Fort_NNP Detrick_NNP ,_, Md._NNP The_DT cause_NN of_IN death_NN was_VBD an_DT overdose_NN of_IN the_DT painkiller_NN Tylenol_NNP ._. No_DT autopsy_NN was_VBD performed_VBN ,_, and_CC there_EX was_VBD no_DT suicide_NN note_NN ._. Less_JJR than_IN a_DT week_NN after_IN his_PRP$ apparent_JJ suicide_NN ,_, the_DT FBI_NNP declared_VBD Ivins_NNP to_TO have_VB been_VBN the_DT sole_JJ perpetrator_NN of_IN the_DT 2001_CD Anthrax_NNP attacks_NNS ,_, and_CC the_DT person_NN who_WP mailed_VBD deadly_JJ anthrax_NN spores_NNS to_IN NBC_NNP ,_, the_DT New_NNP York_NNP Post_NNP ,_, and_CC Sens_NNP ._. Tom_NNP Daschle_NNP and_CC Patrick_NNP Leahy_NNP ._. These_DT attacks_NNS killed_VBD five_CD people_NNS ,_, closed_VBD down_RP a_DT Senate_NNP office_NN building_NN ,_, caused_VBD a_DT national_JJ panic_NN ,_, and_CC nearly_RB paralyzed_VBD the_DT postal_JJ system_NN ._. The_DT FBI_NNP ’s_POS six_CD -_HYPH year_NN investigation_NN was_VBD the_DT largest_JJS inquest_NN in_IN its_PRP$ history_NN ,_, involving_VBG 9,000_CD interviews_NNS ,_, 6,000_CD subpoenas_NNS ,_, and_CC the_DT examination_NN of_IN tens_NNS of_IN thousands_NNS of_IN photocopiers_NNS ,_, typewriters_NNS ,_, computers_NNS and_CC mailboxes_NNS ._. Yet_CC it_PRP failed_VBD to_TO find_VB a_DT shred_NN of_IN evidence_NN that_WDT identified_VBD the_DT anthrax_NN killer–or_NN even_RB a_DT witness_NN to_IN the_DT mailings_NNS ._. With_IN the_DT help_NN of_IN a_DT task_NN force_NN of_IN scientists_NNS ,_, it_PRP found_VBD a_DT flask_NN of_IN anthrax_NN that_WDT closely_RB matched_VBD –through_RP its_PRP$ genetic_JJ markers_NNS –the_DT anthrax_NN used_VBN in_IN the_DT attack_NN ._. This_DT flask_NN had_VBD been_VBN in_IN the_DT custody_NN of_IN Ivins_NNP ,_, who_WP had_VBD published_VBN no_RB fewer_JJR than_IN 44_CD scientific_JJ papers_NNS over_IN three_CD decades_NNS as_IN a_DT microbiologist_NN and_CC who_WP was_VBD working_VBG on_IN developing_VBG vaccines_NNS against_IN anthrax_NN ._. As_IN custodian_NN ,_, he_PRP provided_VBD samples_NNS of_IN it_PRP to_IN other_JJ scientists_NNS at_IN Fort_NNP Detrick_NNP ,_, the_DT Battelle_NNP Memorial_NNP Institute_NNP in_IN Columbus_NNP ,_, Ohio_NNP ,_, and_CC other_JJ facilities_NNS involved_VBN in_IN anthrax_NN research_NN ._. According_VBG to_IN the_DT FBI_NNP ’s_POS reckoning_NN ,_, over_RB 100_CD scientists_NNS had_VBD been_VBN given_VBN access_NN to_IN it_PRP ._. Any_DT of_IN these_DT scientists_NNS (_-LRB- or_CC their_PRP$ co-workers_NNS )_-RRB- could_MD have_VB stolen_VBN a_DT minute_NN quantity_NN of_IN this_DT anthrax_NN and_CC ,_, by_IN mixing_VBG it_PRP into_IN a_DT media_NN of_IN water_NN and_CC nutrients_NNS ,_, used_VBD it_PRP to_TO grow_VB enough_JJ spores_NNS to_TO launch_VB the_DT anthrax_NN attacks_NNS ._.","The NNP VBD its JJ NN about how the NN NNS VBD VBN . The NN of the 2001 NN NNS VBD RB RB as the NN VBD on NNP 29 , 2008 , with the NN of NNP NNP , a JJ NN NN at the NNP NNP NNP NNP NNP of NNP NNPS ( NNP ) in NNP NNP , NNP The NN of NN VBD an NN of the NN NNP . No NN VBD VBN , and there VBD no NN NN . JJR than a NN after his JJ NN , the NNP VBD NNP to VB VBN the JJ NN of the 2001 NNP NNS , and the NN who VBD JJ NN NNS to NNP , the NNP NNP NNP , and NNP . NNP NNP and NNP NNP . These NNS VBD five NNS , VBD down a NNP NN NN , VBD a JJ NN , and RB VBD the JJ NN . The NNP ’s six - NN NN VBD the JJS NN in its NN , VBG 9,000 NNS , 6,000 NNS , and the NN of NNS of NNS of NNS , NNS , NNS and NNS . Yet it VBD to VB a NN of NN that VBD the NN NN RB a NN to the NNS . With the NN of a NN NN of NNS , it VBD a NN of NN that RB VBD –through its JJ NNS –the NN VBN in the NN . This NN VBD VBN in the NN of NNP , who VBD VBN RB JJR than 44 JJ NNS over three NNS as a NN and who VBD VBG on VBG NNS against NN . As NN , he VBD NNS of it to JJ NNS at NNP NNP , the NNP NNP NNP in NNP , NNP , and JJ NNS VBN in NN NN . VBG to the NNP ’s NN , RB 100 NNS VBD VBN VBN NN to it . Any of these NNS ( or their NNS ) could VB VBN a NN NN of this NN and , by VBG it into a NN of NN and NNS , VBD it to VB JJ NNS to VB the NN NNS ."
4,192,mainstream,M0b163,vaccine,"A_DT shot_NN in_IN the_DT dark_NN ?_. Some_DT say_VBP flu_NN vaccine_NN hard_JJ to_TO find_VB Some_DT parts_NNS of_IN the_DT country_NN are_VBP experiencing_VBG spot_NN shortages_NNS of_IN flu_NN vaccine_NN because_IN of_IN increased_VBN demand_NN in_IN a_DT flu_NN season_NN that_WDT started_VBD earlier_RBR and_CC is_VBZ more_RBR severe_JJ than_IN previous_JJ years_NNS ._. In_IN Las_NNP Vegas_NNP ,_, Celeste_NNP Tom_NNP tried_VBD six_CD times_NNS before_IN she_PRP found_VBD a_DT flu_NN shot_NN for_IN her_PRP$ boyfriend_NN ._. ""_`` I_PRP 'd_VBD been_VBN bugging_VBG him_PRP to_TO get_VB a_DT flu_NN shot_NN ,_, but_CC he_PRP kept_VBD putting_VBG it_PRP off_RP ,_, ""_'' said_VBD Tom_NNP ,_, 55_CD ._. The_DT Smith_NNP 's_POS Food_NNP and_CC Drug_NNP Center_NNP where_WRB she_PRP got_VBD her_PRP$ shot_NN was_VBD out_RB ._. Her_PRP$ partner_NN called_VBD his_PRP$ doctor_NN 's_POS office_NN ,_, but_CC they_PRP were_VBD out_RB ,_, too_RB ._. Next_RB she_PRP tried_VBD a_DT Walgreens_NNP and_CC then_RB a_DT CVS_NNP pharmacy_NN ;_, no_DT vaccine_NN ._. She_PRP called_VBD another_DT Smith's_NNP ,_, but_CC it_PRP would_MD administer_VB vaccine_NN only_RB to_IN people_NNS over_IN 65_CD ._. On_IN Monday_NNP ,_, she_PRP found_VBD a_DT Walgreens_NNP that_WDT had_VBD 10_CD doses_NNS left_VBN ._. ""_`` I_PRP called_VBD back_RB when_WRB he_PRP got_VBD off_IN work_NN at_IN 1_CD p.m._NN to_TO make_VB sure_JJ they_PRP still_RB had_VBD some_DT ,_, and_CC he_PRP finally_RB went_VBD in_RB ._. ""_'' ""_`` The_DT bottom_JJ line_NN is_VBZ there_EX 's_VBZ vaccine_NN out_RB there_RB ,_, ""_'' said_VBD Tom_NNP Skinner_NNP ,_, a_DT spokesman_NN for_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. ""_`` There_EX may_MD be_VB places_NNS where_WRB there_EX are_VBP spot_NN shortages_NNS ,_, but_CC there_EX should_MD be_VB a_DT little_JJ bit_NN more_RBR coming_VBG ,_, so_IN people_NNS may_MD have_VB to_TO check_VB around_RB for_IN it_PRP ._. ""_'' It_PRP took_VBD Pam_NNP Copley_NNP a_DT full_JJ day_NN ._. The_DT Staten_NNP Island_NNP ,_, N.Y._NNP ,_, mom_NN ,_, 42_CD ,_, tried_VBD her_PRP$ pediatrician_NN ,_, but_CC the_DT office_NN had_VBD no_DT appointments_NNS until_IN February_NNP ._. She_PRP and_CC daughter_NN Colleen_NNP ,_, 15_CD ,_, got_VBD in_IN line_NN at_IN a_DT CVS_NNP ,_, only_RB to_TO have_VB the_DT nurse_NN come_VB and_CC and_CC say_VB she_PRP did_VBD n't_RB have_VB shots_NNS for_IN anyone_NN under_IN 18_CD ._. After_IN ""_`` a_DT bunch_NN of_IN phone_NN calls_NNS ,_, ""_'' Copley_NNP found_VBD vaccine_NN at_IN an_DT urgent_JJ -_HYPH care_NN clinic_NN ._. They_PRP had_VBD to_TO wait_VB there_RB for_IN five_CD hours_NNS ,_, but_CC it_PRP was_VBD worth_JJ it_PRP ,_, she_PRP said_VBD ._. ""_`` There_EX 's_VBZ lots_NNS of_IN flu_NN in_IN the_DT schools_NNS here_RB right_RB now_RB ._. U.S._NNP flu_NN vaccine_NN manufacturers_NNS have_VBP increased_VBN the_DT number_NN of_IN doses_NNS they_PRP expect_VBP to_TO produce_VB this_DT year_NN to_IN 145_CD million_CD from_IN previous_JJ estimates_NNS of_IN 137_CD million_CD ,_, Skinner_NNP said_VBD ._. About_RB 128_CD million_CD doses_NNS have_VBP been_VBN shipped_VBN ,_, and_CC the_DT ""_`` vast_JJ majority_NN ""_'' of_IN those_DT have_VBP been_VBN used_VBN ,_, he_PRP said_VBD ._. ""_`` We_PRP had_VBD 112_CD million_CD people_NNS vaccinated_VBN by_IN the_DT end_NN of_IN November_NNP ._. ""_'' The_DT CDC_NNP is_VBZ working_VBG with_IN the_DT National_NNP Influenza_NNP Vaccine_NNP Summit_NNP ,_, a_DT coalition_NN that_WDT monitors_VBZ the_DT flu_NN and_CC vaccine_NN supply_NN ,_, to_TO tell_VB doctors_NNS and_CC other_JJ health_NN care_NN providers_NNS which_WDT distributors_NNS and_CC vaccine_NN manufacturers_NNS have_VBP vaccine_NN available_JJ to_TO order_VB ,_, Skinner_NNP said_VBD ._. ""_`` Spot_NN shortages_NNS are_VBP not_RB due_IN to_IN any_DT manufacturing_NN issues_NNS ,_, ""_'' said_VBD Rita_NNP Chappelle_NNP ,_, a_DT spokeswoman_NN for_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP ._. It_PRP 's_VBZ more_RBR an_DT effect_NN of_IN a_DT mild_JJ flu_NN season_NN last_JJ year_NN and_CC a_DT more_RBR severe_JJ one_NN this_DT year_NN ._. ""_`` Demand_NN for_IN the_DT vaccine_NN is_VBZ high_JJ ._. ""_'' Ordering_VBG flu_NN vaccine_NN can_MD be_VB a_DT challenge_NN ,_, said_VBD Cameron_NNP Wolfe_NNP with_IN the_DT division_NN of_IN infectious_JJ diseases_NNS at_IN Duke_NNP University_NNP School_NNP of_IN Medicine_NNP in_IN Durham_NNP ,_, N.C_NNP ._. It_PRP requires_VBZ ""_`` pharmacies_NNS ,_, physicians_NNS '_POS offices_NNS and_CC clinics_NNS to_TO pre-order_VB their_PRP$ supply_NN ,_, and_CC given_VBN the_DT variability_NN in_IN the_DT flu_NN season_NN ,_, it_PRP is_VBZ always_RB an_DT educated_VBN estimate_NN of_IN what_WP you_PRP 'll_MD actually_RB need_VB ._. ""_'' There_EX are_VBP two_CD main_JJ vaccine_NN producers_NNS in_IN the_DT United_NNP States_NNPS ,_, Sanofi_NNP US_NNP in_IN Bridgewater_NNP ,_, Conn._NNP ,_, and_CC GlaxoSmithKline_NNP in_IN Upper_NNP Merion_NNP ,_, Pa_NNP ._. For_IN the_DT 2012_CD -_HYPH 2013_CD flu_NN season_NN GlaxoSmithKline_NNP ,_, also_RB known_VBN as_IN GSK_NNP ,_, produced_VBD about_RB 25_CD million_CD doses_NNS of_IN flu_NN vaccine_NN ._. All_PDT those_DT 25_CD million_CD doses_NNS of_IN flu_NN vaccine_NN are_VBP spoken_VBN for_IN ,_, and_CC shipping_NN will_MD be_VB finished_VBN by_IN early_RB to_IN mid-February_NNP ,_, GSK_NNP spokesman_NN Robert_NNP Perry_NNP said_VBD ._. That_DT does_VBZ n't_RB mean_VB there_EX 's_VBZ no_DT more_JJR flu_NN vaccine_NN available_JJ to_IN doctors_NNS ._. Much_JJ of_IN GSK_NNP 's_POS production_NN goes_VBZ to_IN medical_JJ suppliers_NNS that_WDT take_VBP orders_NNS from_IN doctors_NNS '_POS offices_NNS ,_, Perry_NNP said_VBD ._. The_DT company_NN had_VBD the_DT capacity_NN to_TO produce_VB more_JJR flu_NN shots_NNS ,_, but_CC 25_CD million_CD doses_NNS was_VBD ""_`` what_WP customers_NNS told_VBD us_PRP they_PRP would_MD need_VB ,_, ""_'' Perry_NNP said_VBD ._. In_IN the_DT past_JJ two_CD years_NNS about_RB half_NN of_IN Americans_NNPS get_VBP vaccinated_VBN ._. It_PRP 's_VBZ tricky_JJ to_TO estimate_VB how_WRB much_JJ to_TO produce_VB because_IN flu_NN vaccine_NN takes_VBZ six_CD to_IN nine_CD months_NNS to_TO produce_VB ,_, so_RB manufacturers_NNS have_VBP to_TO plan_VB production_NN before_IN all_PDT the_DT orders_NNS are_VBP in_IN ._. GSK_NNP began_VBD taking_VBG orders_NNS for_IN this_DT flu_NN season_NN in_IN October_NNP 2011_CD ._. It_PRP will_MD finish_VB taking_VBG orders_NNS for_IN next_JJ year_NN 's_POS flu_NN season_NN next_JJ month_NN ._. Health_NN care_NN providers_NNS base_VBP their_PRP$ estimates_NNS on_IN previous_JJ year_NN 's_POS demand_NN ._. A_DT single_JJ dose_NN costs_VBZ $_$ 7.90_CD to_IN $_$ 8.85_CD wholesale_NN ,_, and_CC doctors_NNS are_VBP careful_JJ not_RB to_TO order_VB too_RB much_RB ._. It_PRP 's_VBZ still_RB not_RB too_RB late_JJ to_TO get_VB vaccinated_VBN ._. Flu_NN seasons_NNS are_VBP unpredictable_JJ in_IN their_PRP$ length_NN ,_, and_CC it_PRP 's_VBZ unclear_JJ whether_IN cases_NNS are_VBP still_RB building_VBG or_CC beginning_VBG to_TO wane_VB ,_, according_VBG to_IN the_DT CDC_NNP ._. ""_`` Being_VBG vaccinated_VBN with_IN the_DT flu_NN vaccine_NN each_DT year_NN remains_VBZ the_DT best_JJS way_NN to_TO prevent_VB the_DT flu_NN ,_, ""_'' Chappelle_NNP said_VBD ._. Information_NN on_IN flu_NN vaccine_NN availability_NN is_VBZ at_IN www.flu.gov._ADD","A NN in the NN ? Some VBP NN NN JJ to VB Some NNS of the NN VBP VBG NN NNS of NN NN because of VBN NN in a NN NN that VBD RBR and VBZ RBR JJ than JJ NNS . In NNP NNP , NNP NNP VBD six NNS before she VBD a NN NN for her NN . "" I VBD VBN VBG him to VB a NN NN , but he VBD VBG it off , "" VBD NNP , 55 . The NNP 's NNP and NNP NNP where she VBD her NN VBD RB . Her NN VBD his NN 's NN , but they VBD RB , RB . RB she VBD a NNP and RB a NNP NN ; no NN . She VBD another NNP , but it would VB NN RB to NNS over 65 . On NNP , she VBD a NNP that VBD 10 NNS VBN . "" I VBD RB when he VBD off NN at 1 NN to VB JJ they RB VBD some , and he RB VBD RB . "" "" The JJ NN VBZ there VBZ NN RB RB , "" VBD NNP NNP , a NN for the NNPS for NNP NNP and NNP . "" There may VB NNS where there VBP NN NNS , but there should VB a JJ NN RBR VBG , so NNS may VB to VB RB for it . "" It VBD NNP NNP a JJ NN . The NNP NNP , NNP , NN , 42 , VBD her NN , but the NN VBD no NNS until NNP . She and NN NNP , 15 , VBD in NN at a NNP , RB to VB the NN VB and and VB she VBD RB VB NNS for NN under 18 . After "" a NN of NN NNS , "" NNP VBD NN at an JJ - NN NN . They VBD to VB RB for five NNS , but it VBD JJ it , she VBD . "" There VBZ NNS of NN in the NNS RB RB RB . NNP NN NN NNS VBP VBN the NN of NNS they VBP to VB this NN to 145 million from JJ NNS of 137 million , NNP VBD . RB 128 million NNS VBP VBN VBN , and the "" JJ NN "" of those VBP VBN VBN , he VBD . "" We VBD 112 million NNS VBN by the NN of NNP . "" The NNP VBZ VBG with the NNP NNP NNP NNP , a NN that VBZ the NN and NN NN , to VB NNS and JJ NN NN NNS which NNS and NN NNS VBP NN JJ to VB , NNP VBD . "" NN NNS VBP RB due to any NN NNS , "" VBD NNP NNP , a NN for the NNP and NNP NNP . It VBZ RBR an NN of a JJ NN NN JJ NN and a RBR JJ NN this NN . "" NN for the NN VBZ JJ . "" VBG NN NN can VB a NN , VBD NNP NNP with the NN of JJ NNS at NNP NNP NNP of NNP in NNP , NNP . It VBZ "" NNS , NNS ' NNS and NNS to VB their NN , and VBN the NN in the NN NN , it VBZ RB an VBN NN of what you 'll RB VB . "" There VBP two JJ NN NNS in the NNP NNPS , NNP NNP in NNP , NNP , and NNP in NNP NNP , NNP . For the 2012 - 2013 NN NN NNP , RB VBN as NNP , VBD RB 25 million NNS of NN NN . All those 25 million NNS of NN NN VBP VBN for , and NN will VB VBN by RB to NNP , NNP NN NNP NNP VBD . That VBZ RB VB there VBZ no JJR NN NN JJ to NNS . JJ of NNP 's NN VBZ to JJ NNS that VBP NNS from NNS ' NNS , NNP VBD . The NN VBD the NN to VB JJR NN NNS , but 25 million NNS VBD "" what NNS VBD us they would VB , "" NNP VBD . In the JJ two NNS RB NN of NNPS VBP VBN . It VBZ JJ to VB how JJ to VB because NN NN VBZ six to nine NNS to VB , RB NNS VBP to VB NN before all the NNS VBP in . NNP VBD VBG NNS for this NN NN in NNP 2011 . It will VB VBG NNS for JJ NN 's NN NN JJ NN . NN NN NNS VBP their NNS on JJ NN 's NN . A JJ NN VBZ $ 7.90 to $ 8.85 NN , and NNS VBP JJ RB to VB RB RB . It VBZ RB RB RB JJ to VB VBN . NN NNS VBP JJ in their NN , and it VBZ JJ whether NNS VBP RB VBG or VBG to VB , VBG to the NNP . "" VBG VBN with the NN NN each NN VBZ the JJS NN to VB the NN , "" NNP VBD . NN on NN NN NN VBZ at www.flu.gov."
5,893,mainstream,M080cc,vaccine,"Emily_NNP P._NNP Wen_NNP ,_, PhD_NNP ,_, is_VBZ currently_RB a_DT Research_NN Fellow_NN at_IN the_DT Merck_NNP Research_NNP Laboratory_NNP in_IN the_DT department_NN of_IN Vaccine_NNP Process_NNP Development_NNP ._. Dr._NNP Wen_NNP has_VBZ led_VBN process_NN developments_NNS for_IN several_JJ major_JJ vaccine_NN products_NNS from_IN Phase_NN I_CD to_IN Phase_NN III_CD clinical_JJ trials_NNS ,_, including_VBG vaccines_NNS against_IN hepatitis_NN B_NN ,_, Haemophilus_NN influenzae_NN type_NN b_NN ,_, Pneumococcal_NN ,_, Meningococcal_NN ,_, and_CC Group_NN B_NN Streptococcus_NN ._. Ronald_NNP J._NNP Ellis_NNP ,_, PhD_NNP ,_, is_VBZ Chief_JJ Technology_NN Officer_NN at_IN FutuRx_NNP Ltd_NNP in_IN Israel_NNP ._. Dr._NNP Ellis_NNP has_VBZ >_SYM 30_CD years_NNS of_IN industry_NN experience_NN in_IN line_NN and_CC senior_JJ management_NN in_IN many_JJ companies_NNS ,_, including_VBG roles_NNS as_IN project_NN leader_NN and_CC champion_NN of_IN projects_NNS that_WDT resulted_VBD in_IN 5_CD licensed_VBN vaccines_NNS which_WDT accrue_VBP ~_SYM $_$ 4B_CD in_IN annual_JJ sales_NNS ._. He_PRP is_VBZ the_DT founding_VBG and_CC incumbent_JJ Editor_NNP -_HYPH in_IN -_HYPH Chief_NNP of_IN the_DT MedLine_NNP -_HYPH /_, PubMed_NNP -_HYPH indexed_VBN journal_NN Human_NNP Vaccines_NNPS &_CC Immunotherapeutics_NNP ._. Narahari_NNP S._NNP Pujar_NNP ,_, PhD_NNP ,_, MBA_NNP ,_, is_VBZ currently_RB an_DT Executive_JJ Director_NN and_CC Integrated_VBN Product_NN Leader_NN in_IN the_DT Vaccine_NN Business_NNP Line_NNP at_IN Merck_NNP &_CC Co._NNP ,_, Inc._NNP Dr._NNP Pujar_NNP has_VBZ contributed_VBN to_IN a_DT variety_NN of_IN vaccines_NNS and_CC biologics_NNS products_NNS and_CC product_NN candidates_NNS ._. He_PRP is_VBZ an_DT active_JJ member_NN of_IN the_DT American_NNP Chemical_NNP Society_NNP and_CC was_VBD the_DT past_JJ chair_NN of_IN the_DT Division_NNP of_IN Biochemical_NNP Technology_NNP ._. Anurag_NNP S._NNP Rathore_NNP ,_, PhD_NN ,_, is_VBZ Professor_NNP in_IN the_DT Department_NNP of_IN Chemical_NNP Engineering_NNP at_IN IIT_NNP Delhi_NNP ,_, India_NNP ._. He_PRP is_VBZ an_DT active_JJ member_NN of_IN the_DT Parenteral_NNP Drug_NNP Association_NNP (_-LRB- PDA_NNP )_-RRB- and_CC American_NNP Chemical_NNP Society_NNP (_-LRB- ACS_NNP )_-RRB- and_CC have_VBP authored_VBN more_JJR than_IN 200_CD publications_NNS and_CC presentations_NNS in_IN these_DT areas_NNS ._.","NNP NNP NNP , NNP , VBZ RB a NN NN at the NNP NNP NNP in the NN of NNP NNP NNP . NNP NNP VBZ VBN NN NNS for JJ JJ NN NNS from NN I to NN III JJ NNS , VBG NNS against NN NN , NN NN NN NN , NN , NN , and NN NN NN . NNP NNP NNP , NNP , VBZ JJ NN NN at NNP NNP in NNP . NNP NNP VBZ > 30 NNS of NN NN in NN and JJ NN in JJ NNS , VBG NNS as NN NN and NN of NNS that VBD in 5 VBN NNS which VBP ~ $ 4B in JJ NNS . He VBZ the VBG and JJ NNP - in - NNP of the NNP - / NNP - VBN NN NNP NNPS & NNP . NNP NNP NNP , NNP , NNP , VBZ RB an JJ NN and VBN NN NN in the NN NNP NNP at NNP & NNP , NNP NNP NNP VBZ VBN to a NN of NNS and NNS NNS and NN NNS . He VBZ an JJ NN of the NNP NNP NNP and VBD the JJ NN of the NNP of NNP NNP . NNP NNP NNP , NN , VBZ NNP in the NNP of NNP NNP at NNP NNP , NNP . He VBZ an JJ NN of the NNP NNP NNP ( NNP ) and NNP NNP NNP ( NNP ) and VBP VBN JJR than 200 NNS and NNS in these NNS ."
6,427,mainstream,M08c0c,vaccine.autism,"Jeff_NNP Bradstreet_NNP ,_, who_WP has_VBZ been_VBN described_VBN as_IN a_DT “_`` controversial_JJ autism_NN researcher_NN ,_, ”_'' has_VBZ now_RB become_VBN the_DT center_NN of_IN conspiracy_NN rumors_NNS after_IN reports_NNS of_IN his_PRP$ apparent_JJ suicide_NN ._. His_PRP$ death_NN is_VBZ said_VBN to_TO have_VB followed_VBN on_IN the_DT heels_NNS of_IN a_DT raid_NN by_IN the_DT US_NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- of_IN his_PRP$ Bradstreet_NNP Wellness_NNP Center_NNP in_IN Buford_NNP ,_, Georgia_NNP (_-LRB- update_VB 27JUN2015_CD :_: the_DT Georgia_NNP Drugs_NNPS and_CC Narcotics_NNP Agency_NNP is_VBZ reported_VBN to_TO have_VB aided_VBN in_IN the_DT raid_NN )_-RRB- ._. A_DT fisherman_NN found_VBD Bradstreet_NNP ’s_POS body_NN in_IN a_DT North_NNP Carolina_NNP river_NN on_IN Friday_NNP ,_, June_NNP 19_CD ._. Authorities_NNS in_IN Rutherford_NNP County_NNP ,_, North_NNP Carolina_NNP ,_, state_VBP that_IN he_PRP had_VBD a_DT gunshot_NN wound_NN to_IN the_DT chest_NN ,_, “_'' which_WDT appears_VBZ to_TO be_VB self_NN -_HYPH inflicted_VBN ,_, ”_'' according_VBG to_IN the_DT local_JJ newspaper_NN ,_, the_DT Gwinnett_NNP Daily_NNP Post_NNP ._. The_DT Post_NNP also_RB reports_VBZ that_IN That_DT speculation_NN has_VBZ spread_VBN like_IN a_DT virus_NN through_IN the_DT community_NN of_IN people_NNS who_WP are_VBP mourning_VBG the_DT loss_NN of_IN a_DT man_NN whom_WP they_PRP viewed_VBD as_IN a_DT courageous_JJ crusader_NN against_IN mainstream_JJ medicine_NN and_CC who_WP believe_VBP ,_, as_IN Bradstreet_NNP argued_VBD ,_, that_IN the_DT mercury_NN in_IN vaccines_NNS causes_VBZ autism_NN (_-LRB- the_DT evidence_NN emphatically_RB indicates_VBZ otherwise_RB )_-RRB- ._. According_VBG to_IN his_PRP$ website_NN ,_, Bradstreet_NNP ,_, whose_WP$ own_JJ son_NN is_VBZ autistic_JJ ,_, embraced_VBD a_DT number_NN of_IN unproven_JJ or_CC untested_JJ interventions_NNS for_IN autism_NN ,_, including_VBG using_VBG stem_NN cells_NNS in_IN an_DT overseas_JJ study_NN he_PRP chronicles_VBZ ,_, and_CC hyperbaric_JJ oxygen_NN therapy_NN ,_, which_WDT the_DT FDA_NNP cracked_VBD down_RP on_IN in_IN 2013_CD ._. He_PRP was_VBD known_VBN for_IN his_PRP$ use_NN of_IN chelation_NN therapy_NN ._. As_IN I_PRP ’ve_VBP written_VBN about_IN here_RB before_RB ,_, those_DT who_WP are_VBP attracted_VBN to_IN conspiracy_NN theories_NNS to_TO explain_VB their_PRP$ world_NN have_VBP a_DT tendency_NN to_TO see_VB conspiracy_NN all_RB around_IN them_PRP ._. With_IN the_DT death_NN of_IN Bradstreet_NNP ,_, this_DT tendency_NN is_VBZ emerging_VBG in_IN force_NN ._. A_DT related_JJ fundraiser_NN with_IN the_DT title_NN “_`` Finding_VBG out_RP the_DT truth_NN ”_'' references_VBZ an_DT “_`` exhaustive_JJ investigation_NN into_IN the_DT possibility_NN of_IN foul_JJ play_NN ._. ”_'' At_IN last_JJ look_NN ,_, the_DT funds_NNS raised_VBN were_VBD in_IN the_DT low_JJ five_CD figures_NNS ._. Some_DT seem_VBP to_TO think_VB that_IN the_DT location_NN of_IN the_DT wound_NN suggests_VBZ foul_NN play_NN ,_, but_CC about_RB a_DT fifth_NN of_IN suicides_NNS by_IN gunshot_NN involve_VBP a_DT wound_NN to_IN the_DT chest_NN ._. A_DT handgun_NN also_RB was_VBD found_VBN in_IN the_DT river_NN where_WRB Bradstreet_NNP ’s_POS body_NN was_VBD discovered_VBN ._. Studies_NNS of_IN people_NNS who_WP are_VBP prone_JJ to_TO subscribe_VB to_IN conspiracy_NN theories_NNS indicate_VBP that_IN readers_NNS drawn_VBN to_IN conspiracy_NN -_HYPH related_JJ online_JJ news_NN tend_VBP to_TO be_VB more_RBR focused_VBN on_IN what_WP filters_VBZ into_IN their_PRP$ narrow_JJ ,_, conspiracy_NN -_HYPH oriented_VBN communities_NNS ,_, reinforcing_VBG confirmation_NN biases_NNS and_CC adding_VBG fuel_NN to_IN the_DT conspiratorial_JJ machine_NN ._. In_IN the_DT US_NNP ,_, “_`` conspiracist_NN beliefs_NNS ,_, ”_'' which_WDT are_VBP widespread_JJ ,_, correlate_VBP with_IN being_VBG more_RBR likely_JJ to_TO use_VB alternative_JJ medicine_NN and_CC to_TO shun_VB mainstream_JJ medicine_NN ,_, even_RB to_IN the_DT point_NN of_IN being_VBG less_RBR likely_JJ to_TO have_VB an_DT annual_JJ physical_NN ._. Researchers_NNS call_VBP the_DT internet_NN a_DT “_`` natural_JJ medium_NN ”_'' for_IN the_DT diffusion_NN of_IN conspiracy_NN theories_NNS ,_, and_CC the_DT rapidity_NN with_IN which_WDT this_DT one_NN spread_VBD and_CC took_VBD hold_NN is_VBZ no_DT exception_NN ._.","NNP NNP , who VBZ VBN VBN as a “ JJ NN NN , ” VBZ RB VBN the NN of NN NNS after NNS of his JJ NN . His NN VBZ VBN to VB VBN on the NNS of a NN by the NNP NNP and NNP NNP ( NNP ) of his NNP NNP NNP in NNP , NNP ( VB 27JUN2015 : the NNP NNPS and NNP NNP VBZ VBN to VB VBN in the NN ) . A NN VBD NNP ’s NN in a NNP NNP NN on NNP , NNP 19 . NNS in NNP NNP , NNP NNP , VBP that he VBD a NN NN to the NN , “ which VBZ to VB NN - VBN , ” VBG to the JJ NN , the NNP NNP NNP . The NNP RB VBZ that That NN VBZ VBN like a NN through the NN of NNS who VBP VBG the NN of a NN whom they VBD as a JJ NN against JJ NN and who VBP , as NNP VBD , that the NN in NNS VBZ NN ( the NN RB VBZ RB ) . VBG to his NN , NNP , whose JJ NN VBZ JJ , VBD a NN of JJ or JJ NNS for NN , VBG VBG NN NNS in an JJ NN he VBZ , and JJ NN NN , which the NNP VBD down on in 2013 . He VBD VBN for his NN of NN NN . As I VBP VBN about RB RB , those who VBP VBN to NN NNS to VB their NN VBP a NN to VB NN RB around them . With the NN of NNP , this NN VBZ VBG in NN . A JJ NN with the NN “ VBG out the NN ” VBZ an “ JJ NN into the NN of JJ NN . ” At JJ NN , the NNS VBN VBD in the JJ five NNS . Some VBP to VB that the NN of the NN VBZ NN NN , but RB a NN of NNS by NN VBP a NN to the NN . A NN RB VBD VBN in the NN where NNP ’s NN VBD VBN . NNS of NNS who VBP JJ to VB to NN NNS VBP that NNS VBN to NN - JJ JJ NN VBP to VB RBR VBN on what VBZ into their JJ , NN - VBN NNS , VBG NN NNS and VBG NN to the JJ NN . In the NNP , “ NN NNS , ” which VBP JJ , VBP with VBG RBR JJ to VB JJ NN and to VB JJ NN , RB to the NN of VBG RBR JJ to VB an JJ NN . NNS VBP the NN a “ JJ NN ” for the NN of NN NNS , and the NN with which this NN VBD and VBD NN VBZ no NN ."
7,591,mainstream,M08dae,vaccine.covid,"by_IN Ashley_NNP AustrewPoliticians_NNPS are_VBP n’t_RB exactly_RB known_VBN for_IN being_VBG honest_JJ ._. President_NNP Nixon_NNP had_VBD the_DT Watergate_NNP scandal_NN ._. President_NNP Bill_NNP Clinton_NNP lied_VBD about_IN his_PRP$ affair_NN with_IN Monica_NNP Lewinsky_NNP ._. And_CC ,_, in_IN the_DT first_JJ two_CD years_NNS Donald_NNP Trump_NNP was_VBD president_NN ,_, the_DT Washington_NNP Post_NNP reported_VBD he_PRP ’s_VBZ made_VBN over_RB 8,000_CD “_`` false_JJ or_CC misleading_JJ claims_NNS ”_'' to_IN the_DT American_JJ public_NN ._. Still_RB ,_, it_PRP is_VBZ rare_JJ to_TO see_VB a_DT headline_NN declaring_VBG any_DT president_NN or_CC politician_NN a_DT liar_NN ._. Why_WRB is_VBZ that_DT ?_. First_RB of_IN all_DT ,_, what_WP does_VBZ it_PRP mean_VB to_TO lie_VB ?_. The_DT noun_NN and_CC verb_NN lie_VBP are_VBP both_RB recorded_VBN in_IN Old_NNP English_NNP by_IN the_DT 900s_NNS ._. To_TO lie_VB is_VBZ “_`` to_TO speak_VB falsely_RB or_CC utter_JJ truth_NN knowingly_RB ,_, as_IN with_IN intent_NN to_TO deceive_VB ._. ”_'' More_RBR generally_RB ,_, to_TO lie_VB is_VBZ “_`` to_TO express_VB what_WP is_VBZ false_JJ ,_, convey_VB a_DT false_JJ impression_NN ._. ”_'' So_RB ,_, when_WRB a_DT person_NN lies_VBZ ,_, they_PRP are_VBP n’t_RB just_RB sharing_VBG false_JJ information_NN ,_, they_PRP ’re_VBP doing_VBG it_PRP with_IN the_DT sinister_JJ intent_NN of_IN getting_VBG others_NNS to_TO believe_VB misleading_VBG information_NN ._. If_IN someone_NN does_VBZ this_DT habitually_RB ,_, then_RB we_PRP would_MD call_VB them_PRP a_DT liar_NN ,_, “_`` a_DT person_NN who_WP tells_VBZ lies_NNS ._. ”_'' This_DT word_NN is_VBZ also_RB attested_VBN to_IN in_IN the_DT 900s_NNS ._. Why_WRB do_VBP n’t_RB journalists_NNS use_VB the_DT word_NN liar_NN ?_. The_DT main_JJ reason_NN why_WRB many_JJ journalists_NNS avoid_VBP accusations_NNS of_IN lying_NN is_VBZ because_IN it_PRP is_VBZ difficult_JJ to_TO determine_VB one_CD key_JJ word_NN in_IN that_DT definition_NN above_IN :_: intent_NN ._. If_IN a_DT lie_NN is_VBZ “_`` a_DT false_JJ statement_NN that_WDT is_VBZ made_VBN with_IN deliberate_JJ intent_NN to_TO deceive_VB ,_, ”_'' then_RB calling_VBG someone_NN a_DT liar_NN means_VBZ you_PRP know_VBP they_PRP are_VBP intentionally_RB trying_VBG to_TO mislead_VB people_NNS ._. While_IN many_JJ of_IN us_PRP make_VBP that_DT assumption_NN about_IN politicians_NNS ,_, it_PRP ’s_VBZ different_JJ when_WRB you_PRP ’re_VBP a_DT member_NN of_IN the_DT media_NN tasked_VBN with_IN reporting_VBG the_DT news_NN —_: not_RB your_PRP$ own_JJ conclusions_NNS about_IN it_PRP ._. David_NNP Greenberg_NNP ,_, a_DT professor_NN of_IN history_NN and_CC media_NN studies_NNS at_IN Rutgers_NNP University_NNP and_CC a_DT contributing_VBG editor_NN at_IN Politico_NNP ,_, wrote_VBD in_IN 2017_CD that_IN the_DT media_NN declaring_VBG the_DT president_NN a_DT liar_NN would_MD cross_VB a_DT serious_JJ line_NN ._. That_DT ’s_VBZ not_RB to_TO say_VB that_IN it_PRP should_MD never_RB be_VB done_VBN ._. Prior_JJ to_IN the_DT Watergate_NNP scandal_NN ,_, as_IN Greenberg_NNP observed_VBD ,_, a_DT National_NNP Press_NNP Club_NNP report_NN found_VBD Nixon_NNP guilty_JJ of_IN “_`` an_DT unprecedented_JJ ,_, government_NN -_HYPH wide_JJ effort_NN to_TO control_VB ,_, restrict_VB and_CC conceal_VB information_NN ”_'' and_CC “_`` discredit_VB the_DT press_NN ._. ”_'' Still_RB ,_, it_PRP was_VBD n’t_RB until_IN the_DT Watergate_NNP story_NN broke_VBD and_CC investigations_NNS proved_VBD Nixon_NNP ’s_POS intent_NN that_IN the_DT media_NN declared_VBD the_DT president_NN a_DT liar_NN ._. If_IN the_DT media_NN wants_VBZ to_TO retain_VB their_PRP$ credibility_NN ,_, Greenberg_NNP argued_VBD ,_, they_PRP are_VBP right_JJ to_TO hold_VB back_RB from_IN declaring_VBG President_NNP Trump_NNP ,_, or_CC anyone_NN else_JJ ,_, a_DT liar_NN ._. “_`` Though_IN it_PRP may_MD seem_VB fainthearted_VBN to_TO use_VB words_NNS like_IN ‘_`` falsehood_NN ’_'' and_CC ‘_`` untruth_NN ,_, ’_'' in_IN the_DT long_JJ run_NN the_DT press_NN will_MD have_VB more_JJR influence_NN if_IN it_PRP avoids_VBZ insinuating_VBG more_JJR than_IN it_PRP can_MD confidently_RB assert_VB to_TO be_VB true_JJ ,_, ”_'' he_PRP wrote_VBD ._. Should_MD journalists_NNS use_VB liar_NN anyways_RB ?_. On_IN January_NNP 21_CD ,_, 2019_CD ,_, the_DT Washington_NNP Post_NNP reported_VBD that_IN ,_, in_IN the_DT first_JJ two_CD years_NNS of_IN his_PRP$ presidency_NN alone_RB ,_, Trump_NNP made_VBD 8,158_CD false_JJ claims_NNS about_IN the_DT economy_NN ,_, immigration_NN ,_, trade_NN ,_, foreign_JJ policy_NN ,_, and_CC other_JJ matters_NNS ._. In_IN just_RB one_CD instance_NN in_IN March_NNP 2019_CD ,_, Trump_NNP wrongly_RB identified_VBD Patrick_NNP Moore_NNP ,_, a_DT man_NN with_IN early_JJ involvement_NN in_IN Greenpeace_NNP ,_, as_IN a_DT cofounder_NN of_IN the_DT organization_NN in_IN a_DT tweet_NN about_IN him_PRP calling_VBG climate_NN change_NN “_`` fake_JJ news_NN ._. ”_'' Greenpeace_NNP was_VBD quick_JJ to_TO correct_VB Trump_NNP on_IN the_DT fact_NN that_IN Moore_NNP was_VBD not_RB a_DT cofounder_NN ,_, but_CC that_DT did_VBD n’t_RB change_VB the_DT fact_NN that_IN many_JJ people_NNS were_VBD exposed_VBN to_IN the_DT tweet_NN and_CC may_MD have_VB accepted_VBN the_DT president_NN ’s_POS words_NNS as_IN true_JJ ._. Since_IN the_DT 2016_CD US_NNP presidential_JJ election_NN ,_, people_NNS have_VBP grown_VBN increasingly_RB frustrated_JJ with_IN the_DT media_NN ’s_POS treatment_NN of_IN public_JJ figures_NNS who_WP lie_VBP ,_, with_IN many_JJ concerned_JJ that_IN we_PRP live_VBP in_IN a_DT post_NN -_HYPH truth_NN society_NN where_WRB facts_NNS have_VBP become_VBN irrelevant_JJ ._. And_CC ,_, it_PRP ’s_VBZ not_RB only_RB Trump_NNP ._. That_DT election_NN brought_VBD us_PRP the_DT Hillary_NNP Clinton_NNP email_NN scandal_NN ,_, during_IN which_WDT Clinton_NNP said_VBD she_PRP “_`` never_RB received_VBD nor_CC sent_VBD any_DT material_NN that_WDT was_VBD marked_VBN classified_VBN ”_'' on_IN her_PRP$ private_JJ email_NN server_NN as_IN Secretary_NNP of_IN State_NNP —_: a_DT claim_NN that_IN Politifact_NNP characterized_VBD as_IN false_JJ ._. During_IN the_DT 2016_CD presidential_JJ election_NN ,_, Politifact_NNP also_RB found_VBD that_IN 84_CD percent_NN of_IN claims_NNS Ben_NNP Carson_NNP ,_, now_RB Secretary_NNP of_IN the_DT Department_NNP of_IN Housing_NNP and_CC Urban_NNP Development_NNP ,_, made_VBN since_IN 2007_CD were_VBD false_JJ ,_, including_VBG his_PRP$ assertion_NN that_IN there_EX are_VBP a_DT “_`` multitude_NN ”_'' of_IN unnecessary_JJ vaccines_NNS available_JJ to_IN the_DT public_NN ._. Texas_NNP Senator_NNP Ted_NNP Cruz_NNP told_VBD lies_NNS about_RB 66_CD percent_NN of_IN the_DT time_NN in_IN that_DT time_NN frame_NN ,_, including_VBG that_IN “_`` the_DT federal_JJ government_NN is_VBZ going_VBG after_IN school_NN districts_NNS ,_, trying_VBG to_TO force_VB them_PRP to_TO let_VB boys_NNS shower_VB with_IN little_JJ girls_NNS ._. ”_'' Blurring_VBG the_DT lines_NNS between_IN fact_NN and_CC fiction_NN even_RB more_RBR ,_, Trump_NNP has_VBZ popularized_VBN the_DT term_NN fake_JJ news_NN —_: not_RB to_TO call_VB out_RP actual_JJ fake_JJ news_NN but_CC to_TO discredit_VB anyone_NN or_CC anything_NN perceived_VBN as_IN unflattering_JJ to_IN him_PRP ._. That_DT strategy_NN has_VBZ been_VBN incredibly_RB effective_JJ ,_, and_CC he_PRP has_VBZ succeeded_VBN in_IN creating_VBG an_DT environment_NN in_IN which_WDT the_DT truth_NN is_VBZ difficult_JJ to_TO discern_VB ._. Many_JJ argue_VBP that_IN the_DT media_NN simply_RB can’t_MD tolerate_VB this_DT level_NN of_IN misinformation_NN anymore_RB ._. Even_RB journalists_NNS are_VBP starting_VBG to_TO call_VB one_CD another_DT out_RP ._. In_IN January_NNP ,_, Esquire_NNP published_VBD an_DT op_NN -ed_NN by_IN journalist_NN Dan_NNP Sinker_NNP called_VBD “_`` In_IN 2019_CD ,_, The_DT Media_NN Has_VBZ to_TO Do_VB Better_JJR in_IN Calling_VBG Out_IN Trump_NNP ’s_POS Sh*t_NN [_-LRB- edited_VBN ]_-RRB- ._. ”_'' Sinker_NNP noted_VBD that_IN journalists_NNS do_VBP n’t_RB use_VB words_NNS like_IN lie_NN and_CC liar_NN because_IN they_PRP ’re_VBP supposed_VBN to_TO maintain_VB a_DT level_NN of_IN objectivity_NN ._. Nonetheless_RB ,_, he_PRP added_VBD :_: Of_IN course_NN ,_, being_VBG objective_JJ does_VBZ n’t_RB mean_VB letting_VBG liars_NNS lie_VBP ._. “_`` Balance_NN ”_'' is_VBZ n’t_RB setting_VBG two_CD pundits_NNS up_RB to_TO argue_VB over_IN what_WP everyone_NN knows_VBZ is_VBZ a_DT false_JJ statement_NN ._. There_EX ’s_VBZ no_DT bias_NN in_IN saying_VBG something_NN is_VBZ patently_RB untrue_JJ if_IN it_PRP is_VBZ ,_, in_IN fact_NN ,_, patently_RB untrue_JJ ._. In_IN fact_NN ,_, saying_VBG things_NNS are_VBP n’t_RB true_JJ from_IN jump_NN is_VBZ kinda_RB the_DT most_RBS important_JJ part_NN of_IN the_DT job_NN ._. Some_DT major_JJ news_NN organizations_NNS have_VBP indeed_RB been_VBN using_VBG the_DT word_NN liar_NN in_IN content_NN ._. In_IN August_NNP 2018_CD ,_, The_DT New_NNP Yorker_NNP ran_VBD the_DT headline_NN “_`` It_PRP ’s_VBZ True_JJ :_: Trump_NNP Is_VBZ Lying_VBG More_JJR &_CC He_PRP ’s_VBZ Doing_VBG It_PRP On_IN Purpose_NN ._. ”_'' In_IN October_NNP ,_, CNN_NNP published_VBD “_`` Donald_NNP Trump_NNP Lies_NNPS And_CC He_PRP ’s_VBZ Doing_VBG A_DT Lot_NN More_JJR of_IN It_PRP Lately_RB ._. ”_'' The_DT Atlantic_NNP joined_VBD the_DT call_NN -_HYPH out_RP in_IN November_NNP 2018_CD with_IN a_DT piece_NN simply_RB titled_VBN :_: “_`` The_DT President_NNP ’s_POS Lies_NNS ._. ”_'' In_IN the_DT era_NN of_IN fake_JJ news_NN ,_, publications_NNS have_VBP to_TO contend_VB with_IN the_DT fact_NN that_IN any_DT escalation_NN on_IN their_PRP$ part_NN (_-LRB- i.e._FW ,_, calling_VBG someone_NN a_DT liar_NN )_-RRB- ,_, also_RB comes_VBZ with_IN an_DT escalation_NN in_IN the_DT intense_JJ scrutiny_NN the_DT media_NN is_VBZ already_RB facing_VBG ._. The_DT media_NN has_VBZ the_DT unique_JJ ability_NN to_TO speak_VB truth_NN to_IN power_NN ,_, and_CC that_DT includes_VBZ calling_VBG out_RP politicians_NNS and_CC not_RB allowing_VBG them_PRP to_TO get_VB away_RB with_IN lies_NNS ._. There_EX may_MD be_VB disagreement_NN on_IN where_WRB the_DT liar_NN line_NN should_MD be_VB ,_, but_CC that_DT does_VBZ n’t_RB change_VB the_DT fact_NN that_IN we_PRP need_VBP to_TO draw_VB one_CD —_: even_RB if_IN intent_NN is_VBZ tricky_JJ to_TO determine_VB ._. Ashley_NNP Austrew_NNP is_VBZ a_DT freelance_JJ writer_NN from_IN Omaha_NNP ,_, Nebraska_NNP ._. Her_PRP$ work_NN has_VBZ been_VBN published_VBN at_IN Cosmopolitan_NNP ,_, Scary_NNP Mommy_NNP ,_, Scholastic_NNP ,_, and_CC other_JJ outlets_NNS ._. For_IN more_JJR by_IN Ashley_NNP ,_, read_VB :_: “_`` Why_WRB Ca_MD n’t_RB Women_NNS Swear_VB ?_. ”_'' |_NFP “_`` Is_VBZ It_PRP Time_NN For_IN All_DT Couples_NNS To_TO Use_VB The_DT Term_NN “_`` Partner_NN ”_'' ?_. |_NFP “_'' Is_VBZ “_`` Crude_JJ ”_'' The_DT Right_JJ Word_NN To_TO Use_VB To_TO Describe_VB Someone_NN ’s_POS Language_NN ?_. ”_'' |_NFP “_`` What_WP Does_VBZ It_PRP Mean_VB To_TO Be_VB Electable_JJ ?_. ”_'' |_NFP “_`` Has_VBZ The_DT Word_NNP ‘_`` Expert_NN ’_'' Lost_VBN Its_PRP$ Meaning_NN In_IN 2019_CD ?_. ”_'' |_NFP “_`` Does_VBZ ‘_`` Spark_VB Joy_NNP ’_'' Mean_VB The_DT Same_JJ Thing_NN In_IN English_NNP And_CC Japanese_JJ ?_. ”_'' |_NFP Is_VBZ There_EX A_DT Difference_NN Between_IN “_`` Calling_VBG In_IN ”_'' And_CC “_`` Calling_VBG Out_RP ”_'' ?_.","by NNP NNPS VBP RB RB VBN for VBG JJ . NNP NNP VBD the NNP NN . NNP NNP NNP VBD about his NN with NNP NNP . And , in the JJ two NNS NNP NNP VBD NN , the NNP NNP VBD he VBZ VBN RB 8,000 “ JJ or JJ NNS ” to the JJ NN . RB , it VBZ JJ to VB a NN VBG any NN or NN a NN . Why VBZ that ? RB of all , what VBZ it VB to VB ? The NN and NN VBP VBP RB VBN in NNP NNP by the NNS . To VB VBZ “ to VB RB or JJ NN RB , as with NN to VB . ” RBR RB , to VB VBZ “ to VB what VBZ JJ , VB a JJ NN . ” RB , when a NN VBZ , they VBP RB RB VBG JJ NN , they VBP VBG it with the JJ NN of VBG NNS to VB VBG NN . If NN VBZ this RB , RB we would VB them a NN , “ a NN who VBZ NNS . ” This NN VBZ RB VBN to in the NNS . Why VBP RB NNS VB the NN NN ? The JJ NN why JJ NNS VBP NNS of NN VBZ because it VBZ JJ to VB one JJ NN in that NN above : NN . If a NN VBZ “ a JJ NN that VBZ VBN with JJ NN to VB , ” RB VBG NN a NN VBZ you VBP they VBP RB VBG to VB NNS . While JJ of us VBP that NN about NNS , it VBZ JJ when you VBP a NN of the NN VBN with VBG the NN — RB your JJ NNS about it . NNP NNP , a NN of NN and NN NNS at NNP NNP and a VBG NN at NNP , VBD in 2017 that the NN VBG the NN a NN would VB a JJ NN . That VBZ RB to VB that it should RB VB VBN . JJ to the NNP NN , as NNP VBD , a NNP NNP NNP NN VBD NNP JJ of “ an JJ , NN - JJ NN to VB , VB and VB NN ” and “ VB the NN . ” RB , it VBD RB until the NNP NN VBD and NNS VBD NNP ’s NN that the NN VBD the NN a NN . If the NN VBZ to VB their NN , NNP VBD , they VBP JJ to VB RB from VBG NNP NNP , or NN JJ , a NN . “ Though it may VB VBN to VB NNS like ‘ NN ’ and ‘ NN , ’ in the JJ NN the NN will VB JJR NN if it VBZ VBG JJR than it can RB VB to VB JJ , ” he VBD . Should NNS VB NN RB ? On NNP 21 , 2019 , the NNP NNP VBD that , in the JJ two NNS of his NN RB , NNP VBD 8,158 JJ NNS about the NN , NN , NN , JJ NN , and JJ NNS . In RB one NN in NNP 2019 , NNP RB VBD NNP NNP , a NN with JJ NN in NNP , as a NN of the NN in a NN about him VBG NN NN “ JJ NN . ” NNP VBD JJ to VB NNP on the NN that NNP VBD RB a NN , but that VBD RB VB the NN that JJ NNS VBD VBN to the NN and may VB VBN the NN ’s NNS as JJ . Since the 2016 NNP JJ NN , NNS VBP VBN RB JJ with the NN ’s NN of JJ NNS who VBP , with JJ JJ that we VBP in a NN - NN NN where NNS VBP VBN JJ . And , it VBZ RB RB NNP . That NN VBD us the NNP NNP NN NN , during which NNP VBD she “ RB VBD nor VBD any NN that VBD VBN VBN ” on her JJ NN NN as NNP of NNP — a NN that NNP VBD as JJ . During the 2016 JJ NN , NNP RB VBD that 84 NN of NNS NNP NNP , RB NNP of the NNP of NNP and NNP NNP , VBN since 2007 VBD JJ , VBG his NN that there VBP a “ NN ” of JJ NNS JJ to the NN . NNP NNP NNP NNP VBD NNS RB 66 NN of the NN in that NN NN , VBG that “ the JJ NN VBZ VBG after NN NNS , VBG to VB them to VB NNS VB with JJ NNS . ” VBG the NNS between NN and NN RB RBR , NNP VBZ VBN the NN JJ NN — RB to VB out JJ JJ NN but to VB NN or NN VBN as JJ to him . That NN VBZ VBN RB JJ , and he VBZ VBN in VBG an NN in which the NN VBZ JJ to VB . JJ VBP that the NN RB can’t VB this NN of NN RB . RB NNS VBP VBG to VB one another out . In NNP , NNP VBD an NN NN by NN NNP NNP VBD “ In 2019 , The NN VBZ to VB JJR in VBG Out NNP ’s NN [ VBN ] . ” NNP VBD that NNS VBP RB VB NNS like NN and NN because they VBP VBN to VB a NN of NN . RB , he VBD : Of NN , VBG JJ VBZ RB VB VBG NNS VBP . “ NN ” VBZ RB VBG two NNS RB to VB over what NN VBZ VBZ a JJ NN . There VBZ no NN in VBG NN VBZ RB JJ if it VBZ , in NN , RB JJ . In NN , VBG NNS VBP RB JJ from NN VBZ RB the RBS JJ NN of the NN . Some JJ NN NNS VBP RB VBN VBG the NN NN in NN . In NNP 2018 , The NNP NNP VBD the NN “ It VBZ JJ : NNP VBZ VBG JJR & He VBZ VBG It On NN . ” In NNP , NNP VBD “ NNP NNP NNPS And He VBZ VBG A NN JJR of It RB . ” The NNP VBD the NN - out in NNP 2018 with a NN RB VBN : “ The NNP ’s NNS . ” In the NN of JJ NN , NNS VBP to VB with the NN that any NN on their NN ( FW , VBG NN a NN ) , RB VBZ with an NN in the JJ NN the NN VBZ RB VBG . The NN VBZ the JJ NN to VB NN to NN , and that VBZ VBG out NNS and RB VBG them to VB RB with NNS . There may VB NN on where the NN NN should VB , but that VBZ RB VB the NN that we VBP to VB one — RB if NN VBZ JJ to VB . NNP NNP VBZ a JJ NN from NNP , NNP . Her NN VBZ VBN VBN at NNP , NNP NNP , NNP , and JJ NNS . For JJR by NNP , VB : “ Why Ca RB NNS VB ? ” | “ VBZ It NN For All NNS To VB The NN “ NN ” ? | “ VBZ “ JJ ” The JJ NN To VB To VB NN ’s NN ? ” | “ What VBZ It VB To VB JJ ? ” | “ VBZ The NNP ‘ NN ’ VBN Its NN In 2019 ? ” | “ VBZ ‘ VB NNP ’ VB The JJ NN In NNP And JJ ? ” | VBZ There A NN Between “ VBG In ” And “ VBG Out ” ?"
8,948,mainstream,M0bcbf,vaccine.autism,"It_PRP 's_VBZ midday_NN at_IN a_DT busy_JJ pediatrician_NN 's_POS surgery_NN in_IN Karlsruhe_NNP ,_, a_DT mid-sized_JJ town_NN in_IN the_DT southwest_JJ German_JJ state_NN of_IN Baden_NNP -_HYPH Württemberg_NNP ._. A_DT mother_NN carries_VBZ her_PRP$ sleeping_NN child_NN into_IN the_DT waiting_NN room_NN ,_, while_IN a_DT sick_JJ baby_NN screams_VBZ so_RB loudly_RB that_IN the_DT receptionist_NN has_VBZ difficulty_NN making_VBG herself_PRP understood_VBN on_IN the_DT phone_NN ._. Over_IN in_IN a_DT corner_NN ,_, an_DT assistant_NN is_VBZ preparing_VBG a_DT combined_VBN measles_NNS ,_, mumps_NNS ,_, rubella_NN and_CC chickenpox_NN vaccination_NN for_IN the_DT next_JJ patient_NN ._. She_PRP carefully_RB puts_VBZ a_DT needle_NN and_CC a_DT syringe_NN on_IN a_DT tray_NN together_RB some_DT medical_JJ swabs_NNS ,_, and_CC then_RB removes_VBZ the_DT vaccine_NN from_IN the_DT fridge_NN ._. It_PRP still_RB needs_VBZ to_TO be_VB drawn_VBN and_CC diluted_VBN before_IN being_VBG injected_VBN ._. The_DT World_NNP Health_NNP Organization_NNP recommends_VBZ that_IN all_DT children_NNS have_VBP two_CD doses_NNS of_IN the_DT vaccine_NN to_TO ensure_VB immunity_NN from_IN measles_NNS ._. ""_`` All_DT of_IN my_PRP$ children_NNS have_VBP been_VBN vaccinated_VBN against_IN measles_NNS ,_, ""_'' says_VBZ Dr_NNP Dieter_NNP Knöbl_NNP from_IN behind_IN his_PRP$ desk_NN ._. Dr_NNP Knöbl_NNP ,_, one_CD of_IN three_CD pediatricians_NNS who_WP work_VBP here_RB ,_, has_VBZ been_VBN treating_VBG children_NNS in_IN this_DT surgery_NN for_IN 20_CD years_NNS ._. Before_IN that_IN he_PRP spent_VBD 14_CD years_NNS on_IN the_DT pediatric_JJ ward_NN of_IN the_DT Karlsruhe_NNP public_JJ hospital_NN ._. He_PRP says_VBZ he_PRP 's_VBZ seen_VBN so_RB ""_`` many_JJ children_NNS suffering_VBG from_IN measles_NNS and_CC many_JJ from_IN measles_NNS complications_NNS ""_'' that_WDT he_PRP always_RB advises_VBZ parents_NNS to_TO vaccinate_VB ._. The_DT measles_NNS complications_NNS Dr_NNP Knöbl_NNP is_VBZ talking_VBG about_IN include_VBP middle_JJ ear_NN infections_NNS ,_, pneumonia_NN and_CC measles_NNS encephalitis_NN ._. The_DT latter_NN is_VBZ an_DT inflammation_NN of_IN the_DT brain_NN ,_, which_WDT can_MD cause_VB permanent_JJ brain_NN damage_NN and_CC even_RB death_NN ._. Another_DT complication_NN is_VBZ the_DT quite_RB rare_JJ but_CC fatal_JJ disease_NN with_IN the_DT unwieldy_JJ name_NN of_IN subacute_JJ sclerosing_NN panencephalitis_NN (_-LRB- SSPE_NNP )_-RRB- ._. With_IN SSPE_NNP ,_, the_DT virus_NN slowly_RB attacks_VBZ the_DT central_JJ nervous_JJ system_NN ._. ""_`` It_PRP 's_VBZ as_IN if_IN the_DT children_NNS have_VBP Alzheimer_NNP 's_POS even_RB though_IN they_PRP are_VBP young_JJ ,_, ""_'' Knöbl_NNP says_VBZ ._. ""_`` As_IN the_DT disease_NN progresses_VBZ the_DT infected_VBN children_NNS physically_RB and_CC mentally_RB deteriorate_VB ._. They_PRP can't_MD speak_VB ,_, they_PRP are_VBP paralyzed_VBN and_CC at_IN the_DT end_NN ,_, they_PRP just_RB lie_VBP there_RB and_CC gasp_VBP for_IN air_NN ._. It_PRP is_VBZ a_DT wretched_VBN death_NN ._. ""_'' During_IN his_PRP$ time_NN working_VBG at_IN the_DT hospital_NN ,_, Dr_NNP Knöbl_NNP experienced_VBD three_CD children_NNS dying_VBG of_IN SSPE_NN and_CC one_CD of_IN pneumonia_NN ._. Measles_NN complications_NNS are_VBP more_RBR common_JJ than_IN many_JJ people_NNS think_VBP ._. Of_IN the_DT nearly_RB three_CD hundred_CD people_NNS who_WP caught_VBD measles_NNS in_IN an_DT outbreak_NN in_IN Berlin_NNP in_IN 2013_CD ,_, more_JJR than_IN a_DT hundred_CD ended_VBD up_RP in_IN hospital_NN -_, that_DT 's_VBZ a_DT hospitalization_NN rate_NN of_IN more_JJR than_IN 30_CD percent_NN ._. On_IN average_NN ,_, one_CD in_IN a_DT thousand_CD measles_NNS patients_NNS will_MD develop_VB encephalitis_NN ._. In_IN western_JJ countries_NNS ,_, about_RB one_CD in_IN three_CD thousand_CD people_NNS infected_VBN with_IN measles_NNS will_MD die_VB (_-LRB- the_DT figure_NN is_VBZ much_RB higher_JJR in_IN developing_VBG countries_NNS ,_, where_WRB added_VBN factors_NNS ,_, such_JJ as_IN malnutrition_NN ,_, can_MD result_VB in_IN measles_NNS fatality_NN rates_NNS of_IN up_IN to_IN 30_CD percent_NN )_-RRB- ._. To_TO make_VB matters_NNS worse_JJR ,_, measles_NNS is_VBZ one_CD of_IN the_DT most_RBS contagious_JJ diseases_NNS on_IN the_DT planet_NN ._. But_CC many_JJ refuse_VBP to_TO vaccinate_VB Despite_IN the_DT risks_NNS ,_, there_EX are_VBP many_JJ parents_NNS who_WP refuse_VBP to_TO have_VB their_PRP$ children_NNS vaccinated_VBN ._. Some_DT doctor_NN 's_POS surgeries_NNS in_IN Germany_NNP refuse_VBP to_TO take_VB on_IN children_NNS who_WP have_VBP n't_RB had_VBN all_PDT their_PRP$ jabs_NNS ,_, saying_VBG it_PRP 's_VBZ the_DT only_JJ way_NN to_TO protect_VB their_PRP$ other_JJ patients_NNS ._. ""_`` That_DT is_VBZ n't_RB our_PRP$ philosophy_NN ,_, ""_'' says_VBZ Dr_NNP Knöbl_NNP ._. He_PRP and_CC his_PRP$ colleagues_NNS believe_VBP that_IN by_IN turning_VBG away_RB unvaccinated_JJ children_NNS the_DT parents_NNS may_MD deliberately_RB seek_VB out_RP doctors_NNS who_WP share_VBP their_PRP$ opposition_NN to_IN vaccination_NN ._. By_IN keeping_VBG the_DT parents_NNS coming_VBG to_IN his_PRP$ surgery_NN ,_, he_PRP hopes_VBZ there_EX is_VBZ a_DT chance_NN the_DT doctors_NNS can_MD win_VB them_PRP over_RP ._. ""_`` In_IN our_PRP$ experience_NN ,_, the_DT younger_JJR the_DT child_NN ,_, the_DT more_RBR worried_JJ the_DT parents_NNS are_VBP about_IN vaccinating_VBG ,_, ""_'' Dr_NNP Knöbl_NNP says_VBZ ._. ""_`` But_CC if_IN you_PRP accept_VBP their_PRP$ fears_NNS and_CC give_VBP them_PRP a_DT bit_NN of_IN time_NN ,_, most_JJS of_IN them_PRP change_VBP their_PRP$ mind_NN ._. ""_'' In_IN 1998_CD ,_, the_DT British_JJ medical_JJ doctor_NN Andrew_NNP Wakefield_NNP alleged_VBD the_DT MMR_NNP (_-LRB- measles_NNS ,_, mumps_NNS ,_, rubella_NN )_-RRB- vaccine_NN caused_VBD autism_NN ._. Although_IN Wakefield_NNP 's_POS study_NN has_VBZ since_RB been_VBN discredited_VBN and_CC withdrawn_VBN -_, and_CC Wakefield_NNP has_VBZ been_VBN struck_VBN off_RP as_IN a_DT British_JJ medical_JJ practitioner_NN -_HYPH rumors_NNS of_IN the_DT link_NN continue_VBP to_TO abound_VB ._. In_IN addition_NN ,_, there_EX are_VBP parents_NNS who_WP are_VBP unwilling_JJ to_TO risk_VB their_PRP$ children_NNS getting_VBG encephalitis_NN ,_, which_WDT is_VBZ a_DT rare_JJ side_NN -_HYPH effect_NN of_IN the_DT vaccine_NN ._. At_IN around_RB a_DT chance_NN of_IN one_CD -_HYPH in_IN -_HYPH a_DT -_HYPH million_CD ,_, the_DT risk_NN is_VBZ considerably_RB less_JJR than_IN the_DT one_CD -_HYPH in_IN -_HYPH a_DT -_HYPH thousand_CD chance_NN of_IN developing_VBG encephalitis_NN from_IN measles_NNS itself_PRP ._. But_CC add_VB these_DT fears_NNS to_IN the_DT general_JJ public_JJ distrust_NN of_IN doctors_NNS ,_, medicines_NNS and_CC pharmaceutical_JJ companies_NNS -_, which_WDT is_VBZ more_RBR pronounced_VBN in_IN the_DT southern_JJ German_JJ states_NNS of_IN Baden_NNP -_HYPH Württemberg_NNP and_CC Bavaria_NNP -_, together_RB with_IN those_DT who_WP simply_RB forget_VBP to_TO bring_VB their_PRP$ child_NN for_IN a_DT follow_NN -_HYPH up_NN jab_NN and_CC you_PRP have_VBP a_DT significant_JJ number_NN of_IN children_NNS who_WP are_VBP n't_RB immunized_VBN ._. In_IN Germany_NNP ,_, the_DT measles_NNS immunization_NN rate_NN is_VBZ 92_CD percent_NN -_, in_IN Baden_NNP -_HYPH Württemberg_NNP it_PRP 's_VBZ even_RB lower_JJR at_IN 89_CD percent_NN ._. This_DT might_MD sound_VB like_IN a_DT lot_NN ,_, but_CC it_PRP is_VBZ well_RB below_IN the_DT 95_CD percent_NN goal_NN set_VBN by_IN Germany_NNP and_CC other_JJ European_JJ nations_NNS to_TO eradicate_VB the_DT disease_NN by_IN 2015_CD ._. In_IN 2013_CD ,_, the_DT then_RB German_JJ health_NN minister_NN Daniel_NNP Bahr_NNP raised_VBD the_DT idea_NN of_IN mandatory_JJ vaccination_NN as_IN a_DT way_NN of_IN increasing_VBG the_DT measles_NNS vaccination_NN rate_NN ._. But_CC Dr_NNP Günter_NNP Pfaff_NNP ,_, the_DT chief_JJ epidemiologist_NN at_IN the_DT Baden_NNP -_HYPH Württemberg_NNP State_NNP Health_NNP Authority_NNP is_VBZ n't_RB convinced_VBN that_IN such_JJ measures_NNS would_MD work_VB in_IN Germany_NNP ._. ""_`` We_PRP probably_RB would_MD have_VB to_TO use_VB more_JJR energy_NN to_TO fight_VB against_IN opposition_NN to_IN mandatory_JJ vaccination_NN than_IN we_PRP could_MD use_VB to_TO convince_VB people_NNS that_IN vaccination_NN is_VBZ good_JJ ,_, and_CC that_IN it_PRP would_MD be_VB a_DT benefit_NN for_IN their_PRP$ children_NNS ,_, ""_'' he_PRP says_VBZ from_IN his_PRP$ office_NN in_IN Stuttgart_NNP ._. For_IN Pfaff_NNP ,_, defeating_VBG measles_NNS in_IN Germany_NNP is_VBZ about_IN minutely_RB analyzing_VBG the_DT data_NNS ._. He_PRP turns_VBZ around_IN a_DT giant_JJ whiteboard_NN covered_VBN with_IN a_DT map_NN of_IN the_DT state_NN ._. It_PRP shows_VBZ the_DT measles_NNS vaccination_NN rate_NN for_IN every_DT health_NN district_NN ._. Some_DT are_VBP dark_JJ blue_JJ -_, that_DT 's_VBZ good_JJ because_IN it_PRP means_VBZ the_DT vaccination_NN rate_NN is_VBZ more_JJR than_IN 95_CD percent_NN ._. Others_NNS are_VBP light_JJ blue_JJ -_, which_WDT is_VBZ n't_RB so_RB good_JJ ._. ""_`` You_PRP can_MD see_VB there_EX are_VBP a_DT few_JJ communities_NNS ,_, where_WRB there_EX is_VBZ quite_PDT a_DT stark_JJ contrast_NN between_IN [_-LRB- them_PRP and_CC ]_-RRB- neighboring_VBG communities_NNS ,_, and_CC there_EX is_VBZ hardly_RB another_DT way_NN of_IN explaining_VBG this_DT than_IN that_IN the_DT practice_NN of_IN provision_NN of_IN medical_JJ services_NNS varies_VBZ from_IN town_NN to_IN town_NN ,_, ""_'' he_PRP says_VBZ ._. One_CD approach_NN the_DT state_NN health_NN authority_NN (_-LRB- Landesgesundheitsamt_NNP Baden_NNP -_HYPH Württemberg_NNP )_-RRB- is_VBZ looking_VBG into_IN is_VBZ directly_RB approaching_VBG doctors_NNS in_IN villages_NNS and_CC towns_NNS with_IN low_JJ vaccination_NN rates_NNS ._. It_PRP is_VBZ something_NN Dr_NNP Pfaff_NNP has_VBZ tried_VBN in_IN a_DT few_JJ cases_NNS ._. ""_`` What_WP we_PRP [_-LRB- want_VB to_TO do_VB ]_-RRB- is_VBZ ask_VB the_DT doctors_NNS '_'' did_VBD you_PRP notice_VB that_IN in_IN your_PRP$ town_NN vaccinations_NNS are_VBP much_RB lower_JJR than_IN in_IN the_DT neighboring_VBG village_NN ?_. And_CC how_WRB come_VBP ?_. We_PRP would_MD like_VB to_TO draw_VB your_PRP$ attention_NN to_IN this_DT and_CC we_PRP would_MD like_VB to_TO talk_VB to_IN you_PRP about_IN it_PRP ,_, '_'' ""_'' he_PRP says_VBZ ._. Another_DT approach_NN they_PRP have_VBP been_VBN using_VBG is_VBZ publishing_VBG the_DT measles_NNS vaccination_NN rates_NNS for_IN villages_NNS and_CC districts_NNS in_IN community_NN newsletters_NNS along_IN with_IN comparisons_NNS to_IN neighboring_VBG places_NNS ._. This_DT kind_NN of_IN specific_JJ ,_, local_JJ information_NN has_VBZ been_VBN found_VBN to_TO help_VB more_JJR than_IN public_JJ information_NN campaigns_NNS on_IN a_DT national_JJ level_NN or_CC in_IN mainstream_JJ ,_, national_JJ media_NN ._. Whatever_WDT the_DT approach_NN ,_, it_PRP is_VBZ possible_JJ to_TO eradicate_VB measles_NNS ._. The_DT Americas_NNPS -_, both_CC north_NN and_CC south_NN -_HYPH succeeded_VBD in_IN 2002_CD ._. But_CC Germany_NNP -_, one_CD of_IN Europe_NNP 's_POS most_RBS advanced_JJ countries_NNS -_, still_RB has_VBZ a_DT long_JJ way_NN to_TO go_VB ._.","It VBZ NN at a JJ NN 's NN in NNP , a JJ NN in the JJ JJ NN of NNP - NNP . A NN VBZ her NN NN into the NN NN , while a JJ NN VBZ RB RB that the NN VBZ NN VBG herself VBN on the NN . Over in a NN , an NN VBZ VBG a VBN NNS , NNS , NN and NN NN for the JJ NN . She RB VBZ a NN and a NN on a NN RB some JJ NNS , and RB VBZ the NN from the NN . It RB VBZ to VB VBN and VBN before VBG VBN . The NNP NNP NNP VBZ that all NNS VBP two NNS of the NN to VB NN from NNS . "" All of my NNS VBP VBN VBN against NNS , "" VBZ NNP NNP NNP from behind his NN . NNP NNP , one of three NNS who VBP RB , VBZ VBN VBG NNS in this NN for 20 NNS . Before that he VBD 14 NNS on the JJ NN of the NNP JJ NN . He VBZ he VBZ VBN RB "" JJ NNS VBG from NNS and JJ from NNS NNS "" that he RB VBZ NNS to VB . The NNS NNS NNP NNP VBZ VBG about VBP JJ NN NNS , NN and NNS NN . The NN VBZ an NN of the NN , which can VB JJ NN NN and RB NN . Another NN VBZ the RB JJ but JJ NN with the JJ NN of JJ NN NN ( NNP ) . With NNP , the NN RB VBZ the JJ JJ NN . "" It VBZ as if the NNS VBP NNP 's RB though they VBP JJ , "" NNP VBZ . "" As the NN VBZ the VBN NNS RB and RB VB . They can't VB , they VBP VBN and at the NN , they RB VBP RB and VBP for NN . It VBZ a VBN NN . "" During his NN VBG at the NN , NNP NNP VBD three NNS VBG of NN and one of NN . NN NNS VBP RBR JJ than JJ NNS VBP . Of the RB three hundred NNS who VBD NNS in an NN in NNP in 2013 , JJR than a hundred VBD up in NN - that VBZ a NN NN of JJR than 30 NN . On NN , one in a thousand NNS NNS will VB NN . In JJ NNS , RB one in three thousand NNS VBN with NNS will VB ( the NN VBZ RB JJR in VBG NNS , where VBN NNS , JJ as NN , can VB in NNS NN NNS of up to 30 NN ) . To VB NNS JJR , NNS VBZ one of the RBS JJ NNS on the NN . But JJ VBP to VB Despite the NNS , there VBP JJ NNS who VBP to VB their NNS VBN . Some NN 's NNS in NNP VBP to VB on NNS who VBP RB VBN all their NNS , VBG it VBZ the JJ NN to VB their JJ NNS . "" That VBZ RB our NN , "" VBZ NNP NNP . He and his NNS VBP that by VBG RB JJ NNS the NNS may RB VB out NNS who VBP their NN to NN . By VBG the NNS VBG to his NN , he VBZ there VBZ a NN the NNS can VB them over . "" In our NN , the JJR the NN , the RBR JJ the NNS VBP about VBG , "" NNP NNP VBZ . "" But if you VBP their NNS and VBP them a NN of NN , JJS of them VBP their NN . "" In 1998 , the JJ JJ NN NNP NNP VBD the NNP ( NNS , NNS , NN ) NN VBD NN . Although NNP 's NN VBZ RB VBN VBN and VBN - and NNP VBZ VBN VBN off as a JJ JJ NN - NNS of the NN VBP to VB . In NN , there VBP NNS who VBP JJ to VB their NNS VBG NN , which VBZ a JJ NN - NN of the NN . At RB a NN of one - in - a - million , the NN VBZ RB JJR than the one - in - a - thousand NN of VBG NN from NNS itself . But VB these NNS to the JJ JJ NN of NNS , NNS and JJ NNS - which VBZ RBR VBN in the JJ JJ NNS of NNP - NNP and NNP - RB with those who RB VBP to VB their NN for a NN - NN NN and you VBP a JJ NN of NNS who VBP RB VBN . In NNP , the NNS NN NN VBZ 92 NN - in NNP - NNP it VBZ RB JJR at 89 NN . This might VB like a NN , but it VBZ RB below the 95 NN NN VBN by NNP and JJ JJ NNS to VB the NN by 2015 . In 2013 , the RB JJ NN NN NNP NNP VBD the NN of JJ NN as a NN of VBG the NNS NN NN . But NNP NNP NNP , the JJ NN at the NNP - NNP NNP NNP NNP VBZ RB VBN that JJ NNS would VB in NNP . "" We RB would VB to VB JJR NN to VB against NN to JJ NN than we could VB to VB NNS that NN VBZ JJ , and that it would VB a NN for their NNS , "" he VBZ from his NN in NNP . For NNP , VBG NNS in NNP VBZ about RB VBG the NNS . He VBZ around a JJ NN VBN with a NN of the NN . It VBZ the NNS NN NN for every NN NN . Some VBP JJ JJ - that VBZ JJ because it VBZ the NN NN VBZ JJR than 95 NN . NNS VBP JJ JJ - which VBZ RB RB JJ . "" You can VB there VBP a JJ NNS , where there VBZ quite a JJ NN between [ them and ] VBG NNS , and there VBZ RB another NN of VBG this than that the NN of NN of JJ NNS VBZ from NN to NN , "" he VBZ . One NN the NN NN NN ( NNP NNP - NNP ) VBZ VBG into VBZ RB VBG NNS in NNS and NNS with JJ NN NNS . It VBZ NN NNP NNP VBZ VBN in a JJ NNS . "" What we [ VB to VB ] VBZ VB the NNS ' VBD you VB that in your NN NNS VBP RB JJR than in the VBG NN ? And how VBP ? We would VB to VB your NN to this and we would VB to VB to you about it , ' "" he VBZ . Another NN they VBP VBN VBG VBZ VBG the NNS NN NNS for NNS and NNS in NN NNS along with NNS to VBG NNS . This NN of JJ , JJ NN VBZ VBN VBN to VB JJR than JJ NN NNS on a JJ NN or in JJ , JJ NN . Whatever the NN , it VBZ JJ to VB NNS . The NNPS - both NN and NN - VBD in 2002 . But NNP - one of NNP 's RBS JJ NNS - RB VBZ a JJ NN to VB ."
9,941,mainstream,M0ba13,vaccine.autism,"Measles_NN ,_, also_RB called_VBN rubeola_NN ,_, is_VBZ a_DT viral_JJ infection_NN that_WDT 's_VBZ one_CD of_IN the_DT most_RBS contagious_JJ infectious_JJ diseases_NNS in_IN the_DT world_NN ._. The_DT disease_NN is_VBZ marked_VBN by_IN symptoms_NNS that_WDT are_VBP similar_JJ to_IN a_DT common_JJ cold_NN ,_, as_RB well_RB as_IN a_DT characteristic_JJ red_JJ rash_NN ._. Between_IN 2000_CD and_CC 2010_CD ,_, the_DT global_JJ incidence_NN of_IN measles_NNS decreased_VBN by_IN 66_CD %_NN and_CC the_DT mortality_NN caused_VBN by_IN the_DT disease_NN decreased_VBD 74_CD %_NN ,_, according_VBG to_IN a_DT report_NN published_VBN in_IN the_DT journal_NN The_DT Lancet_NNP ._. Less_JJR than_IN two_CD decades_NNS ago_RB ,_, measles_NNS was_VBD almost_RB wiped_VBN out_RP in_IN the_DT United_NNP States_NNPS ,_, thanks_NN to_IN vaccines_NNS ._. But_CC recently_RB ,_, the_DT virus_NN has_VBZ had_VBN a_DT resurgence_NN ._. Globally_RB ,_, the_DT number_NN of_IN cases_NNS has_VBZ jumped_VBN 30_CD %_NN due_IN to_IN vaccine_NN hesitancy_NN ._. More_JJR than_IN 760_CD cases_NNS of_IN measles_NNS were_VBD reported_VBN in_IN the_DT U.S._NNP between_IN Jan._NNP 1_CD and_CC May_NNP 3_CD ,_, 2019_CD ,_, according_VBG to_IN Dr._NNP Deepa_NNP Mukundan_NNP ,_, a_DT pediatric_JJ infectious_JJ diseases_NNS specialist_NN at_IN the_DT University_NNP of_IN Toledo_NNP Medical_NNP Center_NNP in_IN Ohio_NNP ._. This_DT is_VBZ up_RB from_IN 372_CD cases_NNS over_IN the_DT entire_JJ year_NN in_IN 2018_CD and_CC up_RB from_IN 120_CD cases_NNS over_IN the_DT entire_JJ year_NN in_IN 2017_CD ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ._. How_WRB contagious_JJ is_VBZ it_PRP ?_. Measles_NN is_VBZ caused_VBN by_IN Measles_NN morbillivirus_NN ,_, a_DT virus_NN in_IN the_DT paramyxoviridae_NN family_NN ._. According_VBG to_IN the_DT CDC_NNP ,_, the_DT measles_NNS virus_NN settles_VBZ in_IN the_DT nose_NN and_CC throat_NN mucus_NN of_IN an_DT infected_VBN person_NN ._. When_WRB a_DT person_NN infected_VBN with_IN the_DT virus_NN coughs_VBZ ,_, sneezes_NNS or_CC exhales_VBZ ,_, the_DT virus_NN becomes_VBZ airborne_JJ and_CC can_MD spread_VB to_IN other_JJ people_NNS ._. ""_`` The_DT virus_NN can_MD remain_VB in_IN the_DT air_NN for_IN significant_JJ periods_NNS of_IN time_NN ,_, ""_'' Mukundan_NNP told_VBD Live_NNP Science_NNP ._. ""_`` One_PRP can_MD get_VB the_DT measles_NNS just_RB by_IN being_VBG in_IN a_DT room_NN where_WRB a_DT person_NN with_IN measles_NNS has_VBZ been_VBN ,_, even_RB up_IN to_IN 2_CD hours_NNS after_IN that_DT person_NN has_VBZ left_VBN ._. ""_'' Indeed_RB ,_, the_DT virus_NN is_VBZ incredibly_RB contagious_JJ —_: 90_CD %_NN of_IN people_NNS who_WP are_VBP not_RB vaccinated_VBN against_IN measles_NNS will_MD become_VB infected_VBN if_IN they_PRP share_VBP space_NN with_IN someone_NN who_WP has_VBZ the_DT virus_NN ._. ""_`` Another_DT reason_NN that_IN it_PRP is_VBZ transmitted_VBN so_RB effectively_RB is_VBZ because_IN the_DT hallmark_NN of_IN measles_NNS ,_, the_DT rash_NN ,_, only_RB comes_VBZ several_JJ days_NNS after_IN someone_NN is_VBZ contagious_JJ ,_, ""_'' said_VBD Dr._NNP Jennifer_NNP Lighter_NNP ,_, a_DT pediatric_JJ infectious_JJ disease_NN specialist_NN at_IN New_NNP York_NNP University_NNP Langone_NNP Health_NNP ._. Therefore_RB ,_, infected_VBN individuals_NNS can_MD spread_VB the_DT virus_NN for_IN several_JJ days_NNS before_IN realizing_VBG they_PRP 're_VBP ill_JJ ._. The_DT contagious_JJ period_NN lasts_VBZ about_RB four_CD days_NNS before_RB and_CC four_CD days_NNS after_IN the_DT rash_NN appears_VBZ ._. A_DT person_NN with_IN measles_NNS is_VBZ likely_JJ to_TO infect_VB between_IN 5_CD and_CC 18_CD unvaccinated_JJ people_NNS ,_, according_VBG to_IN a_DT 2019_CD review_NN published_VBN in_IN the_DT journal_NN Emerging_NNP Infectious_NNP Diseases_NNPS ._. Most_JJS cases_NNS of_IN measles_NNS cause_VBP some_DT combination_NN of_IN cough_NN ,_, runny_JJ nose_NN ,_, red_JJ eyes_NNS ,_, high_JJ fever_NN and_CC tiny_JJ white_JJ to_IN bluish_JJ spots_NNS in_IN the_DT mouth_NN ,_, said_VBD Dr._NNP Aileen_NNP M._NNP Marty_NNP ,_, a_DT professor_NN of_IN infectious_JJ diseases_NNS at_IN Florida_NNP International_NNP University_NNP 's_POS Herbert_NNP Wertheim_NNP College_NNP of_IN Medicine_NNP in_IN Miami_NNP ._. As_IN the_DT infection_NN progresses_VBZ ,_, the_DT characteristic_JJ red_JJ rash_NN will_MD develop_VB ._. The_DT rash_NN typically_RB looks_VBZ like_IN large_JJ ,_, red_JJ ,_, flat_JJ splotches_NNS on_IN the_DT skin_NN ._. To_TO test_VB for_IN measles_NNS ,_, a_DT doctor_NN will_MD examine_VB the_DT patient_NN for_IN telltale_NN symptoms_NNS ,_, such_JJ as_IN spots_NNS inside_IN of_IN the_DT mouth_NN and_CC the_DT skin_NN rash_NN ._. If_IN the_DT doctor_NN has_VBZ any_DT doubt_NN ,_, they_PRP may_MD order_VB a_DT blood_NN test_NN to_TO confirm_VB infection_NN ,_, according_VBG to_IN the_DT Mayo_NNP Clinic_NNP ._. Almost_RB all_DT cases_NNS require_VBP treatment_NN by_IN a_DT doctor_NN ._. ""_`` This_DT is_VBZ a_DT disease_NN where_WRB complications_NNS are_VBP common_JJ —_: complications_NNS such_JJ as_IN ear_NN infection_NN (_-LRB- acute_JJ otitis_NN media_NN )_-RRB- ,_, diarrhea_NN and_CC dehydration_NN ,_, pneumonia_NN ,_, encephalitis_NN and_CC even_JJ death_NN ,_, ""_'' Marty_NNP told_VBD Live_NNP Science_NNP ._. ""_`` In_IN the_DT United_NNP States_NNPS ,_, one_CD to_IN three_CD of_IN every_DT 1,000_CD infected_VBN persons_NNS will_MD die_VB from_IN [_-LRB- measles_NNS ]_-RRB- complications_NNS —_: which_WDT is_VBZ better_JJR than_IN in_IN the_DT Third_NNP World_NNP ,_, where_WRB as_RB many_JJ as_IN two_CD to_IN 15_CD per_IN 100_CD infected_VBN persons_NNS die_VBP from_IN measles_NNS and_CC its_PRP$ complications_NNS ._. ""_'' Young_JJ children_NNS are_VBP much_RB more_RBR susceptible_JJ to_IN the_DT virus_NN ._. According_VBG to_IN the_DT Mayo_NNP Clinic_NNP ,_, measles_NNS kills_VBZ 100,000_CD people_NNS a_DT year_NN ,_, most_RBS under_IN the_DT age_NN of_IN 5_CD ._. Pregnant_JJ women_NNS and_CC those_DT with_IN a_DT compromised_VBN immune_JJ system_NN are_VBP also_RB at_IN risk_NN of_IN severe_JJ complications_NNS ._. There_EX is_VBZ no_DT specific_JJ drug_NN for_IN treating_VBG measles_NNS ._. Instead_RB ,_, doctors_NNS treat_VBP the_DT symptoms_NNS ._. ""_`` This_DT means_VBZ we_PRP provide_VBP /_, advise_VBP hydration_NN ,_, antipyretics_NNS (_-LRB- e.g._FW ,_, acetaminophen_NN )_-RRB- for_IN comfort_NN and_CC fever_NN control_NN ,_, airway_NN humidification_NN in_IN patients_NNS with_IN respiratory_JJ tract_NN involvement_NN ,_, ""_'' Marty_NNP said_VBD ._. Though_IN not_RB licensed_VBN in_IN the_DT United_NNP States_NNPS for_IN the_DT treatment_NN of_IN measles_NNS ,_, some_DT pediatricians_NNS have_VBP used_VBN Ribavirin_NNP ,_, an_DT antiviral_JJ medication_NN ,_, to_TO treat_VB severe_JJ pneumonia_NN caused_VBN by_IN measles_NNS ,_, Marty_NNP added_VBD ._. To_TO protect_VB those_DT who_WP have_VBP been_VBN exposed_VBN to_IN the_DT virus_NN but_CC have_VBP not_RB been_VBN vaccinated_VBN ,_, a_DT doctor_NN may_MD order_VB a_DT post_NN -_HYPH exposure_NN vaccination_NN ._. If_IN given_VBN within_IN 72_CD hours_NNS of_IN exposure_NN ,_, the_DT vaccination_NN may_MD prevent_VB the_DT measles_NNS ._. Even_RB if_IN it_PRP does_VBZ n't_RB prevent_VB the_DT disease_NN ,_, the_DT vaccinated_VBN patient_NN will_MD only_RB have_VB a_DT mild_JJ case_NN of_IN the_DT measles_NNS ,_, according_VBG to_IN the_DT Mayo_NNP Clinic_NNP ._. Another_DT way_NN to_TO protect_VB at_IN -_HYPH risk_NN individuals_NNS is_VBZ to_TO inject_VB them_PRP with_IN immune_JJ serum_NN globulin_NN (_-LRB- antibodies_NNS or_CC proteins_NNS derived_VBN from_IN the_DT blood_NN of_IN donors_NNS with_IN measles_NNS immunity_NN )_-RRB- within_IN six_CD days_NNS of_IN exposure_NN to_IN the_DT virus_NN ._. Like_IN a_DT vaccination_NN ,_, this_DT treatment_NN can_MD prevent_VB measles_NNS or_CC make_VB the_DT onset_NN less_RBR severe_JJ ._. For_IN many_JJ people_NNS ,_, recovering_VBG from_IN the_DT measles_NNS includes_VBZ resting_NN at_IN home_NN until_IN the_DT symptoms_NNS subside_VBP ._. It_PRP is_VBZ important_JJ for_IN patients_NNS to_TO drink_VB plenty_NN of_IN fluids_NNS to_TO replace_VB fluids_NNS lost_VBN during_IN fevers_NNS ._. It_PRP may_MD also_RB be_VB helpful_JJ to_TO use_VB a_DT humidifier_NN to_TO relieve_VB congestion_NN and_CC to_TO block_VB out_RP bright_JJ lights_NNS that_WDT may_MD bother_VB sensitive_JJ eyes_NNS ,_, according_VBG to_IN the_DT Mayo_NNP Clinic_NNP ._. Once_IN the_DT disease_NN has_VBZ run_VBN its_PRP$ course_NN ,_, the_DT person_NN will_MD be_VB immune_JJ to_IN the_DT virus_NN ._. However_RB ,_, the_DT immune_NN system_NN may_MD be_VB significantly_RB weakened_VBN for_IN up_IN to_IN 2_CD years_NNS after_IN recovering_VBG from_IN the_DT measles_NNS ,_, according_VBG to_IN Lighter_JJR ._. During_IN this_DT time_NN ,_, people_NNS can_MD be_VB more_RBR susceptible_JJ to_IN secondary_JJ viral_JJ and_CC bacterial_JJ infections_NNS ,_, which_WDT may_MD cause_VB more_JJR complications_NNS than_IN the_DT original_JJ measles_NNS infection_NN ._. The_DT best_JJS way_NN to_TO prevent_VB measles_NNS is_VBZ by_IN vaccination_NN ._. The_DT CDC_NNP recommends_VBZ 2_CD doses_NNS of_IN the_DT vaccine_NN ;_: the_DT first_JJ for_IN those_DT between_IN 12_CD and_CC 15_CD months_NNS of_IN age_NN and_CC the_DT second_JJ for_IN children_NNS between_IN 4_CD and_CC 6_CD years_NNS of_IN age_NN ._. The_DT vaccine_NN is_VBZ 97_CD %_NN effective_JJ for_IN those_DT who_WP receive_VBP both_CC doses_NNS and_CC about_RB 93_CD %_NN effective_JJ for_IN those_DT receiving_VBG one_CD ._. Getting_VBG the_DT proper_JJ vaccinations_NNS not_RB only_RB protects_VBZ the_DT individual_NN receiving_VBG the_DT vaccine_NN ,_, it_PRP also_RB protects_VBZ those_DT who_WP cannot_MD be_VB vaccinated_VBN :_: those_DT allergic_JJ to_IN components_NNS of_IN the_DT vaccine_NN ,_, those_DT with_IN a_DT compromised_VBN immune_JJ system_NN or_CC those_DT too_RB young_JJ to_TO receive_VB the_DT vaccine_NN ._. ""_`` Vaccines_NNS are_VBP one_CD of_IN the_DT most_RBS effective_JJ tools_NNS we_PRP have_VBP to_TO protect_VB public_JJ health_NN and_CC prevent_VB deaths_NNS around_IN the_DT world_NN ,_, ""_'' said_VBD Dr._NNP Scott_NNP Lillibridge_NNP ,_, an_DT infectious_JJ disease_NN expert_NN and_CC professor_NN at_IN the_DT Texas_NNP A&M_NNP Health_NNP Science_NNP Center_NNP School_NNP of_IN Public_NNP Health_NNP ._. About_RB 94_CD %_NN of_IN the_DT U.S._NNP population_NN is_VBZ vaccinated_VBN against_IN measles_NNS ,_, according_VBG to_IN Mukundan_NNP ,_, although_IN there_EX are_VBP pockets_NNS of_IN people_NNS who_WP delay_VBP or_CC refuse_VBP vaccines_NNS ._. The_DT groups_NNS of_IN unvaccinated_JJ people_NNS make_VBP it_PRP difficult_JJ to_TO control_VB the_DT spread_NN of_IN measles_NNS ,_, she_PRP said_VBD ._. ""_`` All_DT measles_NNS outbreaks_NNS in_IN the_DT U.S._NNP start_VBP either_CC with_IN a_DT visiting_VBG international_JJ traveler_NN infected_VBN with_IN measles_NNS or_CC from_IN an_DT unvaccinated_JJ U.S._NNP resident_NN returning_VBG from_IN an_DT international_JJ trip_NN with_IN a_DT measles_NN infection_NN ,_, ""_'' Mukundan_NNP said_VBD ._. The_DT infection_NN is_VBZ then_RB spread_VBN to_IN others_NNS in_IN the_DT community_NN who_WP are_VBP unvaccinated_JJ ._. Most_JJS measles_NN cases_NNS occur_VBP in_IN locations_NNS with_IN groups_NNS of_IN unvaccinated_JJ individuals_NNS ,_, according_VBG to_IN the_DT CDC_NNP ._. In_IN 2000_CD ,_, the_DT U.S._NNP declared_VBD that_IN measles_NNS was_VBD effectively_RB eliminated_VBN in_IN the_DT country_NN ._. But_CC since_IN then_RB ,_, the_DT disease_NN has_VBZ been_VBN making_VBG a_DT comeback_NN ,_, likely_RB due_IN to_IN anti-vaxxers_NNS ._. ""_`` The_DT antivax_NN movement_NN is_VBZ a_DT small_JJ percentage_NN of_IN the_DT population_NN but_CC they_PRP are_VBP loud_JJ and_CC draw_VBP a_DT lot_NN of_IN undue_JJ media_NN attention_NN ,_, ""_'' Lighter_NNP said_VBD ._. Anti-vaxxers_NNS are_VBP driven_VBN by_IN emotion_NN rather_RB than_IN the_DT science_NN behind_IN the_DT vaccines_NNS ,_, she_PRP said_VBD ._. Modern_JJ opposition_NN to_IN vaccines_NNS is_VBZ largely_RB fueled_VBN by_IN religious_JJ beliefs_NNS and_CC the_DT unwarranted_JJ concern_NN that_IN vaccines_NNS are_VBP somehow_RB linked_VBN to_IN autism_NN ,_, among_IN other_JJ reasons_NNS ,_, according_VBG to_IN the_DT Measles_NNP &_CC Rubella_NNP Initiative_NNP ,_, a_DT collaboration_NN of_IN the_DT world_NN 's_POS largest_JJS health_NN organizations_NNS that_WDT aims_VBZ to_TO eliminate_VB measles_NNS and_CC rubella_NN ._. Before_IN the_DT measles_NNS vaccine_NN approval_NN in_IN 1963_CD ,_, an_DT estimated_VBN 3_CD to_IN 4_CD million_CD people_NNS in_IN the_DT U.S._NNP contracted_VBD the_DT measles_NNS per_IN year_NN ,_, with_IN 400_CD to_IN 500_CD dying_VBG from_IN complications_NNS ,_, according_VBG to_IN the_DT CDC_NNP ._. Introduction_NN of_IN the_DT vaccine_NN led_VBD to_IN a_DT greater_JJR than_IN 99_CD %_NN reduction_NN in_IN measles_NNS cases_NNS in_IN the_DT U.S._NNP A_DT wealth_NN of_IN research_NN has_VBZ confirmed_VBN that_IN there_EX is_VBZ no_DT relationship_NN between_IN vaccines_NNS and_CC autism_NN and_CC has_VBZ repeatedly_RB validated_VBN the_DT safety_NN of_IN the_DT measles_NNS vaccine_NN ._. ""_`` Protect_VB yourself_PRP and_CC your_PRP$ loved_VBN ones_NNS by_IN making_VBG sure_JJ that_IN they_PRP are_VBP up_RB to_IN date_NN on_IN the_DT measles_NNS vaccine_NN ,_, ""_'' Mukundan_NNP said_VBD ._. ""_`` Prevention_NN ,_, meaning_VBG vaccination_NN ,_, is_VBZ always_RB better_JJR than_IN cure_NN ._. ""_'' •_NFP Find_VB answers_NNS to_IN frequently_RB asked_VBN questions_NNS about_IN measles_NNS ,_, from_IN the_DT San_NNP Francisco_NNP Department_NNP of_IN Public_NNP Health_NNP ._. •_NFP Learn_VB more_JJR about_IN the_DT measles_NNS vaccine_NN from_IN the_DT U.S._NNP Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS ._. •_NFP Read_VB about_IN the_DT World_NNP Health_NNP Organization_NNP 's_POS position_NN on_IN the_DT measles_NNS vaccine_NN and_CC their_PRP$ goal_NN to_TO eradicate_VB measles_NNS ._.","NN , RB VBN NN , VBZ a JJ NN that VBZ one of the RBS JJ JJ NNS in the NN . The NN VBZ VBN by NNS that VBP JJ to a JJ NN , RB RB as a JJ JJ NN . Between 2000 and 2010 , the JJ NN of NNS VBN by 66 NN and the NN VBN by the NN VBD 74 NN , VBG to a NN VBN in the NN The NNP . JJR than two NNS RB , NNS VBD RB VBN out in the NNP NNPS , NN to NNS . But RB , the NN VBZ VBN a NN . RB , the NN of NNS VBZ VBN 30 NN due to NN NN . JJR than 760 NNS of NNS VBD VBN in the NNP between NNP 1 and NNP 3 , 2019 , VBG to NNP NNP NNP , a JJ JJ NNS NN at the NNP of NNP NNP NNP in NNP . This VBZ RB from 372 NNS over the JJ NN in 2018 and RB from 120 NNS over the JJ NN in 2017 , VBG to the NNPS for NNP NNP and NNP ( NNP ) . How JJ VBZ it ? NN VBZ VBN by NN NN , a NN in the NN NN . VBG to the NNP , the NNS NN VBZ in the NN and NN NN of an VBN NN . When a NN VBN with the NN VBZ , NNS or VBZ , the NN VBZ JJ and can VB to JJ NNS . "" The NN can VB in the NN for JJ NNS of NN , "" NNP VBD NNP NNP . "" One can VB the NNS RB by VBG in a NN where a NN with NNS VBZ VBN , RB up to 2 NNS after that NN VBZ VBN . "" RB , the NN VBZ RB JJ — 90 NN of NNS who VBP RB VBN against NNS will VB VBN if they VBP NN with NN who VBZ the NN . "" Another NN that it VBZ VBN RB RB VBZ because the NN of NNS , the NN , RB VBZ JJ NNS after NN VBZ JJ , "" VBD NNP NNP NNP , a JJ JJ NN NN at NNP NNP NNP NNP NNP . RB , VBN NNS can VB the NN for JJ NNS before VBG they VBP JJ . The JJ NN VBZ RB four NNS RB and four NNS after the NN VBZ . A NN with NNS VBZ JJ to VB between 5 and 18 JJ NNS , VBG to a 2019 NN VBN in the NN NNP NNP NNPS . JJS NNS of NNS VBP some NN of NN , JJ NN , JJ NNS , JJ NN and JJ JJ to JJ NNS in the NN , VBD NNP NNP NNP NNP , a NN of JJ NNS at NNP NNP NNP 's NNP NNP NNP of NNP in NNP . As the NN VBZ , the JJ JJ NN will VB . The NN RB VBZ like JJ , JJ , JJ NNS on the NN . To VB for NNS , a NN will VB the NN for NN NNS , JJ as NNS inside of the NN and the NN NN . If the NN VBZ any NN , they may VB a NN NN to VB NN , VBG to the NNP NNP . RB all NNS VBP NN by a NN . "" This VBZ a NN where NNS VBP JJ — NNS JJ as NN NN ( JJ NN NN ) , NN and NN , NN , NN and JJ NN , "" NNP VBD NNP NNP . "" In the NNP NNPS , one to three of every 1,000 VBN NNS will VB from [ NNS ] NNS — which VBZ JJR than in the NNP NNP , where RB JJ as two to 15 per 100 VBN NNS VBP from NNS and its NNS . "" JJ NNS VBP RB RBR JJ to the NN . VBG to the NNP NNP , NNS VBZ 100,000 NNS a NN , RBS under the NN of 5 . JJ NNS and those with a VBN JJ NN VBP RB at NN of JJ NNS . There VBZ no JJ NN for VBG NNS . RB , NNS VBP the NNS . "" This VBZ we VBP / VBP NN , NNS ( FW , NN ) for NN and NN NN , NN NN in NNS with JJ NN NN , "" NNP VBD . Though RB VBN in the NNP NNPS for the NN of NNS , some NNS VBP VBN NNP , an JJ NN , to VB JJ NN VBN by NNS , NNP VBD . To VB those who VBP VBN VBN to the NN but VBP RB VBN VBN , a NN may VB a NN - NN NN . If VBN within 72 NNS of NN , the NN may VB the NNS . RB if it VBZ RB VB the NN , the VBN NN will RB VB a JJ NN of the NNS , VBG to the NNP NNP . Another NN to VB at - NN NNS VBZ to VB them with JJ NN NN ( NNS or NNS VBN from the NN of NNS with NNS NN ) within six NNS of NN to the NN . Like a NN , this NN can VB NNS or VB the NN RBR JJ . For JJ NNS , VBG from the NNS VBZ NN at NN until the NNS VBP . It VBZ JJ for NNS to VB NN of NNS to VB NNS VBN during NNS . It may RB VB JJ to VB a NN to VB NN and to VB out JJ NNS that may VB JJ NNS , VBG to the NNP NNP . Once the NN VBZ VBN its NN , the NN will VB JJ to the NN . RB , the NN NN may VB RB VBN for up to 2 NNS after VBG from the NNS , VBG to JJR . During this NN , NNS can VB RBR JJ to JJ JJ and JJ NNS , which may VB JJR NNS than the JJ NNS NN . The JJS NN to VB NNS VBZ by NN . The NNP VBZ 2 NNS of the NN ; the JJ for those between 12 and 15 NNS of NN and the JJ for NNS between 4 and 6 NNS of NN . The NN VBZ 97 NN JJ for those who VBP both NNS and RB 93 NN JJ for those VBG one . VBG the JJ NNS RB RB VBZ the NN VBG the NN , it RB VBZ those who cannot VB VBN : those JJ to NNS of the NN , those with a VBN JJ NN or those RB JJ to VB the NN . "" NNS VBP one of the RBS JJ NNS we VBP to VB JJ NN and VB NNS around the NN , "" VBD NNP NNP NNP , an JJ NN NN and NN at the NNP NNP NNP NNP NNP NNP of NNP NNP . RB 94 NN of the NNP NN VBZ VBN against NNS , VBG to NNP , although there VBP NNS of NNS who VBP or VBP NNS . The NNS of JJ NNS VBP it JJ to VB the NN of NNS , she VBD . "" All NNS NNS in the NNP VBP either with a VBG JJ NN VBN with NNS or from an JJ NNP NN VBG from an JJ NN with a NN NN , "" NNP VBD . The NN VBZ RB VBN to NNS in the NN who VBP JJ . JJS NN NNS VBP in NNS with NNS of JJ NNS , VBG to the NNP . In 2000 , the NNP VBD that NNS VBD RB VBN in the NN . But since RB , the NN VBZ VBN VBG a NN , RB due to NNS . "" The NN NN VBZ a JJ NN of the NN but they VBP JJ and VBP a NN of JJ NN NN , "" NNP VBD . NNS VBP VBN by NN RB than the NN behind the NNS , she VBD . JJ NN to NNS VBZ RB VBN by JJ NNS and the JJ NN that NNS VBP RB VBN to NN , among JJ NNS , VBG to the NNP & NNP NNP , a NN of the NN 's JJS NN NNS that VBZ to VB NNS and NN . Before the NNS NN NN in 1963 , an VBN 3 to 4 million NNS in the NNP VBD the NNS per NN , with 400 to 500 VBG from NNS , VBG to the NNP . NN of the NN VBD to a JJR than 99 NN NN in NNS NNS in the NNP A NN of NN VBZ VBN that there VBZ no NN between NNS and NN and VBZ RB VBN the NN of the NNS NN . "" VB yourself and your VBN NNS by VBG JJ that they VBP RB to NN on the NNS NN , "" NNP VBD . "" NN , VBG NN , VBZ RB JJR than NN . "" • VB NNS to RB VBN NNS about NNS , from the NNP NNP NNP of NNP NNP . • VB JJR about the NNS NN from the NNP NNP of NNP and NNP NNPS . • VB about the NNP NNP NNP 's NN on the NNS NN and their NN to VB NNS ."
10,43,mainstream,M07efe,vaccine,"This_DT schedule_NN of_IN recommended_VBN immunizations_NNS may_MD vary_VB depending_VBG upon_IN where_WRB you_PRP live_VBP ,_, your_PRP$ child_NN 's_POS health_NN ,_, the_DT type_NN of_IN vaccine_NN ,_, and_CC the_DT vaccines_NNS available_JJ ._. Some_DT of_IN the_DT vaccines_NNS may_MD be_VB given_VBN as_IN part_NN of_IN a_DT combination_NN vaccine_NN so_IN that_IN a_DT child_NN gets_VBZ fewer_JJR shots_NNS ._. Talk_VB with_IN your_PRP$ doctor_NN about_IN which_WDT vaccines_NNS your_PRP$ kids_NNS need_VBP ._. •_SYM HepB_NN :_: Hepatitis_NN B_NN vaccine_NN ._. Ideally_RB ,_, the_DT first_JJ dose_NN is_VBZ given_VBN within_IN 24_CD hours_NNS of_IN birth_NN ,_, but_CC kids_NNS not_RB previously_RB immunized_VBN can_MD get_VB it_PRP at_IN any_DT age_NN ._. Some_DT low_JJ birth_NN weight_NN infants_NNS will_MD get_VB it_PRP at_IN 1_CD month_NN or_CC when_WRB they_PRP 're_VBP discharged_VBN from_IN the_DT hospital_NN ._. •_SYM HepB_NN :_: Second_JJ dose_NN should_MD be_VB given_VBN 1_CD to_IN 2_CD months_NNS after_IN the_DT first_JJ dose_NN ._. •_NFP Hib_NNP :_: This_DT third_JJ dose_NN may_MD be_VB needed_VBN ,_, depending_VBG on_IN the_DT brand_NN of_IN vaccine_NN used_VBN in_IN previous_JJ Hib_NNP immunizations_NNS ._. •_SYM RV_NN :_: This_DT third_JJ dose_NN may_MD be_VB needed_VBN ,_, depending_VBG on_IN the_DT brand_NN of_IN vaccine_NN used_VBN in_IN previous_JJ RV_NN immunizations_NNS ._. •_SYM Influenza_NN (_-LRB- Flu_NN )_-RRB- :_: The_DT flu_NN vaccine_NN is_VBZ recommended_VBN every_DT year_NN for_IN children_NNS 6_CD months_NNS and_CC older_JJR :_: •_SYM Kids_NNS younger_JJR than_IN 9_CD who_WP get_VBP the_DT flu_NN vaccine_NN for_IN the_DT first_JJ time_NN (_-LRB- or_CC who_WP have_VBP only_RB had_VBN one_CD dose_NN before_IN July_NNP 2019_CD )_-RRB- will_MD get_VB it_PRP in_IN 2_CD separate_JJ doses_NNS at_IN least_JJS a_DT month_NN apart_RB ._. •_NFP Those_DT younger_JJR than_IN 9_CD who_WP have_VBP had_VBN at_IN least_JJS 2_CD doses_NNS of_IN flu_NN vaccine_NN previously_RB (_-LRB- in_IN the_DT same_JJ or_CC different_JJ seasons_NNS )_-RRB- will_MD only_RB need_VB 1_CD dose_NN ._. •_NFP Kids_NNS older_JJR than_IN 9_CD need_VBP only_RB 1_CD dose_NN ._. •_NFP The_DT vaccine_NN is_VBZ given_VBN by_IN injection_NN with_IN a_DT needle_NN (_-LRB- the_DT flu_NN shot_NN )_-RRB- or_CC by_IN nasal_JJ spray_NN ._. Both_DT types_NNS of_IN vaccine_NN can_MD be_VB used_VBN this_DT flu_NN season_NN (_-LRB- 2019_CD –2020_CD )_-RRB- because_IN they_PRP seem_VBP to_TO work_VB equally_RB well_RB ._. Your_PRP$ doctor_NN will_MD recommend_VB which_WDT to_TO use_VB based_VBN on_IN your_PRP$ child_NN 's_POS age_NN and_CC general_JJ health_NN ._. The_DT nasal_JJ spray_NN is_VBZ only_RB for_IN healthy_JJ people_NNS ages_NNS 2_CD –49_CD ._. People_NNS with_IN weak_JJ immune_NN systems_NNS or_CC some_DT health_NN conditions_NNS (_-LRB- such_JJ as_IN asthma_NN )_-RRB- and_CC pregnant_JJ women_NNS should_MD not_RB get_VB the_DT nasal_JJ spray_NN vaccine_NN ._. •_SYM HepA_NN :_: Hepatitis_NN A_DT vaccine_NN ;_: given_VBN as_IN 2_CD shots_NNS at_IN least_JJS 6_CD months_NNS apart_RB •_SYM HPV_NN :_: Human_JJ papillomavirus_NN vaccine_NN ,_, given_VBN in_IN 2_CD shots_NNS over_IN a_DT 6_CD -_SYM to_IN 12_CD -_HYPH month_NN period_NN ._. It_PRP can_MD be_VB given_VBN as_RB early_RB as_IN age_NN 9_CD ._. For_IN teens_NNS and_CC young_JJ adults_NNS (_-LRB- ages_NNS 15_CD –_SYM 26_CD in_IN girls_NNS and_CC boys_NNS both_DT )_-RRB- ,_, it_PRP is_VBZ given_VBN in_IN 3_CD shots_NNS over_IN 6_CD months_NNS ._. It_PRP 's_VBZ recommended_VBN for_IN both_CC girls_NNS and_CC boys_NNS to_TO prevent_VB genital_JJ warts_NNS and_CC some_DT types_NNS of_IN cancer_NN ._. •_SYM Tdap_NN :_: Tetanus_NN ,_, diphtheria_NN ,_, and_CC pertussis_NN booster_NN ._. Also_RB recommended_VBN during_IN each_DT pregnancy_NN a_DT woman_NN has_VBZ ._. •_SYM Meningococcal_NNP conjugate_NN vaccine_NN :_: And_CC a_DT booster_NN dose_NN is_VBZ recommended_VBN at_IN age_NN 16_CD ._. •_SYM Meningococcal_NNP B_NN vaccine_NN (_-LRB- MenB_NNP )_-RRB- :_: The_DT MenB_NN vaccine_NN may_MD be_VB given_VBN to_IN kids_NNS and_CC teens_NNS in_IN 2_CD or_CC 3_CD doses_NNS ,_, depending_VBG on_IN the_DT brand_NN ._. Unlike_IN the_DT meningococcal_JJ conjugate_NN vaccine_NN ,_, which_WDT is_VBZ recommended_VBN ,_, the_DT decision_NN to_TO get_VB the_DT MenB_NN vaccine_NN is_VBZ made_VBN by_IN the_DT teens_NNS ,_, their_PRP$ parents_NNS ,_, and_CC the_DT doctor_NN ._. •_NFP HepA_NN can_MD be_VB given_VBN as_RB early_RB as_IN 6_CD months_NNS of_IN age_NN to_IN babies_NNS who_WP will_MD travel_VB to_IN a_DT place_NN where_WRB hepatitis_NN A_NN is_VBZ common_JJ (_-LRB- they_PRP will_MD still_RB need_VB routine_JJ vaccination_NN after_IN their_PRP$ first_JJ birthday_NN )_-RRB- ._. It_PRP 's_VBZ also_RB recommended_VBN for_IN older_JJR kids_NNS who_WP did_VBD not_RB get_VB it_PRP in_IN the_DT past_NN ._. •_NFP The_DT MMR_NNP vaccine_NN can_MD be_VB given_VBN to_IN babies_NNS as_RB young_JJ as_IN 6_CD months_NNS old_JJ if_IN they_PRP will_MD be_VB traveling_VBG internationally_RB ._. These_DT children_NNS should_MD still_RB get_VB the_DT recommended_VBN routine_JJ doses_NNS at_IN 12_CD –_SYM 15_CD months_NNS and_CC 4_CD –6_CD years_NNS of_IN age_NN ,_, but_CC can_MD get_VB the_DT second_JJ dose_NN as_RB early_RB as_IN 4_CD weeks_NNS after_IN the_DT first_JJ if_IN they_PRP will_MD still_RB be_VB traveling_VBG and_CC at_IN risk_NN ._. •_NFP The_DT flu_NN vaccine_NN is_VBZ especially_RB important_JJ for_IN kids_NNS who_WP are_VBP at_IN risk_NN for_IN health_NN problems_NNS from_IN the_DT flu_NN ._. High_JJ -_HYPH risk_NN groups_NNS include_VBP ,_, but_CC are_VBP n't_RB limited_VBN to_IN ,_, kids_NNS younger_JJR than_IN 5_CD years_NNS old_JJ and_CC those_DT with_IN chronic_JJ medical_JJ conditions_NNS ,_, such_JJ as_IN asthma_NN ,_, heart_NN problems_NNS ,_, sickle_NN cell_NN disease_NN ,_, diabetes_NN ,_, or_CC HIV_NN ._. •_NFP Pneumococcal_JJ vaccines_NNS can_MD be_VB given_VBN to_IN older_JJR kids_NNS (_-LRB- age_NN 2_CD and_CC up_NN )_-RRB- who_WP have_VBP conditions_NNS that_WDT affect_VBP their_PRP$ immune_JJ systems_NNS ,_, such_JJ as_IN asplenia_NN or_CC HIV_NN infection_NN ,_, or_CC other_JJ conditions_NNS ,_, like_IN a_DT cochlear_JJ implant_NN ,_, chronic_JJ heart_NN disease_NN ,_, or_CC chronic_JJ lung_NN disease_NN ._. •_NFP The_DT meningococcal_JJ vaccines_NNS can_MD be_VB given_VBN to_IN kids_NNS as_RB young_JJ as_IN 8_CD weeks_NNS old_JJ (_-LRB- depending_VBG on_IN the_DT vaccine_NN brand_NN )_-RRB- who_WP are_VBP at_IN risk_NN for_IN a_DT meningococcal_JJ infection_NN ,_, such_JJ as_IN meningitis_NN ._. This_DT includes_VBZ children_NNS with_IN some_DT immune_JJ disorders_NNS ._. Kids_NNS who_WP live_VBP in_IN (_-LRB- or_CC will_MD travel_VB to_IN )_-RRB- countries_NNS where_WRB meningitis_NN is_VBZ common_JJ ,_, or_CC where_WRB there_EX is_VBZ an_DT outbreak_NN ,_, also_RB should_MD get_VB the_DT vaccine_NN ._. Note_NN :_: An_DT outbreak_NN is_VBZ when_WRB a_DT disease_NN happens_VBZ in_IN greater_JJR numbers_NNS than_IN expected_VBN in_IN a_DT particular_JJ area_NN ._. If_IN you_PRP have_VBP questions_NNS about_IN vaccinating_VBG your_PRP$ family_NN during_IN an_DT outbreak_NN ,_, ask_VB your_PRP$ health_NN care_NN provider_NN or_CC contact_VB your_PRP$ state_NN or_CC local_JJ health_NN department_NN ._.","This NN of VBN NNS may VB VBG upon where you VBP , your NN 's NN , the NN of NN , and the NNS JJ . Some of the NNS may VB VBN as NN of a NN NN so that a NN VBZ JJR NNS . VB with your NN about which NNS your NNS VBP . • NN : NN NN NN . RB , the JJ NN VBZ VBN within 24 NNS of NN , but NNS RB RB VBN can VB it at any NN . Some JJ NN NN NNS will VB it at 1 NN or when they VBP VBN from the NN . • NN : JJ NN should VB VBN 1 to 2 NNS after the JJ NN . • NNP : This JJ NN may VB VBN , VBG on the NN of NN VBN in JJ NNP NNS . • NN : This JJ NN may VB VBN , VBG on the NN of NN VBN in JJ NN NNS . • NN ( NN ) : The NN NN VBZ VBN every NN for NNS 6 NNS and JJR : • NNS JJR than 9 who VBP the NN NN for the JJ NN ( or who VBP RB VBN one NN before NNP 2019 ) will VB it in 2 JJ NNS at JJS a NN RB . • Those JJR than 9 who VBP VBN at JJS 2 NNS of NN NN RB ( in the JJ or JJ NNS ) will RB VB 1 NN . • NNS JJR than 9 VBP RB 1 NN . • The NN VBZ VBN by NN with a NN ( the NN NN ) or by JJ NN . Both NNS of NN can VB VBN this NN NN ( 2019 –2020 ) because they VBP to VB RB RB . Your NN will VB which to VB VBN on your NN 's NN and JJ NN . The JJ NN VBZ RB for JJ NNS NNS 2 –49 . NNS with JJ NN NNS or some NN NNS ( JJ as NN ) and JJ NNS should RB VB the JJ NN NN . • NN : NN A NN ; VBN as 2 NNS at JJS 6 NNS RB • NN : JJ NN NN , VBN in 2 NNS over a 6 - to 12 - NN NN . It can VB VBN RB RB as NN 9 . For NNS and JJ NNS ( NNS 15 – 26 in NNS and NNS both ) , it VBZ VBN in 3 NNS over 6 NNS . It VBZ VBN for both NNS and NNS to VB JJ NNS and some NNS of NN . • NN : NN , NN , and NN NN . RB VBN during each NN a NN VBZ . • NNP NN NN : And a NN NN VBZ VBN at NN 16 . • NNP NN NN ( NNP ) : The NN NN may VB VBN to NNS and NNS in 2 or 3 NNS , VBG on the NN . Unlike the JJ NN NN , which VBZ VBN , the NN to VB the NN NN VBZ VBN by the NNS , their NNS , and the NN . • NN can VB VBN RB RB as 6 NNS of NN to NNS who will VB to a NN where NN NN VBZ JJ ( they will RB VB JJ NN after their JJ NN ) . It VBZ RB VBN for JJR NNS who VBD RB VB it in the NN . • The NNP NN can VB VBN to NNS RB JJ as 6 NNS JJ if they will VB VBG RB . These NNS should RB VB the VBN JJ NNS at 12 – 15 NNS and 4 –6 NNS of NN , but can VB the JJ NN RB RB as 4 NNS after the JJ if they will RB VB VBG and at NN . • The NN NN VBZ RB JJ for NNS who VBP at NN for NN NNS from the NN . JJ - NN NNS VBP , but VBP RB VBN to , NNS JJR than 5 NNS JJ and those with JJ JJ NNS , JJ as NN , NN NNS , NN NN NN , NN , or NN . • JJ NNS can VB VBN to JJR NNS ( NN 2 and NN ) who VBP NNS that VBP their JJ NNS , JJ as NN or NN NN , or JJ NNS , like a JJ NN , JJ NN NN , or JJ NN NN . • The JJ NNS can VB VBN to NNS RB JJ as 8 NNS JJ ( VBG on the NN NN ) who VBP at NN for a JJ NN , JJ as NN . This VBZ NNS with some JJ NNS . NNS who VBP in ( or will VB to ) NNS where NN VBZ JJ , or where there VBZ an NN , RB should VB the NN . NN : An NN VBZ when a NN VBZ in JJR NNS than VBN in a JJ NN . If you VBP NNS about VBG your NN during an NN , VB your NN NN NN or VB your NN or JJ NN NN ."
11,885,mainstream,M0a379,vaccine,"The_DT Duke_NNP and_CC Duchess_NNP of_IN Cambridge_NNP are_VBP fronting_VBG a_DT new_JJ campaign_NN looking_VBG at_IN mental_JJ health_NN issues_NNS amid_IN the_DT coronavirus_NN pandemic_NN ._. They_PRP have_VBP been_VBN interviewed_VBN on_IN the_DT BBC_NNP about_IN the_DT scheme_NN -_, called_VBN Every_DT Mind_NNP Matters_NNPS ._. Here_RB is_VBZ the_DT transcript_NN ._. Q_NN :_: How_WRB are_VBP you_PRP helping_VBG get_VB the_DT message_NN out_RB there_RB with_IN Every_DT Mind_NN Matters_NNS ?_. Duke_NNP of_IN Cambridge_NNP :_: So_RB Every_DT Mind_NN Matters_NNS obviously_RB is_VBZ in_IN its_PRP$ second_JJ guise_NN now_RB coming_VBG out_RP -_, we_PRP got_VBD a_DT lot_NN of_IN feedback_NN from_IN the_DT NHS_NNP and_CC from_IN others_NNS that_IN people_NNS were_VBD accessing_VBG the_DT online_JJ plan_NN ,_, so_RB we_PRP felt_VBD very_RB strongly_RB that_IN now_RB more_JJR than_IN ever_RB this_DT was_VBD a_DT vital_JJ tool_NN and_CC a_DT vital_JJ service_NN that_WDT people_NNS could_MD easily_RB access_VB at_IN home_NN to_TO guide_VB them_PRP and_CC give_VB them_PRP just_RB some_DT very_RB basic_JJ tips_NNS to_TO mind_VB their_PRP$ mental_JJ health_NN ,_, to_TO mind_VB their_PRP$ mental_JJ wellbeing_NN through_IN this_DT process_NN ._. I_PRP think_VBP again_RB staying_VBG connected_VBN ,_, staying_VBG positive_JJ and_CC being_VBG able_JJ to_TO talk_VB to_IN friends_NNS and_CC family_NN is_VBZ so_RB crucial_JJ and_CC having_VBG just_RB some_DT tips_NNS and_CC some_DT ideas_NNS as_IN to_IN how_WRB to_TO tackle_VB some_DT of_IN these_DT strange_JJ feelings_NNS and_CC difficult_JJ circumstances_NNS we_PRP ’re_VBP finding_VBG ourselves_PRP in_IN is_VBZ really_RB important_JJ ,_, just_RB to_TO nudge_VB us_PRP through_IN these_DT next_JJ few_JJ weeks_NNS ._. Duke_NNP of_IN Cambridge_NNP :_: What_WP I_PRP ’ve_VBP heard_VBN as_IN well_RB Tina_NNP is_VBZ about_IN the_DT fact_NN that_IN in_IN many_JJ of_IN these_DT cases_NNS obviously_RB NHS_NNP workers_NNS ,_, frontline_JJ workers_NNS are_VBP used_VBN to_IN dealing_VBG sadly_RB with_IN very_RB sad_JJ situations_NNS ,_, death_NN and_CC things_NNS like_IN that_DT but_CC I_PRP think_VBP the_DT scale_NN and_CC the_DT speed_NN of_IN what_WP ’s_VBZ going_VBG on_RP in_IN hospitals_NNS ,_, bearing_VBG in_IN mind_NN also_RB the_DT isolation_NN ,_, a_DT lot_NN of_IN these_DT patients_NNS are_VBP dying_VBG with_IN no_DT family_NN members_NNS around_IN them_PRP ._. I_PRP think_VBP for_IN the_DT NHS_NNP frontline_NN workers_NNS that_DT is_VBZ very_RB difficult_JJ ,_, because_IN they_PRP are_VBP there_RB right_RB next_RB to_IN the_DT bedsides_NNS ,_, looking_VBG after_RB and_CC caring_VBG for_IN each_DT and_CC every_DT patient_NN in_IN a_DT critical_JJ condition_NN and_CC I_PRP think_VBP they_PRP take_VBP away_RP that_DT pain_NN and_CC that_IN sometimes_RB that_DT fear_NN and_CC loneliness_NN that_WDT these_DT patients_NNS have_VBP to_TO go_VB through_IN ,_, they_PRP ’re_VBP the_DT ones_NNS who_WP absorb_VBP that_DT and_CC take_VBP it_PRP home_RB to_IN their_PRP$ families_NNS and_CC I_PRP think_VBP again_RB ,_, I_PRP ’ve_VBP spoken_VBN about_IN the_DT attrition_NN and_CC the_DT daily_JJ attrition_NN rate_NN of_IN that_DT happening_VBG to_IN somebody_NN is_VBZ not_RB normal_JJ and_CC we_PRP ’re_VBP not_RB super_RB human_JJ any_DT of_IN us_PRP ,_, so_RB to_TO be_VB able_JJ to_TO manage_VB those_DT emotions_NNS and_CC that_DT feeling_NN is_VBZ going_VBG to_TO take_VB some_DT time_NN after_IN all_PDT this_DT is_VBZ over_RB as_RB well_RB ._. Q_NN :_: Do_VBP you_PRP think_VB this_DT will_MD fundamentally_RB change_VB who_WP we_PRP are_VBP and_CC what_WP we_PRP value_VBP ?_. Duchess_NNP of_IN Cambridge_NNP :_: Yeah_UH ,_, absolutely_RB ,_, I_PRP think_VBP what_WP we_PRP ’re_VBP saying_VBG now_RB is_VBZ the_DT NHS_NNP and_CC the_DT frontline_NN workers_NNS are_VBP doing_VBG the_DT most_RBS extraordinary_JJ job_NN and_CC that_DT ’s_VBZ really_RB come_VBN to_IN the_DT forefront_NN in_IN the_DT last_JJ few_JJ weeks_NNS and_CC I_PRP think_VBP it_PRP ’s_VBZ going_VBG to_TO dramatically_RB change_VB how_WRB we_PRP all_DT value_VBP and_CC see_VBP our_PRP$ frontline_JJ workers_NNS and_CC I_PRP think_VBP that_DT is_VBZ one_CD of_IN the_DT main_JJ positives_NNS that_WDT you_PRP can_MD take_VB from_IN this_DT ._. They_PRP do_VBP an_DT extraordinary_JJ job_NN it_PRP does_VBZ unrecognised_JJ daily_RB and_CC now_RB I_PRP think_VBP all_DT of_IN us_PRP as_IN a_DT nation_NN can_MD really_RB see_VB how_WRB hard_RB they_PRP work_VBP and_CC how_WRB vital_JJ their_PRP$ work_NN is_VBZ ._.","The NNP and NNP of NNP VBP VBG a JJ NN VBG at JJ NN NNS amid the NN NN . They VBP VBN VBN on the NNP about the NN - VBN Every NNP NNPS . RB VBZ the NN . NN : How VBP you VBG VB the NN RB RB with Every NN NNS ? NNP of NNP : RB Every NN NNS RB VBZ in its JJ NN RB VBG out - we VBD a NN of NN from the NNP and from NNS that NNS VBD VBG the JJ NN , RB we VBD RB RB that RB JJR than RB this VBD a JJ NN and a JJ NN that NNS could RB VB at NN to VB them and VB them RB some RB JJ NNS to VB their JJ NN , to VB their JJ NN through this NN . I VBP RB VBG VBN , VBG JJ and VBG JJ to VB to NNS and NN VBZ RB JJ and VBG RB some NNS and some NNS as to how to VB some of these JJ NNS and JJ NNS we VBP VBG ourselves in VBZ RB JJ , RB to VB us through these JJ JJ NNS . NNP of NNP : What I VBP VBN as RB NNP VBZ about the NN that in JJ of these NNS RB NNP NNS , JJ NNS VBP VBN to VBG RB with RB JJ NNS , NN and NNS like that but I VBP the NN and the NN of what VBZ VBG on in NNS , VBG in NN RB the NN , a NN of these NNS VBP VBG with no NN NNS around them . I VBP for the NNP NN NNS that VBZ RB JJ , because they VBP RB RB RB to the NNS , VBG RB and VBG for each and every NN in a JJ NN and I VBP they VBP away that NN and that RB that NN and NN that these NNS VBP to VB through , they VBP the NNS who VBP that and VBP it RB to their NNS and I VBP RB , I VBP VBN about the NN and the JJ NN NN of that VBG to NN VBZ RB JJ and we VBP RB RB JJ any of us , RB to VB JJ to VB those NNS and that NN VBZ VBG to VB some NN after all this VBZ RB RB RB . NN : VBP you VB this will RB VB who we VBP and what we VBP ? NNP of NNP : Yeah , RB , I VBP what we VBP VBG RB VBZ the NNP and the NN NNS VBP VBG the RBS JJ NN and that VBZ RB VBN to the NN in the JJ JJ NNS and I VBP it VBZ VBG to RB VB how we all VBP and VBP our JJ NNS and I VBP that VBZ one of the JJ NNS that you can VB from this . They VBP an JJ NN it VBZ JJ RB and RB I VBP all of us as a NN can RB VB how RB they VBP and how JJ their NN VBZ ."
12,1248,conspiracy,C0056b,bill.gates; vaccine,"Days_NNS after_IN it_PRP was_VBD revealed_VBN in_IN an_DT intercepted_VBN human_JJ intelligence_NN report_NN that_IN Bill_NNP Gates_NNP offered_VBD $_$ 10_CD million_CD bribe_NN for_IN a_DT forced_VBN Coronavirus_NNP vaccination_NN program_NN in_IN Nigeria_NNP ,_, now_RB an_DT Italian_JJ politician_NN has_VBZ demanded_VBN the_DT arrest_NN of_IN Bill_NNP Gates_NNP in_IN the_DT Italian_JJ parliament_NN ._. Sara_NNP Cunial_NNP ,_, the_DT Member_NN of_IN Parliament_NNP for_IN Rome_NNP denounced_VBD Bill_NNP Gates_NNP as_IN a_DT “_`` vaccine_NN criminal_NN ”_'' and_CC urged_VBD the_DT Italian_JJ President_NNP to_TO hand_VB him_PRP over_RP to_IN the_DT International_NNP Criminal_NNP Court_NNP for_IN crimes_NNS against_IN humanity_NN ._. She_PRP also_RB exposed_VBD Bill_NNP Gates_NNP ’_POS agenda_NN in_IN India_NNP and_CC Africa_NNP ,_, along_IN with_IN the_DT plans_NNS to_TO chip_VB the_DT human_JJ race_NN through_IN the_DT digital_JJ identification_NN program_NN ID2020_NN ._. As_IN reported_VBN by_IN GreatGameIndia_NNP earlier_RBR ,_, in_IN 2015_CD it_PRP were_VBD the_DT Italians_NNPS who_WP exposed_VBD secret_JJ Chinese_JJ biological_JJ experiments_NNS with_IN Coronavirus_NNP ._. The_DT video_NN ,_, which_WDT was_VBD broadcast_VBN in_IN November_NNP ,_, 2015_CD ,_, showed_VBD how_WRB Chinese_JJ scientists_NNS were_VBD doing_VBG biological_JJ experiments_NNS on_IN a_DT SARS_NNP connected_VBN virus_NN believed_VBN to_TO be_VB Coronavirus_NN ,_, derived_VBN from_IN bats_NNS and_CC mice_NNS ,_, asking_VBG whether_IN it_PRP was_VBD worth_JJ the_DT risk_NN in_IN order_NN to_TO be_VB able_JJ to_TO modify_VB the_DT virus_NN for_IN compatibility_NN with_IN human_JJ organisms_NNS ._. In_IN an_DT extraordinary_JJ seven_CD -_HYPH minute_NN speech_NN met_VBN with_IN wide_JJ applause_NN ,_, Sara_NNP Cunial_NNP ,_, the_DT Member_NN of_IN Parliament_NNP for_IN Rome_NNP said_VBD that_IN Italy_NNP had_VBD been_VBN subjected_VBN to_IN a_DT “_`` Holy_JJ Inquisition_NN of_IN false_JJ science_NN ._. ”_'' She_PRP roundly_RB criticized_VBD the_DT unnecessary_JJ lockdown_NN imposed_VBN on_IN her_PRP$ fellow_JJ Italians_NNPS in_IN the_DT service_NN of_IN a_DT globalist_JJ agenda_NN ._. She_PRP urged_VBD fellow_JJ political_JJ leaders_NNS to_TO desist_VB in_IN any_DT plans_NNS to_TO compel_VB citizens_NNS to_TO surrender_VB themselves_PRP to_IN compulsory_JJ COVID_NN -_HYPH 19_CD vaccination_NN at_IN the_DT hands_NNS of_IN the_DT corrupt_JJ elite_NN –_: whom_WP she_PRP identified_VBD as_IN the_DT Deep_NNP State_NNP ._. Below_RB is_VBZ the_DT transcription_NN of_IN the_DT full_JJ speech_NN delivered_VBN to_IN the_DT Italian_JJ Parliament_NNP by_IN Sara_NNP Cunial_NNP ,_, the_DT Member_NN of_IN Parliament_NNP for_IN Rome_NNP ._. Sara_NNP Cunial_NNP The_DT Member_NN of_IN Parliament_NNP for_IN Rome_NNP Speech_NN delivered_VBD to_IN the_DT Italian_JJ Parliament_NN May_NNP 2020_CD Hobbes_NNP said_VBD that_IN absolute_JJ power_NN does_VBZ not_RB come_VB from_IN an_DT imposition_NN from_IN above_RB but_CC by_IN the_DT choice_NN of_IN individuals_NNS who_WP feel_VBP more_RBR protected_VBN renouncing_VBG to_IN their_PRP$ own_JJ freedom_NN and_CC granting_VBG it_PRP to_IN a_DT third_JJ party_NN ._. With_IN this_DT ,_, you_PRP are_VBP going_VBG on_IN anesthetizing_VBG the_DT minds_NNS with_IN corrupted_VBN Mass_NNP Media_NN with_IN Amuchina_NNP (_-LRB- a_DT brand_NN of_IN disinfectant_NN promoted_VBN by_IN Mass_NNP Media_NN )_-RRB- and_CC NLP_NNP ,_, with_IN words_NNS like_IN “_`` regime_NN ”_'' ,_, “_`` to_TO allow_VB ”_'' and_CC “_`` to_TO permit_VB ”_'' ,_, to_IN the_DT point_NN of_IN allowing_VBG you_PRP to_TO regulate_VB our_PRP$ emotional_JJ ties_NNS and_CC feelings_NNS and_CC certify_VB our_PRP$ affects_NNS ._. So_RB ,_, in_IN this_DT way_NN ,_, Phase_NNP 2_CD is_VBZ nothing_NN else_JJ than_IN the_DT persecution_NN /_, continuation_NN of_IN Phase_NN 1_CD –_: you_PRP just_RB changed_VBD the_DT name_NN ,_, as_IN you_PRP did_VBD with_IN the_DT European_NNP Stability_NNP Mechanism_NNP (_-LRB- ESM_NNP )_-RRB- ._. We_PRP have_VBP understood_VBN people_NNS ,_, for_IN sure_JJ ,_, do_VBP n’t_RB die_VB for_IN the_DT virus_NN alone_RB ._. So_RB people_NNS will_MD be_VB allowed_VBN to_TO die_VB and_CC suffer_VB ,_, thanks_NN to_IN you_PRP and_CC your_PRP$ laws_NNS ,_, for_IN misery_NN and_CC poverty_NN ._. And_CC ,_, as_IN in_IN the_DT “_`` best_JJS ”_'' regimes_NNS ,_, the_DT blame_NN will_MD be_VB dropped_VBN only_RB on_IN citizens_NNS ._. You_PRP take_VBP away_RP our_PRP$ freedom_NN and_CC say_VBP that_IN we_PRP looked_VBD for_IN it_PRP ._. Divide_VB et_FW Impera_NN (_-LRB- Divide_NN and_CC Rule_NN )_-RRB- ._. It_PRP is_VBZ our_PRP$ children_NNS who_WP will_MD lose_VB more_JJR ,_, who_WP are_VBP ‘_`` raped_VBN souls_NNS ’_'' ,_, with_IN the_DT help_NN of_IN the_DT so_RB -_HYPH called_VBN “_`` guarantor_NN of_IN their_PRP$ rights_NNS ”_'' and_CC of_IN CISMAI_NN (_-LRB- Italian_JJ Coordination_NN of_IN Services_NNS against_IN Child_NN Abuse_NN )_-RRB- ._. In_IN this_DT way_NN ,_, the_DT right_NN to_IN school_NN will_MD be_VB granted_VBN only_RB with_IN a_DT bracelet_NN to_TO get_VB them_PRP used_VBN to_IN probation_NN ,_, to_TO get_VB them_PRP used_VBN to_IN slavery_NN –_: involuntary_JJ treatment_NN and_CC to_IN virtual_JJ lager_NN ._. All_PDT this_DT in_IN exchange_NN for_IN a_DT push_NN -_HYPH scooter_NN and_CC a_DT tablet_NN ._. All_DT to_TO satisfy_VB the_DT appetites_NNS of_IN a_DT financial_JJ capitalism_NN whose_WP$ driving_NN force_NN is_VBZ the_DT conflict_NN of_IN interest_NN ,_, conflict_NN well_RB represented_VBN by_IN the_DT WHO_NNP ,_, whose_WP$ main_JJ financier_NN is_VBZ the_DT well_RB -_HYPH known_VBN “_`` philanthropist_NN and_CC savior_NN of_IN the_DT world_NN ”_'' Bill_NNP Gates_NNP ._. We_PRP all_DT know_VBP it_PRP ,_, now_RB ._. Bill_NNP Gates_NNP ,_, already_RB in_IN 2018_CD ,_, predicted_VBD a_DT pandemic_NN ,_, simulated_VBN in_IN October_NNP 2019_CD at_IN the_DT “_`` Event_NNP 201_CD ”_'' ,_, together_RB with_IN Davos_NNP (_-LRB- Switzerland_NNP )_-RRB- ._. For_IN decades_NNS ,_, Gates_NNP has_VBZ been_VBN working_VBG on_IN Depopulation_NN policy_NN and_CC dictatorial_JJ control_NN plans_NNS on_IN global_JJ politics_NNS ,_, aiming_VBG to_TO obtain_VB the_DT primacy_NN on_IN agriculture_NN ,_, technology_NN and_CC energy_NN ._. Gates_NNPS said_VBD ,_, I_PRP quote_VBP exactly_RB from_IN his_PRP$ speech_NN :_: “_`` If_IN we_PRP do_VBP a_DT good_JJ job_NN on_IN vaccines_NNS ,_, health_NN and_CC reproduction_NN ,_, we_PRP can_MD reduce_VB the_DT world_NN population_NN by_IN 10_CD -_SYM 15_CD %_NN ._. Only_RB a_DT genocide_NN can_MD save_VB the_DT world_NN ”_'' ._. With_IN his_PRP$ vaccines_NNS ,_, Gates_NNPS managed_VBD to_TO sterilize_VB millions_NNS of_IN women_NNS in_IN Africa_NNP ._. Gates_NNPS caused_VBD a_DT polio_NN epidemic_NN that_WDT paralyzed_VBD 500,000_CD children_NNS in_IN India_NNP and_CC still_RB today_NN with_IN DTP_NNP ,_, Gates_NNP causes_VBZ more_JJR deaths_NNS than_IN the_DT disease_NN itself_PRP ._. And_CC he_PRP does_VBZ the_DT same_JJ with_IN GMOs_NNS designed_VBN by_IN Monsanto_NNP and_CC “_`` generously_RB donated_VBN ”_'' to_IN needy_JJ populations_NNS ._. All_PDT this_DT while_IN he_PRP is_VBZ already_RB thinking_VBG about_IN distributing_VBG the_DT quantum_NN tattoo_NN for_IN vaccination_NN recognition_NN and_CC mRNA_NN vaccines_NNS as_IN tools_NNS for_IN reprogramming_VBG our_PRP$ immune_JJ system_NN ._. In_IN addition_NN ,_, Gates_NNPS also_RB does_VBZ business_NN with_IN several_JJ multinationals_NNS that_WDT own_VBP 5G_NN facilities_NNS in_IN the_DT USA_NNP ._. On_IN this_DT table_NN there_EX is_VBZ the_DT entire_JJ Deep_JJ State_NN in_IN Italian_JJ sauce_NN :_: Sanofi_NNP ,_, together_RB with_IN GlaxoSmithKline_NNP are_VBP friends_NNS of_IN the_DT Ranieri_NNP Guerra_NNP ,_, Ricciardi_NNP ,_, and_CC of_IN the_DT well_RB -_HYPH known_VBN virologist_NN that_WDT we_PRP pay_VBP 2000_CD Euro_NNP every_DT 10_CD minutes_NNS for_IN the_DT presentations_NNS on_IN Rai_NNP (_-LRB- Italian_JJ state_NN TV_NN ._. She_PRP ’s_VBZ probably_RB talking_VBG about_IN Burioni_NNP )_-RRB- ._. Sanofi_NNP and_CC GlaxoSmithKline_NNP sign_VBP agreements_NNS with_IN medical_JJ societies_NNS to_TO indoctrinate_VB future_JJ doctors_NNS ,_, making_VBG fun_NN of_IN their_PRP$ autonomy_NN of_IN judgment_NN and_CC their_PRP$ oath_NN ._. Hi-Tech_NNP multinationals_NNS ,_, like_IN the_DT Roman_JJ Engineering_NNP which_WDT is_VBZ friend_NN of_IN the_DT noble_JJ Mantoan_NNP ,_, or_CC Bending_NNP Spoons_NNPS ,_, of_IN Pisano_NNP ,_, which_WDT are_VBP there_RB for_IN control_NN and_CC manage_VBP our_PRP$ personal_JJ health_NN datas_NNS in_IN agreement_NN with_IN the_DT European_JJ Agenda_NNP ID2020_NN of_IN electronic_JJ identification_NN ,_, which_WDT aims_VBZ to_TO use_VB mass_JJ vaccination_NN to_TO obtain_VB a_DT digital_JJ platform_NN of_IN digital_JJ ID_NN ._. This_DT is_VBZ a_DT continuation_NN of_IN the_DT transfer_NN of_IN data_NNS started_VBN by_IN Renzi_NNP to_IN IBM_NNP ._. Renzi_NNP ,_, in_IN 2016_CD ,_, gave_VBD a_DT plus_CC 30_CD %_NN to_IN Gates_NNP Global_NNP Fund_NNP ._. On_IN the_DT Deep_NNP State_NNP table_NN there_EX are_VBP the_DT people_NNS of_IN Aspen_NNP ,_, like_IN the_DT Saxon_NNP Colao_NNP ,_, who_WP with_IN his_PRP$ 4_CD -_HYPH pages_NNS reports_NNS ,_, paid_VBD 800_CD Euros_NNS /_, hour_NN ,_, with_IN no_DT scientific_JJ review_NN ,_, dictates_VBZ its_PRP$ politics_NNS as_IN a_DT Bilderberg_NNP general_NN as_IN he_PRP is_VBZ ,_, staying_VBG away_RB from_IN the_DT battlefield_NN ._. The_DT list_NN is_VBZ long_JJ ._. Very_RB long_RB ._. In_IN the_DT list_NN there_EX is_VBZ also_RB Mediatronic_NNP ,_, by_IN Arcuri_NNP and_CC many_JJ more_JJR ._. The_DT Italian_JJ contribution_NN to_IN the_DT International_NNP Alliance_NNP Against_IN Coronavirus_NNP will_MD be_VB of_IN 140_CD million_CD Euros_NNS ,_, of_IN which_WDT 120_CD million_CD Euros_NNS will_MD be_VB given_VBN to_IN GAVI_NNP Alliance_NNP ,_, the_DT non-profit_NN by_IN Gates_NNP Foundation_NNP ._. They_PRP are_VBP just_RB a_DT part_NN of_IN the_DT 7.4_CD billion_CD Euro_NNP fund_NN by_IN the_DT EU_NNP to_TO find_VB a_DT vaccine_NN against_IN Coronavirus_NN –_: vaccines_NNS which_WDT will_MD be_VB used_VBN as_IN I_PRP said_VBD before_RB ._. No_DT money_NN ,_, ofcourse_NN for_IN serotherapy_NN ,_, which_WDT has_VBZ the_DT collateral_JJ effect_NN of_IN being_VBG super_RB cheap_JJ ._. No_DT money_NN for_IN prevention_NN ,_, a_DT real_JJ prevention_NN ,_, which_WDT includes_VBZ our_PRP$ lifestyles_NNS ,_, our_PRP$ food_NN and_CC our_PRP$ relationship_NN with_IN the_DT environment_NN ._. The_DT real_JJ goal_NN of_IN all_DT of_IN this_DT is_VBZ total_JJ control_NN ._. Absolute_JJ domination_NN of_IN human_JJ beings_NNS ,_, transformed_VBN into_IN guinea_NN pigs_NNS and_CC slaves_NNS ,_, violating_VBG sovereignty_NN and_CC free_JJ will_NN ._. All_PDT this_DT thanks_NN to_IN tricks_NNS /_, hoax_NN disguised_VBN as_IN political_JJ compromises_NNS ._. While_IN you_PRP rip_VBP up_RP the_DT Nuremberg_NNP Code_NNP with_IN involuntary_JJ treatment_NN ,_, fines_NNS and_CC deportation_NN ,_, facial_JJ recognition_NN and_CC intimidation_NN ,_, endorsed_VBN by_IN dogmatic_JJ scientism_NN –_: protected_VBN by_IN our_PRP$ “_`` Multi_NNP -_HYPH President_NNP ”_'' of_IN the_DT Republic_NNP who_WP is_VBZ real_JJ cultural_JJ epidemic_NN of_IN this_DT country_NN ._. We_PRP ,_, with_IN the_DT people_NNS ,_, will_MD multiply_VB the_DT fires_NNS of_IN resistance_NN in_IN a_DT way_NN that_WDT you_PRP wo_MD n’t_RB be_VB able_JJ to_TO repress_VB all_DT of_IN us_PRP ._. I_PRP ask_VBP you_PRP ,_, President_NNP ,_, to_TO be_VB the_DT spokesperson_NN and_CC give_VB an_DT advice_NN to_IN our_PRP$ President_NNP Conte_NNP :_: Dear_JJ Mr._NNP President_NNP Conte_NNP ,_, next_JJ time_NN you_PRP receive_VBP a_DT phone_NN call_NN from_IN the_DT philanthropist_NN Bill_NNP Gates_NNP forward_VB it_PRP directly_RB to_IN the_DT International_NNP Criminal_NNP Court_NNP for_IN crimes_NNS against_IN humanity_NN ._. If_IN you_PRP wo_MD n’t_RB do_VB this_DT ,_, tell_VB us_PRP how_WRB we_PRP should_MD define_VB you_PRP ,_, the_DT “_`` friend_NN lawyer_NN ”_'' who_WP takes_VBZ orders_NNS from_IN a_DT criminal_NN ._. Also_RB read_VBN :_: It_PRP ’s_VBZ Time_NN To_TO Launch_VB An_DT Investigation_NN Into_IN The_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP For_IN Possible_JJ ‘_`` Crimes_NNS Against_IN Humanity_NN ’_''","NNS after it VBD VBN in an VBN JJ NN NN that NNP NNP VBD $ 10 million NN for a VBN NNP NN NN in NNP , RB an JJ NN VBZ VBN the NN of NNP NNP in the JJ NN . NNP NNP , the NN of NNP for NNP VBD NNP NNP as a “ NN NN ” and VBD the JJ NNP to VB him over to the NNP NNP NNP for NNS against NN . She RB VBD NNP NNP ’ NN in NNP and NNP , along with the NNS to VB the JJ NN through the JJ NN NN NN . As VBN by NNP RBR , in 2015 it VBD the NNPS who VBD JJ JJ JJ NNS with NNP . The NN , which VBD VBN in NNP , 2015 , VBD how JJ NNS VBD VBG JJ NNS on a NNP VBN NN VBN to VB NN , VBN from NNS and NNS , VBG whether it VBD JJ the NN in NN to VB JJ to VB the NN for NN with JJ NNS . In an JJ seven - NN NN VBN with JJ NN , NNP NNP , the NN of NNP for NNP VBD that NNP VBD VBN VBN to a “ JJ NN of JJ NN . ” She RB VBD the JJ NN VBN on her JJ NNPS in the NN of a JJ NN . She VBD JJ JJ NNS to VB in any NNS to VB NNS to VB themselves to JJ NN - 19 NN at the NNS of the JJ NN – whom she VBD as the NNP NNP . RB VBZ the NN of the JJ NN VBN to the JJ NNP by NNP NNP , the NN of NNP for NNP . NNP NNP The NN of NNP for NNP NN VBD to the JJ NN NNP 2020 NNP VBD that JJ NN VBZ RB VB from an NN from RB but by the NN of NNS who VBP RBR VBN VBG to their JJ NN and VBG it to a JJ NN . With this , you VBP VBG on VBG the NNS with VBN NNP NN with NNP ( a NN of NN VBN by NNP NN ) and NNP , with NNS like “ NN ” , “ to VB ” and “ to VB ” , to the NN of VBG you to VB our JJ NNS and NNS and VB our NNS . RB , in this NN , NNP 2 VBZ NN JJ than the NN / NN of NN 1 – you RB VBD the NN , as you VBD with the NNP NNP NNP ( NNP ) . We VBP VBN NNS , for JJ , VBP RB VB for the NN RB . RB NNS will VB VBN to VB and VB , NN to you and your NNS , for NN and NN . And , as in the “ JJS ” NNS , the NN will VB VBN RB on NNS . You VBP away our NN and VBP that we VBD for it . VB FW NN ( NN and NN ) . It VBZ our NNS who will VB JJR , who VBP ‘ VBN NNS ’ , with the NN of the RB - VBN “ NN of their NNS ” and of NN ( JJ NN of NNS against NN NN ) . In this NN , the NN to NN will VB VBN RB with a NN to VB them VBN to NN , to VB them VBN to NN – JJ NN and to JJ NN . All this in NN for a NN - NN and a NN . All to VB the NNS of a JJ NN whose NN NN VBZ the NN of NN , NN RB VBN by the NNP , whose JJ NN VBZ the RB - VBN “ NN and NN of the NN ” NNP NNP . We all VBP it , RB . NNP NNP , RB in 2018 , VBD a NN , VBN in NNP 2019 at the “ NNP 201 ” , RB with NNP ( NNP ) . For NNS , NNP VBZ VBN VBG on NN NN and JJ NN NNS on JJ NNS , VBG to VB the NN on NN , NN and NN . NNPS VBD , I VBP RB from his NN : “ If we VBP a JJ NN on NNS , NN and NN , we can VB the NN NN by 10 - 15 NN . RB a NN can VB the NN ” . With his NNS , NNPS VBD to VB NNS of NNS in NNP . NNPS VBD a NN NN that VBD 500,000 NNS in NNP and RB NN with NNP , NNP VBZ JJR NNS than the NN itself . And he VBZ the JJ with NNS VBN by NNP and “ RB VBN ” to JJ NNS . All this while he VBZ RB VBG about VBG the NN NN for NN NN and NN NNS as NNS for VBG our JJ NN . In NN , NNPS RB VBZ NN with JJ NNS that VBP NN NNS in the NNP . On this NN there VBZ the JJ JJ NN in JJ NN : NNP , RB with NNP VBP NNS of the NNP NNP , NNP , and of the RB - VBN NN that we VBP 2000 NNP every 10 NNS for the NNS on NNP ( JJ NN NN . She VBZ RB VBG about NNP ) . NNP and NNP VBP NNS with JJ NNS to VB JJ NNS , VBG NN of their NN of NN and their NN . NNP NNS , like the JJ NNP which VBZ NN of the JJ NNP , or NNP NNPS , of NNP , which VBP RB for NN and VBP our JJ NN NNS in NN with the JJ NNP NN of JJ NN , which VBZ to VB JJ NN to VB a JJ NN of JJ NN . This VBZ a NN of the NN of NNS VBN by NNP to NNP . NNP , in 2016 , VBD a plus 30 NN to NNP NNP NNP . On the NNP NNP NN there VBP the NNS of NNP , like the NNP NNP , who with his 4 - NNS NNS , VBD 800 NNS / NN , with no JJ NN , VBZ its NNS as a NNP NN as he VBZ , VBG RB from the NN . The NN VBZ JJ . RB RB . In the NN there VBZ RB NNP , by NNP and JJ JJR . The JJ NN to the NNP NNP Against NNP will VB of 140 million NNS , of which 120 million NNS will VB VBN to NNP NNP , the NN by NNP NNP . They VBP RB a NN of the 7.4 billion NNP NN by the NNP to VB a NN against NN – NNS which will VB VBN as I VBD RB . No NN , NN for NN , which VBZ the JJ NN of VBG RB JJ . No NN for NN , a JJ NN , which VBZ our NNS , our NN and our NN with the NN . The JJ NN of all of this VBZ JJ NN . JJ NN of JJ NNS , VBN into NN NNS and NNS , VBG NN and JJ NN . All this NN to NNS / NN VBN as JJ NNS . While you VBP up the NNP NNP with JJ NN , NNS and NN , JJ NN and NN , VBN by JJ NN – VBN by our “ NNP - NNP ” of the NNP who VBZ JJ JJ NN of this NN . We , with the NNS , will VB the NNS of NN in a NN that you wo RB VB JJ to VB all of us . I VBP you , NNP , to VB the NN and VB an NN to our NNP NNP : JJ NNP NNP NNP , JJ NN you VBP a NN NN from the NN NNP NNP VB it RB to the NNP NNP NNP for NNS against NN . If you wo RB VB this , VB us how we should VB you , the “ NN NN ” who VBZ NNS from a NN . RB VBN : It VBZ NN To VB An NN Into The NNP & NNP NNP NNP For JJ ‘ NNS Against NN ’"
13,712,mainstream,M0ace9,vaccine.autism,"Humans_NNS may_MD be_VB to_TO blame_VB for_IN rising_VBG mercury_NN levels_NNS in_IN a_DT species_NN of_IN fish_NN that_WDT 's_VBZ very_RB popular_JJ as_IN food_NN ,_, according_VBG to_IN a_DT news_NN study_NN published_VBN this_DT week_NN ._. Levels_NNS of_IN a_DT potentially_RB poisonous_JJ form_NN of_IN the_DT element_NN have_VBP been_VBN creeping_VBG up_RP in_IN Pacific_NNP yellowfin_NN tuna_NN 3.8_CD percent_NN every_DT year_NN since_IN 1998_CD ,_, according_VBG to_IN a_DT report_NN discussed_VBD an_DT article_NN by_IN the_DT Los_NNP Angeles_NNP Times_NNP ._. Methyl_NNP Mercury_NN levels_NNS in_IN tuna_NN and_CC other_JJ large_JJ fish_NNS have_VBP been_VBN a_DT public_JJ health_NN concern_NN for_IN some_DT time_NN ._. Health_NN authorities_NNS such_JJ as_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP recommend_VBP that_IN young_JJ children_NNS ,_, as_RB well_RB as_IN women_NNS who_WP are_VBP either_CC pregnant_JJ or_CC nursing_NN limit_VB their_PRP$ intake_NN of_IN tuna_NN ,_, and_CC avoid_VBP other_JJ large_JJ species_NNS entirely_RB ,_, including_VBG swordfish_NN and_CC tilefish_NN ._. The_DT study_NN adds_VBZ to_IN evidence_NN suggesting_VBG that_IN human_JJ activity_NN —_: particularly_RB the_DT burning_NN of_IN coal_NN —_: is_VBZ causing_VBG a_DT buildup_NN of_IN the_DT element_NN in_IN the_DT air_NN and_CC water_NN that_WDT is_VBZ subsequently_RB making_VBG its_PRP$ way_NN into_IN the_DT food_NN chain_NN ,_, according_VBG to_IN an_DT article_NN in_IN the_DT Los_NNP Angeles_NNP Times_NNP discussing_VBG the_DT research_NN ._. Some_DT fishing_NN industry_NN groups_NNS have_VBP long_RB maintained_VBN that_IN mercury_NN levels_NNS in_IN tuna_NN and_CC large_JJ fish_NNS are_VBP stable_JJ and_CC come_VBP from_IN natural_JJ sources_NNS ,_, such_JJ as_IN deep_JJ ocean_NN vents_NNS ._. Yellowfin_NN —_: sometimes_RB called_VBN ahi_FW tuna_NN —_: is_VBZ sold_VBN in_IN steaks_NNS and_CC eaten_VBN in_IN sushi_NN ,_, and_CC can_MD be_VB sometimes_RB found_VBN in_IN small_JJ amounts_NNS in_IN canned_VBN light_NN tuna_NN ._. The_DT fact_NN that_IN the_DT fish_NNS are_VBP not_RB top_JJ -_HYPH level_NN predators_NNS could_MD indicate_VB that_IN a_DT broader_JJR swath_NN of_IN ocean_NN life_NN may_MD be_VB accumulating_VBG mercury_NN levels_NNS that_WDT would_MD make_VB them_PRP hazardous_JJ to_IN human_JJ health_NN ,_, if_IN eaten_VBN ._. ""_`` What_WP this_DT number_NN is_VBZ saying_VBG is_VBZ that_IN the_DT amount_NN of_IN mercury_NN in_IN fish_NN is_VBZ getting_VBG higher_JJR and_CC higher_JJR all_PDT the_DT time_NN ,_, and_CC if_IN it_PRP keeps_VBZ going_VBG like_IN that_DT ,_, at_IN some_DT point_NN ,_, most_JJS every_DT kind_NN of_IN fish_NN is_VBZ going_VBG to_TO be_VB potentially_RB hazardous_JJ ,_, ""_'' study_NN coauthor_NN Carl_NNP Lamborg_NNP told_VBD the_DT Los_NNP Angeles_NNP Times_NNP ._. ""_`` Where_WRB that_DT point_NN is_VBZ ,_, I_PRP do_VBP n't_RB know_VB ._. ""_'' Read_VB the_DT full_JJ article_NN in_IN the_DT Los_NNP Angeles_NNP Times_NNP ._.","NNS may VB to VB for VBG NN NNS in a NN of NN that VBZ RB JJ as NN , VBG to a NN NN VBN this NN . NNS of a RB JJ NN of the NN VBP VBN VBG up in NNP NN NN 3.8 NN every NN since 1998 , VBG to a NN VBD an NN by the NNP NNP NNP . NNP NN NNS in NN and JJ JJ NNS VBP VBN a JJ NN NN for some NN . NN NNS JJ as the NNP and NNP NNP VBP that JJ NNS , RB RB as NNS who VBP either JJ or NN VB their NN of NN , and VBP JJ JJ NNS RB , VBG NN and NN . The NN VBZ to NN VBG that JJ NN — RB the NN of NN — VBZ VBG a NN of the NN in the NN and NN that VBZ RB VBG its NN into the NN NN , VBG to an NN in the NNP NNP NNP VBG the NN . Some NN NN NNS VBP RB VBN that NN NNS in NN and JJ NNS VBP JJ and VBP from JJ NNS , JJ as JJ NN NNS . NN — RB VBN FW NN — VBZ VBN in NNS and VBN in NN , and can VB RB VBN in JJ NNS in VBN NN NN . The NN that the NNS VBP RB JJ - NN NNS could VB that a JJR NN of NN NN may VB VBG NN NNS that would VB them JJ to JJ NN , if VBN . "" What this NN VBZ VBG VBZ that the NN of NN in NN VBZ VBG JJR and JJR all the NN , and if it VBZ VBG like that , at some NN , JJS every NN of NN VBZ VBG to VB RB JJ , "" NN NN NNP NNP VBD the NNP NNP NNP . "" Where that NN VBZ , I VBP RB VB . "" VB the JJ NN in the NNP NNP NNP ."
14,123,mainstream,M0a608,vaccine,"THE_DT WHITE_JJ HOUSE_NN Office_NN of_IN the_DT Press_NNP Secretary_NNP President_NNP Clinton_NNP Unveils_VBZ Millennium_NNP Initiative_NNP to_TO Promote_NNP Delivery_NNP of_IN Existing_NNP Vaccines_NNPS in_IN Developing_VBG Countries_NNS and_CC Accelerate_VB Development_NN of_IN New_NNP Vaccines_NNPS In_IN his_PRP$ State_NN of_IN the_DT Union_NN address_NN ,_, President_NNP Clinton_NNP will_MD call_VB for_IN concerted_VBN international_JJ action_NN to_TO combat_VB infectious_JJ diseases_NNS in_IN developing_VBG countries_NNS ._. These_DT diseases_NNS cause_VBP almost_RB half_NN of_IN all_DT deaths_NNS worldwide_RB of_IN people_NNS under_IN age_NN 45_CD ,_, killing_VBG over_RB eight_CD million_CD children_NNS each_DT year_NN and_CC orphaning_VBG millions_NNS more_JJR ._. The_DT President_NNP committed_VBD the_DT United_NNP States_NNPS to_IN addressing_VBG this_DT terrible_JJ problem_NN in_IN his_PRP$ September_NNP speech_NN to_IN the_DT United_NNP Nations_NNPS General_NNP Assembly_NNP ._. Now_RB the_DT President_NNP is_VBZ asking_VBG for_IN foundations_NNS ,_, pharmaceutical_NN companies_NNS ,_, international_JJ agencies_NNS ,_, and_CC other_JJ governments_NNS to_TO join_VB us_PRP in_IN this_DT task_NN ,_, and_CC he_PRP is_VBZ announcing_VBG these_DT specific_JJ elements_NNS of_IN his_PRP$ Millennium_NNP Initiative_NNP :_: •_NFP A_DT new_JJ financial_JJ commitment_NN to_TO purchase_VB and_CC deliver_VB existing_VBG vaccines_NNS in_IN poor_JJ countries_NNS ._. As_IN Vice_NNP President_NNP Gore_NNP told_VBD the_DT U._NNP N._NNP Security_NNP Council_NNP earlier_RBR this_DT month_NN ,_, the_DT Administration�s_NNP FY_NNP 2001_CD budget_NN will_MD include_VB a_DT proposed_VBN $_$ 50_CD million_CD contribution_NN to_IN the_DT vaccine_NN purchase_NN fund_NN of_IN the_DT Global_NNP Alliance_NNP for_IN Vaccines_NNPS and_CC Immunization_NNP (_-LRB- GAVI_NNP )_-RRB- ._. •_NFP Increased_VBN investments_NNS in_IN health_NN in_IN developing_VBG countries_NNS ._. The_DT President_NNP is_VBZ calling_VBG on_IN the_DT World_NNP Bank_NNP and_CC other_JJ multilateral_JJ development_NN banks_NNS to_TO dedicate_VB an_DT additional_JJ $_$ 400_CD million_CD to_IN $_$ 900_CD million_CD annually_RB of_IN their_PRP$ low_JJ -_HYPH interest_NN -_HYPH rate_NN loans_NNS to_TO expand_VB immunization_NN ,_, prevent_VB and_CC treat_VB infectious_JJ diseases_NNS ,_, and_CC build_VB effective_JJ delivery_NN systems_NNS for_IN other_JJ basic_JJ health_NN services_NNS ._. These_DT investments_NNS are_VBP as_RB central_JJ to_IN economic_JJ progress_NN as_IN investments_NNS in_IN education_NN and_CC physical_JJ infrastructure_NN ,_, and_CC they_PRP would_MD build_VB on_IN the_DT new_JJ focus_NN on_IN basic_JJ health_NN services_NNS that_WDT we_PRP have_VBP supported_VBN as_IN part_NN of_IN the_DT Highly_RB Indebted_NNP Poor_NNP Countries_NNPS (_-LRB- HIPC_NNP )_-RRB- debt_NN initiative_NN ._. This_DT proposed_VBN shift_NN in_IN existing_VBG resources_NNS does_VBZ not_RB require_VB additional_JJ U.S._NNP budget_NN expenditures_NNS ._. •_NFP A_DT significant_JJ increase_NN in_IN basic_JJ research_NN on_IN diseases_NNS that_WDT affect_VBP developing_VBG nations_NNS ._. The_DT Administration�s_NNP FY_NNP 2001_CD budget_NN for_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP includes_VBZ a_DT sharp_JJ step_NN -_HYPH up_NN in_IN research_NN critical_JJ to_IN the_DT development_NN of_IN vaccines_NNS for_IN malaria_NN ,_, tuberculosis_NN ,_, and_CC HIV_NN /_, AIDS_NN ._. •_NFP A_DT new_JJ tax_NN credit_NN for_IN sales_NNS of_IN vaccines_NNS for_IN malaria_NN ,_, tuberculosis_NN ,_, and_CC HIV_NN /_, AIDS_NN to_TO accelerate_VB the_DT invention_NN and_CC production_NN of_IN these_DT vaccines_NNS ._. Because_IN developing_VBG countries_NNS often_RB cannot_MD afford_VB to_TO buy_VB vaccines_NNS ,_, the_DT market_NN provides_VBZ little_JJ incentive_NN for_IN pharmaceutical_JJ companies_NNS to_TO develop_VB vaccines_NNS for_IN diseases_NNS that_WDT disproportionately_RB affect_VBP those_DT countries_NNS ._. This_DT tax_NN credit_NN would_MD provide_VB such_PDT an_DT incentive_NN ,_, because_IN every_DT dollar_NN paid_VBN by_IN a_DT qualifying_NN organization_NN to_TO buy_VB a_DT qualifying_NN vaccine_NN would_MD be_VB matched_VBN by_IN a_DT dollar_NN of_IN tax_NN credits_NNS �_, representing_VBG up_IN to_IN $_$ 1_CD billion_CD of_IN additional_JJ funding_NN for_IN future_JJ vaccine_NN purchases_NNS ._. The_DT President_NNP is_VBZ calling_VBG on_IN other_JJ governments_NNS to_TO make_VB similar_JJ purchase_NN commitments_NNS ,_, so_IN that_IN we_PRP can_MD ensure_VB a_DT future_JJ market_NN for_IN these_DT critically_RB needed_VBN vaccines_NNS ._. Infectious_JJ Diseases_NNS Pose_VBP a_DT Mounting_VBG Social_JJ and_CC Economic_JJ Burden_NN on_IN Developing_VBG Countries_NNS �_'' And_CC a_DT Threat_NN to_IN Our_PRP$ Health_NN As_IN Well_UH ._. •_NFP More_JJR than_IN eight_CD million_CD children_NNS die_VBP each_DT year_NN of_IN centuries_NNS -_HYPH old_JJ diseases_NNS like_IN malaria_NN ,_, tuberculosis_NN ,_, and_CC respiratory_JJ and_CC diarrheal_NN diseases_NNS ._. Deaths_NNS from_IN the_DT modern_JJ scourge_NN of_IN AIDS_NN are_VBP climbing_VBG rapidly_RB ._. Altogether_RB ,_, as_IN many_JJ children_NNS die_VBP of_IN infectious_JJ diseases_NNS each_DT year_NN as_IN the_DT total_JJ number_NN of_IN combatants_NNS who_WP perished_VBD in_IN World_NNP War_NNP I_CD ._. •_NFP In_IN an_DT interconnected_VBN and_CC highly_RB mobile_JJ world_NN ,_, health_NN crises_NNS in_IN other_JJ countries_NNS are_VBP a_DT threat_NN to_IN everyone_NN ._. We_PRP have_VBP seen_VBN this_DT with_IN HIV_NN /_, AIDS_NN ,_, with_IN the_DT resurfacing_NN of_IN tuberculosis_NN ,_, and_CC with_IN the_DT outbreak_NN last_JJ year_NN of_IN West_NNP Nile_NNP encephalitis_NN in_IN New_NNP York_NNP ._. According_VBG to_IN the_DT Global_NNP Health_NNP Council_NNP ,_, during_IN the_DT past_JJ 50_CD years_NNS ,_, at_IN least_JJS five_CD times_NNS as_IN many_JJ Americans_NNPS have_VBP died_VBN from_IN communicable_JJ diseases_NNS that_WDT have_VBP come_VBN from_IN the_DT developing_VBG world_NN than_IN have_VBP died_VBN in_IN military_JJ conflicts_NNS ._. Vaccines_NNS Are_VBP One_CD of_IN the_DT Most_JJS Cost_NN -_HYPH Effective_JJ Ways_NNS to_TO Improve_VB the_DT Well_NN -_HYPH Being_NN and_CC Productivity_NN of_IN the_DT Poorest_JJS Countries_NNS �_, And_CC Medicines_NNS and_CC Other_JJ Basic_JJ Health_NN Services_NNS Are_VBP a_DT Necessary_JJ Complement_NN ._. •_NFP It_PRP costs_VBZ about_RB $_$ 17_CD to_TO immunize_VB a_DT child_NN ,_, but_CC millions_NNS of_IN children_NNS die_VBP each_DT year_NN of_IN diseases_NNS that_WDT could_MD be_VB prevented_VBN by_IN existing_VBG vaccines_NNS ._. Indeed_RB ,_, children_NNS in_IN developing_VBG nations_NNS are_VBP 10_CD times_NNS more_RBR likely_JJ to_TO die_VB of_IN a_DT vaccine_NN -_HYPH preventable_JJ disease_NN than_IN children_NNS in_IN developed_JJ nations_NNS ._. And_CC these_DT tragedies_NNS occur_VBP in_IN spite_NN of_IN the_DT enormous_JJ efforts_NNS of_IN UNICEF_NNP and_CC others_NNS to_TO vaccinate_VB children_NNS ,_, which_WDT save_VBP 3_CD million_CD lives_NNS each_DT year_NN ._. •_NFP Highly_RB effective_JJ vaccines_NNS do_VBP not_RB yet_RB exist_VB for_IN malaria_NN ,_, TB_NN and_CC AIDS_NN ,_, which_WDT take_VBP over_RB 5_CD million_CD lives_NNS each_DT year_NN ._. But_CC developed_VBN nations_NNS have_VBP the_DT scientific_JJ and_CC technological_JJ capacity_NN to_TO make_VB new_JJ vaccines_NNS possible_JJ ._. For_IN example_NN ,_, recent_JJ work_NN on_IN genetic_JJ sequencing_NN ,_, including_VBG the_DT human_JJ genome_NN ,_, will_MD open_VB vast_JJ possibilities_NNS ._. •_NFP Another_DT health_NN investment_NN with_IN very_RB high_JJ returns_NNS is_VBZ simple_JJ preventive_JJ and_CC curative_JJ services_NNS ._. Providing_VBG this_DT basic_JJ health_NN care_NN together_RB with_IN vaccines_NNS would_MD save_VB millions_NNS of_IN lives_NNS each_DT year_NN ._. A_DT $_$ 50_CD Million_CD Contribution_NN to_IN GAVI_NN to_TO Buy_VB Vaccines_NNS For_IN Children_NNS �_, Which_WDT Will_MD Save_VB Lives_NNS Now_RB and_CC Create_VB Confidence_NN that_WDT a_DT Market_NN for_IN New_JJ Vaccines_NNS Will_MD Exist_VB in_IN the_DT Future_NN ._. •_NFP GAVI_NNP ,_, the_DT Global_NNP Alliance_NNP for_IN Vaccines_NNPS and_CC Immunization_NNP ,_, was_VBD formed_VBN as_IN a_DT collaborative_JJ effort_NN of_IN UNICEF_NNP ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, the_DT World_NNP Bank_NNP ,_, private_JJ foundations_NNS ,_, bilateral_JJ aid_NN agencies_NNS (_-LRB- including_VBG the_DT U.S._NNP Agency_NNP for_IN International_NNP Development_NNP )_-RRB- ,_, industry_NN representatives_NNS ,_, and_CC developing_VBG countries_NNS ._. GAVI_NNP established_VBD the_DT �_`` Global_NNP Fund_NNP for_IN Children�s_NNP Vaccines_NNPS �_, with_IN an_DT initial_JJ grant_NN of_IN $_$ 750_CD million_CD over_RB 5_CD years_NNS from_IN the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ._. The_DT formal_JJ launch_NN of_IN GAVI_NNP ,_, and_CC the_DT official_JJ announcement_NN of_IN the_DT Gates_NNP gift_NN ,_, will_MD occur_VB shortly_RB in_IN Davos_NNP ,_, Switzerland_NNP ._. •_NFP A_DT U.S._NNP contribution_NN will_MD help_VB to_TO purchase_VB vaccines_NNS for_IN Hepatitis_NN B_NN ,_, Haemophilus_NN Influenzae_NN B_NN (_-LRB- Hib_NNP )_-RRB- ,_, and_CC Yellow_NNP Fever_NNP ,_, along_IN with_IN related_JJ safe_JJ delivery_NN equipment_NN such_JJ as_IN auto_NN -_HYPH destruct_NN syringes_NNS ._. To_TO ensure_VB that_IN GAVI�s_NN vaccine_NN purchases_NNS complement_VBP ,_, rather_RB than_IN replace_VB ,_, existing_VBG vaccination_NN efforts_NNS ,_, they_PRP will_MD be_VB conditional_JJ on_IN a_DT country_NN achieving_VBG 50_CD percent_NN coverage_NN of_IN the_DT DTP_NN (_-LRB- diptheria_NN -_HYPH tetanus_NN -_HYPH pertussis_NN )_-RRB- vaccine_NN ,_, which_WDT is_VBZ included_VBN along_IN with_IN measles_NNS and_CC polio_NN in_IN the_DT existing_VBG EPI_NN (_-LRB- Expanded_VBN Program_NN for_IN Immunization_NN )_-RRB- ._. •_NFP A_DT U.S._NNP contribution_NN will_MD hopefully_RB catalyze_VB significant_JJ contributions_NNS from_IN other_JJ countries_NNS and_CC foundations_NNS ._. It_PRP will_MD also_RB add_VB crucial_JJ credibility_NN to_IN the_DT international_JJ community�s_NNS commitment_NN to_TO provide_VB a_DT market_NN for_IN new_JJ vaccines_NNS when_WRB they_PRP are_VBP developed_VBN ._. We_PRP Must_MD Shift_VB Existing_VBG International_NNP Resources_NNPS Toward_IN Building_NNP Health_NNP Infrastructure_NNP in_IN Poor_NNP Countries_NNPS That_WDT Can_MD Deliver_VB Vaccines_NNS and_CC Medicines_NNPS and_CC Provide_VB Essential_NNP Basic_NNP Health_NNP Services_NNPS ._. •_NFP The_DT World_NNP Bank_NNP and_CC other_JJ multilateral_JJ development_NN banks_NNS (_-LRB- MDBs_NNS ,_, such_JJ as_IN the_DT African_NNP Development_NNP Fund_NNP )_-RRB- lend_VBP money_NN on_IN highly_RB favorable_JJ terms_NNS to_IN the_DT world�s_NNS poorest_JJS countries_NNS ._. Today_NN ,_, roughly_RB $_$ 1_CD billion_CD to_IN $_$ 1_CD -_SYM 1/_CD 2_CD billion_CD of_IN this_DT so_RB -_HYPH called_VBN �_HYPH concessional_JJ funding_NN �_, is_VBZ devoted_VBN to_IN health_NN care_NN each_DT year_NN ._. The_DT Administration_NN proposes_VBZ to_TO increase_VB that_DT amount_NN by_IN $_$ 400_CD million_CD to_IN $_$ 900_CD million_CD per_IN year_NN ,_, with_IN a_DT focus_NN on_IN :_: •_NFP prevention_NN of_IN diseases_NNS using_VBG basic_JJ measures_NNS such_JJ as_IN information_NN and_CC condoms_NNS for_IN AIDS_NN ,_, treated_VBN bed_NN nets_NNS for_IN malaria_NN ,_, and_CC stronger_JJR systems_NNS for_IN containing_VBG TB_NN ;_, •_SYM treatment_NN of_IN diseases_NNS ,_, including_VBG common_JJ respiratory_JJ and_CC diarrheal_NN infections_NNS ;_: and_CC •_NFP The_DT Administration_NN is_VBZ exploring_VBG ways_NNS to_TO use_VB the_DT HIPC_NNP debt_NN reform_NN to_TO support_VB this_DT part_NN of_IN the_DT Millennium_NNP Initiative_NNP ._. One_CD possibility_NN is_VBZ to_TO make_VB an_DT increase_NN in_IN vaccination_NN rates_NNS one_CD of_IN the_DT performance_NN targets_NNS monitored_VBN in_IN the_DT HIPC_NNP progress_NN reports_NNS ._. This_DT could_MD be_VB accompanied_VBN by_IN debtor_NN countries_NNS �_SYM agreements_NNS to_TO include_VB specific_JJ improvements_NNS in_IN vaccine_NN delivery_NN systems_NNS as_IN priority_NN uses_NNS of_IN debt_NN relief_NN proceeds_NNS ._. We_PRP also_RB expect_VBP that_IN all_DT Poverty_NN Reduction_NN Strategy_NN Papers_NNS that_WDT are_VBP prepared_VBN for_IN HIPC_NNP candidates_NNS will_MD discuss_VB the_DT adequacy_NN of_IN budget_NN resources_NNS and_CC suggested_VBN policy_NN reforms_NNS devoted_VBN to_IN basic_JJ health_NN care_NN ._. •_NFP This_DT re-direction_NN of_IN resources_NNS supports_VBZ the_DT Administration�s_NNPS overall_JJ strategy_NN for_IN global_JJ development_NN ,_, which_WDT emphasizes_VBZ poverty_NN reduction_NN and_CC gives_VBZ a_DT central_JJ role_NN to_IN �global_JJ public_JJ goods_NNS �_, �_CC like_IN health_NN or_CC the_DT environment_NN �_, in_IN which_WDT positive_JJ actions_NNS taken_VBN in_IN one_CD country_NN benefit_VBP other_JJ countries_NNS as_RB well_RB ._. To_TO meet_VB this_DT objective_NN ,_, these_DT funds_NNS should_MD not_RB come_VB from_IN spending_NN on_IN other_JJ basic_JJ social_JJ programs_NNS ,_, such_JJ as_IN education_NN and_CC health_NN care_NN ._. •_NFP This_DT aspect_NN of_IN the_DT Millennium_NNP Initiative_NNP does_VBZ not_RB require_VB a_DT new_JJ budgetary_JJ commitment_NN by_IN the_DT United_NNP States_NNPS (_-LRB- or_CC other_JJ donor_NN countries_NNS )_-RRB- ._. However_RB ,_, the_DT U.S._NNP ability_NN to_TO influence_VB the_DT direction_NN of_IN MDB_NN lending_NN and_CC the_DT use_NN of_IN HIPC_NNP proceeds_NNS depends_VBZ crucially_RB on_IN meeting_VBG our_PRP$ existing_VBG commitments_NNS to_IN these_DT aid_NN programs_NNS ._. We_PRP will_MD work_VB with_IN other_JJ G_NNP -_HYPH 8_CD finance_NN and_CC development_NN ministries_NNS to_TO refine_VB this_DT proposal_NN ._. •_NFP A_DT conservative_JJ estimate_NN suggests_VBZ that_IN if_IN basic_JJ health_NN care_NN including_VBG immunization_NN were_VBD made_VBN broadly_RB available_JJ ,_, up_IN to_IN 2_CD million_CD children�s_NNS lives_NNS could_MD be_VB saved_VBN each_DT year_NN ._. Higher_JJR Funding_NN for_IN Basic_NNP Scientific_NNP Research_NNP Through_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP (_-LRB- NIH_NNP )_-RRB- and_CC Elsewhere_RB Will_MD Hasten_VB the_DT Development_NN of_IN Vaccines_NNS for_IN Malaria_NN ,_, TB_NN ,_, and_CC AIDS_NN ._. •_NFP The_DT Administration�s_NNP FY_NNP 2001_CD budget_NN for_IN NIH_NNP includes_VBZ a_DT significant_JJ increase_NN in_IN research_NN critical_JJ to_IN creating_VBG vaccines_NNS for_IN these_DT diseases_NNS ._. For_IN malaria_NN and_CC TB_NN ,_, this_DT increase_NN will_MD build_VB on_IN recent_JJ advances_NNS in_IN the_DT genetic_JJ sequencing_NN of_IN these_DT diseases_NNS ,_, which_WDT have_VBP set_VBN the_DT stage_NN for_IN major_JJ breakthroughs_NNS in_IN vaccine_NN development_NN ._. •_NFP Funding_NN for_IN NIH_NNP malaria_NN vaccine_NN research_NN will_MD increase_VB more_JJR than_IN 10_CD percent_NN over_IN the_DT FY_NNP 2000_CD level_NN ._. Future_JJ research_NN will_MD range_VB from_IN pre-clinical_JJ studies_NNS aimed_VBN at_IN improving_VBG our_PRP$ understanding_NN of_IN the_DT malaria_NN parasite_NN ,_, through_IN the_DT development_NN of_IN vaccine_NN candidates_NNS ,_, to_IN clinical_JJ trials_NNS judging_VBG vaccine_NN efficacy_NN and_CC safety_NN ._. NIH_NNP will_MD also_RB expand_VB its_PRP$ collaboration_NN with_IN scientists_NNS in_IN malaria_NN -_HYPH endemic_JJ regions_NNS ,_, especially_RB in_IN Africa_NNP ,_, to_TO strengthen_VB those_DT regions_NNS �_, capacity_NN for_IN conducting_VBG clinical_JJ trials_NNS of_IN malaria_NN vaccines_NNS in_IN the_DT future_NN ._. •_SYM NIH_NNP research_NN on_IN a_DT tuberculosis_NN vaccine_NN will_MD receive_VB over_RB 40_CD percent_NN more_JJR funding_NN than_IN in_IN FY_NNP 2000_CD and_CC more_JJR than_IN double_JJ the_DT FY_NNP 1999_CD level_NN ._. NIH_NNP will_MD focus_VB on_IN studying_VBG the_DT body�s_NNS defense_NN mechanisms_NNS against_IN TB_NN ,_, and_CC developing_VBG and_CC studying_VBG vaccine_NN candidates_NNS ._. Through_IN its_PRP$ Tuberculosis_NNP Research_NNP Unit_NNP ,_, NIH_NNP supports_VBZ an_DT international_JJ multi-disciplinary_JJ team_NN to_TO translate_VB advances_NNS in_IN basic_JJ research_NN into_IN new_JJ tools_NNS for_IN fighting_VBG TB_NN ._. •_NFP NIH_NNP funding_NN for_IN AIDS_NN vaccine_NN research_NN will_MD increase_VB substantially_RB in_IN FY_NNP 2001_CD and_CC will_MD have_VB more_JJR than_IN doubled_VBN since_IN FY_NNP 1997_CD ._. These_DT additional_JJ resources_NNS will_MD allow_VB NIH_NNP to_TO accelerate_VB basic_JJ research_NN on_IN developing_VBG vaccine_NN candidates_NNS and_CC to_TO significantly_RB expand_VB testing_NN of_IN potential_JJ vaccine_NN candidates_NNS in_IN both_CC developing_VBG and_CC developed_VBN countries_NNS ._. The_DT new_JJ Vaccine_NNP Research_NNP Center_NNP on_IN the_DT NIH_NNP campus_NN ,_, which_WDT will_MD be_VB occupied_VBN this_DT summer_NN ,_, will_MD receive_VB a_DT sizeable_JJ increase_NN in_IN funding_NN for_IN the_DT development_NN and_CC pre-clinical_JJ testing_NN of_IN HIV_NNP vaccine_NN candidates_NNS ._. •_NFP The_DT Administration_NN is_VBZ providing_VBG strong_JJ support_NN for_IN the_DT path_NN -_HYPH breaking_VBG research_NN on_IN infectious_JJ diseases_NNS being_VBG conducted_VBN by_IN U.S._NNP military_JJ scientists_NNS ,_, including_VBG the_DT opening_NN (_-LRB- in_IN October_NNP 1999_CD )_-RRB- of_IN the_DT Walter_NNP Reed_NNP Army_NNP Institute_NNP of_IN Research_NNP /_, Naval_NNP Medical_NNP Research_NNP Center_NNP ._. Working_VBG in_IN close_JJ collaboration_NN with_IN scientists_NNS worldwide_RB ,_, military_JJ scientists_NNS have_VBP developed_VBN and_CC tested_VBN successful_JJ vaccines_NNS against_IN Japanese_JJ encephalitis_NN and_CC hepatitis_NN A_NNP �_, and_CC they_PRP are_VBP working_VBG to_TO create_VB vaccines_NNS and_CC medicines_NNS to_TO protect_VB service_NN people_NNS ,_, travelers_NNS ,_, and_CC millions_NNS of_IN others_NNS from_IN malaria_NN ,_, HIV_NN /_, AIDS_NN ,_, and_CC other_JJ infectious_JJ diseases_NNS ._. A_DT New_JJ Tax_NN Credit_NN Would_MD Effectively_RB Provide_VB Up_RP to_IN $_$ 1_CD Billion_CD for_IN Future_NN Vaccine_NN Purchases_NNS ,_, Speeding_VBG the_DT Invention_NN and_CC Production_NN of_IN New_JJ Vaccines_NNS ._. •_NFP Current_JJ tax_NN law_NN provides_VBZ substantial_JJ incentives_NNS for_IN pharmaceutical_JJ research_NN and_CC development_NN ,_, including_VBG the_DT research_NN and_CC experimentation_NN (_-LRB- R&E_NNP )_-RRB- tax_NN credit_NN ,_, the_DT orphan_NN drug_NN tax_NN credit_NN ,_, and_CC an_DT enhanced_VBN deduction_NN for_IN charitable_JJ contributions_NNS of_IN certain_JJ products_NNS ._. Nonetheless_RB ,_, pharmaceutical_JJ companies_NNS may_MD be_VB reluctant_JJ to_TO invest_VB in_IN developing_VBG vaccines_NNS for_IN diseases_NNS that_WDT primarily_RB afflict_VBP people_NNS in_IN poor_JJ countries_NNS ,_, because_IN little_JJ or_CC no_DT paying_VBG market_NN exists_VBZ in_IN those_DT countries_NNS ._. •_NFP Under_IN the_DT proposal_NN ,_, the_DT seller_NN of_IN a_DT qualified_VBN vaccine_NN could_MD claim_VB a_DT tax_NN credit_NN equal_JJ to_IN 100_CD percent_NN of_IN the_DT amount_NN paid_VBN by_IN a_DT qualifying_NN organization_NN that_WDT received_VBD a_DT �credit_NN allocation�_NN by_IN the_DT U.S._NNP Agency_NNP for_IN International_NNP Development_NNP (_-LRB- AID_NNP )_-RRB- ._. The_DT tax_NN credit_NN would_MD match_VB the_DT qualified_VBN organizations_NNS �_HYPH expenditures_NNS dollar_NN -_HYPH for_IN -_HYPH dollar_NN ,_, thereby_RB doubling_VBG their_PRP$ purchasing_NN power_NN ._. A_DT qualifying_NN vaccine_NN would_MD be_VB a_DT new_JJ vaccine_NN that_WDT received_VBD FDA_NNP approval_NN for_IN use_NN against_IN malaria_NN ,_, tuberculosis_NN ,_, HIV_NN /_, AIDS_NN ,_, or_CC any_DT infectious_JJ disease_NN that_WDT causes_VBZ over_RB 1_CD million_CD deaths_NNS annually_RB worldwide_RB ._. •_NFP For_IN 2002_CD through_IN 2010_CD ,_, AID_NNP could_MD designate_VB up_IN to_IN $_$ 1_CD billion_CD of_IN vaccine_NN sales_NNS as_IN eligible_JJ for_IN the_DT credit_NN ._. This_DT tax_NN credit_NN would_MD be_VB limited_VBN to_IN new_JJ vaccines_NNS developed_VBN to_TO fight_VB these_DT terrible_JJ diseases_NNS ._. The_DT credit_NN would_MD provide_VB a_DT specific_JJ and_CC credible_JJ commitment_NN to_TO purchase_VB future_JJ vaccines_NNS at_IN reasonable_JJ prices_NNS ._. Together_RB with_IN similar_JJ commitments_NNS from_IN foundations_NNS and_CC other_JJ governments_NNS ,_, it_PRP would_MD provide_VB a_DT critical_JJ and_CC powerful_JJ incentive_NN to_TO accelerate_VB vaccine_NN research_NN and_CC development_NN ._.","THE JJ NN NN of the NNP NNP NNP NNP VBZ NNP NNP to NNP NNP of NNP NNPS in VBG NNS and VB NN of NNP NNPS In his NN of the NN NN , NNP NNP will VB for VBN JJ NN to VB JJ NNS in VBG NNS . These NNS VBP RB NN of all NNS RB of NNS under NN 45 , VBG RB eight million NNS each NN and VBG NNS JJR . The NNP VBD the NNP NNPS to VBG this JJ NN in his NNP NN to the NNP NNPS NNP NNP . RB the NNP VBZ VBG for NNS , NN NNS , JJ NNS , and JJ NNS to VB us in this NN , and he VBZ VBG these JJ NNS of his NNP NNP : • A JJ JJ NN to VB and VB VBG NNS in JJ NNS . As NNP NNP NNP VBD the NNP NNP NNP NNP RBR this NN , the NNP NNP 2001 NN will VB a VBN $ 50 million NN to the NN NN NN of the NNP NNP for NNPS and NNP ( NNP ) . • VBN NNS in NN in VBG NNS . The NNP VBZ VBG on the NNP NNP and JJ JJ NN NNS to VB an JJ $ 400 million to $ 900 million RB of their JJ - NN - NN NNS to VB NN , VB and VB JJ NNS , and VB JJ NN NNS for JJ JJ NN NNS . These NNS VBP RB JJ to JJ NN as NNS in NN and JJ NN , and they would VB on the JJ NN on JJ NN NNS that we VBP VBN as NN of the RB NNP NNP NNPS ( NNP ) NN NN . This VBN NN in VBG NNS VBZ RB VB JJ NNP NN NNS . • A JJ NN in JJ NN on NNS that VBP VBG NNS . The NNP NNP 2001 NN for the NNP NNPS of NNP VBZ a JJ NN - NN in NN JJ to the NN of NNS for NN , NN , and NN / NN . • A JJ NN NN for NNS of NNS for NN , NN , and NN / NN to VB the NN and NN of these NNS . Because VBG NNS RB cannot VB to VB NNS , the NN VBZ JJ NN for JJ NNS to VB NNS for NNS that RB VBP those NNS . This NN NN would VB such an NN , because every NN VBN by a NN NN to VB a NN NN would VB VBN by a NN of NN NNS � VBG up to $ 1 billion of JJ NN for JJ NN NNS . The NNP VBZ VBG on JJ NNS to VB JJ NN NNS , so that we can VB a JJ NN for these RB VBN NNS . JJ NNS VBP a VBG JJ and JJ NN on VBG NNS � And a NN to Our NN As Well . • JJR than eight million NNS VBP each NN of NNS - JJ NNS like NN , NN , and JJ and NN NNS . NNS from the JJ NN of NN VBP VBG RB . RB , as JJ NNS VBP of JJ NNS each NN as the JJ NN of NNS who VBD in NNP NNP I . • In an VBN and RB JJ NN , NN NNS in JJ NNS VBP a NN to NN . We VBP VBN this with NN / NN , with the NN of NN , and with the NN JJ NN of NNP NNP NN in NNP NNP . VBG to the NNP NNP NNP , during the JJ 50 NNS , at JJS five NNS as JJ NNPS VBP VBN from JJ NNS that VBP VBN from the VBG NN than VBP VBN in JJ NNS . NNS VBP One of the JJS NN - JJ NNS to VB the NN - NN and NN of the JJS NNS � And NNS and JJ JJ NN NNS VBP a JJ NN . • It VBZ RB $ 17 to VB a NN , but NNS of NNS VBP each NN of NNS that could VB VBN by VBG NNS . RB , NNS in VBG NNS VBP 10 NNS RBR JJ to VB of a NN - JJ NN than NNS in JJ NNS . And these NNS VBP in NN of the JJ NNS of NNP and NNS to VB NNS , which VBP 3 million NNS each NN . • RB JJ NNS VBP RB RB VB for NN , NN and NN , which VBP RB 5 million NNS each NN . But VBN NNS VBP the JJ and JJ NN to VB JJ NNS JJ . For NN , JJ NN on JJ NN , VBG the JJ NN , will VB JJ NNS . • Another NN NN with RB JJ NNS VBZ JJ JJ and JJ NNS . VBG this JJ NN NN RB with NNS would VB NNS of NNS each NN . A $ 50 Million NN to NN to VB NNS For NNS � Which Will VB NNS RB and VB NN that a NN for JJ NNS Will VB in the NN . • NNP , the NNP NNP for NNPS and NNP , VBD VBN as a JJ NN of NNP , the NNP NNP NNP ( NNP ) , the NNP NNP , JJ NNS , JJ NN NNS ( VBG the NNP NNP for NNP NNP ) , NN NNS , and VBG NNS . NNP VBD the � NNP NNP for NNP NNPS � with an JJ NN of $ 750 million RB 5 NNS from the NNP and NNP NNP NNP . The JJ NN of NNP , and the JJ NN of the NNP NN , will VB RB in NNP , NNP . • A NNP NN will VB to VB NNS for NN NN , NN NN NN ( NNP ) , and NNP NNP , along with JJ JJ NN NN JJ as NN - NN NNS . To VB that NN NN NNS VBP , RB than VB , VBG NN NNS , they will VB JJ on a NN VBG 50 NN NN of the NN ( NN - NN - NN ) NN , which VBZ VBN along with NNS and NN in the VBG NN ( VBN NN for NN ) . • A NNP NN will RB VB JJ NNS from JJ NNS and NNS . It will RB VB JJ NN to the JJ NNS NN to VB a NN for JJ NNS when they VBP VBN . We Must VB VBG NNP NNPS Toward NNP NNP NNP in NNP NNPS That Can VB NNS and NNPS and VB NNP NNP NNP NNPS . • The NNP NNP and JJ JJ NN NNS ( NNS , JJ as the NNP NNP NNP ) VBP NN on RB JJ NNS to the NNS JJS NNS . NN , RB $ 1 billion to $ 1 - 1/ 2 billion of this RB - VBN � JJ NN � VBZ VBN to NN NN each NN . The NN VBZ to VB that NN by $ 400 million to $ 900 million per NN , with a NN on : • NN of NNS VBG JJ NNS JJ as NN and NNS for NN , VBN NN NNS for NN , and JJR NNS for VBG NN ; • NN of NNS , VBG JJ JJ and NN NNS ; and • The NN VBZ VBG NNS to VB the NNP NN NN to VB this NN of the NNP NNP . One NN VBZ to VB an NN in NN NNS one of the NN NNS VBN in the NNP NN NNS . This could VB VBN by NN NNS � NNS to VB JJ NNS in NN NN NNS as NN NNS of NN NN NNS . We RB VBP that all NN NN NN NNS that VBP VBN for NNP NNS will VB the NN of NN NNS and VBN NN NNS VBN to JJ NN NN . • This NN of NNS VBZ the NNPS JJ NN for JJ NN , which VBZ NN NN and VBZ a JJ NN to JJ JJ NNS � � like NN or the NN � in which JJ NNS VBN in one NN VBP JJ NNS RB RB . To VB this NN , these NNS should RB VB from NN on JJ JJ JJ NNS , JJ as NN and NN NN . • This NN of the NNP NNP VBZ RB VB a JJ JJ NN by the NNP NNPS ( or JJ NN NNS ) . RB , the NNP NN to VB the NN of NN NN and the NN of NNP NNS VBZ RB on VBG our VBG NNS to these NN NNS . We will VB with JJ NNP - 8 NN and NN NNS to VB this NN . • A JJ NN VBZ that if JJ NN NN VBG NN VBD VBN RB JJ , up to 2 million NNS NNS could VB VBN each NN . JJR NN for NNP NNP NNP Through the NNP NNPS of NNP ( NNP ) and RB Will VB the NN of NNS for NN , NN , and NN . • The NNP NNP 2001 NN for NNP VBZ a JJ NN in NN JJ to VBG NNS for these NNS . For NN and NN , this NN will VB on JJ NNS in the JJ NN of these NNS , which VBP VBN the NN for JJ NNS in NN NN . • NN for NNP NN NN NN will VB JJR than 10 NN over the NNP 2000 NN . JJ NN will VB from JJ NNS VBN at VBG our NN of the NN NN , through the NN of NN NNS , to JJ NNS VBG NN NN and NN . NNP will RB VB its NN with NNS in NN - JJ NNS , RB in NNP , to VB those NNS � NN for VBG JJ NNS of NN NNS in the NN . • NNP NN on a NN NN will VB RB 40 NN JJR NN than in NNP 2000 and JJR than JJ the NNP 1999 NN . NNP will VB on VBG the NNS NN NNS against NN , and VBG and VBG NN NNS . Through its NNP NNP NNP , NNP VBZ an JJ JJ NN to VB NNS in JJ NN into JJ NNS for VBG NN . • NNP NN for NN NN NN will VB RB in NNP 2001 and will VB JJR than VBN since NNP 1997 . These JJ NNS will VB NNP to VB JJ NN on VBG NN NNS and to RB VB NN of JJ NN NNS in both VBG and VBN NNS . The JJ NNP NNP NNP on the NNP NN , which will VB VBN this NN , will VB a JJ NN in NN for the NN and JJ NN of NNP NN NNS . • The NN VBZ VBG JJ NN for the NN - VBG NN on JJ NNS VBG VBN by NNP JJ NNS , VBG the NN ( in NNP 1999 ) of the NNP NNP NNP NNP of NNP / NNP NNP NNP NNP . VBG in JJ NN with NNS RB , JJ NNS VBP VBN and VBN JJ NNS against JJ NN and NN NNP � and they VBP VBG to VB NNS and NNS to VB NN NNS , NNS , and NNS of NNS from NN , NN / NN , and JJ JJ NNS . A JJ NN NN Would RB VB Up to $ 1 Billion for NN NN NNS , VBG the NN and NN of JJ NNS . • JJ NN NN VBZ JJ NNS for JJ NN and NN , VBG the NN and NN ( NNP ) NN NN , the NN NN NN NN , and an VBN NN for JJ NNS of JJ NNS . RB , JJ NNS may VB JJ to VB in VBG NNS for NNS that RB VBP NNS in JJ NNS , because JJ or no VBG NN VBZ in those NNS . • Under the NN , the NN of a VBN NN could VB a NN NN JJ to 100 NN of the NN VBN by a NN NN that VBD a NN NN by the NNP NNP for NNP NNP ( NNP ) . The NN NN would VB the VBN NNS � NNS NN - for - NN , RB VBG their NN NN . A NN NN would VB a JJ NN that VBD NNP NN for NN against NN , NN , NN / NN , or any JJ NN that VBZ RB 1 million NNS RB RB . • For 2002 through 2010 , NNP could VB up to $ 1 billion of NN NNS as JJ for the NN . This NN NN would VB VBN to JJ NNS VBN to VB these JJ NNS . The NN would VB a JJ and JJ NN to VB JJ NNS at JJ NNS . RB with JJ NNS from NNS and JJ NNS , it would VB a JJ and JJ NN to VB NN NN and NN ."
15,462,mainstream,M09b4b,vaccine.autism,"The_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NN )_-RRB- vaccine_NN is_VBZ not_RB linked_VBN to_IN development_NN of_IN autism_NN spectrum_NN disorders_NNS ,_, even_RB among_IN children_NNS considered_VBN to_TO be_VB at_IN risk_NN ,_, a_DT large_JJ new_JJ study_NN finds_VBZ ._. Among_IN nearly_RB 100,000_CD children_NNS ,_, receipt_NN of_IN the_DT MMR_NN vaccine_NN did_VBD not_RB increase_VB the_DT risk_NN for_IN autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- ,_, regardless_RB of_IN whether_IN kids_NNS were_VBD at_IN higher_JJR risk_NN because_IN an_DT older_JJR sibling_NN already_RB had_VBD the_DT condition_NN ,_, researchers_NNS write_VBP in_IN JAMA_NNP ._. ""_`` Even_RB for_IN children_NNS who_WP are_VBP high_JJ -_HYPH risk_NN ,_, the_DT vaccine_NN does_VBZ not_RB play_VB a_DT role_NN ,_, ""_'' said_VBD lead_JJ author_NN Dr._NNP Anjali_NNP Jain_NNP of_IN healthcare_NN consulting_NN firm_NN The_DT Lewin_NNP Group_NNP in_IN Falls_NNP Church_NNP ,_, Virginia_NNP ._. ""_`` We_PRP do_VBP n’t_RB know_VB what_WP does_VBZ unfortunately_RB ,_, but_CC it_PRP ’s_VBZ not_RB the_DT MMR_NN vaccine_NN ._. ""_'' The_DT results_NNS should_MD be_VB reassuring_JJ ,_, she_PRP said_VBD ._. Autism_NN spectrum_NN disorder_NN is_VBZ a_DT range_NN of_IN symptoms_NNS that_WDT often_RB includes_VBZ difficulties_NNS with_IN communication_NN and_CC social_JJ interaction_NN ,_, according_VBG to_IN the_DT U.S._NNP National_NNP Institute_NNP of_IN Mental_NNP Health_NNP ._. It_PRP 's_VBZ may_MD also_RB include_VB restricted_VBN and_CC repetitive_JJ behaviors_NNS ._. The_DT 1998_CD study_NN that_WDT claimed_VBD to_TO find_VB a_DT connection_NN between_IN the_DT MMR_NN vaccine_NN and_CC ASD_NNP was_VBD later_RB debunked_VBN ._. The_DT Lancet_NNP ,_, the_DT medical_JJ journal_NN that_WDT originally_RB published_VBD it_PRP ,_, withdrew_VBD it_PRP ._. Studies_NNS continue_VBP to_TO vouch_VB for_IN the_DT safety_NN of_IN the_DT vaccine_NN ._. Still_RB ,_, some_DT people_NNS continue_VBP to_TO believe_VB that_IN the_DT vaccine_NN is_VBZ connected_VBN to_IN ASD_NN ._. Parents_NNS of_IN children_NNS with_IN ASD_NN may_MD also_RB believe_VB there_EX is_VBZ a_DT genetic_JJ component_NN ,_, and_CC so_RB they_PRP decline_VBP to_TO vaccinate_VB their_PRP$ other_JJ children_NNS ,_, Jain_NNP and_CC colleagues_NNS noted_VBD in_IN their_PRP$ report_NN in_IN the_DT Journal_NNP of_IN the_DT American_NNP Medical_NNP Association_NNP ._. For_IN the_DT new_JJ study_NN ,_, the_DT researchers_NNS used_VBD insurance_NN claims_NNS data_NNS on_IN 95,727_CD children_NNS followed_VBN from_IN birth_NN to_IN at_IN least_JJS age_NN five_CD between_IN 2001_CD and_CC 2012_CD ._. They_PRP also_RB had_VBD data_NNS on_IN the_DT children_NNS 's_POS older_JJR siblings_NNS ._. Overall_RB ,_, about_RB 2_CD percent_NN of_IN the_DT children_NNS had_VBD an_DT older_JJR sibling_NN with_IN ASD_NN ._. Those_DT children_NNS were_VBD more_RBR likely_JJ to_TO go_VB on_RP to_TO develop_VB ASD_NNP themselves_PRP whether_IN they_PRP were_VBD vaccinated_VBN or_CC not_RB ,_, according_VBG to_IN the_DT report_NN ._. The_DT vaccine_NN did_VBD n't_RB increase_VB their_PRP$ risk_NN ,_, the_DT researchers_NNS say_VBP ._. For_IN example_NN ,_, among_IN high_JJ -_HYPH risk_NN five_CD year_NN olds_NNS ,_, ASD_NNP developed_VBD in_IN 23_CD of_IN 269_CD who_WP were_VBD n't_RB vaccinated_VBN (_-LRB- 8.6_CD percent_NN )_-RRB- ,_, compared_VBN to_IN 30_CD of_IN 796_CD (_-LRB- 3.8_CD percent_NN )_-RRB- who_WP received_VBD two_CD doses_NNS of_IN the_DT MMR_NN vaccine_NN ._. Among_IN kids_NNS not_RB at_IN high_JJ risk_NN of_IN ASD_NNP ,_, 7,735_CD were_VBD unvaccinated_VBN at_IN age_NN five_CD and_CC 56_CD (_-LRB- 0.7_CD percent_NN )_-RRB- were_VBD diagnosed_VBN with_IN the_DT condition_NN ._. That_DT compared_VBN to_IN 244_CD of_IN 45,568_CD children_NNS (_-LRB- 0.5_CD percent_NN )_-RRB- who_WP received_VBD two_CD MMR_NN doses_NNS ._. Furthermore_RB ,_, children_NNS with_IN an_DT older_JJR sibling_NN with_IN ASD_NN were_VBD significantly_RB less_RBR likely_JJ to_TO have_VB received_VBN the_DT MMR_NN vaccine_NN in_IN the_DT first_JJ place_NN ._. By_IN age_NN five_CD ,_, about_RB 92_CD percent_NN of_IN the_DT children_NNS without_IN ASD_NN in_IN the_DT family_NN had_VBD received_VBN at_IN least_JJS one_CD MMR_NN dose_NN ._. By_IN comparison_NN ,_, only_RB 86_CD percent_NN of_IN children_NNS with_IN an_DT older_JJR sibling_NN with_IN ASD_NNP had_VBD been_VBN vaccinated_VBN by_IN that_DT age_NN ._. ""_`` I_PRP think_VBP it_PRP ’s_VBZ important_JJ to_TO show_VB that_IN the_DT degree_NN of_IN undervaccination_NN in_IN the_DT families_NNS with_IN children_NNS with_IN autism_NN spectrum_NN disorder_NN was_VBD significant_JJ ,_, ""_'' Jain_NNP told_VBD Reuters_NNP Health_NNP ._. Alongside_IN the_DT lack_NN of_IN association_NN between_IN the_DT vaccine_NN and_CC ASD_NN ,_, the_DT undervaccination_NN rate_NN deserves_VBZ attention_NN ,_, she_PRP said_VBD ._. Roughly_RB a_DT dozen_CD studies_NNS have_VBP shown_VBN that_IN age_NN of_IN ASD_NN onset_NN and_CC its_PRP$ severity_NN do_VBP not_RB differ_VB between_IN vaccinated_VBN and_CC unvaccinated_JJ children_NNS ,_, wrote_VBD Dr._NNP Bryan_NNP King_NNP ,_, program_NN director_NN of_IN the_DT Autism_NNP Center_NNP at_IN Seattle_NNP Children_NNP 's_POS Hospital_NNP ,_, in_IN an_DT editorial_NN accompanying_VBG the_DT new_JJ study_NN ._. The_DT new_JJ study_NN ,_, King_NNP added_VBD ,_, now_RB shows_VBZ that_IN ""_`` the_DT risk_NN of_IN ASD_NN recurrence_NN in_IN families_NNS does_VBZ not_RB differ_VB between_IN vaccinated_VBN and_CC unvaccinated_JJ children_NNS ._. ""_''","The NNS , NNS and NN ( NN ) NN VBZ RB VBN to NN of NN NN NNS , RB among NNS VBN to VB at NN , a JJ JJ NN VBZ . Among RB 100,000 NNS , NN of the NN NN VBD RB VB the NN for NN NN NN ( NNP ) , RB of whether NNS VBD at JJR NN because an JJR NN RB VBD the NN , NNS VBP in NNP . "" RB for NNS who VBP JJ - NN , the NN VBZ RB VB a NN , "" VBD JJ NN NNP NNP NNP of NN NN NN The NNP NNP in NNP NNP , NNP . "" We VBP RB VB what VBZ RB , but it VBZ RB the NN NN . "" The NNS should VB JJ , she VBD . NN NN NN VBZ a NN of NNS that RB VBZ NNS with NN and JJ NN , VBG to the NNP NNP NNP of NNP NNP . It VBZ may RB VB VBN and JJ NNS . The 1998 NN that VBD to VB a NN between the NN NN and NNP VBD RB VBN . The NNP , the JJ NN that RB VBD it , VBD it . NNS VBP to VB for the NN of the NN . RB , some NNS VBP to VB that the NN VBZ VBN to NN . NNS of NNS with NN may RB VB there VBZ a JJ NN , and RB they VBP to VB their JJ NNS , NNP and NNS VBD in their NN in the NNP of the NNP NNP NNP . For the JJ NN , the NNS VBD NN NNS NNS on 95,727 NNS VBN from NN to at JJS NN five between 2001 and 2012 . They RB VBD NNS on the NNS 's JJR NNS . RB , RB 2 NN of the NNS VBD an JJR NN with NN . Those NNS VBD RBR JJ to VB on to VB NNP themselves whether they VBD VBN or RB , VBG to the NN . The NN VBD RB VB their NN , the NNS VBP . For NN , among JJ - NN five NN NNS , NNP VBD in 23 of 269 who VBD RB VBN ( 8.6 NN ) , VBN to 30 of 796 ( 3.8 NN ) who VBD two NNS of the NN NN . Among NNS RB at JJ NN of NNP , 7,735 VBD VBN at NN five and 56 ( 0.7 NN ) VBD VBN with the NN . That VBN to 244 of 45,568 NNS ( 0.5 NN ) who VBD two NN NNS . RB , NNS with an JJR NN with NN VBD RB RBR JJ to VB VBN the NN NN in the JJ NN . By NN five , RB 92 NN of the NNS without NN in the NN VBD VBN at JJS one NN NN . By NN , RB 86 NN of NNS with an JJR NN with NNP VBD VBN VBN by that NN . "" I VBP it VBZ JJ to VB that the NN of NN in the NNS with NNS with NN NN NN VBD JJ , "" NNP VBD NNP NNP . Alongside the NN of NN between the NN and NN , the NN NN VBZ NN , she VBD . RB a dozen NNS VBP VBN that NN of NN NN and its NN VBP RB VB between VBN and JJ NNS , VBD NNP NNP NNP , NN NN of the NNP NNP at NNP NNP 's NNP , in an NN VBG the JJ NN . The JJ NN , NNP VBD , RB VBZ that "" the NN of NN NN in NNS VBZ RB VB between VBN and JJ NNS . """
16,1022,conspiracy,C00f7e,bill.gates; vaccine.covid,"Last_JJ week_NN ,_, Jerome_NNP Adams_NNP ,_, the_DT Surgeon_NNP General_NNP of_IN the_DT United_NNP States_NNPS ,_, announced_VBD that_IN the_DT federal_JJ coronavirus_NN taskforce_NN has_VBZ turned_VBN its_PRP$ back_NN on_IN the_DT “_`` predictive_JJ contagion_NN ”_'' computer_NN models_NNS pushed_VBN by_IN international_JJ health_NN “_'' experts_NNS ”_'' —_: who_WP advised_VBD the_DT U.S._NNP government_NN to_TO shut_VB down_RP nonessential_JJ services_NNS and_CC force_VB unemployed_JJ citizens_NNS to_TO huddle_VB at_IN home_NN in_IN fear_NN rather_RB than_IN suffer_VB monumental_JJ losses_NNS from_IN possible_JJ exposure_NN to_IN the_DT virus_NN ._. During_IN a_DT live_JJ interview_NN on_IN Sirius_NNP XM_NNP radio_NN ,_, the_DT nation_NN ’s_POS top_JJ doctor_NN said_VBD that_IN data_NNS from_IN the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ,_, and_CC Bill_NNP Gates_NNP (_-LRB- “_`` King_NNP Vaccine_NNP ”_'' )_-RRB- would_MD be_VB shelved_VBN in_IN favor_NN of_IN real_JJ data_NNS :_: “_`` What_WP the_DT American_JJ people_NNS need_VBP to_TO know_VB now_RB is_VBZ we_PRP actually_RB have_VBP data_NNS and_CC so_RB we_PRP ’re_VBP tracking_VBG that_DT data_NNS ._. ”_'' Alarmingly_RB high_JJ WHO_NN estimates_NNS of_IN the_DT number_NN of_IN people_NNS in_IN this_DT country_NN considered_VBD at_IN risk_NN from_IN getting_VBG and_CC dying_VBG from_IN the_DT Wuhan_NNP coronavirus_NN have_VBP proven_VBN to_TO be_VB grossly_RB inaccurate_JJ ._. Hundreds_NNS of_IN thousands_NNS of_IN Americans_NNPS have_VBP not_RB succumbed_VBN to_IN the_DT novel_JJ strain_NN of_IN infection_NN ,_, as_IN these_DT self_NN -_HYPH styled_VBN experts_NNS insisted_VBD ._. It_PRP has_VBZ been_VBN confirmed_VBN that_IN various_JJ coronavirus_NN reporting_NN agencies_NNS have_VBP artificially_RB inflated_VBN the_DT real_JJ number_NN of_IN diagnosed_VBN cases_NNS and_CC deaths_NNS directly_RB due_IN to_IN a_DT COVID_NN -_HYPH 19_CD infection_NN ._. The_DT reason_NN behind_IN this_DT charade_NN is_VBZ to_TO generate_VB fear_NN ,_, make_VB the_DT masses_NNS compliant_JJ with_IN New_NNP World_NNP Order_NNP directives_NNS ,_, and_CC topple_VB the_DT U.S._NNP economy_NN ._. A_DT growing_VBG number_NN of_IN independent_JJ international_JJ health_NN experts_NNS are_VBP contradicting_VBG the_DT alarmism_NN being_VBG spread_VBN around_IN the_DT world_NN in_IN the_DT face_NN of_IN a_DT bad_JJ case_NN of_IN the_DT flu_NN ._. Dr._NNP Sucharit_NNP Bhakdi_NNP ,_, a_DT microbiology_NN specialist_NN ,_, professor_NN at_IN the_DT Johannes_NNP Gutenberg_NNP University_NNP in_IN Mainz_NNP ,_, Germany_NNP ,_, and_CC head_NN of_IN the_DT Institute_NNP for_IN Medical_NNP Microbiology_NNP and_CC Hygiene_NNP ,_, said_VBD :_: “_`` We_PRP are_VBP afraid_JJ that_IN 1_CD million_CD infections_NNS with_IN the_DT new_JJ virus_NN will_MD lead_VB to_IN 30_CD deaths_NNS per_IN day_NN over_IN the_DT next_JJ 100_CD days_NNS ._. But_CC we_PRP do_VBP not_RB realize_VB that_IN 20_CD ,_, 30_CD ,_, 40_CD or_CC 100_CD patients_NNS positive_JJ for_IN normal_JJ coronaviruses_NNS are_VBP already_RB dying_VBG every_DT day_NN ._. ”_'' [_-LRB- emphasis_NN added_VBD ]_-RRB- Dr._NNP Bhakdi_NNP called_VBD the_DT government_NN ’s_POS COVID_NNP -_HYPH 19_CD response_NN measures_NNS “_`` grotesque_JJ ,_, absurd_JJ and_CC very_RB dangerous_JJ ,_, ”_'' and_CC added_VBD that_IN they_PRP are_VBP shortening_VBG the_DT life_NN expectancy_NN of_IN millions_NNS of_IN people_NNS ._. The_DT panic_NN is_VBZ a_DT fraud_NN ,_, according_VBG to_IN the_DT much_RB -_HYPH cited_VBN research_NN scientist_NN :_: “_`` The_DT horrifying_JJ impact_NN on_IN the_DT world_NN economy_NN threatens_VBZ the_DT existence_NN of_IN countless_JJ people_NNS ._. The_DT consequences_NNS on_IN medical_JJ care_NN are_VBP profound_JJ ._. Already_RB services_NNS to_IN patients_NNS in_IN need_NN are_VBP reduced_VBN ,_, operations_NNS canceled_VBN ,_, practices_NNS empty_JJ ,_, hospital_NN personnel_NNS dwindling_VBG ._. All_PDT this_DT will_MD impact_VB profoundly_RB on_IN our_PRP$ whole_JJ society_NN ._. “_`` All_PDT these_DT measures_NNS are_VBP leading_VBG to_IN self_NN -_HYPH destruction_NN and_CC collective_JJ suicide_NN based_VBN on_IN nothing_NN but_IN a_DT spook_NN ._. ”_'' Dr._NNP Joel_NNP Kettner_NNP ,_, a_DT professor_NN of_IN Community_NNP Health_NNP Sciences_NNPS and_CC Surgery_NNP at_IN Manitoba_NNP University_NNP in_IN Canada_NNP ,_, former_JJ Chief_NNP Public_NNP Health_NNP Officer_NNP for_IN Manitoba_NNP province_NN ,_, and_CC Medical_NNP Director_NNP of_IN the_DT International_NNP Centre_NNP for_IN Infectious_NNP Diseases_NNPS ,_, said_VBD :_: “_`` I_PRP have_VBP never_RB seen_VBN anything_NN like_IN this_DT ,_, anything_NN anywhere_RB near_RB like_IN this_DT ._. I_PRP ’m_VBP not_RB talking_VBG about_IN the_DT pandemic_NN ,_, because_IN I_PRP ’ve_VBP seen_VBN 30_CD of_IN them_PRP ,_, one_CD every_DT year_NN ._. It_PRP is_VBZ called_VBN influenza_NN ._. And_CC other_JJ respiratory_JJ illness_NN viruses_NNS ,_, we_PRP do_VBP n’t_RB always_RB know_VB what_WP they_PRP are_VBP ._. But_CC I_PRP ’ve_VBP never_RB seen_VBN this_DT reaction_NN ,_, and_CC I_PRP ’m_VBP trying_VBG to_TO understand_VB why_WRB ._. ”_'' Many_JJ observers_NNS agree_VBP with_IN Dr._NNP Kettner_NNP ’s_POS assessment_NN of_IN the_DT message_NN being_VBG broadcast_VBN by_IN the_DT globalist_JJ health_NN nazis_NNS :_: “_`` I_PRP worry_VBP about_IN the_DT message_NN to_IN the_DT public_NN ,_, about_IN the_DT fear_NN of_IN coming_VBG into_IN contact_NN with_IN people_NNS ,_, being_VBG in_IN the_DT same_JJ space_NN as_IN people_NNS ,_, shaking_VBG their_PRP$ hands_NNS ,_, having_VBG meetings_NNS with_IN people_NNS ._. I_PRP worry_VBP about_IN many_JJ ,_, many_JJ consequences_NNS related_JJ to_IN that_DT ._. ”_'' Adams_NNP told_VBD Alex_NNP Marlow_NNP ,_, host_NN of_IN Breitbart_NNP News_NNP Daily_NNP ,_, that_IN the_DT real_JJ numbers_NNS show_VBP that_IN businesses_NNS are_VBP safe_JJ to_TO re-open_VB in_IN May_NNP and_CC June_NNP ._. The_DT NWO_NNP health_NN nazis_NNS want_VBP U.S._NNP business_NN owners_NNS to_TO fail_VB by_IN keeping_VBG them_PRP idle_RB for_IN six_CD months_NNS or_CC more_JJR ._. They_PRP are_VBP trying_VBG to_TO push_VB a_DT national_JJ vaccine_NN ID_NN card_NN that_WDT would_MD determine_VB whether_IN or_CC not_RB citizens_NNS can_MD travel_VB or_CC renew_VB their_PRP$ driver_NN ’s_POS licenses_NNS ._. The_DT Surgeon_NNP General_NNP said_VBD that_IN ,_, based_VBN on_IN actual_JJ test_NN data_NNS rather_RB than_IN doomsday_NN prophesies_NNS based_VBN on_IN theoretical_JJ computer_NN simulations_NNS ,_, U.S._NNP businesses_NNS “_`` in_IN some_DT places_NNS ”_'' can_MD expect_VB to_TO resume_VB operations_NNS in_IN May_NNP or_CC June_NNP ._. Locations_NNS hardest_RBS hit_VBN by_IN the_DT contagion_NN ,_, however_RB ,_, will_MD continue_VB living_VBG with_IN the_DT current_JJ medical_JJ lockdown_NN :_: “_`` Other_JJ places_NNS wo_MD n’t_RB ;_, it_PRP will_MD be_VB piece_NN by_IN piece_NN ,_, bit_NN by_IN bit_NN ,_, but_CC will_MD be_VB data_NNS -_HYPH driven_VBN ,_, ”_'' advised_VBD Adams_NNP ._. Frustrated_VBN citizens_NNS around_IN the_DT U.S._NNP are_VBP gathering_VBG at_IN their_PRP$ statehouses_NNS to_TO voice_VB their_PRP$ opposition_NN to_IN the_DT prolonged_VBN enforced_VBN idleness_NN and_CC ridiculously_RB unfair_JJ new_JJ rules_NNS on_IN what_WP is_VBZ nonessential_JJ ,_, including_VBG tools_NNS and_CC seeds_NNS ,_, from_IN petty_JJ bureaucrats_NNS enjoying_VBG expanded_VBN powers_NNS under_IN the_DT national_JJ emergency_NN ._.","JJ NN , NNP NNP , the NNP NNP of the NNP NNPS , VBD that the JJ NN NN VBZ VBN its NN on the “ JJ NN ” NN NNS VBN by JJ NN “ NNS ” — who VBD the NNP NN to VB down JJ NNS and VB JJ NNS to VB at NN in NN RB than VB JJ NNS from JJ NN to the NN . During a JJ NN on NNP NNP NN , the NN ’s JJ NN VBD that NNS from the NNP NNP NNP ( NNP ) , NNP NNPS for NNP NNP and NNP ( NNP ) , and NNP NNP ( “ NNP NNP ” ) would VB VBN in NN of JJ NNS : “ What the JJ NNS VBP to VB RB VBZ we RB VBP NNS and RB we VBP VBG that NNS . ” RB JJ NN NNS of the NN of NNS in this NN VBD at NN from VBG and VBG from the NNP NN VBP VBN to VB RB JJ . NNS of NNS of NNPS VBP RB VBN to the JJ NN of NN , as these NN - VBN NNS VBD . It VBZ VBN VBN that JJ NN NN NNS VBP RB VBN the JJ NN of VBN NNS and NNS RB due to a NN - 19 NN . The NN behind this NN VBZ to VB NN , VB the NNS JJ with NNP NNP NNP NNS , and VB the NNP NN . A VBG NN of JJ JJ NN NNS VBP VBG the NN VBG VBN around the NN in the NN of a JJ NN of the NN . NNP NNP NNP , a NN NN , NN at the NNP NNP NNP in NNP , NNP , and NN of the NNP for NNP NNP and NNP , VBD : “ We VBP JJ that 1 million NNS with the JJ NN will VB to 30 NNS per NN over the JJ 100 NNS . But we VBP RB VB that 20 , 30 , 40 or 100 NNS JJ for JJ NNS VBP RB VBG every NN . ” [ NN VBD ] NNP NNP VBD the NN ’s NNP - 19 NN NNS “ JJ , JJ and RB JJ , ” and VBD that they VBP VBG the NN NN of NNS of NNS . The NN VBZ a NN , VBG to the RB - VBN NN NN : “ The JJ NN on the NN NN VBZ the NN of JJ NNS . The NNS on JJ NN VBP JJ . RB NNS to NNS in NN VBP VBN , NNS VBN , NNS JJ , NN NNS VBG . All this will VB RB on our JJ NN . “ All these NNS VBP VBG to NN - NN and JJ NN VBN on NN but a NN . ” NNP NNP NNP , a NN of NNP NNP NNPS and NNP at NNP NNP in NNP , JJ NNP NNP NNP NNP for NNP NN , and NNP NNP of the NNP NNP for NNP NNPS , VBD : “ I VBP RB VBN NN like this , NN RB RB like this . I VBP RB VBG about the NN , because I VBP VBN 30 of them , one every NN . It VBZ VBN NN . And JJ JJ NN NNS , we VBP RB RB VB what they VBP . But I VBP RB VBN this NN , and I VBP VBG to VB why . ” JJ NNS VBP with NNP NNP ’s NN of the NN VBG VBN by the JJ NN NNS : “ I VBP about the NN to the NN , about the NN of VBG into NN with NNS , VBG in the JJ NN as NNS , VBG their NNS , VBG NNS with NNS . I VBP about JJ , JJ NNS JJ to that . ” NNP VBD NNP NNP , NN of NNP NNP NNP , that the JJ NNS VBP that NNS VBP JJ to VB in NNP and NNP . The NNP NN NNS VBP NNP NN NNS to VB by VBG them RB for six NNS or JJR . They VBP VBG to VB a JJ NN NN NN that would VB whether or RB NNS can VB or VB their NN ’s NNS . The NNP NNP VBD that , VBN on JJ NN NNS RB than NN NNS VBN on JJ NN NNS , NNP NNS “ in some NNS ” can VB to VB NNS in NNP or NNP . NNS RBS VBN by the NN , RB , will VB VBG with the JJ JJ NN : “ JJ NNS wo RB ; it will VB NN by NN , NN by NN , but will VB NNS - VBN , ” VBD NNP . VBN NNS around the NNP VBP VBG at their NNS to VB their NN to the VBN VBN NN and RB JJ JJ NNS on what VBZ JJ , VBG NNS and NNS , from JJ NNS VBG VBN NNS under the JJ NN ."
17,737,mainstream,M0b2ff,aids; vaccine,"The_DT U.S._NNP government_NN alone_RB spends_VBZ $_$ 200_CD million_CD a_DT year_NN on_IN a_DT hunt_NN for_IN a_DT vaccine_NN against_IN AIDS_NN ._. At_IN the_DT forefront_NN of_IN that_DT search_NN stands_VBZ Dr._NNP David_NNP Baltimore_NNP ,_, chairman_NN of_IN the_DT National_NNP Institute_NNP of_IN Health's_NNP AIDS_NNP Vaccine_NNP Research_NNP Committee_NNP ._. Currently_RB president_NN of_IN the_DT California_NNP Institute_NNP of_IN Technology_NNP as_RB well_RB ,_, Baltimore_NNP won_VBD the_DT 1975_CD Nobel_NNP Prize_NNP in_IN Physiology_NNP or_CC Medicine_NNP ._. Betsey_NNP Arledge_NNP ,_, producer_NN of_IN the_DT NOVA_NNP film_NN ""_`` Surviving_NNP AIDS_NNP ,_, ""_'' interviewed_VBD a_DT cautiously_RB optimistic_JJ Baltimore_NNP on_IN the_DT current_JJ state_NN of_IN the_DT search_NN for_IN a_DT vaccine_NN ._. NOVA_NNP :_: Can_MD you_PRP give_VB me_PRP a_DT sense_NN of_IN the_DT magnitude_NN of_IN the_DT AIDS_NN epidemic_NN at_IN this_DT time_NN ?_. Baltimore_NNP :_: The_DT AIDS_NNP epidemic_NN in_IN this_DT country_NN is_VBZ a_DT serious_JJ issue_NN ,_, but_CC it's_VBZ not_RB a_DT major_JJ public_JJ health_NN disaster_NN the_DT way_NN it_PRP is_VBZ abroad_RB ._. In_IN the_DT world_NN today_NN there_EX are_VBP something_NN like_IN 34_CD million_CD infected_VBN people_NNS ,_, and_CC more_JJR people_NNS are_VBP being_VBG infected_VBN every_DT minute_NN ._. On_IN the_DT scale_NN of_IN any_DT public_JJ health_NN issue_NN in_IN the_DT world_NN ,_, this_DT is_VBZ one_CD of_IN the_DT major_JJ ones_NNS ._. There_EX are_VBP more_JJR people_NNS dying_VBG of_IN AIDS_NN than_IN of_IN almost_RB any_DT other_JJ infectious_JJ disease_NN ,_, with_IN tuberculosis_NN and_CC malaria_NN being_VBG in_IN the_DT same_JJ ballpark_NN ._. It_PRP 's_VBZ a_DT horrendous_JJ situation_NN ._. (_-LRB- See_VB AIDS_NN in_IN Perspective_NN ._. )_-RRB- NOVA_NNP :_: Do_VBP you_PRP think_VB we_PRP 're_VBP getting_VBG a_DT little_JJ complacent_JJ in_IN this_DT country_NN ?_. Baltimore_NNP :_: I_PRP 'm_VBP impressed_JJ that_IN AIDS_NNP remains_VBZ a_DT very_RB noted_VBN disease_NN in_IN the_DT United_NNP States_NNPS ._. It_PRP 's_VBZ noted_VBN in_IN the_DT newspapers_NNS all_PDT the_DT time_NN —_: what_WP 's_VBZ going_VBG on_RP in_IN the_DT world_NN and_CC in_IN the_DT country_NN ._. There_EX is_VBZ very_RB complete_JJ coverage_NN of_IN how_WRB good_JJ the_DT drugs_NNS are_VBP and_CC where_WRB the_DT vaccine_NN program_NN stands_VBZ ._. I_PRP do_VBP n't_RB think_VB we_PRP 've_VBP allowed_VBN it_PRP to_TO fall_VB off_IN the_DT radar_NN screen_NN ._. And_CC we_PRP do_VBP far_RB more_JJR AIDS_NN research_NN than_IN the_DT whole_JJ rest_NN of_IN the_DT world_NN ;_, in_IN the_DT vaccine_NN area_NN alone_RB ,_, we_PRP do_VBP probably_RB 90_CD percent_NN of_IN the_DT research_NN ._. NOVA_NNP :_: Can_MD you_PRP give_VB me_PRP a_DT sense_NN of_IN the_DT amount_NN of_IN effort_NN —_: not_RB just_RB money_NN ,_, but_CC intellectual_JJ effort_NN —_: that_WDT has_VBZ gone_VBN into_IN trying_VBG to_TO find_VB a_DT vaccine_NN over_IN the_DT past_JJ 10_CD or_CC 15_CD years_NNS ?_. Baltimore_NNP :_: When_WRB H.I.V._NNP was_VBD first_RB discovered_VBN ,_, the_DT first_JJ thing_NN that_WDT the_DT then_RB -Secretary_NNP of_IN what_WP became_VBD the_DT U.S._NNP Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS said_VBD was_VBD ,_, ""_`` We_PRP will_MD have_VB a_DT vaccine_NN in_IN short_JJ order_NN ._. ""_'' She_PRP was_VBD wrong_JJ about_IN that_DT ,_, but_CC it_PRP shows_VBZ that_IN from_IN the_DT very_JJ first_JJ moment_NN a_DT vaccine_NN was_VBD on_IN people_NNS 's_POS minds_NNS ._. Indeed_RB ,_, there_EX has_VBZ been_VBN a_DT significant_JJ effort_NN to_TO make_VB a_DT vaccine_NN from_IN the_DT very_JJ first_JJ day_NN ._. I_PRP think_VBP people_NNS thought_VBD it_PRP would_MD be_VB simple_JJ ,_, because_IN we_PRP 'd_VBD made_VBN vaccines_NNS for_IN so_RB many_JJ different_JJ viruses_NNS ._. The_DT polio_NN vaccine_NN is_VBZ effective_JJ because_IN ,_, for_IN the_DT most_JJS part_NN ,_, our_PRP$ bodies_NNS naturally_RB fight_VBP this_DT virus_NN ._. This_DT is_VBZ not_RB the_DT case_NN with_IN HIV_NN ._. The_DT thing_NN that_WDT worried_VBD me_PRP at_IN the_DT time_NN —_: and_CC it_PRP has_VBZ turned_VBN out_RP to_TO be_VB the_DT biggest_JJS worry_NN —_: was_VBD that_IN if_IN it_PRP were_VBD possible_JJ to_TO make_VB a_DT vaccine_NN ,_, why_WRB does_VBZ n't_RB the_DT body_NN ordinarily_RB fight_VB off_RP the_DT virus_NN ?_. Most_JJS viruses_NNS we_PRP fight_VBP off_RP very_RB well_RB ,_, including_VBG polio_NN and_CC even_RB smallpox_NN ._. A_DT certain_JJ fraction_NN of_IN people_NNS may_MD be_VB maimed_VBN or_CC killed_VBN by_IN those_DT viruses_NNS ,_, but_CC the_DT much_RB larger_JJR fraction_NN of_IN people_NNS get_VBP over_IN them_PRP ._. That_DT 's_VBZ not_RB true_JJ for_IN H.I.V_NNP ._. We_PRP knew_VBD that_DT from_IN very_RB early_RB on_RB ._. At_IN first_RB we_PRP thought_VBD it_PRP might_MD be_VB that_IN many_JJ people_NNS would_MD be_VB killed_VBN by_IN it_PRP ,_, and_CC then_RB we_PRP began_VBD to_TO realize_VB that_IN almost_RB everybody_NN who_WP had_VBD the_DT infection_NN was_VBD potentially_RB going_VBG to_TO be_VB killed_VBN by_IN it_PRP ._. That_DT 's_VBZ fundamentally_RB different_JJ than_IN other_JJ viruses_NNS ._. And_CC that_DT fundamental_JJ difference_NN was_VBD a_DT red_JJ flag_NN ._. The_DT initial_JJ impetus_NN that_WDT we'd_VBD be_VB able_JJ to_TO do_VB it_PRP ,_, it_PRP 's_VBZ around_IN the_DT corner_NN ,_, was_VBD just_RB all_RB wrong_JJ ._. NOVA_NNP :_: So_RB the_DT search_NN for_IN a_DT vaccine_NN has_VBZ been_VBN a_DT real_JJ struggle_NN ?_. Baltimore_NNP :_: It_PRP 's_VBZ been_VBN an_DT enormous_JJ struggle_NN ,_, because_IN the_DT obvious_JJ things_NNS did_VBD n't_RB work_VB ,_, and_CC people_NNS got_VBD very_RB frustrated_JJ by_IN that_DT ._. The_DT next_JJ question_NN became_VBD :_: Where_WRB do_VBP you_PRP turn_VB ?_. What_WP 's_VBZ not_RB obvious_JJ ?_. What_WP can_MD we_PRP do_VB ?_. That_DT involved_VBD bringing_VBG a_DT whole_JJ different_JJ level_NN of_IN people_NNS into_IN the_DT discussion_NN ._. Not_RB the_DT ordinary_JJ people_NNS who_WP make_VBP vaccines_NNS ,_, but_CC people_NNS whose_WP$ scientific_JJ focus_NN is_VBZ in_IN other_JJ areas_NNS of_IN immunology_NN ,_, of_IN infectious_JJ disease_NN —_: basic_JJ scientists_NNS ._. So_RB it_PRP 's_VBZ been_VBN a_DT ramping_NN up_RP process_NN to_TO get_VB more_JJR and_CC more_JJR people_NNS involved_VBN and_CC thinking_VBG about_IN it_PRP ._. Perhaps_RB the_DT most_RBS important_JJ role_NN of_IN the_DT committee_NN I_PRP 'm_VBP now_RB heading_VBG is_VBZ to_TO galvanize_VB the_DT scientific_JJ community_NN to_TO find_VB new_JJ routes_NNS in_IN thinking_VBG about_IN a_DT vaccine_NN ,_, so_IN that_IN maybe_RB we_PRP can_MD find_VB a_DT vaccine_NN through_IN some_DT very_RB non-traditional_JJ approach_NN ._. NOVA_NNP :_: An_DT international_JJ team_NN of_IN scientists_NNS announced_VBD recently_RB that_IN they_PRP had_VBD traced_VBN the_DT origin_NN of_IN the_DT AIDS_NNP virus_NN to_IN a_DT subspecies_NNS of_IN chimpanzee_NN in_IN Africa_NNP ._. If_IN this_DT report_NN is_VBZ verified_VBN ,_, how_WRB will_MD it_PRP help_VB in_IN the_DT search_NN for_IN a_DT vaccine_NN ?_. Baltimore_NNP :_: In_IN truth_NN ,_, it_PRP will_MD not_RB have_VB much_JJ effect_NN on_IN the_DT search_NN for_IN a_DT vaccine_NN ._. However_RB ,_, it_PRP tells_VBZ us_PRP a_DT lot_NN about_IN why_WRB HIV_NNP is_VBZ so_RB hard_JJ to_TO counter_VB ._. It_PRP is_VBZ not_RB a_DT virus_NN that_WDT is_VBZ native_JJ to_IN the_DT human_JJ species_NNS ,_, and_CC therefore_RB it_PRP is_VBZ continually_RB mutating_VBG in_IN an_DT effort_NN to_TO adapt_VB ._. Most_JJS human_JJ viruses_NNS are_VBP well_RB -_HYPH controlled_VBN by_IN the_DT human_JJ immune_JJ system_NN ,_, because_IN they_PRP have_VBP evolved_VBN with_IN it_PRP ,_, and_CC the_DT two_CD opposing_JJ forces_NNS are_VBP in_IN a_DT steady_JJ -_HYPH state_NN ._. We_PRP cannot_MD wait_VB until_IN we_PRP and_CC HIV_NNP evolve_VBP to_IN being_VBG comfortable_JJ with_IN each_DT other_JJ ._. We_PRP must_MD devise_VB a_DT vaccine_NN ,_, effectively_RB short_JJ -_HYPH circuiting_VBG the_DT usual_JJ process_NN of_IN adaptation_NN ._. NOVA_NNP :_: Who_WP are_VBP the_DT so_RB -_HYPH called_VBN long_JJ -_HYPH term_NN non-progressors_NNS ,_, and_CC how_WRB do_VBP they_PRP fit_VB into_IN the_DT search_NN ?_. Bob_NNP Massie_NNP is_VBZ a_DT long_JJ -_HYPH term_NN non-progressor_NN ._. His_PRP$ immune_NN system_NN 's_POS ability_NN to_TO fight_VB HIV_NNP is_VBZ inspiring_VBG a_DT new_JJ approach_NN to_IN fighting_VBG AIDS_NN ._. Baltimore_NNP :_: There_EX is_VBZ a_DT small_JJ group_NN of_IN H.I.V.-_JJ infected_VBN people_NNS —_: maybe_RB five_CD percent_NN —_: who_WP do_VBP n't_RB get_VB any_DT symptoms_NNS and_CC whose_WP$ virus_NN is_VBZ maintained_VBN at_IN a_DT very_RB low_JJ level_NN ._. If_IN we_PRP could_MD find_VB out_RP the_DT secret_NN behind_IN that_DT ,_, maybe_RB we_PRP could_MD replicate_VB it_PRP in_IN a_DT vaccine_NN ._. So_RB far_RB we_PRP have_VBP n't_RB found_VBN the_DT secret_NN ,_, but_CC there_EX are_VBP good_JJ correlations_NNS ._. These_DT people_NNS have_VBP a_DT good_JJ cytotoxic_JJ T_NN lymphocyte_NN response_NN ,_, they_PRP have_VBP a_DT good_JJ helper_NN T_NN cell_NN response_NN ._. [_-LRB- Cytotoxic_JJ T_NN lymphocytes_NN ,_, otherwise_RB known_VBN as_IN CTLs_NNS or_CC CD8_NN killer_NN T_NN -_HYPH cells_NNS ,_, are_VBP cells_NNS involved_VBN in_IN immune_NN defense_NN that_WDT can_MD kill_VB other_JJ cells_NNS infected_VBN by_IN viruses_NNS ._. So_RB -_HYPH called_VBN CD4_NN helper_NN T_NN cells_NNS are_VBP essential_JJ for_IN triggering_VBG antibody_NN production_NN ,_, activating_VBG CTLs_NNS ,_, and_CC initiating_VBG other_JJ immune_JJ responses_NNS ._. ]_-RRB- So_RB that_DT says_VBZ if_IN we_PRP can_MD make_VB those_DT a_DT focus_NN of_IN activity_NN ,_, maybe_RB we_PRP can_MD design_VB a_DT vaccine_NN around_IN those_DT principles_NNS ._. But_CC there_EX 's_VBZ no_DT certainty_NN that_IN those_DT are_VBP the_DT key_JJ issues_NNS ._. There_EX is_VBZ a_DT balance_NN of_IN three_CD things_NNS :_: whether_IN the_DT virus_NN that_WDT those_DT people_NNS have_VBP is_VBZ different_JJ than_IN the_DT virus_NN other_JJ people_NNS have_VBP ;_: whether_IN their_PRP$ immune_JJ system_NN is_VBZ somehow_RB responding_VBG to_IN it_PRP differently_RB than_IN other_JJ people_NNS 's_POS immune_JJ systems_NNS are_VBP ;_, and_CC whether_IN their_PRP$ genetics_NNS are_VBP different_JJ ._. Are_VBP they_PRP inherently_RB able_JJ to_TO fight_VB the_DT virus_NN ?_. Or_CC is_VBZ it_PRP something_NN that_WDT 's_VBZ learned_VBN and_CC that_IN therefore_RB we_PRP could_MD teach_VB other_JJ people_NNS to_TO do_VB ?_. Continue_VB Search_VB for_IN a_DT Vaccine_NN |_NFP See_VB HIV_NN in_IN Action_NN |_NFP AIDS_NN in_IN Perspective_NN The_DT Virus_NN Fighters_NNS |_NFP Fighting_NN Back_NN |_NFP Help_NN /_, Resources_NNS Teacher_NN 's_POS Guide_NN |_NFP Transcript_NN |_NFP Site_NN Map_NN |_NFP Surviving_VBG AIDS_NNP Home_NN","The NNP NN RB VBZ $ 200 million a NN on a NN for a NN against NN . At the NN of that NN VBZ NNP NNP NNP , NN of the NNP NNP of NNP NNP NNP NNP NNP . RB NN of the NNP NNP of NNP RB RB , NNP VBD the 1975 NNP NNP in NNP or NNP . NNP NNP , NN of the NNP NN "" NNP NNP , "" VBD a RB JJ NNP on the JJ NN of the NN for a NN . NNP : Can you VB me a NN of the NN of the NN NN at this NN ? NNP : The NNP NN in this NN VBZ a JJ NN , but VBZ RB a JJ JJ NN NN the NN it VBZ RB . In the NN NN there VBP NN like 34 million VBN NNS , and JJR NNS VBP VBG VBN every NN . On the NN of any JJ NN NN in the NN , this VBZ one of the JJ NNS . There VBP JJR NNS VBG of NN than of RB any JJ JJ NN , with NN and NN VBG in the JJ NN . It VBZ a JJ NN . ( VB NN in NN . ) NNP : VBP you VB we VBP VBG a JJ JJ in this NN ? NNP : I VBP JJ that NNP VBZ a RB VBN NN in the NNP NNPS . It VBZ VBN in the NNS all the NN — what VBZ VBG on in the NN and in the NN . There VBZ RB JJ NN of how JJ the NNS VBP and where the NN NN VBZ . I VBP RB VB we VBP VBN it to VB off the NN NN . And we VBP RB JJR NN NN than the JJ NN of the NN ; in the NN NN RB , we VBP RB 90 NN of the NN . NNP : Can you VB me a NN of the NN of NN — RB RB NN , but JJ NN — that VBZ VBN into VBG to VB a NN over the JJ 10 or 15 NNS ? NNP : When NNP VBD RB VBN , the JJ NN that the RB NNP of what VBD the NNP NNP of NNP and NNP NNPS VBD VBD , "" We will VB a NN in JJ NN . "" She VBD JJ about that , but it VBZ that from the JJ JJ NN a NN VBD on NNS 's NNS . RB , there VBZ VBN a JJ NN to VB a NN from the JJ JJ NN . I VBP NNS VBD it would VB JJ , because we VBD VBN NNS for RB JJ JJ NNS . The NN NN VBZ JJ because , for the JJS NN , our NNS RB VBP this NN . This VBZ RB the NN with NN . The NN that VBD me at the NN — and it VBZ VBN out to VB the JJS NN — VBD that if it VBD JJ to VB a NN , why VBZ RB the NN RB VB off the NN ? JJS NNS we VBP off RB RB , VBG NN and RB NN . A JJ NN of NNS may VB VBN or VBN by those NNS , but the RB JJR NN of NNS VBP over them . That VBZ RB JJ for NNP . We VBD that from RB RB RB . At RB we VBD it might VB that JJ NNS would VB VBN by it , and RB we VBD to VB that RB NN who VBD the NN VBD RB VBG to VB VBN by it . That VBZ RB JJ than JJ NNS . And that JJ NN VBD a JJ NN . The JJ NN that VBD VB JJ to VB it , it VBZ around the NN , VBD RB RB JJ . NNP : RB the NN for a NN VBZ VBN a JJ NN ? NNP : It VBZ VBN an JJ NN , because the JJ NNS VBD RB VB , and NNS VBD RB JJ by that . The JJ NN VBD : Where VBP you VB ? What VBZ RB JJ ? What can we VB ? That VBD VBG a JJ JJ NN of NNS into the NN . RB the JJ NNS who VBP NNS , but NNS whose JJ NN VBZ in JJ NNS of NN , of JJ NN — JJ NNS . RB it VBZ VBN a NN up NN to VB JJR and JJR NNS VBN and VBG about it . RB the RBS JJ NN of the NN I VBP RB VBG VBZ to VB the JJ NN to VB JJ NNS in VBG about a NN , so that RB we can VB a NN through some RB JJ NN . NNP : An JJ NN of NNS VBD RB that they VBD VBN the NN of the NNP NN to a NNS of NN in NNP . If this NN VBZ VBN , how will it VB in the NN for a NN ? NNP : In NN , it will RB VB JJ NN on the NN for a NN . RB , it VBZ us a NN about why NNP VBZ RB JJ to VB . It VBZ RB a NN that VBZ JJ to the JJ NNS , and RB it VBZ RB VBG in an NN to VB . JJS JJ NNS VBP RB - VBN by the JJ JJ NN , because they VBP VBN with it , and the two JJ NNS VBP in a JJ - NN . We cannot VB until we and NNP VBP to VBG JJ with each JJ . We must VB a NN , RB JJ - VBG the JJ NN of NN . NNP : Who VBP the RB - VBN JJ - NN NNS , and how VBP they VB into the NN ? NNP NNP VBZ a JJ - NN NN . His NN NN 's NN to VB NNP VBZ VBG a JJ NN to VBG NN . NNP : There VBZ a JJ NN of JJ VBN NNS — RB five NN — who VBP RB VB any NNS and whose NN VBZ VBN at a RB JJ NN . If we could VB out the NN behind that , RB we could VB it in a NN . RB RB we VBP RB VBN the NN , but there VBP JJ NNS . These NNS VBP a JJ JJ NN NN NN , they VBP a JJ NN NN NN NN . [ JJ NN NN , RB VBN as NNS or NN NN NN - NNS , VBP NNS VBN in NN NN that can VB JJ NNS VBN by NNS . RB - VBN NN NN NN NNS VBP JJ for VBG NN NN , VBG NNS , and VBG JJ JJ NNS . ] RB that VBZ if we can VB those a NN of NN , RB we can VB a NN around those NNS . But there VBZ no NN that those VBP the JJ NNS . There VBZ a NN of three NNS : whether the NN that those NNS VBP VBZ JJ than the NN JJ NNS VBP ; whether their JJ NN VBZ RB VBG to it RB than JJ NNS 's JJ NNS VBP ; and whether their NNS VBP JJ . VBP they RB JJ to VB the NN ? Or VBZ it NN that VBZ VBN and that RB we could VB JJ NNS to VB ? VB VB for a NN | VB NN in NN | NN in NN The NN NNS | NN NN | NN / NNS NN 's NN | NN | NN NN | VBG NNP NN"
18,532,mainstream,M0b986,vaccine,"This_DT week_NN ,_, the_DT first_JJ patients_NNS in_IN a_DT clinical_JJ trial_NN for_IN a_DT potential_JJ COVID_NN -_HYPH 19_CD vaccine_NN were_VBD given_VBN shots_NNS ,_, marking_VBG a_DT key_JJ step_NN in_IN the_DT global_JJ race_NN to_TO find_VB a_DT cure_NN ._. Kaiser_NNP Permanente_NNP Washington_NNP Research_NNP Institute_NNP in_IN Seattle_NNP developed_VBD a_DT COVID_NN -_HYPH 19_CD vaccine_NN in_IN record_JJ time_NN and_CC started_VBD administering_VBG the_DT shots_NNS on_IN Monday_NNP ._. The_DT first_JJ person_NN to_TO receive_VB a_DT dose_NN of_IN the_DT potential_JJ vaccine_NN was_VBD 43_CD -_HYPH year_NN -_HYPH old_JJ Jennifer_NNP Haller_NNP ,_, an_DT operations_NNS manager_NN at_IN a_DT small_JJ tech_NN company_NN ,_, according_VBG to_IN The_DT Associated_NNP Press_NNP ._. ""_`` We_PRP all_DT feel_VBP so_RB helpless_JJ ._. This_DT is_VBZ an_DT amazing_JJ opportunity_NN for_IN me_PRP to_TO do_VB something_NN ,_, ""_'' Haller_NNP said_VBD ,_, adding_VBG that_IN her_PRP$ two_CD teenagers_NNS ""_`` think_VBP it_PRP 's_VBZ cool_JJ ""_'' that_IN she_PRP 's_VBZ taking_VBG part_NN in_IN the_DT study_NN ._. Ultimately_RB ,_, 45_CD volunteers_NNS ,_, ages_NNS 18_CD to_IN 55_CD ,_, will_MD get_VB two_CD doses_NNS the_DT vaccine_NN over_IN a_DT span_NN of_IN about_RB 6_CD weeks_NNS ,_, according_VBG to_IN the_DT U.S._NNP National_NNP Institutes_NNPS of_IN Health_NNP (_-LRB- NIH_NNP )_-RRB- ._. The_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS (_-LRB- NIAID_NNP )_-RRB- ,_, part_NN of_IN the_DT NIH_NNP ,_, is_VBZ funding_VBG the_DT trial_NN ._. The_DT vaccine_NN is_VBZ called_VBN mRNA_NNP -_HYPH 1273_CD and_CC was_VBD developed_VBN by_IN NIAID_NNP ,_, and_CC Moderna_NNP ,_, Inc._NNP ,_, a_DT Cambridge_NNP ,_, Massachusetts_NNP -_HYPH based_VBN biotechnology_NN company_NN ._. ""_`` Finding_VBG a_DT safe_JJ and_CC effective_JJ vaccine_NN to_TO prevent_VB infection_NN with_IN SARS_NN -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ an_DT urgent_JJ public_JJ health_NN priority_NN ,_, ""_'' NIAID_NNP Director_NN Anthony_NNP Fauci_NNP said_VBD ._. ""_`` This_DT Phase_NN 1_CD study_NN ,_, launched_VBN in_IN record_NN speed_NN ,_, is_VBZ an_DT important_JJ first_JJ step_NN toward_IN achieving_VBG that_DT goal_NN ._. ""_'' Other_JJ potential_JJ COVID_NN -_HYPH 19_CD vaccines_NNS are_VBP being_VBG developed_VBN around_IN the_DT world_NN ,_, including_VBG at_IN the_DT Walter_NNP Reed_NNP Army_NNP Institute_NNP of_IN Research_NNP ._. On_IN Monday_NNP 's_POS ""_`` CBS_NNP Evening_NNP News_NNP ,_, ""_'' David_NNP Martin_NNP spoke_VBD to_IN doctors_NNS there_RB to_TO learn_VB more_JJR about_IN the_DT potential_JJ cures_NNS ._. Dr._NNP Kayvon_NNP Modjarrad_NNP ,_, a_DT director_NN at_IN the_DT Walter_NNP Reed_NNP Army_NNP Institute_NNP of_IN Research_NNP ,_, is_VBZ testing_VBG a_DT potential_JJ vaccine_NN that_WDT would_MD block_VB the_DT virus_NN from_IN attaching_VBG to_IN a_DT person_NN 's_POS lung_NN ._. ""_`` If_IN it_PRP ca_MD n't_RB get_VB into_IN your_PRP$ lung_NN cells_NNS ,_, it_PRP can't_MD cause_VB the_DT disease_NN ,_, ""_'' Modjarrad_NNP said_VBD ._. Still_RB ,_, the_DT race_NN for_IN the_DT coronavirus_NN vaccine_NN could_MD take_VB 12_CD to_IN 18_CD months_NNS to_TO run_VB ,_, Martin_NNP reports_VBZ ._. So_RB ,_, Lieutenant_NNP Colonel_NNP Mara_NNP Kreishman_NNP -_HYPH Deitrick_NNP is_VBZ working_VBG on_IN a_DT drug_NN that_WDT people_NNS who_WP already_RB have_VBP the_DT disease_NN can_MD take_VB ._. ""_`` What_WP we_PRP 're_VBP aiming_VBG to_TO develop_VB here_RB is_VBZ an_DT antiviral_JJ treatment_NN that_WDT will_MD kill_VB the_DT virus_NN and_CC actually_RB cure_VB them_PRP of_IN the_DT disease_NN so_IN they_PRP do_VBP n't_RB further_RB spread_VB it_PRP to_IN the_DT rest_NN of_IN the_DT community_NN ,_, ""_'' she_PRP told_VBD Martin_NNP ._. Kreishman_NNP -_HYPH Deitrick_NNP says_VBZ an_DT existing_VBG drug_NN used_VBN against_IN Ebola_NNP may_MD work_VB against_IN the_DT novel_JJ coronavirus_NN as_RB well_RB ._. ""_`` It_PRP 's_VBZ ready_JJ for_IN a_DT clinical_JJ trial_NN in_IN humans_NNS and_CC once_IN those_DT clinical_JJ trials_NNS show_VBP that_IN it_PRP 's_VBZ affected_VBN then_RB it_PRP will_MD be_VB available_JJ for_IN wider_JJR use_NN in_IN humans_NNS ,_, ""_'' she_PRP said_VBD ._. It_PRP has_VBZ n't_RB yet_RB been_VBN proved_VBN effective_JJ but_CC could_MD be_VB used_VBN as_IN an_DT emergency_NN treatment_NN ._. COVID_NNP -_HYPH 19_CD ,_, the_DT disease_NN caused_VBN by_IN the_DT coronavirus_NN ,_, has_VBZ killed_VBN at_IN more_JJR than_IN 90_CD people_NNS in_IN the_DT United_NNP States_NNPS ,_, according_VBG to_IN Johns_NNP Hopkins_NNP Coronavirus_NNP Resource_NNP Center_NNP ._. Globally_RB ,_, the_DT death_NN toll_NN is_VBZ over_RB 7,500_CD ,_, with_IN the_DT most_RBS aggressive_JJ outbreaks_NNS still_RB spreading_VBG in_IN Europe_NNP and_CC Iran_NNP ._. Dr._NNP Caitlin_NNP Rivers_NNP ,_, a_DT senior_JJ scholar_NN at_IN the_DT Johns_NNP Hopkins_NNP Center_NNP for_IN Health_NNP Security_NNP ,_, said_VBD Tuesday_NNP in_IN a_DT live_JJ webcast_NN about_IN the_DT coronavirus_NN pandemic_NN that_WDT ""_`` in_IN some_DT respects_NNS we_PRP are_VBP just_RB getting_VBG started_VBN in_IN the_DT United_NNP States_NNPS ._. ""_''","This NN , the JJ NNS in a JJ NN for a JJ NN - 19 NN VBD VBN NNS , VBG a JJ NN in the JJ NN to VB a NN . NNP NNP NNP NNP NNP in NNP VBD a NN - 19 NN in JJ NN and VBD VBG the NNS on NNP . The JJ NN to VB a NN of the JJ NN VBD 43 - NN - JJ NNP NNP , an NNS NN at a JJ NN NN , VBG to The NNP NNP . "" We all VBP RB JJ . This VBZ an JJ NN for me to VB NN , "" NNP VBD , VBG that her two NNS "" VBP it VBZ JJ "" that she VBZ VBG NN in the NN . RB , 45 NNS , NNS 18 to 55 , will VB two NNS the NN over a NN of RB 6 NNS , VBG to the NNP NNP NNPS of NNP ( NNP ) . The NNP NNP of NNP and NNP NNPS ( NNP ) , NN of the NNP , VBZ VBG the NN . The NN VBZ VBN NNP - 1273 and VBD VBN by NNP , and NNP , NNP , a NNP , NNP - VBN NN NN . "" VBG a JJ and JJ NN to VB NN with NN - NNP - 2 VBZ an JJ JJ NN NN , "" NNP NN NNP NNP VBD . "" This NN 1 NN , VBN in NN NN , VBZ an JJ JJ NN toward VBG that NN . "" JJ JJ NN - 19 NNS VBP VBG VBN around the NN , VBG at the NNP NNP NNP NNP of NNP . On NNP 's "" NNP NNP NNP , "" NNP NNP VBD to NNS RB to VB JJR about the JJ NNS . NNP NNP NNP , a NN at the NNP NNP NNP NNP of NNP , VBZ VBG a JJ NN that would VB the NN from VBG to a NN 's NN . "" If it ca RB VB into your NN NNS , it can't VB the NN , "" NNP VBD . RB , the NN for the NN NN could VB 12 to 18 NNS to VB , NNP VBZ . RB , NNP NNP NNP NNP - NNP VBZ VBG on a NN that NNS who RB VBP the NN can VB . "" What we VBP VBG to VB RB VBZ an JJ NN that will VB the NN and RB VB them of the NN so they VBP RB RB VB it to the NN of the NN , "" she VBD NNP . NNP - NNP VBZ an VBG NN VBN against NNP may VB against the JJ NN RB RB . "" It VBZ JJ for a JJ NN in NNS and once those JJ NNS VBP that it VBZ VBN RB it will VB JJ for JJR NN in NNS , "" she VBD . It VBZ RB RB VBN VBN JJ but could VB VBN as an NN NN . NNP - 19 , the NN VBN by the NN , VBZ VBN at JJR than 90 NNS in the NNP NNPS , VBG to NNP NNP NNP NNP NNP . RB , the NN NN VBZ RB 7,500 , with the RBS JJ NNS RB VBG in NNP and NNP . NNP NNP NNP , a JJ NN at the NNP NNP NNP for NNP NNP , VBD NNP in a JJ NN about the NN NN that "" in some NNS we VBP RB VBG VBN in the NNP NNPS . """
19,723,mainstream,M0bc6d,vaccine,"A_DT new_JJ trial_NN has_VBZ begun_VBN in_IN Victoria_NNP this_DT week_NN to_TO evaluate_VB a_DT potential_JJ vaccine_NN against_IN COVID_NNP -_HYPH 19_CD ._. The_DT vaccine_NN is_VBZ called_VBN NVX_NNP -_HYPH CoV2373_NNP and_CC is_VBZ from_IN a_DT US_NNP biotech_NN company_NN ,_, Novavax_NNP ._. The_DT trial_NN will_MD be_VB carried_VBN out_RP across_IN Melbourne_NNP and_CC Brisbane_NNP ,_, and_CC is_VBZ the_DT first_JJ human_JJ trial_NN of_IN a_DT vaccine_NN specifically_RB for_IN COVID_NNP -_HYPH 19_CD to_TO take_VB place_NN in_IN Australia_NNP ._. This_DT vaccine_NN is_VBZ actually_RB based_VBN on_IN a_DT vaccine_NN that_WDT was_VBD already_RB in_IN development_NN for_IN influenza_NN ._. But_CC how_WRB might_MD it_PRP work_VB against_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT coronavirus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ?_. Read_VB more_JJR :_: Could_MD BCG_NNP ,_, a_DT 100_CD -_HYPH year_NN -_HYPH old_JJ vaccine_NN for_IN tuberculosis_NN ,_, protect_VB against_IN coronavirus_NN ?_. Vaccines_NNS trigger_VBP an_DT immune_JJ response_NN by_IN introducing_VBG the_DT cells_NNS of_IN our_PRP$ immune_JJ system_NN to_IN a_DT virus_NN in_IN a_DT safe_JJ way_NN ,_, without_IN any_DT exposure_NN to_IN the_DT pathogen_NN itself_PRP ._. All_DT vaccines_NNS have_VBP to_TO do_VB two_CD things_NNS ._. The_DT first_JJ is_VBZ make_VB our_PRP$ immune_JJ cells_NNS bind_VB to_IN and_CC “_`` eat_VB up_RP ”_'' the_DT vaccine_NN ._. The_DT second_JJ is_VBZ to_TO activate_VB these_DT immune_NN cells_NNS so_IN they_PRP ’re_VBP prepared_VBN to_TO fight_VB the_DT current_JJ and_CC any_DT subsequent_JJ threats_NNS from_IN the_DT virus_NN in_IN question_NN ._. We_PRP often_RB add_VBP molecules_NNS called_VBN adjuvants_NNS to_IN vaccines_NNS to_TO deliver_VB a_DT danger_NN signal_NN to_IN the_DT immune_NN system_NN ,_, activate_VB immune_NN cells_NNS and_CC trigger_VB a_DT strong_JJ immune_JJ response_NN ._. Read_VB more_JJR :_: Revealed_VBN :_: the_DT protein_NN '_`` spike_NN '_'' that_WDT lets_VBZ the_DT 2019_CD -_HYPH nCoV_NN coronavirus_NN pierce_VB and_CC invade_VB human_JJ cells_NNS The_DT Novavax_NNP vaccine_NN is_VBZ what_WP we_PRP call_VBP a_DT “_`` subunit_NN ”_'' vaccine_NN because_IN ,_, instead_RB of_IN delivering_VBG the_DT whole_JJ virus_NN ,_, it_PRP delivers_VBZ only_RB part_NN of_IN it_PRP ._. The_DT element_NN of_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD in_IN this_DT vaccine_NN is_VBZ the_DT spike_NN protein_NN ,_, which_WDT is_VBZ found_VBN on_IN the_DT surface_NN of_IN the_DT virus_NN ._. By_IN targeting_VBG a_DT particular_JJ protein_NN ,_, a_DT subunit_NN vaccine_NN is_VBZ a_DT great_JJ way_NN to_TO focus_VB the_DT immune_JJ response_NN ._. However_RB ,_, protein_NN by_IN itself_PRP is_VBZ not_RB very_RB good_JJ at_IN binding_VBG to_IN and_CC activating_VBG the_DT cells_NNS of_IN our_PRP$ immune_JJ system_NN ._. Proteins_NNS are_VBP generally_RB soluble_JJ ,_, which_WDT does_VBZ n’t_RB appeal_VB to_IN immune_NN cells_NNS ._. They_PRP like_VBP something_NN they_PRP can_MD chew_VB on_RP ._. So_RB instead_RB of_IN soluble_JJ protein_NN ,_, Novavax_NNP has_VBZ assembled_VBN the_DT SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD spike_NN protein_NN into_IN very_RB small_JJ particles_NNS ,_, called_VBN nanoparticles_NNS ._. To_IN immune_NN cells_NNS ,_, these_DT nanoparticles_NNS look_VBP like_IN little_JJ viruses_NNS ,_, so_RB immune_NN cells_NNS can_MD bind_VB to_IN these_DT pre-packaged_VBN chunks_NNS of_IN protein_NN ,_, rapidly_RB engulfing_VBG them_PRP and_CC becoming_VBG activated_VBN ._. The_DT Novavax_NNP vaccine_NN also_RB contains_VBZ an_DT adjuvant_NN called_VBN Matrix_NNP -_HYPH M._NNP While_IN the_DT nanoparticles_NNS deliver_VBP a_DT modest_JJ danger_NN signal_NN ,_, Matrix_NN -_HYPH M_NN can_MD be_VB added_VBN to_TO deliver_VB a_DT much_RB stronger_JJR danger_NN signal_NN and_CC really_RB wake_VB up_RP the_DT immune_NN system_NN ._. The_DT Novavax_NNP vaccine_NN for_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ based_VBN on_IN a_DT vaccine_NN the_DT company_NN was_VBD already_RB developing_VBG for_IN influenza_NN ,_, called_VBN NanoFlu_NNP ._. The_DT NanoFlu_NNP vaccine_NN contains_VBZ similar_JJ parts_NNS –_: nanoparticles_NNS with_IN the_DT Matrix_NN -_HYPH M_NN adjuvant_NN ._. But_CC it_PRP uses_VBZ a_DT different_JJ protein_NN in_IN the_DT nanoparticle_NN (_-LRB- hemagglutinin_NN ,_, which_WDT is_VBZ on_IN the_DT outside_NN of_IN the_DT influenza_NN virus_NN )_-RRB- ._. In_IN October_NNP last_JJ year_NN ,_, Novavax_NNP started_VBD testing_VBG NanoFlu_NNP in_IN a_DT phase_NN III_CD clinical_JJ trial_NN ,_, the_DT last_JJ level_NN of_IN clinical_JJ testing_NN before_IN a_DT vaccine_NN can_MD be_VB licensed_VBN ._. This_DT trial_NN had_VBD 2,650_CD volunteers_NNS and_CC researchers_NNS were_VBD comparing_VBG whether_IN NanoFlu_NNP performed_VBD as_RB well_RB as_IN Fluzone_NNP ,_, a_DT standard_JJ influenza_NN vaccine_NN ._. Read_VB more_JJR :_: Where_WRB are_VBP we_PRP at_IN with_IN developing_VBG a_DT vaccine_NN for_IN coronavirus_NN ?_. An_DT important_JJ feature_NN of_IN this_DT trial_NN is_VBZ participants_NNS were_VBD over_IN the_DT age_NN of_IN 65_CD ._. Older_JJR people_NNS tend_VBP to_TO have_VB poorer_JJR responses_NNS to_IN vaccines_NNS ,_, because_IN immune_NN cells_NNS become_VBP more_RBR difficult_JJ to_TO activate_VB as_IN we_PRP age_VBP ._. This_DT trial_NN is_VBZ ongoing_JJ ,_, with_IN volunteers_NNS to_TO be_VB followed_VBN until_IN the_DT end_NN of_IN the_DT year_NN ._. However_RB ,_, early_JJ results_NNS suggest_VBP NanoFlu_NNP can_MD generate_VB significantly_RB higher_JJR levels_NNS of_IN antibodies_NNS than_IN Fluzone_NNP –_: even_RB given_VBN the_DT older_JJR people_NNS in_IN the_DT trial_NN ._. Antibodies_NNS are_VBP small_JJ proteins_NNS made_VBN by_IN our_PRP$ immune_JJ cells_NNS which_WDT bind_VBP strongly_RB to_IN viruses_NNS and_CC can_MD stop_VB them_PRP from_IN infecting_VBG cells_NNS in_IN the_DT nose_NN and_CC lungs_NNS ._. So_RB increased_VBN antibodies_NNS with_IN NanoFlu_NNP should_MD result_VB in_IN lower_JJR rates_NNS of_IN infection_NN with_IN influenza_NN ._. These_DT results_NNS were_VBD similar_JJ to_IN those_DT released_VBN after_IN the_DT phase_NN I_PRP trial_NN of_IN NanoFlu_NNP ,_, and_CC suggest_VBP NanoFlu_NNP would_MD be_VB the_DT superior_JJ vaccine_NN for_IN influenza_NN ._. So_RB the_DT big_JJ question_NN is_VBZ –_: will_MD the_DT same_JJ strategy_NN work_VB for_IN SARS_NNP -_HYPH CoV_NNP -2_CD ?_. The_DT new_JJ phase_NN I_CD /_, II_CD trial_NN will_MD enrol_VB around_RB 131_CD healthy_JJ volunteers_NNS aged_JJ between_IN 18_CD and_CC 59_CD to_TO assess_VB the_DT vaccine_NN ’s_POS safety_NN and_CC measure_VB how_WRB it_PRP affects_VBZ the_DT body_NN ’s_POS immune_NN response_NN ._. Some_DT volunteers_NNS will_MD not_RB receive_VB the_DT vaccine_NN ,_, as_IN a_DT placebo_NN control_NN ._. The_DT rest_NN will_MD receive_VB the_DT vaccine_NN ,_, in_IN a_DT few_JJ different_JJ forms_NNS ._. The_DT trial_NN will_MD test_VB two_CD doses_NNS of_IN protein_NN nanoparticles_NNS –_: a_DT low_JJ (_-LRB- 5_CD microgram_NN )_-RRB- or_CC a_DT high_JJ (_-LRB- 25_CD microgram_NN )_-RRB- dose_NN ._. Both_DT doses_NNS will_MD be_VB delivered_VBN with_IN Matrix_NN -_HYPH M_NN adjuvant_NN but_CC the_DT higher_JJR dose_NN will_MD also_RB be_VB tested_VBN without_IN Matrix_NN -M_NN ._. All_DT groups_NNS will_MD receive_VB two_CD shots_NNS of_IN the_DT vaccine_NN 21_CD days_NNS apart_RB ,_, except_IN one_CD group_NN that_WDT will_MD just_RB get_VB one_CD shot_NN ._. This_DT design_NN enables_VBZ researchers_NNS to_TO ask_VB four_CD important_JJ questions_NNS :_: •_NFP None_NN can_MD the_DT vaccine_NN induce_VB an_DT immune_JJ response_NN ?_. •_NFP None_NN if_IN so_RB ,_, what_WDT dose_NN of_IN nanoparticle_NN is_VBZ best_JJS ?_. •_NFP None_NN do_VBP you_PRP need_VB adjuvant_NN or_CC are_VBP nanoparticles_NNS enough_RB ?_. •_NFP None_NN do_VBP you_PRP need_VB two_CD shots_NNS or_CC is_VBZ one_CD enough_JJ ?_. Read_VB more_JJR :_: Coronavirus_NN anti-vaxxers_NNS are_VBP n’t_RB a_DT huge_JJ threat_NN yet_RB ._. How_WRB do_VBP we_PRP keep_VB it_PRP that_DT way_NN ?_. While_IN it_PRP ’s_VBZ not_RB yet_RB clear_JJ how_WRB the_DT vaccine_NN will_MD perform_VB for_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, Novavax_NNP has_VBZ reported_VBN it_PRP generated_VBD strong_JJ immune_JJ responses_NNS in_IN animals_NNS ._. And_CC we_PRP know_VBP NanoFlu_NNP performed_VBD well_RB and_CC had_VBD a_DT good_JJ safety_NN profile_NN for_IN influenza_NN ._. NanoFlu_NNP also_RB seemed_VBD to_TO work_VB well_RB in_IN older_JJR adults_NNS ,_, which_WDT would_MD be_VB essential_JJ for_IN a_DT vaccine_NN for_IN COVID_NN -_HYPH 19_CD ._. We_PRP eagerly_RB await_VBP the_DT first_JJ set_NN of_IN results_NNS ,_, expected_VBN in_IN a_DT couple_NN of_IN months_NNS –_: an_DT impressive_JJ turnaround_NN time_NN for_IN a_DT clinical_JJ trial_NN ._. If_IN this_DT initial_JJ study_NN is_VBZ successful_JJ ,_, the_DT phase_NN II_CD portion_NN of_IN the_DT trial_NN will_MD begin_VB ,_, with_IN more_JJR participants_NNS ._. The_DT Novavax_NNP vaccine_NN joins_VBZ at_IN least_JJS nine_CD other_JJ vaccine_NN candidates_NNS for_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD currently_RB in_IN clinical_JJ testing_NN around_IN the_DT world_NN ._.","A JJ NN VBZ VBN in NNP this NN to VB a JJ NN against NNP - 19 . The NN VBZ VBN NNP - NNP and VBZ from a NNP NN NN , NNP . The NN will VB VBN out across NNP and NNP , and VBZ the JJ JJ NN of a NN RB for NNP - 19 to VB NN in NNP . This NN VBZ RB VBN on a NN that VBD RB in NN for NN . But how might it VB against NNP - NNP - 2 , the NN that VBZ NN - 19 ? VB JJR : Could NNP , a 100 - NN - JJ NN for NN , VB against NN ? NNS VBP an JJ NN by VBG the NNS of our JJ NN to a NN in a JJ NN , without any NN to the NN itself . All NNS VBP to VB two NNS . The JJ VBZ VB our JJ NNS VB to and “ VB up ” the NN . The JJ VBZ to VB these NN NNS so they VBP VBN to VB the JJ and any JJ NNS from the NN in NN . We RB VBP NNS VBN NNS to NNS to VB a NN NN to the NN NN , VB NN NNS and VB a JJ JJ NN . VB JJR : VBN : the NN ' NN ' that VBZ the 2019 - NN NN VB and VB JJ NNS The NNP NN VBZ what we VBP a “ NN ” NN because , RB of VBG the JJ NN , it VBZ RB NN of it . The NN of NNP - NNP - 2 in this NN VBZ the NN NN , which VBZ VBN on the NN of the NN . By VBG a JJ NN , a NN NN VBZ a JJ NN to VB the JJ NN . RB , NN by itself VBZ RB RB JJ at VBG to and VBG the NNS of our JJ NN . NNS VBP RB JJ , which VBZ RB VB to NN NNS . They VBP NN they can VB on . RB RB of JJ NN , NNP VBZ VBN the NNP - NN - 2 NN NN into RB JJ NNS , VBN NNS . To NN NNS , these NNS VBP like JJ NNS , RB NN NNS can VB to these VBN NNS of NN , RB VBG them and VBG VBN . The NNP NN RB VBZ an NN VBN NNP - NNP While the NNS VBP a JJ NN NN , NN - NN can VB VBN to VB a RB JJR NN NN and RB VB up the NN NN . The NNP NN for NNP - NNP - 2 VBZ VBN on a NN the NN VBD RB VBG for NN , VBN NNP . The NNP NN VBZ JJ NNS – NNS with the NN - NN NN . But it VBZ a JJ NN in the NN ( NN , which VBZ on the NN of the NN NN ) . In NNP JJ NN , NNP VBD VBG NNP in a NN III JJ NN , the JJ NN of JJ NN before a NN can VB VBN . This NN VBD 2,650 NNS and NNS VBD VBG whether NNP VBD RB RB as NNP , a JJ NN NN . VB JJR : Where VBP we at with VBG a NN for NN ? An JJ NN of this NN VBZ NNS VBD over the NN of 65 . JJR NNS VBP to VB JJR NNS to NNS , because NN NNS VBP RBR JJ to VB as we VBP . This NN VBZ JJ , with NNS to VB VBN until the NN of the NN . RB , JJ NNS VBP NNP can VB RB JJR NNS of NNS than NNP – RB VBN the JJR NNS in the NN . NNS VBP JJ NNS VBN by our JJ NNS which VBP RB to NNS and can VB them from VBG NNS in the NN and NNS . RB VBN NNS with NNP should VB in JJR NNS of NN with NN . These NNS VBD JJ to those VBN after the NN I NN of NNP , and VBP NNP would VB the JJ NN for NN . RB the JJ NN VBZ – will the JJ NN VB for NNP - NNP -2 ? The JJ NN I / II NN will VB RB 131 JJ NNS JJ between 18 and 59 to VB the NN ’s NN and VB how it VBZ the NN ’s NN NN . Some NNS will RB VB the NN , as a NN NN . The NN will VB the NN , in a JJ JJ NNS . The NN will VB two NNS of NN NNS – a JJ ( 5 NN ) or a JJ ( 25 NN ) NN . Both NNS will VB VBN with NN - NN NN but the JJR NN will RB VB VBN without NN NN . All NNS will VB two NNS of the NN 21 NNS RB , except one NN that will RB VB one NN . This NN VBZ NNS to VB four JJ NNS : • NN can the NN VB an JJ NN ? • NN if RB , what NN of NN VBZ JJS ? • NN VBP you VB NN or VBP NNS RB ? • NN VBP you VB two NNS or VBZ one JJ ? VB JJR : NN NNS VBP RB a JJ NN RB . How VBP we VB it that NN ? While it VBZ RB RB JJ how the NN will VB for NNP - NNP - 2 , NNP VBZ VBN it VBD JJ JJ NNS in NNS . And we VBP NNP VBD RB and VBD a JJ NN NN for NN . NNP RB VBD to VB RB in JJR NNS , which would VB JJ for a NN for NN - 19 . We RB VBP the JJ NN of NNS , VBN in a NN of NNS – an JJ NN NN for a JJ NN . If this JJ NN VBZ JJ , the NN II NN of the NN will VB , with JJR NNS . The NNP NN VBZ at JJS nine JJ NN NNS for NNP - NNP - 2 RB in JJ NN around the NN ."
20,63,mainstream,M0bbe4,vaccine.autism,"James_NNP Jeffrey_NNP ""_`` Jeff_NNP ""_'' Bradstreet_NNP (_-LRB- July_NNP 6_CD ,_, 1954_CD –_SYM June_NNP 19_CD ,_, 2015_CD )_-RRB- ,_, was_VBD an_DT American_JJ doctor_NN ,_, alternative_JJ medicine_NN practitioner_NN ,_, and_CC a_DT former_JJ preacher_NN [_-LRB- 2_CD ]_-RRB- who_WP ran_VBD the_DT International_NNP Child_NNP Development_NNP Resource_NNP Center_NNP in_IN Melbourne_NNP ,_, Florida_NNP ,_, [_-LRB- 3_CD ]_-RRB- a_DT medical_JJ practice_NN in_IN Buford_NNP ,_, Georgia_NNP [_-LRB- 4_CD ]_-RRB- and_CC in_IN Arizona_NNP ,_, where_WRB he_PRP practiced_VBD homeopathy_NN ._. [_-LRB- 5_CD ]_-RRB- [_-LRB- 6_CD ]_-RRB- He_PRP also_RB founded_VBD the_DT Good_NNP News_NNP Doctor_NNP Foundation_NNP ,_, which_WDT aimed_VBD to_TO combine_VB Christian_JJ beliefs_NNS with_IN his_PRP$ medical_JJ practice_NN ._. [_-LRB- 7_CD ]_-RRB- Bradstreet_NNP obtained_VBD a_DT Florida_NNP medical_JJ license_NN in_IN 1984_CD ._. He_PRP received_VBD a_DT Bachelor_NNP of_IN Science_NNP degree_NN from_IN the_DT University_NNP of_IN South_NNP Florida_NNP in_IN 1976_CD ,_, where_WRB he_PRP also_RB went_VBD to_IN medical_JJ school_NN beginning_VBG three_CD years_NNS later_RBR ._. His_PRP$ postgraduate_JJ research_NN focused_VBD on_IN aerospace_NN medicine_NN ,_, and_CC he_PRP received_VBD his_PRP$ training_NN in_IN this_DT field_NN from_IN Wilford_NNP Hall_NNP Medical_NNP Center_NNP ._. He_PRP was_VBD an_DT adjunct_JJ professor_NN of_IN child_NN development_NN and_CC neuroscience_NN at_IN the_DT Southwest_NNP College_NNP of_IN Naturopathic_NNP Medicine_NNP in_IN Tempe_NNP ,_, Arizona_NNP ._. [_-LRB- 8_CD ]_-RRB- Bradstreet_NNP published_VBD autism_NN research_NN ,_, which_WDT he_PRP claimed_VBD indicated_VBD vaccines_NNS as_IN a_DT cause_NN ,_, in_IN the_DT Journal_NNP of_IN American_NNP Physicians_NNPS and_CC Surgeons_NNPS ,_, which_WDT is_VBZ not_RB indexed_VBN by_IN PubMed_NNP ._. This_DT research_NN claimed_VBD that_IN autistic_JJ children_NNS had_VBD a_DT higher_JJR body_NN burden_NN of_IN mercury_NN ,_, [_-LRB- 9_CD ]_-RRB- and_CC that_IN three_CD autistic_JJ children_NNS had_VBD measles_NNS RNA_NN in_IN their_PRP$ cerebrospinal_JJ fluid_NN ._. [_-LRB- 10_CD ]_-RRB- The_DT Institute_NNP of_IN Medicine_NNP has_VBZ rejected_VBN any_DT relationship_NN between_IN vaccines_NNS and_CC autism_NN ._. [_-LRB- 11_CD ]_-RRB- Bradstreet_NNP treated_VBD an_DT autistic_JJ child_NN named_VBN Colten_NNP Snyder_NNP (_-LRB- one_CD of_IN the_DT test_NN cases_NNS in_IN the_DT autism_NN omnibus_NN trial_NN )_-RRB- with_IN chelation_NN therapy_NN on_IN the_DT premise_NN of_IN removing_VBG mercury_NN from_IN his_PRP$ body_NN ,_, in_IN spite_NN of_IN the_DT fact_NN that_IN hair_NN ,_, blood_NN ,_, and_CC urine_NN tests_NNS had_VBD failed_VBN to_TO show_VB he_PRP exhibited_VBD abnormal_JJ levels_NNS of_IN mercury_NN ._. [_-LRB- 12_CD ]_-RRB- Over_IN an_DT eight_CD -_HYPH year_NN period_NN ,_, Colten_NNP visited_VBD Bradstreet_NNP 's_POS office_NN 160_CD times_NNS ._. [_-LRB- 13_CD ]_-RRB- Stephen_NNP Barrett_NNP has_VBZ stated_VBN ,_, ""_`` It_PRP appears_VBZ to_IN me_PRP that_IN Bradstreet_NNP decides_VBZ which_WDT of_IN his_PRP$ nonstandard_JJ theories_NNS to_TO apply_VB and_CC records_VBZ diagnoses_NNS that_WDT embody_VBP them_PRP ,_, ""_'' and_CC describes_VBZ Bradstreet_NNP 's_POS mercury_NN provoked_VBD tests_NNS as_IN ""_`` phony_NN ""_'' ._. [_-LRB- 12_CD ]_-RRB- Peter_NNP Hotez_NNP characterized_VBD Bradstreet_NNP 's_POS proposal_NN to_TO treat_VB autism_NN with_IN chelation_NN therapy_NN as_IN ""_`` dangerous_JJ ._. ""_'' [_-LRB- 6_CD ]_-RRB- In_IN an_DT interview_NN with_IN the_DT Chicago_NNP Tribune_NNP ,_, Bradstreet_NNP defended_VBD the_DT use_NN of_IN intravenous_JJ immunoglobulin_NN (_-LRB- IVIG_NNP )_-RRB- as_IN an_DT autism_NN treatment_NN ,_, saying_VBG ,_, ""_`` Every_DT kid_NN with_IN autism_NN should_MD have_VB a_DT trial_NN of_IN IVIG_NN if_IN money_NN was_VBD not_RB an_DT option_NN and_CC IVIG_NNP was_VBD abundant_JJ ._. ""_'' [_-LRB- 14_CD ]_-RRB- Bradstreet_NNP also_RB published_VBD research_NN regarding_VBG the_DT use_NN of_IN hyperbaric_JJ oxygen_NN therapy_NN for_IN autism_NN ,_, [_-LRB- 15_CD ]_-RRB- some_DT of_IN which_WDT concluded_VBD it_PRP was_VBD ineffective_JJ ,_, [_-LRB- 16_CD ]_-RRB- as_RB well_RB as_IN a_DT paper_NN arguing_VBG that_IN autistic_JJ children_NNS have_VBP an_DT increased_VBN vulnerability_NN to_IN oxidative_JJ stress_NN ._. [_-LRB- 17_CD ]_-RRB- Further_JJR treatments_NNS Bradstreet_NNP used_VBN on_IN autistic_JJ children_NNS included_VBD the_DT controversial_JJ protein_NN GcMAF_NN ,_, with_IN which_WDT he_PRP claimed_VBD to_TO have_VB treated_VBN 600_CD children_NNS ._. [_-LRB- 18_CD ]_-RRB- In_IN an_DT article_NN for_IN an_DT anti-vaccine_JJ magazine_NN ,_, Bradstreet_NNP endorsed_VBD stem_NN cell_NN therapy_NN as_IN an_DT autism_NN treatment_NN ._. [_-LRB- 19_CD ]_-RRB- Bradstreet_NNP was_VBD found_VBN dead_JJ from_IN a_DT gunshot_NN wound_NN to_IN the_DT chest_NN in_IN the_DT Broad_NNP River_NNP in_IN Rutherford_NNP County_NNP ,_, North_NNP Carolina_NNP in_IN June_NNP 2015_CD ,_, after_IN his_PRP$ Buford_NNP ,_, Georgia_NNP medical_JJ office_NN was_VBD raided_VBN by_IN the_DT FDA_NNP in_IN connection_NN with_IN an_DT investigation_NN into_IN GcMAF_NNP treatments_NNS ._. [_-LRB- 4]_CD [_-LRB- 20_CD ]_-RRB- [_-LRB- 21_CD ]_-RRB- At_IN the_DT time_NN of_IN his_PRP$ death_NN ,_, he_PRP lived_VBD in_IN Braselton_NNP and_CC ran_VBD his_PRP$ medical_JJ practice_NN in_IN Buford_NNP ._. [_-LRB- 4_CD ]_-RRB- While_IN the_DT police_NNS ruled_VBD Bradstreet_NNP 's_POS death_NN a_DT suicide_NN ,_, several_JJ family_NN members_NNS and_CC anti-vaccine_JJ activists_NNS claimed_VBD he_PRP was_VBD murdered_VBN in_IN connection_NN with_IN his_PRP$ criticism_NN of_IN vaccines_NNS ._. [_-LRB- 22_CD ]_-RRB- Bradstreet_NNP 's_POS son_NN is_VBZ autistic_JJ ,_, which_WDT Bradstreet_NNP attributed_VBD to_IN a_DT vaccination_NN his_PRP$ son_NN received_VBD at_IN age_NN 15_CD months_NNS ._. [_-LRB- 23_CD ]_-RRB- •_, None_NNP Siniscalco_NNP ,_, D._NNP ;_: Sapone_NNP ,_, A._NNP ;_: Giordano_NNP ,_, C._NNP ;_: Cirillo_NNP ,_, A._NNP ;_: Magistris_NNP ,_, L._NNP ;_: Rossi_NNP ,_, F._NNP ;_: Fasano_NNP ,_, A._NNP ;_: Bradstreet_NNP ,_, J._NNP J._NNP ;_: Maione_NNP ,_, S._NNP ;_: Antonucci_NNP ,_, N._NNP (_-LRB- 2013_CD )_-RRB- ._. ""_`` Cannabinoid_NNP Receptor_NN Type_NN 2_CD ,_, but_CC not_RB Type_NN 1_CD ,_, is_VBZ Up_IN -_HYPH Regulated_VBN in_IN Peripheral_NNP Blood_NNP Mononuclear_NNP Cells_NNPS of_IN Children_NNPS Affected_VBN by_IN Autistic_NNP Disorders_NNPS ""_'' ._. Journal_NNP of_IN Autism_NNP and_CC Developmental_NNP Disorders_NNPS ._. 43_CD (_-LRB- 11_CD )_-RRB- :_: 2686_CD –95_CD ._. doi:10.1007/s10803-013-1824-9_CD ._. PMID_NNP 23585028_CD ._. •_SYM None_NN Siniscalco_NNP ,_, D._NNP ;_: Bradstreet_NNP ,_, J._NNP J._NNP ;_: Antonucci_NNP ,_, N._NNP (_-LRB- 2013_CD )_-RRB- ._. ""_`` Therapeutic_JJ Role_NN of_IN Hematopoietic_JJ Stem_NN Cells_NNS in_IN Autism_NN Spectrum_NN Disorder_NN -_HYPH Related_JJ Inflammation_NN ""_'' ._. Frontiers_NNPS in_IN Immunology_NNP ._. 4_CD :_: 140_CD ._. doi:10.3389/fimmu.2013.00140_NN ._. PMC_NN ._. PMID_NNP 23772227_CD ._. •_SYM None_NN Adams_NNP ,_, J._NNP B._NNP ;_: Baral_NNP ,_, M._NNP ;_: Geis_NNP ,_, E._NNP ;_: Mitchell_NNP ,_, J._NNP ;_: Ingram_NNP ,_, J._NNP ;_: Hensley_NNP ,_, A._NNP ;_: Zappia_NNP ,_, I._NNP ;_: Newmark_NNP ,_, S._NNP ;_: Gehn_NNP ,_, E._NNP ;_: Rubin_NNP ,_, R._NNP A._NNP ;_: Mitchell_NNP ,_, K._NNP ;_: Bradstreet_NNP ,_, J._NNP ;_: El_NNP -_HYPH Dahr_NNP ,_, J._NNP (_-LRB- 2009_CD )_-RRB- ._. ""_`` Safety_NN and_CC efficacy_NN of_IN oral_JJ DMSA_NN therapy_NN for_IN children_NNS with_IN autism_NN spectrum_NN disorders_NNS :_: Part_NN A_NN -_HYPH Medical_JJ results_NNS ""_'' ._. BMC_NNP Clinical_JJ Pharmacology_NN ._. 9_CD :_: 16_LS ._. doi:10.1186/1472-6904-9-16_LS ._. PMC_NN ._. PMID_NNP 19852789_CD ._. •_NFP None_NN Bradstreet_NNP ,_, JJ_NNP ;_: Dahr_NNP ,_, JE_NNP (_-LRB- 2004_CD )_-RRB- ._. ""_`` Detection_NNP of_IN Measles_NNP Virus_NNP Genomic_NNP RNA_NNP in_IN Cerebrospinal_NNP Fluid_NNP of_IN Three_NNP Children_NNPS with_IN Regressive_NNP Autism_NNP :_: a_DT Report_NN of_IN Three_NNP Cases_NNPS ""_'' ._. Journal_NNP of_IN American_NNP Physicians_NNPS and_CC Surgeons_NNPS ._. Association_NNP of_IN American_NNP Physicians_NNPS and_CC Surgeons_NNPS ._. 9_CD (_-LRB- 2_CD )_-RRB- :_: 38–45_CD ._.","NNP NNP "" NNP "" NNP ( NNP 6 , 1954 – NNP 19 , 2015 ) , VBD an JJ NN , JJ NN NN , and a JJ NN [ 2 ] who VBD the NNP NNP NNP NNP NNP in NNP , NNP , [ 3 ] a JJ NN in NNP , NNP [ 4 ] and in NNP , where he VBD NN . [ 5 ] [ 6 ] He RB VBD the NNP NNP NNP NNP , which VBD to VB JJ NNS with his JJ NN . [ 7 ] NNP VBD a NNP JJ NN in 1984 . He VBD a NNP of NNP NN from the NNP of NNP NNP in 1976 , where he RB VBD to JJ NN VBG three NNS RBR . His JJ NN VBD on NN NN , and he VBD his NN in this NN from NNP NNP NNP NNP . He VBD an JJ NN of NN NN and NN at the NNP NNP of NNP NNP in NNP , NNP . [ 8 ] NNP VBD NN NN , which he VBD VBD NNS as a NN , in the NNP of NNP NNPS and NNPS , which VBZ RB VBN by NNP . This NN VBD that JJ NNS VBD a JJR NN NN of NN , [ 9 ] and that three JJ NNS VBD NNS NN in their JJ NN . [ 10 ] The NNP of NNP VBZ VBN any NN between NNS and NN . [ 11 ] NNP VBD an JJ NN VBN NNP NNP ( one of the NN NNS in the NN NN NN ) with NN NN on the NN of VBG NN from his NN , in NN of the NN that NN , NN , and NN NNS VBD VBN to VB he VBD JJ NNS of NN . [ 12 ] Over an eight - NN NN , NNP VBD NNP 's NN 160 NNS . [ 13 ] NNP NNP VBZ VBN , "" It VBZ to me that NNP VBZ which of his JJ NNS to VB and VBZ NNS that VBP them , "" and VBZ NNP 's NN VBD NNS as "" NN "" . [ 12 ] NNP NNP VBD NNP 's NN to VB NN with NN NN as "" JJ . "" [ 6 ] In an NN with the NNP NNP , NNP VBD the NN of JJ NN ( NNP ) as an NN NN , VBG , "" Every NN with NN should VB a NN of NN if NN VBD RB an NN and NNP VBD JJ . "" [ 14 ] NNP RB VBD NN VBG the NN of JJ NN NN for NN , [ 15 ] some of which VBD it VBD JJ , [ 16 ] RB RB as a NN VBG that JJ NNS VBP an VBN NN to JJ NN . [ 17 ] JJR NNS NNP VBN on JJ NNS VBD the JJ NN NN , with which he VBD to VB VBN 600 NNS . [ 18 ] In an NN for an JJ NN , NNP VBD NN NN NN as an NN NN . [ 19 ] NNP VBD VBN JJ from a NN NN to the NN in the NNP NNP in NNP NNP , NNP NNP in NNP 2015 , after his NNP , NNP JJ NN VBD VBN by the NNP in NN with an NN into NNP NNS . [ 4] [ 20 ] [ 21 ] At the NN of his NN , he VBD in NNP and VBD his JJ NN in NNP . [ 4 ] While the NNS VBD NNP 's NN a NN , JJ NN NNS and JJ NNS VBD he VBD VBN in NN with his NN of NNS . [ 22 ] NNP 's NN VBZ JJ , which NNP VBD to a NN his NN VBD at NN 15 NNS . [ 23 ] • NNP NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP NNP ; NNP , NNP ; NNP , NNP ( 2013 ) . "" NNP NN NN 2 , but RB NN 1 , VBZ Up - VBN in NNP NNP NNP NNPS of NNPS VBN by NNP NNPS "" . NNP of NNP and NNP NNPS . 43 ( 11 ) : 2686 –95 . doi:10.1007/s10803-013-1824-9 . NNP 23585028 . • NN NNP , NNP ; NNP , NNP NNP ; NNP , NNP ( 2013 ) . "" JJ NN of JJ NN NNS in NN NN NN - JJ NN "" . NNPS in NNP . 4 : 140 . NN . NN . NNP 23772227 . • NN NNP , NNP NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP ; NNP , NNP NNP ; NNP , NNP ; NNP , NNP ; NNP - NNP , NNP ( 2009 ) . "" NN and NN of JJ NN NN for NNS with NN NN NNS : NN NN - JJ NNS "" . NNP JJ NN . 9 : 16 . doi:10.1186/1472-6904-9-16 . NN . NNP 19852789 . • NN NNP , NNP ; NNP , NNP ( 2004 ) . "" NNP of NNP NNP NNP NNP in NNP NNP of NNP NNPS with NNP NNP : a NN of NNP NNPS "" . NNP of NNP NNPS and NNPS . NNP of NNP NNPS and NNPS . 9 ( 2 ) : 38–45 ."
21,331,mainstream,M09bbb,vaccine.autism,"Measles_NN cases_NNS have_VBP spread_VBN across_IN the_DT US_NNP this_DT year_NN ,_, with_IN the_DT state_NN of_IN New_NNP York_NNP now_RB facing_VBG its_PRP$ worst_JJS outbreak_NN in_IN decades_NNS ._. Since_IN last_JJ autumn_NN ,_, more_JJR than_IN 150_CD cases_NNS have_VBP been_VBN recorded_VBN in_IN Rockland_NNP County_NNP ,_, a_DT New_NNP York_NNP suburb_NN home_NN to_IN a_DT large_JJ ultra-Orthodox_JJ Jewish_JJ community_NN where_WRB there_EX has_VBZ been_VBN some_DT resistance_NN to_IN vaccinations_NNS ._. The_DT vast_JJ majority_NN of_IN US_NNP states_NNS allow_VBP families_NNS to_TO opt_VB out_IN of_IN getting_VBG vaccinated_VBN if_IN they_PRP object_VBP on_IN religious_JJ grounds_NNS and_CC parents_NNS seem_VBP to_TO take_VB advantage_NN of_IN these_DT rules_NNS ._. Researchers_NNS have_VBP found_VBN that_IN broad_JJ philosophical_JJ and_CC religious_JJ exemptions_NNS to_IN vaccine_NN requirements_NNS are_VBP associated_VBN with_IN higher_JJR rates_NNS of_IN unvaccinated_JJ children_NNS ._. But_CC this_DT year_NN ’s_POS outbreaks_NNS are_VBP now_RB raising_VBG public_JJ health_NN questions_NNS about_IN why_WRB states_NNS allow_VBP such_JJ exemptions_NNS ._. Here_RB is_VBZ how_WRB religious_JJ exemptions_NNS work_VBP :_: What_WP is_VBZ a_DT religious_JJ exemption_NN to_IN a_DT vaccine_NN ,_, and_CC which_WDT US_NNP states_NNPS have_VBP them_PRP ?_. Religious_JJ exemptions_NNS allow_VBP parents_NNS to_TO opt_VB their_PRP$ children_NNS out_IN of_IN mandated_VBN vaccination_NN policies_NNS if_IN they_PRP object_VBP to_IN the_DT vaccine_NN for_IN religious_JJ reasons_NNS and_CC if_IN they_PRP follow_VBP the_DT state_NN ’s_POS opt_NN -_HYPH out_NN process_NN ._. Almost_RB every_DT state_NN ,_, plus_CC Washington_NNP DC_NNP ,_, allows_VBZ for_IN a_DT religious_JJ exemption_NN beginning_VBG at_IN least_JJS in_IN kindergarten_NN ._. Four_CD states_NNS do_VBP not_RB :_: California_NNP ,_, West_NNP Virginia_NNP ,_, Mississippi_NNP and_CC Arizona_NNP ._. Each_DT state_NN has_VBZ its_PRP$ own_JJ rules_NNS regarding_VBG vaccinations_NNS for_IN children_NNS who_WP attend_VBP public_JJ schools_NNS ._. In_IN addition_NN to_IN the_DT religious_JJ exemption_NN ,_, all_DT 50_CD states_NNS ,_, plus_CC Washington_NNP DC_NNP ,_, allow_VBP exceptions_NNS for_IN medical_JJ reasons_NNS ._. Examples_NNS include_VBP a_DT child_NN who_WP has_VBZ a_DT condition_NN like_IN cancer_NN or_CC an_DT immune_JJ disorder_NN where_WRB a_DT vaccine_NN could_MD be_VB harmful_JJ to_IN the_DT child_NN ’s_POS health_NN ._. And_CC more_JJR than_IN a_DT dozen_CD states_NNS offer_VBP philosophical_JJ exemptions_NNS ,_, sometimes_RB known_VBN as_IN personal_JJ -_HYPH belief_NN exemptions_NNS ,_, which_WDT do_VBP not_RB require_VB that_IN a_DT parent_NN ’s_POS desire_NN to_TO opt_VB out_RP be_VB specifically_RB about_IN their_PRP$ religious_JJ beliefs_NNS ._. Instead_RB ,_, they_PRP can_MD include_VB exemptions_NNS for_IN conscience_NN or_CC moral_JJ ideology_NN ._. California_NNP ,_, West_NNP Virginia_NNP and_CC Mississippi_NNP ,_, which_WDT do_VBP not_RB allow_VB religious_JJ exemptions_NNS ,_, also_RB do_VBP not_RB allow_VB philosophical_JJ objections_NNS ._. How_WRB are_VBP religious_JJ exemptions_NNS connected_VBN to_IN the_DT recent_JJ US_NNP measles_NNS outbreak_NN ?_. The_DT measles_NNS outbreak_NN in_IN the_DT New_NNP York_NNP suburb_NN of_IN Rockland_NNP County_NNP has_VBZ largely_RB been_VBN cantered_VBN in_IN an_DT ultra-Orthodox_JJ Jewish_JJ community_NN ,_, where_WRB there_EX has_VBZ been_VBN some_DT recent_JJ resistance_NN to_IN vaccinations_NNS ._. Vaccination_NN rates_NNS tend_VBP to_TO be_VB low_JJ among_IN the_DT ultra-Orthodox_JJ ,_, and_CC the_DT reasons_NNS vary_VBP ,_, from_IN fear_NN of_IN interference_NN from_IN outsiders_NNS to_IN confusion_NN over_IN accurate_JJ religious_JJ and_CC medical_JJ information_NN ._. The_DT current_JJ flare_NN -_HYPH up_NN in_IN New_NNP York_NNP and_CC New_NNP Jersey_NNP ,_, both_DT of_IN which_WDT allow_VBP religious_JJ exemptions_NNS ,_, can_MD be_VB traced_VBN back_RB to_IN the_DT measles_NN outbreaks_NNS in_IN Israel_NNP last_JJ year_NN ._. Because_IN ultra-Orthodox_JJ parents_NNS often_RB send_VBP their_PRP$ children_NNS to_IN their_PRP$ own_JJ religious_JJ schools_NNS ,_, the_DT outbreak_NN was_VBD initially_RB largely_RB contained_VBN ._. But_CC it_PRP has_VBZ recently_RB spread_VBN significantly_RB ._. Some_DT Orthodox_JJ Jewish_JJ schools_NNS have_VBP been_VBN allowing_VBG unvaccinated_JJ children_NNS to_TO attend_VB school_NN ,_, against_IN the_DT New_NNP York_NNP Health_NNP Department_NNP ’s_POS mandate_NN ,_, during_IN the_DT measles_NN outbreak_NN ._. How_WRB are_VBP vaccines_NNS a_DT religious_JJ issue_NN for_IN some_DT people_NNS ?_. Some_DT people_NNS worry_VBP that_IN vaccinating_NN interrupts_VBZ a_DT divine_JJ plan_NN for_IN someone_NN ’s_POS life_NN ,_, and_CC they_PRP do_VBP not_RB want_VB to_TO interfere_VB in_IN God_NNP ’s_POS will_NN ._. Others_NNS have_VBP concerns_NNS that_IN some_DT vaccines_NNS could_MD violate_VB religious_JJ dietary_NN laws_NNS ,_, unless_IN they_PRP are_VBP designated_VBN kosher_NN or_CC halal_JJ ._. Last_JJ year_NN an_DT influential_JJ Islamic_JJ group_NN in_IN Indonesia_NNP issued_VBD a_DT controversial_JJ fatwa_NN ,_, which_WDT was_VBD later_RB overturned_VBN ,_, against_IN the_DT measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN ,_, or_CC MMR_NN ,_, vaccine_NN ,_, citing_VBG its_PRP$ use_NN of_IN porcine_NN gelatin_NN ._. And_CC many_JJ of_IN those_DT who_WP oppose_VBP abortion_NN object_VBP to_IN certain_JJ vaccines_NNS ,_, like_IN those_DT designed_VBN to_TO prevent_VB chickenpox_NN or_CC hepatitis_NN A_NN ._. Those_DT vaccines_NNS are_VBP made_VBN by_IN growing_VBG viruses_NNS in_IN fetal_JJ embryo_NN fibroblast_NN cells_NNS ,_, or_CC cell_NN lines_NNS that_WDT are_VBP grown_VBN in_IN laboratories_NNS but_CC are_VBP derived_VBN from_IN two_CD elective_JJ abortions_NNS in_IN the_DT 1960s_NNS ._. A_DT Catholic_JJ family_NN in_IN Kentucky_NNP ,_, for_IN example_NN ,_, has_VBZ filed_VBN a_DT lawsuit_NN against_IN the_DT Northern_NNP Kentucky_NNP Health_NNP Department_NNP for_IN banning_VBG unvaccinated_JJ students_NNS from_IN school_NN and_CC athletics_NNS during_IN a_DT chickenpox_NN outbreak_NN at_IN their_PRP$ son_NN ’s_POS Catholic_JJ school_NN ._. Are_VBP the_DT recent_JJ measles_NNS outbreaks_NNS causing_VBG some_DT US_NNP states_NNS to_TO reconsider_VB exemptions_NNS ?_. To_IN an_DT extent_NN ,_, yes_UH ._. Vaccine_NN exemptions_NNS for_IN children_NNS enrolled_VBN in_IN kindergarten_NN have_VBP slowly_RB grown_VBN over_IN the_DT past_JJ decade_NN ,_, according_VBG to_IN the_DT Centres_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ,_, prompting_VBG some_DT states_NNS to_TO consider_VB changes_NNS ._. California_NNP got_VBD rid_JJ of_IN its_PRP$ non-medical_JJ exemptions_NNS in_IN 2015_CD ._. A_DT few_JJ states_NNS that_WDT allow_VBP religious_JJ exemptions_NNS have_VBP made_VBN them_PRP more_RBR difficult_JJ to_TO get_VB ,_, requiring_VBG things_NNS like_IN a_DT signed_VBN affidavit_NN from_IN a_DT religious_JJ leader_NN instead_RB of_IN simply_RB filling_VBG out_RP an_DT online_JJ form_NN ._. State_NN lawmakers_NNS ,_, often_RB Republicans_NNPS ,_, around_IN the_DT country_NN introduced_VBD more_JJR than_IN 150_CD bills_NNS from_IN 2011_CD through_IN 2017_CD that_WDT would_MD have_VB made_VBN it_PRP easier_JJR to_TO obtain_VB exemptions_NNS from_IN vaccine_NN policies_NNS ._. But_CC according_VBG to_IN a_DT study_NN in_IN the_DT American_NNP Journal_NNP of_IN Public_NNP Health_NNP published_VBN in_IN January_NNP ,_, the_DT 13_CD bills_NNS signed_VBN into_IN law_NN actually_RB limited_VBD the_DT ability_NN to_TO exempt_VB ._. Some_DT professional_JJ organisations_NNS have_VBP also_RB taken_VBN action_NN ._. The_DT American_NNP Association_NNP of_IN Pediatrics_NNP has_VBZ made_VBN the_DT elimination_NN of_IN non-medical_JJ vaccination_NN exemptions_NNS its_PRP$ top_JJ priority_NN this_DT year_NN ,_, even_RB ranking_VBG it_PRP above_IN family_NN separations_NNS at_IN the_DT border_NN ._. Are_VBP religious_JJ leaders_NNS doing_VBG anything_NN to_TO address_VB the_DT issue_NN ?_. Yes_UH ._. Rabbis_NNPS and_CC doctors_NNS organised_VBD a_DT public_JJ health_NN campaign_NN to_TO stress_VB the_DT importance_NN of_IN vaccines_NNS ._. The_DT Orthodox_NNP Union_NNP and_CC the_DT Rabbinal_NNP Council_NNP of_IN America_NNP have_VBP strongly_RB urged_VBN parents_NNS to_TO vaccinate_VB their_PRP$ children_NNS ._. “_`` It_PRP is_VBZ well_RB known_VBN that_IN those_DT facing_VBG even_RB a_DT potential_JJ life_NN -_HYPH or_CC -_HYPH death_NN situation_NN are_VBP instructed_VBN to_TO set_VB aside_RP the_DT Sabbath_NNP and_CC other_JJ key_JJ tenets_NNS of_IN halachic_NN (_-LRB- Jewish_JJ law_NN )_-RRB- observance_NN until_IN the_DT emergency_NN has_VBZ passed_VBN ,_, ”_'' they_PRP said_VBD in_IN November_NNP ._. Elsewhere_RB ,_, local_JJ health_NN and_CC community_NN leaders_NNS have_VBP stressed_VBN open_JJ communication_NN between_IN health_NN officials_NNS and_CC religious_JJ leaders_NNS to_TO bridge_VB cultural_JJ divides_NNS ._. In_IN Colorado_NNP ,_, Dr_NNP Joshua_NNP Williams_NNP ,_, an_DT assistant_JJ professor_NN of_IN pediatrics_NN at_IN the_DT University_NNP of_IN Colorado_NNP Denver_NNP School_NNP of_IN Medicine_NNP ,_, has_VBZ recommended_VBN that_IN the_DT groups_NNS talk_VBP at_IN specific_JJ times_NNS ,_, such_JJ as_IN when_WRB the_DT academic_JJ year_NN begins_VBZ or_CC at_IN the_DT start_NN of_IN influenza_NN season_NN ,_, and_CC not_RB just_RB during_IN a_DT health_NN crisis_NN ._. He_PRP is_VBZ also_RB working_VBG with_IN the_DT state_NN ’s_POS Council_NNP of_IN Churches_NNPS to_TO hold_VB sessions_NNS with_IN parishioners_NNS to_TO hear_VB their_PRP$ concerns_NNS ._. “_`` Religious_JJ vaccinations_NNS exemptions_NNS impact_VBP public_JJ health_NN ,_, ”_'' Dr_NNP Williams_NNP said_VBD ._. “_`` There_EX is_VBZ a_DT need_NN to_TO dialogue_VB with_IN religious_JJ leaders_NNS around_IN vaccine_NN exemptions_NNS at_IN local_JJ and_CC national_JJ levels_NNS ._. ”_''","NN NNS VBP VBN across the NNP this NN , with the NN of NNP NNP RB VBG its JJS NN in NNS . Since JJ NN , JJR than 150 NNS VBP VBN VBN in NNP NNP , a NNP NNP NN NN to a JJ JJ JJ NN where there VBZ VBN some NN to NNS . The JJ NN of NNP NNS VBP NNS to VB out of VBG VBN if they VBP on JJ NNS and NNS VBP to VB NN of these NNS . NNS VBP VBN that JJ JJ and JJ NNS to NN NNS VBP VBN with JJR NNS of JJ NNS . But this NN ’s NNS VBP RB VBG JJ NN NNS about why NNS VBP JJ NNS . RB VBZ how JJ NNS VBP : What VBZ a JJ NN to a NN , and which NNP NNPS VBP them ? JJ NNS VBP NNS to VB their NNS out of VBN NN NNS if they VBP to the NN for JJ NNS and if they VBP the NN ’s NN - NN NN . RB every NN , plus NNP NNP , VBZ for a JJ NN VBG at JJS in NN . Four NNS VBP RB : NNP , NNP NNP , NNP and NNP . Each NN VBZ its JJ NNS VBG NNS for NNS who VBP JJ NNS . In NN to the JJ NN , all 50 NNS , plus NNP NNP , VBP NNS for JJ NNS . NNS VBP a NN who VBZ a NN like NN or an JJ NN where a NN could VB JJ to the NN ’s NN . And JJR than a dozen NNS VBP JJ NNS , RB VBN as JJ - NN NNS , which VBP RB VB that a NN ’s NN to VB out VB RB about their JJ NNS . RB , they can VB NNS for NN or JJ NN . NNP , NNP NNP and NNP , which VBP RB VB JJ NNS , RB VBP RB VB JJ NNS . How VBP JJ NNS VBN to the JJ NNP NNS NN ? The NNS NN in the NNP NNP NN of NNP NNP VBZ RB VBN VBN in an JJ JJ NN , where there VBZ VBN some JJ NN to NNS . NN NNS VBP to VB JJ among the JJ , and the NNS VBP , from NN of NN from NNS to NN over JJ JJ and JJ NN . The JJ NN - NN in NNP NNP and NNP NNP , both of which VBP JJ NNS , can VB VBN RB to the NN NNS in NNP JJ NN . Because JJ NNS RB VBP their NNS to their JJ JJ NNS , the NN VBD RB RB VBN . But it VBZ RB VBN RB . Some JJ JJ NNS VBP VBN VBG JJ NNS to VB NN , against the NNP NNP NNP NNP ’s NN , during the NN NN . How VBP NNS a JJ NN for some NNS ? Some NNS VBP that NN VBZ a JJ NN for NN ’s NN , and they VBP RB VB to VB in NNP ’s NN . NNS VBP NNS that some NNS could VB JJ NN NNS , unless they VBP VBN NN or JJ . JJ NN an JJ JJ NN in NNP VBD a JJ NN , which VBD RB VBN , against the NNS - NNS - NN , or NN , NN , VBG its NN of NN NN . And JJ of those who VBP NN VBP to JJ NNS , like those VBN to VB NN or NN NN . Those NNS VBP VBN by VBG NNS in JJ NN NN NNS , or NN NNS that VBP VBN in NNS but VBP VBN from two JJ NNS in the NNS . A JJ NN in NNP , for NN , VBZ VBN a NN against the NNP NNP NNP NNP for VBG JJ NNS from NN and NNS during a NN NN at their NN ’s JJ NN . VBP the JJ NNS NNS VBG some NNP NNS to VB NNS ? To an NN , yes . NN NNS for NNS VBN in NN VBP RB VBN over the JJ NN , VBG to the NNPS for NNP NNP and NNP ( NNP ) , VBG some NNS to VB NNS . NNP VBD JJ of its JJ NNS in 2015 . A JJ NNS that VBP JJ NNS VBP VBN them RBR JJ to VB , VBG NNS like a VBN NN from a JJ NN RB of RB VBG out an JJ NN . NN NNS , RB NNPS , around the NN VBD JJR than 150 NNS from 2011 through 2017 that would VB VBN it JJR to VB NNS from NN NNS . But VBG to a NN in the NNP NNP of NNP NNP VBN in NNP , the 13 NNS VBN into NN RB VBD the NN to VB . Some JJ NNS VBP RB VBN NN . The NNP NNP of NNP VBZ VBN the NN of JJ NN NNS its JJ NN this NN , RB VBG it above NN NNS at the NN . VBP JJ NNS VBG NN to VB the NN ? Yes . NNPS and NNS VBD a JJ NN NN to VB the NN of NNS . The NNP NNP and the NNP NNP of NNP VBP RB VBN NNS to VB their NNS . “ It VBZ RB VBN that those VBG RB a JJ NN - or - NN NN VBP VBN to VB aside the NNP and JJ JJ NNS of NN ( JJ NN ) NN until the NN VBZ VBN , ” they VBD in NNP . RB , JJ NN and NN NNS VBP VBN JJ NN between NN NNS and JJ NNS to VB JJ NNS . In NNP , NNP NNP NNP , an JJ NN of NN at the NNP of NNP NNP NNP of NNP , VBZ VBN that the NNS VBP at JJ NNS , JJ as when the JJ NN VBZ or at the NN of NN NN , and RB RB during a NN NN . He VBZ RB VBG with the NN ’s NNP of NNPS to VB NNS with NNS to VB their NNS . “ JJ NNS NNS VBP JJ NN , ” NNP NNP VBD . “ There VBZ a NN to VB with JJ NNS around NN NNS at JJ and JJ NNS . ”"
22,1041,mainstream,M0a208,vaccine,"Prof_NNP Openshaw_NNP ,_, an_DT expert_NN in_IN experimental_JJ medicine_NN at_IN Imperial_NNP College_NNP London_NNP ,_, said_VBD :_: ""_`` We_PRP 're_VBP actually_RB considering_VBG a_DT paper_NN at_IN Nervtag_NNP this_DT week_NN which_WDT is_VBZ about_IN targeting_NN of_IN different_JJ sub-populations_NNS with_IN vaccines_NNS ._. ""_`` I_PRP would_MD say_VB that_IN sometimes_RB it_PRP 's_VBZ possible_JJ to_TO protect_VB a_DT vulnerable_JJ group_NN by_IN targeting_VBG another_DT group_NN ._. This_DT ,_, for_IN example_NN ,_, is_VBZ being_VBG done_VBN with_IN influenza_NN ._. ""_'' Although_IN they_PRP stand_VBP to_TO benefit_VB most_JJS because_IN of_IN their_PRP$ vulnerability_NN ,_, older_JJR people_NNS often_RB derive_VBP the_DT least_JJS benefit_NN from_IN vaccines_NNS because_IN the_DT drugs_NNS tend_VBP to_TO prompt_VB a_DT weaker_JJR immune_JJ response_NN ._. Prof_NNP Openshaw_NNP said_VBD healthcare_NN workers_NNS and_CC people_NNS in_IN other_JJ public_JJ -_HYPH facing_VBG jobs_NNS could_MD also_RB be_VB considered_VBN for_IN vaccination_NN first_RB ._. Also_RB giving_VBG evidence_NN ,_, Professor_NNP Arne_NNP Akbar_NNP ,_, the_DT president_NN of_IN the_DT British_NNP Society_NNP of_IN Immunology_NNP ,_, said_VBD :_: ""_`` Vaccines_NNS do_VBP n't_RB work_VB very_RB well_RB in_IN older_JJR people_NNS ._. This_DT has_VBZ been_VBN shown_VBN with_IN many_JJ other_JJ vaccines_NNS in_IN the_DT past_NN ._. ""_`` So_RB we_PRP might_MD have_VB to_TO have_VB something_NN as_RB well_RB as_IN a_DT vaccine_NN to_TO get_VB optimum_JJ protection_NN for_IN older_JJR people_NNS ._. ""_'' He_PRP suggested_VBD that_IN ,_, alongside_IN a_DT vaccine_NN ,_, older_JJR people_NNS could_MD be_VB offered_VBN an_DT anti-inflammatory_JJ drug_NN such_JJ as_IN dexamethasone_NN ,_, which_WDT has_VBZ recently_RB shown_VBN strong_JJ results_NNS in_IN those_DT who_WP are_VBP severely_RB ill_JJ with_IN coronavirus_NN ._. ""_`` Just_RB a_DT vaccine_NN alone_RB will_MD help_VB the_DT younger_JJR people_NNS ,_, and_CC that_DT will_MD be_VB good_JJ because_IN then_RB ,_, if_IN the_DT younger_JJR people_NNS are_VBP not_RB infected_VBN ,_, they_PRP will_MD not_RB spread_VB it_PRP to_IN the_DT older_JJR people_NNS –_: but_CC it_PRP wo_MD n't_RB directly_RB help_VB the_DT older_JJR group_NN very_RB much_RB ,_, ""_'' Prof_NNP Akbar_NNP said_VBD ._. His_PRP$ comments_NNS came_VBD as_IN a_DT new_JJ study_NN of_IN the_DT potential_JJ Oxford_NNP vaccine_NN in_IN pigs_NNS found_VBD that_IN two_CD doses_NNS induced_VBD a_DT better_JJR response_NN than_IN one_CD ._. The_DT study_NN ,_, by_IN the_DT Pirbright_NNP Institute_NNP ,_, of_IN ChAdOx1_NNP nCoV_NNP -_HYPH 19_CD (_-LRB- AZD1222_NNP )_-RRB- vaccine_NN showed_VBD a_DT marked_VBN increase_NN in_IN neutralising_VBG antibodies_NNS ,_, which_WDT bind_VBP to_IN the_DT virus_NN in_IN a_DT way_NN that_WDT blocks_VBZ infection_NN ._.","NNP NNP , an NN in JJ NN at NNP NNP NNP , VBD : "" We VBP RB VBG a NN at NNP this NN which VBZ about NN of JJ NNS with NNS . "" I would VB that RB it VBZ JJ to VB a JJ NN by VBG another NN . This , for NN , VBZ VBG VBN with NN . "" Although they VBP to VB JJS because of their NN , JJR NNS RB VBP the JJS NN from NNS because the NNS VBP to VB a JJR JJ NN . NNP NNP VBD NN NNS and NNS in JJ JJ - VBG NNS could RB VB VBN for NN RB . RB VBG NN , NNP NNP NNP , the NN of the NNP NNP of NNP , VBD : "" NNS VBP RB VB RB RB in JJR NNS . This VBZ VBN VBN with JJ JJ NNS in the NN . "" RB we might VB to VB NN RB RB as a NN to VB JJ NN for JJR NNS . "" He VBD that , alongside a NN , JJR NNS could VB VBN an JJ NN JJ as NN , which VBZ RB VBN JJ NNS in those who VBP RB JJ with NN . "" RB a NN RB will VB the JJR NNS , and that will VB JJ because RB , if the JJR NNS VBP RB VBN , they will RB VB it to the JJR NNS – but it wo RB RB VB the JJR NN RB RB , "" NNP NNP VBD . His NNS VBD as a JJ NN of the JJ NNP NN in NNS VBD that two NNS VBD a JJR NN than one . The NN , by the NNP NNP , of NNP NNP - 19 ( NNP ) NN VBD a VBN NN in VBG NNS , which VBP to the NN in a NN that VBZ NN ."
23,1211,conspiracy,C00bbf,vaccine.covid,"Following_VBG the_DT recent_JJ terror_NN attack_NN in_IN Manchester_NNP ,_, Theresa_NNP May_NNP is_VBZ urging_VBG G7_NNP Leaders_NNS to_TO tackle_VB Online_JJ extremism_NN ._. The_DT question_NN is_VBZ ,_, what_WP is_VBZ deemed_VBN extremism_NN ?_. The_DT G7_NNP backed_VBD Mrs_NNP May_NNP ’s_POS call_NN for_IN more_JJR pressure_NN to_TO be_VB put_VBN on_IN internet_NN companies_NNS such_JJ as_IN Google_NNP ,_, Facebook_NNP and_CC Twitter_NNP to_TO target_VB extremist_JJ messages_NNS online_RB ._. This_DT will_MD include_VB developing_VBG technology_NN which_WDT automatically_RB identifies_VBZ and_CC removes_VBZ messages_NNS that_WDT incite_VBP violence_NN ….._. The_DT G7_NNP will_MD support_VB the_DT creation_NN of_IN an_DT international_JJ industry_NN -_HYPH led_VBN forum_NN to_TO develop_VB and_CC share_VB tools_NNS of_IN this_DT type_NN ,_, she_PRP said_VBD ._. Of_IN course_NN by_IN extremism_NN they_PRP are_VBP referring_VBG to_IN ISIS_NNP and_CC the_DT radicalisation_NN of_IN young_JJ muslim_JJ men_NNS ,_, well_UH at_IN least_JJS that_DT is_VBZ what_WP we_PRP are_VBP led_VBN to_TO believe_VB is_VBZ their_PRP$ purpose_NN for_IN such_JJ measures_NNS ._. But_CC in_IN reality_NN this_DT is_VBZ not_RB just_RB about_IN ISIS_NNP ,_, in_IN fact_NN it_PRP has_VBZ nothing_NN whatsoever_JJ to_TO do_VB with_IN ISIS_NNP ._. Last_JJ week_NN we_PRP reported_VBD how_WRB Theresa_NNP May_NNP proposed_VBD to_TO ‘_`` Govern_VB the_DT Internet_NNP ’_'' in_IN order_NN to_TO control_VB explicit_JJ material_NN :_: Then_RB a_DT few_JJ days_NNS later_RBR we_PRP have_VBP the_DT Manchester_NNP Suicide_NNP bomber_NN Salman_NNP Abedi_NNP ,_, allegedly_RB kill_VB 22_CD people_NNS and_CC injure_VB many_JJ others_NNS ._. The_DT last_JJ few_JJ terror_NN attacks_NNS in_IN Europe_NNP have_VBP raised_VBN questions_NNS over_IN Encrypted_VBN messaging_NN applications_NNS such_JJ as_IN Whatsapp_NNP ,_, with_IN World_NNP leaders_NNS demanding_VBG that_IN Whatapp_NNP developers_NNS integrate_VBP backdoor_NN access_NN for_IN intelligence_NN agents_NNS :_: This_DT is_VBZ nothing_NN more_JJR than_IN the_DT take_NN down_RP of_IN the_DT Internet_NNP as_IN we_PRP know_VBP it_PRP ._. The_DT ability_NN to_TO share_VB information_NN about_IN the_DT murderous_JJ governments_NNS ruling_VBG our_PRP$ World_NN is_VBZ doing_VBG far_RB to_IN much_JJ damage_NN to_IN the_DT Elites_NNPS agenda_NN ._. ‘_`` Extremism_NN ’_'' comes_VBZ in_IN many_JJ forms_NNS ,_, from_IN Western_NNP Government_NNP backed_VBN Jihadist_NNP ’s_POS brainwashing_VBG young_JJ Muslims_NNPS to_TO join_VB their_PRP$ club_NN ,_, to_IN Anarchist_NNP ’s_POS like_IN ourselves_PRP who_WP expose_VBP the_DT corrupt_JJ Government_NN ’s_POS running_VBG the_DT World_NNP ._. Arguing_VBG that_IN you_PRP do_VBP n’t_RB care_VB about_IN the_DT right_NN to_IN privacy_NN because_IN you_PRP have_VBP nothing_NN to_TO hide_VB is_VBZ no_RB different_JJ than_IN saying_VBG you_PRP do_VBP n’t_RB care_VB about_IN free_JJ speech_NN because_IN you_PRP have_VBP nothing_NN to_TO say_VB ._.","VBG the JJ NN NN in NNP , NNP NNP VBZ VBG NNP NNS to VB JJ NN . The NN VBZ , what VBZ VBN NN ? The NNP VBD NNP NNP ’s NN for JJR NN to VB VBN on NN NNS JJ as NNP , NNP and NNP to VB JJ NNS RB . This will VB VBG NN which RB VBZ and VBZ NNS that VBP NN ….. The NNP will VB the NN of an JJ NN - VBN NN to VB and VB NNS of this NN , she VBD . Of NN by NN they VBP VBG to NNP and the NN of JJ JJ NNS , well at JJS that VBZ what we VBP VBN to VB VBZ their NN for JJ NNS . But in NN this VBZ RB RB about NNP , in NN it VBZ NN JJ to VB with NNP . JJ NN we VBD how NNP NNP VBD to ‘ VB the NNP ’ in NN to VB JJ NN : RB a JJ NNS RBR we VBP the NNP NNP NN NNP NNP , RB VB 22 NNS and VB JJ NNS . The JJ JJ NN NNS in NNP VBP VBN NNS over VBN NN NNS JJ as NNP , with NNP NNS VBG that NNP NNS VBP NN NN for NN NNS : This VBZ NN JJR than the NN down of the NNP as we VBP it . The NN to VB NN about the JJ NNS VBG our NN VBZ VBG RB to JJ NN to the NNPS NN . ‘ NN ’ VBZ in JJ NNS , from NNP NNP VBN NNP ’s VBG JJ NNPS to VB their NN , to NNP ’s like ourselves who VBP the JJ NN ’s VBG the NNP . VBG that you VBP RB VB about the NN to NN because you VBP NN to VB VBZ RB JJ than VBG you VBP RB VB about JJ NN because you VBP NN to VB ."
24,965,mainstream,M07e1f,coronavirus; covid.19; vaccine,"Recent_JJ trends_NNS in_IN Covid_NNP -_HYPH 19_CD data_NNS appear_VBP to_TO show_VB little_JJ signs_NNS of_IN slowing_VBG ,_, as_IN a_DT number_NN of_IN states_NNS continued_VBD to_TO report_VB a_DT rise_NN in_IN new_JJ cases_NNS and_CC hospitalizations_NNS ._. The_DT World_NNP Health_NNP Organization_NNP reported_VBD record_JJ rises_NNS in_IN several_JJ countries_NNS ,_, and_CC denied_VBD claims_NNS that_IN increased_VBN testing_NN is_VBZ the_DT sole_JJ driver_NN behind_IN higher_JJR case_NN numbers_NNS ._. The_DT coverage_NN on_IN this_DT live_JJ blog_NN has_VBZ ended_VBN —_: but_CC for_IN up_IN -_HYPH to_IN -_HYPH the_DT -_HYPH minute_NN coverage_NN on_IN the_DT coronavirus_NN ,_, visit_VB the_DT live_JJ blog_NN from_IN CNBC's_NNP U.S._NNP team_NN ._. •_SYM U.S._NNP cases_NNS :_: More_JJR than_IN 2.3_CD million_CD •_SYM U.S._NNP deaths_NNS :_: At_IN least_JJS 120,402_CD The_DT data_NNS above_RB was_VBD compiled_VBN by_IN Johns_NNP Hopkins_NNP University_NNP ._. 11:00_CD a.m._NN London_NNP time_NN :_: South_NNP African_JJ President_NNP Cyril_NNP Ramaphosa_NNP has_VBZ warned_VBN that_IN ""_`` difficult_JJ decisions_NNS and_CC difficult_JJ days_NNS lie_VBP ahead_RB ""_'' as_IN the_DT country_NN tries_VBZ to_TO deal_VB with_IN the_DT economic_JJ fallout_NN from_IN the_DT coronavirus_NN pandemic_NN ._. In_IN an_DT address_NN to_IN the_DT nation_NN Monday_NNP ,_, Ramaphosa_NNP highlighted_VBD that_IN businesses_NNS in_IN all_DT sectors_NNS had_VBD announced_VBN job_NN cuts_NNS or_CC total_JJ closures_NNS as_IN a_DT result_NN of_IN losses_NNS incurred_VBN since_IN the_DT nation_NN implemented_VBD strict_JJ lockdown_NN measures_NNS on_IN March_NNP 26_CD ._. Aware_JJ of_IN the_DT economic_JJ toll_NN being_VBG wreaked_VBN by_IN the_DT lockdowns_NNS ,_, the_DT government_NN has_VBZ begun_VBN lifting_VBG restrictions_NNS ,_, but_CC South_NNP Africa_NNP now_RB has_VBZ 101,590_CD confirmed_VBN cases_NNS of_IN Covid_NNP -_HYPH 19_CD ,_, the_DT most_RBS on_IN the_DT continent_NN ,_, with_IN 1,991_CD deaths_NNS as_IN of_IN Tuesday_NNP morning_NN ,_, according_VBG to_IN Johns_NNP Hopkins_NNP University_NNP ._. —_NFP Elliot_NNP Smith_NNP Chinese_JJ firm_NN gets_VBZ approval_NN to_TO begin_VB human_JJ testing_NN for_IN potential_JJ vaccine_NN New_NNP York_NNP City_NNP ER_NNP doctor_NN says_VBZ he_PRP hopes_VBZ America_NNP learned_VBD from_IN city_NN 's_POS outbreak_NN Trump_NNP to_TO halt_VB entry_NN of_IN certain_JJ foreign_JJ workers_NNS ,_, opening_VBG up_RP an_DT estimated_VBN 525,000_CD jobs_NNS ,_, official_JJ says_VBZ 5:30_CD p.m._NN ET_NN —_: California_NNP Gov._NNP Gavin_NNP Newsom_NNP said_VBD the_DT state_NN is_VBZ still_RB caught_VBN in_IN the_DT first_JJ wave_NN of_IN the_DT coronavirus_NN and_CC that_IN he_PRP expects_VBZ cases_NNS to_TO continue_VB rising_VBG ._. The_DT state_NN reported_VBD 46,735_CD coronavirus_NN cases_NNS over_IN the_DT past_JJ 14_CD days_NNS ,_, representing_VBG 36_CD %_NN of_IN California_NNP 's_POS total_JJ cases_NNS ._. ""_`` The_DT positivity_NN rate_NN had_VBD been_VBN stable_JJ ,_, but_CC now_RB it_PRP 's_VBZ going_VBG slightly_RB up_RP ,_, ""_'' Newsom_NNP said_VBD at_IN a_DT press_NN briefing_NN ._. Although_IN more_JJR people_NNS are_VBP being_VBG tested_VBN in_IN California_NNP ,_, that_DT does_VBZ n't_RB provide_VB the_DT full_JJ explanation_NN behind_IN the_DT rising_VBG case_NN numbers_NNS ,_, according_VBG to_IN Newsom_NNP ._. He_PRP said_VBD the_DT state_NN is_VBZ prepared_VBN to_TO absorb_VB further_JJR increases_NNS in_IN positive_JJ cases_NNS in_IN terms_NNS of_IN providing_VBG hospital_NN beds_NNS and_CC care_NN ,_, and_CC that_IN he_PRP has_VBZ mitigation_NN strategies_NNS if_IN the_DT pandemic_NN worsens_VBZ in_IN California_NNP ._. Newsom_NNP also_RB gave_VBD an_DT update_NN on_IN the_DT state_NN 's_POS challenging_JJ jobs_NNS situation_NN ._. He_PRP said_VBD California_NNP has_VBZ distributed_VBN $_$ 34.3_CD billion_CD since_IN March_NNP 15_CD in_IN Pandemic_NNP Unemployment_NNP Assistance_NNP ._. ""_`` That_DT 's_VBZ not_RB something_NN the_DT state_NN has_VBZ ever_RB had_VBN to_TO do_VB in_IN the_DT past_NN ,_, ""_'' he_PRP said_VBD ._. —_: Hannah_NNP Miller_NNP Texas_NNP governor_NN warns_VBZ tougher_JJR actions_NNS will_MD be_VB required_VBN if_IN cases_NNS ,_, hospitalizations_NNS continue_VBP spiking_VBG 5:05_CD p.m._NN ET_NN —_: Texas_NNP Gov._NNP Greg_NNP Abbott_NNP said_VBD that_IN ""_`` additional_JJ measures_NNS are_VBP going_VBG to_TO be_VB necessary_JJ ""_'' and_CC the_DT state_NN will_MD have_VB to_TO take_VB ""_`` tougher_JJR actions_NNS ""_'' if_IN daily_JJ coronavirus_NN cases_NNS and_CC hospitalizations_NNS continue_VBP to_TO climb_VB at_IN current_JJ rates_NNS into_IN July_NNP ._. On_IN June_NNP 12_CD ,_, Abbott_NNP said_VBD that_IN there_EX 's_VBZ ""_`` no_DT real_JJ need_NN to_TO ratchet_VB back_RP the_DT reopening_NN of_IN businesses_NNS in_IN the_DT state_NN ._. ""_'' Texas_NNP has_VBZ since_RB reported_VBN days_NNS of_IN record_JJ hospitalizations_NNS and_CC daily_JJ increases_NNS in_IN Covid_NNP -_HYPH 19_CD cases_NNS ._. ""_`` If_IN we_PRP were_VBD to_TO experience_VB another_DT doubling_NN of_IN those_DT numbers_NNS over_IN the_DT next_JJ month_NN ,_, that_DT would_MD mean_VB we_PRP 're_VBP in_IN an_DT urgent_JJ situation_NN where_WRB tougher_JJR actions_NNS will_MD be_VB required_VBN to_TO make_VB sure_JJ that_IN we_PRP do_VBP contain_VB the_DT spread_NN of_IN Covid_NNP -_HYPH 19_CD ,_, ""_'' he_PRP said_VBD ._. As_IN of_IN Sunday_NNP ,_, there_EX 's_VBZ been_VBN a_DT seven_CD -_HYPH day_NN average_NN of_IN 2,913_CD people_NNS currently_RB hospitalized_VBN in_IN Texas_NNP with_IN Covid_NNP -_HYPH 19_CD ,_, a_DT 37_CD %_NN increase_NN compared_VBN with_IN a_DT week_NN ago_RB ,_, according_VBG to_IN data_NNS from_IN the_DT Covid_NNP Tracking_NNP Project_NNP ._. The_DT state_NN 's_POS seven_CD -_HYPH day_NN average_NN of_IN new_JJ Covid_NNP -_HYPH 19_CD cases_NNS has_VBZ increased_VBN more_JJR than_IN 86_CD %_NN compared_VBN with_IN a_DT week_NN ago_RB ,_, according_VBG to_IN data_NNS from_IN Johns_NNP Hopkins_NNP University_NNP ._. —_: Noah_NNP Higgins_NNP -_HYPH Dunn_NNP Contact_VB tracing_NN '_'' will_MD save_VB lives_NNS '_'' if_IN the_DT U.S._NNP builds_VBZ it_PRP 4:30_CD p.m._NN ET_NN —_: Contact_NN tracing_NN ,_, in_IN which_WDT trained_VBN health_NN officials_NNS contact_VBP infected_VBN people_NNS to_TO investigate_VB the_DT source_NN of_IN an_DT outbreak_NN and_CC alert_VB potentially_RB exposed_VBN people_NNS ,_, is_VBZ one_CD of_IN the_DT few_JJ proven_VBN tactics_NNS the_DT U.S._NNP has_VBZ to_TO combat_VB the_DT coronavirus_NN ._. In_IN lieu_NN of_IN federal_JJ leadership_NN ,_, the_DT effort_NN has_VBZ been_VBN largely_RB relegated_VBN to_IN often_RB underfunded_VBN health_NN departments_NNS that_WDT are_VBP struggling_VBG to_TO meet_VB the_DT unprecedented_JJ demand_NN placed_VBN on_IN them_PRP by_IN the_DT coronavirus_NN pandemic_NN ._. ″_`` [_-LRB- Contact_VB tracing_NN ]_-RRB- is_VBZ a_DT standard_JJ tool_NN and_CC it_PRP really_RB works_VBZ ,_, but_CC when_WRB it_PRP 's_VBZ not_RB in_IN place_NN ,_, or_CC in_IN the_DT case_NN of_IN when_WRB you_PRP start_VBP trying_VBG to_TO implement_VB it_PRP after_IN the_DT virus_NN is_VBZ quite_RB literally_RB already_RB spreading_VBG in_IN your_PRP$ community_NN ,_, it_PRP 's_VBZ almost_RB impossible_JJ to_TO catch_VB up_RP ,_, ""_'' said_VBD Dr._NNP Karen_NNP Smith_NNP ,_, former_JJ director_NN of_IN the_DT California_NNP Department_NNP of_IN Public_NNP Health_NNP ._. Here_RB 's_VBZ how_WRB various_JJ cities_NNS and_CC counties_NNS are_VBP ramping_VBG up_RP their_PRP$ contact_NN tracing_NN programs_NNS ._. —_: Will_MD Feuer_NNP Consumers_NNS are_VBP more_RBR cautious_JJ about_IN dining_NN out_RP than_IN they_PRP were_VBD in_IN April_NNP 3:20_CD p.m._NN ET_NNP —_: Los_NNP Angeles_NNP International_NNP Airport_NNP on_IN Tuesday_NNP will_MD start_VB trials_NNS of_IN temperature_NN -_HYPH screening_NN cameras_NNS ,_, the_DT latest_JJS effort_NN by_IN airports_NNS to_TO weed_VB out_RP travelers_NNS who_WP may_MD have_VB Covid_NNP -_HYPH 19_CD ._. The_DT cameras_NNS will_MD be_VB set_VBN up_RP in_IN both_CC departure_NN and_CC arrival_NN areas_NNS at_IN Tom_NNP Bradley_NNP International_NNP Terminal_NNP and_CC the_DT trials_NNS will_MD be_VB voluntary_JJ ,_, Los_NNP Angeles_NNP Mayor_NNP Eric_NNP Garcetti_NNP said_VBD ._. Departing_VBG passengers_NNS will_MD be_VB told_VBN by_IN staff_NN that_IN they_PRP should_MD not_RB travel_VB if_IN they_PRP register_VBP temperatures_NNS of_IN over_RB 100.4_CD degrees_NNS ._. Arriving_VBG travelers_NNS will_MD be_VB referred_VBN to_IN staff_NN from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP if_IN they_PRP register_VBP temperatures_NNS that_WDT high_JJ ._. Airports_NNS and_CC airlines_NNS are_VBP scrambling_VBG to_TO come_VB up_RP with_IN ways_NNS to_TO root_VB out_RP potential_JJ cases_NNS of_IN Covid_NNP -_HYPH 19_CD and_CC ease_VB travelers_NNS fears_NNS about_IN flying_VBG during_IN the_DT pandemic_NN ,_, which_WDT has_VBZ sent_VBN demand_NN down_RB to_IN the_DT lowest_JJS levels_NNS in_IN more_JJR than_IN five_CD decades_NNS ._. Air_NN travel_NN demand_NN has_VBZ rebounded_VBN from_IN lows_NNS hit_VBN in_IN April_NNP ,_, it_PRP 's_VBZ still_RB off_RB around_RB 80_CD %_NN from_IN a_DT year_NN ago_RB ._. —_: Leslie_NNP Josephs_NNP WHO_WP says_VBZ global_JJ case_NN uptick_NN not_RB a_DT '_`` testing_NN phenomenon_NN '_'' Google_NNP 's_POS U.S._NNP ad_NN revenue_NN will_MD drop_VB for_IN the_DT first_JJ time_NN ever_RB ,_, as_IN the_DT pandemic_NN delivers_VBZ blow_NN to_IN businesses_NNS 12:55_CD p.m._NN ET_NN —_: Google_NNP 's_POS U.S._NNP advertising_NN revenue_NN will_MD see_VB its_PRP$ first_JJ -_HYPH ever_RB decline_NN this_DT year_NN ,_, according_VBG to_IN research_NN firm_NN eMarketer_NNP ,_, which_WDT began_VBD modeling_VBG the_DT business_NN in_IN 2008_CD ._. The_DT new_JJ report_NN shows_VBZ the_DT extent_NN to_IN which_WDT even_RB Google_NNP 's_POS robust_JJ digital_JJ ad_NN business_NN has_VBZ likely_RB suffered_VBN during_IN the_DT coronavirus_NN pandemic_NN ,_, which_WDT has_VBZ taken_VBN an_DT especially_RB hard_JJ toll_NN on_IN some_DT of_IN the_DT platform_NN 's_POS biggest_JJS advertisers_NNS in_IN the_DT travel_NN industry_NN ._. While_IN advertising_NN on_IN YouTube_NNP is_VBZ expected_VBN to_TO grow_VB ,_, it_PRP wo_MD n't_RB make_VB up_RP for_IN Google_NNP 's_POS expected_VBN 7.2_CD %_NN drop_NN in_IN net_NN U.S._NNP search_NN ad_NN revenue_NN this_DT year_NN ,_, according_VBG to_IN eMarketer_NNP ._. The_DT model_NN also_RB signals_VBZ that_IN Google_NNP 's_POS digital_JJ advertising_NN rivals_NNS may_MD be_VB able_JJ to_TO close_VB in_RP on_IN the_DT company_NN 's_POS No._NN 1_CD spot_NN in_IN share_NN of_IN digital_JJ ad_NN spend_NN in_IN the_DT U.S._NNP Both_CC Facebook_NNP and_CC Amazon_NNP are_VBP expected_VBN to_TO continue_VB growing_VBG their_PRP$ U.S._NNP advertising_NN revenue_NN this_DT year_NN ,_, though_IN at_IN slower_JJR rates_NNS than_IN in_IN previous_JJ years_NNS ._. Facebook_NNP and_CC Amazon_NNP 's_POS ad_NN businesses_NNS have_VBP less_JJR exposure_NN to_IN the_DT travel_NN industry_NN than_IN Google_NNP ,_, which_WDT could_MD help_VB them_PRP weather_VB the_DT crisis_NN ._. —_: Lauren_NNP Feiner_NNP Hospitalizations_NNS grow_VBP in_IN Arizona_NNP ,_, Texas_NNP as_IN cases_NNS continue_VBP to_TO increase_VB across_IN the_DT U.S_NNP ._. Existing_VBG home_NN sales_NNS plummet_VBP in_IN May_NNP from_IN coronavirus_NN effect_NN Northeast_NNP unlikely_JJ to_TO see_VB spike_NN despite_IN reopening_NN ,_, Dr._NNP Scott_NNP Gottlieb_NNP says_VBZ 10:34_CD a.m._NN ET_NN —_: With_IN New_NNP York_NNP City_NNP moving_VBG its_PRP$ next_JJ phase_NN of_IN reopening_NN ,_, former_JJ Food_NNP and_CC Drug_NNP Administration_NNP Commissioner_NNP Dr._NNP Scott_NNP Gottlieb_NNP says_VBZ the_DT city_NN and_CC region_NN are_VBP unlikely_JJ to_TO see_VB a_DT major_JJ spike_NN in_IN new_JJ cases_NNS ._. Some_DT states_NNS mostly_RB in_IN the_DT South_NNP and_CC West_NNP that_WDT reopened_VBD early_RB —_: before_IN they_PRP had_VBD driven_VBN spread_VBN down_RB to_IN a_DT contained_VBN level_NN and_CC before_IN they_PRP had_VBD the_DT necessary_JJ testing_NN and_CC tracing_NN infrastructure_NN in_IN place_NN —_: have_VBP seen_VBN major_JJ resurgences_NNS in_IN infection_NN over_IN the_DT past_JJ couple_NN of_IN weeks_NNS ._. ""_`` We_PRP 'll_MD see_VB an_DT increase_NN in_IN cases_NNS ,_, but_CC we_PRP 're_VBP reopening_VBG against_IN a_DT much_RB different_JJ backdrop_NN ,_, ""_'' Gottlieb_NNP said_VBD on_IN ""_`` Squawk_NNP Box_NN ._. ""_'' ""_`` So_RB I_PRP would_MD n't_RB expect_VB to_TO see_VB the_DT big_JJ increases_NNS that_WDT they_PRP 're_VBP seeing_VBG in_IN the_DT Southeast_NNP and_CC the_DT South_NNP here_RB when_WRB we_PRP reopen_VBP ._. ""_'' Gottlieb_NNP said_VBD that_IN because_IN so_RB many_JJ people_NNS were_VBD initially_RB infected_VBN in_IN New_NNP York_NNP City_NNP and_CC the_DT tri-state_NN region_NN ,_, a_DT large_JJ portion_NN of_IN the_DT population_NN likely_RB has_VBZ some_DT level_NN of_IN immunity_NN against_IN the_DT virus_NN already_RB ._. That_DT will_MD help_VB limit_VB spread_NN ,_, Gottlieb_NNP added_VBD ._. —_: William_NNP Feuer_NNP Disclosure_NN :_: Scott_NNP Gottlieb_NNP is_VBZ a_DT CNBC_NNP contributor_NN and_CC is_VBZ a_DT member_NN of_IN the_DT boards_NNS of_IN Pfizer_NNP ,_, genetic_JJ -_HYPH testing_NN start_NN -_HYPH up_RP Tempus_NNP and_CC biotech_NN company_NN Illumina_NNP ._. Minnesota_NNP Timberwolves_NNPS want_VBP to_TO increase_VB social_JJ awareness_NN with_IN NBA_NNP jersey_NN patch_NN opening_NN 10:27_CD a.m._NN ET_NN —_: The_DT Minnesota_NNP Timberwolves_NNP '_POS season_NN is_VBZ officially_RB ended_VBN ,_, and_CC the_DT team_NN is_VBZ now_RB looking_VBG to_TO turn_VB the_DT page_NN on_IN the_DT 2019_CD -_HYPH 20_CD season_NN ,_, and_CC the_DT transition_NN will_MD include_VB a_DT change_NN to_IN the_DT team_NN jerseys_NNS ._. The_DT Timberwolves_NNPS '_POS NBA_NNP jersey_NN patch_NN partnership_NN with_IN tech_NN company_NN Fitbit_NNP has_VBZ expired_VBN ,_, and_CC the_DT team_NN is_VBZ looking_VBG to_TO add_VB a_DT new_JJ corporate_JJ sponsor_NN that_WDT aligns_VBZ with_IN its_PRP$ renewed_VBN mission_NN of_IN combating_VBG racism_NN and_CC social_JJ inequality_NN ._. Timberwolves_NNP COO_NNP Ryan_NNP Tanke_NNP told_VBD CNBC_NNP the_DT club_NN is_VBZ seeking_VBG a_DT company_NN that_WDT will_MD help_VB ""_`` create_VB impact_NN in_IN our_PRP$ community_NN ""_'' and_CC ""_`` be_VB a_DT champion_NN for_IN social_JJ advancement_NN ""_'' as_IN the_DT Minnesota_NNP community_NN continues_VBZ to_TO heal_VB following_VBG the_DT death_NN of_IN George_NNP Floyd_NNP ._. The_DT Timberwolves_NNPS have_VBP been_VBN one_CD of_IN the_DT most_RBS hit_VBN organizations_NNS throughout_IN the_DT sports_NNS industry_NN since_IN March_NNP 12_CD ,_, when_WRB sports_NNS halted_VBD due_IN to_IN Covid_NNP -_HYPH 19_CD ._. Timberwolves_NNP star_NN center_NN Karl_NNP -_HYPH Anthony_NNP Towns_NNPS '_POS mother_NN ,_, Jacqueline_NNP ,_, died_VBD on_IN April_NNP 13_CD due_IN to_IN Covid_NNP -_HYPH 19_CD ._. Tanke_NNP said_VBD both_CC events_NNS are_VBP ""_`` critically_RB important_JJ ,_, ""_'' adding_VBG Floyd_NNP 's_POS murder_NN ""_`` unlocked_VBN for_IN us_PRP this_DT chance_NN to_TO be_VB a_DT vocal_JJ leader_NN with_IN Minneapolis_NNP being_VBG the_DT epicenter_NN of_IN this_DT ._. ""_'' —_NFP Jabari_NNP Young_NNP Grocery_NN stores_NNS look_VBP to_IN robots_NNS ,_, salad_NN kiosks_NNS and_CC more_JJR to_TO revive_VB prepared_VBN food_NN South_NNP Korea_NNP fears_VBZ it_PRP is_VBZ battling_VBG '_`` second_JJ wave_NN '_'' 7:26_CD a.m._NN ET_NN —_: Health_NN authorities_NNS in_IN South_NNP Korea_NNP said_VBD for_IN the_DT first_JJ time_NN on_IN Monday_NNP that_IN the_DT country_NN is_VBZ experiencing_VBG a_DT ""_`` second_JJ wave_NN ""_'' of_IN coronavirus_NN infections_NNS around_IN the_DT capital_NN Seoul_NNP ._. On_IN Monday_NNP ,_, the_DT director_NN of_IN Korea_NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP Jeong_NNP Eun-kyeong_NNP said_VBD a_DT holiday_NN in_IN early_JJ May_NNP marked_VBD the_DT beginning_NN of_IN a_DT ""_`` second_JJ wave_NN ""_'' of_IN cases_NNS in_IN the_DT greater_JJR Seoul_NNP area_NN ,_, Reuters_NNP reported_VBD ._. ""_`` In_IN the_DT metropolitan_JJ area_NN ,_, we_PRP believe_VBP that_IN the_DT first_JJ wave_NN was_VBD from_IN March_NNP to_IN April_NNP as_RB well_RB as_IN February_NNP to_IN March_NNP ,_, ""_'' Jeong_NNP said_VBD at_IN a_DT news_NN briefing_NN ,_, according_VBG to_IN Reuters_NNP ._. ""_`` Then_RB we_PRP see_VBP that_IN the_DT second_JJ wave_NN which_WDT was_VBD triggered_VBN by_IN the_DT May_NNP holiday_NN has_VBZ been_VBN going_VBG on_RP ._. ""_'' South_NNP Korea_NNP has_VBZ 12,438_CD confirmed_VBN cases_NNS of_IN the_DT virus_NN ,_, according_VBG to_IN Johns_NNP Hopkins_NNP University_NNP ,_, and_CC has_VBZ reported_VBN 280_CD deaths_NNS ._. —_: Holly_NNP Ellyatt_NNP 7:21_CD a.m._NN ET_NN —_: The_DT World_NNP Health_NNP Organization_NNP on_IN Sunday_NNP reported_VBD the_DT largest_JJS single_JJ -_HYPH day_NN increase_NN of_IN coronavirus_NN cases_NNS around_IN the_DT world_NN since_IN the_DT virus_NN emerged_VBD in_IN Wuhan_NNP ,_, China_NNP more_JJR than_IN six_CD months_NNS ago_RB ._. The_DT United_NNP Nations_NNPS agency_NN said_VBD more_JJR than_IN 183,000_CD new_JJ cases_NNS were_VBD reported_VBN on_IN Sunday_NNP ._. Brazil_NNP was_VBD the_DT biggest_JJS contributor_NN ,_, reporting_VBG 54,771_CD new_JJ cases_NNS ._. The_DT U.S._NNP tallied_VBD 36,617_CD new_JJ cases_NNS ._. On_IN Friday_NNP ,_, WHO_NNP Director_NN -_HYPH General_NNP Tedros_NNP Adhanom_NNP Ghebreyesus_NNP warned_VBD that_IN the_DT pandemic_NN has_VBZ entered_VBN a_DT ""_`` new_JJ and_CC dangerous_JJ phase_NN ,_, ""_'' as_IN the_DT spread_NN of_IN the_DT virus_NN continues_VBZ to_TO accelerate_VB in_IN new_JJ communities_NNS and_CC resurge_NN in_IN some_DT that_WDT had_VBD already_RB been_VBN hit_VBN hard_RB ._. ""_`` Many_JJ people_NNS are_VBP understandably_RB fed_VBN up_RP with_IN being_VBG at_IN home_NN ._. Countries_NNS are_VBP understandably_RB eager_JJ to_TO open_VB up_RP their_PRP$ societies_NNS and_CC economies_NNS ,_, ""_'' he_PRP said_VBD ._. ""_`` But_CC the_DT virus_NN is_VBZ still_RB spreading_VBG fast_RB ._. It_PRP is_VBZ still_RB deadly_JJ and_CC most_JJS people_NNS are_VBP still_RB susceptible_JJ ._. ""_'' The_DT coronavirus_NN has_VBZ now_RB infected_VBN more_JJR than_IN 8,970,977_CD people_NNS around_IN the_DT world_NN and_CC killed_VBD at_IN least_JJS 468,589_CD people_NNS ,_, according_VBG to_IN data_NNS from_IN Johns_NNP Hopkins_NNP University_NNP ._. —_: Will_MD Feuer_NNP","JJ NNS in NNP - 19 NNS VBP to VB JJ NNS of VBG , as a NN of NNS VBD to VB a NN in JJ NNS and NNS . The NNP NNP NNP VBD JJ NNS in JJ NNS , and VBD NNS that VBN NN VBZ the JJ NN behind JJR NN NNS . The NN on this JJ NN VBZ VBN — but for up - to - the - NN NN on the NN , VB the JJ NN from NNP NNP NN . • NNP NNS : JJR than 2.3 million • NNP NNS : At JJS 120,402 The NNS RB VBD VBN by NNP NNP NNP . 11:00 NN NNP NN : NNP JJ NNP NNP NNP VBZ VBN that "" JJ NNS and JJ NNS VBP RB "" as the NN VBZ to VB with the JJ NN from the NN NN . In an NN to the NN NNP , NNP VBD that NNS in all NNS VBD VBN NN NNS or JJ NNS as a NN of NNS VBN since the NN VBD JJ NN NNS on NNP 26 . JJ of the JJ NN VBG VBN by the NNS , the NN VBZ VBN VBG NNS , but NNP NNP RB VBZ 101,590 VBN NNS of NNP - 19 , the RBS on the NN , with 1,991 NNS as of NNP NN , VBG to NNP NNP NNP . — NNP NNP JJ NN VBZ NN to VB JJ NN for JJ NN NNP NNP NNP NNP NN VBZ he VBZ NNP VBD from NN 's NN NNP to VB NN of JJ JJ NNS , VBG up an VBN 525,000 NNS , JJ VBZ 5:30 NN NN — NNP NNP NNP NNP VBD the NN VBZ RB VBN in the JJ NN of the NN and that he VBZ NNS to VB VBG . The NN VBD 46,735 NN NNS over the JJ 14 NNS , VBG 36 NN of NNP 's JJ NNS . "" The NN NN VBD VBN JJ , but RB it VBZ VBG RB up , "" NNP VBD at a NN NN . Although JJR NNS VBP VBG VBN in NNP , that VBZ RB VB the JJ NN behind the VBG NN NNS , VBG to NNP . He VBD the NN VBZ VBN to VB JJR NNS in JJ NNS in NNS of VBG NN NNS and NN , and that he VBZ NN NNS if the NN VBZ in NNP . NNP RB VBD an NN on the NN 's JJ NNS NN . He VBD NNP VBZ VBN $ 34.3 billion since NNP 15 in NNP NNP NNP . "" That VBZ RB NN the NN VBZ RB VBN to VB in the NN , "" he VBD . — NNP NNP NNP NN VBZ JJR NNS will VB VBN if NNS , NNS VBP VBG 5:05 NN NN — NNP NNP NNP NNP VBD that "" JJ NNS VBP VBG to VB JJ "" and the NN will VB to VB "" JJR NNS "" if JJ NN NNS and NNS VBP to VB at JJ NNS into NNP . On NNP 12 , NNP VBD that there VBZ "" no JJ NN to VB back the NN of NNS in the NN . "" NNP VBZ RB VBN NNS of JJ NNS and JJ NNS in NNP - 19 NNS . "" If we VBD to VB another NN of those NNS over the JJ NN , that would VB we VBP in an JJ NN where JJR NNS will VB VBN to VB JJ that we VBP VB the NN of NNP - 19 , "" he VBD . As of NNP , there VBZ VBN a seven - NN NN of 2,913 NNS RB VBN in NNP with NNP - 19 , a 37 NN NN VBN with a NN RB , VBG to NNS from the NNP NNP NNP . The NN 's seven - NN NN of JJ NNP - 19 NNS VBZ VBN JJR than 86 NN VBN with a NN RB , VBG to NNS from NNP NNP NNP . — NNP NNP - NNP VB NN ' will VB NNS ' if the NNP VBZ it 4:30 NN NN — NN NN , in which VBN NN NNS VBP VBN NNS to VB the NN of an NN and VB RB VBN NNS , VBZ one of the JJ VBN NNS the NNP VBZ to VB the NN . In NN of JJ NN , the NN VBZ VBN RB VBN to RB VBN NN NNS that VBP VBG to VB the JJ NN VBN on them by the NN NN . ″ [ VB NN ] VBZ a JJ NN and it RB VBZ , but when it VBZ RB in NN , or in the NN of when you VBP VBG to VB it after the NN VBZ RB RB RB VBG in your NN , it VBZ RB JJ to VB up , "" VBD NNP NNP NNP , JJ NN of the NNP NNP of NNP NNP . RB VBZ how JJ NNS and NNS VBP VBG up their NN NN NNS . — Will NNP NNS VBP RBR JJ about NN out than they VBD in NNP 3:20 NN NNP — NNP NNP NNP NNP on NNP will VB NNS of NN - NN NNS , the JJS NN by NNS to VB out NNS who may VB NNP - 19 . The NNS will VB VBN up in both NN and NN NNS at NNP NNP NNP NNP and the NNS will VB JJ , NNP NNP NNP NNP NNP VBD . VBG NNS will VB VBN by NN that they should RB VB if they VBP NNS of RB 100.4 NNS . VBG NNS will VB VBN to NN from the NNPS for NNP NNP and NNP if they VBP NNS that JJ . NNS and NNS VBP VBG to VB up with NNS to VB out JJ NNS of NNP - 19 and VB NNS NNS about VBG during the NN , which VBZ VBN NN RB to the JJS NNS in JJR than five NNS . NN NN NN VBZ VBN from NNS VBN in NNP , it VBZ RB RB RB 80 NN from a NN RB . — NNP NNP WHO VBZ JJ NN NN RB a ' NN NN ' NNP 's NNP NN NN will VB for the JJ NN RB , as the NN VBZ NN to NNS 12:55 NN NN — NNP 's NNP NN NN will VB its JJ - RB NN this NN , VBG to NN NN NNP , which VBD VBG the NN in 2008 . The JJ NN VBZ the NN to which RB NNP 's JJ JJ NN NN VBZ RB VBN during the NN NN , which VBZ VBN an RB JJ NN on some of the NN 's JJS NNS in the NN NN . While NN on NNP VBZ VBN to VB , it wo RB VB up for NNP 's VBN 7.2 NN NN in NN NNP NN NN NN this NN , VBG to NNP . The NN RB VBZ that NNP 's JJ NN NNS may VB JJ to VB in on the NN 's NN 1 NN in NN of JJ NN NN in the NNP Both NNP and NNP VBP VBN to VB VBG their NNP NN NN this NN , though at JJR NNS than in JJ NNS . NNP and NNP 's NN NNS VBP JJR NN to the NN NN than NNP , which could VB them VB the NN . — NNP NNP NNS VBP in NNP , NNP as NNS VBP to VB across the NNP . VBG NN NNS VBP in NNP from NN NN NNP JJ to VB NN despite NN , NNP NNP NNP VBZ 10:34 NN NN — With NNP NNP NNP VBG its JJ NN of NN , JJ NNP and NNP NNP NNP NNP NNP NNP VBZ the NN and NN VBP JJ to VB a JJ NN in JJ NNS . Some NNS RB in the NNP and NNP that VBD RB — before they VBD VBN VBN RB to a VBN NN and before they VBD the JJ NN and NN NN in NN — VBP VBN JJ NNS in NN over the JJ NN of NNS . "" We 'll VB an NN in NNS , but we VBP VBG against a RB JJ NN , "" NNP VBD on "" NNP NN . "" "" RB I would RB VB to VB the JJ NNS that they VBP VBG in the NNP and the NNP RB when we VBP . "" NNP VBD that because RB JJ NNS VBD RB VBN in NNP NNP NNP and the NN NN , a JJ NN of the NN RB VBZ some NN of NN against the NN RB . That will VB VB NN , NNP VBD . — NNP NNP NN : NNP NNP VBZ a NNP NN and VBZ a NN of the NNS of NNP , JJ - NN NN - up NNP and NN NN NNP . NNP NNPS VBP to VB JJ NN with NNP NN NN NN 10:27 NN NN — The NNP NNP ' NN VBZ RB VBN , and the NN VBZ RB VBG to VB the NN on the 2019 - 20 NN , and the NN will VB a NN to the NN NNS . The NNPS ' NNP NN NN NN with NN NN NNP VBZ VBN , and the NN VBZ VBG to VB a JJ JJ NN that VBZ with its VBN NN of VBG NN and JJ NN . NNP NNP NNP NNP VBD NNP the NN VBZ VBG a NN that will VB "" VB NN in our NN "" and "" VB a NN for JJ NN "" as the NNP NN VBZ to VB VBG the NN of NNP NNP . The NNPS VBP VBN one of the RBS VBN NNS throughout the NNS NN since NNP 12 , when NNS VBD due to NNP - 19 . NNP NN NN NNP - NNP NNPS ' NN , NNP , VBD on NNP 13 due to NNP - 19 . NNP VBD both NNS VBP "" RB JJ , "" VBG NNP 's NN "" VBN for us this NN to VB a JJ NN with NNP VBG the NN of this . "" — NNP NNP NN NNS VBP to NNS , NN NNS and JJR to VB VBN NN NNP NNP VBZ it VBZ VBG ' JJ NN ' 7:26 NN NN — NN NNS in NNP NNP VBD for the JJ NN on NNP that the NN VBZ VBG a "" JJ NN "" of NN NNS around the NN NNP . On NNP , the NN of NNP NNPS for NNP NNP and NNP NNP NNP VBD a NN in JJ NNP VBD the NN of a "" JJ NN "" of NNS in the JJR NNP NN , NNP VBD . "" In the JJ NN , we VBP that the JJ NN VBD from NNP to NNP RB RB as NNP to NNP , "" NNP VBD at a NN NN , VBG to NNP . "" RB we VBP that the JJ NN which VBD VBN by the NNP NN VBZ VBN VBG on . "" NNP NNP VBZ 12,438 VBN NNS of the NN , VBG to NNP NNP NNP , and VBZ VBN 280 NNS . — NNP NNP 7:21 NN NN — The NNP NNP NNP on NNP VBD the JJS JJ - NN NN of NN NNS around the NN since the NN VBD in NNP , NNP JJR than six NNS RB . The NNP NNPS NN VBD JJR than 183,000 JJ NNS VBD VBN on NNP . NNP VBD the JJS NN , VBG 54,771 JJ NNS . The NNP VBD 36,617 JJ NNS . On NNP , NNP NN - NNP NNP NNP NNP VBD that the NN VBZ VBN a "" JJ and JJ NN , "" as the NN of the NN VBZ to VB in JJ NNS and NN in some that VBD RB VBN VBN RB . "" JJ NNS VBP RB VBN up with VBG at NN . NNS VBP RB JJ to VB up their NNS and NNS , "" he VBD . "" But the NN VBZ RB VBG RB . It VBZ RB JJ and JJS NNS VBP RB JJ . "" The NN VBZ RB VBN JJR than 8,970,977 NNS around the NN and VBD at JJS 468,589 NNS , VBG to NNS from NNP NNP NNP . — Will NNP"
25,367,conspiracy,C0000f,5g; coronavirus; covid.19; drug.companies; mind.control; vaccine,"Legendary_JJ gold_NN and_CC market_NN expert_NN Jim_NNP Sinclair_NNP says_VBZ the_DT virus_NN that_WDT originated_VBD in_IN China_NNP may_MD have_VB ,_, oddly_RB enough_RB ,_, done_VBN some_DT good_NN ._. Sinclair_NNP explains_VBZ ,_, “_`` The_DT effect_NN of_IN the_DT coronavirus_NN was_VBD literally_RB to_TO shut_VB down_RP business_NN globally_RB ,_, therefore_RB ,_, shut_VBD off_RP the_DT demand_NN for_IN loans_NNS ,_, which_WDT also_RB shut_VBD off_RP demand_NN for_IN short_JJ term_NN money_NN ._. So_RB ,_, what_WP the_DT public_NN has_VBZ not_RB seen_VBN ,_, is_VBZ not_RB considering_VBG and_CC does_VBZ not_RB understand_VB is_VBZ we_PRP were_VBD stepping_VBG into_IN the_DT door_NN of_IN a_DT major_JJ financial_JJ crisis_NN magnitudes_NNS larger_JJR than_IN what_WP happened_VBD in_IN 2008_CD and_CC 2009_CD ._. It_PRP ’s_VBZ a_DT horrible_JJ thing_NN that_WDT this_DT virus_NN occurred_VBD ,_, but_CC if_IN it_PRP had_VBD not_RB occurred_VBN ,_, we_PRP would_MD have_VB been_VBN in_IN a_DT crisis_NN much_RB more_RBR serious_JJ than_IN 2008_CD and_CC 2009_CD ._. ._. ._. ._. It_PRP was_VBD blowing_VBG sky_NN high_JJ ._. ._. ._. ._. Shutting_VBG down_RP demand_NN is_VBZ all_DT we_PRP could_MD do_VB ._. It_PRP stopped_VBD the_DT explosion_NN of_IN interest_NN rates_NNS ._. ”_'' Where_WRB do_VBP we_PRP go_VB from_IN here_RB ?_. Sinclair_NNP says_VBZ ,_, “_`` We_PRP are_VBP going_VBG to_TO make_VB a_DT recovery_NN ._. It_PRP ’s_VBZ not_RB going_VBG to_TO be_VB a_DT ‘_`` V_NN ’_'' by_IN any_DT means_NNS ._. The_DT stock_NN market_NN could_MD be_VB a_DT ‘_`` V_NN ’_'' because_IN the_DT stock_NN market_NN has_VBZ very_RB little_JJ to_TO do_VB with_IN reality_NN ._. ._. ._. ._. As_RB far_RB as_IN business_NN is_VBZ concerned_VBN ,_, very_RB serious_JJ damage_NN has_VBZ been_VBN done_VBN to_IN the_DT infrastructure_NN to_IN the_DT business_NN equation_NN ._. Many_JJ employers_NNS are_VBP gone_VBN ._. Many_JJ corporations_NNS have_VBP significant_JJ readjustments_NNS to_TO be_VB able_JJ to_TO build_VB up_RP again_RB ._. The_DT supply_NN lines_NNS and_CC logistics_NNS ,_, where_WRB did_VBD everything_NN come_VB from_IN ?_. China_NNP ._. ._. ._. ._. This_DT is_VBZ a_DT major_JJ worldwide_JJ adjustment_NN ,_, both_CC economically_RB and_CC politically_RB ._. ._. ._. ._. We_PRP had_VBD everything_NN made_VBN in_IN the_DT cheapest_JJS place_NN possible_JJ ._. ._. ._. ._. This_DT is_VBZ not_RB a_DT passing_VBG phenomenon_NN ._. ._. ._. ._. The_DT only_JJ thing_NN that_WDT has_VBZ been_VBN steady_JJ is_VBZ gold_NN ._. ._. ._. ._. The_DT change_NN that_WDT this_DT brings_VBZ about_IN is_VBZ a_DT reconstruction_NN of_IN the_DT basic_JJ business_NN foundations_NNS ._. It_PRP ’s_VBZ a_DT start_NN over_RP ,_, it_PRP ’s_VBZ not_RB just_RB a_DT slowdown_NN ._. How_WRB many_JJ restaurants_NNS make_VBP money_NN on_IN 50_CD %_NN of_IN the_DT clients_NNS ?_. You_PRP can_MD ’t_RB ._. How_WRB many_JJ automobiles_NNS have_VBP built_VBN up_RP on_IN the_DT lots_NNS ?_. Enormous_JJ amounts_NNS ._. How_WRB many_JJ clothing_NN stores_NNS shut_VBP down_RP full_JJ of_IN winter_NN clothes_NNS and_CC ca_MD n’t_RB make_VB the_DT shift_NN to_IN summer_NN wear_NN ?_. You_PRP can_MD go_VB down_IN the_DT entire_JJ line_NN ._. So_RB ,_, this_DT recovery_NN will_MD be_VB more_RBR like_IN an_DT ‘_`` L_NNP ’_'' ._. We_PRP ’ve_VBP come_VBN straight_RB down_RP ,_, and_CC we_PRP are_VBP going_VBG to_TO go_VB sideways_RB now_RB ._. ._. ._. ._. Many_JJ businesses_NNS are_VBP not_RB going_VBG to_TO open_VB up_RP again_RB ._. ._. ._. ._. The_DT idea_NN of_IN the_DT coming_VBG inflation_NN as_IN a_DT result_NN of_IN this_DT is_VBZ simple_JJ ._. Everything_NN that_WDT you_PRP need_VBP will_MD go_VB up_RP in_IN price_NN ._. Everything_NN you_PRP do_VBP n’t_RB need_VB is_VBZ not_RB going_VBG to_TO hold_VB value_NN ._. You_PRP are_VBP better_JJR off_RP with_IN a_DT freezer_NN full_JJ of_IN fine_JJ cuts_NNS of_IN beef_NN than_IN you_PRP are_VBP with_IN a_DT brand_NN new_JJ Tesla_NNP ._. The_DT beef_NN will_MD go_VB up_RP in_IN price_NN ,_, the_DT Tesla_NNP will_MD go_VB down_RP ._. ”_'' On_IN gold_NN ,_, Sinclair_NNP says_VBZ the_DT ultimate_JJ price_NN is_VBZ an_DT easy_JJ -_HYPH to_IN -_HYPH calculate_NN math_NN problem_NN ._. How_WRB much_JJ gold_NN does_VBZ America_NNP have_VB compared_VBN to_IN how_WRB much_JJ debt_NN it_PRP has_VBZ ?_. So_RB ,_, how_WRB high_JJ could_MD gold_NN ultimately_RB go_VB ?_. Sinclair_NNP says_VBZ ,_, “_`` It_PRP ’s_VBZ simple_JJ math_NN ._. You_PRP take_VBP the_DT amount_NN of_IN gold_NN the_DT U.S._NNP says_VBZ it_PRP has_VBZ ,_, and_CC then_RB you_PRP take_VBP the_DT debt_NN it_PRP has_VBZ ,_, and_CC what_WDT price_NN would_MD you_PRP need_VB for_IN the_DT debt_NN to_TO balance_VB to_IN zero_CD ?_. The_DT price_NN on_IN the_DT low_JJ end_NN is_VBZ $_$ 50,000_CD per_IN ounce_NN ._. The_DT true_JJ price_NN is_VBZ $_$ 87,500_CD per_IN ounce_NN ._. ”_'' Is_VBZ a_DT biblical_JJ debt_NN jubilee_NN coming_VBG to_IN America_NNP ?_. Sinclair_NNP says_VBZ ,_, “_`` We_PRP already_RB have_VBP jubilees_NNS ._. If_IN you_PRP do_VBP n’t_RB pay_VB your_PRP$ rent_NN ,_, you_PRP have_VBP a_DT jubilee_NN ._. If_IN you_PRP do_VBP n’t_RB pay_VB your_PRP$ student_NN loan_NN ,_, you_PRP have_VBP a_DT jubilee_NN ._. If_IN the_DT payment_NN of_IN your_PRP$ auto_NN insurance_NN is_VBZ postponed_VBN ,_, you_PRP have_VBP a_DT jubilee_NN ._. We_PRP ’ve_VBP got_VBN jubilee_NN after_IN jubilee_NN after_IN jubilee_NN ._. Keep_VB in_IN mind_NN ,_, one_CD man_NN ’s_POS jubilee_NN is_VBZ another_DT man_NN ’s_POS disaster_NN ._. It_PRP ’s_VBZ almost_RB as_IN if_IN the_DT Bible_NNP is_VBZ correct_JJ in_IN terms_NNS of_IN economics_NNS ._. Also_RB ,_, keep_VB in_IN mind_NN ,_, the_DT people_NNS who_WP are_VBP n’t_RB being_VBG paid_VBN are_VBP being_VBG hurt_VBN very_RB badly_RB ._. ”_'' Sinclair_NNP thinks_VBZ the_DT recovery_NN will_MD take_VB a_DT decade_NN or_CC longer_RBR ,_, and_CC Sinclair_NNP says_VBZ ,_, “_`` It_PRP will_MD be_VB just_RB like_IN the_DT period_NN between_IN 1929_CD up_IN to_IN WWII_NNP (_-LRB- 1941_CD )_-RRB- ._. ”_'' Join_VB Greg_NNP Hunter_NNP as_IN he_PRP goes_VBZ One_CD -_HYPH on_IN -_HYPH One_CD with_IN renowned_VBN gold_NN expert_NN Jim_NNP Sinclair_NNP ._. Sinclair_NNP did_VBD call_VB back_RB in_RP and_CC said_VBD his_PRP$ power_NN was_VBD knocked_VBN out_RP for_IN a_DT short_JJ while_NN ._. He_PRP also_RB added_VBD ,_, “_`` I_PRP will_MD give_VB the_DT re-election_NN of_IN President_NNP Trump_NNP a_DT 50/50_CD chance_NN ._. Trump_NNP knows_VBZ what_WP he_PRP has_VBZ to_TO do_VB ,_, and_CC that_DT is_VBZ bring_VB the_DT economy_NN back_RB ._. If_IN he_PRP does_VBZ that_DT ,_, Trumps_NNP re-election_NN will_MD be_VB a_DT slam_NN dunk_NN ._. If_IN Trump_NNP is_VBZ not_RB re-elected_VBN ,_, the_DT game_NN board_NN breaks_VBZ ._. ”_'' If_IN you_PRP want_VBP to_TO know_VB about_IN Sinclair_NNP ’s_POS company_NN that_WDT he_PRP talked_VBD about_IN and_CC news_NN that_IN gold_NN is_VBZ finally_RB being_VBG brought_VBN up_RP out_IN of_IN the_DT ground_NN ,_, go_VB to_IN TanGoldCorp.com_NNP ._. There_EX is_VBZ much_JJ free_JJ information_NN ,_, articles_NNS and_CC analysis_NN on_IN the_DT homepage_NN of_IN JSMineset.com_NNP ._. To_TO get_VB even_RB more_RBR original_JJ information_NN ,_, articles_NNS and_CC analysis_NN ,_, you_PRP can_MD become_VB a_DT subscriber_NN for_IN $_$ 129_CD per_IN year_NN ._. Click_VB here_RB to_TO be_VB a_DT subscriber_NN to_IN JSMineset.com_ADD ._. This_DT segment_NN is_VBZ sponsored_VBN by_IN Discount_NNP Gold_NNP and_CC Silver_NNP Trading_NNP ._. Ask_VB for_IN Melody_NNP Cedarstrom_NNP ,_, the_DT owner_NN ,_, at_IN 1-800-375-4188_CD ._.","JJ NN and NN NN NNP NNP VBZ the NN that VBD in NNP may VB , RB RB , VBN some NN . NNP VBZ , “ The NN of the NN VBD RB to VB down NN RB , RB , VBD off the NN for NNS , which RB VBD off NN for JJ NN NN . RB , what the NN VBZ RB VBN , VBZ RB VBG and VBZ RB VB VBZ we VBD VBG into the NN of a JJ JJ NN NNS JJR than what VBD in 2008 and 2009 . It VBZ a JJ NN that this NN VBD , but if it VBD RB VBN , we would VB VBN in a NN RB RBR JJ than 2008 and 2009 . . . . It VBD VBG NN JJ . . . . VBG down NN VBZ all we could VB . It VBD the NN of NN NNS . ” Where VBP we VB from RB ? NNP VBZ , “ We VBP VBG to VB a NN . It VBZ RB VBG to VB a ‘ NN ’ by any NNS . The NN NN could VB a ‘ NN ’ because the NN NN VBZ RB JJ to VB with NN . . . . RB RB as NN VBZ VBN , RB JJ NN VBZ VBN VBN to the NN to the NN NN . JJ NNS VBP VBN . JJ NNS VBP JJ NNS to VB JJ to VB up RB . The NN NNS and NNS , where VBD NN VB from ? NNP . . . . This VBZ a JJ JJ NN , both RB and RB . . . . We VBD NN VBN in the JJS NN JJ . . . . This VBZ RB a VBG NN . . . . The JJ NN that VBZ VBN JJ VBZ NN . . . . The NN that this VBZ about VBZ a NN of the JJ NN NNS . It VBZ a NN over , it VBZ RB RB a NN . How JJ NNS VBP NN on 50 NN of the NNS ? You can RB . How JJ NNS VBP VBN up on the NNS ? JJ NNS . How JJ NN NNS VBP down JJ of NN NNS and ca RB VB the NN to NN NN ? You can VB down the JJ NN . RB , this NN will VB RBR like an ‘ NNP ’ . We VBP VBN RB down , and we VBP VBG to VB RB RB . . . . JJ NNS VBP RB VBG to VB up RB . . . . The NN of the VBG NN as a NN of this VBZ JJ . NN that you VBP will VB up in NN . NN you VBP RB VB VBZ RB VBG to VB NN . You VBP JJR off with a NN JJ of JJ NNS of NN than you VBP with a NN JJ NNP . The NN will VB up in NN , the NNP will VB down . ” On NN , NNP VBZ the JJ NN VBZ an JJ - to - NN NN NN . How JJ NN VBZ NNP VB VBN to how JJ NN it VBZ ? RB , how JJ could NN RB VB ? NNP VBZ , “ It VBZ JJ NN . You VBP the NN of NN the NNP VBZ it VBZ , and RB you VBP the NN it VBZ , and what NN would you VB for the NN to VB to zero ? The NN on the JJ NN VBZ $ 50,000 per NN . The JJ NN VBZ $ 87,500 per NN . ” VBZ a JJ NN NN VBG to NNP ? NNP VBZ , “ We RB VBP NNS . If you VBP RB VB your NN , you VBP a NN . If you VBP RB VB your NN NN , you VBP a NN . If the NN of your NN NN VBZ VBN , you VBP a NN . We VBP VBN NN after NN after NN . VB in NN , one NN ’s NN VBZ another NN ’s NN . It VBZ RB as if the NNP VBZ JJ in NNS of NNS . RB , VB in NN , the NNS who VBP RB VBG VBN VBP VBG VBN RB RB . ” NNP VBZ the NN will VB a NN or RBR , and NNP VBZ , “ It will VB RB like the NN between 1929 up to NNP ( 1941 ) . ” VB NNP NNP as he VBZ One - on - One with VBN NN NN NNP NNP . NNP VBD VB RB in and VBD his NN VBD VBN out for a JJ NN . He RB VBD , “ I will VB the NN of NNP NNP a 50/50 NN . NNP VBZ what he VBZ to VB , and that VBZ VB the NN RB . If he VBZ that , NNP NN will VB a NN NN . If NNP VBZ RB VBN , the NN NN VBZ . ” If you VBP to VB about NNP ’s NN that he VBD about and NN that NN VBZ RB VBG VBN up out of the NN , VB to NNP . There VBZ JJ JJ NN , NNS and NN on the NN of NNP . To VB RB RBR JJ NN , NNS and NN , you can VB a NN for $ 129 per NN . VB RB to VB a NN to JSMineset.com . This NN VBZ VBN by NNP NNP and NNP NNP . VB for NNP NNP , the NN , at 1-800-375-4188 ."
26,774,mainstream,M0aa09,vaccine,"The_DT measles_NNS outbreaks_NNS continue_VBP to_TO spread_VB ,_, with_IN New_NNP York_NNP City_NNP declaring_VBG a_DT public_JJ health_NN emergency_NN and_CC requiring_VBG people_NNS in_IN four_CD ZIP_NN codes_NNS to_TO have_VB their_PRP$ children_NNS vaccinated_VBN or_CC face_VB penalties_NNS ,_, including_VBG a_DT fine_NN of_IN US_NNP $_$ 1,000_CD and_CC or_CC imprisonment_NN ._. Since_IN September_NNP 2018_CD ,_, 285_CD measles_NN cases_NNS have_VBP been_VBN reported_VBN in_IN Brooklyn_NNP and_CC Queens_NNP ,_, mainly_RB in_IN neighborhoods_NNS where_WRB ultra-Orthodox_JJ Jews_NNPS have_VBP chosen_VBN to_TO not_RB have_VB their_PRP$ children_NNS vaccinated_VBN ._. The_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ,_, said_VBD that_IN from_IN Jan._NNP 1_CD to_IN April_NNP 4_CD ,_, 2019_CD ,_, 465_CD individual_JJ cases_NNS of_IN measles_NNS have_VBP been_VBN confirmed_VBN in_IN 19_CD states_NNS ._. This_DT is_VBZ the_DT second_JJ -_HYPH highest_JJS number_NN of_IN cases_NNS since_IN the_DT CDC_NNP declared_VBD measles_NNS eliminated_VBN in_IN 2000_CD ;_, in_IN 2014_CD ,_, 667_CD cases_NNS occurred_VBD ._. Cases_NNS have_VBP still_RB been_VBN occurring_VBG each_DT year_NN ,_, often_RB brought_VBN into_IN the_DT United_NNP States_NNPS from_IN international_JJ travelers_NNS ._. Officials_NNS believe_VBP that_DT to_TO be_VB the_DT cause_NN of_IN the_DT outbreak_NN in_IN Rockland_NNP County_NNP ,_, New_NNP York_NNP ,_, where_WRB 168_CD cases_NNS were_VBD reported_VBN as_IN of_IN April_NNP 8_CD ,_, 2019_CD ._. Rockland_NNP public_JJ health_NN officials_NNS issued_VBD a_DT ban_NN that_WDT would_MD keep_VB unvaccinated_JJ children_NNS out_IN of_IN public_JJ places_NNS ,_, but_CC a_DT judge_NN overruled_VBD that_DT on_IN April_NNP 5_CD ._. On_IN April_NNP 9_CD ,_, county_NN officials_NNS said_VBD they_PRP would_MD appeal_VB ._. But_CC there_EX are_VBP limits_NNS to_IN what_WDT health_NN care_NN providers_NNS ,_, public_JJ health_NN officials_NNS and_CC legislators_NNS can_MD do_VB ._. It_PRP is_VBZ crucial_JJ to_TO consider_VB both_CC the_DT power_NN –_: and_CC the_DT limits_NNS –_: of_IN potential_JJ solutions_NNS that_WDT will_MD provide_VB education_NN ,_, medical_JJ care_NN and_CC protection_NN for_IN the_DT public_NN while_IN still_RB upholding_VBG principles_NNS of_IN informed_VBN consent_NN ,_, parental_JJ decision_NN -_HYPH making_VBG and_CC sustaining_VBG public_JJ trust_NN ._. As_IN a_DT professor_NN who_WP researches_VBZ and_CC teaches_VBZ health_NN law_NN ,_, public_JJ health_NN law_NN and_CC medical_JJ ethics_NN ,_, I_PRP think_VBP it_PRP ’s_VBZ worth_JJ clarifying_VBG what_WDT states_NNS can_MD or_CC cannot_MD legally_RB do_VB when_WRB responding_VBG to_IN cases_NNS of_IN communicable_JJ disease_NN ._. The_DT law_NN recognizes_VBZ the_DT right_NN of_IN an_DT individual_NN to_TO refuse_VB medical_JJ interventions_NNS ._. Health_NN law_NN has_VBZ a_DT strong_JJ history_NN of_IN recognizing_VBG bodily_NN integrity_NN :_: Adults_NNS can_MD choose_VB whether_IN to_TO accept_VB or_CC reject_VB a_DT proposed_VBN medical_JJ intervention_NN ,_, even_RB in_IN instances_NNS where_WRB public_JJ health_NN authorities_NNS conclude_VBP a_DT vaccine_NN would_MD benefit_VB both_CC the_DT individual_NN and_CC society_NN ._. The_DT Supreme_NNP Court_NNP has_VBZ recognized_VBN parents_NNS ’_POS ability_NN to_TO direct_VB the_DT care_NN and_CC control_NN of_IN their_PRP$ children_NNS ,_, including_VBG consenting_VBG or_CC forgoing_VBG medical_JJ treatment_NN for_IN their_PRP$ child_NN except_IN in_IN very_RB specific_JJ circumstances_NNS ._. In_IN the_DT 1905_CD Jacobson_NNP v._NNP Massachusetts_NNP case_NN ,_, the_DT Supreme_NNP Court_NNP upheld_VBD a_DT state_NN law_NN delegating_VBG power_NN to_IN local_JJ health_NN officials_NNS mandating_VBG that_IN adults_NNS receive_VBP one_CD smallpox_NN vaccine_NN in_IN the_DT midst_NN of_IN an_DT epidemic_NN or_CC pay_VB a_DT fine_NN (_-LRB- about_RB $_$ 130_CD today_NN )_-RRB- ._. Under_IN the_DT concept_NN of_IN police_NN power_NN ,_, states_NNS have_VBP a_DT duty_NN to_TO enact_VB laws_NNS that_WDT promote_VBP the_DT health_NN ,_, safety_NN and_CC welfare_NN of_IN its_PRP$ residents_NNS ._. Public_JJ health_NN authorities_NNS may_MD offer_VB vaccines_NNS as_IN a_DT method_NN of_IN prevention_NN ,_, but_CC medical_JJ professionals_NNS ,_, public_JJ health_NN authorities_NNS and_CC even_RB courts_NNS may_MD not_RB legally_RB compel_VB a_DT person_NN to_TO submit_VB to_IN a_DT vaccine_NN ._. The_DT Jacobson_NNP decision_NN also_RB set_VBD forth_RB limits_NNS on_IN police_NN power_NN ,_, yet_CC subsequent_JJ cases_NNS addressing_VBG vaccine_NN mandates_NNS discarded_VBD these_DT requirements_NNS ,_, extending_VBG multiple_JJ vaccine_NN mandates_NNS to_IN school_NN attendance_NN for_IN disease_NN not_RB in_IN circulation_NN and_CC in_IN the_DT absence_NN of_IN an_DT epidemic_NN ._. Deferring_VBG to_IN respected_VBN scientific_JJ consensus_NN as_IN a_DT means_NN to_TO justify_VB forced_VBN medical_JJ interventions_NNS in_IN the_DT name_NN of_IN individual_JJ benefit_NN and_CC the_DT public_JJ good_NN has_VBZ historically_RB resulted_VBN in_IN some_DT of_IN the_DT most_RBS egregious_JJ constitutional_JJ and_CC human_JJ rights_NNS atrocities_NNS in_IN the_DT U.S_NNP ._. The_DT mass_JJ forcible_JJ sterilization_NN during_IN the_DT eugenics_NN movement_NN is_VBZ but_CC one_CD example_NN ._. The_DT history_NN of_IN science_NN and_CC medicine_NN further_RB demonstrates_VBZ the_DT fallibility_NN of_IN commonly_RB accepted_VBN medical_JJ knowledge_NN ,_, such_JJ as_IN when_WRB Bayer_NNP introduced_VBD heroin_NN as_IN a_DT safe_JJ ,_, non-addictive_JJ substitute_NN for_IN morphine_NN ,_, or_CC physicians_NNS prescribed_VBN Bendectin_NNP and_CC thalidomide_NN to_TO relieve_VB nausea_NN ,_, only_RB to_TO find_VB these_DT medications_NNS resulted_VBN in_IN babies_NNS born_VBN with_IN severe_JJ birth_NN defects_NNS ._. The_DT law_NN is_VBZ also_RB quite_RB clear_JJ that_IN public_JJ health_NN authorities_NNS and_CC law_NN enforcement_NN may_MD place_VB restrictions_NNS on_IN a_DT person_NN ’s_POS individual_JJ liberty_NN –_: including_VBG religious_JJ liberty_NN –_: in_IN situations_NNS where_WRB a_DT person_NN ’s_POS actions_NNS pose_VBP a_DT direct_JJ ,_, immediate_JJ and_CC compelling_JJ harm_NN to_IN others_NNS ,_, such_JJ as_IN using_VBG venomous_JJ snakes_NNS in_IN religious_JJ worship_NN or_CC asserting_VBG a_DT nonexistent_JJ “_`` right_NN ”_'' to_TO use_VB an_DT illegal_JJ substance_NN such_JJ as_IN marijuana_NN when_WRB operating_VBG a_DT motor_NN vehicle_NN ._. In_IN public_JJ health_NN law_NN relating_VBG to_IN communicable_JJ disease_NN ,_, this_DT constitutes_VBZ a_DT very_RB specific_JJ standard_NN :_: A_DT person_NN must_MD have_VB a_DT present_JJ disease_NN ,_, and_CC this_DT person_NN ’s_POS actions_NNS must_MD pose_VB a_DT direct_JJ threat_NN to_IN others_NNS ._. For_IN example_NN ,_, health_NN officials_NNS may_MD seek_VB a_DT quarantine_NN order_NN or_CC civil_JJ commitment_NN for_IN a_DT person_NN with_IN active_JJ tuberculosis_NN who_WP continues_VBZ to_TO frequent_VB highly_RB populated_VBN public_JJ spaces_NNS until_IN the_DT person_NN is_VBZ no_RB longer_RBR contagious_JJ ._. Even_RB in_IN such_PDT a_DT case_NN ,_, health_NN authorities_NNS can_MD offer_VB treatment_NN and_CC limit_VB a_DT person_NN ’s_POS movement_NN to_TO prevent_VB infecting_VBG others_NNS ,_, but_CC the_DT law_NN does_VBZ not_RB permit_VB forcibly_RB medicating_VBG a_DT competent_JJ person_NN against_IN his_PRP$ will_NN ._. Accordingly_RB ,_, legal_JJ precedent_NN does_VBZ not_RB support_VB quarantining_VBG vast_JJ geographic_JJ areas_NNS of_IN healthy_JJ persons_NNS who_WP have_VBP not_RB been_VBN exposed_VBN to_IN the_DT communicable_JJ illness_NN ,_, but_CC would_MD support_VB tailored_VBN voluntary_JJ isolation_NN and_CC quarantine_NN of_IN persons_NNS who_WP have_VBP been_VBN exposed_VBN to_IN ,_, or_CC currently_RB have_VBP ,_, the_DT illness_NN ._. What_WDT health_NN officials_NNS can_MD do_VB to_TO protect_VB children_NNS The_DT CDC_NNP classifies_VBZ vaccines_NNS as_IN one_CD of_IN the_DT top_JJ 10_CD public_JJ health_NN achievements_NNS ._. The_DT vast_JJ majority_NN (_-LRB- about_RB 98_CD %_NN )_-RRB- of_IN parents_NNS across_IN the_DT U.S._NNP as_IN a_DT whole_NN comply_VBP with_IN the_DT state_NN law_NN mandated_VBN schedule_NN of_IN vaccines_NNS for_IN their_PRP$ children_NNS ._. Vaccines_NNS ,_, like_IN any_DT other_JJ FDA_NN -_HYPH approved_VBN product_NN such_JJ as_IN a_DT prescription_NN drug_NN or_CC medical_JJ device_NN ,_, carry_VBP a_DT set_NN of_IN risks_NNS and_CC benefits_NNS ._. These_DT calculations_NNS vary_VBP depending_VBG on_IN the_DT vaccine_NN ,_, its_PRP$ efficacy_NN ,_, safety_NN ,_, potential_JJ side_NN effects_NNS ,_, the_DT severity_NN of_IN the_DT illness_NN the_DT vaccine_NN aims_VBZ to_TO protect_VB against_IN ,_, and_CC the_DT individual_NN to_IN whom_WP it_PRP is_VBZ administered_VBN ._. Vaccine_NN science_NN and_CC practice_NN similarly_RB evolved_VBN with_IN historical_JJ mistakes_NNS (_-LRB- the_DT Cutter_NNP incident_NN )_-RRB- and_CC ongoing_JJ disputes_NNS about_IN risks_NNS and_CC benefits_NNS for_IN individual_JJ vaccines_NNS like_IN flu_NN and_CC anthrax_NN ._. To_TO promote_VB vaccination_NN for_IN children_NNS ,_, health_NN officials_NNS may_MD offer_VB educational_JJ campaigns_NNS and_CC set_VB up_RP free_JJ clinics_NNS for_IN parents_NNS to_TO bring_VB their_PRP$ children_NNS ._. State_NN laws_NNS may_MD also_RB mandate_VB vaccines_NNS as_IN a_DT condition_NN for_IN school_NN attendance_NN ,_, or_CC require_VB excluding_VBG unvaccinated_JJ children_NNS during_IN an_DT active_JJ outbreak_NN at_IN their_PRP$ school_NN ._. However_RB ,_, if_IN states_NNS offer_VBP a_DT religious_JJ or_CC nonmedical_JJ exemption_NN ,_, courts_NNS have_VBP been_VBN clear_JJ that_IN health_NN officials_NNS and_CC school_NN officials_NNS do_VBP not_RB have_VB discretion_NN to_TO require_VB the_DT child_NN ’s_POS parent_NN to_TO identify_VB with_IN an_DT organized_VBN religion_NN or_CC reject_VB the_DT sincerity_NN of_IN the_DT parent_NN ’s_POS beliefs_NNS because_IN this_DT violates_VBZ the_DT First_NNP Amendment_NN ._. Public_JJ health_NN professionals_NNS worry_VBP that_IN parents_NNS who_WP forgo_VBP vaccination_NN are_VBP placing_VBG their_PRP$ child_NN and_CC the_DT community_NN at_IN risk_NN ._. Some_DT have_VBP advocated_VBN that_IN the_DT state_NN should_MD step_VB in_RP with_IN coercive_JJ measures_NNS such_JJ as_IN eliminating_VBG any_DT nonmedical_JJ exemptions_NNS for_IN all_DT children_NNS or_CC intervene_VB by_IN force_NN ,_, such_JJ as_IN classifying_VBG parents_NNS ’_POS decision_NN as_IN child_NN neglect_NN or_CC seeking_VBG a_DT court_NN order_NN to_TO vaccinate_VB the_DT child_NN ._. In_IN my_PRP$ opinion_NN ,_, these_DT strategies_NNS rely_VBP on_IN a_DT distortion_NN of_IN legal_JJ precedent_NN ,_, dismiss_VBP longstanding_JJ authority_NN of_IN parents_NNS to_TO make_VB decisions_NNS for_IN their_PRP$ children_NNS ,_, and_CC threaten_VBP to_TO undermine_VB an_DT already_RB fractured_VBN public_JJ trust_NN ._. Cases_NNS that_WDT uphold_VBP state_NN intervention_NN to_TO protect_VB a_DT child_NN by_IN compelling_VBG medical_JJ treatment_NN generally_RB require_VBP that_IN the_DT child_NN has_VBZ an_DT illness_NN ,_, the_DT illness_NN is_VBZ severe_JJ and_CC life_NN -_HYPH threatening_VBG ,_, and_CC the_DT risks_NNS and_CC benefits_NNS of_IN intervening_VBG are_VBP assessed_VBN ._. This_DT requires_VBZ medical_JJ professionals_NNS and_CC health_NN officials_NNS to_TO maintain_VB precision_NN in_IN distinguishing_VBG whether_IN the_DT parents_NNS are_VBP deciding_VBG to_TO forgo_VB recommended_VBN vaccines_NNS ,_, or_CC whether_IN they_PRP are_VBP refusing_VBG medical_JJ care_NN for_IN a_DT critically_RB ill_JJ child_NN ._. Indeed_RB ,_, a_DT recent_JJ case_NN in_IN Chandler_NNP ,_, Arizona_NNP ,_, demonstrated_VBD how_WRB a_DT climate_NN of_IN coercion_NN and_CC force_NN may_MD result_VB in_IN parental_JJ fear_NN and_CC refusal_NN to_TO constructively_RB engage_VB with_IN state_NN officials_NNS for_IN even_RB an_DT ill_JJ child_NN ._. State_NN public_JJ health_NN officials_NNS have_VBP the_DT duty_NN to_TO protect_VB residents_NNS from_IN illness_NN and_CC communicable_JJ disease_NN ,_, but_CC these_DT strategies_NNS must_MD fall_VB within_IN appropriate_JJ legal_JJ parameters_NNS ._. Dismissing_VBG these_DT legal_JJ boundaries_NNS or_CC justifying_VBG unnecessary_JJ force_NN not_RB only_RB undermines_VBZ fundamental_JJ liberties_NNS ,_, but_CC in_IN my_PRP$ view_NN fuels_VBZ parental_JJ and_CC community_NN distrust_NN of_IN health_NN officials_NNS and_CC sets_VBZ back_RB the_DT ultimate_JJ goals_NNS of_IN protecting_VBG the_DT public_NN ._.","The NNS NNS VBP to VB , with NNP NNP NNP VBG a JJ NN NN and VBG NNS in four NN NNS to VB their NNS VBN or VB NNS , VBG a NN of NNP $ 1,000 and or NN . Since NNP 2018 , 285 NN NNS VBP VBN VBN in NNP and NNP , RB in NNS where JJ NNPS VBP VBN to RB VB their NNS VBN . The NNPS for NNP NNP and NNP , VBD that from NNP 1 to NNP 4 , 2019 , 465 JJ NNS of NNS VBP VBN VBN in 19 NNS . This VBZ the JJ - JJS NN of NNS since the NNP VBD NNS VBN in 2000 ; in 2014 , 667 NNS VBD . NNS VBP RB VBN VBG each NN , RB VBN into the NNP NNPS from JJ NNS . NNS VBP that to VB the NN of the NN in NNP NNP , NNP NNP , where 168 NNS VBD VBN as of NNP 8 , 2019 . NNP JJ NN NNS VBD a NN that would VB JJ NNS out of JJ NNS , but a NN VBD that on NNP 5 . On NNP 9 , NN NNS VBD they would VB . But there VBP NNS to what NN NN NNS , JJ NN NNS and NNS can VB . It VBZ JJ to VB both the NN – and the NNS – of JJ NNS that will VB NN , JJ NN and NN for the NN while RB VBG NNS of VBN NN , JJ NN - VBG and VBG JJ NN . As a NN who VBZ and VBZ NN NN , JJ NN NN and JJ NN , I VBP it VBZ JJ VBG what NNS can or cannot RB VB when VBG to NNS of JJ NN . The NN VBZ the NN of an NN to VB JJ NNS . NN NN VBZ a JJ NN of VBG NN NN : NNS can VB whether to VB or VB a VBN JJ NN , RB in NNS where JJ NN NNS VBP a NN would VB both the NN and NN . The NNP NNP VBZ VBN NNS ’ NN to VB the NN and NN of their NNS , VBG VBG or VBG JJ NN for their NN except in RB JJ NNS . In the 1905 NNP NNP NNP NN , the NNP NNP VBD a NN NN VBG NN to JJ NN NNS VBG that NNS VBP one NN NN in the NN of an NN or VB a NN ( RB $ 130 NN ) . Under the NN of NN NN , NNS VBP a NN to VB NNS that VBP the NN , NN and NN of its NNS . JJ NN NNS may VB NNS as a NN of NN , but JJ NNS , JJ NN NNS and RB NNS may RB RB VB a NN to VB to a NN . The NNP NN RB VBD RB NNS on NN NN , yet JJ NNS VBG NN NNS VBD these NNS , VBG JJ NN NNS to NN NN for NN RB in NN and in the NN of an NN . VBG to VBN JJ NN as a NN to VB VBN JJ NNS in the NN of JJ NN and the JJ NN VBZ RB VBN in some of the RBS JJ JJ and JJ NNS NNS in the NNP . The JJ JJ NN during the NN NN VBZ but one NN . The NN of NN and NN RB VBZ the NN of RB VBN JJ NN , JJ as when NNP VBD NN as a JJ , JJ NN for NN , or NNS VBN NNP and NN to VB NN , RB to VB these NNS VBN in NNS VBN with JJ NN NNS . The NN VBZ RB RB JJ that JJ NN NNS and NN NN may VB NNS on a NN ’s JJ NN – VBG JJ NN – in NNS where a NN ’s NNS VBP a JJ , JJ and JJ NN to NNS , JJ as VBG JJ NNS in JJ NN or VBG a JJ “ NN ” to VB an JJ NN JJ as NN when VBG a NN NN . In JJ NN NN VBG to JJ NN , this VBZ a RB JJ NN : A NN must VB a JJ NN , and this NN ’s NNS must VB a JJ NN to NNS . For NN , NN NNS may VB a NN NN or JJ NN for a NN with JJ NN who VBZ to VB RB VBN JJ NNS until the NN VBZ RB RBR JJ . RB in such a NN , NN NNS can VB NN and VB a NN ’s NN to VB VBG NNS , but the NN VBZ RB VB RB VBG a JJ NN against his NN . RB , JJ NN VBZ RB VB VBG JJ JJ NNS of JJ NNS who VBP RB VBN VBN to the JJ NN , but would VB VBN JJ NN and NN of NNS who VBP VBN VBN to , or RB VBP , the NN . What NN NNS can VB to VB NNS The NNP VBZ NNS as one of the JJ 10 JJ NN NNS . The JJ NN ( RB 98 NN ) of NNS across the NNP as a NN VBP with the NN NN VBN NN of NNS for their NNS . NNS , like any JJ NN - VBN NN JJ as a NN NN or JJ NN , VBP a NN of NNS and NNS . These NNS VBP VBG on the NN , its NN , NN , JJ NN NNS , the NN of the NN the NN VBZ to VB against , and the NN to whom it VBZ VBN . NN NN and NN RB VBN with JJ NNS ( the NNP NN ) and JJ NNS about NNS and NNS for JJ NNS like NN and NN . To VB NN for NNS , NN NNS may VB JJ NNS and VB up JJ NNS for NNS to VB their NNS . NN NNS may RB VB NNS as a NN for NN NN , or VB VBG JJ NNS during an JJ NN at their NN . RB , if NNS VBP a JJ or JJ NN , NNS VBP VBN JJ that NN NNS and NN NNS VBP RB VB NN to VB the NN ’s NN to VB with an VBN NN or VB the NN of the NN ’s NNS because this VBZ the NNP NN . JJ NN NNS VBP that NNS who VBP NN VBP VBG their NN and the NN at NN . Some VBP VBN that the NN should VB in with JJ NNS JJ as VBG any JJ NNS for all NNS or VB by NN , JJ as VBG NNS ’ NN as NN NN or VBG a NN NN to VB the NN . In my NN , these NNS VBP on a NN of JJ NN , VBP JJ NN of NNS to VB NNS for their NNS , and VBP to VB an RB VBN JJ NN . NNS that VBP NN NN to VB a NN by VBG JJ NN RB VBP that the NN VBZ an NN , the NN VBZ JJ and NN - VBG , and the NNS and NNS of VBG VBP VBN . This VBZ JJ NNS and NN NNS to VB NN in VBG whether the NNS VBP VBG to VB VBN NNS , or whether they VBP VBG JJ NN for a RB JJ NN . RB , a JJ NN in NNP , NNP , VBD how a NN of NN and NN may VB in JJ NN and NN to RB VB with NN NNS for RB an JJ NN . NN JJ NN NNS VBP the NN to VB NNS from NN and JJ NN , but these NNS must VB within JJ JJ NNS . VBG these JJ NNS or VBG JJ NN RB RB VBZ JJ NNS , but in my NN VBZ JJ and NN NN of NN NNS and VBZ RB the JJ NNS of VBG the NN ."
27,756,mainstream,M07fd6,vaccine,"Pathogens_NNS are_VBP microbes_NNS that_WDT cause_VBP diseases_NNS ._. Vaccines_NNS allow_VBP a_DT dead_JJ or_CC altered_VBN form_NN of_IN the_DT disease_NN causing_VBG pathogen_NN to_TO be_VB introduced_VBN into_IN the_DT body_NN ,_, which_WDT contain_VBP a_DT specific_JJ antigen_NN ._. This_DT causes_VBZ the_DT immune_NN system_NN ,_, specifically_RB the_DT white_JJ blood_NN cells_NNS ,_, to_TO produce_VB complementary_JJ antibodies_NNS ,_, which_WDT target_VBP and_CC attach_VB to_IN the_DT antigen_NN ._. When_WRB a_DT white_JJ blood_NN cell_NN engulfs_VBZ and_CC digests_VBZ a_DT pathogen_NN it_PRP is_VBZ called_VBN phagocytosis_NN ._. During_IN the_DT primary_JJ infection_NN the_DT antibodies_NNS slowly_RB increase_VBP ,_, peak_VBP at_IN around_RB ten_CD days_NNS and_CC then_RB gradually_RB decrease_VB ._. A_DT second_JJ exposure_NN to_IN the_DT same_JJ pathogen_NN causes_VBZ the_DT white_JJ blood_NN cells_NNS to_TO respond_VB quickly_RB in_IN order_NN to_TO produce_VB lots_NNS of_IN the_DT relevant_JJ antibodies_NNS ,_, which_WDT prevents_VBZ infection_NN ._.","NNS VBP NNS that VBP NNS . NNS VBP a JJ or VBN NN of the NN VBG NN to VB VBN into the NN , which VBP a JJ NN . This VBZ the NN NN , RB the JJ NN NNS , to VB JJ NNS , which VBP and VB to the NN . When a JJ NN NN VBZ and VBZ a NN it VBZ VBN NN . During the JJ NN the NNS RB VBP , VBP at RB ten NNS and RB RB VB . A JJ NN to the JJ NN VBZ the JJ NN NNS to VB RB in NN to VB NNS of the JJ NNS , which VBZ NN ."
28,887,mainstream,M0af8d,vaccine.autism,"A_DT teenager_NN who_WP made_VBD headlines_NNS for_IN getting_VBG vaccinated_VBN despite_IN his_PRP$ family_NN 's_POS wishes_NNS has_VBZ testified_VBN about_IN his_PRP$ experience_NN to_IN US_NNP lawmakers_NNS ._. Ethan_NNP Lindenberger_NNP ,_, from_IN Ohio_NNP ,_, sought_VBD immunisations_NNS aged_JJ 18_CD after_IN turning_VBG to_IN the_DT internet_NN for_IN advice_NN ._. Federal_JJ data_NNS suggests_VBZ the_DT proportion_NN of_IN US_NNP children_NNS under_IN two_CD not_RB being_VBG immunised_VBN has_VBZ quadrupled_VBN since_IN 2001_CD ._. Doctors_NNS at_IN the_DT hearing_NN blamed_VBD online_JJ misinformation_NN and_CC discredited_VBD science_NN for_IN scaring_VBG parents_NNS away_RB from_IN vaccines_NNS ._. Mr_NNP Lindenberger_NNP ,_, who_WP is_VBZ still_RB a_DT senior_JJ in_IN high_JJ school_NN ,_, spoke_VBD on_IN Tuesday_NNP at_IN the_DT Senate_NNP Committee_NNP on_IN Health_NNP ,_, Education_NNP ,_, Labor_NNP and_CC Pensions_NNPS alongside_IN four_CD doctors_NNS who_WP are_VBP experts_NNS in_IN the_DT field_NN ._. He_PRP said_VBD much_JJ of_IN his_PRP$ mother_NN 's_POS opposition_NN to_IN routine_JJ vaccines_NNS came_VBD from_IN fear_NN they_PRP could_MD cause_VB side_NN -_HYPH effects_NNS like_IN brain_NN damage_NN or_CC autism_NN ._. In_IN 1998_CD ,_, a_DT study_NN by_IN a_DT British_JJ doctor_NN Andrew_NNP Wakefield_NNP incorrectly_RB linked_VBD the_DT MMR_NNP (_-LRB- Measles_NNP ,_, mumps_NNS and_CC rubella_FW )_-RRB- vaccine_NN to_IN autism_NN ._. His_PRP$ research_NN has_VBZ since_RB been_VBN completely_RB discredited_VBN and_CC Mr_NNP Wakefield_NNP has_VBZ been_VBN struck_VBN off_RP -_, but_CC the_DT theory_NN has_VBZ endured_VBN within_IN the_DT global_JJ anti-vaccination_NN community_NN ._. •_NFP '_`` Do_VB n't_RB be_VB taken_VBN in_RP by_IN social_JJ media_NN vaccine_NN myths_NNS '_'' All_DT four_CD doctors_NNS at_IN Tuesday_NNP 's_POS hearing_NN echoed_VBD that_IN there_EX was_VBD ""_`` absolutely_RB no_DT evidence_NN ""_'' that_WDT exists_VBZ which_WDT supports_VBZ the_DT link_NN ._. This_DT is_VBZ also_RB affirmed_VBN in_IN new_JJ Danish_JJ research_NN released_VBN on_IN Tuesday_NNP ._. The_DT study_NN examined_VBD 650,000_CD children_NNS over_RB 10_CD years_NNS and_CC categorically_RB concludes_VBZ that_IN MMR_NNP does_VBZ not_RB increase_VB the_DT risk_NN of_IN autism_NN or_CC trigger_VB it_PRP in_IN those_DT susceptible_JJ ._. Mr_NNP Lindenbenger_NNP ,_, doctors_NNS and_CC members_NNS of_IN Congress_NNP at_IN the_DT hearing_NN all_RB pointed_VBD out_RP the_DT internet_NN fuels_VBZ the_DT spread_NN of_IN misinformation_NN ._. ""_`` My_PRP$ mother_NN would_MD turn_VB to_IN anti-vax_JJ groups_NNS online_JJ and_CC social_JJ media_NN rather_RB than_IN health_NN officials_NNS and_CC critical_JJ sources_NNS ,_, ""_'' the_DT teenager_NN told_VBD the_DT hearing_NN ._. He_PRP also_RB pointed_VBD out_RP his_PRP$ mother_NN 's_POS decision_NN had_VBD come_VBN from_IN concern_NN ,_, not_RB malice_NN ._. ""_`` There_EX 's_VBZ a_DT lot_NN of_IN emotional_JJ appeals_NNS talking_VBG about_IN families_NNS ,_, children_NNS and_CC appealing_JJ to_IN a_DT parent_NN 's_POS love_NN ,_, and_CC manipulating_VBG that_DT to_TO convince_VB them_PRP vaccines_NNS are_VBP dangerous_JJ ,_, ""_'' he_PRP told_VBD the_DT hearing_NN about_IN the_DT nature_NN of_IN online_JJ posts_NNS ._. ""_`` That_DT 's_VBZ the_DT issue_NN I_PRP take_VBP ._. I_PRP have_VBP tried_VBN to_TO convey_VB to_IN my_PRP$ parents_NNS I_PRP do_VBP n't_RB think_VB they_PRP are_VBP stupid_JJ for_IN believing_VBG that_DT ,_, but_CC people_NNS are_VBP very_RB convincing_JJ and_CC that_DT 's_VBZ very_RB dangerous_JJ ._. ""_'' Mr_NNP Lindenberger_NNP 's_POS story_NN went_VBD viral_JJ in_IN late_JJ 2018_CD when_WRB he_PRP asked_VBD online_JJ forum_NN Reddit_NNP about_IN the_DT subject_NN ._. At_IN one_CD point_NN during_IN Tuesday_NNP 's_POS hearing_NN ,_, Republican_JJ Senator_NNP Johnny_NNP Isakson_NNP joked_VBD that_IN he_PRP would_MD ""_`` love_VB ""_'' to_TO be_VB a_DT guest_NN at_IN the_DT Linderberger_NNP family_NN home_NN for_IN Thanksgiving_NNP dinner_NN ._. ""_`` Would_MD be_VB a_DT heck_NN of_IN a_DT discussion_NN everybody_NN would_MD have_VB ,_, ""_'' he_PRP said_VBD about_IN the_DT family_NN 's_POS public_JJ disagreement_NN ._. Health_NN experts_NNS have_VBP long_RB warned_VBN about_IN the_DT risk_NN posed_VBN by_IN parents_NNS who_WP do_VBP not_RB vaccinate_VB ._. They_PRP say_VBP the_DT decision_NN affects_VBZ not_RB only_RB their_PRP$ families_NNS but_CC everyone_NN else_JJ because_IN high_JJ vaccination_NN rates_NNS are_VBP integral_JJ to_TO keep_VB communities_NNS protected_VBN ._. This_DT concept_NN ,_, which_WDT is_VBZ known_VBN as_IN herd_NN immunity_NN ,_, offers_VBZ protection_NN for_IN people_NNS like_IN newborns_NNS and_CC people_NNS with_IN auto_NN -_HYPH immune_NN diseases_NNS who_WP are_VBP not_RB able_JJ to_TO be_VB vaccinated_VBN ._. The_DT US_NNP has_VBZ been_VBN battling_VBG a_DT number_NN of_IN outbreaks_NNS of_IN preventable_JJ diseases_NNS in_IN recent_JJ years_NNS ._. Senator_NNP Patty_NNP Murray_NNP ,_, from_IN Washington_NNP state_NN ,_, spoke_VBD at_IN the_DT hearing_NN about_IN a_DT recent_JJ measles_NNS outbreak_NN in_IN her_PRP$ local_JJ Clark_NNP County_NNP where_WRB 70_CD cases_NNS have_VBP been_VBN confirmed_VBN ._. Less_JJR than_IN 80_CD %_NN of_IN nursery_NN -_HYPH age_NN children_NNS were_VBD immunised_VBN there_RB in_IN 2017_CD -_, well_RB below_IN the_DT target_NN rate_NN of_IN about_RB 95_CD %_NN for_IN herd_NN immunity_NN ._. At_IN Tuesday_NNP 's_POS hearing_NN ,_, doctors_NNS implored_VBD the_DT federal_JJ government_NN to_TO increase_VB funding_NN for_IN vaccine_NN education_NN ._. They_PRP also_RB asked_VBD state_NN lawmakers_NNS to_TO increase_VB limits_NNS on_IN non-medical_JJ vaccination_NN exemptions_NNS for_IN parents_NNS ._. California_NNP is_VBZ one_CD state_NN that_WDT has_VBZ already_RB cracked_VBN down_RP on_IN exemptions_NNS ,_, following_VBG an_DT outbreak_NN of_IN measles_NNS linked_VBN to_IN Disneyland_NNP in_IN 2015_CD ._. Similar_JJ outbreaks_NNS are_VBP not_RB isolated_VBN to_IN the_DT US_NNP -_, there_EX have_VBP been_VBN increases_NNS recorded_VBN elsewhere_RB around_IN the_DT world_NN ._. In_IN 2018_CD ,_, Europe_NNP saw_VBD three_CD times_NNS more_JJR measles_NNS case_NN than_IN the_DT year_NN before_RB ._. The_DT World_NNP Health_NNP Organisation_NNP (_-LRB- WHO_NNP )_-RRB- have_VBP blamed_VBN growing_VBG vaccine_NN hesitancy_NN for_IN the_DT outbreaks_NNS ._. ""_`` Industrialised_JJ countries_NNS must_MD not_RB be_VB complacent_JJ and_CC forget_VB that_IN the_DT disease_NN can_MD come_VB back_RB like_IN a_DT storm_NN ,_, ""_'' WHO_NNP 's_POS Dr_NNP Martin_NNP Friede_NNP told_VBD the_DT BBC_NNP after_IN the_DT data_NNS was_VBD released_VBN ._.","A NN who VBD NNS for VBG VBN despite his NN 's NNS VBZ VBN about his NN to NNP NNS . NNP NNP , from NNP , VBD NNS JJ 18 after VBG to the NN for NN . JJ NNS VBZ the NN of NNP NNS under two RB VBG VBN VBZ VBN since 2001 . NNS at the NN VBD JJ NN and VBD NN for VBG NNS RB from NNS . NNP NNP , who VBZ RB a JJ in JJ NN , VBD on NNP at the NNP NNP on NNP , NNP , NNP and NNPS alongside four NNS who VBP NNS in the NN . He VBD JJ of his NN 's NN to JJ NNS VBD from NN they could VB NN - NNS like NN NN or NN . In 1998 , a NN by a JJ NN NNP NNP RB VBD the NNP ( NNP , NNS and FW ) NN to NN . His NN VBZ RB VBN RB VBN and NNP NNP VBZ VBN VBN off - but the NN VBZ VBN within the JJ NN NN . • ' VB RB VB VBN in by JJ NN NN NNS ' All four NNS at NNP 's NN VBD that there VBD "" RB no NN "" that VBZ which VBZ the NN . This VBZ RB VBN in JJ JJ NN VBN on NNP . The NN VBD 650,000 NNS RB 10 NNS and RB VBZ that NNP VBZ RB VB the NN of NN or VB it in those JJ . NNP NNP , NNS and NNS of NNP at the NN RB VBD out the NN VBZ the NN of NN . "" My NN would VB to JJ NNS JJ and JJ NN RB than NN NNS and JJ NNS , "" the NN VBD the NN . He RB VBD out his NN 's NN VBD VBN from NN , RB NN . "" There VBZ a NN of JJ NNS VBG about NNS , NNS and JJ to a NN 's NN , and VBG that to VB them NNS VBP JJ , "" he VBD the NN about the NN of JJ NNS . "" That VBZ the NN I VBP . I VBP VBN to VB to my NNS I VBP RB VB they VBP JJ for VBG that , but NNS VBP RB JJ and that VBZ RB JJ . "" NNP NNP 's NN VBD JJ in JJ 2018 when he VBD JJ NN NNP about the NN . At one NN during NNP 's NN , JJ NNP NNP NNP VBD that he would "" VB "" to VB a NN at the NNP NN NN for NNP NN . "" Would VB a NN of a NN NN would VB , "" he VBD about the NN 's JJ NN . NN NNS VBP RB VBN about the NN VBN by NNS who VBP RB VB . They VBP the NN VBZ RB RB their NNS but NN JJ because JJ NN NNS VBP JJ to VB NNS VBN . This NN , which VBZ VBN as NN NN , VBZ NN for NNS like NNS and NNS with NN - NN NNS who VBP RB JJ to VB VBN . The NNP VBZ VBN VBG a NN of NNS of JJ NNS in JJ NNS . NNP NNP NNP , from NNP NN , VBD at the NN about a JJ NNS NN in her JJ NNP NNP where 70 NNS VBP VBN VBN . JJR than 80 NN of NN - NN NNS VBD VBN RB in 2017 - RB below the NN NN of RB 95 NN for NN NN . At NNP 's NN , NNS VBD the JJ NN to VB NN for NN NN . They RB VBD NN NNS to VB NNS on JJ NN NNS for NNS . NNP VBZ one NN that VBZ RB VBN down on NNS , VBG an NN of NNS VBN to NNP in 2015 . JJ NNS VBP RB VBN to the NNP - there VBP VBN NNS VBN RB around the NN . In 2018 , NNP VBD three NNS JJR NNS NN than the NN RB . The NNP NNP NNP ( NNP ) VBP VBN VBG NN NN for the NNS . "" JJ NNS must RB VB JJ and VB that the NN can VB RB like a NN , "" NNP 's NNP NNP NNP VBD the NNP after the NNS VBD VBN ."
29,351,mainstream,M09ac6,vaccine.autism,"The_DT best_JJS ways_NNS to_TO convince_VB people_NNS of_IN the_DT benefits_NNS of_IN vaccinations_NNS may_MD be_VB to_TO show_VB them_PRP pictures_NNS of_IN a_DT child_NN with_IN measles_NNS or_CC to_TO have_VB them_PRP read_VB a_DT description_NN of_IN the_DT disease_NN written_VBN by_IN a_DT mom_NN whose_WP$ child_NN was_VBD infected_VBN ,_, according_VBG to_IN a_DT new_JJ study_NN ._. These_DT ways_NNS are_VBP more_RBR effective_JJ than_IN showing_VBG people_NNS information_NN summarizing_VBG recent_JJ research_NN that_WDT shows_VBZ there_EX is_VBZ no_DT link_NN between_IN vaccines_NNS and_CC an_DT increased_VBN risk_NN of_IN autism_NN in_IN children_NNS ,_, the_DT researchers_NNS found_VBD ._. The_DT researchers_NNS found_VBD that_IN directing_VBG people_NNS 's_POS attention_NN to_IN the_DT risks_NNS posed_VBN by_IN not_RB getting_VBG vaccinated_VBN by_IN showing_VBG them_PRP the_DT pictures_NNS of_IN sick_JJ children_NNS and_CC having_VBG them_PRP read_VB a_DT mom's_NN written_VBN account_NN of_IN her_PRP$ child_NN 's_POS disease_NN changed_VBD their_PRP$ attitudes_NNS ,_, leading_VBG them_PRP to_TO think_VB more_RBR positively_RB about_IN vaccinations_NNS ,_, study_NN author_NN Zachary_NNP Horne_NNP ,_, a_DT graduate_NN student_NN at_IN the_DT University_NNP of_IN Illinois_NNP ,_, said_VBD in_IN a_DT statement_NN ._. That_DT was_VBD true_JJ for_IN even_RB ""_`` the_DT most_RBS skeptical_JJ participants_NNS in_IN the_DT study_NN ,_, ""_'' Horne_NNP said_VBD ._. There_EX were_VBD 644_CD cases_NNS of_IN measles_NNS in_IN the_DT United_NNP States_NNPS in_IN 2014_CD ,_, according_VBG to_IN the_DT study_NN ._. That_DT 's_VBZ triple_JJ the_DT number_NN seen_VBN in_IN 2013_CD ._. And_CC back_RB in_IN 2000_CD ,_, researchers_NNS thought_VBD that_IN this_DT disease_NN had_VBD been_VBN eliminated_VBN from_IN the_DT U.S._NNP ,_, according_VBG to_IN the_DT study_NN ._. [_-LRB- 5_CD Dangerous_JJ Vaccine_NN Myths_NNS ]_-RRB- ""_`` The_DT re-emergence_NN of_IN measles_NNS has_VBZ been_VBN linked_VBN to_IN an_DT increase_NN in_IN the_DT number_NN of_IN parents_NNS refusing_VBG to_TO vaccinate_VB their_PRP$ children_NNS ,_, ""_'' the_DT researchers_NNS wrote_VBD in_IN their_PRP$ study_NN ._. One_CD reason_NN that_IN parents_NNS do_VBP n't_RB vaccinate_VB their_PRP$ children_NNS is_VBZ the_DT mistaken_JJ belief_NN that_IN the_DT vaccine_NN that_WDT protects_VBZ against_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- the_DT MMR_NN vaccine_NN )_-RRB- is_VBZ linked_VBN with_IN an_DT increased_VBN risk_NN of_IN autism_NN ._. Researchers_NNS have_VBP been_VBN looking_VBG for_IN effective_JJ ways_NNS to_TO convince_VB people_NNS who_WP hold_VBP this_DT mistaken_JJ belief_NN about_IN the_DT benefits_NNS of_IN vaccinations_NNS ._. In_IN the_DT new_JJ study_NN ,_, the_DT researchers_NNS asked_VBD 315_CD people_NNS questions_NNS to_TO examine_VB their_PRP$ views_NNS on_IN several_JJ potentially_RB controversial_JJ subjects_NNS ,_, including_VBG their_PRP$ attitudes_NNS toward_IN vaccines_NNS and_CC their_PRP$ willingness_NN to_TO vaccinate_VB their_PRP$ kids_NNS ._. Then_RB ,_, the_DT people_NNS in_IN the_DT study_NN were_VBD assigned_VBN to_IN one_CD of_IN three_CD groups_NNS ._. People_NNS in_IN the_DT first_JJ group_NN looked_VBD at_IN science_NN -_HYPH based_VBN materials_NNS that_WDT challenged_VBD the_DT anti-vaccination_NN point_NN of_IN view_NN ._. People_NNS in_IN the_DT second_JJ group_NN read_VBD a_DT paragraph_NN written_VBN by_IN a_DT mother_NN describing_VBG her_PRP$ child_NN 's_POS infection_NN with_IN measles_NNS ,_, and_CC also_RB looked_VBD at_IN pictures_NNS of_IN children_NNS with_IN measles_NNS ,_, mumps_NNS or_CC rubella_NN ._. They_PRP also_RB read_VBD three_CD warnings_NNS about_IN why_WRB it_PRP is_VBZ important_JJ to_TO vaccinate_VB kids_NNS ._. People_NNS in_IN the_DT third_JJ group_NN ,_, which_WDT was_VBD a_DT comparison_NN group_NN ,_, were_VBD asked_VBN to_TO read_VB about_IN a_DT subject_NN not_RB related_JJ to_IN vaccines_NNS ._. Then_RB ,_, the_DT researchers_NNS again_RB evaluated_VBD the_DT people_NNS 's_POS views_NNS on_IN vaccination_NN and_CC their_PRP$ intentions_NNS to_TO vaccinate_VB their_PRP$ children_NNS in_IN the_DT future_NN ._. The_DT investigators_NNS found_VBD that_IN the_DT intervention_NN that_WDT involved_VBD showing_VBG people_NNS the_DT consequences_NNS of_IN the_DT diseases_NNS was_VBD the_DT one_NN that_WDT had_VBD the_DT biggest_JJS effect_NN on_IN the_DT people_NNS who_WP were_VBD initially_RB the_DT most_RBS skeptical_JJ about_IN vaccinations_NNS ,_, Horne_NNP said_VBD ._. In_IN contrast_NN ,_, showing_VBG people_NNS the_DT scientific_JJ evidence_NN that_IN there_EX is_VBZ no_DT link_NN between_IN vaccines_NNS and_CC autism_NN did_VBD not_RB change_VB the_DT people_NNS 's_POS views_NNS on_IN vaccination_NN ,_, the_DT researchers_NNS said_VBD ._. The_DT reason_NN this_DT type_NN of_IN intervention_NN does_VBZ n't_RB work_VB is_VBZ likely_JJ that_IN trying_VBG to_TO convince_VB someone_NN that_IN his_PRP$ or_CC her_PRP$ beliefs_NNS are_VBP false_JJ is_VBZ not_RB the_DT best_JJS argumentative_JJ strategy_NN ,_, Horne_NNP said_VBD ._. The_DT study_NN shows_VBZ that_IN ""_`` instead_RB of_IN going_VBG up_RP against_IN the_DT belief_NN about_IN the_DT link_NN between_IN vaccines_NNS and_CC autism_NN ,_, ""_'' researchers_NNS should_MD aim_VB to_TO convince_VB people_NNS that_IN ,_, independent_JJ of_IN whether_IN they_PRP believe_VBP in_IN that_DT link_NN ,_, they_PRP should_MD also_RB believe_VB that_IN there_EX are_VBP serious_JJ consequences_NNS of_IN not_RB getting_VBG children_NNS vaccinated_VBN ,_, Horne_NNP told_VBD Live_NNP Science_NNP ._. ""_`` The_DT insight_NN [_-LRB- from_IN the_DT study_NN ]_-RRB- was_VBD to_TO direct_VB their_PRP$ attention_NN towards_IN those_DT consequences_NNS ,_, rather_RB than_IN trying_VBG to_TO combat_VB their_PRP$ false_JJ beliefs_NNS that_IN there_EX is_VBZ some_DT link_NN where_WRB there_EX is_VBZ not_RB ,_, ""_'' Horne_NNP said_VBD ._. The_DT new_JJ study_NN was_VBD published_VBN today_NN (_-LRB- Aug._NNP 3_CD )_-RRB- in_IN the_DT journal_NNP Proceedings_NNPS of_IN the_DT National_NNP Academy_NNP of_IN Sciences_NNPS ._. •_SYM 10_CD Medical_JJ Myths_NNS that_WDT Just_RB Wo_MD n't_RB Go_VB Away_RB •_SYM Beyond_IN Vaccines_NNS :_: 5_CD Things_NNS that_WDT Might_MD Really_RB Cause_VB Autism_NN Copyright_NN 2015_CD LiveScience_NNP ,_, a_DT Purch_NN company_NN ._. All_DT rights_NNS reserved_VBN ._. This_DT material_NN may_MD not_RB be_VB published_VBN ,_, broadcast_VBN ,_, rewritten_VBN or_CC redistributed_VBN ._.","The JJS NNS to VB NNS of the NNS of NNS may VB to VB them NNS of a NN with NNS or to VB them VB a NN of the NN VBN by a NN whose NN VBD VBN , VBG to a JJ NN . These NNS VBP RBR JJ than VBG NNS NN VBG JJ NN that VBZ there VBZ no NN between NNS and an VBN NN of NN in NNS , the NNS VBD . The NNS VBD that VBG NNS 's NN to the NNS VBN by RB VBG VBN by VBG them the NNS of JJ NNS and VBG them VB a NN VBN NN of her NN 's NN VBD their NNS , VBG them to VB RBR RB about NNS , NN NN NNP NNP , a NN NN at the NNP of NNP , VBD in a NN . That VBD JJ for RB "" the RBS JJ NNS in the NN , "" NNP VBD . There VBD 644 NNS of NNS in the NNP NNPS in 2014 , VBG to the NN . That VBZ JJ the NN VBN in 2013 . And RB in 2000 , NNS VBD that this NN VBD VBN VBN from the NNP , VBG to the NN . [ 5 JJ NN NNS ] "" The NN of NNS VBZ VBN VBN to an NN in the NN of NNS VBG to VB their NNS , "" the NNS VBD in their NN . One NN that NNS VBP RB VB their NNS VBZ the JJ NN that the NN that VBZ against NNS , NNS and NN ( the NN NN ) VBZ VBN with an VBN NN of NN . NNS VBP VBN VBG for JJ NNS to VB NNS who VBP this JJ NN about the NNS of NNS . In the JJ NN , the NNS VBD 315 NNS NNS to VB their NNS on JJ RB JJ NNS , VBG their NNS toward NNS and their NN to VB their NNS . RB , the NNS in the NN VBD VBN to one of three NNS . NNS in the JJ NN VBD at NN - VBN NNS that VBD the NN NN of NN . NNS in the JJ NN VBD a NN VBN by a NN VBG her NN 's NN with NNS , and RB VBD at NNS of NNS with NNS , NNS or NN . They RB VBD three NNS about why it VBZ JJ to VB NNS . NNS in the JJ NN , which VBD a NN NN , VBD VBN to VB about a NN RB JJ to NNS . RB , the NNS RB VBD the NNS 's NNS on NN and their NNS to VB their NNS in the NN . The NNS VBD that the NN that VBD VBG NNS the NNS of the NNS VBD the NN that VBD the JJS NN on the NNS who VBD RB the RBS JJ about NNS , NNP VBD . In NN , VBG NNS the JJ NN that there VBZ no NN between NNS and NN VBD RB VB the NNS 's NNS on NN , the NNS VBD . The NN this NN of NN VBZ RB VB VBZ JJ that VBG to VB NN that his or her NNS VBP JJ VBZ RB the JJS JJ NN , NNP VBD . The NN VBZ that "" RB of VBG up against the NN about the NN between NNS and NN , "" NNS should VB to VB NNS that , JJ of whether they VBP in that NN , they should RB VB that there VBP JJ NNS of RB VBG NNS VBN , NNP VBD NNP NNP . "" The NN [ from the NN ] VBD to VB their NN towards those NNS , RB than VBG to VB their JJ NNS that there VBZ some NN where there VBZ RB , "" NNP VBD . The JJ NN VBD VBN NN ( NNP 3 ) in the NNP NNPS of the NNP NNP of NNPS . • 10 JJ NNS that RB Wo RB VB RB • Beyond NNS : 5 NNS that Might RB VB NN NN 2015 NNP , a NN NN . All NNS VBN . This NN may RB VB VBN , VBN , VBN or VBN ."
30,261,mainstream,M0b242,vaccine.autism,"The_DT MMR_NNP vaccine_NN protects_VBZ your_PRP$ child_NN against_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- German_JJ measles_NNS )_-RRB- ._. MMR_NNP has_VBZ three_CD separate_JJ vaccines_NNS in_IN one_CD injection_NN ._. Your_PRP$ child_NN should_MD receive_VB one_CD dose_NN of_IN MMR_NNP just_RB after_IN their_PRP$ first_JJ birthday_NN and_CC a_DT second_JJ dose_NN when_WRB they_PRP are_VBP aged_JJ three_CD years_NNS and_CC four_CD months_NNS old_JJ ._. Measles_NN is_VBZ a_DT viral_JJ infection_NN which_WDT is_VBZ spread_VBN from_IN person_NN to_IN person_NN ._. Symptoms_NNS of_IN measles_NNS include_VBP :_: Symptoms_NNS can_MD last_VB up_IN to_IN 10_CD days_NNS in_IN children_NNS and_CC longer_JJR in_IN adults_NNS ._. The_DT infection_NN can_MD cause_VB serious_JJ complications_NNS ._. Mumps_NNS is_VBZ caused_VBN by_IN a_DT virus_NN ._. Symptoms_NNS for_IN most_JJS people_NNS are_VBP :_: •_SYM painful_JJ swollen_JJ glands_NNS in_IN the_DT face_NN and_CC neck_NN Symptoms_NNS last_VBP up_IN to_IN 10_CD days_NNS ._. The_DT condition_NN can_MD also_RB cause_VB complications_NNS ._. Rubella_NNP is_VBZ a_DT mild_JJ viral_JJ disease_NN ,_, also_RB known_VBN as_IN German_JJ measles_NNS ._. •_NFP None_NN swollen_JJ glands_NNS behind_IN the_DT ear_NN and_CC the_DT back_NN of_IN the_DT neck_NN Some_DT adults_NNS also_RB have_VBP painful_JJ joints_NNS ._. The_DT infection_NN is_VBZ very_RB serious_JJ in_IN pregnancy_NN ._. It_PRP is_VBZ important_JJ to_TO protect_VB children_NNS against_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN as_IN these_DT diseases_NNS can_MD have_VB serious_JJ complications_NNS ._. In_IN some_DT cases_NNS ,_, measles_NNS can_MD cause_VB death_NN ._. In_IN children_NNS aged_JJ under_IN two_CD years_NNS ,_, one_CD child_NN in_IN 8,000_CD will_MD develop_VB a_DT fatal_JJ degenerative_JJ brain_NN condition_NN within_IN eight_CD years_NNS of_IN getting_VBG measles_NNS ._. •_NFP deafness_NN -_, usually_RB with_IN partial_JJ or_CC complete_JJ recovery_NN Rubella_NNP can_MD cause_VB inflammation_NN of_IN the_DT brain_NN and_CC can_MD affect_VB blood_NN clotting_NN ._. In_IN pregnant_JJ women_NNS ,_, it_PRP can_MD cause_VB miscarriage_NN or_CC major_JJ health_NN problems_NNS for_IN their_PRP$ babies_NNS such_JJ as_IN :_: MMR_NNP vaccine_NN protects_VBZ your_PRP$ child_NN against_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN ._. They_PRP get_VBP the_DT vaccine_NN in_IN two_CD doses_NNS :_: •_NFP when_WRB they_PRP are_VBP around_RB 13_CD months_NNS old_JJ ;_: and_CC Experts_NNS from_IN around_IN the_DT world_NN ,_, including_VBG the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, agree_VBP that_IN there_EX is_VBZ no_DT link_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ._. Separate_JJ vaccines_NNS for_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN are_VBP not_RB recommended_VBN ._. Single_JJ vaccines_NNS put_VBP children_NNS at_IN risk_NN while_IN they_PRP wait_VBP between_IN each_DT vaccine_NN ._. It_PRP also_RB means_VBZ that_IN children_NNS need_VBP repeat_NN injections_NNS and_CC are_VBP more_RBR at_IN risk_NN of_IN adverse_JJ reactions_NNS at_IN the_DT injection_NN site_NN ._. •_NFP Immunisation_NN for_IN babies_NNS up_IN to_IN one_CD year_NN old_JJ •_, Immunisation_NN for_IN babies_NNS after_IN their_PRP$ first_JJ birthday_NN •_, Immunisation_NN for_IN pre-school_NN children_NNS aged_JJ three_CD years_NNS and_CC four_CD months_NNS old_JJ","The NNP NN VBZ your NN against NNS , NNS and NN ( JJ NNS ) . NNP VBZ three JJ NNS in one NN . Your NN should VB one NN of NNP RB after their JJ NN and a JJ NN when they VBP JJ three NNS and four NNS JJ . NN VBZ a JJ NN which VBZ VBN from NN to NN . NNS of NNS VBP : NNS can VB up to 10 NNS in NNS and JJR in NNS . The NN can VB JJ NNS . NNS VBZ VBN by a NN . NNS for JJS NNS VBP : • JJ JJ NNS in the NN and NN NNS VBP up to 10 NNS . The NN can RB VB NNS . NNP VBZ a JJ JJ NN , RB VBN as JJ NNS . • NN JJ NNS behind the NN and the NN of the NN Some NNS RB VBP JJ NNS . The NN VBZ RB JJ in NN . It VBZ JJ to VB NNS against NNS , NNS and NN as these NNS can VB JJ NNS . In some NNS , NNS can VB NN . In NNS JJ under two NNS , one NN in 8,000 will VB a JJ JJ NN NN within eight NNS of VBG NNS . • NN - RB with JJ or JJ NN NNP can VB NN of the NN and can VB NN NN . In JJ NNS , it can VB NN or JJ NN NNS for their NNS JJ as : NNP NN VBZ your NN against NNS , NNS and NN . They VBP the NN in two NNS : • when they VBP RB 13 NNS JJ ; and NNS from around the NN , VBG the NNP NNP NNP ( NNP ) , VBP that there VBZ no NN between the NN NN and NN . JJ NNS for NNS , NNS and NN VBP RB VBN . JJ NNS VBP NNS at NN while they VBP between each NN . It RB VBZ that NNS VBP NN NNS and VBP RBR at NN of JJ NNS at the NN NN . • NN for NNS up to one NN JJ • NN for NNS after their JJ NN • NN for NN NNS JJ three NNS and four NNS JJ"
31,478,mainstream,M0a2d8,vaccine,"Note_NN :_: You_PRP Call_VBP the_DT Shots_NN is_VBZ updated_VBN regularly_RB to_TO include_VB the_DT latest_JJS guidelines_NNS and_CC recommendations_NNS in_IN vaccine_NN practice_NN ._. The_DT latest_JJS modules_NNS are_VBP below_RB ._. You_PRP Call_VBP the_DT Shots_NNP is_VBZ an_DT interactive_JJ ,_, web_NN -_HYPH based_VBN immunization_NN training_NN course_NN ._. It_PRP consists_VBZ of_IN a_DT series_NN of_IN modules_NNS that_WDT discuss_VBP vaccine_NN -_HYPH preventable_JJ diseases_NNS and_CC explain_VBP the_DT latest_JJS recommendations_NNS for_IN vaccine_NN use_NN ._. Each_DT module_NN provides_VBZ learning_NN opportunities_NNS ,_, self_NN -_HYPH test_NN practice_NN questions_NNS ,_, reference_NN and_CC resource_NN materials_NNS ,_, and_CC an_DT extensive_JJ glossary_NN ._. To_TO receive_VB continuing_VBG education_NN (_-LRB- CE_NN )_-RRB- or_CC print_VB a_DT certificate_NN ,_, please_UH visit_VB TCEO_NNP and_CC follow_VB these_DT 9_CD Simple_JJ Steps_NNS ._. If_IN you_PRP do_VBP not_RB need_VB CE_NN ,_, but_CC require_VB a_DT certificate_NN for_IN training_NN requirements_NNS ,_, please_UH select_VB CEU_NNP as_IN the_DT type_NN of_IN continuing_VBG education_NN you_PRP ’d_MD like_VB to_TO earn_VB ._. •_NFP Understanding_VBG the_DT Basics_NNS :_: General_JJ Best_JJS Practice_NN Guidelines_NNS on_IN Immunization_NN","NN : You VBP the NN VBZ VBN RB to VB the JJS NNS and NNS in NN NN . The JJS NNS VBP RB . You VBP the NNP VBZ an JJ , NN - VBN NN NN NN . It VBZ of a NN of NNS that VBP NN - JJ NNS and VBP the JJS NNS for NN NN . Each NN VBZ NN NNS , NN - NN NN NNS , NN and NN NNS , and an JJ NN . To VB VBG NN ( NN ) or VB a NN , please VB NNP and VB these 9 JJ NNS . If you VBP RB VB NN , but VB a NN for NN NNS , please VB NNP as the NN of VBG NN you ’d VB to VB . • VBG the NNS : JJ JJS NN NNS on NN"
32,1319,mainstream,M0bec3,vaccine.autism,"In_IN response_NN to_IN outbreaks_NNS of_IN measles_NNS in_IN France_NNP and_CC Italy_NNP ,_, resulting_VBG from_IN a_DT growing_VBG trend_NN for_IN parents_NNS to_TO refuse_VB vaccinations_NNS for_IN their_PRP$ children_NNS ,_, authorities_NNS have_VBP announced_VBN plans_NNS to_TO make_VB childhood_NN immunisation_NN compulsory_JJ ._. Last_JJ week_NN ,_, a_DT newspaper_NN editorial_NN demanded_VBD similar_JJ measures_NNS in_IN Britain_NNP ,_, insisting_VBG that_IN parental_JJ refusal_NN of_IN immunisation_NN “_'' should_MD not_RB be_VB tolerated_VBN ”_'' ._. Though_IN I_PRP have_VBP been_VBN actively_RB involved_VBN over_IN the_DT past_JJ decade_NN in_IN promoting_VBG the_DT MMR_NNP vaccine_NN in_IN face_NN of_IN claims_NNS of_IN a_DT link_NN with_IN autism_NN ,_, I_PRP hope_VBP British_JJ immunisation_NN authorities_NNS will_MD continue_VB to_TO resists_VBZ calls_NNS for_IN compulsion_NN ._. As_IN the_DT father_NN of_IN a_DT child_NN with_IN autism_NN who_WP was_VBD also_RB as_IN a_DT GP_NN administering_VBG vaccinations_NNS to_IN babies_NNS ,_, I_PRP read_VBD with_IN great_JJ interest_NN Andrew_NNP Wakefield_NNP ’s_POS now_RB notorious_JJ 1998_CD study_NN in_IN the_DT The_DT Lancet_NNP suggesting_VBG a_DT link_NN between_IN MMR_NN and_CC autism_NN ._. It_PRP was_VBD immediately_RB obvious_JJ that_IN though_IN this_DT paper_NN presented_VBD no_DT evidence_NN for_IN this_DT link_NN ,_, it_PRP would_MD cause_VB undue_JJ alarm_NN among_IN parents_NNS of_IN children_NNS with_IN autism_NN as_RB well_RB as_IN among_IN parents_NNS of_IN children_NNS due_IN for_IN vaccinations_NNS ._. In_IN response_NN I_PRP wrote_VBD the_DT first_JJ of_IN a_DT series_NN of_IN articles_NNS ,_, culminating_VBG in_IN 2004_CD in_IN a_DT book_NN MMR_NNP and_CC Autism_NN :_: What_WDT Parents_NNS Need_VBP To_TO Know_VB ._. This_DT book_NN sought_VBD to_TO reassure_VB parents_NNS that_IN they_PRP had_VBD no_DT grounds_NNS to_TO fear_VB that_IN MMR_NNP had_VBD caused_VBN their_PRP$ children_NNS ’s_POS autism_NN ,_, and_CC that_IN it_PRP offered_VBD effective_JJ protection_NN against_IN serious_JJ diseases_NNS ._. It_PRP was_VBD a_DT great_JJ relief_NN when_WRB Wakefield_NNP ’s_POS work_NN was_VBD finally_RB exposed_VBN as_IN fraudulent_JJ and_CC he_PRP departed_VBD Britain_NNP to_TO join_VB a_DT wacky_JJ fringe_NN of_IN conspiracy_NN theorists_NNS and_CC alternative_JJ health_NN cranks_NNS in_IN the_DT United_NNP States_NNPS ._.","In NN to NNS of NNS in NNP and NNP , VBG from a VBG NN for NNS to VB NNS for their NNS , NNS VBP VBN NNS to VB NN NN JJ . JJ NN , a NN NN VBD JJ NNS in NNP , VBG that JJ NN of NN “ should RB VB VBN ” . Though I VBP VBN RB VBN over the JJ NN in VBG the NNP NN in NN of NNS of a NN with NN , I VBP JJ NN NNS will VB to VBZ NNS for NN . As the NN of a NN with NN who VBD RB as a NN VBG NNS to NNS , I VBD with JJ NN NNP NNP ’s RB JJ 1998 NN in the The NNP VBG a NN between NN and NN . It VBD RB JJ that though this NN VBD no NN for this NN , it would VB JJ NN among NNS of NNS with NN RB RB as among NNS of NNS due for NNS . In NN I VBD the JJ of a NN of NNS , VBG in 2004 in a NN NNP and NN : What NNS VBP To VB . This NN VBD to VB NNS that they VBD no NNS to VB that NNP VBD VBN their NNS ’s NN , and that it VBD JJ NN against JJ NNS . It VBD a JJ NN when NNP ’s NN VBD RB VBN as JJ and he VBD NNP to VB a JJ NN of NN NNS and JJ NN NNS in the NNP NNPS ."
33,1255,mainstream,M0807c,vaccine.autism,"The_DT report_NN that_WDT first_RB triggered_VBD scares_NNS that_WDT a_DT vaccine_NN to_TO prevent_VB measles_NNS ,_, mumps_NNS and_CC rubella_NN might_MD cause_VB autism_NN in_IN children_NNS has_VBZ received_VBN another_DT devastating_JJ blow_NN to_IN its_PRP$ credibility_NN ._. The_DT British_NNP Medical_NNP Journal_NNP has_VBZ declared_VBN that_IN the_DT research_NN was_VBD not_RB simply_RB bad_JJ science_NN ,_, as_IN has_VBZ been_VBN known_VBN for_IN years_NNS ,_, but_CC a_DT deliberate_JJ fraud_NN ._. The_DT study_NN ,_, led_VBN by_IN Dr._NNP Andrew_NNP Wakefield_NNP ,_, was_VBD published_VBN in_IN The_DT Lancet_NNP in_IN 1998_CD ._. It_PRP was_VBD based_VBN on_IN just_RB 12_CD children_NNS with_IN supposedly_RB autismlike_JJ disorders_NNS and_CC purported_VBD to_TO find_VB a_DT link_NN between_IN the_DT vaccine_NN ,_, the_DT gastrointestinal_JJ problems_NNS found_VBN in_IN many_JJ autistic_JJ children_NNS ,_, and_CC autism_NN ._. While_IN parents_NNS around_IN the_DT world_NN were_VBD understandably_RB alarmed_VBN ,_, many_JJ scientists_NNS rejected_VBD the_DT claims_NNS ,_, including_VBG ,_, eventually_RB ,_, 10_CD of_IN Dr._NNP Wakefield_NNP ’s_POS co-authors_NNS ._. A_DT high_JJ -_HYPH level_NN British_JJ medical_JJ group_NN ,_, after_IN an_DT exhaustive_JJ fitness_NN -_HYPH to_IN -_HYPH practice_NN hearing_NN ,_, found_VBD Dr._NNP Wakefield_NNP guilty_JJ of_IN dishonesty_NN and_CC misconduct_NN ._. The_DT Lancet_NNP retracted_VBD the_DT article_NN in_IN part_NN ,_, it_PRP said_VBD ,_, because_IN the_DT authors_NNS had_VBD made_VBN false_JJ claims_NNS about_IN how_WRB the_DT study_NN was_VBD conducted_VBN ._. Now_RB the_DT British_NNP Medical_NNP Journal_NNP has_VBZ taken_VBN the_DT extraordinary_JJ step_NN of_IN publishing_VBG a_DT lengthy_JJ report_NN by_IN Brian_NNP Deer_NNP ,_, the_DT British_JJ investigative_JJ journalist_NN who_WP first_RB brought_VBD the_DT paper_NN ’s_POS flaws_NNS to_IN light_NN _, and_CC has_VBZ put_VBN its_PRP$ own_JJ reputation_NN on_IN the_DT line_NN by_IN endorsing_VBG his_PRP$ findings_NNS ._.","The NN that RB VBD NNS that a NN to VB NNS , NNS and NN might VB NN in NNS VBZ VBN another JJ NN to its NN . The NNP NNP NNP VBZ VBN that the NN VBD RB RB JJ NN , as VBZ VBN VBN for NNS , but a JJ NN . The NN , VBN by NNP NNP NNP , VBD VBN in The NNP in 1998 . It VBD VBN on RB 12 NNS with RB JJ NNS and VBD to VB a NN between the NN , the JJ NNS VBN in JJ JJ NNS , and NN . While NNS around the NN VBD RB VBN , JJ NNS VBD the NNS , VBG , RB , 10 of NNP NNP ’s NNS . A JJ - NN JJ JJ NN , after an JJ NN - to - NN NN , VBD NNP NNP JJ of NN and NN . The NNP VBD the NN in NN , it VBD , because the NNS VBD VBN JJ NNS about how the NN VBD VBN . RB the NNP NNP NNP VBZ VBN the JJ NN of VBG a JJ NN by NNP NNP , the JJ JJ NN who RB VBD the NN ’s NNS to NN  and VBZ VBN its JJ NN on the NN by VBG his NNS ."
34,940,mainstream,M0aedc,vaccine.covid,"This_DT May_NNP 4_CD ,_, 2020_CD photo_NN from_IN the_DT University_NNP of_IN Maryland_NNP School_NNP of_IN Medicine_NNP ,_, the_DT first_JJ patient_NN enrolled_VBN in_IN Pfizer_NNP 's_POS COVID_NNP -_HYPH 19_CD coronavirus_NN vaccine_NN clinical_JJ trial_NN at_IN the_DT University_NNP of_IN Maryland_NNP School_NNP of_IN Medicine_NNP in_IN Baltimore_NNP ,_, receives_VBZ an_DT injection_NN ._. Only_RB about_RB half_NN of_IN Americans_NNPS say_VBP they_PRP would_MD get_VB a_DT COVID_NN -_HYPH 19_CD vaccine_NN if_IN the_DT scientists_NNS working_VBG furiously_RB to_TO create_VB one_CD succeed_NN ,_, according_VBG to_IN a_DT poll_NN conducted_VBN May_NNP 14_CD -_SYM 18_CD by_IN The_DT Associated_NNP Press_NNP -_HYPH NORC_NNP Center_NNP for_IN Public_NNP Affairs_NNPS Research_NNP ._. (_-LRB- University_NNP of_IN Maryland_NNP School_NNP of_IN Medicine_NNP via_IN AP_NNP )_-RRB- University_NNP of_IN Maryland_NNP School_NNP of_IN Medicine_NNP /_, AP_NNP Photo_NNP Only_RB about_RB half_NN of_IN Americans_NNPS say_VBP they_PRP would_MD get_VB a_DT COVID_NN -_HYPH 19_CD vaccine_NN if_IN the_DT scientists_NNS working_VBG furiously_RB to_TO create_VB one_CD succeed_NN ,_, according_VBG to_IN a_DT new_JJ poll_NN from_IN ._. That_DT ’s_VBZ surprisingly_RB low_JJ considering_VBG the_DT effort_NN going_VBG into_IN the_DT against_IN the_DT coronavirus_NN that_WDT has_VBZ sparked_VBN a_DT pandemic_NN since_IN first_RB emerging_VBG from_IN China_NNP late_RB last_JJ year_NN ._. But_CC more_JJR people_NNS might_MD eventually_RB roll_VB up_RP their_PRP$ sleeves_NNS :_: The_DT poll_NN ,_, released_VBN Wednesday_NNP ,_, found_VBD 31_CD %_NN simply_RB were_VBD n’t_RB sure_JJ if_IN they_PRP ’d_MD get_VB vaccinated_VBN ._. Another_DT 1_CD in_IN 5_CD said_VBD they_PRP ’d_MD refuse_VB ._. Health_NN experts_NNS already_RB worry_VBP about_IN the_DT whiplash_NN if_IN vaccine_NN promises_VBZ like_IN President_NNP Donald_NNP Trump_NNP ’s_POS goal_NN of_IN a_DT 300_CD million_CD -_HYPH dose_NN stockpile_NN by_IN January_NNP fail_VBP ._. Only_RB time_NN and_CC science_NN will_MD tell_VB --_, and_CC the_DT new_JJ poll_NN shows_VBZ the_DT public_NN is_VBZ indeed_RB skeptical_JJ ._. “_`` It_PRP ’s_VBZ always_RB better_JJR to_TO under_IN -_HYPH promise_NN and_CC over_RB -_HYPH deliver_VB ,_, ”_'' said_VBD Dr._NNP William_NNP Schaffner_NNP ,_, an_DT infectious_JJ disease_NN specialist_NN at_IN Vanderbilt_NNP University_NNP Medical_NNP Center_NNP ._. “_`` The_DT unexpected_JJ looms_VBZ large_JJ and_CC that_DT ’s_VBZ why_WRB I_PRP think_VBP for_IN any_DT of_IN these_DT vaccines_NNS ,_, we_PRP ’re_VBP going_VBG to_TO need_VB a_DT large_JJ safety_NN database_NN to_TO provide_VB the_DT reassurance_NN ,_, ”_'' he_PRP added_VBD ._. Among_IN Americans_NNPS who_WP say_VBP they_PRP would_MD n’t_RB get_VB vaccinated_VBN ,_, 7_CD in_IN 10_CD worry_VBP about_IN safety_NN ._. “_`` I_PRP am_VBP not_RB an_DT anti-vaxxer_NN ,_, ”_'' said_VBD Melanie_NNP Dries_NNP ,_, 56_CD ,_, of_IN Colorado_NNP Springs_NNP ,_, Colorado_NNP ._. But_CC ,_, “_`` to_TO get_VB a_DT COVID_NN -_HYPH 19_CD vaccine_NN within_IN a_DT year_NN or_CC two_CD ..._, causes_VBZ me_PRP to_TO fear_VB that_IN it_PRP wo_MD n’t_RB be_VB widely_RB tested_VBN as_IN to_IN side_NN effects_NNS ._. ”_'' Dr._NNP Francis_NNP Collins_NNP ,_, who_WP directs_VBZ the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, insists_VBZ safety_NN is_VBZ the_DT top_JJ priority_NN ._. The_DT NIH_NNP is_VBZ creating_VBG a_DT master_NN plan_NN for_IN testing_VBG the_DT leading_VBG COVID_NNP -_HYPH 19_CD vaccine_NN candidates_NNS in_IN tens_NNS of_IN thousands_NNS of_IN people_NNS ,_, to_TO prove_VB if_IN they_PRP really_RB work_VBP and_CC also_RB if_IN they_PRP 're_VBP safe_JJ ._. “_`` I_PRP would_MD not_RB want_VB people_NNS to_TO think_VB that_IN we_PRP ’re_VBP cutting_VBG corners_NNS because_IN that_DT would_MD be_VB a_DT big_JJ mistake_NN ._. I_PRP think_VBP this_DT is_VBZ an_DT effort_NN to_TO try_VB to_TO achieve_VB efficiencies_NNS ,_, but_CC not_RB to_TO sacrifice_VB rigor_NN ,_, ”_'' Collins_NNP told_VBD the_DT AP_NNP earlier_RBR this_DT month_NN ._. “_`` Definitely_RB the_DT worst_JJS thing_NN that_WDT could_MD happen_VB is_VBZ if_IN we_PRP rush_VBP through_IN a_DT vaccine_NN that_WDT turns_VBZ out_RP to_TO have_VB significant_JJ side_NN effects_NNS ,_, ”_'' Collins_NNP added_VBD ._. Among_IN those_DT who_WP want_VBP a_DT vaccine_NN ,_, the_DT AP_NNP -_HYPH NORC_NNP poll_NN found_VBD protecting_VBG themselves_PRP ,_, their_PRP$ family_NN and_CC the_DT community_NN are_VBP the_DT top_JJ reasons_NNS ._. ""_`` I_PRP ’m_VBP definitely_RB going_VBG to_TO get_VB it_PRP ,_, ”_'' said_VBD Brandon_NNP Grimes_NNP ,_, 35_CD ,_, of_IN Austin_NNP ,_, Texas_NNP ._. “_`` As_IN a_DT father_NN who_WP takes_VBZ care_NN of_IN his_PRP$ family_NN ,_, I_PRP think_VBP ..._, it_PRP ’s_VBZ important_JJ for_IN me_PRP to_TO get_VB vaccinated_VBN as_RB soon_RB as_IN it_PRP ’s_VBZ available_JJ to_TO better_RBR protect_VB my_PRP$ family_NN ._. ”_'' And_CC about_RB 7_CD in_IN 10_CD of_IN those_DT who_WP would_MD get_VB vaccinated_VBN say_VB life_NN wo_MD n't_RB go_VB back_RB to_IN normal_JJ without_IN a_DT vaccine_NN ._. A_DT site_NN foreman_NN for_IN his_PRP$ family_NN ’s_POS construction_NN business_NN ,_, Grimes_NNP travels_VBZ from_IN house_NN to_IN house_NN interacting_VBG with_IN different_JJ crews_NNS ,_, and_CC said_VBD some_DT of_IN his_PRP$ coworkers_NNS also_RB are_VBP looking_VBG forward_RB to_IN vaccination_NN to_TO minimize_VB on_IN -_HYPH the_DT -_HYPH job_NN risk_NN ._. The_DT new_JJ coronavirus_NN is_VBZ most_RBS dangerous_JJ to_IN older_JJR adults_NNS and_CC people_NNS of_IN any_DT age_NN who_WP have_VBP chronic_JJ health_NN problems_NNS such_JJ as_IN diabetes_NN or_CC heart_NN disease_NN ._. The_DT poll_NN found_VBD 67_CD %_NN of_IN people_NNS 60_CD and_CC older_JJR say_VBP they_PRP ’d_MD get_VB vaccinated_VBN ,_, compared_VBN with_IN 40_CD %_NN who_WP are_VBP younger_JJR ._. And_CC death_NN counts_NNS suggest_VBP black_JJ and_CC Hispanic_JJ Americans_NNPS are_VBP more_RBR vulnerable_JJ to_IN COVID_NN -_HYPH 19_CD ,_, because_IN of_IN unequal_JJ access_NN to_IN health_NN care_NN and_CC other_JJ factors_NNS ._. Yet_CC the_DT poll_NN found_VBD just_RB 25_CD %_NN of_IN African_JJ Americans_NNPS and_CC 37_CD %_NN of_IN Hispanics_NNPS would_MD get_VB a_DT vaccine_NN compared_VBN to_IN 56_CD %_NN of_IN whites_NNS ._. Among_IN people_NNS who_WP do_VBP n't_RB want_VB a_DT vaccine_NN ,_, about_RB 4_CD in_IN 10_CD say_VBP they_PRP 're_VBP concerned_JJ about_IN catching_VBG COVID_NN -_HYPH 19_CD from_IN the_DT shot_NN ._. But_CC most_JJS of_IN the_DT leading_VBG vaccine_NN candidates_NNS do_VBP n't_RB contain_VB the_DT coronavirus_NN itself_PRP ,_, meaning_VBG they_PRP can't_MD cause_VB infection_NN ._. And_CC 3_CD in_IN 10_CD who_WP do_VBP n't_RB want_VB a_DT vaccine_NN do_VBP n't_RB fear_VB getting_VBG seriously_RB ill_JJ from_IN the_DT coronavirus_NN ._. Over_RB 5.5_CD million_CD people_NNS worldwide_RB have_VBP been_VBN confirmed_VBN infected_VBN by_IN the_DT virus_NN ,_, and_CC more_JJR than_IN 340,000_CD deaths_NNS have_VBP been_VBN recorded_VBN ,_, including_VBG nearly_RB 100,000_CD in_IN the_DT U.S._NNP ,_, according_VBG to_IN a_DT tally_NN kept_VBN by_IN Johns_NNP Hopkins_NNP University_NNP ._. Experts_NNS believe_VBP the_DT true_JJ toll_NN is_VBZ significantly_RB higher_JJR ._. And_CC while_IN most_JJS people_NNS who_WP get_VBP COVID_NNP -_HYPH 19_CD have_VBP mild_JJ cases_NNS and_CC recover_VBP ,_, doctors_NNS still_RB are_VBP discovering_VBG the_DT coronavirus_NN attacks_NNS in_IN far_RB sneakier_JJ ways_NNS than_IN just_RB causing_VBG pneumonia_NN —_: from_IN blood_NN clots_NNS to_IN heart_NN and_CC kidney_NN damage_NN to_IN the_DT latest_JJS scare_NN ,_, a_DT life_NN -_HYPH threatening_VBG inflammatory_JJ reaction_NN in_IN children_NNS ._. Whatever_WDT the_DT final_JJ statistics_NNS show_VBP about_IN how_WRB often_RB it_PRP kills_VBZ ,_, health_NN specialists_NNS agree_VBP the_DT new_JJ coronavirus_NN appears_VBZ deadlier_JJR than_IN the_DT typical_JJ flu_NN ._. Yet_CC the_DT survey_NN suggests_VBZ a_DT vaccine_NN would_MD be_VB no_RB more_RBR popular_JJ than_IN the_DT yearly_JJ flu_NN shot_NN ._. Worldwide_RB ,_, are_VBP in_IN early_JJ stages_NNS of_IN testing_NN or_CC poised_VBN to_TO begin_VB ._. British_JJ researchers_NNS are_VBP opening_VBG one_CD of_IN the_DT biggest_JJS studies_NNS so_RB far_RB ,_, to_TO test_VB an_DT Oxford_NNP University_NNP -_HYPH created_VBN shot_VBN in_IN 10,000_CD people_NNS ._. For_IN all_PDT the_DT promises_NNS of_IN the_DT Trump_NNP administration_NN ’s_POS “_`` ,_, ”_'' only_RB 20_CD %_NN of_IN Americans_NNPS expect_VBP any_DT vaccine_NN to_TO be_VB available_JJ to_IN the_DT public_NN by_IN year_NN ’s_POS end_NN ,_, the_DT poll_NN found_VBD ._. Most_JJS think_VBP sometime_RB next_JJ year_NN is_VBZ more_RBR likely_JJ ._. Political_JJ divisions_NNS seen_VBN over_IN how_WRB the_DT country_NN reopens_VBZ the_DT economy_NN are_VBP reflected_VBN in_IN desire_NN for_IN a_DT vaccine_NN ,_, too_RB ._. More_JJR than_IN half_NN of_IN Democrats_NNPS call_VBP a_DT vaccine_NN necessary_JJ for_IN reopening_NN ,_, compared_VBN to_IN about_RB a_DT third_NN of_IN Republicans_NNPS ._. While_IN 62_CD %_NN of_IN Democrats_NNPS would_MD get_VB the_DT vaccine_NN ,_, only_RB 43_CD %_NN of_IN Republicans_NNPS say_VBP the_DT same_JJ ._. “_`` There_EX 's_VBZ still_RB a_DT large_JJ amount_NN of_IN uncertainty_NN around_IN taking_VBG the_DT vaccine_NN ,_, ”_'' said_VBD Caitlin_NNP Oppenheimer_NNP ,_, who_WP leads_VBZ NORC_NNP 's_POS public_JJ health_NN research_NN ._. “_`` There_EX is_VBZ a_DT lot_NN of_IN opportunity_NN to_TO communicate_VB with_IN Americans_NNPS about_IN the_DT value_NN and_CC the_DT safety_NN of_IN a_DT vaccine_NN ._. ”_'' The_DT AP_NNP -_HYPH NORC_NNP poll_NN of_IN 1,056_CD adults_NNS was_VBD conducted_VBN May_NNP 14_CD -_SYM 18_CD using_VBG a_DT sample_NN drawn_VBN from_IN NORC_NNP ’s_POS probability_NN -_HYPH based_VBN AmeriSpeak_NNP Panel_NNP ,_, which_WDT is_VBZ designed_VBN to_TO be_VB representative_JJ of_IN the_DT U.S._NNP population_NN ._. The_DT margin_NN of_IN sampling_NN error_NN for_IN all_DT respondents_NNS is_VBZ plus_CC or_CC minus_RB 4.2_CD percentage_NN points_NNS ._.","This NNP 4 , 2020 NN from the NNP of NNP NNP of NNP , the JJ NN VBN in NNP 's NNP - 19 NN NN JJ NN at the NNP of NNP NNP of NNP in NNP , VBZ an NN . RB RB NN of NNPS VBP they would VB a NN - 19 NN if the NNS VBG RB to VB one NN , VBG to a NN VBN NNP 14 - 18 by The NNP NNP - NNP NNP for NNP NNPS NNP . ( NNP of NNP NNP of NNP via NNP ) NNP of NNP NNP of NNP / NNP NNP RB RB NN of NNPS VBP they would VB a NN - 19 NN if the NNS VBG RB to VB one NN , VBG to a JJ NN from . That VBZ RB JJ VBG the NN VBG into the against the NN that VBZ VBN a NN since RB VBG from NNP RB JJ NN . But JJR NNS might RB VB up their NNS : The NN , VBN NNP , VBD 31 NN RB VBD RB JJ if they ’d VB VBN . Another 1 in 5 VBD they ’d VB . NN NNS RB VBP about the NN if NN VBZ like NNP NNP NNP ’s NN of a 300 million - NN NN by NNP VBP . RB NN and NN will VB -- and the JJ NN VBZ the NN VBZ RB JJ . “ It VBZ RB JJR to under - NN and RB - VB , ” VBD NNP NNP NNP , an JJ NN NN at NNP NNP NNP NNP . “ The JJ VBZ JJ and that VBZ why I VBP for any of these NNS , we VBP VBG to VB a JJ NN NN to VB the NN , ” he VBD . Among NNPS who VBP they would RB VB VBN , 7 in 10 VBP about NN . “ I VBP RB an NN , ” VBD NNP NNP , 56 , of NNP NNP , NNP . But , “ to VB a NN - 19 NN within a NN or two ... VBZ me to VB that it wo RB VB RB VBN as to NN NNS . ” NNP NNP NNP , who VBZ the NNP NNPS of NNP , VBZ NN VBZ the JJ NN . The NNP VBZ VBG a NN NN for VBG the VBG NNP - 19 NN NNS in NNS of NNS of NNS , to VB if they RB VBP and RB if they VBP JJ . “ I would RB VB NNS to VB that we VBP VBG NNS because that would VB a JJ NN . I VBP this VBZ an NN to VB to VB NNS , but RB to VB NN , ” NNP VBD the NNP RBR this NN . “ RB the JJS NN that could VB VBZ if we VBP through a NN that VBZ out to VB JJ NN NNS , ” NNP VBD . Among those who VBP a NN , the NNP - NNP NN VBD VBG themselves , their NN and the NN VBP the JJ NNS . "" I VBP RB VBG to VB it , ” VBD NNP NNP , 35 , of NNP , NNP . “ As a NN who VBZ NN of his NN , I VBP ... it VBZ JJ for me to VB VBN RB RB as it VBZ JJ to RBR VB my NN . ” And RB 7 in 10 of those who would VB VBN VB NN wo RB VB RB to JJ without a NN . A NN NN for his NN ’s NN NN , NNP VBZ from NN to NN VBG with JJ NNS , and VBD some of his NNS RB VBP VBG RB to NN to VB on - the - NN NN . The JJ NN VBZ RBS JJ to JJR NNS and NNS of any NN who VBP JJ NN NNS JJ as NN or NN NN . The NN VBD 67 NN of NNS 60 and JJR VBP they ’d VB VBN , VBN with 40 NN who VBP JJR . And NN NNS VBP JJ and JJ NNPS VBP RBR JJ to NN - 19 , because of JJ NN to NN NN and JJ NNS . Yet the NN VBD RB 25 NN of JJ NNPS and 37 NN of NNPS would VB a NN VBN to 56 NN of NNS . Among NNS who VBP RB VB a NN , RB 4 in 10 VBP they VBP JJ about VBG NN - 19 from the NN . But JJS of the VBG NN NNS VBP RB VB the NN itself , VBG they can't VB NN . And 3 in 10 who VBP RB VB a NN VBP RB VB VBG RB JJ from the NN . RB 5.5 million NNS RB VBP VBN VBN VBN by the NN , and JJR than 340,000 NNS VBP VBN VBN , VBG RB 100,000 in the NNP , VBG to a NN VBN by NNP NNP NNP . NNS VBP the JJ NN VBZ RB JJR . And while JJS NNS who VBP NNP - 19 VBP JJ NNS and VBP , NNS RB VBP VBG the NN NNS in RB JJ NNS than RB VBG NN — from NN NNS to NN and NN NN to the JJS NN , a NN - VBG JJ NN in NNS . Whatever the JJ NNS VBP about how RB it VBZ , NN NNS VBP the JJ NN VBZ JJR than the JJ NN . Yet the NN VBZ a NN would VB RB RBR JJ than the JJ NN NN . RB , VBP in JJ NNS of NN or VBN to VB . JJ NNS VBP VBG one of the JJS NNS RB RB , to VB an NNP NNP - VBN VBN in 10,000 NNS . For all the NNS of the NNP NN ’s “ , ” RB 20 NN of NNPS VBP any NN to VB JJ to the NN by NN ’s NN , the NN VBD . JJS VBP RB JJ NN VBZ RBR JJ . JJ NNS VBN over how the NN VBZ the NN VBP VBN in NN for a NN , RB . JJR than NN of NNPS VBP a NN JJ for NN , VBN to RB a NN of NNPS . While 62 NN of NNPS would VB the NN , RB 43 NN of NNPS VBP the JJ . “ There VBZ RB a JJ NN of NN around VBG the NN , ” VBD NNP NNP , who VBZ NNP 's JJ NN NN . “ There VBZ a NN of NN to VB with NNPS about the NN and the NN of a NN . ” The NNP - NNP NN of 1,056 NNS VBD VBN NNP 14 - 18 VBG a NN VBN from NNP ’s NN - VBN NNP NNP , which VBZ VBN to VB JJ of the NNP NN . The NN of NN NN for all NNS VBZ plus or RB 4.2 NN NNS ."
35,943,mainstream,M0ae25,vaccine,"Be_VB the_DT first_JJ to_TO know_VB about_IN every_DT new_JJ Coronavirus_NNP story_NN With_IN long_JJ time_NN horizons_NNS ,_, complex_JJ science_NN and_CC high_JJ failure_NN rates_NNS ,_, vaccine_NN development_NN is_VBZ not_RB for_IN the_DT faint_JJ -_HYPH hearted_JJ philanthropist_NN ._. But_CC in_IN a_DT world_NN gripped_VBN by_IN coronavirus_NN ,_, many_JJ donors_NNS have_VBP put_VBN aside_RP such_JJ concerns_NNS and_CC are_VBP writing_VBG large_JJ cheques_NNS in_IN the_DT hope_NN of_IN contributing_VBG to_IN the_DT end_NN of_IN the_DT pandemic_NN ._. Alibaba_NNP founder_NN Jack_NNP Ma_NNP has_VBZ promised_VBN more_JJR than_IN $_$ 14_CD m_CD for_IN coronavirus_NN research_NN ,_, while_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP has_VBZ pledged_VBN up_IN to_IN $_$ 100_CD m_CD to_IN the_DT global_JJ response_NN to_IN Covid_NNP -_HYPH 19_CD ,_, including_VBG funding_NN to_TO accelerate_VB the_DT development_NN of_IN vaccines_NNS ._. Even_RB the_DT Gates_NNP Foundation_NNP ’s_POS move_NN pales_VBZ in_IN comparison_NN with_IN the_DT funds_NNS now_RB being_VBG committed_VBN by_IN governments_NNS and_CC pharmaceutical_JJ companies_NNS ._. In_IN the_DT US_NNP alone_RB ,_, the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, the_DT federal_JJ research_NN centres_NNS ,_, have_VBP secured_VBN $_$ 1.8bn_CD in_IN additional_JJ government_NN funding_NN for_IN Covid_NNP -_HYPH 19_CD work_NN ,_, including_VBG vaccine_NN investigations_NNS ._. Meanwhile_RB the_DT American_JJ drugs_NNS group_NN Johnson_NNP &_CC Johnson_NNP is_VBZ putting_VBG $_$ 1bn_CD into_IN developing_VBG a_DT specific_JJ coronavirus_NN vaccine_NN ,_, in_IN a_DT project_NN jointly_RB funded_VBN by_IN the_DT US_NNP government_NN ._. But_CC charitable_JJ dollars_NNS can_MD still_RB play_VB a_DT crucial_JJ role_NN ._. Philanthropy_NN advisors_NNS say_VBP donors_NNS are_VBP free_JJ from_IN the_DT burdens_NNS of_IN politics_NNS that_WDT often_RB hamper_VBP policymakers_NNS and_CC from_IN the_DT profits_NNS drive_NN that_WDT influences_VBZ companies_NNS (_-LRB- even_RB if_IN ,_, as_IN with_IN J&J_NNP ’s_POS Covid_NNP -_HYPH 19_CD vaccine_NN ,_, executives_NNS claim_VBP a_DT particular_JJ move_NN is_VBZ profit_NN -_HYPH free_JJ )_-RRB- ._. This_DT can_MD allow_VB philanthropists_NNS to_TO back_VB very_RB long_JJ term_NN research_NN and_CC bring_VB together_RP disparate_JJ groups_NNS of_IN partners_NNS ,_, including_VBG universities_NNS ,_, research_NN laboratories_NNS and_CC other_JJ donors_NNS ._. “_`` We_PRP can_MD fund_VB longer_JJR timelines_NNS than_IN government_NN or_CC industry_NN ,_, ”_'' says_VBZ Heather_NNP Youngs_NNP ,_, programme_NN officer_NN for_IN scientific_JJ research_NN at_IN Open_NNP Philanthropy_NNP ,_, a_DT research_NN and_CC grant_NN -_HYPH making_VBG organisation_NN ._. “_`` They_PRP have_VBP constraints_NNS because_IN of_IN the_DT stakeholder_NN groups_NNS they_PRP have_VBP to_TO answer_VB to_IN ,_, whether_IN voters_NNS or_CC shareholders_NNS ._. So_RB philanthropy_NN can_MD fill_VB in_RP the_DT gaps_NNS ._. ”_'' An_DT example_NN is_VBZ Open_NNP Philanthropy_NNP ,_, where_WRB the_DT main_JJ funders_NNS are_VBP Cari_NNP Tuna_NNP and_CC her_PRP$ husband_NN and_CC Facebook_NNP co-founder_NN Dustin_NNP Moskovitz_NNP ._. The_DT foundation_NN makes_VBZ grants_NNS to_IN vaccine_NN research_NN centres_NNS globally_RB ,_, such_JJ as_IN a_DT 2017_CD award_NN of_IN more_JJR than_IN $_$ 11_CD m_CD to_TO support_VB research_NN at_IN the_DT University_NNP of_IN Washington_NNP ’s_POS Institute_NNP for_IN Protein_NNP Design_NNP for_IN the_DT development_NN a_DT universal_JJ influenza_NN vaccine_NN ._. Philanthropy_NN is_VBZ particularly_RB important_JJ in_IN vaccine_NN development_NN because_IN drug_NN companies_NNS find_VBP it_PRP hard_JJ to_TO achieve_VB a_DT financial_JJ return_NN on_IN the_DT large_JJ ,_, long_JJ -_HYPH term_NN investments_NNS needed_VBN ._. “_`` You_PRP get_VBP these_DT glaring_JJ market_NN failures_NNS ,_, many_JJ of_IN them_PRP in_IN the_DT vaccine_NN space_NN ,_, ”_'' says_VBZ Mark_NNP Suzman_NNP ,_, chief_JJ executive_NN of_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, which_WDT since_IN inception_NN has_VBZ committed_VBN more_JJR than_IN $_$ 18bn_CD to_IN the_DT discovery_NN ,_, development_NN and_CC delivery_NN of_IN vaccines_NNS ._. Suzman_NNP cites_VBZ malaria_NN ,_, which_WDT despite_IN being_VBG responsible_JJ for_IN hundreds_NNS of_IN thousands_NNS of_IN deaths_NNS a_DT year_NN ,_, still_RB has_VBZ no_DT effective_JJ vaccine_NN ._. “_`` We_PRP do_VBP n’t_RB have_VB malaria_NN problems_NNS in_IN rich_JJ countries_NNS because_IN we_PRP have_VBP effective_JJ prophylaxis_NN :_: if_IN you_PRP visit_VBP a_DT malarial_JJ zone_NN ,_, you_PRP can_MD take_VB pills_NNS and_CC you_PRP wo_MD n’t_RB get_VB the_DT disease_NN ,_, ”_'' he_PRP says_VBZ ._. “_`` So_RB there_EX is_VBZ n’t_RB an_DT incentive_NN for_IN the_DT private_JJ sector_NN to_TO put_VB in_RP the_DT billions_NNS of_IN dollars_NNS that_WDT are_VBP needed_VBN to_TO underwrite_VB a_DT new_JJ vaccine_NN ._. ”_'' And_CC while_IN large_JJ pharmaceutical_JJ groups_NNS were_VBD successful_JJ in_IN developing_VBG an_DT Ebola_NNP vaccine_NN ,_, the_DT market_NN —_: limited_VBN largely_RB to_IN a_DT few_JJ African_JJ countries_NNS —_: was_VBD not_RB large_JJ enough_RB for_IN them_PRP to_TO recover_VB their_PRP$ costs_NNS ._. “_`` In_IN the_DT end_NN they_PRP are_VBP businesses_NNS ,_, and_CC some_DT of_IN them_PRP got_VBD quite_RB burnt_VBN by_IN that_DT ,_, ”_'' says_VBZ Suzman_NNP ._. When_WRB companies_NNS do_VBP invest_VB ,_, it_PRP tends_VBZ to_TO be_VB in_IN the_DT later_JJR stages_NNS of_IN vaccine_NN development_NN ,_, says_VBZ Melissa_NNP Stevens_NNP ,_, executive_JJ director_NN of_IN the_DT Milken_NNP Institute_NNP Center_NNP for_IN Strategic_NNP Philanthropy_NNP ,_, which_WDT advises_VBZ families_NNS ,_, foundations_NNS and_CC individual_JJ philanthropists_NNS ._. Charitable_JJ dollars_NNS can_MD play_VB a_DT critical_JJ role_NN in_IN closing_VBG the_DT gap_NN between_IN the_DT original_JJ research_NN project_NN and_CC delivering_VBG a_DT vaccine_NN to_IN the_DT public_NN ,_, perhaps_RB 10_CD -_SYM 15_CD years_NNS later_RBR ._. Donors_NNS fund_VBP the_DT earlier_JJR ,_, riskier_JJR stages_NNS in_IN the_DT journey_NN of_IN vaccines_NNS from_IN academia_NN ,_, government_NN labs_NNS and_CC entrepreneurial_JJ biotech_NN firms_NNS to_IN pre-clinical_JJ trials_NNS and_CC ensuring_VBG they_PRP meet_VBP the_DT regulatory_JJ standards_NNS needed_VBN to_TO enter_VB clinical_JJ trials_NNS ._. “_`` That_DT ’s_VBZ where_WRB philanthropy_NN can_MD have_VB an_DT outsized_JJ impact_NN ,_, ”_'' says_VBZ Stevens_NNP ._. British_JJ philanthropist_NN Richard_NNP Ross_NNP agrees_VBZ ._. He_PRP chairs_VBZ Rosetrees_NNP Trust_NNP ,_, a_DT fund_NN specialising_VBG in_IN medical_JJ research_NN established_VBN by_IN his_PRP$ late_JJ entrepreneur_NN parents_NNS ,_, which_WDT has_VBZ distributed_VBN nearly_RB £_$ 50_CD m_CD since_IN its_PRP$ foundation_NN in_IN 1987_CD ._. “_`` A_DT lot_NN of_IN [_-LRB- early_JJ research_NN ]_-RRB- is_VBZ basic_JJ science_NN ,_, which_WDT can_MD be_VB 30_CD years_NNS away_RB from_IN practical_JJ application_NN in_IN medicine_NN ,_, ”_'' he_PRP says_VBZ ._. “_`` People_NNS come_VBP and_CC say_VBP I_PRP ca_MD n’t_RB get_VB grant_NN money_NN because_IN I_PRP have_VBP no_DT data_NNS ._. We_PRP can_MD make_VB a_DT difference_NN with_IN one_CD year_NN ’s_POS money_NN or_CC three_CD years_NNS ’_POS money_NN ._. That_DT ’s_VBZ an_DT entrepreneurial_JJ approach_NN ._. ”_'' Rosetrees_NNP ,_, which_WDT has_VBZ set_VBN aside_RP money_NN for_IN Covid_NNP -_HYPH 19_CD research_NN ,_, is_VBZ considering_VBG about_RB 10_CD projects_NNS ,_, including_VBG one_CD involving_VBG a_DT drug_NN used_VBN for_IN brain_NN tumours_NNS and_CC another_DT an_DT existing_VBG tuberculosis_NN vaccine_NN ._. Philanthropists_NNS can_MD also_RB fund_VB vaccine_NN -_HYPH linked_VBN education_NN ._. “_`` You_PRP see_VBP a_DT growing_VBG anti-vaccination_NN movement_NN based_VBN in_IN ignorance_NN ,_, ”_'' says_VBZ Amir_NNP Pasic_NNP ,_, dean_NN of_IN Indiana_NNP University_NNP ’s_POS Lilly_NNP Family_NNP School_NNP of_IN Philanthropy_NNP ._. “_`` You_PRP ca_MD n’t_RB overestimate_VB the_DT importance_NN of_IN education_NN ,_, and_CC I_PRP think_VBP we_PRP ’ll_MD see_VB more_JJR of_IN that_DT ._. ”_'' While_IN philanthropists_NNS financed_VBD vaccine_NN research_NN long_RB before_IN Covid_NNP -_HYPH 19_CD came_VBD along_RB ,_, the_DT pandemic_NN has_VBZ sparked_VBN a_DT wave_NN of_IN interest_NN among_IN potential_JJ new_JJ donors_NNS ._. Eric_NNP Kessler_NNP ,_, founder_NN ,_, principal_NN and_CC senior_JJ managing_NN director_NN at_IN Arabella_NNP Advisors_NNPS ,_, a_DT US_NNP -_HYPH based_VBN philanthropic_JJ consultancy_NN ,_, says_VBZ :_: “_`` Donors_NNS who_WP have_VBP historically_RB focused_VBN on_IN global_JJ health_NN are_VBP tripling_VBG down_RP right_RB now_RB ,_, and_CC many_JJ donors_NNS who_WP ’ve_VBP never_RB focused_VBN on_IN global_JJ health_NN are_VBP getting_VBG into_IN the_DT fray_NN for_IN the_DT first_JJ time_NN ._. It_PRP ’s_VBZ hard_JJ to_TO know_VB how_WRB much_JJ is_VBZ going_VBG specifically_RB into_IN vaccine_NN research_NN ,_, but_CC we_PRP can_MD say_VB it_PRP ’s_VBZ significant_JJ ._. ”_'' Kasey_NNP Oliver_NNP ,_, a_DT director_NN in_IN the_DT consulting_NN practice_NN at_IN philanthropic_JJ advisory_NN company_NN Geneva_NNP Global_NNP ,_, says_VBZ that_IN as_RB well_RB as_IN reacting_VBG to_IN an_DT event_NN such_JJ as_IN the_DT Covid_NNP -_HYPH 19_CD pandemic_NN ,_, donors_NNS can_MD be_VB motivated_VBN by_IN anything_NN from_IN wanting_VBG to_TO help_VB eradicate_VB a_DT disease_NN that_WDT has_VBZ killed_VBN a_DT family_NN member_NN to_IN wishing_VBG to_TO bet_VB on_IN something_NN that_WDT could_MD bring_VB long_JJ -_HYPH term_NN change_NN ._. However_RB ,_, participating_VBG in_IN vaccine_NN research_NN as_IN a_DT philanthropist_NN is_VBZ not_RB easy_JJ ._. First_RB ,_, it_PRP involves_VBZ complex_JJ and_CC emerging_VBG science_NN and_CC so_RB means_VBZ relying_VBG on_IN experts_NNS ._. “_`` You_PRP need_VBP to_TO be_VB willing_JJ and_CC able_JJ to_TO be_VB flexible_JJ and_CC a_DT little_JJ hands_NNS -_HYPH off_RB ,_, ”_'' says_VBZ Stevens_NNP ._. “_`` And_CC not_RB everyone_NN goes_VBZ into_IN their_PRP$ philanthropy_NN with_IN that_DT type_NN of_IN mindset_NN ._. ”_'' And_CC because_IN it_PRP requires_VBZ the_DT involvement_NN of_IN the_DT private_JJ sector_NN ,_, particularly_RB in_IN manufacturing_NN and_CC distribution_NN ,_, donors_NNS may_MD face_VB obstacles_NNS in_IN ensuring_VBG that_IN any_DT successful_JJ vaccine_NN can_MD be_VB sold_VBN cheaply_RB enough_RB to_TO benefit_VB poor_JJ communities_NNS ._. To_TO address_VB this_DT ,_, in_IN 2003_CD the_DT Gates_NNP Foundation_NNP developed_VBD its_PRP$ Global_JJ Access_NN model_NN for_IN grant_NN contracts_NNS ._. This_DT stipulates_VBZ that_IN companies_NNS or_CC universities_NNS that_WDT receive_VBP its_PRP$ funding_NN must_MD make_VB the_DT resulting_VBG treatments_NNS widely_RB available_JJ at_IN affordable_JJ prices_NNS ._. They_PRP are_VBP also_RB required_VBN to_TO share_VB data_NNS ._. Another_DT challenge_NN for_IN individual_JJ philanthropists_NNS without_IN the_DT resources_NNS of_IN billionaire_NN donors_NNS is_VBZ the_DT sheer_JJ amount_NN of_IN money_NN required_VBN for_IN vaccine_NN development_NN ._. This_DT was_VBD among_IN the_DT reasons_NNS behind_IN a_DT new_JJ collaborative_JJ fund_NN ,_, which_WDT was_VBD launched_VBN in_IN January_NNP to_TO accelerate_VB the_DT development_NN of_IN vaccines_NNS against_IN emerging_VBG diseases_NNS ._. With_IN an_DT initial_JJ investment_NN of_IN $_$ 460_CD m_CD from_IN the_DT German_JJ ,_, Japanese_JJ and_CC Norwegian_JJ governments_NNS ,_, the_DT Gates_NNP Foundation_NNP and_CC the_DT UK_NNP ’s_POS Wellcome_NNP Trust_NNP ,_, the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS acts_VBZ as_IN a_DT hub_NN to_IN which_WDT any_DT philanthropist_NN can_MD contribute_VB ._. The_DT group_NN has_VBZ issued_VBN an_DT urgent_JJ call_NN for_IN $_$ 2bn_CD to_TO develop_VB a_DT Covid_NNP -_HYPH 19_CD vaccine_NN ._. Another_DT way_NN for_IN a_DT philanthropist_NN with_IN less_JJR money_NN than_IN Gates_NNPS to_TO help_VB is_VBZ to_TO create_VB a_DT prize_NN to_TO stimulate_VB academic_JJ competition_NN ._. American_JJ philanthropists_NNS Gary_NNP and_CC Alya_NNP Michelson_NNP have_VBP done_VBN just_RB that_DT through_IN the_DT Michelson_NNP Prizes_NNPS ._. Their_PRP$ annual_JJ awards_NNS go_VBP to_IN young_JJ scientists_NNS —_: each_DT winner_NN receiving_VBG $_$ 150,000_CD —_: who_WP are_VBP working_VBG in_IN new_JJ ways_NNS on_IN human_JJ immunology_NN ,_, vaccine_NN discovery_NN ,_, and_CC immunotherapy_NN research_NN in_IN major_JJ global_JJ diseases_NNS ._. At_IN least_JJS with_IN prizes_NNS ,_, the_DT donors_NNS ’_POS names_NNS can_MD be_VB recognised_VBN ._. Otherwise_RB ,_, unlike_IN with_IN gifts_NNS to_IN an_DT opera_NN house_NN or_CC university_NN building_NN ,_, or_CC even_RB the_DT endowment_NN of_IN an_DT academic_JJ post_NN or_CC a_DT scholarship_NN ,_, it_PRP is_VBZ hard_JJ to_TO attach_VB a_DT donor_NN ’s_POS name_NN to_IN long_JJ -_HYPH term_NN medical_JJ research_NN ._. “_`` Does_VBZ this_DT appeal_VB to_IN people_NNS who_WP want_VBP their_PRP$ name_NN on_IN the_DT wall_NN ?_. No_UH ,_, ”_'' says_VBZ Ross_NNP ._. Moreover_RB ,_, with_IN vaccine_NN projects_NNS ,_, as_IN with_IN most_JJS long_JJ term_NN medical_JJ research_NN ,_, there_EX is_VBZ the_DT likelihood_NN of_IN failure_NN ._. Few_JJ donors_NNS want_VBP to_TO fund_VB a_DT loser_NN ._. But_CC developing_VBG vaccines_NNS ,_, from_IN the_DT pre-clinical_JJ phase_NN to_IN production_NN ,_, typically_RB takes_VBZ more_JJR than_IN a_DT decade_NN and_CC has_VBZ just_RB a_DT 6_CD per_NN cent_NN probability_NN of_IN making_VBG it_PRP to_IN market_NN ,_, according_VBG to_IN a_DT 2013_CD study_NN led_VBN by_IN researchers_NNS at_IN Erasmus_NNP University_NNP in_IN the_DT Netherlands_NNPS ._. “_`` The_DT trouble_NN with_IN vaccines_NNS is_VBZ they_PRP ’re_VBP expensive_JJ ,_, ”_'' says_VBZ Peter_NNP Hotez_NNP ,_, co-director_NN of_IN the_DT Center_NNP for_IN Vaccine_NNP Development_NNP at_IN Texas_NNP Children_NNP ’s_POS Hospital_NNP ._. “_`` You_PRP need_VBP substantial_JJ funding_NN and_CC the_DT timelines_NNS are_VBP pretty_RB long_JJ —_: and_CC often_RB donors_NNS ,_, especially_RB the_DT more_RBR entrepreneurial_JJ donors_NNS ,_, want_VBP a_DT more_RBR immediate_JJ return_NN ._. That_DT ’s_VBZ the_DT toughest_JJS part_NN of_IN this_DT ._. ”_'' But_CC Maria_NNP Elena_NNP Bottazzi_NNP ,_, Hotez_NNP ’s_POS co-director_NN ,_, argues_VBZ that_IN even_RB when_WRB it_PRP results_VBZ in_IN failure_NN ,_, funding_NN vaccine_NN research_NN is_VBZ extremely_RB valuable_JJ ._. “_`` It_PRP ’s_VBZ transformative_JJ ,_, because_IN you_PRP are_VBP at_IN the_DT same_JJ time_NN building_VBG the_DT next_JJ generation_NN of_IN innovators_NNS and_CC scientists_NNS ,_, ”_'' she_PRP says_VBZ ._. And_CC ,_, as_IN the_DT coronavirus_NN pandemic_NN has_VBZ demonstrated_VBN ,_, success_NN can_MD have_VB a_DT social_JJ and_CC economic_JJ impact_NN that_WDT is_VBZ global_JJ ._. “_`` Where_WRB would_MD we_PRP be_VB right_RB now_RB if_IN we_PRP had_VBD a_DT vaccine_NN for_IN Covid_NNP -_HYPH 19_CD ?_. ”_'' says_VBZ Oliver_NNP ._. “_`` Vaccines_NNS are_VBP game_NN changers_NNS ._. They_PRP reshape_VBP the_DT world_NN —_: imagine_VB if_IN that_DT was_VBD part_NN of_IN your_PRP$ philanthropic_JJ legacy_NN ._. ”_''","VB the JJ to VB about every JJ NNP NN With JJ NN NNS , JJ NN and JJ NN NNS , NN NN VBZ RB for the JJ - JJ NN . But in a NN VBN by NN , JJ NNS VBP VBN aside JJ NNS and VBP VBG JJ NNS in the NN of VBG to the NN of the NN . NNP NN NNP NNP VBZ VBN JJR than $ 14 m for NN NN , while the NNP & NNP NNP NNP VBZ VBN up to $ 100 m to the JJ NN to NNP - 19 , VBG NN to VB the NN of NNS . RB the NNP NNP ’s NN VBZ in NN with the NNS RB VBG VBN by NNS and JJ NNS . In the NNP RB , the NNP NNPS of NNP , the JJ NN NNS , VBP VBN $ 1.8bn in JJ NN NN for NNP - 19 NN , VBG NN NNS . RB the JJ NNS NN NNP & NNP VBZ VBG $ 1bn into VBG a JJ NN NN , in a NN RB VBN by the NNP NN . But JJ NNS can RB VB a JJ NN . NN NNS VBP NNS VBP JJ from the NNS of NNS that RB VBP NNS and from the NNS NN that VBZ NNS ( RB if , as with NNP ’s NNP - 19 NN , NNS VBP a JJ NN VBZ NN - JJ ) . This can VB NNS to VB RB JJ NN NN and VB together JJ NNS of NNS , VBG NNS , NN NNS and JJ NNS . “ We can VB JJR NNS than NN or NN , ” VBZ NNP NNP , NN NN for JJ NN at NNP NNP , a NN and NN - VBG NN . “ They VBP NNS because of the NN NNS they VBP to VB to , whether NNS or NNS . RB NN can VB in the NNS . ” An NN VBZ NNP NNP , where the JJ NNS VBP NNP NNP and her NN and NNP NN NNP NNP . The NN VBZ NNS to NN NN NNS RB , JJ as a 2017 NN of JJR than $ 11 m to VB NN at the NNP of NNP ’s NNP for NNP NNP for the NN a JJ NN NN . NN VBZ RB JJ in NN NN because NN NNS VBP it JJ to VB a JJ NN on the JJ , JJ - NN NNS VBN . “ You VBP these JJ NN NNS , JJ of them in the NN NN , ” VBZ NNP NNP , JJ NN of the NNP & NNP NNP NNP , which since NN VBZ VBN JJR than $ 18bn to the NN , NN and NN of NNS . NNP VBZ NN , which despite VBG JJ for NNS of NNS of NNS a NN , RB VBZ no JJ NN . “ We VBP RB VB NN NNS in JJ NNS because we VBP JJ NN : if you VBP a JJ NN , you can VB NNS and you wo RB VB the NN , ” he VBZ . “ RB there VBZ RB an NN for the JJ NN to VB in the NNS of NNS that VBP VBN to VB a JJ NN . ” And while JJ JJ NNS VBD JJ in VBG an NNP NN , the NN — VBN RB to a JJ JJ NNS — VBD RB JJ RB for them to VB their NNS . “ In the NN they VBP NNS , and some of them VBD RB VBN by that , ” VBZ NNP . When NNS VBP VB , it VBZ to VB in the JJR NNS of NN NN , VBZ NNP NNP , JJ NN of the NNP NNP NNP for NNP NNP , which VBZ NNS , NNS and JJ NNS . JJ NNS can VB a JJ NN in VBG the NN between the JJ NN NN and VBG a NN to the NN , RB 10 - 15 NNS RBR . NNS VBP the JJR , JJR NNS in the NN of NNS from NN , NN NNS and JJ NN NNS to JJ NNS and VBG they VBP the JJ NNS VBN to VB JJ NNS . “ That VBZ where NN can VB an JJ NN , ” VBZ NNP . JJ NN NNP NNP VBZ . He VBZ NNP NNP , a NN VBG in JJ NN VBN by his JJ NN NNS , which VBZ VBN RB £ 50 m since its NN in 1987 . “ A NN of [ JJ NN ] VBZ JJ NN , which can VB 30 NNS RB from JJ NN in NN , ” he VBZ . “ NNS VBP and VBP I ca RB VB NN NN because I VBP no NNS . We can VB a NN with one NN ’s NN or three NNS ’ NN . That VBZ an JJ NN . ” NNP , which VBZ VBN aside NN for NNP - 19 NN , VBZ VBG RB 10 NNS , VBG one VBG a NN VBN for NN NNS and another an VBG NN NN . NNS can RB VB NN - VBN NN . “ You VBP a VBG NN NN VBN in NN , ” VBZ NNP NNP , NN of NNP NNP ’s NNP NNP NNP of NNP . “ You ca RB VB the NN of NN , and I VBP we ’ll VB JJR of that . ” While NNS VBD NN NN RB before NNP - 19 VBD RB , the NN VBZ VBN a NN of NN among JJ JJ NNS . NNP NNP , NN , NN and JJ NN NN at NNP NNPS , a NNP - VBN JJ NN , VBZ : “ NNS who VBP RB VBN on JJ NN VBP VBG down RB RB , and JJ NNS who VBP RB VBN on JJ NN VBP VBG into the NN for the JJ NN . It VBZ JJ to VB how JJ VBZ VBG RB into NN NN , but we can VB it VBZ JJ . ” NNP NNP , a NN in the NN NN at JJ NN NN NNP NNP , VBZ that RB RB as VBG to an NN JJ as the NNP - 19 NN , NNS can VB VBN by NN from VBG to VB VB a NN that VBZ VBN a NN NN to VBG to VB on NN that could VB JJ - NN NN . RB , VBG in NN NN as a NN VBZ RB JJ . RB , it VBZ JJ and VBG NN and RB VBZ VBG on NNS . “ You VBP to VB JJ and JJ to VB JJ and a JJ NNS - RB , ” VBZ NNP . “ And RB NN VBZ into their NN with that NN of NN . ” And because it VBZ the NN of the JJ NN , RB in NN and NN , NNS may VB NNS in VBG that any JJ NN can VB VBN RB RB to VB JJ NNS . To VB this , in 2003 the NNP NNP VBD its JJ NN NN for NN NNS . This VBZ that NNS or NNS that VBP its NN must VB the VBG NNS RB JJ at JJ NNS . They VBP RB VBN to VB NNS . Another NN for JJ NNS without the NNS of NN NNS VBZ the JJ NN of NN VBN for NN NN . This VBD among the NNS behind a JJ JJ NN , which VBD VBN in NNP to VB the NN of NNS against VBG NNS . With an JJ NN of $ 460 m from the JJ , JJ and JJ NNS , the NNP NNP and the NNP ’s NNP NNP , the NNP for NNP NNP NNPS VBZ as a NN to which any NN can VB . The NN VBZ VBN an JJ NN for $ 2bn to VB a NNP - 19 NN . Another NN for a NN with JJR NN than NNPS to VB VBZ to VB a NN to VB JJ NN . JJ NNS NNP and NNP NNP VBP VBN RB that through the NNP NNPS . Their JJ NNS VBP to JJ NNS — each NN VBG $ 150,000 — who VBP VBG in JJ NNS on JJ NN , NN NN , and NN NN in JJ JJ NNS . At JJS with NNS , the NNS ’ NNS can VB VBN . RB , unlike with NNS to an NN NN or NN NN , or RB the NN of an JJ NN or a NN , it VBZ JJ to VB a NN ’s NN to JJ - NN JJ NN . “ VBZ this VB to NNS who VBP their NN on the NN ? No , ” VBZ NNP . RB , with NN NNS , as with JJS JJ NN JJ NN , there VBZ the NN of NN . JJ NNS VBP to VB a NN . But VBG NNS , from the JJ NN to NN , RB VBZ JJR than a NN and VBZ RB a 6 NN NN NN of VBG it to NN , VBG to a 2013 NN VBN by NNS at NNP NNP in the NNPS . “ The NN with NNS VBZ they VBP JJ , ” VBZ NNP NNP , NN of the NNP for NNP NNP at NNP NNP ’s NNP . “ You VBP JJ NN and the NNS VBP RB JJ — and RB NNS , RB the RBR JJ NNS , VBP a RBR JJ NN . That VBZ the JJS NN of this . ” But NNP NNP NNP , NNP ’s NN , VBZ that RB when it VBZ in NN , NN NN NN VBZ RB JJ . “ It VBZ JJ , because you VBP at the JJ NN VBG the JJ NN of NNS and NNS , ” she VBZ . And , as the NN NN VBZ VBN , NN can VB a JJ and JJ NN that VBZ JJ . “ Where would we VB RB RB if we VBD a NN for NNP - 19 ? ” VBZ NNP . “ NNS VBP NN NNS . They VBP the NN — VB if that VBD NN of your JJ NN . ”"
36,889,mainstream,M0b01e,vaccine.autism,"There_EX may_MD be_VB no_DT force_NN on_IN earth_NN more_RBR powerful_JJ than_IN the_DT protective_JJ instincts_NNS of_IN a_DT parent_NN ._. It_PRP can_MD overcome_VB almost_RB any_DT obstacle_NN for_IN good_JJ or_CC ill_JJ –_: including_VBG logical_JJ thought_NN and_CC rational_JJ argument_NN ._. The_DT Conspiracy_NNP Files_NNS :_: Vaccine_NNP Wars_NNPS (_-LRB- BBC_NNP Two_CD )_-RRB- exposed_VBD this_DT phenomenon_NN at_IN its_PRP$ most_RBS dangerous_JJ ,_, forensically_RB pulling_VBG apart_RB the_DT anti-vaxxer_JJ movement_NN with_IN widely_RB discredited_VBN concepts_NNS such_JJ as_IN “_`` facts_NNS ”_'' and_CC “_`` experts_NNS ”_'' until_IN there_EX was_VBD nothing_NN left_VBN but_CC opportunists_NNS ,_, cranks_NNS and_CC social_JJ -_HYPH media_NN bots_NNS using_VBG it_PRP to_TO attack_VB Big_NNP Government_NNP and_CC Big_NNP Pharma_NNP ._. Caught_VBN in_IN the_DT crossfire_NN :_: angry_JJ ,_, grief_NN -_HYPH stricken_JJ mothers_NNS and_CC fathers_NNS trying_VBG to_TO come_VB to_IN terms_NNS with_IN their_PRP$ son_NN or_CC daughter_NN ’s_POS condition_NN ._. This_DT was_VBD a_DT battle_NN of_IN evidence_NN against_IN emotion_NN ,_, with_IN no_DT winners_NNS ._. Victoria_NNP James_NNP ’s_POS excellent_JJ film_NN painted_VBD a_DT detailed_JJ picture_NN of_IN a_DT conspiracy_NN metastasising_VBG in_IN the_DT Fake_NNP News_NNP era_NN ._. She_PRP interviewed_VBD people_NNS from_IN all_DT sides_NNS of_IN the_DT debate_NN ,_, from_IN concerned_JJ scientists_NNS and_CC government_NN officials_NNS to_IN parents_NNS and_CC leaders_NNS of_IN movements_NNS who_WP allege_VBP links_NNS between_IN childhood_NN vaccinations_NNS and_CC traumatic_JJ conditions_NNS such_JJ as_IN autism_NN ._. That_IN these_DT parents_NNS had_VBD suffered_VBN dreadfully_RB was_VBD not_RB disputed_VBN ,_, but_CC a_DT patchwork_NN of_IN anecdotal_JJ tragedies_NNS could_MD never_RB represent_VB irrefutable_JJ proof_NN ._. Their_PRP$ stance_NN ,_, at_IN least_JJS ,_, was_VBD defensible_JJ ._. Far_RB worse_JJR were_VBD the_DT likes_NNS of_IN the_DT disgraced_VBN and_CC disbarred_VBN doctor_NN Andrew_NNP Wakefield_NNP ,_, a_DT regular_NN on_IN InfoWars_NNP and_CC producer_NN of_IN the_DT derided_VBN ,_, sensationalist_JJ “_`` documentary_NN ”_'' Vaxxed_NNP ._.","There may VB no NN on NN RBR JJ than the JJ NNS of a NN . It can VB RB any NN for JJ or JJ – VBG JJ NN and JJ NN . The NNP NNS : NNP NNPS ( NNP Two ) VBD this NN at its RBS JJ , RB VBG RB the JJ NN with RB VBN NNS JJ as “ NNS ” and “ NNS ” until there VBD NN VBN but NNS , NNS and JJ - NN NNS VBG it to VB NNP NNP and NNP NNP . VBN in the NN : JJ , NN - JJ NNS and NNS VBG to VB to NNS with their NN or NN ’s NN . This VBD a NN of NN against NN , with no NNS . NNP NNP ’s JJ NN VBD a JJ NN of a NN VBG in the NNP NNP NN . She VBD NNS from all NNS of the NN , from JJ NNS and NN NNS to NNS and NNS of NNS who VBP NNS between NN NNS and JJ NNS JJ as NN . That these NNS VBD VBN RB VBD RB VBN , but a NN of JJ NNS could RB VB JJ NN . Their NN , at JJS , VBD JJ . RB JJR VBD the NNS of the VBN and VBN NN NNP NNP , a NN on NNP and NN of the VBN , JJ “ NN ” NNP ."
37,890,mainstream,M0bba2,vaccine.covid,"When_WRB could_MD a_DT COVID_NNP -_HYPH 19_CD vaccine_NN be_VB ready_JJ ?_. Top_JJ health_NN officials_NNS say_VBP the_DT end_NN of_IN this_DT year_NN would_MD be_VB a_DT best_JJS case_NN scenario_NN ._. But_CC scientists_NNS have_VBP never_RB created_VBN a_DT vaccine_NN so_RB quickly_RB ,_, and_CC there_EX ’s_VBZ no_DT guarantee_NN any_DT under_IN development_NN will_MD ultimately_RB work_VB ._. Worldwide_RB ,_, testing_NN recently_RB started_VBN or_CC is_VBZ about_RB to_TO start_VB for_IN about_RB a_DT dozen_CD potential_JJ vaccines_NNS ._. The_DT most_RBS promising_JJ vaccine_NN candidates_NNS are_VBP expected_VBN to_TO move_VB into_IN larger_JJR tests_NNS this_DT summer_NN ._. How_WRB quickly_RB those_DT studies_NNS can_MD determine_VB whether_IN the_DT vaccines_NNS are_VBP safe_JJ and_CC effective_JJ depends_VBZ in_IN part_NN on_IN how_WRB widely_RB the_DT coronavirus_NN is_VBZ still_RB spreading_VBG ._. The_DT studies_NNS will_MD need_VB to_TO enroll_VB 20,000_CD people_NNS or_CC more_JJR for_IN each_DT vaccine_NN candidate_NN ,_, with_IN half_NN of_IN them_PRP getting_VBG the_DT real_JJ vaccine_NN and_CC the_DT rest_NN getting_VBG a_DT dummy_NN shot_NN ._. Then_RB it_PRP ’s_VBZ a_DT matter_NN of_IN waiting_VBG to_TO see_VB how_WRB many_JJ in_IN each_DT group_NN become_VBP infected_VBN with_IN the_DT virus_NN ._. Answers_NNS will_MD come_VB faster_RBR if_IN volunteers_NNS are_VBP recruited_VBN in_IN places_NNS where_WRB outbreaks_NNS are_VBP worsening_VBG ,_, a_DT trend_NN that_WDT can_MD be_VB hard_JJ to_TO predict_VB ._. One_CD way_NN to_TO speed_VB up_RP distribution_NN is_VBZ to_TO start_VB manufacturing_NN doses_NNS before_IN test_NN results_NNS are_VBP in_IN ._. But_CC it_PRP ’s_VBZ a_DT gamble_NN that_WDT could_MD mean_VB throwing_VBG away_RB tons_NNS of_IN vaccines_NNS that_WDT fail_VBP ._. The_DT AP_NN is_VBZ answering_VBG your_PRP$ questions_NNS about_IN the_DT coronavirus_NN in_IN this_DT series_NN ._. Submit_VB them_PRP at_IN :_: FactCheck@AP.org_NNP ._.","When could a NNP - 19 NN VB JJ ? JJ NN NNS VBP the NN of this NN would VB a JJS NN NN . But NNS VBP RB VBN a NN RB RB , and there VBZ no NN any under NN will RB VB . RB , NN RB VBN or VBZ RB to VB for RB a dozen JJ NNS . The RBS JJ NN NNS VBP VBN to VB into JJR NNS this NN . How RB those NNS can VB whether the NNS VBP JJ and JJ VBZ in NN on how RB the NN VBZ RB VBG . The NNS will VB to VB 20,000 NNS or JJR for each NN NN , with NN of them VBG the JJ NN and the NN VBG a NN NN . RB it VBZ a NN of VBG to VB how JJ in each NN VBP VBN with the NN . NNS will VB RBR if NNS VBP VBN in NNS where NNS VBP VBG , a NN that can VB JJ to VB . One NN to VB up NN VBZ to VB NN NNS before NN NNS VBP in . But it VBZ a NN that could VB VBG RB NNS of NNS that VBP . The NN VBZ VBG your NNS about the NN in this NN . VB them at : NNP ."
38,727,conspiracy,C0076b,new.world.order; vaccine.autism,"CDC_NNP whistleblower_NN :_: “_`` We_PRP were_VBD ordered_VBN to_TO cover_VB up_RP vaccine_NN -_HYPH autism_NN link_NN ”_'' (_-LRB- VIDEO_NN )_-RRB- This_DT video_NN contains_VBZ an_DT extraordinary_JJ conversation_NN for_IN extraordinary_JJ times_NNS ._. Biblical_JJ times_NNS ,_, really_RB ._. When_WRB the_DT lie_NN becomes_VBZ the_DT truth_NN and_CC the_DT truth_NN becomes_VBZ a_DT lie_NN ._. These_DT days_NNS ,_, lying_NN is_VBZ not_RB just_RB okey_JJ dokey_NN ,_, nor_CC is_VBZ it_PRP an_DT occasional_JJ little_JJ white_JJ one_NN –_: there_EX ’s_VBZ no_DT such_JJ thing_NN ._. It_PRP is_VBZ not_RB merely_RB the_DT flavor_NN for_IN the_DT month_NN ._. It_PRP is_VBZ all_DT of_IN the_DT above_JJ ,_, and_CC so_RB much_RB more_JJR ._. It_PRP ’s_VBZ the_DT new_JJ American_JJ tradition_NN ._. Now_RB it_PRP ’s_VBZ politically_RB correct_JJ to_TO remove_VB Native_JJ American_JJ names_NNS from_IN sports_NNS teams_NNS ._. Do_VB n’t_RB talk_VB about_IN small_JJ pox_NN blankets_NNS and_CC decimating_VBG buffalo_NNP from_IN the_DT windows_NNS of_IN steam_NN engine_NN trains_NNS ._. Just_RB remove_VB a_DT word_NN ,_, no_DT worries_NNS ._. No_DT harm_NN done_VBN ._. Withholding_VBG evidence_NN is_VBZ also_RB a_DT lie_NN ._. Change_VB the_DT message_NN ,_, bury_VB the_DT truth_NN ._. Like_IN around_RB fourteen_CD years_NNS ago_RB ,_, when_WRB men_NNS and_CC women_NNS destroyed_VBD the_DT evidence_NN of_IN Merck_NNP ’s_POS MMR_NNP vaccine_NN showing_VBG a_DT causal_JJ relationship_NN with_IN autism_NN ,_, with_IN increased_VBN risk_NN reserved_VBN for_IN African_JJ American_JJ male_JJ children_NNS ._. Corrupted_VBN souls_NNS filled_VBN with_IN fraud_NN ,_, deception_NN ,_, flat_JJ out_RP lying_VBG to_IN Congress_NNP and_CC themselves_PRP did_VBD not_RB have_VB the_DT mindset_NN of_IN “_`` do_VB no_DT harm_NN ._. ”_'' CDC_NNP scientists_NNS destroyed_VBD the_DT proof_NN that_IN children_NNS injected_VBN with_IN the_DT MMR_NNP vaccine_NN could_MD very_RB well_RB have_VB a_DT full_JJ cognitive_JJ life_NN taken_VBN from_IN them_PRP via_IN autism_NN ._. If_IN truth_NN were_VBD told_VBN ,_, their_PRP$ profits_NNS and_CC brotherhood_NN would_MD suffer_VB ,_, so_RB ,_, no_DT worries_NNS ,_, just_RB destroy_VB the_DT evidence_NN and_CC go_VB on_IN your_PRP$ merry_JJ way_NN ._. Change_VB a_DT word_NN or_CC two_CD ._. Allow_VB another_DT slaughter_NN of_IN the_DT innocent_NN begin_VB ._. And_CC when_WRB the_DT truth_NN starts_VBZ to_TO trickle_VB out_RP it_PRP is_VBZ ignored_VBN ,_, suppressed_VBN or_CC mocked_VBN ._. But_CC the_DT truth_NN can_MD not_RB be_VB contained_VBN ._. Here_RB ’s_VBZ an_DT except_IN from_IN the_DT Dr._NNP Andrew_NNP Wakefield_NNP ’s_POS interview_NN with_IN Alex_NNP Jones_NNP :_: Mother_NNP Nature_NNP 's_POS micronutrient_NN secret_NN :_: Organic_NNP Broccoli_NNP Sprout_NNP Capsules_NNPS now_RB available_JJ ,_, delivering_VBG 280_CD mg_NNS of_IN high_JJ -_HYPH density_NN nutrition_NN ,_, including_VBG the_DT extraordinary_JJ ""_`` sulforaphane_NN ""_'' and_CC ""_`` glucosinolate_NN ""_'' nutrients_NNS found_VBN only_RB in_IN cruciferous_JJ healing_NN foods_NNS ._. Every_DT lot_NN laboratory_NN tested_VBN ._. See_VB availability_NN here_RB ._. “_`` I_PRP ’m_VBP twenty_CD years_NNS into_IN this_DT battle_NN ,_, and_CC it_PRP could_MD have_VB continued_VBN the_DT way_NN it_PRP was_VBD going_VBG ,_, until_IN one_CD man_NN stepped_VBD forward_RB ,_, [_-LRB- William_NNP Thompson_NNP ]_-RRB- a_DT senior_JJ scientist_NN ,_, a_DT CDC_NNP insider_NN saying_VBG ,_, “_`` I_PRP was_VBD in_IN charge_NN of_IN a_DT study_NN where_WRB we_PRP tested_VBD a_DT hypotheses_NNS and_CC we_PRP found_VBD the_DT MMR_NNP vaccination_NN was_VBD causally_RB associated_VBN with_IN autism_NN and_CC we_PRP hid_VBD the_DT findings_NNS ._. We_PRP hid_VBD it_PRP for_IN fourteen_CD years_NNS and_CC we_PRP have_VBP know_VBN for_IN fourteen_CD years_NNS that_IN this_DT vaccine_NN is_VBZ causally_RB associated_VBN with_IN autism_NN and_CC we_PRP have_VBP concealed_VBN it_PRP ._. We_PRP ’ve_VBP put_VBN millions_NNS of_IN Americas_NNPS children_NNS in_IN harms_NNS way_NN and_CC I_PRP can_MD live_VB with_IN that_DT no_RB longer_RBR ._. ”_'' It_PRP ’s_VBZ a_DT note_NN of_IN hope_NN that_IN a_DT man_NN no_RB longer_RBR can_MD live_VB with_IN his_PRP$ lie_NN ._. So_RB he_PRP turns_VBZ away_RB and_CC walks_VBZ a_DT new_JJ direction_NN ._. That_DT ’s_VBZ called_VBN repentance_NN ._. America_NNP must_MD follow_VB suite_NN ._. You_PRP must_MD see_VB the_DT movie_NN VAXXED_NNP and_CC spread_VB the_DT truth_NN Andrew_NNP Wakefield_NNP ,_, made_VBD the_DT film_NN featuring_VBG William_NNP Thompson_NNP ,_, a_DT former_JJ CDC_NNP senior_JJ scientist_NN turned_VBN whistleblower_NN ._. Thompson_NNP has_VBZ provided_VBN the_DT world_NN 100_CD %_NN proof_NN that_IN even_RB the_DT then_RB top_JJ dog_NN of_IN the_DT CDC_NNP ,_, Judy_NNP Gerberding_NNP ,_, M.D._NNP ,_, knew_VBD Merck_NNP ’s_POS MMR_NNP vaccine_NN would_MD harm_VB children_NNS ._. Back_RB in_IN 2004_CD ,_, Ms._NNP Gerberding_NNP was_VBD too_RB busy_JJ vying_VBG for_IN her_PRP$ new_JJ revolving_VBG door_NN job_NN as_IN President_NNP of_IN the_DT Vaccine_NNP Division_NNP of_IN Merck_NNP ._. Call_VB those_DT revolving_NN doors_NNS kickbacks_NNS ,_, bribery_NN or_CC sociopathic_JJ fascism_NN ,_, whatever_WDT the_DT monogram_NN ,_, autism_NN has_VBZ skyrocketed_VBN ,_, parents_NNS are_VBP grieving_VBG and_CC our_PRP$ nation_NN is_VBZ killing_VBG it_PRP ’s_VBZ young_JJ ,_, not_RB just_RB the_DT 60_CD million_CD in_IN the_DT womb_NN ,_, but_CC the_DT infants_NNS who_WP are_VBP born_VBN healthy_JJ ,_, have_VBP a_DT vaccination_NN and_CC never_RB speak_VBP again_RB ._. Lying_NN has_VBZ taken_VBN on_RP a_DT life_NN of_IN its_PRP$ own_JJ ._. America_NNP ,_, Lies_NNS are_VBP U.S_NNP ._. It_PRP ’s_VBZ imperative_JJ to_TO share_VB this_DT interview_NN ._. Another_DT part_NN of_IN the_DT discussion_NN mentions_VBZ neonatal_JJ nurses_NNS who_WP have_VBP been_VBN tasked_VBN with_IN giving_VBG underweight_JJ infants_NNS vaccinations_NNS ._. And_CC when_WRB that_DT happens_VBZ ,_, these_DT children_NNS die_VBP ._. The_DT proof_NN ,_, and_CC the_DT truth_NN about_IN food_NN ,_, fluoride_NN ,_, Big_NNP Pharma_NNP ,_, Fukushima_NNP ,_, birth_NN certificate_NN bond_NN trust_NN documents_NNS ,_, banking_NN and_CC the_DT march_NN toward_IN NWO_NNP is_VBZ out_RB there_RB ._. Find_VB it_PRP and_CC be_VB set_VBN free_JJ ._.","NNP NN : “ We VBD VBN to VB up NN - NN NN ” ( NN ) This NN VBZ an JJ NN for JJ NNS . JJ NNS , RB . When the NN VBZ the NN and the NN VBZ a NN . These NNS , NN VBZ RB RB JJ NN , nor VBZ it an JJ JJ JJ NN – there VBZ no JJ NN . It VBZ RB RB the NN for the NN . It VBZ all of the JJ , and RB RB JJR . It VBZ the JJ JJ NN . RB it VBZ RB JJ to VB JJ JJ NNS from NNS NNS . VB RB VB about JJ NN NNS and VBG NNP from the NNS of NN NN NNS . RB VB a NN , no NNS . No NN VBN . VBG NN VBZ RB a NN . VB the NN , VB the NN . Like RB fourteen NNS RB , when NNS and NNS VBD the NN of NNP ’s NNP NN VBG a JJ NN with NN , with VBN NN VBN for JJ JJ JJ NNS . VBN NNS VBN with NN , NN , JJ out VBG to NNP and themselves VBD RB VB the NN of “ VB no NN . ” NNP NNS VBD the NN that NNS VBN with the NNP NN could RB RB VB a JJ JJ NN VBN from them via NN . If NN VBD VBN , their NNS and NN would VB , RB , no NNS , RB VB the NN and VB on your JJ NN . VB a NN or two . VB another NN of the NN VB . And when the NN VBZ to VB out it VBZ VBN , VBN or VBN . But the NN can RB VB VBN . RB VBZ an except from the NNP NNP NNP ’s NN with NNP NNP : NNP NNP 's NN NN : NNP NNP NNP NNPS RB JJ , VBG 280 NNS of JJ - NN NN , VBG the JJ "" NN "" and "" NN "" NNS VBN RB in JJ NN NNS . Every NN NN VBN . VB NN RB . “ I VBP twenty NNS into this NN , and it could VB VBN the NN it VBD VBG , until one NN VBD RB , [ NNP NNP ] a JJ NN , a NNP NN VBG , “ I VBD in NN of a NN where we VBD a NNS and we VBD the NNP NN VBD RB VBN with NN and we VBD the NNS . We VBD it for fourteen NNS and we VBP VBN for fourteen NNS that this NN VBZ RB VBN with NN and we VBP VBN it . We VBP VBN NNS of NNPS NNS in NNS NN and I can VB with that RB RBR . ” It VBZ a NN of NN that a NN RB RBR can VB with his NN . RB he VBZ RB and VBZ a JJ NN . That VBZ VBN NN . NNP must VB NN . You must VB the NN NNP and VB the NN NNP NNP , VBD the NN VBG NNP NNP , a JJ NNP JJ NN VBN NN . NNP VBZ VBN the NN 100 NN NN that RB the RB JJ NN of the NNP , NNP NNP , NNP , VBD NNP ’s NNP NN would VB NNS . RB in 2004 , NNP NNP VBD RB JJ VBG for her JJ VBG NN NN as NNP of the NNP NNP of NNP . VB those NN NNS NNS , NN or JJ NN , whatever the NN , NN VBZ VBN , NNS VBP VBG and our NN VBZ VBG it VBZ JJ , RB RB the 60 million in the NN , but the NNS who VBP VBN JJ , VBP a NN and RB VBP RB . NN VBZ VBN on a NN of its JJ . NNP , NNS VBP NNP . It VBZ JJ to VB this NN . Another NN of the NN VBZ JJ NNS who VBP VBN VBN with VBG JJ NNS NNS . And when that VBZ , these NNS VBP . The NN , and the NN about NN , NN , NNP NNP , NNP , NN NN NN NN NNS , NN and the NN toward NNP VBZ RB RB . VB it and VB VBN JJ ."
39,464,mainstream,M0b7d7,vaccine.autism,"Mercury_NN from_IN vaccines_NNS seems_VBZ to_TO disappear_VB rapidly_RB from_IN the_DT blood_NN ,_, returning_VBG to_IN pre-vaccination_NN levels_NNS in_IN one_CD month_NN ,_, according_VBG to_IN a_DT small_JJ study_NN of_IN children_NNS in_IN Argentina_NNP ._. The_DT findings_NNS bolster_VBP the_DT argument_NN that_IN a_DT mercury_NN -_HYPH based_VBN vaccine_NN preservative_NN does_VBZ n't_RB cause_VB autism_NN in_IN children_NNS ,_, although_IN it_PRP 's_VBZ unclear_JJ from_IN the_DT study_NN whether_IN some_DT mercury_NN may_MD linger_VB elsewhere_RB in_IN the_DT body_NN ._. The_DT research_NN addresses_VBZ an_DT unanswered_JJ question_NN about_IN the_DT safety_NN of_IN thimerosal_NN ,_, a_DT preservative_NN that_WDT has_VBZ been_VBN eliminated_VBN from_IN routine_JJ U.S._NNP vaccines_NNS ,_, and_CC breaks_VBZ down_RP as_IN ethyl_JJ mercury_NN in_IN the_DT body_NN ._. It_PRP is_VBZ still_RB used_VBN in_IN other_JJ countries_NNS ,_, including_VBG Argentina_NNP ._. Scientists_NNS assumed_VBD the_DT health_NN risks_NNS from_IN ethyl_JJ mercury_NN were_VBD similar_JJ to_IN methyl_JJ mercury_NN from_IN eating_VBG fish_NN ._. And_CC in_IN 1999_CD ,_, the_DT federal_JJ government_NN and_CC vaccine_NN manufacturers_NNS agreed_VBD that_IN thimerosal_NN should_MD be_VB reduced_VBN or_CC eliminated_VBN in_IN vaccines_NNS to_TO lower_JJR exposure_NN to_IN mercury_NN from_IN all_DT sources_NNS ._. The_DT decision_NN was_VBD based_VBN on_IN what_WP was_VBD known_VBN about_IN methyl_JJ mercury_NN exposure_NN ._. The_DT new_JJ findings_NNS suggest_VBP that_IN methyl_NN mercury_NN and_CC ethyl_JJ mercury_NN are_VBP very_RB different_JJ and_CC that_IN the_DT removal_NN of_IN thimerosal_NN from_IN vaccines_NNS may_MD have_VB been_VBN over_RB -_HYPH cautious_JJ ._. ""_`` The_DT study_NN supports_VBZ the_DT decision_NN by_IN the_DT World_NNP Health_NNP Organization_NNP to_TO continue_VB to_TO permit_VB thimerosal_NN to_TO remain_VB in_IN vaccines_NNS for_IN the_DT world_NN 's_POS children_NNS ,_, ""_'' said_VBD study_NN co-author_NN Dr._NNP Michael_NNP Pichichero_NNP of_IN the_DT University_NNP of_IN Rochester_NNP in_IN Rochester_NNP ,_, N.Y_NNP ._. He_PRP said_VBD thimerosal_NN vaccines_NNS are_VBP cheaper_JJR to_TO produce_VB and_CC therefore_RB more_RBR accessible_JJ to_IN much_JJ of_IN the_DT world_NN ._. In_IN the_DT U.S._NNP -_HYPH funded_VBN study_NN ,_, blood_NN samples_NNS were_VBD taken_VBN from_IN 216_CD healthy_JJ babies_NNS before_RB and_CC after_IN they_PRP got_VBD vaccines_NNS containing_VBG the_DT preservative_JJ thimerosal_NN ._. Blood_NN levels_NNS of_IN mercury_NN were_VBD highest_JJS shortly_RB after_IN the_DT babies_NNS were_VBD vaccinated_VBN and_CC fell_VBD to_IN pre-vaccination_NN levels_NNS within_IN a_DT few_JJ weeks_NNS ._. ""_`` The_DT amount_NN found_VBN in_IN the_DT blood_NN was_VBD about_RB one_CD -_HYPH tenth_NN of_IN that_DT predicted_VBD in_IN that_DT the_DT late_JJ 1990s_NNS and_CC the_DT length_NN of_IN time_NN it_PRP stays_VBZ in_IN the_DT blood_NN is_VBZ one_CD -_HYPH tenth_NN of_IN that_DT predicted_VBN ,_, ""_'' Pichichero_NNP said_VBD ._. Mercury_NN levels_NNS also_RB were_VBD measured_VBN in_IN the_DT babies_NNS '_POS stools_NNS and_CC urine_NN ._. In_IN the_DT stool_NN samples_NNS ,_, the_DT levels_NNS were_VBD highest_JJS after_IN vaccination_NN and_CC also_RB fell_VBD ,_, but_CC more_RBR slowly_RB than_IN blood_NN levels_NNS ._. There_EX was_VBD no_DT significant_JJ amount_NN of_IN mercury_NN in_IN the_DT urine_NN ._. The_DT authors_NNS could_MD not_RB determine_VB what_WP happened_VBD to_IN all_PDT the_DT mercury_NN after_IN it_PRP left_VBD the_DT blood_NN ._. All_PDT the_DT infants_NNS gave_VBD samples_NNS twice_RB :_: before_IN vaccination_NN and_CC at_IN one_CD other_JJ time_NN ,_, ranging_VBG from_IN 12_CD hours_NNS later_RBR to_IN 30_CD days_NNS ._. The_DT study_NN will_MD be_VB published_VBN in_IN the_DT February_NNP issue_NN of_IN the_DT journal_NNP Pediatrics_NNP ._. The_DT medical_JJ journal_NN released_VBD the_DT findings_NNS early_RB because_IN of_IN a_DT controversy_NN surrounding_VBG a_DT new_JJ TV_NN series_NN premiering_VBG Thursday_NNP ,_, which_WDT features_VBZ a_DT lawyer_NN who_WP argues_VBZ in_IN court_NN that_IN a_DT flu_NN vaccine_NN made_VBD a_DT child_NN autistic_JJ ._. The_DT journal_NN is_VBZ published_VBN by_IN the_DT American_NNP Academy_NNP of_IN Pediatrics_NNP ,_, which_WDT on_IN Monday_NNP called_VBD on_IN ABC_NNP to_TO cancel_VB the_DT first_JJ episode_NN of_IN the_DT series_NN ,_, ""_`` Eli_NNP Stone_NNP ,_, ""_'' saying_VBG that_IN it_PRP perpetuates_VBZ the_DT myth_NN that_IN vaccines_NNS can_MD cause_VB autism_NN ._. Autism_NN is_VBZ a_DT complex_JJ disorder_NN featuring_VBG repetitive_JJ behaviors_NNS and_CC poor_JJ social_JJ interaction_NN and_CC communication_NN skills_NNS ._. Scientists_NNS generally_RB believe_VBP that_IN genetics_NN plays_VBZ a_DT role_NN in_IN causing_VBG the_DT disorder_NN ;_: a_DT theory_NN that_IN thimerosal_NN is_VBZ to_TO blame_VB has_VBZ been_VBN repeatedly_RB discounted_VBN in_IN scientific_JJ studies_NNS ._. Pichichero_NNP said_VBD he_PRP has_VBZ received_VBN research_NN grants_NNS and_CC served_VBN as_IN a_DT consultant_NN to_IN several_JJ vaccine_NN makers_NNS ,_, but_CC said_VBD there_EX was_VBD no_DT industry_NN involvement_NN in_IN the_DT new_JJ study_NN ._. He_PRP is_VBZ an_DT unpaid_JJ consultant_NN to_IN the_DT WHO_NN on_IN vaccines_NNS ._.","NN from NNS VBZ to VB RB from the NN , VBG to NN NNS in one NN , VBG to a JJ NN of NNS in NNP . The NNS VBP the NN that a NN - VBN NN NN VBZ RB VB NN in NNS , although it VBZ JJ from the NN whether some NN may VB RB in the NN . The NN VBZ an JJ NN about the NN of NN , a NN that VBZ VBN VBN from JJ NNP NNS , and VBZ down as JJ NN in the NN . It VBZ RB VBN in JJ NNS , VBG NNP . NNS VBD the NN NNS from JJ NN VBD JJ to JJ NN from VBG NN . And in 1999 , the JJ NN and NN NNS VBD that NN should VB VBN or VBN in NNS to JJR NN to NN from all NNS . The NN VBD VBN on what VBD VBN about JJ NN NN . The JJ NNS VBP that NN NN and JJ NN VBP RB JJ and that the NN of NN from NNS may VB VBN RB - JJ . "" The NN VBZ the NN by the NNP NNP NNP to VB to VB NN to VB in NNS for the NN 's NNS , "" VBD NN NN NNP NNP NNP of the NNP of NNP in NNP , NNP . He VBD NN NNS VBP JJR to VB and RB RBR JJ to JJ of the NN . In the NNP - VBN NN , NN NNS VBD VBN from 216 JJ NNS RB and after they VBD NNS VBG the JJ NN . NN NNS of NN VBD JJS RB after the NNS VBD VBN and VBD to NN NNS within a JJ NNS . "" The NN VBN in the NN VBD RB one - NN of that VBD in that the JJ NNS and the NN of NN it VBZ in the NN VBZ one - NN of that VBN , "" NNP VBD . NN NNS RB VBD VBN in the NNS ' NNS and NN . In the NN NNS , the NNS VBD JJS after NN and RB VBD , but RBR RB than NN NNS . There VBD no JJ NN of NN in the NN . The NNS could RB VB what VBD to all the NN after it VBD the NN . All the NNS VBD NNS RB : before NN and at one JJ NN , VBG from 12 NNS RBR to 30 NNS . The NN will VB VBN in the NNP NN of the NNP NNP . The JJ NN VBD the NNS RB because of a NN VBG a JJ NN NN VBG NNP , which VBZ a NN who VBZ in NN that a NN NN VBD a NN JJ . The NN VBZ VBN by the NNP NNP of NNP , which on NNP VBD on NNP to VB the JJ NN of the NN , "" NNP NNP , "" VBG that it VBZ the NN that NNS can VB NN . NN VBZ a JJ NN VBG JJ NNS and JJ JJ NN and NN NNS . NNS RB VBP that NN VBZ a NN in VBG the NN ; a NN that NN VBZ to VB VBZ VBN RB VBN in JJ NNS . NNP VBD he VBZ VBN NN NNS and VBN as a NN to JJ NN NNS , but VBD there VBD no NN NN in the JJ NN . He VBZ an JJ NN to the NN on NNS ."
40,1037,mainstream,M09dc7,vaccine.autism,"Brain_NN scans_NNS ,_, analyzed_VBN using_VBG a_DT type_NN of_IN artificial_JJ intelligence_NN ,_, can_MD reveal_VB whether_IN 6_CD -_HYPH month_NN -_HYPH old_JJ babies_NNS are_VBP likely_JJ to_TO develop_VB autism_NN ,_, a_DT new_JJ study_NN shows_VBZ ._. The_DT study_NN examined_VBD 59_CD infants_NNS who_WP were_VBD at_IN high_JJ risk_NN of_IN developing_VBG autism_NN ;_, that_DT is_VBZ ,_, each_DT had_VBD an_DT older_JJR sibling_NN with_IN autism_NN ._. The_DT artificial_JJ intelligence_NN predicted_VBD with_IN 100_CD percent_NN accuracy_NN that_IN 48_CD infants_NNS would_MD not_RB develop_VB autism_NN ._. In_IN addition_NN ,_, of_IN the_DT 11_CD infants_NNS who_WP did_VBD develop_VB the_DT disorder_NN by_IN the_DT time_NN they_PRP were_VBD 2_CD years_NNS old_JJ ,_, the_DT system_NN correctly_RB predicted_VBD nine_CD of_IN the_DT cases_NNS ._. ""_`` It_PRP was_VBD extremely_RB accurate_JJ ,_, ""_'' Robert_NNP Emerson_NNP ,_, the_DT lead_JJ author_NN on_IN the_DT study_NN and_CC a_DT former_JJ cognitive_JJ neuroscience_NN postdoctoral_JJ fellow_NN at_IN the_DT University_NNP of_IN North_NNP Carolina_NNP (_-LRB- UNC_NNP )_-RRB- ,_, told_VBD Live_NNP Science_NNP ._. [_-LRB- 5_CD Things_NNS That_WDT May_MD Cause_VB Autism_NN ]_-RRB- Studies_NNS show_VBP that_IN 20_CD percent_NN of_IN babies_NNS who_WP have_VBP older_JJR siblings_NNS with_IN autism_NN will_MD develop_VB the_DT disorder_NN ;_: among_IN babies_NNS in_IN the_DT general_JJ population_NN ,_, 1.5_CD percent_NN develop_VBP autism_NN ,_, Emerson_NNP told_VBD Live_NNP Science_NNP ._. The_DT results_NNS of_IN the_DT new_JJ research_NN could_MD lead_VB to_IN new_JJ diagnostic_JJ tools_NNS that_WDT identify_VBP autism_NN before_IN symptoms_NNS occur_VBP ,_, giving_VBG clinicians_NNS the_DT opportunity_NN to_TO intervene_VB early_RB ,_, the_DT researchers_NNS said_VBD ._. ""_`` The_DT idea_NN is_VBZ that_IN we_PRP can_MD be_VB more_RBR effective_JJ if_IN we_PRP can_MD get_VB to_IN these_DT kids_NNS before_IN they_PRP develop_VBP autism_NN ,_, perhaps_RB ameliorating_VBG or_CC preventing_VBG it_PRP ,_, ""_'' Dr._NNP Joseph_NNP Piven_NNP ,_, a_DT professor_NN of_IN psychiatry_NN at_IN the_DT UNC_NNP School_NNP of_IN Medicine_NNP and_CC director_NN of_IN the_DT Carolina_NNP Institute_NNP for_IN Developmental_NNP Disabilities_NNPS ,_, told_VBD Live_NNP Science_NNP ._. The_DT researchers_NNS published_VBD their_PRP$ results_NNS today_NN (_-LRB- June_NNP 7_CD )_-RRB- in_IN the_DT journal_NNP Science_NNP Translational_NNP Medicine_NNP ._. Autism_NN spectrum_NN disorder_NN ,_, a_DT brain_NN -_HYPH based_VBN disorder_NN characterized_VBN by_IN a_DT wide_JJ range_NN of_IN social_JJ -_HYPH communication_NN challenges_NNS and_CC repetitive_JJ behaviors_NNS ,_, affects_VBZ about_RB one_CD out_IN of_IN every_DT 68_CD children_NNS in_IN the_DT United_NNP States_NNPS ._. Behavioral_JJ symptoms_NNS typically_RB begin_VBP to_TO appear_VB in_IN children_NNS at_IN around_IN age_NN 2_CD ._. Emerson_NNP and_CC his_PRP$ colleagues_NNS demonstrated_VBD that_IN they_PRP could_MD identify_VB biomarkers_NNS for_IN the_DT disorder_NN before_IN the_DT symptoms_NNS occur_VBP ._. As_IN part_NN of_IN their_PRP$ study_NN ,_, the_DT researchers_NNS used_VBD MRI_NN scanners_NNS to_TO image_VB the_DT brains_NNS of_IN the_DT infants_NNS while_IN they_PRP slept_VBD ._. During_IN the_DT scans_NNS ,_, the_DT researchers_NNS recorded_VBD the_DT neural_JJ activity_NN of_IN 230_CD different_JJ regions_NNS in_IN the_DT brain_NN ,_, looking_VBG particularly_RB at_IN whether_IN or_CC not_RB pairs_NNS of_IN these_DT region_NN —_: referred_VBN to_IN as_IN functional_JJ connections_NNS —_: were_VBD synchronized_VBN with_IN each_DT other_JJ ,_, and_CC if_IN so_RB ,_, to_IN what_WDT extent_NN ._. In_IN total_NN ,_, the_DT researchers_NNS measured_VBD 26,335_CD functional_JJ connections_NNS crucial_JJ for_IN cognition_NN ,_, memory_NN and_CC behavior_NN ._. When_WRB the_DT children_NNS reached_VBD age_NN 2_CD ,_, they_PRP came_VBD back_RB in_RP for_IN a_DT behavior_NN assessment_NN ._. The_DT researchers_NNS looked_VBD at_IN the_DT children_NNS 's_POS social_JJ interactions_NNS ,_, communication_NN ,_, motor_NN development_NN and_CC tendency_NN to_TO perform_VB repetitive_JJ actions_NNS ,_, and_CC determined_VBD whether_IN each_DT child_NN had_VBD autism_NN ._. [_-LRB- 11_CD Facts_NNS Every_DT Parent_NN Should_MD Know_VB About_IN Their_PRP$ Baby's_NNS Brain_NN ]_-RRB- With_IN all_DT of_IN the_DT data_NNS in_IN hand_NN ,_, the_DT researchers_NNS set_VBD out_RP to_TO first_RB train_VB their_PRP$ machine_NN learning_NN program_NN ,_, and_CC then_RB use_VB it_PRP to_TO run_VB predictions_NNS ._. They_PRP wanted_VBD to_TO see_VB how_WRB accurately_RB it_PRP could_MD predict_VB which_WDT infants_NNS had_VBD developed_VBN autism_NN ,_, using_VBG only_RB the_DT functional_JJ connections_NNS data_NNS from_IN when_WRB the_DT children_NNS were_VBD 6_CD months_NNS old_JJ ._. In_IN other_JJ words_NNS ,_, although_IN the_DT researchers_NNS knew_VBD which_WDT babies_NNS had_VBD developed_VBN into_IN toddlers_NNS with_IN autism_NN and_CC which_WDT had_VBD not_RB ,_, the_DT machine_NN learning_NN program_NN did_VBD not_RB ._. Machine_NN learning_NN is_VBZ a_DT kind_NN of_IN artificial_JJ intelligence_NN system_NN that_WDT gets_VBZ smarter_JJR based_VBN on_IN the_DT data_NNS it_PRP processes_VBZ ._. In_IN this_DT case_NN ,_, the_DT program_NN was_VBD learning_VBG to_TO spot_VB differences_NNS between_IN the_DT functional_JJ connections_NNS imaged_VBN in_IN the_DT MRI_NNP data_NNS collected_VBN at_IN 6_CD months_NNS old_JJ that_WDT correlate_VBP with_IN cognition_NN ,_, memory_NN and_CC behavior_NN and_CC the_DT details_NNS from_IN the_DT behavioral_JJ assessments_NNS collected_VBN at_IN 24_CD months_NNS ._. As_IN the_DT program_NN did_VBD this_DT ,_, it_PRP separated_VBD the_DT children_NNS into_IN two_CD groups_NNS —_: those_DT with_IN autism_NN and_CC those_DT without_IN the_DT condition_NN ._. Once_IN it_PRP was_VBD trained_VBN ,_, it_PRP could_MD make_VB predictions_NNS ._. [_-LRB- 7_CD Baby_NNP Myths_NNP Debunked_VBN ]_-RRB- But_CC during_IN the_DT training_NN process_NN ,_, the_DT researchers_NNS did_VBD n't_RB use_VB the_DT data_NNS from_IN all_DT 59_CD kids_NNS ._. Instead_RB ,_, they_PRP fed_VBD data_NNS in_RP from_IN 58_CD of_IN the_DT 59_CD infants_NNS to_TO train_VB the_DT model_NN ,_, and_CC then_RB to_TO get_VB the_DT prediction_NN ,_, they_PRP inputed_VBD the_DT data_NNS from_IN the_DT one_CD infant_NN they_PRP had_VBD left_VBN out_RP ._. They_PRP repeated_VBD this_DT for_IN all_DT 59_CD children_NNS ._. ""_`` Each_DT child_NN was_VBD predicted_VBN separately_RB based_VBN on_IN a_DT model_NN from_IN the_DT other_JJ children_NNS in_IN the_DT group_NN ,_, ""_'' Emerson_NNP said_VBD ._. In_IN the_DT end_NN ,_, the_DT machine_NN learning_NN program_NN was_VBD correct_JJ in_IN 82_CD percent_NN of_IN the_DT cases_NNS in_IN which_WDT the_DT children_NNS did_VBD develop_VB autism_NN ._. Piven_NNP said_VBD the_DT team_NN published_VBD a_DT study_NN earlier_RBR in_IN the_DT year_NN that_WDT also_RB showed_VBD an_DT impressive_JJ prediction_NN rate_NN ,_, but_CC that_DT study_NN required_VBD two_CD MRI_NN scans_NNS ,_, one_CD at_IN 6_CD months_NNS of_IN age_NN and_CC one_CD at_IN 1_CD year_NN ._. Moving_VBG the_DT needle_NN to_IN an_DT earlier_JJR age_NN is_VBZ a_DT big_JJ advance_NN ,_, Piven_NNP said_VBD ._. The_DT research_NN team_NN was_VBD amazed_VBN by_IN the_DT parents_NNS who_WP participated_VBD in_IN this_DT and_CC other_JJ studies_NNS over_IN the_DT years_NNS ,_, given_VBN all_DT that_WDT was_VBD required_VBN ,_, he_PRP said_VBD ._. ""_`` This_DT is_VBZ an_DT extraordinary_JJ group_NN of_IN people_NNS ,_, ""_'' Piven_NNP said_VBD ._. ""_`` Not_RB only_RB do_VBP they_PRP have_VB an_DT older_JJR child_NN with_IN autism_NN ,_, but_CC they_PRP bring_VBP their_PRP$ babies_NNS ,_, often_RB multiple_JJ times_NNS and_CC from_IN very_RB far_RB away_RB ,_, to_IN one_CD of_IN our_PRP$ four_CD clinical_JJ sites_NNS around_IN the_DT country_NN ._. ""_'' The_DT researchers_NNS said_VBD they_PRP hope_VBP their_PRP$ contributions_NNS will_MD lead_VB to_IN more_RBR effective_JJ interventions_NNS for_IN children_NNS on_IN the_DT brink_NN of_IN developing_VBG autism_NN ._.","NN NNS , VBN VBG a NN of JJ NN , can VB whether 6 - NN - JJ NNS VBP JJ to VB NN , a JJ NN VBZ . The NN VBD 59 NNS who VBD at JJ NN of VBG NN ; that VBZ , each VBD an JJR NN with NN . The JJ NN VBD with 100 NN NN that 48 NNS would RB VB NN . In NN , of the 11 NNS who VBD VB the NN by the NN they VBD 2 NNS JJ , the NN RB VBD nine of the NNS . "" It VBD RB JJ , "" NNP NNP , the JJ NN on the NN and a JJ JJ NN JJ NN at the NNP of NNP NNP ( NNP ) , VBD NNP NNP . [ 5 NNS That May VB NN ] NNS VBP that 20 NN of NNS who VBP JJR NNS with NN will VB the NN ; among NNS in the JJ NN , 1.5 NN VBP NN , NNP VBD NNP NNP . The NNS of the JJ NN could VB to JJ JJ NNS that VBP NN before NNS VBP , VBG NNS the NN to VB RB , the NNS VBD . "" The NN VBZ that we can VB RBR JJ if we can VB to these NNS before they VBP NN , RB VBG or VBG it , "" NNP NNP NNP , a NN of NN at the NNP NNP of NNP and NN of the NNP NNP for NNP NNPS , VBD NNP NNP . The NNS VBD their NNS NN ( NNP 7 ) in the NNP NNP NNP NNP . NN NN NN , a NN - VBN NN VBN by a JJ NN of JJ - NN NNS and JJ NNS , VBZ RB one out of every 68 NNS in the NNP NNPS . JJ NNS RB VBP to VB in NNS at around NN 2 . NNP and his NNS VBD that they could VB NNS for the NN before the NNS VBP . As NN of their NN , the NNS VBD NN NNS to VB the NNS of the NNS while they VBD . During the NNS , the NNS VBD the JJ NN of 230 JJ NNS in the NN , VBG RB at whether or RB NNS of these NN — VBN to as JJ NNS — VBD VBN with each JJ , and if RB , to what NN . In NN , the NNS VBD 26,335 JJ NNS JJ for NN , NN and NN . When the NNS VBD NN 2 , they VBD RB in for a NN NN . The NNS VBD at the NNS 's JJ NNS , NN , NN NN and NN to VB JJ NNS , and VBD whether each NN VBD NN . [ 11 NNS Every NN Should VB About Their NNS NN ] With all of the NNS in NN , the NNS VBD out to RB VB their NN NN NN , and RB VB it to VB NNS . They VBD to VB how RB it could VB which NNS VBD VBN NN , VBG RB the JJ NNS NNS from when the NNS VBD 6 NNS JJ . In JJ NNS , although the NNS VBD which NNS VBD VBN into NNS with NN and which VBD RB , the NN NN NN VBD RB . NN NN VBZ a NN of JJ NN NN that VBZ JJR VBN on the NNS it VBZ . In this NN , the NN VBD VBG to VB NNS between the JJ NNS VBN in the NNP NNS VBN at 6 NNS JJ that VBP with NN , NN and NN and the NNS from the JJ NNS VBN at 24 NNS . As the NN VBD this , it VBD the NNS into two NNS — those with NN and those without the NN . Once it VBD VBN , it could VB NNS . [ 7 NNP NNP VBN ] But during the NN NN , the NNS VBD RB VB the NNS from all 59 NNS . RB , they VBD NNS in from 58 of the 59 NNS to VB the NN , and RB to VB the NN , they VBD the NNS from the one NN they VBD VBN out . They VBD this for all 59 NNS . "" Each NN VBD VBN RB VBN on a NN from the JJ NNS in the NN , "" NNP VBD . In the NN , the NN NN NN VBD JJ in 82 NN of the NNS in which the NNS VBD VB NN . NNP VBD the NN VBD a NN RBR in the NN that RB VBD an JJ NN NN , but that NN VBD two NN NNS , one at 6 NNS of NN and one at 1 NN . VBG the NN to an JJR NN VBZ a JJ NN , NNP VBD . The NN NN VBD VBN by the NNS who VBD in this and JJ NNS over the NNS , VBN all that VBD VBN , he VBD . "" This VBZ an JJ NN of NNS , "" NNP VBD . "" RB RB VBP they VB an JJR NN with NN , but they VBP their NNS , RB JJ NNS and from RB RB RB , to one of our four JJ NNS around the NN . "" The NNS VBD they VBP their NNS will VB to RBR JJ NNS for NNS on the NN of VBG NN ."
41,802,mainstream,M0b39d,vaccine.autism,"A_DT large_JJ measles_NN outbreak_NN occurred_VBD in_IN South_NNP Wales_NNP in_IN 2012/2013_CD ._. The_DT outbreak_NN has_VBZ been_VBN attributed_VBN to_IN low_JJ take_NN -_HYPH up_NN of_IN measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN (_-LRB- MMR_NNP )_-RRB- immunization_NN in_IN the_DT early_JJ 2000s_NNS ._. To_TO understand_VB better_JJR the_DT factors_NNS that_WDT led_VBD to_IN this_DT outbreak_NN we_PRP present_VBP the_DT findings_NNS of_IN a_DT case_NN -_HYPH control_NN study_NN carried_VBN out_RP in_IN the_DT outbreak_NN area_NN in_IN 2001_CD to_TO investigate_VB parents_NNS '_POS decision_NN on_IN whether_IN to_TO accept_VB MMR_NNP ._. Parents_NNS who_WP decided_VBD not_RB to_TO take_VB -_HYPH up_RP MMR_NN at_IN the_DT time_NN were_VBD more_RBR likely_JJ to_TO be_VB older_JJR and_CC better_RBR educated_VBN ,_, more_RBR likely_JJ to_TO report_VB being_VBG influenced_VBN by_IN newspapers_NNS [_-LRB- adjusted_VBN odds_NNS ratio_NN (_-LRB- aOR_NN )_-RRB- 3·07_CD ,_, 95_CD %_NN confidence_NN interval_NN (_-LRB- CI_NN )_-RRB- 1·62–5·80_CD ]_-RRB- ,_, television_NN (_-LRB- aOR_NN 3·30_CD ,_, 95_CD %_NN CI_NN 1·70_CD –6·43_CD )_-RRB- ,_, the_DT internet_NN (_-LRB- aOR_NN 7·23_CD ,_, 3·26_CD –16·06_CD )_-RRB- and_CC vaccine_NN pressure_NN groups_NNS (_-LRB- aOR_NN 5·20_CD ,_, 95_CD %_NN CI_NN 2·22_CD –_SYM 12·16_CD )_-RRB- ,_, and_CC less_RBR likely_JJ to_TO be_VB influenced_VBN by_IN a_DT health_NN visitor_NN (_-LRB- aOR_NN 0·30_CD ,_, 95_CD %_NN CI_NN 0·16–0·57_CD )_-RRB- ._. In_IN this_DT area_NN of_IN Wales_NNP ,_, daily_JJ English_JJ -_HYPH language_NN regional_JJ newspapers_NNS ,_, UK_NNP news_NN programmes_NNS and_CC the_DT internet_NN appeared_VBD to_TO have_VB a_DT powerful_JJ negative_JJ influence_NN ._. We_PRP consider_VBP the_DT relevance_NN of_IN these_DT findings_NNS to_IN the_DT epidemiology_NN of_IN the_DT outbreak_NN and_CC the_DT subsequent_JJ public_JJ health_NN response_NN ._.","A JJ NN NN VBD in NNP NNP in 2012/2013 . The NN VBZ VBN VBN to JJ NN - NN of NNS - NNS - NN ( NNP ) NN in the JJ NNS . To VB JJR the NNS that VBD to this NN we VBP the NNS of a NN - NN NN VBN out in the NN NN in 2001 to VB NNS ' NN on whether to VB NNP . NNS who VBD RB to VB - up NN at the NN VBD RBR JJ to VB JJR and RBR VBN , RBR JJ to VB VBG VBN by NNS [ VBN NNS NN ( NN ) 3·07 , 95 NN NN NN ( NN ) 1·62–5·80 ] , NN ( NN 3·30 , 95 NN NN 1·70 –6·43 ) , the NN ( NN 7·23 , 3·26 –16·06 ) and NN NN NNS ( NN 5·20 , 95 NN NN 2·22 – 12·16 ) , and RBR JJ to VB VBN by a NN NN ( NN 0·30 , 95 NN NN 0·16–0·57 ) . In this NN of NNP , JJ JJ - NN JJ NNS , NNP NN NNS and the NN VBD to VB a JJ JJ NN . We VBP the NN of these NNS to the NN of the NN and the JJ JJ NN NN ."
42,48,mainstream,M093b9,vaccine,"While_IN the_DT world_NN is_VBZ firmly_RB in_IN the_DT grip_NN of_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, we_PRP take_VBP a_DT look_NN back_RB at_IN SARS_NNP and_CC MERS_NNP and_CC their_PRP$ underlying_JJ pathogens_NNS ,_, which_WDT are_VBP also_RB coronaviruses_NNS ._. Three_CD new_JJ coronaviruses_NNS have_VBP emerged_VBN since_IN the_DT turn_NN of_IN the_DT century_NN ._. All_DT data_NNS and_CC statistics_NNS are_VBP based_VBN on_IN publicly_RB available_JJ data_NNS at_IN the_DT time_NN of_IN publication_NN ._. Some_DT information_NN may_MD be_VB out_IN of_IN date_NN ._. Visit_VB our_PRP$ coronavirus_NN hub_NN and_CC follow_VB our_PRP$ live_JJ updates_NNS page_NN for_IN the_DT most_RBS recent_JJ information_NN on_IN the_DT COVID_NN -_HYPH 19_CD outbreak_NN ._. Coronaviruses_NNS are_VBP a_DT large_JJ family_NN of_IN enveloped_VBN RNA_NN viruses_NNS that_WDT mostly_RB infect_VBP birds_NNS and_CC mammals_NNS ._. In_IN humans_NNS ,_, they_PRP can_MD cause_VB mild_JJ infection_NN in_IN the_DT upper_JJ respiratory_JJ tract_NN ,_, like_IN the_DT common_JJ cold_NN ,_, but_CC also_RB more_RBR serious_JJ lower_JJR respiratory_JJ tract_NN infections_NNS ._. These_DT infections_NNS can_MD manifest_VB as_IN bronchitis_NN ,_, pneumonia_NN ,_, or_CC a_DT severe_JJ respiratory_JJ illness_NN ,_, such_JJ as_IN severe_JJ acute_JJ respiratory_JJ syndrome_NN (_-LRB- SARS_NN )_-RRB- ,_, Middle_NNP East_NNP respiratory_JJ syndrome_NN (_-LRB- MERS_NNP )_-RRB- ,_, or_CC coronavirus_NN disease_NN 19_CD (_-LRB- COVID_NNP -_SYM 19_CD )_-RRB- ._. But_CC how_WRB similar_JJ are_VBP the_DT SARS_NN ,_, MERS_NN ,_, and_CC COVID_NN -_HYPH 19_CD coronaviruses_NNS ?_. And_CC how_WRB do_VBP the_DT diseases_NNS compare_VB ?_. In_IN this_DT feature_NN ,_, we_PRP explore_VBP the_DT history_NN of_IN each_DT coronavirus_NN outbreak_NN ,_, as_RB well_RB as_IN the_DT statistics_NNS and_CC medical_JJ advances_NNS ._. Stay_VB informed_VBN with_IN live_JJ updates_NNS on_IN the_DT current_JJ COVID_NN -_HYPH 19_CD outbreak_NN and_CC visit_VB our_PRP$ coronavirus_NN hub_NN for_IN more_JJR advice_NN on_IN prevention_NN and_CC treatment_NN ._. The_DT coronavirus_NN that_WDT causes_VBZ SARS_NNP is_VBZ called_VBN SARS_NNP -_HYPH CoV_NNP ._. According_VBG to_IN the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, the_DT first_JJ cluster_NN of_IN SARS_NNP cases_NNS occurred_VBD in_IN China_NNP ’s_POS Guangdong_NNP province_NN in_IN November_NNP 2002_CD ._. Research_NN has_VBZ identified_VBN horseshoe_NN bats_NNS as_IN the_DT natural_JJ reservoir_NN of_IN SARS_NNP -_HYPH CoV_NNP ._. Civets_NNS and_CC animals_NNS in_IN wet_JJ markets_NNS also_RB likely_RB contributed_VBD to_IN the_DT virus_NN crossing_VBG from_IN animals_NNS into_IN humans_NNS ._. The_DT organization_NN was_VBD first_RB notified_VBN ,_, of_IN more_JJR than_IN 100_CD deaths_NNS due_IN to_IN a_DT new_JJ infectious_JJ disease_NN ,_, on_IN February_NNP 10_CD ,_, 2003_CD ._. The_DT next_JJ day_NN ,_, the_DT Chinese_JJ health_NN ministry_NN made_VBD an_DT official_JJ report_NN of_IN 300_CD cases_NNS and_CC five_CD deaths_NNS due_IN to_IN an_DT acute_JJ respiratory_JJ syndrome_NN ._. On_IN March_NNP 12_CD ,_, 2003_CD ,_, the_DT WHO_NNP issued_VBD a_DT global_JJ alert_NN ,_, warning_VBG of_IN atypical_JJ pneumonia_NN spreading_VBG among_IN hospital_NN staff_NN ._. A_DT mere_JJ 3_CD days_NNS later_RBR ,_, the_DT WHO_NNP coined_VBD the_DT name_NN SARS_NNP and_CC put_VBD out_RP an_DT emergency_NN travel_NN advisory_NN ,_, asking_VBG travelers_NNS to_TO be_VB familiar_JJ with_IN the_DT symptoms_NNS of_IN the_DT condition_NN ._. They_PRP also_RB proposed_VBD that_IN the_DT disease_NN was_VBD spreading_VBG throughout_IN the_DT world_NN by_IN people_NNS using_VBG air_NN transport_NN ._. Later_RBR in_IN March_NNP ,_, the_DT WHO_NNP recommended_VBD that_IN airports_NNS in_IN areas_NNS with_IN cases_NNS of_IN SARS_NNP screen_NN passengers_NNS ._. From_IN April_NNP of_IN that_DT year_NN onward_RB ,_, the_DT WHO_NNP issued_VBD a_DT number_NN of_IN warnings_NNS ,_, asking_VBG people_NNS to_TO postpone_VB all_DT but_CC essential_JJ travel_NN to_IN affected_VBN areas_NNS ._. These_DT areas_NNS included_VBN ,_, at_IN various_JJ times_NNS ,_, Hong_NNP Kong_NNP ,_, Toronto_NNP ,_, several_JJ areas_NNS of_IN mainland_JJ China_NNP ,_, and_CC Taiwan_NNP ._. A_DT paper_NN published_VBN May_NNP 15_CD ,_, 2003_CD in_IN The_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP identified_VBD a_DT new_JJ coronavirus_NN as_IN the_DT underlying_JJ pathogen_NN ._. The_DT WHO_NNP officially_RB declared_VBD the_DT SARS_NNP epidemic_NN to_TO be_VB contained_VBN on_IN July_NNP 5_CD of_IN that_DT year_NN ._. Since_IN then_RB ,_, there_EX have_VBP been_VBN four_CD small_JJ outbreaks_NNS of_IN SARS_NNP ._. Of_IN these_DT ,_, three_CD involved_VBD people_NNS who_WP worked_VBD with_IN the_DT SARS_NNP virus_NN in_IN laboratory_NN settings_NNS and_CC acquired_VBD the_DT virus_NN accidentally_RB ._. The_DT fourth_JJ incidence_NN has_VBZ been_VBN mostly_RB attributed_VBN to_IN infection_NN from_IN an_DT animal_NN source_NN ._. There_EX have_VBP been_VBN no_DT reported_VBN cases_NNS of_IN SARS_NNP since_IN then_RB ,_, although_IN the_DT WHO_NNP warn_VBP that_IN “_`` These_DT events_NNS demonstrate_VBP that_IN the_DT resurgence_NN of_IN SARS_NNP leading_VBG to_IN an_DT outbreak_NN remains_VBZ a_DT distinct_JJ possibility_NN and_CC does_VBZ not_RB allow_VB for_IN complacency_NN ._. ”_'' •_NFP Total_JJ number_NN of_IN cases_NNS :_: 8,439_CD ,_, 21_CD %_NN of_IN which_WDT developed_VBD in_IN healthcare_NN workers_NNS •_, Number_NN of_IN cases_NNS in_IN the_DT United_NNP States_NNPS :_: 73_CD •_SYM Mode_NN of_IN transmission_NN :_: Droplets_NNS produced_VBN by_IN coughing_NN ,_, sneezing_NN ,_, talking_NN ,_, or_CC breathing_NN •_SYM Key_NN symptoms_NNS :_: A_DT cough_NN (_-LRB- dry_JJ at_IN first_JJ )_-RRB- ,_, a_DT fever_NN ,_, and_CC diarrhea_NN in_IN the_DT first_JJ or_CC second_JJ week_NN of_IN illness_NN ,_, or_CC both_DT MERS_NNP occurs_VBZ as_IN a_DT result_NN of_IN infection_NN with_IN the_DT coronavirus_NN MERS_NN -_HYPH CoV_NNP ._. On_IN September_NNP 20_CD ,_, 2012_CD ,_, the_DT Program_NNP for_IN Monitoring_NNP Emerging_NNP Diseases_NNPS reported_VBD a_DT novel_JJ coronavirus_NN isolated_VBN from_IN sputum_NN samples_NNS of_IN a_DT 60_CD -_HYPH year_NN -_HYPH old_JJ man_NN from_IN Saudi_NNP Arabia_NNP ,_, who_WP had_VBD died_VBN 3_CD months_NNS earlier_RBR ._. Within_IN the_DT next_JJ month_NN ,_, the_DT number_NN of_IN confirmed_VBN MERS_NNP cases_NNS rose_VBD to_IN nine_CD ,_, with_IN five_CD fatalities_NNS ._. The_DT earliest_JJS case_NN dated_VBN back_RB to_IN April_NNP 2012_CD ._. Across_IN the_DT globe_NN ,_, 27_CD countries_NNS have_VBP reported_VBN cases_NNS of_IN MERS_NNP since_IN 2012_CD ,_, but_CC around_RB 80_CD %_NN of_IN cases_NNS have_VBP occurred_VBN in_IN Saudi_NNP Arabia_NNP ._. MERS_NNP -_, CoV_NNP is_VBZ a_DT zoonotic_JJ virus_NN ,_, meaning_VBG that_IN most_JJS cases_NNS of_IN infection_NN pass_VBP from_IN animals_NNS to_IN humans_NNS ._. According_VBG to_IN the_DT WHO_NN ,_, direct_JJ or_CC indirect_JJ contact_NN with_IN dromedary_NN camels_NNS is_VBZ the_DT most_RBS common_JJ route_NN of_IN infection_NN ._. Transmission_NN among_IN people_NNS is_VBZ rare_JJ ,_, and_CC it_PRP mostly_RB occurs_VBZ among_IN family_NN members_NNS or_CC in_IN healthcare_NN settings_NNS ._. The_DT MERS_NNP -_HYPH CoV_NNP virus_NN has_VBZ similarities_NNS to_IN European_JJ bat_NN coronaviruses_NNS ._. •_NFP Number_NN of_IN cases_NNS in_IN the_DT U.S._NNP :_: 2_CD •_, Mode_NN of_IN transmission_NN :_: Droplets_NNS from_IN person_NN to_IN person_NN ,_, unclear_JJ from_IN camels_NNS to_IN humans_NNS •_. At_IN risk_NN groups_NNS :_: Men_NNS above_IN the_DT age_NN of_IN 60_CD ,_, particularly_RB those_DT with_IN underlying_JJ medical_JJ conditions_NNS such_JJ as_IN diabetes_NN ,_, high_JJ blood_NN pressure_NN ,_, and_CC kidney_NN failure_NN The_DT coronavirus_NN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ the_DT pathogen_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. The_DT virus_NN has_VBZ a_DT close_JJ resemblance_NN to_IN SARS_NNP -_HYPH CoV_NNP ._. The_DT first_JJ cases_NNS of_IN COVID_NN -_HYPH 19_CD were_VBD reported_VBN in_IN Wuhan_NNP ,_, China_NNP ,_, in_IN December_NNP 2019_CD ._. On_IN January_NNP 5_CD ,_, 2020_CD ,_, the_DT WHO_NNP published_VBD the_DT first_JJ news_NN of_IN an_DT outbreak_NN of_IN unknown_JJ cause_NN ._. By_IN the_DT end_NN of_IN January_NNP ,_, the_DT organization_NN had_VBD declared_VBN COVID_NNP -_HYPH 19_CD to_TO be_VB a_DT public_JJ health_NN emergency_NN of_IN international_JJ concern_NN ._. The_DT name_NN COVID_NNP -_HYPH 19_CD was_VBD officially_RB coined_VBN ,_, by_IN the_DT WHO_NNP ,_, on_IN February_NNP 11_CD ._. Exactly_RB 1_CD month_NN later_RBR ,_, the_DT organization_NN declared_VBD a_DT pandemic_NN ._. To_IN date_NN ,_, cases_NNS of_IN COVID_NN -_HYPH 19_CD have_VBP been_VBN reported_VBN on_IN every_DT continent_NN except_IN Antarctica_NNP ._. Governments_NNS across_IN the_DT world_NN have_VBP responded_VBN with_IN varying_VBG degrees_NNS of_IN social_JJ distancing_NN measures_NNS in_IN a_DT bid_NN to_TO curb_VB the_DT spread_NN of_IN the_DT virus_NN ._. As_IN the_DT numbers_NNS of_IN infections_NNS and_CC deaths_NNS from_IN COVID_NN -_HYPH 19_CD continue_VBP to_TO rise_VB ,_, researchers_NNS are_VBP working_VBG to_TO identify_VB suitable_JJ treatments_NNS and_CC vaccines_NNS to_TO curb_VB the_DT pandemic_NN ._. •_NFP Number_NN of_IN cases_NNS in_IN the_DT U.S._NNP :_: 432,438_CD •_SYM Mode_NN of_IN transmission_NN :_: Droplets_NNS produced_VBN by_IN coughing_NN ,_, sneezing_NN ,_, or_CC talking_VBG ,_, limited_JJ evidence_NN of_IN other_JJ routes_NNS •_NFP At_IN risk_NN groups_NNS :_: Adults_NNS aged_JJ 65_CD and_CC over_RB ,_, and_CC people_NNS of_IN all_DT ages_NNS with_IN underlying_JJ medical_JJ conditions_NNS •_NFP Treatment_NN :_: No_DT specific_JJ treatment_NN ,_, although_IN several_JJ candidate_NN drugs_NNS are_VBP undergoing_VBG testing_NN •_SYM Vaccine_NN :_: No_DT vaccine_NN ,_, although_IN several_JJ candidate_NN vaccines_NNS are_VBP in_IN development_NN Each_DT of_IN the_DT three_CD new_JJ coronaviruses_NNS that_WDT has_VBZ emerged_VBN since_IN the_DT turn_NN of_IN the_DT century_NN has_VBZ caused_VBN respiratory_JJ disease_NN outbreaks_NNS ,_, but_CC each_DT has_VBZ also_RB displayed_VBN unique_JJ features_NNS ._. SARS_NNP and_CC MERS_NNP have_VBP significantly_RB higher_JJR case_NN fatality_NN rates_NNS than_IN COVID_NNP -_HYPH 19_CD ._. Yet_CC COVID_NNP -_HYPH 19_CD is_VBZ more_RBR infectious_JJ —_: the_DT underlying_JJ SARS_NN -_HYPH CoV_NN -_HYPH 2_CD virus_NN spreads_VBZ more_RBR easily_RB among_IN people_NNS ,_, leading_VBG to_IN greater_JJR case_NN numbers_NNS ._. Despite_IN the_DT lower_JJR case_NN fatality_NN rate_NN ,_, the_DT overall_JJ number_NN of_IN deaths_NNS from_IN COVID_NN -_HYPH 19_CD far_RB outweighs_VBZ that_DT from_IN SARS_NN or_CC MERS_NN ._. There_EX have_VBP been_VBN no_DT cases_NNS of_IN SARS_NNP for_IN over_IN a_DT decade_NN ._. But_CC MERS_NNP is_VBZ an_DT ongoing_JJ public_JJ health_NN concern_NN ._. One_CD factor_NN that_WDT could_MD contribute_VB to_IN the_DT extent_NN of_IN damage_NN that_WDT any_DT new_JJ coronavirus_NN can_MD cause_VB is_VBZ globalization_NN ._. As_IN infectious_JJ disease_NN specialist_NN and_CC WHO_NNP advisor_NN Prof._NNP David_NNP Heymann_NNP told_VBD Medical_NNP News_NNP Today_NN in_IN an_DT interview_NN :_: “_`` In_IN the_DT past_NN ,_, coronaviruses_NNS that_WDT cause_VBP the_DT common_JJ cold_NN in_IN humans_NNS also_RB emerged_VBD ,_, possibly_RB in_IN the_DT same_JJ way_NN as_IN did_VBD the_DT current_JJ pandemic_NN ._. ”_'' “_`` But_CC they_PRP did_VBD not_RB have_VB the_DT opportunity_NN to_TO hop_VB on_IN international_JJ flights_NNS and_CC spread_VB rapidly_RB around_IN the_DT globe_NN ,_, ”_'' he_PRP continued_VBD ._. “_`` They_PRP likely_RB circulated_VBD locally_RB and_CC then_RB gradually_RB spread_VBD to_IN neighboring_VBG countries_NNS and_CC onward_RB throughout_IN the_DT world_NN ._. ”_'' For_IN live_JJ updates_NNS on_IN the_DT latest_JJS developments_NNS regarding_VBG the_DT novel_JJ coronavirus_NN and_CC COVID_NN -_HYPH 19_CD ,_, click_VB here_RB ._.","While the NN VBZ RB in the NN of the NN - 19 NN , we VBP a NN RB at NNP and NNP and their JJ NNS , which VBP RB NNS . Three JJ NNS VBP VBN since the NN of the NN . All NNS and NNS VBP VBN on RB JJ NNS at the NN of NN . Some NN may VB out of NN . VB our NN NN and VB our JJ NNS NN for the RBS JJ NN on the NN - 19 NN . NNS VBP a JJ NN of VBN NN NNS that RB VBP NNS and NNS . In NNS , they can VB JJ NN in the JJ JJ NN , like the JJ NN , but RB RBR JJ JJR JJ NN NNS . These NNS can VB as NN , NN , or a JJ JJ NN , JJ as JJ JJ JJ NN ( NN ) , NNP NNP JJ NN ( NNP ) , or NN NN 19 ( NNP - 19 ) . But how JJ VBP the NN , NN , and NN - 19 NNS ? And how VBP the NNS VB ? In this NN , we VBP the NN of each NN NN , RB RB as the NNS and JJ NNS . VB VBN with JJ NNS on the JJ NN - 19 NN and VB our NN NN for JJR NN on NN and NN . The NN that VBZ NNP VBZ VBN NNP - NNP . VBG to the NNP NNP NNP ( NNP ) , the JJ NN of NNP NNS VBD in NNP ’s NNP NN in NNP 2002 . NN VBZ VBN NN NNS as the JJ NN of NNP - NNP . NNS and NNS in JJ NNS RB RB VBD to the NN VBG from NNS into NNS . The NN VBD RB VBN , of JJR than 100 NNS due to a JJ JJ NN , on NNP 10 , 2003 . The JJ NN , the JJ NN NN VBD an JJ NN of 300 NNS and five NNS due to an JJ JJ NN . On NNP 12 , 2003 , the NNP VBD a JJ NN , VBG of JJ NN VBG among NN NN . A JJ 3 NNS RBR , the NNP VBD the NN NNP and VBD out an NN NN NN , VBG NNS to VB JJ with the NNS of the NN . They RB VBD that the NN VBD VBG throughout the NN by NNS VBG NN NN . RBR in NNP , the NNP VBD that NNS in NNS with NNS of NNP NN NNS . From NNP of that NN RB , the NNP VBD a NN of NNS , VBG NNS to VB all but JJ NN to VBN NNS . These NNS VBN , at JJ NNS , NNP NNP , NNP , JJ NNS of JJ NNP , and NNP . A NN VBN NNP 15 , 2003 in The NNP NNP NNP of NNP VBD a JJ NN as the JJ NN . The NNP RB VBD the NNP NN to VB VBN on NNP 5 of that NN . Since RB , there VBP VBN four JJ NNS of NNP . Of these , three VBD NNS who VBD with the NNP NN in NN NNS and VBD the NN RB . The JJ NN VBZ VBN RB VBN to NN from an NN NN . There VBP VBN no VBN NNS of NNP since RB , although the NNP VBP that “ These NNS VBP that the NN of NNP VBG to an NN VBZ a JJ NN and VBZ RB VB for NN . ” • JJ NN of NNS : 8,439 , 21 NN of which VBD in NN NNS • NN of NNS in the NNP NNPS : 73 • NN of NN : NNS VBN by NN , NN , NN , or NN • NN NNS : A NN ( JJ at JJ ) , a NN , and NN in the JJ or JJ NN of NN , or both NNP VBZ as a NN of NN with the NN NN - NNP . On NNP 20 , 2012 , the NNP for NNP NNP NNPS VBD a JJ NN VBN from NN NNS of a 60 - NN - JJ NN from NNP NNP , who VBD VBN 3 NNS RBR . Within the JJ NN , the NN of VBN NNP NNS VBD to nine , with five NNS . The JJS NN VBN RB to NNP 2012 . Across the NN , 27 NNS VBP VBN NNS of NNP since 2012 , but RB 80 NN of NNS VBP VBN in NNP NNP . NNP - NNP VBZ a JJ NN , VBG that JJS NNS of NN VBP from NNS to NNS . VBG to the NN , JJ or JJ NN with NN NNS VBZ the RBS JJ NN of NN . NN among NNS VBZ JJ , and it RB VBZ among NN NNS or in NN NNS . The NNP - NNP NN VBZ NNS to JJ NN NNS . • NN of NNS in the NNP : 2 • NN of NN : NNS from NN to NN , JJ from NNS to NNS • At NN NNS : NNS above the NN of 60 , RB those with JJ JJ NNS JJ as NN , JJ NN NN , and NN NN The NN NNP - NNP - 2 VBZ the NN that VBZ NN - 19 . The NN VBZ a JJ NN to NNP - NNP . The JJ NNS of NN - 19 VBD VBN in NNP , NNP , in NNP 2019 . On NNP 5 , 2020 , the NNP VBD the JJ NN of an NN of JJ NN . By the NN of NNP , the NN VBD VBN NNP - 19 to VB a JJ NN NN of JJ NN . The NN NNP - 19 VBD RB VBN , by the NNP , on NNP 11 . RB 1 NN RBR , the NN VBD a NN . To NN , NNS of NN - 19 VBP VBN VBN on every NN except NNP . NNS across the NN VBP VBN with VBG NNS of JJ NN NNS in a NN to VB the NN of the NN . As the NNS of NNS and NNS from NN - 19 VBP to VB , NNS VBP VBG to VB JJ NNS and NNS to VB the NN . • NN of NNS in the NNP : 432,438 • NN of NN : NNS VBN by NN , NN , or VBG , JJ NN of JJ NNS • At NN NNS : NNS JJ 65 and RB , and NNS of all NNS with JJ JJ NNS • NN : No JJ NN , although JJ NN NNS VBP VBG NN • NN : No NN , although JJ NN NNS VBP in NN Each of the three JJ NNS that VBZ VBN since the NN of the NN VBZ VBN JJ NN NNS , but each VBZ RB VBN JJ NNS . NNP and NNP VBP RB JJR NN NN NNS than NNP - 19 . Yet NNP - 19 VBZ RBR JJ — the JJ NN - NN - 2 NN VBZ RBR RB among NNS , VBG to JJR NN NNS . Despite the JJR NN NN NN , the JJ NN of NNS from NN - 19 RB VBZ that from NN or NN . There VBP VBN no NNS of NNP for over a NN . But NNP VBZ an JJ JJ NN NN . One NN that could VB to the NN of NN that any JJ NN can VB VBZ NN . As JJ NN NN and NNP NN NNP NNP NNP VBD NNP NNP NN in an NN : “ In the NN , NNS that VBP the JJ NN in NNS RB VBD , RB in the JJ NN as VBD the JJ NN . ” “ But they VBD RB VB the NN to VB on JJ NNS and VB RB around the NN , ” he VBD . “ They RB VBD RB and RB RB VBD to VBG NNS and RB throughout the NN . ” For JJ NNS on the JJS NNS VBG the JJ NN and NN - 19 , VB RB ."
43,1075,mainstream,M0b7a3,vaccine.autism,Yet_CC another_DT study_NN has_VBZ found_VBN that_IN a_DT controversial_JJ vaccine_NN preservative_NN appears_VBZ to_TO be_VB harmless_JJ ._. But_CC the_DT study_NN is_VBZ unlikely_JJ to_TO end_VB the_DT increasingly_RB charged_VBN debate_NN about_IN vaccine_NN safety_NN ._. The_DT study_NN examined_VBD whether_IN thimerosal_NN —_: a_DT mercury_NN -_HYPH containing_VBG vaccine_NN preservative_NN that_WDT was_VBD almost_RB entirely_RB eliminated_VBN from_IN childhood_NN vaccines_NNS by_IN 2002_CD —_: is_VBZ associated_VBN with_IN neurological_JJ or_CC certain_JJ psychological_JJ problems_NNS in_IN children_NNS ages_NNS 7_CD to_IN 10_CD ._. Some_DT parents_NNS ’_POS groups_NNS and_CC prominent_JJ legislators_NNS contend_VBP that_IN thimerosal_NN has_VBZ caused_VBN an_DT epidemic_NN of_IN childhood_NN autism_NN ._. Several_JJ studies_NNS have_VBP examined_VBN this_DT question_NN and_CC found_VBD no_DT evidence_NN that_IN thimerosal_NN is_VBZ associated_VBN with_IN autism_NN ._. The_DT most_RBS recent_JJ study_NN did_VBD not_RB assess_VB thimerosal_NN ’s_POS association_NN with_IN autism_NN directly_RB ._. The_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP is_VBZ conducting_VBG a_DT separate_JJ autism_NN and_CC thimerosal_NN study_NN that_WDT is_VBZ expected_VBN to_TO be_VB published_VBN next_JJ year_NN ._.,Yet another NN VBZ VBN that a JJ NN NN VBZ to VB JJ . But the NN VBZ JJ to VB the RB VBN NN about NN NN . The NN VBD whether NN — a NN - VBG NN NN that VBD RB RB VBN from NN NNS by 2002 — VBZ VBN with JJ or JJ JJ NNS in NNS NNS 7 to 10 . Some NNS ’ NNS and JJ NNS VBP that NN VBZ VBN an NN of NN NN . JJ NNS VBP VBN this NN and VBD no NN that NN VBZ VBN with NN . The RBS JJ NN VBD RB VB NN ’s NN with NN RB . The NNPS for NNP NNP and NNP VBZ VBG a JJ NN and NN NN that VBZ VBN to VB VBN JJ NN .
44,184,mainstream,M07d54,vaccine.autism,"A_DT sign_NN warns_VBZ people_NNS of_IN measles_NNS in_IN the_DT ultra-Orthodox_JJ Jewish_JJ community_NN in_IN Williamsburg_NNP on_IN April_NNP 10_CD ,_, 2019_CD in_IN New_NNP York_NNP City_NNP ._. Health_NN officials_NNS confirmed_VBD another_DT 41_CD measles_NNS cases_NNS last_JJ week_NN ,_, the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP said_VBD Monday_NNP ,_, bringing_VBG the_DT total_NN to_IN 880_CD for_IN 2019_CD ,_, already_RB the_DT worst_JJS year_NN for_IN the_DT disease_NN since_IN 1994_CD ._. The_DT CDC_NNP said_VBD it_PRP has_VBZ now_RB confirmed_VBN measles_NNS in_IN 24_CD states_NNS this_DT year_NN ._. While_IN the_DT total_JJ number_NN continued_VBD to_TO rise_VB ,_, the_DT pace_NN appears_VBZ to_TO be_VB slowing_VBG down_RP —_: although_IN the_DT agency_NN will_MD need_VB to_TO see_VB if_IN the_DT trend_NN continues_VBZ before_IN it_PRP can_MD officially_RB say_VB the_DT spread_NN is_VBZ slowing_VBG ,_, a_DT spokesman_NN said_VBD ._. Thirty_CD of_IN the_DT 41_CD new_JJ cases_NNS were_VBD reported_VBN in_IN New_NNP York_NNP ,_, where_WRB health_NN officials_NNS have_VBP battled_VBN two_CD large_JJ outbreaks_NNS since_IN the_DT fall_NN ._. In_IN New_NNP York_NNP City_NNP ,_, 21_CD new_JJ cases_NNS were_VBD reported_VBN ._. In_IN nearby_JJ Rockland_NNP County_NNP ,_, nine_CD new_JJ cases_NNS were_VBD reported_VBN ,_, the_DT CDC_NNP said_VBD ._. Health_NN officials_NNS blame_VBP the_DT recent_JJ surge_NN of_IN cases_NNS —_: after_IN saying_VBG in_IN 2000_CD that_IN the_DT disease_NN had_VBD been_VBN eliminated_VBN from_IN the_DT U.S._NNP —_: on_IN an_DT increasing_VBG number_NN of_IN parents_NNS who_WP refuse_VBP to_TO vaccinate_VB their_PRP$ children_NNS ._. Measles_NN is_VBZ highly_RB contagious_JJ yet_CC preventable_JJ with_IN a_DT vaccine_NN for_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN ._. More_JJR parents_NNS are_VBP refusing_VBG to_TO vaccinate_VB their_PRP$ children_NNS ,_, sometimes_RB based_VBN on_IN false_JJ information_NN that_WDT vaccines_NNS cause_VBP autism_NN ._. The_DT disease_NN spreads_VBZ quickly_RB and_CC easily_RB among_IN people_NNS who_WP are_VBP n't_RB immunized_VBN ,_, leaving_VBG communities_NNS with_IN high_JJ rates_NNS of_IN people_NNS who_WP are_VBP n't_RB protected_VBN particularly_RB vulnerable_JJ ._. Measles_NN starts_VBZ with_IN a_DT fever_NN ,_, runny_JJ nose_NN ,_, cough_NN ,_, red_JJ eyes_NNS and_CC sore_JJ throat_NN ._. It_PRP then_RB causes_VBZ a_DT rash_NN ._. Some_DT people_NNS develop_VBP severe_JJ complications_NNS ,_, such_JJ as_IN pneumonia_NN or_CC brain_NN swelling_NN ._. Children_NNS younger_JJR than_IN 5_CD and_CC adults_NNS older_JJR than_IN 20_CD are_VBP more_RBR likely_JJ to_TO experience_VB complications_NNS ,_, the_DT CDC_NNP says_VBZ ._. The_DT disease_NN is_VBZ still_RB common_JJ in_IN other_JJ countries_NNS ._. Unvaccinated_JJ people_NNS can_MD pick_VB up_RP the_DT disease_NN while_IN traveling_VBG and_CC bring_VB it_PRP back_RB to_IN the_DT U.S._NNP ,_, where_WRB they_PRP can_MD spread_VB it_PRP to_IN other_JJ unvaccinated_JJ people_NNS ._.","A NN VBZ NNS of NNS in the JJ JJ NN in NNP on NNP 10 , 2019 in NNP NNP NNP . NN NNS VBD another 41 NNS NNS JJ NN , the NNPS for NNP NNP and NNP VBD NNP , VBG the NN to 880 for 2019 , RB the JJS NN for the NN since 1994 . The NNP VBD it VBZ RB VBN NNS in 24 NNS this NN . While the JJ NN VBD to VB , the NN VBZ to VB VBG down — although the NN will VB to VB if the NN VBZ before it can RB VB the NN VBZ VBG , a NN VBD . Thirty of the 41 JJ NNS VBD VBN in NNP NNP , where NN NNS VBP VBN two JJ NNS since the NN . In NNP NNP NNP , 21 JJ NNS VBD VBN . In JJ NNP NNP , nine JJ NNS VBD VBN , the NNP VBD . NN NNS VBP the JJ NN of NNS — after VBG in 2000 that the NN VBD VBN VBN from the NNP — on an VBG NN of NNS who VBP to VB their NNS . NN VBZ RB JJ yet JJ with a NN for NNS , NNS and NN . JJR NNS VBP VBG to VB their NNS , RB VBN on JJ NN that NNS VBP NN . The NN VBZ RB and RB among NNS who VBP RB VBN , VBG NNS with JJ NNS of NNS who VBP RB VBN RB JJ . NN VBZ with a NN , JJ NN , NN , JJ NNS and JJ NN . It RB VBZ a NN . Some NNS VBP JJ NNS , JJ as NN or NN NN . NNS JJR than 5 and NNS JJR than 20 VBP RBR JJ to VB NNS , the NNP VBZ . The NN VBZ RB JJ in JJ NNS . JJ NNS can VB up the NN while VBG and VB it RB to the NNP , where they can VB it to JJ JJ NNS ."
45,1227,mainstream,M08ea3,vaccine.autism,"Thursday_NNP ’s_POS World_NNP Malaria_NNP Day_NN arrived_VBD with_IN some_DT good_JJ news_NN stories_NNS :_: the_DT large_JJ -_HYPH scale_NN launch_NN of_IN a_DT pioneering_VBG vaccine_NN in_IN Malawi_NNP is_VBZ just_RB one_CD promising_JJ fresh_JJ approach_NN to_IN tackling_VBG the_DT disease_NN ._. Others_NNS include_VBP the_DT introduction_NN of_IN better_JJR bednets_NNS ,_, insecticides_NNS and_CC diagnostics_NNS ,_, new_JJ drugs_NNS to_TO respond_VB to_IN the_DT continuing_VBG threat_NN of_IN resistance_NN and_CC the_DT potential_NN through_IN “_`` gene_NN -_HYPH drive_NN ”_'' technology_NN to_TO wipe_VB out_RP the_DT mosquito_NN that_WDT transmits_VBZ the_DT parasite_NN between_IN humans_NNS ._. There_EX has_VBZ been_VBN some_DT progress_NN towards_IN ending_VBG the_DT disease_NN among_IN the_DT 21_CD countries_NNS targeted_VBN for_IN its_PRP$ elimination_NN by_IN next_JJ year_NN ._. Yet_CC the_DT trend_NN is_VBZ less_RBR impressive_JJ in_IN some_DT of_IN the_DT highest_JJS burden_NN countries_NNS such_JJ as_IN Nigeria_NNP and_CC there_EX is_VBZ backsliding_VBG elsewhere_RB ,_, notably_RB in_IN Venezuela_NNP ,_, where_WRB government_NN failures_NNS are_VBP undermining_VBG the_DT health_NN system_NN and_CC imposing_VBG a_DT heavy_JJ human_JJ burden_NN ._. Much_JJ work_NN still_RB needs_VBZ to_TO be_VB done_VBN to_TO improve_VB the_DT data_NNS on_IN malaria_NN ’s_POS impact_NN ,_, notably_RB to_TO help_VB countries_NNS focus_VB their_PRP$ resources_NNS ._. But_CC it_PRP is_VBZ clear_JJ that_IN global_JJ progress_NN has_VBZ stagnated_VBN ,_, with_IN around_RB 200_CD m_CD annual_JJ cases_NNS and_CC at_IN least_JJS 430,000_CD deaths_NNS imposing_VBG a_DT heavy_JJ human_JJ and_CC financial_JJ toll_NN ._. There_EX is_VBZ limited_JJ potential_NN or_CC appetite_NN for_IN private_JJ sector_NN funding_NN mechanisms_NNS and_CC in_IN the_DT build_NN -_HYPH up_RP to_IN “_`` replenishment_NN ”_'' fundraisings_NNS for_IN international_JJ funding_NN agencies_NNS this_DT year_NN ,_, the_DT monies_NNS invested_VBN remain_VBP far_RB below_IN the_DT levels_NNS estimated_VBN to_TO be_VB necessary_JJ to_TO tackle_VB the_DT disease_NN ._. Listen_VB to_IN the_DT podcast_NN :_: Gene_NNP -_HYPH drive_VB technology_NN and_CC the_DT fight_NN against_IN malaria_NN Register_VB here_RB to_TO get_VB FT_NNP Health_NNP by_IN email_NN for_IN free_JJ each_DT Friday_NNP Abdourahmane_NNP Diallo_NNP ,_, former_JJ health_NN minister_NN of_IN Guinea_NNP and_CC newly_RB appointed_VBN chief_JJ executive_NN of_IN the_DT Roll_NNP Back_NNP Malaria_NNP Partnership_NNP ._. What_WP is_VBZ your_PRP$ interest_NN in_IN malaria_NN ?_. I_PRP ’m_VBP originally_RB from_IN Guinea_NNP and_CC I_PRP could_MD n’t_RB say_VB how_WRB many_JJ times_NNS I_PRP ’ve_VBP had_VBN malaria_NN since_IN I_PRP was_VBD a_DT child_NN ._. I_PRP ’m_VBP a_DT medical_JJ doctor_NN by_IN training_NN and_CC had_VBD an_DT international_JJ public_JJ health_NN career_NN focused_VBN on_IN developing_VBG countries_NNS ._. I_PRP worked_VBD for_IN [_-LRB- US_NNP consultancy_NN ]_-RRB- JSI_NNP and_CC the_DT US_NNP President_NNP ’s_POS Malaria_NNP Initiative_NNP ._. I_PRP became_VBD minister_NN of_IN health_NN in_IN 2016_CD and_CC when_WRB I_PRP finished_VBD I_PRP wanted_VBD to_TO go_VB back_RB into_IN public_JJ health_NN and_CC help_VB tackle_VB a_DT disease_NN with_IN a_DT global_JJ dimension_NN ._. What_WP are_VBP your_PRP$ priorities_NNS at_IN RBM_NNP ?_. We_PRP are_VBP at_IN a_DT critical_JJ phase_NN in_IN the_DT fight_NN against_IN malaria_NN ._. With_IN the_DT Global_JJ Fund_NN to_TO Fight_VB Aids_NN ,_, TB_NNP and_CC Malaria_NNP replenishment_NN this_DT year_NN ,_, we_PRP will_MD step_VB up_RP the_DT fight_NN ._. My_PRP$ priority_NN is_VBZ to_TO really_RB call_VB on_IN all_DT governments_NNS to_TO play_VB their_PRP$ part_NN ._. To_TO make_VB the_DT biggest_JJS difference_NN ,_, we_PRP need_VBP to_TO help_VB the_DT highest_JJS malaria_NN -_HYPH burden_NN countries_NNS get_VBP back_RB on_IN track_NN through_IN four_CD key_JJ responses_NNS :_: political_JJ will_NN ,_, strategic_JJ data_NNS to_TO drive_VB impact_NN ,_, better_JJR guidance_NN on_IN up_RP -_HYPH to_IN -_HYPH date_NN scientifically_RB proven_VBN approaches_NNS ,_, and_CC a_DT co-ordinated_VBN response_NN ._. What_WP is_VBZ the_DT likelihood_NN of_IN ending_VBG malaria_NN ?_. We_PRP believe_VBP it_PRP is_VBZ possible_JJ to_TO end_VB malaria_NN within_IN our_PRP$ lifetime_NN ._. But_CC there_EX has_VBZ to_TO be_VB a_DT global_JJ collective_JJ effort_NN from_IN all_DT angles_NNS with_IN all_DT stakeholders_NNS to_TO make_VB it_PRP happen_VB ._. Our_PRP$ theme_NN is_VBZ “_`` malaria_NN starts_VBZ with_IN me_PRP ”_'' ._. We_PRP are_VBP calling_VBG on_IN pretty_RB much_RB everyone_NN to_TO contribute_VB :_: political_JJ leaders_NNS to_TO maintain_VB their_PRP$ commitment_NN to_IN funding_NN ;_, the_DT private_JJ sector_NN ;_, and_CC the_DT citizens_NNS of_IN every_DT country_NN to_TO play_VB their_PRP$ part_NN themselves_PRP ,_, by_IN teaching_VBG others_NNS and_CC holding_VBG their_PRP$ political_JJ leaders_NNS accountable_JJ ._. Budgeting_NN for_IN health_NN New_JJ official_JJ data_NN breaks_VBZ down_RP UK_NNP health_NN spending_NN by_IN financing_NN mechanism_NN ,_, function_NN ,_, and_CC provider_NN organisation_NN ._. Government_NN expenditure_NN accounted_VBD for_IN 79_CD per_NN cent_NN of_IN the_DT 2017_CD total_NN ,_, a_DT proportion_NN little_RB changed_VBN since_IN 2013_CD ._. (_-LRB- ONS_NNP )_-RRB- Vaccination_NN fears_NNS grow_VBP World_NN immunisation_NN week_NN celebrated_VBD vaccination_NN successes_NNS but_CC also_RB noted_VBD the_DT damage_NN from_IN misinformation_NN in_IN places_NNS like_IN the_DT Democratic_NNP Republic_NNP of_IN Congo_NNP where_WRB the_DT Ebola_NNP outbreak_NN is_VBZ spiralling_VBG ._. New_NNP WHO_NNP and_CC Unicef_NNP analysis_NN said_VBD more_JJR than_IN 20_CD m_NN children_NNS went_VBD unvaccinated_VBN each_DT year_NN over_IN the_DT past_JJ eight_CD years_NNS ,_, leaving_VBG 170_CD m_NNS under_IN -_HYPH 10s_NNS currently_RB without_IN protection_NN ._. The_DT top_JJ high_JJ -_HYPH income_NN countries_NNS where_WRB children_NNS did_VBD not_RB receive_VB a_DT first_JJ vaccine_NN dose_NN are_VBP the_DT US_NNP —_: which_WDT this_DT week_NN hit_VBD record_JJ levels_NNS of_IN measles_NNS since_IN it_PRP was_VBD eliminated_VBN in_IN 2000_CD —_: followed_VBN by_IN France_NNP ,_, UK_NNP ,_, Argentina_NNP and_CC Italy_NNP ._. (_-LRB- VoA_NNP ,_, Guardian_NNP ,_, Washington_NNP Post_NNP ,_, Unicef_NNP )_-RRB- Antibiotics_NNS alert_NN A_DT biotech_NN bankruptcy_NN illustrated_VBD the_DT disaster_NN in_IN the_DT antibiotics_NNS market_NN ,_, said_VBD the_DT Wellcome_NNP Trust_NNP chief_NN :_: there_EX is_VBZ no_DT viable_JJ route_NN to_IN market_NN for_IN new_JJ drugs_NNS ,_, however_RB valuable_JJ they_PRP may_MD be_VB to_IN society_NN ._. One_CD possible_JJ route_NN is_VBZ switching_VBG to_TO “_`` pull_VB ”_'' incentives_NNS which_WDT reward_VBP R&D_NN done_VBN well_RB ._. (_-LRB- FT_NNP ,_, Wired_NNP )_-RRB- Sexual_JJ health_NN The_DT US_NNP came_VBD under_IN fire_NN for_IN having_VBG references_NNS to_IN sexual_JJ and_CC reproductive_JJ health_NN removed_VBN from_IN a_DT UN_NNP resolution_NN on_IN sexual_JJ violence_NN ._. British_JJ MPs_NNS hit_VBD out_RP at_IN anomalies_NNS in_IN abortion_NN rights_NNS in_IN Northern_NNP Ireland_NNP ._. (_-LRB- BBC_NNP ,_, UK_NNP parliament_NN )_-RRB- Frontline_NN dilemmas_NNS Better_JJR guidance_NN and_CC training_NN are_VBP needed_VBN for_IN humanitarian_JJ workers_NNS in_IN conflict_NN zones_NNS faced_VBN with_IN difficult_JJ ethical_JJ decisions_NNS ._. When_WRB a_DT hospital_NN is_VBZ bombed_VBN ,_, is_VBZ it_PRP better_JJR to_TO rebuild_VB at_IN the_DT same_JJ location_NN or_CC move_VB to_IN a_DT safer_JJR area_NN but_CC one_CD which_WDT may_MD make_VB access_NN for_IN locals_NNS more_RBR difficult_JJ ?_. (_-LRB- Johns_NNP Hopkins_NNP Center_NNP for_IN Humanitarian_NNP Health_NNP )_-RRB- Drugs_NNS by_IN drone_NN The_DT world_NN 's_POS largest_JJS drone_NN delivery_NN network_NN is_VBZ bringing_VBG medicines_NNS ,_, vaccines_NNS and_CC blood_NN to_IN 2,000_CD clinics_NNS in_IN Ghana_NNP ._. Health_NN workers_NNS will_MD receive_VB deliveries_NNS via_IN a_DT parachute_NN drop_NN within_IN about_RB 30_CD minutes_NNS of_IN placing_VBG their_PRP$ orders_NNS by_IN text_NN message_NN ._. (_-LRB- FT_NN )_-RRB- Food_NN for_IN thought_VBN The_DT WHO_NNP called_VBD for_IN industrially_RB produced_VBN trans_NN fats_NNS to_TO be_VB replaced_VBN by_IN healthier_JJR fats_NNS and_CC oils_NNS and_CC eliminated_VBN from_IN processed_VBN foods_NNS completely_RB by_IN 2023_CD ._. Some_DT UK_NNP campaigners_NNS highlighted_VBD the_DT limited_JJ powers_NNS of_IN local_JJ authorities_NNS to_TO restrict_VB advertising_NN on_IN unhealthy_JJ foods_NNS while_IN others_NNS called_VBD for_IN a_DT new_JJ watchdog_NN to_TO tackle_VB children_NNS ’s_POS food_NN insecurity_NN ._. The_DT FT_NNP said_VBD meat_NN needed_VBN to_TO justify_VB its_PRP$ presence_NN on_IN dining_NN tables_NNS in_IN the_DT face_NN of_IN concerns_NNS over_IN human_JJ health_NN ,_, animal_NN welfare_NN and_CC the_DT environment_NN ._. (_-LRB- WHO_NNP ,_, Guardian_NNP ,_, Food_NNP Foundation_NNP ,_, FT_NNP )_-RRB- Indian_JJ health_NN Healthcare_NN is_VBZ yet_RB to_TO become_VB a_DT major_JJ issue_NN in_IN the_DT Indian_JJ general_JJ election_NN despite_IN serious_JJ problems_NNS such_JJ as_IN out_IN -_HYPH of_IN -_HYPH pocket_NN medical_JJ expenses_NNS causing_VBG great_JJ hardship_NN ._. A_DT dedicated_VBN LGBT_NNP clinic_NN in_IN Mumbai_NNP offers_VBZ some_DT respite_NN from_IN the_DT discrimination_NN experienced_VBN at_IN many_JJ state_NN facilities_NNS ._. (_-LRB- The_DT Wire_NNP ,_, Guardian_NNP )_-RRB- Keeping_VBG active_JJ Some_DT 23_CD per_NN cent_NN of_IN adults_NNS and_CC 80_CD per_NN cent_NN of_IN adolescents_NNS are_VBP not_RB sufficiently_RB physically_RB active_JJ and_CC risk_VBP diseases_NNS such_JJ as_IN obesity_NN ._. The_DT WHO_NNP 's_POS first_JJ guidelines_NNS for_IN children_NNS 's_POS physical_JJ activity_NN include_VBP recommendations_NNS on_IN screen_NN time_NN ._. Some_DT experts_NNS doubted_VBD the_DT report_NN ’s_POS evidence_NN base_NN ._. A_DT separate_JJ study_NN showed_VBD Americans_NNPS becoming_VBG increasingly_RB sedentary_JJ ._. (_-LRB- WHO_WP ,_, Guardian_NNP ,_, Jama_NNP )_-RRB- Millennial_JJ malaise_NN A_DT long_RB -_HYPH running_VBG US_NNP survey_NN found_VBD millennials_NNS (_-LRB- those_DT born_VBN between_IN 1981_CD and_CC 1996_CD )_-RRB- were_VBD less_RBR healthy_JJ than_IN their_PRP$ Generation_NN X_NNP predecessors_NNS at_IN the_DT same_JJ age_NN ._. The_DT trend_NN could_MD have_VB serious_JJ effects_NNS on_IN the_DT US_NNP economy_NN over_IN the_DT next_JJ 20_CD years_NNS including_VBG on_IN workplace_NN productivity_NN and_CC healthcare_NN costs_NNS ._. (_-LRB- Blue_NNP Cross_NNP Blue_NNP Shield_NNP )_-RRB- Opioids_NNS crisis_NN The_DT US_NNP government_NN filed_VBD the_DT first_JJ criminal_JJ charges_NNS against_IN a_DT drug_NN distributor_NN for_IN allegedly_RB fuelling_VBG the_DT country_NN 's_POS opioid_JJ epidemic_NN ._. President_NNP Trump_NNP vowed_VBD to_TO continue_VB the_DT fight_NN to_IN the_DT finish_NN ._. (_-LRB- Reuters_NNP )_-RRB- Big_JJ Pharma_NN bets_NNS big_JJ As_IN patents_NNS rise_VBP and_CC shareholder_NN pressure_NN leads_VBZ to_IN cuts_NNS in_IN R&D_NN ,_, Big_NNP Pharma_NNP has_VBZ been_VBN buying_VBG smaller_JJR companies_NNS to_TO fill_VB their_PRP$ drug_NN pipelines_NNS ._. Will_MD the_DT gamble_NN be_VB worth_JJ it_PRP ?_. AstraZeneca_NNP boss_NN Pascal_NNP Soriot_NNP reflects_VBZ on_IN Pfizer_NNP 's_POS attempted_VBN takeover_NN of_IN his_PRP$ company_NN ._. (_-LRB- FT_NN video_NN ,_, FT_NNP )_-RRB- Dentistry_NN doubts_VBZ “_`` We_PRP have_VBP a_DT fraught_JJ relationship_NN with_IN dentists_NNS as_IN authority_NN figures_NNS ,_, ”_'' argues_VBZ a_DT new_JJ analysis_NN by_IN The_DT Atlantic_NNP ._. The_DT profession_NN lacks_VBZ the_DT same_JJ level_NN of_IN scientific_JJ scrutiny_NN as_IN medicine_NN ,_, it_PRP says_VBZ ,_, often_RB leading_VBG to_IN gratuitous_JJ procedures_NNS ._. Dentists_NNS are_VBP however_RB ideally_RB placed_VBN to_TO help_VB detect_VB diabetes_NN and_CC cardiovascular_JJ disease_NN ._. (_-LRB- The_DT Atlantic_NNP ,_, BMJ_NNP )_-RRB- Truth_NN or_CC scare_NN ?_. A_DT BBC_NNP series_NN aims_VBZ to_TO separate_VB medical_JJ truth_NN from_IN fiction_NN ._. (_-LRB- BBC_NNP iPlayer_NNP )_-RRB- Best_JJS from_IN the_DT journals_NNS Investing_VBG in_IN adolescent_JJ health_NN More_JJR children_NNS and_CC adolescents_NNS than_IN ever_RB before_RB are_VBP exposed_VBN to_IN risks_NNS of_IN diseases_NNS from_IN factors_NNS such_JJ as_IN tobacco_NN and_CC alcohol_NN use_NN ,_, processed_VBN foods_NNS and_CC reduced_VBN physical_JJ activity_NN ._. Early_JJ intervention_NN could_MD bring_VB high_JJ returns_NNS on_IN investment_NN and_CC reduce_VB the_DT risk_NN of_IN premature_JJ deaths_NNS ._. (_-LRB- BMJ_NNP )_-RRB- Health_NN emergencies_NNS Half_PDT the_DT world_NN 's_POS deaths_NNS come_VBP from_IN medical_JJ emergencies_NNS ,_, such_JJ as_IN accidents_NNS ,_, falls_NNS and_CC burns_NNS (_-LRB- 22_CD per_NN cent_NN )_-RRB- ;_: heart_NN attacks_NNS (_-LRB- 17_CD per_NN cent_NN )_-RRB- ;_: lung_NN infections_NNS (_-LRB- 11_CD per_NN cent_NN )_-RRB- ;_: and_CC strokes_NNS (_-LRB- 7_CD per_NN cent_NN )_-RRB- ,_, with_IN a_DT much_RB higher_JJR incidence_NN in_IN poorer_JJR countries_NNS ._. Improvement_NN could_MD come_VB through_IN strengthening_VBG healthcare_NN ,_, transport_NN ,_, training_NN and_CC communication_NN systems_NNS ._. (_-LRB- BMJ_NNP )_-RRB- Medical_JJ misinformation_NN Medical_JJ journals_NNS have_VBP an_DT important_JJ role_NN to_TO play_VB in_IN galvanising_VBG and_CC co-ordinating_VBG the_DT response_NN from_IN the_DT health_NN community_NN to_IN medical_JJ misinformation_NN ._. (_-LRB- Jama_NNP )_-RRB- Transgender_JJ health_NN The_DT story_NN of_IN how_WRB one_CD man_NN built_VBD the_DT largest_JJS study_NN of_IN transgender_JJ people_NNS in_IN the_DT world_NN :_: The_DT European_NNP Network_NNP for_IN the_DT Investigation_NNP of_IN Gender_NNP Incongruence_NNP ._. (_-LRB- Nature_NN )_-RRB- A_DT hidden_VBN disease_NN Thousands_NNS of_IN non-smokers_NNS die_VBP from_IN lung_NN cancer_NN thanks_NNS to_IN air_NN pollution_NN and_CC other_JJ carcinogens_NNS but_CC the_DT condition_NN is_VBZ still_RB viewed_VBN as_IN a_DT “_`` smoker_NN ’s_POS disease_NN ”_'' ._. Screening_VBG for_IN the_DT condition_NN has_VBZ long_RB been_VBN controversial_JJ ._. (_-LRB- Journal_NNP of_IN the_DT Royal_NNP Society_NNP of_IN Medicine_NNP ,_, The_DT Economist_NNP )_-RRB- Fantastic_JJ voyage_NN Surgeons_NNS for_IN a_DT while_NN have_VBP been_VBN able_JJ to_TO steer_VB robotic_JJ devices_NNS such_JJ as_IN catheters_NNS but_CC a_DT new_JJ “_`` self_NN -_HYPH driving_NN ”_'' model_NN uses_VBZ artificial_JJ intelligence_NN and_CC image_NN -_HYPH processing_NN to_TO reach_VB its_PRP$ destination_NN ._. One_CD analogy_NN consists_VBZ of_IN fighter_NN pilot_NN and_CC fighter_NN plane_NN :_: “_`` The_DT fighter_NN plane_NN takes_VBZ on_RP the_DT routine_JJ tasks_NNS like_IN flying_VBG the_DT plane_NN ,_, so_IN the_DT pilot_NN can_MD focus_VB on_IN the_DT higher_JJR -_HYPH level_NN tasks_NNS of_IN the_DT mission_NN ._. ”_'' (_-LRB- Science_NNP Robotics_NNP )_-RRB- Best_JJS meal_NN of_IN the_DT day_NN Missing_VBG breakfast_NN could_MD mean_VB an_DT increased_VBN risk_NN of_IN cardiovascular_JJ disease_NN ._. (_-LRB- Journal_NNP of_IN the_DT American_NNP College_NNP of_IN Cardiology_NNP )_-RRB- Traveller_NN health_NN The_DT traveller_NN community_NN suffers_VBZ poor_JJ health_NN outcomes_NNS because_IN of_IN problems_NNS accessing_VBG health_NN and_CC education_NN services_NNS ._. How_WRB can_MD GPs_NNS and_CC hospitals_NNS support_VB this_DT neglected_VBN group_NN ?_. (_-LRB- BMJ_NNP ,_, 28_CD m_NNS )_-RRB- FT_NNP Health_NNP is_VBZ free_JJ to_TO read_VB —_: please_UH forward_VB and_CC encourage_VB others_NNS to_TO register_VB here_RB Contact_VB us_PRP via_IN Twitter_NNP ,_, Facebook_NNP ,_, LinkedIn_NNP or_CC email_NN health@ft.com_ADD Latest_JJS news_NN at_IN www.ft.com/health_NNP and_CC on_IN Twitter_NNP @FTHealth_NNP Greta_NNP Thunberg_NNP ,_, the_DT 16_CD -_HYPH year_NN old_JJ climate_NN change_NN activist_NN and_CC Asperger_NNP ’s_POS sufferer_NN ,_, has_VBZ taken_VBN the_DT world_NN by_IN storm_NN ,_, but_CC too_RB many_JJ people_NNS with_IN autism_NN still_RB face_VBP cruel_JJ treatment_NN ._. (_-LRB- The_DT Guardian_NNP )_-RRB-","NNP ’s NNP NNP NN VBD with some JJ NN NNS : the JJ - NN NN of a VBG NN in NNP VBZ RB one JJ JJ NN to VBG the NN . NNS VBP the NN of JJR NNS , NNS and NNS , JJ NNS to VB to the VBG NN of NN and the NN through “ NN - NN ” NN to VB out the NN that VBZ the NN between NNS . There VBZ VBN some NN towards VBG the NN among the 21 NNS VBN for its NN by JJ NN . Yet the NN VBZ RBR JJ in some of the JJS NN NNS JJ as NNP and there VBZ VBG RB , RB in NNP , where NN NNS VBP VBG the NN NN and VBG a JJ JJ NN . JJ NN RB VBZ to VB VBN to VB the NNS on NN ’s NN , RB to VB NNS VB their NNS . But it VBZ JJ that JJ NN VBZ VBN , with RB 200 m JJ NNS and at JJS 430,000 NNS VBG a JJ JJ and JJ NN . There VBZ JJ NN or NN for JJ NN NN NNS and in the NN - up to “ NN ” NNS for JJ NN NNS this NN , the NNS VBN VBP RB below the NNS VBN to VB JJ to VB the NN . VB to the NN : NNP - VB NN and the NN against NN VB RB to VB NNP NNP by NN for JJ each NNP NNP NNP , JJ NN NN of NNP and RB VBN JJ NN of the NNP NNP NNP NNP . What VBZ your NN in NN ? I VBP RB from NNP and I could RB VB how JJ NNS I VBP VBN NN since I VBD a NN . I VBP a JJ NN by NN and VBD an JJ JJ NN NN VBN on VBG NNS . I VBD for [ NNP NN ] NNP and the NNP NNP ’s NNP NNP . I VBD NN of NN in 2016 and when I VBD I VBD to VB RB into JJ NN and VB VB a NN with a JJ NN . What VBP your NNS at NNP ? We VBP at a JJ NN in the NN against NN . With the JJ NN to VB NN , NNP and NNP NN this NN , we will VB up the NN . My NN VBZ to RB VB on all NNS to VB their NN . To VB the JJS NN , we VBP to VB the JJS NN - NN NNS VBP RB on NN through four JJ NNS : JJ NN , JJ NNS to VB NN , JJR NN on up - to - NN RB VBN NNS , and a VBN NN . What VBZ the NN of VBG NN ? We VBP it VBZ JJ to VB NN within our NN . But there VBZ to VB a JJ JJ NN from all NNS with all NNS to VB it VB . Our NN VBZ “ NN VBZ with me ” . We VBP VBG on RB RB NN to VB : JJ NNS to VB their NN to NN ; the JJ NN ; and the NNS of every NN to VB their NN themselves , by VBG NNS and VBG their JJ NNS JJ . NN for NN JJ JJ NN VBZ down NNP NN NN by NN NN , NN , and NN NN . NN NN VBD for 79 NN NN of the 2017 NN , a NN RB VBN since 2013 . ( NNP ) NN NNS VBP NN NN NN VBD NN NNS but RB VBD the NN from NN in NNS like the NNP NNP of NNP where the NNP NN VBZ VBG . NNP NNP and NNP NN VBD JJR than 20 NN NNS VBD VBN each NN over the JJ eight NNS , VBG 170 NNS under - NNS RB without NN . The JJ JJ - NN NNS where NNS VBD RB VB a JJ NN NN VBP the NNP — which this NN VBD JJ NNS of NNS since it VBD VBN in 2000 — VBN by NNP , NNP , NNP and NNP . ( NNP , NNP , NNP NNP , NNP ) NNS NN A NN NN VBD the NN in the NNS NN , VBD the NNP NNP NN : there VBZ no JJ NN to NN for JJ NNS , RB JJ they may VB to NN . One JJ NN VBZ VBG to “ VB ” NNS which VBP NN VBN RB . ( NNP , NNP ) JJ NN The NNP VBD under NN for VBG NNS to JJ and JJ NN VBN from a NNP NN on JJ NN . JJ NNS VBD out at NNS in NN NNS in NNP NNP . ( NNP , NNP NN ) NN NNS JJR NN and NN VBP VBN for JJ NNS in NN NNS VBN with JJ JJ NNS . When a NN VBZ VBN , VBZ it JJR to VB at the JJ NN or VB to a JJR NN but one which may VB NN for NNS RBR JJ ? ( NNP NNP NNP for NNP NNP ) NNS by NN The NN 's JJS NN NN NN VBZ VBG NNS , NNS and NN to 2,000 NNS in NNP . NN NNS will VB NNS via a NN NN within RB 30 NNS of VBG their NNS by NN NN . ( NN ) NN for VBN The NNP VBD for RB VBN NN NNS to VB VBN by JJR NNS and NNS and VBN from VBN NNS RB by 2023 . Some NNP NNS VBD the JJ NNS of JJ NNS to VB NN on JJ NNS while NNS VBD for a JJ NN to VB NNS ’s NN NN . The NNP VBD NN VBN to VB its NN on NN NNS in the NN of NNS over JJ NN , NN NN and the NN . ( NNP , NNP , NNP NNP , NNP ) JJ NN NN VBZ RB to VB a JJ NN in the JJ JJ NN despite JJ NNS JJ as out - of - NN JJ NNS VBG JJ NN . A VBN NNP NN in NNP VBZ some NN from the NN VBN at JJ NN NNS . ( The NNP , NNP ) VBG JJ Some 23 NN NN of NNS and 80 NN NN of NNS VBP RB RB RB JJ and VBP NNS JJ as NN . The NNP 's JJ NNS for NNS 's JJ NN VBP NNS on NN NN . Some NNS VBD the NN ’s NN NN . A JJ NN VBD NNPS VBG RB JJ . ( WHO , NNP , NNP ) JJ NN A RB - VBG NNP NN VBD NNS ( those VBN between 1981 and 1996 ) VBD RBR JJ than their NN NNP NNS at the JJ NN . The NN could VB JJ NNS on the NNP NN over the JJ 20 NNS VBG on NN NN and NN NNS . ( NNP NNP NNP NNP ) NNS NN The NNP NN VBD the JJ JJ NNS against a NN NN for RB VBG the NN 's JJ NN . NNP NNP VBD to VB the NN to the NN . ( NNP ) JJ NN NNS JJ As NNS VBP and NN NN VBZ to NNS in NN , NNP NNP VBZ VBN VBG JJR NNS to VB their NN NNS . Will the NN VB JJ it ? NNP NN NNP NNP VBZ on NNP 's VBN NN of his NN . ( NN NN , NNP ) NN VBZ “ We VBP a JJ NN with NNS as NN NNS , ” VBZ a JJ NN by The NNP . The NN VBZ the JJ NN of JJ NN as NN , it VBZ , RB VBG to JJ NNS . NNS VBP RB RB VBN to VB VB NN and JJ NN . ( The NNP , NNP ) NN or NN ? A NNP NN VBZ to VB JJ NN from NN . ( NNP NNP ) JJS from the NNS VBG in JJ NN JJR NNS and NNS than RB RB VBP VBN to NNS of NNS from NNS JJ as NN and NN NN , VBN NNS and VBN JJ NN . JJ NN could VB JJ NNS on NN and VB the NN of JJ NNS . ( NNP ) NN NNS Half the NN 's NNS VBP from JJ NNS , JJ as NNS , NNS and NNS ( 22 NN NN ) ; NN NNS ( 17 NN NN ) ; NN NNS ( 11 NN NN ) ; and NNS ( 7 NN NN ) , with a RB JJR NN in JJR NNS . NN could VB through VBG NN , NN , NN and NN NNS . ( NNP ) JJ NN JJ NNS VBP an JJ NN to VB in VBG and VBG the NN from the NN NN to JJ NN . ( NNP ) JJ NN The NN of how one NN VBD the JJS NN of JJ NNS in the NN : The NNP NNP for the NNP of NNP NNP . ( NN ) A VBN NN NNS of NNS VBP from NN NN NNS to NN NN and JJ NNS but the NN VBZ RB VBN as a “ NN ’s NN ” . VBG for the NN VBZ RB VBN JJ . ( NNP of the NNP NNP of NNP , The NNP ) JJ NN NNS for a NN VBP VBN JJ to VB JJ NNS JJ as NNS but a JJ “ NN - NN ” NN VBZ JJ NN and NN - NN to VB its NN . One NN VBZ of NN NN and NN NN : “ The NN NN VBZ on the JJ NNS like VBG the NN , so the NN can VB on the JJR - NN NNS of the NN . ” ( NNP NNP ) JJS NN of the NN VBG NN could VB an VBN NN of JJ NN . ( NNP of the NNP NNP of NNP ) NN NN The NN NN VBZ JJ NN NNS because of NNS VBG NN and NN NNS . How can NNS and NNS VB this VBN NN ? ( NNP , 28 NNS ) NNP NNP VBZ JJ to VB — please VB and VB NNS to VB RB VB us via NNP , NNP , NNP or NN health@ft.com JJS NN at NNP and on NNP NNP NNP NNP , the 16 - NN JJ NN NN NN and NNP ’s NN , VBZ VBN the NN by NN , but RB JJ NNS with NN RB VBP JJ NN . ( The NNP )"
46,1269,mainstream,M078a1,vaccine.autism,"“_`` Leaky_JJ gut_NN autism_NN theory_NN doubted_VBN ”_'' ,_, was_VBD the_DT headline_NN from_IN BBC_NNP News_NNP on_IN March_NNP 17_CD 2008_CD ._. The_DT Daily_NNP Telegraph_NNP and_CC the_DT Daily_NNP Mail_NNP also_RB reported_VBD that_IN researchers_NNS have_VBP found_VBN no_DT evidence_NN to_TO support_VB the_DT ’_`` leaky_JJ gut_NN theory_NN ’_'' ._. They_PRP say_VBP that_IN this_DT theory_NN proposes_VBZ that_IN vaccines_NNS such_JJ as_IN MMR_NNP damage_VBP the_DT intestine_NN causing_VBG digestive_JJ problems_NNS ,_, leading_VBG to_IN the_DT production_NN of_IN peptides_NNS “_'' which_WDT can_MD damage_VB the_DT brain_NN and_CC possibly_RB cause_VB autism_NN ”_'' ._. This_DT well_RB conducted_VBN study_NN used_VBD reliable_JJ analysis_NN techniques_NNS to_TO compare_VB autistic_JJ children_NNS across_IN a_DT broad_JJ range_NN of_IN intelligences_NNS to_IN age_NN -_HYPH matched_VBN control_NN children_NNS ._. Despite_IN the_DT newspaper_NN headlines_NNS and_CC coverage_NN ,_, the_DT study_NN did_VBD not_RB look_VB at_IN the_DT effects_NNS of_IN the_DT MMR_NN jab_NN and_CC autism_NN ._. Instead_RB ,_, it_PRP tested_VBD and_CC compared_VBD the_DT urine_NN of_IN autistic_JJ boys_NNS with_IN the_DT urine_NN of_IN boys_NNS without_IN autism_NN ._. The_DT researchers_NNS conclude_VBP that_IN there_EX were_VBD no_DT differences_NNS between_IN the_DT levels_NNS of_IN peptides_NNS in_IN the_DT groups_NNS and_CC say_VBP they_PRP have_VBP effectively_RB disproved_VBN the_DT ’_`` leaky_JJ gut_NN theory_NN ‘_'' ._. However_RB ,_, further_JJ research_NN is_VBZ needed_VBN to_TO establish_VB whether_IN a_DT casein_NN and_CC gluten_NN -_HYPH free_JJ diet_NN has_VBZ other_JJ effects_NNS on_IN autism_NN ._. The_DT researchers_NNS call_VBP for_IN more_JJR studies_NNS into_IN special_JJ diet_NN as_IN a_DT treatment_NN for_IN autism_NN ,_, but_CC they_PRP do_VBP not_RB suggest_VB that_IN their_PRP$ research_NN has_VBZ any_DT implication_NN for_IN the_DT discredited_VBN MMR_NN vaccine_NN /_, autism_NN theory_NN ._. Where_WRB did_VBD the_DT story_NN come_VB from_IN ?_. Dr_NNP Hilary_NNP Cass_NNP from_IN the_DT Great_NNP Ormond_NNP Street_NNP Hospital_NNP for_IN Children_NNPS and_CC colleagues_NNS from_IN around_IN England_NNP and_CC Scotland_NNP carried_VBD out_RP the_DT research_NN ._. The_DT authors_NNS acknowledge_VBP the_DT support_NN of_IN the_DT research_NN and_CC development_NN fund_NN of_IN the_DT Royal_NNP Hospital_NNP for_IN Sick_NNP Children_NNPS in_IN Edinburgh_NNP and_CC the_DT Chief_NNP Scientist_NNP Office_NNP in_IN Scotland_NNP ._. Competing_VBG interests_NNS were_VBD declared_VBN ._. The_DT study_NN was_VBD published_VBN in_IN Archives_NNPS of_IN Disease_NNP in_IN Childhood_NNP ,_, a_DT peer_NN -_HYPH reviewed_VBN medical_JJ journal_NN ._. What_WDT kind_NN of_IN scientific_JJ study_NN was_VBD this_DT ?_. This_DT was_VBD a_DT case_NN control_NN study_NN that_WDT compared_VBD 65_CD boys_NNS with_IN autism_NN ,_, aged_JJ between_IN five_CD and_CC 11_CD years_NNS ,_, with_IN 158_CD control_NN boys_NNS of_IN a_DT similar_JJ age_NN ._. The_DT researchers_NNS say_VBP that_IN ,_, for_IN a_DT number_NN of_IN years_NNS ,_, it_PRP has_VBZ been_VBN thought_VBN that_IN the_DT urine_NN of_IN children_NNS with_IN autism_NN contains_VBZ opioid_JJ peptides_NNS that_WDT originate_VBP from_IN outside_IN the_DT body_NN ._. Opioid_NN peptides_NNS are_VBP chemical_JJ compounds_NNS that_WDT are_VBP so_RB called_VBN because_IN they_PRP resemble_VBP morphine_NN ._. They_PRP can_MD be_VB produced_VBN by_IN the_DT body_NN and_CC through_IN the_DT digestion_NN of_IN foods_NNS such_JJ as_IN grain_NN and_CC milk_NN ._. Grains_NNS such_JJ as_IN wheat_NN ,_, rye_NN ,_, barley_NN and_CC oats_NNS contain_VBP the_DT protein_NN gluten_NN ,_, that_WDT produces_VBZ opioid_JJ peptides_NNS in_IN the_DT gut_NN ,_, while_IN milk_NN produces_VBZ another_DT variety_NN ,_, casein_NN ._. One_CD theory_NN for_IN the_DT development_NN of_IN autism_NN is_VBZ the_DT ’_`` leaky_JJ gut_NN theory_NN ‘_'' :_: the_DT idea_NN that_IN children_NNS with_IN autism_NN become_VBP sensitive_JJ to_IN gluten_NN ._. The_DT gluten_NN is_VBZ thought_VBN to_TO inflame_VB the_DT small_JJ bowel_NN ._. The_DT resulting_VBG damage_NN allows_VBZ opioid_JJ peptides_NNS from_IN food_NN to_TO be_VB absorbed_VBN into_IN the_DT blood_NN and_CC then_RB enter_VB the_DT urine_NN ._. Before_IN the_DT opioid_JJ peptides_NNS in_IN the_DT blood_NN are_VBP excreted_VBN they_PRP are_VBP assumed_VBN to_TO cross_VB into_IN the_DT brain_NN and_CC result_VB in_IN the_DT symptoms_NNS of_IN autism_NN ._. Previous_JJ research_NN has_VBZ proposed_VBN that_IN excluding_VBG casein_NN and_CC gluten_NN (_-LRB- milk_NN and_CC grains_NNS )_-RRB- from_IN the_DT diet_NN might_MD help_VB children_NNS with_IN autism_NN by_IN reducing_VBG the_DT amount_NN of_IN circulating_VBG opioid_JJ peptides_NNS ._. The_DT theory_NN proposes_VBZ that_IN opioid_JJ peptides_NNS found_VBN in_IN urine_NN reflect_VBP a_DT disturbance_NN in_IN the_DT integrity_NN of_IN the_DT gut_NN epithelium_NN (_-LRB- i.e._FW a_DT leaky_JJ gut_NN )_-RRB- ._. Proponents_NNS of_IN the_DT theory_NN hope_VBP that_IN the_DT peptides_NNS can_MD act_VB as_IN a_DT diagnostic_JJ marker_NN for_IN autism_NN and_CC predict_VBP that_IN a_DT diet_NN excluding_VBG gluten_NN and_CC casein_NN could_MD help_VB to_TO treat_VB children_NNS with_IN autistic_JJ symptoms_NNS ._. This_DT study_NN aimed_VBD to_TO determine_VB the_DT occurrence_NN of_IN the_DT peptides_NNS in_IN the_DT urine_NN of_IN children_NNS who_WP have_VBP autism_NN and_CC those_DT who_WP do_VBP not_RB ._. The_DT researchers_NNS recruited_VBD 65_CD boys_NNS from_IN two_CD hospitals_NNS specialising_VBG in_IN autistic_JJ spectrum_NN disorders_NNS in_IN London_NNP ._. For_IN the_DT control_NN group_NN ,_, 202_CD non-autistic_JJ boys_NNS of_IN similar_JJ age_NN were_VBD recruited_VBN from_IN mainstream_JJ infant_NN and_CC primary_JJ schools_NNS in_IN the_DT same_JJ area_NN ._. A_DT questionnaire_NN was_VBD given_VBN to_IN the_DT parents_NNS of_IN the_DT controls_NNS to_TO ‘_`` screen_VB out_RP ’_POS children_NNS with_IN possible_JJ neurological_JJ or_CC psychiatric_JJ difficulties_NNS ._. Forty_CD of_IN the_DT controls_NNS were_VBD excluded_VBN from_IN the_DT study_NN as_IN their_PRP$ parents_NNS did_VBD not_RB complete_VB the_DT questionnaire_NN ,_, or_CC the_DT boys_NNS ’_POS results_NNS were_VBD abnormal_JJ or_CC borderline_JJ ._. Urine_NN samples_NNS were_VBD collected_VBN from_IN all_PDT the_DT children_NNS and_CC analysed_VBN using_VBG equipment_NN that_WDT separates_VBZ the_DT chemical_NN in_IN a_DT liquid_NN (_-LRB- HPLC_NN )_-RRB- ._. Other_JJ equipment_NN was_VBD used_VBN to_TO identify_VB small_JJ and_CC fragile_JJ biological_JJ molecules_NNS ,_, such_JJ as_IN the_DT opioid_JJ peptides_NNS (_-LRB- MALDI_NNP -_HYPH TOF_NNP MS_NNP )_-RRB- ._. What_WP were_VBD the_DT results_NNS of_IN the_DT study_NN ?_. The_DT researchers_NNS say_VBP that_IN their_PRP$ study_NN finds_VBZ no_DT evidence_NN of_IN opioid_JJ peptides_NNS in_IN the_DT urine_NN of_IN boys_NNS with_IN autism_NN or_CC similar_JJ disorders_NNS ._. After_IN adjusting_VBG for_IN the_DT amount_NN of_IN creatinine_NN in_IN the_DT urine_NN ,_, which_WDT is_VBZ a_DT measure_NN of_IN kidney_NN function_NN ,_, the_DT researchers_NNS found_VBD no_DT significant_JJ differences_NNS in_IN the_DT urinary_JJ profiles_NNS (_-LRB- shown_VBN by_IN HPLC_NN )_-RRB- between_IN groups_NNS of_IN boys_NNS with_IN or_CC without_IN autism_NN ._. In_IN those_DT cases_NNS where_WRB HPLC_NNP showed_VBD peaks_NNS in_IN the_DT locations_NNS at_IN which_WDT opioid_JJ peptides_NNS might_MD be_VB expected_VBN to_TO be_VB found_VBN ,_, further_JJ testing_NN by_IN mass_JJ spectrometry_NN (_-LRB- MALDI_NNP -_HYPH TOF_NNP )_-RRB- showed_VBD that_IN these_DT peaks_NNS did_VBD not_RB represent_VB opioid_JJ peptides_NNS ._. What_WDT interpretations_NNS did_VBD the_DT researchers_NNS draw_VB from_IN these_DT results_NNS ?_. The_DT researchers_NNS say_VBP that_IN “_`` given_VBN the_DT lack_NN of_IN evidence_NN for_IN any_DT opioid_JJ peptiduria_NN in_IN children_NNS with_IN autism_NN it_PRP can_MD neither_CC serve_VB as_IN a_DT biomedical_JJ marker_NN for_IN autism_NN ,_, nor_CC be_VB employed_VBN to_TO predict_VB or_CC monitor_VB response_NN to_IN a_DT casein_NN and_CC gluten_NN exclusion_NN diet_NN ”_'' ._. The_DT researchers_NNS say_VBP that_IN these_DT findings_NNS effectively_RB disprove_VBP the_DT ’_`` leaky_JJ gut_NN theory_NN ‘_'' ,_, which_WDT predicts_VBZ that_IN these_DT proteins_NNS should_MD be_VB found_VBN in_IN the_DT urine_NN of_IN autistic_JJ children_NNS ._. They_PRP suggest_VBP that_IN healthcare_NN professionals_NNS and_CC parents_NNS should_MD stop_VB testing_VBG children_NNS with_IN autism_NN for_IN urinary_JJ opioid_JJ peptides_NNS ,_, and_CC note_VB that_IN commercial_JJ laboratories_NNS around_IN the_DT world_NN still_RB widely_RB advertise_VBP these_DT tests_NNS on_IN the_DT internet_NN ._. What_WP does_VBZ the_DT NHS_NNP Knowledge_NN Service_NN make_VB of_IN this_DT study_NN ?_. This_DT study_NN has_VBZ a_DT number_NN of_IN strengths_NNS ._. The_DT researchers_NNS used_VBD accepted_VBD and_CC applied_VBD definitions_NNS of_IN autism_NN and_CC selected_VBN children_NNS across_IN a_DT broad_JJ range_NN of_IN intelligence_NN ._. The_DT urine_NN testing_NN appears_VBZ to_TO have_VB been_VBN conducted_VBN reliably_RB and_CC the_DT researchers_NNS further_RB analysed_VBD the_DT peptide_NN peaks_NNS found_VBN by_IN chromatography_NN (_-LRB- HPLC_NNP )_-RRB- with_IN advanced_JJ mass_NN spectroscopy_NN techniques_NNS (_-LRB- MALDI_NNP -_HYPH TOF_NNP )_-RRB- ._. They_PRP acknowledge_VBP some_DT limitations_NNS ,_, however_RB ,_, including_VBG :_: •_NFP The_DT autistic_JJ children_NNS were_VBD selected_VBN from_IN tertiary_JJ or_CC specialist_NN centres_NNS ._. This_DT may_MD mean_VB that_IN they_PRP had_VBD more_RBR severe_JJ autism_NN than_IN that_DT commonly_RB found_VBN in_IN the_DT community_NN ._. •_NFP It_PRP was_VBD not_RB possible_JJ to_TO match_VB the_DT autistic_JJ children_NNS with_IN low_JJ IQ_NN to_TO control_VB children_NNS with_IN the_DT same_JJ level_NN of_IN IQ_NN ._. Strictly_RB speaking_VBG ,_, this_DT means_VBZ that_IN the_DT groups_NNS were_VBD not_RB balanced_VBN at_IN the_DT start_NN of_IN the_DT study_NN ._. However_RB ,_, as_IN no_DT significant_JJ differences_NNS were_VBD found_VBN in_IN the_DT peptide_NN levels_NNS between_IN any_DT of_IN the_DT groups_NNS that_WDT were_VBD examined_VBN ,_, it_PRP is_VBZ unlikely_JJ that_IN a_DT link_NN would_MD have_VB been_VBN found_VBN between_IN peptide_NN levels_NNS and_CC IQ_NN either_RB ._. The_DT researchers_NNS say_VBP that_IN there_EX is_VBZ no_DT evidence_NN that_IN opioid_JJ peptides_NNS can_MD leak_VB through_IN the_DT gut_NN and_CC cause_VB autism_NN in_IN children_NNS ._. However_RB ,_, further_JJ research_NN is_VBZ needed_VBN to_TO establish_VB whether_IN a_DT casein_NN and_CC gluten_NN -_HYPH free_JJ diet_NN has_VBZ other_JJ effects_NNS on_IN autism_NN ._. The_DT researchers_NNS do_VBP not_RB comment_VB on_IN any_DT implications_NNS of_IN their_PRP$ study_NN with_IN regard_NN to_IN the_DT MMR_NN vaccine_NN ._. Immunisation_NN is_VBZ topical_JJ and_CC attracts_VBZ the_DT reader_NN ’s_POS attention_NN ,_, but_CC well_RB -_HYPH designed_VBN research_NN into_IN other_JJ theories_NNS of_IN how_WRB autism_NN is_VBZ caused_VBN is_VBZ needed_VBN ._.","“ JJ NN NN NN VBN ” , VBD the NN from NNP NNP on NNP 17 2008 . The NNP NNP and the NNP NNP RB VBD that NNS VBP VBN no NN to VB the ’ JJ NN NN ’ . They VBP that this NN VBZ that NNS JJ as NNP VBP the NN VBG JJ NNS , VBG to the NN of NNS “ which can VB the NN and RB VB NN ” . This RB VBN NN VBD JJ NN NNS to VB JJ NNS across a JJ NN of NNS to NN - VBN NN NNS . Despite the NN NNS and NN , the NN VBD RB VB at the NNS of the NN NN and NN . RB , it VBD and VBD the NN of JJ NNS with the NN of NNS without NN . The NNS VBP that there VBD no NNS between the NNS of NNS in the NNS and VBP they VBP RB VBN the ’ JJ NN NN ‘ . RB , JJ NN VBZ VBN to VB whether a NN and NN - JJ NN VBZ JJ NNS on NN . The NNS VBP for JJR NNS into JJ NN as a NN for NN , but they VBP RB VB that their NN VBZ any NN for the VBN NN NN / NN NN . Where VBD the NN VB from ? NNP NNP NNP from the NNP NNP NNP NNP for NNPS and NNS from around NNP and NNP VBD out the NN . The NNS VBP the NN of the NN and NN NN of the NNP NNP for NNP NNPS in NNP and the NNP NNP NNP in NNP . VBG NNS VBD VBN . The NN VBD VBN in NNPS of NNP in NNP , a NN - VBN JJ NN . What NN of JJ NN VBD this ? This VBD a NN NN NN that VBD 65 NNS with NN , JJ between five and 11 NNS , with 158 NN NNS of a JJ NN . The NNS VBP that , for a NN of NNS , it VBZ VBN VBN that the NN of NNS with NN VBZ JJ NNS that VBP from outside the NN . NN NNS VBP JJ NNS that VBP RB VBN because they VBP NN . They can VB VBN by the NN and through the NN of NNS JJ as NN and NN . NNS JJ as NN , NN , NN and NNS VBP the NN NN , that VBZ JJ NNS in the NN , while NN VBZ another NN , NN . One NN for the NN of NN VBZ the ’ JJ NN NN ‘ : the NN that NNS with NN VBP JJ to NN . The NN VBZ VBN to VB the JJ NN . The VBG NN VBZ JJ NNS from NN to VB VBN into the NN and RB VB the NN . Before the JJ NNS in the NN VBP VBN they VBP VBN to VB into the NN and VB in the NNS of NN . JJ NN VBZ VBN that VBG NN and NN ( NN and NNS ) from the NN might VB NNS with NN by VBG the NN of VBG JJ NNS . The NN VBZ that JJ NNS VBN in NN VBP a NN in the NN of the NN NN ( FW a JJ NN ) . NNS of the NN VBP that the NNS can VB as a JJ NN for NN and VBP that a NN VBG NN and NN could VB to VB NNS with JJ NNS . This NN VBD to VB the NN of the NNS in the NN of NNS who VBP NN and those who VBP RB . The NNS VBD 65 NNS from two NNS VBG in JJ NN NNS in NNP . For the NN NN , 202 JJ NNS of JJ NN VBD VBN from JJ NN and JJ NNS in the JJ NN . A NN VBD VBN to the NNS of the NNS to ‘ VB out ’ NNS with JJ JJ or JJ NNS . Forty of the NNS VBD VBN from the NN as their NNS VBD RB VB the NN , or the NNS ’ NNS VBD JJ or JJ . NN NNS VBD VBN from all the NNS and VBN VBG NN that VBZ the NN in a NN ( NN ) . JJ NN VBD VBN to VB JJ and JJ JJ NNS , JJ as the JJ NNS ( NNP - NNP NNP ) . What VBD the NNS of the NN ? The NNS VBP that their NN VBZ no NN of JJ NNS in the NN of NNS with NN or JJ NNS . After VBG for the NN of NN in the NN , which VBZ a NN of NN NN , the NNS VBD no JJ NNS in the JJ NNS ( VBN by NN ) between NNS of NNS with or without NN . In those NNS where NNP VBD NNS in the NNS at which JJ NNS might VB VBN to VB VBN , JJ NN by JJ NN ( NNP - NNP ) VBD that these NNS VBD RB VB JJ NNS . What NNS VBD the NNS VB from these NNS ? The NNS VBP that “ VBN the NN of NN for any JJ NN in NNS with NN it can neither VB as a JJ NN for NN , nor VB VBN to VB or VB NN to a NN and NN NN NN ” . The NNS VBP that these NNS RB VBP the ’ JJ NN NN ‘ , which VBZ that these NNS should VB VBN in the NN of JJ NNS . They VBP that NN NNS and NNS should VB VBG NNS with NN for JJ JJ NNS , and VB that JJ NNS around the NN RB RB VBP these NNS on the NN . What VBZ the NNP NN NN VB of this NN ? This NN VBZ a NN of NNS . The NNS VBD VBD and VBD NNS of NN and VBN NNS across a JJ NN of NN . The NN NN VBZ to VB VBN VBN RB and the NNS RB VBD the NN NNS VBN by NN ( NNP ) with JJ NN NN NNS ( NNP - NNP ) . They VBP some NNS , RB , VBG : • The JJ NNS VBD VBN from JJ or NN NNS . This may VB that they VBD RBR JJ NN than that RB VBN in the NN . • It VBD RB JJ to VB the JJ NNS with JJ NN to VB NNS with the JJ NN of NN . RB VBG , this VBZ that the NNS VBD RB VBN at the NN of the NN . RB , as no JJ NNS VBD VBN in the NN NNS between any of the NNS that VBD VBN , it VBZ JJ that a NN would VB VBN VBN between NN NNS and NN RB . The NNS VBP that there VBZ no NN that JJ NNS can VB through the NN and VB NN in NNS . RB , JJ NN VBZ VBN to VB whether a NN and NN - JJ NN VBZ JJ NNS on NN . The NNS VBP RB VB on any NNS of their NN with NN to the NN NN . NN VBZ JJ and VBZ the NN ’s NN , but RB - VBN NN into JJ NNS of how NN VBZ VBN VBZ VBN ."
47,1139,mainstream,M0a5b7,drug.companies; vaccine,"In_IN the_DT American_JJ political_JJ system_NN ,_, lobbying_NN is_VBZ par_JJ for_IN the_DT course_NN ._. It_PRP has_VBZ come_VBN to_TO be_VB expected_VBN that_IN major_JJ industries_NNS ,_, and_CC the_DT leading_VBG corporations_NNS in_IN those_DT industries_NNS ,_, will_MD seek_VB to_TO influence_VB legislation_NN ,_, regulation_NN ,_, and_CC the_DT enforcement_NN of_IN government_NN decisions_NNS ,_, such_JJ that_IN they_PRP receive_VBP preferential_JJ treatment_NN ._. This_DT could_MD come_VB in_IN the_DT form_NN of_IN campaign_NN contributions_NNS ,_, or_CC actual_JJ lobbying_NN ,_, with_IN a_DT lobbyist_NN working_VBG on_IN behalf_NN of_IN the_DT corporation_NN that_WDT has_VBZ paid_VBN them_PRP to_TO influence_VB a_DT particular_JJ vote_NN or_CC governmental_JJ decision_NN ._. What_WP it_PRP is_VBZ they_PRP are_VBP lobbying_VBG for_IN ,_, though_RB ,_, is_VBZ a_DT more_RBR involved_VBN question_NN ._. Here_RB ,_, using_VBG data_NNS from_IN opensecrets.org_NNP ,_, we_PRP break_VBP down_RP lobbying_NN efforts_NNS ,_, industry_NN by_IN industry_NN ,_, combining_VBG all_DT political_JJ contributions_NNS and_CC lobbying_NN spending_NN from_IN Jan._NNP 1998_CD to_IN March_NNP 31_CD ,_, 2020_CD ._. Figures_NNS are_VBP calculations_NNS by_IN the_DT Center_NNP for_IN Responsive_NNP Politics_NNPS based_VBN on_IN data_NNS from_IN the_DT Senate_NNP Office_NNP of_IN Public_NNP Records_NNPS ._. Let_VB 's_PRP take_VB a_DT closer_JJR look_NN at_IN how_WRB much_JJ each_DT industry_NN spends_VBZ on_IN lobbying_NN ,_, the_DT top_JJ corporate_JJ spenders_NNS in_IN each_DT category_NN ,_, and_CC what_WP spurs_VBZ their_PRP$ lobbying_NN efforts_NNS ._. Spending_VBG $_$ 4.45_CD billion_CD over_IN the_DT past_JJ 22_CD years_NNS ,_, the_DT pharmaceutical_NN and_CC health_NN products_NNS industry_NN has_VBZ far_RB outpaced_VBN all_DT other_JJ industries_NNS in_IN lobbying_NN spending_NN ._. It_PRP 's_VBZ important_JJ to_TO note_VB that_IN this_DT industry_NN includes_VBZ not_RB only_RB drug_NN manufacturers_NNS ,_, but_CC also_RB the_DT sellers_NNS of_IN medical_JJ products_NNS and_CC nutritional_JJ and_CC dietary_NN supplements_NNS ._. From_IN Jan._NNP 2020_CD through_IN March_NNP 2020_CD ,_, spending_NN was_VBD topped_VBN by_IN the_DT Pharmaceutical_NNP Research_NNP and_CC Manufacturers_NNPS of_IN America_NNP and_CC Pfizer_NNP Inc_NNP ._. Overall_RB ,_, the_DT industry_NN is_VBZ primarily_RB concerned_JJ with_IN ""_`` resisting_VBG government_NN -_HYPH run_VBN health_NN care_NN ,_, ensuring_VBG a_DT quicker_JJR approval_NN process_NN for_IN drugs_NNS and_CC products_NNS entering_VBG the_DT market_NN ,_, and_CC strengthening_VBG intellectual_JJ property_NN protections_NNS ._. ”_'' In_IN recent_JJ years_NNS ,_, lobbying_NN has_VBZ focused_VBN more_RBR specifically_RB “_'' on_IN the_DT patent_NN system_NN ,_, research_NN funding_NN ,_, and_CC Medicare_NNP ._. ”_'' As_IN is_VBZ to_TO be_VB expected_VBN ,_, lobbying_NN efforts_NNS reached_VBD a_DT fever_NN pitch_NN in_IN 2009_CD ,_, around_IN the_DT drafting_NN of_IN the_DT Affordable_NNP Care_NNP Act_NNP (_-LRB- ACA_NNP )_-RRB- ,_, and_CC reported_VBD a_DT high_NN in_IN 2017_CD with_IN legislative_JJ enactments_NNS again_RB focusing_VBG on_IN changes_NNS to_IN health_NN care_NN ._. Including_VBG health_NN ,_, property_NN ,_, and_CC car_NN insurance_NN companies_NNS ,_, along_IN with_IN agents_NNS and_CC brokers_NNS ,_, the_DT insurance_NN industry_NN has_VBZ historically_RB been_VBN the_DT second_JJ most_RBS generous_JJ /_, aggressive_JJ industry_NN in_IN lobbying_VBG for_IN their_PRP$ interests_NNS ._. In_IN 2019_CD ,_, spending_NN was_VBD $_$ 155.3_CD million_CD ._. Following_VBG the_DT passage_NN of_IN the_DT ACA_NNP and_CC subsequent_JJ developments_NNS under_IN the_DT Trump_NNP administration_NN ,_, health_NN insurance_NN companies_NNS have_VBP been_VBN very_RB involved_VBN in_IN the_DT legislative_JJ process_NN ,_, looking_VBG to_TO influence_VB new_JJ regulations_NNS ._. In_IN 2019_CD ,_, the_DT leading_VBG insurance_NN industry_NN lobbyist_NN corporation_NN was_VBD Blue_NNP Cross_NNP /_, Blue_NNP Shield_NNP ._. The_DT electric_JJ utilities_NNS industry_NN monitors_VBZ legislative_JJ and_CC regulatory_JJ action_NN taken_VBN on_IN a_DT number_NN of_IN fronts_NNS ,_, including_VBG clean_JJ air_NN regulation_NN ,_, waste_NN storage_NN ,_, cybersecurity_NN ,_, and_CC infrastructure_NN ._. The_DT top_JJ lobbyist_NN in_IN electric_JJ utilities_NNS as_IN of_IN March_NNP 2020_CD is_VBZ Duke_NNP Energy_NNP ._. These_DT are_VBP your_PRP$ classic_JJ software_NN and_CC hardware_NN computer_NN tech_NN companies_NNS ,_, some_DT of_IN the_DT founders_NNS of_IN the_DT tech_NN movement_NN that_WDT exists_VBZ today_NN ._. As_IN this_DT industry_NN has_VBZ become_VBN increasingly_RB profitable_JJ ,_, its_PRP$ political_JJ contributions_NNS have_VBP increased_VBN ._. The_DT industry_NN is_VBZ relatively_RB non-partisan_JJ ,_, usually_RB given_VBN to_IN each_DT party_NN evenly_RB ,_, with_IN slight_JJ favoring_VBG to_IN the_DT party_NN in_IN the_DT White_NNP House_NNP ._. Given_VBN the_DT ubiquity_NN of_IN hardware_NN and_CC software_NN ,_, and_CC tech_NN more_RBR generally_RB ,_, it_PRP makes_VBZ sense_NN that_IN lobbying_NN from_IN the_DT electronics_NNS sector_NN is_VBZ varied_VBN ,_, with_IN lobbying_NN efforts_NNS on_IN homeland_NN security_NN ,_, taxes_NNS ,_, copyright_NN ,_, immigration_NN ,_, human_JJ rights_NNS ,_, cybersecurity_NN ,_, and_CC law_NN enforcement_NN data_NN storage_NN ._. As_IN of_IN March_NNP 2020_CD ,_, the_DT top_JJ lobbying_NN spenders_NNS were_VBD Qualcomm_NNP Inc_NNP and_CC Microsoft_NNP Corp_NNP ._. This_DT grouping_NN includes_VBZ small_JJ business_NN ,_, pro-business_JJ ,_, and_CC international_JJ trade_NN associations_NNS ,_, as_RB well_RB as_IN chambers_NNS of_IN commerce_NN ._. Business_NN associations_NNS lobby_VBP on_IN issues_NNS like_IN labor_NN regulations_NNS ,_, intellectual_JJ property_NN ,_, product_NN safety_NN ,_, and_CC taxes_NNS ,_, but_CC mostly_RB ,_, lobbying_NN efforts_NNS have_VBP focused_VBN on_IN civil_JJ justice_NN system_NN reform_NN ._. Business_NN associations_NNS want_VBP to_TO make_VB sure_JJ that_IN damages_NNS awarded_VBN to_IN plaintiffs_NNS involving_VBG torts_NNS or_CC wrongful_JJ acts_NNS that_WDT led_VBD to_IN legal_JJ liabilities_NNS are_VBP limited_VBN (_-LRB- asbestos_NN ,_, medical_JJ malpractice_NN ,_, etc._FW )_-RRB- ._. Other_JJ important_JJ legal_JJ issues_NNS include_VBP business_NN tax_NN reform_NN ,_, including_VBG corporate_JJ tax_NN policy_NN and_CC taxation_NN of_IN U.S._NNP subsidiaries_NNS of_IN foreign_JJ companies_NNS ._. The_DT top_JJ business_NN association_NN lobbyist_NN in_IN 2019_CD was_VBD the_DT U.S_NNP Chamber_NNP of_IN Commerce_NNP ._. As_IN you_PRP might_MD imagine_VB ,_, the_DT oil_NN and_CC gas_NN lobbying_NN sector_NN is_VBZ one_CD of_IN the_DT most_RBS active_JJ lobbying_NN groups_NNS ._. Lobbyist_NN efforts_NNS have_VBP historically_RB focused_VBN on_IN promoting_VBG legislators_NNS with_IN pro-energy_JJ views_NNS in_IN the_DT areas_NNS of_IN fossil_NN fuel_NN production_NN ,_, commodity_NN exploration_NN ,_, and_CC extraction_NN ._. As_IN of_IN March_NNP 2020_CD ,_, the_DT top_JJ lobbying_NN spenders_NNS in_IN the_DT industry_NN were_VBD Chevron_NNP Corp_NNP ,_, Koch_NNP Industries_NNP ,_, and_CC Exxon_NNP Mobil_NNP ._. With_IN spending_NN of_IN nearly_RB $_$ 1.9_CD billion_CD in_IN lobbying_NN efforts_NNS over_IN the_DT past_JJ 22_CD years_NNS ,_, miscellaneous_JJ manufacturing_NN and_CC distributing_VBG is_VBZ an_DT influential_JJ force_NN in_IN legislation_NN and_CC governmental_JJ regulation_NN ._. The_DT sector_NN has_VBZ members_NNS like_IN Honeywell_NNP International_NNP ,_, General_NNP Electric_NNP ,_, Cummins_NNP Inc._NNP ,_, 3_CD M_NNP ,_, and_CC Procter_NNP &_CC Gamble_NNP ,_, and_CC its_PRP$ lobbying_NN interests_NNS and_CC efforts_NNS reflect_VBP this_DT wide_JJ array_NN ._. Having_VBG spent_VBN $_$ 3.4_CD million_CD from_IN Jan._NNP 2020_CD through_IN March_NNP 2020_CD ,_, the_DT National_NNP Association_NNP of_IN Manufacturers_NNPS is_VBZ the_DT industry_NN ’s_POS top_JJ lobbyist_NN ._. This_DT category_NN includes_VBZ all_DT healthcare_NN institutions_NNS —_: hospitals_NNS ,_, nursing_NN homes_NNS ,_, hospice_NN providers_NNS ,_, and_CC drug_NN and_CC alcohol_NN inpatient_NN centers_NNS ._. Lobbying_NN in_IN this_DT industry_NN was_VBD especially_RB active_JJ in_IN 2009_CD and_CC again_RB in_IN 2017_CD with_IN legislative_JJ actions_NNS involving_VBG health_NN care_NN and_CC the_DT Affordable_NNP Care_NNP Act_NNP ._. At_IN present_NN ,_, lobbyist_NN efforts_NNS in_IN the_DT sector_NN are_VBP generally_RB focused_VBN on_IN cost_NN management_NN ,_, insurance_NN allocations_NNS ,_, spending_NN on_IN employee_NN training_NN ,_, prevention_NN of_IN physician_NN pay_NN reductions_NNS ,_, and_CC costs_NNS associated_VBN with_IN Medicaid_NN and_CC Medicare_NNP ._. The_DT leading_VBG spender_NN from_IN Jan._NNP 2020_CD through_IN March_NNP 2020_CD was_VBD the_DT American_NNP Hospital_NNP Association_NNP ,_, with_IN $_$ 7.2_CD million_CD ._. Political_JJ contributions_NNS and_CC lobbying_NN efforts_NNS from_IN the_DT education_NN industry_NN come_VBP mostly_RB from_IN individual_JJ educators_NNS or_CC administrators_NNS ,_, as_IN educational_JJ institutions_NNS are_VBP not_RB usually_RB able_JJ to_TO form_VB political_JJ action_NN committees_NNS (_-LRB- PACs_NNS )_-RRB- ._. Areas_NNS of_IN interest_NN for_IN educators_NNS and_CC education_NN lobbyists_NNS include_VBP the_DT federal_JJ budget_NN (_-LRB- allocations_NNS for_IN research_NN money_NN ,_, programs_NNS ,_, and_CC student_NN aid_NN )_-RRB- and_CC student_NN loans_NNS ,_, and_CC specifically_RB the_DT Student_NNP Loan_NNP Fairness_NNP Act_NNP ,_, which_WDT prevented_VBD student_NN loans_NNS from_IN doubling_VBG when_WRB the_DT congressional_JJ agreement_NN expired_VBD ._. Lobbyists_NNS in_IN the_DT education_NN sector_NN spent_VBD $_$ 82.2_CD million_CD in_IN 2019_CD with_IN the_DT Association_NNP of_IN American_NNP Medical_NNP Colleges_NNPS coming_VBG in_RP as_IN a_DT top_JJ spender_NN ._.","In the JJ JJ NN , NN VBZ JJ for the NN . It VBZ VBN to VB VBN that JJ NNS , and the VBG NNS in those NNS , will VB to VB NN , NN , and the NN of NN NNS , JJ that they VBP JJ NN . This could VB in the NN of NN NNS , or JJ NN , with a NN VBG on NN of the NN that VBZ VBN them to VB a JJ NN or JJ NN . What it VBZ they VBP VBG for , RB , VBZ a RBR VBN NN . RB , VBG NNS from NNP , we VBP down NN NNS , NN by NN , VBG all JJ NNS and NN NN from NNP 1998 to NNP 31 , 2020 . NNS VBP NNS by the NNP for NNP NNPS VBN on NNS from the NNP NNP of NNP NNPS . VB 's VB a JJR NN at how JJ each NN VBZ on NN , the JJ JJ NNS in each NN , and what VBZ their NN NNS . VBG $ 4.45 billion over the JJ 22 NNS , the NN and NN NNS NN VBZ RB VBN all JJ NNS in NN NN . It VBZ JJ to VB that this NN VBZ RB RB NN NNS , but RB the NNS of JJ NNS and JJ and NN NNS . From NNP 2020 through NNP 2020 , NN VBD VBN by the NNP NNP and NNPS of NNP and NNP NNP . RB , the NN VBZ RB JJ with "" VBG NN - VBN NN NN , VBG a JJR NN NN for NNS and NNS VBG the NN , and VBG JJ NN NNS . ” In JJ NNS , NN VBZ VBN RBR RB “ on the NN NN , NN NN , and NNP . ” As VBZ to VB VBN , NN NNS VBD a NN NN in 2009 , around the NN of the NNP NNP NNP ( NNP ) , and VBD a NN in 2017 with JJ NNS RB VBG on NNS to NN NN . VBG NN , NN , and NN NN NNS , along with NNS and NNS , the NN NN VBZ RB VBN the JJ RBS JJ / JJ NN in VBG for their NNS . In 2019 , NN VBD $ 155.3 million . VBG the NN of the NNP and JJ NNS under the NNP NN , NN NN NNS VBP VBN RB VBN in the JJ NN , VBG to VB JJ NNS . In 2019 , the VBG NN NN NN NN VBD NNP NNP / NNP NNP . The JJ NNS NN VBZ JJ and JJ NN VBN on a NN of NNS , VBG JJ NN NN , NN NN , NN , and NN . The JJ NN in JJ NNS as of NNP 2020 VBZ NNP NNP . These VBP your JJ NN and NN NN NN NNS , some of the NNS of the NN NN that VBZ NN . As this NN VBZ VBN RB JJ , its JJ NNS VBP VBN . The NN VBZ RB JJ , RB VBN to each NN RB , with JJ VBG to the NN in the NNP NNP . VBN the NN of NN and NN , and NN RBR RB , it VBZ NN that NN from the NNS NN VBZ VBN , with NN NNS on NN NN , NNS , NN , NN , JJ NNS , NN , and NN NN NN NN . As of NNP 2020 , the JJ NN NNS VBD NNP NNP and NNP NNP . This NN VBZ JJ NN , JJ , and JJ NN NNS , RB RB as NNS of NN . NN NNS VBP on NNS like NN NNS , JJ NN , NN NN , and NNS , but RB , NN NNS VBP VBN on JJ NN NN NN . NN NNS VBP to VB JJ that NNS VBN to NNS VBG NNS or JJ NNS that VBD to JJ NNS VBP VBN ( NN , JJ NN , FW ) . JJ JJ JJ NNS VBP NN NN NN , VBG JJ NN NN and NN of NNP NNS of JJ NNS . The JJ NN NN NN in 2019 VBD the NNP NNP of NNP . As you might VB , the NN and NN NN NN VBZ one of the RBS JJ NN NNS . NN NNS VBP RB VBN on VBG NNS with JJ NNS in the NNS of NN NN NN , NN NN , and NN . As of NNP 2020 , the JJ NN NNS in the NN VBD NNP NNP , NNP NNP , and NNP NNP . With NN of RB $ 1.9 billion in NN NNS over the JJ 22 NNS , JJ NN and VBG VBZ an JJ NN in NN and JJ NN . The NN VBZ NNS like NNP NNP , NNP NNP , NNP NNP , 3 NNP , and NNP & NNP , and its NN NNS and NNS VBP this JJ NN . VBG VBN $ 3.4 million from NNP 2020 through NNP 2020 , the NNP NNP of NNPS VBZ the NN ’s JJ NN . This NN VBZ all NN NNS — NNS , NN NNS , NN NNS , and NN and NN NN NNS . NN in this NN VBD RB JJ in 2009 and RB in 2017 with JJ NNS VBG NN NN and the NNP NNP NNP . At NN , NN NNS in the NN VBP RB VBN on NN NN , NN NNS , NN on NN NN , NN of NN NN NNS , and NNS VBN with NN and NNP . The VBG NN from NNP 2020 through NNP 2020 VBD the NNP NNP NNP , with $ 7.2 million . JJ NNS and NN NNS from the NN NN VBP RB from JJ NNS or NNS , as JJ NNS VBP RB RB JJ to VB JJ NN NNS ( NNS ) . NNS of NN for NNS and NN NNS VBP the JJ NN ( NNS for NN NN , NNS , and NN NN ) and NN NNS , and RB the NNP NNP NNP NNP , which VBD NN NNS from VBG when the JJ NN VBD . NNS in the NN NN VBD $ 82.2 million in 2019 with the NNP of NNP NNP NNPS VBG in as a JJ NN ."
48,1213,conspiracy,C00bb3,coronavirus; covid.19; planned.parenthood; vaccine.covid,"On_IN March_NNP 23_CD ,_, UK_NNP Prime_NNP Minister_NNP Boris_NNP Johnson_NNP announced_VBD a_DT nationwide_JJ lockdown_NN to_TO contain_VB the_DT coronavirus_NN epidemic_NN ,_, despite_IN British_JJ health_NN officials_NNS quietly_RB lowering_VBG the_DT official_JJ threat_NN level_NN for_IN the_DT pandemic_NN just_RB days_NNS earlier_RBR ._. The_DT UK_NNP government_NN website_NN reads_VBZ :_: “_`` As_IN of_IN 19_CD March_NNP 2020_CD ,_, COVID_NNP -_HYPH 19_CD is_VBZ no_RB longer_RBR considered_VBN to_TO be_VB a_DT high_JJ consequence_NN infectious_JJ diseases_NNS (_-LRB- HCID_NN )_-RRB- in_IN the_DT UK_NNP ._. ”_'' Just_RB days_NNS before_IN U.K._NNP Prime_NNP Minister_NNP Boris_NNP Johnson_NNP announced_VBD a_DT nationwide_JJ lockdown_NN to_TO contain_VB the_DT coronavirus_NN epidemic_NN ,_, health_NN officials_NNS in_IN Britain_NNP quietly_RB lowered_VBD the_DT official_JJ threat_NN level_NN for_IN the_DT pandemic_NN ,_, saying_VBG the_DT COVID_NN -_HYPH 19_CD virus_NN did_VBD not_RB meet_VB the_DT criteria_NNS to_TO qualify_VB as_IN a_DT “_`` high_JJ consequence_NN infectious_JJ disease_NN ”_'' (_-LRB- HCID_NN )_-RRB- ._. U.K._NNP health_NN officials_NNS had_VBD tentatively_RB identified_VBN COVID_NNP -_HYPH 19_CD as_IN an_DT HCID_NN in_IN late_JJ January_NNP ,_, but_CC said_VBD in_IN a_DT March_NNP 19_CD statement_NN it_PRP was_VBD rescinding_VBG its_PRP$ interim_JJ decision_NN ._. “_`` This_DT was_VBD based_VBN on_IN consideration_NN of_IN the_DT U.K._NNP HCID_NNP criteria_NNS about_IN the_DT virus_NN and_CC the_DT disease_NN with_IN information_NN available_JJ during_IN the_DT early_JJ stages_NNS of_IN the_DT outbreak_NN ,_, ”_'' the_DT statement_NN said_VBD ._. “_`` Now_RB that_IN more_JJR is_VBZ known_VBN about_IN COVID_NNP -_HYPH 19_CD ,_, the_DT public_JJ health_NN bodies_NNS in_IN the_DT UK_NNP have_VBP …_: determined_VBN that_IN several_JJ features_NNS have_VBP now_RB changed_VBN ;_, in_IN particular_JJ ,_, more_JJR information_NN is_VBZ available_JJ about_IN mortality_NN rates_NNS (_-LRB- low_JJ overall_RB )_-RRB- ,_, and_CC there_EX is_VBZ now_RB greater_JJR clinical_JJ awareness_NN and_CC a_DT specific_JJ and_CC sensitive_JJ laboratory_NN test_NN ,_, the_DT availability_NN of_IN which_WDT continues_VBZ to_TO increase_VB ._. ”_'' The_DT statement_NN said_VBD a_DT government_NN body_NN that_WDT deals_VBZ with_IN pathogens_NNS agreed_VBD the_DT virus_NN did_VBD not_RB merit_VB the_DT HCID_NN designation_NN ,_, but_CC also_RB added_VBD that_IN the_DT risk_NN to_IN the_DT U.K_NNP from_IN the_DT outbreak_NN “_'' has_VBZ been_VBN raised_VBN to_IN high_JJ ._. ”_''","On NNP 23 , NNP NNP NNP NNP NNP VBD a JJ NN to VB the NN NN , despite JJ NN NNS RB VBG the JJ NN NN for the NN RB NNS RBR . The NNP NN NN VBZ : “ As of 19 NNP 2020 , NNP - 19 VBZ RB RBR VBN to VB a JJ NN JJ NNS ( NN ) in the NNP . ” RB NNS before NNP NNP NNP NNP NNP VBD a JJ NN to VB the NN NN , NN NNS in NNP RB VBD the JJ NN NN for the NN , VBG the NN - 19 NN VBD RB VB the NNS to VB as a “ JJ NN JJ NN ” ( NN ) . NNP NN NNS VBD RB VBN NNP - 19 as an NN in JJ NNP , but VBD in a NNP 19 NN it VBD VBG its JJ NN . “ This VBD VBN on NN of the NNP NNP NNS about the NN and the NN with NN JJ during the JJ NNS of the NN , ” the NN VBD . “ RB that JJR VBZ VBN about NNP - 19 , the JJ NN NNS in the NNP VBP … VBN that JJ NNS VBP RB VBN ; in JJ , JJR NN VBZ JJ about NN NNS ( JJ RB ) , and there VBZ RB JJR JJ NN and a JJ and JJ NN NN , the NN of which VBZ to VB . ” The NN VBD a NN NN that VBZ with NNS VBD the NN VBD RB VB the NN NN , but RB VBD that the NN to the NNP from the NN “ VBZ VBN VBN to JJ . ”"
49,650,mainstream,M08198,coronavirus; vaccine; vaccine.covid,"(_-LRB- CNN_NNP )_-RRB- As_IN the_DT world_NN works_VBZ to_TO produce_VB an_DT effective_JJ Covid_NN -_HYPH 19_CD vaccine_NN ,_, some_DT experts_NNS suggest_VBP an_DT existing_VBG vaccine_NN that_WDT almost_RB everyone_NN already_RB gets_VBZ might_MD help_VB ._. There_EX is_VBZ plenty_NN of_IN evidence_NN that_IN existing_VBG vaccines_NNS such_JJ as_IN polio_NN vaccines_NNS protect_VBP children_NNS against_IN a_DT wide_JJ range_NN of_IN infections_NNS and_CC it's_PRP worth_JJ trying_VBG them_PRP out_RP against_IN the_DT new_JJ coronavirus_NN ,_, a_DT team_NN of_IN experts_NNS wrote_VBD in_IN Science_NNP magazine_NNP Thursday_NNP ._. An_DT oral_JJ polio_NN vaccine_NN is_VBZ safe_JJ ,_, cheap_JJ ,_, easy_JJ to_TO give_VB and_CC widely_RB available_JJ ,_, with_IN more_JJR than_IN 1_CD billion_CD doses_NNS produced_VBN and_CC used_VBN annually_RB in_IN more_JJR than_IN 140_CD countries_NNS ,_, according_VBG to_IN the_DT team_NN ,_, which_WDT includes_VBZ one_CD of_IN the_DT scientists_NNS who_WP discovered_VBD HIV_NNP and_CC a_DT vaccine_NN expert_NN from_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP ._. The_DT vaccine_NN has_VBZ nearly_RB eradicated_VBN polio_NN worldwide_RB ._. The_DT oral_JJ polio_NN vaccine_NN uses_VBZ a_DT weakened_VBN version_NN of_IN the_DT polio_NN virus_NN ._. The_DT live_JJ attenuated_VBN vaccines_NNS produce_VBP a_DT strong_JJ and_CC long_JJ -_HYPH lasting_VBG immune_JJ response_NN ,_, vaccine_NN experts_NNS said_VBD ._. They_PRP 're_VBP slower_JJR to_TO manufacture_VB than_IN modern_JJ vaccines_NNS that_WDT just_RB use_VBP a_DT piece_NN of_IN genetic_JJ material_NN from_IN a_DT virus_NN ,_, and_CC the_DT US_NNP and_CC European_JJ companies_NNS working_VBG on_IN coronavirus_NN vaccines_NNS are_VBP focusing_VBG on_IN quicker_JJR ways_NNS ._. It_PRP would_MD make_VB sense_NN to_TO at_IN least_JJS test_VB it_PRP to_TO see_VB i_PRP f_VBP it_PRP helps_VBZ against_IN coronavirus_NN ,_, said_VBD Konstantin_NNP Chumakov_NNP of_IN the_DT FDA_NNP and_CC Dr._NNP Robert_NNP Gallo_NNP of_IN the_DT Institute_NNP of_IN Human_NNP Virology_NNP at_IN the_DT University_NNP of_IN Maryland_NNP School_NNP of_IN Medicine_NNP ,_, along_IN with_IN their_PRP$ colleagues_NNS ._. Gallo_NNP co-discovered_VBD the_DT virus_NN that_WDT causes_VBZ AIDS_NN while_IN Chumakov_NNP is_VBZ associate_JJ director_NN for_IN research_NN at_IN the_DT FDA_NNP 's_POS vaccine_NN division_NN ._. ""_`` We_PRP propose_VBP the_DT use_NN of_IN OPV_NN (_-LRB- oral_JJ poliovirus_NN vaccine_NN )_-RRB- to_TO ameliorate_VB or_CC prevent_VB COVID_NN -_HYPH 19_CD ._. Both_CC poliovirus_NN and_CC coronavirus_NN are_VBP positive_JJ -_HYPH strand_NN RNA_NN viruses_NNS ;_, therefore_RB ,_, it_PRP is_VBZ likely_JJ that_IN they_PRP may_MD induce_VB and_CC be_VB affected_VBN by_IN common_JJ innate_JJ immunity_NN mechanisms_NNS ,_, ""_'' they_PRP wrote_VBD ._. ""_'' ..._, Oral_JJ poliovirus_NN vaccine_NN in_IN particular_JJ ,_, could_MD provide_VB temporary_JJ protection_NN against_IN coronavirus_NN disease_NN ._. ""_'' The_DT oral_JJ polio_NN vaccine_NN produces_VBZ herd_NN effects_NNS ,_, they_PRP wrote_VBD ._. Herd_NN immunity_NN is_VBZ reached_VBN when_WRB the_DT majority_NN of_IN a_DT given_VBN population_NN --_, 70_CD %_NN to_IN 90_CD %_NN --_, becomes_VBZ immune_NN to_IN an_DT infectious_JJ disease_NN ,_, either_CC because_IN they_PRP have_VBP become_VBN infected_VBN and_CC recovered_VBN ,_, or_CC through_IN vaccination_NN ._. In_IN addition_NN to_IN protecting_VBG vulnerable_JJ individuals_NNS ,_, it_PRP could_MD also_RB prevent_VB the_DT spread_NN of_IN the_DT new_JJ coronavirus_NN by_IN increasing_VBG the_DT proportion_NN of_IN unsusceptible_JJ individuals_NNS ,_, Chumakov_NNP ,_, Gallo_NNP and_CC colleagues_NNS wrote_VBD ._. ""_`` The_DT risk_NN of_IN complications_NNS due_IN to_IN OPV_NN is_VBZ extremely_RB low_JJ ,_, ""_'' they_PRP added_VBD ._. It_PRP can_MD cause_VB a_DT polio_NN -_HYPH like_JJ complication_NN ,_, but_CC only_RB in_IN about_RB one_CD out_IN of_IN every_DT 3_CD million_CD doses_NNS given_VBN ,_, and_CC then_RB mostly_RB in_IN immunocompromised_JJ children_NNS ._. Doctors_NNS know_VBP that_IN the_DT benefits_NNS of_IN vaccination_NN extend_VBP beyond_IN the_DT particular_JJ germs_NNS targeted_VBN ._. ""_`` Other_JJ live_JJ attenuated_VBN viral_JJ vaccines_NNS such_JJ as_IN those_DT against_IN measles_NNS and_CC smallpox_NN have_VBP also_RB been_VBN associated_VBN with_IN pronounced_VBN nonspecific_JJ protective_JJ effects_NNS against_IN infectious_JJ diseases_NNS ,_, ""_'' they_PRP wrote_VBD ._. ""_`` In_IN Africa_NNP ,_, when_WRB measles_NNS vaccine_NN was_VBD introduced_VBN in_IN the_DT community_NN ,_, the_DT overall_JJ mortality_NN in_IN children_NNS declined_VBD by_IN more_JJR than_IN 50_CD %_NN ,_, a_DT reduction_NN that_WDT was_VBD far_RB larger_JJR than_IN anticipated_VBN on_IN the_DT basis_NN of_IN the_DT protection_NN against_IN measles_NNS deaths_NNS alone_RB ,_, ""_'' they_PRP added_VBD ._. The_DT OPV_NN is_VBZ no_RB longer_RBR licensed_VBN or_CC available_JJ in_IN the_DT United_NNP States_NNPS ,_, but_CC is_VBZ still_RB used_VBN in_IN some_DT parts_NNS of_IN the_DT world_NN ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. Children_NNS get_VBP vaccine_NN doses_NNS by_IN drops_NNS in_IN the_DT mouth_NN ._.","( NNP ) As the NN VBZ to VB an JJ NN - 19 NN , some NNS VBP an VBG NN that RB NN RB VBZ might VB . There VBZ NN of NN that VBG NNS JJ as NN NNS VBP NNS against a JJ NN of NNS and it's JJ VBG them out against the JJ NN , a NN of NNS VBD in NNP NNP NNP . An JJ NN NN VBZ JJ , JJ , JJ to VB and RB JJ , with JJR than 1 billion NNS VBN and VBN RB in JJR than 140 NNS , VBG to the NN , which VBZ one of the NNS who VBD NNP and a NN NN from the NNP and NNP NNP . The NN VBZ RB VBN NN RB . The JJ NN NN VBZ a VBN NN of the NN NN . The JJ VBN NNS VBP a JJ and JJ - VBG JJ NN , NN NNS VBD . They VBP JJR to VB than JJ NNS that RB VBP a NN of JJ NN from a NN , and the NNP and JJ NNS VBG on NN NNS VBP VBG on JJR NNS . It would VB NN to at JJS VB it to VB i VBP it VBZ against NN , VBD NNP NNP of the NNP and NNP NNP NNP of the NNP of NNP NNP at the NNP of NNP NNP of NNP , along with their NNS . NNP VBD the NN that VBZ NN while NNP VBZ JJ NN for NN at the NNP 's NN NN . "" We VBP the NN of NN ( JJ NN NN ) to VB or VB NN - 19 . Both NN and NN VBP JJ - NN NN NNS ; RB , it VBZ JJ that they may VB and VB VBN by JJ JJ NN NNS , "" they VBD . "" ... JJ NN NN in JJ , could VB JJ NN against NN NN . "" The JJ NN NN VBZ NN NNS , they VBD . NN NN VBZ VBN when the NN of a VBN NN -- 70 NN to 90 NN -- VBZ NN to an JJ NN , either because they VBP VBN VBN and VBN , or through NN . In NN to VBG JJ NNS , it could RB VB the NN of the JJ NN by VBG the NN of JJ NNS , NNP , NNP and NNS VBD . "" The NN of NNS due to NN VBZ RB JJ , "" they VBD . It can VB a NN - JJ NN , but RB in RB one out of every 3 million NNS VBN , and RB RB in JJ NNS . NNS VBP that the NNS of NN VBP beyond the JJ NNS VBN . "" JJ JJ VBN JJ NNS JJ as those against NNS and NN VBP RB VBN VBN with VBN JJ JJ NNS against JJ NNS , "" they VBD . "" In NNP , when NNS NN VBD VBN in the NN , the JJ NN in NNS VBD by JJR than 50 NN , a NN that VBD RB JJR than VBN on the NN of the NN against NNS NNS RB , "" they VBD . The NN VBZ RB RBR VBN or JJ in the NNP NNPS , but VBZ RB VBN in some NNS of the NN , VBG to the NNPS for NNP NNP and NNP . NNS VBP NN NNS by NNS in the NN ."
50,51,mainstream,M0779e,vaccine.autism,"The_DT number_NN of_IN measles_NNS cases_NNS in_IN the_DT United_NNP States_NNPS has_VBZ reached_VBN a_DT 25_CD -_HYPH year_NN peak_NN ,_, propelled_VBN by_IN the_DT spread_NN of_IN misinformation_NN about_IN the_DT vaccine_NN that_WDT can_MD prevent_VB the_DT disease_NN ,_, federal_JJ health_NN officials_NNS said_VBD on_IN Monday_NNP ._. The_DT US_NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- reported_VBD 704_CD cases_NNS as_IN of_IN April_NNP 26_CD ,_, a_DT 1.3_CD percent_NN increase_NN since_IN the_DT most_RBS recent_JJ tally_NN of_IN 695_CD reported_VBD on_IN Wednesday_NNP ._. The_DT vast_JJ majority_NN of_IN cases_NNS have_VBP occurred_VBN in_IN children_NNS who_WP have_VBP not_RB received_VBN the_DT measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN (_-LRB- MMR_NNP )_-RRB- vaccine_NN ,_, which_WDT confers_VBZ immunity_NN to_IN the_DT disease_NN ,_, officials_NNS said_VBD ._. ""_`` The_DT suffering_NN we_PRP are_VBP seeing_VBG today_NN is_VBZ completely_RB avoidable_JJ ,_, ""_'' US_NNP Health_NNP and_CC Human_NNP Services_NNPS Secretary_NNP Alex_NNP Azar_NNP said_VBD on_IN Monday_NNP ._. ""_`` We_PRP know_VBP vaccines_NNS are_VBP safe_JJ because_IN they_PRP 're_VBP among_IN some_DT of_IN the_DT most_RBS studied_VBN medical_JJ products_NNS we_PRP have_VBP ._. ""_'' A_DT vocal_JJ fringe_NN of_IN US_NNP parents_NNS refuses_VBZ to_TO vaccinate_VB their_PRP$ children_NNS believing_VBG ,_, contrary_JJ to_IN scientific_JJ evidence_NN ,_, that_IN ingredients_NNS in_IN them_PRP can_MD cause_VB autism_NN or_CC other_JJ disorders_NNS ._. According_VBG to_IN the_DT CDC_NNP ,_, 94_CD percent_NN of_IN children_NNS entering_VBG kindergarten_NN in_IN the_DT US_NNP in_IN 2017_CD had_VBD received_VBN their_PRP$ two_CD doses_NNS of_IN the_DT MMR_NN vaccine_NN ._. Some_DT 22_CD states_NNS have_VBP recorded_VBN cases_NNS of_IN the_DT extremely_RB contagious_JJ and_CC sometimes_RB deadly_JJ disease_NN ._. None_NN of_IN the_DT victims_NNS of_IN the_DT recent_JJ outbreak_NN has_VBZ died_VBN ,_, but_CC three_CD percent_NN have_VBP contracted_VBN pneumonia_NN and_CC nine_CD percent_NN have_VBP been_VBN hospitalised_VBN due_IN to_IN complications_NNS from_IN the_DT disease_NN ,_, CDC_NNP director_NN Robert_NNP Redfield_NNP said_VBD on_IN Monday_NNP ._. US_NNP President_NNP Donald_NNP Trump_NNP urged_VBD Americans_NNPS last_JJ week_NN to_TO get_VB vaccinated_VBN to_TO prevent_VB the_DT spread_NN of_IN measles_NNS ,_, changing_VBG course_NN from_IN remarks_NNS he_PRP made_VBD in_IN 2014_CD when_WRB he_PRP expressed_VBD doubt_NN about_IN giving_VBG children_NNS government_NN -_HYPH recommended_VBN doses_NNS of_IN vaccines_NNS ._. ""_`` The_DT vaccinations_NNS are_VBP so_RB important_JJ ._. This_DT is_VBZ really_RB going_VBG around_RB now_RB ,_, ""_'' Trump_NNP said_VBD on_IN Friday_NNP ._. There_EX were_VBD 17_CD measles_NNS outbreaks_NNS in_IN 2018_CD ,_, but_CC most_JJS of_IN the_DT cases_NNS were_VBD from_IN outbreaks_NNS in_IN New_NNP York_NNP state_NN ,_, New_NNP York_NNP City_NNP ,_, and_CC New_NNP Jersey_NNP ._. The_DT current_JJ outbreak_NN has_VBZ been_VBN concentrated_VBN in_IN New_NNP York_NNP City_NNP ,_, where_WRB officials_NNS said_VBD more_JJR than_IN 390_CD cases_NNS have_VBP been_VBN recorded_VBN since_IN October_NNP ,_, mostly_RB among_IN children_NNS in_IN Orthodox_JJ Jewish_JJ communities_NNS in_IN Brooklyn_NNP ._. The_DT national_JJ outbreak_NN has_VBZ escalated_VBN since_IN 82_CD people_NNS in_IN 2018_CD and_CC more_JJR than_IN 40_CD people_NNS in_IN 2019_CD brought_VBD measles_NNS to_IN the_DT US_NNP from_IN other_JJ countries_NNS ,_, most_RBS frequently_RB Ukraine_NNP ,_, Israel_NNP and_CC the_DT Philippines_NNPS ,_, federal_JJ officials_NNS said_VBD ._. Although_IN the_DT virus_NN was_VBD eliminated_VBN from_IN the_DT country_NN in_IN 2000_CD ,_, meaning_VBG it_PRP was_VBD no_RB longer_RBR continually_RB present_JJ year_NN -_HYPH round_RB ,_, outbreaks_NNS still_RB happen_VBP via_IN travellers_NNS coming_VBG from_IN countries_NNS where_WRB measles_NNS is_VBZ still_RB common_JJ ,_, the_DT CDC_NNP says_VBZ ._.","The NN of NNS NNS in the NNP NNPS VBZ VBN a 25 - NN NN , VBN by the NN of NN about the NN that can VB the NN , JJ NN NNS VBD on NNP . The NNP NNPS for NNP NNP and NNP ( NNP ) VBD 704 NNS as of NNP 26 , a 1.3 NN NN since the RBS JJ NN of 695 VBD on NNP . The JJ NN of NNS VBP VBN in NNS who VBP RB VBN the NNS - NNS - NN ( NNP ) NN , which VBZ NN to the NN , NNS VBD . "" The NN we VBP VBG NN VBZ RB JJ , "" NNP NNP and NNP NNPS NNP NNP NNP VBD on NNP . "" We VBP NNS VBP JJ because they VBP among some of the RBS VBN JJ NNS we VBP . "" A JJ NN of NNP NNS VBZ to VB their NNS VBG , JJ to JJ NN , that NNS in them can VB NN or JJ NNS . VBG to the NNP , 94 NN of NNS VBG NN in the NNP in 2017 VBD VBN their two NNS of the NN NN . Some 22 NNS VBP VBN NNS of the RB JJ and RB JJ NN . NN of the NNS of the JJ NN VBZ VBN , but three NN VBP VBN NN and nine NN VBP VBN VBN due to NNS from the NN , NNP NN NNP NNP VBD on NNP . NNP NNP NNP NNP VBD NNPS JJ NN to VB VBN to VB the NN of NNS , VBG NN from NNS he VBD in 2014 when he VBD NN about VBG NNS NN - VBN NNS of NNS . "" The NNS VBP RB JJ . This VBZ RB VBG RB RB , "" NNP VBD on NNP . There VBD 17 NNS NNS in 2018 , but JJS of the NNS VBD from NNS in NNP NNP NN , NNP NNP NNP , and NNP NNP . The JJ NN VBZ VBN VBN in NNP NNP NNP , where NNS VBD JJR than 390 NNS VBP VBN VBN since NNP , RB among NNS in JJ JJ NNS in NNP . The JJ NN VBZ VBN since 82 NNS in 2018 and JJR than 40 NNS in 2019 VBD NNS to the NNP from JJ NNS , RBS RB NNP , NNP and the NNPS , JJ NNS VBD . Although the NN VBD VBN from the NN in 2000 , VBG it VBD RB RBR RB JJ NN - RB , NNS RB VBP via NNS VBG from NNS where NNS VBZ RB JJ , the NNP VBZ ."
51,1100,mainstream,M09f12,vaccine.autism,"Innovation_NNP Pharmaceuticals_NNPS ,_, Inc._NNP is_VBZ a_DT clinical_JJ stage_NN biotechnology_NN company_NN ._. It_PRP focuses_VBZ on_IN the_DT discover_NN of_IN small_JJ molecule_NN drugs_NNS for_IN hard_JJ to_TO treat_VB diseases_NNS ,_, including_VBG drug_NN -_HYPH resistant_JJ cancers_NNS ,_, psoriasis_NN ,_, autism_NN ,_, and_CC inflammatory_JJ disease_NN ._. The_DT company_NN 's_POS lead_JJ cancer_NN compound_NN ,_, Kevetrin_NNP ,_, is_VBZ an_DT anti-cancer_JJ dr_NN ..._. Innovation_NNP Pharmaceuticals_NNPS ,_, Inc._NNP is_VBZ a_DT clinical_JJ stage_NN biotechnology_NN company_NN ._. It_PRP focuses_VBZ on_IN the_DT discover_NN of_IN small_JJ molecule_NN drugs_NNS for_IN hard_JJ to_TO treat_VB diseases_NNS ,_, including_VBG drug_NN -_HYPH resistant_JJ cancers_NNS ,_, psoriasis_NN ,_, autism_NN ,_, and_CC inflammatory_JJ disease_NN ._. The_DT company_NN 's_POS lead_JJ cancer_NN compound_NN ,_, Kevetrin_NNP ,_, is_VBZ an_DT anti-cancer_JJ drug_NN which_WDT has_VBZ demonstrated_VBN the_DT ability_NN in_IN pre-clinical_JJ studies_NNS to_TO regulate_VB the_DT p53_NN pathway_NN and_CC attack_VB cancers_NNS ._. Innovation_NNP Pharmaceuticals_NNPS was_VBD founded_VBN by_IN Krishna_NNP Kumar_NNP Menon_NNP and_CC Leo_NNP Ehrlich_NNP in_IN June_NNP 20_CD ,_, 2007_CD and_CC is_VBZ headquartered_VBN in_IN Beverly_NNP ,_, MA_NNP ._.","NNP NNPS , NNP VBZ a JJ NN NN NN . It VBZ on the NN of JJ NN NNS for JJ to VB NNS , VBG NN - JJ NNS , NN , NN , and JJ NN . The NN 's JJ NN NN , NNP , VBZ an JJ NN ... NNP NNPS , NNP VBZ a JJ NN NN NN . It VBZ on the NN of JJ NN NNS for JJ to VB NNS , VBG NN - JJ NNS , NN , NN , and JJ NN . The NN 's JJ NN NN , NNP , VBZ an JJ NN which VBZ VBN the NN in JJ NNS to VB the NN NN and VB NNS . NNP NNPS VBD VBN by NNP NNP NNP and NNP NNP in NNP 20 , 2007 and VBZ VBN in NNP , NNP ."
52,554,mainstream,M076c8,coronavirus; vaccine.covid,"The_DT drug_NN maker_NN Sanofi_NNP Pasteur_NNP is_VBZ entering_VBG the_DT race_NN to_TO develop_VB a_DT vaccine_NN to_TO protect_VB against_IN the_DT new_JJ coronavirus_NN sweeping_VBG through_IN China_NNP ,_, the_DT company_NN announced_VBD Monday_NNP ._. David_NNP Loew_NNP ,_, Sanofi_NNP ’s_POS global_JJ head_NN of_IN vaccines_NNS ,_, announced_VBD the_DT company_NN would_MD partner_VB with_IN the_DT U.S._NNP Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP —_: known_VBN as_IN BARDA_NNP —_: to_TO make_VB a_DT vaccine_NN using_VBG the_DT company_NN ’s_POS recombinant_NN DNA_NN platform_NN ._. Loew_NNP said_VBD the_DT company_NN ’s_POS previous_JJ work_NN to_TO develop_VB a_DT vaccine_NN for_IN SARS_NN —_: a_DT cousin_NN virus_NN —_: gives_VBZ it_PRP a_DT leg_NN up_RP on_IN this_DT work_NN ._. “_`` Addressing_VBG a_DT global_JJ health_NN threat_NN such_JJ as_IN this_DT newest_JJS coronavirus_NN is_VBZ going_VBG to_TO take_VB a_DT collaborative_JJ effort_NN ,_, which_WDT is_VBZ why_WRB we_PRP are_VBP working_VBG with_IN BARDA_NNP to_TO quickly_RB advance_VB a_DT potential_JJ vaccine_NN candidate_NN ,_, ”_'' said_VBD Loew_NNP ._. “_`` While_IN we_PRP are_VBP lending_VBG our_PRP$ expertise_NN where_WRB possible_JJ ,_, we_PRP believe_VBP the_DT collaboration_NN with_IN BARDA_NNP may_MD provide_VB the_DT most_RBS meaningful_JJ results_NNS in_IN protecting_VBG the_DT public_NN from_IN this_DT latest_JJS outbreak_NN ,_, ”_'' he_PRP said_VBD ._. Loew_NNP said_VBD the_DT company_NN expects_VBZ to_TO have_VB a_DT vaccine_NN candidate_NN —_: a_DT prototype_NN —_: to_TO test_VB in_IN vitro_NN within_IN six_CD months_NNS and_CC could_MD be_VB ready_JJ to_TO test_VB the_DT vaccine_NN in_IN people_NNS within_IN a_DT year_NN or_CC 18_CD months_NNS ._. Loew_NNP noted_VBD the_DT DNA_NN recombinant_NN platform_NN is_VBZ already_RB used_VBN to_TO make_VB flu_NN vaccine_NN licensed_VBN in_IN the_DT U.S._NNP ,_, which_WDT means_VBZ regulators_NNS are_VBP familiar_JJ with_IN it_PRP ._. Sanofi_NNP also_RB has_VBZ large_JJ -_HYPH scale_NN manufacturing_NN capacity_NN for_IN these_DT types_NNS of_IN vaccines_NNS ._. Sanofi_NNP is_VBZ the_DT second_JJ major_JJ vaccine_NN maker_NN to_TO announce_VB it_PRP will_MD try_VB to_TO make_VB a_DT vaccine_NN against_IN the_DT new_JJ virus_NN ,_, which_WDT has_VBZ infected_VBN over_RB 70,000_CD people_NNS ,_, mostly_RB in_IN China_NNP ._. Johnson_NNP &_CC Johnson_NNP ’s_POS vaccine_NN division_NN ,_, Janssen_NNP ,_, has_VBZ also_RB announced_VBN it_PRP will_MD try_VB to_TO make_VB a_DT vaccine_NN ._. Republished_VBN with_IN permission_NN from_IN STAT_NNP ._. This_DT article_NN originally_RB appeared_VBD on_IN February_NNP 18_CD 2020_CD","The NN NN NNP NNP VBZ VBG the NN to VB a NN to VB against the JJ NN VBG through NNP , the NN VBD NNP . NNP NNP , NNP ’s JJ NN of NNS , VBD the NN would VB with the NNP NNP NNP NNP and NNP NNP — VBN as NNP — to VB a NN VBG the NN ’s NN NN NN . NNP VBD the NN ’s JJ NN to VB a NN for NN — a NN NN — VBZ it a NN up on this NN . “ VBG a JJ NN NN JJ as this JJS NN VBZ VBG to VB a JJ NN , which VBZ why we VBP VBG with NNP to RB VB a JJ NN NN , ” VBD NNP . “ While we VBP VBG our NN where JJ , we VBP the NN with NNP may VB the RBS JJ NNS in VBG the NN from this JJS NN , ” he VBD . NNP VBD the NN VBZ to VB a NN NN — a NN — to VB in NN within six NNS and could VB JJ to VB the NN in NNS within a NN or 18 NNS . NNP VBD the NN NN NN VBZ RB VBN to VB NN NN VBN in the NNP , which VBZ NNS VBP JJ with it . NNP RB VBZ JJ - NN NN NN for these NNS of NNS . NNP VBZ the JJ JJ NN NN to VB it will VB to VB a NN against the JJ NN , which VBZ VBN RB 70,000 NNS , RB in NNP . NNP & NNP ’s NN NN , NNP , VBZ RB VBN it will VB to VB a NN . VBN with NN from NNP . This NN RB VBD on NNP 18 2020"
53,175,mainstream,M0b27a,vaccine.autism,"Facebook_NNP has_VBZ a_DT problem_NN with_IN more_JJR than_IN just_RB fake_JJ news_NN ._. Add_VB vaccine_NN misinformation_NN on_IN the_DT social_JJ network_NN to_IN the_DT list_NN ._. Revealed_VBN Thursday_NNP :_: The_DT social_JJ network_NN says_VBZ it_PRP will_MD reduce_VB distribution_NN and_CC provide_VB users_NNS with_IN ""_`` authoritative_JJ information_NN ""_'' on_IN the_DT topic_NN ._. Facebook_NNP is_VBZ following_VBG the_DT lead_NN of_IN Pinterest_NNP ,_, which_WDT has_VBZ blocked_VBN all_DT searches_NNS using_VBG terms_NNS related_JJ to_IN vaccines_NNS or_CC vaccinations_NNS as_IN part_NN of_IN a_DT plan_NN to_TO stop_VB the_DT spread_NN of_IN misinformation_NN related_JJ to_IN anti-vaxx_NN posts_NNS ._. In_IN mid-February_NNP ,_, Facebook_NNP told_VBD USA_NNP TODAY_NNP it_PRP had_VBD ""_`` taken_VBN steps_NNS ""_'' to_TO reduce_VB fake_JJ health_NN news_NN and_CC anti-vaxx_JJ posts_NNS and_CC said_VBD it_PRP was_VBD considering_VBG making_VBG anti-vaccination_NN content_NN on_IN its_PRP$ site_NN less_RBR visible_JJ amid_IN a_DT measles_NN outbreak_NN that_WDT has_VBZ reignited_VBN a_DT conversation_NN about_IN preventative_JJ shots_NNS ._. At_IN the_DT time_NN ,_, Facebook_NNP said_VBD ,_, ""_`` we_PRP know_VBP we_PRP have_VBP more_JJR to_TO do_VB ._. ""_'' Facebook_NNP has_VBZ been_VBN fighting_VBG misinformation_NN on_IN its_PRP$ platform_NN since_IN the_DT 2016_CD presidential_JJ election_NN after_IN fake_JJ accounts_NNS and_CC news_NN stories_NNS aimed_VBN at_IN sowing_VBG discord_NN among_IN users_NNS were_VBD discovered_VBN ._. Social_JJ media_NN sites_NNS have_VBP grappled_VBN with_IN how_WRB to_TO handle_VB anti-vaxx_JJ posts_NNS from_IN users_NNS amid_IN a_DT measles_NN outbreak_NN in_IN Washington_NNP state_NN affecting_VBG more_JJR than_IN 60_CD people_NNS ._. —_: It_PRP will_MD reduce_VB the_DT ranking_NN of_IN Facebook_NNP groups_NNS and_CC Pages_NNS that_WDT spread_VBP misinformation_NN about_IN vaccinations_NNS in_IN News_NN Feed_NN and_CC Search_NN ._. ""_`` These_DT groups_NNS and_CC Pages_NNS will_MD not_RB be_VB included_VBN in_IN recommendations_NNS or_CC in_IN predictions_NNS when_WRB you_PRP type_VBP into_IN Search_NN ,_, ""_'' Facebook_NNP said_VBD ._. —_: When_WRB it_PRP discovers_VBZ ads_NNS with_IN misinformation_NN about_IN vaccinations_NNS ,_, ""_'' we_PRP will_MD reject_VB them_PRP ._. ""_'' —_: Facebook_NNP said_VBD it_PRP has_VBZ removed_VBN related_JJ targeting_NN options_NNS ,_, like_IN “_`` vaccine_NN controversies_NNS ,_, ""_'' in_IN ads_NNS ._. ""_`` For_IN ad_NN accounts_NNS that_WDT continue_VBP to_TO violate_VB our_PRP$ policies_NNS ,_, we_PRP may_MD take_VB further_JJR action_NN ,_, such_JJ as_IN disabling_VBG the_DT ad_NN account_NN ._. ""_'' Additionally_RB ,_, Facebook_NNP said_VBD it_PRP would_MD n't_RB show_VB or_CC recommend_VB content_NN that_WDT contains_VBZ misinformation_NN about_IN vaccinations_NNS on_IN the_DT Explore_NN section_NN of_IN Facebook_NNP -_HYPH owned_VBN Instagram_NNP or_CC on_IN its_PRP$ hashtag_NN pages_NNS ._. More_RBR :_: Teen_NN who_WP vaccinated_VBD himself_PRP says_VBZ anti-vaxx_JJ Mom_NN gets_VBZ misinformation_NN from_IN Facebook_NNP More_RBR :_: Facebook_NNP may_MD hide_VB anti-vaxx_JJ posts_NNS after_IN it's_PRP accused_VBN of_IN spreading_VBG fake_JJ health_NN news_NN More_JJR :_: Large_JJ study_NN adds_VBZ to_IN proof_NN that_IN measles_NNS vaccine_NN does_VBZ n’t_RB cause_VB autism_NN Facebook_NNP noted_VBD that_IN global_JJ health_NN organizations_NNS like_IN the_DT World_NNP Health_NNP Organization_NNP and_CC the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP have_VBP publicly_RB identified_VBN verifiable_JJ vaccine_NN hoaxes_NNS ._. ""_`` If_IN these_DT vaccine_NN hoaxes_NNS appear_VBP on_IN Facebook_NNP ,_, we_PRP will_MD take_VB action_NN against_IN them_PRP ,_, ""_'' Facebook_NNP said_VBD ._. ""_`` We_PRP also_RB believe_VBP in_IN providing_VBG people_NNS with_IN additional_JJ context_NN so_IN they_PRP can_MD decide_VB whether_IN to_TO read_VB ,_, share_VB ,_, or_CC engage_VB in_IN conversations_NNS about_IN information_NN they_PRP see_VBP on_IN Facebook_NNP ,_, ""_'' the_DT company_NN said_VBD ._. ""_`` We_PRP are_VBP exploring_VBG ways_NNS to_TO give_VB people_NNS more_RBR accurate_JJ information_NN from_IN expert_NN organizations_NNS about_IN vaccines_NNS at_IN the_DT top_NN of_IN results_NNS for_IN related_JJ searches_NNS ,_, on_IN Pages_NNS discussing_VBG the_DT topic_NN ,_, and_CC on_IN invitations_NNS to_TO join_VB groups_NNS about_IN the_DT topic_NN ._. We_PRP will_MD have_VB an_DT update_NN on_IN this_DT soon_RB ._. ""_'' Follow_VB USA_NNP TODAY_NN 's_POS Jefferson_NNP Graham_NNP on_IN Twitter_NNP ,_, @jeffersongraham_NNP","NNP VBZ a NN with JJR than RB JJ NN . VB NN NN on the JJ NN to the NN . VBN NNP : The JJ NN VBZ it will VB NN and VB NNS with "" JJ NN "" on the NN . NNP VBZ VBG the NN of NNP , which VBZ VBN all NNS VBG NNS JJ to NNS or NNS as NN of a NN to VB the NN of NN JJ to NN NNS . In NNP , NNP VBD NNP NNP it VBD "" VBN NNS "" to VB JJ NN NN and JJ NNS and VBD it VBD VBG VBG NN NN on its NN RBR JJ amid a NN NN that VBZ VBN a NN about JJ NNS . At the NN , NNP VBD , "" we VBP we VBP JJR to VB . "" NNP VBZ VBN VBG NN on its NN since the 2016 JJ NN after JJ NNS and NN NNS VBN at VBG NN among NNS VBD VBN . JJ NN NNS VBP VBN with how to VB JJ NNS from NNS amid a NN NN in NNP NN VBG JJR than 60 NNS . — It will VB the NN of NNP NNS and NNS that VBP NN about NNS in NN NN and NN . "" These NNS and NNS will RB VB VBN in NNS or in NNS when you VBP into NN , "" NNP VBD . — When it VBZ NNS with NN about NNS , "" we will VB them . "" — NNP VBD it VBZ VBN JJ NN NNS , like “ NN NNS , "" in NNS . "" For NN NNS that VBP to VB our NNS , we may VB JJR NN , JJ as VBG the NN NN . "" RB , NNP VBD it would RB VB or VB NN that VBZ NN about NNS on the NN NN of NNP - VBN NNP or on its NN NNS . RBR : NN who VBD himself VBZ JJ NN VBZ NN from NNP RBR : NNP may VB JJ NNS after it's VBN of VBG JJ NN NN JJR : JJ NN VBZ to NN that NNS NN VBZ RB VB NN NNP VBD that JJ NN NNS like the NNP NNP NNP and the NNP NNPS for NNP NNP and NNP VBP RB VBN JJ NN NNS . "" If these NN NNS VBP on NNP , we will VB NN against them , "" NNP VBD . "" We RB VBP in VBG NNS with JJ NN so they can VB whether to VB , VB , or VB in NNS about NN they VBP on NNP , "" the NN VBD . "" We VBP VBG NNS to VB NNS RBR JJ NN from NN NNS about NNS at the NN of NNS for JJ NNS , on NNS VBG the NN , and on NNS to VB NNS about the NN . We will VB an NN on this RB . "" VB NNP NN 's NNP NNP on NNP , NNP"
54,527,conspiracy,C00940,vaccine,"Flu_NN vaccines_NNS ,_, according_VBG to_IN the_DT best_JJS scientific_JJ evidence_NN available_JJ today_NN ,_, will_MD only_RB work_VB against_IN 10_CD %_NN of_IN the_DT circulating_VBG viruses_NNS that_WDT cause_VBP the_DT symptoms_NNS of_IN seasonal_JJ epidemic_NN influenza_NN ._. Additionally_RB ,_, flu_NN vaccines_NNS have_VBP been_VBN found_VBN to_TO elicit_VB inflammatory_JJ reactions_NNS that_WDT may_MD harm_VB the_DT human_JJ heart_NN ,_, the_DT developing_VBG fetus_NN ,_, and_CC the_DT fragile_JJ immune_NN systems_NNS of_IN our_PRP$ infants_NNS ._. So_RB ,_, do_VBP the_DT theoretical_JJ benefits_NNS really_RB outweigh_VB the_DT known_VBN harms_NNS ?_. In_IN a_DT recent_JJ article_NN ,_, The_DT Shocking_NNP Lack_NNP of_IN Evidence_NNP Supporting_NNP Flu_NNP Vaccines_NNPS ,_, we_PRP addressed_VBD the_DT surprising_JJ lack_NN of_IN empirical_JJ evidence_NN supporting_VBG the_DT use_NN of_IN flu_NN vaccines_NNS in_IN the_DT prevention_NN of_IN seasonal_JJ influenza_NN ,_, in_IN children_NNS under_IN two_CD ,_, healthy_JJ adults_NNS ,_, the_DT elderly_JJ ,_, and_CC healthcare_NN workers_NNS who_WP care_VBP for_IN the_DT elderly_NN ._. The_DT reality_NN is_VBZ that_IN vaccines_NNS not_RB only_RB do_VBP not_RB work_VB as_IN advertised_VBN ,_, but_CC they_PRP represent_VBP a_DT significant_JJ health_NN threat_NN ,_, likely_RB on_IN the_DT same_JJ order_NN of_IN magnitude_NN as_IN influenza_NN itself_PRP ,_, due_IN to_IN their_PRP$ well_RB -_HYPH known_VBN role_NN in_IN compromising_VBG immunological_JJ self_NN -_HYPH tolerance_NN (_-LRB- autoimmunity_NN )_-RRB- ,_, as_RB well_RB as_IN by_IN eliciting_VBG a_DT wide_JJ range_NN of_IN adverse_JJ health_NN effects_NNS associated_VBN with_IN the_DT use_NN of_IN adjuvants_NNS ,_, preservatives_NNS ,_, foreign_JJ animal_NN DNA_NN and_CC cell_NN byproducts_NNS ,_, adventitious_JJ viruses_NNS ,_, and_CC other_JJ so_RB -_HYPH called_VBN “_`` inactive_JJ ingredients_NNS ,_, ”_'' including_VBG even_RB the_DT unnatural_JJ route_NN and_CC method_NN of_IN antigen_NN administration_NN itself_PRP ._. [_-LRB- i_CD ]_-RRB- Basic_JJ Virology_NN Facts_NNS Reveal_VBP Trivalent_NN Flu_NN Vaccines_NNS Are_VBP At_IN Best_JJS 10_CD %_NN Effective_JJ But_CC it_PRP should_MD n’t_RB take_VB expensive_JJ ,_, elaborate_JJ ,_, time_NN -_HYPH consuming_VBG research_NN to_TO grasp_VB the_DT obvious_JJ limitations_NNS in_IN effectiveness_NN of_IN flu_NN vaccines_NNS from_IN the_DT perspective_NN of_IN this_DT fundamental_JJ fact_NN of_IN influenza_NN virology_NN :_: Indeed_RB ,_, if_IN facts_NNS like_IN these_DT were_VBD not_RB so_RB commonly_RB ignored_VBN or_CC denied_VBN ,_, and_CC it_PRP was_VBD the_DT actuallyclinically_RB -_HYPH confirmed_VBN ,_, unequivocal_JJ “_`` evidence_NN ”_'' that_WDT drove_VBD the_DT so_RB -_HYPH called_VBN “_`` evidence_NN -_HYPH based_VBN ”_'' medical_JJ system_NN into_IN its_PRP$ annual_JJ ,_, seasonal_JJ influenza_NN -_HYPH induced_VBN ,_, frenzy_NN of_IN pro-vaccine_JJ propagandizing_NN and_CC proselytizing_NN ,_, we_PRP might_MD look_VB at_IN this_DT ritual_NN of_IN mass_JJ vaccination_NN as_IN something_NN other_JJ than_IN just_RB a_DT profit-_NN ,_, policy_NN -_, ,_, and_CC ,_, for_IN the_DT masses_NNS ,_, faith_NN -_HYPH based_VBN indoctrination_NN ,_, which_WDT sadly_RB it_PRP has_VBZ become_VBN ._. “_`` Science_NN -_HYPH Based_VBN ”_'' Medicine_NN Unwilling_VBG To_TO Look_VB At_IN Empirical_JJ Evidence_NN On_IN Vaccine_NN Harms_NNPS Similarly_RB ,_, were_VBD those_DT self_NN -_HYPH avowed_VBN “_`` skeptics_NNS ,_, ”_'' and_CC would_MD -_HYPH be_VB advocates_NNS of_IN “_`` science_NN -_HYPH based_VBN medicine_NN ,_, ”_'' who_WP claim_VBP vaccinating_NN is_VBZ always_RB safer_JJR and_CC more_RBR effective_JJ than_IN not_RB vaccinating_VBG ,_, to_TO acknowledge_VB research_NN indicating_VBG the_DT limitations_NNS and_CC increasing_VBG failings_NNS of_IN vaccination_NN ,_, as_RB well_RB as_IN the_DT value_NN of_IN natural_JJ influenza_NN flu_NN alternatives_NNS ,_, *_NFP they_PRP might_MD someday_RB earn_VB the_DT right_NN to_TO use_VB powerful_JJ -_HYPH sounding_VBG words_NNS like_IN “_`` Science_NNP ”_'' and_CC “_`` Evidence_NN ”_'' in_IN their_PRP$ crusade_NN against_IN your_PRP$ access_NN to_IN the_DT empirical_JJ truth_NN and_CC your_PRP$ right_NN to_TO bodily_NN self_NN -_HYPH possession_NN ,_, i.e._FW your_PRP$ right_NN to_TO make_VB free_JJ and_CC informed_VBN decisions_NNS for_IN yourself_PRP to_TO engage_VB or_CC disengage_VB from_IN medical_JJ interventions_NNS ,_, that_WDT carry_VBP a_DT known_VBN risk_NN of_IN harm_NN and_CC even_RB death_NN ._. The_DT reality_NN is_VBZ that_IN many_JJ top_JJ biomedical_JJ journals_NNS cannot_MD and_CC will_MD not_RB suppress_VB the_DT truth_NN concerning_VBG the_DT many_JJ unintended_JJ ,_, adverse_JJ health_NN effects_NNS of_IN vaccines_NNS ._. This_DT would_MD ,_, after_IN all_DT ,_, be_VB both_CC immoral_JJ and_CC illegal_JJ ,_, especially_RB when_WRB human_JJ lives_NNS ,_, and_CC particularly_RB the_DT lives_NNS of_IN our_PRP$ most_RBS vulnerable_JJ ,_, our_PRP$ children_NNS ,_, are_VBP on_IN the_DT line_NN ._. In_IN other_JJ words_NNS ,_, by_IN publishing_VBG empirical_JJ research_NN that_WDT shows_VBZ vaccines_NNS are_VBP not_RB safe_JJ and_CC effective_JJ a_DT priori_NN ,_, many_JJ thwart_VBP the_DT party_NN line_NN ,_, as_IN represented_VBN by_IN the_DT policies_NNS and_CC official_JJ statements_NNS of_IN the_DT CDC_NNP ,_, the_DT FDA_NNP ,_, and_CC the_DT ACIP_NNP ,_, and_CC many_JJ online_JJ skeptic_JJ bloggers_NNS (_-LRB- anti-anti_JJ -_HYPH vaccine_NN groups_NNS ,_, if_IN you_PRP will_MD ;_: most_JJS whom_WP fail_VBP to_TO grasp_VB the_DT foolishness_NN of_IN such_PDT a_DT dialectic_NN ,_, since_IN they_PRP rarely_RB take_VBP a_DT critical_JJ look_NN in_IN the_DT mirror_NN )_-RRB- who_WP claim_VBP those_DT refusing_VBG vaccines_NNS ,_, or_CC educating_VBG about_IN their_PRP$ harms_NNS ,_, are_VBP guilty_JJ of_IN crimes_NNS ,_, or_CC have_VBP blood_NN on_IN their_PRP$ hands_NNS ._. For_IN example_NN ,_, a_DT concerning_VBG study_NN published_VBN in_IN 2011_CD in_IN the_DT International_NNP Journal_NNP of_IN Medicinerevealed_NNP a_DT fact_NN rarely_RB addressed_VBN by_IN conventional_JJ health_NN authorities_NNS ,_, or_CC the_DT mostly_RB uncritical_JJ mainstream_JJ media_NN ,_, namely_RB :_: flu_NN vaccines_NNS result_VBP in_IN inflammatory_JJ cardiovascular_JJ changes_NNS indicative_JJ of_IN increased_VBN risk_NN for_IN serious_JJ heart_NN -_HYPH related_JJ events_NNS such_JJ as_IN heart_NN attack_NN ._. [_-LRB- ii_CD ]_-RRB- Titled_VBN ,_, “_`` Inflammation_NN -_HYPH related_JJ effects_NNS of_IN adjuvant_NN influenza_NN A_NN vaccination_NN on_IN platelet_NN activation_NN and_CC cardiac_JJ autonomic_JJ function_NN ,_, ”_'' their_PRP$ study_NN concluded_VBD :_: The_DT four_CD main_JJ areas_NNS of_IN concern_NN mentioned_VBN above_RB are_VBP :_: •_NFP Platelet_NN Activation_NN :_: An_DT indicator_NN of_IN increased_VBN risk_NN for_IN pathological_JJ clotting_NN and_CC /_, or_CC obstruction_NN of_IN a_DT blood_NN vessel_NN ,_, e.g._FW heart_NN attack_NN ,_, embolism_NN or_CC stroke_NN ._. •_NFP Sympathovagal_NNP imbalance_NN towards_IN adrenergic_JJ predominance_NN :_: An_DT indication_NN of_IN disturbed_VBN autonomic_JJ regulation_NN within_IN the_DT heart_NN ._. •_NFP Elevation_NN of_IN C-_NN Reactive_JJ Protein_NN :_: An_DT indicator_NN of_IN inflammation_NN -_HYPH mediated_VBN cardiovascular_JJ disease_NN risk_NN ._. This_DT study_NN is_VBZ not_RB ,_, however_RB ,_, the_DT first_JJ to_TO raise_VB concern_NN over_IN states_NNS of_IN pathological_JJ inflammation_NN caused_VBN by_IN flu_NN vaccines_NNS ,_, and_CC vaccines_NNS in_IN general_JJ ._. In_IN 2011_CD ,_, the_DT journal_NN Vaccine_NNP published_VBD a_DT study_NN titled_VBN ,_, “_`` Inflammatory_JJ responses_NNS to_IN trivalent_JJ influenza_NN virus_NN vaccine_NN among_IN pregnant_JJ women_NNS ,_, ”_'' which_WDT found_VBD that_IN flu_NN vaccination_NN causes_VBZ measurable_JJ increases_NNS in_IN inflammation_NN in_IN pregnant_JJ women_NNS which_WDT may_MD increase_VB the_DT risk_NN of_IN preeclempsia_NN and_CC other_JJ adverse_JJ outcomes_NNS such_JJ as_IN preterm_NN birth_NN .[_-LRB- iii_CD ]_-RRB- In_IN this_DT study_NN both_CC CRP_NN and_CC tumor_NN necrosis_NN factor_NN (_-LRB- TNF_NNP )_-RRB- -α_HYPH levels_NNS increased_VBD to_IN concerning_VBG levels_NNS between_IN one_CD to_IN two_CD days_NNS after_IN vaccination_NN ._. Should_MD we_PRP be_VB surprised_VBN ,_, considering_VBG flu_NN vaccines_NNS still_RB contain_VBP highly_RB inflammatory_JJ ,_, neurotoxic_JJ and_CC immunotoxic_JJ heavy_JJ metals_NNS ,_, such_JJ as_IN mercury_NN -_HYPH based_VBN thimerosal_NN ?_. Even_RB when_WRB the_DT precautionary_JJ principle_NN is_VBZ employed_VBN ,_, and_CC mercury_NN -_HYPH based_VBN adjuvants_NNS removed_VBN in_IN tacit_JJ recognition_NN of_IN its_PRP$ profound_JJ dangers_NNS ,_, aluminum_NN hydroxide_NN is_VBZ then_RB used_VBN to_TO replace_VB it_PRP ,_, injected_VBN directly_RB into_IN the_DT bodies_NNS of_IN healthy_JJ infants_NNS in_IN the_DT name_NN of_IN synthetically_RB modifying_VBG and_CC “_`` improving_VBG ”_'' their_PRP$ immunity_NN (_-LRB- see_VB :_: Can_MD We_PRP Continue_VB To_TO Justify_VB Injecting_VBG Aluminum_NN Into_IN Children_NNS ?_. )_-RRB- ._. And_CC so_RB ,_, despite_IN the_DT fact_NN that_IN vaccine_NN -_HYPH induced_VBN disruption_NN and_CC dysregulation_NN of_IN a_DT pregnant_JJ woman_NN ’s_POS immune_NN system_NN could_MD compromise_VB her_PRP$ pregnancy_NN ,_, resulting_VBG in_IN birth_NN defects_NNS [_-LRB- iv_CD ]_-RRB- and_CC miscarriage_NN (_-LRB- which_WDT is_VBZ a_DT well_RB -_HYPH known_VBN phenomena_NNS within_IN the_DT veterinary_JJ field_NN :_: vaccine_NN -_HYPH induced_VBN abortion_NN )_-RRB- ,_, the_DT CDC_NNP has_VBZ defied_VBN both_CC common_JJ sense_NN and_CC the_DT precautionary_JJ principle_NN by_IN urging_VBG pregnant_JJ women_NNS to_TO receive_VB flu_NN vaccines_NNS ,_, without_IN informing_VBG them_PRP of_IN their_PRP$ true_JJ risks_NNS ._. Infants_NNS At_IN Risk_NN of_IN Pathological_JJ Inflammation_NN Following_VBG Vaccines_NNS Just_RB as_IN disturbing_JJ is_VBZ the_DT CDC_NNP ’s_POS recommendation_NN that_IN all_DT infants_NNS ,_, six_CD months_NNS or_CC older_JJR ,_, receive_VBP flu_NN vaccines_NNS on_IN top_NN of_IN an_DT already_RB burgeoning_VBG vaccination_NN schedule_NN ,_, which_WDT begins_VBZ at_IN the_DT day_NN of_IN birth_NN with_IN the_DT STD_NN vaccine_NN containing_VBG hepatitis_NN B_NN surface_NN antigen_NN ,_, despite_IN clear_JJ evidence_NN that_IN infants_NNS experience_VBP cardiorespiratory_JJ complications_NNS and_CC C_NN -_HYPH reactive_JJ protein_NN responses_NNS as_IN a_DT result_NN of_IN all_DT vaccines_NNS ,_, administered_VBN either_CC singularly_RB or_CC simultaneously_RB in_IN combination_NN ._. One_CD 2007_CD study_NN published_VBN in_IN the_DT Journal_NNP of_IN Pediatrics_NNP ,_, found_VBD that_IN 85_CD %_NN of_IN newborn_NN infants_NNS experienced_VBD abnormal_JJ elevations_NNS of_IN CRP_NN when_WRB administered_VBN multiple_JJ vaccines_NNS and_CC up_IN to_IN 70_CD %_NN in_IN those_DT given_VBN a_DT single_JJ vaccine_NN ._. Also_RB ,_, overall_RB ,_, 16_CD %_NN of_IN infants_NNS were_VBD reported_VBN to_TO experience_VB vaccine_NN -_HYPH associated_VBN cardiorespiratory_JJ events_NNS within_IN 48_CD hours_NNS postimmunization_NN ._. [_-LRB- v_CD ]_-RRB- Suffice_VB it_PRP to_TO say_VB ,_, vaccinating_VBG against_IN the_DT flu_NN (_-LRB- or_CC any_DT pathogen_NN )_-RRB- is_VBZ not_RB as_RB safe_JJ and_CC effective_JJ as_IN we_PRP are_VBP being_VBG told_VBN ._. But_CC please_UH do_VB not_RB adopt_VB my_PRP$ opinion_NN on_IN the_DT matter_NN as_IN your_PRP$ own_JJ ._. Do_VB your_PRP$ own_JJ research_NN ,_, and_CC feel_VB free_JJ to_TO review_VB some_DT of_IN the_DT underreported_VBN and_CC /_, or_CC otherwise_RB suppressed_VBN research_NN on_IN vaccination_NN we_PRP have_VBP collated_VBN at_IN our_PRP$ Vaccine_NN Research_NNP and_CC Education_NNP page_NN ._. *_NFP Never_RB mind_VB the_DT timelessly_RB and_CC often_RB cross-culturally_RB confirmed_VBN and_CC reconfirmed_VBN evidence_NN contained_VBN within_IN “_`` orally_RB transmitted_VBN ”_'' traditional_JJ ,_, plant_NN -_HYPH based_VBN medical_JJ systems_NNS ,_, used_VBN the_DT world_NN over_RB ._. •_NFP None_NN [_-LRB- ii_CD ]_-RRB- Gaetano_NNP A_NNP Lanza_NNP ,_, Lucy_NNP Barone_NNP ,_, Giancarla_NNP Scalone_NNP ,_, Dario_NNP Pitocco_NNP ,_, Gregory_NNP A_NNP Sgueglia_NNP ,_, Roberto_NNP Mollo_NNP ,_, Roberto_NNP Nerla_NNP ,_, Francesco_NNP Zaccardi_NNP ,_, Giovanni_NNP Ghirlanda_NNP ,_, Filippo_NNP Crea_NNP ._. Inflammation_NN -_HYPH related_JJ effects_NNS of_IN adjuvant_NN influenza_NN A_NN vaccination_NN on_IN platelet_NN activation_NN and_CC cardiac_JJ autonomic_JJ function_NN ._. J_NNP Intern_NNP Med._NNP 2010_CD Sep_NNP 1_CD ._. Epub_NNP 2010_CD Sep_NNP 1_CD ._. PMID_NNP :_: [_-LRB- ii_CD ]_-RRB- Gaetano_NNP A_NNP Lanza_NNP ,_, Lucy_NNP Barone_NNP ,_, Giancarla_NNP Scalone_NNP ,_, Dario_NNP Pitocco_NNP ,_, Gregory_NNP A_NNP Sgueglia_NNP ,_, Roberto_NNP Mollo_NNP ,_, Roberto_NNP Nerla_NNP ,_, Francesco_NNP Zaccardi_NNP ,_, Giovanni_NNP Ghirlanda_NNP ,_, Filippo_NNP Crea_NNP ._. Inflammation_NN -_HYPH related_JJ effects_NNS of_IN adjuvant_NN influenza_NN A_NN vaccination_NN on_IN platelet_NN activation_NN and_CC cardiac_JJ autonomic_JJ function_NN ._. J_NNP Intern_NNP Med._NNP 2010_CD Sep_NNP 1_CD ._. Epub_NNP 2010_CD Sep_NNP 1_CD ._. PMID_NN :_: 20964738_CD •_, None_NN [_-LRB- iv_CD ]_-RRB- Margaret_NNP A_NNP K_NNP Ryan_NNP ,_, Tyler_NNP C_NNP Smith_NNP ,_, Carter_NNP J_NNP Sevick_NNP ,_, William_NNP K_NNP Honner_NNP ,_, Rosha_NNP A_NNP Loach_NNP ,_, Cynthia_NNP A_NNP Moore_NNP ,_, J_NNP David_NNP Erickson_NNP ._. Birth_NN defects_NNS among_IN infants_NNS born_VBN to_IN women_NNS who_WP received_VBD anthrax_NN vaccine_NN in_IN pregnancy_NN ._. Am_VBP J_NNP Epidemiol_NNP ._. 2008_CD Aug_NNP 15_CD ;_, 168(4):434-42_CD ._. Epub_NNP 2008_CD Jul_NNP 2_CD ._. PMID_NN :_: •_NFP None_NN [_-LRB- v_CD ]_-RRB- Massroor_NNP Pourcyrous_NNP ,_, Sheldon_NNP B_NNP Korones_NNP ,_, Kristopher_NNP L_NNP Arheart_NNP ,_, Henrietta_NNP S_NNP Bada_NNP ._. Primary_JJ immunization_NN of_IN premature_JJ infants_NNS with_IN gestational_JJ age_NN <_-LRB- 35_CD weeks_NNS :_: cardiorespiratory_JJ complications_NNS and_CC C_NN -_HYPH reactive_JJ protein_NN responses_NNS associated_VBN with_IN administration_NN of_IN single_JJ and_CC multiple_JJ separate_JJ vaccines_NNS simultaneously_RB ._. J_NNP Pediatr_NNP ._. 2007_CD Aug_NNP ;_, 151(2)_CD :167-72_CD ._. Epub_NNP 2007_CD Jun_NNP 22_CD ._. PMID_NNP :_:","NN NNS , VBG to the JJS JJ NN JJ NN , will RB VB against 10 NN of the VBG NNS that VBP the NNS of JJ NN NN . RB , NN NNS VBP VBN VBN to VB JJ NNS that may VB the JJ NN , the VBG NN , and the JJ NN NNS of our NNS . RB , VBP the JJ NNS RB VB the VBN NNS ? In a JJ NN , The NNP NNP of NNP NNP NNP NNPS , we VBD the JJ NN of JJ NN VBG the NN of NN NNS in the NN of JJ NN , in NNS under two , JJ NNS , the JJ , and NN NNS who VBP for the NN . The NN VBZ that NNS RB RB VBP RB VB as VBN , but they VBP a JJ NN NN , RB on the JJ NN of NN as NN itself , due to their RB - VBN NN in VBG JJ NN - NN ( NN ) , RB RB as by VBG a JJ NN of JJ NN NNS VBN with the NN of NNS , NNS , JJ NN NN and NN NNS , JJ NNS , and JJ RB - VBN “ JJ NNS , ” VBG RB the JJ NN and NN of NN NN itself . [ i ] JJ NN NNS VBP NN NN NNS VBP At JJS 10 NN JJ But it should RB VB JJ , JJ , NN - VBG NN to VB the JJ NNS in NN of NN NNS from the NN of this JJ NN of NN NN : RB , if NNS like these VBD RB RB RB VBN or VBN , and it VBD the RB - VBN , JJ “ NN ” that VBD the RB - VBN “ NN - VBN ” JJ NN into its JJ , JJ NN - VBN , NN of JJ NN and NN , we might VB at this NN of JJ NN as NN JJ than RB a NN , NN - , and , for the NNS , NN - VBN NN , which RB it VBZ VBN . “ NN - VBN ” NN VBG To VB At JJ NN On NN NNPS RB , VBD those NN - VBN “ NNS , ” and would - VB NNS of “ NN - VBN NN , ” who VBP NN VBZ RB JJR and RBR JJ than RB VBG , to VB NN VBG the NNS and VBG NNS of NN , RB RB as the NN of JJ NN NN NNS , * they might RB VB the NN to VB JJ - VBG NNS like “ NNP ” and “ NN ” in their NN against your NN to the JJ NN and your NN to NN NN - NN , FW your NN to VB JJ and VBN NNS for yourself to VB or VB from JJ NNS , that VBP a VBN NN of NN and RB NN . The NN VBZ that JJ JJ JJ NNS cannot and will RB VB the NN VBG the JJ JJ , JJ NN NNS of NNS . This would , after all , VB both JJ and JJ , RB when JJ NNS , and RB the NNS of our RBS JJ , our NNS , VBP on the NN . In JJ NNS , by VBG JJ NN that VBZ NNS VBP RB JJ and JJ a NN , JJ VBP the NN NN , as VBN by the NNS and JJ NNS of the NNP , the NNP , and the NNP , and JJ JJ JJ NNS ( JJ - NN NNS , if you will ; JJS whom VBP to VB the NN of such a NN , since they RB VBP a JJ NN in the NN ) who VBP those VBG NNS , or VBG about their NNS , VBP JJ of NNS , or VBP NN on their NNS . For NN , a VBG NN VBN in 2011 in the NNP NNP of NNP a NN RB VBN by JJ NN NNS , or the RB JJ JJ NN , RB : NN NNS VBP in JJ JJ NNS JJ of VBN NN for JJ NN - JJ NNS JJ as NN NN . [ ii ] VBN , “ NN - JJ NNS of NN NN NN NN on NN NN and JJ JJ NN , ” their NN VBD : The four JJ NNS of NN VBN RB VBP : • NN NN : An NN of VBN NN for JJ NN and / or NN of a NN NN , FW NN NN , NN or NN . • NNP NN towards JJ NN : An NN of VBN JJ NN within the NN . • NN of NN JJ NN : An NN of NN - VBN JJ NN NN . This NN VBZ RB , RB , the JJ to VB NN over NNS of JJ NN VBN by NN NNS , and NNS in JJ . In 2011 , the NN NNP VBD a NN VBN , “ JJ NNS to JJ NN NN NN among JJ NNS , ” which VBD that NN NN VBZ JJ NNS in NN in JJ NNS which may VB the NN of NN and JJ JJ NNS JJ as NN NN .[ iii ] In this NN both NN and NN NN NN ( NNP ) -α NNS VBD to VBG NNS between one to two NNS after NN . Should we VB VBN , VBG NN NNS RB VBP RB JJ , JJ and JJ JJ NNS , JJ as NN - VBN NN ? RB when the JJ NN VBZ VBN , and NN - VBN NNS VBN in JJ NN of its JJ NNS , NN NN VBZ RB VBN to VB it , VBN RB into the NNS of JJ NNS in the NN of RB VBG and “ VBG ” their NN ( VB : Can We VB To VB VBG NN Into NNS ? ) . And RB , despite the NN that NN - VBN NN and NN of a JJ NN ’s NN NN could VB her NN , VBG in NN NNS [ iv ] and NN ( which VBZ a RB - VBN NNS within the JJ NN : NN - VBN NN ) , the NNP VBZ VBN both JJ NN and the JJ NN by VBG JJ NNS to VB NN NNS , without VBG them of their JJ NNS . NNS At NN of JJ NN VBG NNS RB as JJ VBZ the NNP ’s NN that all NNS , six NNS or JJR , VBP NN NNS on NN of an RB VBG NN NN , which VBZ at the NN of NN with the NN NN VBG NN NN NN NN , despite JJ NN that NNS VBP JJ NNS and NN - JJ NN NNS as a NN of all NNS , VBN either RB or RB in NN . One 2007 NN VBN in the NNP of NNP , VBD that 85 NN of NN NNS VBD JJ NNS of NN when VBN JJ NNS and up to 70 NN in those VBN a JJ NN . RB , RB , 16 NN of NNS VBD VBN to VB NN - VBN JJ NNS within 48 NNS NN . [ v ] VB it to VB , VBG against the NN ( or any NN ) VBZ RB RB JJ and JJ as we VBP VBG VBN . But please VB RB VB my NN on the NN as your JJ . VB your JJ NN , and VB JJ to VB some of the VBN and / or RB VBN NN on NN we VBP VBN at our NN NNP and NNP NN . * RB VB the RB and RB RB VBN and VBN NN VBN within “ RB VBN ” JJ , NN - VBN JJ NNS , VBN the NN RB . • NN [ ii ] NNP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP . NN - JJ NNS of NN NN NN NN on NN NN and JJ JJ NN . NNP NNP NNP 2010 NNP 1 . NNP 2010 NNP 1 . NNP : [ ii ] NNP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP . NN - JJ NNS of NN NN NN NN on NN NN and JJ JJ NN . NNP NNP NNP 2010 NNP 1 . NNP 2010 NNP 1 . NN : 20964738 • NN [ iv ] NNP NNP NNP NNP , NNP NNP NNP , NNP NNP NNP , NNP NNP NNP , NNP NNP NNP , NNP NNP NNP , NNP NNP NNP . NN NNS among NNS VBN to NNS who VBD NN NN in NN . VBP NNP NNP . 2008 NNP 15 ; 168(4):434-42 . NNP 2008 NNP 2 . NN : • NN [ v ] NNP NNP , NNP NNP NNP , NNP NNP NNP , NNP NNP NNP . JJ NN of JJ NNS with JJ NN < 35 NNS : JJ NNS and NN - JJ NN NNS VBN with NN of JJ and JJ JJ NNS RB . NNP NNP . 2007 NNP ; 151(2) :167-72 . NNP 2007 NNP 22 . NNP :"
55,970,mainstream,M0ac04,coronavirus; covid.19; vaccine,"It_PRP ’s_VBZ easy_JJ to_TO confuse_VB viruses_NNS and_CC bacteria_NNS ._. They_PRP are_VBP both_RB extremely_RB tiny_JJ ,_, for_IN one_CD thing_NN ,_, and_CC ,_, depending_VBG on_IN what_WDT kind_NN of_IN bug_NN you_PRP get_VBP ,_, they_PRP can_MD make_VB you_PRP sick_JJ ._. OK_UH ,_, “_`` extremely_RB tiny_JJ ”_'' and_CC “_`` make_VB you_PRP sick_JJ ”_'' ?_. We_PRP do_VBP have_VB technical_JJ words_NNS for_IN these_DT things_NNS ._. Viruses_NNS and_CC bacteria_NNS are_VBP microscopic_JJ ,_, meaning_VBG they_PRP are_VBP too_RB small_JJ to_TO see_VB with_IN the_DT unaided_JJ eye_NN ._. And_CC pathogens_NNS are_VBP “_`` disease_NN -_HYPH producing_VBG agents_NNS ,_, ”_'' especially_RB viruses_NNS and_CC certain_JJ kinds_NNS of_IN bacteria_NN ._. But_CC ,_, there_EX are_VBP many_JJ differences_NNS between_IN viruses_NNS and_CC bacteria_NN too_RB —_: and_CC they_PRP ’re_VBP not_RB just_RB important_JJ to_TO know_VB to_TO ace_VB your_PRP$ science_NN exams_NNS ._. These_DT differences_NNS can_MD be_VB vital_JJ to_IN your_PRP$ health_NN and_CC safety_NN ._. A_DT virus_NN is_VBZ an_DT ultramicroscopic_JJ (_-LRB- 20_CD to_IN 300_CD nm_NN in_IN diameter_NN )_-RRB- ,_, metabolically_RB inert_JJ ,_, infectious_JJ agent_NN that_WDT replicates_VBZ only_RB within_IN the_DT cells_NNS of_IN living_NN hosts_NNS ,_, mainly_RB bacteria_NN ,_, plants_NNS ,_, and_CC animals_NNS :_: composed_VBN of_IN an_DT RNA_NN or_CC DNA_NN core_NN ,_, a_DT protein_NN coat_NN ,_, and_CC ,_, in_IN more_RBR complex_JJ types_NNS ,_, a_DT surrounding_VBG envelope_NN ._. Virus_NN ,_, explained_VBN in_IN everyday_JJ words_NNS ,_, is_VBZ an_DT extremely_RB tiny_JJ particle_NN that_WDT causes_VBZ an_DT infectious_JJ disease_NN ._. It_PRP is_VBZ generally_RB made_VBN up_RP of_IN some_DT RNA_NN or_CC DNA_NN coated_VBN in_IN protein_NN ._. It_PRP can_MD only_RB multiply_VB in_IN the_DT cell_NN of_IN hosts_NNS that_WDT are_VBP alive_JJ ._. That_DT means_VBZ ,_, technically_RB ,_, viruses_NNS are_VBP not_RB themselves_PRP living_VBG ._. In_IN informal_JJ contexts_NNS ,_, virus_NN is_VBZ also_RB commonly_RB used_VBN to_TO refer_VB to_IN the_DT disease_NN caused_VBN by_IN the_DT virus_NN ._. And_CC of_IN course_NN ,_, virus_NN has_VBZ another_DT special_JJ meaning_NN when_WRB it_PRP comes_VBZ to_IN computers_NNS ._. Where_WRB does_VBZ the_DT word_NN virus_NN come_VB from_IN ?_. The_DT word_NN virus_NN entered_VBD English_NNP around_IN 1590_CD –_SYM 1600_CD ._. It_PRP comes_VBZ directly_RB from_IN the_DT Latin_NNP vīrus_NN ,_, meaning_VBG “_`` slime_NN ,_, poison_NN ._. ”_'' The_DT adjective_NN virulent_NN is_VBZ also_RB ultimately_RB derived_VBN from_IN the_DT Latin_JJ vīrus_NN ._. In_IN medical_JJ and_CC scientific_JJ settings_NNS ,_, virulent_JJ specifically_RB means_VBZ “_`` highly_RB infective_JJ ”_'' or_CC “_`` causing_VBG clinical_JJ symptoms_NNS ._. ”_'' More_RBR generally_RB ,_, virulent_JJ can_MD mean_VB “_`` actively_RB poisonous_JJ ,_, ”_'' “_`` violently_RB hostile_JJ ,_, ”_'' or_CC “_`` intensely_RB bitter_JJ ._. ”_'' What_WP does_VBZ bacteria_NN mean_VB ?_. Bacteria_NNS are_VBP ubiquitous_JJ one_CD -_HYPH celled_VBN organisms_NNS ,_, spherical_JJ ,_, spiral_NN ,_, or_CC rod-shaped_JJ and_CC appearing_VBG singly_RB or_CC in_IN chains_NNS ,_, comprising_VBG the_DT Schizomycota_NNP ,_, a_DT phylum_NN of_IN the_DT kingdom_NN Monera_NNP (_-LRB- in_IN some_DT classification_NN systems_NNS the_DT plant_NN class_NN Schizomycetes_NNPS )_-RRB- ,_, various_JJ species_NNS of_IN which_WDT are_VBP involved_VBN in_IN fermentation_NN ,_, putrefaction_NN ,_, infectious_JJ diseases_NNS ,_, or_CC nitrogen_NN fixation_NN ._. One_CD -_HYPH celled_VBN organisms_NNS that_WDT sometimes_RB cause_VBP infectious_JJ diseases_NNS but_CC ,_, very_RB often_RB ,_, are_VBP essential_JJ to_IN keeping_VBG us_PRP healthy_JJ or_CC are_VBP harmless_JJ ._. They_PRP come_VBP in_IN three_CD shapes_NNS ,_, resembling_VBG a_DT sphere_NN ,_, spiral_NN ,_, or_CC rod_NN ._. We_PRP generally_RB refer_VBP to_IN bacteria_NN just_RB like_IN that_DT :_: bacteria_NN ._. But_CC note_VB that_IN bacteria_NN is_VBZ technically_RB the_DT plural_JJ form_NN of_IN the_DT singular_JJ bacterium_NN ._. (_-LRB- You_PRP can_MD blame_VB that_DT on_IN Latin_NNP ._. )_-RRB- You_PRP might_MD need_VB to_TO use_VB bacterium_NN when_WRB discussing_VBG the_DT specific_JJ kind_NN of_IN bacteria_NN that_WDT causes_VBZ a_DT disease_NN ,_, such_JJ as_IN Yersinia_NNP pestis_NN ,_, which_WDT causes_VBZ the_DT plague_NN ._. Where_WRB does_VBZ the_DT word_NN bacteria_NNS come_VB from_IN ?_. Bacteria_NN is_VBZ first_RB recorded_VBN in_IN English_NNP around_IN 1905_CD –_SYM 10_CD ._. Bacterium_NN is_VBZ older_JJR ,_, evidenced_VBN by_IN 1840_CD –_SYM 50_CD ._. Both_DT words_NNS ultimately_RB come_VBP ,_, via_IN Latin_NNP ,_, from_IN the_DT Greek_JJ baktēría_NN ,_, meaning_VBG “_`` staff_NN ._. ”_'' Remember_VB how_WRB we_PRP mentioned_VBD that_IN bacteria_NNS come_VBP in_IN three_CD shapes_NNS ?_. The_DT Greek_JJ baktēría_NN is_VBZ related_JJ to_IN the_DT Latin_NNP word_NN bacillus_NN ,_, a_DT name_NN for_IN rod-shaped_JJ bacteria_NN ._. Sphere_NN -_HYPH shaped_VBN bacteria_NN are_VBP also_RB referred_VBN to_IN as_IN coccus_NN (_-LRB- cocci_NN in_IN the_DT plural_JJ ;_, again_RB ,_, thanks_NN Latin_NNP )_-RRB- ._. You_PRP may_MD have_VB encountered_VBN coccus_NN in_IN streptococcus_NN ,_, which_WDT can_MD cause_VB strep_NN throat_NN ._. What_WP are_VBP some_DT other_JJ differences_NNS between_IN a_DT virus_NN and_CC bacteria_NN ?_. As_IN we_PRP noted_VBD in_IN the_DT intro_NN ,_, a_DT pathogen_NN is_VBZ an_DT agent_NN that_WDT can_MD cause_VB a_DT disease_NN ,_, especially_RB a_DT virus_NN or_CC bacterium_NN ._. Some_DT fungi_NN and_CC algae_NN can_MD be_VB pathogenic_JJ ,_, too_RB ._. Viruses_NNS cause_VBP infection_NN ,_, and_CC those_DT infections_NNS very_RB often_RB result_VBP in_IN disease_NN ._. Bacteria_NNS can_MD sometimes_RB cause_VB infectious_JJ disease_NN ,_, too_RB ,_, but_CC a_DT great_JJ deal_NN of_IN bacteria_NN are_VBP completely_RB harmless_JJ or_CC even_RB beneficial_JJ ._. (_-LRB- Think_VB of_IN all_PDT those_DT good_JJ bacteria_NN you_PRP ’re_VBP supposed_VBN to_TO get_VB from_IN yogurt_NN ._. )_-RRB- Because_IN viruses_NNS are_VBP n’t_RB technically_RB alive_JJ ,_, they_PRP also_RB are_VBP n’t_RB technically_RB microorganisms_NNS ._. A_DT microorganism_NN is_VBZ “_`` any_DT organism_NN too_RB small_JJ to_TO be_VB viewed_VBN by_IN the_DT unaided_JJ eye_NN ,_, as_IN bacteria_NN ,_, protozoa_NN ,_, and_CC some_DT fungi_NN and_CC algae_NN ._. ”_'' Another_DT word_NN for_IN a_DT microorganism_NN is_VBZ a_DT microbe_NN ._. However_RB ,_, microbe_NN is_VBZ often_RB used_VBN specifically_RB to_TO refer_VB to_IN pathogenic_JJ (_-LRB- disease_NN -_HYPH causing_VBG )_-RRB- bacteria_NN ._. And_CC because_IN viruses_NNS are_VBP microscopic_JJ and_CC infectious_JJ ,_, they_PRP are_VBP also_RB sometimes_RB referred_VBN to_IN as_IN microbes_NNS ._. An_DT everyday_JJ term_NN for_IN microbes_NNS is_VBZ germs_NNS ._. Yeah_UH ,_, we_PRP know_VBP it_PRP ’s_VBZ confusing_JJ ._. Language_NN —_: just_RB as_IN life_NN —_: can_MD get_VB messy_JJ ._. Another_DT area_NN of_IN difference_NN between_IN viruses_NNS and_CC bacteria_NN concerns_VBZ what_WP treats_VBZ them_PRP ._. Both_CC vaccines_NNS and_CC antibiotics_NNS are_VBP used_VBN to_TO treat_VB infectious_JJ diseases_NNS ._. There_EX are_VBP vaccines_NNS that_WDT work_VBP against_IN both_CC viruses_NNS and_CC bacterias_NNS ._. Antibiotics_NNS ,_, however_RB ,_, only_RB work_VBP against_IN bacteria_NN and_CC other_JJ microorganisms_NNS ._. What_WP does_VBZ vaccine_NN mean_VB ?_. A_DT vaccine_NN is_VBZ any_DT preparation_NN used_VBN as_IN a_DT preventive_JJ inoculation_NN to_TO confer_VB immunity_NN against_IN a_DT specific_JJ disease_NN ,_, usually_RB employing_VBG an_DT innocuous_JJ form_NN of_IN the_DT disease_NN agent_NN ,_, such_JJ as_IN killed_VBN or_CC weakened_VBN bacteria_NN or_CC viruses_NNS ,_, to_TO stimulate_VB antibody_NN production_NN ._. What_WP does_VBZ antibiotic_NN mean_VB ?_. An_DT antibiotic_NN is_VBZ any_DT of_IN a_DT large_JJ group_NN of_IN chemical_JJ substances_NNS ,_, as_IN penicillin_NN or_CC streptomycin_NN ,_, produced_VBN by_IN various_JJ microorganisms_NNS and_CC fungi_NN ,_, having_VBG the_DT capacity_NN in_IN dilute_JJ solutions_NNS to_TO inhibit_VB the_DT growth_NN of_IN or_CC to_TO destroy_VB bacteria_NN and_CC other_JJ microorganisms_NNS ,_, used_VBN chiefly_RB in_IN the_DT treatment_NN of_IN infectious_JJ diseases_NNS ._. What_WP are_VBP different_JJ types_NNS of_IN viruses_NNS ?_. COVID_NNP -_HYPH 19_CD is_VBZ the_DT disease_NN caused_VBN by_IN the_DT novel_JJ coronavirus_NN ._. Coronavirus_NN is_VBZ a_DT family_NN of_IN viruses_NNS that_WDT includes_VBZ SARS_NNS and_CC MERS_NNP ._. The_DT flu_NN is_VBZ also_RB caused_VBN by_IN viruses_NNS ,_, but_CC the_DT novel_JJ coronavirus_NN is_VBZ not_RB the_DT flu_NN ._. There_EX are_VBP many_JJ types_NNS of_IN flus_NNS ._. Different_JJ strains_NNS of_IN what_WP ’s_VBZ known_VBN as_IN the_DT H1N1_NNP virus_NN have_VBP caused_VBN some_DT particularly_RB lethal_JJ pandemics_NNS ,_, including_VBG the_DT 2009_CD swine_NN flu_NN and_CC 1918_CD pandemic_NN flu_NN ,_, commonly_RB referred_VBN to_IN as_IN the_DT Spanish_JJ flu_NN ._. There_EX are_VBP many_JJ types_NNS of_IN other_JJ viruses_NNS that_WDT you_PRP have_VBP probably_RB heard_VBN of_IN ,_, notably_RB hantavirus_NN and_CC HIV_NN ._. Some_DT diseases_NNS caused_VBN by_IN viruses_NNS include_VBP chickenpox_NN ,_, Ebola_NNP ,_, polio_NN ,_, and_CC smallpox_NN ._. Seasonal_JJ flus_NNS and_CC ,_, yes_UH ,_, the_DT common_JJ cold_NN are_VBP viral_JJ infections_NNS ,_, too_RB ._. What_WP does_VBZ flu_NNP mean_VB ?_. The_DT word_NN flu_NN is_VBZ short_JJ for_IN influenza_NN —_: borrowed_VBN from_IN Italian_JJ and_CC from_IN the_DT same_JJ Latin_JJ root_NN that_WDT gives_VBZ English_NNP the_DT word_NN influence_NN ._. Formally_RB defined_VBN ,_, influenza_NN is_VBZ an_DT acute_JJ ,_, commonly_RB epidemic_NN disease_NN ,_, occurring_VBG in_IN several_JJ forms_NNS ._. It_PRP is_VBZ caused_VBN by_IN numerous_JJ rapidly_RB mutating_VBG viral_JJ strains_NNS and_CC characterized_VBN by_IN respiratory_JJ symptoms_NNS and_CC general_JJ prostration_NN ._. General_JJ prostration_NN ?_. That_DT ’s_VBZ another_DT way_NN of_IN saying_VBG “_`` I_PRP just_RB ca_MD n’t_RB get_VB out_IN of_IN bed_NN ._. ”_'' And_CC on_IN that_DT note_NN ,_, stay_VB safe_JJ ,_, stay_VB at_IN home_NN when_WRB you_PRP can_MD ,_, and_CC wash_VB your_PRP$ hands_NNS ._. That_DT will_MD help_VB you_PRP ,_, and_CC others_NNS ,_, avoid_VB general_JJ prostration_NN —_: or_CC worse_JJR ._.","It VBZ JJ to VB NNS and NNS . They VBP RB RB JJ , for one NN , and , VBG on what NN of NN you VBP , they can VB you JJ . OK , “ RB JJ ” and “ VB you JJ ” ? We VBP VB JJ NNS for these NNS . NNS and NNS VBP JJ , VBG they VBP RB JJ to VB with the JJ NN . And NNS VBP “ NN - VBG NNS , ” RB NNS and JJ NNS of NN . But , there VBP JJ NNS between NNS and NN RB — and they VBP RB RB JJ to VB to VB your NN NNS . These NNS can VB JJ to your NN and NN . A NN VBZ an JJ ( 20 to 300 NN in NN ) , RB JJ , JJ NN that VBZ RB within the NNS of NN NNS , RB NN , NNS , and NNS : VBN of an NN or NN NN , a NN NN , and , in RBR JJ NNS , a VBG NN . NN , VBN in JJ NNS , VBZ an RB JJ NN that VBZ an JJ NN . It VBZ RB VBN up of some NN or NN VBN in NN . It can RB VB in the NN of NNS that VBP JJ . That VBZ , RB , NNS VBP RB themselves VBG . In JJ NNS , NN VBZ RB RB VBN to VB to the NN VBN by the NN . And of NN , NN VBZ another JJ NN when it VBZ to NNS . Where VBZ the NN NN VB from ? The NN NN VBD NNP around 1590 – 1600 . It VBZ RB from the NNP NN , VBG “ NN , NN . ” The NN NN VBZ RB RB VBN from the JJ NN . In JJ and JJ NNS , JJ RB VBZ “ RB JJ ” or “ VBG JJ NNS . ” RBR RB , JJ can VB “ RB JJ , ” “ RB JJ , ” or “ RB JJ . ” What VBZ NN VB ? NNS VBP JJ one - VBN NNS , JJ , NN , or JJ and VBG RB or in NNS , VBG the NNP , a NN of the NN NNP ( in some NN NNS the NN NN NNPS ) , JJ NNS of which VBP VBN in NN , NN , JJ NNS , or NN NN . One - VBN NNS that RB VBP JJ NNS but , RB RB , VBP JJ to VBG us JJ or VBP JJ . They VBP in three NNS , VBG a NN , NN , or NN . We RB VBP to NN RB like that : NN . But VB that NN VBZ RB the JJ NN of the JJ NN . ( You can VB that on NNP . ) You might VB to VB NN when VBG the JJ NN of NN that VBZ a NN , JJ as NNP NN , which VBZ the NN . Where VBZ the NN NNS VB from ? NN VBZ RB VBN in NNP around 1905 – 10 . NN VBZ JJR , VBN by 1840 – 50 . Both NNS RB VBP , via NNP , from the JJ NN , VBG “ NN . ” VB how we VBD that NNS VBP in three NNS ? The JJ NN VBZ JJ to the NNP NN NN , a NN for JJ NN . NN - VBN NN VBP RB VBN to as NN ( NN in the JJ ; RB , NN NNP ) . You may VB VBN NN in NN , which can VB NN NN . What VBP some JJ NNS between a NN and NN ? As we VBD in the NN , a NN VBZ an NN that can VB a NN , RB a NN or NN . Some NN and NN can VB JJ , RB . NNS VBP NN , and those NNS RB RB VBP in NN . NNS can RB VB JJ NN , RB , but a JJ NN of NN VBP RB JJ or RB JJ . ( VB of all those JJ NN you VBP VBN to VB from NN . ) Because NNS VBP RB RB JJ , they RB VBP RB RB NNS . A NN VBZ “ any NN RB JJ to VB VBN by the JJ NN , as NN , NN , and some NN and NN . ” Another NN for a NN VBZ a NN . RB , NN VBZ RB VBN RB to VB to JJ ( NN - VBG ) NN . And because NNS VBP JJ and JJ , they VBP RB RB VBN to as NNS . An JJ NN for NNS VBZ NNS . Yeah , we VBP it VBZ JJ . NN — RB as NN — can VB JJ . Another NN of NN between NNS and NN VBZ what VBZ them . Both NNS and NNS VBP VBN to VB JJ NNS . There VBP NNS that VBP against both NNS and NNS . NNS , RB , RB VBP against NN and JJ NNS . What VBZ NN VB ? A NN VBZ any NN VBN as a JJ NN to VB NN against a JJ NN , RB VBG an JJ NN of the NN NN , JJ as VBN or VBN NN or NNS , to VB NN NN . What VBZ NN VB ? An NN VBZ any of a JJ NN of JJ NNS , as NN or NN , VBN by JJ NNS and NN , VBG the NN in JJ NNS to VB the NN of or to VB NN and JJ NNS , VBN RB in the NN of JJ NNS . What VBP JJ NNS of NNS ? NNP - 19 VBZ the NN VBN by the JJ NN . NN VBZ a NN of NNS that VBZ NNS and NNP . The NN VBZ RB VBN by NNS , but the JJ NN VBZ RB the NN . There VBP JJ NNS of NNS . JJ NNS of what VBZ VBN as the NNP NN VBP VBN some RB JJ NNS , VBG the 2009 NN NN and 1918 NN NN , RB VBN to as the JJ NN . There VBP JJ NNS of JJ NNS that you VBP RB VBN of , RB NN and NN . Some NNS VBN by NNS VBP NN , NNP , NN , and NN . JJ NNS and , yes , the JJ NN VBP JJ NNS , RB . What VBZ NNP VB ? The NN NN VBZ JJ for NN — VBN from JJ and from the JJ JJ NN that VBZ NNP the NN NN . RB VBN , NN VBZ an JJ , RB NN NN , VBG in JJ NNS . It VBZ VBN by JJ RB VBG JJ NNS and VBN by JJ NNS and JJ NN . JJ NN ? That VBZ another NN of VBG “ I RB ca RB VB out of NN . ” And on that NN , VB JJ , VB at NN when you can , and VB your NNS . That will VB you , and NNS , VB JJ NN — or JJR ."
56,1178,mainstream,M0b2aa,vaccine.covid,"A_DT MULTI_JJ -_HYPH MILLION_NN pound_NN investment_NN will_MD help_VB in_IN the_DT race_NN to_TO manufacture_VB millions_NNS of_IN doses_NNS of_IN a_DT coronavirus_NN vaccine_NN ._. Construction_NN of_IN a_DT new_JJ dedicated_VBN centre_NN is_VBZ 12_CD months_NNS ahead_RB of_IN schedule_NN and_CC will_MD have_VB the_DT ability_NN to_TO produce_VB enough_JJ vaccines_NNS for_IN the_DT entire_JJ population_NN in_IN just_RB six_CD months_NNS ._. ⚠️_NFP Read_VB our_PRP$ coronavirus_NN live_JJ blog_NN for_IN the_DT latest_JJS news_NN &_CC updates_NNS The_DT new_JJ Vaccine_NNP Manufacturing_NNP and_CC Innovation_NNP Centre_NNP based_VBN in_IN Oxfordshire_NNP to_TO open_VB next_JJ year_NN will_MD also_RB help_VB increase_VB the_DT long_JJ -_HYPH term_NN capacity_NN against_IN any_DT future_JJ viruses_NNS ._. It_PRP will_MD also_RB help_VB produce_VB jabs_NNS for_IN existing_VBG illnesses_NNS including_VBG the_DT flu_NN virus_NN ._. A_DT temporary_JJ facility_NN will_MD receive_VB £_$ 38_CD million_CD to_TO begin_VB manufacturing_VBG from_IN this_DT summer_NN ._. Ministers_NNS have_VBP also_RB appointed_VBN Kate_NNP Bingham_NNP as_IN chair_NN of_IN the_DT UK_NNP ’s_POS Vaccine_NNP Taskforce_NNP to_TO lead_VB efforts_NNS to_TO find_VB and_CC manufacture_VB a_DT coronavirus_NN outbreak_NN ._. Business_NN Secretary_NNP Alok_NNP Sharma_NNP said_VBD :_: “_`` As_IN the_DT biggest_JJS contributor_NN to_IN the_DT international_JJ coalition_NN to_TO find_VB a_DT vaccine_NN ,_, the_DT UK_NNP is_VBZ leading_VBG the_DT global_JJ response_NN ._. “_`` Once_IN a_DT breakthrough_NN is_VBZ made_VBN ,_, we_PRP need_VBP to_TO be_VB ready_JJ to_TO manufacture_VB a_DT vaccine_NN by_IN the_DT millions_NNS ._. ”_'' Meanwhile_RB ,_, a_DT large_JJ scale_NN study_NN of_IN coronavirus_NN immunity_NN is_VBZ being_VBG launched_VBN to_TO track_VB its_PRP$ progress_NN ._. Twenty_CD thousand_CD people_NNS are_VBP being_VBG asked_VBN to_TO take_VB part_NN with_IN research_NN measuring_VBG blood_NN antibodies_NNS ._. Experts_NNS will_MD then_RB be_VB able_JJ to_TO determine_VB who_WP has_VBZ had_VBN the_DT virus_NN ,_, how_WRB long_RB it_PRP lasts_VBZ and_CC how_WRB it_PRP affects_VBZ people_NNS differently_RB ._. •_NFP GOT_VBD a_DT story_NN ?_. RING_NN The_DT Sun_NNP 0207_CD 782_CD 4104_CD or_CC WHATSAPP_NNP 07423720250_CD or_CC EMAIL_NN exclusive@the-sun.co.uk_ADD","A JJ - NN NN NN will VB in the NN to VB NNS of NNS of a NN NN . NN of a JJ VBN NN VBZ 12 NNS RB of NN and will VB the NN to VB JJ NNS for the JJ NN in RB six NNS . ⚠️ VB our NN JJ NN for the JJS NN & NNS The JJ NNP NNP and NNP NNP VBN in NNP to VB JJ NN will RB VB VB the JJ - NN NN against any JJ NNS . It will RB VB VB NNS for VBG NNS VBG the NN NN . A JJ NN will VB £ 38 million to VB VBG from this NN . NNS VBP RB VBN NNP NNP as NN of the NNP ’s NNP NNP to VB NNS to VB and VB a NN NN . NN NNP NNP NNP VBD : “ As the JJS NN to the JJ NN to VB a NN , the NNP VBZ VBG the JJ NN . “ Once a NN VBZ VBN , we VBP to VB JJ to VB a NN by the NNS . ” RB , a JJ NN NN of NN NN VBZ VBG VBN to VB its NN . Twenty thousand NNS VBP VBG VBN to VB NN with NN VBG NN NNS . NNS will RB VB JJ to VB who VBZ VBN the NN , how RB it VBZ and how it VBZ NNS RB . • VBD a NN ? NN The NNP 0207 782 4104 or NNP 07423720250 or NN exclusive@the-sun.co.uk"
57,54,mainstream,M079bb,vaccine.autism,"The_DT number_NN of_IN rubella_NN infections_NNS is_VBZ rising_VBG in_IN India_NNP ._. Rubella_NN infection_NN is_VBZ transmitted_VBN from_IN a_DT pregnant_JJ woman_NN to_IN foetus_NN ,_, thus_RB resulting_VBG in_IN babies_NNS born_VBN with_IN various_JJ diseases_NNS ._. It_PRP is_VBZ a_DT contagious_JJ ,_, but_CC generally_RB mild_JJ viral_JJ infection_NN which_WDT usually_RB occurs_VBZ in_IN children_NNS and_CC young_JJ adults_NNS ._. Congenital_JJ rubella_NN syndrome_NN is_VBZ a_DT condition_NN which_WDT can_MD cause_VB deafness_NN ,_, heart_NN defects_NNS ,_, mental_JJ retardation_NN and_CC cataract_NN in_IN newborn_JJ babies_NNS ._. A_DT surveillance_NN was_VBD conducted_VBN by_IN the_DT health_NN ministry_NN on_IN 150_CD babies_NNS for_IN screening_NN rubella_NN syndrome_NN ._. 50_CD of_IN these_DT babies_NNS were_VBD screened_VBN with_IN congenital_JJ rubella_NN syndrome_NN and_CC birth_NN defects_NNS ._. The_DT foetus_NN gets_VBZ infected_VBN within_IN the_DT first_JJ 3_CD months_NNS of_IN pregnancy_NN ._. Congenital_JJ rubella_NN syndrome_NN is_VBZ one_CD of_IN the_DT leading_VBG causes_NNS of_IN birth_NN defects_NNS ,_, but_CC is_VBZ vaccine_NN preventable_JJ ._. Pregnant_JJ women_NNS infected_VBN with_IN rubella_NN infection_NN are_VBP at_IN risk_NN of_IN foetal_JJ death_NN or_CC congenital_JJ defects_NNS -_, which_WDT is_VBZ known_VBN as_IN congenital_JJ rubella_NN syndrome_NN ._. Rubella_NNP is_VBZ spread_VBN in_IN airborne_JJ droplets_NNS when_WRB the_DT ones_NNS who_WP are_VBP infected_VBN by_IN it_PRP sneeze_VBP or_CC cough_VB ._. Once_IN a_DT person_NN is_VBZ infected_VBN by_IN rubella_NN ,_, the_DT virus_NN spreads_VBZ throughout_IN the_DT body_NN in_IN around_RB five_CD to_IN seven_CD days_NNS ._. Also_RB read_VBN :_: Are_VBP Rising_VBG Temperatures_NNS Responsible_JJ For_IN Increased_VBN Childhood_NN Viral_NN Infections_NNS ?_. There_EX is_VBZ no_DT specific_JJ treatment_NN for_IN rubella_NN ,_, the_DT disease_NN is_VBZ preventable_JJ by_IN vaccination_NN ._. Symptoms_NNS of_IN rubella_NN infection_NN include_VBP mild_JJ fever_NN ,_, rashes_NNS and_CC illness_NN in_IN children_NNS ._. Pregnant_JJ women_NNS infected_VBN by_IN rubella_NN vaccine_NN are_VBP at_IN risks_NNS of_IN miscarriage_NN ,_, foetal_JJ death_NN and_CC stillbirth_NN ._. Infants_NNS are_VBP at_IN risk_NN of_IN congenital_JJ birth_NN defects_NNS -_, known_VBN as_IN congenital_JJ rubella_NN syndrome_NN ._. Also_RB read_VBN :_: 4_CD Reasons_NNS Why_WRB Your_PRP$ Newborn_NN Is_VBZ n't_RB Sleeping_VBG At_IN Night_NN These_DT children_NNS are_VBP also_RB likely_JJ to_TO suffer_VB from_IN hearing_NN impairments_NNS and_CC defects_NNS in_IN eye_NN and_CC heart_NN ._. They_PRP are_VBP likely_JJ to_TO suffer_VB from_IN lifelong_JJ disabilities_NNS like_IN diabetes_NN mellitus_NN ,_, thyroid_NN dysfunction_NN and_CC autism_NN ._. Most_RBS serious_JJ consequences_NNS of_IN rubella_NN infections_NNS can_MD be_VB acquired_VBN during_IN the_DT first_JJ trimester_NN during_IN pregnancy_NN ._. Women_NNS can_MD get_VB their_PRP$ measles_NNS rubella_NN vaccine_NN even_RB during_IN their_PRP$ menstrual_JJ cycle_NN ._. People_NNS at_IN high_JJ risk_NN of_IN rubella_NN infections_NNS are_VBP non-immunised_VBN young_JJ adults_NNS ._. Before_IN the_DT vaccine_NN was_VBD available_JJ until_IN 1969_CD ,_, rubella_NN epidemics_NNS happened_VBD every_DT 6_CD to_IN 9_CD years_NNS in_IN kids_NNS from_IN 5_CD to_IN 9_CD years_NNS of_IN age_NN ._. Cases_NNS of_IN congenital_JJ rubella_NN syndrome_NN were_VBD also_RB widespread_JJ ._. Also_RB read_VBN :_: Salmonella_NN Infection_NN :_: Here_RB 's_VBZ Everything_NN You_PRP Should_MD Know_VB About_IN It_PRP 30,000_CD cases_NNS of_IN congenital_JJ rubella_NN syndrome_NN have_VBP been_VBN estimated_VBN in_IN India_NNP every_DT year_NN ._. The_DT measles_NNS rubella_NN vaccination_NN drives_NNS have_VBP been_VBN completed_VBN in_IN 20_CD states_NNS and_CC union_NN territories_NNS of_IN India_NNP ._. Campaigns_NNS for_IN spreading_VBG awareness_NN about_IN the_DT vaccine_NN are_VBP still_RB carried_VBN on_RP in_IN 6_CD states_NNS ._. 11.85_CD crore_NN children_NNS have_VBP been_VBN safely_RB vaccinated_VBN in_IN 26_CD states_NNS and_CC union_NN territories_NNS so_RB far_RB ._. Disclaimer_NN :_: This_DT content_NN including_VBG advice_NN provides_VBZ generic_JJ information_NN only_RB ._. It_PRP is_VBZ in_IN no_DT way_NN a_DT substitute_NN for_IN qualified_JJ medical_JJ opinion_NN ._. Always_RB consult_VB a_DT specialist_NN or_CC your_PRP$ own_JJ doctor_NN for_IN more_JJR information_NN ._. NDTV_NNP does_VBZ not_RB claim_VB responsibility_NN for_IN this_DT information_NN ._.","The NN of NN NNS VBZ VBG in NNP . NN NN VBZ VBN from a JJ NN to NN , RB VBG in NNS VBN with JJ NNS . It VBZ a JJ , but RB JJ JJ NN which RB VBZ in NNS and JJ NNS . JJ NN NN VBZ a NN which can VB NN , NN NNS , JJ NN and NN in JJ NNS . A NN VBD VBN by the NN NN on 150 NNS for NN NN NN . 50 of these NNS VBD VBN with JJ NN NN and NN NNS . The NN VBZ VBN within the JJ 3 NNS of NN . JJ NN NN VBZ one of the VBG NNS of NN NNS , but VBZ NN JJ . JJ NNS VBN with NN NN VBP at NN of JJ NN or JJ NNS - which VBZ VBN as JJ NN NN . NNP VBZ VBN in JJ NNS when the NNS who VBP VBN by it VBP or VB . Once a NN VBZ VBN by NN , the NN VBZ throughout the NN in RB five to seven NNS . RB VBN : VBP VBG NNS JJ For VBN NN NN NNS ? There VBZ no JJ NN for NN , the NN VBZ JJ by NN . NNS of NN NN VBP JJ NN , NNS and NN in NNS . JJ NNS VBN by NN NN VBP at NNS of NN , JJ NN and NN . NNS VBP at NN of JJ NN NNS - VBN as JJ NN NN . RB VBN : 4 NNS Why Your NN VBZ RB VBG At NN These NNS VBP RB JJ to VB from NN NNS and NNS in NN and NN . They VBP JJ to VB from JJ NNS like NN NN , NN NN and NN . RBS JJ NNS of NN NNS can VB VBN during the JJ NN during NN . NNS can VB their NNS NN NN RB during their JJ NN . NNS at JJ NN of NN NNS VBP VBN JJ NNS . Before the NN VBD JJ until 1969 , NN NNS VBD every 6 to 9 NNS in NNS from 5 to 9 NNS of NN . NNS of JJ NN NN VBD RB JJ . RB VBN : NN NN : RB VBZ NN You Should VB About It 30,000 NNS of JJ NN NN VBP VBN VBN in NNP every NN . The NNS NN NN NNS VBP VBN VBN in 20 NNS and NN NNS of NNP . NNS for VBG NN about the NN VBP RB VBN on in 6 NNS . 11.85 NN NNS VBP VBN RB VBN in 26 NNS and NN NNS RB RB . NN : This NN VBG NN VBZ JJ NN RB . It VBZ in no NN a NN for JJ JJ NN . RB VB a NN or your JJ NN for JJR NN . NNP VBZ RB VB NN for this NN ."
58,881,mainstream,M07713,coronavirus; vaccine.covid,"The_DT current_JJ COVID_NN -_HYPH 19_CD pandemic_NN is_VBZ unprecedented_JJ ,_, but_CC the_DT global_JJ response_NN draws_VBZ on_IN the_DT lessons_NNS learned_VBN from_IN other_JJ disease_NN outbreaks_NNS over_IN the_DT past_JJ several_JJ decades_NNS ._. As_IN part_NN of_IN WHO_NNP ’s_POS response_NN ,_, the_DT R&D_NNP Blueprint_NNP was_VBD activated_VBN to_TO accelerate_VB diagnostics_NNS ,_, vaccines_NNS and_CC therapeutics_NNS for_IN this_DT novel_JJ coronavirus_NN ._. The_DT Blueprint_NNP aims_VBZ to_TO improve_VB coordination_NN between_IN scientists_NNS and_CC global_JJ health_NN professionals_NNS ,_, accelerate_VB the_DT research_NN and_CC development_NN process_NN ,_, and_CC develop_VB new_JJ norms_NNS and_CC standards_NNS to_TO learn_VB from_IN and_CC improve_VB upon_IN the_DT global_JJ response_NN ._. On_IN 30_CD January_NNP 2020_CD ,_, following_VBG the_DT recommendations_NNS of_IN the_DT Emergency_NN Committee_NNP ,_, the_DT WHO_NNP Director_NNP -_HYPH General_NNP declared_VBD that_IN the_DT outbreak_NN constitutes_VBZ a_DT Public_NNP Health_NNP Emergency_NNP of_IN International_NNP Concern_NNP (_-LRB- PHEIC_NNP )_-RRB- ._. World_NN scientists_NNS on_IN COVID_NNP -_HYPH 19_CD then_RB met_VBN at_IN the_DT World_NNP Health_NNP Organization_NNP ’s_POS Geneva_NNP headquarters_NN on_IN 11_CD –_SYM 12_CD February_NNP 2020_CD to_TO assess_VB the_DT current_JJ level_NN of_IN knowledge_NN about_IN the_DT new_JJ virus_NN ,_, agree_VBP on_IN critical_JJ research_NN questions_NNS that_WDT need_VBP to_TO be_VB answered_VBN urgently_RB ,_, and_CC to_TO find_VB ways_NNS to_TO work_VB together_RB to_TO accelerate_VB and_CC fund_VB priority_NN research_NN to_TO curtail_VB this_DT outbreak_NN and_CC prepare_VB for_IN those_DT in_IN the_DT future_NN ._. The_DT discussion_NN led_VBD to_IN an_DT agreement_NN on_IN two_CD main_JJ goals_NNS ._. The_DT first_JJ was_VBD to_TO accelerate_VB innovative_JJ research_NN to_TO help_VB contain_VB the_DT spread_NN of_IN the_DT epidemic_NN and_CC facilitate_VB care_NN for_IN those_DT affected_VBN ._. The_DT second_JJ was_VBD to_TO support_VB research_NN priorities_NNS that_WDT contribute_VBP to_IN global_JJ research_NN platforms_NNS in_IN hopes_NNS of_IN learning_VBG from_IN the_DT current_JJ pandemic_NN response_NN to_TO better_JJR prepare_VB for_IN the_DT next_JJ unforeseen_JJ epidemic_NN ._. Building_VBG on_IN the_DT response_NN to_IN recent_JJ outbreaks_NNS of_IN Ebola_NNP virus_NN disease_NN ,_, SARS_NNP -_HYPH CoV_NNP and_CC MERS_NNP -_HYPH CoV_NNP ,_, the_DT R&D_NNP Blueprint_NNP has_VBZ facilitated_VBN a_DT coordinated_VBN and_CC accelerated_VBN response_NN to_IN COVID_NNP -_HYPH 19_CD ,_, including_VBG an_DT unprecedented_JJ program_NN to_TO develop_VB a_DT vaccine_NN ,_, research_NN into_IN potential_JJ pharmaceutical_JJ treatments_NNS and_CC strengthened_VBN channels_NNS for_IN information_NN sharing_NN between_IN countries_NNS ._.","The JJ NN - 19 NN VBZ JJ , but the JJ NN VBZ on the NNS VBN from JJ NN NNS over the JJ JJ NNS . As NN of NNP ’s NN , the NNP NNP VBD VBN to VB NNS , NNS and NNS for this JJ NN . The NNP VBZ to VB NN between NNS and JJ NN NNS , VB the NN and NN NN , and VB JJ NNS and NNS to VB from and VB upon the JJ NN . On 30 NNP 2020 , VBG the NNS of the NN NNP , the NNP NNP - NNP VBD that the NN VBZ a NNP NNP NNP of NNP NNP ( NNP ) . NN NNS on NNP - 19 RB VBN at the NNP NNP NNP ’s NNP NN on 11 – 12 NNP 2020 to VB the JJ NN of NN about the JJ NN , VBP on JJ NN NNS that VBP to VB VBN RB , and to VB NNS to VB RB to VB and VB NN NN to VB this NN and VB for those in the NN . The NN VBD to an NN on two JJ NNS . The JJ VBD to VB JJ NN to VB VB the NN of the NN and VB NN for those VBN . The JJ VBD to VB NN NNS that VBP to JJ NN NNS in NNS of VBG from the JJ NN NN to JJR VB for the JJ JJ NN . VBG on the NN to JJ NNS of NNP NN NN , NNP - NNP and NNP - NNP , the NNP NNP VBZ VBN a VBN and VBN NN to NNP - 19 , VBG an JJ NN to VB a NN , NN into JJ JJ NNS and VBN NNS for NN NN between NNS ."
59,989,mainstream,M09851,vaccine.covid,"Solidarity_NN with_IN World_NNP ’s_POS Most_RBS Vulnerable_NNP Prerequisite_NNP for_IN Overcoming_NNP Crisis_NNP ,_, Secretary_NN -_HYPH General_NNP Says_NNP as_IN Humanitarian_NNP Chief_NNP Warns_NNPS ‘_`` Stakes_NNPS Have_VBP Never_RB Been_VBN Higher_JJR ’_'' Standing_VBG in_IN solidarity_NN with_IN those_DT least_RBS able_JJ to_TO protect_VB themselves_PRP from_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN is_VBZ not_RB only_RB the_DT right_JJ thing_NN to_TO do_VB ,_, but_CC the_DT only_JJ way_NN the_DT world_NN will_MD overcome_VB this_DT ,_, United_NNP Nations_NNPS Secretary_NNP -_HYPH General_NNP António_NNP Guterres_NNP told_VBD the_DT Economic_NNP and_CC Social_NNP Council_NNP ,_, which_WDT launched_VBD a_DT global_JJ call_NN to_IN action_NN at_IN its_PRP$ 2020_CD Humanitarian_NNP Affairs_NNPS Segment_NNP ,_, convened_VBN from_IN 9_CD to_IN 11_CD June_NNP via_IN videoconference_NN due_IN to_IN coronavirus_NN -_HYPH related_JJ restrictions_NNS ._. The_DT 54_CD -_HYPH member_NN Economic_NNP and_CC Social_NNP Council_NNP launched_VBD the_DT Call_NN to_IN Action_NN in_IN support_NN of_IN the_DT humanitarian_JJ response_NN in_IN fighting_VBG the_DT COVID_NNP -_HYPH 19_CD pandemic_NN ,_, including_VBG a_DT set_NN of_IN 13_CD concrete_JJ actions_NNS encompassing_VBG flexible_JJ funding_NN ,_, fast_RB -_HYPH tracking_NN health_NN and_CC aid_NN personnel_NNS at_IN borders_NNS and_CC special_JJ measures_NNS to_TO serve_VB vulnerable_JJ populations_NNS ._. The_DT actions_NNS aimed_VBD to_TO save_VB lives_NNS and_CC prevent_VB the_DT spread_NN of_IN COVID_NN -_HYPH 19_CD ,_, given_VBN that_IN during_IN the_DT span_NN of_IN the_DT three_CD -_HYPH day_NN meeting_NN ,_, the_DT number_NN of_IN confirmed_VBN cases_NNS rose_VBD to_IN 7.1_CD million_CD from_IN 6.9_CD million_CD ,_, and_CC the_DT death_NN toll_NN reached_VBD 408,000_CD since_IN the_DT outbreak_NN was_VBD reported_VBN ._. The_DT Call_NN to_IN Action_NN stated_VBD :_: “_`` As_IN the_DT world_NN faces_VBZ the_DT unprecedented_JJ challenge_NN of_IN responding_VBG to_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, we_PRP must_MD commit_VB to_TO act_VB with_IN urgency_NN and_CC determination_NN to_TO respond_VB to_IN this_DT crisis_NN ._. We_PRP must_MD recommit_VB to_IN doing_VBG so_RB through_IN international_JJ solidarity_NN ,_, cooperation_NN ,_, unity_NN and_CC humanity_NN ._. ”_'' The_DT Council_NN called_VBD for_IN urgent_JJ ,_, determined_VBN measures_NNS to_TO meet_VB humanitarian_JJ needs_NNS and_CC prevent_VB and_CC mitigate_VB further_JJR devastating_JJ humanitarian_JJ impacts_NNS on_IN those_DT disproportionately_RB impacted_VBN by_IN the_DT pandemic_NN ,_, including_VBG women_NNS and_CC children_NNS ,_, older_JJR persons_NNS ,_, persons_NNS with_IN disabilities_NNS ,_, refugees_NNS ,_, internally_RB displaced_VBN persons_NNS and_CC migrants_NNS ._. Provisions_NNS of_IN the_DT Call_NN to_IN Action_NN also_RB urged_VBD Member_NNP States_NNPS and_CC other_JJ potential_JJ donors_NNS to_TO support_VB scaling_VBG up_RP emergency_NN efforts_NNS to_TO contain_VB the_DT pandemic_NN and_CC consider_VB urgently_RB funding_VBG the_DT Global_NNP Humanitarian_NNP Response_NNP Plan_NN to_TO meet_VB its_PRP$ requirements_NNS ,_, without_IN diverting_VBG funds_NNS from_IN other_JJ areas_NNS of_IN need_NN ._. Other_JJ provisions_NNS called_VBD upon_IN Member_NNP States_NNPS to_TO work_VB closely_RB with_IN the_DT United_NNP Nations_NNPS and_CC to_TO facilitate_VB the_DT provision_NN of_IN humanitarian_JJ assistance_NN ,_, including_VBG fast_RB -_HYPH tracking_VBG the_DT passage_NN of_IN health_NN and_CC humanitarian_JJ personnel_NNS at_IN borders_NNS and_CC in_IN -country_NN ,_, ensuring_VBG their_PRP$ health_NN ,_, safety_NN and_CC well_RB -_HYPH being_NN ,_, and_CC designating_VBG them_PRP as_IN essential_JJ workers_NNS ._. The_DT action_NN plan_NN further_RB called_VBD on_IN Member_NNP States_NNPS and_CC other_JJ relevant_JJ stakeholders_NNS to_TO take_VB steps_NNS to_TO prevent_VB speculation_NN and_CC undue_JJ stockpiling_NN that_WDT may_MD hinder_VB access_NN to_IN safe_JJ ,_, effective_JJ and_CC affordable_JJ essential_JJ medicines_NNS ,_, vaccines_NNS ,_, personal_JJ protective_JJ equipment_NN and_CC medical_JJ equipment_NN ,_, as_RB well_RB as_IN to_TO provide_VB access_NN to_IN and_CC fair_JJ distribution_NN of_IN all_DT essential_JJ health_NN technologies_NNS and_CC products_NNS ,_, including_VBG their_PRP$ requisite_JJ components_NNS and_CC precursors_NNS ,_, as_IN a_DT global_JJ priority_NN ,_, and_CC to_TO urgently_RB remove_VB unjustified_JJ obstacles_NNS ._. All_DT stakeholders_NNS were_VBD asked_VBN to_TO heed_VB the_DT Secretary_NNP -_HYPH General_NNP ’s_POS calls_NNS to_TO address_VB COVID_NNP -_HYPH 19_CD ,_, including_VBG for_IN an_DT immediate_JJ global_JJ ceasefire_NN so_IN as_IN to_TO lessen_VB the_DT devastating_VBG humanitarian_JJ effects_NNS of_IN armed_JJ conflicts_NNS and_CC to_TO enable_VB more_JJR emphasis_NN on_IN responding_VBG to_IN the_DT pandemic_NN ._. The_DT 2020_CD Humanitarian_NNP Affairs_NNPS Segment_NNP focused_VBD on_IN the_DT theme_NN “_`` Reinforcing_VBG humanitarian_JJ assistance_NN in_IN the_DT context_NN of_IN the_DT seventy_CD -_HYPH fifth_JJ anniversary_NN of_IN the_DT United_NNP Nations_NNPS :_: taking_VBG action_NN for_IN people_NNS -_HYPH centred_VBN solutions_NNS ,_, strengthening_VBG effectiveness_NN ,_, respecting_VBG international_JJ humanitarian_JJ law_NN and_CC promoting_VBG the_DT humanitarian_JJ principles_NNS ”_'' ._. Since_IN 1998_CD ,_, the_DT Humanitarian_NNP Affairs_NNPS Segment_NNP has_VBZ been_VBN a_DT platform_NN for_IN discussing_VBG issues_NNS related_JJ to_IN strengthening_VBG the_DT coordination_NN and_CC effectiveness_NN of_IN the_DT United_NNP Nations_NNPS humanitarian_JJ assistance_NN ,_, including_VBG assessing_VBG progress_NN and_CC identifying_VBG emerging_VBG issues_NNS ,_, obstacles_NNS and_CC challenges_NNS ._. It_PRP also_RB promotes_VBZ the_DT sharing_NN of_IN experiences_NNS and_CC lessons_NNS learned_VBN at_IN national_JJ and_CC regional_JJ levels_NNS ._. During_IN the_DT 2020_CD Humanitarian_NNP Affairs_NNPS Segment_NNP ,_, Economic_NNP and_CC Social_NNP Council_NNP members_NNS participated_VBD in_IN a_DT high_JJ -_HYPH level_NN event_NN on_IN combating_VBG and_CC preventing_VBG sexual_JJ and_CC gender_NN -_HYPH based_VBN violence_NN in_IN humanitarian_JJ crises_NNS and_CC three_CD interactive_JJ high_JJ -_HYPH level_NN panels_NNS ,_, focusing_VBG on_IN health_NN ,_, technology_NN and_CC assisting_VBG internally_RB displaced_VBN persons_NNS ._. Prior_JJ to_IN the_DT opening_VBG session_NN ,_, the_DT Chairs_NNPS of_IN the_DT Operational_NNP Activity_NNP for_IN Development_NNP Segment_NNP and_CC the_DT Humanitarian_NNP Affairs_NNPS Segment_NNP jointly_RB convened_VBD a_DT virtual_JJ high_JJ -_HYPH level_NN panel_NN event_NN on_IN 8_CD June_NNP on_IN the_DT theme_NN “_`` Transition_NN from_IN Relief_NN to_IN Development_NN :_: The_DT multidimensional_JJ and_CC interconnected_VBN challenges_NNS in_IN the_DT Central_NNP Sahel_NNP region_NN :_: reducing_VBG needs_NNS ,_, risks_NNS and_CC vulnerabilities_NNS for_IN people_NNS through_IN closer_JJR humanitarian_JJ ,_, development_NN and_CC peacebuilding_NN collaboration_NN ._. ”_'' Side_NN events_NNS were_VBD also_RB held_VBN virtually_RB on_IN the_DT following_VBG themes_NNS :_: saving_VBG lives_NNS ,_, building_VBG trust_NN ,_, and_CC informing_VBG humanitarian_JJ action_NN :_: how_WRB good_JJ practice_NN and_CC lessons_NNS learned_VBN from_IN community_NN engagement_NN can_MD help_VB beat_VB COVID_NNP -_HYPH 19_CD ;_, strengthening_VBG the_DT protection_NN of_IN children_NNS during_IN COVID_NNP -_HYPH 19_CD :_: launching_VBG the_DT Child_NNP Protection_NNP Minimum_NNP Standards_NNPS ;_, anticipatory_JJ approach_NN to_IN COVID_NNP -_HYPH 19_CD and_CC other_JJ crises_NNS ;_, and_CC counter_NN -_HYPH terrorism_NN and_CC humanitarian_JJ action_NN in_IN the_DT age_NN of_IN COVID_NNP -_HYPH 19_CD ._. The_DT following_VBG side_NN -_HYPH events_NNS were_VBD held_VBN on_IN 12_CD June_NNP :_: mental_JJ health_NN and_CC psychosocial_JJ support_NN for_IN displaced_VBN and_CC migrant_JJ populations_NNS during_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN and_CC beyond_RB ;_, humanitarian_JJ consequences_NNS arising_VBG from_IN the_DT use_NN of_IN explosive_JJ weapons_NNS in_IN populated_VBN areas_NNS ;_, and_CC towards_IN more_RBR inclusive_JJ and_CC disaggregated_VBN data_NNS on_IN displacement_NN ._. Secretary_NN -_HYPH General_NNP António_NNP Guterres_NNP ,_, delivering_VBG the_DT keynote_NN address_NN in_IN a_DT video_NN message_NN ,_, said_VBD that_IN even_RB before_IN the_DT COVID_NNP -_HYPH 19_CD pandemic_NN ,_, the_DT world_NN faced_VBD unprecedented_JJ levels_NNS of_IN humanitarian_JJ suffering_NN ._. Now_RB ,_, at_IN a_DT time_NN when_WRB the_DT coronavirus_NN threatens_VBZ to_TO increase_VB hunger_NN and_CC poverty_NN and_CC risk_VB the_DT reversal_NN of_IN decades_NNS of_IN development_NN gains_NNS ,_, he_PRP urged_VBD Member_NNP States_NNPS and_CC other_JJ donors_NNS to_TO swiftly_RB fund_VB the_DT COVID_NNP -_HYPH 19_CD Global_NNP Humanitarian_NNP Response_NNP Plan_NNP and_CC sustain_VB funding_NN to_IN existing_VBG humanitarian_JJ operations_NNS ._. “_`` We_PRP must_MD act_VB now_RB to_TO save_VB lives_NNS and_CC prevent_VB future_JJ suffering_NN ,_, ”_'' he_PRP said_VBD ._. “_`` When_WRB human_JJ rights_NNS are_VBP at_IN the_DT centre_NN ,_, we_PRP deliver_VBP better_JJR outcomes_NNS ._. ”_'' Emphasizing_VBG that_IN respect_NN for_IN international_JJ law_NN must_MD form_VB the_DT foundation_NN of_IN the_DT response_NN ,_, he_PRP said_VBD the_DT wider_JJR drivers_NNS of_IN suffering_NN around_IN the_DT world_NN must_MD also_RB be_VB examined_VBN ,_, including_VBG persistent_JJ inequalities_NNS ,_, climate_NN change_NN and_CC prolonged_VBN conflict_NN ._. He_PRP also_RB wished_VBD participants_NNS a_DT constructive_JJ segment_NN ._. Chaired_VBN by_IN Economic_NNP and_CC Social_NNP Council_NNP Vice_NNP -_HYPH President_NNP Omar_NNP Hilale_NNP (_-LRB- Morocco_NNP )_-RRB- ,_, the_DT opening_NN session_NN featured_VBN :_: Mark_NNP Lowcock_NNP ,_, Under_IN -_HYPH Secretary_NNP -_HYPH General_NNP for_IN Humanitarian_NNP Affairs_NNPS and_CC Emergency_NNP Relief_NNP Coordinator_NN ;_: Henrietta_NNP Fore_NNP ,_, Executive_JJ Director_NN of_IN the_DT United_NNP Nations_NNPS Children_NNP ’s_POS Fund_NNP (_-LRB- UNICEF_NNP )_-RRB- ;_: Qu_NNP Dongyu_NNP ,_, Director_NNP -_HYPH General_NNP of_IN the_DT Food_NNP and_CC Agriculture_NNP Organization_NNP of_IN the_DT United_NNP Nations_NNPS (_-LRB- FAO_NNP )_-RRB- ;_: and_CC Abby_NNP Maxman_NNP ,_, Chief_JJ Executive_JJ Officer_NN of_IN Oxfam_NNP ._. Peter_NNP Maurer_NNP ,_, President_NN of_IN the_DT International_NNP Committee_NNP of_IN the_DT Red_NNP Cross_NNP (_-LRB- ICRC_NNP )_-RRB- ,_, sent_VBD a_DT video_NN message_NN ._. Mr._NNP Lowcock_NNP said_VBD :_: “_`` this_DT pandemic_NN is_VBZ unlike_IN anything_NN we_PRP have_VBP dealt_VBN with_IN in_IN our_PRP$ lifetime_NN ;_, extraordinary_JJ measures_NNS are_VBP needed_VBN ._. Our_PRP$ response_NN must_MD be_VB proportionate_JJ to_IN the_DT scale_NN of_IN the_DT problem_NN we_PRP face_VBP ._. ”_'' Emphasizing_VBG that_IN discussions_NNS over_IN the_DT coming_VBG days_NNS present_VBP an_DT opportunity_NN to_TO harden_VB the_DT resolve_NN to_TO fight_VB the_DT virus_NN and_CC find_VB solutions_NNS ,_, he_PRP declared_VBD that_IN “_`` the_DT stakes_NNS have_VBP never_RB been_VBN higher_JJR ;_, we_PRP will_MD either_CC win_VB this_DT battle_NN together_RB ,_, or_CC not_RB at_IN all_DT ._. ”_'' Laying_VBG out_RP the_DT landscape_NN ,_, he_PRP said_VBD that_IN as_IN of_IN 8_CD June_NNP ,_, there_EX are_VBP 6.9_CD million_CD confirmed_VBN cases_NNS worldwide_RB ,_, approximately_RB 1_CD in_IN every_DT 1,100_CD people_NNS ._. Over_IN the_DT past_JJ month_NN ,_, rapid_JJ increases_NNS have_VBP been_VBN reported_VBN in_IN Africa_NNP ,_, from_IN roughly_RB 55,000_CD cases_NNS on_IN 8_CD May_NNP to_IN more_JJR than_IN 190,000_CD a_DT month_NN later_RBR ,_, and_CC in_IN Latin_NNP America_NNP and_CC the_DT Caribbean_NNP ,_, which_WDT is_VBZ now_RB considered_VBN the_DT epicenter_NN of_IN the_DT pandemic_NN ,_, with_IN 1.3_CD million_CD cases_NNS ._. The_DT disease_NN is_VBZ set_VBN to_TO peak_VB in_IN the_DT most_RBS fragile_JJ places_NNS on_IN Earth_NNP in_IN the_DT next_JJ three_CD to_IN six_CD months_NNS and_CC could_MD potentially_RB be_VB catastrophic_JJ in_IN the_DT developing_VBG world_NN ._. The_DT pandemic_NN ’s_POS secondary_JJ effects_NNS are_VBP equally_RB worrisome_JJ ,_, he_PRP said_VBD ,_, as_IN they_PRP pose_VBP a_DT deeper_JJR and_CC longer_RBR -_HYPH lasting_VBG threat_NN to_IN some_DT developing_VBG countries_NNS than_IN the_DT virus_NN itself_PRP ._. Indeed_RB ,_, the_DT biggest_JJS economic_JJ slowdown_NN in_IN living_NN memory_NN has_VBZ led_VBN to_IN the_DT United_NNP Nations_NNPS Development_NNP Programme_NNP (_-LRB- UNDP_NNP )_-RRB- estimating_VBG that_IN the_DT main_JJ measures_NNS of_IN human_JJ development_NN are_VBP set_VBN to_TO decline_VB in_IN 2020_CD for_IN the_DT first_JJ time_NN since_IN 1990_CD ._. The_DT World_NNP Bank_NNP forecasts_VBZ that_IN the_DT pandemic_NN could_MD push_VB as_RB many_JJ as_IN 60_CD million_CD people_NNS into_IN extreme_JJ poverty_NN while_IN the_DT World_NNP Food_NNP Programme_NNP (_-LRB- WFP_NNP )_-RRB- predicts_VBZ it_PRP could_MD move_VB 130_CD million_CD people_NNS towards_IN the_DT brink_NN of_IN starvation_NN ,_, almost_RB double_JJ the_DT 2019_CD figure_NN ._. COVID_NNP -_HYPH 19_CD is_VBZ also_RB compounding_VBG pre-pandemic_JJ humanitarian_JJ threats_NNS ,_, including_VBG the_DT world_NN ’s_POS unprecedented_JJ 60_CD million_CD displaced_VBN persons_NNS ,_, countries_NNS facing_VBG negative_JJ climate_NN change_NN consequences_NNS ,_, sharply_RB rising_VBG food_NN insecurity_NN ,_, disease_NN outbreaks_NNS and_CC the_DT worst_JJS infestation_NN of_IN locusts_NNS in_IN generations_NNS ._. Meanwhile_RB ,_, he_PRP said_VBD ,_, innovative_JJ steps_NNS are_VBP being_VBG taken_VBN to_TO address_VB the_DT erosion_NN of_IN humanitarian_JJ access_NN crippled_VBN by_IN cancelled_VBN flights_NNS in_IN some_DT places_NNS ,_, border_NN closures_NNS ,_, quarantine_NN measures_NNS ,_, lockdowns_NNS ,_, curfews_NNS and_CC disrupted_VBN supply_NN routes_NNS that_WDT have_VBP made_VBN it_PRP almost_RB impossible_JJ to_TO get_VB help_NN to_IN people_NNS in_IN need_NN ._. They_PRP include_VBP air_NN bridges_NNS for_IN humanitarian_JJ aid_NN and_CC personnel_NNS to_TO get_VB to_IN vulnerable_JJ populations_NNS and_CC technology_NN tools_NNS to_TO trace_VB and_CC track_VB infection_NN and_CC fight_VB the_DT spread_NN of_IN disinformation_NN ._. Still_RB ,_, an_DT estimated_VBN $_$ 90_CD billion_CD is_VBZ needed_VBN to_TO provide_VB humanitarian_JJ assistance_NN to_IN those_DT in_IN the_DT world_NN ’s_POS poorest_JJS countries_NNS ,_, he_PRP said_VBD ._. At_IN the_DT same_JJ time_NN ,_, the_DT COVID_NNP ‑19_NNP Global_NNP Humanitarian_NNP Response_NNP Plan_NNP is_VBZ the_DT international_JJ community_NN ’s_POS primary_JJ fundraising_NN vehicle_NN to_TO respond_VB to_IN the_DT impact_NN of_IN the_DT virus_NN in_IN low_JJ -_HYPH and_CC middle_JJ -_HYPH income_NN countries_NNS and_CC support_VB their_PRP$ efforts_NNS to_TO fight_VB it_PRP ._. While_IN $_$ 6.7_CD billion_CD would_MD cover_VB the_DT period_NN until_IN December_NNP ,_, only_RB $_$ 1.2_CD billion_CD ,_, or_CC 17.4_CD per_NN cent_NN ,_, is_VBZ funded_VBN to_IN date_NN ,_, he_PRP said_VBD ,_, warning_VBG that_IN diverting_VBG resources_NNS from_IN humanitarian_JJ operations_NNS to_TO fund_VB the_DT COVID_NNP -_HYPH 19_CD response_NN would_MD be_VB counter_NN -_HYPH productive_JJ and_CC lead_VB to_IN more_JJR and_CC faster_JJR loss_NN of_IN life_NN ._. As_IN such_JJ ,_, he_PRP called_VBD on_IN donors_NNS to_TO continue_VB providing_VBG flexible_JJ funding_NN that_WDT allows_VBZ for_IN quick_JJ ,_, agile_JJ decision_NN -_HYPH making_NN wherever_WRB possible_JJ ._. Ms._NNP Fore_NNP ,_, outlining_VBG UNICEF_NNP efforts_NNS and_CC obstacles_NNS ,_, said_VBD the_DT pandemic_NN marks_VBZ an_DT opportunity_NN for_IN the_DT entire_JJ humanitarian_JJ community_NN to_TO “_`` do_VB things_NNS differently_RB ”_'' to_TO more_RBR effectively_RB reach_VB those_DT most_RBS in_IN need_NN ,_, including_VBG the_DT world_NN ’s_POS children_NNS ._. In_IN just_RB a_DT few_JJ short_JJ months_NNS ,_, the_DT pandemic_NN and_CC efforts_NNS to_TO contain_VB it_PRP have_VBP laid_VBN bare_JJ existing_VBG inequities_NNS ,_, vulnerabilities_NNS and_CC weaknesses_NNS of_IN national_JJ systems_NNS around_IN the_DT world_NN ,_, the_DT result_NN of_IN decades_NNS of_IN under_IN -_HYPH investment_NN in_IN what_WP is_VBZ needed_VBN to_TO support_VB children_NNS ’s_POS futures_NNS ._. While_IN the_DT landscape_NN has_VBZ changed_VBN ,_, children_NNS ’s_POS needs_NNS have_VBP not_RB ,_, including_VBG vaccinations_NNS ,_, schools_NNS ,_, water_NN ,_, sanitation_NN ,_, hygiene_NN ,_, nutrition_NN ,_, release_NN from_IN detention_NN and_CC protection_NN both_CC from_IN violence_NN and_CC now_RB the_DT spread_NN of_IN COVID_NN -_HYPH 19_CD ._. Highlighting_VBG interwoven_JJ challenges_NNS preventing_VBG the_DT humanitarian_JJ community_NN from_IN serving_VBG the_DT world_NN ’s_POS most_RBS vulnerable_JJ children_NNS ,_, she_PRP cautioned_VBD that_IN there_EX is_VBZ a_DT new_JJ Ebola_NNP outbreak_NN in_IN the_DT Democratic_NNP Republic_NNP of_IN the_DT Congo_NNP ,_, 60_CD countries_NNS have_VBP put_VBN vaccination_NN campaigns_NNS on_IN hold_NN while_IN focusing_VBG on_IN defeating_VBG COVID_NN -_HYPH 19_CD and_CC new_JJ outbreaks_NNS of_IN measles_NNS and_CC cholera_NN are_VBP likely_JJ to_TO worsen_VB as_IN a_DT consequence_NN of_IN coronavirus_NN responses_NNS ._. In_IN addition_NN ,_, staff_NNS and_CC partners_NNS face_VBP violence_NN and_CC harassment_NN due_IN to_IN stigma_NN and_CC people_NNS fearful_JJ of_IN becoming_VBG infected_VBN ,_, convoys_NNS and_CC missions_NNS are_VBP subjected_VBN to_IN delays_NNS and_CC searches_NNS ,_, and_CC vehicles_NNS are_VBP being_VBG expropriated_VBN ._. She_PRP also_RB pointed_VBD at_IN reports_NNS of_IN violence_NN against_IN mostly_RB female_JJ health_NN -_HYPH care_NN workers_NNS responding_VBG to_IN COVID_NNP -_HYPH 19_CD across_IN countries_NNS ._. In_IN some_DT cases_NNS ,_, security_NN forces_NNS are_VBP violently_RB enforcing_VBG lockdowns_NNS ,_, which_WDT could_MD lead_VB to_IN potential_JJ under-_JJ reporting_NN and_CC “_`` hidden_VBN caseloads_NNS ”_'' of_IN the_DT coronavirus_NN ._. She_PRP said_VBD improving_VBG responses_NNS now_RB depends_VBZ on_IN strengthening_VBG health_NN systems_NNS ,_, reinforcing_VBG local_JJ groups_NNS and_CC increasing_VBG collaboration_NN with_IN donors_NNS to_TO change_VB the_DT conditionalities_NNS that_WDT often_RB limit_VBP the_DT ability_NN to_TO provide_VB assistance_NN that_WDT is_VBZ impartial_JJ ,_, rather_RB than_IN political_JJ ._. The_DT humanitarian_JJ community_NN must_MD unite_VB in_IN finding_VBG new_JJ ways_NNS to_TO share_VB the_DT risks_NNS of_IN this_DT important_JJ work_NN ._. “_`` Let_VB us_PRP use_VB this_DT moment_NN as_IN a_DT time_NN to_TO define_VB a_DT new_JJ contract_NN among_IN the_DT global_JJ humanitarian_JJ community_NN ,_, as_IN we_PRP seek_VBP to_TO better_RBR serve_VB and_CC support_VB the_DT world_NN ’s_POS most_RBS vulnerable_JJ communities_NNS ,_, ”_'' she_PRP said_VBD ._. Other_JJ speakers_NNS described_VBD factors_NNS affecting_VBG the_DT present_JJ and_CC future_JJ humanitarian_JJ landscape_NN ._. Reflecting_VBG on_IN how_WRB the_DT humanitarian_JJ system_NN is_VBZ responding_VBG and_CC adapting_VBG quickly_RB and_CC collaborating_VBG with_IN a_DT range_NN of_IN partners_NNS ,_, and_CC what_WP more_JJR can_MD be_VB done_VBN ,_, they_PRP also_RB examined_VBD the_DT value_NN of_IN collective_JJ humanitarian_JJ action_NN to_IN multilateralism_NN and_CC to_IN global_JJ solidarity_NN for_IN affected_VBN people_NNS and_CC communities_NNS ._. Following_VBG the_DT opening_VBG session_NN on_IN 9_CD June_NNP ,_, a_DT high_JJ -_HYPH level_NN panel_NN was_VBD convened_VBN on_IN the_DT theme_NN “_`` Addressing_VBG the_DT increasing_VBG complexity_NN of_IN health_NN challenges_NNS in_IN humanitarian_JJ contexts_NNS ”_'' ._. It_PRP focused_VBD on_IN the_DT critical_JJ next_JJ steps_NNS needed_VBN to_TO mitigate_VB the_DT impacts_NNS of_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN and_CC to_TO respond_VB to_IN increasing_VBG needs_NNS driven_VBN by_IN it_PRP ,_, recognizing_VBG trends_NNS in_IN recent_JJ years_NNS of_IN disease_NN outbreaks_NNS and_CC epidemics_NNS ._. Chaired_VBN by_IN Mr._NNP Hilale_NNP and_CC moderated_VBN by_IN Mr._NNP Lowcock_NNP ,_, it_PRP featured_VBD the_DT following_VBG panellists_NNS :_: Sigrid_NNP Kaag_NNP ,_, Minister_NNP for_IN Foreign_NNP Trade_NNP and_CC Development_NNP Cooperation_NNP of_IN the_DT Netherlands_NNPS ;_: Ibrahima_NNP Socé_NNP Fall_NNP ,_, Assistant_NNP Director_NNP -_HYPH General_NNP for_IN Emergency_NNP Response_NNP at_IN the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ;_: Amir_NNP Abdulla_NNP ,_, Deputy_NNP Executive_JJ Director_NN of_IN the_DT WFP_NNP ;_: Jagan_NNP Chapagain_NNP ,_, Secretary_NNP General_NNP of_IN the_DT International_NNP Federation_NNP of_IN the_DT Red_NNP Cross_NNP and_CC Red_NNP Crescent_NNP Societies_NNPS (_-LRB- IFRC_NNP )_-RRB- ;_: Christos_NNP Christou_NNP ,_, International_NNP President_NNP of_IN Médecins_NNP Sans_NNP Frontiers_NNP ;_: Raji_NNP Tajudeen_NNP ,_, Head_NNP ,_, Division_NNP of_IN Public_NNP Health_NNP Institutes_NNPS and_CC Research_NNP ,_, Africa_NNP Centres_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ;_: and_CC Atim_NNP Caroline_NNP Ogwang_NNP ,_, Director_NNP of_IN the_DT South_NNP Sudan_NNP Women_NNPS with_IN Disability_NNP Network_NNP ._. Mr._NNP Lowcock_NNP said_VBD humanitarian_JJ agencies_NNS are_VBP doing_VBG all_DT they_PRP can_MD to_TO maintain_VB and_CC adapt_VB ongoing_JJ operations_NNS in_IN the_DT face_NN of_IN the_DT unprecedented_JJ challenges_NNS brought_VBN on_RP by_IN COVID_NNP -_HYPH 19_CD ._. Along_IN with_IN Governments_NNS ,_, they_PRP are_VBP using_VBG creativity_NN to_TO ensure_VB that_IN they_PRP can_MD deliver_VB ongoing_JJ services_NNS and_CC launch_VB new_JJ ones_NNS wherever_WRB feasible_JJ ._. WHO_NNP and_CC other_JJ humanitarian_JJ health_NN response_NN organizations_NNS are_VBP scaling_VBG up_RP preparedness_NN ,_, planning_NN and_CC response_NN to_IN the_DT pandemic_NN in_IN dozens_NNS of_IN countries_NNS while_IN adapting_VBG their_PRP$ pre-COVID_NN -_HYPH 19_CD responses_NNS to_IN this_DT new_JJ reality_NN ,_, working_VBG with_IN hundreds_NNS of_IN health_NN partners_NNS and_CC community_NN workers_NNS ._. Highlighting_VBG several_JJ examples_NNS ,_, he_PRP said_VBD that_IN partners_NNS in_IN Afghanistan_NNP ,_, Bangladesh_NNP ,_, Djibouti_NNP and_CC Sudan_NNP are_VBP providing_VBG larger_JJR food_NN rations_NNS ,_, requiring_VBG less_RBR frequent_JJ deliveries_NNS ,_, and_CC pre-positioning_VBG supplies_NNS closer_JJR to_IN camps_NNS ._. In_IN Niger_NNP ,_, they_PRP are_VBP collaborating_VBG to_TO provide_VB assistance_NN on_IN all_DT fronts_NNS at_IN once_RB —_: health_NN ,_, food_NN ,_, nutrition_NN and_CC protection_NN —_: to_TO reduce_VB infection_NN risks_NNS ;_, and_CC in_IN Ukraine_NNP ,_, aid_NN is_VBZ provided_VBN door_NN -_HYPH to_IN -_HYPH door_NN where_WRB possible_JJ ._. All_DT over_IN the_DT world_NN ,_, aid_NN agencies_NNS are_VBP increasing_VBG their_PRP$ use_NN of_IN cash_NN over_IN in_IN -_HYPH kind_NN assistance_NN to_TO limit_VB human_JJ contact_NN ._. Citing_VBG the_DT Secretary_NNP -_HYPH General_NNP ’s_POS message_NN ,_, he_PRP said_VBD :_: “_`` We_PRP are_VBP in_IN this_DT fight_NN together_RB ,_, so_RB now_RB it_PRP is_VBZ our_PRP$ job_NN as_IN humanitarian_JJ agencies_NNS to_TO ensure_VB that_IN no_DT one_NN is_VBZ left_VBN behind_RB ._. ”_'' Panellists_NNS discussed_VBD how_WRB the_DT United_NNP Nations_NNPS and_CC its_PRP$ partners_NNS are_VBP mobilizing_VBG responses_NNS and_CC working_VBG with_IN local_JJ organizations_NNS to_TO adapt_VB to_IN current_JJ and_CC future_JJ challenges_NNS while_IN identifying_VBG emerging_VBG needs_NNS ,_, addressing_VBG access_NN issues_NNS and_CC implementing_VBG preparedness_NN measures_NNS to_TO mitigate_VB further_JJ risks_NNS ._. They_PRP also_RB explained_VBD how_WRB to_TO anchor_VB these_DT new_JJ humanitarian_JJ principle_NN approaches_NNS in_IN a_DT context_NN where_WRB related_JJ needs_NNS are_VBP driven_VBN by_IN an_DT increasingly_RB complex_JJ mix_NN of_IN health_NN ,_, economic_JJ and_CC development_NN crises_NNS ,_, and_CC by_IN protracted_VBN conflicts_NNS ._. Further_RBR ,_, they_PRP highlighted_VBD measures_NNS required_VBN to_TO lower_VB the_DT human_JJ costs_NNS of_IN these_DT new_JJ dynamics_NNS and_CC described_VBD ways_NNS they_PRP are_VBP meeting_VBG urgent_JJ existing_VBG needs_NNS ,_, even_RB as_IN the_DT COVID_NNP -_HYPH 19_CD pandemic_NN threatens_VBZ to_TO drive_VB already_RB historic_JJ levels_NNS of_IN hunger_NN to_IN new_JJ extremes_NNS and_CC add_VB hundreds_NNS of_IN millions_NNS to_IN the_DT ranks_NNS of_IN poverty_NN ._. Speakers_NNS also_RB offered_VBD solutions_NNS for_IN facilitating_VBG the_DT flow_NN of_IN humanitarian_JJ and_CC medical_JJ supplies_NNS to_IN where_WRB they_PRP are_VBP most_RBS needed_VBN ._. Finally_RB ,_, they_PRP discussed_VBD the_DT pandemic_NN ’s_POS mental_JJ health_NN and_CC psychosocial_JJ impact_NN ,_, along_IN with_IN solutions_NNS for_IN affected_VBN people_NNS ,_, and_CC for_IN front_JJ -_HYPH line_NN humanitarian_JJ workers_NNS ._. In_IN the_DT afternoon_NN a_DT high_JJ -_HYPH level_NN event_NN was_VBD held_VBN on_IN the_DT theme_NN “_`` Combating_VBG and_CC preventing_VBG sexual_JJ and_CC gender_NN -_HYPH based_VBN violence_NN in_IN humanitarian_JJ crises_NNS ”_'' ._. The_DT event_NN brought_VBD together_RP key_JJ stakeholders_NNS ,_, including_VBG Member_NNP States_NNPS ,_, humanitarians_NNS ,_, civil_JJ society_NN and_CC survivors_NNS ,_, to_TO engage_VB in_IN dialogue_NN about_IN key_JJ issues_NNS and_CC experiences_NNS ,_, and_CC share_VB best_JJS practices_NNS to_TO address_VB sexual_JJ and_CC gender_NN -_HYPH based_VBN violence_NN ._. Chaired_VBN by_IN Mr._NNP Hilale_NNP and_CC moderated_VBN by_IN Mr._NNP Lowcock_NNP ,_, it_PRP featured_VBD the_DT following_VBG panellists_NNS :_: Ine_NNP Marie_NNP Eriksen_NNP Søreide_NNP ,_, Minister_NN for_IN Foreign_JJ Affairs_NNS of_IN Norway_NNP ;_: acclaimed_VBN author_NN Chimamanda_NNP Ngozi_NNP Adichie_NNP ;_: Natalia_NNP Kanem_NNP ,_, Executive_JJ Director_NN of_IN the_DT United_NNP Nations_NNPS Population_NNP Fund_NNP (_-LRB- UNFPA_NNP )_-RRB- ;_: Henrietta_NNP Fore_NNP ,_, Executive_JJ Director_NN of_IN UNICEF_NNP ;_: Kelly_NNP Clements_NNP ,_, Deputy_NNP United_NNP Nations_NNPS High_NNP Commissioner_NNP for_IN Refugees_NNPS ;_: Elinor_NNP Raikes_NNP ,_, Vice_NNP -_HYPH President_NNP and_CC Head_NNP of_IN Programme_NNP Delivery_NNP at_IN the_DT International_NNP Rescue_NNP Committee_NNP ;_: Christine_NNP Seisun_NNP ,_, Sexual_NNP Violence_NNP Operations_NNPS Manager_NN at_IN the_DT ICRC_NNP ,_, South_NNP Sudan_NNP ;_: and_CC Fátima_NNP Shehu_NNP Imam_NNP ,_, Director_NNP of_IN the_DT Network_NNP of_IN Civil_NNP Society_NNP Organizations_NNPS in_IN Borno_NNP State_NNP ._. Mr._NNP Lowcock_NNP said_VBD COVID_NNP -_HYPH 19_CD has_VBZ multiplied_VBN threats_NNS to_IN human_JJ rights_NNS and_CC dignity_NN while_IN also_RB threatening_VBG to_TO reverse_VB gains_NNS towards_IN gender_NN equality_NN and_CC women_NNS ’s_POS rights_NNS ._. Many_JJ women_NNS and_CC girls_NNS have_VBP faced_VBN gender_NN -_HYPH based_VBN violence_NN ,_, including_VBG sexual_JJ violence_NN ,_, and_CC sexual_JJ exploitation_NN and_CC abuse_NN ,_, and_CC in_IN many_JJ places_NNS ,_, calls_NNS to_IN hotlines_NNS have_VBP increased_VBN by_IN 30_CD to_IN 40_CD per_NN cent_NN following_VBG quarantine_NN and_CC lockdown_NN measures_NNS ._. “_`` It_PRP has_VBZ forced_VBN us_PRP to_TO take_VB a_DT hard_JJ ,_, and_CC I_PRP hope_VBP ,_, honest_JJ look_NN ,_, at_IN inequalities_NNS and_CC how_WRB we_PRP protect_VBP our_PRP$ most_RBS vulnerable_JJ ,_, ”_'' he_PRP said_VBD ._. “_`` This_DT is_VBZ also_RB a_DT moment_NN of_IN opportunity_NN to_TO act_VB fast_RB and_CC in_IN unity_NN ,_, while_IN there_EX is_VBZ global_JJ momentum_NN to_TO recover_VB better_RBR from_IN the_DT pandemic_NN ._. ”_'' Everyone_NN must_MD pull_VB together_RB ,_, he_PRP said_VBD ,_, to_TO put_VB girls_NNS and_CC women_NNS at_IN the_DT centre_NN of_IN efforts_NNS through_IN a_DT whole_JJ -_HYPH of_IN -_HYPH system_NN approach_NN working_VBG with_IN local_JJ communities_NNS ,_, civil_JJ society_NN ,_, Governments_NNS ,_, regional_JJ organizations_NNS ,_, donors_NNS ,_, and_CC humanitarian_JJ and_CC development_NN organizations_NNS ._. Actions_NNS to_TO address_VB these_DT concerns_NNS must_MD be_VB prioritized_VBN now_RB ,_, he_PRP said_VBD ,_, stressing_VBG that_IN one_CD in_IN three_CD women_NNS will_MD experience_VB some_DT form_NN of_IN physical_JJ or_CC sexual_JJ violence_NN in_IN her_PRP$ lifetime_NN ,_, and_CC the_DT likelihood_NN of_IN that_DT happening_VBG is_VBZ worse_JJR for_IN women_NNS with_IN disabilities_NNS ._. Leadership_NN ,_, including_VBG by_IN involving_VBG women_NNS in_IN humanitarian_JJ decision_NN -_HYPH making_VBG ,_, and_CC addressing_VBG gender_NN inequality_NN ,_, are_VBP some_DT of_IN the_DT ways_NNS forward_RB ._. For_IN its_PRP$ part_NN ,_, the_DT Office_NNP for_IN the_DT Coordination_NNP of_IN Humanitarian_NNP Affairs_NNPS is_VBZ working_VBG to_TO mitigate_VB ,_, respond_VB to_IN and_CC prevent_VB gender_NN -_HYPH based_VBN violence_NN in_IN humanitarian_JJ emergencies_NNS ._. It_PRP is_VBZ also_RB prioritizing_VBG gender_NN equality_NN and_CC addressing_VBG gender_NN -_HYPH based_VBN violence_NN in_IN response_NN to_IN the_DT pandemic_NN through_IN the_DT COVID_NNP -_HYPH 19_CD Global_NNP Humanitarian_NNP Response_NNP Plan_NNP ,_, he_PRP said_VBD ,_, adding_VBG that_IN :_: “_`` We_PRP are_VBP doing_VBG this_DT because_IN responding_VBG to_IN gender_NN -_HYPH based_VBN violence_NN reduces_VBZ suffering_NN and_CC saves_VBZ lives_NNS ._. ”_'' Panellists_NNS drew_VBD attention_NN to_IN the_DT current_JJ situation_NN ,_, assessing_VBG the_DT disproportionate_JJ impact_NN on_IN women_NNS and_CC girls_NNS in_IN humanitarian_JJ crises_NNS ._. They_PRP also_RB discussed_VBD trends_NNS exposed_VBN in_IN light_NN of_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, what_WP is_VBZ being_VBG done_VBN and_CC what_WP more_JJR needs_VBZ to_TO urgently_RB be_VB done_VBN to_TO prevent_VB and_CC respond_VB to_IN ongoing_JJ concerns_NNS in_IN humanitarian_JJ contexts_NNS ._. On_IN 10_CD June_NNP ,_, a_DT high_JJ -_HYPH level_NN panel_NN addressed_VBD the_DT theme_NN “_`` improving_VBG humanitarian_JJ effectiveness_NN through_IN new_JJ technology_NN and_CC innovation_NN :_: opportunities_NNS and_CC challenges_NNS ”_'' ._. Chaired_VBN by_IN Mr._NNP Hilale_NNP and_CC moderated_VBN by_IN Ramesh_NNP Rajasingham_NNP ,_, Acting_NNP Assistant_NNP Secretary_NNP -_HYPH General_NNP for_IN Humanitarian_NNP Affairs_NNPS and_CC Deputy_NNP Emergency_NNP Relief_NNP Coordinator_NN ,_, it_PRP featured_VBD the_DT following_VBG panellists_NNS :_: Fabrizio_NNP Hochschild_NNP ,_, Special_JJ Adviser_NNP to_IN the_DT Secretary_NNP -_HYPH General_NNP on_IN the_DT Commemoration_NNP of_IN the_DT United_NNP Nations_NNPS Seventy_NNP -_HYPH Fifth_NNP Anniversary_NNP ;_: Valerie_NNP Guarnieri_NNP ,_, Assistant_NNP Executive_JJ Director_NN of_IN WFP_NNP ;_: Balthasar_NNP Staehelin_NNP ,_, Director_NNP of_IN Digital_JJ Transformation_NN and_CC Data_NN at_IN the_DT ICRC_NNP ;_: Adelina_NNP Kamal_NNP ,_, Executive_JJ Director_NN of_IN the_DT Association_NNP of_IN Southeast_NNP Asian_NNP Nations_NNPS (_-LRB- ASEAN_NNP )_-RRB- Coordinating_NNP Centre_NNP for_IN Humanitarian_NNP Assistance_NNP on_IN Disaster_NNP Management_NNP ;_: Patrick_NNP Meier_NNP ,_, Chief_JJ Executive_JJ Officer_NN of_IN WeRobotics_NNP at_IN the_DT Fletcher_NNP School_NNP of_IN Law_NNP and_CC Diplomacy_NNP ;_: Raj_NNP Kumar_NNP ,_, Founding_NNP President_NNP and_CC Editor_NNP -_HYPH in_IN -_HYPH Chief_NNP of_IN Devex_NNP ;_: and_CC Sunita_NNP Grote_NNP ,_, Innovation_NN Fund_NN Manager_NN at_IN UNICEF_NNP ._. Mr._NNP Rajasingham_NNP recalled_VBD that_IN “_`` flatten_VB the_DT curve_NN ”_'' is_VBZ among_IN the_DT terms_NNS recently_RB penetrating_VBG public_JJ discourse_NN in_IN most_JJS countries_NNS ,_, many_JJ languages_NNS and_CC all_DT age_NN groups_NNS ._. This_DT commonly_RB used_VBN shorthand_NN covers_VBZ a_DT long_JJ and_CC complex_JJ process_NN of_IN data_NN collection_NN and_CC verification_NN ,_, analysis_NN ,_, computer_NN modelling_NN ,_, forecasting_NN and_CC data_NN visualization_NN to_TO get_VB to_IN the_DT “_`` curve_NN ”_'' ._. It_PRP also_RB demonstrates_VBZ that_IN data_NN -_HYPH driven_VBN decision_NN -_HYPH making_VBG language_NN in_IN most_JJS countries_NNS is_VBZ now_RB driving_VBG public_JJ conversations_NNS about_IN how_WRB the_DT world_NN should_MD respond_VB to_IN the_DT pandemic_NN ._. Modelling_NN and_CC forecasting_NN in_IN various_JJ forms_NNS are_VBP not_RB new_JJ to_IN humanitarian_JJ planning_NN and_CC preparedness_NN ,_, he_PRP said_VBD ,_, pointing_VBG to_IN such_JJ tools_NNS as_IN artificial_JJ intelligence_NN ,_, machine_NN learning_NN and_CC predictive_JJ analytics_NNS that_WDT are_VBP used_VBN to_TO more_RBR quickly_RB and_CC efficiently_RB analyze_VB and_CC make_VB decisions_NNS about_IN how_WRB to_TO respond_VB to_IN crises_NNS ._. In_IN 2019_CD ,_, the_DT WFP_NNP quickened_VBD its_PRP$ emergency_NN response_NN to_IN cyclones_NNS in_IN Mozambique_NNP by_IN relying_VBG on_IN artificial_JJ intelligence_NN and_CC machine_NN learning_NN for_IN disaster_NN mapping_NN ._. Data_NNS compiled_VBN in_IN large_JJ and_CC complex_JJ humanitarian_JJ and_CC development_NN databases_NNS form_VBP the_DT building_NN blocks_NNS of_IN this_DT new_JJ technology_NN and_CC innovation_NN ,_, he_PRP said_VBD ,_, adding_VBG that_IN many_JJ public_JJ ,_, private_JJ and_CC academic_JJ partnerships_NNS across_IN the_DT international_JJ community_NN use_VBP analytics_NNS to_TO forecast_VB ,_, prevent_VB and_CC mitigate_VB the_DT spread_NN of_IN disease_NN ,_, hunger_NN ,_, flood_NN damage_NN and_CC other_JJ hazards_NNS ._. Citing_VBG other_JJ ongoing_JJ initiatives_NNS ,_, he_PRP pointed_VBD at_IN biometrics_NNS to_TO provide_VB digital_JJ identities_NNS for_IN people_NNS needing_VBG aid_NN ,_, blockchain_NN technology_NN to_TO send_VB digital_JJ cash_NN ,_, drones_NNS to_TO assess_VB disasters_NNS and_CC deliver_VB aid_NN ,_, 3D_NN printing_NN to_TO dramatically_RB shorten_VB delivery_NN time_NN and_CC costs_NNS ,_, and_CC chatbots_NNS to_TO communicate_VB with_IN affected_VBN communities_NNS ._. Through_IN the_DT Centre_NNP for_IN Humanitarian_NNP Data_NNP in_IN The_DT Hague_NNP ,_, the_DT Office_NNP for_IN the_DT Coordination_NNP of_IN Humanitarian_NNP Affairs_NNPS is_VBZ exploring_VBG predictive_JJ analytics_NNS that_WDT can_MD drive_VB anticipatory_JJ action_NN to_TO get_VB ahead_RB of_IN a_DT crisis_NN and_CC avert_VB the_DT worst_JJS consequences_NNS ._. However_RB ,_, these_DT promising_JJ innovations_NNS have_VBP great_JJ potential_NN while_IN posing_VBG new_JJ challenges_NNS and_CC risks_NNS ,_, he_PRP said_VBD ,_, among_IN them_PRP privacy_NN ,_, data_NN protection_NN and_CC spreading_VBG false_JJ information_NN ._. During_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, a_DT new_JJ risk_NN is_VBZ now_RB labelled_VBN the_DT “_`` infodemic_NN ”_'' :_: the_DT spread_NN of_IN misinformation_NN and_CC disinformation_NN ,_, and_CC the_DT use_NN of_IN technology_NN to_TO stigmatize_VB people_NNS or_CC incite_VB tensions_NNS ._. To_TO overcome_VB such_JJ risks_NNS and_CC challenges_NNS ,_, he_PRP said_VBD the_DT “_`` do_VBP no_DT harm_NN ”_'' concept_NN must_MD apply_VB ,_, as_IN should_MD respect_NN for_IN other_JJ international_JJ principles_NNS and_CC norms_NNS guiding_VBG humanitarian_JJ work_NN ._. Panellists_NNS addressed_VBD concrete_JJ ways_NNS the_DT humanitarian_JJ sector_NN is_VBZ improving_VBG effectiveness_NN in_IN a_DT changing_VBG landscape_NN by_IN using_VBG new_JJ technology_NN and_CC innovation_NN ._. Some_DT showcased_VBD innovations_NNS being_VBG used_VBN to_TO improve_VB the_DT impact_NN of_IN humanitarian_JJ operations_NNS while_IN sharing_VBG best_JJS practices_NNS and_CC lessons_NNS learned_VBN ._. They_PRP discussed_VBD how_WRB the_DT humanitarian_JJ sector_NN is_VBZ positioning_VBG itself_PRP to_TO work_VB with_IN partners_NNS ,_, including_VBG regional_JJ ,_, national_JJ ,_, and_CC local_JJ actors_NNS and_CC the_DT private_JJ sector_NN ,_, to_TO identify_VB and_CC roll_VB -_HYPH out_RP further_JJR opportunities_NNS ._. They_PRP also_RB identified_VBD the_DT risks_NNS and_CC challenges_NNS associated_VBN with_IN new_JJ and_CC emerging_VBG technologies_NNS and_CC how_WRB these_DT can_MD be_VB mitigated_VBN ._. On_IN 11_CD June_NNP ,_, a_DT high_JJ -_HYPH level_NN panel_NN was_VBD held_VBN on_IN the_DT theme_NN “_`` Mobilizing_VBG action_NN to_TO improve_VB humanitarian_JJ assistance_NN for_IN internally_RB displaced_VBN persons_NNS and_CC achieve_VB durable_JJ solutions_NNS ”_'' ._. Chaired_VBN by_IN Mr._NNP Hilale_NNP and_CC moderated_VBN by_IN Mr._NNP Lowcock_NNP ,_, it_PRP featured_VBD the_DT following_VBG panellists_NNS :_: Federica_NNP Mogherini_NNP ,_, Co-Chair_NNP of_IN the_DT United_NNP Nations_NNPS Secretary_NNP -_HYPH General_NNP ’s_POS High_NNP -_HYPH Level_NNP Panel_NNP on_IN Internal_NNP Displacement_NNP ;_: Michelle_NNP Bachelet_NNP ,_, United_NNP Nations_NNPS High_NNP Commissioner_NNP for_IN Human_NNP Rights_NNP ;_: Filippo_NNP Grandi_NNP ,_, United_NNP Nations_NNPS High_NNP Commissioner_NNP for_IN Refugees_NNPS ;_: António_NNP Vitorino_NNP ,_, Director_NNP General_NNP of_IN the_DT International_NNP Organization_NNP for_IN Migration_NNP (_-LRB- IOM_NNP )_-RRB- ;_: Asha_NNP Mohammed_NNP ,_, Secretary_NNP General_NNP of_IN the_DT Kenya_NNP Red_NNP Cross_NNP Society_NNP ;_: Nasir_NNP Ahmad_NNP Andisha_NNP ,_, Co-Chair_NNP of_IN the_DT Group_NNP of_IN Friends_NNPS on_IN Internal_NNP Displacement_NNP and_CC Permanent_NNP Representative_NNP of_IN Afghanistan_NNP to_IN the_DT United_NNP Nations_NNPS Office_NNP in_IN Geneva_NNP ;_: and_CC Veronica_NNP Ngum_NNP Ndi_NNP ,_, Gender_NNP Officer_NNP in_IN the_DT Coordinating_NNP Unit_NNP of_IN the_DT Associations_NNPS of_IN Persons_NNPS with_IN Disabilities_NNPS ._. Panellists_NNS shared_VBD experiences_NNS involving_VBG the_DT diverse_JJ needs_NNS of_IN internally_RB displaced_VBN persons_NNS and_CC new_JJ approaches_NNS towards_IN achieving_VBG durable_JJ solutions_NNS ._. Speakers_NNS explained_VBD how_WRB long_RB -_HYPH term_NN solutions_NNS can_MD be_VB advanced_VBN from_IN the_DT very_JJ outset_NN of_IN a_DT humanitarian_JJ emergency_NN ._. They_PRP also_RB explored_VBD concrete_JJ ways_NNS the_DT international_JJ community_NN can_MD better_RBR support_VB internally_RB displaced_VBN persons_NNS ,_, host_NN communities_NNS and_CC Governments_NNS ._. On_IN 11_CD June_NNP ,_, at_IN the_DT closing_NN session_NN ,_, Mr._NNP Rajasingham_NNP said_VBD that_IN the_DT two_CD leading_VBG messages_NNS emerging_VBG from_IN discussions_NNS are_VBP that_IN the_DT COVID_NNP -_HYPH 19_CD pandemic_NN has_VBZ exacerbated_VBN pre-existing_VBG humanitarian_JJ challenges_NNS while_IN also_RB exposing_VBG and_CC amplifying_VBG existing_VBG inequalities_NNS ._. “_`` The_DT most_RBS important_JJ takeaway_NN of_IN this_DT Humanitarian_JJ Affairs_NNS Segment_NN is_VBZ that_IN challenges_NNS will_MD remain_VB with_IN us_PRP ,_, but_CC we_PRP need_VBP to_TO rise_VB to_IN the_DT occasion_NN ,_, working_VBG with_IN Member_NNP States_NNPS ,_, affected_VBN people_NNS and_CC all_DT of_IN our_PRP$ partners_NNS to_TO save_VB lives_NNS and_CC prevent_VB suffering_NN ,_, ”_'' he_PRP said_VBD ._. “_`` We_PRP now_RB need_VBP to_TO act_VB urgently_RB and_CC differently_RB ._. This_DT moment_NN is_VBZ an_DT opportunity_NN to_TO do_VB things_NNS better_RBR ,_, together_RB ._. ”_'' Mr._NNP Hilale_NNP ,_, thanking_VBG participants_NNS for_IN a_DT constructive_JJ session_NN ,_, summarized_VBD discussions_NNS held_VBN and_CC presented_VBD a_DT range_NN of_IN recommendations_NNS ,_, such_JJ as_IN investing_VBG in_IN community_NN engagement_NN ,_, which_WDT is_VBZ essential_JJ and_CC will_MD lead_VB to_IN a_DT more_RBR effective_JJ humanitarian_JJ response_NN ._. The_DT pandemic_NN has_VBZ also_RB demonstrated_VBN that_IN anticipation_NN and_CC preparation_NN can_MD save_VB lives_NNS and_CC reduce_VB suffering_NN and_CC costs_NNS ._. One_CD critical_JJ anticipatory_JJ step_NN the_DT entire_JJ international_JJ community_NN can_MD take_VB right_RB now_RB is_VBZ to_TO commit_VB to_IN what_WP the_DT United_NNP Nations_NNPS and_CC the_DT IFRC_NNP have_VBP described_VBN as_IN a_DT “_`` people_NN ’s_POS vaccine_NN ”_'' to_IN COVID_NN -_HYPH 19_CD to_TO ensure_VB that_IN no_DT one_NN is_VBZ left_VBN behind_RB from_IN the_DT vaccine_NN ._. A_DT “_`` business_NN as_IN usual_JJ ”_'' approach_NN will_MD not_RB be_VB effective_JJ ,_, nor_CC should_MD it_PRP be_VB acceptable_JJ ,_, he_PRP said_VBD ._. Other_JJ recommendations_NNS included_VBD investing_VBG in_IN mental_JJ health_NN and_CC psychosocial_JJ support_NN ;_, prioritizing_VBG women_NNS ’s_POS experiences_NNS ,_, protection_NN ,_, capacities_NNS and_CC leadership_NN ;_, and_CC better_RBR harnessing_VBG the_DT transformative_JJ potential_NN of_IN new_JJ technology_NN and_CC innovation_NN ._. Inclusiveness_NN is_VBZ key_JJ across_IN the_DT board_NN in_IN humanitarian_JJ action_NN ,_, he_PRP said_VBD ,_, underlining_VBG the_DT importance_NN of_IN focusing_VBG on_IN vulnerable_JJ groups_NNS ,_, including_VBG internally_RB displaced_VBN persons_NNS ._. In_IN addition_NN ,_, such_JJ ongoing_JJ threats_NNS as_IN terrorism_NN and_CC the_DT adverse_JJ impact_NN of_IN climate_NN change_NN must_MD be_VB addressed_VBN ._. Launching_VBG the_DT global_JJ Call_NN to_IN Action_NN ,_, he_PRP declared_VBD that_DT :_: “_`` Ultimately_RB ,_, no_DT one_NN can_MD be_VB safe_JJ from_IN COVID_NNP -_HYPH 19_CD until_IN we_PRP are_VBP all_RB safe_JJ from_IN COVID_NNP -_HYPH 19_CD ._. The_DT Call_NN to_IN Action_NN in_IN support_NN of_IN humanitarian_JJ response_NN in_IN fighting_VBG the_DT COVID_NNP -_HYPH 19_CD pandemic_NN addresses_VBZ our_PRP$ determination_NN and_CC the_DT urgency_NN to_TO act_VB now_RB ._. ”_'' Mr._NNP Hilale_NNP also_RB said_VBD the_DT resolution_NN traditionally_RB adopted_VBN at_IN each_DT Humanitarian_JJ Affairs_NNS Segment_NNP will_MD be_VB adopted_VBN at_IN the_DT Council_NNP ’s_POS first_JJ formal_JJ meeting_NN ,_, following_VBG the_DT lifting_NN of_IN restrictions_NNS related_VBN to_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ._.","NN with NNP ’s RBS NNP NNP for NNP NNP , NN - NNP NNP as NNP NNP NNPS ‘ NNPS VBP RB VBN JJR ’ VBG in NN with those RBS JJ to VB themselves from the NN - 19 NN VBZ RB RB the JJ NN to VB , but the JJ NN the NN will VB this , NNP NNPS NNP - NNP NNP NNP VBD the NNP and NNP NNP , which VBD a JJ NN to NN at its 2020 NNP NNPS NNP , VBN from 9 to 11 NNP via NN due to NN - JJ NNS . The 54 - NN NNP and NNP NNP VBD the NN to NN in NN of the JJ NN in VBG the NNP - 19 NN , VBG a NN of 13 JJ NNS VBG JJ NN , RB - NN NN and NN NNS at NNS and JJ NNS to VB JJ NNS . The NNS VBD to VB NNS and VB the NN of NN - 19 , VBN that during the NN of the three - NN NN , the NN of VBN NNS VBD to 7.1 million from 6.9 million , and the NN NN VBD 408,000 since the NN VBD VBN . The NN to NN VBD : “ As the NN VBZ the JJ NN of VBG to the NN - 19 NN , we must VB to VB with NN and NN to VB to this NN . We must VB to VBG RB through JJ NN , NN , NN and NN . ” The NN VBD for JJ , VBN NNS to VB JJ NNS and VB and VB JJR JJ JJ NNS on those RB VBN by the NN , VBG NNS and NNS , JJR NNS , NNS with NNS , NNS , RB VBN NNS and NNS . NNS of the NN to NN RB VBD NNP NNPS and JJ JJ NNS to VB VBG up NN NNS to VB the NN and VB RB VBG the NNP NNP NNP NN to VB its NNS , without VBG NNS from JJ NNS of NN . JJ NNS VBD upon NNP NNPS to VB RB with the NNP NNPS and to VB the NN of JJ NN , VBG RB - VBG the NN of NN and JJ NNS at NNS and in NN , VBG their NN , NN and RB - NN , and VBG them as JJ NNS . The NN NN RB VBD on NNP NNPS and JJ JJ NNS to VB NNS to VB NN and JJ NN that may VB NN to JJ , JJ and JJ JJ NNS , NNS , JJ JJ NN and JJ NN , RB RB as to VB NN to and JJ NN of all JJ NN NNS and NNS , VBG their JJ NNS and NNS , as a JJ NN , and to RB VB JJ NNS . All NNS VBD VBN to VB the NNP - NNP ’s NNS to VB NNP - 19 , VBG for an JJ JJ NN so as to VB the VBG JJ NNS of JJ NNS and to VB JJR NN on VBG to the NN . The 2020 NNP NNPS NNP VBD on the NN “ VBG JJ NN in the NN of the seventy - JJ NN of the NNP NNPS : VBG NN for NNS - VBN NNS , VBG NN , VBG JJ JJ NN and VBG the JJ NNS ” . Since 1998 , the NNP NNPS NNP VBZ VBN a NN for VBG NNS JJ to VBG the NN and NN of the NNP NNPS JJ NN , VBG VBG NN and VBG VBG NNS , NNS and NNS . It RB VBZ the NN of NNS and NNS VBN at JJ and JJ NNS . During the 2020 NNP NNPS NNP , NNP and NNP NNP NNS VBD in a JJ - NN NN on VBG and VBG JJ and NN - VBN NN in JJ NNS and three JJ JJ - NN NNS , VBG on NN , NN and VBG RB VBN NNS . JJ to the VBG NN , the NNPS of the NNP NNP for NNP NNP and the NNP NNPS NNP RB VBD a JJ JJ - NN NN NN on 8 NNP on the NN “ NN from NN to NN : The JJ and VBN NNS in the NNP NNP NN : VBG NNS , NNS and NNS for NNS through JJR JJ , NN and NN NN . ” NN NNS VBD RB VBN RB on the VBG NNS : VBG NNS , VBG NN , and VBG JJ NN : how JJ NN and NNS VBN from NN NN can VB VB NNP - 19 ; VBG the NN of NNS during NNP - 19 : VBG the NNP NNP NNP NNPS ; JJ NN to NNP - 19 and JJ NNS ; and NN - NN and JJ NN in the NN of NNP - 19 . The VBG NN - NNS VBD VBN on 12 NNP : JJ NN and JJ NN for VBN and JJ NNS during the NN - 19 NN and RB ; JJ NNS VBG from the NN of JJ NNS in VBN NNS ; and towards RBR JJ and VBN NNS on NN . NN - NNP NNP NNP , VBG the NN NN in a NN NN , VBD that RB before the NNP - 19 NN , the NN VBD JJ NNS of JJ NN . RB , at a NN when the NN VBZ to VB NN and NN and VB the NN of NNS of NN NNS , he VBD NNP NNPS and JJ NNS to RB VB the NNP - 19 NNP NNP NNP NNP and VB NN to VBG JJ NNS . “ We must VB RB to VB NNS and VB JJ NN , ” he VBD . “ When JJ NNS VBP at the NN , we VBP JJR NNS . ” VBG that NN for JJ NN must VB the NN of the NN , he VBD the JJR NNS of NN around the NN must RB VB VBN , VBG JJ NNS , NN NN and VBN NN . He RB VBD NNS a JJ NN . VBN by NNP and NNP NNP NNP - NNP NNP NNP ( NNP ) , the NN NN VBN : NNP NNP , Under - NNP - NNP for NNP NNPS and NNP NNP NN ; NNP NNP , JJ NN of the NNP NNPS NNP ’s NNP ( NNP ) ; NNP NNP , NNP - NNP of the NNP and NNP NNP of the NNP NNPS ( NNP ) ; and NNP NNP , JJ JJ NN of NNP . NNP NNP , NN of the NNP NNP of the NNP NNP ( NNP ) , VBD a NN NN . NNP NNP VBD : “ this NN VBZ unlike NN we VBP VBN with in our NN ; JJ NNS VBP VBN . Our NN must VB JJ to the NN of the NN we VBP . ” VBG that NNS over the VBG NNS VBP an NN to VB the NN to VB the NN and VB NNS , he VBD that “ the NNS VBP RB VBN JJR ; we will either VB this NN RB , or RB at all . ” VBG out the NN , he VBD that as of 8 NNP , there VBP 6.9 million VBN NNS RB , RB 1 in every 1,100 NNS . Over the JJ NN , JJ NNS VBP VBN VBN in NNP , from RB 55,000 NNS on 8 NNP to JJR than 190,000 a NN RBR , and in NNP NNP and the NNP , which VBZ RB VBN the NN of the NN , with 1.3 million NNS . The NN VBZ VBN to VB in the RBS JJ NNS on NNP in the JJ three to six NNS and could RB VB JJ in the VBG NN . The NN ’s JJ NNS VBP RB JJ , he VBD , as they VBP a JJR and RBR - VBG NN to some VBG NNS than the NN itself . RB , the JJS JJ NN in NN NN VBZ VBN to the NNP NNPS NNP NNP ( NNP ) VBG that the JJ NNS of JJ NN VBP VBN to VB in 2020 for the JJ NN since 1990 . The NNP NNP VBZ that the NN could VB RB JJ as 60 million NNS into JJ NN while the NNP NNP NNP ( NNP ) VBZ it could VB 130 million NNS towards the NN of NN , RB JJ the 2019 NN . NNP - 19 VBZ RB VBG JJ JJ NNS , VBG the NN ’s JJ 60 million VBN NNS , NNS VBG JJ NN NN NNS , RB VBG NN NN , NN NNS and the JJS NN of NNS in NNS . RB , he VBD , JJ NNS VBP VBG VBN to VB the NN of JJ NN VBN by VBN NNS in some NNS , NN NNS , NN NNS , NNS , NNS and VBN NN NNS that VBP VBN it RB JJ to VB NN to NNS in NN . They VBP NN NNS for JJ NN and NNS to VB to JJ NNS and NN NNS to VB and VB NN and VB the NN of NN . RB , an VBN $ 90 billion VBZ VBN to VB JJ NN to those in the NN ’s JJS NNS , he VBD . At the JJ NN , the NNP NNP NNP NNP NNP NNP VBZ the JJ NN ’s JJ NN NN to VB to the NN of the NN in JJ - and JJ - NN NNS and VB their NNS to VB it . While $ 6.7 billion would VB the NN until NNP , RB $ 1.2 billion , or 17.4 NN NN , VBZ VBN to NN , he VBD , VBG that VBG NNS from JJ NNS to VB the NNP - 19 NN would VB NN - JJ and VB to JJR and JJR NN of NN . As JJ , he VBD on NNS to VB VBG JJ NN that VBZ for JJ , JJ NN - NN wherever JJ . NNP NNP , VBG NNP NNS and NNS , VBD the NN VBZ an NN for the JJ JJ NN to “ VB NNS RB ” to RBR RB VB those RBS in NN , VBG the NN ’s NNS . In RB a JJ JJ NNS , the NN and NNS to VB it VBP VBN JJ VBG NNS , NNS and NNS of JJ NNS around the NN , the NN of NNS of under - NN in what VBZ VBN to VB NNS ’s NNS . While the NN VBZ VBN , NNS ’s NNS VBP RB , VBG NNS , NNS , NN , NN , NN , NN , NN from NN and NN both from NN and RB the NN of NN - 19 . VBG JJ NNS VBG the JJ NN from VBG the NN ’s RBS JJ NNS , she VBD that there VBZ a JJ NNP NN in the NNP NNP of the NNP , 60 NNS VBP VBN NN NNS on NN while VBG on VBG NN - 19 and JJ NNS of NNS and NN VBP JJ to VB as a NN of NN NNS . In NN , NNS and NNS VBP NN and NN due to NN and NNS JJ of VBG VBN , NNS and NNS VBP VBN to NNS and NNS , and NNS VBP VBG VBN . She RB VBD at NNS of NN against RB JJ NN - NN NNS VBG to NNP - 19 across NNS . In some NNS , NN NNS VBP RB VBG NNS , which could VB to JJ JJ NN and “ VBN NNS ” of the NN . She VBD VBG NNS RB VBZ on VBG NN NNS , VBG JJ NNS and VBG NN with NNS to VB the NNS that RB VBP the NN to VB NN that VBZ JJ , RB than JJ . The JJ NN must VB in VBG JJ NNS to VB the NNS of this JJ NN . “ VB us VB this NN as a NN to VB a JJ NN among the JJ JJ NN , as we VBP to RBR VB and VB the NN ’s RBS JJ NNS , ” she VBD . JJ NNS VBD NNS VBG the JJ and JJ JJ NN . VBG on how the JJ NN VBZ VBG and VBG RB and VBG with a NN of NNS , and what JJR can VB VBN , they RB VBD the NN of JJ JJ NN to NN and to JJ NN for VBN NNS and NNS . VBG the VBG NN on 9 NNP , a JJ - NN NN VBD VBN on the NN “ VBG the VBG NN of NN NNS in JJ NNS ” . It VBD on the JJ JJ NNS VBN to VB the NNS of the NN - 19 NN and to VB to VBG NNS VBN by it , VBG NNS in JJ NNS of NN NNS and NNS . VBN by NNP NNP and VBN by NNP NNP , it VBD the VBG NNS : NNP NNP , NNP for NNP NNP and NNP NNP of the NNPS ; NNP NNP NNP , NNP NNP - NNP for NNP NNP at the NNP NNP NNP ( NNP ) ; NNP NNP , NNP JJ NN of the NNP ; NNP NNP , NNP NNP of the NNP NNP of the NNP NNP and NNP NNP NNPS ( NNP ) ; NNP NNP , NNP NNP of NNP NNP NNP ; NNP NNP , NNP , NNP of NNP NNP NNPS and NNP , NNP NNPS for NNP NNP and NNP ; and NNP NNP NNP , NNP of the NNP NNP NNPS with NNP NNP . NNP NNP VBD JJ NNS VBP VBG all they can to VB and VB JJ NNS in the NN of the JJ NNS VBN on by NNP - 19 . Along with NNS , they VBP VBG NN to VB that they can VB JJ NNS and VB JJ NNS wherever JJ . NNP and JJ JJ NN NN NNS VBP VBG up NN , NN and NN to the NN in NNS of NNS while VBG their NN - 19 NNS to this JJ NN , VBG with NNS of NN NNS and NN NNS . VBG JJ NNS , he VBD that NNS in NNP , NNP , NNP and NNP VBP VBG JJR NN NNS , VBG RBR JJ NNS , and VBG NNS JJR to NNS . In NNP , they VBP VBG to VB NN on all NNS at RB — NN , NN , NN and NN — to VB NN NNS ; and in NNP , NN VBZ VBN NN - to - NN where JJ . All over the NN , NN NNS VBP VBG their NN of NN over in - NN NN to VB JJ NN . VBG the NNP - NNP ’s NN , he VBD : “ We VBP in this NN RB , RB RB it VBZ our NN as JJ NNS to VB that no NN VBZ VBN RB . ” NNS VBD how the NNP NNPS and its NNS VBP VBG NNS and VBG with JJ NNS to VB to JJ and JJ NNS while VBG VBG NNS , VBG NN NNS and VBG NN NNS to VB JJ NNS . They RB VBD how to VB these JJ JJ NN NNS in a NN where JJ NNS VBP VBN by an RB JJ NN of NN , JJ and NN NNS , and by VBN NNS . RBR , they VBD NNS VBN to VB the JJ NNS of these JJ NNS and VBD NNS they VBP VBG JJ VBG NNS , RB as the NNP - 19 NN VBZ to VB RB JJ NNS of NN to JJ NNS and VB NNS of NNS to the NNS of NN . NNS RB VBD NNS for VBG the NN of JJ and JJ NNS to where they VBP RBS VBN . RB , they VBD the NN ’s JJ NN and JJ NN , along with NNS for VBN NNS , and for JJ - NN JJ NNS . In the NN a JJ - NN NN VBD VBN on the NN “ VBG and VBG JJ and NN - VBN NN in JJ NNS ” . The NN VBD together JJ NNS , VBG NNP NNPS , NNS , JJ NN and NNS , to VB in NN about JJ NNS and NNS , and VB JJS NNS to VB JJ and NN - VBN NN . VBN by NNP NNP and VBN by NNP NNP , it VBD the VBG NNS : NNP NNP NNP NNP , NN for JJ NNS of NNP ; VBN NN NNP NNP NNP ; NNP NNP , JJ NN of the NNP NNPS NNP NNP ( NNP ) ; NNP NNP , JJ NN of NNP ; NNP NNP , NNP NNP NNPS NNP NNP for NNPS ; NNP NNP , NNP - NNP and NNP of NNP NNP at the NNP NNP NNP ; NNP NNP , NNP NNP NNPS NN at the NNP , NNP NNP ; and NNP NNP NNP , NNP of the NNP of NNP NNP NNPS in NNP NNP . NNP NNP VBD NNP - 19 VBZ VBN NNS to JJ NNS and NN while RB VBG to VB NNS towards NN NN and NNS ’s NNS . JJ NNS and NNS VBP VBN NN - VBN NN , VBG JJ NN , and JJ NN and NN , and in JJ NNS , NNS to NNS VBP VBN by 30 to 40 NN NN VBG NN and NN NNS . “ It VBZ VBN us to VB a JJ , and I VBP , JJ NN , at NNS and how we VBP our RBS JJ , ” he VBD . “ This VBZ RB a NN of NN to VB RB and in NN , while there VBZ JJ NN to VB RBR from the NN . ” NN must VB RB , he VBD , to VB NNS and NNS at the NN of NNS through a JJ - of - NN NN VBG with JJ NNS , JJ NN , NNS , JJ NNS , NNS , and JJ and NN NNS . NNS to VB these NNS must VB VBN RB , he VBD , VBG that one in three NNS will VB some NN of JJ or JJ NN in her NN , and the NN of that VBG VBZ JJR for NNS with NNS . NN , VBG by VBG NNS in JJ NN - VBG , and VBG NN NN , VBP some of the NNS RB . For its NN , the NNP for the NNP of NNP NNPS VBZ VBG to VB , VB to and VB NN - VBN NN in JJ NNS . It VBZ RB VBG NN NN and VBG NN - VBN NN in NN to the NN through the NNP - 19 NNP NNP NNP NNP , he VBD , VBG that : “ We VBP VBG this because VBG to NN - VBN NN VBZ NN and VBZ NNS . ” NNS VBD NN to the JJ NN , VBG the JJ NN on NNS and NNS in JJ NNS . They RB VBD NNS VBN in NN of the NN - 19 NN , what VBZ VBG VBN and what JJR VBZ to RB VB VBN to VB and VB to JJ NNS in JJ NNS . On 10 NNP , a JJ - NN NN VBD the NN “ VBG JJ NN through JJ NN and NN : NNS and NNS ” . VBN by NNP NNP and VBN by NNP NNP , NNP NNP NNP - NNP for NNP NNPS and NNP NNP NNP NN , it VBD the VBG NNS : NNP NNP , JJ NNP to the NNP - NNP on the NNP of the NNP NNPS NNP - NNP NNP ; NNP NNP , NNP JJ NN of NNP ; NNP NNP , NNP of JJ NN and NN at the NNP ; NNP NNP , JJ NN of the NNP of NNP NNP NNPS ( NNP ) NNP NNP for NNP NNP on NNP NNP ; NNP NNP , JJ JJ NN of NNP at the NNP NNP of NNP and NNP ; NNP NNP , NNP NNP and NNP - in - NNP of NNP ; and NNP NNP , NN NN NN at NNP . NNP NNP VBD that “ VB the NN ” VBZ among the NNS RB VBG JJ NN in JJS NNS , JJ NNS and all NN NNS . This RB VBN NN VBZ a JJ and JJ NN of NN NN and NN , NN , NN NN , NN and NN NN to VB to the “ NN ” . It RB VBZ that NN - VBN NN - VBG NN in JJS NNS VBZ RB VBG JJ NNS about how the NN should VB to the NN . NN and NN in JJ NNS VBP RB JJ to JJ NN and NN , he VBD , VBG to JJ NNS as JJ NN , NN NN and JJ NNS that VBP VBN to RBR RB and RB VB and VB NNS about how to VB to NNS . In 2019 , the NNP VBD its NN NN to NNS in NNP by VBG on JJ NN and NN NN for NN NN . NNS VBN in JJ and JJ JJ and NN NNS VBP the NN NNS of this JJ NN and NN , he VBD , VBG that JJ JJ , JJ and JJ NNS across the JJ NN VBP NNS to VB , VB and VB the NN of NN , NN , NN NN and JJ NNS . VBG JJ JJ NNS , he VBD at NNS to VB JJ NNS for NNS VBG NN , NN NN to VB JJ NN , NNS to VB NNS and VB NN , NN NN to RB VB NN NN and NNS , and NNS to VB with VBN NNS . Through the NNP for NNP NNP in The NNP , the NNP for the NNP of NNP NNPS VBZ VBG JJ NNS that can VB JJ NN to VB RB of a NN and VB the JJS NNS . RB , these JJ NNS VBP JJ NN while VBG JJ NNS and NNS , he VBD , among them NN , NN NN and VBG JJ NN . During the NN - 19 NN , a JJ NN VBZ RB VBN the “ NN ” : the NN of NN and NN , and the NN of NN to VB NNS or VB NNS . To VB JJ NNS and NNS , he VBD the “ VBP no NN ” NN must VB , as should NN for JJ JJ NNS and NNS VBG JJ NN . NNS VBD JJ NNS the JJ NN VBZ VBG NN in a VBG NN by VBG JJ NN and NN . Some VBD NNS VBG VBN to VB the NN of JJ NNS while VBG JJS NNS and NNS VBN . They VBD how the JJ NN VBZ VBG itself to VB with NNS , VBG JJ , JJ , and JJ NNS and the JJ NN , to VB and VB - out JJR NNS . They RB VBD the NNS and NNS VBN with JJ and VBG NNS and how these can VB VBN . On 11 NNP , a JJ - NN NN VBD VBN on the NN “ VBG NN to VB JJ NN for RB VBN NNS and VB JJ NNS ” . VBN by NNP NNP and VBN by NNP NNP , it VBD the VBG NNS : NNP NNP , NNP of the NNP NNPS NNP - NNP ’s NNP - NNP NNP on NNP NNP ; NNP NNP , NNP NNPS NNP NNP for NNP NNP ; NNP NNP , NNP NNPS NNP NNP for NNPS ; NNP NNP , NNP NNP of the NNP NNP for NNP ( NNP ) ; NNP NNP , NNP NNP of the NNP NNP NNP NNP ; NNP NNP NNP , NNP of the NNP of NNPS on NNP NNP and NNP NNP of NNP to the NNP NNPS NNP in NNP ; and NNP NNP NNP , NNP NNP in the NNP NNP of the NNPS of NNPS with NNPS . NNS VBD NNS VBG the JJ NNS of RB VBN NNS and JJ NNS towards VBG JJ NNS . NNS VBD how RB - NN NNS can VB VBN from the JJ NN of a JJ NN . They RB VBD JJ NNS the JJ NN can RBR VB RB VBN NNS , NN NNS and NNS . On 11 NNP , at the NN NN , NNP NNP VBD that the two VBG NNS VBG from NNS VBP that the NNP - 19 NN VBZ VBN VBG JJ NNS while RB VBG and VBG VBG NNS . “ The RBS JJ NN of this JJ NNS NN VBZ that NNS will VB with us , but we VBP to VB to the NN , VBG with NNP NNPS , VBN NNS and all of our NNS to VB NNS and VB NN , ” he VBD . “ We RB VBP to VB RB and RB . This NN VBZ an NN to VB NNS RBR , RB . ” NNP NNP , VBG NNS for a JJ NN , VBD NNS VBN and VBD a NN of NNS , JJ as VBG in NN NN , which VBZ JJ and will VB to a RBR JJ JJ NN . The NN VBZ RB VBN that NN and NN can VB NNS and VB NN and NNS . One JJ JJ NN the JJ JJ NN can VB RB RB VBZ to VB to what the NNP NNPS and the NNP VBP VBN as a “ NN ’s NN ” to NN - 19 to VB that no NN VBZ VBN RB from the NN . A “ NN as JJ ” NN will RB VB JJ , nor should it VB JJ , he VBD . JJ NNS VBD VBG in JJ NN and JJ NN ; VBG NNS ’s NNS , NN , NNS and NN ; and RBR VBG the JJ NN of JJ NN and NN . NN VBZ JJ across the NN in JJ NN , he VBD , VBG the NN of VBG on JJ NNS , VBG RB VBN NNS . In NN , JJ JJ NNS as NN and the JJ NN of NN NN must VB VBN . VBG the JJ NN to NN , he VBD that : “ RB , no NN can VB JJ from NNP - 19 until we VBP RB JJ from NNP - 19 . The NN to NN in NN of JJ NN in VBG the NNP - 19 NN VBZ our NN and the NN to VB RB . ” NNP NNP RB VBD the NN RB VBN at each JJ NNS NNP will VB VBN at the NNP ’s JJ JJ NN , VBG the NN of NNS VBN to the NN - 19 NN ."
60,503,conspiracy,C01114,vaccine,"An_DT alarming_JJ video_NN published_VBN in_IN February_NNP by_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP (_-LRB- CDC_NNP )_-RRB- has_VBZ revealed_VBN some_DT startling_JJ information_NN about_IN vaccine_NN testing_NN and_CC approval_NN procedures_NNS ._. Even_RB the_DT biggest_JJS supporter_NN of_IN vaccines_NNS will_MD NOT_RB believe_VB their_PRP$ eyes_NNS !_. (_-LRB- the_DT video_NN –_: below_RB –_: says_VBZ it_PRP all_DT ._. )_-RRB- Simply_RB put_VBN ,_, (_-LRB- and_CC the_DT evidence_NN is_VBZ undeniable_JJ )_-RRB- vaccines_NNS and_CC related_JJ pharmaceuticals_NNS are_VBP literally_RB rushed_VBN to_IN the_DT market_NN without_IN proper_JJ testing_NN and_CC verification_NN ._. We_PRP ,_, at_IN NaturalHealth365_NNP ,_, have_VBP been_VBN talking_VBG about_IN this_DT for_IN years_NNS –_: but_CC ,_, now_RB ,_, we_PRP have_VBP (_-LRB- video_NN )_-RRB- proof_NN ._. In_IN reality_NN ,_, “_`` test_NN results_NNS ”_'' are_VBP derived_VBN from_IN consumers_NNS ._. Safety_NN data_NNS on_IN these_DT drugs_NNS literally_RB are_VBP not_RB available_JJ until_IN people_NNS start_VBP taking_VBG the_DT vaccine_NN ._. During_IN this_DT horrifying_JJ revelation_NN captured_VBN on_IN video_NN (_-LRB- below_RB )_-RRB- ,_, it_PRP is_VBZ even_RB admitted_VBN that_IN we_PRP and_CC our_PRP$ children_NNS are_VBP supposed_VBN to_TO be_VB the_DT ‘_`` guinea_NN pigs_NNS ’_'' for_IN these_DT vaccines_NNS in_IN lieu_NN of_IN clinical_JJ testing_NN ._. Here_RB is_VBZ the_DT full_JJ video_NN released_VBN by_IN the_DT CDC_NNP from_IN the_DT 2018_CD Advisory_NNP Committee_NNP on_IN Immunization_NNP Practices_NNPS (_-LRB- ACIP_NNP )_-RRB- conference_NN ._. The_DT most_RBS relevant_JJ portion_NN begins_VBZ at_IN the_DT 47:23_CD mark_NN and_CC continues_VBZ until_IN one_CD hour_NN 7_CD seconds_NNS :_: A_DT more_RBR condensed_VBN and_CC concise_JJ Facebook_NNP version_NN is_VBZ available_JJ at_IN this_DT link_NN :_: Some_DT vaccine_NN ingredients_NNS include_VBP the_DT adjuvants_NNS aluminum_NN ,_, chromium_NN and_CC mercury_NN ,_, which_WDT are_VBP known_VBN neurotoxins_NNS ._. They_PRP are_VBP bad_JJ enough_RB for_IN adults_NNS ,_, but_CC when_WRB administered_VBN to_IN children_NNS ,_, exposure_NN to_IN these_DT substances_NNS far_RB exceeds_VBZ CDC_NNP recommended_VBN safe_JJ levels_NNS ._. (_-LRB- Should_MD any_DT amount_NN of_IN metal_NN in_IN a_DT food_NN or_CC drug_NN be_VB considered_VBN safe_JJ ?_. !_. )_-RRB- Here_RB ’s_VBZ another_DT valid_JJ point_NN to_TO consider_VB :_: despite_IN vaccine_NN use_NN ,_, the_DT incidents_NNS of_IN many_JJ diseases_NNS and_CC health_NN conditions_NNS are_VBP actually_RB higher_JJR ._. Rates_NNS of_IN cervical_JJ cancer_NN ,_, infectious_JJ diseases_NNS and_CC autism_NN are_VBP still_RB way_RB to_IN high_JJ –_: especially_RB when_WRB you_PRP consider_VBP the_DT fact_NN that_IN vaccines_NNS are_VBP supposed_VBN to_TO reduce_VB our_PRP$ risk_NN ._. In_IN addition_NN to_IN vaccine_NN side_NN effects_NNS such_JJ as_IN neurological_JJ problems_NNS and_CC autism_NN ,_, vaccines_NNS have_VBP also_RB been_VBN linked_VBN to_IN many_JJ autoimmune_JJ disorders_NNS ._. One_PRP has_VBZ to_TO wonder_VB why_WRB autoimmune_JJ diseases_NNS are_VBP on_IN the_DT rise_NN ._. The_DT National_NNP Institutes_NNPS of_IN Health_NNP reports_VBZ that_IN up_IN to_IN 23.5_CD million_CD Americans_NNPS have_VBP an_DT autoimmune_JJ condition_NN ._. We_PRP MUST_MD admit_VB the_DT obvious_JJ :_: Leadership_NN –_: within_IN the_DT medical_JJ community_NN –_: IS_VBZ aware_JJ of_IN unsafe_JJ vaccines_NNS For_IN example_NN ,_, a_DT pair_NN of_IN Italian_JJ scientists_NNS have_VBP verified_VBN unsafe_JJ levels_NNS of_IN contaminants_NNS in_IN vaccines_NNS in_IN a_DT 2017_CD study_NN ._. Using_VBG electron_NN -_HYPH microscopy_NN ,_, they_PRP examined_VBD 30_CD human_JJ and_CC veterinary_JJ vaccines_NNS ,_, including_VBG for_IN hepatitis_NN ,_, influenza_NN ,_, cervical_JJ cancer_NN ,_, meningitis_NN and_CC allergies_NNS ._. ALL_DT BUT_CC ONE_CD of_IN the_DT tested_VBN samples_NNS tested_VBD positive_JJ for_IN inorganic_JJ contaminants_NNS ._. Both_CC single_JJ types_NNS of_IN contaminants_NNS and_CC disturbing_JJ assemblages_NNS of_IN toxic_JJ substances_NNS were_VBD found_VBN in_IN the_DT vaccines_NNS ._. The_DT researchers_NNS admitted_VBD to_IN being_VBG “_`` baffled_VBN ”_'' by_IN the_DT bizarre_JJ compositions_NNS of_IN some_DT of_IN these_DT contaminant_NN combinations_NNS ._. Lead_JJ particles_NNS were_VBD found_VBN in_IN cervical_JJ cancer_NN vaccines_NNS Cervarix_NNP and_CC Gardasil_NNP ,_, as_RB well_RB as_IN in_IN the_DT meningitis_NN vaccine_NN Meningetec_NNP and_CC the_DT seasonal_JJ flu_NN vaccine_NN Aggripal_NNP ._. In_IN addition_NN to_IN heavy_JJ metals_NNS ,_, red_JJ cells_NNS from_IN either_CC humans_NNS or_CC animals_NNS were_VBD found_VBN in_IN some_DT of_IN the_DT drugs_NNS ._. (_-LRB- how_WRB can_MD doctors_NNS think_VB this_DT is_VBZ ‘_`` safe_JJ !_. ’_'' )_-RRB- WARNING_NN :_: Incidents_NNS of_IN autoimmune_JJ disease_NN and_CC other_JJ conditions_NNS higher_JJR despite_IN vaccine_NN use_NN The_DT researchers_NNS believe_VBP these_DT contaminants_NNS are_VBP causing_VBG the_DT immune_NN system_NN to_TO react_VB ,_, releasing_VBG microphages_NNS to_TO fight_VB the_DT foreign_JJ bodies_NNS ._. This_DT leads_VBZ to_IN systemic_JJ inflammation_NN and_CC the_DT other_JJ characteristics_NNS of_IN autoimmune_JJ disease_NN ._. In_IN a_DT pattern_NN that_WDT is_VBZ all_RB too_RB familiar_JJ ,_, not_RB long_RB after_IN the_DT husband_NN and_CC wife_NN team_NN released_VBD their_PRP$ findings_NNS ,_, their_PRP$ home_NN was_VBD raided_VBN by_IN Italian_JJ police_NNS and_CC their_PRP$ data_NNS seized_VBN ._. It_PRP ’s_VBZ time_NN to_TO speak_VB up_RP and_CC demand_VB that_IN vaccines_NNS be_VBP thoroughly_RB tested_VBN before_IN release_NN to_IN the_DT public_NN ._. Parents_NNS should_MD continue_VB to_TO fight_VB for_IN the_DT right_NN to_TO opt_VB out_IN of_IN vaccine_NN programs_NNS unless_IN and_CC until_IN they_PRP are_VBP properly_RB tested_VBN and_CC verified_VBN as_IN safe_JJ ._.","An JJ NN VBN in NNP by the NNP NNPS for NNP NNP ( NNP ) VBZ VBN some JJ NN about NN NN and NN NNS . RB the JJS NN of NNS will RB VB their NNS ! ( the NN – RB – VBZ it all . ) RB VBN , ( and the NN VBZ JJ ) NNS and JJ NNS VBP RB VBN to the NN without JJ NN and NN . We , at NNP , VBP VBN VBG about this for NNS – but , RB , we VBP ( NN ) NN . In NN , “ NN NNS ” VBP VBN from NNS . NN NNS on these NNS RB VBP RB JJ until NNS VBP VBG the NN . During this JJ NN VBN on NN ( RB ) , it VBZ RB VBN that we and our NNS VBP VBN to VB the ‘ NN NNS ’ for these NNS in NN of JJ NN . RB VBZ the JJ NN VBN by the NNP from the 2018 NNP NNP on NNP NNPS ( NNP ) NN . The RBS JJ NN VBZ at the 47:23 NN and VBZ until one NN 7 NNS : A RBR VBN and JJ NNP NN VBZ JJ at this NN : Some NN NNS VBP the NNS NN , NN and NN , which VBP VBN NNS . They VBP JJ RB for NNS , but when VBN to NNS , NN to these NNS RB VBZ NNP VBN JJ NNS . ( Should any NN of NN in a NN or NN VB VBN JJ ? ! ) RB VBZ another JJ NN to VB : despite NN NN , the NNS of JJ NNS and NN NNS VBP RB JJR . NNS of JJ NN , JJ NNS and NN VBP RB RB to JJ – RB when you VBP the NN that NNS VBP VBN to VB our NN . In NN to NN NN NNS JJ as JJ NNS and NN , NNS VBP RB VBN VBN to JJ JJ NNS . One VBZ to VB why JJ NNS VBP on the NN . The NNP NNPS of NNP VBZ that up to 23.5 million NNPS VBP an JJ NN . We MUST VB the JJ : NN – within the JJ NN – VBZ JJ of JJ NNS For NN , a NN of JJ NNS VBP VBN JJ NNS of NNS in NNS in a 2017 NN . VBG NN - NN , they VBD 30 JJ and JJ NNS , VBG for NN , NN , JJ NN , NN and NNS . ALL BUT ONE of the VBN NNS VBD JJ for JJ NNS . Both JJ NNS of NNS and JJ NNS of JJ NNS VBD VBN in the NNS . The NNS VBD to VBG “ VBN ” by the JJ NNS of some of these NN NNS . JJ NNS VBD VBN in JJ NN NNS NNP and NNP , RB RB as in the NN NN NNP and the JJ NN NN NNP . In NN to JJ NNS , JJ NNS from either NNS or NNS VBD VBN in some of the NNS . ( how can NNS VB this VBZ ‘ JJ ! ’ ) NN : NNS of JJ NN and JJ NNS JJR despite NN NN The NNS VBP these NNS VBP VBG the NN NN to VB , VBG NNS to VB the JJ NNS . This VBZ to JJ NN and the JJ NNS of JJ NN . In a NN that VBZ RB RB JJ , RB RB after the NN and NN NN VBD their NNS , their NN VBD VBN by JJ NNS and their NNS VBN . It VBZ NN to VB up and VB that NNS VBP RB VBN before NN to the NN . NNS should VB to VB for the NN to VB out of NN NNS unless and until they VBP RB VBN and VBN as JJ ."
61,529,conspiracy,C01153,pharmaceutical.industry; september.11.attack; vaccine.covid,"Part_NN 5_CD :_: The_DT Canadian_NNP Broadcasting_NNP Corporation_NNP Masks_NNPS Its_PRP$ Own_JJ Ineptitude_NN by_IN Attacking_VBG ‘_`` Conspiracy_NNP Theorists_NNPS ’_'' and_CC ‘_`` Vigilantes_NNPS ’_'' Spiro_NNP Skouras_NNP ,_, former_JJ executive_JJ producer_NN at_IN Newsbud_NNP ,_, has_VBZ emerged_VBN as_IN one_CD of_IN the_DT more_RBR engaging_VBG and_CC erudite_JJ of_IN the_DT young_JJ investigative_JJ journalists_NNS who_WP have_VBP been_VBN delving_VBG into_IN the_DT Wuhan_NNP Coronavirus_NNP epidemic_NN ._. Skouras_NNP has_VBZ documented_VBN the_DT position_NN of_IN many_JJ prominent_JJ figures_NNS that_WDT have_VBP questioned_VBN the_DT dubious_JJ claim_NN that_IN the_DT source_NN of_IN COVID_NN -_HYPH 19_CD infection_NN was_VBD a_DT diseased_JJ animal_NN in_IN Wuhan_NNP ’s_POS open_JJ -_HYPH air_NN food_NN market_NN ._. Skouras_NNP has_VBZ argued_VBN it_PRP would_MD be_VB “_`` negligent_JJ ”_'' for_IN researchers_NNS to_TO refrain_VB from_IN investigating_VBG “_`` the_DT full_JJ array_NN of_IN possibilities_NNS ”_'' on_IN how_WRB the_DT contagion_NN originated_VBD and_CC how_WRB it_PRP spread_VBD ._. Among_IN the_DT first_JJ figures_NNS ,_, Skouras_NNP interviewed_VBD on_IN the_DT crisis_NN was_VBD Francis_NNP Boyle_NNP ,_, the_DT renowned_JJ professor_NN of_IN international_JJ law_NN at_IN the_DT University_NNP of_IN Illinois_NNP ._. Prof._NNP Boyle_NNP drafted_VBD the_DT Biological_NNP Weapons_NNPS and_CC Terrorism_NNP Act_NNP ,_, legislation_NN that_WDT enabled_VBD US_NNP ratification_NN of_IN the_DT UN_NNP ’s_POS Biological_NNP Warfare_NNP Convention_NNP in_IN 1990_CD ._. Prof_NNP ._. Boyle_NNP indicated_VBD in_IN his_PRP$ interview_NN with_IN Skouras_NNP that_IN COVID_NNP -_HYPH 19_CD is_VBZ most_RBS likely_RB a_DT genetically_RB -_HYPH engineered_VBN pathogen_NN that_WDT escaped_VBD from_IN the_DT so_RB -_HYPH called_VBN Biosafety_NNP Laboratory_NNP in_IN Wuhan_NNP ._. Prof_NNP ._. Boyle_NNP indicated_VBD ,_, Prof_NNP ._. Boyle_NNP points_VBZ to_IN the_DT fact_NN that_IN the_DT SARS_NNP virus_NN leaked_VBD out_RP from_IN a_DT Beijing_NNP lab_NN in_IN 2004_CD ._. He_PRP describes_VBZ as_IN “_`` propaganda_NN ”_'' the_DT widely_RB promulgated_VBN opinion_NN that_WDT COVID_NNP -_HYPH 19_CD originated_VBD in_IN Wuhan_NNP ’s_POS exotic_JJ ,_, open_JJ -_HYPH air_NN food_NN market_NN ._. Prof_NNP ._. Boyle_NNP expanded_VBD some_DT of_IN his_PRP$ interpretations_NNS in_IN a_DT subsequent_JJ interview_NN published_VBN by_IN GreatGameIndia_NNP ._. Skouras_NNP specifically_RB asked_VBD Dr._NNP Boyle_NNP about_IN his_PRP$ relationship_NN with_IN mainstream_JJ media_NN given_VBN his_PRP$ record_NN as_IN one_CD of_IN the_DT foremost_JJS academic_JJ experts_NNS on_IN international_JJ law_NN and_CC military_JJ culture_NN concerning_VBG the_DT development_NN of_IN bioweaponry_NN in_IN the_DT United_NNP States_NNPS ._. Dr._NNP Boyle_NNP responded_VBD that_IN he_PRP was_VBD pretty_RB much_RB blacklisted_VBN from_IN commenting_VBG on_IN the_DT subject_NN of_IN biological_JJ warfare_NN ever_RB since_IN he_PRP publicly_RB shared_VBD his_PRP$ interpretation_NN of_IN the_DT anthrax_NN attacks_NNS on_IN two_CD US_NNP Senators_NNPS in_IN October_NNP of_IN 2001_CD ._. There_EX has_VBZ been_VBN considerable_JJ scholarly_JJ scrutiny_NN of_IN the_DT anthrax_NN attacks_NNS targeting_VBG the_DT US_NNP Congress_NNP and_CC some_DT media_NN organizations_NNS in_IN early_JJ October_NNP of_IN 2001_CD ._. The_DT anthrax_NN attacks_NNS constitute_VBP the_DT most_RBS serious_JJ assault_NN ever_RB on_IN the_DT operations_NNS of_IN the_DT US_NNP Congress_NNP ,_, the_DT primary_JJ interface_NN between_IN law_NN and_CC politics_NNS in_IN the_DT United_NNP States_NNPS ._. These_DT attacks_NNS have_VBP come_VBN to_TO be_VB understood_VBN as_IN an_DT integral_JJ part_NN of_IN the_DT large_JJ body_NN of_IN crimes_NNS committed_VBN in_IN Manhattan_NNP and_CC Washington_NNP DC_NNP on_IN 9/11_CD ._. The_DT anthrax_NN attacks_NNS killed_VBD five_CD people_NNS including_VBG two_CD postal_JJ workers_NNS ._. Seventeen_CD people_NNS were_VBD injured_VBN and_CC Congress_NNP was_VBD shut_VBN down_RP for_IN a_DT few_JJ days_NNS ._. Anthrax_NN -_HYPH laden_JJ letter_NN attacks_NNS were_VBD specifically_RB directed_VBN at_IN two_CD Democratic_NNP Party_NNP Senators_NNPS ,_, Patrick_NNP Leahy_NNP and_CC Tom_NNP Daschle_NNP ._. When_WRB they_PRP received_VBD the_DT contaminated_VBN letters_NNS both_DT lawmakers_NNS were_VBD engaged_VBN in_IN questioning_NN provisions_NNS of_IN the_DT post_NN -_HYPH 9/11_CD emergency_NN measures_NNS legislation_NN known_VBN as_IN the_DT Patriot_NNP Act_NNP ._. Both_CC Senators_NNPS Leahy_NNP and_CC Daschle_NNP were_VBD hesitant_JJ to_TO rubber_NN stamp_VB the_DT enactment_NN that_WDT was_VBD seemingly_RB instantly_RB drafted_VBN and_CC put_VBN before_IN Congress_NNP within_IN three_CD weeks_NNS of_IN the_DT 9/11_CD debacle_NN ._. The_DT anthrax_NN attacks_NNS took_VBD place_NN just_RB as_IN the_DT US_NNP Armed_JJ Forces_NNS began_VBD invading_VBG Afghanistan_NNP where_WRB the_DT culprits_NNS of_IN the_DT 9/11_CD crimes_NNS were_VBD supposed_VBN to_TO be_VB hiding_VBG out_RP ._. The_DT perpetrators_NNS of_IN the_DT anthrax_NN attack_NN ,_, who_WP we_PRP were_VBD supposed_VBN to_TO imagine_VB at_IN the_DT time_NN as_IN al_NNP -_HYPH Qaeda_NNP terrorists_NNS ,_, succeeded_VBD in_IN easing_VBG aside_RP the_DT major_JJ locus_NN of_IN opposition_NN to_IN the_DT Patriot_NNP Act_NNP ’s_POS speedy_JJ passage_NN in_IN late_JJ October_NNP ._. Why_WRB ,_, one_PRP might_MD legitimately_RB ask_VB ,_, ask_VB ,_, would_MD Islamic_JJ jihadists_NNS want_VB the_DT Patriot_NNP Act_NNP to_TO be_VB rushed_VBN through_IN Congress_NNP ._. In_IN early_JJ October_NNP the_DT US_NNP Armed_JJ Forces_NNS invaded_VBD Afghanistan_NNP at_IN the_DT same_JJ time_NN that_IN the_DT US_NNP executive_JJ branch_NN was_VBD seeking_VBG with_IN the_DT Patriot_NNP a_DT license_NN to_TO kill_VB and_CC torture_VB and_CC steal_VB without_IN any_DT checks_NNS of_IN accountability_NN ._. Once_IN the_DT US_NNP Armed_JJ Forces_NNS went_VBD to_IN war_NN with_IN Afghanistan_NNP on_IN the_DT basis_NN of_IN a_DT fraudulent_JJ explanation_NN of_IN 9/11_CD ’s_POS genesis_NN ,_, there_EX was_VBD basically_RB no_DT chance_NN that_IN a_DT genuine_JJ and_CC legitimate_JJ evidence_NN -_HYPH based_VBN investigation_NN of_IN the_DT September_NNP 11_CD crimes_NNS would_MD ever_RB take_VB place_NN ._. To_IN this_DT day_NN the_DT Global_JJ War_NN on_IN Terror_NN continues_VBZ to_TO unfold_VB on_IN a_DT foundation_NN of_IN lies_NNS and_CC illusions_NNS that_WDT have_VBP had_VBN devastating_JJ consequences_NNS for_IN the_DT quality_NN of_IN life_NN for_IN average_JJ people_NNS throughout_IN the_DT United_NNP States_NNPS and_CC the_DT world_NN ._. In_IN his_PRP$ 2005_CD book_NN ,_, Biowarfare_NNP and_CC Terrorism_NNP ,_, Prof_NNP ._. Boyle_NNP ’s_POS analysis_NN pointed_VBD to_IN major_JJ problems_NNS in_IN the_DT FBI_NNP ’s_POS investigation_NN of_IN the_DT anthrax_NN attacks_NNS including_VBG the_DT agency_NN ’s_POS destruction_NN of_IN relevant_JJ evidence_NN ._. To_IN Prof_NNP ._. Boyle_NNP ,_, the_DT highly_RB refined_VBN military_JJ -_HYPH grade_NN quality_NN of_IN the_DT anthrax_NN made_VBD it_PRP almost_RB certain_JJ that_IN the_DT anthrax_NN bioweapon_NN was_VBD produced_VBN within_IN the_DT US_NNP Armed_JJ Forces_NNS at_IN the_DT lab_NN in_IN Fort_NNP Detrick_NNP Maryland_NNP ._. Anthrax_NN ,_, or_CC Bacillus_NN anthracis_NN ,_, is_VBZ a_DT rod_NN -_HYPH shaped_VBN bacteria_NN found_VBN naturally_RB in_IN soil_NN ._. Looking_VBG back_RB at_IN the_DT episode_NN Dr._NNP Boyle_NNP observed_VBD ,_, “_`` The_DT Pentagon_NNP and_CC the_DT C.I.A._NNP are_VBP ready_JJ ,_, willing_JJ ,_, and_CC able_JJ to_TO launch_VB biowarfare_NN when_WRB it_PRP suits_VBZ their_PRP$ interests_NNS ._. They_PRP already_RB attacked_VBD the_DT American_NNP People_NNP and_CC Congress_NNP and_CC disabled_VBD our_PRP$ Republic_NNP with_IN super_RB -_HYPH weapons_NNS -_HYPH grade_NN anthrax_NN in_IN October_NNP 2001_CD ._. ”_'' Prof_NNP ._. Boyle_NNP ’s_POS interpretation_NN was_VBD later_RB verified_VBN and_CC expanded_VBN upon_IN in_IN a_DT book_NN by_IN Canadian_NNP Prof._NNP Graeme_NNP MacQueen_NNP ._. Prof_NNP ._. Boyle_NNP acknowledges_VBZ the_DT veracity_NN of_IN Prof._NNP MacQueen_NNP ’s_POS study_NN of_IN the_DT anthrax_NN deception_NN as_IN part_NN of_IN a_DT “_`` domestic_JJ conspiracy_NN ._. ”_'' He_PRP sees_VBZ The_DT 2001_CD Anthrax_NN Deception_NN as_IN the_DT most_RBS advanced_JJ finding_NN of_IN academic_JJ research_NN on_IN the_DT topic_NN so_RB far_RB ._. Prof._NNP MacQueen_NNP is_VBZ prominent_JJ among_IN a_DT very_RB large_JJ group_NN of_IN academics_NNS and_CC public_JJ officials_NNS who_WP condemn_VBP the_DT official_JJ narrative_NN of_IN 9/11_CD for_IN its_PRP$ dramatic_JJ inconsistencies_NNS with_IN the_DT available_JJ evidence_NN ._. Those_DT who_WP share_VBP this_DT understanding_NN include_VBP former_JJ Italian_JJ Prime_NNP Minister_NNP Francesco_NNP Cossiga_NNP ,_, former_JJ German_JJ Defence_NNP Minister_NNP Andreas_NNP von_NNP Bülow_NNP ,_, former_JJ UK_NNP Minister_NNP of_IN the_DT Environment_NNP Michael_NNP Meacher_NNP ,_, former_JJ Assistant_NNP Secretary_NNP of_IN the_DT US_NNP Treasury_NNP Paul_NNP Craig_NNP Roberts_NNP ,_, former_JJ Director_NNP of_IN the_DT US_NNP Star_NNP Wars_NNPS Missile_NNP Defense_NNP Program_NNP Lt._NNP Col._NNP Bob_NNP Bowman_NNP ,_, Princeton_NNP International_NNP Law_NNP Professor_NNP Richard_NNP Falk_NNP ,_, and_CC the_DT author_NN of_IN ten_CD academic_JJ books_NNS on_IN different_JJ aspects_NNS of_IN the_DT 9/11_CD debacle_NN ,_, Claremont_NNP Graduate_NNP University_NNP Professor_NNP David_NNP Ray_NNP Griffin_NNP ._. Prof._NNP Francis_NNP Boyle_NNP shared_VBD the_DT 9/11_CD skepticism_NN of_IN many_JJ when_WRB he_PRP asked_VBD ,_, In_IN his_PRP$ coverage_NN of_IN the_DT Wuhan_NNP Coronavirus_NNP epidemic_NN ,_, Spiro_NNP Skouras_NNP highlighted_VBD the_DT proceedings_NNS known_VBN as_IN Event_NN 201_CD ._. Event_NN 201_CD brought_VBD together_RB in_IN New_NNP York_NNP on_IN October_NNP 18_CD ,_, 2019_CD an_DT assembly_NN of_IN delegates_NNS hosted_VBN by_IN the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, the_DT World_NNP Economic_NNP Forum_NNP and_CC the_DT Johns_NNP Hopkins_NNP Center_NNP for_IN Health_NNP Security_NNP ._. The_DT gathering_NN anticipated_VBD the_DT COVID_NNP -_HYPH 19_CD crisis_NN by_IN just_RB a_DT few_JJ weeks_NNS ._. I_PRP retrospect_VBP it_PRP is_VBZ almost_RB as_IN if_IN Event_NN 201_CD announced_VBD many_JJ of_IN the_DT controversies_NNS about_IN to_TO arise_VB with_IN the_DT outbreak_NN of_IN the_DT real_JJ epidemic_NN in_IN Wuhan_NNP China_NNP ._. Event_NN 201_CD performed_VBD functions_NNS similar_JJ to_IN those_DT of_IN the_DT drills_NNS that_WDT frequently_RB mimic_VBP the_DT engineered_VBN scenarios_NNS animating_VBG false_JJ flag_NN terror_NN events_NNS but_CC especially_RB those_DT of_IN 9/11_CD ._. A_DT major_JJ subject_NN of_IN the_DT meeting_NN highlighted_VBD the_DT perceived_VBN need_NN to_TO control_VB communications_NNS during_IN an_DT epidemic_NN ._. Levan_NNP Thiru_NNP of_IN the_DT Monetary_NNP Authority_NNP of_IN Singapore_NNP went_VBD as_RB far_RB as_IN to_TO call_VB for_IN “_`` a_DT step_NN up_RP on_IN the_DT part_NN of_IN governments_NNS to_TO take_VB action_NN against_IN Fake_NNP News_NNP ._. ”_'' Thiru_NNP called_VBD for_IN recriminatory_JJ litigation_NN aimed_VBN at_IN criminalizing_VBG “_`` bad_JJ actors_NNS ._. ”_'' Cautioning_VBG against_IN this_DT kind_NN of_IN censorship_NN ,_, Skouras_NNP asked_VBD ,_, Who_WP is_VBZ going_VBG to_TO decide_VB what_WP constitutes_VBZ “_`` Fake_JJ News_NN ”_'' ?_. If_IN fact_NN checkers_NNS are_VBP to_TO be_VB employed_VBN ,_, “_`` who_WP will_MD fact_VB check_VB the_DT fact_NN checkers_NNS ”_'' ?_. Hasti_NNP Taghi_NNP ,_, a_DT media_NN executive_NN with_IN NBC_NNP Universal_NNP in_IN New_NNP York_NNP ,_, was_VBD especially_RB outspoken_JJ in_IN condemning_VBG the_DT activities_NNS of_IN “_`` conspiracy_NN theorists_NNS ”_'' that_WDT have_VBP organized_VBN themselves_PRP to_TO question_VB the_DT motives_NNS and_CC methods_NNS of_IN the_DT complex_NN of_IN agencies_NNS involved_VBN in_IN developing_VBG and_CC disseminating_VBG vaccines_NNS ._. She_PRP frequently_RB condemned_VBD the_DT role_NN of_IN “_`` conspiracy_NN theories_NNS ”_'' in_IN energizing_VBG public_JJ distrust_NN of_IN the_DT role_NN of_IN pharmaceutical_JJ companies_NNS and_CC media_NN conglomerates_NNS in_IN their_PRP$ interactions_NNS with_IN government_NN ._. Tom_NNP Ingelsby_NNP of_IN the_DT Johns_NNP Hopkins_NNP Center_NNP for_IN Health_NNP Security_NNP injected_VBD an_DT interesting_JJ twist_NN into_IN the_DT discussion_NN ._. He_PRP asked_VBD ,_, “_`` How_WRB much_JJ control_NN of_IN information_NN should_MD there_EX be_VB ?_. By_IN whom_WP should_MD control_NN of_IN information_NN be_VB exercised_VBN ?_. How_WRB can_MD false_JJ information_NN be_VB effectively_RB challenged_VBN ?_. ”_'' Ingelsby_NNP then_RB added_VBD ,_, “_`` What_WP happens_VBZ if_IN the_DT false_JJ information_NN is_VBZ coming_VBG from_IN companies_NNS and_CC governments_NNS ?_. ”_'' This_DT final_JJ question_NN encapsulates_VBZ a_DT major_JJ problem_NN for_IN conscientious_JJ citizens_NNS trying_VBG to_TO find_VB their_PRP$ way_NN through_IN the_DT corruption_NN and_CC disinformation_NN that_WDT often_RB permeates_VBZ our_PRP$ key_JJ institutions_NNS ._. Those_DT that_WDT try_VBP to_TO counter_VB the_DT problem_NN that_WDT governments_NNS and_CC corporations_NNS sometimes_RB peddle_VBP false_JJ information_NN can_MD pretty_RB much_RB expect_VB to_TO face_VB accusations_NNS that_IN they_PRP are_VBP “_`` conspiracy_NN theorists_NNS ._. ”_'' Too_RB often_RB the_DT calculations_NNS involved_VBN in_IN deciding_VBG whom_WP or_CC what_WP is_VBZ credible_JJ (_-LRB- or_CC not_RB )_-RRB- depends_VBZ primarily_RB on_IN simple_JJ arithmetic_NN favouring_VBG the_DT preponderance_NN of_IN wealth_NN and_CC power_NN ._. Spiro_NNP Skouras_NNP gives_VBZ careful_JJ consideration_NN to_IN the_DT possibility_NN that_IN the_DT United_NNP States_NNPS instigated_VBD the_DT COVID_NNP -_HYPH 19_CD epidemic_NN starting_VBG in_IN Wuhan_NNP China_NNP ._. He_PRP notes_VBZ the_DT precedent_NN set_VBN in_IN 1945_CD on_IN the_DT atomic_JJ attacks_NNS by_IN the_DT US_NNP government_NN on_IN the_DT civilian_JJ populations_NNS of_IN Hiroshima_NNP and_CC Nagasaki_NNP ._. Skouras_NNP points_VBZ out_RP that_IN there_EX is_VBZ proof_NN that_IN since_IN the_DT Second_NNP World_NNP War_NNP ,_, the_DT US_NNP government_NN has_VBZ conducted_VBN at_IN least_JJS 239_CD experiments_NNS ,_, secretly_RB deploying_VBG toxic_JJ chemical_JJ and_CC biological_JJ agents_NNS against_IN portions_NNS of_IN its_PRP$ own_JJ population_NN ._. On_IN the_DT history_NN of_IN US_NNP involvement_NN in_IN biological_JJ warfare_NN see_VB here_RB ,_, here_RB and_CC here_RB ._. Skouras_NNP highlights_VBZ the_DT window_NN presented_VBN for_IN a_DT covert_JJ US_NNP bioweapon_NN attack_NN at_IN the_DT World_NNP Military_NNP Games_NNP in_IN Wuhan_NNP China_NNP in_IN the_DT second_JJ half_NN of_IN October_NNP of_IN 2019_CD ._. He_PRP notes_VBZ that_IN 300_CD US_NNP soldiers_NNS participated_VBD as_IN athletes_NNS in_IN the_DT Wuhan_NNP Military_NNP Games_NNPS together_RB with_IN a_DT large_JJ contingent_NN of_IN American_JJ support_NN personnel_NNS ._. The_DT timing_NN and_CC the_DT circumstances_NNS of_IN the_DT event_NN were_VBD more_RBR or_CC less_RBR ideal_JJ to_TO open_VB up_RP a_DT new_JJ pathogenic_JJ front_NN in_IN the_DT US_NNP government_NN ’s_POS informal_JJ “_`` hybrid_JJ war_NN ”_'' against_IN China_NNP ._. On_IN Feb._NNP 15_CD at_IN the_DT Munich_NNP Security_NNP Conference_NNP ,_, US_NNP Defence_NNP Secretary_NNP ,_, Mark_NNP T._NNP Esper_NNP ,_, developed_VBD a_DT highly_RB critical_JJ characterization_NN of_IN Chinese_JJ wrongdoing_NN in_IN order_NN to_TO seemingly_RB justify_VB recriminatory_JJ actions_NNS ._. Esper_NNP asserted_VBD ,_, “_`` China_NNP ’s_POS growth_NN over_IN the_DT years_NNS has_VBZ been_VBN remarkable_JJ ,_, but_CC in_IN many_JJ ways_NNS it_PRP is_VBZ fuelled_VBN by_IN theft_NN ,_, coercion_NN ,_, and_CC exploitation_NN of_IN free_JJ market_NN economies_NNS ,_, private_JJ companies_NNS ,_, and_CC colleges_NNS and_CC universities_NNS …_. Huawei_NNP and_CC 5G_NNP are_VBP today_NN ’s_POS poster_NN child_NN for_IN this_DT nefarious_JJ activity_NN ._. The_DT US_NNP antagonism_NN to_IN Huawei_NNP ’s_POS leadership_NN in_IN the_DT design_NN and_CC worldwide_JJ dissemination_NN of_IN 5_CD G_NN technology_NN might_MD well_RB be_VB a_DT factor_NN in_IN the_DT scandal_NN generated_VBN by_IN the_DT Chinese_JJ connection_NN to_IN intertwined_VBN research_NN in_IN microbiology_NN at_IN the_DT level_NN 4_CD labs_NNS in_IN Winnipeg_NNP and_CC Wuhan_NNP ._. Back_RB in_IN 2000_CD the_DT notorious_JJ report_NN entitled_VBN Rebuilding_NNP America_NNP ’s_POS Defenses_NNPS ,_, a_DT publication_NN brought_VBN forward_RB by_IN the_DT neoconservative_JJ Project_NNP for_IN the_DT New_NNP American_NNP Century_NNP (_-LRB- PNAC_NNP )_-RRB- ,_, proposed_VBD that_IN the_DT US_NNP government_NN should_MD refurbish_VB and_CC invoke_VB its_PRP$ capacity_NN to_TO wage_VB biological_JJ warfare_NN ._. PNAC_NNP was_VBD the_DT think_NN tank_NN that_WDT anticipated_VBD the_DT events_NNS of_IN September_NNP 11_CD ,_, 2001_CD by_IN outlining_VBG a_DT strategic_JJ scheme_NN that_WDT could_MD only_RB be_VB realized_VBN by_IN mobilizing_VBG American_JJ public_JJ opinion_NN with_IN “_`` a_DT catalytic_JJ event_NN like_IN a_DT New_NNP Pearl_NNP Harbor_NNP ._. ”_'' After_IN 9/11_CD ,_, the_DT PNAC_NNP Team_NN of_IN related_JJ neoconservative_JJ activists_NNS and_CC Zionist_JJ organizations_NNS pretty_RB much_RB took_VBD over_RP the_DT governance_NN of_IN the_DT United_NNP States_NNPS along_IN with_IN the_DT build_NN up_RP and_CC deployment_NN of_IN its_PRP$ formidable_JJ war_NN machine_NN ._. PNAC_NNP called_VBD for_IN the_DT invocation_NN of_IN “_`` advanced_JJ forms_NNS of_IN biological_JJ warfare_NN that_WDT can_MD ‘_`` target_VB ’_POS specific_JJ genotypes_NNS ._. ”_'' In_IN this_DT fashion_NN “_`` biological_JJ warfare_NN might_MD be_VB transformed_VBN into_IN a_DT politically_RB useful_JJ tool_NN ._. ”_'' The_DT relationship_NN of_IN this_DT pandemic_NN to_IN internal_JJ disagreements_NNS within_IN China_NNP has_VBZ been_VBN put_VBN on_IN full_JJ display_NN in_IN Steve_NNP Bannon_NNP ’s_POS coverage_NN of_IN the_DT crisis_NN entitled_VBN War_NNP Room_NNP :_: Pandemic_NNP ._. A_DT prominent_JJ member_NN of_IN US_NNP President_NNP Donald_NNP Trump_NNP ’s_POS inner_JJ circle_NN ,_, Steve_NNP Bannon_NNP is_VBZ often_RB accompanied_VBN on_IN the_DT daily_JJ show_NN by_IN Chinese_JJ billionaire_NN dissident_NN ,_, Miles_NNP Guo_NNP (_-LRB- aka_RB Guo_NNP Wengui_NNP ,_, Miles_NNP Haoyun_NNP ,_, Miles_NNP Kwok_NNP )_-RRB- ._. Guo_NNP is_VBZ an_DT outspoken_JJ Chinese_JJ refugee_NN ._. He_PRP is_VBZ a_DT persistent_JJ critic_NN of_IN virtually_RB every_DT facet_NN of_IN the_DT policies_NNS and_CC actions_NNS of_IN the_DT Chinese_NNP Communist_NNP Party_NNP ._. Guo_NNP regularly_RB condemns_VBZ those_DT who_WP dominate_VBP China_NNP ’s_POS one_CD -_HYPH party_NN system_NN ,_, a_DT system_NN run_VBN by_IN an_DT elite_NN who_WP ,_, he_PRP alleges_VBZ ,_, are_VBP corrupt_JJ ,_, incompetent_JJ and_CC inveterate_JJ liars_NNS ._. Guo_NNP regularly_RB asserts_VBZ that_IN all_DT of_IN the_DT Chinese_JJ government_NN ’s_POS numbers_NNS on_IN the_DT pandemic_NN ,_, including_VBG death_NN rates_NNS and_CC infection_NN rates_NNS ,_, can_MD probably_RB be_VB multiplied_VBN by_IN 10X_CD or_CC even_RB 100X_CD to_TO get_VB closer_JJR to_IN accuracy_NN ._. [_-LRB- On_IN the_DT 10X_NN guestimate_NN of_IN mortality_NN and_CC infection_NN see_VB this_DT ._. ]_-RRB- Clearly_RB Bannon_NNP and_CC Guo_NNP would_MD like_VB to_TO see_VB the_DT emergency_NN conditions_NNS created_VBN by_IN the_DT pandemic_NN as_IN a_DT wedge_NN of_IN division_NN ,_, protest_NN and_CC regime_NN change_NN within_IN China_NNP ._. One_CD of_IN the_DT subjects_NNS they_PRP regularly_RB raise_VBP ,_, as_IN do_VB others_NNS who_WP accuse_VBP the_DT Chinese_JJ government_NN of_IN systematic_JJ lying_NN and_CC deception_NN ,_, is_VBZ that_IN the_DT crematoriums_NNS in_IN Wuhan_NNP and_CC nearby_JJ Chongqing_NNP are_VBP burning_VBG corpses_NNS of_IN dead_JJ people_NNS at_IN a_DT rate_NN far_RB higher_JJR than_IN official_JJ death_NN figures_NNS ._. Some_DT reports_NNS indicated_VBD that_IN portable_JJ incinerators_NNS were_VBD being_VBG brought_VBN into_IN the_DT most_RBS infected_VBN core_NN of_IN the_DT Wuhan_NNP Coronavirus_NNP epidemic_NN ._. It_PRP is_VBZ troubling_JJ ,_, to_TO say_VB the_DT least_JJS ,_, that_IN some_DT reports_NNS indicate_VBP dead_JJ people_NNS are_VBP being_VBG cremated_VBN far_RB faster_JJR and_CC at_IN far_RB higher_JJR rates_NNS than_IN the_DT Chinese_JJ government_NN and_CC the_DT World_NNP Health_NNP Organization_NNP are_VBP reporting_VBG ._. Some_DT reckoning_NN with_IN the_DT apparent_JJ disparity_NN between_IN reported_VBN and_CC actual_JJ deaths_NNS has_VBZ led_VBN to_IN widespread_JJ suspicions_NNS about_IN what_WP is_VBZ actually_RB going_VBG in_IN the_DT scenes_NNS of_IN violent_JJ and_CC angry_JJ exchanges_NNS between_IN people_NNS in_IN the_DT Wuhan_NNP area_NN ._. Many_JJ of_IN these_DT videos_NNS show_VBP brutal_JJ confrontations_NNS between_IN Chinese_JJ civilians_NNS and_CC Chinese_JJ security_NN police_NN ._. The_DT displays_NNS of_IN desperation_NN by_IN some_DT of_IN those_DT trying_VBG to_TO escape_VB apprehensions_NNS by_IN uniformed_JJ officials_NNS seem_VBP sometimes_RB to_TO suggest_VB the_DT severity_NN of_IN a_DT life_NN or_CC death_NN struggle_NN ._. It_PRP is_VBZ made_VBN to_TO seem_VB that_IN those_DT seeking_VBG to_TO escape_VB the_DT grip_NN of_IN authorities_NNS are_VBP aware_JJ that_IN their_PRP$ failure_NN to_TO do_VB so_RB might_MD lead_VB to_IN a_DT quick_JJ death_NN and_CC a_DT quick_JJ exit_NN by_IN incineration_NN ._. These_DT reflections_NNS are_VBP ,_, of_IN course_NN ,_, speculative_JJ rather_RB than_IN definitive_JJ ._. Questions_NNS concerning_VBG who_WP we_PRP are_VBP supposed_VBN to_TO believe_VB or_CC not_RB in_IN this_DT crisis_NN are_VBP becoming_VBG ever_RB more_RBR pressing_JJ and_CC volatile_JJ ._. One_CD of_IN the_DT emerging_VBG themes_NNS in_IN the_DT discourse_NN developed_VBN at_IN War_NNP Room_NNP :_: Pandemic_NNP is_VBZ the_DT propensity_NN of_IN some_DT of_IN the_DT core_NN agencies_NNS of_IN mainstream_JJ media_NN in_IN the_DT United_NNP States_NNPS to_TO accept_VB at_IN face_NN value_NN the_DT reports_NNS they_PRP receive_VBP from_IN official_JJ media_NN outlets_NNS answering_VBG to_IN the_DT Chinese_NNP Communist_NNP Party_NNP ._. To_IN Banning_NNP and_CC Guo_NNP this_DT pattern_NN makes_VBZ media_NN organizations_NNS like_IN the_DT New_NNP York_NNP Times_NNP ,_, The_DT Washington_NNP Post_NNP ,_, and_CC CNN_NNP essentially_RB propaganda_NN extensions_NNS of_IN the_DT Chinese_JJ government_NN ._. The_DT Chinese_JJ people_NNS themselves_PRP are_VBP clearly_RB grappling_VBG in_IN new_JJ ways_NNS with_IN the_DT problem_NN of_IN how_WRB to_TO understand_VB the_DT information_NN and_CC directives_NNS given_VBN them_PRP by_IN the_DT governing_VBG apparatus_NN of_IN the_DT Chinese_NNP Communist_NNP Party_NNP ._. Clearly_RB the_DT Party_NNP initially_RB failed_VBD the_DT people_NNS by_IN not_RB intervening_VBG early_RB and_CC decisively_RB enough_RB after_IN the_DT first_JJ cases_NNS of_IN Coronavirus_NN illness_NN began_VBD to_TO show_VB up_RP ._. The_DT exit_NN from_IN Wuhan_NNP of_IN almost_RB five_CD million_CD people_NNS in_IN prior_JJ to_IN the_DT Chinese_JJ Lunar_NNP New_NNP Year_NNP celebrations_NNS had_VBD huge_JJ implications_NNS for_IN spreading_VBG the_DT contagion_NN ._. As_IN noted_VBN in_IN the_DT introduction_NN ,_, the_DT death_NN in_IN Wuhan_NNP of_IN Dr._NNP Li_NNP Wenliang_NNP on_IN 7_CD February_NNP has_VBZ become_VBN a_DT flash_NN point_NN for_IN popular_JJ criticism_NN of_IN the_DT Chinese_NNP Communist_NNP Party_NNP led_VBN by_IN General_NNP Secretary_NNP Xi_NNP Jinping_NNP ._. Dr._NNP Li_NNP wrote_VBD to_IN members_NNS of_IN his_PRP$ medical_JJ school_NN alumnus_NN group_NN suggesting_VBG that_IN some_DT significant_JJ action_NN should_MD be_VB taken_VBN in_IN response_NN to_IN the_DT appearance_NN of_IN SARS_NN -_HYPH like_JJ symptoms_NNS that_WDT suddenly_RB afflicted_VBD his_PRP$ patients_NNS ._. For_IN sending_VBG out_RP this_DT unauthorized_JJ communication_NN ,_, Dr._NNP Li_NNP was_VBD summoned_VBN along_IN with_IN seven_CD other_JJ supposed_VBN offenders_NNS to_IN the_DT Public_NNP Security_NNP Bureau_NNP ._. There_RB he_PRP was_VBD warned_VBN by_IN police_NNS to_TO stop_VB “_`` making_VBG false_JJ statements_NNS ._. ”_'' He_PRP was_VBD ordered_VBN to_TO cease_VB and_CC desist_VB “_`` spreading_VBG rumors_NNS ,_, ”_'' and_CC “_`` acting_VBG illegally_RB to_TO disturb_VB social_JJ order_NN ._. ”_'' Dr._NNP Li_NNP signed_VBD a_DT form_NN indicating_VBG he_PRP would_MD refrain_VB from_IN continuing_VBG to_TO do_VB what_WP he_PRP had_VBD been_VBN accused_VBN of_IN doing_VBG ._. The_DT chastised_VBN professional_NN returned_VBD to_IN his_PRP$ medical_JJ practice_NN ._. He_PRP took_VBD his_PRP$ own_JJ advice_NN and_CC began_VBD treating_VBG patients_NNS exhibiting_VBG signs_NNS of_IN the_DT new_JJ illness_NN ._. He_PRP himself_PRP soon_RB died_VBD from_IN COVID_NNP -_HYPH 19_CD when_WRB it_PRP was_VBD still_RB known_VBN as_IN 19_CD -_HYPH nCoV_NNP ._. Is_VBZ Twitter_NNP ’s_POS permanent_JJ deplatforming_NN of_IN the_DT Zero_NNP Hedge_NN web_NN site_NN a_DT North_NNP American_JJ version_NN of_IN the_DT police_NN intervention_NN in_IN China_NNP with_IN the_DT goal_NN of_IN silencing_VBG Dr._NNP Li_NNP ?_. Is_VBZ the_DT censorship_NN of_IN the_DT Internet_NNP in_IN the_DT name_NN of_IN opposing_VBG “_`` conspiracy_NN theorists_NNS ”_'' repeating_VBG the_DT Chinese_NNP Communist_NNP Party_NNP ’s_POS effort_NN to_TO silence_VB Dr._NNP Li_NNP ?_. Is_VBZ Dr._NNP Li_NNP to_TO be_VB appropriately_RB understood_VBN as_IN a_DT Chinese_JJ version_NN of_IN a_DT “_`` conspiracy_NN theorist_NN ”_'' ?_. How_WRB different_JJ was_VBD his_PRP$ treatment_NN for_IN allegedly_RB “_`` spreading_VBG rumours_NNS ”_'' and_CC “_`` acting_VBG illegally_RB to_TO disturb_VB social_JJ order_NN ”_'' from_IN the_DT treatment_NN of_IN those_DT in_IN the_DT Occident_NNP who_WP have_VBP been_VBN deplatformed_VBN ,_, smeared_VBN and_CC professionally_RB defrocked_VBN for_IN attempting_VBG to_TO speak_VB truth_NN to_TO power_NN ?_. I_PRP have_VBP developed_VBN responses_NNS to_IN these_DT incursions_NNS based_VBN on_IN hard_RB -_HYPH won_VBN experiences_NNS facing_VBG the_DT propaganda_NN blows_NNS of_IN an_DT especially_RB powerful_JJ political_JJ lobby_NN able_JJ to_TO seize_VB control_NN of_IN the_DT governing_VBG board_NN of_IN my_PRP$ university_NN ._. These_DT professional_JJ lobbyists_NNS seek_VBP to_TO discredit_VB academic_JJ analysis_NN of_IN their_PRP$ own_JJ violations_NNS of_IN law_NN ,_, ethics_NN and_CC civility_NN by_IN labelling_VBG critics_NNS of_IN their_PRP$ zealotry_NN as_IN “_`` conspiracy_NN theorists_NNS ”_'' or_CC worse_JJR ._. More_RBR recently_RB I_PRP have_VBP been_VBN grappling_VBG against_IN a_DT variation_NN on_IN this_DT process_NN in_IN trying_VBG to_TO counter_VB the_DT censorious_JJ attacks_NNS on_IN the_DT American_NNP Herald_NNP Tribune_NNP ._. These_DT assaults_NNS on_IN free_JJ expression_NN and_CC open_JJ debate_NN began_VBD with_IN the_DT machinations_NNS of_IN military_JJ hawks_NNS whose_WP$ hit_VBD job_NN instructions_NNS were_VBD passed_VBN along_RB to_IN the_DT disinformation_NN specialists_NNS at_IN CNN_NNP and_CC the_DT Washington_NNP Post_NNP ._. No_DT one_NN can_MD say_VB for_IN sure_JJ where_WRB the_DT Wuhan_NNP Coronavirus_NNP epidemic_NN is_VBZ taking_VBG the_DT world_NN ._. Wherever_WRB we_PRP are_VBP headed_VBN ,_, however_RB ,_, we_PRP are_VBP leaving_VBG behind_IN an_DT era_NN that_WDT can_MD never_RB be_VB recreated_VBN ._. Whatever_WP happened_VBD to_TO originate_VB the_DT contagion_NN ,_, this_DT crisis_NN is_VBZ forcing_VBG us_PRP to_TO take_VB stock_NN of_IN the_DT framework_NN of_IN biological_JJ warfare_NN as_IN it_PRP has_VBZ been_VBN developing_VBG in_IN China_NNP ,_, Russia_NNP ,_, Israel_NNP and_CC probably_RB many_JJ other_JJ countries_NNS ._. Nowhere_RB ,_, however_RB ,_, is_VBZ biological_JJ warfare_NN being_VBG more_RBR expansively_RB and_CC expensively_RB developed_VBN and_CC probably_RB deployed_VBN than_IN by_IN the_DT US_NNP Armed_JJ Forces_NNS ._. The_DT death_NN and_CC destruction_NN that_WDT humanity_NN is_VBZ presently_RB experiencing_VBG should_MD signal_VB to_IN us_PRP that_IN it_PRP is_VBZ time_NN to_TO get_VB much_RB more_RBR serious_JJ about_IN inspecting_VBG military_JJ facilities_NNS and_CC enforcing_VBG the_DT terms_NNS of_IN the_DT Biological_NNP Warfare_NNP Convention_NNP of_IN 1972_CD ._. It_PRP is_VBZ ,_, in_IN fact_NN ,_, time_NN to_TO get_VB much_RB more_RBR serious_JJ about_IN enforcing_VBG all_DT aspects_NNS of_IN international_JJ criminal_JJ law_NN in_IN balanced_VBN ways_NNS that_WDT transcend_VBP the_DT biases_NNS of_IN Victors_NNPS ’_POS Justice_NN ._. It_PRP is_VBZ time_NN to_TO throw_VB off_RP the_DT weight_NN of_IN the_DT pseudo_NN -_HYPH laws_NNS introduced_VBN after_IN 9/11_CD through_IN abhorrent_JJ tactics_NNS like_IN the_DT inside_JJ -_HYPH job_NN military_JJ anthrax_NN attack_NN on_IN Congress_NNP ._. Most_JJS certainly_RB ,_, it_PRP is_VBZ time_NN to_TO draw_VB a_DT clear_JJ distinction_NN between_IN research_NN in_IN the_DT field_NN of_IN public_JJ health_NN and_CC research_NN in_IN the_DT development_NN of_IN lethal_JJ bioweapons_NNS ._. Better_RBR yet_RB ,_, we_PRP should_MD work_VB towards_IN putting_VBG an_DT end_NN altogether_RB to_IN militarization_NN through_IN the_DT massive_JJ expansion_NN of_IN the_DT ""_`` death_NN sciences_NNS ._. ""_'' The_DT vile_JJ activities_NNS of_IN fallen_VBN practitioners_NNS of_IN the_DT endangered_JJ life_NN sciences_NNS are_VBP ,_, for_IN starters_NNS ,_, undermining_VBG the_DT integrity_NN of_IN our_PRP$ besieged_VBN institutions_NNS of_IN higher_JJR learning_NN ._.","NN 5 : The NNP NNP NNP NNPS Its JJ NN by VBG ‘ NNP NNPS ’ and ‘ NNPS ’ NNP NNP , JJ JJ NN at NNP , VBZ VBN as one of the RBR VBG and JJ of the JJ JJ NNS who VBP VBN VBG into the NNP NNP NN . NNP VBZ VBN the NN of JJ JJ NNS that VBP VBN the JJ NN that the NN of NN - 19 NN VBD a JJ NN in NNP ’s JJ - NN NN NN . NNP VBZ VBN it would VB “ JJ ” for NNS to VB from VBG “ the JJ NN of NNS ” on how the NN VBD and how it VBD . Among the JJ NNS , NNP VBD on the NN VBD NNP NNP , the JJ NN of JJ NN at the NNP of NNP . NNP NNP VBD the NNP NNPS and NNP NNP , NN that VBD NNP NN of the NNP ’s NNP NNP NNP in 1990 . NNP . NNP VBD in his NN with NNP that NNP - 19 VBZ RBS RB a RB - VBN NN that VBD from the RB - VBN NNP NNP in NNP . NNP . NNP VBD , NNP . NNP VBZ to the NN that the NNP NN VBD out from a NNP NN in 2004 . He VBZ as “ NN ” the RB VBN NN that NNP - 19 VBD in NNP ’s JJ , JJ - NN NN NN . NNP . NNP VBD some of his NNS in a JJ NN VBN by NNP . NNP RB VBD NNP NNP about his NN with JJ NN VBN his NN as one of the JJS JJ NNS on JJ NN and JJ NN VBG the NN of NN in the NNP NNPS . NNP NNP VBD that he VBD RB RB VBN from VBG on the NN of JJ NN RB since he RB VBD his NN of the NN NNS on two NNP NNPS in NNP of 2001 . There VBZ VBN JJ JJ NN of the NN NNS VBG the NNP NNP and some NN NNS in JJ NNP of 2001 . The NN NNS VBP the RBS JJ NN RB on the NNS of the NNP NNP , the JJ NN between NN and NNS in the NNP NNPS . These NNS VBP VBN to VB VBN as an JJ NN of the JJ NN of NNS VBN in NNP and NNP NNP on 9/11 . The NN NNS VBD five NNS VBG two JJ NNS . Seventeen NNS VBD VBN and NNP VBD VBN down for a JJ NNS . NN - JJ NN NNS VBD RB VBN at two NNP NNP NNPS , NNP NNP and NNP NNP . When they VBD the VBN NNS both NNS VBD VBN in NN NNS of the NN - 9/11 NN NNS NN VBN as the NNP NNP . Both NNPS NNP and NNP VBD JJ to NN VB the NN that VBD RB RB VBN and VBN before NNP within three NNS of the 9/11 NN . The NN NNS VBD NN RB as the NNP JJ NNS VBD VBG NNP where the NNS of the 9/11 NNS VBD VBN to VB VBG out . The NNS of the NN NN , who we VBD VBN to VB at the NN as NNP - NNP NNS , VBD in VBG aside the JJ NN of NN to the NNP NNP ’s JJ NN in JJ NNP . Why , one might RB VB , VB , would JJ NNS VB the NNP NNP to VB VBN through NNP . In JJ NNP the NNP JJ NNS VBD NNP at the JJ NN that the NNP JJ NN VBD VBG with the NNP a NN to VB and VB and VB without any NNS of NN . Once the NNP JJ NNS VBD to NN with NNP on the NN of a JJ NN of 9/11 ’s NN , there VBD RB no NN that a JJ and JJ NN - VBN NN of the NNP 11 NNS would RB VB NN . To this NN the JJ NN on NN VBZ to VB on a NN of NNS and NNS that VBP VBN JJ NNS for the NN of NN for JJ NNS throughout the NNP NNPS and the NN . In his 2005 NN , NNP and NNP , NNP . NNP ’s NN VBD to JJ NNS in the NNP ’s NN of the NN NNS VBG the NN ’s NN of JJ NN . To NNP . NNP , the RB VBN JJ - NN NN of the NN VBD it RB JJ that the NN NN VBD VBN within the NNP JJ NNS at the NN in NNP NNP NNP . NN , or NN NN , VBZ a NN - VBN NN VBN RB in NN . VBG RB at the NN NNP NNP VBD , “ The NNP and the NNP VBP JJ , JJ , and JJ to VB NN when it VBZ their NNS . They RB VBD the NNP NNP and NNP and VBD our NNP with RB - NNS - NN NN in NNP 2001 . ” NNP . NNP ’s NN VBD RB VBN and VBN upon in a NN by NNP NNP NNP NNP . NNP . NNP VBZ the NN of NNP NNP ’s NN of the NN NN as NN of a “ JJ NN . ” He VBZ The 2001 NN NN as the RBS JJ NN of JJ NN on the NN RB RB . NNP NNP VBZ JJ among a RB JJ NN of NNS and JJ NNS who VBP the JJ NN of 9/11 for its JJ NNS with the JJ NN . Those who VBP this NN VBP JJ JJ NNP NNP NNP NNP , JJ JJ NNP NNP NNP NNP NNP , JJ NNP NNP of the NNP NNP NNP , JJ NNP NNP of the NNP NNP NNP NNP NNP , JJ NNP of the NNP NNP NNPS NNP NNP NNP NNP NNP NNP NNP , NNP NNP NNP NNP NNP NNP , and the NN of ten JJ NNS on JJ NNS of the 9/11 NN , NNP NNP NNP NNP NNP NNP NNP . NNP NNP NNP VBD the 9/11 NN of JJ when he VBD , In his NN of the NNP NNP NN , NNP NNP VBD the NNS VBN as NN 201 . NN 201 VBD RB in NNP NNP on NNP 18 , 2019 an NN of NNS VBN by the NNP and NNP NNP NNP , the NNP NNP NNP and the NNP NNP NNP for NNP NNP . The NN VBD the NNP - 19 NN by RB a JJ NNS . I VBP it VBZ RB as if NN 201 VBD JJ of the NNS about to VB with the NN of the JJ NN in NNP NNP . NN 201 VBD NNS JJ to those of the NNS that RB VBP the VBN NNS VBG JJ NN NN NNS but RB those of 9/11 . A JJ NN of the NN VBD the VBN NN to VB NNS during an NN . NNP NNP of the NNP NNP of NNP VBD RB RB as to VB for “ a NN up on the NN of NNS to VB NN against NNP NNP . ” NNP VBD for JJ NN VBN at VBG “ JJ NNS . ” VBG against this NN of NN , NNP VBD , Who VBZ VBG to VB what VBZ “ JJ NN ” ? If NN NNS VBP to VB VBN , “ who will VB VB the NN NNS ” ? NNP NNP , a NN NN with NNP NNP in NNP NNP , VBD RB JJ in VBG the NNS of “ NN NNS ” that VBP VBN themselves to VB the NNS and NNS of the NN of NNS VBN in VBG and VBG NNS . She RB VBD the NN of “ NN NNS ” in VBG JJ NN of the NN of JJ NNS and NN NNS in their NNS with NN . NNP NNP of the NNP NNP NNP for NNP NNP VBD an JJ NN into the NN . He VBD , “ How JJ NN of NN should there VB ? By whom should NN of NN VB VBN ? How can JJ NN VB RB VBN ? ” NNP RB VBD , “ What VBZ if the JJ NN VBZ VBG from NNS and NNS ? ” This JJ NN VBZ a JJ NN for JJ NNS VBG to VB their NN through the NN and NN that RB VBZ our JJ NNS . Those that VBP to VB the NN that NNS and NNS RB VBP JJ NN can RB RB VB to VB NNS that they VBP “ NN NNS . ” RB RB the NNS VBN in VBG whom or what VBZ JJ ( or RB ) VBZ RB on JJ NN VBG the NN of NN and NN . NNP NNP VBZ JJ NN to the NN that the NNP NNPS VBD the NNP - 19 NN VBG in NNP NNP . He VBZ the NN VBN in 1945 on the JJ NNS by the NNP NN on the JJ NNS of NNP and NNP . NNP VBZ out that there VBZ NN that since the NNP NNP NNP , the NNP NN VBZ VBN at JJS 239 NNS , RB VBG JJ JJ and JJ NNS against NNS of its JJ NN . On the NN of NNP NN in JJ NN VB RB , RB and RB . NNP VBZ the NN VBN for a JJ NNP NN NN at the NNP NNP NNP in NNP NNP in the JJ NN of NNP of 2019 . He VBZ that 300 NNP NNS VBD as NNS in the NNP NNP NNPS RB with a JJ NN of JJ NN NNS . The NN and the NNS of the NN VBD RBR or RBR JJ to VB up a JJ JJ NN in the NNP NN ’s JJ “ JJ NN ” against NNP . On NNP 15 at the NNP NNP NNP , NNP NNP NNP , NNP NNP NNP , VBD a RB JJ NN of JJ NN in NN to RB VB JJ NNS . NNP VBD , “ NNP ’s NN over the NNS VBZ VBN JJ , but in JJ NNS it VBZ VBN by NN , NN , and NN of JJ NN NNS , JJ NNS , and NNS and NNS … NNP and NNP VBP NN ’s NN NN for this JJ NN . The NNP NN to NNP ’s NN in the NN and JJ NN of 5 NN NN might RB VB a NN in the NN VBN by the JJ NN to VBN NN in NN at the NN 4 NNS in NNP and NNP . RB in 2000 the JJ NN VBN NNP NNP ’s NNPS , a NN VBN RB by the JJ NNP for the NNP NNP NNP ( NNP ) , VBD that the NNP NN should VB and VB its NN to VB JJ NN . NNP VBD the NN NN that VBD the NNS of NNP 11 , 2001 by VBG a JJ NN that could RB VB VBN by VBG JJ JJ NN with “ a JJ NN like a NNP NNP NNP . ” After 9/11 , the NNP NN of JJ JJ NNS and JJ NNS RB RB VBD over the NN of the NNP NNPS along with the NN up and NN of its JJ NN NN . NNP VBD for the NN of “ JJ NNS of JJ NN that can ‘ VB ’ JJ NNS . ” In this NN “ JJ NN might VB VBN into a RB JJ NN . ” The NN of this NN to JJ NNS within NNP VBZ VBN VBN on JJ NN in NNP NNP ’s NN of the NN VBN NNP NNP : NNP . A JJ NN of NNP NNP NNP NNP ’s JJ NN , NNP NNP VBZ RB VBN on the JJ NN by JJ NN NN , NNP NNP ( RB NNP NNP , NNP NNP , NNP NNP ) . NNP VBZ an JJ JJ NN . He VBZ a JJ NN of RB every NN of the NNS and NNS of the NNP NNP NNP . NNP RB VBZ those who VBP NNP ’s one - NN NN , a NN VBN by an NN who , he VBZ , VBP JJ , JJ and JJ NNS . NNP RB VBZ that all of the JJ NN ’s NNS on the NN , VBG NN NNS and NN NNS , can RB VB VBN by 10X or RB 100X to VB JJR to NN . [ On the NN NN of NN and NN VB this . ] RB NNP and NNP would VB to VB the NN NNS VBN by the NN as a NN of NN , NN and NN NN within NNP . One of the NNS they RB VBP , as VB NNS who VBP the JJ NN of JJ NN and NN , VBZ that the NNS in NNP and JJ NNP VBP VBG NNS of JJ NNS at a NN RB JJR than JJ NN NNS . Some NNS VBD that JJ NNS VBD VBG VBN into the RBS VBN NN of the NNP NNP NN . It VBZ JJ , to VB the JJS , that some NNS VBP JJ NNS VBP VBG VBN RB JJR and at RB JJR NNS than the JJ NN and the NNP NNP NNP VBP VBG . Some NN with the JJ NN between VBN and JJ NNS VBZ VBN to JJ NNS about what VBZ RB VBG in the NNS of JJ and JJ NNS between NNS in the NNP NN . JJ of these NNS VBP JJ NNS between JJ NNS and JJ NN NN . The NNS of NN by some of those VBG to VB NNS by JJ NNS VBP RB to VB the NN of a NN or NN NN . It VBZ VBN to VB that those VBG to VB the NN of NNS VBP JJ that their NN to VB RB might VB to a JJ NN and a JJ NN by NN . These NNS VBP , of NN , JJ RB than JJ . NNS VBG who we VBP VBN to VB or RB in this NN VBP VBG RB RBR JJ and JJ . One of the VBG NNS in the NN VBN at NNP NNP : NNP VBZ the NN of some of the NN NNS of JJ NN in the NNP NNPS to VB at NN NN the NNS they VBP from JJ NN NNS VBG to the NNP NNP NNP . To NNP and NNP this NN VBZ NN NNS like the NNP NNP NNP , The NNP NNP , and NNP RB NN NNS of the JJ NN . The JJ NNS themselves VBP RB VBG in JJ NNS with the NN of how to VB the NN and NNS VBN them by the VBG NN of the NNP NNP NNP . RB the NNP RB VBD the NNS by RB VBG RB and RB RB after the JJ NNS of NN NN VBD to VB up . The NN from NNP of RB five million NNS in JJ to the JJ NNP NNP NNP NNS VBD JJ NNS for VBG the NN . As VBN in the NN , the NN in NNP of NNP NNP NNP on 7 NNP VBZ VBN a NN NN for JJ NN of the NNP NNP NNP VBN by NNP NNP NNP NNP . NNP NNP VBD to NNS of his JJ NN NN NN VBG that some JJ NN should VB VBN in NN to the NN of NN - JJ NNS that RB VBD his NNS . For VBG out this JJ NN , NNP NNP VBD VBN along with seven JJ VBN NNS to the NNP NNP NNP . RB he VBD VBN by NNS to VB “ VBG JJ NNS . ” He VBD VBN to VB and VB “ VBG NNS , ” and “ VBG RB to VB JJ NN . ” NNP NNP VBD a NN VBG he would VB from VBG to VB what he VBD VBN VBN of VBG . The VBN NN VBD to his JJ NN . He VBD his JJ NN and VBD VBG NNS VBG NNS of the JJ NN . He himself RB VBD from NNP - 19 when it VBD RB VBN as 19 - NNP . VBZ NNP ’s JJ NN of the NNP NN NN NN a NNP JJ NN of the NN NN in NNP with the NN of VBG NNP NNP ? VBZ the NN of the NNP in the NN of VBG “ NN NNS ” VBG the NNP NNP NNP ’s NN to VB NNP NNP ? VBZ NNP NNP to VB RB VBN as a JJ NN of a “ NN NN ” ? How JJ VBD his NN for RB “ VBG NNS ” and “ VBG RB to VB JJ NN ” from the NN of those in the NNP who VBP VBN VBN , VBN and RB VBN for VBG to VB NN to NN ? I VBP VBN NNS to these NNS VBN on RB - VBN NNS VBG the NN NNS of an RB JJ JJ NN JJ to VB NN of the VBG NN of my NN . These JJ NNS VBP to VB JJ NN of their JJ NNS of NN , NN and NN by VBG NNS of their NN as “ NN NNS ” or JJR . RBR RB I VBP VBN VBG against a NN on this NN in VBG to VB the JJ NNS on the NNP NNP NNP . These NNS on JJ NN and JJ NN VBD with the NNS of JJ NNS whose VBD NN NNS VBD VBN RB to the NN NNS at NNP and the NNP NNP . No NN can VB for JJ where the NNP NNP NN VBZ VBG the NN . Wherever we VBP VBN , RB , we VBP VBG behind an NN that can RB VB VBN . Whatever VBD to VB the NN , this NN VBZ VBG us to VB NN of the NN of JJ NN as it VBZ VBN VBG in NNP , NNP , NNP and RB JJ JJ NNS . RB , RB , VBZ JJ NN VBG RBR RB and RB VBN and RB VBN than by the NNP JJ NNS . The NN and NN that NN VBZ RB VBG should VB to us that it VBZ NN to VB RB RBR JJ about VBG JJ NNS and VBG the NNS of the NNP NNP NNP of 1972 . It VBZ , in NN , NN to VB RB RBR JJ about VBG all NNS of JJ JJ NN in VBN NNS that VBP the NNS of NNPS ’ NN . It VBZ NN to VB off the NN of the NN - NNS VBN after 9/11 through JJ NNS like the JJ - NN JJ NN NN on NNP . JJS RB , it VBZ NN to VB a JJ NN between NN in the NN of JJ NN and NN in the NN of JJ NNS . RBR RB , we should VB towards VBG an NN RB to NN through the JJ NN of the "" NN NNS . "" The JJ NNS of VBN NNS of the JJ NN NNS VBP , for NNS , VBG the NN of our VBN NNS of JJR NN ."
62,415,mainstream,M08a36,vaccine,"BERLIN_NNP (_-LRB- Reuters_NNP )_-RRB- -_, German_JJ drugmaker_NN CureVac_NNP ,_, in_IN which_WDT the_DT government_NN is_VBZ taking_VBG a_DT sizeable_JJ stake_NN to_TO help_VB fund_VB a_DT COVID_NN -_HYPH 19_CD vaccine_NN ,_, is_VBZ planning_VBG an_DT initial_JJ public_JJ offering_NN in_IN the_DT United_NNP States_NNPS next_JJ month_NN ,_, a_DT finance_NN ministry_NN document_NN seen_VBN by_IN Reuters_NNP on_IN Monday_NNP showed_VBD ._. The_DT German_JJ government_NN plans_VBZ to_TO invest_VB 300_CD million_CD euros_NNS (_-LRB- $_$ 338.5_CD million_CD )_-RRB- in_IN a_DT 23_CD %_NN holding_NN in_IN previously_RB unlisted_VBN CureVac_NN to_TO aid_VB the_DT further_JJR development_NN of_IN the_DT biotech_NN company_NN ’s_POS vaccine_NN against_IN the_DT disease_NN caused_VBN by_IN the_DT novel_JJ coronavirus_NN ._. The_DT finance_NN ministry_NN said_VBD in_IN a_DT letter_NN to_IN parliament_NN ’s_POS budget_NN committee_NN dated_VBN June_NNP 15_CD that_IN CureVac_NNP “_'' currently_RB has_VBZ a_DT big_JJ capital_NN requirement_NN and_CC plans_VBZ a_DT flotation_NN on_IN the_DT Nasdaq_NNP in_IN New_NNP York_NNP in_IN July_NNP 2020_CD ._. ”_'' European_JJ biotech_NN firms_NNS prefer_VBP the_DT Nasdaq_NNP because_IN the_DT U.S._NNP capital_NN market_NN offers_VBZ a_DT critical_JJ mass_NN of_IN highly_RB specialised_VBN biopharma_NN investors_NNS ,_, analysts_NNS say_VBP ._. German_JJ biotech_NN firms_NNS BioNtech_NNP and_CC Morphosys_NNPS have_VBP recently_RB sought_VBN U.S._NNP listings_NNS ._. The_DT ministry_NN added_VBD in_IN its_PRP$ letter_NN that_IN the_DT decision_NN to_TO acquire_VB a_DT stake_NN in_IN CureVac_NNP had_VBD to_TO be_VB made_VBN quickly_RB given_VBN legal_JJ requirements_NNS attached_VBN to_IN the_DT planned_VBN flotation_NN ,_, which_WDT is_VBZ expected_VBN to_TO take_VB place_NN in_IN mid-July_NNP ._. Economy_NN Minister_NNP Peter_NNP Altmaier_NNP on_IN Monday_NNP confirmed_VBD an_DT earlier_JJR Reuters_NNP report_NN that_IN Germany_NNP will_MD take_VB a_DT stake_NN in_IN the_DT unlisted_JJ biotech_NN company_NN ._. The_DT deal_NN values_VBZ the_DT firm_NN at_IN 1.3_CD billion_CD euros_NNS ._. That_DT follows_VBZ reported_VBN attempts_NNS by_IN the_DT U.S._NNP government_NN to_TO acquire_VB CureVac_NNP or_CC its_PRP$ assets_NNS in_IN March_NNP ,_, which_WDT stirred_VBD a_DT backlash_NN in_IN Germany_NNP ,_, with_IN government_NN officials_NNS voicing_VBG support_NN for_IN keeping_VBG CureVac_NNP German_NNP ._. Altmaier_NNP said_VBD the_DT government_NN wanted_VBD to_TO strengthen_VB the_DT life_NN sciences_NNS and_CC biotech_NN sectors_NNS in_IN Germany_NNP ,_, and_CC that_IN it_PRP would_MD not_RB have_VB any_DT influence_NN over_IN CureVac_NNP ’s_POS business_NN strategy_NN ._. “_`` With_IN this_DT investment_NN we_PRP aim_VBP to_TO give_VB CureVac_NN financial_JJ security_NN so_IN that_IN it_PRP can_MD continue_VB to_TO work_VB on_IN vaccine_NN production_NN with_IN the_DT same_JJ commitment_NN ,_, ”_'' Altmaier_NNP told_VBD a_DT news_NN conference_NN ._. A_DT government_NN source_NN said_VBD the_DT measure_NN reflected_VBD German_JJ concerns_NNS about_IN relying_VBG too_RB much_JJ on_IN overseas_JJ suppliers_NNS for_IN healthcare_NN products_NNS and_CC equipment_NN ._. Reflecting_VBG the_DT sensitivity_NN surrounding_VBG ownership_NN of_IN the_DT country_NN ’s_POS two_CD coronavirus_NN vaccine_NN developers_NNS ,_, CureVac_NNP and_CC BioNTech_NNP ,_, the_DT government_NN gave_VBD itself_PRP new_JJ powers_NNS in_IN May_NNP to_TO veto_VB hostile_JJ foreign_JJ takeover_NN bids_NNS for_IN healthcare_NN firms_NNS ._. Dietmar_NNP Hopp_NNP ,_, co-founder_NN of_IN software_NN firm_NN SAP_NN and_CC owner_NN of_IN a_DT more_JJR than_IN 80_CD %_NN stake_NN in_IN CureVac_NNP ,_, said_VBD none_NN of_IN the_DT existing_VBG CureVac_NNP investors_NNS would_MD sell_VB shares_NNS to_IN the_DT government_NN ,_, and_CC that_IN their_PRP$ stakes_NNS would_MD be_VB diluted_VBN by_IN the_DT deal_NN on_IN a_DT pro-rata_NN basis_NN ._.","NNP ( NNP ) - JJ NN NNP , in which the NN VBZ VBG a JJ NN to VB VB a NN - 19 NN , VBZ VBG an JJ JJ NN in the NNP NNPS JJ NN , a NN NN NN VBN by NNP on NNP VBD . The JJ NN VBZ to VB 300 million NNS ( $ 338.5 million ) in a 23 NN NN in RB VBN NN to VB the JJR NN of the NN NN ’s NN against the NN VBN by the JJ NN . The NN NN VBD in a NN to NN ’s NN NN VBN NNP 15 that NNP “ RB VBZ a JJ NN NN and VBZ a NN on the NNP in NNP NNP in NNP 2020 . ” JJ NN NNS VBP the NNP because the NNP NN NN VBZ a JJ NN of RB VBN NN NNS , NNS VBP . JJ NN NNS NNP and NNPS VBP RB VBN NNP NNS . The NN VBD in its NN that the NN to VB a NN in NNP VBD to VB VBN RB VBN JJ NNS VBN to the VBN NN , which VBZ VBN to VB NN in NNP . NN NNP NNP NNP on NNP VBD an JJR NNP NN that NNP will VB a NN in the JJ NN NN . The NN VBZ the NN at 1.3 billion NNS . That VBZ VBN NNS by the NNP NN to VB NNP or its NNS in NNP , which VBD a NN in NNP , with NN NNS VBG NN for VBG NNP NNP . NNP VBD the NN VBD to VB the NN NNS and NN NNS in NNP , and that it would RB VB any NN over NNP ’s NN NN . “ With this NN we VBP to VB NN JJ NN so that it can VB to VB on NN NN with the JJ NN , ” NNP VBD a NN NN . A NN NN VBD the NN VBD JJ NNS about VBG RB JJ on JJ NNS for NN NNS and NN . VBG the NN VBG NN of the NN ’s two NN NN NNS , NNP and NNP , the NN VBD itself JJ NNS in NNP to VB JJ JJ NN NNS for NN NNS . NNP NNP , NN of NN NN NN and NN of a JJR than 80 NN NN in NNP , VBD NN of the VBG NNP NNS would VB NNS to the NN , and that their NNS would VB VBN by the NN on a NN NN ."
63,398,mainstream,M0aca3,vaccine; vaccine.covid,"The_DT University_NNP of_IN Oxford_NNP in_IN the_DT UK_NNP has_VBZ reported_VBN positive_JJ findings_NNS of_IN its_PRP$ Covid_NNP -_HYPH 19_CD vaccine_NN candidate_NN in_IN a_DT small_JJ preclinical_JJ study_NN involving_VBG six_CD monkeys_NNS ._. This_DT preliminary_JJ data_NNS of_IN the_DT vaccine_NN ,_, currently_RB in_IN human_JJ trials_NNS ,_, has_VBZ been_VBN published_VBN on_IN the_DT preprint_NN website_NN bioRxiv_NNP ,_, noted_VBN Reuters_NNP ._. According_VBG to_IN the_DT publication_NN ,_, some_DT monkeys_NNS administered_VBN with_IN a_DT single_JJ shot_NN of_IN the_DT vaccine_NN generated_VBD antibodies_NNS against_IN the_DT virus_NN within_IN 14_CD days_NNS while_IN all_DT monkeys_NNS developed_VBD antibodies_NNS within_IN 28_CD days_NNS ,_, prior_JJ to_IN being_VBG exposed_VBN to_IN high_JJ virus_NN doses_NNS ._. Following_VBG exposure_NN to_IN the_DT coronavirus_NN ,_, the_DT vaccine_NN candidate_NN was_VBD prevented_VBN damage_NN to_IN the_DT lungs_NNS and_CC blocked_VBD the_DT virus_NN from_IN replication_NN ._. However_RB ,_, the_DT virus_NN was_VBD found_VBN to_TO be_VB actively_RB replicating_VBG in_IN the_DT nose_NN ._. London_NNP School_NNP of_IN Hygiene_NNP &_CC Tropical_NNP Medicine_NNP pharmacoepidemiology_NN professor_NN Stephen_NNP Evans_NNP said_VBD that_IN the_DT animal_NN data_NNS was_VBD ‘_`` good_JJ news_NN ’_'' ._. Evans_NNP was_VBD quoted_VBN as_IN saying_VBG :_: “_`` It_PRP is_VBZ one_CD of_IN the_DT hurdles_NNS to_TO be_VB passed_VBN by_IN the_DT Oxford_NNP vaccine_NN and_CC it_PRP has_VBZ cleared_VBN it_PRP well_RB ._. ”_'' The_DT professor_NN also_RB noted_VBD that_IN no_DT evidence_NN of_IN immune_NN -_HYPH enhanced_VBN disease_NN ,_, where_WRB a_DT vaccine_NN makes_VBZ the_DT disease_NN worse_JJR ,_, was_VBD reassuring_JJ ._. Evans_NNP added_VBD :_: “_`` This_DT was_VBD a_DT definite_JJ theoretical_JJ concern_NN for_IN a_DT vaccine_NN against_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD and_CC finding_VBG no_DT evidence_NN for_IN it_PRP in_IN this_DT study_NN is_VBZ very_RB encouraging_JJ ._. ”_'' Last_JJ month_NN ,_, the_DT University_NNP of_IN Oxford_NNP signed_VBD an_DT agreement_NN with_IN AstraZeneca_NNP to_TO develop_VB and_CC distribute_VB its_PRP$ Covid_NNP -_HYPH 19_CD vaccine_NN candidate_NN ,_, a_DT recombinant_JJ adenovirus_NN vaccine_NN in_IN development_NN by_IN Jenner_NNP Institute_NNP and_CC Oxford_NNP Vaccine_NNP Group_NNP at_IN the_DT university_NN ._. Results_NNS from_IN the_DT human_JJ trial_NN are_VBP expected_VBN next_JJ month_NN ,_, with_IN plans_NNS to_TO start_VB late_JJ -_HYPH stage_NN trials_NNS by_IN the_DT middle_NN of_IN this_DT year_NN ._. As_IN part_NN of_IN the_DT deal_NN ,_, AstraZeneca_NNP will_MD carry_VB out_RP the_DT development_NN and_CC global_JJ manufacturing_NN and_CC distribution_NN of_IN the_DT vaccine_NN ._.","The NNP of NNP in the NNP VBZ VBN JJ NNS of its NNP - 19 NN NN in a JJ JJ NN VBG six NNS . This JJ NNS of the NN , RB in JJ NNS , VBZ VBN VBN on the NN NN NNP , VBN NNP . VBG to the NN , some NNS VBN with a JJ NN of the NN VBD NNS against the NN within 14 NNS while all NNS VBD NNS within 28 NNS , JJ to VBG VBN to JJ NN NNS . VBG NN to the NN , the NN NN VBD VBN NN to the NNS and VBD the NN from NN . RB , the NN VBD VBN to VB RB VBG in the NN . NNP NNP of NNP & NNP NNP NN NN NNP NNP VBD that the NN NNS VBD ‘ JJ NN ’ . NNP VBD VBN as VBG : “ It VBZ one of the NNS to VB VBN by the NNP NN and it VBZ VBN it RB . ” The NN RB VBD that no NN of NN - VBN NN , where a NN VBZ the NN JJR , VBD JJ . NNP VBD : “ This VBD a JJ JJ NN for a NN against NNP - NNP - 2 and VBG no NN for it in this NN VBZ RB JJ . ” JJ NN , the NNP of NNP VBD an NN with NNP to VB and VB its NNP - 19 NN NN , a JJ NN NN in NN by NNP NNP and NNP NNP NNP at the NN . NNS from the JJ NN VBP VBN JJ NN , with NNS to VB JJ - NN NNS by the NN of this NN . As NN of the NN , NNP will VB out the NN and JJ NN and NN of the NN ."
64,1263,mainstream,M0b726,vaccine,"Unsubstantiated_JJ safety_NN scares_NNS have_VBP been_VBN associated_VBN with_IN large_JJ declines_NNS in_IN HPV_NN vaccine_NN uptake_NN in_IN several_JJ countries_NNS ._. Immunization_NN programs_NNS ’_POS resilience_NN to_IN shocks_NNS is_VBZ central_JJ to_IN their_PRP$ success_NN ,_, but_CC little_JJ empirical_JJ evidence_NN documents_VBZ resilience_NN in_IN action_NN ._. We_PRP sought_VBD to_TO characterize_VB the_DT decline_NN of_IN HPV_NN vaccination_NN in_IN Denmark_NNP after_IN negative_JJ media_NN coverage_NN and_CC recovery_NN during_IN a_DT national_JJ information_NN campaign_NN ._. We_PRP conducted_VBD a_DT population_NN -_HYPH based_VBN retrospective_JJ cohort_NN study_NN of_IN all_DT girls_NNS born_VBN in_IN Denmark_NNP from_IN 1997_CD to_IN 2006_CD (_-LRB- N_NNP =_SYM 328,779_CD )_-RRB- ,_, aged_JJ 12_CD –_SYM 15_CD ._. The_DT outcome_NN measure_NN was_VBD HPV_NN vaccine_NN uptake_NN (_-LRB- first_JJ dose_NN )_-RRB- ,_, as_IN reported_VBN to_IN the_DT Danish_JJ national_JJ health_NN registry_NN from_IN 2009_CD to_IN 2019_CD ,_, when_WRB HPV_NN vaccine_NN was_VBD freely_RB available_JJ to_IN girls_NNS in_IN primary_JJ care_NN clinics_NNS in_IN Denmark_NNP ._. Events_NNS that_WDT created_VBD 4_CD natural_JJ time_NN periods_NNS for_IN study_NN were_VBD HPV_NN vaccine_NN reaching_VBG the_DT uptake_NN of_IN other_JJ vaccines_NNS in_IN the_DT national_JJ program_NN (_-LRB- 2009_CD )_-RRB- ,_, some_DT negative_JJ media_NN coverage_NN of_IN HPV_NN vaccination_NN (_-LRB- 2013_CD )_-RRB- ,_, extensive_JJ negative_JJ media_NN coverage_NN (_-LRB- 2015_CD )_-RRB- ,_, and_CC a_DT national_JJ information_NN campaign_NN about_IN the_DT vaccine_NN ’s_POS safety_NN and_CC effectiveness_NN (_-LRB- 2017–2019_CD )_-RRB- ._. In_IN the_DT period_NN with_IN some_DT negative_JJ media_NN coverage_NN ,_, HPV_NN vaccine_NN uptake_NN fell_VBD to_IN 83.6_CD %_NN (_-LRB- 95_CD %_NN CI_NN :78.0_CD %_NN –89.7_CD %_NN )_-RRB- of_IN baseline_NN uptake_NN ._. In_IN the_DT period_NN with_IN extensive_JJ negative_JJ media_NN coverage_NN ,_, uptake_NN fell_VBD even_RB further_RBR to_IN 49.6_CD %_NN (_-LRB- 95_CD %_NN CI:44.5_CD %_NN –55.2_CD %_NN )_-RRB- of_IN baseline_NN uptake_NN ._. After_IN the_DT information_NN campaign_NN ,_, HPV_NNP vaccine_NN uptake_NN recovered_VBD to_IN its_PRP$ baseline_NN level_NN (_-LRB- 109.2_CD %_NN ,_, 95_CD %_NN CI:90.1_CD %_NN –132.4_CD %_NN )_-RRB- due_IN in_IN part_NN to_TO catch_VB -_HYPH up_RP doses_NNS ._. Despite_IN the_DT recovery_NN ,_, an_DT estimated_VBN 26,000_CD fewer_JJR girls_NNS initiated_VBD the_DT vaccine_NN than_IN if_IN uptake_NN had_VBD not_RB declined_VBN ._. The_DT experience_NN in_IN Denmark_NNP offers_VBZ one_CD of_IN the_DT first_JJ opportunities_NNS to_TO document_VB how_WRB a_DT nation_NN grappled_VBD with_IN negative_JJ media_NN coverage_NN of_IN HPV_NN vaccination_NN and_CC the_DT steadying_VBG impact_NN of_IN action_NN by_IN national_JJ authorities_NNS ._.","JJ NN NNS VBP VBN VBN with JJ NNS in NN NN NN in JJ NNS . NN NNS ’ NN to NNS VBZ JJ to their NN , but JJ JJ NN VBZ NN in NN . We VBD to VB the NN of NN NN in NNP after JJ NN NN and NN during a JJ NN NN . We VBD a NN - VBN JJ NN NN of all NNS VBN in NNP from 1997 to 2006 ( NNP = 328,779 ) , JJ 12 – 15 . The NN NN VBD NN NN NN ( JJ NN ) , as VBN to the JJ JJ NN NN from 2009 to 2019 , when NN NN VBD RB JJ to NNS in JJ NN NNS in NNP . NNS that VBD 4 JJ NN NNS for NN VBD NN NN VBG the NN of JJ NNS in the JJ NN ( 2009 ) , some JJ NN NN of NN NN ( 2013 ) , JJ JJ NN NN ( 2015 ) , and a JJ NN NN about the NN ’s NN and NN ( 2017–2019 ) . In the NN with some JJ NN NN , NN NN NN VBD to 83.6 NN ( 95 NN NN :78.0 NN –89.7 NN ) of NN NN . In the NN with JJ JJ NN NN , NN VBD RB RBR to 49.6 NN ( 95 NN CI:44.5 NN –55.2 NN ) of NN NN . After the NN NN , NNP NN NN VBD to its NN NN ( 109.2 NN , 95 NN CI:90.1 NN –132.4 NN ) due in NN to VB - up NNS . Despite the NN , an VBN 26,000 JJR NNS VBD the NN than if NN VBD RB VBN . The NN in NNP VBZ one of the JJ NNS to VB how a NN VBD with JJ NN NN of NN NN and the VBG NN of NN by JJ NNS ."
65,788,conspiracy,C0081c,vaccine.covid,"Before_IN COVID_NNP -_HYPH 19_CD was_VBD even_RB detected_VBN in_IN the_DT United_NNP States_NNPS ,_, Dan_NNP Erickson_NNP ,_, a_DT former_JJ emergency_NN room_NN physician_NN who_WP now_RB co-owns_VBZ Accelerated_NNP Urgent_NNP Care_NNP in_IN Bakersfield_NNP ,_, bought_VBD as_IN many_JJ tests_NNS for_IN the_DT virus_NN as_IN he_PRP could_MD ._. He_PRP knew_VBD it_PRP would_MD be_VB here_RB eventually_RB and_CC wanted_VBD to_TO be_VB ready_JJ to_TO test_VB those_DT who_WP needed_VBD and_CC wanted_VBD it_PRP ._. Now_RB ,_, after_IN testing_VBG thousands_NNS of_IN people_NNS ,_, he_PRP and_CC his_PRP$ business_NN partner_NN ,_, physician_NN Artin_NNP Massihi_NNP ,_, say_VBP they_PRP have_VBP enough_JJ data_NNS to_TO draw_VB some_DT conclusions_NNS about_IN COVID_NNP -_HYPH 19_CD ._. Their_PRP$ message_NN :_: COVID_NNP -_HYPH 19_CD is_VBZ more_RBR ubiquitous_JJ and_CC less_RBR deadly_JJ than_IN we_PRP think_VBP ._. It_PRP ’s_VBZ similar_JJ to_IN influenza_NN and_CC we_PRP should_MD therefore_RB reopen_VB society_NN and_CC stop_VB treating_VBG the_DT situation_NN like_IN the_DT lethal_JJ menace_NN it_PRP was_VBD initially_RB thought_VBN to_TO be_VB ._. “_`` Two_CD months_NNS ago_RB we_PRP did_VBD n’t_RB know_VB this_DT so_RB I_PRP ’m_VBP bringing_VBG it_PRP to_IN light_NN now_RB ,_, ”_'' Erickson_NNP said_VBD Wednesday_NNP at_IN a_DT news_NN conference_NN held_VBN at_IN his_PRP$ Coffee_NNP Road_NNP urgent_JJ care_NN ._. Kern_NNP County_NNP Public_NNP Health_NNP Services_NNPS Spokeswoman_NN Michelle_NNP Corson_NNP and_CC an_DT epidemiologist_NN contacted_VBN by_IN The_DT Californian_NNP said_VBD they_PRP did_VBD n’t_RB agree_VB with_IN the_DT doctors_NNS ’_POS recommendation_NN to_TO end_VB social_JJ distancing_NN and_CC immediately_RB start_VB reopening_VBG society_NN ._. “_`` This_DT is_VBZ a_DT many_JJ -_HYPH headed_VBN hydra_NN ._. It_PRP ’s_VBZ really_RB unfortunate_JJ to_TO boil_VB this_DT all_RB down_RP to_IN it_PRP ’s_VBZ just_RB flu_NN ,_, ”_'' said_VBD Andrew_NNP Noymer_NNP ,_, associate_NN professor_NN of_IN public_JJ health_NN at_IN UC_NNP Irvine_NNP ._. “_`` There_EX ’s_VBZ no_DT flu_NN season_NN that_WDT looks_VBZ anything_NN like_IN New_NNP York_NNP does_VBZ right_RB now_RB ._. ”_'' Accelerated_VBN urgent_JJ care_NN has_VBZ done_VBN 5,213_CD COVID_NN -_SYM 19_CD tests_NNS at_IN its_PRP$ five_CD Bakersfield_NNP locations_NNS ,_, Erickson_NNP said_VBD —_: which_WDT is_VBZ more_JJR than_IN half_PDT the_DT 9,197_CD tests_NNS done_VBN so_RB far_RB in_IN Kern_NNP County_NNP ._. Of_IN those_DT ,_, 340_CD were_VBD positive_JJ ,_, according_VBG to_IN Erickson_NNP ._. If_IN that_DT percentage_NN of_IN positive_JJ cases_NNS were_VBD assumed_VBN to_TO represent_VB the_DT entire_JJ population_NN of_IN Kern_NNP County_NNP ,_, which_WDT is_VBZ roughly_RB 900,000_CD ,_, it_PRP would_MD mean_VB about_RB 58,000_CD people_NNS in_IN Kern_NNP have_VBP had_VBN the_DT virus_NN ,_, far_RB more_JJR than_IN the_DT nearly_RB 700_CD official_NN confirmed_VBN ,_, Erickson_NNP said_VBD ._. That_IN many_JJ cases_NNS would_MD “_`` indicate_VB there_EX is_VBZ a_DT widespread_JJ (_-LRB- COVID_NN -_HYPH 19_CD )_-RRB- infection_NN ,_, similar_JJ to_IN flu_NN ,_, ”_'' Erickson_NNP said_VBD ._. And_CC if_IN we_PRP do_VBP n’t_RB shutdown_VB the_DT country_NN for_IN flu_NN ,_, should_MD we_PRP keep_VB doing_VBG it_PRP for_IN coronavirus_NN ?_. “_`` It_PRP ’s_VBZ about_IN looking_VBG at_IN trends_NNS and_CC saying_VBG we_PRP ’re_VBP not_RB seeing_VBG what_WP they_PRP ’ve_VBP been_VBN talking_VBG about_IN for_IN the_DT past_JJ six_CD to_IN eight_CD weeks_NNS ,_, ”_'' said_VBD Massihi_NNP ,_, referring_VBG to_IN predictions_NNS that_IN up_IN to_IN 100,000_CD Americans_NNPS could_MD die_VB of_IN the_DT virus_NN and_CC hospitals_NNS would_MD become_VB swamped_VBN with_IN patients_NNS ._. “_`` We_PRP ’ve_VBP crippled_VBN the_DT economy_NN ._. There_EX ’s_VBZ a_DT lot_NN of_IN domestic_JJ issues_NNS going_VBG on_RP ._. Is_VBZ social_JJ isolation_NN warranted_VBN for_IN the_DT healthy_JJ ?_. ”_'' Using_VBG the_DT same_JJ calculation_NN ,_, Erickson_NNP estimates_VBZ 12_CD percent_NN of_IN the_DT population_NN statewide_JJ ,_, or_CC some_DT 4.7_CD million_CD Californians_NNPS ,_, have_VBP already_RB had_VBN COVID_NN -_HYPH 19_CD ._. With_IN about_RB 1,400_CD deaths_NNS so_RB far_RB in_IN California_NNP ,_, that_DT puts_VBZ the_DT statewide_JJ death_NN rate_NN at_IN about_RB .03_CD percent_NN ,_, he_PRP said_VBD ._. “_`` Does_VBZ that_DT (_-LRB- low_JJ death_NN rate_NN )_-RRB- necessitate_VB sheltering_VBG in_IN place_NN ?_. Does_VBZ that_DT necessitate_VB shutting_VBG down_RP medical_JJ systems_NNS ?_. Does_VBZ that_DT necessitate_VB being_VBG out_IN of_IN work_NN ?_. ”_'' Erickson_NNP asked_VBD ._. Nationwide_RB ,_, about_RB 42,000_CD people_NNS have_VBP died_VBN of_IN coronavirus_NN as_IN of_IN Wednesday_NNP ._. Between_IN 30,000_CD and_CC 60,000_CD die_VBP of_IN flu_NN annually_RB ,_, Erickson_NNP said_VBD ,_, citing_VBG CDC_NNP data_NNS ._. The_DT secondary_JJ effects_NNS of_IN the_DT shutdown_NN are_VBP considerable_JJ ,_, too_RB ,_, he_PRP said_VBD ._. They_PRP include_VBP a_DT dramatic_JJ decrease_NN in_IN volumes_NNS at_IN hospitals_NNS and_CC even_RB Erickson_NNP ’s_POS urgent_JJ care_NN practice_NN ,_, where_WRB staff_NN are_VBP mostly_RB testing_VBG patients_NNS for_IN COVID_NN -_HYPH 19_CD these_DT days_NNS ._.","Before NNP - 19 VBD RB VBN in the NNP NNPS , NNP NNP , a JJ NN NN NN who RB VBZ NNP NNP NNP in NNP , VBD as JJ NNS for the NN as he could . He VBD it would VB RB RB and VBD to VB JJ to VB those who VBD and VBD it . RB , after VBG NNS of NNS , he and his NN NN , NN NNP NNP , VBP they VBP JJ NNS to VB some NNS about NNP - 19 . Their NN : NNP - 19 VBZ RBR JJ and RBR JJ than we VBP . It VBZ JJ to NN and we should RB VB NN and VB VBG the NN like the JJ NN it VBD RB VBN to VB . “ Two NNS RB we VBD RB VB this RB I VBP VBG it to NN RB , ” NNP VBD NNP at a NN NN VBN at his NNP NNP JJ NN . NNP NNP NNP NNP NNPS NN NNP NNP and an NN VBN by The NNP VBD they VBD RB VB with the NNS ’ NN to VB JJ NN and RB VB VBG NN . “ This VBZ a JJ - VBN NN . It VBZ RB JJ to VB this RB down to it VBZ RB NN , ” VBD NNP NNP , NN NN of JJ NN at NNP NNP . “ There VBZ no NN NN that VBZ NN like NNP NNP VBZ RB RB . ” VBN JJ NN VBZ VBN 5,213 NN - 19 NNS at its five NNP NNS , NNP VBD — which VBZ JJR than half the 9,197 NNS VBN RB RB in NNP NNP . Of those , 340 VBD JJ , VBG to NNP . If that NN of JJ NNS VBD VBN to VB the JJ NN of NNP NNP , which VBZ RB 900,000 , it would VB RB 58,000 NNS in NNP VBP VBN the NN , RB JJR than the RB 700 NN VBN , NNP VBD . That JJ NNS would “ VB there VBZ a JJ ( NN - 19 ) NN , JJ to NN , ” NNP VBD . And if we VBP RB VB the NN for NN , should we VB VBG it for NN ? “ It VBZ about VBG at NNS and VBG we VBP RB VBG what they VBP VBN VBG about for the JJ six to eight NNS , ” VBD NNP , VBG to NNS that up to 100,000 NNPS could VB of the NN and NNS would VB VBN with NNS . “ We VBP VBN the NN . There VBZ a NN of JJ NNS VBG on . VBZ JJ NN VBN for the JJ ? ” VBG the JJ NN , NNP VBZ 12 NN of the NN JJ , or some 4.7 million NNPS , VBP RB VBN NN - 19 . With RB 1,400 NNS RB RB in NNP , that VBZ the JJ NN NN at RB .03 NN , he VBD . “ VBZ that ( JJ NN NN ) VB VBG in NN ? VBZ that VB VBG down JJ NNS ? VBZ that VB VBG out of NN ? ” NNP VBD . RB , RB 42,000 NNS VBP VBN of NN as of NNP . Between 30,000 and 60,000 VBP of NN RB , NNP VBD , VBG NNP NNS . The JJ NNS of the NN VBP JJ , RB , he VBD . They VBP a JJ NN in NNS at NNS and RB NNP ’s JJ NN NN , where NN VBP RB VBG NNS for NN - 19 these NNS ."
66,994,mainstream,M083fa,vaccine,"This_DT year_NN 's_POS World_NNP Malaria_NNP Day_NNP marks_VBZ a_DT critical_JJ moment_NN in_IN time_NN as_IN the_DT international_JJ malaria_NN community_NN has_VBZ less_JJR than_IN a_DT year_NN to_TO meet_VB the_DT 2010_CD targets_NNS of_IN delivering_VBG effective_JJ and_CC affordable_JJ protection_NN and_CC treatment_NN to_IN all_DT people_NNS at_IN risk_NN of_IN malaria_NN ._. Experts_NNS say_VBP a_DT safe_JJ and_CC effective_JJ vaccine_NN is_VBZ an_DT important_JJ component_NN of_IN a_DT comprehensive_JJ malaria_NN control_NN program_NN ._. The_DT RTS_NNP ,_, S_NNP malaria_NN vaccine_NN candidate_NN was_VBD created_VBN in_IN 1987_CD and_CC is_VBZ said_VBN to_TO be_VB the_DT most_RBS clinically_RB advanced_JJ in_IN the_DT world_NN ._. In_IN clinical_JJ trials_NNS ,_, scientists_NNS say_VBP ,_, it_PRP was_VBD the_DT first_JJ to_TO demonstrate_VB that_IN it_PRP can_MD protect_VB young_JJ children_NNS and_CC infants_NNS in_IN malaria_NN -_HYPH endemic_JJ areas_NNS against_IN infection_NN and_CC clinical_JJ disease_NN caused_VBN by_IN Plasmodium_NN falciparum_NN ,_, the_DT most_RBS deadly_JJ species_NNS of_IN the_DT malaria_NN parasite_NN ._. It_PRP is_VBZ also_RB the_DT first_JJ vaccine_NN designed_VBN primarily_RB for_IN use_NN in_IN Africa_NNP and_CC is_VBZ now_RB undergoing_VBG Phase_NN III_CD trials_NNS in_IN various_JJ countries_NNS on_IN the_DT continent_NN Infrastructure_NN for_IN vaccine_NN research_NN Dr._NNP Tsiri_NNP Agbenyega_NNP ,_, a_DT professor_NN of_IN Physiology_NNP and_CC a_DT medical_JJ doctor_NN at_IN the_DT Komfo_NNP -_HYPH Anokye_NNP Teaching_NNP Hospital_NNP in_IN Kumasi_NNP Ghana_NNP said_VBD the_DT Phase_NNP III_CD trials_NNS are_VBP very_RB essential_JJ ._. ?_. Phase_NNP III_CD is_VBZ the_DT phase_NN you_PRP go_VBP through_RP before_IN you_PRP present_VBP your_PRP$ data_NNS to_IN regulatory_JJ authorities_NNS for_IN its_PRP$ licensing_NN ,_, he_PRP said_VBD .?_. The_DT Ghanaian_JJ doctor_NN said_VBD running_VBG the_DT trials_NNS have_VBP helped_VBN a_DT lot_NN in_IN creating_VBG the_DT infrastructure_NN for_IN further_JJR work_NN in_IN vaccine_NN research_NN ._. He_PRP said_VBD when_WRB the_DT vaccine_NN finally_RB reaches_VBZ the_DT market_NN it_PRP will_MD be_VB made_VBN affordable_JJ for_IN those_DT who_WP need_VBP it_PRP most_JJS ._.","This NN 's NNP NNP NNP VBZ a JJ NN in NN as the JJ NN NN VBZ JJR than a NN to VB the 2010 NNS of VBG JJ and JJ NN and NN to all NNS at NN of NN . NNS VBP a JJ and JJ NN VBZ an JJ NN of a JJ NN NN NN . The NNP , NNP NN NN NN VBD VBN in 1987 and VBZ VBN to VB the RBS RB JJ in the NN . In JJ NNS , NNS VBP , it VBD the JJ to VB that it can VB JJ NNS and NNS in NN - JJ NNS against NN and JJ NN VBN by NN NN , the RBS JJ NNS of the NN NN . It VBZ RB the JJ NN VBN RB for NN in NNP and VBZ RB VBG NN III NNS in JJ NNS on the NN NN for NN NN NNP NNP NNP , a NN of NNP and a JJ NN at the NNP - NNP NNP NNP in NNP NNP VBD the NNP III NNS VBP RB JJ . ? NNP III VBZ the NN you VBP through before you VBP your NNS to JJ NNS for its NN , he VBD .? The JJ NN VBD VBG the NNS VBP VBN a NN in VBG the NN for JJR NN in NN NN . He VBD when the NN RB VBZ the NN it will VB VBN JJ for those who VBP it JJS ."
67,636,conspiracy,C00f7f,vaccine.autism,"The_DT Amish_NNP ,_, who_WP do_VBP n’t_RB get_VB vaccinated_VBN ,_, rarely_RB get_VBP autism_NN ,_, cancer_NN ,_, or_CC heart_NN disease_NN –_: coincidence_NN ?_. Do_VB not_RB talk_VB about_IN whether_IN vaccines_NNS work_VBP or_CC not_RB ,_, or_CC whether_IN or_CC not_RB they_PRP cause_VBP autism_NN ,_, unless_IN you_PRP ’re_VBP ready_JJ for_IN a_DT very_RB heated_VBN debate_NN ._. Although_IN the_DT link_NN between_IN vaccines_NNS and_CC autism_NN is_VBZ nothing_NN new_JJ ,_, to_TO even_RB speak_VB of_IN it_PRP can_MD get_VB you_PRP labeled_VBN as_IN an_DT “_`` anti-vaxxer_NN ”_'' or_CC a_DT health_NN fanatic_NN of_IN sorts_NNS by_IN the_DT sheeple_NN (_-LRB- brainwashed_VBN masses_NNS )_-RRB- that_WDT believe_VBP every_DT vaccine_NN the_DT CDC_NNP recommends_VBZ not_RB only_RB works_VBZ ,_, but_CC is_VBZ 100_CD %_NN safe_JJ and_CC 100_CD %_NN effective_JJ 100_CD %_NN of_IN the_DT time_NN ._. Even_RB if_IN some_DT vaccines_NNS work_VBP some_DT of_IN the_DT time_NN ,_, are_VBP they_PRP worth_JJ the_DT health_NN risk_NN ?_. That_DT is_VBZ the_DT ultimate_JJ question_NN ,_, because_IN one_CD statistic_NN you_PRP may_MD not_RB know_VB is_VBZ that_IN children_NNS who_WP receive_VBP mercury_NN -_HYPH containing_VBG vaccinations_NNS (_-LRB- listed_VBN as_IN thimerosal_NN usually_RB )_-RRB- are_VBP 27_CD times_NNS more_RBR likely_JJ to_TO develop_VB autism_NN than_IN those_DT who_WP do_VBP n’t_RB get_VB those_DT jabs_NNS ._. That_DT comes_VBZ from_IN a_DT recent_JJ study_NN based_VBN on_IN the_DT CDC_NNP ’s_POS own_JJ data_NNS ._. Still_RB want_VBP to_TO keep_VB it_PRP a_DT hush_NN -_HYPH hush_NN topic_NN ?_. Pediatricians_NNS in_IN America_NNP are_VBP not_RB allowed_VBN to_TO question_VB vaccines_NNS at_IN all_DT ,_, nor_CC are_VBP they_PRP allowed_VBN to_TO recommend_VB less_JJR than_IN the_DT CDC_NNP recommends_VBZ ,_, or_CC they_PRP face_VBP the_DT wrath_NN of_IN the_DT AMA_NNP –_: the_DT infamous_JJ American_NNP Medical_NNP Association_NNP –_: that_WDT finds_VBZ a_DT way_NN to_TO shut_VB down_RP the_DT “_`` contenders_NNS ,_, ”_'' sometimes_RB even_RB taking_VBG away_RP their_PRP$ license_NN to_TO practice_VB medicine_NN ._. Big_JJ question_NN :_: would_MD the_DT statistics_NNS of_IN autism_NN suddenly_RB bottom_VB out_RP if_IN mercury_NN was_VBD removed_VBN from_IN all_DT vaccines_NNS ,_, including_VBG flu_NN shots_NNS ?_. (_-LRB- By_IN the_DT way_NN ,_, the_DT CDC_NNP lied_VBD when_WRB they_PRP said_VBD mercury_NN has_VBZ been_VBN removed_VBN from_IN all_DT vaccines_NNS )_-RRB- ._. Nary_NN is_VBZ a_DT case_NN of_IN autism_NN in_IN the_DT Amish_NNP communities_NNS of_IN America_NNP For_IN starters_NNS ,_, children_NNS are_VBP not_RB born_VBN with_IN autism_NN ._. It_PRP appears_VBZ during_IN infancy_NN or_CC childhood_NN ,_, and_CC is_VBZ brought_VBN on_RP by_IN an_DT overload_NN of_IN neurotoxins_NNS either_CC consumed_VBN ,_, injected_VBN or_CC ingested_VBN from_IN environmental_JJ factors_NNS ,_, or_CC all_DT of_IN the_DT above_JJ ._. In_IN fact_NN ,_, the_DT recent_JJ autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- spike_NN over_IN the_DT past_JJ two_CD decades_NNS in_IN the_DT USA_NNP directly_RB coincides_VBZ with_IN the_DT vaccine_NN schedule_NN increase_NN ,_, by_IN quantity_NN and_CC frequency_NN ,_, enforced_VBN by_IN the_DT CDC_NNP ._. To_TO understand_VB why_WRB autism_NN is_VBZ next_JJ to_IN non-existent_JJ for_IN the_DT Amish_NNP ,_, consider_VB that_IN the_DT Amish_NNP have_VBP been_VBN “_`` cut_VBN off_RP ”_'' from_IN American_JJ scientific_JJ and_CC medical_JJ “_`` progress_NN ”_'' for_IN centuries_NNS ,_, thus_RB they_PRP ’ve_VBP had_VBN less_JJR exposure_NN to_IN the_DT major_JJ factors_NNS that_WDT trigger_VBP autism_NN ,_, including_VBG the_DT most_RBS likely_JJ proponent–vaccines_NNS ._. Take_VB a_DT little_JJ trip_NN to_IN the_DT heart_NN of_IN Pennsylvania_NNP Dutch_JJ country_NN and_CC try_VB to_TO tag_VB yourself_PRP even_RB half_PDT a_DT dozen_CD Amish_NNP children_NNS with_IN autism_NN and_CC you_PRP ’ll_MD come_VB up_RB short_JJ ._. If_IN statistics_NNS matched_VBD our_PRP$ national_JJ average_NN ,_, there_EX would_MD be_VB about_RB 200_CD in_IN the_DT Amish_NNP community_NN ,_, but_CC to_IN date_NN ,_, there_EX are_VBP only_RB three_CD ,_, one_CD of_IN which_WDT was_VBD adopted_VBN and_CC brought_VBN over_RP from_IN China_NNP ._. Go_VB figure_NN ._. Another_DT one_NN actually_RB did_VBD get_VB vaccinated_VBN and_CC developed_VBN autism_NN shortly_RB afterwards_RB ._. Go_VB figure_NN again_RB ._. Here_RB are_VBP some_DT universal_JJ and_CC national_JJ statistics_NNS to_TO consider_VB ._. Autism_NN affects_VBZ over_RB 20_CD million_CD people_NNS around_IN the_DT world_NN ,_, and_CC occurs_VBZ in_IN boys_NNS four_CD to_IN five_CD times_NNS more_RBR often_RB than_IN girls_NNS ._. In_IN the_DT US_NNP ,_, one_CD in_IN every_DT 68_CD children_NNS has_VBZ some_DT form_NN of_IN ASD_NN ,_, a_DT 30_CD %_NN increase_NN from_IN just_RB 2012_CD ._. Why_WRB is_VBZ that_DT ,_, you_PRP ’re_VBP asking_VBG yourself_PRP ?_. United_NNP States_NNPS kids_NNS get_VBP 50_CD inoculations_NNS before_IN age_NN seven_CD ,_, many_JJ that_WDT are_VBP combinations_NNS containing_VBG multiple_JJ disease_NN strains_NNS ,_, mercury_NN ,_, formaldehyde_NN (_-LRB- yes_UH ,_, embalming_NN fluid_NN for_IN the_DT dead_JJ )_-RRB- ,_, monosodium_NN glutamate_NN (_-LRB- MSG_NN )_-RRB- and_CC aluminum_NN ,_, just_RB to_TO name_VB a_DT few_JJ neurotoxins_NNS ._. Flu_NN shots_NNS contain_VBP the_DT highest_JJS levels_NNS of_IN mercury_NN ,_, up_IN to_IN 25,000_CD times_NNS what_WP the_DT EPA_NNP allows_VBZ as_IN a_DT maximum_NN in_IN drinking_NN water_NN and_CC edible_JJ fish_NN ._. Mercury_NNP is_VBZ the_DT second_JJ most_RBS poisonous_JJ element_NN know_VBN to_IN mankind_NN ._. Due_IN to_IN religious_JJ beliefs_NNS ,_, the_DT Amish_NNP opt_VBP out_IN of_IN all_DT vaccines_NNS Fortunately_RB for_IN the_DT Amish_NNP ,_, they_PRP ’re_VBP also_RB opting_VBG out_IN of_IN three_CD of_IN the_DT most_RBS controversial_JJ vaccines_NNS on_IN the_DT market_NN today_NN :_: hepatitis_NN B_NN ,_, HPV_NN (_-LRB- human_JJ papillomavirus_NN )_-RRB- and_CC of_IN course_NN ,_, the_DT MMR_NN (_-LRB- measles_NNS ,_, mumps_NNS ,_, rubella_NN combo_NN )_-RRB- that_WDT was_VBD implicated_VBN in_IN the_DT CDC_NNP vaccine_NN -_HYPH autism_NN -_HYPH link_NN and_CC biggest_JJS medical_JJ cover_NN -_HYPH up_NN in_IN history_NN ,_, ever_RB ._. Conflicting_VBG with_IN CDC_NNP claims_VBZ ,_, the_DT multi-_JJ dose_NN version_NN of_IN hepatitis_NN B_NN still_RB contains_VBZ thimerosal_NN (_-LRB- 50_CD %_NN mercury_NN )_-RRB- ._. The_DT immature_JJ central_JJ nervous_JJ systems_NNS and_CC the_DT liver_NN of_IN Amish_NNP newborns_NNS are_VBP spared_VBN this_DT volatile_JJ toxin_NN thanks_NNS to_IN their_PRP$ parent_NN ’s_POS religious_JJ beliefs_NNS ._. Amish_JJ children_NNS experience_VBP hardly_RB any_DT learning_NN disabilities_NNS at_IN all_DT ,_, in_IN fact_NN ._. Nor_CC are_VBP the_DT Amish_NNP experiencing_VBG typical_JJ US_NNP diseases_NNS like_IN cancer_NN ,_, heart_NN disease_NN and_CC diabetes_NN ._. This_DT could_MD all_RB be_VB because_IN they_PRP do_VBP n’t_RB eat_VB GMO_NN ,_, take_VB chemical_JJ pharmaceuticals_NNS ,_, or_CC vaccines_NNS ._. Surely_RB ,_, no_DT government_NN run_VBN regulatory_JJ agency_NN will_MD ever_RB run_VB this_DT comparison_NN of_IN Amish_JJ health_NN vs._IN non-Amish_JJ health_NN ,_, but_CC the_DT reality_NN speaks_VBZ for_IN itself_PRP ._. Still_RB ,_, the_DT CDC_NNP refuses_VBZ to_TO regulate_VB the_DT vaccine_NN industry_NN and_CC instead_RB literally_RB promotes_VBZ toxic_JJ chemicals_NNS ,_, dangerous_JJ heavy_JJ metal_NN toxins_NNS ,_, carcinogens_NNS and_CC lethal_JJ “_`` preservatives_NNS ”_'' like_IN mercury_NN ._. It_PRP ’s_VBZ all_RB about_IN lifestyle_NN and_CC natural_JJ health_NN these_DT days_NNS ,_, if_IN you_PRP really_RB want_VBP immunity_NN that_WDT does_VBZ n’t_RB come_VB with_IN a_DT boatload_NN of_IN permanent_JJ and_CC debilitating_JJ “_`` side_NN effects_NNS ,_, ”_'' like_IN autism_NN spectrum_NN disorder_NN ,_, Asperger_NN ’s_POS syndrome_NN or_CC liver_NN cancer_NN ._.","The NNP , who VBP RB VB VBN , RB VBP NN , NN , or NN NN – NN ? VB RB VB about whether NNS VBP or RB , or whether or RB they VBP NN , unless you VBP JJ for a RB VBN NN . Although the NN between NNS and NN VBZ NN JJ , to RB VB of it can VB you VBN as an “ NN ” or a NN NN of NNS by the NN ( VBN NNS ) that VBP every NN the NNP VBZ RB RB VBZ , but VBZ 100 NN JJ and 100 NN JJ 100 NN of the NN . RB if some NNS VBP some of the NN , VBP they JJ the NN NN ? That VBZ the JJ NN , because one NN you may RB VB VBZ that NNS who VBP NN - VBG NNS ( VBN as NN RB ) VBP 27 NNS RBR JJ to VB NN than those who VBP RB VB those NNS . That VBZ from a JJ NN VBN on the NNP ’s JJ NNS . RB VBP to VB it a NN - NN NN ? NNS in NNP VBP RB VBN to VB NNS at all , nor VBP they VBN to VB JJR than the NNP VBZ , or they VBP the NN of the NNP – the JJ NNP NNP NNP – that VBZ a NN to VB down the “ NNS , ” RB RB VBG away their NN to VB NN . JJ NN : would the NNS of NN RB VB out if NN VBD VBN from all NNS , VBG NN NNS ? ( By the NN , the NNP VBD when they VBD NN VBZ VBN VBN from all NNS ) . NN VBZ a NN of NN in the NNP NNS of NNP For NNS , NNS VBP RB VBN with NN . It VBZ during NN or NN , and VBZ VBN on by an NN of NNS either VBN , VBN or VBN from JJ NNS , or all of the JJ . In NN , the JJ NN NN NN ( NNP ) NN over the JJ two NNS in the NNP RB VBZ with the NN NN NN , by NN and NN , VBN by the NNP . To VB why NN VBZ JJ to JJ for the NNP , VB that the NNP VBP VBN “ VBN off ” from JJ JJ and JJ “ NN ” for NNS , RB they VBP VBN JJR NN to the JJ NNS that VBP NN , VBG the RBS JJ NNS . VB a JJ NN to the NN of NNP JJ NN and VB to VB yourself RB half a dozen NNP NNS with NN and you ’ll VB RB JJ . If NNS VBD our JJ NN , there would VB RB 200 in the NNP NN , but to NN , there VBP RB three , one of which VBD VBN and VBN over from NNP . VB NN . Another NN RB VBD VB VBN and VBN NN RB RB . VB NN RB . RB VBP some JJ and JJ NNS to VB . NN VBZ RB 20 million NNS around the NN , and VBZ in NNS four to five NNS RBR RB than NNS . In the NNP , one in every 68 NNS VBZ some NN of NN , a 30 NN NN from RB 2012 . Why VBZ that , you VBP VBG yourself ? NNP NNPS NNS VBP 50 NNS before NN seven , JJ that VBP NNS VBG JJ NN NNS , NN , NN ( yes , NN NN for the JJ ) , NN NN ( NN ) and NN , RB to VB a JJ NNS . NN NNS VBP the JJS NNS of NN , up to 25,000 NNS what the NNP VBZ as a NN in NN NN and JJ NN . NNP VBZ the JJ RBS JJ NN VBN to NN . Due to JJ NNS , the NNP VBP out of all NNS RB for the NNP , they VBP RB VBG out of three of the RBS JJ NNS on the NN NN : NN NN , NN ( JJ NN ) and of NN , the NN ( NNS , NNS , NN NN ) that VBD VBN in the NNP NN - NN - NN and JJS JJ NN - NN in NN , RB . VBG with NNP VBZ , the JJ NN NN of NN NN RB VBZ NN ( 50 NN NN ) . The JJ JJ JJ NNS and the NN of NNP NNS VBP VBN this JJ NN NNS to their NN ’s JJ NNS . JJ NNS VBP RB any NN NNS at all , in NN . Nor VBP the NNP VBG JJ NNP NNS like NN , NN NN and NN . This could RB VB because they VBP RB VB NN , VB JJ NNS , or NNS . RB , no NN VBN JJ NN will RB VB this NN of JJ NN vs. JJ NN , but the NN VBZ for itself . RB , the NNP VBZ to VB the NN NN and RB RB VBZ JJ NNS , JJ JJ NN NNS , NNS and JJ “ NNS ” like NN . It VBZ RB about NN and JJ NN these NNS , if you RB VBP NN that VBZ RB VB with a NN of JJ and JJ “ NN NNS , ” like NN NN NN , NN ’s NN or NN NN ."
68,277,mainstream,M0ae97,vaccine.autism,"It_PRP is_VBZ one_CD of_IN the_DT most_RBS serious_JJ allegations_NNS that_WDT could_MD be_VB made_VBN about_IN a_DT doctor_NN :_: manipulating_VBG patients_NNS '_POS histories_NNS to_TO make_VB money_NN ._. So_RB it_PRP is_VBZ no_DT wonder_NN that_IN the_DT charges_NNS ,_, levied_VBN by_IN editors_NNS of_IN the_DT British_NNP Medical_NNP Journal_NNP (_-LRB- BMJ_NNP )_-RRB- in_IN January_NNP against_IN medical_JJ researcher_NN Andrew_NNP Wakefield_NNP ,_, are_VBP still_RB getting_VBG close_JJ scrutiny_NN ._. Now_RB an_DT American_JJ whistleblower_NN advocacy_NN group_NN has_VBZ joined_VBN the_DT fray_NN over_IN Wakefield_NNP ,_, who_WP in_IN 1998_CD hypothesized_VBD a_DT link_NN ,_, now_RB scientifically_RB disproven_VBN ,_, between_IN the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN (_-LRB- MMR_NN )_-RRB- and_CC autism_NN ._. On_IN November_NNP 9_CD ,_, David_NNP Lewis_NNP of_IN the_DT National_NNP Whistleblower_NNP 's_POS Center_NNP in_IN Washington_NNP DC_NNP published_VBD a_DT letter_NN in_IN the_DT BMJ_NNP (_-LRB- http://bmj.com)_NNP arguing_VBG that_IN Wakefield_NNP did_VBD not_RB commit_VB research_NN fraud_NN ._. Lewis_NNP told_VBD Nature_NNP that_IN he_PRP thinks_VBZ the_DT combination_NN of_IN public_JJ charges_NNS and_CC a_DT slow_JJ ,_, secretive_JJ investigation_NN has_VBZ left_VBN the_DT public_NN not_RB knowing_VBG whom_WP to_TO believe_VB and_CC is_VBZ unfair_JJ to_IN the_DT accused_VBN researcher_NN ._. ""_`` [_-LRB- The_DT system_NN ]_-RRB- throws_VBZ people_NNS like_IN Andy_NNP into_IN a_DT no_DT -_HYPH man_NN 's_POS -_HYPH land_NN ,_, ""_'' Lewis_NNP says_VBZ ._. Wakefield_NNP was_VBD the_DT lead_JJ author_NN of_IN a_DT 1998_CD paper_NN in_IN The_DT Lancet_NNP (_-LRB- A._NNP J._NNP Wakefield_NNP et_FW al._FW Lancet_NNP 351_CD ,_, 637–641_CD ;_, 1998_CD )_-RRB- reporting_VBG on_IN the_DT case_NN histories_NNS of_IN 12_CD children_NNS who_WP had_VBD received_VBN the_DT MMR_NN vaccine_NN and_CC developed_VBD symptoms_NNS of_IN autism_NN or_CC inflammatory_JJ bowel_NN disease_NN ._. The_DT paper_NN inflamed_VBD public_JJ fears_NNS about_IN vaccines_NNS ,_, but_CC it_PRP was_VBD retracted_VBN in_IN 2010_CD after_IN the_DT UK_NNP General_NNP Medical_NNP Council_NNP (_-LRB- GMC_NNP )_-RRB- concluded_VBD that_IN Wakefield_NNP had_VBD a_DT charge_NN of_IN serious_JJ professional_JJ misconduct_NN to_TO answer_VB ,_, in_IN part_NN because_IN it_PRP found_VBD that_IN his_PRP$ team_NN did_VBD not_RB have_VB proper_JJ ethical_JJ approval_NN for_IN tests_NNS performed_VBN on_IN the_DT children_NNS ._. Later_RBR in_IN the_DT year_NN ,_, the_DT GMC_NNP found_VBD him_PRP guilty_JJ of_IN the_DT misconduct_NN charge_NN and_CC revoked_VBD his_PRP$ licence_NN to_TO practice_VB as_IN a_DT doctor_NN ._. By_IN then_RB ,_, more_JJR than_IN 12_CD large_JJ -_HYPH scale_NN epidemiological_JJ studies_NNS had_VBD failed_VBN to_TO find_VB evidence_NN of_IN the_DT hypothesized_VBN link_NN (_-LRB- J._NNP S._NNP Gerber_NNP and_CC P._NNP A._NNP Offit_NNP Clin._NNP Infect_NNP ._. Dis._NNP 48_CD ,_, 456–461_CD ;_, 2009_CD )_-RRB- and_CC the_DT MMR_NNP vaccine_NN is_VBZ today_NN regarded_VBN as_IN safe_JJ ._. But_CC was_VBD the_DT paper_NN merely_RB mistaken_JJ ,_, or_CC a_DT deliberate_JJ fraud_NN ?_. Articles_NNS by_IN medical_JJ journalist_NN Brian_NNP Deer_NNP published_VBN in_IN the_DT BMJ_NNP in_IN 2010_CD and_CC 2011_CD accused_VBD Wakefield_NNP of_IN reporting_VBG histories_NNS for_IN the_DT children_NNS that_WDT were_VBD not_RB consistent_JJ with_IN their_PRP$ records_NNS and_CC their_PRP$ parents_NNS '_POS recollections_NNS ,_, at_IN a_DT time_NN when_WRB Wakefield_NNP was_VBD also_RB being_VBG paid_VBN by_IN lawyers_NNS intending_VBG to_TO sue_VB MMR_NNP manufacturers_NNS ._. Deer_NNP 's_POS articles_NNS themselves_PRP did_VBD not_RB allege_VB fraud_NN ,_, but_CC on_IN their_PRP$ basis_NN a_DT BMJ_NNP editorial_NN in_IN January_NNP 2011_CD called_VBD the_DT paper_NN fraudulent_JJ ._. Wakefield_NNP has_VBZ always_RB denied_VBN allegations_NNS of_IN manipulating_VBG data_NNS or_CC having_VBG a_DT financial_JJ motive_NN in_IN the_DT Lancet_NNP paper_NN ,_, but_CC no_DT institution_NN has_VBZ yet_RB ruled_VBN on_IN the_DT matter_NN ._. In_IN March_NNP ,_, University_NNP College_NNP London_NNP (_-LRB- UCL_NNP )_-RRB- ,_, which_WDT took_VBD over_RP divisions_NNS of_IN the_DT Royal_NNP Free_NNP Hospital_NNP where_WRB Wakefield_NNP worked_VBD ,_, said_VBD it_PRP had_VBD launched_VBN an_DT investigation_NN ._. In_IN the_DT meantime_NN ,_, Lewis_NNP ,_, a_DT microbiologist_NN and_CC former_JJ whistleblower_NN who_WP says_VBZ he_PRP was_VBD falsely_RB accused_VBN of_IN misconduct_NN after_IN alleging_VBG links_NNS between_IN human_JJ illness_NN and_CC the_DT spreading_NN of_IN sewage_NN sludge_NN ,_, asked_VBD Wakefield_NNP for_IN the_DT chance_NN to_TO review_VB his_PRP$ files_NNS ._. His_PRP$ claims_NNS are_VBP not_RB likely_JJ to_TO challenge_VB the_DT conclusion_NN based_VBN on_IN much_JJ other_JJ evidence_NN that_IN the_DT vaccine_NN does_VBZ not_RB trigger_VB autism_NN ._. But_CC they_PRP could_MD complicate_VB the_DT debates_NNS about_IN Wakefield_NNP 's_POS integrity_NN and_CC the_DT UCL_NNP investigation_NN ._. The_DT documents_NNS that_WDT Lewis_NNP reviewed_VBD include_VBP confidential_JJ forms_NNS describing_VBG biopsies_NNS from_IN the_DT guts_NNS of_IN children_NNS ._. The_DT forms_NNS were_VBD filled_VBN out_RP by_IN pathologists_NNS Andrew_NNP Anthony_NNP and_CC Paul_NNP Dhillon_NNP ,_, who_WP worked_VBD with_IN Wakefield_NNP at_IN the_DT Royal_NNP Free_NNP ._. These_DT documents_NNS ,_, Lewis_NNP says_VBZ ,_, are_VBP relevant_JJ to_IN Deer_NNP 's_POS charge_NN that_IN records_NNS he_PRP obtained_VBD do_VB not_RB support_VB Wakefield_NNP 's_POS claims_NNS in_IN the_DT Lancet_NNP paper_NN that_IN the_DT children_NNS had_VBD nonspecific_JJ colitis_NN ,_, a_DT supposed_VBN element_NN of_IN an_DT MMR_NN -_HYPH induced_VBN syndrome_NN ._. On_IN sheets_NNS for_IN three_CD of_IN the_DT children_NNS graded_VBN by_IN Anthony_NNP ,_, the_DT handwritten_JJ word_NN ""_`` colitis_NN ""_'' appears_VBZ ,_, and_CC Dhillon_NNP checked_VBD a_DT box_NN labelled_VBN ""_`` non-specific_JJ ""_'' on_IN 10_CD forms_NNS ._. Anthony_NNP 's_POS sheets_NNS are_VBP dated_VBN after_IN the_DT Lancet_NNP publication_NN ,_, whereas_IN Dhillon_NNP 's_POS are_VBP dated_VBN before_RB ._. Lewis_NNP believes_VBZ that_IN the_DT sheets_NNS show_VBP that_IN Anthony_NNP and_CC Dhillon_NNP were_VBD making_VBG good_JJ -_HYPH faith_NN diagnoses_NNS of_IN colitis_NN ._. Anthony_NNP ,_, who_WP has_VBZ left_VBN UCL_NNP ,_, could_MD not_RB be_VB reached_VBN by_IN Nature_NNP ,_, and_CC Dhillon_NNP indicated_VBD that_IN UCL_NNP had_VBD told_VBN him_PRP not_RB to_TO comment_VB ._. (_-LRB- Neither_CC has_VBZ been_VBN accused_VBN of_IN manipulating_VBG data_NNS ._. )_-RRB- Before_IN publishing_VBG Lewis_NNP 's_POS letter_NN ,_, the_DT BMJ_NNP asked_VBD Ingvar_NNP Bjarnason_NNP ,_, a_DT gastroenterologist_NN at_IN King_NNP 's_POS College_NNP Hospital_NNP ,_, London_NNP ,_, to_TO review_VB the_DT materials_NNS ._. Bjarnason_NNP says_VBZ he_PRP does_VBZ n't_RB believe_VB they_PRP are_VBP sufficient_JJ to_TO support_VB claims_NNS in_IN the_DT Lancet_NNP paper_NN of_IN a_DT new_JJ disease_NN process_NN ._. He_PRP also_RB questions_VBZ whether_IN ""_`` non-specific_JJ ""_'' on_IN the_DT grading_NN sheets_NNS refers_VBZ to_IN colitis_NN ,_, saying_VBG it_PRP could_MD refer_VB to_IN any_DT kind_NN of_IN gut_NN changes_NNS ._. But_CC he_PRP says_VBZ that_IN the_DT forms_NNS do_VBP n't_RB clearly_RB support_VB charges_NNS that_IN Wakefield_NNP deliberately_RB misinterpreted_VBD the_DT records_NNS ._. ""_`` The_DT data_NNS are_VBP subjective_JJ ._. It_PRP 's_VBZ different_JJ to_TO say_VB it_PRP 's_VBZ deliberate_JJ falsification_NN ,_, ""_'' he_PRP says_VBZ ._. Deer_NNP notes_VBZ that_IN he_PRP never_RB accused_VBD Wakefield_NNP of_IN fraud_NN over_IN his_PRP$ interpretation_NN of_IN pathology_NN records_NNS ._. But_CC he_PRP says_VBZ that_IN records_NNS read_VBD to_IN him_PRP from_IN the_DT Royal_NNP Free_NNP pathology_NN service_NN clearly_RB stated_VBD that_IN the_DT children_NNS 's_POS gut_NN biopsies_NNS were_VBD within_IN normal_JJ limits_NNS ,_, even_RB though_IN they_PRP were_VBD reported_VBN in_IN the_DT Lancet_NNP paper_NN as_IN having_VBG enterocolitis_NN ._. Fiona_NNP Godlee_NNP ,_, the_DT editor_NN of_IN the_DT BMJ_NNP ,_, says_VBZ that_IN the_DT journal_NN 's_POS conclusion_NN of_IN fraud_NN was_VBD not_RB based_VBN on_IN the_DT pathology_NN but_CC on_IN a_DT number_NN of_IN discrepancies_NNS between_IN the_DT children_NNS 's_POS records_NNS and_CC the_DT claims_NNS in_IN the_DT Lancet_NNP paper_NN ._. She_PRP says_VBZ she_PRP will_MD be_VB calling_VBG for_IN a_DT public_JJ inquiry_NN into_IN the_DT matter_NN ,_, noting_VBG that_IN it_PRP has_VBZ been_VBN more_JJR than_IN a_DT year_NN since_IN she_PRP first_RB informed_VBD UCL_NNP about_IN concerns_NNS over_IN Wakefield_NNP 's_POS work_NN ._. Wakefield_NNP denies_VBZ charges_NNS of_IN data_NN manipulation_NN ._. He_PRP says_VBZ that_IN UCL_NNP has_VBZ yet_RB to_TO officially_RB request_VB his_PRP$ response_NN to_IN any_DT charges_NNS and_CC he_PRP is_VBZ n't_RB convinced_VBN that_IN the_DT inquiry_NN will_MD give_VB him_PRP a_DT fair_JJ hearing_NN ._. A_DT UCL_NNP spokesman_NN says_VBZ that_IN the_DT investigation_NN will_MD be_VB ""_`` thorough_JJ ,_, fair_JJ and_CC wide_JJ -_HYPH ranging_VBG ""_'' ._. But_CC eight_CD months_NNS after_IN announcing_VBG its_PRP$ inquiry_NN ,_, the_DT university_NN is_VBZ still_RB looking_VBG for_IN a_DT suitable_JJ external_JJ chairman_NN ._. This_DT article_NN is_VBZ reproduced_VBN with_IN permission_NN from_IN the_DT magazine_NN Nature_NNP ._. The_DT article_NN was_VBD first_RB published_VBN on_IN November_NNP 9_CD ,_, 2011_CD ._.","It VBZ one of the RBS JJ NNS that could VB VBN about a NN : VBG NNS ' NNS to VB NN . RB it VBZ no NN that the NNS , VBN by NNS of the NNP NNP NNP ( NNP ) in NNP against JJ NN NNP NNP , VBP RB VBG JJ NN . RB an JJ NN NN NN VBZ VBN the NN over NNP , who in 1998 VBD a NN , RB RB VBN , between the NNS , NNS and NN NN ( NN ) and NN . On NNP 9 , NNP NNP of the NNP NNP 's NNP in NNP NNP VBD a NN in the NNP ( NNP VBG that NNP VBD RB VB NN NN . NNP VBD NNP that he VBZ the NN of JJ NNS and a JJ , JJ NN VBZ VBN the NN RB VBG whom to VB and VBZ JJ to the VBN NN . "" [ The NN ] VBZ NNS like NNP into a no - NN 's - NN , "" NNP VBZ . NNP VBD the JJ NN of a 1998 NN in The NNP ( NNP NNP NNP FW FW NNP 351 , 637–641 ; 1998 ) VBG on the NN NNS of 12 NNS who VBD VBN the NN NN and VBD NNS of NN or JJ NN NN . The NN VBD JJ NNS about NNS , but it VBD VBN in 2010 after the NNP NNP NNP NNP ( NNP ) VBD that NNP VBD a NN of JJ JJ NN to VB , in NN because it VBD that his NN VBD RB VB JJ JJ NN for NNS VBN on the NNS . RBR in the NN , the NNP VBD him JJ of the NN NN and VBD his NN to VB as a NN . By RB , JJR than 12 JJ - NN JJ NNS VBD VBN to VB NN of the VBN NN ( NNP NNP NNP and NNP NNP NNP NNP NNP . NNP 48 , 456–461 ; 2009 ) and the NNP NN VBZ NN VBN as JJ . But VBD the NN RB JJ , or a JJ NN ? NNS by JJ NN NNP NNP VBN in the NNP in 2010 and 2011 VBD NNP of VBG NNS for the NNS that VBD RB JJ with their NNS and their NNS ' NNS , at a NN when NNP VBD RB VBG VBN by NNS VBG to VB NNP NNS . NNP 's NNS themselves VBD RB VB NN , but on their NN a NNP NN in NNP 2011 VBD the NN JJ . NNP VBZ RB VBN NNS of VBG NNS or VBG a JJ NN in the NNP NN , but no NN VBZ RB VBN on the NN . In NNP , NNP NNP NNP ( NNP ) , which VBD over NNS of the NNP NNP NNP where NNP VBD , VBD it VBD VBN an NN . In the NN , NNP , a NN and JJ NN who VBZ he VBD RB VBN of NN after VBG NNS between JJ NN and the NN of NN NN , VBD NNP for the NN to VB his NNS . His NNS VBP RB JJ to VB the NN VBN on JJ JJ NN that the NN VBZ RB VB NN . But they could VB the NNS about NNP 's NN and the NNP NN . The NNS that NNP VBD VBP JJ NNS VBG NNS from the NNS of NNS . The NNS VBD VBN out by NNS NNP NNP and NNP NNP , who VBD with NNP at the NNP NNP . These NNS , NNP VBZ , VBP JJ to NNP 's NN that NNS he VBD VB RB VB NNP 's NNS in the NNP NN that the NNS VBD JJ NN , a VBN NN of an NN - VBN NN . On NNS for three of the NNS VBN by NNP , the JJ NN "" NN "" VBZ , and NNP VBD a NN VBN "" JJ "" on 10 NNS . NNP 's NNS VBP VBN after the NNP NN , whereas NNP 's VBP VBN RB . NNP VBZ that the NNS VBP that NNP and NNP VBD VBG JJ - NN NNS of NN . NNP , who VBZ VBN NNP , could RB VB VBN by NNP , and NNP VBD that NNP VBD VBN him RB to VB . ( Neither VBZ VBN VBN of VBG NNS . ) Before VBG NNP 's NN , the NNP VBD NNP NNP , a NN at NNP 's NNP NNP , NNP , to VB the NNS . NNP VBZ he VBZ RB VB they VBP JJ to VB NNS in the NNP NN of a JJ NN NN . He RB VBZ whether "" JJ "" on the NN NNS VBZ to NN , VBG it could VB to any NN of NN NNS . But he VBZ that the NNS VBP RB RB VB NNS that NNP RB VBD the NNS . "" The NNS VBP JJ . It VBZ JJ to VB it VBZ JJ NN , "" he VBZ . NNP VBZ that he RB VBD NNP of NN over his NN of NN NNS . But he VBZ that NNS VBD to him from the NNP NNP NN NN RB VBD that the NNS 's NN NNS VBD within JJ NNS , RB though they VBD VBN in the NNP NN as VBG NN . NNP NNP , the NN of the NNP , VBZ that the NN 's NN of NN VBD RB VBN on the NN but on a NN of NNS between the NNS 's NNS and the NNS in the NNP NN . She VBZ she will VB VBG for a JJ NN into the NN , VBG that it VBZ VBN JJR than a NN since she RB VBD NNP about NNS over NNP 's NN . NNP VBZ NNS of NN NN . He VBZ that NNP VBZ RB to RB VB his NN to any NNS and he VBZ RB VBN that the NN will VB him a JJ NN . A NNP NN VBZ that the NN will VB "" JJ , JJ and JJ - VBG "" . But eight NNS after VBG its NN , the NN VBZ RB VBG for a JJ JJ NN . This NN VBZ VBN with NN from the NN NNP . The NN VBD RB VBN on NNP 9 , 2011 ."
69,1236,mainstream,M0b0e8,vaccine.covid,"Rinderpest_NNP (_-LRB- also_RB cattle_NN plague_NN or_CC steppe_NN murrain_NN )_-RRB- was_VBD an_DT infectious_JJ viral_JJ disease_NN of_IN cattle_NN ,_, domestic_JJ buffalo_NN ,_, and_CC many_JJ other_JJ species_NNS of_IN even_RB -_HYPH toed_VBN ungulates_NNS ,_, including_VBG buffaloes_NNS ,_, large_JJ antelope_NN ,_, deer_NN ,_, giraffes_NNS ,_, wildebeests_NNS ,_, and_CC warthogs_NNS ._. [_-LRB- 2_CD ]_-RRB- The_DT disease_NN was_VBD characterized_VBN by_IN fever_NN ,_, oral_JJ erosions_NNS ,_, diarrhea_NN ,_, lymphoid_JJ necrosis_NN ,_, and_CC high_JJ mortality_NN ._. Death_NN rates_NNS during_IN outbreaks_NNS were_VBD usually_RB extremely_RB high_JJ ,_, approaching_VBG 100_CD %_NN in_IN immunologically_RB naïve_JJ populations_NNS ._. [_-LRB- 3_CD ]_-RRB- Rinderpest_NNP was_VBD mainly_RB transmitted_VBN by_IN direct_JJ contact_NN and_CC by_IN drinking_VBG contaminated_VBN water_NN ,_, although_IN it_PRP could_MD also_RB be_VB transmitted_VBN by_IN air_NN ._. [_-LRB- 4_CD ]_-RRB- After_IN a_DT global_JJ eradication_NN campaign_NN since_IN the_DT mid-20th_JJ century_NN ,_, the_DT last_JJ confirmed_VBN case_NN of_IN rinderpest_NN was_VBD diagnosed_VBN in_IN 2001_CD ._. [_-LRB- 5_CD ]_-RRB- On_IN 14_CD October_NNP 2010_CD ,_, the_DT United_NNP Nations_NNPS Food_NNP and_CC Agriculture_NNP Organization_NNP (_-LRB- FAO_NNP )_-RRB- announced_VBD that_IN field_NN activities_NNS in_IN the_DT decades_NNS -_HYPH long_JJ ,_, worldwide_JJ campaign_NN to_TO eradicate_VB the_DT disease_NN were_VBD ending_VBG ,_, paving_VBG the_DT way_NN for_IN a_DT formal_JJ declaration_NN in_IN June_NNP 2011_CD of_IN the_DT global_JJ eradication_NN of_IN rinderpest_NN ._. [_-LRB- 6_CD ]_-RRB- On_IN 25_CD May_NNP 2011_CD ,_, the_DT World_NNP Organisation_NNP for_IN Animal_NNP Health_NNP announced_VBD the_DT free_JJ status_NN of_IN the_DT last_JJ eight_CD countries_NNS not_RB yet_RB recognized_VBN (_-LRB- a_DT total_NN of_IN 198_CD countries_NNS were_VBD now_RB free_JJ of_IN the_DT disease_NN )_-RRB- ,_, officially_RB declaring_VBG the_DT eradication_NN of_IN the_DT disease_NN ._. [_-LRB- 7_CD ]_-RRB- In_IN June_NNP 2011_CD ,_, the_DT United_NNP Nations_NNPS FAO_NNP confirmed_VBD the_DT disease_NN was_VBD eradicated_VBN ,_, making_VBG rinderpest_NN only_RB the_DT second_JJ disease_NN in_IN history_NN to_TO be_VB fully_RB wiped_VBN out_RP (_-LRB- outside_IN laboratory_NN stocks_NNS )_-RRB- ,_, following_VBG smallpox_NN ._. [_-LRB- 8_CD ]_-RRB- In_IN June_NNP 2019_CD the_DT UK_NNP destroyed_VBD its_PRP$ stocks_NNS of_IN rinderpest_JJ virus_NN ,_, held_VBN at_IN the_DT Pirbright_NNP Institute_NNP in_IN Surrey_NNP ,_, which_WDT were_VBD most_JJS of_IN the_DT world_NN 's_POS retained_VBN samples_NNS ._. This_DT followed_VBD the_DT compilation_NN of_IN a_DT digital_JJ record_NN of_IN the_DT virus_NN 's_POS genetic_JJ code_NN ,_, thereby_RB obviating_VBG the_DT need_NN to_TO store_VB samples_NNS as_IN a_DT protective_JJ resource_NN in_IN case_NN the_DT virus_NN re-emerges_VBZ ._. Researchers_NNS at_IN Pirbright_NNP and_CC the_DT United_NNP Nations_NNPS expressed_VBD a_DT hope_NN that_IN the_DT other_JJ samples_NNS in_IN laboratories_NNS around_IN the_DT world_NN will_MD also_RB be_VB destroyed_VBN ,_, totally_RB eradicating_VBG the_DT virus_NN from_IN the_DT Earth_NNP ._. [_-LRB- 9_CD ]_-RRB- Rinderpest_NNP is_VBZ believed_VBN to_TO have_VB originated_VBN in_IN Asia_NNP ,_, later_RBR spreading_VBG through_IN the_DT transport_NN of_IN cattle_NNS ._. [_-LRB- 10_CD ]_-RRB- The_DT term_NN Rinderpest_NNP is_VBZ a_DT German_JJ word_NN meaning_VBG ""_`` cattle_NN -_HYPH plague_NN ""_'' ._. [_-LRB- 2_CD ]_-RRB- [_-LRB- 10_CD ]_-RRB- The_DT rinderpest_NN virus_NN (_-LRB- RPV_NN )_-RRB- was_VBD closely_RB related_JJ to_IN the_DT measles_NNS and_CC canine_NN distemper_NN viruses_NNS ._. [_-LRB- 11_CD ]_-RRB- The_DT measles_NNS virus_NN possibly_RB emerged_VBD from_IN rinderpest_NN as_IN a_DT zoonotic_JJ disease_NN around_IN 600_CD BC_NN ,_, a_DT period_NN that_WDT coincides_VBZ with_IN the_DT rise_NN of_IN large_JJ human_JJ settlements_NNS ._. [_-LRB- 12_CD ]_-RRB- [_-LRB- 13_CD ]_-RRB- Rinderpest_NNP virus_NN (_-LRB- RPV_NNP )_-RRB- ,_, a_DT member_NN of_IN the_DT genus_NN Morbillivirus_NNP ,_, is_VBZ closely_RB related_JJ to_IN the_DT measles_NNS and_CC canine_NN distemper_NN viruses_NNS ._. [_-LRB- 11_CD ]_-RRB- Like_IN other_JJ members_NNS of_IN the_DT Paramyxoviridae_NNP family_NN ,_, it_PRP produces_VBZ enveloped_VBN virions_NNS ,_, and_CC is_VBZ a_DT negative_JJ -_HYPH sense_NN single_JJ -_HYPH stranded_VBN RNA_NN virus_NN ._. The_DT virus_NN was_VBD particularly_RB fragile_JJ and_CC is_VBZ quickly_RB inactivated_VBN by_IN heat_NN ,_, desiccation_NN and_CC sunlight_NN ._. [_-LRB- 14_CD ]_-RRB- Measles_NN virus_NN evolved_VBD from_IN the_DT then_RB -_HYPH widespread_JJ rinderpest_NN virus_NN most_RBS probably_RB between_IN the_DT 11th_JJ and_CC 12th_JJ centuries_NNS ._. [_-LRB- 13_CD ]_-RRB- The_DT earliest_JJS likely_JJ origin_NN is_VBZ during_IN the_DT seventh_JJ century_NN ;_, some_DT linguistic_JJ evidence_NN exists_VBZ for_IN this_DT earlier_JJR origin_NN ._. [_-LRB- 15_CD ]_-RRB- [_-LRB- 16_CD ]_-RRB- Death_NN rates_NNS during_IN outbreaks_NNS were_VBD usually_RB extremely_RB high_JJ ,_, approaching_VBG 100_CD %_NN in_IN immunologically_RB naïve_JJ populations_NNS ._. [_-LRB- 3_CD ]_-RRB- The_DT disease_NN was_VBD mainly_RB spread_VBN by_IN direct_JJ contact_NN and_CC by_IN drinking_VBG contaminated_VBN water_NN ,_, although_IN it_PRP could_MD also_RB be_VB transmitted_VBN by_IN air_NN ._. [_-LRB- 4_CD ]_-RRB- Initial_JJ symptoms_NNS include_VBP fever_NN ,_, loss_NN of_IN appetite_NN ,_, and_CC nasal_JJ and_CC eye_NN discharges_NNS ._. Subsequently_RB ,_, irregular_JJ erosions_NNS appear_VBP in_IN the_DT mouth_NN ,_, the_DT lining_NN of_IN the_DT nose_NN ,_, and_CC the_DT genital_JJ tract_NN ._. [_-LRB- 3_CD ]_-RRB- Acute_JJ diarrhea_NN ,_, preceded_VBN by_IN constipation_NN ,_, is_VBZ also_RB a_DT common_JJ feature_NN ._. [_-LRB- 4_CD ]_-RRB- Most_JJS animals_NNS die_VBP 6_CD -_SYM 12_CD days_NNS after_IN the_DT onset_NN of_IN these_DT clinical_JJ signs_NNS ._. [_-LRB- 3_CD ]_-RRB- The_DT disease_NN is_VBZ believed_VBN to_TO have_VB originated_VBN in_IN Asia_NNP ,_, later_RBR spreading_VBG through_IN the_DT transport_NN of_IN cattle_NNS ._. [_-LRB- 10_CD ]_-RRB- Other_JJ cattle_NN epizootics_NNS are_VBP noted_VBN in_IN ancient_JJ times_NNS :_: a_DT cattle_NN plague_NN is_VBZ thought_VBN to_TO be_VB one_CD of_IN the_DT 10_CD plagues_NNS of_IN Egypt_NNP described_VBN in_IN the_DT Hebrew_NNP Bible_NNP ._. By_IN around_RB 3,000_CD BC_NN ,_, a_DT cattle_NN plague_NN had_VBD reached_VBN Egypt_NNP ,_, and_CC rinderpest_NN later_RBR spread_VBD throughout_IN the_DT remainder_NN of_IN Africa_NNP ,_, following_VBG European_JJ colonization_NN ._. [_-LRB- 10_CD ]_-RRB- In_IN the_DT 4th_JJ century_NN Roman_JJ writer_NN Severus_NNP Sanctus_NNP Endelechius_NNP described_VBD rinderpest_NN in_IN his_PRP$ book_NN ,_, On_IN the_DT Deaths_NNPS of_IN Cattle_NNP ._. [_-LRB- 17_CD ]_-RRB- Cattle_NN plagues_NNS recurred_VBD throughout_IN history_NN ,_, often_RB accompanying_VBG wars_NNS and_CC military_JJ campaigns_NNS ._. They_PRP hit_VBD Europe_NNP especially_RB hard_RB in_IN the_DT 18th_JJ century_NN ,_, with_IN three_CD long_JJ panzootics_NNS ,_, which_WDT although_IN varying_VBG in_IN intensity_NN and_CC duration_NN from_IN region_NN to_IN region_NN ,_, took_VBD place_NN in_IN the_DT periods_NNS of_IN 1709_CD –_SYM 1720_CD ,_, 1742_CD –1760_CD ,_, and_CC 1768_CD –1786_CD ._. [_-LRB- 18_CD ]_-RRB- In_IN the_DT early_JJ 18th_JJ century_NN ,_, the_DT disease_NN was_VBD seen_VBN as_IN similar_JJ to_IN smallpox_NN ,_, due_IN to_IN its_PRP$ analogous_JJ symptoms_NNS ._. The_DT personal_JJ physician_NN of_IN the_DT pope_NN ,_, Giovanni_NNP Maria_NNP Lancisi_NNP ,_, recommended_VBD the_DT destruction_NN of_IN all_DT infected_JJ and_CC exposed_VBN animals_NNS ._. This_DT policy_NN was_VBD not_RB very_RB popular_JJ and_CC used_VBN only_RB sparingly_RB in_IN the_DT first_JJ part_NN of_IN the_DT century_NN ._. Later_RBR ,_, it_PRP was_VBD used_VBN successfully_RB in_IN several_JJ countries_NNS ,_, although_IN it_PRP was_VBD sometimes_RB seen_VBN as_IN too_RB costly_JJ or_CC drastic_JJ ,_, and_CC depended_VBD on_IN a_DT strong_JJ central_JJ authority_NN to_TO be_VB effective_JJ (_-LRB- which_WDT was_VBD notably_RB lacking_VBG in_IN the_DT Dutch_NNP Republic_NNP )_-RRB- ._. Because_IN of_IN these_DT downsides_NNS ,_, numerous_JJ attempts_NNS were_VBD made_VBN to_TO inoculate_VB animals_NNS against_IN the_DT disease_NN ._. These_DT attempts_NNS met_VBD with_IN varying_VBG success_NN ,_, but_CC the_DT procedure_NN was_VBD not_RB widely_RB used_VBN and_CC was_VBD no_RB longer_RBR practiced_VBN at_IN all_DT in_IN 19th_JJ -_HYPH century_NN Western_JJ or_CC Central_JJ Europe_NNP ._. Rinderpest_NNP was_VBD an_DT immense_JJ problem_NN ,_, but_CC inoculation_NN was_VBD not_RB a_DT valid_JJ solution_NN ._. In_IN many_JJ cases_NNS ,_, it_PRP caused_VBD too_RB many_JJ losses_NNS ._. Even_RB more_RBR importantly_RB ,_, it_PRP perpetuated_VBD the_DT circulation_NN of_IN the_DT virus_NN in_IN the_DT cattle_NN population_NN ._. The_DT pioneers_NNS of_IN inoculation_NN did_VBD contribute_VB significantly_RB to_IN knowledge_NN about_IN infectious_JJ diseases_NNS ._. Their_PRP$ experiments_NNS confirmed_VBD the_DT concepts_NNS of_IN those_DT who_WP saw_VBD infectious_JJ diseases_NNS as_IN caused_VBN by_IN specific_JJ agents_NNS ,_, and_CC were_VBD the_DT first_JJ to_TO recognize_VB maternally_RB derived_VBN immunity_NN ._. [_-LRB- 11_CD ]_-RRB- The_DT first_JJ written_VBN report_NN of_IN rinderpest_NN inoculation_NN was_VBD published_VBN in_IN a_DT letter_NN signed_VBN ""_`` T.S._NNP ""_'' in_IN the_DT November_NNP 1754_CD issue_NN of_IN The_DT Gentleman_NNP 's_POS Magazine_NNP ,_, [_-LRB- 11_CD ]_-RRB- a_DT widely_RB read_VBN journal_NN which_WDT also_RB supported_VBD the_DT progress_NN of_IN smallpox_NN inoculation_NN ._. This_DT letter_NN reported_VBD that_IN a_DT Mr_NNP Dobsen_NNP had_VBD inoculated_VBN his_PRP$ cattle_NNS and_CC had_VBD thus_RB preserved_VBN 9_CD out_IN of_IN 10_CD of_IN them_PRP ,_, although_IN this_DT was_VBD retracted_VBN in_IN the_DT next_JJ issue_NN ,_, as_IN it_PRP was_VBD apparently_RB a_DT Sir_NNP William_NNP St._NNP Quintin_NNP who_WP had_VBD done_VBN the_DT inoculating_NN (_-LRB- this_DT was_VBD done_VBN by_IN placing_VBG bits_NNS of_IN material_NN previously_RB dipped_VBN in_IN morbid_JJ discharge_NN into_IN an_DT incision_NN made_VBN in_IN the_DT dewlap_NN of_IN the_DT animal_NN )_-RRB- ._. These_DT letters_NNS encouraged_VBD further_JJ application_NN of_IN inoculation_NN in_IN the_DT fight_NN against_IN diseases_NNS ._. The_DT first_JJ inoculation_NN against_IN measles_NNS was_VBD made_VBN three_CD years_NNS after_IN their_PRP$ publication_NN ._. [_-LRB- 11_CD ]_-RRB- From_IN early_JJ 1755_CD onwards_RB ,_, experiments_NNS were_VBD taking_VBG place_NN in_IN the_DT Netherlands_NNPS ,_, as_RB well_RB ,_, results_NNS of_IN which_WDT were_VBD also_RB published_VBN in_IN The_DT Gentleman_NNP 's_POS Magazine_NNP ._. As_IN in_IN England_NNP ,_, the_DT disease_NN was_VBD seen_VBN as_IN analogous_JJ with_IN smallpox_NN ._. While_IN these_DT experiments_NNS were_VBD reasonably_RB successful_JJ ,_, they_PRP did_VBD not_RB have_VB a_DT significant_JJ impact_NN :_: The_DT total_JJ number_NN of_IN inoculations_NNS in_IN England_NNP appears_VBZ to_TO have_VB been_VBN very_RB limited_VBN ,_, and_CC after_IN 1780_CD ,_, the_DT English_JJ interest_NN in_IN inoculation_NN disappeared_VBD almost_RB entirely_RB ._. [_-LRB- 11_CD ]_-RRB- Almost_RB all_DT further_JJR experimentation_NN was_VBD done_VBN in_IN the_DT Netherlands_NNPS ,_, northern_JJ Germany_NNP and_CC Denmark_NNP ._. Further_JJR trials_NNS in_IN the_DT Netherlands_NNP Due_IN to_IN a_DT very_RB severe_JJ outbreak_NN at_IN the_DT end_NN of_IN the_DT 1760s_NNS ,_, some_DT of_IN the_DT best_RBS -_HYPH known_VBN names_NNS in_IN Dutch_JJ medicine_NN became_VBD involved_JJ in_IN the_DT struggle_NN against_IN the_DT disease_NN ._. Several_JJ independent_JJ trials_NNS were_VBD begun_VBN ,_, most_RBS notably_RB by_IN Pieter_NNP Camper_NNP in_IN Groningen_NNP and_CC Friesland_NNP ._. The_DT results_NNS of_IN his_PRP$ experiment_NN in_IN Friesland_NNP were_VBD encouraging_VBG ,_, but_CC they_PRP proved_VBD to_TO be_VB the_DT exception_NN ;_, testing_NN by_IN others_NNS in_IN the_DT provinces_NNS of_IN Utrecht_NNP and_CC Friesland_NNP obtained_VBD disastrous_JJ results_NNS ._. As_IN a_DT result_NN ,_, the_DT Frisian_JJ authorities_NNS concluded_VBD in_IN 1769_CD that_IN the_DT cause_NN of_IN rinderpest_NN was_VBD God_NNP 's_POS displeasure_NN with_IN the_DT sinful_JJ behavior_NN of_IN the_DT Frisian_JJ people_NNS ,_, and_CC proclaimed_VBD 15_CD November_NNP a_DT day_NN of_IN fasting_NN and_CC prayer_NN ._. Interest_NN in_IN inoculation_NN declined_VBD sharply_RB across_IN the_DT country_NN ._. [_-LRB- 11_CD ]_-RRB- In_IN this_DT climate_NN of_IN discouragement_NN and_CC scepticism_NN ,_, Geert_NNP Reinders_NNP ,_, a_DT farmer_NN in_IN the_DT province_NN of_IN Groningen_NNP and_CC a_DT self_NN -_HYPH taught_VBN man_NN ,_, decided_VBD to_TO continue_VB the_DT experiments_NNS ._. He_PRP collaborated_VBD with_IN Wijnold_NNP Munniks_NNP ,_, who_WP had_VBD supervised_VBN earlier_JJR trials_NNS ._. They_PRP tried_VBD different_JJ inoculation_NN procedures_NNS and_CC a_DT variety_NN of_IN treatments_NNS to_TO lighten_VB the_DT symptoms_NNS ,_, all_DT of_IN them_PRP without_IN significant_JJ effect_NN ._. Although_IN they_PRP were_VBD not_RB able_JJ to_TO perfect_VB the_DT inoculation_NN procedure_NN ,_, they_PRP did_VBD make_VB some_DT useful_JJ observations_NNS ._. [_-LRB- 11_CD ]_-RRB- Reinders_NNPS resumed_VBD his_PRP$ experiments_NNS in_IN 1774_CD ,_, concentrating_VBG on_IN the_DT inoculation_NN of_IN calves_NNS from_IN cows_NNS that_WDT had_VBD recovered_VBN from_IN rinderpest_NN ._. He_PRP was_VBD probably_RB the_DT first_JJ to_TO make_VB practical_JJ use_NN of_IN maternally_RB derived_VBN immunity_NN ._. [_-LRB- 11_CD ]_-RRB- The_DT detailed_JJ results_NNS of_IN his_PRP$ trials_NNS were_VBD published_VBN in_IN 1776_CD and_CC reprinted_VBN in_IN 1777_CD ._. His_PRP$ inoculation_NN procedure_NN did_VBD not_RB differ_VB much_RB from_IN what_WP had_VBD been_VBN used_VBN previously_RB ,_, except_IN for_IN the_DT use_NN of_IN three_CD separate_JJ inoculations_NNS at_IN an_DT early_JJ age_NN ._. This_DT produced_VBD far_RB better_JJR results_NNS ,_, and_CC the_DT publication_NN of_IN his_PRP$ work_NN renewed_VBN interest_NN in_IN inoculation_NN ._. For_IN the_DT period_NN of_IN 1777_CD to_IN 1781_CD ,_, 89_CD %_NN of_IN inoculated_VBN animals_NNS survived_VBD ,_, compared_VBN to_IN a_DT 29_CD %_NN survival_NN rate_NN after_IN natural_JJ infection_NN ._. [_-LRB- 11_CD ]_-RRB- In_IN the_DT Netherlands_NNPS ,_, too_RB ,_, interest_NN in_IN rinderpest_JJ inoculation_NN declined_VBD in_IN the_DT 1780s_NNS because_IN the_DT disease_NN itself_PRP decreased_VBD in_IN intensity_NN ._. Apart_RB from_IN the_DT Dutch_NNP Republic_NNP ,_, the_DT only_JJ other_JJ regions_NNS where_WRB inoculation_NN was_VBD used_VBN to_IN any_DT significant_JJ level_NN were_VBD northern_JJ Germany_NNP and_CC Denmark_NNP ._. Experiments_NNS started_VBD in_IN Mecklenburg_NNP during_IN the_DT epizootic_NN of_IN the_DT late_JJ 1770s_NNS ._. ""_`` Insurance_NN companies_NNS ""_'' were_VBD created_VBN which_WDT provided_VBD inoculation_NN in_IN special_JJ ""_`` institutes_NNS ""_'' ._. Although_IN these_DT were_VBD private_JJ initiatives_NNS ,_, they_PRP were_VBD created_VBN with_IN full_JJ encouragement_NN from_IN the_DT authorities_NNS ._. Though_IN neighboring_VBG states_NNS followed_VBD this_DT practice_NN with_IN interest_NN ,_, the_DT practice_NN never_RB caught_VBD on_RP outside_IN Mecklenburg_NNP ;_, many_JJ were_VBD still_RB opposed_VBN to_IN inoculation_NN ._. [_-LRB- 11_CD ]_-RRB- While_IN some_DT experimentation_NN occurred_VBD in_IN other_JJ countries_NNS (_-LRB- most_RBS extensively_RB in_IN Denmark_NNP )_-RRB- ,_, in_IN the_DT majority_NN of_IN European_JJ countries_NNS ,_, the_DT struggle_NN against_IN the_DT disease_NN was_VBD based_VBN on_IN stamping_VBG it_PRP out_RP ._. Sometimes_RB this_DT could_MD be_VB done_VBN with_IN minimal_JJ sacrifices_NNS ;_, at_IN other_JJ times_NNS ,_, it_PRP required_VBD slaughter_NN at_IN a_DT massive_JJ scale_NN ._. [_-LRB- 11_CD ]_-RRB- A_DT major_JJ outbreak_NN affected_VBD the_DT whole_NN of_IN the_DT British_NNP Isles_NNPS for_IN three_CD years_NNS after_IN 1865_CD ._. [_-LRB- 19_CD ]_-RRB- Around_IN the_DT turn_NN of_IN the_DT century_NN ,_, a_DT plague_NN struck_VBD in_IN Southern_NNP Africa_NNP ._. [_-LRB- 19_CD ]_-RRB- The_DT outbreak_NN in_IN the_DT 1890s_NNS killed_VBD an_DT estimated_VBN 80_CD to_IN 90_CD %_NN of_IN all_DT cattle_NNS in_IN eastern_JJ and_CC southern_JJ Africa_NNP ,_, as_RB well_RB as_IN in_IN the_DT Horn_NNP of_IN Africa_NNP ._. Sir_NNP Arnold_NNP Theiler_NNP was_VBD instrumental_JJ in_IN developing_VBG a_DT vaccine_NN that_WDT curbed_VBD the_DT epizootic_NN ._. The_DT loss_NN of_IN animals_NNS caused_VBD famine_NN which_WDT depopulated_VBD sub-Saharan_JJ Africa_NNP ,_, allowing_VBG thornbush_NN to_TO colonise_VB ._. This_DT formed_VBD ideal_JJ habitat_NN for_IN tsetse_NN fly_NN ,_, which_WDT carries_VBZ sleeping_NN sickness_NN ,_, and_CC is_VBZ unsuitable_JJ for_IN livestock_NN ._. [_-LRB- 20_CD ]_-RRB- In_IN his_PRP$ classic_JJ study_NN of_IN the_DT Nuer_NNP of_IN southern_JJ Sudan_NNP ,_, E._NNP E._NNP Evans_NNP -_HYPH Pritchard_NNP suggested_VBD rinderpest_NN might_MD have_VB affected_VBN the_DT Nuer_NNP 's_POS social_JJ organization_NN before_IN and_CC during_IN the_DT 1930s_NNS ._. Since_IN the_DT Nuer_NNPS were_VBD pastoralists_NNS ,_, much_JJ of_IN their_PRP$ livelihood_NN was_VBD based_VBN on_IN cattle_NN husbandry_NN ,_, and_CC bride_NN -_HYPH prices_NNS were_VBD paid_VBN in_IN cattle_NN ;_, prices_NNS may_MD have_VB changed_VBN as_IN a_DT result_NN of_IN cattle_NN depletion_NN ._. Rinderpest_NNP might_MD also_RB have_VB increased_VBN dependence_NN on_IN horticulture_NN among_IN the_DT Nuer_NNP ._. [_-LRB- 21_CD ]_-RRB- A_DT more_RBR recent_JJ rinderpest_NN outbreak_NN in_IN Africa_NNP in_IN 1982_CD –1984_CD resulted_VBD in_IN an_DT estimated_VBN US_NNP $_$ 2_CD billion_CD in_IN stock_NN losses_NNS ._. [_-LRB- 22_CD ]_-RRB- In_IN 1917_CD –_SYM 18_CD ,_, William_NNP Hutchins_NNP Boynton_NNP (_-LRB- 1881_CD –1959_CD )_-RRB- ,_, the_DT chief_JJ veterinary_NN pathologist_NN with_IN the_DT Philippine_NNP Bureau_NNP of_IN Agriculture_NNP ,_, developed_VBD an_DT early_JJ vaccine_NN for_IN rinderpest_NN ,_, based_VBN on_IN treated_VBN animal_NN organ_NN extracts_NNS ._. [_-LRB- 23_CD ]_-RRB- [_-LRB- 24_CD ]_-RRB- Walter_NNP Plowright_NNP worked_VBD on_IN a_DT vaccine_NN for_IN the_DT RBOK_NNP strain_NN of_IN the_DT rinderpest_NN virus_NN for_IN about_RB a_DT decade_NN ,_, from_IN 1956_CD to_IN 1962_CD ._. [_-LRB- 25_CD ]_-RRB- Plowright_NNP was_VBD awarded_VBN the_DT World_NNP Food_NNP Prize_NNP in_IN 1999_CD for_IN developing_VBG a_DT vaccine_NN against_IN a_DT strain_NN of_IN rinderpest_NN ._. In_IN 1999_CD ,_, the_DT FAO_NNP predicted_VBD that_IN with_IN vaccination_NN ,_, rinderpest_NN would_MD be_VB eradicated_VBN by_IN 2010_CD ._. [_-LRB- 26_CD ]_-RRB- Widespread_JJ eradication_NN efforts_NNS began_VBD in_IN the_DT early_JJ 20th_JJ century_NN although_IN ,_, until_IN the_DT 1950s_NNS ,_, they_PRP mostly_RB took_VBD place_NN on_IN an_DT individual_JJ country_NN basis_NN ,_, using_VBG vaccination_NN campaigns_NNS ._. In_IN 1924_CD ,_, the_DT World_NNP Organisation_NNP for_IN Animal_NNP Health_NNP (_-LRB- OIE_NNP )_-RRB- was_VBD formed_VBN in_IN response_NN to_IN rinderpest_NN ._. [_-LRB- 28_CD ]_-RRB- In_IN 1950_CD ,_, the_DT Inter_NNP -_HYPH African_JJ Bureau_NNP of_IN Epizootic_NNP Diseases_NNPS was_VBD formed_VBN ,_, with_IN the_DT stated_VBN goal_NN of_IN eliminating_VBG rinderpest_NN from_IN Africa_NNP ._. [_-LRB- 28_CD ]_-RRB- During_IN the_DT 1960s_NNS ,_, a_DT program_NN called_VBN JP_NNP 15_CD attempted_VBD to_TO vaccinate_VB all_DT cattle_NNS in_IN participating_VBG countries_NNS and_CC ,_, by_IN 1979_CD ,_, only_RB one_CD of_IN the_DT countries_NNS involved_VBN ,_, Sudan_NNP ,_, reported_VBD cases_NNS of_IN rinderpest_NN ._. [_-LRB- 28_CD ]_-RRB- In_IN 1969_CD ,_, an_DT outbreak_NN of_IN the_DT disease_NN originated_VBD in_IN Afghanistan_NNP ,_, travelling_VBG westwards_RB and_CC promoting_VBG a_DT mass_JJ vaccination_NN plan_NN ,_, which_WDT by_IN 1972_CD ,_, had_VBD eliminated_VBN rinderpest_NN in_IN all_DT areas_NNS of_IN Asia_NNP except_IN for_IN Lebanon_NNP and_CC India_NNP ;_, both_DT countries_NNS were_VBD the_DT site_NN of_IN further_JJR occurrences_NNS of_IN the_DT disease_NN in_IN the_DT 1980s_NNS ._. [_-LRB- 28_CD ]_-RRB- During_IN the_DT 1980s_NNS ,_, however_RB ,_, an_DT outbreak_NN of_IN rinderpest_NN from_IN Sudan_NNP spread_VBD throughout_IN Africa_NNP ,_, killing_VBG millions_NNS of_IN cattle_NNS ,_, as_RB well_RB as_IN wildlife_NN ._. [_-LRB- 28_CD ]_-RRB- In_IN response_NN ,_, the_DT Pan_NNP -_HYPH African_NNP Rinderpest_NNP Campaign_NNP was_VBD initiated_VBN in_IN 1987_CD ,_, using_VBG vaccination_NN and_CC surveillance_NN to_TO combat_VB the_DT disease_NN ._. [_-LRB- 28_CD ]_-RRB- By_IN the_DT 1990s_NNS ,_, nearly_RB all_DT of_IN Africa_NNP ,_, with_IN the_DT exception_NN of_IN parts_NNS of_IN Sudan_NNP and_CC Somalia_NNP ,_, was_VBD declared_VBN free_JJ of_IN rinderpest_NN ._. [_-LRB- 28_CD ]_-RRB- Worldwide_RB ,_, the_DT Global_NNP Rinderpest_NNP Eradication_NNP Programme_NNP was_VBD initiated_VBN in_IN 1994_CD ,_, supported_VBN by_IN the_DT Food_NNP and_CC Agriculture_NNP Organization_NNP ,_, the_DT OIE_NNP ,_, and_CC the_DT International_NNP Atomic_NNP Energy_NNP Agency_NNP ._. [_-LRB- 28_CD ]_-RRB- This_DT program_NN was_VBD successful_JJ in_IN reducing_VBG rinderpest_NN outbreaks_NNS to_IN few_JJ and_CC far_RB between_IN by_IN the_DT late_JJ 1990s_NNS ._. [_-LRB- 28_CD ]_-RRB- The_DT program_NN is_VBZ estimated_VBN to_TO have_VB saved_VBN affected_VBN farmers_NNS 58_CD million_CD net_JJ euros_NNS ._. [_-LRB- 29_CD ]_-RRB- The_DT last_JJ confirmed_VBN case_NN of_IN rinderpest_NN was_VBD reported_VBN in_IN Kenya_NNP in_IN 2001_CD ._. [_-LRB- 30_CD ]_-RRB- Since_IN then_RB ,_, while_IN no_DT cases_NNS have_VBP been_VBN confirmed_VBN ,_, the_DT disease_NN is_VBZ believed_VBN to_TO have_VB been_VBN present_JJ in_IN parts_NNS of_IN Somalia_NNP past_IN that_DT date_NN ._. [_-LRB- 30_CD ]_-RRB- The_DT final_JJ vaccinations_NNS were_VBD administered_VBN in_IN 2006_CD ,_, and_CC the_DT last_JJ surveillance_NN operations_NNS took_VBD place_NN in_IN 2009_CD ,_, failing_VBG to_TO find_VB any_DT evidence_NN of_IN the_DT disease_NN ._. [_-LRB- 30_CD ]_-RRB- In_IN 2008_CD ,_, scientists_NNS involved_VBN in_IN rinderpest_NN eradication_NN efforts_NNS believed_VBD a_DT good_JJ chance_NN existed_VBD that_IN rinderpest_NN would_MD join_VB smallpox_NN as_IN officially_RB ""_`` wiped_VBN off_IN the_DT face_NN of_IN the_DT planet_NN ""_'' ._. [_-LRB- 5_CD ]_-RRB- The_DT FAO_NNP ,_, which_WDT had_VBD been_VBN co-ordinating_VBG the_DT global_JJ eradication_NN program_NN for_IN the_DT disease_NN ,_, announced_VBD in_IN November_NNP 2009_CD that_IN it_PRP expected_VBD the_DT disease_NN to_TO be_VB eradicated_VBN within_IN 18_CD months_NNS ._. [_-LRB- 31_CD ]_-RRB- In_IN October_NNP 2010_CD ,_, the_DT FAO_NNP announced_VBD it_PRP was_VBD confident_JJ the_DT disease_NN has_VBZ been_VBN eradicated_VBN ._. [_-LRB- 6_CD ]_-RRB- The_DT agency_NN said_VBD that_IN ""_`` [_-LRB- a_LS ]_-RRB- s_POS of_IN mid_NN 2010_CD ,_, FAO_NNP is_VBZ confident_JJ that_IN the_DT rinderpest_JJ virus_NN has_VBZ been_VBN eliminated_VBN from_IN Europe_NNP ,_, Asia_NNP ,_, Middle_NNP East_NNP ,_, Arabian_NNP Peninsula_NNP ,_, and_CC Africa_NNP ,_, ""_'' which_WDT were_VBD the_DT locations_NNS where_WRB the_DT virus_NN had_VBD been_VBN last_RB reported_VBN ._. [_-LRB- 6_CD ]_-RRB- Eradication_NN was_VBD confirmed_VBN by_IN the_DT World_NNP Organization_NNP for_IN Animal_NNP Health_NNP on_IN 25_CD May_NNP 2011_CD ._. [_-LRB- 7_CD ]_-RRB- On_IN 28_CD June_NNP 2011_CD ,_, FAO_NNP and_CC its_PRP$ members_NNS countries_NNS officially_RB recognized_VBD global_JJ freedom_NN from_IN the_DT deadly_JJ cattle_NN virus_NN ._. On_IN this_DT day_NN ,_, the_DT FAO_NNP Conference_NNP ,_, the_DT highest_JJS body_NN of_IN the_DT UN_NNP agency_NN ,_, adopted_VBD a_DT resolution_NN declaring_VBG the_DT eradication_NN of_IN rinderpest_NN ._. The_DT resolution_NN also_RB called_VBD on_IN the_DT world_NN community_NN to_TO follow_VB up_RP by_IN ensuring_VBG that_IN samples_NNS of_IN rinderpest_NN viruses_NNS and_CC vaccines_NNS be_VBP kept_VBN under_IN safe_JJ laboratory_NN conditions_NNS and_CC that_IN rigorous_JJ standards_NNS for_IN disease_NN surveillance_NN and_CC reporting_NN be_VB applied_VBN ._. ""_`` While_IN we_PRP are_VBP celebrating_VBG one_CD of_IN the_DT greatest_JJS successes_NNS for_IN FAO_NNP and_CC its_PRP$ partners_NNS ,_, I_PRP wish_VBP to_TO remind_VB you_PRP that_IN this_DT extraordinary_JJ achievement_NN would_MD not_RB have_VB been_VBN possible_JJ without_IN the_DT joint_JJ efforts_NNS and_CC strong_JJ commitments_NNS of_IN governments_NNS ,_, the_DT main_JJ organizations_NNS in_IN Africa_NNP ,_, Asia_NNP and_CC Europe_NNP ,_, and_CC without_IN the_DT continuous_JJ support_NN of_IN donors_NNS and_CC international_JJ institutions_NNS ""_'' ,_, FAO_NNP Director_NN -_HYPH General_NNP Jacques_NNP Diouf_NNP commented_VBD ._. [_-LRB- 32_CD ]_-RRB- The_DT rinderpest_NN eradication_NN effort_NN is_VBZ estimated_VBN to_TO have_VB cost_VBN $_$ 5_CD billion_CD ._. [_-LRB- 33_CD ]_-RRB- Stocks_NNS of_IN the_DT rinderpest_NN virus_NN are_VBP still_RB maintained_VBN by_IN highly_RB specialized_VBN laboratories_NNS ._. [_-LRB- 30_CD ]_-RRB- In_IN 2015_CD ,_, FAO_NNP launched_VBD a_DT campaign_NN calling_VBG for_IN the_DT destruction_NN or_CC sequestering_NN of_IN the_DT remaining_VBG stocks_NNS of_IN rinderpest_JJ virus_NN in_IN laboratories_NNS in_IN 24_CD different_JJ countries_NNS ,_, citing_VBG risks_NNS of_IN inadvertent_JJ or_CC malicious_JJ release_NN ._. [_-LRB- 34_CD ]_-RRB- On_IN 14_CD June_NNP 2019_CD the_DT largest_JJS stock_NN of_IN the_DT rinderpest_NN virus_NN was_VBD destroyed_VBN at_IN the_DT Pirbright_NNP Institute_NNP ._. [_-LRB- 35_CD ]_-RRB- Rinderpest_NNP was_VBD one_CD of_IN more_JJR than_IN a_DT dozen_CD agents_NNS the_DT United_NNP States_NNPS researched_VBD as_IN potential_JJ biological_JJ weapons_NNS before_IN terminating_VBG its_PRP$ biological_JJ weapons_NNS program_NN ._. [_-LRB- 36_CD ]_-RRB- Rinderpest_NNP is_VBZ of_IN concern_NN as_IN a_DT biological_JJ weapon_NN for_IN the_DT following_VBG reasons_NNS :_: •_NFP The_DT disease_NN has_VBZ high_JJ rates_NNS of_IN morbidity_NN and_CC mortality_NN ._. •_NFP The_DT disease_NN is_VBZ highly_RB communicable_JJ and_CC spreads_VBZ rapidly_RB once_RB introduced_VBN into_IN nonimmune_JJ herds_NNS ._. •_NFP Cattle_NN herds_NNS are_VBP no_RB longer_RBR immunized_VBN against_IN RPV_NN ,_, so_RB are_VBP susceptible_JJ to_IN infection_NN ._. [_-LRB- 37_CD ]_-RRB- Rinderpest_NNP was_VBD also_RB considered_VBN as_IN a_DT biological_JJ weapon_NN in_IN the_DT United_NNP Kingdom_NNP 's_POS program_NN during_IN World_NNP War_NNP II_CD ._. [_-LRB- 38_CD ]_-RRB-","NNP ( RB NN NN or NN NN ) VBD an JJ JJ NN of NN , JJ NN , and JJ JJ NNS of RB - VBN NNS , VBG NNS , JJ NN , NN , NNS , NNS , and NNS . [ 2 ] The NN VBD VBN by NN , JJ NNS , NN , JJ NN , and JJ NN . NN NNS during NNS VBD RB RB JJ , VBG 100 NN in RB JJ NNS . [ 3 ] NNP VBD RB VBN by JJ NN and by VBG VBN NN , although it could RB VB VBN by NN . [ 4 ] After a JJ NN NN since the JJ NN , the JJ VBN NN of NN VBD VBN in 2001 . [ 5 ] On 14 NNP 2010 , the NNP NNPS NNP and NNP NNP ( NNP ) VBD that NN NNS in the NNS - JJ , JJ NN to VB the NN VBD VBG , VBG the NN for a JJ NN in NNP 2011 of the JJ NN of NN . [ 6 ] On 25 NNP 2011 , the NNP NNP for NNP NNP VBD the JJ NN of the JJ eight NNS RB RB VBN ( a NN of 198 NNS VBD RB JJ of the NN ) , RB VBG the NN of the NN . [ 7 ] In NNP 2011 , the NNP NNPS NNP VBD the NN VBD VBN , VBG NN RB the JJ NN in NN to VB RB VBN out ( outside NN NNS ) , VBG NN . [ 8 ] In NNP 2019 the NNP VBD its NNS of JJ NN , VBN at the NNP NNP in NNP , which VBD JJS of the NN 's VBN NNS . This VBD the NN of a JJ NN of the NN 's JJ NN , RB VBG the NN to VB NNS as a JJ NN in NN the NN VBZ . NNS at NNP and the NNP NNPS VBD a NN that the JJ NNS in NNS around the NN will RB VB VBN , RB VBG the NN from the NNP . [ 9 ] NNP VBZ VBN to VB VBN in NNP , RBR VBG through the NN of NNS . [ 10 ] The NN NNP VBZ a JJ NN VBG "" NN - NN "" . [ 2 ] [ 10 ] The NN NN ( NN ) VBD RB JJ to the NNS and NN NN NNS . [ 11 ] The NNS NN RB VBD from NN as a JJ NN around 600 NN , a NN that VBZ with the NN of JJ JJ NNS . [ 12 ] [ 13 ] NNP NN ( NNP ) , a NN of the NN NNP , VBZ RB JJ to the NNS and NN NN NNS . [ 11 ] Like JJ NNS of the NNP NN , it VBZ VBN NNS , and VBZ a JJ - NN JJ - VBN NN NN . The NN VBD RB JJ and VBZ RB VBN by NN , NN and NN . [ 14 ] NN NN VBD from the RB - JJ NN NN RBS RB between the JJ and JJ NNS . [ 13 ] The JJS JJ NN VBZ during the JJ NN ; some JJ NN VBZ for this JJR NN . [ 15 ] [ 16 ] NN NNS during NNS VBD RB RB JJ , VBG 100 NN in RB JJ NNS . [ 3 ] The NN VBD RB VBN by JJ NN and by VBG VBN NN , although it could RB VB VBN by NN . [ 4 ] JJ NNS VBP NN , NN of NN , and JJ and NN NNS . RB , JJ NNS VBP in the NN , the NN of the NN , and the JJ NN . [ 3 ] JJ NN , VBN by NN , VBZ RB a JJ NN . [ 4 ] JJS NNS VBP 6 - 12 NNS after the NN of these JJ NNS . [ 3 ] The NN VBZ VBN to VB VBN in NNP , RBR VBG through the NN of NNS . [ 10 ] JJ NN NNS VBP VBN in JJ NNS : a NN NN VBZ VBN to VB one of the 10 NNS of NNP VBN in the NNP NNP . By RB 3,000 NN , a NN NN VBD VBN NNP , and NN RBR VBD throughout the NN of NNP , VBG JJ NN . [ 10 ] In the JJ NN JJ NN NNP NNP NNP VBD NN in his NN , On the NNPS of NNP . [ 17 ] NN NNS VBD throughout NN , RB VBG NNS and JJ NNS . They VBD NNP RB RB in the JJ NN , with three JJ NNS , which although VBG in NN and NN from NN to NN , VBD NN in the NNS of 1709 – 1720 , 1742 –1760 , and 1768 –1786 . [ 18 ] In the JJ JJ NN , the NN VBD VBN as JJ to NN , due to its JJ NNS . The JJ NN of the NN , NNP NNP NNP , VBD the NN of all JJ and VBN NNS . This NN VBD RB RB JJ and VBN RB RB in the JJ NN of the NN . RBR , it VBD VBN RB in JJ NNS , although it VBD RB VBN as RB JJ or JJ , and VBD on a JJ JJ NN to VB JJ ( which VBD RB VBG in the NNP NNP ) . Because of these NNS , JJ NNS VBD VBN to VB NNS against the NN . These NNS VBD with VBG NN , but the NN VBD RB RB VBN and VBD RB RBR VBN at all in JJ - NN JJ or JJ NNP . NNP VBD an JJ NN , but NN VBD RB a JJ NN . In JJ NNS , it VBD RB JJ NNS . RB RBR RB , it VBD the NN of the NN in the NN NN . The NNS of NN VBD VB RB to NN about JJ NNS . Their NNS VBD the NNS of those who VBD JJ NNS as VBN by JJ NNS , and VBD the JJ to VB RB VBN NN . [ 11 ] The JJ VBN NN of NN NN VBD VBN in a NN VBN "" NNP "" in the NNP 1754 NN of The NNP 's NNP , [ 11 ] a RB VBN NN which RB VBD the NN of NN NN . This NN VBD that a NNP NNP VBD VBN his NNS and VBD RB VBN 9 out of 10 of them , although this VBD VBN in the JJ NN , as it VBD RB a NNP NNP NNP NNP who VBD VBN the NN ( this VBD VBN by VBG NNS of NN RB VBN in JJ NN into an NN VBN in the NN of the NN ) . These NNS VBD JJ NN of NN in the NN against NNS . The JJ NN against NNS VBD VBN three NNS after their NN . [ 11 ] From JJ 1755 RB , NNS VBD VBG NN in the NNPS , RB RB , NNS of which VBD RB VBN in The NNP 's NNP . As in NNP , the NN VBD VBN as JJ with NN . While these NNS VBD RB JJ , they VBD RB VB a JJ NN : The JJ NN of NNS in NNP VBZ to VB VBN RB VBN , and after 1780 , the JJ NN in NN VBD RB RB . [ 11 ] RB all JJR NN VBD VBN in the NNPS , JJ NNP and NNP . JJR NNS in the NNP Due to a RB JJ NN at the NN of the NNS , some of the RBS - VBN NNS in JJ NN VBD JJ in the NN against the NN . JJ JJ NNS VBD VBN , RBS RB by NNP NNP in NNP and NNP . The NNS of his NN in NNP VBD VBG , but they VBD to VB the NN ; NN by NNS in the NNS of NNP and NNP VBD JJ NNS . As a NN , the JJ NNS VBD in 1769 that the NN of NN VBD NNP 's NN with the JJ NN of the JJ NNS , and VBD 15 NNP a NN of NN and NN . NN in NN VBD RB across the NN . [ 11 ] In this NN of NN and NN , NNP NNP , a NN in the NN of NNP and a NN - VBN NN , VBD to VB the NNS . He VBD with NNP NNP , who VBD VBN JJR NNS . They VBD JJ NN NNS and a NN of NNS to VB the NNS , all of them without JJ NN . Although they VBD RB JJ to VB the NN NN , they VBD VB some JJ NNS . [ 11 ] NNPS VBD his NNS in 1774 , VBG on the NN of NNS from NNS that VBD VBN from NN . He VBD RB the JJ to VB JJ NN of RB VBN NN . [ 11 ] The JJ NNS of his NNS VBD VBN in 1776 and VBN in 1777 . His NN NN VBD RB VB RB from what VBD VBN VBN RB , except for the NN of three JJ NNS at an JJ NN . This VBD RB JJR NNS , and the NN of his NN VBN NN in NN . For the NN of 1777 to 1781 , 89 NN of VBN NNS VBD , VBN to a 29 NN NN NN after JJ NN . [ 11 ] In the NNPS , RB , NN in JJ NN VBD in the NNS because the NN itself VBD in NN . RB from the NNP NNP , the JJ JJ NNS where NN VBD VBN to any JJ NN VBD JJ NNP and NNP . NNS VBD in NNP during the NN of the JJ NNS . "" NN NNS "" VBD VBN which VBD NN in JJ "" NNS "" . Although these VBD JJ NNS , they VBD VBN with JJ NN from the NNS . Though VBG NNS VBD this NN with NN , the NN RB VBD on outside NNP ; JJ VBD RB VBN to NN . [ 11 ] While some NN VBD in JJ NNS ( RBS RB in NNP ) , in the NN of JJ NNS , the NN against the NN VBD VBN on VBG it out . RB this could VB VBN with JJ NNS ; at JJ NNS , it VBD NN at a JJ NN . [ 11 ] A JJ NN VBD the NN of the NNP NNPS for three NNS after 1865 . [ 19 ] Around the NN of the NN , a NN VBD in NNP NNP . [ 19 ] The NN in the NNS VBD an VBN 80 to 90 NN of all NNS in JJ and JJ NNP , RB RB as in the NNP of NNP . NNP NNP NNP VBD JJ in VBG a NN that VBD the NN . The NN of NNS VBD NN which VBD JJ NNP , VBG NN to VB . This VBD JJ NN for NN NN , which VBZ NN NN , and VBZ JJ for NN . [ 20 ] In his JJ NN of the NNP of JJ NNP , NNP NNP NNP - NNP VBD NN might VB VBN the NNP 's JJ NN before and during the NNS . Since the NNPS VBD NNS , JJ of their NN VBD VBN on NN NN , and NN - NNS VBD VBN in NN ; NNS may VB VBN as a NN of NN NN . NNP might RB VB VBN NN on NN among the NNP . [ 21 ] A RBR JJ NN NN in NNP in 1982 –1984 VBD in an VBN NNP $ 2 billion in NN NNS . [ 22 ] In 1917 – 18 , NNP NNP NNP ( 1881 –1959 ) , the JJ NN NN with the NNP NNP of NNP , VBD an JJ NN for NN , VBN on VBN NN NN NNS . [ 23 ] [ 24 ] NNP NNP VBD on a NN for the NNP NN of the NN NN for RB a NN , from 1956 to 1962 . [ 25 ] NNP VBD VBN the NNP NNP NNP in 1999 for VBG a NN against a NN of NN . In 1999 , the NNP VBD that with NN , NN would VB VBN by 2010 . [ 26 ] JJ NN NNS VBD in the JJ JJ NN although , until the NNS , they RB VBD NN on an JJ NN NN , VBG NN NNS . In 1924 , the NNP NNP for NNP NNP ( NNP ) VBD VBN in NN to NN . [ 28 ] In 1950 , the NNP - JJ NNP of NNP NNPS VBD VBN , with the VBN NN of VBG NN from NNP . [ 28 ] During the NNS , a NN VBN NNP 15 VBD to VB all NNS in VBG NNS and , by 1979 , RB one of the NNS VBN , NNP , VBD NNS of NN . [ 28 ] In 1969 , an NN of the NN VBD in NNP , VBG RB and VBG a JJ NN NN , which by 1972 , VBD VBN NN in all NNS of NNP except for NNP and NNP ; both NNS VBD the NN of JJR NNS of the NN in the NNS . [ 28 ] During the NNS , RB , an NN of NN from NNP VBD throughout NNP , VBG NNS of NNS , RB RB as NN . [ 28 ] In NN , the NNP - NNP NNP NNP VBD VBN in 1987 , VBG NN and NN to VB the NN . [ 28 ] By the NNS , RB all of NNP , with the NN of NNS of NNP and NNP , VBD VBN JJ of NN . [ 28 ] RB , the NNP NNP NNP NNP VBD VBN in 1994 , VBN by the NNP and NNP NNP , the NNP , and the NNP NNP NNP NNP . [ 28 ] This NN VBD JJ in VBG NN NNS to JJ and RB between by the JJ NNS . [ 28 ] The NN VBZ VBN to VB VBN VBN NNS 58 million JJ NNS . [ 29 ] The JJ VBN NN of NN VBD VBN in NNP in 2001 . [ 30 ] Since RB , while no NNS VBP VBN VBN , the NN VBZ VBN to VB VBN JJ in NNS of NNP past that NN . [ 30 ] The JJ NNS VBD VBN in 2006 , and the JJ NN NNS VBD NN in 2009 , VBG to VB any NN of the NN . [ 30 ] In 2008 , NNS VBN in NN NN NNS VBD a JJ NN VBD that NN would VB NN as RB "" VBN off the NN of the NN "" . [ 5 ] The NNP , which VBD VBN VBG the JJ NN NN for the NN , VBD in NNP 2009 that it VBD the NN to VB VBN within 18 NNS . [ 31 ] In NNP 2010 , the NNP VBD it VBD JJ the NN VBZ VBN VBN . [ 6 ] The NN VBD that "" [ a ] s of NN 2010 , NNP VBZ JJ that the JJ NN VBZ VBN VBN from NNP , NNP , NNP NNP , NNP NNP , and NNP , "" which VBD the NNS where the NN VBD VBN RB VBN . [ 6 ] NN VBD VBN by the NNP NNP for NNP NNP on 25 NNP 2011 . [ 7 ] On 28 NNP 2011 , NNP and its NNS NNS RB VBD JJ NN from the JJ NN NN . On this NN , the NNP NNP , the JJS NN of the NNP NN , VBD a NN VBG the NN of NN . The NN RB VBD on the NN NN to VB up by VBG that NNS of NN NNS and NNS VBP VBN under JJ NN NNS and that JJ NNS for NN NN and NN VB VBN . "" While we VBP VBG one of the JJS NNS for NNP and its NNS , I VBP to VB you that this JJ NN would RB VB VBN JJ without the JJ NNS and JJ NNS of NNS , the JJ NNS in NNP , NNP and NNP , and without the JJ NN of NNS and JJ NNS "" , NNP NN - NNP NNP NNP VBD . [ 32 ] The NN NN NN VBZ VBN to VB VBN $ 5 billion . [ 33 ] NNS of the NN NN VBP RB VBN by RB VBN NNS . [ 30 ] In 2015 , NNP VBD a NN VBG for the NN or NN of the VBG NNS of JJ NN in NNS in 24 JJ NNS , VBG NNS of JJ or JJ NN . [ 34 ] On 14 NNP 2019 the JJS NN of the NN NN VBD VBN at the NNP NNP . [ 35 ] NNP VBD one of JJR than a dozen NNS the NNP NNPS VBD as JJ JJ NNS before VBG its JJ NNS NN . [ 36 ] NNP VBZ of NN as a JJ NN for the VBG NNS : • The NN VBZ JJ NNS of NN and NN . • The NN VBZ RB JJ and VBZ RB RB VBN into JJ NNS . • NN NNS VBP RB RBR VBN against NN , RB VBP JJ to NN . [ 37 ] NNP VBD RB VBN as a JJ NN in the NNP NNP 's NN during NNP NNP II . [ 38 ]"
70,731,mainstream,M0b263,vaccine.covid,"Coronavirus_NN :_: I_PRP was_VBD in_IN the_DT stay_NN -_HYPH home_NN -_HYPH until_IN -_, it_PRP 's_VBZ -_HYPH safe_JJ camp_NN ._. But_CC I_PRP just_RB can't_MD take_VB it_PRP anymore_RB ._. I_PRP ’m_VBP inherently_RB lazy_JJ ,_, so_RB I_PRP hate_VBP working_VBG out_RP ._. Given_VBN my_PRP$ druthers_NNS ,_, I_PRP ’d_MD spend_VB my_PRP$ days_NNS eating_VBG ice_NN cream_NN bonbons_NNS and_CC watching_VBG episodes_NNS of_IN ""_`` The_DT Real_NNP Housewives_NNPS ._. ""_'' It_PRP ’s_VBZ odd_JJ then_RB ,_, that_IN the_DT thing_NN I_PRP miss_VBP most_JJS about_IN the_DT time_NN before_IN coronavirus_NN and_CC stay_NN -_HYPH at_IN -_HYPH home_NN orders_NNS is_VBZ going_VBG to_IN the_DT gym_NN ._. For_IN 40_CD years_NNS ,_, the_DT gym_NN has_VBZ been_VBN the_DT thread_NN that_WDT tied_VBD my_PRP$ physical_JJ being_NN to_IN my_PRP$ precarious_JJ sanity_NN ._. Murder_NN trials_NNS ,_, surgery_NN and_CC personal_JJ tragedies_NNS have_VBP never_RB kept_VBN me_PRP from_IN the_DT gym_NN for_IN more_JJR than_IN two_CD weeks_NNS ._. So_RB when_WRB rabid_JJ armed_JJ protesters_NNS recently_RB stormed_VBD state_NN capitals_NNS demanding_VBG businesses_NNS reopen_VB ,_, the_DT stupidest_JJS part_NN of_IN me_PRP hoped_VBD they_PRP would_MD succeed_VB and_CC end_VB my_PRP$ months_NNS of_IN gym_NN exile_NN ._. Two_CD camps_NNS ,_, largely_RB paralleling_VBG America_NNP ’s_POS two_CD political_JJ parties_NNS ,_, have_VBP formed_VBN since_IN the_DT initial_JJ shock_NN of_IN COVID_NNP -_HYPH 19_CD ’s_POS global_JJ rampage_NN ._. My_PRP$ status_NN as_IN a_DT die_NN -_HYPH hard_JJ Democrat_NNP placed_VBD me_PRP firmly_RB in_IN the_DT “_`` stay_VB at_IN home_NN until_IN it_PRP ’s_VBZ safe_JJ ”_'' faction_NN ._. And_CC I_PRP ’ve_VBP not_RB been_VBN shy_JJ about_IN deriding_VBG the_DT gun-toting_JJ mobs_NNS who_WP insisted_VBD on_IN standing_VBG shoulder_NN to_IN shoulder_NN as_IN they_PRP emptied_VBD their_PRP$ lungs_NNS at_IN governors_NNS who_WP are_VBP desperately_RB trying_VBG to_TO keep_VB their_PRP$ citizens_NNS safe_JJ ._. Rand_NNP Paul_NNP ,_, Andy_NNP Biggs_NNP :_: Anthony_NNP Fauci_NNP wants_VBZ America_NNP closed_VBN until_IN there_EX 's_VBZ nothing_NN to_TO reopen_VB But_CC as_IN time_NN has_VBZ worn_VBN on_RP ,_, I_PRP ’ve_VBP abandoned_VBN what_WP I_PRP thought_VBD was_VBD the_DT moral_JJ high_JJ ground_NN in_IN camp_NN stay_NN -_HYPH at_IN -_HYPH home_NN ._. New_JJ circumstances_NNS have_VBP convinced_VBN me_PRP that_IN cities_NNS should_MD reopen_VB sooner_RBR rather_RB than_IN later_RBR ._. A_DT vaccine_NN looks_VBZ more_RBR unlikely_JJ No_DT one_NN but_CC President_NNP Donald_NNP Trump_NNP ’s_POS most_RBS cultish_JJ supporters_NNS believed_VBD his_PRP$ promise_NN that_IN this_DT virus_NN would_MD disappear_VB with_IN warm_JJ weather_NN ,_, or_CC that_IN we_PRP could_MD have_VB a_DT vaccine_NN in_IN three_CD to_IN four_CD months_NNS ._. But_CC at_IN the_DT outset_NN of_IN the_DT federal_JJ guidelines_NNS that_WDT placed_VBD the_DT United_NNP States_NNPS into_IN suspended_VBN animation_NN ,_, many_JJ of_IN us_PRP believed_VBD that_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ,_, and_CC endless_JJ government_NN resources_NNS ,_, would_MD quickly_RB find_VB a_DT treatment_NN —_: and_CC a_DT vaccine_NN would_MD follow_VB in_IN due_JJ time_NN ._. More_JJR than_IN two_CD months_NNS in_RB ,_, as_IN the_DT U.S._NNP death_NN toll_NN barrels_VBZ toward_IN 100,000_CD ,_, those_DT assumptions_NNS have_VBP proved_VBN wrong_JJ ,_, and_CC the_DT most_RBS basic_JJ precepts_NNS of_IN viral_JJ epidemiology_NN have_VBP been_VBN thrown_VBN into_IN question_NN ._. Usually_RB ,_, when_WRB people_NNS successfully_RB fight_VBP a_DT virus_NN ,_, they_PRP develop_VBP antibodies_NNS that_WDT protect_VBP against_IN further_JJ infection_NN ._. But_CC people_NNS who_WP have_VBP contracted_VBN and_CC survived_VBN COVID_NNP -_HYPH 19_CD appear_VBP able_JJ to_TO get_VB reinfected_VBN after_IN winning_VBG the_DT battle_NN of_IN their_PRP$ lives_NNS ._. The_DT World_NNP Health_NNP Organization_NNP announced_VBD last_JJ month_NN that_IN the_DT antibodies_NNS that_WDT normally_RB keep_VBP people_NNS safe_JJ from_IN reinfection_NN might_MD not_RB work_VB against_IN the_DT coronavirus_NN ._. Since_IN vaccines_NNS function_VBP by_IN stimulating_VBG antibody_NN production_NN ,_, this_DT revelation_NN means_VBZ the_DT chance_NN of_IN an_DT effective_JJ vaccine_NN is_VBZ far_RB from_IN guaranteed_VBN ._. A_DT stark_JJ reality_NN is_VBZ being_VBG whispered_VBN by_IN leading_VBG health_NN experts_NNS :_: the_DT majority_NN of_IN the_DT world_NN ’s_POS population_NN could_MD be_VB exposed_VBN to_IN the_DT coronavirus_NN ._. When_WRB lockdowns_NNS began_VBD ,_, most_JJS of_IN us_PRP were_VBD willing_JJ to_TO stay_VB home_RB and_CC make_VB the_DT necessary_JJ sacrifices_NNS we_PRP believed_VBD guaranteed_VBD safe_JJ passage_NN to_IN the_DT other_JJ side_NN ._. Flights_NNS ,_, weddings_NNS and_CC dental_JJ appointments_NNS were_VBD rescheduled_VBN months_NNS down_IN the_DT road_NN ._. But_CC given_VBN that_IN June_NNP is_VBZ likely_JJ to_TO be_VB no_RB different_JJ than_IN September_NNP ,_, and_CC July_NNP no_RB different_JJ than_IN November_NNP ,_, staying_VBG home_RB wo_MD n’t_RB deliver_VB us_PRP to_IN the_DT safety_NN zone_NN that_WDT prompted_VBD the_DT shelter_NN -_HYPH in_IN -_HYPH place_NN orders_NNS in_IN the_DT first_JJ place_NN ._. This_DT is_VBZ n't_RB a_DT vacation_NN :_: I_PRP 'm_VBP a_DT survivor_NN of_IN domestic_JJ abuse_NN ._. Quarantine_NN with_IN my_PRP$ father_NN would_MD have_VB been_VBN hell_NN ._. It_PRP ’s_VBZ true_JJ that_IN if_IN no_DT one_NN ever_RB leaves_VBZ home_NN ,_, viral_JJ transmission_NN will_MD end_VB ._. But_CC this_DT is_VBZ not_RB economically_RB feasible_JJ ._. If_IN the_DT U.S._NNP Treasury_NNP continues_VBZ to_TO print_VB money_NN with_IN little_JJ to_IN no_DT manufacturing_NN or_CC labor_NN to_TO back_VB it_PRP up_RP ,_, the_DT house_NN of_IN cards_NNS will_MD eventually_RB fall_VB ._. I_PRP realize_VBP this_DT statement_NN has_VBZ dropped_VBN me_PRP into_IN traitor_NN territory_NN ._. But_CC to_IN the_DT chorus_NN from_IN the_DT left_NN :_: No_UH ,_, reopening_VBG the_DT country_NN due_IN to_IN economic_JJ considerations_NNS is_VBZ not_RB the_DT same_JJ as_IN saying_VBG money_NN is_VBZ more_RBR important_JJ than_IN human_JJ life_NN ._. We_PRP face_VBP economic_JJ realities_NNS every_DT day_NN ,_, independent_JJ of_IN the_DT coronavirus_NN ._. Gun_NN violence_NN ,_, drunken_JJ drivers_NNS ,_, transmissible_JJ diseases_NNS and_CC a_DT panoply_NN of_IN other_JJ dangers_NNS could_MD all_RB be_VB brought_VBN to_IN a_DT screeching_VBG halt_NN if_IN we_PRP locked_VBD down_RP indefinitely_RB ._. But_CC a_DT life_NN of_IN home_NN confinement_NN is_VBZ not_RB a_DT world_NN in_IN which_WDT most_JJS of_IN us_PRP would_MD want_VB to_TO live_VB ._. Reopen_VB —_: with_IN eyes_NNS open_JJ to_IN the_DT risks_NNS With_IN more_JJR states_NNS reopening_VBG over_IN the_DT next_JJ several_JJ weeks_NNS ,_, people_NNS are_VBP likely_JJ to_TO believe_VB that_IN local_JJ health_NN officials_NNS have_VBP determined_VBN things_NNS are_VBP safe_JJ ._. They_PRP ’re_VBP not_RB ._. Texas_NNP was_VBD one_CD of_IN the_DT first_JJ states_NNS to_TO reopen_VB and_CC recently_RB saw_VBD its_PRP$ highest_JJS single_JJ day_NN of_IN new_JJ cases_NNS since_IN the_DT pandemic_NN began_VBD ._. While_IN reopening_VBG is_VBZ a_DT necessity_NN ,_, it_PRP need_MD not_RB be_VB reckless_JJ ._. Governors_NNS have_VBP a_DT continuing_VBG duty_NN to_TO tailor_VB reasonable_JJ restrictions_NNS to_IN community_NN conditions_NNS ._. The_DT value_NN in_IN early_JJ shelter_NN -_HYPH in_IN -_HYPH place_NN orders_NNS was_VBD that_IN overwhelmed_VBN hospitals_NNS were_VBD given_VBN an_DT opportunity_NN to_TO stabilize_VB and_CC avoid_VB rationing_NN treatment_NN ._. That_DT ’s_VBZ a_DT justification_NN worthy_JJ of_IN respect_NN ,_, and_CC we_PRP should_MD prepare_VB ourselves_PRP to_TO accept_VB the_DT possibility_NN of_IN local_JJ rolling_VBG shutdowns_NNS due_IN to_IN filled_VBN hospital_NN beds_NNS and_CC occupied_VBN ventilators_NNS ._. For_IN the_DT past_JJ two_CD months_NNS I_PRP ’ve_VBP stayed_VBN safe_JJ by_IN staying_VBG home_RB ,_, limiting_VBG my_PRP$ grocery_NN shopping_NN excursions_NNS to_IN once_RB a_DT week_NN ._. I_PRP ’d_MD like_VB to_TO visit_VB family_NN ,_, but_CC the_DT thought_NN of_IN picking_VBG up_RP coronavirus_NN at_IN Trader_NNP Joe_NNP ’s_POS and_CC unintentionally_RB killing_VBG my_PRP$ own_JJ parents_NNS is_VBZ a_DT Greek_JJ tragedy_NN I_PRP ’m_VBP desperate_JJ to_TO avoid_VB ._. Moving_VBG into_IN the_DT third_JJ month_NN of_IN home_NN isolation_NN ,_, the_DT toll_NN on_IN each_DT of_IN us_PRP is_VBZ different_JJ ._. Some_DT face_VBP financial_JJ hardship_NN ._. Some_DT have_VBP seen_VBN their_PRP$ education_NN thrown_VBN into_IN limbo_NN ._. For_IN me_PRP ,_, the_DT longer_JJR I_PRP ’m_VBP home_RB alone_RB ,_, the_DT more_RBR my_PRP$ obsessive_JJ -_HYPH compulsive_JJ disorder_NN flares_NNS ._. I_PRP did_VBD n’t_RB realize_VB this_DT until_IN a_DT phone_NN call_NN in_IN which_WDT a_DT friend_NN asked_VBD whether_IN I_PRP was_VBD staying_VBG safe_JJ ._. I_PRP explained_VBD that_IN I_PRP had_VBD found_VBN a_DT way_NN to_TO test_VB myself_PRP for_IN coronavirus_NN :_: Loss_NN of_IN taste_NN is_VBZ one_CD of_IN the_DT first_JJ signs_NNS of_IN infection_NN ,_, so_RB I_PRP bought_VBD a_DT 5_CD pound_NN tub_NN of_IN jelly_NN beans_NNS with_IN 49_CD flavors_NNS ._. I_PRP eat_VBP several_JJ handfuls_NNS daily_RB ,_, one_CD bean_NN at_IN a_DT time_NN ._. If_IN I_PRP recognize_VBP each_DT of_IN the_DT different_JJ flavors_NNS ,_, I_PRP figure_VBP that_IN I_PRP ’m_VBP safe_JJ ._. The_DT dead_JJ silence_NN on_IN the_DT line_NN convinced_VBD me_PRP it_PRP was_VBD time_NN to_TO book_VB a_DT Zoom_NNP therapy_NN session_NN ._. When_WRB the_DT gravity_NN of_IN this_DT pandemic_NN made_VBD itself_PRP known_VBN ,_, I_PRP expected_VBD my_PRP$ government_NN to_TO protect_VB me_PRP ._. But_CC Trump_NNP has_VBZ spent_VBN two_CD months_NNS blaming_VBG former_JJ President_NNP Barack_NNP Obama_NNP for_IN a_DT lack_NN of_IN personal_JJ protective_JJ equipment_NN ,_, peddling_VBG snake_NN -_HYPH oil_NN cures_NNS and_CC denying_VBG the_DT shortage_NN of_IN COVID_NN -_HYPH 19_CD test_NN kits_NNS ._. Sadly_RB ,_, the_DT president_NN has_VBZ shown_VBN that_IN in_IN order_NN to_TO make_VB it_PRP through_IN this_DT crisis_NN ,_, we_PRP ’re_VBP going_VBG to_TO have_VB to_TO fend_VB for_IN ourselves_PRP ._. As_IN cities_NNS reopen_VBP ,_, each_DT of_IN us_PRP will_MD have_VB hard_JJ choices_NNS to_TO make_VB ._. Choices_NNS about_IN working_VBG from_IN home_NN ,_, going_VBG to_IN restaurants_NNS and_CC visiting_VBG friends_NNS ._. I_PRP ’ve_VBP decided_VBN I_PRP ’ll_MD go_VB the_DT gym_NN ,_, but_CC not_RB restaurants_NNS or_CC movie_NN theaters_NNS ._. I_PRP ’ve_VBP also_RB decided_VBN that_IN despite_IN the_DT discomfort_NN ,_, I_PRP ’ll_MD wear_VB a_DT mask_NN when_WRB I_PRP ’m_VBP in_IN an_DT indoor_JJ public_JJ space_NN —_: every_DT time_NN ._. Staying_VBG out_IN of_IN harm_NN ’s_POS way_NN in_IN the_DT time_NN of_IN coronavirus_NN promises_VBZ to_TO be_VB a_DT never_RB -_HYPH ending_VBG struggle_NN to_TO balance_VB risk_NN and_CC reward_NN ._. I_PRP hope_VBP I_PRP strike_VBP the_DT right_JJ balance_NN ._. I_PRP cringe_VBP at_IN the_DT idea_NN of_IN the_DT progressive_JJ Twitter_NNP crowd_NN posting_VBG news_NN of_IN my_PRP$ untimely_JJ demise_NN as_IN a_DT cautionary_JJ tale_NN ._. Michael_NNP J._NNP Stern_NNP ,_, a_DT member_NN of_IN USA_NNP TODAY_NNP 's_POS Board_NNP of_IN Contributors_NNPS ,_, was_VBD a_DT federal_JJ prosecutor_NN for_IN 25_CD years_NNS in_IN Detroit_NNP and_CC Los_NNP Angeles_NNP ._. Follow_VB him_PRP on_IN Twitter_NNP :_: @_IN MichaelJStern1_NNP","NN : I VBD in the NN - NN - until - it VBZ - JJ NN . But I RB can't VB it RB . I VBP RB JJ , RB I VBP VBG out . VBN my NNS , I ’d VB my NNS VBG NN NN NNS and VBG NNS of "" The NNP NNPS . "" It VBZ JJ RB , that the NN I VBP JJS about the NN before NN and NN - at - NN NNS VBZ VBG to the NN . For 40 NNS , the NN VBZ VBN the NN that VBD my JJ NN to my JJ NN . NN NNS , NN and JJ NNS VBP RB VBN me from the NN for JJR than two NNS . RB when JJ JJ NNS RB VBD NN NNS VBG NNS VB , the JJS NN of me VBD they would VB and VB my NNS of NN NN . Two NNS , RB VBG NNP ’s two JJ NNS , VBP VBN since the JJ NN of NNP - 19 ’s JJ NN . My NN as a NN - JJ NNP VBD me RB in the “ VB at NN until it VBZ JJ ” NN . And I VBP RB VBN JJ about VBG the JJ NNS who VBD on VBG NN to NN as they VBD their NNS at NNS who VBP RB VBG to VB their NNS JJ . NNP NNP , NNP NNP : NNP NNP VBZ NNP VBN until there VBZ NN to VB But as NN VBZ VBN on , I VBP VBN what I VBD VBD the JJ JJ NN in NN NN - at - NN . JJ NNS VBP VBN me that NNS should VB RBR RB than RBR . A NN VBZ RBR JJ No NN but NNP NNP NNP ’s RBS JJ NNS VBD his NN that this NN would VB with JJ NN , or that we could VB a NN in three to four NNS . But at the NN of the JJ NNS that VBD the NNP NNPS into VBN NN , JJ of us VBD that the NNPS for NNP NNP and NNP , and JJ NN NNS , would RB VB a NN — and a NN would VB in JJ NN . JJR than two NNS RB , as the NNP NN NN VBZ toward 100,000 , those NNS VBP VBN JJ , and the RBS JJ NNS of JJ NN VBP VBN VBN into NN . RB , when NNS RB VBP a NN , they VBP NNS that VBP against JJ NN . But NNS who VBP VBN and VBN NNP - 19 VBP JJ to VB VBN after VBG the NN of their NNS . The NNP NNP NNP VBD JJ NN that the NNS that RB VBP NNS JJ from NN might RB VB against the NN . Since NNS VBP by VBG NN NN , this NN VBZ the NN of an JJ NN VBZ RB from VBN . A JJ NN VBZ VBG VBN by VBG NN NNS : the NN of the NN ’s NN could VB VBN to the NN . When NNS VBD , JJS of us VBD JJ to VB RB and VB the JJ NNS we VBD VBD JJ NN to the JJ NN . NNS , NNS and JJ NNS VBD VBN NNS down the NN . But VBN that NNP VBZ JJ to VB RB JJ than NNP , and NNP RB JJ than NNP , VBG RB wo RB VB us to the NN NN that VBD the NN - in - NN NNS in the JJ NN . This VBZ RB a NN : I VBP a NN of JJ NN . NN with my NN would VB VBN NN . It VBZ JJ that if no NN RB VBZ NN , JJ NN will VB . But this VBZ RB RB JJ . If the NNP NNP VBZ to VB NN with JJ to no NN or NN to VB it up , the NN of NNS will RB VB . I VBP this NN VBZ VBN me into NN NN . But to the NN from the NN : No , VBG the NN due to JJ NNS VBZ RB the JJ as VBG NN VBZ RBR JJ than JJ NN . We VBP JJ NNS every NN , JJ of the NN . NN NN , JJ NNS , JJ NNS and a NN of JJ NNS could RB VB VBN to a VBG NN if we VBD down RB . But a NN of NN NN VBZ RB a NN in which JJS of us would VB to VB . VB — with NNS JJ to the NNS With JJR NNS VBG over the JJ JJ NNS , NNS VBP JJ to VB that JJ NN NNS VBP VBN NNS VBP JJ . They VBP RB . NNP VBD one of the JJ NNS to VB and RB VBD its JJS JJ NN of JJ NNS since the NN VBD . While VBG VBZ a NN , it need RB VB JJ . NNS VBP a VBG NN to VB JJ NNS to NN NNS . The NN in JJ NN - in - NN NNS VBD that VBN NNS VBD VBN an NN to VB and VB NN NN . That VBZ a NN JJ of NN , and we should VB ourselves to VB the NN of JJ VBG NNS due to VBN NN NNS and VBN NNS . For the JJ two NNS I VBP VBN JJ by VBG RB , VBG my NN NN NNS to RB a NN . I ’d VB to VB NN , but the NN of VBG up NN at NNP NNP ’s and RB VBG my JJ NNS VBZ a JJ NN I VBP JJ to VB . VBG into the JJ NN of NN NN , the NN on each of us VBZ JJ . Some VBP JJ NN . Some VBP VBN their NN VBN into NN . For me , the JJR I VBP RB RB , the RBR my JJ - JJ NN NNS . I VBD RB VB this until a NN NN in which a NN VBD whether I VBD VBG JJ . I VBD that I VBD VBN a NN to VB myself for NN : NN of NN VBZ one of the JJ NNS of NN , RB I VBD a 5 NN NN of NN NNS with 49 NNS . I VBP JJ NNS RB , one NN at a NN . If I VBP each of the JJ NNS , I VBP that I VBP JJ . The JJ NN on the NN VBD me it VBD NN to VB a NNP NN NN . When the NN of this NN VBD itself VBN , I VBD my NN to VB me . But NNP VBZ VBN two NNS VBG JJ NNP NNP NNP for a NN of JJ JJ NN , VBG NN - NN NNS and VBG the NN of NN - 19 NN NNS . RB , the NN VBZ VBN that in NN to VB it through this NN , we VBP VBG to VB to VB for ourselves . As NNS VBP , each of us will VB JJ NNS to VB . NNS about VBG from NN , VBG to NNS and VBG NNS . I VBP VBN I ’ll VB the NN , but RB NNS or NN NNS . I VBP RB VBN that despite the NN , I ’ll VB a NN when I VBP in an JJ JJ NN — every NN . VBG out of NN ’s NN in the NN of NN VBZ to VB a RB - VBG NN to VB NN and NN . I VBP I VBP the JJ NN . I VBP at the NN of the JJ NNP NN VBG NN of my JJ NN as a JJ NN . NNP NNP NNP , a NN of NNP NNP 's NNP of NNPS , VBD a JJ NN for 25 NNS in NNP and NNP NNP . VB him on NNP : @ NNP"
71,542,conspiracy,C006b4,fluoride.water; vaccine.covid; zika.virus,"America_NNP :_: Home_NN of_IN the_DT HUMAN_JJ LAB_NNP RATS_NNS …_. Why_WRB prescription_NN medications_NNS are_VBP mostly_RB unsafe_JJ chemical_JJ experiments_NNS that_WDT worsen_VBP overall_JJ health_NN Most_JJS people_NNS think_VBP it_PRP ’s_VBZ completely_RB normal_JJ to_TO take_VB prescription_NN medications_NNS ,_, believing_VBG that_IN our_PRP$ bodies_NNS need_VBP synthetic_JJ ,_, lab_NN -_HYPH made_VBN chemicals_NNS to_TO balance_VB or_CC help_VB control_VB bodily_NN functions_NNS or_CC biological_JJ processes_NNS that_WDT are_VBP n’t_RB performing_VBG properly_RB ._. What_WDT other_JJ choices_NNS do_VBP we_PRP have_VB ,_, after_IN all_DT ?_. Put_VB it_PRP this_DT way_NN :_: Medical_JJ doctors_NNS go_VBP to_IN college_NN for_IN eight_CD years_NNS to_TO learn_VB how_WRB to_TO juggle_VB multiple_JJ medications_NNS while_IN reading_VBG all_DT of_IN your_PRP$ symptoms_NNS with_IN fancy_JJ technological_JJ diagnostic_JJ tests_NNS ,_, so_RB should_MD n’t_RB you_PRP just_RB shut_VB the_DT heck_NN up_RP and_CC do_VB what_WP you_PRP ’re_VBP told_VBN ,_, when_WRB you_PRP ’re_VBP told_VBN ,_, without_IN asking_VBG annoying_JJ ,_, invasive_JJ questions_NNS that_WDT will_MD most_RBS likely_RB have_VB boondoggles_NNS for_IN answers_NNS ?_. How_WRB many_JJ people_NNS ,_, after_IN all_DT ,_, are_VBP not_RB taking_VBG at_IN least_JJS one_CD medication_NN for_IN anxiety_NN ,_, depression_NN ,_, inflammation_NN ,_, cholesterol_NN ,_, blood_NN pressure_NN ,_, insomnia_NN or_CC pain_NN ?_. Actually_RB ,_, there_EX are_VBP plenty_NN of_IN us_PRP ,_, because_IN we_PRP know_VBP that_IN “_`` Western_JJ ”_'' medicine_NN is_VBZ n’t_RB really_RB medicine_NN at_IN all_DT ,_, but_CC symptom_NN -_HYPH cover_NN -_HYPH up_RP chemicals_NNS for_IN deeper_JJR rooted_VBN problems_NNS that_WDT almost_RB always_RB stem_VBP from_IN what_WP we_PRP eat_VBP ,_, drink_VBP and_CC put_VBP on_IN our_PRP$ bodies_NNS ._. Are_VBP you_PRP a_DT “_`` drug_NN abuser_NN ”_'' when_WRB you_PRP simply_RB take_VBP the_DT drugs_NNS prescribed_VBN to_IN you_PRP by_IN a_DT medical_JJ doctor_NN ?_. Prescription_NN drugs_NNS and_CC their_PRP$ abuse_NN in_IN America_NNP date_VBP back_RB over_IN a_DT century_NN ._. It_PRP all_DT started_VBD with_IN a_DT concoction_NN made_VBN with_IN alcohol_NN and_CC opium_NN called_VBN Laudanum_NNP ._. Yes_UH ,_, it_PRP was_VBD a_DT pain_NN “_`` remedy_NN ”_'' that_WDT doctors_NNS cross-prescribed_VBD for_IN anxiety_NN ,_, sleeplessness_NN ,_, diarrhea_NN or_CC incessant_JJ coughing_NN ._. Sound_VB familiar_JJ ?_. It_PRP was_VBD quite_RB addictive_JJ ,_, as_IN any_DT watered_VBN -_HYPH down_RP heroin_NN can_MD be_VB ._. Since_IN women_NNS in_IN the_DT 1800s_NNS in_IN America_NNP were_VBD prohibited_VBN from_IN drinking_VBG at_IN taverns_NNS and_CC saloons_NNS ,_, they_PRP simply_RB went_VBD to_IN the_DT doctor_NN for_IN treatment_NN for_IN cramps_NNS or_CC emotional_JJ problems_NNS ,_, and_CC voila_NN !_. Currently_RB ,_, about_RB 35_CD million_CD people_NNS abuse_NN opioids_NNS worldwide_RB ._. Unintentional_JJ overdoses_NNS have_VBP quadrupled_VBN since_IN 2000_CD ._. Thanks_NN to_IN drugs_NNS like_IN oxycodone_NN (_-LRB- think_VB of_IN Percocet_NNP )_-RRB- and_CC hydrocodone_NN (_-LRB- think_VB of_IN Vicodin_NNP )_-RRB- ,_, the_DT U.S._NNP is_VBZ the_DT biggest_JJS consumer_NN of_IN deadly_JJ prescription_NN painkillers_NNS ._. Did_VBD you_PRP know_VB that_IN for_IN the_DT past_JJ 15_CD years_NNS ,_, death_NN certificates_NNS have_VBP listed_VBN opioid_JJ analgesic_JJ poisoning_NN as_IN the_DT cause_NN of_IN death_NN more_RBR often_RB than_IN cocaine_NN or_CC heroin_NN ?_. Maybe_RB you_PRP ’re_VBP just_RB addicted_JJ to_IN soda_NN ,_, though_RB ._. Did_VBD you_PRP know_VB that_IN a_DT doctor_NN invented_VBD Coca_NNP Cola_NNP ,_, but_CC in_IN the_DT process_NN jump_NN -_HYPH started_VBN his_PRP$ own_JJ morphine_NN addiction_NN when_WRB he_PRP added_VBD cocaine_NN to_IN this_DT new_JJ drink_NN and_CC sold_VBD it_PRP at_IN a_DT pharmacy_NN in_IN Atlanta_NNP during_IN the_DT Civil_NNP War_NNP ?_. Ask_VB your_PRP$ doctor_NN if_IN soda_NN and_CC addictive_JJ ,_, deadly_JJ ,_, heroin_NN -_HYPH based_VBN prescription_NN drugs_NNS are_VBP right_JJ for_IN you_PRP ._. Are_VBP you_PRP a_DT lab_NN rat_NN in_IN the_DT middle_NN of_IN an_DT extended_VBN ,_, insidious_JJ experiment_NN being_VBG carried_VBN out_RP by_IN mad_JJ scientists_NNS and_CC medical_JJ doctors_NNS ?_. Have_VBP you_PRP been_VBN told_VBN repeatedly_RB that_IN your_PRP$ health_NN problems_NNS are_VBP all_RB “_`` genetic_JJ ?_. ”_'' That_DT ’s_VBZ because_IN doctors_NNS want_VBP you_PRP to_TO believe_VB that_IN there_EX ’s_VBZ no_DT cure_NN ,_, only_RB chemical_JJ medication_NN “_'' management_NN ._. ”_'' Have_VBP you_PRP been_VBN told_VBN you_PRP have_VBP a_DT chemical_JJ imbalance_NN in_IN your_PRP$ brain_NN ?_. That_DT ’s_VBZ because_IN you_PRP ’re_VBP consuming_VBG chemicals_NNS regularly_RB in_IN your_PRP$ food_NN and_CC medicine_NN ,_, including_VBG in_IN artificial_JJ sweeteners_NNS ,_, tap_NN water_NN ,_, prescription_NN medications_NNS and_CC vaccinations_NNS ._. Most_JJS prescription_NN drugs_NNS and_CC inoculations_NNS are_VBP never_RB tested_VBN for_IN safety_NN or_CC efficacy_NN ,_, but_CC rather_RB are_VBP “_`` fast_RB -_HYPH tracked_VBN ”_'' through_IN FDA_NN and_CC CDC_NN approval_NN when_WRB pharma_NN lobbyists_NNS pay_VBP regulators_NNS millions_NNS of_IN dollars_NNS to_TO just_RB say_VB “_`` yes_UH ._. ”_'' In_IN most_JJS other_JJ instances_NNS ,_, scientific_JJ “_`` testing_NN ”_'' is_VBZ simply_RB faked_VBN ,_, flawed_JJ ,_, altered_VBN and_CC skewed_VBN to_TO produce_VB the_DT results_NNS the_DT pharma_NN companies_NNS need_VBP to_TO make_VB profits_NNS and_CC spread_VB more_JJR disease_NN and_CC disorder_NN (_-LRB- think_VB of_IN the_DT Swine_NN flu_NN and_CC Zika_NNP virus_NN vaccines_NNS here_RB )_-RRB- ._. Even_RB the_DT yearly_JJ flu_NN shot_NN is_VBZ one_CD huge_JJ ,_, dangerous_JJ medical_JJ experiment_NN that_WDT the_DT CDC_NNP admits_VBZ is_VBZ often_RB a_DT failure_NN ._. Maybe_RB the_DT reason_NN you_PRP need_VBP prescription_NN medications_NNS is_VBZ because_IN you_PRP ’re_VBP taking_VBG prescription_NN medications_NNS ._. Think_VB about_IN that_DT for_IN a_DT minute_NN ._. Now_RB do_VB the_DT math_NN :_: If_IN the_DT flu_NN shot_NN is_VBZ a_DT hoax_NN ,_, and_CC prescribed_VBN painkillers_NNS kill_VBP millions_NNS of_IN people_NNS ,_, then_RB do_VBP you_PRP really_RB believe_VB your_PRP$ prescription_NN medications_NNS ,_, which_WDT are_VBP dished_VBN out_RP by_IN the_DT same_JJ rogue_NN doctors_NNS and_CC scientists_NNS ,_, are_VBP given_VBN with_IN your_PRP$ “_`` good_JJ health_NN ”_'' in_IN mind_NN ?_. Let_VB ’s_PRP take_VB an_DT inside_JJ look_NN at_IN what_WP all_PDT the_DT American_JJ “_`` lab_NN rats_NNS ”_'' are_VBP experiencing_VBG ._. Chantix_NNP (_-LRB- stop_VB -_HYPH smoking_NN medication_NN )_-RRB- can_MD cause_VB suicidal_JJ thoughts_NNS ._. Nexium_NN can_MD cause_VB inflammation_NN of_IN your_PRP$ kidneys_NNS and_CC vitamin_NN deficiencies_NNS ._. Vasotec_NNP can_MD ruin_VB your_PRP$ liver_NN ._. Xanax_NNP is_VBZ extremely_RB addictive_JJ and_CC abrupt_JJ stoppage_NN can_MD cause_VB seizures_NNS ._. Plavix_NNP can_MD cause_VB you_PRP to_TO cough_VB up_RP blood_NN ._. Lipitor_NN can_MD break_VB down_RP your_PRP$ muscles_NNS ,_, and_CC can_MD cause_VB kidney_NN failure_NN and_CC long_JJ -_HYPH term_NN nerve_NN problems_NNS ._. Mirapex_NNP gives_VBZ some_DT people_NNS hallucinations_NNS and_CC causes_VBZ memory_NN gaps_NNS ._. Ambien_NNP can_MD cause_VB impaired_JJ thinking_NN ._. Risperdal_NN can_MD give_VB you_PRP muscle_NN tremors_NNS and_CC uncontrolled_JJ movements_NNS (_-LRB- drive_VB recklessly_RB much_JJ ?_. )_-RRB- ._. Klonopin_NNP can_MD make_VB depression_NN symptoms_NNS worse_JJR ,_, adding_VBG in_IN suicidal_JJ thoughts_NNS and_CC addiction_NN ._. Actos_NNS and_CC Avandia_NNP heighten_VBP the_DT risk_NN of_IN heart_NN attacks_NNS and_CC bladder_NN cancer_NN ._. Hey_UH America_NNP …_: picture_VB yourself_PRP blindfolded_VBN ,_, drugged_VBN up_RP and_CC running_VBG through_IN a_DT rigged_VBN maze_NN with_IN dangerous_JJ traps_NNS and_CC no_DT exits_NNS ._. This_DT is_VBZ the_DT world_NN of_IN flu_NN shots_NNS ,_, prescription_NN medications_NNS ,_, genetically_RB modified_VBN food_NN and_CC fluoridated_VBN tap_NN water_NN ._. It_PRP ’s_VBZ time_NN to_TO go_VB organic_JJ and_CC natural_JJ for_IN good_JJ ._. Talk_VB to_IN a_DT naturopathic_JJ physician_NN and_CC question_VB anything_NN that_WDT has_VBZ side_NN effects_NNS worse_JJR than_IN the_DT condition_NN you_PRP ’re_VBP considering_VBG treating_VBG ._. Then_RB research_VB the_DT power_NN of_IN natural_JJ remedies_NNS at_IN NaturalPedia.com_NNP ._. Remember_VB ,_, you_PRP do_VBP n’t_RB have_VB to_TO be_VB a_DT lab_NN rat_NN !_.","NNP : NN of the JJ NNP NNS … Why NN NNS VBP RB JJ JJ NNS that VBP JJ NN JJS NNS VBP it VBZ RB JJ to VB NN NNS , VBG that our NNS VBP JJ , NN - VBN NNS to VB or VB VB NN NNS or JJ NNS that VBP RB VBG RB . What JJ NNS VBP we VB , after all ? VB it this NN : JJ NNS VBP to NN for eight NNS to VB how to VB JJ NNS while VBG all of your NNS with JJ JJ JJ NNS , RB should RB you RB VB the NN up and VB what you VBP VBN , when you VBP VBN , without VBG JJ , JJ NNS that will RBS RB VB NNS for NNS ? How JJ NNS , after all , VBP RB VBG at JJS one NN for NN , NN , NN , NN , NN NN , NN or NN ? RB , there VBP NN of us , because we VBP that “ JJ ” NN VBZ RB RB NN at all , but NN - NN - up NNS for JJR VBN NNS that RB RB VBP from what we VBP , VBP and VBP on our NNS . VBP you a “ NN NN ” when you RB VBP the NNS VBN to you by a JJ NN ? NN NNS and their NN in NNP VBP RB over a NN . It all VBD with a NN VBN with NN and NN VBN NNP . Yes , it VBD a NN “ NN ” that NNS VBD for NN , NN , NN or JJ NN . VB JJ ? It VBD RB JJ , as any VBN - down NN can VB . Since NNS in the NNS in NNP VBD VBN from VBG at NNS and NNS , they RB VBD to the NN for NN for NNS or JJ NNS , and NN ! RB , RB 35 million NNS NN NNS RB . JJ NNS VBP VBN since 2000 . NN to NNS like NN ( VB of NNP ) and NN ( VB of NNP ) , the NNP VBZ the JJS NN of JJ NN NNS . VBD you VB that for the JJ 15 NNS , NN NNS VBP VBN JJ JJ NN as the NN of NN RBR RB than NN or NN ? RB you VBP RB JJ to NN , RB . VBD you VB that a NN VBD NNP NNP , but in the NN NN - VBN his JJ NN NN when he VBD NN to this JJ NN and VBD it at a NN in NNP during the NNP NNP ? VB your NN if NN and JJ , JJ , NN - VBN NN NNS VBP JJ for you . VBP you a NN NN in the NN of an VBN , JJ NN VBG VBN out by JJ NNS and JJ NNS ? VBP you VBN VBN RB that your NN NNS VBP RB “ JJ ? ” That VBZ because NNS VBP you to VB that there VBZ no NN , RB JJ NN “ NN . ” VBP you VBN VBN you VBP a JJ NN in your NN ? That VBZ because you VBP VBG NNS RB in your NN and NN , VBG in JJ NNS , NN NN , NN NNS and NNS . JJS NN NNS and NNS VBP RB VBN for NN or NN , but RB VBP “ RB - VBN ” through NN and NN NN when NN NNS VBP NNS NNS of NNS to RB VB “ yes . ” In JJS JJ NNS , JJ “ NN ” VBZ RB VBN , JJ , VBN and VBN to VB the NNS the NN NNS VBP to VB NNS and VB JJR NN and NN ( VB of the NN NN and NNP NN NNS RB ) . RB the JJ NN NN VBZ one JJ , JJ JJ NN that the NNP VBZ VBZ RB a NN . RB the NN you VBP NN NNS VBZ because you VBP VBG NN NNS . VB about that for a NN . RB VB the NN : If the NN NN VBZ a NN , and VBN NNS VBP NNS of NNS , RB VBP you RB VB your NN NNS , which VBP VBN out by the JJ NN NNS and NNS , VBP VBN with your “ JJ NN ” in NN ? VB ’s VB an JJ NN at what all the JJ “ NN NNS ” VBP VBG . NNP ( VB - NN NN ) can VB JJ NNS . NN can VB NN of your NNS and NN NNS . NNP can VB your NN . NNP VBZ RB JJ and JJ NN can VB NNS . NNP can VB you to VB up NN . NN can VB down your NNS , and can VB NN NN and JJ - NN NN NNS . NNP VBZ some NNS NNS and VBZ NN NNS . NNP can VB JJ NN . NN can VB you NN NNS and JJ NNS ( VB RB JJ ? ) . NNP can VB NN NNS JJR , VBG in JJ NNS and NN . NNS and NNP VBP the NN of NN NNS and NN NN . Hey NNP … VB yourself VBN , VBN up and VBG through a VBN NN with JJ NNS and no NNS . This VBZ the NN of NN NNS , NN NNS , RB VBN NN and VBN NN NN . It VBZ NN to VB JJ and JJ for JJ . VB to a JJ NN and VB NN that VBZ NN NNS JJR than the NN you VBP VBG VBG . RB VB the NN of JJ NNS at NNP . VB , you VBP RB VB to VB a NN NN !"
72,174,mainstream,M0aed3,vaccine.autism,"•_NFP A_DT high_JJ school_NN in_IN Michigan_NNP has_VBZ banned_VBN unvaccinated_JJ kids_NNS following_VBG a_DT chickenpox_NN outbreak_NN ._. •_NFP Many_JJ schools_NNS are_VBP grappling_VBG with_IN an_DT uptick_NN in_IN unvaccinated_JJ kids_NNS ,_, which_WDT has_VBZ led_VBN to_IN various_JJ outbreaks_NNS ._. •_NFP Experts_NNS say_VBP keeping_VBG unvaccinated_JJ kids_NNS home_NN is_VBZ the_DT only_JJ real_JJ way_NN to_TO contain_VB these_DT outbreaks_NNS ._. Parents_NNS of_IN high_JJ school_NN students_NNS at_IN an_DT eastern_JJ Michigan_NNP high_JJ school_NN have_VBP been_VBN issued_VBN a_DT stark_JJ order_NN ._. If_IN your_PRP$ children_NNS are_VBP n’t_RB vaccinated_VBN ,_, they_PRP are_VBP n’t_RB allowed_VBN to_TO return_VB to_IN school_NN until_IN they_PRP ’ve_VBP gotten_VBN their_PRP$ shots_NNS ._. Following_VBG a_DT chickenpox_NN outbreak_NN at_IN Marysville_NNP High_NNP School_NNP ,_, the_DT St._NNP Clair_NNP County_NNP Health_NNP Department_NNP identified_VBD 37_CD students_NNS who_WP could_MD n’t_RB prove_VB they_PRP ’d_VBD been_VBN inoculated_VBN ._. In_IN a_DT letter_NN to_IN parents_NNS ,_, health_NN department_NN officials_NNS said_VBD the_DT affected_VBN students_NNS wo_MD n’t_RB be_VB allowed_VBN to_TO attend_VB school_NN until_IN they_PRP ’ve_VBP proven_VBN that_IN their_PRP$ chickenpox_NN shots_NNS are_VBP up_RB to_IN date_NN ._. While_IN such_JJ stories_NNS may_MD raise_VB the_DT ire_NN of_IN those_DT who_WP subscribe_VBP to_IN the_DT anti-vaccination_NN movement_NN ,_, experts_NNS agree_VBP that_IN this_DT is_VBZ a_DT case_NN of_IN a_DT government_NN agency_NN promoting_VBG good_JJ public_JJ health_NN ._. “_`` The_DT health_NN department_NN is_VBZ facing_VBG some_DT hard_JJ decisions_NNS in_IN this_DT case_NN ,_, ”_'' Dr._NNP Michael_NNP Grosso_NNP ,_, chief_JJ medical_JJ officer_NN and_CC chair_NN of_IN pediatrics_NN at_IN Northwell_NNP Health_NNP ’s_POS Huntington_NNP Hospital_NNP in_IN Huntington_NNP ,_, New_NNP York_NNP ,_, told_VBD Healthline_NNP ._. “_`` Chickenpox_NN ,_, also_RB called_VBN varicella_NN ,_, becomes_VBZ contagious_JJ before_IN the_DT rash_NN appears_VBZ and_CC remains_VBZ so_RB until_IN all_DT lesions_NNS have_VBP crusted_VBN ,_, ”_'' Grosso_NNP explained_VBD ._. “_`` The_DT incubation_NN period_NN is_VBZ up_IN to_IN three_CD weeks_NNS ._. Of_IN course_NN ,_, administering_VBG vaccine_NN to_IN the_DT unimmunized_JJ is_VBZ helpful_JJ ,_, but_CC protection_NN takes_VBZ several_JJ weeks_NNS ._. ”_'' While_IN chickenpox_NN was_VBD once_RB seen_VBN as_IN a_DT benign_JJ rite_NN of_IN passage_NN ,_, the_DT vaccine_NN means_VBZ it_PRP ’s_VBZ no_RB longer_RBR necessary_JJ to_TO suffer_VB through_IN the_DT itchy_JJ —_: and_CC sometimes_RB dangerous_JJ —_: ailment_NN ._. “_`` Though_IN most_JJS often_RB an_DT uncomplicated_JJ ,_, if_IN uncomfortable_JJ ,_, viral_JJ infection_NN ,_, varicella_NN can_MD attack_VB the_DT liver_NN and_CC brain_NN ,_, cause_VB serious_JJ secondary_JJ infections_NNS ,_, and_CC occasionally_RB lead_VB to_IN death_NN ,_, ”_'' said_VBD Grosso_NNP ._.","• A JJ NN in NNP VBZ VBN JJ NNS VBG a NN NN . • JJ NNS VBP VBG with an NN in JJ NNS , which VBZ VBN to JJ NNS . • NNS VBP VBG JJ NNS NN VBZ the JJ JJ NN to VB these NNS . NNS of JJ NN NNS at an JJ NNP JJ NN VBP VBN VBN a JJ NN . If your NNS VBP RB VBN , they VBP RB VBN to VB to NN until they VBP VBN their NNS . VBG a NN NN at NNP NNP NNP , the NNP NNP NNP NNP NNP VBD 37 NNS who could RB VB they VBD VBN VBN . In a NN to NNS , NN NN NNS VBD the VBN NNS wo RB VB VBN to VB NN until they VBP VBN that their NN NNS VBP RB to NN . While JJ NNS may VB the NN of those who VBP to the NN NN , NNS VBP that this VBZ a NN of a NN NN VBG JJ JJ NN . “ The NN NN VBZ VBG some JJ NNS in this NN , ” NNP NNP NNP , JJ JJ NN and NN of NN at NNP NNP ’s NNP NNP in NNP , NNP NNP , VBD NNP . “ NN , RB VBN NN , VBZ JJ before the NN VBZ and VBZ RB until all NNS VBP VBN , ” NNP VBD . “ The NN NN VBZ up to three NNS . Of NN , VBG NN to the JJ VBZ JJ , but NN VBZ JJ NNS . ” While NN VBD RB VBN as a JJ NN of NN , the NN VBZ it VBZ RB RBR JJ to VB through the JJ — and RB JJ — NN . “ Though JJS RB an JJ , if JJ , JJ NN , NN can VB the NN and NN , VB JJ JJ NNS , and RB VB to NN , ” VBD NNP ."
73,259,conspiracy,C0041f,ebola; george.soros; vaccine,"I_PRP know_VBP you_PRP have_VBP been_VBN hearing_VBG all_DT about_IN Ebola_NNP ,_, and_CC it_PRP looks_VBZ like_IN things_NNS are_VBP getting_VBG worse_JJR ,_, not_RB better_JJR ._. Look_VB at_IN this_DT headline_NN from_IN USA_NNP Today_NN “_`` 10,000_CD Cases_NNS of_IN Ebola_NNP per_IN Week_NN ._. ”_'' That_DT ’s_VBZ what_WP the_DT World_NNP Health_NNP Organization_NNP says_VBZ we_PRP could_MD be_VB getting_VBG in_IN West_NNP Africa_NNP in_IN a_DT few_JJ months_NNS ._. So_RB ,_, why_WRB are_VBP there_EX no_DT flight_NN restrictions_NNS out_IN of_IN West_NNP Africa_NNP ?_. Do_VBP the_DT dimwits_NNS at_IN the_DT CDC_NNP not_RB understand_VB the_DT concept_NN of_IN quarantine_NN ?_. This_DT is_VBZ the_DT number_NN one_CD protocol_NN of_IN infectious_JJ disease_NN ,_, and_CC many_JJ doctors_NNS and_CC politicians_NNS are_VBP saying_VBG the_DT same_JJ thing_NN ._. Why_WRB not_RB temporarily_RB stop_VB people_NNS from_IN coming_VBG into_IN the_DT U.S._NNP ?_. Many_JJ other_JJ countries_NNS are_VBP banning_VBG folks_NNS from_IN West_NNP Africa_NNP ,_, and_CC that_DT is_VBZ exactly_RB what_WDT countries_NNS bordering_VBG the_DT infected_VBN countries_NNS did_VBD ._. Not_RB the_DT U.S._NNP The_DT CDC_NNP says_VBZ it_PRP ca_MD n’t_RB fight_VB the_DT outbreak_NN with_IN a_DT travel_NN ban_NN ._. What_WP ?_. You_PRP let_VBP more_JJR people_NNS who_WP are_VBP possibly_RB infected_VBN into_IN the_DT U.S._NNP ?_. Is_VBZ this_DT too_RB stupid_JJ to_TO be_VB stupid_JJ ?_. Now_RB ,_, there_EX are_VBP some_DT medical_JJ experts_NNS who_WP are_VBP worried_VBN that_IN Ebola_NNP could_MD mutate_VB and_CC become_VB airborne_JJ ._. If_IN that_DT happens_VBZ ,_, expect_VB panic_NN in_IN the_DT general_JJ public_NN around_IN the_DT globe_NN ._. The_DT stock_NN market_NN is_VBZ having_VBG some_DT wicked_JJ gyrations_NNS ._. Look_VB at_IN how_WRB the_DT USA_NNP Today_NN characterized_VBD the_DT big_JJ rebound_NN after_IN it_PRP plunged_VBD 460_CD points_NNS ._. The_DT headline_NN reads_VBZ “_`` Bargain_NN Hunters_NNS Rescue_NN Stocks_NNS From_IN Gut_NN Punch_NN ._. ”_'' Really_RB ?_. Bargain_NN hunters_NNS ?_. You_PRP mean_VBP the_DT USA_NNP Today_NN does_VBZ n’t_RB know_VB the_DT President_NNP ’s_POS Working_NNP Group_NNP on_IN Financial_NNP Markets_NNPS or_CC the_DT Plunge_NNP Protection_NNP Team_NNP is_VBZ alive_JJ and_CC well_RB today_NN ?_. Bargain_NN hunters_NNS ?_. Please_UH stop_VB calling_VBG yourselves_PRP journalists_NNS ,_, and_CC just_RB use_VB the_DT term_NN “_`` government_NN spin_NN doctors_NNS ”_'' because_IN that_DT is_VBZ what_WP you_PRP are_VBP ._. Former_JJ Assistant_NNP Treasury_NNP Secretary_NNP Dr._NNP Paul_NNP Craig_NNP Roberts_NNP said_VBD the_DT government_NN intervened_VBD through_IN the_DT Plunge_NNP Protection_NNP Team_NNP and_CC bought_VBD futures_NNS on_IN the_DT S&P_NNP ,_, and_CC that_DT is_VBZ the_DT main_JJ reason_NN the_DT stock_NN market_NN rebounded_VBD ._. He_PRP will_MD come_VB on_RB early_RB next_JJ week_NN for_IN updates_NNS on_IN multiple_JJ fronts_NNS ._. Also_RB ,_, in_IN economic_JJ news_NN ,_, China_NNP is_VBZ the_DT new_JJ number_NN one_CD economy_NN in_IN the_DT world_NN ,_, according_VBG to_IN the_DT International_NNP Monetary_NNP Fund_NNP ._. That_DT ’s_VBZ right_JJ ._. America_NNP is_VBZ the_DT number_NN two_CD economy_NN in_IN the_DT world_NN ,_, and_CC it_PRP may_MD never_RB be_VB number_NN one_CD again_RB ._. This_DT is_VBZ what_WP happens_VBZ when_WRB you_PRP offshore_VBP all_PDT your_PRP$ manufacturing_NN to_IN another_DT country_NN to_TO save_VB a_DT few_JJ bucks_NNS ._. Germany_NNP did_VBD n’t_RB do_VB that_DT with_IN its_PRP$ manufacturing_NN ._. How_WRB can_MD the_DT U.S._NNP dollar_NN remain_VB the_DT world_NN reserve_NN currency_NN when_WRB it_PRP ’s_VBZ number_NN two_CD ?_. How_WRB can_MD the_DT U.S._NNP dollar_NN be_VB a_DT reserve_NN currency_NN with_IN unpayable_JJ debt_NN that_WDT is_VBZ growing_VBG by_IN leaps_NNS and_CC bounds_NNS every_DT year_NN ?_. Short_JJ answer–it_NN can’t_VB ._. At_IN some_DT point_NN ,_, the_DT dollar_NN world_NN ends_VBZ badly_RB ._. The_DT two_CD really_RB hot_JJ spots_NNS for_IN war_NN in_IN the_DT world_NN ,_, Ukraine_NNP and_CC the_DT Middle_NNP East_NNP ,_, are_VBP not_RB going_VBG well_RB for_IN the_DT West_NNP ._. In_IN Ukraine_NNP ,_, there_EX is_VBZ a_DT declared_VBN ceasefire_NN ,_, but_CC that_DT is_VBZ debatable_JJ ._. What_WP is_VBZ not_RB debatable_JJ is_VBZ financial_JJ warfare_NN being_VBG conducted_VBN between_IN Russia_NNP and_CC the_DT U.S._NNP and_CC Europe_NNP ._. Russia_NNP is_VBZ not_RB happy_JJ ._. The_DT leader_NN of_IN Russia_NNP ,_, Vladimir_NNP Putin_NNP ,_, is_VBZ letting_VBG people_NNS know_VB sanctions_NNS ,_, or_CC what_WP he_PRP calls_VBZ “_`` blackmail_NN ,_, ”_'' does_VBZ not_RB work_VB and_CC is_VBZ a_DT “_`` hostile_JJ ”_'' act_NN ._. He_PRP also_RB reminded_VBD everyone_NN that_IN Russia_NNP is_VBZ a_DT nuclear_JJ power_NN and_CC warned_VBD of_IN creating_VBG instability_NN ._. The_DT Ukraine_NNP crisis_NN is_VBZ far_RB from_IN over_RB ._. In_IN the_DT Middle_NNP East_NNP ,_, the_DT air_NN war_NN against_IN the_DT Islamic_NNP State_NNP is_VBZ not_RB going_VBG well_RB and_CC ,_, shockingly_RB ,_, President_NNP Obama_NNP admitted_VBD it_PRP ._. Even_RB though_IN the_DT bombing_NN attacks_NNS continue_VBP ,_, The_DT Islamic_NNP State_NNP is_VBZ still_RB taking_VBG ground_NN and_CC is_VBZ very_RB close_JJ to_IN Baghdad_NNP ._. Now_RB ,_, the_DT Turks_NNPS ,_, as_RB well_RB as_IN others_NNS ,_, want_VBP not_RB only_RB to_TO take_VB out_RP The_DT Islamic_NNP State_NNP ,_, but_CC also_RB take_VB out_RP Assad_NNP in_IN Syria_NNP at_IN the_DT same_JJ time_NN ._. Well_UH ,_, there_EX is_VBZ one_CD very_RB big_JJ problem_NN with_IN that_DT strategy_NN and_CC that_DT is_VBZ Russia_NNP is_VBZ backing_VBG Assad_NNP and_CC has_VBZ warned_VBN of_IN wider_JJR war_NN if_IN there_EX are_VBP attempts_NNS to_TO take_VB him_PRP down_RP ._. Finally_RB ,_, Harvey_NNP Organ_NNP ’s_POS website_NN of_IN 15_CD years_NNS was_VBD taken_VBN down_RP by_IN court_NN order_NN ._. This_DT happened_VBD a_DT little_JJ more_JJR than_IN a_DT month_NN after_IN he_PRP made_VBD a_DT bold_JJ prediction_NN on_IN USAWartchdog.com_NNP that_IN the_DT gold_NN and_CC silver_NN price_NN manipulation_NN would_MD end_VB before_IN the_DT end_NN of_IN 2014_CD ._. was_VBD it_PRP a_DT coincidence_NN his_PRP$ site_NN was_VBD taken_VBN down_RP ?_. Maybe_RB ,_, and_CC then_RB again_RB ,_, maybe_RB not_RB ._. Harvey_NNP Organ_NNP reports_VBZ on_IN inventories_NNS of_IN gold_NN and_CC silver_NN at_IN COMEX_NNP and_CC the_DT LBMA_NNP ._. I_PRP have_VBP talked_VBN to_IN Harvey_NNP by_IN phone_NN ,_, and_CC he_PRP still_RB does_VBZ not_RB know_VB why_WRB his_PRP$ site_NN was_VBD taken_VBN down_RP ._. He_PRP told_VBD me_PRP he_PRP ’s_VBZ asked_VBN Google_NNP for_IN the_DT court_NN order_NN ,_, and_CC it_PRP has_VBZ not_RB been_VBN produced_VBN ._. I_PRP will_MD book_VB him_PRP as_RB soon_RB as_IN he_PRP is_VBZ available_JJ ._. I_PRP think_VBP that_IN when_WRB Mr._NNP Organ_NNP came_VBD on_IN USAWatchdog.com_NNP a_DT little_JJ more_JJR than_IN a_DT month_NN ago_RB and_CC said_VBD silver_NN and_CC gold_NN manipulation_NN is_VBZ going_VBG to_TO end_VB this_DT year_NN ,_, he_PRP ’s_VBZ probably_RB hitting_VBG a_DT nerve_NN somewhere_RB ._. His_PRP$ main_JJ contention_NN is_VBZ that_IN gold_NN and_CC silver_NN is_VBZ in_IN very_RB short_JJ supply_NN ,_, and_CC if_IN you_PRP do_VBP n’t_RB have_VB the_DT metal_NN ,_, you_PRP ca_MD n’t_RB control_VB the_DT price_NN ._. Join_VB Greg_NNP Hunter_NNP as_IN he_PRP analyzes_VBZ these_DT stories_NNS and_CC more_JJR in_IN the_DT Weekly_NNP News_NNP Wrap_NN -_HYPH Up_NNP ._.","I VBP you VBP VBN VBG all about NNP , and it VBZ like NNS VBP VBG JJR , RB JJR . VB at this NN from NNP NN “ 10,000 NNS of NNP per NN . ” That VBZ what the NNP NNP NNP VBZ we could VB VBG in NNP NNP in a JJ NNS . RB , why VBP there no NN NNS out of NNP NNP ? VBP the NNS at the NNP RB VB the NN of NN ? This VBZ the NN one NN of JJ NN , and JJ NNS and NNS VBP VBG the JJ NN . Why RB RB VB NNS from VBG into the NNP ? JJ JJ NNS VBP VBG NNS from NNP NNP , and that VBZ RB what NNS VBG the VBN NNS VBD . RB the NNP The NNP VBZ it ca RB VB the NN with a NN NN . What ? You VBP JJR NNS who VBP RB VBN into the NNP ? VBZ this RB JJ to VB JJ ? RB , there VBP some JJ NNS who VBP VBN that NNP could VB and VB JJ . If that VBZ , VB NN in the JJ NN around the NN . The NN NN VBZ VBG some JJ NNS . VB at how the NNP NN VBD the JJ NN after it VBD 460 NNS . The NN VBZ “ NN NNS NN NNS From NN NN . ” RB ? NN NNS ? You VBP the NNP NN VBZ RB VB the NNP ’s NNP NNP on NNP NNPS or the NNP NNP NNP VBZ JJ and RB NN ? NN NNS ? Please VB VBG yourselves NNS , and RB VB the NN “ NN NN NNS ” because that VBZ what you VBP . JJ NNP NNP NNP NNP NNP NNP NNP VBD the NN VBD through the NNP NNP NNP and VBD NNS on the NNP , and that VBZ the JJ NN the NN NN VBD . He will VB RB RB JJ NN for NNS on JJ NNS . RB , in JJ NN , NNP VBZ the JJ NN one NN in the NN , VBG to the NNP NNP NNP . That VBZ JJ . NNP VBZ the NN two NN in the NN , and it may RB VB NN one RB . This VBZ what VBZ when you VBP all your NN to another NN to VB a JJ NNS . NNP VBD RB VB that with its NN . How can the NNP NN VB the NN NN NN when it VBZ NN two ? How can the NNP NN VB a NN NN with JJ NN that VBZ VBG by NNS and NNS every NN ? JJ NN VB . At some NN , the NN NN VBZ RB . The two RB JJ NNS for NN in the NN , NNP and the NNP NNP , VBP RB VBG RB for the NNP . In NNP , there VBZ a VBN NN , but that VBZ JJ . What VBZ RB JJ VBZ JJ NN VBG VBN between NNP and the NNP and NNP . NNP VBZ RB JJ . The NN of NNP , NNP NNP , VBZ VBG NNS VB NNS , or what he VBZ “ NN , ” VBZ RB VB and VBZ a “ JJ ” NN . He RB VBD NN that NNP VBZ a JJ NN and VBD of VBG NN . The NNP NN VBZ RB from RB . In the NNP NNP , the NN NN against the NNP NNP VBZ RB VBG RB and , RB , NNP NNP VBD it . RB though the NN NNS VBP , The NNP NNP VBZ RB VBG NN and VBZ RB JJ to NNP . RB , the NNPS , RB RB as NNS , VBP RB RB to VB out The NNP NNP , but RB VB out NNP in NNP at the JJ NN . Well , there VBZ one RB JJ NN with that NN and that VBZ NNP VBZ VBG NNP and VBZ VBN of JJR NN if there VBP NNS to VB him down . RB , NNP NNP ’s NN of 15 NNS VBD VBN down by NN NN . This VBD a JJ JJR than a NN after he VBD a JJ NN on NNP that the NN and NN NN NN would VB before the NN of 2014 . VBD it a NN his NN VBD VBN down ? RB , and RB RB , RB RB . NNP NNP VBZ on NNS of NN and NN at NNP and the NNP . I VBP VBN to NNP by NN , and he RB VBZ RB VB why his NN VBD VBN down . He VBD me he VBZ VBN NNP for the NN NN , and it VBZ RB VBN VBN . I will VB him RB RB as he VBZ JJ . I VBP that when NNP NNP VBD on NNP a JJ JJR than a NN RB and VBD NN and NN NN VBZ VBG to VB this NN , he VBZ RB VBG a NN RB . His JJ NN VBZ that NN and NN VBZ in RB JJ NN , and if you VBP RB VB the NN , you ca RB VB the NN . VB NNP NNP as he VBZ these NNS and JJR in the NNP NNP NN - NNP ."
74,411,mainstream,M09344,vaccine.autism,"What_WP happened_VBD to_IN little_JJ ,_, red_JJ -_HYPH haired_VBN Hannah_NNP Poling_NNP is_VBZ hardly_RB unique_JJ in_IN the_DT world_NN of_IN autism_NN ._. She_PRP had_VBD an_DT uneventful_JJ birth_NN ;_, she_PRP seemed_VBD to_TO be_VB developing_VBG normally_RB _HYPH smiling_VBG ,_, babbling_NN ,_, engaging_VBG in_IN imaginative_JJ play_NN ,_, speaking_VBG about_RB 20_CD words_NNS by_IN 19_CD months_NNS ._. And_CC then_RB ,_, right_RB after_IN receiving_VBG a_DT bunch_NN of_IN vaccines_NNS ,_, she_PRP fell_VBD ill_JJ and_CC it_PRP all_DT stopped_VBD ._. Hannah_NNP ,_, now_RB 9_CD ,_, recovered_VBD from_IN her_PRP$ acute_JJ illness_NN but_CC she_PRP lost_VBD her_PRP$ words_NNS ,_, her_PRP$ eye_NN contact_NN and_CC ,_, in_IN a_DT matter_NN of_IN months_NNS ,_, began_VBD exhibiting_VBG the_DT repetitive_JJ behaviors_NNS and_CC social_JJ withdrawal_NN that_WDT typify_VBP autism_NN ._. ""_`` Something_NN happened_VBD after_IN the_DT vaccines_NNS ,_, ""_'' says_VBZ her_PRP$ mom_NN ,_, Terry_NNP Poling_NNP ,_, who_WP is_VBZ a_DT registered_VBN nurse_NN and_CC an_DT attorney_NN ._. ""_`` She_PRP just_RB deteriorated_VBD and_CC never_RB came_VBD back_RB ._. ""_'' Parents_NNS of_IN kids_NNS like_IN Hannah_NNP have_VBP been_VBN fingering_VBG vaccines_NNS _, and_CC ,_, in_IN particular_JJ ,_, the_DT mercury_NN -_HYPH based_VBN vaccine_NN preservative_NN thimerosal_NN _, as_IN a_DT cause_NN of_IN autism_NN for_IN over_IN a_DT decade_NN ,_, but_CC researchers_NNS have_VBP repeatedly_RB failed_VBN to_TO find_VB a_DT link_NN ._. What_WP 's_VBZ unique_JJ about_IN Hannah_NNP 's_POS case_NN is_VBZ that_IN for_IN the_DT first_JJ time_NN federal_JJ authorities_NNS have_VBP conceded_VBN a_DT connection_NN between_IN her_PRP$ autistic_JJ symptoms_NNS and_CC the_DT vaccines_NNS she_PRP received_VBD ,_, though_IN the_DT connection_NN is_VBZ by_IN no_DT means_NNS simple_JJ ._. A_DT panel_NN of_IN medical_JJ evaluators_NNS at_IN the_DT Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS concluded_VBD that_IN Hannah_NNP had_VBD been_VBN injured_VBN by_IN vaccines_NNS _, and_CC recommended_VBD that_IN her_PRP$ family_NN be_VB compensated_VBN for_IN the_DT injuries_NNS ._. The_DT panel_NN said_VBD that_IN Hannah_NNP had_VBD an_DT underlying_JJ cellular_JJ disorder_NN that_WDT was_VBD aggravated_VBN by_IN the_DT vaccines_NNS ,_, causing_VBG brain_NN damage_NN with_IN features_NNS of_IN autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- ._. A_DT special_JJ federal_JJ vaccine_NN court_NN has_VBZ yet_RB to_TO award_VB damages_NNS ,_, but_CC the_DT recommendation_NN ,_, made_VBN public_JJ last_JJ week_NN ,_, is_VBZ causing_VBG a_DT sensation_NN in_IN the_DT autism_NN advocacy_NN community_NN ._. The_DT Polings_NNPS ,_, who_WP live_VBP in_IN Athens_NNP ,_, Ga._NNP ,_, were_VBD originally_RB part_NN of_IN a_DT group_NN of_IN nearly_RB 5,000_CD families_NNS with_IN autistic_JJ children_NNS seeking_VBG damages_NNS through_IN the_DT National_NNP Vaccine_NNP Injury_NNP Compensation_NNP Program_NNP ._. The_DT other_JJ cases_NNS remain_VBP before_IN the_DT court_NN ._. The_DT Poling_NNP case_NN is_VBZ also_RB causing_VBG deep_JJ concern_NN among_IN public_JJ health_NN officials_NNS ,_, eager_JJ to_TO reassure_VB parents_NNS that_IN vaccines_NNS are_VBP safe_JJ and_CC ,_, indeed_RB ,_, hugely_RB beneficial_JJ ._. In_IN a_DT public_JJ statement_NN on_IN Friday_NNP ,_, Dr._NNP Julie_NNP Gerberding_NNP ,_, director_NN of_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ,_, insisted_VBD that_IN ""_`` the_DT government_NN has_VBZ made_VBN absolutely_RB no_DT statement_NN about_IN indicating_VBG that_IN vaccines_NNS are_VBP the_DT cause_NN of_IN autism_NN ,_, as_IN this_DT would_MD be_VB a_DT complete_JJ mischaracterization_NN of_IN any_DT of_IN the_DT science_NN that_WDT we_PRP have_VBP at_IN our_PRP$ disposal_NN today_NN ._. ""_'' Gerberding_NNP and_CC other_JJ health_NN authorities_NNS point_VBP out_RP that_IN the_DT benefits_NNS of_IN vaccines_NNS far_RB exceed_VBP their_PRP$ risks_NNS ._. They_PRP also_RB note_VBP that_IN thimerosal_NN was_VBD eliminated_VBN from_IN routinely_RB administered_VBN childhood_NN vaccines_NNS manufactured_VBN after_IN 2001_CD ,_, and_CC yet_CC autism_NN rates_NNS have_VBP continued_VBN to_TO climb_VB ._. The_DT current_JJ CDC_NNP estimate_NN is_VBZ that_IN 1_CD of_IN 150_CD American_JJ children_NNS has_VBZ an_DT autism_NN spectrum_NN disorder_NN ._. Nonetheless_RB ,_, there_EX 's_VBZ no_DT denying_VBG that_IN the_DT court_NN 's_POS decision_NN to_TO award_VB damages_NNS to_IN the_DT Poling_NNP family_NN puts_VBZ a_DT chink_NN _, a_DT question_NN mark_NN _'' in_IN what_WP had_VBD been_VBN an_DT unqualified_JJ defense_NN of_IN vaccine_NN safety_NN with_IN regard_NN to_IN autism_NN ._. If_IN Hannah_NNP Poling_NNP had_VBD an_DT underlying_JJ condition_NN that_WDT made_VBD her_PRP vulnerable_JJ to_IN being_VBG harmed_VBN by_IN vaccines_NNS ,_, it_PRP stands_VBZ to_IN reason_NN that_IN other_JJ children_NNS might_MD also_RB have_VB such_JJ vulnerabilities_NNS ._. But_CC there_EX are_VBP circumstances_NNS that_WDT make_VBP Hannah_NNP 's_POS case_NN a_DT bit_NN unusual_JJ ._. For_IN one_CD thing_NN ,_, she_PRP received_VBD an_DT unusually_RB large_JJ number_NN of_IN vaccines_NNS in_IN 2000_CD (_-LRB- when_WRB thimerosal_NN was_VBD still_RB in_IN use_NN )_-RRB- ._. Because_IN of_IN a_DT series_NN of_IN ear_NN infections_NNS ,_, Hannah_NNP had_VBD fallen_VBN behind_RB in_IN the_DT vaccine_NN schedule_NN ,_, so_RB in_IN a_DT single_JJ day_NN she_PRP was_VBD given_VBN five_CD inoculations_NNS covering_VBG a_DT total_NN of_IN nine_CD diseases_NNS :_: measles_NNS ,_, mumps_NNS ,_, rubella_NN ,_, polio_NN ,_, varicella_NN ,_, diphtheria_NN ,_, pertussis_NN ,_, tetanus_NN ,_, and_CC Haemophilus_NN influenzae_NN ._. ""_`` That_DT was_VBD just_RB too_RB many_JJ vaccines_NNS ,_, ""_'' says_VBZ Terry_NNP Poling_NNP ._. ""_`` I_PRP did_VBD n't_RB find_VB out_RP for_IN several_JJ months_NNS that_IN they_PRP had_VBD thimerosal_NN ,_, which_WDT contains_VBZ mercury_NN ,_, a_DT powerful_JJ neurotoxin_NN ._. Had_VBD I_PRP known_VBN ,_, I_PRP never_RB would_MD have_VB allowed_VBN it_PRP to_TO be_VB injected_VBN into_IN my_PRP$ child_NN ._. ""_'' Another_DT confounding_VBG issue_NN in_IN Hannah_NNP 's_POS case_NN is_VBZ the_DT finding_NN that_IN she_PRP suffers_VBZ from_IN a_DT mitochondrial_JJ disorder_NN _, a_DT dysfunction_NN in_IN basic_JJ cell_NN metabolism_NN ._. Mitochondria_NNP serve_VBP as_IN power_NN generators_NNS for_IN each_DT cell_NN in_IN the_DT body_NN ,_, converting_VBG food_NN and_CC oxygen_NN into_IN energy_NN ._. There_EX are_VBP a_DT wide_JJ range_NN of_IN these_DT disorders_NNS ,_, causing_VBG symptoms_NNS that_WDT vary_VBP widely_RB but_CC can_MD include_VB muscle_NN weakness_NN ,_, cardiac_JJ or_CC liver_NN disease_NN ,_, diabetes_NN ,_, developmental_JJ delays_NNS and_CC susceptibility_NN to_IN infection_NN ._. In_IN Hannah_NNP 's_POS case_NN ,_, the_DT vaccine_NN court_NN determined_VBD that_IN the_DT underlying_JJ dysfunction_NN of_IN her_PRP$ mitochondria_NN put_VBD her_PRP at_IN an_DT increased_VBN risk_NN of_IN injury_NN from_IN vaccines_NNS ._. That_DT decision_NN ,_, however_RB ,_, comes_VBZ as_IN a_DT surprise_NN to_IN experts_NNS on_IN mitochondrial_JJ disorders_NNS ._. In_IN response_NN to_IN the_DT Poling_NNP case_NN ,_, the_DT United_NNP Mitochondrial_NNP Disease_NNP Foundation_NNP has_VBZ released_VBN a_DT statement_NN saying_VBG ,_, ""_`` There_EX are_VBP no_DT scientific_JJ studies_NNS documenting_VBG that_IN childhood_NN vaccinations_NNS cause_VBP mitochondrial_JJ diseases_NNS or_CC worsen_VB mitochondrial_JJ disease_NN symptoms_NNS ._. ""_'' Dr._NNP John_NNP Shoffner_NNP ,_, the_DT Atlanta_NNP -_HYPH based_VBN neurologist_NN who_WP identified_VBD Hannah_NNP Poling_NNP 's_POS mitochondrial_JJ disorder_NN ,_, is_VBZ ""_`` genuinely_RB puzzled_VBN ""_'' by_IN the_DT court_NN 's_POS judgment_NN ._. Shoffner_NNP ,_, who_WP has_VBZ been_VBN studying_VBG and_CC treating_VBG these_DT disorders_NNS for_IN 20_CD years_NNS ,_, says_VBZ it_PRP 's_VBZ impossible_JJ to_TO say_VB whether_IN Hannah_NNP 's_POS mitochondrial_JJ disorder_NN was_VBD ,_, in_IN fact_NN ,_, a_DT pre-existing_VBG condition_NN that_WDT set_VBD the_DT stage_NN for_IN her_PRP$ autism_NN (_-LRB- as_IN the_DT government_NN contends_VBZ )_-RRB- or_CC if_IN it_PRP developed_VBD along_IN with_IN her_PRP$ autism_NN ._. A_DT specialist_NN in_IN mitochondrial_NN disorders_NNS ,_, he_PRP is_VBZ investigating_VBG the_DT relationship_NN between_IN autism_NN and_CC these_DT disorders_NNS and_CC plans_VBZ to_TO present_VB a_DT paper_NN on_IN the_DT topic_NN at_IN the_DT annual_JJ meeting_NN of_IN the_DT American_NNP Academy_NNP of_IN Neurology_NNP in_IN April_NNP ._. ""_`` In_IN some_DT subset_NN of_IN people_NNS with_IN ASD_NN _, a_DT small_JJ group_NN of_IN patients_NNS ,_, I_PRP think_VBP _HYPH mitochondrial_JJ dysfunction_NN is_VBZ an_DT important_JJ part_NN of_IN their_PRP$ disease_NN ._. But_CC it_PRP 's_VBZ too_RB early_JJ to_TO say_VB whether_IN it_PRP gets_VBZ the_DT ball_NN rolling_VBG or_CC if_IN it_PRP comes_VBZ about_RB after_IN the_DT ball_NN got_VBD rolling_VBG ._. ""_'' Experts_NNS on_IN autism_NN spectrum_NN disorders_NNS believe_VBP that_IN most_JJS cases_NNS are_VBP caused_VBN by_IN a_DT combination_NN of_IN genetic_JJ vulnerabilities_NNS and_CC environmental_JJ factors_NNS ._. There_EX may_MD be_VB hundreds_NNS of_IN roads_NNS to_IN autism_NN ,_, involving_VBG numerous_JJ combinations_NNS of_IN genes_NNS and_CC external_JJ factors_NNS ._. Could_MD thimerosal_NN or_CC some_DT other_JJ aspect_NN of_IN vaccines_NNS be_VB one_CD of_IN these_DT factors_NNS ?_. ""_`` It_PRP 's_VBZ always_RB possible_JJ that_IN there_EX 's_VBZ a_DT small_JJ subset_NN of_IN kids_NNS that_WDT have_VBP this_DT vulnerability_NN ,_, ""_'' says_VBZ Dr._NNP Isaac_NNP Pessah_NNP ,_, director_NN of_IN the_DT Center_NNP for_IN Children_NNP 's_POS Environmental_NNP Health_NNP and_CC Disease_NNP Prevention_NNP at_IN the_DT University_NNP of_IN California_NNP ,_, Davis_NNP ._. Pessah_NNP 's_POS lab_NN is_VBZ looking_VBG at_IN dozens_NNS of_IN possible_JJ environmental_JJ factors_NNS ,_, including_VBG pesticides_NNS ,_, plastics_NNS and_CC flame_NN -_HYPH retardants_NNS ._. ""_`` This_DT is_VBZ a_DT very_RB emotional_JJ debate_NN ,_, ""_'' he_PRP says_VBZ ,_, ""_`` and_CC we_PRP need_VBP more_JJR research_NN directed_VBN at_IN these_DT questions_NNS ._. ""_'' It_PRP 's_VBZ difficult_JJ to_TO draw_VB any_DT clear_JJ lessons_NNS from_IN the_DT case_NN of_IN Hannah_NNP Poling_NNP ,_, other_JJ than_IN the_DT dire_JJ need_NN for_IN more_JJR research_NN ._. One_CD plausible_JJ conclusion_NN is_VBZ that_IN pediatricians_NNS should_MD avoid_VB giving_VBG small_JJ children_NNS a_DT large_JJ number_NN of_IN vaccines_NNS at_IN once_RB ,_, even_RB if_IN they_PRP are_VBP thimerosal_NN -_HYPH free_JJ ._. Young_JJ children_NNS have_VBP an_DT immature_JJ immune_JJ system_NN that_WDT 's_VBZ ill_RB -_HYPH equipped_VBN to_TO handle_VB an_DT overload_NN ,_, says_VBZ Dr._NNP Judy_NNP Van_NNP de_NNP Water_NNP ,_, an_DT immunologist_NN who_WP works_VBZ with_IN Pessah_NNP at_IN U.C._NNP Davis_NNP ._. ""_`` Some_DT vaccines_NNS ,_, such_JJ as_IN those_DT aimed_VBN at_IN viral_JJ infections_NNS ,_, are_VBP designed_VBN to_TO ramp_VB up_RP the_DT immune_NN system_NN at_IN warp_NN speed_NN ,_, ""_'' she_PRP says_VBZ ._. ""_`` They_PRP are_VBP designed_VBN to_TO mimic_VB the_DT infection_NN ._. So_RB you_PRP can_MD imagine_VB getting_VBG nine_CD at_IN one_CD time_NN ,_, how_WRB sick_JJ you_PRP could_MD be_VB ._. ""_'' In_IN addition_NN ,_, she_PRP says_VBZ ,_, there_EX 's_VBZ some_DT evidence_NN ,_, that_IN children_NNS who_WP develop_VBP autism_NN may_MD have_VB immune_NN systems_NNS that_WDT are_VBP particularly_RB slow_JJ to_TO mature_VB ._. Van_NNP de_NNP Water_NNP worries_VBZ that_IN current_JJ vaccine_NN schedules_NNS may_MD be_VB overly_RB aggressive_JJ for_IN some_DT children_NNS ._. She_PRP suggests_VBZ that_IN parents_NNS who_WP are_VBP concerned_VBN about_IN vaccine_NN safety_NN ask_VBP their_PRP$ pediatricians_NNS to_TO give_VB fewer_JJR at_IN a_DT time_NN ._. And_CC ,_, she_PRP adds_VBZ ,_, do_VB n't_RB vaccinate_VB a_DT child_NN when_WRB he_PRP or_CC she_PRP is_VBZ ill_JJ ._. Hannah_NNP Poling_NNP is_VBZ now_RB a_DT third_JJ grader_NN in_IN public_JJ school_NN ,_, working_VBG one_CD -_HYPH on_IN -_HYPH one_CD with_IN teachers_NNS in_IN a_DT special_JJ -_HYPH ed_NN classroom_NN ._. She_PRP continues_VBZ to_TO struggle_VB with_IN the_DT effects_NNS of_IN autism_NN and_CC also_RB has_VBZ seizures_NNS ._. Her_PRP$ parents_NNS are_VBP hoping_VBG her_PRP$ case_NN will_MD spur_VB additional_JJ research_NN into_IN the_DT causes_NNS of_IN autism_NN ,_, including_VBG the_DT roles_NNS of_IN vaccines_NNS and_CC mitochondrial_JJ disorders_NNS ._. ""_`` My_PRP$ daughter_NN 's_POS case_NN raises_VBZ more_JJR questions_NNS than_IN it_PRP answers_VBZ ,_, ""_'' concedes_VBZ her_PRP$ father_NN ,_, Dr._NNP Jon_NNP Poling_NNP ,_, a_DT neurologist_NN who_WP also_RB has_VBZ a_DT Ph.D._NN in_IN biophysics_NN ._. Poling_NNP believes_VBZ in_IN the_DT importance_NN of_IN vaccinating_VBG children_NNS :_: ""_`` Vaccines_NNS are_VBP one_CD of_IN the_DT most_RBS important_JJ advances_NNS in_IN the_DT history_NN of_IN medicine_NN ,_, ""_'' he_PRP says_VBZ ,_, ""_'' but_CC people_NNS need_VBP to_TO know_VB there_EX is_VBZ a_DT risk_NN to_IN every_DT medicine_NN ._. There_EX may_MD be_VB a_DT small_JJ percentage_NN of_IN people_NNS who_WP are_VBP susceptible_JJ to_IN injury_NN ._. ""_'' He_PRP and_CC his_PRP$ wife_NN would_MD like_VB to_TO see_VB thimerosal_NN eliminated_VBN from_IN flu_NN vaccines_NNS ,_, which_WDT continue_VBP to_TO be_VB given_VBN to_IN children_NNS and_CC pregnant_JJ women_NNS ,_, a_DT fact_NN that_WDT ,_, he_PRP thinks_VBZ ,_, could_MD be_VB one_CD reason_NN autism_NN rates_NNS have_VBP n't_RB declined_VBN ._. And_CC he_PRP urges_VBZ pediatricians_NNS to_TO take_VB a_DT hard_JJ look_NN at_IN the_DT schedule_NN on_IN which_WDT vaccines_NNS are_VBP given_VBN ._. ""_`` I_PRP think_VBP we_PRP need_VBP a_DT grassroots_JJ movement_NN among_IN pediatricians_NNS to_TO be_VB more_RBR conservative_JJ ,_, and_CC not_RB give_VB so_RB many_JJ shots_NNS at_IN once_RB ._. ""_''","What VBD to JJ , JJ - VBN NNP NNP VBZ RB JJ in the NN of NN . She VBD an JJ NN ; she VBD to VB VBG RB  VBG , NN , VBG in JJ NN , VBG RB 20 NNS by 19 NNS . And RB , RB after VBG a NN of NNS , she VBD JJ and it all VBD . NNP , RB 9 , VBD from her JJ NN but she VBD her NNS , her NN NN and , in a NN of NNS , VBD VBG the JJ NNS and JJ NN that VBP NN . "" NN VBD after the NNS , "" VBZ her NN , NNP NNP , who VBZ a VBN NN and an NN . "" She RB VBD and RB VBD RB . "" NNS of NNS like NNP VBP VBN VBG NNS  and , in JJ , the NN - VBN NN NN NN  as a NN of NN for over a NN , but NNS VBP RB VBN to VB a NN . What VBZ JJ about NNP 's NN VBZ that for the JJ NN JJ NNS VBP VBN a NN between her JJ NNS and the NNS she VBD , though the NN VBZ by no NNS JJ . A NN of JJ NNS at the NNP of NNP and NNP NNPS VBD that NNP VBD VBN VBN by NNS  and VBD that her NN VB VBN for the NNS . The NN VBD that NNP VBD an JJ JJ NN that VBD VBN by the NNS , VBG NN NN with NNS of NN NN NN ( NNP ) . A JJ JJ NN NN VBZ RB to VB NNS , but the NN , VBN JJ JJ NN , VBZ VBG a NN in the NN NN NN . The NNPS , who VBP in NNP , NNP , VBD RB NN of a NN of RB 5,000 NNS with JJ NNS VBG NNS through the NNP NNP NNP NNP NNP . The JJ NNS VBP before the NN . The NNP NN VBZ RB VBG JJ NN among JJ NN NNS , JJ to VB NNS that NNS VBP JJ and , RB , RB JJ . In a JJ NN on NNP , NNP NNP NNP , NN of the NNPS for NNP NNP and NNP ( NNP ) , VBD that "" the NN VBZ VBN RB no NN about VBG that NNS VBP the NN of NN , as this would VB a JJ NN of any of the NN that we VBP at our NN NN . "" NNP and JJ NN NNS VBP out that the NNS of NNS RB VBP their NNS . They RB VBP that NN VBD VBN from RB VBN NN NNS VBN after 2001 , and yet NN NNS VBP VBN to VB . The JJ NNP NN VBZ that 1 of 150 JJ NNS VBZ an NN NN NN . RB , there VBZ no VBG that the NN 's NN to VB NNS to the NNP NN VBZ a NN  a NN NN  in what VBD VBN an JJ NN of NN NN with NN to NN . If NNP NNP VBD an JJ NN that VBD her JJ to VBG VBN by NNS , it VBZ to NN that JJ NNS might RB VB JJ NNS . But there VBP NNS that VBP NNP 's NN a NN JJ . For one NN , she VBD an RB JJ NN of NNS in 2000 ( when NN VBD RB in NN ) . Because of a NN of NN NNS , NNP VBD VBN RB in the NN NN , RB in a JJ NN she VBD VBN five NNS VBG a NN of nine NNS : NNS , NNS , NN , NN , NN , NN , NN , NN , and NN NN . "" That VBD RB RB JJ NNS , "" VBZ NNP NNP . "" I VBD RB VB out for JJ NNS that they VBD NN , which VBZ NN , a JJ NN . VBD I VBN , I RB would VB VBN it to VB VBN into my NN . "" Another VBG NN in NNP 's NN VBZ the NN that she VBZ from a JJ NN  a NN in JJ NN NN . NNP VBP as NN NNS for each NN in the NN , VBG NN and NN into NN . There VBP a JJ NN of these NNS , VBG NNS that VBP RB but can VB NN NN , JJ or NN NN , NN , JJ NNS and NN to NN . In NNP 's NN , the NN NN VBD that the JJ NN of her NN VBD her at an VBN NN of NN from NNS . That NN , RB , VBZ as a NN to NNS on JJ NNS . In NN to the NNP NN , the NNP NNP NNP NNP VBZ VBN a NN VBG , "" There VBP no JJ NNS VBG that NN NNS VBP JJ NNS or VB JJ NN NNS . "" NNP NNP NNP , the NNP - VBN NN who VBD NNP NNP 's JJ NN , VBZ "" RB VBN "" by the NN 's NN . NNP , who VBZ VBN VBG and VBG these NNS for 20 NNS , VBZ it VBZ JJ to VB whether NNP 's JJ NN VBD , in NN , a VBG NN that VBD the NN for her NN ( as the NN VBZ ) or if it VBD along with her NN . A NN in NN NNS , he VBZ VBG the NN between NN and these NNS and VBZ to VB a NN on the NN at the JJ NN of the NNP NNP of NNP in NNP . "" In some NN of NNS with NN  a JJ NN of NNS , I VBP  JJ NN VBZ an JJ NN of their NN . But it VBZ RB JJ to VB whether it VBZ the NN VBG or if it VBZ RB after the NN VBD VBG . "" NNS on NN NN NNS VBP that JJS NNS VBP VBN by a NN of JJ NNS and JJ NNS . There may VB NNS of NNS to NN , VBG JJ NNS of NNS and JJ NNS . Could NN or some JJ NN of NNS VB one of these NNS ? "" It VBZ RB JJ that there VBZ a JJ NN of NNS that VBP this NN , "" VBZ NNP NNP NNP , NN of the NNP for NNP 's NNP NNP and NNP NNP at the NNP of NNP , NNP . NNP 's NN VBZ VBG at NNS of JJ JJ NNS , VBG NNS , NNS and NN - NNS . "" This VBZ a RB JJ NN , "" he VBZ , "" and we VBP JJR NN VBN at these NNS . "" It VBZ JJ to VB any JJ NNS from the NN of NNP NNP , JJ than the JJ NN for JJR NN . One JJ NN VBZ that NNS should VB VBG JJ NNS a JJ NN of NNS at RB , RB if they VBP NN - JJ . JJ NNS VBP an JJ JJ NN that VBZ RB - VBN to VB an NN , VBZ NNP NNP NNP NNP NNP , an NN who VBZ with NNP at NNP NNP . "" Some NNS , JJ as those VBN at JJ NNS , VBP VBN to VB up the NN NN at NN NN , "" she VBZ . "" They VBP VBN to VB the NN . RB you can VB VBG nine at one NN , how JJ you could VB . "" In NN , she VBZ , there VBZ some NN , that NNS who VBP NN may VB NN NNS that VBP RB JJ to VB . NNP NNP NNP VBZ that JJ NN NNS may VB RB JJ for some NNS . She VBZ that NNS who VBP VBN about NN NN VBP their NNS to VB JJR at a NN . And , she VBZ , VB RB VB a NN when he or she VBZ JJ . NNP NNP VBZ RB a JJ NN in JJ NN , VBG one - on - one with NNS in a JJ - NN NN . She VBZ to VB with the NNS of NN and RB VBZ NNS . Her NNS VBP VBG her NN will VB JJ NN into the NNS of NN , VBG the NNS of NNS and JJ NNS . "" My NN 's NN VBZ JJR NNS than it VBZ , "" VBZ her NN , NNP NNP NNP , a NN who RB VBZ a NN in NN . NNP VBZ in the NN of VBG NNS : "" NNS VBP one of the RBS JJ NNS in the NN of NN , "" he VBZ , "" but NNS VBP to VB there VBZ a NN to every NN . There may VB a JJ NN of NNS who VBP JJ to NN . "" He and his NN would VB to VB NN VBN from NN NNS , which VBP to VB VBN to NNS and JJ NNS , a NN that , he VBZ , could VB one NN NN NNS VBP RB VBN . And he VBZ NNS to VB a JJ NN at the NN on which NNS VBP VBN . "" I VBP we VBP a JJ NN among NNS to VB RBR JJ , and RB VB RB JJ NNS at RB . """
75,286,mainstream,M08c80,vaccine.covid,"Amid_IN the_DT race_NN to_TO develop_VB a_DT COVID_NN -_HYPH 19_CD vaccine_NN ,_, Novavax_NNP has_VBZ been_VBN busy_JJ fundraising_NN and_CC inking_NN deals_NNS to_TO prepare_VB for_IN a_DT manufacturing_NN scale_NN -_HYPH up_NN ._. That_DT work_NN continued_VBD Monday_NNP with_IN the_DT company_NN ’s_POS $_$ 200_CD million_CD raise_NN through_IN a_DT private_JJ placement_NN ._. In_IN the_DT deal_NN with_IN life_NN sciences_NNS investment_NN firm_NN RA_NNP Capital_NNP ,_, Novavax_NNP agreed_VBD to_TO sell_VB nearly_RB 4.4_CD million_CD shares_NNS at_IN Friday_NNP ’s_POS closing_NN price_NN of_IN $_$ 45.57_CD ._. The_DT funding_NN provides_VBZ the_DT biotech_NN “_`` the_DT capacity_NN to_TO execute_VB on_IN our_PRP$ critical_JJ priority_NN of_IN providing_VBG a_DT vaccine_NN against_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN as_RB quickly_RB as_IN possible_JJ ""_'' and_CC to_TO submit_VB NanoFlu_NNP for_IN FDA_NNP review_NN ,_, CEO_NN Stanley_NNP Erck_NNP said_VBD in_IN a_DT statement_NN ._. Aside_RB from_IN its_PRP$ closely_RB watched_VBN COVID_NN -_HYPH 19_CD vaccine_NN work_NN ,_, Novavax_NNP recently_RB finished_VBD a_DT phase_NN 3_CD trial_NN of_IN the_DT NanoFlu_NNP shot_NN ._. The_DT Monday_NNP deal_NN follows_VBZ two_CD other_JJ recent_JJ cash_NN infusions_NNS ._. The_DT first_JJ came_VBD in_IN the_DT form_NN of_IN a_DT commitment_NN of_IN up_IN to_IN $_$ 384_CD million_CD from_IN the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS ,_, the_DT group_NN ’s_POS largest_JJS deal_NN ever_RB at_IN the_DT time_NN ._. Then_RB ,_, after_IN The_DT New_NNP York_NNP Times_NNP reported_VBD the_DT company_NN was_VBD left_VBN off_IN the_DT list_NN of_IN Operation_NNP Warp_NNP Speed_NNP finalists_NNS ,_, the_DT company_NN scored_VBD a_DT $_$ 60_CD million_CD Department_NNP of_IN Defense_NNP (_-LRB- DOD_NNP )_-RRB- contract_NN ._. Under_IN that_DT deal_NN ,_, Novavax_NNP will_MD deliver_VB 10_CD million_CD doses_NNS of_IN the_DT vaccine_NN to_IN the_DT DOD_NNP this_DT year_NN ._. RELATED_JJ :_: Left_VBN out_IN of_IN Warp_NNP Speed_NNP ,_, Novavax_NNP scores_VBZ $_$ 60_CD M_CD defense_NN contract_NN for_IN COVID_NNP -_HYPH 19_CD shot_NN Even_RB as_IN the_DT company_NN advances_VBZ its_PRP$ COVID_NN -_HYPH 19_CD vaccine_NN candidate_NN through_IN testing_NN ,_, it_PRP ’s_VBZ eyeing_VBG steps_NNS needed_VBN to_TO produce_VB doses_NNS at_IN a_DT commercial_JJ scale_NN ._. In_IN late_JJ May_NNP ,_, the_DT company_NN purchased_VBD Czech_JJ manufacturer_NN Praha_NNP Vaccines_NNP for_IN $_$ 167_CD million_CD ._. Days_NNS later_RBR ,_, the_DT company_NN enlisted_VBD Japan_NNP ’s_POS AGC_NNP Biologics_NNP for_IN help_NN producing_VBG its_PRP$ vaccine_NN -_HYPH boosting_VBG Matrix_NN -_HYPH M_NN adjuvant_NN ._. Aside_RB from_IN Novavax_NNP ,_, some_DT of_IN the_DT biggest_JJS companies_NNS in_IN the_DT biopharma_NN industry_NN are_VBP involved_VBN in_IN COVID_NN -_HYPH 19_CD vaccine_NN R&D._NNP Pfizer_NNP ,_, Johnson_NNP &_CC Johnson_NNP ,_, AstraZeneca_NNP ,_, Merck_NNP and_CC Moderna_NNP were_VBD reportedly_RB selected_VBN as_IN Warp_NNP Speed_NNP finalists_NNS ._.","Amid the NN to VB a NN - 19 NN , NNP VBZ VBN JJ NN and NN NNS to VB for a NN NN - NN . That NN VBD NNP with the NN ’s $ 200 million NN through a JJ NN . In the NN with NN NNS NN NN NNP NNP , NNP VBD to VB RB 4.4 million NNS at NNP ’s NN NN of $ 45.57 . The NN VBZ the NN “ the NN to VB on our JJ NN of VBG a NN against the NN - 19 NN RB RB as JJ "" and to VB NNP for NNP NN , NN NNP NNP VBD in a NN . RB from its RB VBN NN - 19 NN NN , NNP RB VBD a NN 3 NN of the NNP NN . The NNP NN VBZ two JJ JJ NN NNS . The JJ VBD in the NN of a NN of up to $ 384 million from the NNP for NNP NNP NNPS , the NN ’s JJS NN RB at the NN . RB , after The NNP NNP NNP VBD the NN VBD VBN off the NN of NNP NNP NNP NNS , the NN VBD a $ 60 million NNP of NNP ( NNP ) NN . Under that NN , NNP will VB 10 million NNS of the NN to the NNP this NN . JJ : VBN out of NNP NNP , NNP VBZ $ 60 M NN NN for NNP - 19 NN RB as the NN VBZ its NN - 19 NN NN through NN , it VBZ VBG NNS VBN to VB NNS at a JJ NN . In JJ NNP , the NN VBD JJ NN NNP NNP for $ 167 million . NNS RBR , the NN VBD NNP ’s NNP NNP for NN VBG its NN - VBG NN - NN NN . RB from NNP , some of the JJS NNS in the NN NN VBP VBN in NN - 19 NN NNP NNP , NNP & NNP , NNP , NNP and NNP VBD RB VBN as NNP NNP NNS ."
76,49,mainstream,M081d8,cancer; coronavirus; covid.19; vaccine.covid,"The_DT chloroquine_NN narrative_NN started_VBD with_IN several_JJ small_JJ studies_NNS from_IN China_NNP and_CC France_NNP —_: both_DT of_IN which_WDT have_VBP shortcomings_NNS and_CC offer_VBP few_JJ lessons_NNS for_IN patients_NNS at_IN large_JJ ._. The_DT French_JJ results_NNS are_VBP based_VBN on_IN only_RB 36_CD people_NNS and_CC focus_NN on_IN the_DT patients_NNS ’_POS viral_JJ load_NN ,_, or_CC the_DT amount_NN of_IN virus_NN in_IN the_DT body_NN ._. Indeed_RB ,_, the_DT only_JJ patients_NNS to_TO die_VB or_CC to_TO be_VB sent_VBN to_IN intensive_JJ care_NN in_IN the_DT French_JJ study_NN had_VBD taken_VBN hydroxychloroquine_NN ._. “_`` We_PRP do_VBP n’t_RB have_VB data_NNS from_IN randomised_VBN ,_, controlled_VBN trials_NNS telling_VBG us_PRP how_WRB chloroquine_NN worked_VBD in_IN real_JJ people_NNS ,_, ”_'' says_VBZ Annie_NNP Luetkemeyer_NNP ,_, an_DT HIV_NN and_CC infectious_JJ diseases_NNS specialist_NN at_IN the_DT University_NNP of_IN California_NNP ,_, San_NNP Francisco_NNP ,_, Department_NNP of_IN Medicine_NNP ._. Self_NN -_HYPH medication_NN with_IN hydroxychloroquine_NN and_CC azithromycin_NN may_MD also_RB come_VB with_IN hazards_NNS ,_, as_IN the_DT two_CD drugs_NNS might_MD stress_VB the_DT heart_NN and_CC increase_VB the_DT risk_NN of_IN arrhythmia_NN ._. On_IN Monday_NNP ,_, Donald_NNP Trump_NNP vowed_VBD to_TO send_VB New_NNP York_NNP thousands_NNS of_IN doses_NNS of_IN the_DT combo_NN for_IN an_DT FDA_NNP trial_NN ,_, not_RB long_RB after_IN an_DT Arizona_NNP hospital_NN reported_VBD one_CD of_IN its_PRP$ patients_NNS died_VBD after_IN self_NN -_HYPH medicating_VBG on_IN chloroquine_NN phosphate_NN ,_, a_DT form_NN of_IN the_DT compound_NN used_VBN to_TO clean_VB aquarium_NN tanks_NNS ._. Nigerian_JJ health_NN officials_NNS reported_VBD two_CD cases_NNS of_IN chloroquine_NN overdoses_NNS over_IN the_DT weekend_NN ._. “_`` The_DT last_JJ thing_NN that_WDT we_PRP want_VBP right_RB now_RB is_VBZ to_TO inundate_VB emergency_NN departments_NNS with_IN patients_NNS who_WP believe_VBP they_PRP found_VBD a_DT vague_JJ and_CC risky_JJ solution_NN that_WDT could_MD potentially_RB jeopardise_VB their_PRP$ health_NN ,_, ”_'' Daniel_NNP Brooks_NNP ,_, the_DT medical_JJ director_NN of_IN the_DT Banner_NNP Poison_NNP and_CC Drug_NNP Information_NNP Centre_NNP in_IN Phoenix_NNP ,_, says_VBZ in_IN a_DT statement_NN ._. ACE_NN inhibitors_NNS ,_, drugs_NNS that_WDT are_VBP used_VBN widely_RB to_TO treat_VB high_JJ blood_NN pressure_NN ,_, have_VBP also_RB come_VBN under_IN fire_NN during_IN the_DT COVID_NN -_HYPH 19_CD crisis_NN ,_, with_IN some_DT reports_NNS suggesting_VBG that_IN patients_NNS should_MD stop_VB taking_VBG these_DT medications_NNS if_IN they_PRP develop_VBP symptoms_NNS ._. In_IN a_DT series_NN of_IN letters_NNS in_IN the_DT British_NNP Medical_NNP Journal_NNP ,_, Nature_NNP Reviews_NNPS Cardiology_NNP ,_, and_CC The_DT Lancet_NNP Respiratory_NNP Medicine_NNP ,_, researchers_NNS raised_VBD questions_NNS over_IN whether_IN ACE_NN inhibitors_NNS might_MD help_VB establish_VB coronavirus_NN infections_NNS in_IN people_NNS ’s_POS lungs_NNS ._. The_DT concern_NN stems_VBZ from_IN the_DT fact_NN that_IN SARS_NNP and_CC the_DT new_JJ coronavirus_NN enter_VBP cells_NNS by_IN latching_VBG on_RP to_IN a_DT protein_NN called_VBN angiotensin_NN -_HYPH converting_VBG enzyme_NN 2_CD ,_, or_CC ACE2_NN for_IN short_JJ ._. The_DT protein_NN abounds_VBZ on_IN the_DT surfaces_NNS of_IN cells_NNS in_IN the_DT heart_NN and_CC lungs_NNS ,_, where_WRB it_PRP helps_VBZ regulate_VB a_DT hormone_NN that_WDT affects_VBZ blood_NN pressure_NN constriction_NN ._. One_CD consequence_NN of_IN ACE_NN inhibitors_NNS is_VBZ that_IN they_PRP may_MD prompt_VB cells_NNS to_TO make_VB more_JJR ACE2_NN ._. A_DT 2005_CD study_NN found_VBD evidence_NN of_IN such_PDT an_DT increase_NN in_IN mice_NNS ,_, and_CC a_DT 2015_CD study_NN in_IN humans_NNS found_VBD increased_VBN ACE2_NN levels_NNS in_IN the_DT urine_NN of_IN patients_NNS who_WP were_VBD taking_VBG a_DT medication_NN related_JJ to_IN ACE_NN inhibitors_NNS ._. But_CC there_EX is_VBZ no_DT current_JJ evidence_NN that_IN ACE_NNP inhibitors_NNS worsen_VBP COVID_NN -_HYPH 19_CD outcomes_NNS in_IN humans_NNS ,_, according_VBG to_IN the_DT American_NNP Heart_NNP Association_NNP ,_, the_DT European_NNP Society_NNP of_IN Cardiology_NNP ’s_POS Council_NNP on_IN Hypertension_NNP ,_, and_CC a_DT March_NNP 20_CD review_NN published_VBN in_IN the_DT European_NNP Heart_NNP Journal_NNP ._. Doctors_NNS ’_POS overriding_VBG advice_NN is_VBZ that_IN if_IN you_PRP ’ve_VBP been_VBN prescribed_VBN a_DT medication_NN ,_, continue_VB taking_VBG it_PRP until_IN told_VBN otherwise_RB by_IN your_PRP$ medical_JJ provider_NN ._. “_`` We_PRP should_MD neither_CC be_VB starting_VBG nor_CC stopping_VBG these_DT medications_NNS until_IN we_PRP have_VBP much_RB more_JJR information_NN ,_, ”_'' Luetkemeyer_NNP says_VBZ ._. People_NNS with_IN high_JJ blood_NN pressure_NN and_CC heart_NN disease_NN do_VBP appear_VB to_TO be_VB at_IN higher_JJR risk_NN for_IN COVID_NN -_HYPH 19_CD ,_, but_CC that_DT probably_RB has_VBZ more_JJR to_TO do_VB with_IN the_DT underlying_JJ ailments_NNS themselves_PRP ._. What_WP ’s_VBZ more_JJR ,_, ACE_NNP inhibitors_NNS may_MD have_VB anti-inflammatory_JJ properties_NNS ,_, which_WDT may_MD help_VB the_DT lungs_NNS of_IN COVID_NN -_HYPH 19_CD patients_NNS better_RBR cope_VB with_IN the_DT infection_NN ._. (_-LRB- Learn_VB how_WRB these_DT underlying_JJ conditions_NNS make_VBP coronavirus_NN more_RBR severe_JJ ._. )_-RRB- “_`` That_DT would_MD be_VB a_DT key_JJ study_NN ,_, to_TO compare_VB people_NNS with_IN high_JJ blood_NN pressure_NN plus_CC or_CC minus_IN these_DT drugs_NNS ,_, to_TO see_VB if_IN there_EX ’s_VBZ any_DT difference_NN ,_, ”_'' Perlman_NNP says_VBZ ._. “_`` But_CC it_PRP ’d_MD be_VB very_RB hard_JJ to_TO do_VB ,_, and_CC probably_RB very_RB hard_JJ to_TO ethically_RB justify_VB ._. ”_'' “_`` By_IN all_DT means_NNS ,_, if_IN you_PRP ’re_VBP having_VBG emergency_NN breathing_NN symptoms_NNS or_CC something_NN ’s_VBZ troublesome_JJ ,_, we_PRP do_VBP want_VB you_PRP to_TO seek_VB emergency_NN attention_NN ,_, ”_'' says_VBZ Purvi_NNP Parikh_NNP ,_, an_DT allergy_NN and_CC infectious_JJ disease_NN specialist_NN at_IN NYU_NNP Langone_NNP in_IN New_NNP York_NNP City_NNP ._. If_IN you_PRP choose_VBP to_TO seek_VB help_NN at_IN a_DT local_JJ hospital_NN ,_, here_RB ’s_VBZ one_CD example_NN of_IN what_WP you_PRP might_MD expect_VB ._. At_IN the_DT Inova_NNP Health_NNP System_NNP ’s_POS flagship_NN hospital_NN in_IN Fairfax_NNP ,_, Virginia_NNP ,_, staff_NN have_VBP set_VBN up_RP an_DT outdoor_JJ tent_NN to_TO separate_VB people_NNS reporting_VBG respiratory_JJ ailments_NNS from_IN those_DT with_IN other_JJ illnesses_NNS ._. The_DT two_CD groups_NNS are_VBP processed_VBN in_IN different_JJ parts_NNS of_IN the_DT waiting_NN room_NN ,_, separated_VBN by_IN at_IN least_JJS six_CD feet_NNS of_IN space_NN ._. Due_IN to_IN a_DT shortage_NN of_IN tests_NNS ,_, doctors_NNS in_IN many_JJ U.S._NNP hospitals_NNS say_VBP that_IN if_IN people_NNS arrive_VBP with_IN mild_JJ symptoms_NNS ,_, these_DT patients_NNS are_VBP told_VBN to_TO assume_VB they_PRP have_VBP COVID_NN -_HYPH 19_CD and_CC are_VBP encouraged_VBN to_TO self_NN -_HYPH quarantine_NN to_TO prevent_VB overloading_VBG hospital_NN beds_NNS ._. In_IN the_DT UK_NNP ,_, NHS_NNP 111_CD advises_VBZ those_DT displaying_VBG mild_JJ symptoms_NNS remain_VBP at_IN home_NN ,_, and_CC has_VBZ set_VBN up_RP an_DT online_JJ symptom_NN -_HYPH checker_NN to_IN self_NN -_HYPH asses_NNS how_WRB severe_JJ any_DT infection_NN may_MD be_VB so_IN the_DT patient_NN can_MD make_VB a_DT decision_NN on_IN whether_IN to_TO seek_VB further_JJ help_NN ._. For_IN those_DT arriving_VBG with_IN serious_JJ symptoms_NNS such_JJ as_IN difficulty_NN breathing_NN ,_, health_NN care_NN workers_NNS start_VBP by_IN focusing_VBG on_IN the_DT patient_NN ’s_POS oxygen_NN levels_NNS ,_, blood_NN pressure_NN ,_, and_CC the_DT amount_NN of_IN fluid_NN in_IN their_PRP$ lungs_NNS —_: all_DT in_IN an_DT effort_NN to_TO keep_VB their_PRP$ condition_NN stable_JJ ._. They_PRP also_RB try_VBP to_TO manage_VB fever_NN ,_, which_WDT can_MD cause_VB discomfort_NN and_CC lead_VB to_IN cell_NN damage_NN ._. The_DT most_RBS severe_JJ cases_NNS of_IN COVID_NN -_HYPH 19_CD require_VBP putting_VBG a_DT patient_NN on_IN a_DT mechanical_JJ ventilator_NN —_: a_DT device_NN that_WDT cycles_VBZ air_NN in_IN and_CC out_IN of_IN a_DT person_NN ’s_POS lungs_NNS —_: for_IN more_JJR than_IN a_DT week_NN at_IN a_DT time_NN ._. That_DT ’s_VBZ why_WRB health_NN officials_NNS are_VBP so_RB concerned_JJ about_IN a_DT coming_VBG ventilator_NN shortage_NN ._. The_DT Society_NNP of_IN Critical_NNP Care_NNP Medicine_NNP says_VBZ that_IN up_IN to_IN 200,000_CD ventilators_NNS exist_VBP in_IN U.S._NNP hospitals_NNS ,_, but_CC some_DT are_VBP older_JJR and_CC might_MD not_RB effectively_RB treat_VB COVID_NN -_HYPH 19_CD ._. Meanwhile_RB ,_, one_CD rough_JJ estimate_NN suggests_VBZ that_IN more_JJR than_IN 900,000_CD Americans_NNPS could_MD get_VB COVID_NN -_HYPH 19_CD and_CC need_VB a_DT ventilator_NN ._. In_IN the_DT U.K._NNP various_JJ engineering_NN firms_NNS including_VBG car_NN ,_, aircraft_NN and_CC vacuum_NN cleaner_NN manufacturers_NNS have_VBP switched_VBN production_NN to_TO meet_VB the_DT demand_NN for_IN ventilators_NNS ._.","The NN NN VBD with JJ JJ NNS from NNP and NNP — both of which VBP NNS and VBP JJ NNS for NNS at JJ . The JJ NNS VBP VBN on RB 36 NNS and NN on the NNS ’ JJ NN , or the NN of NN in the NN . RB , the JJ NNS to VB or to VB VBN to JJ NN in the JJ NN VBD VBN NN . “ We VBP RB VB NNS from VBN , VBN NNS VBG us how NN VBD in JJ NNS , ” VBZ NNP NNP , an NN and JJ NNS NN at the NNP of NNP , NNP NNP , NNP of NNP . NN - NN with NN and NN may RB VB with NNS , as the two NNS might VB the NN and VB the NN of NN . On NNP , NNP NNP VBD to VB NNP NNP NNS of NNS of the NN for an NNP NN , RB RB after an NNP NN VBD one of its NNS VBD after NN - VBG on NN NN , a NN of the NN VBN to VB NN NNS . JJ NN NNS VBD two NNS of NN NNS over the NN . “ The JJ NN that we VBP RB RB VBZ to VB NN NNS with NNS who VBP they VBD a JJ and JJ NN that could RB VB their NN , ” NNP NNP , the JJ NN of the NNP NNP and NNP NNP NNP in NNP , VBZ in a NN . NN NNS , NNS that VBP VBN RB to VB JJ NN NN , VBP RB VBN under NN during the NN - 19 NN , with some NNS VBG that NNS should VB VBG these NNS if they VBP NNS . In a NN of NNS in the NNP NNP NNP , NNP NNPS NNP , and The NNP NNP NNP , NNS VBD NNS over whether NN NNS might VB VB NN NNS in NNS ’s NNS . The NN VBZ from the NN that NNP and the JJ NN VBP NNS by VBG on to a NN VBN NN - VBG NN 2 , or NN for JJ . The NN VBZ on the NNS of NNS in the NN and NNS , where it VBZ VB a NN that VBZ NN NN NN . One NN of NN NNS VBZ that they may VB NNS to VB JJR NN . A 2005 NN VBD NN of such an NN in NNS , and a 2015 NN in NNS VBD VBN NN NNS in the NN of NNS who VBD VBG a NN JJ to NN NNS . But there VBZ no JJ NN that NNP NNS VBP NN - 19 NNS in NNS , VBG to the NNP NNP NNP , the NNP NNP of NNP ’s NNP on NNP , and a NNP 20 NN VBN in the NNP NNP NNP . NNS ’ VBG NN VBZ that if you VBP VBN VBN a NN , VB VBG it until VBN RB by your JJ NN . “ We should neither VB VBG nor VBG these NNS until we VBP RB JJR NN , ” NNP VBZ . NNS with JJ NN NN and NN NN VBP VB to VB at JJR NN for NN - 19 , but that RB VBZ JJR to VB with the JJ NNS themselves . What VBZ JJR , NNP NNS may VB JJ NNS , which may VB the NNS of NN - 19 NNS RBR VB with the NN . ( VB how these JJ NNS VBP NN RBR JJ . ) “ That would VB a JJ NN , to VB NNS with JJ NN NN plus or minus these NNS , to VB if there VBZ any NN , ” NNP VBZ . “ But it ’d VB RB JJ to VB , and RB RB JJ to RB VB . ” “ By all NNS , if you VBP VBG NN NN NNS or NN VBZ JJ , we VBP VB you to VB NN NN , ” VBZ NNP NNP , an NN and JJ NN NN at NNP NNP in NNP NNP NNP . If you VBP to VB NN at a JJ NN , RB VBZ one NN of what you might VB . At the NNP NNP NNP ’s NN NN in NNP , NNP , NN VBP VBN up an JJ NN to VB NNS VBG JJ NNS from those with JJ NNS . The two NNS VBP VBN in JJ NNS of the NN NN , VBN by at JJS six NNS of NN . Due to a NN of NNS , NNS in JJ NNP NNS VBP that if NNS VBP with JJ NNS , these NNS VBP VBN to VB they VBP NN - 19 and VBP VBN to NN - NN to VB VBG NN NNS . In the NNP , NNP 111 VBZ those VBG JJ NNS VBP at NN , and VBZ VBN up an JJ NN - NN to NN - NNS how JJ any NN may VB so the NN can VB a NN on whether to VB JJ NN . For those VBG with JJ NNS JJ as NN NN , NN NN NNS VBP by VBG on the NN ’s NN NNS , NN NN , and the NN of NN in their NNS — all in an NN to VB their NN JJ . They RB VBP to VB NN , which can VB NN and VB to NN NN . The RBS JJ NNS of NN - 19 VBP VBG a NN on a JJ NN — a NN that VBZ NN in and out of a NN ’s NNS — for JJR than a NN at a NN . That VBZ why NN NNS VBP RB JJ about a VBG NN NN . The NNP of NNP NNP NNP VBZ that up to 200,000 NNS VBP in NNP NNS , but some VBP JJR and might RB RB VB NN - 19 . RB , one JJ NN VBZ that JJR than 900,000 NNPS could VB NN - 19 and VB a NN . In the NNP JJ NN NNS VBG NN , NN and NN NN NNS VBP VBN NN to VB the NN for NNS ."
77,428,mainstream,M0bc53,drug.companies; population.control; vaccine,"Lloyd_NNP -_HYPH Smith_NNP and_CC other_JJ mathematicians_NNS are_VBP assessing_VBG the_DT strong_JJ and_CC weak_JJ points_NNS in_IN travel_NN screening_NN as_IN it_PRP pertains_VBZ to_IN the_DT COVID_NN -_HYPH 19_CD outbreak_NN ._. Their_PRP$ latest_JJS work_NN is_VBZ inspired_VBN by_IN a_DT study_NN they_PRP published_VBD in_IN 2015_CD ,_, which_WDT built_VBD a_DT model_NN that_WDT systematically_RB estimated_VBD the_DT performance_NN of_IN traveller_NN screening_NN programs_NNS during_IN outbreaks_NNS of_IN SARS_NN ,_, MERS_NN ,_, influenza_NN ,_, and_CC Ebola_NNP ._. As_IN in_IN this_DT earlier_JJR work_NN ,_, the_DT new_JJ model_NN for_IN COVID_NNP -_HYPH 19_CD includes_VBZ basic_JJ factors_NNS like_IN the_DT failure_NN rate_NN for_IN thermometer_NN guns_NNS or_CC how_WRB easily_RB the_DT virus_NN moves_VBZ between_IN people_NNS ._. But_CC it_PRP also_RB accounts_VBZ for_IN more_JJR subtle_JJ variables_NNS ,_, like_IN how_WRB many_JJ people_NNS might_MD transmit_VB the_DT virus_NN before_IN their_PRP$ symptoms_NNS arise_VBP ,_, or_CC how_WRB often_RB people_NNS accurately_RB report_VBP their_PRP$ symptoms_NNS on_IN screening_NN questionnaires_NNS distributed_VBN at_IN airport_NN customs_NNS ._. “_`` It_PRP 's_VBZ pretty_RB evident_JJ from_IN past_JJ outbreaks_NNS that_WDT people_NNS are_VBP n't_RB always_RB honest_JJ about_IN risky_JJ exposures_NNS ,_, ”_'' Lloyd_NNP -_HYPH Smith_NNP says_VBZ ._. “_`` Based_VBN on_IN the_DT past_JJ data_NNS we_PRP had_VBD ,_, it_PRP looked_VBD like_IN one_CD in_IN four_CD passengers_NNS accurately_RB and_CC honestly_RB reported_VBD the_DT risky_JJ exposures_NNS they_PRP had_VBD ._. ”_'' Compute_VB all_PDT these_DT variables_NNS ,_, and_CC their_PRP$ model_NN estimates_VBZ that_IN enhanced_VBN screening_NN is_VBZ at_IN best_RBS catching_VBG 50_CD percent_NN of_IN infected_VBN air_NN travellers_NNS and_CC at_IN worst_JJS just_RB 20_CD percent_NN ,_, primarily_RB because_IN COVID_NN -_HYPH 19_CD symptoms_NNS are_VBP so_RB latent_JJ ._. “_`` Based_VBN on_IN what_WP we_PRP understand_VBP about_IN this_DT virus_NN ,_, something_NN on_IN the_DT order_NN of_IN half_NN of_IN people_NNS are_VBP fundamentally_RB not_RB detectable_JJ [_-LRB- during_IN screening_NN ]_-RRB- ,_, ”_'' Lloyd_NNP -_HYPH Smith_NNP says_VBZ ._. While_IN the_DT results_NNS are_VBP currently_RB being_VBG peer_JJ -_HYPH reviewed_VBN at_IN the_DT journal_NN eLife_NNP ,_, they_PRP mirror_VBP what_WDT preliminary_JJ results_NNS from_IN a_DT separate_JJ research_NN group_NN at_IN the_DT London_NNP School_NNP of_IN Hygiene_NNP and_CC Tropical_NNP Medicine_NNP predict_VBP for_IN air_NN traveller_NN screening_NN with_IN COVID_NNP -_HYPH 19_CD ._. “_`` We_PRP 'd_MD probably_RB only_RB catch_VB about_RB 45_CD percent_NN of_IN infected_VBN travelers_NNS using_VBG exit_NN screening_NN ,_, ”_'' says_VBZ Samuel_NNP Clifford_NNP ,_, an_DT epidemiologist_NN at_IN the_DT London_NNP School_NNP ’s_POS Center_NNP for_IN Mathematical_NNP Modeling_NNP of_IN Infectious_NNP Diseases_NNPS ._. “_`` Out_IN of_IN the_DT remaining_VBG 55_CD percent_NN of_IN people_NNS who_WP are_VBP n't_RB caught_VBN ,_, we_PRP can_MD catch_VB a_DT few_JJ more_JJR on_IN entry_NN ._. You_PRP 've_VBP got_VBN 42_CD percent_NN of_IN the_DT people_NNS [_-LRB- with_IN COVID_NNP -_SYM 19_CD ]_-RRB- still_RB making_VBG it_PRP into_IN the_DT country_NN ._. ”_'' While_IN such_JJ models_NNS can_MD offer_VB an_DT indication_NN of_IN what_WP might_MD be_VB happening_VBG ,_, you_PRP can_MD see_VB these_DT dynamics_NNS play_VB out_RP in_IN real_JJ -_HYPH time_NN by_IN setting_VBG your_PRP$ sights_NNS on_IN one_CD nation_NN :_: Singapore_NNP ._. Singapore_NNP boasts_VBZ one_CD of_IN the_DT highest_RBS -_HYPH regarded_VBN health_NN care_NN systems_NNS on_IN the_DT planet_NN ,_, thanks_NN to_IN public_JJ funding_NN ,_, low_JJ costs_NNS for_IN treatment_NN ,_, and_CC an_DT abundance_NN of_IN doctors_NNS ,_, nurses_NNS ,_, and_CC other_JJ health_NN professionals_NNS ._. This_DT workforce_NN pays_VBZ off_RP during_IN an_DT outbreak_NN ,_, because_IN it_PRP means_VBZ that_IN Singapore_NNP can_MD catch_VB cases_NNS the_DT moment_NN patients_NNS arrive_VBP on_IN their_PRP$ shores_NNS ._. “_`` Singapore_NNP had_VBD such_PDT a_DT remarkable_JJ record_NN during_IN SARS_NNP with_IN following_VBG cases_NNS ,_, and_CC it_PRP seems_VBZ to_TO have_VB a_DT high_JJ ratio_NN of_IN detection_NN this_DT time_NN around_RB ,_, ”_'' says_VBZ Marc_NNP Lipsitch_NNP ,_, an_DT epidemiologist_NN at_IN Harvard_NNP T.H._NNP Chan_NNP School_NNP of_IN Public_NNP Health_NNP ._. He_PRP thinks_VBZ tracking_VBG the_DT COVID_NN -_HYPH 19_CD situation_NN in_IN Singapore_NNP can_MD help_VB gauge_VB how_WRB the_DT outbreak_NN might_MD evolve_VB in_IN other_JJ countries_NNS ,_, especially_RB in_IN areas_NNS with_IN developed_VBN health_NN care_NN systems_NNS or_CC places_NNS that_WDT receive_VBP high_JJ volumes_NNS of_IN travelers_NNS from_IN China_NNP ._. The_DT United_NNP States_NNPS fits_VBZ both_CC aspects_NNS of_IN this_DT billing_NN ,_, given_VBN that_IN it_PRP receives_VBZ as_RB many_JJ travellers_NNS from_IN China_NNP as_IN Singapore_NNP ,_, roughly_RB three_CD million_CD a_DT year_NN ._. Based_VBN on_IN preliminary_JJ modelling_NN in_IN Lipsitch_NNP ’s_POS lab_NN ,_, Singapore_NNP ranked_VBD first_RB out_IN of_IN 191_CD countries_NNS in_IN disease_NN surveillance_NN during_IN the_DT first_JJ weeks_NNS of_IN COVID_NNP -_HYPH 19_CD ._. His_PRP$ team_NN suspects_VBZ that_IN Singapore_NNP 's_POS methods_NNS are_VBP exceptionally_RB sensitive_JJ to_IN new_JJ cases_NNS ,_, and_CC can_MD thus_RB serve_VB as_IN a_DT standard_NN of_IN comparison_NN against_IN other_JJ health_NN systems_NNS ._. By_IN using_VBG Singapore_NNP as_IN a_DT standard_JJ bearer_NN for_IN COVID_NN -_HYPH 19_CD detection_NN ,_, his_PRP$ team_NN can_MD then_RB estimate_VB how_WRB many_JJ cases_NNS are_VBP likely_RB going_VBG unnoticed_JJ in_IN other_JJ countries_NNS ._. Relative_RB to_IN Singapore_NNP ,_, other_JJ nations_NNS with_IN a_DT high_JJ capacity_NN for_IN disease_NN surveillance_NN —_: like_IN the_DT U.S._NNP ,_, Japan_NNP ,_, Thailand_NNP ,_, and_CC afflicted_VBN countries_NNS in_IN Europe_NNP —_: may_MD only_RB be_VB catching_VBG 38_CD percent_NN of_IN travel_NN -_HYPH related_JJ cases_NNS ,_, based_VBN on_IN Lipsitch_NNP ’s_POS model_NN ._. That_DT ’s_VBZ due_IN in_IN part_NN to_IN Singapore_NNP officials_NNS ’_POS dogged_VBD efforts_NNS toward_IN border_NN screening_NN ,_, but_CC also_RB because_IN the_DT island_NN country_NN is_VBZ dense_JJ ._. Its_PRP$ 5.6_CD million_CD people_NNS are_VBP packed_VBN into_IN an_DT area_NN on_IN par_NN with_IN Charlotte_NNP ,_, North_NNP Carolina_NNP ,_, which_WDT makes_VBZ it_PRP easier_JJR to_TO trace_VB the_DT contacts_NNS connected_VBN to_IN individual_JJ cases_NNS ._. “_`` If_IN there_EX are_VBP [_-LRB- COVID_NNP -_SYM 19_CD ]_-RRB- carriers_NNS coming_VBG into_IN the_DT United_NNP States_NNPS that_WDT are_VBP n’t_RB detected_VBN ,_, which_WDT is_VBZ likely_JJ the_DT case_NN ,_, Singapore_NNP would_MD probably_RB have_VB an_DT equivalent_JJ number_NN ,_, ”_'' says_VBZ Scott_NNP Gottlieb_NNP ,_, a_DT former_JJ U.S._NNP FDA_NNP commissioner_NN and_CC resident_NN fellow_NN at_IN the_DT American_NNP Enterprise_NNP Institute_NNP who_WP thinks_VBZ Lipsitch_NNP ’s_POS research_NN is_VBZ on_IN the_DT right_JJ track_NN ._. “_`` But_CC they'd_MD be_VB unmasked_VBN sooner_RBR in_IN Singapore_NNP because_IN it_PRP 's_VBZ a_DT smaller_JJR ,_, more_RBR densely_RB populated_VBN nation_NN ._. ”_'' For_IN this_DT reason_NN ,_, Gottlieb_NNP says_VBZ that_IN Singapore_NNP offers_VBZ an_DT omen_NN for_IN major_JJ cities_NNS in_IN the_DT U.S._NNP ,_, rather_RB than_IN the_DT nation_NN as_IN a_DT whole_NN ._. “_`` They_PRP 're_VBP a_DT good_JJ bellwether_NN for_IN what_WP happens_VBZ when_WRB an_DT outbreak_NN steps_VBZ into_IN a_DT very_RB sophisticated_JJ health_NN care_NN system_NN and_CC advanced_JJ economy_NN in_IN a_DT dense_JJ environment_NN ,_, ”_'' he_PRP says_VBZ ._. There_EX are_VBP caveats_NNS to_IN Lipsitch_NNP ’s_POS models_NNS ,_, including_VBG that_DT mild_JJ or_CC asymptomatic_JJ cases_NNS of_IN COVID_NN -_HYPH 19_CD may_MD not_RB be_VB accounted_VBN for_IN ._. Plus_CC ,_, these_DT models_NNS are_VBP yet_RB to_TO be_VB published_VBN in_IN a_DT peer_NN -_HYPH reviewed_VBN journal_NN ,_, though_IN the_DT process_NN is_VBZ under_IN way_NN ._. But_CC their_PRP$ results_NNS mirror_VBP what_WP others_NNS are_VBP predicting_VBG about_IN the_DT leaky_JJ nature_NN of_IN travel_NN restrictions_NNS and_CC what_WP they_PRP might_MD mean_VB for_IN preparedness_NN in_IN at_IN -_HYPH risk_NN countries_NNS in_IN places_NNS like_IN Africa_NNP ._. The_DT model_NN predicts_VBZ that_IN up_IN to_IN 89_CD percent_NN of_IN imported_VBN cases_NNS might_MD be_VB going_VBG undetected_JJ in_IN countries_NNS with_IN a_DT low_JJ capacity_NN for_IN disease_NN surveillance_NN ._. And_CC undetected_JJ cases_NNS passing_VBG across_IN borders_NNS are_VBP such_PDT a_DT concern_NN because_IN they_PRP represent_VBP the_DT first_JJ step_NN to_IN local_JJ transmission_NN ,_, the_DT stage_NN where_WRB an_DT outbreak_NN becomes_VBZ disconnected_VBN from_IN importation_NN and_CC begins_VBZ to_TO perpetuate_VB freely_RB in_IN a_DT region_NN ._. On_IN Thursday_NNP ,_, researchers_NNS in_IN Singapore_NNP ,_, including_VBG one_CD from_IN the_DT ministry_NN of_IN health_NN ,_, reported_VBD eight_CD of_IN the_DT nation_NN ’s_POS 84_CD cases_NNS are_VBP yet_RB to_TO be_VB linked_VBN to_IN any_DT clear_JJ exposure_NN ._. Meanwhile_RB ,_, the_DT COVID_NNP -_HYPH 19_CD tally_NN doubled_VBN in_IN South_NNP Korea_NNP to_IN 204_CD ,_, due_IN to_IN an_DT outbreak_NN at_IN a_DT church_NN in_IN Daegu_NNP tied_VBN to_IN a_DT 61_CD -_HYPH year_NN -_HYPH old_JJ woman_NN known_VBN only_RB as_IN “_`` Patient_NN 31_CD ._. ”_'' But_CC the_DT source_NN of_IN her_PRP$ infection_NN is_VBZ currently_RB unknown_JJ ._. “_`` Although_IN the_DT total_JJ number_NN of_IN cases_NNS outside_IN China_NNP remains_VBZ relatively_RB small_JJ ,_, we_PRP ’re_VBP concerned_JJ about_IN the_DT number_NN of_IN cases_NNS with_IN no_DT clear_JJ epidemiological_JJ link_NN ,_, ”_'' said_VBD Tedros_NNP Adhanom_NNP Ghebreyesus_NNP ,_, director_NN -_HYPH general_NN of_IN the_DT World_NNP Health_NNP Organisation_NNP ,_, said_VBD at_IN a_DT Friday_NNP press_NN briefing_NN ._. “_`` Apart_RB from_IN the_DT Diamond_NNP Princess_NNP cruise_NN ship_NN ,_, the_DT Republic_NNP of_IN Korea_NNP now_RB has_VBZ the_DT most_JJS cases_NNS outside_IN of_IN China_NNP ._. We_PRP ’re_VBP working_VBG closely_RB with_IN the_DT government_NN to_TO fully_RB understand_VB the_DT transmission_NN dynamics_NNS that_WDT led_VBD to_IN this_DT increase_NN ._. ”_'' More_JJR than_IN 80_CD new_JJ cases_NNS reported_VBN Friday_NNP are_VBP tied_VBN to_IN Patient_NNP 31_CD ,_, and_CC Korea_NNP ’s_POS Centres_NNPS for_IN Disease_NNP Control_NNP &_CC Prevention_NNP described_VBD this_DT incident_NN in_IN Korea_NNP ’s_POS fourth_RB largest_JJS city_NN as_IN a_DT super_RB -_HYPH spreader_NN event_NN ._. “_`` There_EX is_VBZ a_DT real_JJ risk_NN ,_, ”_'' Lipsitch_NNP says_VBZ ,_, “_`` that_IN there_EX 's_VBZ ongoing_JJ transmission_NN in_IN other_JJ countries_NNS ,_, which_WDT if_IN it_PRP remains_VBZ undetected_JJ is_VBZ going_VBG to_TO result_VB in_IN more_JJR and_CC more_JJR cases_NNS ._. ”_''","NNP - NNP and JJ NNS VBP VBG the JJ and JJ NNS in NN NN as it VBZ to the NN - 19 NN . Their JJS NN VBZ VBN by a NN they VBD in 2015 , which VBD a NN that RB VBD the NN of NN NN NNS during NNS of NN , NN , NN , and NNP . As in this JJR NN , the JJ NN for NNP - 19 VBZ JJ NNS like the NN NN for NN NNS or how RB the NN VBZ between NNS . But it RB VBZ for JJR JJ NNS , like how JJ NNS might VB the NN before their NNS VBP , or how RB NNS RB VBP their NNS on NN NNS VBN at NN NNS . “ It VBZ RB JJ from JJ NNS that NNS VBP RB RB JJ about JJ NNS , ” NNP - NNP VBZ . “ VBN on the JJ NNS we VBD , it VBD like one in four NNS RB and RB VBD the JJ NNS they VBD . ” VB all these NNS , and their NN VBZ that VBN NN VBZ at RBS VBG 50 NN of VBN NN NNS and at JJS RB 20 NN , RB because NN - 19 NNS VBP RB JJ . “ VBN on what we VBP about this NN , NN on the NN of NN of NNS VBP RB RB JJ [ during NN ] , ” NNP - NNP VBZ . While the NNS VBP RB VBG JJ - VBN at the NN NNP , they VBP what JJ NNS from a JJ NN NN at the NNP NNP of NNP and NNP NNP VBP for NN NN NN with NNP - 19 . “ We 'd RB RB VB RB 45 NN of VBN NNS VBG NN NN , ” VBZ NNP NNP , an NN at the NNP NNP ’s NNP for NNP NNP of NNP NNPS . “ Out of the VBG 55 NN of NNS who VBP RB VBN , we can VB a JJ JJR on NN . You VBP VBN 42 NN of the NNS [ with NNP - 19 ] RB VBG it into the NN . ” While JJ NNS can VB an NN of what might VB VBG , you can VB these NNS VB out in JJ - NN by VBG your NNS on one NN : NNP . NNP VBZ one of the RBS - VBN NN NN NNS on the NN , NN to JJ NN , JJ NNS for NN , and an NN of NNS , NNS , and JJ NN NNS . This NN VBZ off during an NN , because it VBZ that NNP can VB NNS the NN NNS VBP on their NNS . “ NNP VBD such a JJ NN during NNP with VBG NNS , and it VBZ to VB a JJ NN of NN this NN RB , ” VBZ NNP NNP , an NN at NNP NNP NNP NNP of NNP NNP . He VBZ VBG the NN - 19 NN in NNP can VB VB how the NN might VB in JJ NNS , RB in NNS with VBN NN NN NNS or NNS that VBP JJ NNS of NNS from NNP . The NNP NNPS VBZ both NNS of this NN , VBN that it VBZ RB JJ NNS from NNP as NNP , RB three million a NN . VBN on JJ NN in NNP ’s NN , NNP VBD RB out of 191 NNS in NN NN during the JJ NNS of NNP - 19 . His NN VBZ that NNP 's NNS VBP RB JJ to JJ NNS , and can RB VB as a NN of NN against JJ NN NNS . By VBG NNP as a JJ NN for NN - 19 NN , his NN can RB VB how JJ NNS VBP RB VBG JJ in JJ NNS . RB to NNP , JJ NNS with a JJ NN for NN NN — like the NNP , NNP , NNP , and VBN NNS in NNP — may RB VB VBG 38 NN of NN - JJ NNS , VBN on NNP ’s NN . That VBZ due in NN to NNP NNS ’ VBD NNS toward NN NN , but RB because the NN NN VBZ JJ . Its 5.6 million NNS VBP VBN into an NN on NN with NNP , NNP NNP , which VBZ it JJR to VB the NNS VBN to JJ NNS . “ If there VBP [ NNP - 19 ] NNS VBG into the NNP NNPS that VBP RB VBN , which VBZ JJ the NN , NNP would RB VB an JJ NN , ” VBZ NNP NNP , a JJ NNP NNP NN and NN NN at the NNP NNP NNP who VBZ NNP ’s NN VBZ on the JJ NN . “ But they'd VB VBN RBR in NNP because it VBZ a JJR , RBR RB VBN NN . ” For this NN , NNP VBZ that NNP VBZ an NN for JJ NNS in the NNP , RB than the NN as a NN . “ They VBP a JJ NN for what VBZ when an NN VBZ into a RB JJ NN NN NN and JJ NN in a JJ NN , ” he VBZ . There VBP NNS to NNP ’s NNS , VBG that JJ or JJ NNS of NN - 19 may RB VB VBN for . Plus , these NNS VBP RB to VB VBN in a NN - VBN NN , though the NN VBZ under NN . But their NNS VBP what NNS VBP VBG about the JJ NN of NN NNS and what they might VB for NN in at - NN NNS in NNS like NNP . The NN VBZ that up to 89 NN of VBN NNS might VB VBG JJ in NNS with a JJ NN for NN NN . And JJ NNS VBG across NNS VBP such a NN because they VBP the JJ NN to JJ NN , the NN where an NN VBZ VBN from NN and VBZ to VB RB in a NN . On NNP , NNS in NNP , VBG one from the NN of NN , VBD eight of the NN ’s 84 NNS VBP RB to VB VBN to any JJ NN . RB , the NNP - 19 NN VBN in NNP NNP to 204 , due to an NN at a NN in NNP VBN to a 61 - NN - JJ NN VBN RB as “ NN 31 . ” But the NN of her NN VBZ RB JJ . “ Although the JJ NN of NNS outside NNP VBZ RB JJ , we VBP JJ about the NN of NNS with no JJ JJ NN , ” VBD NNP NNP NNP , NN - NN of the NNP NNP NNP , VBD at a NNP NN NN . “ RB from the NNP NNP NN NN , the NNP of NNP RB VBZ the JJS NNS outside of NNP . We VBP VBG RB with the NN to RB VB the NN NNS that VBD to this NN . ” JJR than 80 JJ NNS VBN NNP VBP VBN to NNP 31 , and NNP ’s NNPS for NNP NNP & NNP VBD this NN in NNP ’s RB JJS NN as a RB - NN NN . “ There VBZ a JJ NN , ” NNP VBZ , “ that there VBZ JJ NN in JJ NNS , which if it VBZ JJ VBZ VBG to VB in JJR and JJR NNS . ”"
78,168,mainstream,M0af20,vaccine.covid,"Kizzmekia_NNP Corbett_NNP works_VBZ seven_CD -_HYPH day_NN weeks_NNS gets_VBZ just_RB three_CD to_IN four_CD hours_NNS of_IN sleep_NN each_DT night_NN Corbett_NNP ,_, 34_CD ,_, is_VBZ a_DT research_NN fellow_NN at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP in_IN Bethesda_NNP ,_, Maryland_NNP ,_, where_WRB she_PRP and_CC her_PRP$ team_NN have_VBP already_RB begun_VBN first_JJ -_HYPH stage_NN clinical_JJ trials_NNS of_IN a_DT vaccine_NN to_TO fight_VB against_IN COVID_NNP -_HYPH 19_CD ,_, according_VBG to_IN The_DT New_NNP York_NNP Times_NNP ._. The_DT trials_NNS began_VBD in_IN Seattle_NNP in_IN March_NNP ,_, and_CC according_VBG to_IN Dr._NNP Anthony_NNP Fauci_NNP ,_, it_PRP happened_VBD in_IN “_`` record_NN speed_NN ._. ”_'' It_PRP took_VBD about_RB two_CD months_NNS ,_, a_DT much_RB faster_JJR turnaround_NN than_IN the_DT 20_CD months_NNS it_PRP took_VBD get_VB a_DT SARS_NNP vaccine_NN to_IN trial_NN in_IN 2003_CD ,_, NBC_NNP News_NNP reported_VBD ._. “_`` There_EX was_VBD ,_, and_CC is_VBZ ,_, already_RB a_DT fair_JJ amount_NN of_IN pressure_NN ._. A_DT lot_NN of_IN people_NNS are_VBP banking_VBG on_IN us_PRP or_CC feel_VBP that_IN we_PRP have_VBP a_DT product_NN that_WDT could_MD ,_, at_IN least_JJS ,_, be_VB part_NN of_IN the_DT answer_NN this_DT world_NN needs_VBZ ,_, ”_'' Corbett_NNP told_VBD NBC_NNP News_NNP ._. “_`` And_CC ,_, well_UH ,_, whew_UH ,_, just_RB saying_VBG that_IN out_RP loud_RB is_VBZ not_RB easy_JJ ._. ”_'' The_DT superstar_NN scientist_NN got_VBD her_PRP$ start_NN with_IN a_DT full_JJ scholarship_NN to_IN the_DT University_NNP of_IN Maryland_NNP ,_, Baltimore_NNP County_NNP ,_, where_WRB she_PRP majored_VBD in_IN biology_NN and_CC sociology_NN ,_, according_VBG to_IN NBC_NNP News_NNP ._. She_PRP went_VBD on_RP to_TO earn_VB a_DT doctorate_NN from_IN the_DT University_NNP of_IN North_NNP Carolina_NNP -_HYPH Chapel_NNP Hill_NNP in_IN 2014_CD ,_, and_CC later_RBR joined_VBD the_DT NIH_NNP ’s_POS Vaccine_NNP Research_NNP Center_NNP as_IN a_DT postdoctoral_JJ fellow_NN that_WDT same_JJ year_NN ._. “_`` [_-LRB- She_PRP ’s_VBZ ]_-RRB- a_DT really_RB quite_RB outstanding_JJ ,_, hard_RB -_HYPH working_VBG scientist_NN ,_, ”_'' UNC_NNP professor_NN Ralph_NNP Baric_NNP ,_, who_WP is_VBZ part_NN of_IN Corbett_NNP ’s_POS vaccine_NN development_NN team_NN ,_, told_VBD NBC_NNP News_NNP ._. “_`` Fate_NNP has_VBZ put_VBN her_PRP in_IN a_DT position_NN to_TO make_VB a_DT huge_JJ difference_NN in_IN human_JJ health_NN ,_, and_CC it_PRP has_VBZ made_VBN a_DT good_JJ choice_NN ._. ”_'' Corbett_NNP ,_, who_WP was_VBD born_VBN in_IN a_DT small_JJ town_NN in_IN North_NNP Carolina_NNP ,_, has_VBZ been_VBN working_VBG seven_CD -_HYPH day_NN weeks_NNS ,_, and_CC getting_VBG just_RB three_CD to_IN four_CD hours_NNS of_IN sleep_NN each_DT night_NN ,_, according_VBG to_IN the_DT outlet_NN ._. “_`` At_IN some_DT point_NN ,_, you_PRP have_VBP to_TO decide_VB how_WRB much_JJ to_TO care_VB ,_, ”_'' she_PRP said_VBD ._. “_`` You_PRP understand_VBP that_IN your_PRP$ work_NN will_MD have_VB to_TO be_VB mighty_JJ so_IN that_IN it_PRP can_MD do_VB your_PRP$ speaking_NN ._. ”_'' In_IN an_DT interview_NN with_IN Black_NNP Enterprise_NNP ,_, she_PRP said_VBD of_IN herself_PRP ,_, “_`` I_PRP am_VBP Christian_NNP ._. I_PRP ’m_VBP black_JJ ._. I_PRP am_VBP Southern_JJ ,_, I_PRP ’m_VBP an_DT empath_NN ._. I_PRP ’m_VBP feisty_JJ ,_, sassy_JJ ,_, and_CC fashionable_JJ ._. ”_'' “_`` I_PRP would_MD say_VB that_IN my_PRP$ role_NN as_IN a_DT scientist_NN is_VBZ really_RB about_IN my_PRP$ passion_NN and_CC purpose_NN for_IN the_DT world_NN and_CC for_IN giving_VBG back_RB to_IN the_DT world_NN ,_, ”_'' she_PRP told_VBD the_DT outlet_NN ._. “_`` She_PRP ’s_VBZ brilliant_JJ and_CC doing_VBG this_DT complicated_JJ work_NN and_CC yet_CC ,_, somehow_RB ,_, is_VBZ also_RB this_DT person_NN who_WP manages_VBZ to_TO remember_VB everybody_NN ’s_POS birthday_NN ._. She_PRP ’s_VBZ really_RB great_JJ at_IN bringing_VBG together_RP groups_NNS of_IN people_NNS with_IN different_JJ skills_NNS and_CC understanding_NN the_DT value_NN and_CC contributions_NNS of_IN each_DT of_IN them_PRP in_IN ways_NNS that_WDT really_RB maximizes_VBZ scientific_JJ impact_NN ,_, ”_'' Andrew_NNP Ward_NNP ,_, a_DT Scripps_NNP Research_NNP professor_NN who_WP is_VBZ part_NN of_IN Corbett_NNP ’s_POS team_NN ,_, told_VBD the_DT outlet_NN ._. As_IN information_NN about_IN the_DT coronavirus_NN pandemic_NN rapidly_RB changes_VBZ ,_, PEOPLE_NNP is_VBZ committed_VBN to_IN providing_VBG the_DT most_RBS recent_JJ data_NNS in_IN our_PRP$ coverage_NN ._. Some_DT of_IN the_DT information_NN in_IN this_DT story_NN may_MD have_VB changed_VBN after_IN publication_NN ._. For_IN the_DT latest_JJS on_IN COVID_NNP -_SYM 19_CD ,_, readers_NNS are_VBP encouraged_VBN to_TO use_VB online_JJ resources_NNS from_IN CDC_NNP ,_, WHO_NNP ,_, and_CC local_JJ public_JJ health_NN departments_NNS ._. To_TO help_VB provide_VB doctors_NNS and_CC nurses_NNS on_IN the_DT front_JJ lines_NNS with_IN life_NN -_HYPH saving_VBG medical_JJ resources_NNS ,_, donate_VB to_IN Direct_JJ Relief_NN here_RB ._.","NNP NNP VBZ seven - NN NNS VBZ RB three to four NNS of NN each NN NNP , 34 , VBZ a NN NN at the NNP NNPS of NNP in NNP , NNP , where she and her NN VBP RB VBN JJ - NN JJ NNS of a NN to VB against NNP - 19 , VBG to The NNP NNP NNP . The NNS VBD in NNP in NNP , and VBG to NNP NNP NNP , it VBD in “ NN NN . ” It VBD RB two NNS , a RB JJR NN than the 20 NNS it VBD VB a NNP NN to NN in 2003 , NNP NNP VBD . “ There VBD , and VBZ , RB a JJ NN of NN . A NN of NNS VBP VBG on us or VBP that we VBP a NN that could , at JJS , VB NN of the NN this NN VBZ , ” NNP VBD NNP NNP . “ And , well , whew , RB VBG that out RB VBZ RB JJ . ” The NN NN VBD her NN with a JJ NN to the NNP of NNP , NNP NNP , where she VBD in NN and NN , VBG to NNP NNP . She VBD on to VB a NN from the NNP of NNP NNP - NNP NNP in 2014 , and RBR VBD the NNP ’s NNP NNP NNP as a JJ NN that JJ NN . “ [ She VBZ ] a RB RB JJ , RB - VBG NN , ” NNP NN NNP NNP , who VBZ NN of NNP ’s NN NN NN , VBD NNP NNP . “ NNP VBZ VBN her in a NN to VB a JJ NN in JJ NN , and it VBZ VBN a JJ NN . ” NNP , who VBD VBN in a JJ NN in NNP NNP , VBZ VBN VBG seven - NN NNS , and VBG RB three to four NNS of NN each NN , VBG to the NN . “ At some NN , you VBP to VB how JJ to VB , ” she VBD . “ You VBP that your NN will VB to VB JJ so that it can VB your NN . ” In an NN with NNP NNP , she VBD of herself , “ I VBP NNP . I VBP JJ . I VBP JJ , I VBP an NN . I VBP JJ , JJ , and JJ . ” “ I would VB that my NN as a NN VBZ RB about my NN and NN for the NN and for VBG RB to the NN , ” she VBD the NN . “ She VBZ JJ and VBG this JJ NN and yet , RB , VBZ RB this NN who VBZ to VB NN ’s NN . She VBZ RB JJ at VBG together NNS of NNS with JJ NNS and NN the NN and NNS of each of them in NNS that RB VBZ JJ NN , ” NNP NNP , a NNP NNP NN who VBZ NN of NNP ’s NN , VBD the NN . As NN about the NN NN RB VBZ , NNP VBZ VBN to VBG the RBS JJ NNS in our NN . Some of the NN in this NN may VB VBN after NN . For the JJS on NNP - 19 , NNS VBP VBN to VB JJ NNS from NNP , NNP , and JJ JJ NN NNS . To VB VB NNS and NNS on the JJ NNS with NN - VBG JJ NNS , VB to JJ NN RB ."
79,1272,mainstream,M09dcd,vaccine.covid,"Hepatitis_NN B_NNP is_VBZ an_DT infection_NN of_IN the_DT liver_NN caused_VBN by_IN a_DT virus_NN that_WDT 's_VBZ spread_VBN through_IN blood_NN and_CC body_NN fluids_NNS ._. It_PRP often_RB does_VBZ not_RB cause_VB any_DT obvious_JJ symptoms_NNS in_IN adults_NNS ,_, and_CC typically_RB passes_VBZ in_IN a_DT few_JJ months_NNS without_IN treatment_NN ._. But_CC in_IN children_NNS ,_, it_PRP often_RB persists_VBZ for_IN years_NNS and_CC may_MD eventually_RB cause_VB serious_JJ liver_NN damage_NN ._. Hepatitis_NN B_NN is_VBZ less_RBR common_JJ in_IN the_DT UK_NNP than_IN other_JJ parts_NNS of_IN the_DT world_NN ,_, but_CC certain_JJ groups_NNS are_VBP at_IN an_DT increased_VBN risk_NN ._. This_DT includes_VBZ people_NNS originally_RB from_IN high_JJ -_HYPH risk_NN countries_NNS ,_, people_NNS who_WP inject_VBP drugs_NNS ,_, and_CC people_NNS who_WP have_VBP unprotected_VBN sex_NN with_IN multiple_JJ sexual_JJ partners_NNS ._. A_DT hepatitis_NN B_NN vaccine_NN is_VBZ available_JJ for_IN people_NNS at_IN high_JJ risk_NN of_IN the_DT condition_NN ._. Many_JJ people_NNS with_IN hepatitis_NN B_NN will_MD not_RB experience_VB any_DT symptoms_NNS and_CC may_MD fight_VB off_RP the_DT virus_NN without_IN realising_VBG they_PRP had_VBD it_PRP ._. If_IN symptoms_NNS do_VBP develop_VB ,_, they_PRP tend_VBP to_TO happen_VB 2_CD or_CC 3_CD months_NNS after_IN exposure_NN to_IN the_DT hepatitis_NN B_NN virus_NN ._. •_SYM yellowing_NN of_IN the_DT skin_NN and_CC eyes_NNS (_-LRB- jaundice_NN )_-RRB- These_DT symptoms_NNS will_MD usually_RB pass_VB within_IN 1_CD to_IN 3_CD months_NNS (_-LRB- acute_JJ hepatitis_NN B_NN )_-RRB- ,_, although_IN occasionally_RB the_DT infection_NN can_MD last_VB for_IN 6_CD months_NNS or_CC more_JJR (_-LRB- chronic_JJ hepatitis_NN B_NN )_-RRB- ._. When_WRB to_TO get_VB medical_JJ advice_NN Hepatitis_NN B_NN can_MD be_VB serious_JJ ,_, so_RB you_PRP should_MD get_VB medical_JJ advice_NN if_IN :_: •_NFP you_PRP think_VBP you_PRP may_MD have_VB been_VBN exposed_VBN to_IN the_DT hepatitis_NN B_NN virus_NN –_: emergency_NN treatment_NN can_MD help_VB prevent_VB infection_NN if_IN given_VBN within_IN a_DT few_JJ days_NNS of_IN exposure_NN •_NFP you_PRP have_VBP symptoms_NNS associated_VBN with_IN hepatitis_NN B_NN •_, you_PRP 're_VBP at_IN a_DT high_JJ risk_NN of_IN hepatitis_NN B_NN –_: high_JJ -_HYPH risk_NN groups_NNS include_VBP people_NNS born_VBN in_IN a_DT country_NN where_WRB the_DT infection_NN is_VBZ common_JJ ,_, babies_NNS born_VBN to_IN mothers_NNS infected_VBN with_IN hepatitis_NN B_NN ,_, and_CC people_NNS who_WP have_VBP ever_RB injected_VBN drugs_NNS You_PRP can_MD go_VB to_IN your_PRP$ local_JJ GP_NN surgery_NN ,_, drug_NN service_NN ,_, genitourinary_JJ medicine_NN (_-LRB- GUM_NN )_-RRB- clinic_NN or_CC sexual_JJ health_NN clinic_NN for_IN help_NN and_CC advice_NN ._. A_DT blood_NN test_NN can_MD be_VB carried_VBN out_RP to_TO check_VB if_IN you_PRP have_VBP hepatitis_NN B_NN or_CC have_VBP had_VBN it_PRP in_IN the_DT past_NN ._. The_DT hepatitis_NN B_NN vaccine_NN may_MD also_RB be_VB recommended_VBN to_TO reduce_VB your_PRP$ risk_NN of_IN infection_NN ._. Treatment_NN for_IN hepatitis_NN B_NN depends_VBZ on_IN how_WRB long_RB you_PRP have_VBP been_VBN infected_VBN for_IN ._. If_IN you_PRP have_VBP been_VBN exposed_VBN to_IN the_DT virus_NN in_IN the_DT past_JJ few_JJ days_NNS ,_, emergency_NN treatment_NN can_MD help_VB stop_VB you_PRP becoming_VBG infected_VBN ._. If_IN you_PRP have_VBP only_RB had_VBN the_DT infection_NN for_IN a_DT few_JJ weeks_NNS or_CC months_NNS (_-LRB- acute_JJ hepatitis_NN B_NN )_-RRB- ,_, you_PRP may_MD only_RB need_VB treatment_NN to_TO relieve_VB your_PRP$ symptoms_NNS while_IN your_PRP$ body_NN fights_VBZ off_RP the_DT infection_NN ._. If_IN you_PRP have_VBP had_VBN the_DT infection_NN for_IN more_JJR than_IN 6_CD months_NNS (_-LRB- chronic_JJ hepatitis_NN B_NN )_-RRB- ,_, you_PRP may_MD be_VB offered_VBN treatment_NN with_IN medicines_NNS that_WDT can_MD keep_VB the_DT virus_NN under_IN control_NN and_CC reduce_VB the_DT risk_NN of_IN liver_NN damage_NN ._. Chronic_JJ hepatitis_NN B_NN often_RB requires_VBZ long_JJ -_HYPH term_NN or_CC lifelong_JJ treatment_NN and_CC regular_JJ monitoring_NN to_TO check_VB for_IN any_DT further_JJR liver_NN problems_NNS ._. The_DT hepatitis_NN B_NN virus_NN is_VBZ found_VBN in_IN the_DT blood_NN and_CC bodily_NN fluids_NNS ,_, such_JJ as_IN semen_NN and_CC vaginal_JJ fluids_NNS ,_, of_IN an_DT infected_VBN person_NN ._. •_SYM from_IN a_DT mother_NN to_IN her_PRP$ newborn_NN baby_NN ,_, particularly_RB in_IN countries_NNS where_WRB the_DT infection_NN is_VBZ common_JJ (_-LRB- read_VB more_JJR about_IN hepatitis_NN B_NN in_IN pregnancy_NN )_-RRB- •_NFP within_IN families_NNS (_-LRB- child_NN to_IN child_NN )_-RRB- in_IN countries_NNS where_WRB the_DT infection_NN is_VBZ common_JJ •_NFP by_IN injecting_VBG drugs_NNS and_CC sharing_VBG needles_NNS and_CC other_JJ drug_NN equipment_NN ,_, such_JJ as_IN spoons_NNS and_CC filters_NNS •_NFP by_IN having_VBG sex_NN with_IN an_DT infected_VBN person_NN without_IN using_VBG a_DT condom_NN •_, by_IN having_VBG a_DT tattoo_NN ,_, body_NN piercing_NN ,_, or_CC medical_JJ or_CC dental_JJ treatment_NN in_IN an_DT unhygienic_JJ environment_NN with_IN unsterilised_JJ equipment_NN •_, by_IN sharing_VBG toothbrushes_NNS or_CC razors_NNS contaminated_VBN with_IN infected_VBN blood_NN Hepatitis_NN B_NN is_VBZ not_RB spread_VBN by_IN kissing_VBG ,_, holding_VBG hands_NNS ,_, hugging_VBG ,_, coughing_NN ,_, sneezing_VBG or_CC sharing_VBG crockery_NN and_CC utensils_NNS ._. A_DT vaccine_NN that_WDT offers_VBZ protection_NN against_IN hepatitis_NN B_NN is_VBZ routinely_RB available_JJ for_IN all_DT babies_NNS born_VBN in_IN the_DT UK_NNP ._. It_PRP 's_VBZ also_RB available_JJ for_IN people_NNS at_IN high_JJ risk_NN of_IN the_DT infection_NN or_CC complications_NNS from_IN it_PRP ._. •_SYM close_JJ family_NN and_CC sexual_JJ partners_NNS of_IN someone_NN with_IN hepatitis_NN B_NN •_, people_NNS travelling_VBG to_IN a_DT part_NN of_IN the_DT world_NN where_WRB hepatitis_NN B_NN is_VBZ widespread_JJ ,_, such_JJ as_IN sub-Saharan_JJ Africa_NNP ,_, east_JJ and_CC southeast_NNP Asia_NNP ,_, and_CC the_DT Pacific_NNP Islands_NNPS •_, people_NNS who_WP inject_VBP drugs_NNS or_CC have_VBP a_DT sexual_JJ partner_NN who_WP injects_VBZ drugs_NNS •_, men_NNS who_WP have_VBP sex_NN with_IN men_NNS •_, people_NNS who_WP work_VBP somewhere_RB that_WDT places_VBZ them_PRP at_IN risk_NN of_IN contact_NN with_IN blood_NN or_CC body_NN fluids_NNS ,_, such_JJ as_IN nurses_NNS ,_, prison_NN staff_NN ,_, doctors_NNS ,_, dentists_NNS and_CC laboratory_NN staff_NN •_, people_NNS who_WP receive_VBP regular_JJ blood_NN or_CC blood_NN products_NNS ,_, and_CC their_PRP$ carers_NNS The_DT hepatitis_NN B_NN vaccine_NN is_VBZ given_VBN to_IN infants_NNS as_IN part_NN of_IN the_DT routine_JJ childhood_NN vaccination_NN schedule_NN and_CC those_DT at_IN high_JJ risk_NN of_IN developing_VBG the_DT infection_NN ._. You_PRP do_VBP not_RB need_VB to_TO pay_VB for_IN the_DT vaccine_NN if_IN your_PRP$ child_NN is_VBZ eligible_JJ to_TO receive_VB it_PRP as_IN part_NN of_IN the_DT routine_JJ childhood_NN vaccination_NN schedule_NN ,_, or_CC they_PRP 're_VBP born_VBN to_IN a_DT mother_NN with_IN hepatitis_NN B_NN ._. Others_NNS may_MD have_VB to_TO pay_VB for_IN it_PRP ._.","NN NNP VBZ an NN of the NN VBN by a NN that VBZ VBN through NN and NN NNS . It RB VBZ RB VB any JJ NNS in NNS , and RB VBZ in a JJ NNS without NN . But in NNS , it RB VBZ for NNS and may RB VB JJ NN NN . NN NN VBZ RBR JJ in the NNP than JJ NNS of the NN , but JJ NNS VBP at an VBN NN . This VBZ NNS RB from JJ - NN NNS , NNS who VBP NNS , and NNS who VBP VBN NN with JJ JJ NNS . A NN NN NN VBZ JJ for NNS at JJ NN of the NN . JJ NNS with NN NN will RB VB any NNS and may VB off the NN without VBG they VBD it . If NNS VBP VB , they VBP to VB 2 or 3 NNS after NN to the NN NN NN . • NN of the NN and NNS ( NN ) These NNS will RB VB within 1 to 3 NNS ( JJ NN NN ) , although RB the NN can VB for 6 NNS or JJR ( JJ NN NN ) . When to VB JJ NN NN NN can VB JJ , RB you should VB JJ NN if : • you VBP you may VB VBN VBN to the NN NN NN – NN NN can VB VB NN if VBN within a JJ NNS of NN • you VBP NNS VBN with NN NN • you VBP at a JJ NN of NN NN – JJ - NN NNS VBP NNS VBN in a NN where the NN VBZ JJ , NNS VBN to NNS VBN with NN NN , and NNS who VBP RB VBN NNS You can VB to your JJ NN NN , NN NN , JJ NN ( NN ) NN or JJ NN NN for NN and NN . A NN NN can VB VBN out to VB if you VBP NN NN or VBP VBN it in the NN . The NN NN NN may RB VB VBN to VB your NN of NN . NN for NN NN VBZ on how RB you VBP VBN VBN for . If you VBP VBN VBN to the NN in the JJ JJ NNS , NN NN can VB VB you VBG VBN . If you VBP RB VBN the NN for a JJ NNS or NNS ( JJ NN NN ) , you may RB VB NN to VB your NNS while your NN VBZ off the NN . If you VBP VBN the NN for JJR than 6 NNS ( JJ NN NN ) , you may VB VBN NN with NNS that can VB the NN under NN and VB the NN of NN NN . JJ NN NN RB VBZ JJ - NN or JJ NN and JJ NN to VB for any JJR NN NNS . The NN NN NN VBZ VBN in the NN and NN NNS , JJ as NN and JJ NNS , of an VBN NN . • from a NN to her NN NN , RB in NNS where the NN VBZ JJ ( VB JJR about NN NN in NN ) • within NNS ( NN to NN ) in NNS where the NN VBZ JJ • by VBG NNS and VBG NNS and JJ NN NN , JJ as NNS and NNS • by VBG NN with an VBN NN without VBG a NN • by VBG a NN , NN NN , or JJ or JJ NN in an JJ NN with JJ NN • by VBG NNS or NNS VBN with VBN NN NN NN VBZ RB VBN by VBG , VBG NNS , VBG , NN , VBG or VBG NN and NNS . A NN that VBZ NN against NN NN VBZ RB JJ for all NNS VBN in the NNP . It VBZ RB JJ for NNS at JJ NN of the NN or NNS from it . • JJ NN and JJ NNS of NN with NN NN • NNS VBG to a NN of the NN where NN NN VBZ JJ , JJ as JJ NNP , JJ and NNP NNP , and the NNP NNPS • NNS who VBP NNS or VBP a JJ NN who VBZ NNS • NNS who VBP NN with NNS • NNS who VBP RB that VBZ them at NN of NN with NN or NN NNS , JJ as NNS , NN NN , NNS , NNS and NN NN • NNS who VBP JJ NN or NN NNS , and their NNS The NN NN NN VBZ VBN to NNS as NN of the JJ NN NN NN and those at JJ NN of VBG the NN . You VBP RB VB to VB for the NN if your NN VBZ JJ to VB it as NN of the JJ NN NN NN , or they VBP VBN to a NN with NN NN . NNS may VB to VB for it ."
80,868,mainstream,M08ce7,aids; vaccine; vaccine.covid,"Trump_NNP praises_VBZ scientists_NNS for_IN nonexistent_JJ AIDS_NN vaccine_NN ,_, predicts_VBZ COVID_NN -_HYPH 19_CD vaccine_NN by_IN the_DT end_NN of_IN 2020_CD WASHINGTON_NNP —_: President_NNP Donald_NNP Trump_NNP on_IN Tuesday_NNP said_VBD he_PRP believes_VBZ there_EX will_MD be_VB a_DT vaccine_NN for_IN the_DT coronavirus_NN ready_JJ by_IN the_DT end_NN of_IN this_DT year_NN ,_, and_CC incorrectly_RB stated_VBD that_IN scientists_NNS and_CC doctors_NNS developed_VBD a_DT vaccine_NN for_IN AIDS_NN ,_, the_DT most_RBS advanced_JJ stage_NN of_IN HIV_NN ._. ""_`` These_DT are_VBP the_DT people_NNS ,_, the_DT best_JJS ,_, the_DT smartest_JJS ,_, the_DT most_RBS brilliant_JJ anywhere_RB ,_, and_CC they_PRP ’ve_VBP come_VBN up_RP with_IN the_DT AIDS_NN vaccine_NN ._. They_PRP 've_VBP come_VBN up_RP with_IN —_: or_CC the_DT AIDS_NN ,_, and_CC ,_, as_IN you_PRP know_VBP ,_, there_EX 's_VBZ various_JJ things_NNS and_CC now_RB various_JJ companies_NNS involved_VBN ._. But_CC the_DT therapeutic_JJ for_IN AIDS_NN ,_, ""_'' Trump_NNP said_VBD from_IN the_DT White_NNP House_NNP Rose_NNP Garden_NNP ._. The_DT president_NN was_VBD delivering_VBG remarks_NNS as_IN he_PRP signed_VBD an_DT executive_JJ order_NN on_IN policing_NN ,_, prompted_VBN by_IN weeks_NNS of_IN nationwide_JJ protests_NNS against_IN police_NN brutality_NN and_CC racism_NN in_IN the_DT wake_NN of_IN the_DT death_NN of_IN George_NNP Floyd_NNP at_IN the_DT hands_NNS of_IN a_DT police_NN officer_NN ._. He_PRP said_VBD that_IN by_IN the_DT end_NN of_IN this_DT year_NN ,_, he_PRP predicts_VBZ there_EX will_MD be_VB a_DT ""_`` very_RB successful_JJ ""_'' vaccine_NN for_IN coronavirus_NN ,_, along_IN with_IN therapeutic_JJ medications_NNS and_CC a_DT cure_NN ._. Trump_NNP said_VBD that_IN even_RB without_IN a_DT vaccine_NN ,_, ""_`` it_PRP goes_VBZ away_RB ._. ""_'' ""_`` We_PRP 're_VBP making_VBG tremendous_JJ progress_NN ._. I_PRP deal_VBP with_IN these_DT incredible_JJ scientists_NNS ,_, doctors_NNS very_RB ,_, very_RB closely_RB ._. I_PRP have_VBP great_JJ respect_NN for_IN their_PRP$ minds_NNS ..._. And_CC they_PRP 've_VBP come_VBN up_RP with_IN many_JJ other_JJ cures_NNS and_CC therapeutics_NNS over_IN the_DT years_NNS ,_, ""_'' Trump_NNP said_VBD ._. Trump_NNP credited_VBD the_DT same_JJ experts_NNS for_IN developing_VBG a_DT vaccine_NN for_IN AIDS_NN ,_, also_RB mentioning_VBG ""_`` the_DT therapeutic_JJ for_IN AIDS_NN ._. ""_'' ""_`` AIDS_NNP was_VBD a_DT death_NN sentence_NN and_CC now_RB people_NNS live_VBP a_DT life_NN with_IN a_DT pill_NN ,_, ""_'' Trump_NNP said_VBD ._. ""_`` It_PRP 's_VBZ an_DT incredible_JJ thing_NN ._. ""_'' There_EX is_VBZ no_DT vaccine_NN for_IN AIDS_NN ,_, but_CC there_EX are_VBP treatments_NNS and_CC preventative_JJ measures_NNS ._. Pre_JJ -exposure_NN prophylaxis_NN ,_, or_CC PrEP_NN ,_, is_VBZ a_DT drug_NN typically_RB taken_VBN once_RB daily_RB in_IN pill_NN form_NN with_IN the_DT guidance_NN of_IN a_DT doctor_NN to_TO prevent_VB contracting_VBG HIV_NN ._. There_EX are_VBP also_RB antiretroviral_JJ therapy_NN medications_NNS effective_JJ at_IN preventing_VBG the_DT virus_NN from_IN progressing_VBG in_IN those_DT who_WP are_VBP HIV_NN -_HYPH positive_JJ ,_, making_VBG it_PRP less_RBR likely_JJ for_IN them_PRP to_TO experience_VB symptoms_NNS or_CC pass_VB it_PRP on_RP to_IN others_NNS ._. HIV_NNP is_VBZ only_RB contracted_VBN through_IN contact_NN with_IN certain_JJ bodily_NN fluids_NNS ._. About_RB 38,000_CD Americans_NNPS received_VBD an_DT HIV_NN diagnosis_NN in_IN 2018_CD ,_, according_VBG to_IN CDC_NNP data_NNS ._. Nearly_RB 16,000_CD people_NNS who_WP had_VBD HIV_NNP died_VBD that_DT year_NN ,_, the_DT CDC_NNP noted_VBD ,_, from_IN any_DT cause_NN ._. In_IN his_PRP$ 2019_CD State_NN of_IN the_DT Union_NN address_NN ,_, Trump_NNP said_VBD that_IN he_PRP would_MD end_VB HIV_NN transmission_NN by_IN 2030_CD ,_, a_DT task_NN that_WDT Kaiser_NNP Health_NNP News_NNP called_VBD ""_`` doable_JJ but_CC daunting_JJ ._. ""_'' Trump_NNP also_RB mentioned_VBD the_DT Ebola_NNP vaccine_NN on_IN Tuesday_NNP in_IN predicting_VBG a_DT vaccine_NN for_IN the_DT coronavirus_NN by_IN the_DT end_NN of_IN this_DT year_NN ._. The_DT FDA_NNP approved_VBD its_PRP$ first_JJ Ebola_NNP vaccine_NN in_IN December_NNP ._. What_WP is_VBZ AIDS_NN ?_. :_: Frequently_RB asked_VBN questions_NNS about_IN HIV_NNP and_CC AIDS_NNP Some_DT health_NN care_NN and_CC LGBTQ_NNP advocates_NNS noted_VBD that_IN there_EX is_VBZ no_DT AIDS_NN or_CC HIV_NN vaccine_NN currently_RB available_JJ ,_, and_CC that_IN the_DT cost_NN of_IN PrEP_NN can_MD be_VB prohibitive_JJ to_IN many_JJ ._. ""_`` FACT_NN CHECK_NN :_: There_EX is_VBZ no_DT AIDS_NN vaccine_NN ._. In_IN fact_NN ,_, PrEP_NNP ,_, a_DT drug_NN that_WDT ’s_VBZ highly_RB effective_JJ in_IN preventing_VBG HIV_NN ,_, can_MD be_VB extremely_RB expensive_JJ —_: and_CC the_DT Trump_NNP administration_NN ’s_POS program_NN that_WDT ’s_VBZ supposed_VBN to_TO cover_VB the_DT cost_NN for_IN thousands_NNS of_IN uninsured_JJ people_NNS requires_VBZ out_IN -_HYPH of_IN -_HYPH pocket_NN testing_NN fees_NNS ,_, ""_'' tweeted_VBD Rep._NNP Pramila_NNP Jayapal_NNP ,_, D_NNP -_HYPH Wash_NNP ._.","NNP VBZ NNS for JJ NN NN , VBZ NN - 19 NN by the NN of 2020 NNP — NNP NNP NNP on NNP VBD he VBZ there will VB a NN for the NN JJ by the NN of this NN , and RB VBD that NNS and NNS VBD a NN for NN , the RBS JJ NN of NN . "" These VBP the NNS , the JJS , the JJS , the RBS JJ RB , and they VBP VBN up with the NN NN . They VBP VBN up with — or the NN , and , as you VBP , there VBZ JJ NNS and RB JJ NNS VBN . But the JJ for NN , "" NNP VBD from the NNP NNP NNP NNP . The NN VBD VBG NNS as he VBD an JJ NN on NN , VBN by NNS of JJ NNS against NN NN and NN in the NN of the NN of NNP NNP at the NNS of a NN NN . He VBD that by the NN of this NN , he VBZ there will VB a "" RB JJ "" NN for NN , along with JJ NNS and a NN . NNP VBD that RB without a NN , "" it VBZ RB . "" "" We VBP VBG JJ NN . I VBP with these JJ NNS , NNS RB , RB RB . I VBP JJ NN for their NNS ... And they VBP VBN up with JJ JJ NNS and NNS over the NNS , "" NNP VBD . NNP VBD the JJ NNS for VBG a NN for NN , RB VBG "" the JJ for NN . "" "" NNP VBD a NN NN and RB NNS VBP a NN with a NN , "" NNP VBD . "" It VBZ an JJ NN . "" There VBZ no NN for NN , but there VBP NNS and JJ NNS . JJ NN NN , or NN , VBZ a NN RB VBN RB RB in NN NN with the NN of a NN to VB VBG NN . There VBP RB JJ NN NNS JJ at VBG the NN from VBG in those who VBP NN - JJ , VBG it RBR JJ for them to VB NNS or VB it on to NNS . NNP VBZ RB VBN through NN with JJ NN NNS . RB 38,000 NNPS VBD an NN NN in 2018 , VBG to NNP NNS . RB 16,000 NNS who VBD NNP VBD that NN , the NNP VBD , from any NN . In his 2019 NN of the NN NN , NNP VBD that he would VB NN NN by 2030 , a NN that NNP NNP NNP VBD "" JJ but JJ . "" NNP RB VBD the NNP NN on NNP in VBG a NN for the NN by the NN of this NN . The NNP VBD its JJ NNP NN in NNP . What VBZ NN ? : RB VBN NNS about NNP and NNP Some NN NN and NNP NNS VBD that there VBZ no NN or NN NN RB JJ , and that the NN of NN can VB JJ to JJ . "" NN NN : There VBZ no NN NN . In NN , NNP , a NN that VBZ RB JJ in VBG NN , can VB RB JJ — and the NNP NN ’s NN that VBZ VBN to VB the NN for NNS of JJ NNS VBZ out - of - NN NN NNS , "" VBD NNP NNP NNP , NNP - NNP ."
81,842,mainstream,M0b6da,vaccine.autism,"Overall_RB ,_, MMR_NNP vaccine_NN is_VBZ implicated_VBN in_IN 13_CD %_NN of_IN claims_NNS ,_, most_JJS of_IN which_WDT are_VBP events_NNS associated_VBN with_IN immunization_NN during_IN the_DT second_JJ year_NN of_IN life_NN ._. Natural_JJ measles_NNS infection_NN is_VBZ known_VBN to_TO cause_VB acute_JJ encephalopathy_NN /_, encephalitis_NN ._. Although_IN the_DT IOM_NNP found_VBD the_DT evidence_NN to_TO be_VB “_`` insufficient_JJ ”_'' to_TO determine_VB whether_IN measles_NNS vaccine_NN can_MD cause_VB acute_JJ encephalopathy_NN ,_, there_EX is_VBZ some_DT evidence_NN of_IN clustering_NN of_IN encephalopathy_NN /_, encephalitis_NN cases_NNS whose_WP$ onset_NN is_VBZ 8_CD to_IN 10_CD days_NNS following_VBG measles_NNS -_HYPH containing_VBG immunization_NN ,_, based_VBN on_IN an_DT analysis_NN of_IN 48_CD VICP_NN claims_NNS ._. 111_CD Only_RB rarely_RB are_VBP biological_JJ markers_NNS demonstrated_VBN to_TO support_VB a_DT genetic_JJ ,_, metabolic_JJ ,_, or_CC vaccine_NN cause_NN ._. In_IN only_RB one_CD VICP_NNP case_NN was_VBD cerebrospinal_JJ fluid_NN measles_NN antibody_NN ,_, a_DT biological_JJ marker_NN for_IN measles_NN causation_NN ,_, found_VBN in_IN a_DT previously_RB healthy_JJ 2_CD -_HYPH year_NN -_HYPH old_JJ girl_NN who_WP received_VBD the_DT first_JJ dose_NN of_IN MMR_NN and_CC varicella_NN vaccine_NN ._. New_JJ -_HYPH onset_NN seizures_NNS following_VBG MMR_NNP vaccine_NN was_VBD alleged_VBN in_IN some_DT claims_NNS ._. Nearly_RB all_DT were_VBD febrile_JJ seizures_NNS occurring_VBG in_IN the_DT 7_CD -_SYM to_IN 14_CD -_HYPH day_NN time_NN frame_NN during_IN which_WDT fever_NN may_MD accompany_VB replication_NN of_IN vaccine_NN virus_NN ._. The_DT cases_NNS that_WDT fell_VBD within_IN the_DT VIT_NNP onset_NN interval_NN were_VBD usually_RB recommended_VBN for_IN entitlement_NN by_IN VICP_NNP staff_NN ._. Most_JJS such_JJ claims_NNS were_VBD adjudicated_VBN before_IN residual_JJ seizure_NN disorder_NN was_VBD removed_VBN from_IN the_DT VIT_NN ._. Another_DT common_JJ diagnosis_NN was_VBD thrombocytopenic_JJ purpura_NN ,_, a_DT VIT_NN condition_NN with_IN prescribed_VBN onset_NN of_IN 7_CD to_IN 35_CD days_NNS following_VBG vaccination_NN ._. Most_RBS involved_VBN children_NNS with_IN documented_VBN thrombocytopenia_NN within_IN this_DT interval_NN ._. In_IN some_DT cases_NNS ,_, additional_JJ episodes_NNS of_IN decreased_VBN platelets_NNS occurred_VBD in_IN the_DT ensuing_JJ months_NNS or_CC years_NNS ._. Many_JJ ,_, however_RB ,_, showed_VBD normalization_NN of_IN their_PRP$ platelet_NN count_NN before_IN the_DT 6_CD months_NNS of_IN continued_VBN effects_NNS required_VBN by_IN the_DT NCVIA_NNP ._. Subacute_JJ sclerosing_NN panencephalitis_NN (_-LRB- SSPE_NNP )_-RRB- claims_NNS have_VBP also_RB been_VBN identified_VBN ,_, more_JJR than_IN half_NN of_IN them_PRP deaths_NNS ._. Early_JJ hearings_NNS resulted_VBD in_IN a_DT few_JJ being_VBG compensated_VBN because_IN of_IN the_DT initial_JJ lack_NN of_IN administrative_JJ resources_NNS to_TO defend_VB claims_NNS ._. Subsequent_JJ testimony_NN by_IN experts_NNS in_IN infectious_JJ disease_NN persuaded_VBD the_DT court_NN of_IN the_DT lack_NN of_IN any_DT data_NNS supporting_VBG a_DT causal_JJ connection_NN ,_, noting_VBG the_DT tremendous_JJ decrease_NN in_IN SSPE_NN incidence_NN since_IN licensure_NN of_IN the_DT vaccine_NN decades_NNS ago_RB ._. Since_IN then_RB ,_, claims_NNS of_IN SSPE_NN -_HYPH related_JJ injury_NN or_CC death_NN have_VBP been_VBN dismissed_VBN ._. Claims_NNS alleging_VBG injury_NN from_IN rubella_NN vaccine_NN comprise_VBP 2_CD %_NN of_IN claims_NNS overall_RB ._. Most_JJS are_VBP filed_VBN on_IN behalf_NN of_IN adult_JJ women_NNS who_WP received_VBD vaccine_NN in_IN the_DT postpartum_NN period_NN or_CC for_IN employment_NN ._. In_IN the_DT majority_NN of_IN cases_NNS ,_, acute_JJ and_CC chronic_JJ arthritis_NN or_CC arthralgia_NN developed_VBD 7_CD to_IN 90_CD days_NNS (_-LRB- median_JJ ,_, 14_CD days_NNS )_-RRB- after_IN rubella_NN immunization_NN ._. Neuropathy_NN and_CC fibromyalgia_NN were_VBD the_DT other_JJ diagnoses_NNS ._. A_DT previous_JJ inventory_NN of_IN 113_CD nonacute_JJ arthritis_NN claims_NNS filed_VBN starting_VBG in_IN 1988_CD showed_VBD 28_CD %_NN with_IN chronic_JJ arthropathy_NN or_CC other_JJ generalized_VBN complaints_NNS similar_JJ to_IN those_DT of_IN chronic_JJ fatigue_NN syndrome_NN and_CC 30_CD %_NN with_IN a_DT variety_NN of_IN non–vaccine_JJ -_HYPH related_JJ conditions_NNS ._. Although_IN 13_CD %_NN to_IN 15_CD %_NN of_IN susceptible_JJ (_-LRB- serology_NN -_HYPH negative_JJ )_-RRB- women_NNS may_MD experience_VB transient_JJ arthritis_NN after_IN the_DT currently_RB used_VBN rubella_NN vaccine_NN ,_, with_IN a_DT higher_JJR percentage_NN (_-LRB- up_IN to_IN 40_CD %_NN )_-RRB- reporting_VBG some_DT type_NN of_IN musculoskeletal_JJ complaint_NN ,_, it_PRP is_VBZ less_RBR clear_JJ what_WDT role_NN ,_, if_IN any_DT ,_, the_DT vaccine_NN has_VBZ in_IN causing_VBG recurrent_JJ or_CC chronic_JJ arthropathy_NN (_-LRB- ie_NN ,_, arthralgia_NN or_CC arthritis_NN )_-RRB- ._. 78,79_CD Based_VBN on_IN the_DT 1991_CD IOM_NNP finding_NN that_IN chronic_JJ arthritis_NN may_MD be_VB caused_VBN by_IN rubella_NN vaccine_NN ,_, a_DT special_JJ master_NN held_VBD a_DT hearing_NN to_TO determine_VB criteria_NNS necessary_JJ for_IN proof_NN of_IN causation_NN ._. Following_VBG the_DT special_JJ master_NN 's_POS publication_NN of_IN these_DT guidelines_NNS ,_, the_DT VICP_NNP added_VBD chronic_JJ arthritis_NN to_IN the_DT VIT_NNP in_IN the_DT 1995_CD final_JJ rule45_NN and_CC incorporated_VBD several_JJ of_IN the_DT court_NN 's_POS criteria_NNS in_IN the_DT 1997_CD final_JJ rule_NN ._. 94_CD The_DT main_JJ difference_NN between_IN the_DT criteria_NNS adopted_VBN by_IN the_DT VICP_NNP and_CC those_DT adopted_VBN by_IN the_DT court_NN has_VBZ been_VBN the_DT latter_NN 's_POS willingness_NN to_TO compensate_VB arthralgia_NN ,_, a_DT subjective_JJ symptom_NN that_WDT is_VBZ difficult_JJ to_TO assess_VB ,_, unlike_IN observable_JJ signs_NNS of_IN arthritis_NN ._. Adjudications_NNS to_IN date_NN have_VBP resulted_VBN in_IN 70_CD claims_NNS being_VBG compensated_VBN and_CC 123_CD being_VBG dismissed_VBN ._. Additional_JJ research_NN published_VBN since_IN the_DT IOM_NNP report_NN ,_, including_VBG retrospective_JJ case_NN reviews_NNS and_CC a_DT prospective_JJ double_JJ -_HYPH blind_JJ study_NN ,_, has_VBZ produced_VBN mixed_VBN results_NNS ._. If_IN rubella_NN vaccine_NN does_VBZ cause_VB chronic_JJ arthropathy_NN ,_, it_PRP would_MD seem_VB that_IN the_DT incidence_NN is_VBZ rare_JJ ._. 112–114_CD","RB , NNP NN VBZ VBN in 13 NN of NNS , JJS of which VBP NNS VBN with NN during the JJ NN of NN . JJ NNS NN VBZ VBN to VB JJ NN / NN . Although the NNP VBD the NN to VB “ JJ ” to VB whether NNS NN can VB JJ NN , there VBZ some NN of NN of NN / NN NNS whose NN VBZ 8 to 10 NNS VBG NNS - VBG NN , VBN on an NN of 48 NN NNS . 111 RB RB VBP JJ NNS VBN to VB a JJ , JJ , or NN NN . In RB one NNP NN VBD JJ NN NN NN , a JJ NN for NN NN , VBN in a RB JJ 2 - NN - JJ NN who VBD the JJ NN of NN and NN NN . JJ - NN NNS VBG NNP NN VBD VBN in some NNS . RB all VBD JJ NNS VBG in the 7 - to 14 - NN NN NN during which NN may VB NN of NN NN . The NNS that VBD within the NNP NN NN VBD RB VBN for NN by NNP NN . JJS JJ NNS VBD VBN before JJ NN NN VBD VBN from the NN . Another JJ NN VBD JJ NN , a NN NN with VBN NN of 7 to 35 NNS VBG NN . RBS VBN NNS with VBN NN within this NN . In some NNS , JJ NNS of VBN NNS VBD in the JJ NNS or NNS . JJ , RB , VBD NN of their NN NN before the 6 NNS of VBN NNS VBN by the NNP . JJ NN NN ( NNP ) NNS VBP RB VBN VBN , JJR than NN of them NNS . JJ NNS VBD in a JJ VBG VBN because of the JJ NN of JJ NNS to VB NNS . JJ NN by NNS in JJ NN VBD the NN of the NN of any NNS VBG a JJ NN , VBG the JJ NN in NN NN since NN of the NN NNS RB . Since RB , NNS of NN - JJ NN or NN VBP VBN VBN . NNS VBG NN from NN NN VBP 2 NN of NNS RB . JJS VBP VBN on NN of JJ NNS who VBD NN in the NN NN or for NN . In the NN of NNS , JJ and JJ NN or NN VBD 7 to 90 NNS ( JJ , 14 NNS ) after NN NN . NN and NN VBD the JJ NNS . A JJ NN of 113 JJ NN NNS VBN VBG in 1988 VBD 28 NN with JJ NN or JJ VBN NNS JJ to those of JJ NN NN and 30 NN with a NN of JJ - JJ NNS . Although 13 NN to 15 NN of JJ ( NN - JJ ) NNS may VB JJ NN after the RB VBN NN NN , with a JJR NN ( up to 40 NN ) VBG some NN of JJ NN , it VBZ RBR JJ what NN , if any , the NN VBZ in VBG JJ or JJ NN ( NN , NN or NN ) . 78,79 VBN on the 1991 NNP NN that JJ NN may VB VBN by NN NN , a JJ NN VBD a NN to VB NNS JJ for NN of NN . VBG the JJ NN 's NN of these NNS , the NNP VBD JJ NN to the NNP in the 1995 JJ NN and VBD JJ of the NN 's NNS in the 1997 JJ NN . 94 The JJ NN between the NNS VBN by the NNP and those VBN by the NN VBZ VBN the NN 's NN to VB NN , a JJ NN that VBZ JJ to VB , unlike JJ NNS of NN . NNS to NN VBP VBN in 70 NNS VBG VBN and 123 VBG VBN . JJ NN VBN since the NNP NN , VBG JJ NN NNS and a JJ JJ - JJ NN , VBZ VBN VBN NNS . If NN NN VBZ VB JJ NN , it would VB that the NN VBZ JJ . 112–114"
82,1115,mainstream,M08cf0,covid.19; vaccine; vaccine.covid,"What_WP if_IN all_DT it_PRP took_VBD for_IN the_DT world_NN to_TO return_VB to_IN normal_NN was_VBD a_DT shot_NN in_IN the_DT arm_NN ?_. Politicians_NNS are_VBP repeating_VBG the_DT mantra_NN that_WDT a_DT coronavirus_NN vaccine_NN is_VBZ the_DT exit_NN strategy_NN ._. But_CC getting_VBG there_RB is_VBZ neither_CC simple_JJ nor_CC even_RB guaranteed_VBN ._. ""_`` A_DT vaccine_NN is_VBZ not_RB a_DT given_VBN ,_, ""_'' said_VBD David_NNP Heymann_NNP ,_, a_DT professor_NN of_IN infectious_JJ disease_NN epidemiology_NN and_CC distinguished_JJ fellow_NN at_IN Chatham_NNP House_NNP ._. There_EX are_VBP hundreds_NNS of_IN vaccine_NN candidates_NNS in_IN development_NN ,_, but_CC the_DT vast_JJ majority_NN will_MD fail_VB ._. Assuming_VBG one_CD is_VBZ successful_JJ ,_, it_PRP could_MD take_VB years_NNS to_TO manufacture_VB billions_NNS of_IN doses_NNS for_IN the_DT entire_JJ globe_NN ._. With_IN this_DT in_IN mind_NN ,_, “_`` waiting_VBG for_IN a_DT vaccine_NN is_VBZ a_DT poor_JJ ,_, poor_JJ exit_NN strategy_NN ,_, ""_'' Heymann_NNP argued_VBD ._. He_PRP and_CC other_JJ experts_NNS say_VBP that_IN the_DT idea_NN that_IN a_DT vaccine_NN is_VBZ the_DT only_JJ way_NN out_RP could_MD provide_VB people_NNS with_IN false_JJ hope_NN and_CC ignore_VB other_JJ vital_JJ public_JJ health_NN measures_NNS already_RB at_IN our_PRP$ disposal_NN ._. For_IN example_NN ,_, politicians_NNS could_MD give_VB equal_JJ attention_NN to_IN a_DT COVID_NN -_HYPH 19_CD cure_NN or_CC to_IN more_RBR comprehensive_JJ testing_NN methods_NNS —_: or_CC promote_VB simple_JJ public_JJ health_NN measures_NNS like_IN hand_NN washing_NN ._. “_`` Instead_RB of_IN going_VBG for_IN silver_NN bullets_NNS and_CC moonshots_NNS ,_, the_DT focus_NN should_MD be_VB on_IN doing_VBG the_DT hard_JJ slog_NN of_IN public_JJ health_NN ,_, ""_'' said_VBD Devi_NNP Sridhar_NNP ,_, chair_NN of_IN global_JJ public_JJ health_NN at_IN the_DT University_NNP of_IN Edinburgh_NNP ._. Here_RB are_VBP four_CD public_JJ health_NN measures_NNS that_WDT experts_NNS say_VBP need_VBP to_TO be_VB put_VBN in_IN place_NN ._. But_CC spoiler_NN alert_NN :_: Most_JJS require_VBP up_RP -_HYPH front_JJ investment_NN and_CC have_VBP their_PRP$ own_JJ hurdles_NNS ._. One_CD of_IN the_DT clear_JJ ways_NNS out_RP is_VBZ knowing_VBG who_WP has_VBZ the_DT virus_NN ._. Testing_NN was_VBD key_JJ at_IN the_DT start_NN of_IN the_DT pandemic_NN ,_, but_CC as_IN people_NNS emerge_VBP from_IN lockdown_NN ,_, ""_`` it_PRP acquires_VBZ an_DT even_RB more_RBR important_JJ position_NN ,_, ""_'' said_VBD John_NNP Middleton_NNP ,_, president_NN of_IN the_DT Association_NNP of_IN Schools_NNPS of_IN Public_NNP Health_NNP in_IN the_DT European_NNP Region_NNP ._. As_IN the_DT number_NN of_IN infected_VBN people_NNS dwindles_VBZ ,_, pinpointing_VBG who_WP has_VBZ the_DT virus_NN makes_VBZ it_PRP possible_JJ to_TO put_VB up_RP a_DT ""_`` cordon_NN sanitaire_NN ""_'' and_CC focus_VB on_IN the_DT ill_JJ and_CC those_DT they_PRP 've_VBP been_VBN in_IN contact_NN with_IN ._. But_CC it_PRP 's_VBZ also_RB vital_JJ in_IN another_DT way_NN ,_, he_PRP noted_VBD ,_, by_IN understanding_VBG factors_NNS like_IN the_DT geographical_JJ extent_NN of_IN the_DT spread_NN ._. ""_`` You_PRP can_MD look_VB at_IN surveillance_NN and_CC population_NN studies_NNS to_TO see_VB how_WRB far_RB the_DT virus_NN has_VBZ spread_VBN ,_, and_CC what_WDT level_NN of_IN immunity_NN there_RB might_MD be_VB in_IN the_DT country_NN ,_, ""_'' Middleton_NNP added_VBD ._. ""_`` That_DT could_MD influence_VB how_WRB safe_JJ it_PRP is_VBZ to_TO [_-LRB- scale_VB back_RB ]_-RRB- lockdown_NN ._. ""_'' There_EX are_VBP ,_, as_IN always_RB ,_, obstacles_NNS to_TO surmount_VB ._. First_RB ,_, ramping_VBG up_RP capacity_NN has_VBZ been_VBN a_DT problem_NN for_IN many_JJ countries_NNS ._. In_IN the_DT U.S._NNP ,_, cuts_NNS to_IN public_JJ health_NN budgets_NNS mean_VBP that_IN there_EX 's_VBZ a_DT lack_NN of_IN qualified_JJ personnel_NNS and_CC machinery_NN ._. Testing_NN capacity_NN there_RB had_VBD to_TO be_VB built_VBN from_IN scratch_NN ,_, Middleton_NNP explained_VBD ._. In_IN the_DT U.K._NNP ,_, shortages_NNS of_IN reagents_NNS meant_VBD that_IN testing_NN was_VBD reserved_VBN for_IN those_DT who_WP were_VBD ill_JJ in_IN the_DT hospital_NN ._. Inaccurate_JJ testing_NN is_VBZ another_DT problem_NN ._. With_IN popular_JJ nasal_JJ swab_NN tests_NNS ,_, false_JJ negatives_NNS rates_NNS can_MD be_VB as_RB high_JJ as_IN three_CD in_IN 10_CD ._. For_IN more_JJR precise_JJ blood_NN tests_NNS ,_, the_DT opposite_NN is_VBZ a_DT bigger_JJR problem_NN —_: false_JJ positives_NNS leading_VBG people_NNS to_TO think_VB they_PRP 've_VBP contracted_VBN the_DT virus_NN and_CC are_VBP immune_JJ ,_, thus_RB skewing_VBG statistics_NNS ,_, Middleton_NNP explained_VBD ._. ""_`` Politicians_NNS have_VBP seen_VBN it_PRP as_IN a_DT beauty_NN contest_NN —_: how_WRB many_JJ tests_NNS are_VBP done_VBN —_: without_IN a_DT proper_JJ understanding_NN about_IN the_DT results_NNS ,_, ""_'' Middleton_NNP said_VBD ._. The_DT good_JJ news_NN is_VBZ that_IN the_DT technology_NN is_VBZ improving_VBG ,_, and_CC better_JJR ,_, more_RBR rapid_JJ tests_NNS are_VBP coming_VBG along_RB ,_, he_PRP added_VBD ._. Austrian_JJ geneticist_NN Hans_NNP Lehrach_NNP ,_, of_IN the_DT Max_NNP Planck_NNP Institute_NNP ,_, thinks_VBZ it_PRP 's_VBZ time_NN for_IN a_DT completely_RB new_JJ way_NN of_IN testing_VBG ._. ""_`` This_DT requires_VBZ a_DT different_JJ approach_NN to_IN testing_NN as_IN landing_VBG a_DT man_NN on_IN the_DT moon_NN required_VBD a_DT different_JJ approach_NN than_IN hot_JJ air_NN balloons_NNS ,_, ""_'' Lehrach_NNP said_VBD ._. Lehrach_NNP 's_POS idea_NN is_VBZ that_IN governments_NNS could_MD test_VB everyone_NN in_IN a_DT given_VBN country_NN or_CC in_IN the_DT EU_NNP for_IN five_CD consecutive_JJ weeks_NNS by_IN genetic_JJ sequencing_NN ._. If_IN countries_NNS did_VBD this_DT ,_, they_PRP could_MD effectively_RB eliminate_VB the_DT virus_NN in_IN that_DT area_NN ._. It_PRP would_MD require_VB citizens_NNS '_POS and_CC governments_NNS '_POS buy_NN -_HYPH in_IN —_: literally_RB ._. But_CC so_RB far_RB ,_, governments_NNS have_VBP been_VBN slow_JJ to_TO take_VB on_RP this_DT new_JJ testing_NN approach_NN ._. ""_`` Whatever_WP we_PRP do_VBP will_MD not_RB be_VB for_IN free_JJ ,_, ""_'' Lehrach_NNP said_VBD ._. But_CC he_PRP argues_VBZ that_IN this_DT approach_NN would_MD eliminate_VB the_DT virus_NN from_IN the_DT targeted_VBN area_NN and_CC allow_VB people_NNS to_TO go_VB back_RB to_IN restaurants_NNS and_CC work_VB knowing_VBG ""_`` that_IN everybody_NN they_PRP meet_VBP is_VBZ free_JJ of_IN the_DT virus_NN ._. ""_'' If_IN there_EX 's_VBZ one_CD immediate_JJ priority_NN that_WDT governments_NNS should_MD invest_VB in_IN for_IN the_DT short_JJ term_NN ,_, it_PRP 's_VBZ contact_NN tracing_NN ,_, argues_VBZ Clare_NNP Wenham_NNP ,_, assistant_JJ professor_NN of_IN global_JJ health_NN policy_NN at_IN the_DT London_NNP School_NNP of_IN Economics_NNP ._. “_`` The_DT countries_NNS that_WDT are_VBP able_JJ to_TO resume_VB normal_JJ life_NN —_: Hong_NNP Kong_NNP ,_, Taiwan_NNP ,_, South_NNP Korea_NNP —_: they_PRP ..._, have_VB the_DT infrastructure_NN to_TO be_VB able_JJ to_TO do_VB really_RB granular_JJ and_CC effective_JJ contact_NN tracing_NN ,_, ”_'' Wenham_NNP said_VBD ._. This_DT requires_VBZ an_DT effective_JJ application_NN and_CC staff_NN who_WP can_MD “_`` join_VB the_DT dots_NNS ._. ”_'' “_`` When_WRB one_CD person_NN gets_VBZ infected_VBN ,_, [_-LRB- the_DT tracers_NNS ]_-RRB- can_MD notify_VB who_WP they_PRP ’ve_VBP been_VBN in_IN contact_NN with_IN ,_, and_CC reach_VB the_DT people_NNS that_WDT were_VBD n’t_RB on_IN the_DT app_NN for_IN whatever_WDT reason_NN ._. A_DT bank_NN of_IN staff_NNS that_WDT can_MD do_VB that_DT last_JJ mile_NN ,_, ”_'' she_PRP said_VBD ._. Numerous_JJ European_JJ countries_NNS are_VBP trying_VBG to_TO do_VB this_DT already_RB ,_, including_VBG the_DT U.K._NNP and_CC Germany_NNP ._. But_CC they_PRP 're_VBP running_VBG into_IN two_CD problems_NNS ._. Many_JJ of_IN these_DT apps_NNS are_VBP n't_RB interoperable_JJ across_IN borders_NNS ,_, so_RB their_PRP$ effectiveness_NN at_IN fighting_VBG major_JJ public_JJ health_NN problems_NNS is_VBZ not_RB known_VBN ._. And_CC many_JJ people_NNS are_VBP afraid_JJ of_IN signing_VBG up_RP ._. “_`` For_IN a_DT lot_NN of_IN Europeans_NNPS ,_, it_PRP ’s_VBZ not_RB a_DT natural_JJ thing_NN to_TO have_VB the_DT government_NN tracking_VBG everything_NN on_IN your_PRP$ phone_NN and_CC your_PRP$ movements_NNS ,_, ”_'' said_VBD Wenham_NNP ._. Assuring_VBG people_NNS that_IN their_PRP$ data_NNS is_VBZ safe_JJ ,_, and_CC not_RB being_VBG used_VBN for_IN any_DT other_JJ purposes_NNS —_: for_IN example_NN to_TO be_VB sold_VBN to_IN third_JJ parties_NNS —_: is_VBZ key_JJ here_RB ,_, Wenham_NNP added_VBD ._. ""_`` This_DT is_VBZ a_DT dataset_NN that_WDT would_MD be_VB rich_JJ for_IN selling_VBG ,_, ""_'' she_PRP said_VBD ._. ""_`` You_PRP need_VBP to_TO make_VB sure_JJ that_IN you_PRP have_VBP that_DT data_NN security_NN ._. ""_'' One_CD major_JJ advantage_NN that_WDT therapies_NNS have_VBP over_IN vaccines_NNS is_VBZ that_IN they_PRP 're_VBP easier_JJR to_TO test_VB —_: and_CC therefore_RB faster_JJR to_TO bring_VB to_IN market_NN ._. David_NNP Salisbury_NNP ,_, an_DT associate_NN fellow_NN at_IN Chatham_NNP House_NNP and_CC former_JJ director_NN of_IN immunization_NN at_IN the_DT U.K._NNP 's_POS Department_NNP of_IN Health_NNP ,_, explained_VBD that_IN this_DT comes_VBZ down_RP to_IN the_DT comparative_JJ ease_NN of_IN setting_VBG up_RP clinical_JJ studies_NNS for_IN drugs_NNS ._. ""_`` You_PRP test_VBP [_-LRB- an_DT ]_-RRB- antiviral_NN in_IN people_NNS who_WP 've_VBP got_VBN the_DT disease_NN ,_, and_CC you_PRP hope_VBP to_TO see_VB that_IN those_DT that_WDT you_PRP treat_VBP with_IN the_DT antiviral_NN get_VB better_JJR and_CC survive_VBP better_JJR than_IN those_DT who_WP have_VBP a_DT placebo_NN or_CC an_DT alternative_JJ treatment_NN ,_, ""_'' Salisbury_NNP explained_VBD ._. ""_`` With_IN a_DT vaccine_NN ,_, you_PRP 've_VBP got_VBN to_TO show_VB that_IN it_PRP stops_VBZ people_NNS actually_RB getting_VBG infected_VBN ,_, ""_'' he_PRP said_VBD ._. ""_`` So_RB it_PRP has_VBZ to_TO be_VB administered_VBN in_IN a_DT place_NN where_WRB the_DT virus_NN is_VBZ circulating_VBG ,_, and_CC administered_VBN in_IN extremely_RB large_JJ doses_NNS ._. ""_'' This_DT means_VBZ vaccine_NN developers_NNS are_VBP constantly_RB racing_VBG to_TO roll_VB out_RP clinical_JJ trials_NNS in_IN places_NNS where_WRB the_DT virus_NN is_VBZ still_RB on_IN the_DT rise_NN ._. Recently_RB ,_, the_DT University_NNP of_IN Oxford_NNP and_CC AstraZeneca_NNP launched_VBD a_DT new_JJ wing_NN of_IN its_PRP$ phase_NN 3_CD clinical_JJ trial_NN in_IN Brazil_NNP because_IN that_DT 's_VBZ where_WRB the_DT ""_`` epidemiological_JJ curve_NN is_VBZ still_RB rising_VBG ._. ""_'' But_CC regardless_RB of_IN whether_IN and_CC when_WRB a_DT vaccine_NN is_VBZ developed_VBN ,_, therapies_NNS are_VBP necessary_JJ ,_, say_VB experts_NNS ._. “_`` We_PRP need_VBP drugs_NNS before_IN we_PRP get_VBP a_DT vaccine_NN ,_, ""_'' said_VBD Nick_NNP Cammack_NNP ,_, COVID_NNP -_HYPH 19_CD therapeutics_NN accelerator_NN lead_NN at_IN the_DT Wellcome_NNP Trust_NNP ._. ""_`` We_PRP need_VBP drugs_NNS while_IN we_PRP have_VBP a_DT vaccine_NN ..._, and_CC we_PRP need_VBP drugs_NNS after_IN we_PRP get_VBP a_DT vaccine_NN ,_, because_IN even_RB for_IN conditions_NNS that_WDT we_PRP currently_RB have_VBP vaccines_NNS for_IN you_PRP still_RB have_VBP breakthrough_NN cases_NNS ._. ""_'' The_DT first_JJ line_NN of_IN defense_NN is_VBZ coming_VBG from_IN repurposed_VBN drugs_NNS ,_, he_PRP noted_VBD at_IN a_DT webinar_NN organized_VBN by_IN the_DT Wellcome_NNP Trust_NNP last_JJ week_NN ._. These_DT are_VBP medicines_NNS already_RB developed_VBN to_TO fight_VB other_JJ diseases_NNS and_CC are_VBP now_RB being_VBG tested_VBN to_TO see_VB if_IN they_PRP help_VBP patients_NNS ._. The_DT two_CD medicines_NNS that_WDT have_VBP been_VBN in_IN the_DT spotlight_NN —_: remdesivir_NN and_CC hydroxychloroquine_NN —_: fit_VB into_IN this_DT category_NN ._. However_RB ,_, evidence_NN of_IN their_PRP$ efficacy_NN is_VBZ ,_, at_IN best_JJS ,_, spotty_JJ ._. Remdesivir_NNP ,_, an_DT antiviral_NN developed_VBN to_TO fight_VB Ebola_NNP by_IN drugmaker_NN Gilead_NNP ,_, has_VBZ shown_VBN it_PRP can_MD moderately_RB shorten_VB the_DT duration_NN of_IN the_DT disease_NN ._. Malaria_NN drug_NN hydroxychloroquine_NN promised_VBD some_DT early_JJ hope_NN but_CC has_VBZ since_RB failed_VBN to_TO pay_VB off_RP ,_, with_IN a_DT major_JJ British_JJ trial_NN declaring_VBG negative_JJ results_NNS ._. In_IN the_DT medium_JJ term_NN ,_, antibodies_NNS can_MD also_RB be_VB applied_VBN as_IN a_DT therapy_NN ,_, Cammack_NNP noted_VBD ._. Plasma_NN from_IN people_NNS who_WP have_VBP already_RB recovered_VBN from_IN the_DT disease_NN carries_VBZ antibodies_NNS against_IN COVID_NN -_HYPH 19_CD ._. If_IN it_PRP ’s_VBZ injected_VBN into_IN patients_NNS that_WDT are_VBP currently_RB sick_JJ ,_, it_PRP can_MD give_VB the_DT immune_JJ system_NN a_DT boost_NN to_TO help_VB fight_VB the_DT virus_NN ._. The_DT problem_NN :_: You_PRP ’re_VBP limited_VBN by_IN the_DT amount_NN of_IN recovered_VBN patients_NNS you_PRP can_MD gather_VB plasma_NN from_IN ._. An_DT alternative_JJ approach_NN is_VBZ monoclonal_JJ antibodies_NNS ,_, which_WDT are_VBP designed_VBN and_CC can_MD be_VB mass_NN -_HYPH produced_VBN in_IN a_DT lab_NN ._. U.S._NNP drugmaker_NN Eli_NNP Lilly_NNP has_VBZ brought_VBN its_PRP$ monoclonal_JJ antibodies_NNS to_IN phase_NN 1_CD trial_NN together_RB with_IN AbCellera_NNP ,_, and_CC expects_VBZ results_NNS at_IN the_DT end_NN of_IN June_NNP ._. ""_`` In_IN the_DT next_JJ six_CD to_IN nine_CD months_NNS we_PRP will_MD know_VB if_IN monoclonal_JJ antibodies_NNS that_WDT are_VBP specific_JJ for_IN COVID_NN -_HYPH 19_CD show_VBP safety_NN and_CC efficacy_NN ,_, ""_'' Cammack_NNP said_VBD ._. ""_`` There_EX 's_VBZ much_JJ excitement_NN around_IN them_PRP as_IN potential_JJ treatments_NNS ._. ""_'' Specific_JJ antiviral_JJ medicines_NNS to_TO target_VB COVID_NN -_HYPH 19_CD —_: likely_JJ to_TO be_VB small_JJ molecule_NN drugs_NNS —_: are_VBP further_RB away_RB and_CC require_VB a_DT number_NN of_IN trials_NNS ._. Beyond_IN the_DT measures_NNS noted_VBN above_RB ,_, experts_NNS argue_VBP ,_, policymakers_NNS need_VBP to_TO keep_VB up_RP basic_JJ public_JJ health_NN work_NN that_WDT has_VBZ become_VBN routine_JJ since_IN lockdowns_NNS started_VBD :_: Washing_NN hands_NNS ,_, wearing_VBG a_DT mask_NN and_CC keeping_VBG distance_NN ._. ""_`` If_IN [_-LRB- people_NNS ]_-RRB- are_VBP underpinning_VBG activities_NNS in_IN a_DT country_NN by_IN protecting_VBG themselves_PRP by_IN social_JJ distancing_NN ,_, that_DT 's_VBZ already_RB a_DT major_JJ step_NN forward_RB ,_, ""_'' Heymann_NNP said_VBD ._. One_CD of_IN the_DT most_RBS important_JJ tools_NNS for_IN politicians_NNS is_VBZ clear_JJ communication_NN ,_, especially_RB considering_VBG that_IN the_DT public_NN needs_VBZ to_TO trust_VB that_IN these_DT measures_NNS —_: testing_NN ,_, contact_NN tracing_NN ,_, drugs_NNS and_CC a_DT vaccine_NN ,_, if_IN it_PRP 's_VBZ found_VBN —_: are_VBP safe_JJ ._. Trudie_NNP Lang_NNP ,_, professor_NN of_IN global_JJ health_NN research_NN at_IN the_DT University_NNP of_IN Oxford_NNP ,_, said_VBD that_IN this_DT was_VBD a_DT lesson_NN first_RB learned_VBN from_IN Ebola_NNP that_WDT 's_VBZ being_VBG learned_VBN again_RB now_RB :_: Public_JJ health_NN measures_NNS are_VBP only_RB as_RB effective_JJ as_IN the_DT amount_NN of_IN trust_NN the_DT public_NN has_VBZ in_IN them_PRP to_TO work_VB ._. “_`` What_WDT messages_NNS to_TO use_VB ?_. How_WRB to_TO gain_VB public_JJ trust_NN ?_. ”_'' Lang_NNP said_VBD ,_, also_RB at_IN the_DT Wellcome_NNP webinar_NN ._. ""_`` In_IN the_DT absence_NN of_IN drugs_NNS and_CC vaccines_NNS ,_, these_DT are_VBP things_NNS that_WDT we_PRP are_VBP left_VBN with_IN ._. ""_'' And_CC even_RB if_IN we_PRP get_VBP a_DT vaccine_NN or_CC an_DT effective_JJ treatment_NN ,_, one_CD of_IN the_DT clearest_JJS messages_NNS from_IN public_JJ health_NN officials_NNS might_MD be_VB that_IN the_DT virus_NN is_VBZ here_RB to_TO stay_VB ._. “_`` This_DT virus_NN is_VBZ not_RB going_VBG to_TO go_VB away_RB ._. Period_NN ,_, ”_'' the_DT World_NNP Health_NNP Organization_NNP ’s_POS David_NNP Nabarro_NNP told_VBD the_DT BBC_NNP ._. “_`` We_PRP do_VBP n’t_RB have_VB a_DT vaccine_NN and_CC we_PRP do_VBP n’t_RB know_VB we_PRP ’re_VBP going_VBG to_TO develop_VB one_CD …_: so_RB we_PRP ’ve_VBP all_RB got_VBN to_TO learn_VB to_TO live_VB with_IN this_DT virus_NN ._. ”_'' This_DT article_NN is_VBZ part_NN of_IN POLITICO_NNP ’s_POS premium_JJ policy_NN service_NN :_: Pro_NNP Health_NNP Care_NNP ._. From_IN drug_NN pricing_NN ,_, EMA_NN ,_, vaccines_NNS ,_, pharma_NN and_CC more_JJR ,_, our_PRP$ specialized_JJ journalists_NNS keep_VBP you_PRP on_IN top_NN of_IN the_DT topics_NNS driving_VBG the_DT health_NN care_NN policy_NN agenda_NN ._. Email_VB pro@politico.eu_NNP for_IN a_DT complimentary_JJ trial_NN ._.","What if all it VBD for the NN to VB to NN VBD a NN in the NN ? NNS VBP VBG the NN that a NN NN VBZ the NN NN . But VBG RB VBZ neither JJ nor RB VBN . "" A NN VBZ RB a VBN , "" VBD NNP NNP , a NN of JJ NN NN and JJ NN at NNP NNP . There VBP NNS of NN NNS in NN , but the JJ NN will VB . VBG one VBZ JJ , it could VB NNS to VB NNS of NNS for the JJ NN . With this in NN , “ VBG for a NN VBZ a JJ , JJ NN NN , "" NNP VBD . He and JJ NNS VBP that the NN that a NN VBZ the JJ NN out could VB NNS with JJ NN and VB JJ JJ JJ NN NNS RB at our NN . For NN , NNS could VB JJ NN to a NN - 19 NN or to RBR JJ NN NNS — or VB JJ JJ NN NNS like NN NN . “ RB of VBG for NN NNS and NNS , the NN should VB on VBG the JJ NN of JJ NN , "" VBD NNP NNP , NN of JJ JJ NN at the NNP of NNP . RB VBP four JJ NN NNS that NNS VBP VBP to VB VBN in NN . But NN NN : JJS VBP up - JJ NN and VBP their JJ NNS . One of the JJ NNS out VBZ VBG who VBZ the NN . NN VBD JJ at the NN of the NN , but as NNS VBP from NN , "" it VBZ an RB RBR JJ NN , "" VBD NNP NNP , NN of the NNP of NNPS of NNP NNP in the NNP NNP . As the NN of VBN NNS VBZ , VBG who VBZ the NN VBZ it JJ to VB up a "" NN NN "" and VB on the JJ and those they VBP VBN in NN with . But it VBZ RB JJ in another NN , he VBD , by VBG NNS like the JJ NN of the NN . "" You can VB at NN and NN NNS to VB how RB the NN VBZ VBN , and what NN of NN RB might VB in the NN , "" NNP VBD . "" That could VB how JJ it VBZ to [ VB RB ] NN . "" There VBP , as RB , NNS to VB . RB , VBG up NN VBZ VBN a NN for JJ NNS . In the NNP , NNS to JJ NN NNS VBP that there VBZ a NN of JJ NNS and NN . NN NN RB VBD to VB VBN from NN , NNP VBD . In the NNP , NNS of NNS VBD that NN VBD VBN for those who VBD JJ in the NN . JJ NN VBZ another NN . With JJ JJ NN NNS , JJ NNS NNS can VB RB JJ as three in 10 . For JJR JJ NN NNS , the NN VBZ a JJR NN — JJ NNS VBG NNS to VB they VBP VBN the NN and VBP JJ , RB VBG NNS , NNP VBD . "" NNS VBP VBN it as a NN NN — how JJ NNS VBP VBN — without a JJ NN about the NNS , "" NNP VBD . The JJ NN VBZ that the NN VBZ VBG , and JJR , RBR JJ NNS VBP VBG RB , he VBD . JJ NN NNP NNP , of the NNP NNP NNP , VBZ it VBZ NN for a RB JJ NN of VBG . "" This VBZ a JJ NN to NN as VBG a NN on the NN VBD a JJ NN than JJ NN NNS , "" NNP VBD . NNP 's NN VBZ that NNS could VB NN in a VBN NN or in the NNP for five JJ NNS by JJ NN . If NNS VBD this , they could RB VB the NN in that NN . It would VB NNS ' and NNS ' NN - in — RB . But RB RB , NNS VBP VBN JJ to VB on this JJ NN NN . "" Whatever we VBP will RB VB for JJ , "" NNP VBD . But he VBZ that this NN would VB the NN from the VBN NN and VB NNS to VB RB to NNS and VB VBG "" that NN they VBP VBZ JJ of the NN . "" If there VBZ one JJ NN that NNS should VB in for the JJ NN , it VBZ NN NN , VBZ NNP NNP , JJ NN of JJ NN NN at the NNP NNP of NNP . “ The NNS that VBP JJ to VB JJ NN — NNP NNP , NNP , NNP NNP — they ... VB the NN to VB JJ to VB RB JJ and JJ NN NN , ” NNP VBD . This VBZ an JJ NN and NN who can “ VB the NNS . ” “ When one NN VBZ VBN , [ the NNS ] can VB who they VBP VBN in NN with , and VB the NNS that VBD RB on the NN for whatever NN . A NN of NNS that can VB that JJ NN , ” she VBD . JJ JJ NNS VBP VBG to VB this RB , VBG the NNP and NNP . But they VBP VBG into two NNS . JJ of these NNS VBP RB JJ across NNS , RB their NN at VBG JJ JJ NN NNS VBZ RB VBN . And JJ NNS VBP JJ of VBG up . “ For a NN of NNPS , it VBZ RB a JJ NN to VB the NN VBG NN on your NN and your NNS , ” VBD NNP . VBG NNS that their NNS VBZ JJ , and RB VBG VBN for any JJ NNS — for NN to VB VBN to JJ NNS — VBZ JJ RB , NNP VBD . "" This VBZ a NN that would VB JJ for VBG , "" she VBD . "" You VBP to VB JJ that you VBP that NN NN . "" One JJ NN that NNS VBP over NNS VBZ that they VBP JJR to VB — and RB JJR to VB to NN . NNP NNP , an NN NN at NNP NNP and JJ NN of NN at the NNP 's NNP of NNP , VBD that this VBZ down to the JJ NN of VBG up JJ NNS for NNS . "" You VBP [ an ] NN in NNS who VBP VBN the NN , and you VBP to VB that those that you VBP with the NN VB JJR and VBP JJR than those who VBP a NN or an JJ NN , "" NNP VBD . "" With a NN , you VBP VBN to VB that it VBZ NNS RB VBG VBN , "" he VBD . "" RB it VBZ to VB VBN in a NN where the NN VBZ VBG , and VBN in RB JJ NNS . "" This VBZ NN NNS VBP RB VBG to VB out JJ NNS in NNS where the NN VBZ RB on the NN . RB , the NNP of NNP and NNP VBD a JJ NN of its NN 3 JJ NN in NNP because that VBZ where the "" JJ NN VBZ RB VBG . "" But RB of whether and when a NN VBZ VBN , NNS VBP JJ , VB NNS . “ We VBP NNS before we VBP a NN , "" VBD NNP NNP , NNP - 19 NN NN NN at the NNP NNP . "" We VBP NNS while we VBP a NN ... and we VBP NNS after we VBP a NN , because RB for NNS that we RB VBP NNS for you RB VBP NN NNS . "" The JJ NN of NN VBZ VBG from VBN NNS , he VBD at a NN VBN by the NNP NNP JJ NN . These VBP NNS RB VBN to VB JJ NNS and VBP RB VBG VBN to VB if they VBP NNS . The two NNS that VBP VBN in the NN — NN and NN — VB into this NN . RB , NN of their NN VBZ , at JJS , JJ . NNP , an NN VBN to VB NNP by NN NNP , VBZ VBN it can RB VB the NN of the NN . NN NN NN VBD some JJ NN but VBZ RB VBN to VB off , with a JJ JJ NN VBG JJ NNS . In the JJ NN , NNS can RB VB VBN as a NN , NNP VBD . NN from NNS who VBP RB VBN from the NN VBZ NNS against NN - 19 . If it VBZ VBN into NNS that VBP RB JJ , it can VB the JJ NN a NN to VB VB the NN . The NN : You VBP VBN by the NN of VBN NNS you can VB NN from . An JJ NN VBZ JJ NNS , which VBP VBN and can VB NN - VBN in a NN . NNP NN NNP NNP VBZ VBN its JJ NNS to NN 1 NN RB with NNP , and VBZ NNS at the NN of NNP . "" In the JJ six to nine NNS we will VB if JJ NNS that VBP JJ for NN - 19 VBP NN and NN , "" NNP VBD . "" There VBZ JJ NN around them as JJ NNS . "" JJ JJ NNS to VB NN - 19 — JJ to VB JJ NN NNS — VBP RB RB and VB a NN of NNS . Beyond the NNS VBN RB , NNS VBP , NNS VBP to VB up JJ JJ NN NN that VBZ VBN JJ since NNS VBD : NN NNS , VBG a NN and VBG NN . "" If [ NNS ] VBP VBG NNS in a NN by VBG themselves by JJ NN , that VBZ RB a JJ NN RB , "" NNP VBD . One of the RBS JJ NNS for NNS VBZ JJ NN , RB VBG that the NN VBZ to VB that these NNS — NN , NN NN , NNS and a NN , if it VBZ VBN — VBP JJ . NNP NNP , NN of JJ NN NN at the NNP of NNP , VBD that this VBD a NN RB VBN from NNP that VBZ VBG VBN RB RB : JJ NN NNS VBP RB RB JJ as the NN of NN the NN VBZ in them to VB . “ What NNS to VB ? How to VB JJ NN ? ” NNP VBD , RB at the NNP NN . "" In the NN of NNS and NNS , these VBP NNS that we VBP VBN with . "" And RB if we VBP a NN or an JJ NN , one of the JJS NNS from JJ NN NNS might VB that the NN VBZ RB to VB . “ This NN VBZ RB VBG to VB RB . NN , ” the NNP NNP NNP ’s NNP NNP VBD the NNP . “ We VBP RB VB a NN and we VBP RB VB we VBP VBG to VB one … RB we VBP RB VBN to VB to VB with this NN . ” This NN VBZ NN of NNP ’s JJ NN NN : NNP NNP NNP . From NN NN , NN , NNS , NN and JJR , our JJ NNS VBP you on NN of the NNS VBG the NN NN NN NN . VB NNP for a JJ NN ."
83,365,mainstream,M08c05,vaccine.covid,"A_DT source_NN tells_VBZ PEOPLE_NNS of_IN the_DT hosts_NNS '_POS work_NN during_IN the_DT coronavirus_NN pandemic_NN ,_, ""_`` They_PRP ’ve_VBP all_RB been_VBN doing_VBG a_DT great_JJ job_NN keeping_VBG the_DT show_NN going_VBG ._. ""_'' From_IN left_JJ to_IN right_NN :_: '_`` View_NN '_'' co-hosts_NNS Whoopi_NNP Goldberg_NNP and_CC Meghan_NNP McCain_NNP during_IN Monday_NNP 's_POS taping_NN ._. The_DT panel_NN was_VBD discussing_VBG the_DT Democrats_NNPS '_POS latest_JJS $_$ 3_CD trillion_CD COVID_NN -_HYPH 19_CD relief_NN bill_NN proposal_NN ,_, which_WDT passed_VBD in_IN the_DT House_NNP of_IN Representatives_NNPS but_CC is_VBZ expected_VBN to_TO be_VB turned_VBN away_RB in_IN the_DT Republican_JJ -_HYPH controlled_VBN Senate_NNP ._. Some_DT Republican_JJ lawmakers_NNS denounced_VBD the_DT relief_NN bill_NN as_IN a_DT ""_`` liberal_JJ wish_NN list_NN ""_'' last_JJ week_NN —_: a_DT comparison_NN McCain_NNP ,_, 35_CD ,_, repeated_VBD on_IN Monday_NNP before_IN Goldberg_NNP ,_, 64_CD ,_, sent_VBD the_DT show_NN to_IN a_DT commercial_JJ break_NN as_IN McCain_NNP was_VBD still_RB talking_VBG ._. ""_`` How_WRB are_VBP we_PRP going_VBG to_TO tax_VB people_NNS if_IN there_EX 's_VBZ no_DT economy_NN ?_. ""_'' McCain_NNP asked_VBD as_IN Goldberg_NNP told_VBD viewers_NNS the_DT show_NN would_MD be_VB right_RB back_RB and_CC ushered_VBD a_DT commercial_JJ break_NN ._. McCain_NNP is_VBZ the_DT youngest_JJS and_CC only_JJ conservative_JJ voice_NN represented_VBN on_IN The_DT View_NNP 's_POS daily_JJ panel_NN and_CC often_RB clashes_VBZ with_IN her_PRP$ co-hosts_NNS ,_, who_WP largely_RB lean_VBP left_VBN on_IN political_JJ and_CC social_JJ issues_NNS ._. The_DT panels_NNS '_POS latest_JJS argument_NN came_VBD when_WRB co-hosts_NNS Sunny_NNP Hostin_NNP and_CC Joy_NNP Behar_NNP joined_VBD Goldberg_NNP in_IN calling_VBG for_IN the_DT Democrats_NNPS '_POS sweeping_JJ relief_NN bill_NN to_TO pass_VB in_IN the_DT Senate_NNP ,_, with_IN both_CC hosts_NNS drawing_VBG on_RP their_PRP$ own_JJ personal_JJ financial_JJ struggles_NNS in_IN the_DT past_NN in_IN forming_VBG their_PRP$ view_NN on_IN the_DT issue_NN ._. Hostin_NNP and_CC Behar_NNP both_DT said_VBD they_PRP want_VBP to_TO see_VB the_DT federal_JJ government_NN give_VB more_JJR aid_NN to_IN struggling_VBG Americans_NNPS ,_, though_IN Behar_NNP admitted_VBD the_DT $_$ 3_CD trillion_CD that_WDT Democrats_NNPS requested_VBD may_MD be_VB too_RB much_JJ but_CC that_IN Congress_NNP is_VBZ supposed_VBN to_TO negotiate_VB ._. Behar_NNP ,_, 77_CD ,_, argued_VBD the_DT relief_NN bill_NN would_MD help_VB American_JJ workers_NNS and_CC families_NNS who_WP can't_MD go_VB to_IN work_NN and_CC are_VBP relying_VBG on_IN unemployment_NN insurance_NN ._. Hostin_NNP ,_, 51_CD ,_, then_RB escalated_VBD the_DT discussion_NN when_WRB she_PRP suggested_VBD Republican_JJ lawmakers_NNS have_VBP more_JJR cynical_JJ reasons_NNS to_TO turn_VB the_DT relief_NN package_NN away_RB ._. “_`` What_WP this_DT is_VBZ really_RB about_IN is_VBZ the_DT '_`` haves_NNS '_'' not_RB wanting_VBG the_DT '_`` have_VB nots_NNS '_'' to_TO survive_VB this_DT and_CC that_DT is_VBZ really_RB ,_, really_RB serious_JJ ,_, ""_'' Hostin_NNP said_VBD ._. ""_`` We_PRP have_VBP the_DT money_NN ._. We_PRP just_RB do_VBP n't_RB seem_VB to_TO have_VB the_DT money_NN to_TO save_VB these_DT people_NNS ._. This_DT is_VBZ what_WP that_DT 's_VBZ about_IN ._. ""_'' ""_`` That_DT is_VBZ just_RB ridiculous_JJ ,_, ""_'' McCain_NNP said_VBD as_IN Goldberg_NNP tried_VBD to_TO speak_VB at_IN the_DT same_JJ time_NN ._. ""_`` It_PRP 's_VBZ a_DT Democrat_NNP wish_NN list_NN ._. ""_'' ""_`` Hold_VB on_RP ,_, I_PRP just_RB want_VBP to_TO —_: just_RB let_VB me_PRP finish_VB ..._, let_VB me_PRP finish_VB my_PRP$ point_NN ,_, ""_'' Goldberg_NNP interjected_VBD before_IN sending_VBG the_DT show_NN to_IN a_DT commercial_JJ break_NN as_IN McCain_NNP continued_VBD speaking_VBG ._. When_WRB the_DT show_NN came_VBD back_RB ,_, the_DT panel_NN moved_VBD on_RP to_TO talk_VB about_IN the_DT growing_VBG public_JJ feud_NN between_IN President_NNP Donald_NNP Trump_NNP and_CC former_JJ President_NNP Barack_NNP Obama_NNP ,_, who_WP appeared_VBD to_TO criticize_VB Trump_NNP 's_POS handling_NN of_IN the_DT pandemic_NN during_IN his_PRP$ virtual_JJ 2020_CD commencement_NN speech_NN over_IN the_DT weekend_NN ._. The_DT rivalry_NN between_IN the_DT two_CD political_JJ figures_NNS is_VBZ representative_JJ of_IN the_DT broader_JJR partisanship_NN between_IN those_DT in_IN the_DT Republican_JJ and_CC Democratic_JJ political_JJ parties_NNS ,_, including_VBG the_DT hosts_NNS of_IN The_DT View_NNP ._. “_`` I_PRP think_VBP at_IN a_DT certain_JJ point_NN ,_, we_PRP have_VBP to_TO start_VB talking_VBG to_IN each_DT other_JJ in_IN the_DT middle_NN ,_, ""_'' McCain_NNP said_VBD ._. ""_`` We_PRP have_VBP to_TO start_VB talking_VBG about_IN the_DT faults_NNS on_IN both_DT sides_NNS ._. ”_'' As_IN information_NN about_IN the_DT coronavirus_NN pandemic_NN rapidly_RB changes_VBZ ,_, PEOPLE_NNP is_VBZ committed_VBN to_IN providing_VBG the_DT most_RBS recent_JJ data_NNS in_IN our_PRP$ coverage_NN ._. Some_DT of_IN the_DT information_NN in_IN this_DT story_NN may_MD have_VB changed_VBN after_IN publication_NN ._. For_IN the_DT latest_JJS on_IN COVID_NNP -_SYM 19_CD ,_, readers_NNS are_VBP encouraged_VBN to_TO use_VB online_JJ resources_NNS from_IN CDC_NNP ,_, WHO_NNP ,_, and_CC local_JJ public_JJ health_NN departments_NNS ._. PEOPLE_NNP has_VBZ partnered_VBN with_IN GoFundMe_NNP to_TO raise_VB money_NN for_IN the_DT COVID_NNP -_HYPH 19_CD Relief_NN Fund_NN ,_, a_DT GoFundMe.org_NNP fundraiser_NN to_TO support_VB everything_NN from_IN frontline_NN responders_NNS to_IN families_NNS in_IN need_NN ,_, as_RB well_RB as_IN organizations_NNS helping_VBG communities_NNS ._. For_IN more_JJR information_NN or_CC to_TO donate_VB ,_, click_VB here_RB ._.","A NN VBZ NNS of the NNS ' NN during the NN NN , "" They VBP RB VBN VBG a JJ NN VBG the NN VBG . "" From JJ to NN : ' NN ' NNS NNP NNP and NNP NNP during NNP 's NN . The NN VBD VBG the NNPS ' JJS $ 3 trillion NN - 19 NN NN NN , which VBD in the NNP of NNPS but VBZ VBN to VB VBN RB in the JJ - VBN NNP . Some JJ NNS VBD the NN NN as a "" JJ NN NN "" JJ NN — a NN NNP , 35 , VBD on NNP before NNP , 64 , VBD the NN to a JJ NN as NNP VBD RB VBG . "" How VBP we VBG to VB NNS if there VBZ no NN ? "" NNP VBD as NNP VBD NNS the NN would VB RB RB and VBD a JJ NN . NNP VBZ the JJS and JJ JJ NN VBN on The NNP 's JJ NN and RB VBZ with her NNS , who RB VBP VBN on JJ and JJ NNS . The NNS ' JJS NN VBD when NNS NNP NNP and NNP NNP VBD NNP in VBG for the NNPS ' JJ NN NN to VB in the NNP , with both NNS VBG on their JJ JJ JJ NNS in the NN in VBG their NN on the NN . NNP and NNP both VBD they VBP to VB the JJ NN VB JJR NN to VBG NNPS , though NNP VBD the $ 3 trillion that NNPS VBD may VB RB JJ but that NNP VBZ VBN to VB . NNP , 77 , VBD the NN NN would VB JJ NNS and NNS who can't VB to NN and VBP VBG on NN NN . NNP , 51 , RB VBD the NN when she VBD JJ NNS VBP JJR JJ NNS to VB the NN NN RB . “ What this VBZ RB about VBZ the ' NNS ' RB VBG the ' VB NNS ' to VB this and that VBZ RB , RB JJ , "" NNP VBD . "" We VBP the NN . We RB VBP RB VB to VB the NN to VB these NNS . This VBZ what that VBZ about . "" "" That VBZ RB JJ , "" NNP VBD as NNP VBD to VB at the JJ NN . "" It VBZ a NNP NN NN . "" "" VB on , I RB VBP to — RB VB me VB ... VB me VB my NN , "" NNP VBD before VBG the NN to a JJ NN as NNP VBD VBG . When the NN VBD RB , the NN VBD on to VB about the VBG JJ NN between NNP NNP NNP and JJ NNP NNP NNP , who VBD to VB NNP 's NN of the NN during his JJ 2020 NN NN over the NN . The NN between the two JJ NNS VBZ JJ of the JJR NN between those in the JJ and JJ JJ NNS , VBG the NNS of The NNP . “ I VBP at a JJ NN , we VBP to VB VBG to each JJ in the NN , "" NNP VBD . "" We VBP to VB VBG about the NNS on both NNS . ” As NN about the NN NN RB VBZ , NNP VBZ VBN to VBG the RBS JJ NNS in our NN . Some of the NN in this NN may VB VBN after NN . For the JJS on NNP - 19 , NNS VBP VBN to VB JJ NNS from NNP , NNP , and JJ JJ NN NNS . NNP VBZ VBN with NNP to VB NN for the NNP - 19 NN NN , a NNP NN to VB NN from NN NNS to NNS in NN , RB RB as NNS VBG NNS . For JJR NN or to VB , VB RB ."
84,1099,mainstream,M0af6b,vaccine,"The_DT British_JJ biotechnology_NN company_NN Microscience_NNP has_VBZ announced_VBN successful_JJ trials_NNS of_IN a_DT new_JJ oral_JJ vaccine_NN against_IN enterotoxigenic_JJ E_NNP coli_NN (_-LRB- ETEC_NNP )_-RRB- -_, the_DT most_RBS significant_JJ cause_NN of_IN travellers_NNS '_POS diarrhoea_NN ._. The_DT vaccine_NN produced_VBD protective_JJ immunity_NN in_IN 70_CD per_NN cent_NN of_IN volunteers_NNS who_WP took_VBD part_NN in_IN a_DT study_NN conducted_VBN at_IN St_NNP George_NNP 's_POS Hospital_NNP ,_, London_NNP ._. More_JJR research_NN is_VBZ needed_VBN to_TO establish_VB the_DT best_JJS dosing_NN regime_NN and_CC the_DT optimum_JJ vaccination_NN schedule_NN ,_, and_CC it_PRP is_VBZ likely_JJ to_TO take_VB years_NNS for_IN the_DT product_NN to_TO become_VB available_JJ commercially_RB ._. However_RB ,_, the_DT drug_NN uses_VBZ innovative_JJ technology_NN that_WDT could_MD herald_VB a_DT new_JJ generation_NN of_IN needle_NN -_HYPH less_JJR vaccines_NNS :_: Microscience_NN is_VBZ now_RB working_VBG on_IN oral_JJ prophylactics_NNS against_IN typhoid_NN ,_, hepatitis_NN B_NN and_CC even_RB anthrax_NN ._. Another_DT oral_JJ vaccine_NN against_IN ETEC_NNP could_MD be_VB licensed_VBN in_IN Britain_NNP in_IN a_DT matter_NN of_IN weeks_NNS ._. Dukoral_NNP is_VBZ already_RB available_JJ in_IN several_JJ countries_NNS ,_, including_VBG Switzerland_NNP and_CC Sweden_NNP ._. ETEC_NNP bacteria_NN and_CC cholera_NN produce_VBP similar_JJ toxins_NNS which_WDT trigger_VBP the_DT outpouring_NN of_IN fluid_NN into_IN the_DT intestine_NN that_WDT is_VBZ characteristic_JJ of_IN severe_JJ diarrhoea_NN ._. Because_IN Dukoral_NNP gives_VBZ protection_NN against_IN this_DT toxin_NN ,_, it_PRP has_VBZ been_VBN licensed_VBN in_IN some_DT countries_NNS as_IN a_DT vaccine_NN for_IN both_CC cholera_NN and_CC ETEC_NNP diarrhoea_NN ._. It_PRP has_VBZ not_RB yet_RB been_VBN announced_VBN whether_IN Dukoral_NNP will_MD be_VB licensed_VBN for_IN both_CC when_WRB it_PRP is_VBZ launched_VBN in_IN Britain_NNP ._. The_DT old_JJ injection_NN against_IN cholera_NN has_VBZ not_RB been_VBN available_JJ for_IN years_NNS -_, and_CC it_PRP gave_VBD negligible_JJ protection_NN ._. Advances_NNS in_IN medicine_NN have_VBP made_VBN cholera_NN a_DT much_RB less_RBR fearsome_JJ disease_NN ,_, but_CC a_DT new_JJ vaccine_NN will_MD be_VB welcome_JJ ,_, especially_RB among_IN intrepid_JJ travellers_NNS and_CC those_DT living_VBG and_CC working_VBG in_IN the_DT developing_VBG world_NN ._. Travellers_NNS '_POS diarrhoea_NN is_VBZ a_DT more_RBR widespread_JJ problem_NN ,_, afflicting_VBG at_IN least_JJS two_CD -_HYPH fifths_NNS of_IN all_DT international_JJ travellers_NNS ._. Although_IN ETEC_NNP is_VBZ the_DT most_RBS common_JJ cause_NN ,_, it_PRP typically_RB accounts_VBZ for_IN only_RB about_RB two_CD -_HYPH fifths_NNS of_IN cases_NNS ._. The_DT rest_NN are_VBP caused_VBN by_IN a_DT vast_JJ range_NN of_IN bacteria_NN ,_, viruses_NNS and_CC parasites_NNS -_, and_CC there_EX is_VBZ no_DT prospect_NN of_IN developing_VBG an_DT effective_JJ vaccine_NN against_IN all_DT of_IN them_PRP ._. •_NFP Dr_NNP Dawood_NNP is_VBZ a_DT specialist_NN in_IN travel_NN medicine_NN at_IN the_DT Fleet_NNP Street_NNP Clinic_NNP ,_, London_NNP (_-LRB- 020_CD 7353_CD 5678_CD )_-RRB- ._.","The JJ NN NN NNP VBZ VBN JJ NNS of a JJ JJ NN against JJ NNP NN ( NNP ) - the RBS JJ NN of NNS ' NN . The NN VBD JJ NN in 70 NN NN of NNS who VBD NN in a NN VBN at NNP NNP 's NNP , NNP . JJR NN VBZ VBN to VB the JJS NN NN and the JJ NN NN , and it VBZ JJ to VB NNS for the NN to VB JJ RB . RB , the NN VBZ JJ NN that could VB a JJ NN of NN - JJR NNS : NN VBZ RB VBG on JJ NNS against NN , NN NN and RB NN . Another JJ NN against NNP could VB VBN in NNP in a NN of NNS . NNP VBZ RB JJ in JJ NNS , VBG NNP and NNP . NNP NN and NN VBP JJ NNS which VBP the NN of NN into the NN that VBZ JJ of JJ NN . Because NNP VBZ NN against this NN , it VBZ VBN VBN in some NNS as a NN for both NN and NNP NN . It VBZ RB RB VBN VBN whether NNP will VB VBN for both when it VBZ VBN in NNP . The JJ NN against NN VBZ RB VBN JJ for NNS - and it VBD JJ NN . NNS in NN VBP VBN NN a RB RBR JJ NN , but a JJ NN will VB JJ , RB among JJ NNS and those VBG and VBG in the VBG NN . NNS ' NN VBZ a RBR JJ NN , VBG at JJS two - NNS of all JJ NNS . Although NNP VBZ the RBS JJ NN , it RB VBZ for RB RB two - NNS of NNS . The NN VBP VBN by a JJ NN of NN , NNS and NNS - and there VBZ no NN of VBG an JJ NN against all of them . • NNP NNP VBZ a NN in NN NN at the NNP NNP NNP , NNP ( 020 7353 5678 ) ."
85,1068,mainstream,M090b8,vaccine; vaccine.covid,"Early_JJ morning_NN on_IN May_NNP 18_CD ,_, Moderna_NNP ,_, a_DT biotechnology_NN company_NN ,_, revealed_VBD the_DT preliminary_JJ findings_NNS for_IN the_DT much_RB anticipated_VBN phase_NN I_CD trial_NN of_IN an_DT mRNA_NN COVID_NN -_HYPH 19_CD vaccine_NN ._. The_DT information_NN sent_VBD Moderna_NNP ’s_POS stock_NN soaring_VBG by_IN more_JJR than_IN 20_CD %_NN and_CC helped_VBD fuel_VB a_DT rally_NN on_IN Wall_NNP Street_NNP ._. Although_IN there_EX was_VBD an_DT enthusiastic_JJ response_NN to_IN the_DT news_NN ,_, the_DT purpose_NN of_IN all_DT phase_NN I_PRP trials_NNS is_VBZ primarily_RB to_TO demonstrate_VB safety_NN and_CC tolerability_NN ._. While_IN the_DT early_JJ results_NNS are_VBP tantalizingly_RB positive_JJ ,_, what_WP Moderna_NNP has_VBZ not_RB revealed_VBN is_VBZ raising_VBG some_DT doubts_NNS ._. I_PRP am_VBP a_DT data_NN scientist_NN and_CC was_VBD ,_, until_IN last_JJ month_NN ,_, working_VBG on_IN vaccine_NN development_NN for_IN Zika_NNP and_CC dengue_NN fever_NN ._. Since_IN the_DT beginning_NN of_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, I_PRP have_VBP spearheaded_VBN building_VBG a_DT consortium_NN of_IN more_JJR than_IN 100_CD cancer_NN centers_NNS to_TO collect_VB data_NNS about_IN cancer_NN patients_NNS who_WP have_VBP been_VBN infected_VBN with_IN COVID_NN -_HYPH 19_CD ._. The_DT purpose_NN of_IN the_DT COVID_NNP -_HYPH 19_CD and_CC Cancer_NNP Consortium_NNP is_VBZ to_TO rapidly_RB collect_VB and_CC disseminate_VB information_NN about_IN this_DT especially_RB vulnerable_JJ population_NN ._. Having_VBG a_DT background_NN in_IN vaccine_NN development_NN ,_, I_PRP found_VBD Moderna_NNP ’s_POS press_NN release_NN lacking_VBG some_DT key_JJ details_NNS ._. A_DT vaccine_NN imitates_VBZ the_DT infection_NN to_TO give_VB the_DT immune_JJ system_NN a_DT preview_NN of_IN the_DT disease_NN ._. Vaccination_NN became_VBD a_DT public_JJ health_NN tool_NN after_IN Edward_NNP Jenner_NNP showed_VBD in_IN 1796_CD that_IN inoculation_NN with_IN the_DT less_RBR virulent_JJ cowpox_NN could_MD prevent_VB smallpox_NN ._. After_IN his_PRP$ son_NN ’s_POS death_NN from_IN smallpox_NN ,_, Benjamin_NNP Franklin_NNP regretted_VBD his_PRP$ decision_NN not_RB to_TO inoculate_VB his_PRP$ son_NN against_IN it_PRP ._. Today_NN vaccines_NNS are_VBP widely_RB credited_VBN for_IN the_DT prevention_NN and_CC eradication_NN of_IN many_JJ of_IN once_RB feared_VBD deadly_JJ diseases_NNS ._. Vaccines_NNS prepare_VBP the_DT immune_NN system_NN by_IN generating_VBG disease_NN -_HYPH fighting_VBG proteins_NNS called_VBN antibodies_NNS ,_, which_WDT seek_VBP out_RP and_CC attack_VBP if_IN the_DT real_JJ infectious_JJ virus_NN ever_RB shows_VBZ up_RP ._. Traditional_JJ vaccines_NNS against_IN viruses_NNS are_VBP either_CC weakened_VBN versions_NNS of_IN the_DT whole_JJ virus_NN that_WDT are_VBP unable_JJ to_TO cause_VB disease_NN ;_, or_CC they_PRP are_VBP made_VBN from_IN signature_NN viral_JJ proteins_NNS called_VBN antigens_NNS ,_, that_WDT then_RB spark_VB an_DT immune_JJ response_NN ._. An_DT antigen_NN in_IN the_DT new_JJ coronavirus_NN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ the_DT crown_NN -_HYPH like_JJ spike_NN (_-LRB- S_NN )_-RRB- protein_NN through_IN which_WDT the_DT virus_NN latches_VBZ to_IN the_DT lung_NN and_CC respiratory_JJ cells_NNS ._. However_RB ,_, developing_VBG vaccines_NNS based_VBN on_IN the_DT viral_JJ proteins_NNS is_VBZ a_DT slow_JJ process_NN because_IN of_IN the_DT difficulties_NNS in_IN producing_VBG pure_JJ proteins_NNS at_IN medical_JJ standards_NNS in_IN large_JJ quantities_NNS ._. But_CC now_RB scientists_NNS have_VBP developed_VBN a_DT different_JJ type_NN of_IN vaccine_NN :_: mRNA_NN vaccines_NNS ._. Rather_RB than_IN giving_VBG a_DT person_NN a_DT protein_NN vaccine_NN ,_, researchers_NNS are_VBP giving_VBG them_PRP mRNA_NN ,_, which_WDT is_VBZ the_DT biological_JJ code_NN that_WDT the_DT cells_NNS read_VBP and_CC translate_VBP to_TO make_VB their_PRP$ own_JJ proteins_NNS ._. So_RB ,_, instead_RB of_IN the_DT traditional_JJ viral_JJ protein_NN vaccines_NNS ,_, an_DT mRNA_NN vaccine_NN provides_VBZ a_DT synthetic_JJ copy_NN of_IN mRNA_NN -_HYPH encoding_VBG individual_JJ proteins_NNS from_IN the_DT virus_NN ,_, which_WDT the_DT host_NN body_NN uses_VBZ to_TO produce_VB the_DT viral_JJ protein_NN itself_PRP ._. As_IN with_IN other_JJ vaccines_NNS ,_, the_DT presence_NN of_IN the_DT protein_NN kicks_VBZ off_RP the_DT body_NN ’s_POS immune_NN system_NN to_TO fight_VB the_DT virus_NN ._. A_DT big_JJ advantage_NN of_IN mRNA_NN vaccines_NNS is_VBZ that_IN scientists_NNS can_MD skip_VB the_DT laboratory_NN production_NN of_IN proteins_NNS by_IN directly_RB injecting_VBG the_DT molecular_JJ instructions_NNS to_TO make_VB the_DT protein_NN into_IN the_DT human_JJ body_NN itself_PRP ._. Massachusetts_NNP -_HYPH based_VBN Moderna_NNP Inc._NNP has_VBZ fast_RB -_HYPH tracked_VBN development_NN and_CC testing_NN of_IN an_DT experimental_JJ COVID_NN -_HYPH 19_CD mRNA_NN vaccine_NN called_VBN mRNA_NN -_SYM 1273_CD ._. Its_PRP$ collaborators_NNS at_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS (_-LRB- NIAID_NNP )_-RRB- were_VBD already_RB working_VBG on_IN experimental_JJ Middle_NNP East_NNP respiratory_JJ syndrome_NN (_-LRB- MERS_NNP )_-RRB- vaccines_NNS ,_, which_WDT targeted_VBD a_DT closely_RB related_JJ coronavirus_NN spike_NN protein_NN ._. So_RB as_RB soon_RB as_IN the_DT genetic_JJ sequence_NN of_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD became_VBD available_JJ ,_, Moderna_NNP and_CC its_PRP$ collaborators_NNS at_IN NIAID_NNP got_VBD a_DT head_NN start_NN ._. With_IN up_IN to_IN US_NNP $_$ 483_CD million_CD in_IN federal_JJ funds_NNS to_TO speed_VB development_NN of_IN a_DT coronavirus_NN vaccine_NN ,_, Moderna_NNP began_VBD testing_VBG the_DT 2019_CD -_HYPH nCoV_NNP vaccine_NN (_-LRB- mRNA_NNP -_SYM 1273_CD )_-RRB- on_IN Feb._NNP 25_CD ,_, 2020_CD ._. The_DT phase_NN 1_CD study_NN of_IN the_DT investigational_JJ vaccine_NN ,_, led_VBN by_IN the_DT NIAID_NNP ,_, part_NN of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP (_-LRB- NIH_NNP )_-RRB- ,_, was_VBD designed_VBN to_TO assess_VB the_DT safety_NN ,_, tolerability_NN and_CC ability_NN to_TO induce_VB an_DT immune_JJ response_NN at_IN three_CD dose_NN levels_NNS –_SYM 25_CD ,_, 100_CD or_CC 250_CD micrograms_NNS ._. On_IN May_NNP 18_CD ,_, Moderna_NNP announced_VBD the_DT interim_JJ phase_NN 1_CD data_NNS ._. mRNA_NNP -1273_CD was_VBD generally_RB safe_JJ and_CC well_RB tolerated_VBN ,_, except_IN for_IN minor_JJ redness_NN and_CC swelling_NN at_IN higher_JJR doses_NNS ._. No_DT volunteers_NNS faced_VBD any_DT life_NN -_HYPH threatening_VBG events_NNS during_IN the_DT six_CD weeks_NNS of_IN study_NN ._. The_DT mRNA_NNP -_HYPH 1273_CD produced_VBD antibodies_NNS which_WDT could_MD bind_VB the_DT target_NN spike_NN protein_NN at_IN each_DT of_IN the_DT injected_VBN doses_NNS ,_, in_IN all_DT 45_CD volunteers_NNS (_-LRB- ages_NNS 18_CD to_IN 55_CD )_-RRB- ._. The_DT production_NN of_IN the_DT binding_VBG antibodies_NNS response_NN from_IN mRNA_NN -_HYPH 1273_CD injection_NN was_VBD similar_JJ to_IN the_DT one_NN found_VBN in_IN patients_NNS who_WP have_VBP recovered_VBN from_IN previous_JJ SARS_NN -_HYPH CoV_NN -_HYPH 2_CD infection_NN ._. It_PRP is_VBZ important_JJ to_TO highlight_VB ,_, though_RB ,_, that_IN even_RB among_IN the_DT survivors_NNS of_IN COVID_NNP -_HYPH 19_CD ,_, the_DT antibody_NN response_NN is_VBZ highly_RB variable_JJ ._. What_WP has_VBZ not_RB been_VBN revealed_VBN Unconventional_JJ for_IN a_DT scientific_JJ study_NN ,_, data_NNS was_VBD given_VBN from_IN only_RB eight_CD of_IN the_DT 45_CD volunteers_NNS —_: four_CD each_DT from_IN the_DT 25_CD and_CC 100_CD microgram_NN doses_NNS ,_, who_WP developed_VBD neutralizing_VBG antibodies_NNS ._. Neutralizing_VBG antibodies_NNS are_VBP essential_JJ for_IN an_DT effective_JJ long_JJ -_HYPH lasting_VBG vaccine_NN because_IN they_PRP not_RB only_RB bind_VBP to_IN the_DT virus_NN ,_, but_CC they_PRP block_VBP an_DT infection_NN ._. The_DT age_NN of_IN the_DT eight_CD volunteers_NNS is_VBZ not_RB known_VBN ._. That_DT is_VBZ important_JJ information_NN because_IN COVID_NNP -_HYPH 19_CD is_VBZ far_RB more_RBR deadly_JJ for_IN older_JJR patients_NNS ._. It_PRP ’s_VBZ important_JJ to_TO know_VB if_IN this_DT immune_NN response_NN was_VBD limited_VBN to_IN the_DT younger_JJR participants_NNS ._. Also_RB ,_, the_DT neutralizing_VBG antibody_NN response_NN in_IN the_DT remaining_VBG 37_CD volunteers_NNS was_VBD not_RB disclosed_VBN ._. So_RB it_PRP is_VBZ impossible_JJ to_TO know_VB whether_IN the_DT mRNA_NNP -_HYPH 1273_CD was_VBD ineffective_JJ in_IN them_PRP ,_, or_CC whether_IN the_DT results_NNS were_VBD not_RB available_JJ at_IN this_DT point_NN ._. The_DT phase_NN 2_CD trial_NN for_IN mRNA_NN -_HYPH 1273_CD has_VBZ already_RB been_VBN approved_VBN by_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP ._. In_IN this_DT trial_NN each_DT subject_NN will_MD receive_VB two_CD vaccinations_NNS –_: prime_JJ and_CC booster_NN –_: of_IN either_CC a_DT placebo_NN ,_, a_DT 50_CD microgram_NN ,_, or_CC a_DT 250_CD microgram_NN dose_NN given_VBN 28_CD days_NNS apart_RB ._. The_DT amended_VBN choice_NN for_IN a_DT higher_JJR dose_NN suggests_VBZ that_IN the_DT lowest_JJS 25_CD microgram_NN dose_NN of_IN phase_NN 1_CD was_VBD not_RB very_RB effective_JJ ._. Moderna_NNP expects_VBZ phase_NN 3_CD trial_NN to_TO start_VB in_IN July_NNP and_CC anticipates_VBZ to_TO produce_VB 1_CD billion_CD doses_NNS of_IN the_DT vaccine_NN soon_RB thereafter_RB ._. [_-LRB- Get_VB facts_NNS about_IN coronavirus_NN and_CC the_DT latest_JJS research_NN ._. Sign_VB up_RP for_IN The_DT Conversation_NNP ’s_POS newsletter_NN ._. ]_-RRB-","JJ NN on NNP 18 , NNP , a NN NN , VBD the JJ NNS for the RB VBN NN I NN of an NN NN - 19 NN . The NN VBD NNP ’s NN VBG by JJR than 20 NN and VBD VB a NN on NNP NNP . Although there VBD an JJ NN to the NN , the NN of all NN I NNS VBZ RB to VB NN and NN . While the JJ NNS VBP RB JJ , what NNP VBZ RB VBN VBZ VBG some NNS . I VBP a NN NN and VBD , until JJ NN , VBG on NN NN for NNP and NN NN . Since the NN of the NN - 19 NN , I VBP VBN VBG a NN of JJR than 100 NN NNS to VB NNS about NN NNS who VBP VBN VBN with NN - 19 . The NN of the NNP - 19 and NNP NNP VBZ to RB VB and VB NN about this RB JJ NN . VBG a NN in NN NN , I VBD NNP ’s NN NN VBG some JJ NNS . A NN VBZ the NN to VB the JJ NN a NN of the NN . NN VBD a JJ NN NN after NNP NNP VBD in 1796 that NN with the RBR JJ NN could VB NN . After his NN ’s NN from NN , NNP NNP VBD his NN RB to VB his NN against it . NN NNS VBP RB VBN for the NN and NN of JJ of RB VBD JJ NNS . NNS VBP the NN NN by VBG NN - VBG NNS VBN NNS , which VBP out and VBP if the JJ JJ NN RB VBZ up . JJ NNS against NNS VBP either VBN NNS of the JJ NN that VBP JJ to VB NN ; or they VBP VBN from NN JJ NNS VBN NNS , that RB VB an JJ NN . An NN in the JJ NN NNP - NNP - 2 VBZ the NN - JJ NN ( NN ) NN through which the NN VBZ to the NN and JJ NNS . RB , VBG NNS VBN on the JJ NNS VBZ a JJ NN because of the NNS in VBG JJ NNS at JJ NNS in JJ NNS . But RB NNS VBP VBN a JJ NN of NN : NN NNS . RB than VBG a NN a NN NN , NNS VBP VBG them NN , which VBZ the JJ NN that the NNS VBP and VBP to VB their JJ NNS . RB , RB of the JJ JJ NN NNS , an NN NN VBZ a JJ NN of NN - VBG JJ NNS from the NN , which the NN NN VBZ to VB the JJ NN itself . As with JJ NNS , the NN of the NN VBZ off the NN ’s NN NN to VB the NN . A JJ NN of NN NNS VBZ that NNS can VB the NN NN of NNS by RB VBG the JJ NNS to VB the NN into the JJ NN itself . NNP - VBN NNP NNP VBZ RB - VBN NN and NN of an JJ NN - 19 NN NN VBN NN - 1273 . Its NNS at the NNP NNP of NNP and NNP NNPS ( NNP ) VBD RB VBG on JJ NNP NNP JJ NN ( NNP ) NNS , which VBD a RB JJ NN NN NN . RB RB RB as the JJ NN of NNP - NNP - 2 VBD JJ , NNP and its NNS at NNP VBD a NN NN . With up to NNP $ 483 million in JJ NNS to VB NN of a NN NN , NNP VBD VBG the 2019 - NNP NN ( NNP - 1273 ) on NNP 25 , 2020 . The NN 1 NN of the JJ NN , VBN by the NNP , NN of the NNP NNPS of NNP ( NNP ) , VBD VBN to VB the NN , NN and NN to VB an JJ NN at three NN NNS – 25 , 100 or 250 NNS . On NNP 18 , NNP VBD the JJ NN 1 NNS . NNP -1273 VBD RB JJ and RB VBN , except for JJ NN and NN at JJR NNS . No NNS VBD any NN - VBG NNS during the six NNS of NN . The NNP - 1273 VBD NNS which could VB the NN NN NN at each of the VBN NNS , in all 45 NNS ( NNS 18 to 55 ) . The NN of the VBG NNS NN from NN - 1273 NN VBD JJ to the NN VBN in NNS who VBP VBN from JJ NN - NN - 2 NN . It VBZ JJ to VB , RB , that RB among the NNS of NNP - 19 , the NN NN VBZ RB JJ . What VBZ RB VBN VBN JJ for a JJ NN , NNS VBD VBN from RB eight of the 45 NNS — four each from the 25 and 100 NN NNS , who VBD VBG NNS . VBG NNS VBP JJ for an JJ JJ - VBG NN because they RB RB VBP to the NN , but they VBP an NN . The NN of the eight NNS VBZ RB VBN . That VBZ JJ NN because NNP - 19 VBZ RB RBR JJ for JJR NNS . It VBZ JJ to VB if this NN NN VBD VBN to the JJR NNS . RB , the VBG NN NN in the VBG 37 NNS VBD RB VBN . RB it VBZ JJ to VB whether the NNP - 1273 VBD JJ in them , or whether the NNS VBD RB JJ at this NN . The NN 2 NN for NN - 1273 VBZ RB VBN VBN by the NNP and NNP NNP . In this NN each NN will VB two NNS – JJ and NN – of either a NN , a 50 NN , or a 250 NN NN VBN 28 NNS RB . The VBN NN for a JJR NN VBZ that the JJS 25 NN NN of NN 1 VBD RB RB JJ . NNP VBZ NN 3 NN to VB in NNP and VBZ to VB 1 billion NNS of the NN RB RB . [ VB NNS about NN and the JJS NN . VB up for The NNP ’s NN . ]"
86,894,conspiracy,C0116d,vaccine.autism,"Mainstream_JJ doctors_NNS and_CC media_NN pundits_NNS are_VBP notorious_JJ for_IN claiming_VBG that_IN the_DT vaccine_NN -_HYPH autism_NN debate_NN is_VBZ over_JJ and_CC that_IN no_DT legitimate_JJ scientific_JJ evidence_NN exists_VBZ to_TO suggest_VB even_RB a_DT possible_JJ link_NN between_IN vaccinations_NNS and_CC autism_NN spectrum_NN disorders_NNS (_-LRB- ASD_NNP )_-RRB- :_: case_NN closed_VBN ._. But_CC a_DT thoroughly_RB -_HYPH researched_VBN report_NN recently_RB published_VBN by_IN Arjun_NNP Walia_NNP over_IN at_IN Activist_NNP Post_NNP reveals_VBZ that_IN there_EX are_VBP at_IN least_JJS 22_CD published_VBN scientific_JJ studies_NNS that_WDT show_VBP a_DT link_NN between_IN vaccines_NNS and_CC autism_NN and_CC that_IN there_EX are_VBP many_JJ more_JJR out_RB there_RB with_IN similar_JJ findings_NNS ._. Much_JJ of_IN the_DT original_JJ controversy_NN stems_VBZ from_IN Dr._NNP Andrew_NNP Wakefield_NNP ’s_POS study_NN back_RB in_IN the_DT late_JJ 1990s_NNS ,_, which_WDT exposed_VBD gastrointestinal_JJ inflammation_NN as_IN an_DT obvious_JJ side_NN effect_NN of_IN vaccination_NN with_IN the_DT combination_NN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NN )_-RRB- vaccine_NN ._. Dr._NNP Wakefield_NNP obviously_RB struck_VBD a_DT major_JJ nerve_NN with_IN his_PRP$ research_NN ,_, which_WDT was_VBD quickly_RB torn_VBN apart_RB by_IN the_DT establishment_NN and_CC maliciously_RB paraded_VBN around_RB as_IN being_VBG fraudulent_JJ ,_, even_RB though_IN his_PRP$ groundbreaking_JJ findings_NNS have_VBP repeatedly_RB been_VBN validated_VBN and_CC replicated_VBN by_IN many_JJ other_JJ studies_NNS ._. A_DT 2002_CD study_NN published_VBN in_IN the_DT Journal_NNP of_IN Biomedical_NNP Sciences_NNPS ,_, for_IN instance_NN ,_, observed_VBD a_DT causal_JJ effect_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ,_, particularly_RB with_IN regards_NNS to_IN the_DT measles_NNS portion_NN of_IN the_DT vaccine_NN ._. The_DT researchers_NNS from_IN Utah_NNP State_NNP University_NNP concluded_VBD that_IN MMR_NNP is_VBZ capable_JJ of_IN inducing_VBG an_DT abnormal_JJ measles_NN infection_NN in_IN some_DT children_NNS ,_, which_WDT in_IN turn_NN can_MD lead_VB to_IN neurological_JJ problems_NNS that_WDT fall_VBP under_IN the_DT umbrella_NN of_IN ASD_NN ._. Another_DT study_NN published_VBN in_IN the_DT journal_NN Entropy_NNP in_IN 2012_CD observed_VBD a_DT strong_JJ correlation_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ,_, except_IN in_IN this_DT case_NN aluminum_NN was_VBD the_DT culprit_NN ._. According_VBG to_IN an_DT abstract_NN of_IN this_DT study_NN ,_, vaccines_NNS that_WDT contain_VBP aluminum_NN are_VBP particularly_RB toxic_JJ to_IN children_NNS ,_, who_WP end_VBP up_RP later_RBR being_VBG diagnosed_VBN with_IN ASD_NN ,_, as_IN they_PRP have_VBP insufficient_JJ serum_NN levels_NNS of_IN both_CC sulfate_NN and_CC glutathione_NN ._. The_DT aluminum_NN found_VBN in_IN some_DT vaccines_NNS ,_, in_IN other_JJ words_NNS ,_, appears_VBZ to_TO be_VB a_DT primary_JJ aggravator_NN of_IN ASD_NN symptoms_NNS ._. “_`` Regardless_RB of_IN the_DT MMR_NN vaccine_NN and_CC autism_NN debate_NN ,_, there_EX are_VBP still_RB a_DT number_NN of_IN studies_NNS that_WDT link_VBP vaccines_NNS to_IN a_DT possible_JJ autism_NN connection_NN ,_, ”_'' writes_VBZ Walia_NNP ._. “_`` [_-LRB- M]ultiple_NNP courts_NNS worldwide_RB have_VBP ruled_VBN in_IN favor_NN of_IN vaccines_NNS causing_VBG autism_NN ,_, brain_NN damage_NN and_CC other_JJ complications_NNS that_WDT include_VBP the_DT MMR_NN vaccine_NN ,_, ”_'' he_PRP adds_VBZ ,_, noting_VBG that_IN many_JJ other_JJ side_NN effects_NNS besides_IN autism_NN have_VBP been_VBN observed_VBN in_IN relation_NN to_IN vaccines_NNS ._. Heavy_JJ metals_NNS ,_, adjuvants_NNS ,_, preservatives_NNS and_CC other_JJ vaccine_NN additives_NNS all_RB linked_VBN to_IN causing_VBG autism_NN Perhaps_RB the_DT most_RBS interesting_JJ aspect_NN of_IN Walia_NNP ’s_POS extensive_JJ research_NN on_IN the_DT subject_NN is_VBZ the_DT fact_NN that_IN there_EX appear_VBP to_TO be_VB multiple_JJ ingredients_NNS in_IN vaccines_NNS responsible_JJ for_IN triggering_VBG autism_NN ._. Besides_IN toxic_JJ metals_NNS like_IN aluminum_NN and_CC mercury_NN ,_, vaccines_NNS also_RB contain_VBP adjuvant_NN materials_NNS ,_, preservatives_NNS and_CC other_JJ additives_NNS that_WDT have_VBP all_RB been_VBN identified_VBN as_IN culprits_NNS in_IN the_DT studies_NNS listed_VBN in_IN his_PRP$ article_NN ._. Realistically_RB ,_, each_DT of_IN these_DT additives_NNS is_VBZ most_RBS likely_RB toxic_JJ both_CC in_IN isolation_NN and_CC in_IN combination_NN with_IN the_DT other_JJ additives_NNS ,_, eliciting_VBG compounded_VBN toxicity_NN depending_VBG on_IN the_DT mixture_NN ._. “_`` Oxidative_NN stress_NN ,_, brain_NN inflammation_NN and_CC microgliosis_NN have_VBP been_VBN much_RB documented_VBN in_IN association_NN with_IN toxic_JJ exposures_NNS including_VBG various_JJ heavy_JJ metals_NNS ,_, ”_'' admits_VBZ one_CD study_NN out_IN of_IN Massachusetts_NNP General_NNP Hospital_NNP ,_, which_WDT verified_VBD that_IN autistic_JJ individuals_NNS possess_VBP a_DT unique_JJ type_NN of_IN neuroinflammation_NN in_IN their_PRP$ brain_NN tissue_NN that_WDT points_VBZ to_IN vaccine_NN damage_NN ._. Several_JJ of_IN the_DT studies_NNS listed_VBN in_IN Walia_NNP ’s_POS report_NN also_RB pin_VB thimerosal_NN ,_, a_DT toxic_JJ mercury_NN derivative_NN that_WDT is_VBZ still_RB being_VBG added_VBN to_IN multidose_JJ vials_NNS of_IN flu_NN vaccine_NN ,_, as_IN a_DT trigger_NN in_IN causing_VBG the_DT types_NNS of_IN brain_NN damage_NN linked_VBN to_IN autism_NN ._. One_CD particular_JJ study_NN out_IN of_IN the_DT University_NNP of_IN Texas_NNP Health_NNP Science_NNP Center_NNP found_VBD that_IN for_IN every_DT 1,000_CD pounds_NNS of_IN mercury_NN released_VBN into_IN the_DT environment_NN ,_, there_EX is_VBZ a_DT consequential_JJ 61_CD percent_NN increase_NN in_IN autism_NN rates_NNS ._. With_IN thimerosal_NN -_HYPH containing_VBG flu_NN shots_NNS now_RB being_VBG administered_VBN to_IN children_NNS as_RB young_JJ as_IN six_CD months_NNS old_JJ ,_, it_PRP is_VBZ highly_RB plausible_JJ that_IN ASD_NN -_HYPH associated_VBN brain_NN damage_NN is_VBZ still_RB occurring_VBG as_IN a_DT result_NN of_IN mercury_NN being_VBG injected_VBN directly_RB into_IN muscle_NN tissue_NN ._. Be_VB sure_JJ to_TO read_VB Walia_NNP ’s_POS full_JJ report_NN ,_, which_WDT contains_VBZ 22_CD cited_VBN scientific_JJ studies_NNS ,_, here_RB :_: The_DT platinum_NN standard_NN of_IN advanced_JJ multivitamin_NN formulations_NNS is_VBZ back_RB in_IN stock_NN !_. Order_VB Vitamin_NN Mineral_NN Fusion_NN at_IN 50_CD %_NN off_RP with_IN double_JJ Patriot_NN Points_NNS and_CC free_JJ shipping_NN today_NN !_.","JJ NNS and NN NNS VBP JJ for VBG that the NN - NN NN VBZ JJ and that no JJ JJ NN VBZ to VB RB a JJ NN between NNS and NN NN NNS ( NNP ) : NN VBN . But a RB - VBN NN RB VBN by NNP NNP over at NNP NNP VBZ that there VBP at JJS 22 VBN JJ NNS that VBP a NN between NNS and NN and that there VBP JJ JJR RB RB with JJ NNS . JJ of the JJ NN VBZ from NNP NNP NNP ’s NN RB in the JJ NNS , which VBD JJ NN as an JJ NN NN of NN with the NN NNS , NNS and NN ( NN ) NN . NNP NNP RB VBD a JJ NN with his NN , which VBD RB VBN RB by the NN and RB VBN RB as VBG JJ , RB though his JJ NNS VBP RB VBN VBN and VBN by JJ JJ NNS . A 2002 NN VBN in the NNP of NNP NNPS , for NN , VBD a JJ NN between the NN NN and NN , RB with NNS to the NNS NN of the NN . The NNS from NNP NNP NNP VBD that NNP VBZ JJ of VBG an JJ NN NN in some NNS , which in NN can VB to JJ NNS that VBP under the NN of NN . Another NN VBN in the NN NNP in 2012 VBD a JJ NN between the NN NN and NN , except in this NN NN VBD the NN . VBG to an NN of this NN , NNS that VBP NN VBP RB JJ to NNS , who VBP up RBR VBG VBN with NN , as they VBP JJ NN NNS of both NN and NN . The NN VBN in some NNS , in JJ NNS , VBZ to VB a JJ NN of NN NNS . “ RB of the NN NN and NN NN , there VBP RB a NN of NNS that VBP NNS to a JJ NN NN , ” VBZ NNP . “ [ NNP NNS RB VBP VBN in NN of NNS VBG NN , NN NN and JJ NNS that VBP the NN NN , ” he VBZ , VBG that JJ JJ NN NNS besides NN VBP VBN VBN in NN to NNS . JJ NNS , NNS , NNS and JJ NN NNS RB VBN to VBG NN RB the RBS JJ NN of NNP ’s JJ NN on the NN VBZ the NN that there VBP to VB JJ NNS in NNS JJ for VBG NN . Besides JJ NNS like NN and NN , NNS RB VBP NN NNS , NNS and JJ NNS that VBP RB VBN VBN as NNS in the NNS VBN in his NN . RB , each of these NNS VBZ RBS RB JJ both in NN and in NN with the JJ NNS , VBG VBN NN VBG on the NN . “ NN NN , NN NN and NN VBP VBN RB VBN in NN with JJ NNS VBG JJ JJ NNS , ” VBZ one NN out of NNP NNP NNP , which VBD that JJ NNS VBP a JJ NN of NN in their NN NN that VBZ to NN NN . JJ of the NNS VBN in NNP ’s NN RB VB NN , a JJ NN NN that VBZ RB VBG VBN to JJ NNS of NN NN , as a NN in VBG the NNS of NN NN VBN to NN . One JJ NN out of the NNP of NNP NNP NNP NNP VBD that for every 1,000 NNS of NN VBN into the NN , there VBZ a JJ 61 NN NN in NN NNS . With NN - VBG NN NNS RB VBG VBN to NNS RB JJ as six NNS JJ , it VBZ RB JJ that NN - VBN NN NN VBZ RB VBG as a NN of NN VBG VBN RB into NN NN . VB JJ to VB NNP ’s JJ NN , which VBZ 22 VBN JJ NNS , RB : The NN NN of JJ NN NNS VBZ RB in NN ! VB NN NN NN at 50 NN off with JJ NN NNS and JJ NN NN !"
87,430,mainstream,M0abd6,vaccine,"•_SYM Mymetics_NNP Covid_NNP -_HYPH 19_CD vaccine_NN development_NN project_NN based_VBN on_IN Mymetics_NNP ’_POS virosome_JJ vaccine_NN carrier_NN platform_NN ,_, will_MD evaluate_VB different_JJ rationally_RB designed_VBN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD antigens_NNS for_IN an_DT effective_JJ and_CC safe_JJ virosome_NN -_HYPH based_VBN Covid_NN -_HYPH 19_CD vaccine_NN •_. The_DT European_JJ vaccine_NN infrastructure_NN ,_, TRANSVAC2_NNP ,_, funded_VBN by_IN the_DT European_NNP Commission_NNP through_IN the_DT Horizon_NNP 2020_CD framework_NN ,_, will_MD provide_VB Mymetics_NN access_NN to_IN high_JJ quality_JJ technical_JJ vaccine_NN development_NN services_NNS in_IN the_DT fields_NNS of_IN antigen_NN production_NN ,_, analytics_NN and_CC animal_NN models_NNS EPALINGES_NNP ,_, SWITZERLAND_NNP /_, ACCESSWIRE_NNP /_, June_NNP 11_CD ,_, 2020_CD /_, Mymetics_NNP Corporation_NNP (_-LRB- OTCQB_NNP :_: MYMX_NNP )_-RRB- ,_, a_DT pioneer_NN and_CC leader_NN in_IN the_DT research_NN and_CC development_NN of_IN virosome_NN -_HYPH based_VBN vaccines_NNS against_IN life_NN threatening_NN and_CC life_NN disabling_NN diseases_NNS ,_, announced_VBD today_NN that_IN its_PRP$ subsidiary_NN ,_, Mymetics_NNP SA_NNP ,_, has_VBZ received_VBN the_DT confirmation_NN to_TO receive_VB access_NN to_IN the_DT European_JJ vaccine_NN infrastructure_NN TRANSVAC2_NNP services_NNS for_IN the_DT evaluation_NN and_CC development_NN of_IN virosome_NN -_HYPH based_VBN vaccines_NNS against_IN Covid_NNP -_HYPH 19_CD ,_, the_DT disease_NN caused_VBN by_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ._. Since_IN April_NNP ,_, Mymetics_NNP has_VBZ started_VBN the_DT investigation_NN for_IN the_DT rapid_JJ development_NN of_IN a_DT Covid_NNP -_HYPH 19_CD virosome_NN -_HYPH based_VBN vaccine_NN and_CC is_VBZ thereby_RB partnering_VBG with_IN leading_VBG academic_JJ institutions_NNS to_TO start_VB evaluating_VBG the_DT most_RBS suitable_JJ antigens_NNS ._. Through_IN TRANSVAC2_NNP ,_, Mymetics_NNP will_MD get_VB access_NN to_IN pre-agreed_JJ services_NNS that_WDT Mymetics_NNP has_VBZ requested_VBN and_CC are_VBP specifically_RB related_JJ to_IN SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD antigen_NN production_NN and_CC animal_NN models_NNS ._. Mymetics_NNP Corporation_NNP (_-LRB- OTCQB_NNP :_: MYMX_NNP )_-RRB- is_VBZ a_DT Swiss_JJ based_VBN biotechnology_NN company_NN ,_, with_IN a_DT research_NN lab_NN in_IN the_DT Netherlands_NNPS ,_, focused_VBN on_IN the_DT development_NN of_IN next_JJ -_HYPH generation_NN preventative_JJ vaccines_NNS for_IN infectious_JJ and_CC life_NN disabling_NN diseases_NNS ._. It_PRP currently_RB has_VBZ several_JJ vaccines_NNS in_IN its_PRP$ pipeline_NN ,_, among_IN which_WDT are_VBP the_DT HIV_NN -_HYPH 1/_CD AIDS_NN ,_, intra-nasal_JJ Influenza_NN and_CC malaria_NN ,_, and_CC collaborative_JJ projects_NNS in_IN the_DT field_NN of_IN allergy_NN immunotherapy_NN and_CC in_IN oncology_NN ._. Mymetics_NNS ’_POS core_NN technology_NN and_CC expertise_NN are_VBP in_IN the_DT use_NN of_IN virosomes_NNS ,_, lipid_NN -_HYPH based_VBN carriers_NNS containing_VBG functional_JJ fusion_NN viral_JJ proteins_NNS and_CC natural_JJ membrane_NN proteins_NNS ,_, in_IN combination_NN with_IN rationally_RB designed_VBN antigens_NNS ._. The_DT company_NN ’s_POS vaccines_NNS are_VBP designed_VBN to_TO induce_VB protection_NN against_IN early_JJ transmission_NN and_CC infection_NN ,_, focusing_VBG on_IN both_CC the_DT mucosal_JJ and_CC serum_NN immune_NN response_NN ._. For_IN further_JJR information_NN ,_, please_UH visit_VB www.mymetics.com_ADD ._. TRANSVAC2_NNP is_VBZ European_JJ vaccine_NN research_NN and_CC development_NN (_-LRB- R&D_NN )_-RRB- infrastructure_NN that_WDT aims_VBZ to_TO accelerate_VB the_DT development_NN of_IN safe_JJ ,_, effective_JJ and_CC affordable_JJ vaccines_NNS ,_, as_IN they_PRP are_VBP one_CD of_IN the_DT most_RBS successful_JJ and_CC cost_NN -_HYPH effective_JJ public_JJ health_NN tools_NNS for_IN disease_NN prevention_NN ._. However_RB ,_, vaccine_NN development_NN is_VBZ time_NN -_HYPH consuming_VBG and_CC complex_JJ ,_, requiring_VBG a_DT combination_NN of_IN specialised_VBN skills_NNS and_CC technical_JJ capacities_NNS not_RB readily_RB available_JJ at_IN a_DT single_JJ organisation_NN ._. In_IN order_NN to_TO facilitate_VB access_NN to_IN these_DT skills_NNS and_CC capacities_NNS ,_, and_CC to_TO promote_VB collaborations_NNS in_IN the_DT European_JJ vaccine_NN landscape_NN TRANSVAC2_NNP offers_VBZ high_JJ quality_NN technical_JJ services_NNS across_IN four_CD different_JJ service_NN platforms_NNS :_: Technology_NN (_-LRB- for_IN process_NN development_NN and_CC GMP_NN production_NN )_-RRB- ,_, Immunocorrelates_NNS &_CC Systems_NNS Biology_NN ,_, Animal_NN models_NNS ,_, and_CC support_NN for_IN Clinical_JJ Trials_NNS ._. TRANSVAC2_NNP has_VBZ received_VBN funding_NN from_IN the_DT European_NNP Union_NNP ’s_POS Horizon_NNP 2020_CD research_NN and_CC innovation_NN programme_NN under_IN grant_NN agreement_NN N°_NN 730964_CD ._. The_DT Private_JJ Securities_NNS Litigation_NN Reform_NN Act_NN of_IN 1995_CD provides_VBZ a_DT “_`` safe_JJ harbor_NN ”_'' for_IN forward_JJ -_HYPH looking_NN statements_NNS ,_, which_WDT are_VBP identified_VBN by_IN the_DT words_NNS “_`` believe_VB ,_, ”_'' “_`` expect_VB ,_, ”_'' “_`` anticipate_VB ,_, ”_'' “_`` intend_VB ,_, ”_'' “_`` plan_NN ”_'' and_CC similar_JJ expressions_NNS ._. The_DT statements_NNS contained_VBN herein_RB which_WDT are_VBP not_RB based_VBN on_IN historical_JJ facts_NNS are_VBP forward_JJ -_HYPH looking_VBG statements_NNS that_WDT involve_VBP known_VBN and_CC unknown_JJ risks_NNS and_CC uncertainties_NNS that_WDT could_MD significantly_RB affect_VB our_PRP$ actual_JJ results_NNS ,_, performance_NN or_CC achievements_NNS in_IN the_DT future_NN and_CC ,_, accordingly_RB ,_, such_JJ actual_JJ results_NNS ,_, performance_NN or_CC achievements_NNS may_MD materially_RB differ_VB from_IN those_DT expressed_VBN or_CC implied_VBN in_IN any_DT forward_JJ -_HYPH looking_NN statements_NNS made_VBN by_IN or_CC on_IN our_PRP$ behalf_NN ._. These_DT risks_NNS and_CC uncertainties_NNS include_VBP ,_, but_CC are_VBP not_RB limited_VBN to_IN ,_, risks_NNS associated_VBN with_IN our_PRP$ ability_NN to_TO successfully_RB develop_VB and_CC protect_VB our_PRP$ intellectual_JJ property_NN ,_, our_PRP$ ability_NN to_TO raise_VB additional_JJ capital_NN to_TO fund_VB future_JJ operations_NNS and_CC compliance_NN with_IN applicable_JJ laws_NNS and_CC changes_NNS in_IN such_JJ laws_NNS and_CC the_DT administration_NN of_IN such_JJ laws_NNS ._. See_VB Mymetics_NNP ’_POS most_RBS recent_JJ Form_NN 10_CD -_SYM K_CD for_IN a_DT discussion_NN of_IN such_JJ risks_NNS ,_, uncertainties_NNS and_CC other_JJ factors_NNS ._. Readers_NNS are_VBP cautioned_VBN not_RB to_TO place_VB undue_JJ reliance_NN on_IN these_DT forward_JJ -_HYPH looking_NN statements_NNS which_WDT speak_VBP only_RB as_IN of_IN the_DT date_NN the_DT statements_NNS were_VBD made_VBN ._.","• NNP NNP - 19 NN NN NN VBN on NNP ’ JJ NN NN NN , will VB JJ RB VBN NN - NN - 2 NNS for an JJ and JJ NN - VBN NN - 19 NN • The JJ NN NN , NNP , VBN by the NNP NNP through the NNP 2020 NN , will VB NN NN to JJ JJ JJ NN NN NNS in the NNS of NN NN , NN and NN NNS NNP , NNP / NNP / NNP 11 , 2020 / NNP NNP ( NNP : NNP ) , a NN and NN in the NN and NN of NN - VBN NNS against NN NN and NN NN NNS , VBD NN that its NN , NNP NNP , VBZ VBN the NN to VB NN to the JJ NN NN NNP NNS for the NN and NN of NN - VBN NNS against NNP - 19 , the NN VBN by NNP - NNP - 2 . Since NNP , NNP VBZ VBN the NN for the JJ NN of a NNP - 19 NN - VBN NN and VBZ RB VBG with VBG JJ NNS to VB VBG the RBS JJ NNS . Through NNP , NNP will VB NN to JJ NNS that NNP VBZ VBN and VBP RB JJ to NNP - NN - 2 NN NN and NN NNS . NNP NNP ( NNP : NNP ) VBZ a JJ VBN NN NN , with a NN NN in the NNPS , VBN on the NN of JJ - NN JJ NNS for JJ and NN NN NNS . It RB VBZ JJ NNS in its NN , among which VBP the NN - 1/ NN , JJ NN and NN , and JJ NNS in the NN of NN NN and in NN . NNS ’ NN NN and NN VBP in the NN of NNS , NN - VBN NNS VBG JJ NN JJ NNS and JJ NN NNS , in NN with RB VBN NNS . The NN ’s NNS VBP VBN to VB NN against JJ NN and NN , VBG on both the JJ and NN NN NN . For JJR NN , please VB www.mymetics.com . NNP VBZ JJ NN NN and NN ( NN ) NN that VBZ to VB the NN of JJ , JJ and JJ NNS , as they VBP one of the RBS JJ and NN - JJ JJ NN NNS for NN NN . RB , NN NN VBZ NN - VBG and JJ , VBG a NN of VBN NNS and JJ NNS RB RB JJ at a JJ NN . In NN to VB NN to these NNS and NNS , and to VB NNS in the JJ NN NN NNP VBZ JJ NN JJ NNS across four JJ NN NNS : NN ( for NN NN and NN NN ) , NNS & NNS NN , NN NNS , and NN for JJ NNS . NNP VBZ VBN NN from the NNP NNP ’s NNP 2020 NN and NN NN under NN NN NN 730964 . The JJ NNS NN NN NN of 1995 VBZ a “ JJ NN ” for JJ - NN NNS , which VBP VBN by the NNS “ VB , ” “ VB , ” “ VB , ” “ VB , ” “ NN ” and JJ NNS . The NNS VBN RB which VBP RB VBN on JJ NNS VBP JJ - VBG NNS that VBP VBN and JJ NNS and NNS that could RB VB our JJ NNS , NN or NNS in the NN and , RB , JJ JJ NNS , NN or NNS may RB VB from those VBN or VBN in any JJ - NN NNS VBN by or on our NN . These NNS and NNS VBP , but VBP RB VBN to , NNS VBN with our NN to RB VB and VB our JJ NN , our NN to VB JJ NN to VB JJ NNS and NN with JJ NNS and NNS in JJ NNS and the NN of JJ NNS . VB NNP ’ RBS JJ NN 10 - K for a NN of JJ NNS , NNS and JJ NNS . NNS VBP VBN RB to VB JJ NN on these JJ - NN NNS which VBP RB as of the NN the NNS VBD VBN ."
88,513,mainstream,M08ae0,vaccine,"«_`` Back_RB to_IN Vaccines_NNS For_IN Children_NNS program_NN «_`` Back_RB to_IN Immunization_NN Managers_NNS Home_NN page_NN Note_NN 1_CD :_: The_DT CDC_NNP Vaccine_NNP Price_NNP Lists_NNPS posted_VBN on_IN this_DT website_NN provide_VBP current_JJ vaccine_NN contract_NN prices_NNS and_CC list_VBP the_DT private_JJ sector_NN vaccine_NN prices_NNS for_IN general_JJ information_NN ._. Contract_NN prices_NNS are_VBP those_DT for_IN CDC_NNP vaccine_NN contracts_NNS that_WDT are_VBP established_VBN for_IN the_DT purchase_NN of_IN vaccines_NNS by_IN immunization_NN programs_NNS that_WDT receive_VBP CDC_NNP immunization_NN cooperative_JJ agreement_NN funds_NNS (_-LRB- i.e._FW ,_, state_NN health_NN departments_NNS ,_, certain_JJ large_JJ city_NN immunization_NN projects_NNS ,_, and_CC certain_JJ current_JJ and_CC former_JJ U.S._NNP territories_NNS )_-RRB- ._. Private_JJ providers_NNS and_CC private_JJ citizens_NNS cannot_MD directly_RB purchase_VB vaccines_NNS through_IN CDC_NNP contracts_NNS ._. Private_JJ sector_NN prices_NNS are_VBP those_DT reported_VBN by_IN vaccine_NN manufacturers_NNS annually_RB to_IN CDC_NNP ._. All_DT questions_NNS regarding_VBG the_DT private_JJ sector_NN prices_NNS should_MD be_VB directed_VBN to_IN the_DT manufacturers_NNS ._. Note_NN 2_CD :_: The_DT CDC_NNP price_NN list_NN does_VBZ not_RB represent_VB all_DT possible_JJ routinely_RB recommended_VBN vaccine_NN presentations_NNS available_JJ to_IN providers_NNS in_IN the_DT United_NNP States_NNPS ._. The_DT price_NN list_NN represents_VBZ only_RB those_DT vaccine_NN presentations_NNS available_JJ through_IN CDC_NNP contracts_NNS ._. •_NFP Vaccine_NN package_NN insert_NN information_NN From_IN this_DT page_NN ,_, you_PRP can_MD get_VB to_IN all_DT of_IN the_DT vaccines_NNS licensed_VBN in_IN the_DT US_NNP ._. Each_DT product_NN page_NN includes_VBZ links_NNS to_IN the_DT prescribing_NN information_NN (_-LRB- package_NN inserts_NNS )_-RRB- ._. As_IN of_IN 5_CD -_SYM 14_CD -_SYM 10_CD ,_, the_DT CDC_NNP Vaccine_NNP Price_NNP List_NNP also_RB shows_VBZ the_DT NDC_NN code_NN and_CC contract_NN number_NN for_IN each_DT vaccine_NN ._. Note_NN :_: The_DT table_NN below_RB reflects_VBZ contracts_NNS for_IN the_DT 2020_CD -_HYPH 2021_CD Pediatric_NNP Flu_NNP ._. Note_NN :_: The_DT table_NN below_RB reflects_VBZ contracts_NNS for_IN the_DT 2020_CD -_HYPH 2021_CD Adult_NNP Flu_NN ._.","« RB to NNS For NNS NN « RB to NN NNS NN NN NN 1 : The NNP NNP NNP NNPS VBN on this NN VBP JJ NN NN NNS and VBP the JJ NN NN NNS for JJ NN . NN NNS VBP those for NNP NN NNS that VBP VBN for the NN of NNS by NN NNS that VBP NNP NN JJ NN NNS ( FW , NN NN NNS , JJ JJ NN NN NNS , and JJ JJ and JJ NNP NNS ) . JJ NNS and JJ NNS cannot RB VB NNS through NNP NNS . JJ NN NNS VBP those VBN by NN NNS RB to NNP . All NNS VBG the JJ NN NNS should VB VBN to the NNS . NN 2 : The NNP NN NN VBZ RB VB all JJ RB VBN NN NNS JJ to NNS in the NNP NNPS . The NN NN VBZ RB those NN NNS JJ through NNP NNS . • NN NN NN NN From this NN , you can VB to all of the NNS VBN in the NNP . Each NN NN VBZ NNS to the NN NN ( NN NNS ) . As of 5 - 14 - 10 , the NNP NNP NNP NNP RB VBZ the NN NN and NN NN for each NN . NN : The NN RB VBZ NNS for the 2020 - 2021 NNP NNP . NN : The NN RB VBZ NNS for the 2020 - 2021 NNP NN ."
89,678,conspiracy,C0129a,vaccine; zika.virus,"Oh_UH ,_, the_DT theory_NN of_IN vaccines_NNS sounds_VBZ great_JJ ._. Inject_VB a_DT tiny_JJ bit_NN of_IN the_DT live_JJ virus_NN into_IN your_PRP$ blood_NN so_IN you_PRP can_MD build_VB antibodies_NNS and_CC thus_RB immunity_NN against_IN the_DT “_`` real_JJ deal_NN ”_'' later_RBR ._. If_IN that_DT ’s_VBZ all_DT there_EX was_VBD to_IN it_PRP ,_, it_PRP could_MD actually_RB work_VB ._. Then_RB there_EX ’s_VBZ the_DT fear_NN mongering_NN that_WDT ’s_VBZ thoroughly_RB “_`` inflamed_JJ ”_'' and_CC propagated_VBN by_IN the_DT press_NN ,_, pharma_NN ,_, and_CC the_DT medical_JJ doctors_NNS of_IN quack_NN Western_JJ medicine_NN ._. This_DT is_VBZ where_WRB the_DT real_JJ money_NN is_VBZ made_VBN ._. If_IN you_PRP get_VBP measles_NNS you_PRP could_MD die_VB !_. If_IN you_PRP get_VBP polio_NN you_PRP ’ll_MD surely_RB be_VB paralyzed_VBN for_IN life_NN !_. If_IN you_PRP get_VBP Zika_NNP ,_, your_PRP$ baby_NN ’s_POS head_NN will_MD be_VB shrunken_JJ and_CC deformed_VBN !_. Yet_CC ,_, what_WP if_IN you_PRP found_VBD out_RP today_NN that_IN the_DT worst_JJS odds_NNS you_PRP or_CC your_PRP$ children_NNS have_VBP of_IN being_VBG infected_VBN with_IN disease_NN ,_, disorder_NN ,_, and_CC deformity_NN exist_VBP in_IN getting_VBG injected_VBN repeatedly_RB with_IN neurotoxins_NNS ,_, genetically_RB modified_VBN bacteria_NN ,_, live_JJ experimental_JJ strains_NNS of_IN multiple_JJ viruses_NNS and_CC pesticides_NNS ?_. Consider_VB this_DT :_: not_RB one_CD single_JJ vaccine_NN ever_RB produced_VBN that_WDT is_VBZ recommended_VBN by_IN the_DT CDC_NNP today_NN has_VBZ ever_RB been_VBN proven_VBN safe_JJ or_CC effective_JJ ._. Why_WRB ?_. They_PRP do_VBP n’t_RB have_VB to_TO prove_VB it_PRP ._. All_DT they_PRP have_VBP to_TO do_VB is_VBZ scare_VB the_DT living_NN hell_NN out_IN of_IN everyone_NN using_VBG propaganda_NN ,_, and_CC it_PRP ’s_VBZ worked_VBN for_IN 75_CD years_NNS ._. Presenting_VBG the_DT 7_CD most_RBS dangerous_JJ vaccines_NNS injected_VBN into_IN humans_NNS without_IN any_DT proof_NN of_IN safety_NN or_CC efficacy_NN #_NN 1._LS Gardasil_NN HPV_NN –_: Forget_VB for_IN a_DT moment_NN the_DT fact_NN that_IN many_JJ girls_NNS who_WP get_VBP the_DT HPV_NN vaccine_NN beginning_VBG at_IN age_NN 9_CD for_IN a_DT sexually_RB transmitted_VBN disease_NN (_-LRB- diseases_NNS they_PRP do_VBP n’t_RB have_VB )_-RRB- go_VB into_IN immediate_JJ anaphylactic_JJ shock_NN and_CC some_DT into_IN comas_NNS and_CC die_VBP ,_, and_CC let_VB ’s_PRP just_RB talk_VB about_IN the_DT insane_JJ boatload_NN of_IN chemicals_NNS the_DT manufacturers_NNS put_VBP in_IN this_DT concoction_NN that_WDT belong_VBP nowhere_RB in_IN medicine_NN ,_, ever_RB ,_, especially_RB that_DT which_WDT is_VBZ injected_VBN directly_RB into_IN muscle_NN tissue_NN and_CC that_DT which_WDT can_MD penetrate_VB the_DT blood_NN /_, brain_NN barrier_NN ._. Plus_CC ,_, remember_VB to_TO triple_VB the_DT amounts_NNS of_IN these_DT carcinogenic_JJ ,_, dangerous_JJ ,_, ludicrous_JJ chemical_JJ ingredients_NNS of_IN Gardasil_NNP ,_, because_IN there_EX are_VBP 3_CD of_IN these_DT toxic_JJ jabs_NNS required_VBN ._. First_RB we_PRP have_VBP sodium_NN borate_NN at_IN 35_CD mcg_NN ._. Also_RB known_VBN as_IN “_`` borax_NN ,_, ”_'' this_DT is_VBZ the_DT main_JJ poisonous_JJ ingredient_NN in_IN boric_JJ acid_NN that_WDT ’s_VBZ used_VBN to_TO kill_VB cockroaches_NNS ._. Is_VBZ your_PRP$ little_JJ girl_NN a_DT cockroach_NN ?_. Is_VBZ it_PRP coincidence_NN that_IN the_DT side_NN effects_NNS listed_VBN and_CC reported_VBN with_IN the_DT Gardasil_NNP vaccine_NN match_VBP those_DT of_IN sodium_NN borate_NN poisoning_NN ?_. No_UH ,_, it_PRP ’s_VBZ not_RB a_DT coincidence_NN ._. Did_VBD you_PRP know_VB that_IN anything_NN imported_VBN into_IN the_DT European_NNP Union_NNP that_WDT contains_VBZ borax_NN must_MD carry_VB a_DT warning_NN label_NN stating_VBG ,_, “_`` May_MD damage_NN fertility_NN ”_'' and_CC “_`` May_MD damage_VB the_DT unborn_JJ child_NN ._. ”_'' This_DT is_VBZ what_WP America_NNP “_'' recommends_VBZ ”_'' for_IN preteen_JJ and_CC teenage_JJ girls_NNS who_WP are_VBP just_RB reaching_VBG the_DT age_NN of_IN fertility_NN ._. Unbelievable_JJ !_. Then_RB ,_, Gardasil_NNP HPV_NNP contains_VBZ aluminum_NN at_IN 225mcg_CD ,_, which_WDT causes_VBZ nerve_NN cell_NN death_NN and_CC helps_VBZ the_DT vaccine_NN chemicals_NNS enter_VB the_DT brain_NN ._. Let_VB ’s_PRP not_RB forget_VB that_IN Gardasil_NNP HPV_NN contains_VBZ polysorbate_NN 80_CD at_IN 50_CD mcg_NN ._. Polysorbate_NNP 80_CD is_VBZ used_VBN as_IN an_DT emulsifier_NN in_IN foods_NNS ,_, but_CC when_WRB injected_VBN into_IN animals_NNS (_-LRB- such_JJ as_IN humans_NNS )_-RRB- ,_, causes_VBZ rapid_JJ ,_, unnatural_JJ growth_NN of_IN reproductive_JJ organs_NNS ,_, causing_VBG sterility_NN ._. This_DT is_VBZ population_NN control_NN through_IN vaccines_NNS ,_, just_RB as_IN Bill_NNP Gates_NNP once_RB said_VBD at_IN a_DT TED_NNP conference_NN would_MD be_VB ideal_JJ for_IN reducing_VBG the_DT world_NN ’s_POS population_NN by_IN a_DT few_JJ billion_CD ._. Polysorbate_NNP 80_CD is_VBZ what_WP causes_VBZ the_DT anaphylactic_JJ shock_NN and_CC also_RB causes_VBZ cancer_NN and_CC birth_NN defects_NNS ,_, while_IN we_PRP ’re_VBP on_IN that_DT topic_NN ._. Sorry_JJ ,_, but_CC there_EX ’s_VBZ not_RB enough_JJ time_NN to_TO talk_VB about_IN the_DT sodium_NN chloride_NN at_IN nearly_RB 10mcg_CD ._. #_NN 2_LS ._. Anthrax_NN vaccine_NN (_-LRB- biothrax_NN )_-RRB- –_: The_DT dreaded_VBN anthrax_NN jab_NN contains_VBZ aluminum_NN hydroxide_NN ,_, formaldehyde_NN (_-LRB- yes_UH ,_, embalming_NN fluid_NN for_IN the_DT dead_JJ )_-RRB- ,_, and_CC benzethonium_NN chloride_NN ._. In_IN 2009_CD ,_, a_DT study_NN published_VBN in_IN the_DT Journal_NNP of_IN Inorganic_NNP Biochemistry_NNP stated_VBD that_IN aluminum_NN hydroxide_NN could_MD be_VB the_DT primary_JJ cause_NN of_IN Gulf_NN War_NN Syndrome_NN ._. Aluminum_NN hydroxide_NN causes_VBZ apoptosis_NN of_IN motor_NN neurons_NNS ,_, leading_VBG to_IN dementia_NN ._. Go_VB figure_NN ._. Thousands_NNS of_IN US_NNP soldiers_NNS given_VBN the_DT mandatory_JJ anthrax_NN jab_NN are_VBP still_RB sick_JJ or_CC have_VBP died_VBN ._. It_PRP was_VBD never_RB approved_VBN by_IN the_DT FDA_NNP ,_, yet_CC any_DT soldier_NN refusing_VBG it_PRP got_VBD dishonorably_RB discharged_VBN ,_, fines_NNS ,_, and_CC possible_JJ prison_NN time_NN ._. President_NNP Clinton_NNP ’s_POS executive_JJ order_NN 13139_CD gave_VBD the_DT DoD_NNP permission_NN to_TO experiment_VB on_IN the_DT US_NNP military_NN with_IN the_DT highly_RB dangerous_JJ anthrax_NN concoction_NN ._. #_NN 3_LS ._. MMR_NNP II_CD –_: Under_IN Appendix_NNP B_NN ,_, listed_VBN on_IN the_DT CDC_NNP website_NN ,_, you_PRP can_MD find_VB the_DT ingredients_NNS for_IN the_DT MMR_NNP (_-LRB- MMR_NNP -_HYPH II_CD )_-RRB- ,_, the_DT combination_NN vaccines_NNS that_WDT contain_VBP recombinant_JJ human_JJ albumin_NN ,_, sorbitol_NN ,_, hydrolized_JJ gelatin_NN ,_, chick_NN (_-LRB- egg_NN )_-RRB- embryo_NN cell_NN culture_NN ,_, human_JJ diploid_JJ lung_NN fibroblasts_NNS ,_, and_CC fetal_JJ bovine_NN serum_NN ,_, among_IN other_JJ certain_JJ preservatives_NNS and_CC chemical_JJ adjuvants_NNS ._. In_IN the_DT “_`` ProQuad_NNP ”_'' version_NN ,_, or_CC MMRV_NN (_-LRB- w/_IN vericella_FW for_IN chicken_NN pox_NN )_-RRB- ,_, they_PRP ’ve_VBP added_VBN monosodium_NN L_NN -_HYPH glutamate_NN ,_, neomycin_NN ,_, and_CC MRC_NN -_HYPH 5_CD cells_NNS ._. And_CC although_IN measles_NNS is_VBZ a_DT respiratory_JJ disease_NN accompanied_VBN by_IN an_DT uncomfortable_JJ rash_NN and_CC fever_NN illness_NN that_WDT anyone_NN with_IN a_DT normal_JJ immune_JJ system_NN will_MD likely_RB survive_VB ,_, the_DT media_NN scares_VBZ the_DT public_NN into_IN getting_VBG jabbed_VBN with_IN neurotoxins_NNS ._. Sorbitol_NNP is_VBZ a_DT synthetic_JJ sweetener_NN which_WDT metabolizes_VBZ very_RB slowly_RB and_CC aggravates_VBZ IBS_NN and_CC gastrointestinal_JJ issues_NNS ._. Fetal_JJ bovine_NN cow_NN serum_NN is_VBZ extracted_VBN from_IN cow_NN skin_NN and_CC when_WRB injected_VBN causes_VBZ connective_JJ tissue_NN disorders_NNS ,_, arthritis_NN and_CC lupus_NN ;_, also_RB shortness_NN of_IN breath_NN ,_, low_JJ blood_NN pressure_NN ,_, chest_NN pain_NN and_CC skin_NN reactions_NNS ._. Sodium_NN chloride_NN raises_VBZ blood_NN pressure_NN and_CC inhibits_VBZ muscle_NN contraction_NN and_CC growth_NN ._. Human_JJ albumin_NN is_VBZ the_DT protein_NN portion_NN of_IN bloodfrom_NN pooled_VBN human_JJ venous_NN plasma_NN and_CC when_WRB injected_VBN causes_VBZ fever_NN ,_, chills_NNS ,_, hives_NNS ,_, rash_NN ,_, headache_NN ,_, nausea_NN ,_, breathing_NN difficulty_NN ,_, and_CC rapid_JJ heart_NN rate_NN ._. Injecting_VBG “_`` pooled_VBN blood_NN ”_'' can_MD result_VB in_IN a_DT loss_NN of_IN body_NN cell_NN mass_NN and_CC cause_VB immunodeficiency_NN virus_NN infection_NN ,_, or_CC contain_VB SV40_NN ,_, AIDS_NN ,_, cancer_NN or_CC Hepatitis_NN B_NN from_IN drug_NN addicts_NNS ._. Still_RB want_VBP that_DT MMR_NN vaccine_NN ?_. Did_VBD n’t_RB think_VB so_RB ._. #_NN 4_LS ._. Swine_NN Flu_NN –_: This_DT loaded_VBN nightmare_NN hoax_NN vaccine_NN contains_VBZ inactivated_VBN H1N1_NN virus_NN propagated_VBN in_IN embryonated_JJ chicken_NN eggs_NNS ._. The_DT multi_NN -_HYPH dose_NN vials_NNS contain_VBP over_RB 24mcg_CD of_IN mercury_NN per_IN .5_CD ml_NNS dose_NN !_. The_DT jab_NN also_RB contains_VBZ antibiotics_NNS polymyxin_NN and_CC neomycin_NN that_WDT annihilate_VBP good_JJ gut_NN bacteria_NN ,_, making_VBG the_DT immune_NN system_NN highly_RB vulnerable_JJ to_IN infection_NN ._. Add_VB in_RP some_DT fluid_NN from_IN chicken_NN eggs_NNS and_CC you_PRP have_VBP one_CD of_IN the_DT most_RBS experimental_JJ jabs_NNS ever_RB created_VBN and_CC a_DT hoax_NN perpetuated_VBN by_IN WHO_NNP ,_, GSK_NNP and_CC the_DT CDC_NNP to_TO profit_VB in_IN the_DT billions_NNS ._. #_NN 5._LS Polio_NN –_: This_DT psycho-jab_NN contains_VBZ inactivated_VBN monkey_NN kidney_NN cells_NNS ,_, newborn_JJ calf_NN serum_NN ,_, embalming_NN fluid_NN ,_, antibiotics_NNS ,_, and_CC bovine_NN albumin_NN ._. Salk_NNP did_VBD n’t_RB invent_VB the_DT cure_NN for_IN polio–he_NN invented_VBD new_JJ strains_NNS of_IN it_PRP by_IN haphazardly_RB combining_VBG several_JJ ._. Get_VB the_DT facts_NNS !_. #_NN 6_LS ._. Influenza_NN vaccine_NN (_-LRB- a.k.a._FW the_DT flu_NN shot_NN )_-RRB- –_: Specifically_RB ,_, the_DT “_`` FluLaval_NN ”_'' flu_NN shot_NN contains_VBZ 25_CD mcg_NN of_IN mercury_NN in_IN one_CD jab_NN ._. The_DT EPA_NNP safety_NN limit_NN for_IN drinking_NN water_NN ?_. Just_RB 5_CD mcg_NNS ._. Do_VB the_DT math_NN ,_, then_RB consider_VB that_IN shots_NNS bypass_VBP digestion_NN ,_, breathing_NN ,_, and_CC skin_NN filters_NNS ._. Common_JJ flu_NN jabs_NNS also_RB contain_VBP formaldehyde_NN and_CC polysorbate_NN 80_CD ._. #_NN 7_LS ._. RotaTeq_NN for_IN Rotavirus_NN –_: Three_CD oral_JJ doses_NNS of_IN this_DT Merck_NNP -_HYPH made_VBN horror_NN story_NN cost_VBD about_RB $_$ 200_CD and_CC are_VBP mandated_VBN for_IN about_RB four_CD million_CD infants_NNS every_DT year_NN ._. Rotavirus_NN vaccine_NN contains_VBZ 5_CD live_JJ strains_NNS ,_, plus_CC some_DT fetal_JJ bovine_NN serum_NN and_CC porcine_NN circovirus–a_NN volatile_JJ and_CC dangerous_JJ virus_NN that_WDT infects_VBZ pigs_NNS ._. Side_NN effects_NNS of_IN RotaTeq_NNP ?_. Difficulty_NN breathing_NN ,_, vomiting_NN and_CC ear_NN infection_NN ,_, followed_VBN by_IN bloody_JJ stool_NN ._. Then_RB the_DT intestines_NNS get_VBP blocked_VBN and_CC twisted_VBN (_-LRB- known_VBN as_IN intussusception_NN )_-RRB- which_WDT can_MD be_VB deadly_JJ and_CC requires_VBZ surgery_NN on_IN infant_NN ’s_POS intestines_NNS ._. Be_VB sure_JJ and_CC call_VB your_PRP$ doctor_NN right_RB away_RB if_IN your_PRP$ child_NN dies_VBZ from_IN RotaTeq_NNP ._.","Oh , the NN of NNS VBZ JJ . VB a JJ NN of the JJ NN into your NN so you can VB NNS and RB NN against the “ JJ NN ” RBR . If that VBZ all there VBD to it , it could RB VB . RB there VBZ the NN NN that VBZ RB “ JJ ” and VBN by the NN , NN , and the JJ NNS of NN JJ NN . This VBZ where the JJ NN VBZ VBN . If you VBP NNS you could VB ! If you VBP NN you ’ll RB VB VBN for NN ! If you VBP NNP , your NN ’s NN will VB JJ and VBN ! Yet , what if you VBD out NN that the JJS NNS you or your NNS VBP of VBG VBN with NN , NN , and NN VBP in VBG VBN RB with NNS , RB VBN NN , JJ JJ NNS of JJ NNS and NNS ? VB this : RB one JJ NN RB VBN that VBZ VBN by the NNP NN VBZ RB VBN VBN JJ or JJ . Why ? They VBP RB VB to VB it . All they VBP to VB VBZ VB the NN NN out of NN VBG NN , and it VBZ VBN for 75 NNS . VBG the 7 RBS JJ NNS VBN into NNS without any NN of NN or NN NN 1. NN NN – VB for a NN the NN that JJ NNS who VBP the NN NN VBG at NN 9 for a RB VBN NN ( NNS they VBP RB VB ) VB into JJ JJ NN and some into NNS and VBP , and VB ’s RB VB about the JJ NN of NNS the NNS VBP in this NN that VBP RB in NN , RB , RB that which VBZ VBN RB into NN NN and that which can VB the NN / NN NN . Plus , VB to VB the NNS of these JJ , JJ , JJ JJ NNS of NNP , because there VBP 3 of these JJ NNS VBN . RB we VBP NN NN at 35 NN . RB VBN as “ NN , ” this VBZ the JJ JJ NN in JJ NN that VBZ VBN to VB NNS . VBZ your JJ NN a NN ? VBZ it NN that the NN NNS VBN and VBN with the NNP NN VBP those of NN NN NN ? No , it VBZ RB a NN . VBD you VB that NN VBN into the NNP NNP that VBZ NN must VB a NN NN VBG , “ May NN NN ” and “ May VB the JJ NN . ” This VBZ what NNP “ VBZ ” for JJ and JJ NNS who VBP RB VBG the NN of NN . JJ ! RB , NNP NNP VBZ NN at 225mcg , which VBZ NN NN NN and VBZ the NN NNS VB the NN . VB ’s RB VB that NNP NN VBZ NN 80 at 50 NN . NNP 80 VBZ VBN as an NN in NNS , but when VBN into NNS ( JJ as NNS ) , VBZ JJ , JJ NN of JJ NNS , VBG NN . This VBZ NN NN through NNS , RB as NNP NNP RB VBD at a NNP NN would VB JJ for VBG the NN ’s NN by a JJ billion . NNP 80 VBZ what VBZ the JJ NN and RB VBZ NN and NN NNS , while we VBP on that NN . JJ , but there VBZ RB JJ NN to VB about the NN NN at RB 10mcg . NN 2 . NN NN ( NN ) – The VBN NN NN VBZ NN NN , NN ( yes , NN NN for the JJ ) , and NN NN . In 2009 , a NN VBN in the NNP of NNP NNP VBD that NN NN could VB the JJ NN of NN NN NN . NN NN VBZ NN of NN NNS , VBG to NN . VB NN . NNS of NNP NNS VBN the JJ NN NN VBP RB JJ or VBP VBN . It VBD RB VBN by the NNP , yet any NN VBG it VBD RB VBN , NNS , and JJ NN NN . NNP NNP ’s JJ NN 13139 VBD the NNP NN to VB on the NNP NN with the RB JJ NN NN . NN 3 . NNP II – Under NNP NN , VBN on the NNP NN , you can VB the NNS for the NNP ( NNP - II ) , the NN NNS that VBP JJ JJ NN , NN , JJ NN , NN ( NN ) NN NN NN , JJ JJ NN NNS , and JJ NN NN , among JJ JJ NNS and JJ NNS . In the “ NNP ” NN , or NN ( w/ FW for NN NN ) , they VBP VBN NN NN - NN , NN , and NN - 5 NNS . And although NNS VBZ a JJ NN VBN by an JJ NN and NN NN that NN with a JJ JJ NN will RB VB , the NN VBZ the NN into VBG VBN with NNS . NNP VBZ a JJ NN which VBZ RB RB and VBZ NN and JJ NNS . JJ NN NN NN VBZ VBN from NN NN and when VBN VBZ JJ NN NNS , NN and NN ; RB NN of NN , JJ NN NN , NN NN and NN NNS . NN NN VBZ NN NN and VBZ NN NN and NN . JJ NN VBZ the NN NN of NN VBN JJ NN NN and when VBN VBZ NN , NNS , NNS , NN , NN , NN , NN NN , and JJ NN NN . VBG “ VBN NN ” can VB in a NN of NN NN NN and VB NN NN NN , or VB NN , NN , NN or NN NN from NN NNS . RB VBP that NN NN ? VBD RB VB RB . NN 4 . NN NN – This VBN NN NN NN VBZ VBN NN NN VBN in JJ NN NNS . The NN - NN NNS VBP RB 24mcg of NN per .5 NNS NN ! The NN RB VBZ NNS NN and NN that VBP JJ NN NN , VBG the NN NN RB JJ to NN . VB in some NN from NN NNS and you VBP one of the RBS JJ NNS RB VBN and a NN VBN by NNP , NNP and the NNP to VB in the NNS . NN 5. NN – This NN VBZ VBN NN NN NNS , JJ NN NN , NN NN , NNS , and NN NN . NNP VBD RB VB the NN for NN VBD JJ NNS of it by RB VBG JJ . VB the NNS ! NN 6 . NN NN ( FW the NN NN ) – RB , the “ NN ” NN NN VBZ 25 NN of NN in one NN . The NNP NN NN for NN NN ? RB 5 NNS . VB the NN , RB VB that NNS VBP NN , NN , and NN NNS . JJ NN NNS RB VBP NN and NN 80 . NN 7 . NN for NN – Three JJ NNS of this NNP - VBN NN NN VBD RB $ 200 and VBP VBN for RB four million NNS every NN . NN NN VBZ 5 JJ NNS , plus some JJ NN NN and NN NN JJ and JJ NN that VBZ NNS . NN NNS of NNP ? NN NN , NN and NN NN , VBN by JJ NN . RB the NNS VBP VBN and VBN ( VBN as NN ) which can VB JJ and VBZ NN on NN ’s NNS . VB JJ and VB your NN RB RB if your NN VBZ from NNP ."
90,1288,conspiracy,C00b76,vaccine.covid,"Scientists_NNS suggest_VBP that_IN maybe_RB the_DT MMR_NNP Vaccine_NN could_MD give_VB some_DT element_NN of_IN protection_NN against_IN coronavirus_NN ._. They_PRP have_VBP discovered_VBN that_IN the_DT key_JJ proteins_NNS in_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN viruses_NNS have_VBP some_DT unexpected_JJ similarity_NN with_IN certain_JJ proteins_NNS in_IN the_DT virus_NN causing_VBG Covid_NNP -_HYPH 19_CD ,_, known_VBN as_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ._. Their_PRP$ revelation_NN comes_VBZ as_IN trials_NNS are_VBP beginning_VBG to_TO see_VB if_IN the_DT BCG_NNP injection_NN ,_, given_VBN to_IN many_JJ Brits_NNPS to_TO prevent_VB TB_NN ,_, can_MD also_RB protect_VB against_IN coronavirus_NN ._. The_DT Cambridge_NNP scientists_NNS made_VBD their_PRP$ suggestion_NN about_IN the_DT MMR_NNP jab_NN after_IN analysing_VBG the_DT structure_NN of_IN MMR_NN viruses_NNS ._. They_PRP discovered_VBD that_IN the_DT “_`` spike_NN protein_NN ”_'' of_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD is_VBZ 20_CD per_NN cent_NN comparable_JJ to_IN the_DT measles_NNS “_`` fusion_NN protein_NN ”_'' ._. [_-LRB- 1_CD ]_-RRB- It_PRP comes_VBZ as_IN no_DT surprise_NN that_IN there_EX is_VBZ no_DT word_NN on_IN the_DT fact_NN that_IN if_IN you_PRP have_VBP had_VBN natural_JJ the_DT natural_JJ version_NN of_IN the_DT viruses_NNS which_WDT the_DT MMR_NN protects_VBZ against_IN ,_, then_RB you_PRP may_MD be_VB even_RB better_RBR protected_VBN from_IN the_DT coronavirus_NN ._. But_CC then_RB what_WP do_VBP you_PRP expect_VB from_IN mainstream_JJ news_NN ._. This_DT would_MD also_RB support_VB the_DT allegedly_RB debunked_VBN claim_NN that_IN ‘_`` Measles_NN is_VBZ good_JJ for_IN your_PRP$ immune_JJ system_NN ’_'' ._.","NNS VBP that RB the NNP NN could VB some NN of NN against NN . They VBP VBN that the JJ NNS in NNS , NNS and NN NNS VBP some JJ NN with JJ NNS in the NN VBG NNP - 19 , VBN as NNP - NNP - 2 . Their NN VBZ as NNS VBP VBG to VB if the NNP NN , VBN to JJ NNPS to VB NN , can RB VB against NN . The NNP NNS VBD their NN about the NNP NN after VBG the NN of NN NNS . They VBD that the “ NN NN ” of NN - NN - 2 VBZ 20 NN NN JJ to the NNS “ NN NN ” . [ 1 ] It VBZ as no NN that there VBZ no NN on the NN that if you VBP VBN JJ the JJ NN of the NNS which the NN VBZ against , RB you may VB RB RBR VBN from the NN . But RB what VBP you VB from JJ NN . This would RB VB the RB VBN NN that ‘ NN VBZ JJ for your JJ NN ’ ."
91,218,conspiracy,C00753,vaccine.autism,"Mysterious_JJ Death_NN :_: Body_NN of_IN Doctor_NN Who_WP Linked_VBD Vaccines_NNS To_IN Autism_NN Found_VBN Floating_VBG in_IN River_NN Dr._NNP Jeff_NNP Bradstreet_NNP helped_VBD families_NNS whose_WP$ children_NNS were_VBD believed_VBN to_TO have_VB been_VBN damaged_VBN by_IN immunizations_NNS A_DT prominent_JJ autism_NN researcher_NN and_CC vaccine_NN opponent_NN was_VBD found_VBN dead_JJ floating_VBG in_IN a_DT North_NNP Carolina_NNP river_NN last_JJ week_NN under_IN what_WP many_JJ are_VBP calling_VBG suspicious_JJ circumstances_NNS ._. A_DT fisherman_NN found_VBD the_DT body_NN of_IN Dr._NNP James_NNP Jeffery_NNP Bradstreet_NNP in_IN the_DT Rocky_NNP Broad_NNP River_NNP in_IN Chimney_NNP Rock_NNP ,_, North_NNP Carolina_NNP ,_, last_JJ Friday_NNP afternoon_NN ._. “_`` Bradstreet_NNP had_VBD a_DT gunshot_NN wound_NN to_IN the_DT chest_NN ,_, which_WDT appeared_VBD to_TO be_VB self_NN inflicted_VBN ,_, according_VBG to_IN deputies_NNS ,_, ”_'' reported_VBD WHNS_NNP ._. In_IN a_DT press_NN release_NN ,_, the_DT Rutherford_NNP County_NNP Sheriff_NNP ’s_POS Office_NNP announced_VBD ,_, “_`` Divers_NNS from_IN the_DT Henderson_NNP County_NNP Rescue_NNP Squad_NNP responded_VBD to_IN the_DT scene_NN and_CC recovered_VBD a_DT handgun_NN from_IN the_DT river_NN ._. ”_'' An_DT investigation_NN into_IN the_DT death_NN is_VBZ ongoing_JJ ,_, and_CC the_DT results_NNS of_IN an_DT autopsy_NN are_VBP also_RB reportedly_RB forthcoming_JJ ._. Dr._NNP Bradstreet_NNP ran_VBD a_DT private_JJ practice_NN in_IN Buford_NNP ,_, Georgia_NNP ,_, which_WDT focused_VBD on_IN “_`` treating_VBG children_NNS with_IN Autism_NN Spectrum_NN Disorder_NN ,_, PPD_NN ,_, and_CC related_JJ neurological_JJ and_CC developmental_JJ disorders_NNS ._. ”_'' Among_IN various_JJ remedies_NNS ,_, Dr._NNP Bradstreet_NNP ’s_POS Wellness_NNP Center_NNP reportedly_RB carried_VBD out_RP “_`` mercury_NN toxicity_NN ”_'' treatments_NNS ,_, believing_VBG the_DT heavy_JJ metal_NN to_TO be_VB a_DT leading_VBG factor_NN in_IN the_DT development_NN of_IN childhood_NN autism_NN ._. Dr._NNP Bradstreet_NNP undertook_VBD the_DT effort_NN to_TO pinpoint_VB the_DT cause_NN of_IN the_DT disease_NN after_IN his_PRP$ own_JJ child_NN developed_VBD the_DT ailment_NN following_VBG routine_JJ vaccination_NN ._. “_`` Autism_NNP taught_VBD me_PRP more_JJR about_IN medicine_NN than_IN medical_JJ school_NN did_VBD ,_, ”_'' the_DT doctor_NN once_RB stated_VBD at_IN a_DT conference_NN ,_, according_VBG to_IN the_DT Epoch_NNP Times_NNP ’_POS Jake_NNP Crosby_NNP ._. In_IN addition_NN to_IN treating_VBG patients_NNS ,_, Bradstreet_NNP has_VBZ also_RB offered_VBN expert_NN testimony_NN in_IN federal_JJ court_NN on_IN behalf_NN of_IN vaccine_NN -_HYPH injured_VBN families_NNS and_CC was_VBD founder_NN and_CC president_NN of_IN the_DT International_NNP Child_NNP Development_NNP Resource_NNP Center_NNP ,_, which_WDT at_IN one_CD time_NN employed_VBD the_DT much_RB -_HYPH scorned_VBN autism_NN expert_NN Dr._NNP Andrew_NNP Wakefield_NNP as_IN “_`` research_NN director_NN ._. ”_'' The_DT circumstances_NNS surrounding_VBG Bradstreet_NNP ’s_POS death_NN are_VBP made_VBN all_PDT the_DT more_RBR curious_JJ by_IN a_DT recent_JJ multi-agency_NN raid_NN led_VBN by_IN the_DT FDA_NNP on_IN his_PRP$ offices_NNS ._. “_`` The_DT FDA_NNP has_VBZ yet_RB to_TO reveal_VB why_WRB agents_NNS searched_VBD the_DT office_NN of_IN the_DT doctor_NN ,_, reportedly_RB a_DT former_JJ pastor_NN who_WP has_VBZ been_VBN controversial_JJ for_IN well_RB over_IN a_DT decade_NN ,_, ”_'' reported_VBD the_DT Gwinnett_NNP Daily_NNP Post_NNP ._. Social_JJ media_NN pages_NNS dedicated_VBN to_IN Bradstreet_NNP ’s_POS memory_NN are_VBP filled_VBN with_IN comments_NNS from_IN families_NNS who_WP say_VBP the_DT deceased_VBN doctor_NN impacted_VBD their_PRP$ lives_NNS for_IN the_DT better_JJR ._. “_`` Dr._NNP Bradstreet_NNP was_VBD my_PRP$ son_NN ’s_POS doctor_NN after_IN my_PRP$ son_NN was_VBD diagnosed_VBN with_IN autism_NN ._. He_PRP worked_VBD miracles_NNS ,_, ”_`` one_CD Facebook_NNP user_NN states_NNS ._. “_`` At_IN 16_CD ,_, my_PRP$ son_NN is_VBZ now_RB looking_VBG at_IN a_DT normal_JJ life_NN thanks_NN to_IN him_PRP ._. I_PRP thank_VBP him_PRP every_DT day_NN ._. ”_'' “_`` I_PRP will_MD forever_RB be_VB grateful_JJ and_CC thankful_JJ for_IN Dr._NNP Bradstreet_NNP recovering_VBG my_PRP$ son…_NN from_IN autism_NN ,_, ”_'' another_DT person_NN writes_VBZ ._. “_`` Treatments_NNS have_VBP changed_VBN my_PRP$ son_NN ’s_POS life_NN so_IN that_IN he_PRP can_MD grow_VB up_RP and_CC live_VB a_DT normal_JJ healthy_JJ life_NN ._. Dr._NNP Bradstreet_NNP will_MD be_VB missed_VBN greatly_RB !_. ”_'' A_DT GoFundMe_NNP page_NN has_VBZ also_RB been_VBN set_VBN up_RP by_IN one_CD of_IN Bradstreet_NNP ’s_POS family_NN members_NNS seeking_VBG “_`` To_TO find_VB the_DT answers_NNS to_IN the_DT many_JJ questions_NNS leading_VBG up_IN to_IN the_DT death_NN of_IN Dr_NNP Bradstreet_NNP ,_, including_VBG an_DT exhaustive_JJ investigation_NN into_IN the_DT possibility_NN of_IN foul_JJ play_NN ._. ”_'' Despite_IN his_PRP$ family_NN requesting_VBG the_DT public_NN refrain_VB from_IN speculation_NN ,_, many_JJ are_VBP nevertheless_RB concluding_VBG the_DT doctor_NN ’s_POS death_NN to_TO be_VB part_NN of_IN a_DT conspiracy_NN ._. “_`` Self_NN -_HYPH inflicted_VBN ?_. In_IN the_DT chest_NN ?_. I_PRP ’m_VBP not_RB buying_VBG this_DT ,_, ”_'' one_CD person_NN in_IN the_DT WHNS_NNP comments_NNS thread_NN states_NNS ._. “_`` This_DT was_VBD a_DT doctor_NN who_WP had_VBD access_NN to_IN pharmaceuticals_NNS of_IN all_DT kinds_NNS ._. This_DT was_VBD a_DT religious_JJ man_NN with_IN a_DT thriving_VBG medical_JJ practice_NN ._. Sorry_JJ ,_, but_CC this_DT stinks_VBZ of_IN murder_NN and_CC cover_NN -up_NN ._. ”_'' Another_DT commentor_NN had_VBD a_DT more_RBR definitive_JJ conjecture_NN :_: “_`` He_PRP did_VBD NOT_RB kill_VB himself_PRP !_. He_PRP was_VBD murdered_VBN for_IN who_WP he_PRP was_VBD speaking_VBG against_IN ,_, what_WP he_PRP knew_VBD ,_, and_CC what_WP he_PRP was_VBD doing_VBG about_IN it_PRP ._. He_PRP was_VBD brilliant_JJ kind_NN compassionate_JJ doctor_NN with_IN amazing_JJ abilities_NNS to_TO heal_VB ._. He_PRP was_VBD taken_VBN ._. Stopped_VBD ._. Silenced_VBN ._. Why_WRB would_MD a_DT doctor_NN who_WP had_VBD access_NN to_IN pharmaceuticals_NNS and_CC could_MD die_VB peacefully_RB shoot_VB himself_PRP in_IN the_DT chest_NN ????_. And_CC throw_VB himself_PRP in_IN a_DT river_NN ??_. THIS_DT IS_VBZ OBVIOUS_JJ !_. MURDER_NN !!_. ”_'' Funeral_NN arrangements_NNS for_IN Dr._NNP Bradstreet_NNP are_VBP still_RB pending_VBG at_IN the_DT Cecil_NNP M._NNP Burton_NNP funeral_NN home_NN in_IN Shelby_NNP ,_, Georgia_NNP ._. This_DT article_NN was_VBD posted_VBN :_: Friday_NNP ,_, June_NNP 26_CD ,_, 2015_CD at_IN 3:05_CD pm_NN","JJ NN : NN of NN Who VBD NNS To NN VBN VBG in NN NNP NNP NNP VBD NNS whose NNS VBD VBN to VB VBN VBN by NNS A JJ NN NN and NN NN VBD VBN JJ VBG in a NNP NNP NN JJ NN under what JJ VBP VBG JJ NNS . A NN VBD the NN of NNP NNP NNP NNP in the NNP NNP NNP in NNP NNP , NNP NNP , JJ NNP NN . “ NNP VBD a NN NN to the NN , which VBD to VB NN VBN , VBG to NNS , ” VBD NNP . In a NN NN , the NNP NNP NNP ’s NNP VBD , “ NNS from the NNP NNP NNP NNP VBD to the NN and VBD a NN from the NN . ” An NN into the NN VBZ JJ , and the NNS of an NN VBP RB RB JJ . NNP NNP VBD a JJ NN in NNP , NNP , which VBD on “ VBG NNS with NN NN NN , NN , and JJ JJ and JJ NNS . ” Among JJ NNS , NNP NNP ’s NNP NNP RB VBD out “ NN NN ” NNS , VBG the JJ NN to VB a VBG NN in the NN of NN NN . NNP NNP VBD the NN to VB the NN of the NN after his JJ NN VBD the NN VBG JJ NN . “ NNP VBD me JJR about NN than JJ NN VBD , ” the NN RB VBD at a NN , VBG to the NNP NNP ’ NNP NNP . In NN to VBG NNS , NNP VBZ RB VBN NN NN in JJ NN on NN of NN - VBN NNS and VBD NN and NN of the NNP NNP NNP NNP NNP , which at one NN VBD the RB - VBN NN NN NNP NNP NNP as “ NN NN . ” The NNS VBG NNP ’s NN VBP VBN all the RBR JJ by a JJ NN NN VBN by the NNP on his NNS . “ The NNP VBZ RB to VB why NNS VBD the NN of the NN , RB a JJ NN who VBZ VBN JJ for RB over a NN , ” VBD the NNP NNP NNP . JJ NN NNS VBN to NNP ’s NN VBP VBN with NNS from NNS who VBP the VBN NN VBD their NNS for the JJR . “ NNP NNP VBD my NN ’s NN after my NN VBD VBN with NN . He VBD NNS , ” one NNP NN NNS . “ At 16 , my NN VBZ RB VBG at a JJ NN NN to him . I VBP him every NN . ” “ I will RB VB JJ and JJ for NNP NNP VBG my NN from NN , ” another NN VBZ . “ NNS VBP VBN my NN ’s NN so that he can VB up and VB a JJ JJ NN . NNP NNP will VB VBN RB ! ” A NNP NN VBZ RB VBN VBN up by one of NNP ’s NN NNS VBG “ To VB the NNS to the JJ NNS VBG up to the NN of NNP NNP , VBG an JJ NN into the NN of JJ NN . ” Despite his NN VBG the NN VB from NN , JJ VBP RB VBG the NN ’s NN to VB NN of a NN . “ NN - VBN ? In the NN ? I VBP RB VBG this , ” one NN in the NNP NNS NN NNS . “ This VBD a NN who VBD NN to NNS of all NNS . This VBD a JJ NN with a VBG JJ NN . JJ , but this VBZ of NN and NN NN . ” Another NN VBD a RBR JJ NN : “ He VBD RB VB himself ! He VBD VBN for who he VBD VBG against , what he VBD , and what he VBD VBG about it . He VBD JJ NN JJ NN with JJ NNS to VB . He VBD VBN . VBD . VBN . Why would a NN who VBD NN to NNS and could VB RB VB himself in the NN ???? And VB himself in a NN ?? THIS VBZ JJ ! NN !! ” NN NNS for NNP NNP VBP RB VBG at the NNP NNP NNP NN NN in NNP , NNP . This NN VBD VBN : NNP , NNP 26 , 2015 at 3:05 NN"
92,810,conspiracy,C0013d,aids; big.pharma; chemtrails; coronavirus; covid.19; vaccine; vaccine.covid,"In_IN four_CD days_NNS this_DT past_JJ week_NN ,_, the_DT market_NN sold_VBD off_RP nearly_RB 4,000_CD points_NNS and_CC wiped_VBD out_RP four_CD months_NNS of_IN gains_NNS ._. Bo_NNP Polny_NNP warned_VBD of_IN a_DT coming_VBG market_NN crash_NN on_IN February_NNP 8_CD on_IN USAWatchdog.com_NNP ._. Polny_NNP was_VBD ridiculed_VBN after_IN the_DT market_NN went_VBD to_IN new_JJ record_NN highs_NNS ,_, but_CC that_DT was_VBD short_JJ lived_VBN ,_, and_CC now_RB Polny_NNP says_VBZ it_PRP ’s_VBZ going_VBG to_TO get_VB worse_JJR ._. The_DT Democrats_NNPS are_VBP facing_VBG a_DT lose_NN /_, lose_NN situation_NN with_IN Bernie_NNP Sanders_NNP ._. If_IN he_PRP wins_VBZ the_DT nomination_NN to_TO represent_VB Democrats_NNPS in_IN November_NNP ,_, many_JJ will_MD turn_VB their_PRP$ backs_NNS on_IN the_DT socialist_NN that_WDT praises_VBZ communism_NN ._. If_IN the_DT Democrats_NNPS stop_VBP him_PRP and_CC cheat_VBP him_PRP again_RB ,_, Bernie_NNP supporters_NNS will_MD flee_VB the_DT party_NN ._. We_PRP are_VBP living_VBG in_IN an_DT age_NN when_WRB lots_NNS of_IN things_NNS are_VBP being_VBG revealed_VBN ._. We_PRP are_VBP finding_VBG out_RP our_PRP$ heroes_NNS are_VBP fake_JJ (_-LRB- Clint_NNP Eastwood_NNP )_-RRB- ,_, right_RB along_IN with_IN our_PRP$ markets_NNS and_CC politicians_NNS ._. Join_VB Greg_NNP Hunter_NNP from_IN USAWatchdog.com_NNP as_IN he_PRP talks_VBZ about_IN these_DT stories_NNS and_CC more_JJR in_IN the_DT Weekly_NNP News_NNP Wrap_NNP -_HYPH Up_NNP ._. Bill_NNP Holter_NNP from_IN JSMineset.com_NNP will_MD be_VB the_DT guest_NN for_IN the_DT Early_JJ Sunday_NNP Release_NNP ._. Do_VB n’t_RB even_RB think_VB that_IN the_DT downturn_NN is_VBZ over_RB —_: it_PRP ’s_VBZ not_RB ._.","In four NNS this JJ NN , the NN VBD off RB 4,000 NNS and VBD out four NNS of NNS . NNP NNP VBD of a VBG NN NN on NNP 8 on NNP . NNP VBD VBN after the NN VBD to JJ NN NNS , but that VBD JJ VBN , and RB NNP VBZ it VBZ VBG to VB JJR . The NNPS VBP VBG a NN / NN NN with NNP NNP . If he VBZ the NN to VB NNPS in NNP , JJ will VB their NNS on the NN that VBZ NN . If the NNPS VBP him and VBP him RB , NNP NNS will VB the NN . We VBP VBG in an NN when NNS of NNS VBP VBG VBN . We VBP VBG out our NNS VBP JJ ( NNP NNP ) , RB along with our NNS and NNS . VB NNP NNP from NNP as he VBZ about these NNS and JJR in the NNP NNP NNP - NNP . NNP NNP from NNP will VB the NN for the JJ NNP NNP . VB RB RB VB that the NN VBZ RB — it VBZ RB ."
93,270,conspiracy,C00452,cancer; gmo; population.control; vaccine; vaccine.covid,"Many_JJ years_NNS have_VBP passed_VBN while_IN alert_NN men_NNS and_CC women_NNS have_VBP watched_VBN the_DT insane_JJ and_CC destructive_JJ policies_NNS of_IN the_DT western_JJ governments_NNS reek_VBP havoc_NN on_IN the_DT world_NN ._. Writers_NNS and_CC reporters_NNS have_VBP spent_VBN countless_JJ hours_NNS cataloging_VBG the_DT damage_NN and_CC ruined_VBN lives_NNS created_VBN by_IN the_DT crazed_VBN decisions_NNS of_IN elected_VBN and_CC appointed_VBN leaders_NNS ,_, and_CC through_IN all_DT of_IN it_PRP seeking_VBG to_TO make_VB sense_NN and_CC convince_VB them_PRP to_TO change_VB their_PRP$ policy_NN ._. Now_RB we_PRP understand_VBP why_WRB they_PRP behave_VBP like_IN demon_NN possessed_VBN brutes_NNS and_CC perverts_NNS ._. That_DT is_VBZ exactly_RB what_WP they_PRP are_VBP !_. High_JJ level_NN policy_NN has_VBZ required_VBN that_IN only_RB those_DT with_IN such_JJ fallibilities_NNS can_MD be_VB trusted_VBN to_TO execute_VB the_DT agenda_NN decided_VBN upon_IN almost_RB seventy_CD years_NNS ago_RB ._. The_DT article_NN quoted_VBD below_RB gives_VBZ a_DT quite_RB reasoned_JJ explanation_NN for_IN these_DT policies_NNS as_IN “_`` hard_JJ choices_NNS ”_'' gone_VBN wrong_JJ ._. The_DT author_NN of_IN the_DT article_NN is_VBZ an_DT advocate_NN of_IN population_NN control_NN ,_, but_CC not_RB in_IN the_DT dishonest_JJ and_CC deceitful_JJ way_NN it_PRP has_VBZ been_VBN approached_VBN since_IN WW2_NNP ._. Read_VB it_PRP and_CC understand_VB that_IN the_DT poisoning_NN of_IN the_DT land_NN water_NN and_CC air_NN is_VBZ no_DT accident_NN ,_, but_CC the_DT intended_VBN route_NN to_IN global_JJ population_NN control_NN ._. …._LS the_DT international_JJ security_NN prerogative_NN of_IN population_NN control_NN ,_, pursued_VBN since_IN its_PRP$ inception_NN in_IN 1945_CD by_IN adulterating_VBG the_DT basic_JJ elements_NNS of_IN life_NN with_IN chemical_JJ and_CC biological_JJ toxins_NNS to_TO subvert_VB fertility_NN and_CC longevity_NN and_CC by_IN undermining_VBG the_DT family_NN structure_NN through_IN psychosocial_JJ and_CC economic_JJ means_NNS to_TO delay_VB the_DT formation_NN of_IN families_NNS and_CC keep_VB them_PRP small_JJ …_. From_IN :_: The_DT Subversion_NNP of_IN Medicine_NNP and_CC Public_NNP Health_NNP by_IN International_NNP Security_NNP Prerogatives_NNPS Far_RB from_IN protecting_VBG the_DT population_NN ,_, the_DT leadership_NN has_VBZ assumed_VBN that_IN it_PRP is_VBZ disposable_JJ ,_, and_CC treated_VBD us_PRP all_DT with_IN a_DT disdain_NN incomprehensible_JJ ,_, except_IN when_WRB we_PRP understand_VBP their_PRP$ depopulation_NN agenda_NN ._. This_DT page_NN is_VBZ intended_VBN as_IN a_DT guide_NN to_TO help_VB our_PRP$ members_NNS discover_VB the_DT truth_NN and_CC act_VB on_IN it_PRP ._. For_IN this_DT reason_NN we_PRP are_VBP focused_VBN on_IN the_DT health_NN issues_NNS personal_JJ choices_NNS can_MD affect_VB ._. Within_IN the_DT context_NN of_IN the_DT above_JJ quote_NN are_VBP so_RB many_JJ deliberate_JJ policies_NNS that_WDT damage_VBP the_DT innocent_NN we_PRP can_MD scarcely_RB begin_VB to_TO list_VB them_PRP here_RB ._. In_IN fact_NN most_JJS of_IN them_PRP are_VBP beyond_IN the_DT ability_NN of_IN individuals_NNS to_TO change_VB or_CC deal_VB with_IN ,_, being_VBG the_DT result_NN of_IN a_DT sequence_NN of_IN high_JJ level_NN decisions_NNS directed_VBN by_IN the_DT depopulation_NN agenda_NN ._. Health_NN issues_NNS can_MD be_VB acted_VBN upon_IN ,_, so_RB here_RB we_PRP have_VBP provided_VBN five_CD pages_NNS of_IN links_NNS relating_VBG to_IN things_NNS you_PRP can_MD avoid_VB or_CC do_VB to_TO live_VB more_RBR securely_RB ._. •_SYM Quantum_NN Leap_NN MMS_NN Documentary_NN and_CC Movement_NN this_DT is_VBZ a_DT simple_JJ discovery_NN by_IN a_DT man_NN who_WP wanted_VBD to_TO help_VB a_DT friend_NN deal_VB with_IN malaria_NN while_IN on_IN an_DT expedition_NN in_IN the_DT Amazon_NNP ._. Instead_RB slowing_VBG the_DT infection_NN it_PRP totally_RB cured_VBD it_PRP within_IN a_DT few_JJ days_NNS ._. From_IN that_DT experience_NN he_PRP went_VBD on_RP to_TO test_VB it_PRP on_IN many_JJ other_JJ problems_NNS with_IN incredible_JJ results_NNS ._. Now_RB the_DT FDA_NNP and_CC big_JJ Pharma_NNP are_VBP working_VBG to_TO crush_VB this_DT information_NN …_, too_RB late_JJ !_. It_PRP ’s_VBZ out_IN of_IN the_DT bag_NN and_CC running_VBG wild_RB all_RB over_IN the_DT world_NN ._. Read_VB the_DT article_NN and_CC discover_VB that_IN it_PRP attacks_VBZ all_DT of_IN diseases_NNS as_RB well_RB as_IN malaria_NN ._. One_CD thing_NN you_PRP may_MD notice_VB is_VBZ that_IN the_DT reason_NN it_PRP is_VBZ being_VBG subverted_VBN is_VBZ not_RB identified_VBN by_IN the_DT MMS_NNP proponents_NNS ,_, but_CC the_DT reason_NN is_VBZ the_DT depopulation_NN agenda_NN ._. It_PRP ’s_VBZ global_JJ policy_NN from_IN the_DT UN_NNP down_IN the_DT local_JJ vaccination_NN clinic_NN ._. Shorten_VB their_PRP$ lives_NNS and_CC make_VB them_PRP infertile_JJ ._. •_NFP The_DT Many_JJ Dangers_NNS of_IN Vaccines_NNS :_: A_DT List_NN of_IN Links_NNS •_SYM Holistic_JJ Cancer_NN Treatments_NNS –_: What_WP The_DT Doctors_NNS Wo_MD n’t_RB Tell_VB you_PRP :_: Links_NNS and_CC Information_NN •_, Dangers_NNS and_CC Truth_NN about_IN Atmospheric_JJ Spraying_NN also_RB known_VBN as_IN Chemtrails_NNS As_IN part_NN of_IN this_DT agenda_NN they_PRP have_VBP suppressed_VBN policies_NNS and_CC technology_NN that_WDT would_MD have_VB solved_VBN all_DT of_IN the_DT problems_NNS they_PRP have_VBP claimed_VBN to_TO justify_VB their_PRP$ intentions_NNS ,_, and_CC this_DT will_MD be_VB discussed_VBN in_IN other_JJ posts_NNS and_CC articles_NNS ._. When_WRB it_PRP is_VBZ all_RB seen_VBN and_CC discussed_VBN ,_, I_PRP believe_VBP we_PRP will_MD discover_VB that_IN they_PRP are_VBP guilty_JJ of_IN criminal_JJ intent_NN ,_, based_VBN on_IN a_DT Satanic_JJ belief_NN system_NN and_CC elitist_JJ perception_NN of_IN themselves_PRP and_CC our_PRP$ world_NN ._. All_DT of_IN this_DT is_VBZ well_RB covered_VBN on_IN this_DT site_NN ._.","JJ NNS VBP VBN while NN NNS and NNS VBP VBN the JJ and JJ NNS of the JJ NNS VBP NN on the NN . NNS and NNS VBP VBN JJ NNS VBG the NN and VBN NNS VBN by the VBN NNS of VBN and VBN NNS , and through all of it VBG to VB NN and VB them to VB their NN . RB we VBP why they VBP like NN VBN NNS and NNS . That VBZ RB what they VBP ! JJ NN NN VBZ VBN that RB those with JJ NNS can VB VBN to VB the NN VBN upon RB seventy NNS RB . The NN VBD RB VBZ a RB JJ NN for these NNS as “ JJ NNS ” VBN JJ . The NN of the NN VBZ an NN of NN NN , but RB in the JJ and JJ NN it VBZ VBN VBN since NNP . VB it and VB that the NN of the NN NN and NN VBZ no NN , but the VBN NN to JJ NN NN . …. the JJ NN NN of NN NN , VBN since its NN in 1945 by VBG the JJ NNS of NN with JJ and JJ NNS to VB NN and NN and by VBG the NN NN through JJ and JJ NNS to VB the NN of NNS and VB them JJ … From : The NNP of NNP and NNP NNP by NNP NNP NNPS RB from VBG the NN , the NN VBZ VBN that it VBZ JJ , and VBD us all with a NN JJ , except when we VBP their NN NN . This NN VBZ VBN as a NN to VB our NNS VB the NN and VB on it . For this NN we VBP VBN on the NN NNS JJ NNS can VB . Within the NN of the JJ NN VBP RB JJ JJ NNS that VBP the NN we can RB VB to VB them RB . In NN JJS of them VBP beyond the NN of NNS to VB or VB with , VBG the NN of a NN of JJ NN NNS VBN by the NN NN . NN NNS can VB VBN upon , RB RB we VBP VBN five NNS of NNS VBG to NNS you can VB or VB to VB RBR RB . • NN NN NN NN and NN this VBZ a JJ NN by a NN who VBD to VB a NN VB with NN while on an NN in the NNP . RB VBG the NN it RB VBD it within a JJ NNS . From that NN he VBD on to VB it on JJ JJ NNS with JJ NNS . RB the NNP and JJ NNP VBP VBG to VB this NN … RB JJ ! It VBZ out of the NN and VBG RB RB over the NN . VB the NN and VB that it VBZ all of NNS RB RB as NN . One NN you may VB VBZ that the NN it VBZ VBG VBN VBZ RB VBN by the NNP NNS , but the NN VBZ the NN NN . It VBZ JJ NN from the NNP down the JJ NN NN . VB their NNS and VB them JJ . • The JJ NNS of NNS : A NN of NNS • JJ NN NNS – What The NNS Wo RB VB you : NNS and NN • NNS and NN about JJ NN RB VBN as NNS As NN of this NN they VBP VBN NNS and NN that would VB VBN all of the NNS they VBP VBN to VB their NNS , and this will VB VBN in JJ NNS and NNS . When it VBZ RB VBN and VBN , I VBP we will VB that they VBP JJ of JJ NN , VBN on a JJ NN NN and JJ NN of themselves and our NN . All of this VBZ RB VBN on this NN ."
94,70,mainstream,M09dd5,covid.19; vaccine,"Pharma_NNP is_VBZ looking_VBG to_TO reset_VB its_PRP$ image_NN with_IN COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS ,_, but_CC landmines_NNS loom_VBP —_: with_IN pricing_NN likely_RB the_DT biggest_JJS ._. The_DT halo_NN from_IN pharma_NN ’s_POS rapid_JJ response_NN in_IN research_NN and_CC discovery_NN —_: and_CC the_DT hope_NN that_IN a_DT vaccine_NN or_CC effective_JJ treatments_NNS will_MD allow_VB the_DT world_NN to_TO return_VB to_IN some_DT sort_NN of_IN normal_JJ —_: has_VBZ propelled_VBN the_DT industry_NN ’s_POS reputation_NN at_IN an_DT all_DT -_HYPH time_NN high_NN ._. Forty_CD percent_NN of_IN Americans_NNPS say_VBP their_PRP$ opinion_NN of_IN the_DT pharma_NN industry_NN has_VBZ turned_VBN positive_JJ during_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, according_VBG to_IN The_DT Harris_NNP Poll_NNP ._. However_RB ,_, pricing_NN lurks_VBZ just_RB beyond_IN the_DT lab_NN ._. Just_RB this_DT week_NN in_IN media_NN ,_, one_CD well_RB -_HYPH known_VBN pundit_NN posited_VBN in_IN a_DT Forbes_NNP column_NN that_WDT the_DT industry_NN ’s_POS reputation_NN hinges_VBZ on_IN the_DT pricing_NN of_IN Gilead_NNP Sciences_NNPS '_POS treatment_NN remdesivir_NN ,_, while_IN another_DT touted_VBD Pfizer_NNP CEO_NN Albert_NNP Bourla_NNP ’s_POS promise_NN to_TO not_RB price_VB its_PRP$ vaccine_NN too_RB high_JJ in_IN part_NN because_IN “_`` people_NNS will_MD not_RB forget_VB if_IN you_PRP do_VBP that_DT ._. ”_'' Yet_CC in_IN the_DT same_JJ Axios_NNP article_NN ,_, Bourla_NNP is_VBZ quoted_VBN as_IN saying_VBG the_DT vaccine_NN represents_VBZ a_DT “_`` huge_JJ commercial_JJ opportunity_NN ”_'' for_IN Pfizer_NNP ._. Industry_NN experts_NNS say_VBP it_PRP ’s_VBZ a_DT safe_JJ bet_NN that_IN other_JJ pharma_NN companies_NNS are_VBP wrangling_VBG with_IN the_DT same_JJ contradictory_JJ issues_NNS ._. RELATED_JJ :_: Can_MD the_DT price_NN be_VB right_JJ ?_. With_IN the_DT world_NN watching_VBG ,_, Gilead_NNP faces_VBZ a_DT no-win_JJ decision_NN on_IN remdesivir_NN Stewart_NNP Lyman_NNP ,_, a_DT biotech_NN and_CC pharma_NN consultant_NN ,_, said_VBD while_IN scientists_NNS and_CC researchers_NNS will_MD be_VB satisfied_JJ with_IN just_RB the_DT discovery_NN of_IN a_DT vaccine_NN ,_, executives_NNS at_IN the_DT top_NN of_IN pharma_NN companies_NNS will_MD likely_RB want_VB more_JJR ._. “_`` I_PRP suspect_VBP they_PRP will_MD be_VB very_RB sensitive_JJ to_IN not_RB gouging_VBG because_IN there_EX will_MD be_VB both_CC political_JJ pressure_NN and_CC pressure_NN from_IN the_DT other_JJ companies_NNS to_TO not_RB do_VB that_DT this_DT one_CD time_NN ,_, ”_'' said_VBD Lyman_NNP ,_, who_WP is_VBZ also_RB a_DT former_JJ scientist_NN at_IN Immunex_NNP ,_, now_RB owned_VBN by_IN Amgen_NNP ._. “_`` (_-LRB- But_CC )_-RRB- they_PRP ’re_VBP going_VBG to_TO be_VB looking_VBG for_IN something_NN in_IN return_NN ,_, ""_'' he_PRP added_VBD ._. ""_`` Exactly_RB how_WRB that_DT gets_VBZ sorted_VBN out_RP ,_, I_PRP do_VBP n’t_RB know_VB ,_, but_CC one_PRP can_MD easily_RB imagine_VB a_DT quid_FW pro_FW quo_FW of_IN some_DT type_NN where_WRB they_PRP say_VBP ‘_`` yes_UH ,_, we_PRP ’re_VBP giving_VBG this_DT to_IN you_PRP for_IN cheap_JJ but_CC let_VB ’s_PRP not_RB have_VB any_DT price_NN controls_NNS ’_'' ”_'' on_IN other_JJ drugs_NNS in_IN the_DT future_NN ._. The_DT Harris_NNP Poll_NN Managing_NN Director_NN Rob_NNP Jekielek_NNP said_VBD pricing_NN alone_RB ,_, whether_IN Gilead_NNP 's_POS remdesivir_NN or_CC vaccines_NNS ,_, has_VBZ n't_RB been_VBN the_DT key_NN to_IN pharma_NN 's_POS improved_VBN reputation_NN during_IN the_DT pandemic_NN ._. Pricing_NN has_VBZ been_VBN a_DT top_JJ three_CD issue_NN in_IN Harris_NNP Poll_NNP surveys_NNS since_IN March_NNP ,_, but_CC vaccines_NNS and_CC treatments_NNS —_: especially_RB vaccines_NNS —_: are_VBP what_WP 's_VBZ driving_VBG the_DT hockey_NN -_HYPH stick_NN spike_NN in_IN the_DT industry_NN 's_POS reputation_NN ._. The_DT bigger_JJR pricing_NN issue_NN will_MD be_VB affordability_NN once_IN vaccines_NNS and_CC treatments_NNS are_VBP released_VBN ,_, he_PRP said_VBD ,_, although_IN as_IN he_PRP pointed_VBD out_RP ,_, that_DT will_MD be_VB a_DT more_RBR integrated_VBN issue_NN across_IN industries_NNS including_VBG pharma_NN ,_, insurance_NN ,_, pharmacy_NN benefit_NN managers_NNS and_CC others_NNS ._. ""_`` If_IN a_DT vaccine_NN or_CC treatment_NN exists_VBZ ,_, but_CC Americans_NNPS ca_MD n’t_RB afford_VB to_TO get_VB it_PRP ,_, especially_RB the_DT most_RBS vulnerable_JJ or_CC at_IN risk_NN populations_NNS —_: for_IN example_NN ,_, lower_JJR income_NN ,_, minority_NN ,_, or_CC living_VBG in_IN more_RBR densely_RB populated_VBN areas_NNS —_: it_PRP will_MD likely_RB be_VB a_DT major_JJ issue_NN ,_, ""_'' Jekielek_NNP said_VBD ._. Of_IN course_NN ,_, pricing_NN is_VBZ n’t_RB the_DT only_JJ hurdle_NN pharma_NN companies_NNS face_VBP in_IN navigating_VBG their_PRP$ reputations_NNS through_IN developing_VBG and_CC delivering_VBG COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS ._. Managing_VBG expectations_NNS —_: for_IN instance_NN ,_, avoiding_VBG overpromising_VBG and_CC underdelivering_VBG on_IN a_DT vaccine_NN 's_POS timeline_NN —_: is_VBZ another_DT important_JJ consideration_NN ,_, said_VBD N._NNP Craig_NNP Smith_NNP ,_, the_DT chaired_VBN professor_NN of_IN ethics_NN and_CC social_JJ responsibility_NN at_IN INSEAD_NNP graduate_NN business_NN school_NN in_IN France_NNP ._. Smith_NNP pointed_VBD to_IN global_JJ access_NN to_IN vaccines_NNS and_CC treatments_NNS ,_, along_IN with_IN manufacturing_NN and_CC distribution_NN issues_NNS ,_, as_IN other_JJ challenges_NNS ._. He_PRP co-authored_VBD an_DT MIT_NNP Sloan_NNP Management_NN Review_NN article_NN about_IN the_DT liability_NN of_IN the_DT pharma_NN industry_NN 's_POS competition_NN -_HYPH based_VBN model_NN in_IN COVID_NN -_HYPH 19_CD drug_NN development_NN ._. “_`` There_EX are_VBP still_RB questions_NNS around_IN how_WRB drugs_NNS and_CC vaccine_NN get_VBP made_VBN available_JJ ,_, who_WP gets_VBZ them_PRP first_RB and_CC what_WDT prices_NNS are_VBP charged_VBN ,_, but_CC I_PRP do_VBP think_VB there_EX ’s_VBZ a_DT great_JJ opportunity_NN here_RB for_IN the_DT industry_NN to_TO come_VB out_RP looking_VBG a_DT whole_JJ lot_NN better_JJR than_IN it_PRP has_VBZ in_IN recent_JJ years_NNS ,_, ”_'' Smith_NNP said_VBD ._. Safety_NN and_CC efficacy_NN of_IN the_DT medicines_NNS is_VBZ yet_RB another_DT consideration_NN ._. While_IN Operation_NNP Warp_NNP Speed_NNP in_IN both_CC name_NN and_CC effort_NN seems_VBZ to_TO be_VB focused_VBN on_IN speed_NN ,_, Lyman_NNP said_VBD ,_, safety_NN and_CC efficacy_NN are_VBP both_CC more_RBR important_JJ ._. “_`` Coming_VBG up_RP with_IN and_CC launching_VBG a_DT vaccine_NN fast_RB —_: but_CC one_CD that_WDT is_VBZ neither_CC safe_JJ or_CC efficacious_JJ or_CC is_VBZ just_RB one_CD of_IN those_DT —_: would_MD be_VB an_DT unmitigated_JJ disaster_NN ,_, ”_'' he_PRP said_VBD ._. “_`` Not_RB just_RB for_IN the_DT COVID_NN -_HYPH 19_CD programs_NNS ,_, but_CC for_IN every_DT other_JJ vaccine_NN made_VBN these_DT days_NNS ._. Because_IN then_RB you_PRP ’re_VBP going_VBG to_TO get_VB people_NNS afraid_JJ ,_, pushed_VBN by_IN these_DT anti-vaccine_JJ groups_NNS ,_, and_CC starting_VBG to_TO question_VB the_DT safety_NN and_CC efficacy_NN of_IN other_JJ vaccines_NNS ._. ”_'' RELATED_JJ :_: One_CD COVID_NN -_HYPH 19_CD opportunity_NN for_IN pharma_NN ?_. A_DT chance_NN to_TO bolster_VB its_PRP$ reputation_NN ,_, Lilly_NNP CEO_NN says_VBZ Jane_NNP Sarasohn_NNP -_HYPH Kahn_NNP ,_, a_DT health_NN economist_NN with_IN THINK_NNP -_HYPH Health_NNP and_CC blogger_NN at_IN Health_NNP Populi_NNP ,_, agreed_VBD about_IN the_DT vaccine_NN concerns_NNS ._. She_PRP has_VBZ already_RB begun_VBN to_TO see_VB shifts_NNS in_IN opinions_NNS in_IN the_DT past_JJ few_JJ weeks_NNS as_IN the_DT pandemic_NN wears_VBZ on_RP ._. “_`` There_EX ’s_VBZ been_VBN an_DT erosion_NN in_IN public_JJ support_NN in_IN the_DT U.S._NNP for_IN vaccines_NNS —_: we_PRP ’ve_VBP seen_VBN challenges_NNS in_IN getting_VBG people_NNS signed_VBN up_RP into_IN trials_NNS ,_, and_CC a_DT growing_VBG chasm_NN between_IN folks_NNS who_WP would_MD plan_VB to_TO take_VB advantage_NN of_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN versus_IN those_DT who_WP would_MD not_RB ,_, ”_'' she_PRP said_VBD in_IN an_DT email_NN ._. Still_RB ,_, pricing_NN is_VBZ top_NN of_IN mind_NN not_RB just_RB for_IN pharma_NN companies_NNS but_CC for_IN government_NN officials_NNS ._. Consumer_NN pricing_NN bills_NNS in_IN both_CC the_DT U.S._NNP House_NNP and_CC Senate_NNP seek_VBP to_TO limit_VB companies_NNS from_IN profiting_VBG during_IN national_JJ emergencies_NNS ._. That_DT includes_VBZ drug_NN companies_NNS and_CC would_MD impose_VB a_DT 10_CD %_NN profit_NN margin_NN for_IN treatments_NNS or_CC vaccines_NNS ._. However_RB ,_, Anthony_NNP Fauci_NNP ,_, M.D._NNP ,_, head_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, cautioned_VBD at_IN BIO_NNP this_DT week_NN that_IN “_`` the_DT federal_JJ government_NN should_MD n’t_RB force_VB drug_NN companies_NNS to_TO lower_VB the_DT costs_NNS of_IN COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS but_CC should_MD encourage_VB fair_JJ pricing_NN ,_, ”_'' according_VBG to_IN a_DT Bloomberg_NNP report_NN ._. Where_WRB does_VBZ that_DT leave_VB the_DT industry_NN ?_. In_IN a_DT delicate_JJ spot_NN ._. As_IN Forbes_NNP contributor_NN John_NNP LaMattina_NNP summed_VBD up_RP in_IN his_PRP$ column_NN about_IN the_DT importance_NN of_IN Gilead_NNP 's_POS pricing_NN decision_NN ,_, saying_VBG that_IN it_PRP “_'' will_MD set_VB the_DT tone_NN for_IN the_DT Covid_NNP -_HYPH 19_CD vaccines_NNS and_CC drugs_NNS that_WDT will_MD follow_VB ._. It_PRP will_MD also_RB impact_VB the_DT reputation_NN of_IN the_DT whole_JJ industry_NN ._. It_PRP ’s_VBZ not_RB an_DT easy_JJ decision_NN ._. Let_VB ’s_PRP hope_VB they_PRP get_VBP it_PRP right_JJ ._. ”_''","NNP VBZ VBG to VB its NN with NN - 19 NNS and NNS , but NNS VBP — with NN RB the JJS . The NN from NN ’s JJ NN in NN and NN — and the NN that a NN or JJ NNS will VB the NN to VB to some NN of JJ — VBZ VBN the NN ’s NN at an all - NN NN . Forty NN of NNPS VBP their NN of the NN NN VBZ VBN JJ during the NN - 19 NN , VBG to The NNP NNP . RB , NN VBZ RB beyond the NN . RB this NN in NN , one RB - VBN NN VBN in a NNP NN that the NN ’s NN VBZ on the NN of NNP NNPS ' NN NN , while another VBD NNP NN NNP NNP ’s NN to RB VB its NN RB JJ in NN because “ NNS will RB VB if you VBP that . ” Yet in the JJ NNP NN , NNP VBZ VBN as VBG the NN VBZ a “ JJ JJ NN ” for NNP . NN NNS VBP it VBZ a JJ NN that JJ NN NNS VBP VBG with the JJ JJ NNS . JJ : Can the NN VB JJ ? With the NN VBG , NNP VBZ a JJ NN on NN NNP NNP , a NN and NN NN , VBD while NNS and NNS will VB JJ with RB the NN of a NN , NNS at the NN of NN NNS will RB VB JJR . “ I VBP they will VB RB JJ to RB VBG because there will VB both JJ NN and NN from the JJ NNS to RB VB that this one NN , ” VBD NNP , who VBZ RB a JJ NN at NNP , RB VBN by NNP . “ ( But ) they VBP VBG to VB VBG for NN in NN , "" he VBD . "" RB how that VBZ VBN out , I VBP RB VB , but one can RB VB a FW FW FW of some NN where they VBP ‘ yes , we VBP VBG this to you for JJ but VB ’s RB VB any NN NNS ’ ” on JJ NNS in the NN . The NNP NN NN NN NNP NNP VBD NN RB , whether NNP 's NN or NNS , VBZ RB VBN the NN to NN 's VBN NN during the NN . NN VBZ VBN a JJ three NN in NNP NNP NNS since NNP , but NNS and NNS — RB NNS — VBP what VBZ VBG the NN - NN NN in the NN 's NN . The JJR NN NN will VB NN once NNS and NNS VBP VBN , he VBD , although as he VBD out , that will VB a RBR VBN NN across NNS VBG NN , NN , NN NN NNS and NNS . "" If a NN or NN VBZ , but NNPS ca RB VB to VB it , RB the RBS JJ or at NN NNS — for NN , JJR NN , NN , or VBG in RBR RB VBN NNS — it will RB VB a JJ NN , "" NNP VBD . Of NN , NN VBZ RB the JJ NN NN NNS VBP in VBG their NNS through VBG and VBG NN - 19 NNS and NNS . VBG NNS — for NN , VBG VBG and VBG on a NN 's NN — VBZ another JJ NN , VBD NNP NNP NNP , the VBN NN of NN and JJ NN at NNP NN NN NN in NNP . NNP VBD to JJ NN to NNS and NNS , along with NN and NN NNS , as JJ NNS . He VBD an NNP NNP NN NN NN about the NN of the NN NN 's NN - VBN NN in NN - 19 NN NN . “ There VBP RB NNS around how NNS and NN VBP VBN JJ , who VBZ them RB and what NNS VBP VBN , but I VBP VB there VBZ a JJ NN RB for the NN to VB out VBG a JJ NN JJR than it VBZ in JJ NNS , ” NNP VBD . NN and NN of the NNS VBZ RB another NN . While NNP NNP NNP in both NN and NN VBZ to VB VBN on NN , NNP VBD , NN and NN VBP both RBR JJ . “ VBG up with and VBG a NN RB — but one that VBZ neither JJ or JJ or VBZ RB one of those — would VB an JJ NN , ” he VBD . “ RB RB for the NN - 19 NNS , but for every JJ NN VBN these NNS . Because RB you VBP VBG to VB NNS JJ , VBN by these JJ NNS , and VBG to VB the NN and NN of JJ NNS . ” JJ : One NN - 19 NN for NN ? A NN to VB its NN , NNP NN VBZ NNP NNP - NNP , a NN NN with NNP - NNP and NN at NNP NNP , VBD about the NN NNS . She VBZ RB VBN to VB NNS in NNS in the JJ JJ NNS as the NN VBZ on . “ There VBZ VBN an NN in JJ NN in the NNP for NNS — we VBP VBN NNS in VBG NNS VBN up into NNS , and a VBG NN between NNS who would VB to VB NN of a NN - 19 NN versus those who would RB , ” she VBD in an NN . RB , NN VBZ NN of NN RB RB for NN NNS but for NN NNS . NN NN NNS in both the NNP NNP and NNP VBP to VB NNS from VBG during JJ NNS . That VBZ NN NNS and would VB a 10 NN NN NN for NNS or NNS . RB , NNP NNP , NNP , NN of the NNP NNP of NNP and NNP NNPS , VBD at NNP this NN that “ the JJ NN should RB VB NN NNS to VB the NNS of NN - 19 NNS and NNS but should VB JJ NN , ” VBG to a NNP NN . Where VBZ that VB the NN ? In a JJ NN . As NNP NN NNP NNP VBD up in his NN about the NN of NNP 's NN NN , VBG that it “ will VB the NN for the NNP - 19 NNS and NNS that will VB . It will RB VB the NN of the JJ NN . It VBZ RB an JJ NN . VB ’s VB they VBP it JJ . ”"
95,76,mainstream,M0bc57,vaccine.covid,"CAMBRIDGE_NNP ,_, Mass_NNP ._. --_, An_DT experimental_JJ vaccine_NN against_IN the_DT coronavirus_NN showed_VBD encouraging_VBG results_NNS in_IN very_RB early_JJ testing_NN ,_, triggering_VBG hoped_VBN -_HYPH for_IN immune_NN responses_NNS in_IN eight_CD healthy_JJ ,_, middle_JJ -_HYPH aged_JJ volunteers_NNS ,_, its_PRP$ maker_NN announced_VBN Monday_NNP ._. Study_NN volunteers_NNS given_VBN either_CC a_DT low_JJ or_CC medium_JJ dose_NN of_IN the_DT vaccine_NN by_IN Cambridge_NNP ,_, Massachusetts_NNP -_HYPH based_VBN Moderna_NNP Inc._NNP had_VBD antibodies_NNS similar_JJ to_IN those_DT seen_VBN in_IN people_NNS who_WP have_VBP recovered_VBN from_IN COVID_NN -_HYPH 19_CD ._. In_IN the_DT next_JJ phase_NN of_IN the_DT study_NN ,_, led_VBN by_IN the_DT U.S._NNP National_NNP Institutes_NNPS of_IN Health_NNP ,_, researchers_NNS will_MD try_VB to_TO determine_VB which_WDT dose_NN is_VBZ best_JJS for_IN a_DT definitive_JJ experiment_NN that_WDT they_PRP aim_VBP to_TO start_VB in_IN July_NNP ._. In_IN all_DT ,_, 45_CD people_NNS have_VBP received_VBN one_CD or_CC two_CD shots_NNS of_IN the_DT vaccine_NN ,_, which_WDT was_VBD being_VBG tested_VBN at_IN three_CD different_JJ doses_NNS ._. The_DT kind_NN of_IN detailed_JJ antibody_NN results_NNS needed_VBN to_TO assess_VB responses_NNS are_VBP only_RB available_JJ on_IN eight_CD volunteers_NNS so_RB far_RB ._. The_DT vaccine_NN seems_VBZ safe_JJ ,_, the_DT company_NN said_VBD ,_, but_CC much_RB more_RBR extensive_JJ testing_NN is_VBZ needed_VBN to_TO see_VB if_IN it_PRP remains_VBZ so_RB ._. A_DT high_JJ dose_NN version_NN is_VBZ being_VBG dropped_VBN after_IN spurring_VBG some_DT short_JJ -_HYPH term_NN side_NN effects_NNS ._. The_DT results_NNS have_VBP not_RB been_VBN published_VBN and_CC are_VBP only_RB from_IN the_DT first_JJ of_IN three_CD stages_NNS of_IN testing_NN that_IN vaccines_NNS and_CC drugs_NNS normally_RB undergo_VBP ._. U.S._NNP government_NN officials_NNS have_VBP launched_VBN a_DT project_NN called_VBN “_`` Operation_NNP Warp_NNP Speed_NNP ”_'' to_TO develop_VB a_DT vaccine_NN and_CC hopefully_RB have_VB 300_CD million_CD doses_NNS by_IN January_NNP ._. Worldwide_RB ,_, about_RB a_DT dozen_CD vaccine_NN candidates_NNS are_VBP in_IN the_DT first_JJ stages_NNS of_IN testing_NN or_CC nearing_VBG it_PRP ._. Health_NN officials_NNS have_VBP said_VBN that_IN if_IN all_DT goes_VBZ well_RB ,_, studies_NNS of_IN a_DT potential_JJ vaccine_NN might_MD wrap_VB up_RP by_IN very_RB late_RB this_DT year_NN or_CC early_RB next_JJ year_NN ._. More_JJR than_IN 4.7_CD million_CD infections_NNS and_CC 315,000_CD deaths_NNS from_IN the_DT coronavirus_NN have_VBP been_VBN confirmed_VBN worldwide_RB since_IN it_PRP emerged_VBD in_IN China_NNP late_RB last_JJ year_NN ._. There_EX are_VBP no_DT specific_JJ approved_VBN treatments_NNS ,_, although_IN several_JJ are_VBP being_VBG used_VBN on_IN an_DT emergency_NN basis_NN after_IN showing_VBG some_DT promise_NN in_IN preliminary_JJ testing_NN ._. The_DT Associated_NNP Press_NNP Health_NNP and_CC Science_NNP Department_NNP receives_VBZ support_NN from_IN the_DT Howard_NNP Hughes_NNP Medical_NNP Institute_NNP ’s_POS Department_NNP of_IN Science_NNP Education_NNP ._. The_DT AP_NN is_VBZ solely_RB responsible_JJ for_IN all_DT content_NN ._.","NNP , NNP . -- An JJ NN against the NN VBD VBG NNS in RB JJ NN , VBG VBN - for NN NNS in eight JJ , JJ - JJ NNS , its NN VBN NNP . NN NNS VBN either a JJ or JJ NN of the NN by NNP , NNP - VBN NNP NNP VBD NNS JJ to those VBN in NNS who VBP VBN from NN - 19 . In the JJ NN of the NN , VBN by the NNP NNP NNPS of NNP , NNS will VB to VB which NN VBZ JJS for a JJ NN that they VBP to VB in NNP . In all , 45 NNS VBP VBN one or two NNS of the NN , which VBD VBG VBN at three JJ NNS . The NN of JJ NN NNS VBN to VB NNS VBP RB JJ on eight NNS RB RB . The NN VBZ JJ , the NN VBD , but RB RBR JJ NN VBZ VBN to VB if it VBZ RB . A JJ NN NN VBZ VBG VBN after VBG some JJ - NN NN NNS . The NNS VBP RB VBN VBN and VBP RB from the JJ of three NNS of NN that NNS and NNS RB VBP . NNP NN NNS VBP VBN a NN VBN “ NNP NNP NNP ” to VB a NN and RB VB 300 million NNS by NNP . RB , RB a dozen NN NNS VBP in the JJ NNS of NN or VBG it . NN NNS VBP VBN that if all VBZ RB , NNS of a JJ NN might VB up by RB RB this NN or RB JJ NN . JJR than 4.7 million NNS and 315,000 NNS from the NN VBP VBN VBN RB since it VBD in NNP RB JJ NN . There VBP no JJ VBN NNS , although JJ VBP VBG VBN on an NN NN after VBG some NN in JJ NN . The NNP NNP NNP and NNP NNP VBZ NN from the NNP NNP NNP NNP ’s NNP of NNP NNP . The NN VBZ RB JJ for all NN ."
96,771,conspiracy,C01011,vaccine.covid,"“_`` Roadmap_NN on_IN Vaccination_NN ”_'' outlines_VBZ 3_CD year_NN plan_NN for_IN boosting_VBG “_`` vaccine_NN confidence_NN ”_'' and_CC advancing_VBG “_`` electronic_JJ tracking_NN ”_'' A_DT report_NN published_VBN by_IN the_DT European_NNP Commission_NNP in_IN late_JJ 2019_CD reveals_VBZ that_IN the_DT EU_NNP has_VBZ been_VBN looking_VBG to_TO increase_VB the_DT scope_NN and_CC power_NN of_IN vaccination_NN programmes_NNS since_IN well_RB before_IN the_DT current_JJ “_`` pandemic_NN ”_'' ._. The_DT endpoint_NN of_IN the_DT Roadmap_NNP is_VBZ ,_, among_IN many_JJ other_JJ things_NNS ,_, to_TO introduce_VB a_DT “_`` common_JJ vaccination_NN card_NN /_, passport_NN ”_'' for_IN all_DT EU_NNP citizens_NNS ._. This_DT proposal_NN will_MD be_VB appearing_VBG before_IN the_DT commission_NN in_IN 2022_CD ,_, with_IN a_DT “_`` feasibility_NN study_NN ”_'' set_VBN to_TO run_VB from_IN 2019_CD through_IN 2021_CD (_-LRB- meaning_VBG ,_, as_IN of_IN now_RB ,_, it_PRP ’s_VBZ about_RB halfway_RB through_RB )_-RRB- ._. To_TO underline_VB the_DT point_NN :_: The_DT “_`` vaccination_NN roadmap_NN ”_'' is_VBZ not_RB an_DT improvised_VBN response_NN to_IN the_DT Covid19_NNP pandemic_NN ,_, but_CC rather_RB an_DT ongoing_JJ plan_NN with_IN roots_NNS going_VBG back_RB to_IN 2018_CD ,_, when_WRB the_DT EU_NNP released_VBD a_DT survey_NN of_IN the_DT public_NN ’s_POS attitude_NN toward_IN vaccines_NNS titled_VBN “_`` 2018_CD State_NNP of_IN Vaccine_NNP Confidence_NNP ”_'' On_IN the_DT back_NN of_IN this_DT research_NN ,_, the_DT EU_NNP then_RB commissioned_VBD a_DT technical_JJ report_NN titled_VBN “_`` Designing_VBG and_CC implementing_VBG an_DT immunisation_NN information_NN system_NN ”_'' ,_, on_IN –_: among_IN other_JJ things_NNS –_: the_DT plausibility_NN of_IN an_DT EU_NNP -_HYPH wide_JJ vaccination_NN monitoring_NN system_NN ._. In_IN the_DT 3rd_JJ quarter_NN of_IN 2019_CD these_DT reports_NNS were_VBD all_RB combined_VBN into_IN the_DT latest_JJS version_NN of_IN the_DT the_DT “_`` Vaccination_NN Roadmap_NN ”_'' ,_, a_DT long_JJ -_HYPH term_NN policy_NN plan_NN to_TO spread_VB vaccine_NN “_`` awareness_NN and_CC understanding_NN ”_'' whilst_IN counteracting_VBG “_`` vaccine_NN myths_NNS ”_'' and_CC combatting_VBG “_`` vaccine_NN hesitancy_NN ”_'' ._.","“ NN on NN ” VBZ 3 NN NN for VBG “ NN NN ” and VBG “ JJ NN ” A NN VBN by the NNP NNP in JJ 2019 VBZ that the NNP VBZ VBN VBG to VB the NN and NN of NN NNS since RB before the JJ “ NN ” . The NN of the NNP VBZ , among JJ JJ NNS , to VB a “ JJ NN NN / NN ” for all NNP NNS . This NN will VB VBG before the NN in 2022 , with a “ NN NN ” VBN to VB from 2019 through 2021 ( VBG , as of RB , it VBZ RB RB RB ) . To VB the NN : The “ NN NN ” VBZ RB an VBN NN to the NNP NN , but RB an JJ NN with NNS VBG RB to 2018 , when the NNP VBD a NN of the NN ’s NN toward NNS VBN “ 2018 NNP of NNP NNP ” On the NN of this NN , the NNP RB VBD a JJ NN VBN “ VBG and VBG an NN NN NN ” , on – among JJ NNS – the NN of an NNP - JJ NN NN NN . In the JJ NN of 2019 these NNS VBD RB VBN into the JJS NN of the the “ NN NN ” , a JJ - NN NN NN to VB NN “ NN and NN ” whilst VBG “ NN NNS ” and VBG “ NN NN ” ."
97,570,mainstream,M07c87,vaccine.covid,"When_WRB you_PRP hear_VBP the_DT term_NN ""_`` ,_, ""_'' you_PRP may_MD think_VB of_IN and_CC the_DT study_NN of_IN the_DT relationships_NNS between_IN different_JJ species_NNS over_IN the_DT span_NN of_IN millions_NNS of_IN years_NNS ._. While_IN the_DT concept_NN of_IN an_DT ""_`` evolutionary_JJ tree_NN ""_'' originated_VBD in_IN Darwin's_NNP ""_`` On_IN the_DT Origin_NN of_IN Species_NNS ,_, ""_'' one_PRP can_MD apply_VB this_DT concept_NN to_IN anything_NN that_WDT evolves_VBZ ,_, including_VBG viruses_NNS ._. Scientists_NNS can_MD study_VB the_DT evolution_NN of_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD to_TO learn_VB more_JJR about_IN how_WRB the_DT genes_NNS of_IN the_DT virus_NN function_VBP ._. It_PRP is_VBZ also_RB useful_JJ to_TO make_VB inferences_NNS about_IN the_DT spread_NN of_IN the_DT virus_NN around_IN the_DT world_NN ,_, and_CC what_WDT type_NN of_IN vaccine_NN may_MD be_VB most_RBS effective_JJ ._. who_WP studies_VBZ the_DT relationships_NNS between_IN epidemics_NNS and_CC viral_JJ evolution_NN ,_, and_CC I_PRP am_VBP among_IN the_DT many_JJ researchers_NNS now_RB studying_VBG the_DT evolution_NN of_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD because_IN it_PRP can_MD help_VB researchers_NNS and_CC public_JJ health_NN officials_NNS track_VB the_DT spread_NN of_IN the_DT virus_NN over_IN time_NN ._. What_WP we_PRP are_VBP finding_VBG is_VBZ that_IN the_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD virus_NN appears_VBZ to_TO be_VB mutating_VBG more_RBR slowly_RB than_IN the_DT seasonal_JJ flu_NN which_WDT may_MD allow_VB scientists_NNS to_TO develop_VB a_DT vaccine_NN ._. Viruses_NNS evolve_VBP by_IN mutating_VBG ._. That_DT is_VBZ ,_, there_EX are_VBP changes_NNS in_IN their_PRP$ genetic_JJ code_NN over_IN time_NN ._. The_DT way_NN it_PRP happens_VBZ is_VBZ a_DT little_JJ like_IN that_DT game_NN of_IN telephone_NN ._. Amy_NNP is_VBZ the_DT first_JJ player_NN ,_, and_CC her_PRP$ word_NN is_VBZ ""_`` CAT_NN ._. ""_'' She_PRP whispers_VBZ her_PRP$ word_NN to_IN Ben_NNP ,_, who_WP accidentally_RB hears_VBZ ""_`` MAT_NN ._. ""_'' Ben_NNP whispers_VBZ his_PRP$ word_NN to_IN Carlos_NNP ,_, who_WP hears_VBZ ""_`` MAD_JJ ._. ""_'' As_IN the_DT game_NN of_IN telephone_NN goes_VBZ on_RP ,_, the_DT word_NN will_MD transform_VB further_RBR and_CC further_RBR away_RB from_IN its_PRP$ original_JJ form_NN ._. We_PRP can_MD think_VB of_IN a_DT biological_JJ genetic_JJ material_NN as_IN a_DT sequence_NN of_IN letters_NNS ,_, and_CC over_IN time_NN ,_, sequences_NNS mutate_VBP :_: The_DT letters_NNS of_IN the_DT sequence_NN can_MD change_VB ._. Scientists_NNS have_VBP developed_VBN various_JJ to_TO help_VB them_PRP study_VB how_WRB mutations_NNS occur_VBP over_IN time_NN ._. Much_JJ like_IN our_PRP$ game_NN of_IN telephone_NN ,_, the_DT genome_NN sequence_NN of_IN the_DT SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD virus_NN changes_VBZ over_IN time_NN :_: Mutations_NNS occur_VBP randomly_RB ,_, and_CC any_DT changes_NNS that_WDT occur_VBP in_IN a_DT given_VBN virus_NN will_MD be_VB inherited_VBN by_IN all_DT copies_NNS of_IN the_DT next_JJ generation_NN ._. Then_RB ,_, much_RB as_IN we_PRP could_MD try_VB to_TO decode_VB how_WRB ""_`` CAT_NN ""_'' became_VBD ""_`` MAD_JJ ,_, ""_'' scientists_NNS can_MD use_VB models_NNS on_IN genetic_JJ evolution_NN to_TO try_VB to_TO determine_VB the_DT most_RBS likely_JJ evolutionary_JJ history_NN of_IN the_DT virus_NN ._. How_WRB can_MD we_PRP apply_VB this_DT to_IN viruses_NNS like_IN COVID_NNP -_HYPH 19_CD ?_. DNA_NN sequencing_NN is_VBZ the_DT process_NN of_IN experimentally_RB finding_VBG the_DT sequence_NN of_IN nucleotides_NNS (_-LRB- A_NNP ,_, C_NNP ,_, G_NNP and_CC T_NN )_-RRB- —_: the_DT chemical_JJ building_NN blocks_NNS of_IN genes_NNS —_: of_IN a_DT piece_NN of_IN DNA_NN ._. DNA_NN sequencing_NN is_VBZ largely_RB used_VBN to_TO study_VB human_JJ diseases_NNS and_CC genetics_NNS ,_, but_CC in_IN recent_JJ years_NNS ,_, sequencing_NN has_VBZ become_VBN a_DT ,_, and_CC as_IN ,_, viral_JJ sequencing_NN will_MD become_VB even_RB more_RBR frequent_JJ as_IN time_NN progresses_VBZ ._. RNA_NNP is_VBZ a_DT molecule_NN similar_JJ to_IN DNA_NN ,_, and_CC it_PRP is_VBZ essentially_RB a_DT temporary_JJ copy_NN of_IN a_DT short_JJ segment_NN of_IN DNA_NN ._. Specifically_RB ,_, in_IN the_DT ,_, DNA_NN is_VBZ transcribed_VBN into_IN RNA_NNP ._. SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ an_DT RNA_NN virus_NN ,_, meaning_VBG our_PRP$ DNA_NN sequencing_NN technologies_NNS cannot_MD directly_RB decode_VB its_PRP$ sequence_NN ._. However_RB ,_, scientists_NNS can_MD first_RB reverse_VB transcribe_VB the_DT RNA_NN of_IN the_DT virus_NN into_IN ,_, which_WDT can_MD then_RB be_VB sequenced_VBN ._. Given_VBN a_DT collection_NN of_IN viral_JJ genome_NN sequences_NNS ,_, we_PRP can_MD use_VB our_PRP$ models_NNS of_IN sequence_NN evolution_NN to_TO predict_VB the_DT virus_NN 's_POS history_NN ,_, and_CC we_PRP can_MD use_VB this_DT to_TO answer_VB questions_NNS like_IN ,_, ""_`` How_WRB fast_RB do_VBP mutations_NNS occur_VB ?_. ""_'' or_CC ""_`` Where_WRB in_IN the_DT genome_NN do_VBP mutations_NNS occur_VBP ?_. ""_'' Knowing_VBG which_WDT genes_NNS are_VBP mutating_VBG frequently_RB can_MD be_VB useful_JJ in_IN drug_NN design_NN ._. Tracking_VBG how_WRB viruses_NNS have_VBP changed_VBN in_IN a_DT location_NN can_MD also_RB answer_VB questions_NNS like_IN ,_, ""_`` How_WRB many_JJ separate_JJ outbreaks_NNS exist_VBP in_IN my_PRP$ community_NN ?_. ""_'' This_DT type_NN of_IN information_NN can_MD help_VB public_JJ health_NN officials_NNS contain_VB the_DT spread_NN of_IN the_DT virus_NN ._. For_IN COVID_NNP -_HYPH 19_CD ,_, there_EX has_VBZ been_VBN a_DT with_IN all_DT scientists_NNS ._. Given_VBN a_DT collection_NN of_IN sequences_NNS with_IN sample_NN dates_NNS ,_, scientists_NNS can_MD infer_VB the_DT evolutionary_JJ history_NN of_IN the_DT samples_NNS in_IN real_JJ -_HYPH time_NN and_CC use_VB the_DT information_NN to_TO ._. One_CD such_JJ initiative_NN is_VBZ ,_, an_DT open_JJ -_HYPH source_NN project_NN that_WDT provides_VBZ users_NNS real_JJ -_HYPH time_NN reports_NNS of_IN the_DT spread_NN of_IN ,_, and_CC many_JJ other_JJ infectious_JJ diseases_NNS ._. Most_RBS recently_RB ,_, they_PRP have_VBP been_VBN spearheading_VBG the_DT evolutionary_JJ tracking_NN of_IN COVID_NN -_HYPH 19_CD by_IN providing_VBG a_DT as_RB well_RB as_IN a_DT meant_VBN to_TO be_VB readable_JJ by_IN the_DT general_JJ public_NN ._. Further_RBR ,_, they_PRP enable_VBP the_DT global_JJ population_NN to_TO benefit_VB from_IN their_PRP$ efforts_NNS by_IN translating_VBG the_DT situation_NN report_NN to_IN many_JJ other_JJ languages_NNS ._. As_IN the_DT amount_NN of_IN available_JJ information_NN grows_VBZ ,_, scientists_NNS need_VBP faster_JJR tools_NNS to_TO be_VB able_JJ to_TO crunch_VB the_DT numbers_NNS ._. at_IN UC_NNP San_NNP Diego_NNP ,_, in_IN collaboration_NN with_IN the_DT led_VBN by_IN ,_, is_VBZ working_VBG to_TO create_VB new_JJ algorithms_NNS ,_, software_NN tools_NNS and_CC computer_NN hardware_NN to_TO make_VB the_DT real_JJ -_HYPH time_NN analysis_NN of_IN the_DT COVID_NN -_HYPH 19_CD epidemic_NN more_RBR feasible_JJ ._. What_WP have_VBP we_PRP learned_VBN about_IN the_DT epidemic_NN ?_. Based_VBN on_IN current_JJ data_NNS ,_, it_PRP seems_VBZ as_IN though_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD mutates_VBZ much_RB more_RBR slowly_RB than_IN the_DT seasonal_JJ flu_NN ._. Specifically_RB ,_, SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD seems_VBZ to_TO have_VB a_DT mutation_NN rate_NN of_IN less_JJR than_IN 25_CD mutations_NNS per_IN year_NN ,_, whereas_IN the_DT seasonal_JJ flu_NN has_VBZ a_DT mutation_NN rate_NN of_IN ._. Given_VBN that_IN the_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD genome_NN is_VBZ almost_RB twice_RB as_RB large_JJ as_IN the_DT seasonal_JJ flu_NN genome_NN ,_, it_PRP seems_VBZ as_IN though_IN the_DT seasonal_JJ flu_NN mutates_VBZ roughly_RB four_CD times_NNS as_RB fast_RB as_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ._. The_DT fact_NN that_IN the_DT seasonal_JJ flu_NN mutates_VBZ so_RB quickly_RB is_VBZ precisely_RB why_WRB it_PRP is_VBZ able_JJ to_TO evade_VB our_PRP$ vaccines_NNS ,_, so_RB the_DT significantly_RB slower_JJR mutation_NN rate_NN of_IN SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD gives_VBZ us_PRP hope_NN for_IN the_DT potential_JJ development_NN of_IN effective_JJ long_JJ -_HYPH lasting_VBG vaccines_NNS against_IN the_DT virus_NN ._. [_-LRB- Get_VB facts_NNS about_IN coronavirus_NN and_CC the_DT latest_JJS research_NN ._. Sign_VB up_RP for_IN The_DT Conversation_NNP 's_POS newsletter_NN ._. ]_-RRB- This_DT article_NN was_VBD originally_RB published_VBN at_IN The_DT publication_NN contributed_VBD the_DT article_NN to_IN Live_NNP Science_NNP 's_POS ._.","When you VBP the NN "" , "" you may VB of and the NN of the NNS between JJ NNS over the NN of NNS of NNS . While the NN of an "" JJ NN "" VBD in NNP "" On the NN of NNS , "" one can VB this NN to NN that VBZ , VBG NNS . NNS can VB the NN of NNP - NNP - 2 to VB JJR about how the NNS of the NN VBP . It VBZ RB JJ to VB NNS about the NN of the NN around the NN , and what NN of NN may VB RBS JJ . who VBZ the NNS between NNS and JJ NN , and I VBP among the JJ NNS RB VBG the NN of NNP - NNP - 2 because it can VB NNS and JJ NN NNS VB the NN of the NN over NN . What we VBP VBG VBZ that the NNP - NNP - 2 NN VBZ to VB VBG RBR RB than the JJ NN which may VB NNS to VB a NN . NNS VBP by VBG . That VBZ , there VBP NNS in their JJ NN over NN . The NN it VBZ VBZ a JJ like that NN of NN . NNP VBZ the JJ NN , and her NN VBZ "" NN . "" She VBZ her NN to NNP , who RB VBZ "" NN . "" NNP VBZ his NN to NNP , who VBZ "" JJ . "" As the NN of NN VBZ on , the NN will VB RBR and RBR RB from its JJ NN . We can VB of a JJ JJ NN as a NN of NNS , and over NN , NNS VBP : The NNS of the NN can VB . NNS VBP VBN JJ to VB them VB how NNS VBP over NN . JJ like our NN of NN , the NN NN of the NNP - NN - 2 NN VBZ over NN : NNS VBP RB , and any NNS that VBP in a VBN NN will VB VBN by all NNS of the JJ NN . RB , RB as we could VB to VB how "" NN "" VBD "" JJ , "" NNS can VB NNS on JJ NN to VB to VB the RBS JJ JJ NN of the NN . How can we VB this to NNS like NNP - 19 ? NN NN VBZ the NN of RB VBG the NN of NNS ( NNP , NNP , NNP and NN ) — the JJ NN NNS of NNS — of a NN of NN . NN NN VBZ RB VBN to VB JJ NNS and NNS , but in JJ NNS , NN VBZ VBN a , and as , JJ NN will VB RB RBR JJ as NN VBZ . NNP VBZ a NN JJ to NN , and it VBZ RB a JJ NN of a JJ NN of NN . RB , in the , NN VBZ VBN into NNP . NNP - NNP - 2 VBZ an NN NN , VBG our NN NN NNS cannot RB VB its NN . RB , NNS can RB VB VB the NN of the NN into , which can RB VB VBN . VBN a NN of JJ NN NNS , we can VB our NNS of NN NN to VB the NN 's NN , and we can VB this to VB NNS like , "" How RB VBP NNS VB ? "" or "" Where in the NN VBP NNS VBP ? "" VBG which NNS VBP VBG RB can VB JJ in NN NN . VBG how NNS VBP VBN in a NN can RB VB NNS like , "" How JJ JJ NNS VBP in my NN ? "" This NN of NN can VB JJ NN NNS VB the NN of the NN . For NNP - 19 , there VBZ VBN a with all NNS . VBN a NN of NNS with NN NNS , NNS can VB the JJ NN of the NNS in JJ - NN and VB the NN to . One JJ NN VBZ , an JJ - NN NN that VBZ NNS JJ - NN NNS of the NN of , and JJ JJ JJ NNS . RBS RB , they VBP VBN VBG the JJ NN of NN - 19 by VBG a RB RB as a VBN to VB JJ by the JJ NN . RBR , they VBP the JJ NN to VB from their NNS by VBG the NN NN to JJ JJ NNS . As the NN of JJ NN VBZ , NNS VBP JJR NNS to VB JJ to VB the NNS . at NNP NNP NNP , in NN with the VBN by , VBZ VBG to VB JJ NNS , NN NNS and NN NN to VB the JJ - NN NN of the NN - 19 NN RBR JJ . What VBP we VBN about the NN ? VBN on JJ NNS , it VBZ as though NNP - NNP - 2 VBZ RB RBR RB than the JJ NN . RB , NNP - NNP - 2 VBZ to VB a NN NN of JJR than 25 NNS per NN , whereas the JJ NN VBZ a NN NN of . VBN that the NNP - NNP - 2 NN VBZ RB RB RB JJ as the JJ NN NN , it VBZ as though the JJ NN VBZ RB four NNS RB RB as NNP - NNP - 2 . The NN that the JJ NN VBZ RB RB VBZ RB why it VBZ JJ to VB our NNS , RB the RB JJR NN NN of NNP - NN - 2 VBZ us NN for the JJ NN of JJ JJ - VBG NNS against the NN . [ VB NNS about NN and the JJS NN . VB up for The NNP 's NN . ] This NN VBD RB VBN at The NN VBD the NN to NNP NNP 's ."
98,107,mainstream,M0b84d,vaccine,"Rising_VBG mumps_NNS cases_NNS in_IN vaccinated_VBN populations_NNS in_IN the_DT United_NNP States_NNPS over_IN the_DT past_JJ decade_NN have_VBP raised_VBN doubts_NNS about_IN mumps_NNS vaccine_NN efficacy_NN ._. Here_RB ,_, Lewnard_NNP et_FW al._FW examined_VBD these_DT outbreaks_NNS using_VBG mumps_NNS vaccine_NN effectiveness_NN data_NNS and_CC dynamic_JJ transmission_NN modeling_NN ._. They_PRP found_VBD that_IN the_DT increase_NN in_IN mumps_NNS cases_NNS is_VBZ more_RBR consistent_JJ with_IN loss_NN of_IN vaccine_NN protection_NN over_IN time_NN ,_, rather_RB than_IN incomplete_JJ protection_NN against_IN an_DT evolving_VBG virus_NN population_NN or_CC lack_NN of_IN immune_JJ response_NN to_IN the_DT vaccine_NN ._. Their_PRP$ work_NN also_RB suggested_VBD that_IN a_DT third_JJ vaccine_NN dose_NN may_MD extend_VB protection_NN ,_, which_WDT could_MD prove_VB useful_JJ in_IN designing_VBG a_DT clinical_JJ action_NN plan_NN to_TO prevent_VB the_DT spread_NN of_IN mumps_NNS ._. After_IN decades_NNS of_IN declining_VBG mumps_NNS incidence_NN amid_IN widespread_JJ vaccination_NN ,_, the_DT United_NNP States_NNPS and_CC other_JJ developed_JJ countries_NNS have_VBP experienced_VBN a_DT resurgence_NN in_IN mumps_NNS cases_NNS over_IN the_DT last_JJ decade_NN ._. Outbreaks_NNS affecting_VBG vaccinated_VBN individuals_NNS and_CC communities_NNS with_IN high_JJ vaccine_NN coverage_NN have_VBP prompted_VBN concerns_NNS about_IN the_DT effectiveness_NN of_IN the_DT live_JJ attenuated_VBN vaccine_NN currently_RB in_IN use_NN ._. It_PRP is_VBZ unclear_JJ whether_IN immune_NN protection_NN wanes_VBZ or_CC whether_IN the_DT vaccine_NN protects_VBZ inadequately_RB against_IN currently_RB circulating_VBG mumps_NNS virus_NN lineages_NNS ._. Synthesizing_VBG data_NNS from_IN six_CD studies_NNS of_IN mumps_NNS vaccine_NN effectiveness_NN ,_, we_PRP estimated_VBD that_IN vaccine_NN -_HYPH derived_VBN immune_NN protection_NN against_IN mumps_NNS wanes_VBZ on_IN average_JJ 27_CD years_NNS (_-LRB- 95_CD %_NN confidence_NN interval_NN ,_, 16_CD to_IN 51_CD years_NNS )_-RRB- after_IN vaccination_NN ._. After_IN accounting_VBG for_IN this_DT waning_NN ,_, we_PRP found_VBD no_DT evidence_NN that_IN the_DT emergence_NN of_IN heterologous_JJ virus_NN genotypes_NNS contributed_VBD to_IN changes_NNS in_IN vaccine_NN effectiveness_NN over_IN time_NN ._. A_DT mathematical_JJ model_NN of_IN mumps_NNS transmission_NN confirmed_VBD the_DT central_JJ role_NN of_IN waning_VBG immunity_NN to_IN the_DT vaccine_NN in_IN the_DT re-emergence_NN of_IN mumps_NNS cases_NNS ._. Outbreaks_NNS from_IN 2006_CD to_IN the_DT present_NN among_IN young_JJ adults_NNS ,_, and_CC outbreaks_NNS in_IN the_DT late_JJ 1980s_NNS and_CC early_JJ 1990s_NNS among_IN adolescents_NNS ,_, aligned_VBN with_IN peaks_NNS in_IN mumps_NNS susceptibility_NN of_IN these_DT age_NN groups_NNS predicted_VBN to_TO be_VB due_IN to_IN loss_NN of_IN vaccine_NN -_HYPH derived_VBN protection_NN ._. In_IN contrast_NN ,_, evolution_NN of_IN mumps_NNS virus_NN strains_NNS escaping_VBG immune_NN pressure_NN would_MD be_VB expected_VBN to_TO cause_VB a_DT higher_JJR proportion_NN of_IN cases_NNS among_IN children_NNS ,_, not_RB adolescents_NNS and_CC young_JJ adults_NNS as_IN observed_VBN ._. Routine_JJ use_NN of_IN a_DT third_JJ vaccine_NN dose_NN at_IN 18_CD years_NNS of_IN age_NN ,_, or_CC booster_NN dosing_NN throughout_IN adulthood_NN ,_, may_MD be_VB a_DT strategy_NN to_TO prevent_VB mumps_NNS re-emergence_NN and_CC should_MD be_VB assessed_VBN in_IN clinical_JJ trials_NNS ._. Over_IN the_DT last_JJ decade_NN ,_, mumps_NNS outbreaks_NNS have_VBP thwarted_VBN the_DT goal_NN of_IN eliminating_VBG indigenous_JJ or_CC nonimported_JJ mumps_NNS virus_NN transmission_NN in_IN the_DT United_NNP States_NNPS by_IN the_DT year_NN 2010_CD (_-LRB- 1_CD ,_, 2_CD )_-RRB- ._. Whereas_IN more_JJR than_IN 90_CD %_NN of_IN U.S._NNP -_HYPH born_VBN children_NNS experienced_VBD mumps_NNS infections_NNS by_IN 20_CD years_NNS of_IN age_NN in_IN the_DT prevaccine_NN era_NN (_-LRB- 3_CD )_-RRB- ,_, incidence_NN declined_VBD substantially_RB after_IN licensure_NN of_IN a_DT live_JJ attenuated_VBN vaccine_NN (_-LRB- the_DT Jeryl_NNP Lynn_NNP vaccine_NN )_-RRB- in_IN 1967_CD ,_, in_IN particular_JJ after_IN the_DT 1977_CD recommendation_NN for_IN its_PRP$ routine_JJ use_NN among_IN infants_NNS as_IN part_NN of_IN the_DT measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN (_-LRB- MMR_NNP )_-RRB- vaccine_NN (_-LRB- 2_CD )_-RRB- ._. Outbreaks_NNS among_IN vaccinated_VBN middle_JJ school–_NN and_CC high_JJ school–aged_JJ children_NNS arose_VBD in_IN the_DT late_JJ 1980s_NNS ,_, followed_VBN by_IN sustained_VBN reductions_NNS in_IN incidence_NN after_IN children_NNS were_VBD recommended_VBN to_TO receive_VB a_DT second_JJ MMR_NN dose_NN at_IN 4_CD to_IN 6_CD years_NNS of_IN age_NN (_-LRB- 4_CD )_-RRB- ._. However_RB ,_, an_DT ongoing_JJ resurgence_NN in_IN mumps_NNS cases_NNS began_VBD with_IN a_DT series_NN of_IN outbreaks_NNS on_IN university_NN campuses_NNS in_IN 2006_CD (_-LRB- 2_CD )_-RRB- ._. An_DT older_JJR age_NN of_IN infection_NN (_-LRB- ages_NNS 18_CD to_IN 29_CD years_NNS ,_, compared_VBN to_IN the_DT prevaccine_JJ average_NN of_IN 5_CD to_IN 9_CD years_NNS )_-RRB- has_VBZ been_VBN a_DT defining_VBG feature_NN of_IN these_DT outbreaks_NNS (_-LRB- 5_CD )_-RRB- ,_, similar_JJ to_IN recent_JJ occurrences_NNS in_IN Canada_NNP ,_, western_JJ Europe_NNP ,_, and_CC Asian_JJ countries_NNS with_IN routine_JJ MMR_NN vaccination_NN (_-LRB- 6_CD –9_CD )_-RRB- ._. These_DT circumstances_NNS are_VBP troubling_JJ on_IN two_CD fronts_NNS ._. First_RB ,_, as_RB many_JJ as_IN 10_CD %_NN of_IN mumps_NNS infections_NNS acquired_VBN after_IN puberty_NN may_MD cause_VB severe_JJ complications_NNS including_VBG orchitis_NN ,_, meningitis_NN ,_, and_CC deafness_NN ,_, in_IN contrast_NN to_IN a_DT milder_JJR clinical_JJ course_NN in_IN children_NNS that_WDT typically_RB involves_VBZ fever_NN and_CC parotid_JJ gland_NN swelling_NN (_-LRB- 10_CD )_-RRB- ._. Second_RB ,_, most_JJS mumps_NNS cases_NNS in_IN recent_JJ outbreaks_NNS have_VBP been_VBN reported_VBN among_IN young_JJ adults_NNS who_WP received_VBD two_CD vaccine_NN doses_NNS as_IN recommended_VBN (_-LRB- 11_CD )_-RRB- ._. This_DT observation_NN has_VBZ prompted_VBN concerns_NNS about_IN suboptimal_JJ performance_NN of_IN the_DT Jeryl_NNP Lynn_NNP vaccine_NN currently_RB in_IN use_NN (_-LRB- 12_CD )_-RRB- ._. It_PRP is_VBZ unclear_JJ whether_IN recent_JJ outbreaks_NNS in_IN vaccinated_VBN communities_NNS are_VBP due_IN to_IN the_DT waning_NN of_IN vaccine_NN -_HYPH derived_VBN immunity_NN or_CC to_IN the_DT emergence_NN of_IN mumps_NNS virus_NN strains_NNS escaping_VBG vaccine_NN -_HYPH driven_VBN immunological_JJ pressure_NN ._. Distinguishing_VBG between_IN these_DT possibilities_NNS is_VBZ critical_JJ to_IN policy_NN -_HYPH makers_NNS and_CC members_NNS of_IN the_DT scientific_JJ and_CC medical_JJ communities_NNS :_: At_IN issue_NN is_VBZ whether_IN the_DT re-emergence_NN of_IN mumps_NNS can_MD be_VB prevented_VBN by_IN modifying_VBG vaccine_NN dosing_NN schedules_NNS or_CC whether_IN a_DT new_JJ vaccine_NN must_MD instead_RB be_VB developed_VBN (_-LRB- 12_CD )_-RRB- ._. To_IN this_DT end_NN ,_, we_PRP sought_VBD to_TO distinguish_VB waning_NN of_IN vaccine_NN -_HYPH derived_VBN protection_NN from_IN long_JJ -_HYPH term_NN changes_NNS in_IN vaccine_NN effectiveness_NN against_IN circulating_VBG mumps_NNS strains_NNS using_VBG data_NNS from_IN six_CD epidemiological_JJ studies_NNS of_IN mumps_NNS vaccine_NN effectiveness_NN performed_VBN over_IN past_JJ decades_NNS in_IN the_DT United_NNP States_NNPS and_CC Europe_NNP (_-LRB- table_NN S1_NNP )_-RRB- ._. Pooling_VBG data_NNS from_IN these_DT studies_NNS ,_, we_PRP tested_VBD whether_IN the_DT strength_NN of_IN vaccine_NN -_HYPH derived_VBN immune_NN protection_NN declines_VBZ with_IN time_NN since_IN receipt_NN of_IN the_DT vaccine_NN —_: a_DT pattern_NN that_WDT would_MD suggest_VB vaccine_NN waning_VBG —_: and_CC whether_IN the_DT degree_NN of_IN protection_NN has_VBZ changed_VBN over_IN recent_JJ decades_NNS amid_IN shifts_NNS in_IN the_DT circulating_VBG population_NN of_IN mumps_NNS virus_NN lineages_NNS ._. We_PRP then_RB measured_VBD the_DT potential_JJ impact_NN of_IN the_DT waning_NN of_IN vaccine_NN -_HYPH derived_VBN immunity_NN on_IN the_DT susceptibility_NN of_IN the_DT U.S._NNP population_NN to_IN mumps_NNS over_IN the_DT decades_NNS since_IN vaccine_NN licensure_NN and_CC used_VBD mathematical_JJ models_NNS to_TO assess_VB whether_IN recent_JJ mumps_NNS virus_NN transmission_NN dynamics_NNS are_VBP more_RBR consistent_JJ with_IN hypotheses_NNS of_IN waning_VBG immunity_NN or_CC vaccine_NN escape_NN ._. Specifically_RB ,_, we_PRP compared_VBD expected_VBN age_NN -_HYPH specific_JJ infection_NN incidence_NN in_IN stochastic_JJ simulations_NNS of_IN mumps_NNS transmission_NN within_IN two_CD hypothetical_JJ vaccinated_VBN populations_NNS ._. The_DT first_JJ was_VBD subject_JJ to_IN waning_VBG protection_NN based_VBN on_IN our_PRP$ estimates_NNS of_IN the_DT duration_NN of_IN vaccine_NN -_HYPH derived_VBN immunity_NN ;_: the_DT second_JJ experienced_VBD durable_JJ protection_NN but_CC confronted_VBD mumps_NNS virus_NN strains_NNS against_IN which_WDT vaccination_NN provided_VBD low_JJ degrees_NNS of_IN protection_NN ._. We_PRP used_VBD our_PRP$ findings_NNS to_TO evaluate_VB alternative_JJ vaccination_NN policies_NNS aiming_VBG to_TO enhance_VB protection_NN among_IN adults_NNS ._. Evidence_NN of_IN waning_VBG immunity_NN in_IN studies_NNS of_IN vaccine_NN effectiveness_NN Uncertainty_NN about_IN the_DT protective_JJ efficacy_NN of_IN the_DT Jeryl_NNP Lynn_NNP mumps_NNS vaccine_NN —_: ranging_VBG from_IN 95_CD %_NN after_IN a_DT single_JJ dose_NN in_IN randomized_VBN controlled_VBN trials_NNS (_-LRB- 13_CD )_-RRB- to_IN <_-LRB- 50_CD %_NN two_CD -_HYPH dose_NN effectiveness_NN during_IN recent_JJ outbreaks_NNS (_-LRB- 14_CD )_-RRB- —has_VBP undermined_VBN efforts_NNS to_TO gauge_VB population_NN immunity_NN ._. This_DT variation_NN in_IN estimates_NNS of_IN effectiveness_NN permitted_VBD us_PRP to_TO evaluate_VB several_JJ hypotheses_NNS about_IN the_DT reasons_NNS mumps_NNS cases_NNS have_VBP re-emerged_VBN among_IN vaccinated_VBN persons_NNS (_-LRB- 2_CD ,_, 12_CD )_-RRB- ._. Fitting_VBG a_DT meta-_JJ regression_NN model_NN to_IN data_NNS from_IN prospective_JJ and_CC retrospective_JJ cohort_NN studies_NNS (_-LRB- table_NN S1_NN )_-RRB- ,_, we_PRP identified_VBD that_IN the_DT time_NN elapsed_VBN since_IN receipt_NN of_IN an_DT individual_NN ’s_POS last_JJ vaccine_NN dose_NN accounted_VBD for_IN 66.4_CD %_NN of_IN unexplained_JJ variation_NN in_IN published_VBN vaccine_NN effectiveness_NN estimates_NNS (_-LRB- Fig._NN 1_CD ,_, A_NNP to_IN C_NNP )_-RRB- ._. Applying_VBG our_PRP$ estimate_NN of_IN the_DT vaccine_NN waning_VBG rate_NN to_IN a_DT model_NN of_IN exponentially_RB distributed_VBN durations_NNS of_IN protection_NN ,_, we_PRP estimated_VBD that_IN immunity_NN persists_VBZ ,_, on_IN average_NN ,_, 27.4_CD years_NNS [_-LRB- 95_CD %_NN confidence_NN interval_NN (_-LRB- CI_NNP )_-RRB- ,_, 16.7_CD to_IN 51.1_CD years_NNS ]_-RRB- after_IN receipt_NN of_IN any_DT dose_NN ._. Among_IN 96.4_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 94.0_CD to_IN 97.8_CD %_NN )_-RRB- of_IN individuals_NNS expected_VBN to_TO mount_VB primary_JJ responses_NNS to_IN mumps_NNS vaccination_NN ,_, we_PRP thus_RB expected_VBD that_IN 25_CD %_NN may_MD lose_VB protection_NN within_IN 7.9_CD years_NNS (_-LRB- 95_CD %_NN CI_NN ,_, 4.7_CD to_IN 14.7_CD years_NNS )_-RRB- ,_, 50_CD %_NN within_IN 19.0_CD years_NNS (_-LRB- 95_CD %_NN CI_NN ,_, 11.2_CD to_IN 35.4_CD years_NNS )_-RRB- ,_, and_CC 75_CD %_NN within_IN 38.0_CD years_NNS (_-LRB- 95_CD %_NN CI_NN ,_, 22.4_CD to_IN 70.8_CD years_NNS )_-RRB- ._. Synthesis_NN of_IN prospective_JJ and_CC retrospective_JJ cohort_NN studies_NNS estimating_VBG the_DT relative_JJ risk_NN of_IN clinical_JJ mumps_NNS in_IN vaccinated_VBN and_CC unvaccinated_JJ individuals_NNS ._. We_PRP illustrate_VBP the_DT results_NNS of_IN our_PRP$ meta_NN -_HYPH analysis_NN of_IN studies_NNS of_IN mumps_NNS vaccine_NN effectiveness_NN ,_, from_IN which_WDT we_PRP estimated_VBD rates_NNS of_IN vaccine_NN waning_VBG ._. (_-LRB- A_LS )_-RRB- Shown_VBN here_RB is_VBZ how_WRB estimates_NNS of_IN vaccine_NN effectiveness_NN (_-LRB- defined_VBN as_IN one_CD minus_IN the_DT relative_JJ risk_NN (_-LRB- RR_NN )_-RRB- of_IN experiencing_VBG mumps_NNS for_IN a_DT vaccinated_VBN individual_NN ,_, relative_JJ to_IN an_DT unvaccinated_JJ individual_NN )_-RRB- differ_VBP across_IN the_DT six_CD studies_NNS analyzed_VBN here_RB ._. Time_NN since_IN last_JJ dose_NN accounts_VBZ for_IN 66.4_CD %_NN of_IN residual_JJ variation_NN in_IN estimates_NNS after_IN accounting_NN for_IN random_JJ sources_NNS of_IN between_IN -_HYPH study_NN heterogeneity_NN ._. Points_NNS representing_VBG study_NN -_HYPH level_NN estimates_NNS are_VBP scaled_VBN in_IN size_NN to_TO reflect_VB differences_NNS in_IN sample_NN size_NN ._. Lines_NNS signify_VBP 95_CD %_NN confidence_NN intervals_NNS (_-LRB- CIs_NN )_-RRB- ;_: arrows_NNS indicate_VBP where_WRB values_NNS rounded_VBD to_IN the_DT nearest_JJS hundredth_NN equal_JJ zero_CD ._. (_-LRB- B_LS )_-RRB- At_IN 6_CD months_NNS after_IN vaccine_NN receipt_NN (_-LRB- the_DT earliest_JJS time_NN point_NN assessed_VBN in_IN primary_JJ studies_NNS )_-RRB- ,_, we_PRP estimate_VBP that_IN 96.4_CD %_NN (_-LRB- 94.0_CD to_IN 97.8_CD %_NN )_-RRB- of_IN recipients_NNS are_VBP protected_VBN ;_, we_PRP apply_VBP this_DT as_IN our_PRP$ estimate_NN of_IN the_DT probability_NN of_IN vaccine_NN take_NN ._. (_-LRB- C_LS )_-RRB- A_DT parsimonious_JJ model_NN of_IN exponentially_RB distributed_VBN durations_NNS of_IN protection_NN predicts_VBZ loss_NN of_IN protection_NN after_IN ,_, on_IN average_NN ,_, years_NNS (_-LRB- 95_CD %_NN CI_NN ,_, 16.7_CD to_IN 51.1_CD )_-RRB- ,_, as_IN indicated_VBN by_IN the_DT yellow_JJ -_HYPH plotted_VBN area_NN ._. The_DT blue_JJ -_HYPH plotted_VBN area_NN illustrates_VBZ the_DT distribution_NN of_IN times_NNS to_IN loss_NN of_IN protection_NN for_IN vaccinated_VBN individuals_NNS ,_, generated_VBN by_IN pooling_VBG exponential_JJ distributions_NNS parameterized_VBN using_VBG estimates_NNS of_IN ω_NN ._. (_-LRB- D_LS )_-RRB- Contrary_JJ to_IN the_DT hypothesis_NN of_IN reduced_VBN effectiveness_NN against_IN diverse_JJ mumps_NNS genotypes_NNS currently_RB in_IN circulation_NN ,_, we_PRP did_VBD not_RB identify_VB evidence_NN of_IN a_DT decline_NN in_IN vaccine_NN effectiveness_NN over_IN time_NN ,_, whereas_IN evidence_NN of_IN waning_VBG vaccine_NN -_HYPH derived_VBN immunity_NN persisted_VBD in_IN a_DT model_NN adjusting_VBG for_IN calendar_NN year_NN ._. Unadjusted_VBN estimates_NNS of_IN the_DT relative_JJ risk_NN of_IN clinical_JJ mumps_NNS given_VBN vaccination_NN —_: and_CC estimates_NNS adjusted_VBN for_IN time_NN since_IN vaccination_NN ,_, years_NNS since_IN 1964_CD ,_, and_CC doses_NNS received_VBN —_: are_VBP calculated_VBN via_IN meta-_JJ regression_NN using_VBG incidence_NN data_NNS from_IN the_DT original_JJ studies_NNS (_-LRB- 13_CD ,_, 46–50_CD )_-RRB- ._. (_-LRB- E_LS )_-RRB- Using_VBG this_DT meta_NN -_HYPH regression_NN framework_NN ,_, we_PRP identified_VBD no_DT difference_NN (_-LRB- posterior_JJ two_CD -_HYPH sided_VBN P_NN >_SYM 0.1_CD )_-RRB- in_IN the_DT waning_VBG rate_NN (_-LRB- as_IN defined_VBN by_IN the_DT inverse_NN of_IN the_DT association_NN between_IN time_NN since_IN vaccination_NN and_CC relative_JJ risk_NN of_IN mumps_NNS given_VBN vaccination_NN ;_: see_VB Materials_NNS and_CC Methods_NNS )_-RRB- after_IN receipt_NN of_IN a_DT first_JJ or_CC second_JJ dose_NN (_-LRB- 95_CD %_NN CI_NN ,_, 33_CD %_NN decrease_NN to_IN 72_CD %_NN increase_NN in_IN the_DT relative_JJ risk_NN of_IN mumps_NNS given_VBN vaccination_NN per_IN log_NN year_NN since_IN vaccination_NN ;_: posterior_JJ two_CD -_HYPH sided_VBN P_NN >_SYM 0.1_CD )_-RRB- ._. The_DT gradual_JJ replacement_NN of_IN predominantly_RB A_JJ -_HYPH genotype_NN mumps_NN virus_NN in_IN the_DT prevaccine_NN era_NN by_IN mixed_VBN genotypes_NNS after_IN vaccine_NN introduction_NN has_VBZ also_RB been_VBN suspected_VBN to_TO contribute_VB to_IN diminished_VBN protection_NN ._. However_RB ,_, we_PRP found_VBD no_DT evidence_NN for_IN a_DT decline_NN in_IN vaccine_NN effectiveness_NN over_IN the_DT years_NNS 1965_CD to_IN 2006_CD ,_, in_IN particular_JJ after_IN controlling_VBG for_IN the_DT effect_NN of_IN vaccine_NN waning_NN (_-LRB- Fig._NN 1D_NN )_-RRB- ._. Whereas_IN we_PRP estimated_VBD a_DT nonsignificant_JJ 1.29_CD (_-LRB- 95_CD %_NN CI_NN ,_, 0.70_CD to_IN 2.37_CD )_-RRB- –fold_JJ increase_NN in_IN the_DT relative_JJ risk_NN of_IN infection_NN given_VBN vaccination_NN for_IN each_DT log_NN year_NN after_IN 1964_CD in_IN unadjusted_JJ analyses_NNS ,_, this_DT trend_NN did_VBD not_RB persist_VB (_-LRB- adjusted_VBN relative_JJ risk_NN ,_, 0.85_CD ;_: 95_CD %_NN CI_NN ,_, 0.56_CD to_IN 1.30_CD )_-RRB- after_IN controlling_VBG for_IN longer_JJR time_NN since_IN vaccination_NN among_IN older_JJR -_HYPH age_NN subjects_NNS in_IN later_JJR studies_NNS ._. Moreover_RB ,_, we_PRP did_VBD not_RB identify_VB a_DT difference_NN in_IN the_DT duration_NN of_IN protection_NN after_IN a_DT first_JJ dose_NN of_IN vaccine_NN as_IN compared_VBN to_IN the_DT duration_NN of_IN protection_NN after_IN a_DT second_JJ dose_NN (_-LRB- Fig._NN 1E_CD )_-RRB- ._. Whereas_IN second_JJ doses_NNS were_VBD originally_RB recommended_VBN to_TO bolster_VB immunity_NN in_IN case_NN of_IN failed_VBN “_`` take_NN ”_'' of_IN the_DT first_JJ dose_NN ,_, our_PRP$ findings_NNS suggested_VBD that_IN the_DT second_JJ dose_NN also_RB restores_VBZ immunity_NN to_IN the_DT degree_NN achieved_VBN before_IN waning_VBG of_IN the_DT first_JJ dose_NN ,_, thus_RB extending_VBG protection_NN to_IN older_JJR ages_NNS ._. Together_RB ,_, our_PRP$ findings_NNS support_VBP the_DT central_JJ role_NN of_IN waning_VBG immune_NN protection_NN as_IN a_DT driver_NN of_IN variation_NN in_IN vaccine_NN performance_NN ._. Changes_NNS in_IN population_NN susceptibility_NN to_IN mumps_NNS virus_NN after_IN vaccine_NN introduction_NN To_TO understand_VB the_DT epidemiologic_JJ context_NN of_IN mumps_NNS resurgence_NN in_IN older_JJR age_NN groups_NNS ,_, we_PRP assessed_VBD how_WRB waning_VBG vaccine_NN -_HYPH derived_VBN immunity_NN and_CC declining_VBG rates_NNS of_IN natural_JJ transmission_NN have_VBP affected_VBN the_DT susceptibility_NN of_IN the_DT U.S._NNP population_NN over_IN the_DT decades_NNS since_IN vaccine_NN introduction_NN ._. We_PRP inferred_VBD the_DT degree_NN of_IN immune_NN protection_NN as_IN of_IN 1967_CD ,_, when_WRB the_DT vaccine_NN was_VBD licensed_VBN ,_, by_IN fitting_VBG a_DT mathematical_JJ model_NN (_-LRB- table_NN S2_NN and_CC fig_NN ._. S1_NNP )_-RRB- to_TO reproduce_VB epidemiological_JJ dynamics_NNS in_IN the_DT prevaccine_JJ era_NN at_IN steady_JJ state_NN (_-LRB- 15_CD )_-RRB- ._. We_PRP estimated_VBD that_IN the_DT basic_JJ reproductive_JJ number_NN (_-LRB- R_NN )_-RRB- of_IN mumps_NNS in_IN the_DT United_NNP States_NNPS —_: the_DT number_NN of_IN infections_NNS expected_VBN to_TO result_VB from_IN an_DT initial_JJ index_NN case_NN in_IN a_DT fully_RB susceptible_JJ population_NN —_: was_VBD 4.79_CD before_IN vaccine_NN rollout_NN ,_, in_IN agreement_NN with_IN previous_JJ estimates_NNS of_IN 3_CD to_IN 7_CD for_IN high_JJ -_HYPH income_NN settings_NNS in_IN the_DT 20th_JJ century_NN (_-LRB- 16_CD ,_, 17_CD )_-RRB- ._. Allowing_VBG for_IN loss_NN of_IN naturally_RB acquired_VBN immunity_NN did_VBD not_RB improve_VB model_NN fit_NN (_-LRB- 15_CD )_-RRB- ,_, consistent_JJ with_IN longer_JJR -_HYPH term_NN persistence_NN of_IN high_JJ antibody_NN titers_NNS after_IN natural_JJ infection_NN in_IN comparison_NN to_IN vaccination_NN in_IN children_NNS (_-LRB- 18_CD )_-RRB- ._. The_DT ongoing_JJ resurgence_NN in_IN mumps_NNS among_IN young_JJ adults_NNS corresponded_VBD to_IN cohort_NN -_HYPH specific_JJ changes_NNS in_IN susceptibility_NN resulting_VBG from_IN vaccine_NN waning_NN and_CC declining_VBG transmission_NN over_IN the_DT decades_NNS since_IN vaccine_NN rollout_NN (_-LRB- Fig._NN 2_CD and_CC fig_NN ._. S2_NNP )_-RRB- ._. We_PRP estimated_VBD that_IN 52.8_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 41.6_CD to_IN 63.1_CD %_NN )_-RRB- of_IN adults_NNS ages_NNS 20_CD to_IN 24_CD years_NNS and_CC 52.6_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 42.4_CD to_IN 61.3_CD %_NN )_-RRB- of_IN adults_NNS ages_NNS 25_CD to_IN 29_CD years_NNS were_VBD susceptible_JJ to_IN mumps_NNS virus_NN infection_NN in_IN 2006_CD at_IN the_DT outset_NN of_IN the_DT ongoing_JJ resurgence_NN ,_, in_IN contrast_NN to_IN 33.8_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 30.4_CD to_IN 37.6_CD %_NN )_-RRB- and_CC 25.2_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 22.8_CD to_IN 27.5_CD %_NN )_-RRB- ,_, respectively_RB ,_, as_IN of_IN 1990_CD and_CC <_-LRB- 10_CD %_NN in_IN each_DT age_NN group_NN before_IN vaccine_NN introduction_NN ._. Susceptibility_NN has_VBZ also_RB permeated_VBN older_JJR age_NN groups_NNS amid_IN the_DT replacement_NN of_IN cohorts_NNS that_WDT experienced_VBD mumps_NNS as_IN children_NNS ._. Whereas_IN most_JJS individuals_NNS ages_NNS 65_CD years_NNS and_CC older_JJR had_VBD natural_JJ immunity_NN as_IN of_IN 2016_CD ,_, we_PRP estimated_VBD that_IN 29.2_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 24.7_CD to_IN 32.3_CD %_NN )_-RRB- of_IN those_DT ages_NNS 40_CD to_IN 64_CD years_NNS were_VBD at_IN risk_NN of_IN infection_NN ._. Mumps_NNS incidence_NN and_CC estimates_NNS of_IN population_NN susceptibility_NN over_IN time_NN ._. Here_RB ,_, we_PRP illustrate_VBP changes_NNS in_IN the_DT proportion_NN of_IN the_DT population_NN ,_, by_IN age_NN ,_, predicted_VBN to_TO be_VB susceptible_JJ to_IN mumps_NNS on_IN the_DT basis_NN of_IN the_DT estimated_VBN waning_VBG rate_NN of_IN vaccine_NN -_HYPH derived_VBN immune_NN protection_NN and_CC the_DT incidence_NN of_IN mumps_NNS infection_NN in_IN the_DT population_NN ._. (_-LRB- A_LS )_-RRB- Overall_JJ rates_NNS of_IN reported_VBN cases_NNS declined_VBD after_IN vaccine_NN licensure_NN in_IN 1967_CD ,_, punctuated_VBN by_IN outbreaks_NNS primarily_RB among_IN adolescents_NNS from_IN 1984_CD to_IN 1992_CD and_CC recent_JJ outbreaks_NNS (_-LRB- 2006_CD onward_RB )_-RRB- centered_VBN among_IN young_JJ adults_NNS ._. These_DT outbreaks_NNS have_VBP corresponded_VBN with_IN (_-LRB- B_LS )_-RRB- peaks_NNS in_IN the_DT model_NN -_HYPH inferred_VBN proportion_NN of_IN individuals_NNS susceptible_JJ to_IN mumps_NNS infection_NN at_IN 10_CD to_IN 19_CD and_CC 20_CD to_IN 29_CD years_NNS of_IN age_NN ,_, respectively_RB ,_, and_CC (_-LRB- C_NNP )_-RRB- reductions_NNS in_IN the_DT proportion_NN of_IN infections_NNS that_WDT cause_VBP symptoms_NNS and_CC are_VBP reported_VBN because_IN of_IN vaccine_NN protection_NN against_IN symptoms_NNS ._. (_-LRB- D_LS )_-RRB- Changes_NNS in_IN the_DT proportion_NN of_IN individuals_NNS susceptible_JJ to_IN infection_NN across_IN different_JJ ages_NNS are_VBP plotted_VBN against_IN rates_NNS of_IN reported_VBN cases_NNS ._. In_IN a_DT further_JJR validation_NN of_IN model_NN predictions_NNS ,_, the_DT emergence_NN and_CC disappearance_NN of_IN mumps_NNS outbreaks_NNS among_IN adolescents_NNS during_IN the_DT late_JJ 1980s_NNS and_CC early_JJ 1990s_NNS corresponded_VBD to_IN a_DT transient_JJ increase_NN in_IN predicted_VBN susceptibility_NN at_IN ages_NNS 10_CD to_IN 19_CD years_NNS (_-LRB- Fig._NNP 2_CD )_-RRB- ._. We_PRP estimated_VBD that_IN susceptibility_NN at_IN ages_NNS 10_CD to_IN 14_CD years_NNS peaked_VBD in_IN 1991_CD ,_, when_WRB 45.8_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 39.3_CD to_IN 52.4_CD %_NN )_-RRB- of_IN children_NNS in_IN this_DT age_NN group_NN were_VBD at_IN risk_NN for_IN infection_NN ,_, together_RB with_IN 43.0_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 37.3_CD to_IN 49.0_CD %_NN )_-RRB- of_IN adolescents_NNS ages_NNS 15_CD to_IN 19_CD years_NNS ._. These_DT estimates_NNS reflect_VBP 2.85_CD (_-LRB- 95_CD %_NN CI_NN ,_, 2.65_CD to_IN 3.30_CD )_-RRB- –fold_NN and_CC 3.96_CD (_-LRB- 95_CD %_NN CI_NN ,_, 3.43_CD to_IN 4.52_CD )_-RRB- –fold_NN increases_VBZ in_IN age_NN -_HYPH specific_JJ susceptibility_NN ,_, respectively_RB ,_, compared_VBN to_IN the_DT prevaccine_NN era_NN ._. Whereas_IN breakthrough_NN outbreaks_NNS beginning_VBG in_IN the_DT 1980s_NNS were_VBD hypothesized_VBN at_IN that_DT time_NN to_TO reflect_VB inadequate_JJ responses_NNS of_IN children_NNS to_IN their_PRP$ first_JJ vaccine_NN dose_NN (_-LRB- 19_CD )_-RRB- ,_, our_PRP$ findings_NNS instead_RB suggest_VBP that_IN vaccine_NN waning_NN and_CC declining_VBG natural_JJ exposure_NN explain_VBP why_WRB adolescents_NNS were_VBD the_DT population_NN at_IN highest_JJS risk_NN for_IN infection_NN at_IN that_DT time_NN ._. We_PRP estimated_VBD that_IN ,_, as_IN of_IN 2016_CD ,_, the_DT prevalence_NN of_IN susceptibility_NN among_IN children_NNS ages_NNS 10_CD to_IN 14_CD years_NNS declined_VBD to_IN 34.8_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 24.3_CD to_IN 45.7_CD %_NN )_-RRB- because_IN of_IN the_DT recommendation_NN in_IN 1989_CD for_IN children_NNS to_TO receive_VB a_DT second_JJ dose_NN at_IN ages_NNS 4_CD to_IN 6_CD years_NNS (_-LRB- 4_CD )_-RRB- ._. Whereas_IN most_JJS adolescents_NNS experiencing_VBG cases_NNS during_IN the_DT initial_JJ resurgence_NN had_VBD received_VBN one_CD dose_NN of_IN vaccine_NN in_IN keeping_VBG with_IN the_DT recommendations_NNS at_IN that_DT time_NN (_-LRB- 20_CD ,_, 21_CD )_-RRB- ,_, recent_JJ outbreaks_NNS have_VBP predominantly_RB included_VBN individuals_NNS eligible_JJ to_TO receive_VB two_CD doses_NNS (_-LRB- fig._FW S3_NN )_-RRB- ._. Thus_RB ,_, the_DT increasing_VBG age_NN of_IN infection_NN in_IN the_DT United_NNP States_NNPS more_RBR likely_JJ tracks_NNS with_IN cases_NNS due_IN to_IN waning_VBG immunity_NN after_IN receipt_NN of_IN the_DT second_JJ dose_NN rather_RB than_IN a_DT continuation_NN of_IN cases_NNS within_IN a_DT single_JJ ,_, underimmunized_JJ cohort_NN ._. These_DT findings_NNS hold_VBP in_IN sensitivity_NN analyses_NNS assuming_VBG 1_CD and_CC 2_CD %_NN annual_JJ declines_NNS in_IN reporting_NN effort_NN (_-LRB- corresponding_VBG to_IN 39_CD and_CC 63_CD %_NN overall_JJ reductions_NNS in_IN disease_NN reporting_NN by_IN 2017_CD )_-RRB- over_IN the_DT decades_NNS since_IN vaccine_NN introduction_NN (_-LRB- figs._JJ S4_NNP and_CC S5_NNP )_-RRB- ._. Our_PRP$ analyses_NNS have_VBP suggested_VBN that_IN reduced_VBN vaccine_NN effectiveness_NN relates_VBZ primarily_RB to_IN waning_VBG protection_NN rather_RB than_IN the_DT emergence_NN of_IN mumps_NNS virus_NN genotypes_NNS escaping_VBG vaccine_NN -_HYPH driven_VBN immunity_NN ._. However_RB ,_, our_PRP$ ability_NN to_TO compare_VB these_DT hypotheses_NNS using_VBG data_NNS from_IN previous_JJ studies_NNS is_VBZ limited_VBN by_IN a_DT lack_NN of_IN data_NNS about_IN genotype_NN -specific_JJ protection_NN ._. To_TO better_RBR understand_VB whether_IN recent_JJ outbreaks_NNS are_VBP more_RBR consistent_JJ with_IN vaccine_NN waning_NN or_CC viral_JJ escape_NN ,_, we_PRP used_VBD a_DT stochastic_JJ transmission_NN model_NN to_TO compare_VB expected_VBN epidemiologic_JJ dynamics_NNS under_IN these_DT scenarios_NNS in_IN the_DT year_NN 2006_CD ,_, when_WRB the_DT ongoing_JJ resurgence_NN began_VBD ._. Using_VBG the_DT approach_NN taken_VBN above_RB to_TO update_VB population_NN immunity_NN and_CC transmission_NN parameters_NNS in_IN the_DT absence_NN of_IN waning_VBG vaccine_NN immunity_NN (_-LRB- figs._NNP S6_NNP and_CC S7_NNP )_-RRB- ,_, we_PRP simulated_VBD the_DT spread_NN of_IN mumps_NNS virus_NN strains_NNS against_IN which_WDT the_DT vaccine_NN provided_VBD partial_JJ protection_NN in_IN a_DT population_NN of_IN 1_CD million_CD ._. Under_IN age_NN -_HYPH structured_VBN social_JJ mixing_NN patterns_NNS that_WDT formerly_RB caused_VBD mumps_NNS cases_NNS to_IN center_NN among_IN school_NN -_HYPH aged_JJ children_NNS ,_, waning_NN of_IN vaccine_NN protection_NN is_VBZ a_DT necessary_JJ mechanism_NN to_TO account_VB for_IN shifts_NNS in_IN the_DT age_NN distribution_NN of_IN cases_NNS toward_IN adolescence_NN and_CC young_JJ adulthood_NN ._. We_PRP found_VBD that_IN strains_NNS capable_JJ of_IN vaccine_NN escape_NN would_MD be_VB expected_VBN to_TO cause_VB higher_JJR -_HYPH than_IN -_HYPH observed_VBN incidence_NN among_IN younger_JJR children_NNS (_-LRB- Fig._NNP 3_CD ,_, A_NNP to_IN E_NNP )_-RRB- ._. In_IN contrast_NN to_IN the_DT median_JJ age_NN of_IN mumps_NNS cases_NNS of_IN 22_CD years_NNS reported_VBN in_IN 2006_CD ,_, the_DT predicted_VBN median_JJ age_NN of_IN cases_NNS approached_VBD 14.2_CD years_NNS (_-LRB- 95_CD %_NN CI_NN ,_, 8.3_CD to_IN 21.7_CD years_NNS )_-RRB- as_IN strain_NN -_HYPH specific_JJ vaccine_NN effectiveness_NN declined_VBD to_IN 0_CD %_NN ._. Although_IN strains_NNS with_IN lower_JJR ability_NN to_TO escape_VB immune_NN pressure_NN may_MD not_RB concentrate_VB to_IN such_PDT an_DT extent_NN among_IN children_NNS ,_, we_PRP expected_VBD such_JJ strains_NNS to_TO cause_VB low_JJ incidence_NN in_IN a_DT population_NN unaffected_VBN by_IN waning_VBG immunity_NN (_-LRB- Fig._NNP 3_CD F_NNP )_-RRB- ._. Model_NN -_HYPH predicted_VBN overall_JJ rates_NNS of_IN mumps_NNS incidence_NN exceeded_VBD reported_VBN rates_NNS at_IN lower_JJR degrees_NNS of_IN cross-protection_NN ._. As_IN compared_VBN to_IN predictions_NNS under_IN scenarios_NNS of_IN viral_JJ escape_NN ,_, model_NN -_HYPH predicted_VBN dynamics_NNS under_IN vaccine_NN waning_NN provided_VBD a_DT closer_JJR match_NN to_IN reported_VBN overall_JJ and_CC age_NN -_HYPH specific_JJ incidence_NN ,_, with_IN an_DT expected_VBN median_JJ age_NN of_IN 22.3_CD years_NNS (_-LRB- 95_CD %_NN CI_NN ,_, 17.7_CD to_IN 26.3_CD years_NNS )_-RRB- among_IN cases_NNS ._. Anticipated_VBN transmission_NN dynamics_NNS under_IN scenarios_NNS of_IN vaccine_NN escape_NN and_CC vaccine_NN waning_NN ._. Here_RB ,_, we_PRP use_VBP a_DT stochastic_JJ simulation_NN model_NN to_TO predict_VB the_DT epidemiology_NN of_IN mumps_NNS outbreaks_NNS under_IN the_DT scenario_NN of_IN mumps_NNS virus_NN escaping_VBG vaccine_NN -_HYPH induced_VBN immune_NN pressure_NN and_CC the_DT scenario_NN of_IN waning_VBG vaccine_NN -_HYPH derived_VBN immunity_NN ._. (_-LRB- A_LS )_-RRB- A_DT stochastic_JJ model_NN of_IN an_DT emerging_VBG vaccine_NN -_HYPH escape_NN strain_NN of_IN mumps_NNS virus_NN in_IN a_DT vaccinated_VBN population_NN predicts_VBZ excess_JJ incidence_NN in_IN young_JJ age_NN groups_NNS ,_, in_IN keeping_VBG with_IN their_PRP$ higher_JJR historical_JJ burden_NN of_IN mumps_NNS ._. (_-LRB- B_LS )_-RRB- In_IN contrast_NN ,_, the_DT fit_NN of_IN a_DT model_NN incorporating_VBG waning_VBG vaccine_NN -_HYPH derived_VBN immunity_NN matches_VBZ the_DT observed_VBN age_NN distribution_NN ._. (_-LRB- C_LS )_-RRB- Higher_JJR overall_JJ incidence_NN rates_NNS and_CC (_-LRB- D_NN )_-RRB- a_DT younger_JJR age_NN distribution_NN of_IN cases_NNS are_VBP predicted_VBN when_WRB immune_NN responses_NNS to_IN the_DT vaccine_NN offer_VBP minimal_JJ cross-protection_NN against_IN the_DT circulating_VBG strain_NN ,_, as_IN compared_VBN to_IN the_DT fit_NN of_IN the_DT model_NN with_IN waning_VBG vaccine_NN immunity_NN ._. (_-LRB- E_LS )_-RRB- Whereas_IN the_DT model_NN with_IN a_DT viral_JJ -_HYPH escape_NN (_-LRB- VE_NN )_-RRB- strain_NN can_MD reproduce_VB the_DT age_NN distribution_NN of_IN cases_NNS at_IN low_JJ degrees_NNS of_IN immunological_JJ mismatch_NN ,_, (_-LRB- F_NNP )_-RRB- lower_JJR -_HYPH than_IN -_HYPH reported_VBN incidence_NN is_VBZ expected_VBN under_IN this_DT scenario_NN ,_, again_RB in_IN contrast_NN to_IN the_DT fit_NN of_IN a_DT model_NN with_IN waning_VBG vaccine_NN immunity_NN ._. Lines_NNS in_IN (_-LRB- E_NNP )_-RRB- and_CC (_-LRB- F_NNP )_-RRB- signify_VBP 95_CD %_NN CIs_NN ._. If_IN vaccine_NN -_HYPH derived_VBN immunity_NN wanes_VBZ or_CC confers_VBZ shorter_JJR -_HYPH lasting_VBG protection_NN against_IN genotypes_NNS currently_RB in_IN circulation_NN as_IN compared_VBN to_IN those_DT circulating_VBG in_IN 1967_CD ,_, then_RB administering_VBG additional_JJ vaccine_NN doses_NNS may_MD help_VB control_VB transmission_NN by_IN extending_VBG immune_JJ protection_NN to_IN older_JJR ages_NNS ._. On_IN the_DT basis_NN of_IN analyses_NNS of_IN the_DT effective_JJ reproductive_JJ number_NN (_-LRB- R_NN )_-RRB- ,_, or_CC the_DT number_NN of_IN new_JJ infectious_JJ cases_NNS emerging_VBG from_IN a_DT single_JJ infectious_JJ case_NN under_IN prevailing_JJ levels_NNS of_IN immunity_NN ,_, we_PRP found_VBD that_IN protection_NN afforded_VBN by_IN two_CD vaccine_NN doses_NNS alone_RB is_VBZ unlikely_JJ to_TO support_VB elimination_NN of_IN endemic_JJ mumps_NNS virus_NN transmission_NN from_IN the_DT United_NNP States_NNPS in_IN the_DT long_JJ term_NN ._. If_IN R_NNP stays_VBZ below_IN 1.0_CD ,_, then_RB epidemics_NNS are_VBP unlikely_JJ to_TO be_VB sustained_VBN in_IN the_DT long_JJ term_NN ;_, because_IN birth_NN cohorts_NNS exposed_VBN to_IN high_JJ rates_NNS of_IN transmission_NN in_IN the_DT 20th_JJ century_NN are_VBP replaced_VBN by_IN individuals_NNS whose_WP$ protection_NN comes_VBZ only_RB through_IN vaccination_NN ,_, we_PRP expect_VBP R_NNP to_TO approach_VB 1.11_CD (_-LRB- 95_CD %_NN CI_NN ,_, 1.04_CD to_IN 1.13_CD ;_: Fig._NN 4_CD )_-RRB- ._. Although_IN administering_VBG a_DT third_JJ vaccine_NN dose_NN by_IN 18_CD years_NNS of_IN age_NN would_MD not_RB necessarily_RB confer_VB life_NN -_HYPH long_JJ protection_NN based_VBN on_IN our_PRP$ estimate_NN of_IN the_DT time_NN to_TO loss_NN of_IN immunity_NN ,_, we_PRP nonetheless_RB predict_VBP that_IN this_DT intervention_NN could_MD extend_VB protection_NN through_IN young_JJ adulthood_NN ,_, thereby_RB protecting_VBG age_NN groups_NNS at_IN risk_NN in_IN recent_JJ outbreaks_NNS ._. Low_JJ (_-LRB- 56_CD %_NN )_-RRB- uptake_NN of_IN a_DT third_JJ dose_NN matching_VBG adult_NN compliance_NN with_IN recommended_VBN tetanus_NN -_HYPH diptheria_NN toxoid_NN booster_NN doses_NNS would_MD be_VB expected_VBN to_TO sustain_VB R_NN around_IN 0.88_CD (_-LRB- 95_CD %_NN CI_NN ,_, 0.83_CD to_IN 0.91_CD )_-RRB- ,_, based_VBN on_IN transmission_NN dynamics_NNS in_IN the_DT United_NNP States_NNPS as_IN of_IN 2016_CD ._. Under_IN a_DT more_RBR optimistic_JJ scenario_NN of_IN 88_CD %_NN third_JJ -_HYPH dose_NN coverage_NN —_: where_WRB third_JJ -_HYPH dose_NN uptake_NN equates_VBZ second_JJ -_HYPH dose_NN uptake_NN among_IN already_RB -_HYPH immunized_VBN individuals_NNS —_: we_PRP expect_VBP R_NN to_TO approach_VB 0.77_CD (_-LRB- 95_CD %_NN CI_NN ,_, 0.72_CD to_IN 0.79_CD )_-RRB- as_IN cohorts_NNS previously_RB exposed_VBN to_IN high_JJ transmission_NN rates_NNS age_NN out_IN of_IN the_DT population_NN ._. Age_NN -_HYPH specific_JJ immunity_NN and_CC transmission_NN dynamics_NNS under_IN two_CD -_HYPH and_CC three_CD -_HYPH dose_NN vaccine_NN schedules_NNS ._. Waning_VBG vaccine_NN -_HYPH derived_VBN protection_NN in_IN the_DT population_NN raises_VBZ the_DT question_NN of_IN how_WRB additional_JJ vaccine_NN doses_NNS would_MD affect_VB mumps_NNS transmission_NN ._. To_TO address_VB this_DT question_NN ,_, we_PRP evaluated_VBD several_JJ scenarios_NNS ._. (_-LRB- A_LS )_-RRB- Cohorts_NNS over_RB 40_CD years_NNS of_IN age_NN as_IN of_IN 2016_CD were_VBD exposed_VBN to_IN endemic_JJ transmission_NN before_RB and_CC shortly_RB after_IN vaccine_NN rollout_NN and_CC likely_RB retain_VBP life_NN -_HYPH long_JJ protection_NN ._. However_RB ,_, a_DT population_NN protected_VBN only_RB by_IN two_CD -_HYPH dose_NN vaccination_NN would_MD be_VB expected_VBN to_TO experience_VB high_JJ prevalence_NN of_IN susceptibility_NN over_RB 20_CD years_NNS of_IN age_NN ._. (_-LRB- B_NN and_CC C_LS )_-RRB- Our_PRP$ modeling_NN suggests_VBZ that_IN the_DT duration_NN of_IN protection_NN can_MD be_VB extended_VBN through_IN young_JJ adulthood_NN by_IN adding_VBG a_DT third_JJ dose_NN around_RB 18_CD years_NNS of_IN age_NN ,_, whereas_IN routine_JJ booster_NN doses_NNS every_DT 10_CD or_CC 20_CD years_NNS would_MD be_VB expected_VBN to_TO sustain_VB longer_JJR -_HYPH term_NN protection_NN ._. Lines_NNS and_CC shaded_VBN areas_NNS delineate_VBP median_JJ estimates_NNS and_CC 95_CD %_NN CIs_NN ,_, respectively_RB ._. (_-LRB- D_LS )_-RRB- Under_IN transmission_NN dynamics_NNS estimated_VBN as_IN of_IN 2016_CD ,_, protection_NN in_IN young_JJ adult_NN age_NN groups_NNS achieved_VBN through_IN the_DT use_NN of_IN a_DT third_JJ vaccine_NN dose_NN is_VBZ expected_VBN to_TO reduce_VB the_DT effective_JJ reproductive_JJ number_NN (_-LRB- R_NN )_-RRB- below_IN 1_CD ._. We_PRP ,_, however_RB ,_, predict_VBP R_NNP to_TO approach_VB 1.10_CD under_IN the_DT two_CD -_HYPH dose_NN schedule_NN as_IN cohorts_NNS that_WDT experienced_VBD high_JJ rates_NNS of_IN mumps_NNS infection_NN age_NN out_IN of_IN the_DT population_NN ;_, larger_JJR reductions_NNS in_IN R_NN are_VBP sustained_VBN at_IN higher_JJR coverage_NN and_CC with_IN more_RBR frequent_JJ dosing_NN ._. Colors_NNS are_VBP the_DT same_JJ as_IN in_IN (_-LRB- A_LS )_-RRB- to_IN (_-LRB- C_NNP )_-RRB- ._. R_NNP ,_, basic_JJ reproductive_JJ number_NN ._. (_-LRB- E_LS )_-RRB- In_IN turn_NN ,_, these_DT extensions_NNS of_IN protection_NN provide_VBP a_DT stronger_JJR barrier_NN against_IN emergence_NN of_IN strains_NNS escaping_VBG vaccine_NN immunity_NN ._. A_DT new_JJ strain_NN with_IN 8.5_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 7.6_CD to_IN 9.8_CD %_NN )_-RRB- probability_NN of_IN evading_VBG vaccine_NN -_HYPH induced_VBN immunity_NN and_CC infecting_VBG a_DT vaccine_NN -_HYPH protected_VBN individual_NN would_MD be_VB expected_VBN to_TO succeed_VB under_IN a_DT three_CD -_HYPH dose_NN schedule_NN with_IN low_JJ coverage_NN ._. We_PRP ,_, however_RB ,_, estimate_VBP that_IN a_DT new_JJ strain_NN would_MD require_VB 22.9_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 16.4_CD to_IN 29.7_CD %_NN )_-RRB- probability_NN of_IN infecting_VBG such_PDT an_DT individual_NN to_TO emerge_VB in_IN a_DT population_NN with_IN 88_CD %_NN uptake_NN of_IN the_DT third_JJ dose_NN and_CC 10_CD -_HYPH year_NN boosters_NNS ._. Lines_NNS denote_VBP 95_CD %_NN CIs_NN ,_, and_CC shaded_VBN areas_NNS represent_VBP distributions_NNS around_IN R_NN estimates_NNS ._. Whereas_IN we_PRP estimated_VBD that_IN most_JJS older_JJR adults_NNS are_VBP currently_RB immune_JJ to_IN mumps_NNS virus_NN because_IN of_IN previous_JJ infection_NN ,_, our_PRP$ modeling_NN suggested_VBD that_IN neither_CC a_DT two_CD -_HYPH dose_NN nor_CC a_DT three_CD -_HYPH dose_NN vaccination_NN program_NN would_MD be_VB expected_VBN to_TO protect_VB more_JJR than_IN 50_CD %_NN of_IN adults_NNS beyond_IN the_DT age_NN of_IN 40_CD years_NNS in_IN the_DT long_JJ term_NN ._. This_DT concern_NN may_MD motivate_VB the_DT use_NN of_IN routine_JJ booster_NN doses_NNS in_IN adulthood_NN (_-LRB- Fig._NNP 4_CD )_-RRB- ._. On_IN the_DT basis_NN of_IN our_PRP$ model_NN ,_, we_PRP expect_VBP that_IN administering_VBG additional_JJ doses_NNS every_DT 10_CD or_CC 20_CD years_NNS would_MD lead_VB to_IN sustained_VBN protection_NN in_IN ,_, at_IN minimum_NN ,_, 68.0_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 58.5_CD to_IN 77.6_CD %_NN )_-RRB- and_CC 55.2_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 44.1_CD to_IN 68.4_CD %_NN )_-RRB- of_IN the_DT population_NN ,_, respectively_RB ,_, under_IN a_DT scenario_NN of_IN 88_CD %_NN vaccine_NN coverage_NN ;_: at_IN the_DT lower_JJR (_-LRB- 56_CD %_NN )_-RRB- coverage_NN level_NN ,_, we_PRP estimated_VBD protection_NN among_IN ,_, at_IN minimum_NN ,_, 59.0_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 48.2_CD to_IN 71.2_CD %_NN )_-RRB- and_CC 45.5_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 34.3_CD to_IN 60.5_CD %_NN )_-RRB- of_IN adults_NNS with_IN dosing_VBG every_DT 10_CD or_CC 20_CD years_NNS ,_, respectively_RB ._. Maintaining_VBG high_JJ prevalence_NN of_IN immunity_NN in_IN the_DT population_NN through_IN repeated_VBN dosing_NN may_MD also_RB help_VB to_TO contain_VB emergence_NN of_IN new_JJ mumps_NNS virus_NN strains_NNS (_-LRB- Fig._NN 4E_CD )_-RRB- ._. To_TO sustain_VB R_NNP ≥_SYM 1_CD under_IN three_CD -_HYPH dose_NN schedules_NNS ,_, we_PRP estimated_VBD that_IN an_DT emerging_VBG strain_NN would_MD require_VB ,_, at_IN minimum_NN ,_, 8.5_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 7.6_CD to_IN 9.8_CD %_NN )_-RRB- to_IN 15.7_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 11.9_CD to_IN 20.3_CD %_NN )_-RRB- probability_NN of_IN causing_VBG infection_NN in_IN exposed_VBN persons_NNS otherwise_RB protected_VBN by_IN vaccination_NN ._. Adding_VBG booster_NN doses_NNS every_DT 10_CD years_NNS increased_VBD this_DT threshold_NN probability_NN to_IN between_IN 16.6_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 12.5_CD to_IN 20.8_CD %_NN )_-RRB- and_CC 22.9_CD %_NN (_-LRB- 95_CD %_NN CI_NN ,_, 16.4_CD to_IN 29.7_CD %_NN )_-RRB- at_IN varying_VBG degrees_NNS of_IN vaccine_NN coverage_NN ._. Resurgent_JJ outbreaks_NNS centered_VBN among_IN young_JJ adults_NNS have_VBP brought_VBN renewed_VBN attention_NN to_IN mumps_NNS after_IN decades_NNS of_IN progress_NN toward_IN its_PRP$ elimination_NN from_IN the_DT United_NNP States_NNPS (_-LRB- 2_CD ,_, 12_CD )_-RRB- ._. Understanding_VBG why_WRB cases_NNS have_VBP re-emerged_VBN is_VBZ essential_JJ for_IN determining_VBG how_WRB to_TO contain_VB the_DT disease_NN through_IN vaccination_NN ._. Our_PRP$ analyses_NNS show_VBP that_IN vaccine_NN -_HYPH derived_VBN immune_NN protection_NN wanes_VBZ over_IN time_NN ._. We_PRP estimate_VBP the_DT rate_NN of_IN waning_NN and_CC demonstrate_VBP that_IN this_DT waning_VBG immunity_NN accounts_VBZ for_IN susceptibility_NN in_IN the_DT age_NN groups_NNS experiencing_VBG outbreaks_NNS over_IN the_DT decades_NNS since_IN vaccine_NN introduction_NN in_IN the_DT United_NNP States_NNPS ._. In_IN contrast_NN ,_, changes_NNS in_IN the_DT circulating_VBG genotypes_NNS of_IN mumps_NNS virus_NN over_IN this_DT same_JJ period_NN have_VBP not_RB been_VBN associated_VBN with_IN reductions_NNS in_IN vaccine_NN effectiveness_NN ;_, moreover_RB ,_, our_PRP$ modeling_NN suggests_VBZ that_IN mumps_NNS virus_NN strains_NNS escaping_VBG vaccine_NN protection_NN would_MD be_VB expected_VBN to_TO cause_VB disproportionate_JJ incidence_NN among_IN younger_JJR children_NNS ,_, which_WDT has_VBZ not_RB been_VBN observed_VBN in_IN most_JJS recent_JJ outbreaks_NNS ._. Guided_VBN by_IN these_DT outcomes_NNS ,_, our_PRP$ model_NN shows_VBZ that_IN routine_JJ use_NN of_IN a_DT third_JJ vaccine_NN dose_NN around_RB 18_CD years_NNS of_IN age_NN ,_, with_IN or_CC without_IN regular_JJ dosing_NN in_IN adulthood_NN ,_, could_MD help_VB maintain_VB immune_JJ protection_NN in_IN the_DT population_NN ._. Distinguishing_VBG between_IN the_DT contributions_NNS of_IN vaccine_NN waning_NN and_CC the_DT emergence_NN of_IN vaccine_NN -_HYPH escape_NN virus_NN strains_NNS to_IN mumps_NN resurgence_NN helps_VBZ inform_VB whether_IN new_JJ vaccines_NNS are_VBP needed_VBN to_TO control_VB transmission_NN (_-LRB- 22_CD ,_, 23_CD )_-RRB- ._. Our_PRP$ findings_NNS that_WDT vaccine_NN effectiveness_NN has_VBZ not_RB declined_VBN amid_IN the_DT replacement_NN of_IN genotype_NN A_NN mumps_NNS viruses_NNS (_-LRB- from_IN which_WDT the_DT Jeryl_NNP Lynn_NNP vaccine_NN strain_NN was_VBD derived_VBN )_-RRB- ,_, and_CC that_IN the_DT age_NN distribution_NN of_IN recent_JJ cases_NNS is_VBZ inconsistent_JJ with_IN expectations_NNS under_IN vaccine_NN escape_NN ,_, are_VBP in_IN agreement_NN with_IN several_JJ lines_NNS of_IN evidence_NN that_WDT mumps_NNS vaccination_NN protects_VBZ broadly_RB against_IN heterologous_JJ strains_NNS (_-LRB- 24_CD )_-RRB- ._. Neutralizing_VBG antibody_NN responses_NNS to_IN the_DT Jeryl_NNP Lynn_NNP strain_NN are_VBP effective_JJ in_IN vitro_NN against_IN wild_JJ -_HYPH type_NN mumps_NNS virus_NN strains_NNS responsible_JJ for_IN recent_JJ outbreaks_NNS among_IN vaccinated_VBN individuals_NNS (_-LRB- 25_CD ,_, 26_CD )_-RRB- ,_, and_CC genetic_JJ distinctions_NNS have_VBP not_RB been_VBN identified_VBN between_IN strains_NNS isolated_VBN from_IN vaccinated_VBN and_CC unvaccinated_JJ mumps_NNS patients_NNS (_-LRB- 27_CD )_-RRB- ._. High_JJ efficacy_NN and_CC effectiveness_NN estimates_NNS for_IN both_CC the_DT Jeryl_NNP Lynn_NNP (_-LRB- genotype_NN A–derived_NN )_-RRB- and_CC Urabe_NNP (_-LRB- genotype_NN B–derived_NN )_-RRB- vaccines_NNS against_IN clinical_JJ illness_NN caused_VBN by_IN heterologous_JJ mumps_NN genotypes_NNS further_RB substantiate_VBP the_DT notion_NN of_IN cross-neutralizing_VBG or_CC monotypic_JJ immune_NN responses_NNS (_-LRB- 12_CD )_-RRB- ._. Although_IN the_DT efficacy_NN of_IN a_DT third_JJ dose_NN has_VBZ not_RB been_VBN assessed_VBN in_IN clinical_JJ trials_NNS ,_, several_JJ observations_NNS suggest_VBP effectiveness_NN of_IN extended_VBN vaccine_NN schedules_NNS ._. Although_IN congregated_VBN U.S._NNP military_JJ populations_NNS resemble_VBP high_JJ -_HYPH risk_NN groups_NNS based_VBN on_IN their_PRP$ age_NN distribution_NN and_CC close_JJ -_HYPH contact_NN environments_NNS ,_, no_DT outbreaks_NNS have_VBP been_VBN reported_VBN in_IN the_DT military_NN since_IN a_DT policy_NN of_IN administering_VBG an_DT MMR_NNP dose_NN to_IN incoming_JJ recruits_NNS ,_, regardless_RB of_IN vaccination_NN history_NN ,_, was_VBD adopted_VBN in_IN 1991_CD (_-LRB- 28_CD )_-RRB- ._. In_IN addition_NN ,_, receiving_VBG a_DT third_JJ dose_NN was_VBD associated_VBN with_IN protection_NN in_IN a_DT recent_JJ observational_JJ study_NN after_IN a_DT third_JJ -_HYPH dose_NN campaign_NN undertaken_VBN in_IN response_NN to_IN a_DT university_NN campus_NN outbreak_NN (_-LRB- 29_CD )_-RRB- ,_, building_VBG on_IN limited_JJ evidence_NN from_IN previous_JJ studies_NNS where_WRB third_JJ doses_NNS were_VBD only_RB administered_VBN at_IN the_DT tail_NN end_NN of_IN outbreaks_NNS (_-LRB- 30–33_CD )_-RRB- ._. Trials_NNS demonstrating_VBG the_DT clinical_JJ effectiveness_NN of_IN adult_JJ vaccine_NN doses_NNS remain_VBP ideal_JJ to_TO guide_VB policy_NN around_IN the_DT benefits_NNS of_IN routine_JJ or_CC reactive_JJ use_NN of_IN third_JJ doses_NNS and_CC may_MD improve_VB our_PRP$ understanding_NN of_IN immunological_JJ correlates_NNS of_IN protection_NN (_-LRB- 34–36_CD )_-RRB- ._. Such_JJ trials_NNS —_: or_CC further_JJ observational_JJ studies_NNS —_: will_MD also_RB play_VB an_DT important_JJ role_NN in_IN establishing_VBG the_DT duration_NN of_IN protection_NN after_IN third_JJ or_CC additional_JJ doses_NNS in_IN adulthood_NN ._. Modifying_VBG MMR_NN vaccines_NNS to_TO improve_VB the_DT magnitude_NN or_CC duration_NN of_IN immune_NN responses_NNS against_IN mumps_NNS virus_NN may_MD also_RB improve_VB protection_NN ._. Notably_RB ,_, the_DT mumps_NNS component_NN of_IN the_DT vaccine_NN induces_VBZ lower_JJR -_HYPH avidity_NN antibody_NN responses_NNS ,_, and_CC weaker_JJR specific_JJ memory_NN B_NN cell_NN proliferation_NN ,_, than_IN the_DT measles_NNS and_CC rubella_NN components_NNS (_-LRB- 37_CD ,_, 38_CD )_-RRB- ._. Several_JJ limitations_NNS of_IN the_DT analysis_NN should_MD be_VB considered_VBN ._. Our_PRP$ use_NN of_IN aggregated_VBN rather_RB than_IN individual_JJ -_HYPH level_NN data_NNS from_IN vaccine_NN effectiveness_NN studies_NNS contributed_VBD to_IN an_DT imprecise_JJ estimate_NN of_IN the_DT time_NN to_IN loss_NN of_IN immunity_NN ,_, in_IN turn_NN limiting_VBG the_DT precision_NN of_IN our_PRP$ estimates_NNS of_IN population_NN susceptibility_NN ._. Individual_JJ -_HYPH level_NN data_NNS from_IN postlicensure_NN vaccine_NN studies_NNS could_MD support_VB better_JJR inferences_NNS about_IN the_DT magnitude_NN and_CC duration_NN of_IN vaccine_NN protection_NN ,_, thus_RB aiding_VBG policy_NN decisions_NNS ._. Identifying_VBG immunological_JJ correlates_NNS of_IN protection_NN from_IN such_JJ data_NN sets_NNS would_MD also_RB aid_VB evaluations_NNS of_IN alternative_JJ vaccination_NN schedules_NNS and_CC measurements_NNS of_IN population_NN immunity_NN ._. Second_RB ,_, we_PRP lack_VBP data_NNS on_IN genotype_NN -_HYPH specific_JJ incidence_NN that_WDT could_MD help_VB us_PRP infer_VB differential_JJ protection_NN of_IN the_DT Jeryl_NNP Lynn_NNP vaccine_NN against_IN circulating_VBG strains_NNS ._. Epidemiological_JJ studies_NNS of_IN outbreaks_NNS caused_VBN by_IN distinct_JJ virus_NN lineages_NNS ,_, and_CC in_IN populations_NNS exposed_VBN to_IN different_JJ circulating_VBG mumps_NNS viruses_NNS ,_, can_MD better_RBR characterize_VB genotype_NN specificity_NN in_IN the_DT strength_NN or_CC duration_NN of_IN vaccine_NN protection_NN ._. Last_JJ ,_, our_PRP$ analysis_NN addresses_VBZ mumps_NNS epidemiology_NN in_IN the_DT United_NNP States_NNPS ,_, where_WRB prevalence_NN of_IN immunity_NN within_IN particular_JJ birth_NN cohorts_NNS may_MD differ_VB in_IN relation_NN to_IN settings_NNS that_WDT introduced_VBD routine_JJ mumps_NNS vaccination_NN later_RBR or_CC use_VB different_JJ vaccine_NN schedules_NNS ._. The_DT burden_NN of_IN cases_NNS and_CC prevalence_NN of_IN immunity_NN across_IN ages_NNS or_CC birth_NN cohorts_NNS should_MD be_VB considered_VBN as_IN a_DT basis_NN to_TO guide_VB vaccination_NN policy_NN within_IN specific_JJ countries_NNS ._. Analyzing_VBG nationally_RB aggregated_VBN incidence_NN data_NNS sets_NNS also_RB limited_VBD our_PRP$ ability_NN to_TO investigate_VB how_WRB geographic_JJ or_CC socioeconomic_JJ differences_NNS in_IN vaccine_NN uptake_NN and_CC contact_NN rates_NNS contribute_VBP to_IN the_DT dynamics_NNS of_IN focal_JJ outbreaks_NNS ,_, as_IN might_MD occur_VB in_IN close_JJ -_HYPH contact_NN settings_NNS such_JJ as_IN university_NN dormitories_NNS (_-LRB- 39_CD ,_, 40_CD )_-RRB- ._. However_RB ,_, our_PRP$ inferences_NNS about_IN vaccine_NN waning_NN and_CC the_DT changing_VBG age_NN distribution_NN of_IN mumps_NNS cases_NNS offer_VBP insight_NN into_IN why_WRB mumps_NNS resurgence_NN has_VBZ been_VBN possible_JJ throughout_IN geographically_RB and_CC socioeconomically_RB distinct_JJ communities_NNS ._. In_IN this_DT regard_NN ,_, the_DT widespread_JJ re-emergence_NN of_IN mumps_NNS in_IN vaccine_NN -_HYPH compliant_JJ communities_NNS stands_VBZ in_IN stark_JJ contrast_NN to_IN the_DT focal_JJ re-emergence_NN of_IN measles_NNS in_IN communities_NNS with_IN low_JJ vaccine_NN coverage_NN (_-LRB- 11_CD )_-RRB- ._. Changes_NNS in_IN the_DT epidemiology_NN of_IN mumps_NNS have_VBP implications_NNS for_IN disease_NN surveillance_NN ._. Diminished_VBN clinical_JJ awareness_NN of_IN mumps_NNS ,_, expectations_NNS that_IN it_PRP appears_VBZ in_IN pediatric_JJ rather_RB than_IN adult_JJ populations_NNS ,_, and_CC protection_NN against_IN symptoms_NNS in_IN vaccinated_VBN individuals_NNS (_-LRB- 41_CD )_-RRB- may_MD limit_VB routine_JJ detection_NN of_IN cases_NNS and_CC thus_RB bias_NN disease_NN reporting_NN ._. Serological_JJ surveys_NNS have_VBP provided_VBN evidence_NN of_IN higher_JJR -_HYPH than_IN -_HYPH reported_VBN rates_NNS of_IN mumps_NNS virus_NN infection_NN in_IN the_DT United_NNP States_NNPS before_IN 2006_CD (_-LRB- 28_CD ,_, 42_CD )_-RRB- ._. The_DT tendency_NN to_TO identify_VB outbreak_NN -_HYPH associated_VBN cases_NNS through_IN contact_NN tracing_NN may_MD also_RB favor_VB detection_NN of_IN cases_NNS in_IN university_NN campuses_NNS and_CC other_JJ closely_RB connected_VBN populations_NNS ,_, underscoring_VBG the_DT importance_NN of_IN epidemiological_JJ surveillance_NN to_TO identify_VB infections_NNS occurring_VBG in_IN the_DT community_NN ._. The_DT ongoing_JJ resurgence_NN in_IN mumps_NNS among_IN young_JJ adults_NNS has_VBZ undermined_VBN previous_JJ enthusiasm_NN about_IN near_JJ -_HYPH term_NN elimination_NN of_IN this_DT disease_NN from_IN the_DT United_NNP States_NNPS (_-LRB- 1_CD )_-RRB- ._. Our_PRP$ analysis_NN suggests_VBZ that_IN vaccinated_VBN individuals_NNS lose_VBP protection_NN against_IN infection_NN on_IN average_NN 27_CD years_NNS after_IN receipt_NN of_IN their_PRP$ last_JJ dose_NN and_CC that_IN this_DT rate_NN of_IN vaccine_NN waning_NN explains_VBZ susceptibility_NN in_IN adolescent_JJ and_CC young_JJ adult_NN cohorts_NNS at_IN the_DT time_NN of_IN postlicensure_NN outbreaks_NNS in_IN these_DT age_NN groups_NNS ._. Re-emergence_NN of_IN mumps_NNS among_IN older_JJR ,_, previously_RB vaccinated_VBN individuals_NNS whose_WP$ immunity_NN has_VBZ waned_VBN parallels_NNS recent_JJ experience_NN with_IN varicella_NN outbreaks_NNS affecting_VBG immunized_VBN communities_NNS as_IN a_DT result_NN of_IN waning_VBG vaccine_NN -_HYPH derived_VBN protection_NN (_-LRB- 43_CD )_-RRB- ._. As_IN demonstrated_VBN in_IN mumps_NNS epidemiology_NN ,_, immunity_NN in_IN previously_RB infected_VBN cohorts_NNS may_MD buffer_VB transmission_NN and_CC delay_VB breakthrough_NN epidemics_NNS from_IN occurring_VBG until_IN decades_NNS after_IN vaccine_NN introduction_NN ._. We_PRP expect_VBP population_NN susceptibility_NN to_TO mumps_NNS to_TO continue_VB increasing_VBG as_IN transient_JJ vaccine_NN -_HYPH derived_VBN immunity_NN supersedes_VBZ previous_JJ infection_NN as_IN the_DT main_JJ determinant_NN of_IN mumps_NNS susceptibility_NN in_IN the_DT U.S._NNP population_NN ._. These_DT observations_NNS indicate_VBP the_DT need_NN for_IN either_CC innovative_JJ clinical_JJ trial_NN designs_NNS to_TO measure_VB the_DT benefit_NN of_IN extending_VBG vaccine_NN dosing_NN schedules_NNS or_CC new_JJ vaccines_NNS to_TO address_VB the_DT problem_NN of_IN waning_VBG vaccine_NN -_HYPH induced_VBN protection_NN (_-LRB- 44_CD )_-RRB- ._. Our_PRP$ study_NN is_VBZ composed_VBN of_IN four_CD parts_NNS ._. First_RB ,_, we_PRP conducted_VBD a_DT meta_NN -_HYPH analysis_NN of_IN six_CD studies_NNS on_IN mumps_NNS vaccine_NN effectiveness_NN in_IN the_DT United_NNP States_NNPS and_CC Europe_NNP to_TO assess_VB hypotheses_NNS of_IN waning_VBG protection_NN and_CC diminished_VBN effectiveness_NN against_IN currently_RB circulating_VBG strains_NNS ._. We_PRP then_RB applied_VBD estimates_NNS of_IN the_DT waning_VBG rate_NN from_IN this_DT analysis_NN to_TO infer_VB changes_NNS over_IN time_NN in_IN the_DT susceptibility_NN of_IN the_DT U.S._NNP population_NN ,_, accounting_NN for_IN vaccine_NN uptake_NN and_CC incidence_NN of_IN natural_JJ infection_NN ._. We_PRP integrated_VBD a_DT system_NN of_IN differential_JJ equations_NNS forward_RB from_IN initial_JJ conditions_NNS ,_, defined_VBN from_IN the_DT prevaccination_NN endemic_JJ equilibrium_NN (_-LRB- as_IN inferred_VBN over_IN the_DT years_NNS 1960_CD to_IN 1964_CD )_-RRB- ,_, by_IN back_NN -_HYPH calculating_VBG transmission_NN rates_NNS from_IN reported_VBN mumps_NNS incidence_NN ._. We_PRP next_RB modeled_VBD expected_VBN transmission_NN dynamics_NNS under_IN scenarios_NNS of_IN vaccine_NN waning_NN and_CC viral_JJ escape_NN and_CC estimated_VBD long_JJ -_HYPH term_NN impacts_NNS of_IN adult_JJ vaccination_NN schedules_NNS on_IN population_NN susceptibility_NN ._. Full_JJ technical_JJ details_NNS pertaining_VBG to_IN our_PRP$ analyses_NNS are_VBP presented_VBN in_IN Supplementary_JJ Materials_NNS and_CC Methods_NNS (_-LRB- a_DT brief_JJ summary_NN is_VBZ provided_VBN here_RB )_-RRB- ._. We_PRP performed_VBD a_DT systematic_JJ review_NN of_IN prospective_JJ and_CC retrospective_JJ cohort_NN studies_NNS calculating_VBG effectiveness_NN of_IN the_DT Jeryl_NNP Lynn_NNP strain_NN mumps_NNS vaccine_NN via_IN a_DT PubMed_NN search_NN and_CC citation_NN tracking_NN ._. Details_NNS of_IN the_DT studies_NNS used_VBN to_TO infer_VB vaccine_NN effectiveness_NN are_VBP listed_VBN in_IN table_NN S1_NN ._. We_PRP used_VBD an_DT inverse_JJ variance_NN -_HYPH weighted_VBN meta-_NN regression_NN model_NN ,_, accounting_NN for_IN study_NN -_HYPH level_NN heterogeneity_NN ,_, to_TO measure_VB unadjusted_JJ and_CC multivariate_JJ -_HYPH adjusted_VBN associations_NNS of_IN the_DT following_VBG variables_NNS with_IN study_NN -_HYPH level_NN estimates_NNS of_IN the_DT relative_JJ risk_NN of_IN infection_NN associated_VBN with_IN vaccination_NN :_: (_-LRB- i_LS )_-RRB- time_NN since_IN receipt_NN of_IN the_DT last_JJ vaccine_NN dose_NN ,_, indicating_VBG waning_VBG vaccine_NN immunity_NN ;_, (_-LRB- ii_LS )_-RRB- time_NN from_IN 1964_CD (_-LRB- when_WRB the_DT Jeryl_NNP Lynn_NNP vaccine_NN was_VBD developed_VBN )_-RRB- to_IN the_DT year_NN of_IN mumps_NNS exposure_NN ,_, indicating_VBG long_JJ -_HYPH term_NN changes_NNS in_IN vaccine_NN effectiveness_NN associated_VBN with_IN changes_NNS in_IN circulating_VBG genotypes_NNS ;_: and_CC (_-LRB- iii_LS )_-RRB- vaccine_NN doses_NNS received_VBN ,_, with_IN an_DT interaction_NN term_NN for_IN time_NN since_IN the_DT last_JJ dose_NN to_TO test_VB for_IN differential_JJ waning_NN of_IN first_JJ and_CC second_JJ doses_NNS ._. Regression_NN model_NN summary_NN statistics_NNS indicated_VBD the_DT proportion_NN of_IN variance_NN explained_VBN by_IN these_DT covariates_NNS ._. We_PRP used_VBD our_PRP$ estimate_NN of_IN the_DT association_NN between_IN instantaneous_JJ risk_NN of_IN infection_NN and_CC time_NN since_IN vaccination_NN to_TO fit_VB an_DT exponential_JJ distribution_NN to_IN the_DT duration_NN of_IN vaccine_NN -_HYPH derived_VBN immune_NN protection_NN and_CC used_VBD this_DT fitted_VBN distribution_NN as_IN the_DT basis_NN for_IN further_JJ modeling_NN ._. We_PRP used_VBD a_DT system_NN of_IN ordinary_JJ differential_JJ equations_NNS to_TO describe_VB changes_NNS in_IN the_DT population_NN of_IN susceptible_JJ and_CC protected_VBN persons_NNS ,_, partitioned_VBN into_IN those_DT who_WP had_VBD and_CC had_VBD not_RB received_VBN mumps_NNS vaccines_NNS ._. Updating_VBG the_DT model_NN to_TO address_VB the_DT contributions_NNS of_IN vaccination_NN and_CC vaccine_NN waning_NN to_IN population_NN immunity_NN ,_, we_PRP back_RB -_HYPH calculated_VBN changes_NNS in_IN natural_JJ immunity_NN in_IN the_DT population_NN based_VBN on_IN the_DT relation_NN between_IN reported_VBN incidence_NN rates_NNS (_-LRB- Λ_LS )_-RRB- in_IN age_NN group_NN i_PRP and_CC year_NN t_NN and_CC the_DT force_NN of_IN infection_NN to_IN which_WDT individuals_NNS were_VBD exposed_VBN (_-LRB- λ_NN )_-RRB- ,_, the_DT populations_NNS of_IN susceptible_JJ unvaccinated_JJ (_-LRB- S_NNP )_-RRB- and_CC vaccinated_VBN (_-LRB- F_NNP )_-RRB- persons_NNS ,_, and_CC the_DT probabilities_NNS (_-LRB- π_NN and_CC π_NN ,_, respectively_RB )_-RRB- for_IN these_DT individuals_NNS to_TO experience_VB symptoms_NNS if_IN infected_VBN ._. As_IN described_VBN in_IN Supplementary_JJ Materials_NNS and_CC Methods_NNS ,_, this_DT approach_NN allowed_VBD us_PRP to_TO account_VB for_IN changes_NNS over_IN time_NN in_IN transmission_NN patterns_NNS leading_VBG to_IN time_NN -_HYPH varying_VBG estimates_NNS of_IN the_DT basic_JJ reproductive_JJ number_NN ._. Susceptible_JJ vaccinated_VBN persons_NNS (_-LRB- F_NNP )_-RRB- comprised_VBD those_DT failing_VBG to_TO mount_VB an_DT immune_JJ response_NN immediately_RB after_IN vaccination_NN (_-LRB- primary_JJ vaccine_NN failure_NN )_-RRB- and_CC those_DT whose_WP$ initial_JJ protection_NN had_VBD waned_VBN (_-LRB- secondary_JJ vaccine_NN failure_NN )_-RRB- ._. Model_NN parameter_NN values_NNS and_CC their_PRP$ sources_NNS are_VBP listed_VBN in_IN table_NN S2_NN ._. Age_NN -_HYPH specific_JJ incidence_NN reports_NNS were_VBD collated_VBN from_IN nationwide_JJ surveillance_NN (_-LRB- 45_CD )_-RRB- ._. Our_PRP$ model_NN accounted_VBD for_IN age_NN -_HYPH structured_VBN mixing_NN among_IN individuals_NNS partitioned_VBN across_IN 10_CD age_NN classes_NNS (_-LRB- 0_CD to_IN 11_CD months_NNS ,_, 1_CD to_IN 4_CD years_NNS ,_, 5_CD to_IN 9_CD years_NNS ,_, 10_CD to_IN 14_CD years_NNS ,_, 15_CD to_IN 19_CD years_NNS ,_, 20_CD to_IN 24_CD years_NNS ,_, 25_CD to_IN 29_CD years_NNS ,_, 30_CD to_IN 39_CD years_NNS ,_, 40_CD to_IN 64_CD years_NNS ,_, and_CC ≥_SYM 65_CD years_NNS )_-RRB- ._. Members_NNS of_IN the_DT ith_JJ age_NN class_NN encountered_VBD the_DT force_NN of_IN infection_NN cumulatively_RB through_IN interactions_NNS with_IN infectious_JJ individuals_NNS (_-LRB- I_PRP )_-RRB- distributed_VBD across_IN all_DT j_NN age_NN classes_NNS ;_: the_DT matrix_NN C_NNP conveyed_VBD age_NN -_HYPH specific_JJ mixing_NN patterns_NNS ._. We_PRP inferred_VBD starting_NN -_HYPH time_NN age_NN -_HYPH specific_JJ prevalence_NN of_IN immunity_NN in_IN the_DT U.S._NNP population_NN (_-LRB- as_IN of_IN 1967_CD )_-RRB- by_IN fitting_VBG a_DT mathematical_JJ model_NN of_IN mumps_NNS transmission_NN to_TO recapitulate_VB age_NN -_HYPH specific_JJ incidence_NN in_IN the_DT prevaccine_NN era_NN at_IN steady_JJ state_NN ._. To_TO compare_VB predicted_VBN incidence_NN during_IN an_DT introduced_VBN outbreak_NN against_IN observations_NNS from_IN the_DT year_NN 2006_CD ,_, we_PRP implemented_VBD stochastic_JJ realizations_NNS of_IN extended_VBN versions_NNS of_IN the_DT model_NN under_IN scenarios_NNS where_WRB we_PRP assumed_VBD waning_NN of_IN immunity_NN or_CC circulation_NN of_IN strains_NNS with_IN differential_JJ risk_NN of_IN infecting_VBG persons_NNS protected_VBN by_IN vaccination_NN ._. We_PRP assessed_VBD which_WDT scenario_NN was_VBD more_RBR consistent_JJ with_IN epidemiological_JJ observations_NNS on_IN the_DT basis_NN of_IN model_NN -_HYPH predicted_VBN age_NN -_HYPH specific_JJ and_CC overall_JJ incidence_NN rates_NNS ,_, as_RB well_RB as_IN the_DT predicted_VBN median_JJ age_NN of_IN infection_NN ._. We_PRP compared_VBD the_DT long_JJ -_HYPH term_NN performance_NN of_IN different_JJ vaccination_NN schedules_NNS including_VBG the_DT addition_NN of_IN a_DT third_JJ dose_NN by_IN 18_CD years_NNS of_IN age_NN and_CC the_DT use_NN of_IN routine_JJ boosters_NNS at_IN 10_CD -_SYM or_CC 20_CD -_HYPH year_NN intervals_NNS through_IN adulthood_NN ._. We_PRP calculated_VBD the_DT prevalence_NN of_IN age_NN -_HYPH specific_JJ immune_NN protection_NN achieved_VBN under_IN these_DT strategies_NNS and_CC resulting_VBG values_NNS of_IN the_DT effective_JJ reproductive_JJ number_NN (_-LRB- R_NN )_-RRB- ,_, describing_VBG the_DT number_NN of_IN cases_NNS an_DT infectious_JJ individual_NN would_MD be_VB expected_VBN to_TO cause_VB under_IN prevailing_JJ conditions_NNS ._. We_PRP also_RB calculated_VBD the_DT minimum_JJ probability_NN of_IN immune_NN escape_NN a_DT novel_JJ mumps_NN virus_NN strain_NN would_MD need_VB to_TO invade_VB a_DT population_NN protected_VBN under_IN these_DT different_JJ strategies_NNS ,_, defined_VBN as_IN the_DT minimum_JJ probability_NN of_IN infecting_VBG a_DT vaccinated_VBN ,_, protected_VBN individual_NN upon_IN exposure_NN such_JJ that_IN R_NN ≥_SYM 1_CD ._. Acknowledgments_NNS :_: We_PRP thank_VBP L._NNP Li_NNP ,_, S._NNP Cobey_NNP ,_, P._NNP Sabeti_NNP ,_, S._NNP Wohl_NNP ,_, N._NNP Yozwiak_NNP ,_, G._NNP Armstrong_NNP ,_, and_CC M._NNP Lipsitch_NNP for_IN input_NN ._. Funding_NN :_: This_DT work_NN was_VBD supported_VBN by_IN National_NNP Institute_NNP of_IN General_NNP Medical_NNP Sciences_NNPS award_NNP U54GM088558_CD (_-LRB- to_IN J.A.L._NNP )_-RRB- and_CC a_DT Doris_NNP Duke_NNP Charitable_NNP Foundation_NNP Clinical_NNP Scientist_NNP Development_NNP Award_NNP (_-LRB- to_IN Y.H.G._NNP )_-RRB- ._. The_DT content_NN is_VBZ solely_RB the_DT responsibility_NN of_IN the_DT authors_NNS and_CC does_VBZ not_RB necessarily_RB represent_VB the_DT official_JJ views_NNS of_IN the_DT National_NNP Institute_NNP of_IN General_NNP Medical_NNP Sciences_NNPS or_CC the_DT NIH_NNP ._. Author_NN contributions_NNS :_: J.A.L._NNP and_CC Y.H.G._NNP conceived_VBD the_DT study_NN ,_, J.A.L._NNP performed_VBD the_DT analyses_NNS with_IN input_NN and_CC discussion_NN from_IN Y.H.G._NNP ,_, and_CC J.A.L._NNP drafted_VBD and_CC Y.H.G._NNP edited_VBD the_DT manuscript_NN ._. Competing_VBG interests_NNS :_: J.A.L._NNP has_VBZ received_VBN grant_NN funding_NN from_IN Pfizer_NNP to_IN Harvard_NNP University_NNP ,_, and_CC previous_JJ consulting_NN for_IN Pfizer_NNP ,_, for_IN work_NN unrelated_JJ to_IN this_DT analysis_NN ._. Y.H.G._NNP discloses_VBZ consulting_NN for_IN GlaxoSmithKline_NNP for_IN work_NN unrelated_JJ to_IN this_DT analysis_NN ._. Data_NN and_CC materials_NNS availability_NN :_: Code_NN for_IN replicating_VBG analyses_NNS and_CC figures_NNS is_VBZ available_JJ at_IN We_PRP thank_VBP L._NNP Li_NNP ,_, S._NNP Cobey_NNP ,_, P._NNP Sabeti_NNP ,_, S._NNP Wohl_NNP ,_, N._NNP Yozwiak_NNP ,_, G._NNP Armstrong_NNP ,_, and_CC M._NNP Lipsitch_NNP for_IN input_NN ._. This_DT work_NN was_VBD supported_VBN by_IN National_NNP Institute_NNP of_IN General_NNP Medical_NNP Sciences_NNPS award_NNP U54GM088558_CD (_-LRB- to_IN J.A.L._NNP )_-RRB- and_CC a_DT Doris_NNP Duke_NNP Charitable_NNP Foundation_NNP Clinical_NNP Scientist_NNP Development_NNP Award_NNP (_-LRB- to_IN Y.H.G._NNP )_-RRB- ._. The_DT content_NN is_VBZ solely_RB the_DT responsibility_NN of_IN the_DT authors_NNS and_CC does_VBZ not_RB necessarily_RB represent_VB the_DT official_JJ views_NNS of_IN the_DT National_NNP Institute_NNP of_IN General_NNP Medical_NNP Sciences_NNPS or_CC the_DT NIH._NNP J.A.L._NNP and_CC Y.H.G._NNP conceived_VBD the_DT study_NN ,_, J.A.L._NNP performed_VBD the_DT analyses_NNS with_IN input_NN and_CC discussion_NN from_IN Y.H.G._NNP ,_, and_CC J.A.L._NNP drafted_VBD and_CC Y.H.G._NNP edited_VBD the_DT manuscript_NN ._. J.A.L._NNP has_VBZ received_VBN grant_NN funding_NN from_IN Pfizer_NNP to_IN Harvard_NNP University_NNP ,_, and_CC previous_JJ consulting_NN for_IN Pfizer_NNP ,_, for_IN work_NN unrelated_JJ to_IN this_DT analysis_NN ._. Y.H.G._NNP discloses_VBZ consulting_NN for_IN GlaxoSmithKline_NNP for_IN work_NN unrelated_JJ to_IN this_DT analysis_NN ._. Code_NN for_IN replicating_VBG analyses_NNS and_CC figures_NNS is_VBZ available_JJ at_IN http://github.com/joelewnard/mumps_ADD","VBG NNS NNS in VBN NNS in the NNP NNPS over the JJ NN VBP VBN NNS about NNS NN NN . RB , NNP FW FW VBD these NNS VBG NNS NN NN NNS and JJ NN NN . They VBD that the NN in NNS NNS VBZ RBR JJ with NN of NN NN over NN , RB than JJ NN against an VBG NN NN or NN of JJ NN to the NN . Their NN RB VBD that a JJ NN NN may VB NN , which could VB JJ in VBG a JJ NN NN to VB the NN of NNS . After NNS of VBG NNS NN amid JJ NN , the NNP NNPS and JJ JJ NNS VBP VBN a NN in NNS NNS over the JJ NN . NNS VBG VBN NNS and NNS with JJ NN NN VBP VBN NNS about the NN of the JJ VBN NN RB in NN . It VBZ JJ whether NN NN VBZ or whether the NN VBZ RB against RB VBG NNS NN NNS . VBG NNS from six NNS of NNS NN NN , we VBD that NN - VBN NN NN against NNS VBZ on JJ 27 NNS ( 95 NN NN NN , 16 to 51 NNS ) after NN . After VBG for this NN , we VBD no NN that the NN of JJ NN NNS VBD to NNS in NN NN over NN . A JJ NN of NNS NN VBD the JJ NN of VBG NN to the NN in the NN of NNS NNS . NNS from 2006 to the NN among JJ NNS , and NNS in the JJ NNS and JJ NNS among NNS , VBN with NNS in NNS NN of these NN NNS VBN to VB due to NN of NN - VBN NN . In NN , NN of NNS NN NNS VBG NN NN would VB VBN to VB a JJR NN of NNS among NNS , RB NNS and JJ NNS as VBN . JJ NN of a JJ NN NN at 18 NNS of NN , or NN NN throughout NN , may VB a NN to VB NNS NN and should VB VBN in JJ NNS . Over the JJ NN , NNS NNS VBP VBN the NN of VBG JJ or JJ NNS NN NN in the NNP NNPS by the NN 2010 ( 1 , 2 ) . Whereas JJR than 90 NN of NNP - VBN NNS VBD NNS NNS by 20 NNS of NN in the NN NN ( 3 ) , NN VBD RB after NN of a JJ VBN NN ( the NNP NNP NN ) in 1967 , in JJ after the 1977 NN for its JJ NN among NNS as NN of the NNS - NNS - NN ( NNP ) NN ( 2 ) . NNS among VBN JJ NN and JJ JJ NNS VBD in the JJ NNS , VBN by VBN NNS in NN after NNS VBD VBN to VB a JJ NN NN at 4 to 6 NNS of NN ( 4 ) . RB , an JJ NN in NNS NNS VBD with a NN of NNS on NN NNS in 2006 ( 2 ) . An JJR NN of NN ( NNS 18 to 29 NNS , VBN to the JJ NN of 5 to 9 NNS ) VBZ VBN a VBG NN of these NNS ( 5 ) , JJ to JJ NNS in NNP , JJ NNP , and JJ NNS with JJ NN NN ( 6 –9 ) . These NNS VBP JJ on two NNS . RB , RB JJ as 10 NN of NNS NNS VBN after NN may VB JJ NNS VBG NN , NN , and NN , in NN to a JJR JJ NN in NNS that RB VBZ NN and JJ NN NN ( 10 ) . RB , JJS NNS NNS in JJ NNS VBP VBN VBN among JJ NNS who VBD two NN NNS as VBN ( 11 ) . This NN VBZ VBN NNS about JJ NN of the NNP NNP NN RB in NN ( 12 ) . It VBZ JJ whether JJ NNS in VBN NNS VBP due to the NN of NN - VBN NN or to the NN of NNS NN NNS VBG NN - VBN JJ NN . VBG between these NNS VBZ JJ to NN - NNS and NNS of the JJ and JJ NNS : At NN VBZ whether the NN of NNS can VB VBN by VBG NN NN NNS or whether a JJ NN must RB VB VBN ( 12 ) . To this NN , we VBD to VB NN of NN - VBN NN from JJ - NN NNS in NN NN against VBG NNS NNS VBG NNS from six JJ NNS of NNS NN NN VBN over JJ NNS in the NNP NNPS and NNP ( NN NNP ) . VBG NNS from these NNS , we VBD whether the NN of NN - VBN NN NN VBZ with NN since NN of the NN — a NN that would VB NN VBG — and whether the NN of NN VBZ VBN over JJ NNS amid NNS in the VBG NN of NNS NN NNS . We RB VBD the JJ NN of the NN of NN - VBN NN on the NN of the NNP NN to NNS over the NNS since NN NN and VBD JJ NNS to VB whether JJ NNS NN NN NNS VBP RBR JJ with NNS of VBG NN or NN NN . RB , we VBD VBN NN - JJ NN NN in JJ NNS of NNS NN within two JJ VBN NNS . The JJ VBD JJ to VBG NN VBN on our NNS of the NN of NN - VBN NN ; the JJ VBD JJ NN but VBD NNS NN NNS against which NN VBD JJ NNS of NN . We VBD our NNS to VB JJ NN NNS VBG to VB NN among NNS . NN of VBG NN in NNS of NN NN NN about the JJ NN of the NNP NNP NNS NN — VBG from 95 NN after a JJ NN in VBN VBN NNS ( 13 ) to < 50 NN two - NN NN during JJ NNS ( 14 ) VBP VBN NNS to VB NN NN . This NN in NNS of NN VBD us to VB JJ NNS about the NNS NNS NNS VBP VBN among VBN NNS ( 2 , 12 ) . VBG a JJ NN NN to NNS from JJ and JJ NN NNS ( NN NN ) , we VBD that the NN VBN since NN of an NN ’s JJ NN NN VBD for 66.4 NN of JJ NN in VBN NN NN NNS ( NN 1 , NNP to NNP ) . VBG our NN of the NN VBG NN to a NN of RB VBN NNS of NN , we VBD that NN VBZ , on NN , 27.4 NNS [ 95 NN NN NN ( NNP ) , 16.7 to 51.1 NNS ] after NN of any NN . Among 96.4 NN ( 95 NN NN , 94.0 to 97.8 NN ) of NNS VBN to VB JJ NNS to NNS NN , we RB VBD that 25 NN may VB NN within 7.9 NNS ( 95 NN NN , 4.7 to 14.7 NNS ) , 50 NN within 19.0 NNS ( 95 NN NN , 11.2 to 35.4 NNS ) , and 75 NN within 38.0 NNS ( 95 NN NN , 22.4 to 70.8 NNS ) . NN of JJ and JJ NN NNS VBG the JJ NN of JJ NNS in VBN and JJ NNS . We VBP the NNS of our NN - NN of NNS of NNS NN NN , from which we VBD NNS of NN VBG . ( A ) VBN RB VBZ how NNS of NN NN ( VBN as one minus the JJ NN ( NN ) of VBG NNS for a VBN NN , JJ to an JJ NN ) VBP across the six NNS VBN RB . NN since JJ NN VBZ for 66.4 NN of JJ NN in NNS after NN for JJ NNS of between - NN NN . NNS VBG NN - NN NNS VBP VBN in NN to VB NNS in NN NN . NNS VBP 95 NN NN NNS ( NN ) ; NNS VBP where NNS VBD to the JJS NN JJ zero . ( B ) At 6 NNS after NN NN ( the JJS NN NN VBN in JJ NNS ) , we VBP that 96.4 NN ( 94.0 to 97.8 NN ) of NNS VBP VBN ; we VBP this as our NN of the NN of NN NN . ( C ) A JJ NN of RB VBN NNS of NN VBZ NN of NN after , on NN , NNS ( 95 NN NN , 16.7 to 51.1 ) , as VBN by the JJ - VBN NN . The JJ - VBN NN VBZ the NN of NNS to NN of NN for VBN NNS , VBN by VBG JJ NNS VBN VBG NNS of NN . ( D ) JJ to the NN of VBN NN against JJ NNS NNS RB in NN , we VBD RB VB NN of a NN in NN NN over NN , whereas NN of VBG NN - VBN NN VBD in a NN VBG for NN NN . VBN NNS of the JJ NN of JJ NNS VBN NN — and NNS VBN for NN since NN , NNS since 1964 , and NNS VBN — VBP VBN via JJ NN VBG NN NNS from the JJ NNS ( 13 , 46–50 ) . ( E ) VBG this NN - NN NN , we VBD no NN ( JJ two - VBN NN > 0.1 ) in the VBG NN ( as VBN by the NN of the NN between NN since NN and JJ NN of NNS VBN NN ; VB NNS and NNS ) after NN of a JJ or JJ NN ( 95 NN NN , 33 NN NN to 72 NN NN in the JJ NN of NNS VBN NN per NN NN since NN ; JJ two - VBN NN > 0.1 ) . The JJ NN of RB JJ - NN NN NN in the NN NN by VBN NNS after NN NN VBZ RB VBN VBN to VB to VBN NN . RB , we VBD no NN for a NN in NN NN over the NNS 1965 to 2006 , in JJ after VBG for the NN of NN NN ( NN NN ) . Whereas we VBD a JJ 1.29 ( 95 NN NN , 0.70 to 2.37 ) JJ NN in the JJ NN of NN VBN NN for each NN NN after 1964 in JJ NNS , this NN VBD RB VB ( VBN JJ NN , 0.85 ; 95 NN NN , 0.56 to 1.30 ) after VBG for JJR NN since NN among JJR - NN NNS in JJR NNS . RB , we VBD RB VB a NN in the NN of NN after a JJ NN of NN as VBN to the NN of NN after a JJ NN ( NN 1E ) . Whereas JJ NNS VBD RB VBN to VB NN in NN of VBN “ NN ” of the JJ NN , our NNS VBD that the JJ NN RB VBZ NN to the NN VBN before VBG of the JJ NN , RB VBG NN to JJR NNS . RB , our NNS VBP the JJ NN of VBG NN NN as a NN of NN in NN NN . NNS in NN NN to NNS NN after NN NN To VB the JJ NN of NNS NN in JJR NN NNS , we VBD how VBG NN - VBN NN and VBG NNS of JJ NN VBP VBN the NN of the NNP NN over the NNS since NN NN . We VBD the NN of NN NN as of 1967 , when the NN VBD VBN , by VBG a JJ NN ( NN NN and NN . NNP ) to VB JJ NNS in the JJ NN at JJ NN ( 15 ) . We VBD that the JJ JJ NN ( NN ) of NNS in the NNP NNPS — the NN of NNS VBN to VB from an JJ NN NN in a RB JJ NN — VBD 4.79 before NN NN , in NN with JJ NNS of 3 to 7 for JJ - NN NNS in the JJ NN ( 16 , 17 ) . VBG for NN of RB VBN NN VBD RB VB NN NN ( 15 ) , JJ with JJR - NN NN of JJ NN NNS after JJ NN in NN to NN in NNS ( 18 ) . The JJ NN in NNS among JJ NNS VBD to NN - JJ NNS in NN VBG from NN NN and VBG NN over the NNS since NN NN ( NN 2 and NN . NNP ) . We VBD that 52.8 NN ( 95 NN NN , 41.6 to 63.1 NN ) of NNS NNS 20 to 24 NNS and 52.6 NN ( 95 NN NN , 42.4 to 61.3 NN ) of NNS NNS 25 to 29 NNS VBD JJ to NNS NN NN in 2006 at the NN of the JJ NN , in NN to 33.8 NN ( 95 NN NN , 30.4 to 37.6 NN ) and 25.2 NN ( 95 NN NN , 22.8 to 27.5 NN ) , RB , as of 1990 and < 10 NN in each NN NN before NN NN . NN VBZ RB VBN JJR NN NNS amid the NN of NNS that VBD NNS as NNS . Whereas JJS NNS NNS 65 NNS and JJR VBD JJ NN as of 2016 , we VBD that 29.2 NN ( 95 NN NN , 24.7 to 32.3 NN ) of those NNS 40 to 64 NNS VBD at NN of NN . NNS NN and NNS of NN NN over NN . RB , we VBP NNS in the NN of the NN , by NN , VBN to VB JJ to NNS on the NN of the VBN VBG NN of NN - VBN NN NN and the NN of NNS NN in the NN . ( A ) JJ NNS of VBN NNS VBD after NN NN in 1967 , VBN by NNS RB among NNS from 1984 to 1992 and JJ NNS ( 2006 RB ) VBN among JJ NNS . These NNS VBP VBN with ( B ) NNS in the NN - VBN NN of NNS JJ to NNS NN at 10 to 19 and 20 to 29 NNS of NN , RB , and ( NNP ) NNS in the NN of NNS that VBP NNS and VBP VBN because of NN NN against NNS . ( D ) NNS in the NN of NNS JJ to NN across JJ NNS VBP VBN against NNS of VBN NNS . In a JJR NN of NN NNS , the NN and NN of NNS NNS among NNS during the JJ NNS and JJ NNS VBD to a JJ NN in VBN NN at NNS 10 to 19 NNS ( NNP 2 ) . We VBD that NN at NNS 10 to 14 NNS VBD in 1991 , when 45.8 NN ( 95 NN NN , 39.3 to 52.4 NN ) of NNS in this NN NN VBD at NN for NN , RB with 43.0 NN ( 95 NN NN , 37.3 to 49.0 NN ) of NNS NNS 15 to 19 NNS . These NNS VBP 2.85 ( 95 NN NN , 2.65 to 3.30 ) NN and 3.96 ( 95 NN NN , 3.43 to 4.52 ) NN VBZ in NN - JJ NN , RB , VBN to the NN NN . Whereas NN NNS VBG in the NNS VBD VBN at that NN to VB JJ NNS of NNS to their JJ NN NN ( 19 ) , our NNS RB VBP that NN NN and VBG JJ NN VBP why NNS VBD the NN at JJS NN for NN at that NN . We VBD that , as of 2016 , the NN of NN among NNS NNS 10 to 14 NNS VBD to 34.8 NN ( 95 NN NN , 24.3 to 45.7 NN ) because of the NN in 1989 for NNS to VB a JJ NN at NNS 4 to 6 NNS ( 4 ) . Whereas JJS NNS VBG NNS during the JJ NN VBD VBN one NN of NN in VBG with the NNS at that NN ( 20 , 21 ) , JJ NNS VBP RB VBN NNS JJ to VB two NNS ( FW NN ) . RB , the VBG NN of NN in the NNP NNPS RBR JJ NNS with NNS due to VBG NN after NN of the JJ NN RB than a NN of NNS within a JJ , JJ NN . These NNS VBP in NN NNS VBG 1 and 2 NN JJ NNS in NN NN ( VBG to 39 and 63 NN JJ NNS in NN NN by 2017 ) over the NNS since NN NN ( JJ NNP and NNP ) . Our NNS VBP VBN that VBN NN NN VBZ RB to VBG NN RB than the NN of NNS NN NNS VBG NN - VBN NN . RB , our NN to VB these NNS VBG NNS from JJ NNS VBZ VBN by a NN of NNS about NN JJ NN . To RBR VB whether JJ NNS VBP RBR JJ with NN NN or JJ NN , we VBD a JJ NN NN to VB VBN JJ NNS under these NNS in the NN 2006 , when the JJ NN VBD . VBG the NN VBN RB to VB NN NN and NN NNS in the NN of VBG NN NN ( NNP NNP and NNP ) , we VBD the NN of NNS NN NNS against which the NN VBD JJ NN in a NN of 1 million . Under NN - VBN JJ NN NNS that RB VBD NNS NNS to NN among NN - JJ NNS , NN of NN NN VBZ a JJ NN to VB for NNS in the NN NN of NNS toward NN and JJ NN . We VBD that NNS JJ of NN NN would VB VBN to VB JJR - than - VBN NN among JJR NNS ( NNP 3 , NNP to NNP ) . In NN to the JJ NN of NNS NNS of 22 NNS VBN in 2006 , the VBN JJ NN of NNS VBD 14.2 NNS ( 95 NN NN , 8.3 to 21.7 NNS ) as NN - JJ NN NN VBD to 0 NN . Although NNS with JJR NN to VB NN NN may RB VB to such an NN among NNS , we VBD JJ NNS to VB JJ NN in a NN VBN by VBG NN ( NNP 3 NNP ) . NN - VBN JJ NNS of NNS NN VBD VBN NNS at JJR NNS of NN . As VBN to NNS under NNS of JJ NN , NN - VBN NNS under NN NN VBD a JJR NN to VBN JJ and NN - JJ NN , with an VBN JJ NN of 22.3 NNS ( 95 NN NN , 17.7 to 26.3 NNS ) among NNS . VBN NN NNS under NNS of NN NN and NN NN . RB , we VBP a JJ NN NN to VB the NN of NNS NNS under the NN of NNS NN VBG NN - VBN NN NN and the NN of VBG NN - VBN NN . ( A ) A JJ NN of an VBG NN - NN NN of NNS NN in a VBN NN VBZ JJ NN in JJ NN NNS , in VBG with their JJR JJ NN of NNS . ( B ) In NN , the NN of a NN VBG VBG NN - VBN NN VBZ the VBN NN NN . ( C ) JJR JJ NN NNS and ( NN ) a JJR NN NN of NNS VBP VBN when NN NNS to the NN VBP JJ NN against the VBG NN , as VBN to the NN of the NN with VBG NN NN . ( E ) Whereas the NN with a JJ - NN ( NN ) NN can VB the NN NN of NNS at JJ NNS of JJ NN , ( NNP ) JJR - than - VBN NN VBZ VBN under this NN , RB in NN to the NN of a NN with VBG NN NN . NNS in ( NNP ) and ( NNP ) VBP 95 NN NN . If NN - VBN NN VBZ or VBZ JJR - VBG NN against NNS RB in NN as VBN to those VBG in 1967 , RB VBG JJ NN NNS may VB VB NN by VBG JJ NN to JJR NNS . On the NN of NNS of the JJ JJ NN ( NN ) , or the NN of JJ JJ NNS VBG from a JJ JJ NN under JJ NNS of NN , we VBD that NN VBN by two NN NNS RB VBZ JJ to VB NN of JJ NNS NN NN from the NNP NNPS in the JJ NN . If NNP VBZ below 1.0 , RB NNS VBP JJ to VB VBN in the JJ NN ; because NN NNS VBN to JJ NNS of NN in the JJ NN VBP VBN by NNS whose NN VBZ RB through NN , we VBP NNP to VB 1.11 ( 95 NN NN , 1.04 to 1.13 ; NN 4 ) . Although VBG a JJ NN NN by 18 NNS of NN would RB RB VB NN - JJ NN VBN on our NN of the NN to NN of NN , we RB VBP that this NN could VB NN through JJ NN , RB VBG NN NNS at NN in JJ NNS . JJ ( 56 NN ) NN of a JJ NN VBG NN NN with VBN NN - NN NN NN NNS would VB VBN to VB NN around 0.88 ( 95 NN NN , 0.83 to 0.91 ) , VBN on NN NNS in the NNP NNPS as of 2016 . Under a RBR JJ NN of 88 NN JJ - NN NN — where JJ - NN NN VBZ JJ - NN NN among RB - VBN NNS — we VBP NN to VB 0.77 ( 95 NN NN , 0.72 to 0.79 ) as NNS RB VBN to JJ NN NNS NN out of the NN . NN - JJ NN and NN NNS under two - and three - NN NN NNS . VBG NN - VBN NN in the NN VBZ the NN of how JJ NN NNS would VB NNS NN . To VB this NN , we VBD JJ NNS . ( A ) NNS RB 40 NNS of NN as of 2016 VBD VBN to JJ NN RB and RB after NN NN and RB VBP NN - JJ NN . RB , a NN VBN RB by two - NN NN would VB VBN to VB JJ NN of NN RB 20 NNS of NN . ( NN and C ) Our NN VBZ that the NN of NN can VB VBN through JJ NN by VBG a JJ NN RB 18 NNS of NN , whereas JJ NN NNS every 10 or 20 NNS would VB VBN to VB JJR - NN NN . NNS and VBN NNS VBP JJ NNS and 95 NN NN , RB . ( D ) Under NN NNS VBN as of 2016 , NN in JJ NN NN NNS VBN through the NN of a JJ NN NN VBZ VBN to VB the JJ JJ NN ( NN ) below 1 . We , RB , VBP NNP to VB 1.10 under the two - NN NN as NNS that VBD JJ NNS of NNS NN NN out of the NN ; JJR NNS in NN VBP VBN at JJR NN and with RBR JJ NN . NNS VBP the JJ as in ( A ) to ( NNP ) . NNP , JJ JJ NN . ( E ) In NN , these NNS of NN VBP a JJR NN against NN of NNS VBG NN NN . A JJ NN with 8.5 NN ( 95 NN NN , 7.6 to 9.8 NN ) NN of VBG NN - VBN NN and VBG a NN - VBN NN would VB VBN to VB under a three - NN NN with JJ NN . We , RB , VBP that a JJ NN would VB 22.9 NN ( 95 NN NN , 16.4 to 29.7 NN ) NN of VBG such an NN to VB in a NN with 88 NN NN of the JJ NN and 10 - NN NNS . NNS VBP 95 NN NN , and VBN NNS VBP NNS around NN NNS . Whereas we VBD that JJS JJR NNS VBP RB JJ to NNS NN because of JJ NN , our NN VBD that neither a two - NN nor a three - NN NN NN would VB VBN to VB JJR than 50 NN of NNS beyond the NN of 40 NNS in the JJ NN . This NN may VB the NN of JJ NN NNS in NN ( NNP 4 ) . On the NN of our NN , we VBP that VBG JJ NNS every 10 or 20 NNS would VB to VBN NN in , at NN , 68.0 NN ( 95 NN NN , 58.5 to 77.6 NN ) and 55.2 NN ( 95 NN NN , 44.1 to 68.4 NN ) of the NN , RB , under a NN of 88 NN NN NN ; at the JJR ( 56 NN ) NN NN , we VBD NN among , at NN , 59.0 NN ( 95 NN NN , 48.2 to 71.2 NN ) and 45.5 NN ( 95 NN NN , 34.3 to 60.5 NN ) of NNS with VBG every 10 or 20 NNS , RB . VBG JJ NN of NN in the NN through VBN NN may RB VB to VB NN of JJ NNS NN NNS ( NN 4E ) . To VB NNP ≥ 1 under three - NN NNS , we VBD that an VBG NN would VB , at NN , 8.5 NN ( 95 NN NN , 7.6 to 9.8 NN ) to 15.7 NN ( 95 NN NN , 11.9 to 20.3 NN ) NN of VBG NN in VBN NNS RB VBN by NN . VBG NN NNS every 10 NNS VBD this NN NN to between 16.6 NN ( 95 NN NN , 12.5 to 20.8 NN ) and 22.9 NN ( 95 NN NN , 16.4 to 29.7 NN ) at VBG NNS of NN NN . JJ NNS VBN among JJ NNS VBP VBN VBN NN to NNS after NNS of NN toward its NN from the NNP NNPS ( 2 , 12 ) . VBG why NNS VBP VBN VBZ JJ for VBG how to VB the NN through NN . Our NNS VBP that NN - VBN NN NN VBZ over NN . We VBP the NN of NN and VBP that this VBG NN VBZ for NN in the NN NNS VBG NNS over the NNS since NN NN in the NNP NNPS . In NN , NNS in the VBG NNS of NNS NN over this JJ NN VBP RB VBN VBN with NNS in NN NN ; RB , our NN VBZ that NNS NN NNS VBG NN NN would VB VBN to VB JJ NN among JJR NNS , which VBZ RB VBN VBN in JJS JJ NNS . VBN by these NNS , our NN VBZ that JJ NN of a JJ NN NN RB 18 NNS of NN , with or without JJ NN in NN , could VB VB JJ NN in the NN . VBG between the NNS of NN NN and the NN of NN - NN NN NNS to NN NN VBZ VB whether JJ NNS VBP VBN to VB NN ( 22 , 23 ) . Our NNS that NN NN VBZ RB VBN amid the NN of NN NN NNS NNS ( from which the NNP NNP NN NN VBD VBN ) , and that the NN NN of JJ NNS VBZ JJ with NNS under NN NN , VBP in NN with JJ NNS of NN that NNS NN VBZ RB against JJ NNS ( 24 ) . VBG NN NNS to the NNP NNP NN VBP JJ in NN against JJ - NN NNS NN NNS JJ for JJ NNS among VBN NNS ( 25 , 26 ) , and JJ NNS VBP RB VBN VBN between NNS VBN from VBN and JJ NNS NNS ( 27 ) . JJ NN and NN NNS for both the NNP NNP ( NN NN ) and NNP ( NN NN ) NNS against JJ NN VBN by JJ NN NNS RB VBP the NN of VBG or JJ NN NNS ( 12 ) . Although the NN of a JJ NN VBZ RB VBN VBN in JJ NNS , JJ NNS VBP NN of VBN NN NNS . Although VBN NNP JJ NNS VBP JJ - NN NNS VBN on their NN NN and JJ - NN NNS , no NNS VBP VBN VBN in the NN since a NN of VBG an NNP NN to JJ NNS , RB of NN NN , VBD VBN in 1991 ( 28 ) . In NN , VBG a JJ NN VBD VBN with NN in a JJ JJ NN after a JJ - NN NN VBN in NN to a NN NN NN ( 29 ) , VBG on JJ NN from JJ NNS where JJ NNS VBD RB VBN at the NN NN of NNS ( 30–33 ) . NNS VBG the JJ NN of JJ NN NNS VBP JJ to VB NN around the NNS of JJ or JJ NN of JJ NNS and may VB our NN of JJ NNS of NN ( 34–36 ) . JJ NNS — or JJ JJ NNS — will RB VB an JJ NN in VBG the NN of NN after JJ or JJ NNS in NN . VBG NN NNS to VB the NN or NN of NN NNS against NNS NN may RB VB NN . RB , the NNS NN of the NN VBZ JJR - NN NN NNS , and JJR JJ NN NN NN NN , than the NNS and NN NNS ( 37 , 38 ) . JJ NNS of the NN should VB VBN . Our NN of VBN RB than JJ - NN NNS from NN NN NNS VBD to an JJ NN of the NN to NN of NN , in NN VBG the NN of our NNS of NN NN . JJ - NN NNS from NN NN NNS could VB JJR NNS about the NN and NN of NN NN , RB VBG NN NNS . VBG JJ NNS of NN from JJ NN NNS would RB VB NNS of JJ NN NNS and NNS of NN NN . RB , we VBP NNS on NN - JJ NN that could VB us VB JJ NN of the NNP NNP NN against VBG NNS . JJ NNS of NNS VBN by JJ NN NNS , and in NNS VBN to JJ VBG NNS NNS , can RBR VB NN NN in the NN or NN of NN NN . JJ , our NN VBZ NNS NN in the NNP NNPS , where NN of NN within JJ NN NNS may VB in NN to NNS that VBD JJ NNS NN RBR or VB JJ NN NNS . The NN of NNS and NN of NN across NNS or NN NNS should VB VBN as a NN to VB NN NN within JJ NNS . VBG RB VBN NN NNS NNS RB VBD our NN to VB how JJ or JJ NNS in NN NN and NN NNS VBP to the NNS of JJ NNS , as might VB in JJ - NN NNS JJ as NN NNS ( 39 , 40 ) . RB , our NNS about NN NN and the VBG NN NN of NNS NNS VBP NN into why NNS NN VBZ VBN JJ throughout RB and RB JJ NNS . In this NN , the JJ NN of NNS in NN - JJ NNS VBZ in JJ NN to the JJ NN of NNS in NNS with JJ NN NN ( 11 ) . NNS in the NN of NNS VBP NNS for NN NN . VBN JJ NN of NNS , NNS that it VBZ in JJ RB than JJ NNS , and NN against NNS in VBN NNS ( 41 ) may VB JJ NN of NNS and RB NN NN NN . JJ NNS VBP VBN NN of JJR - than - VBN NNS of NNS NN NN in the NNP NNPS before 2006 ( 28 , 42 ) . The NN to VB NN - VBN NNS through NN NN may RB VB NN of NNS in NN NNS and JJ RB VBN NNS , VBG the NN of JJ NN to VB NNS VBG in the NN . The JJ NN in NNS among JJ NNS VBZ VBN JJ NN about JJ - NN NN of this NN from the NNP NNPS ( 1 ) . Our NN VBZ that VBN NNS VBP NN against NN on NN 27 NNS after NN of their JJ NN and that this NN of NN NN VBZ NN in JJ and JJ NN NNS at the NN of NN NNS in these NN NNS . NN of NNS among JJR , RB VBN NNS whose NN VBZ VBN NNS JJ NN with NN NNS VBG VBN NNS as a NN of VBG NN - VBN NN ( 43 ) . As VBN in NNS NN , NN in RB VBN NNS may VB NN and VB NN NNS from VBG until NNS after NN NN . We VBP NN NN to NNS to VB VBG as JJ NN - VBN NN VBZ JJ NN as the JJ NN of NNS NN in the NNP NN . These NNS VBP the NN for either JJ JJ NN NNS to VB the NN of VBG NN NN NNS or JJ NNS to VB the NN of VBG NN - VBN NN ( 44 ) . Our NN VBZ VBN of four NNS . RB , we VBD a NN - NN of six NNS on NNS NN NN in the NNP NNPS and NNP to VB NNS of VBG NN and VBN NN against RB VBG NNS . We RB VBD NNS of the VBG NN from this NN to VB NNS over NN in the NN of the NNP NN , NN for NN NN and NN of JJ NN . We VBD a NN of JJ NNS RB from JJ NNS , VBN from the NN JJ NN ( as VBN over the NNS 1960 to 1964 ) , by NN - VBG NN NNS from VBN NNS NN . We RB VBD VBN NN NNS under NNS of NN NN and JJ NN and VBD JJ - NN NNS of JJ NN NNS on NN NN . JJ JJ NNS VBG to our NNS VBP VBN in JJ NNS and NNS ( a JJ NN VBZ VBN RB ) . We VBD a JJ NN of JJ and JJ NN NNS VBG NN of the NNP NNP NN NNS NN via a NN NN and NN NN . NNS of the NNS VBN to VB NN NN VBP VBN in NN NN . We VBD an JJ NN - VBN NN NN NN , NN for NN - NN NN , to VB JJ and JJ - VBN NNS of the VBG NNS with NN - NN NNS of the JJ NN of NN VBN with NN : ( i ) NN since NN of the JJ NN NN , VBG VBG NN NN ; ( ii ) NN from 1964 ( when the NNP NNP NN VBD VBN ) to the NN of NNS NN , VBG JJ - NN NNS in NN NN VBN with NNS in VBG NNS ; and ( iii ) NN NNS VBN , with an NN NN for NN since the JJ NN to VB for JJ NN of JJ and JJ NNS . NN NN NN NNS VBD the NN of NN VBN by these NNS . We VBD our NN of the NN between JJ NN of NN and NN since NN to VB an JJ NN to the NN of NN - VBN NN NN and VBD this VBN NN as the NN for JJ NN . We VBD a NN of JJ JJ NNS to VB NNS in the NN of JJ and VBN NNS , VBN into those who VBD and VBD RB VBN NNS NNS . VBG the NN to VB the NNS of NN and NN NN to NN NN , we RB - VBN NNS in JJ NN in the NN VBN on the NN between VBN NN NNS ( Λ ) in NN NN i and NN NN and the NN of NN to which NNS VBD VBN ( NN ) , the NNS of JJ JJ ( NNP ) and VBN ( NNP ) NNS , and the NNS ( NN and NN , RB ) for these NNS to VB NNS if VBN . As VBN in JJ NNS and NNS , this NN VBD us to VB for NNS over NN in NN NNS VBG to NN - VBG NNS of the JJ JJ NN . JJ VBN NNS ( NNP ) VBD those VBG to VB an JJ NN RB after NN ( JJ NN NN ) and those whose JJ NN VBD VBN ( JJ NN NN ) . NN NN NNS and their NNS VBP VBN in NN NN . NN - JJ NN NNS VBD VBN from JJ NN ( 45 ) . Our NN VBD for NN - VBN NN among NNS VBN across 10 NN NNS ( 0 to 11 NNS , 1 to 4 NNS , 5 to 9 NNS , 10 to 14 NNS , 15 to 19 NNS , 20 to 24 NNS , 25 to 29 NNS , 30 to 39 NNS , 40 to 64 NNS , and ≥ 65 NNS ) . NNS of the JJ NN NN VBD the NN of NN RB through NNS with JJ NNS ( I ) VBD across all NN NN NNS ; the NN NNP VBD NN - JJ NN NNS . We VBD NN - NN NN - JJ NN of NN in the NNP NN ( as of 1967 ) by VBG a JJ NN of NNS NN to VB NN - JJ NN in the NN NN at JJ NN . To VB VBN NN during an VBN NN against NNS from the NN 2006 , we VBD JJ NNS of VBN NNS of the NN under NNS where we VBD NN of NN or NN of NNS with JJ NN of VBG NNS VBN by NN . We VBD which NN VBD RBR JJ with JJ NNS on the NN of NN - VBN NN - JJ and JJ NN NNS , RB RB as the VBN JJ NN of NN . We VBD the JJ - NN NN of JJ NN NNS VBG the NN of a JJ NN by 18 NNS of NN and the NN of JJ NNS at 10 - or 20 - NN NNS through NN . We VBD the NN of NN - JJ NN NN VBN under these NNS and VBG NNS of the JJ JJ NN ( NN ) , VBG the NN of NNS an JJ NN would VB VBN to VB under JJ NNS . We RB VBD the JJ NN of NN NN a JJ NN NN NN would VB to VB a NN VBN under these JJ NNS , VBN as the JJ NN of VBG a VBN , VBN NN upon NN JJ that NN ≥ 1 . NNS : We VBP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , and NNP NNP for NN . NN : This NN VBD VBN by NNP NNP of NNP NNP NNPS NNP U54GM088558 ( to NNP ) and a NNP NNP NNP NNP NNP NNP NNP NNP ( to NNP ) . The NN VBZ RB the NN of the NNS and VBZ RB RB VB the JJ NNS of the NNP NNP of NNP NNP NNPS or the NNP . NN NNS : NNP and NNP VBD the NN , NNP VBD the NNS with NN and NN from NNP , and NNP VBD and NNP VBD the NN . VBG NNS : NNP VBZ VBN NN NN from NNP to NNP NNP , and JJ NN for NNP , for NN JJ to this NN . NNP VBZ NN for NNP for NN JJ to this NN . NN and NNS NN : NN for VBG NNS and NNS VBZ JJ at We VBP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , and NNP NNP for NN . This NN VBD VBN by NNP NNP of NNP NNP NNPS NNP U54GM088558 ( to NNP ) and a NNP NNP NNP NNP NNP NNP NNP NNP ( to NNP ) . The NN VBZ RB the NN of the NNS and VBZ RB RB VB the JJ NNS of the NNP NNP of NNP NNP NNPS or the NNP NNP and NNP VBD the NN , NNP VBD the NNS with NN and NN from NNP , and NNP VBD and NNP VBD the NN . NNP VBZ VBN NN NN from NNP to NNP NNP , and JJ NN for NNP , for NN JJ to this NN . NNP VBZ NN for NNP for NN JJ to this NN . NN for VBG NNS and NNS VBZ JJ at http://github.com/joelewnard/mumps"
99,1111,mainstream,M096d5,vaccine,"Kentucky_NNP Derby_NNP fans_NNS may_MD need_VB to_TO take_VB some_DT extra_JJ precautions_NNS before_IN heading_VBG off_RP to_IN the_DT races_NNS ._. The_DT Indiana_NNP State_NNP Department_NNP of_IN Health_NNP is_VBZ recommending_VBG that_IN its_PRP$ residents_NNS get_VBP vaccinated_VBN against_IN hepatitis_NN A_NN and_CC take_VBP other_JJ steps_NNS to_TO protect_VB themselves_PRP from_IN the_DT illness_NN before_IN traveling_VBG to_IN Kentucky_NNP or_CC Michigan_NNP ,_, both_DT of_IN which_WDT are_VBP experiencing_VBG large_JJ outbreaks_NNS of_IN the_DT viral_JJ infection_NN ._. Kentucky_NNP has_VBZ reported_VBN more_JJR than_IN 300_CD cases_NNS of_IN hepatitis_NN A_NN since_IN November_NNP 2017_CD ,_, with_IN 39_CD new_JJ cases_NNS reported_VBN in_IN the_DT first_JJ week_NN of_IN April_NNP ,_, according_VBG to_IN the_DT Kentucky_NNP Department_NNP for_IN Public_NNP Health_NNP ._. Most_JJS cases_NNS in_IN the_DT state_NN have_VBP occurred_VBN around_IN Louisville_NNP —_: the_DT city_NN where_WRB the_DT Kentucky_NNP Derby_NNP is_VBZ held_VBN ._. The_DT famous_JJ horse_NN race_NN ,_, which_WDT draws_VBZ more_JJR than_IN 150,000_CD people_NNS each_DT year_NN ,_, takes_VBZ place_NN on_IN the_DT first_JJ Saturday_NNP in_IN May_NNP ._. ""_`` With_IN popular_JJ tourist_NN events_NNS coming_VBG up_RP in_IN other_JJ states_NNS ,_, we_PRP know_VBP many_JJ Hoosiers_NNPS will_MD be_VB traveling_VBG to_IN areas_NNS impacted_VBN by_IN hepatitis_NN A_NN ,_, and_CC we_PRP want_VBP them_PRP to_TO be_VB safe_JJ ,_, ""_'' Pam_NNP Pontones_NNP ,_, the_DT Indiana_NNP deputy_NN state_NN health_NN commissioner_NN ,_, said_VBD in_IN a_DT statement_NN ._. ""_`` Getting_VBG vaccinated_VBN and_CC thoroughly_RB washing_VBG your_PRP$ hands_NNS before_IN and_CC after_IN preparing_VBG food_NN and_CC eating_VBG and_CC after_IN using_VBG the_DT restroom_NN are_VBP simple_JJ ,_, safe_JJ and_CC effective_JJ ways_NNS to_TO prevent_VB the_DT spread_NN of_IN hepatitis_NN A_NN ._. ""_'' But_CC do_VBP you_PRP really_RB need_VB to_TO get_VB a_DT hepatitis_NN A_NN vaccine_NN if_IN you_PRP 're_VBP going_VBG to_IN the_DT Kentucky_NNP Derby_NNP ?_. Dr._NNP Amesh_NNP Adalja_NNP ,_, a_DT senior_JJ scholar_NN at_IN the_DT Johns_NNP Hopkins_NNP Center_NNP for_IN Health_NNP Security_NNP ,_, said_VBD the_DT Indiana_NNP recommendation_NN is_VBZ an_DT interesting_JJ step_NN to_TO take_VB ,_, and_CC it_PRP 's_VBZ not_RB a_DT bad_JJ idea_NN ._. ""_`` I_PRP can_MD see_VB why_WRB they_PRP would_MD advise_VB it_PRP ,_, ""_'' Adalja_NNP said_VBD ._. ""_`` It_PRP 's_VBZ something_NN that_WDT 's_VBZ an_DT easy_JJ measure_NN that_WDT can_MD minimize_VB risk_NN ._. ""_'' [_-LRB- 27_CD Devastating_VBG Infectious_JJ Diseases_NNS ]_-RRB- At_IN the_DT same_JJ time_NN ,_, Adalja_NNP told_VBD Live_NNP Science_NNP that_IN the_DT risk_NN of_IN hepatitis_NN A_NN probably_RB is_VBZ n't_RB very_RB high_JJ for_IN the_DT average_JJ visitor_NN to_IN the_DT Derby_NNP ._. A_DT number_NN of_IN recent_JJ U.S._NNP hepatitis_NN A_NN outbreaks_NNS ,_, including_VBG the_DT one_NN in_IN Kentucky_NNP ,_, have_VBP occurred_VBN primarily_RB among_IN the_DT homeless_JJ population_NN and_CC illicit_JJ -_HYPH drug_NN users_NNS —_: a_DT group_NN that_WDT may_MD have_VB limited_VBN access_NN to_IN clean_JJ toilets_NNS and_CC handwashing_NN facilities_NNS ,_, which_WDT are_VBP important_JJ in_IN preventing_VBG the_DT spread_NN of_IN hepatitis_NN A_NN ._. But_CC hepatitis_NN A_NN outbreaks_NNS can_MD also_RB occur_VB through_IN contaminated_VBN food_NN ,_, Adalja_NNP noted_VBD —_: for_IN instance_NN ,_, if_IN food_NN workers_NNS contract_VBP the_DT illness_NN and_CC handle_VBP food_NN without_IN properly_RB washing_VBG their_PRP$ hands_NNS ._. (_-LRB- The_DT Kentucky_NNP hepatitis_NN A_NNP outbreak_NN has_VBZ not_RB been_VBN linked_VBN with_IN contaminated_VBN food_NN ,_, although_IN it_PRP was_VBD recently_RB reported_VBN that_IN a_DT McDonald_NNP 's_POS employee_NN in_IN Berea_NNP ,_, Kentucky_NNP ,_, south_RB of_IN Lexington_NNP ,_, had_VBD the_DT infection_NN and_CC could_MD have_VB potentially_RB spread_VBN it_PRP to_IN customers_NNS ._. )_-RRB- If_IN Kentucky_NNP Derby_NNP -_HYPH goers_NNS want_VBP to_TO minimize_VB their_PRP$ risk_NN of_IN getting_VBG the_DT illness_NN ,_, ""_'' the_DT vaccine_NN is_VBZ one_CD way_NN to_TO do_VB that_DT ,_, ""_'' Adalja_NNP said_VBD ._. Hepatitis_NN A_NN is_VBZ a_DT contagious_JJ liver_NN infection_NN caused_VBN by_IN the_DT hepatitis_NN A_NN virus_NN ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. The_DT virus_NN is_VBZ spread_VBN through_IN the_DT ""_`` fecal_JJ -_HYPH oral_JJ ""_'' route_NN —_: that_DT is_VBZ ,_, when_WRB small_JJ amounts_NNS of_IN stool_NN from_IN an_DT ill_JJ person_NN contaminate_VB objects_NNS ,_, food_NN or_CC drinks_NNS that_WDT are_VBP then_RB touched_VBN and_CC ingested_VBN by_IN another_DT person_NN ,_, the_DT CDC_NNP says_VBZ ._. For_IN this_DT reason_NN ,_, thorough_JJ handwashing_NN —_: particularly_RB after_IN using_VBG the_DT bathroom_NN or_CC changing_VBG a_DT child_NN 's_POS diaper_NN ,_, or_CC before_IN eating_VBG —_: can_MD help_VB reduce_VB a_DT person_NN 's_POS risk_NN of_IN getting_VBG hepatitis_NN A_NN ,_, according_VBG to_IN the_DT Mayo_NNP Clinic_NNP ._. It_PRP 's_VBZ important_JJ to_TO note_VB that_IN the_DT Indiana_NNP announcement_NN is_VBZ not_RB a_DT nationwide_JJ recommendation_NN ._. In_IN general_JJ ,_, the_DT CDC_NNP recommends_VBZ the_DT hepatitis_JJ vaccine_NN for_IN children_NNS at_IN age_NN 1_CD ,_, as_RB well_RB as_IN adults_NNS who_WP may_MD be_VB at_IN higher_JJR risk_NN for_IN hepatitis_NN A_NN or_CC for_IN complications_NNS from_IN the_DT illness_NN ._. These_DT include_VBP travelers_NNS to_IN countries_NNS where_WRB hepatitis_NN A_NN is_VBZ common_JJ ,_, people_NNS who_WP use_VBP recreational_JJ drugs_NNS ,_, people_NNS with_IN chronic_JJ liver_NN disease_NN ,_, men_NNS who_WP have_VBP sexual_JJ contact_NN with_IN other_JJ men_NNS ,_, and_CC people_NNS who_WP have_VBP direct_JJ contact_NN with_IN others_NNS who_WP have_VBP hepatitis_NN A_NN ._. The_DT CDC_NNP says_VBZ that_IN ideally_RB ,_, a_DT person_NN should_MD get_VB the_DT hepatitis_NN vaccine_NN two_CD weeks_NNS or_CC more_JJR before_IN departing_VBG for_IN their_PRP$ trip_NN ,_, but_CC getting_VBG the_DT vaccine_NN any_DT time_NN before_IN travel_NN will_MD provide_VB some_DT protection_NN ._. Adalja_NNP noted_VBD that_IN a_DT number_NN of_IN Americans_NNPS are_VBP already_RB vaccinated_VBN against_IN hepatitis_NN A_NN ._. The_DT vaccine_NN was_VBD first_RB licensed_VBN in_IN 1995_CD and_CC was_VBD recommended_VBN for_IN all_DT U.S._NNP children_NNS starting_VBG in_IN 2006_CD ._. But_CC that_DT would_MD still_RB leave_VB many_JJ adults_NNS today_NN unvaccinated_VBN ,_, unless_IN they_PRP already_RB got_VBD the_DT vaccine_NN for_IN travel_NN or_CC because_IN they_PRP fall_VBP into_IN a_DT group_NN that_WDT 's_VBZ at_IN higher_JJR risk_NN for_IN contracting_VBG the_DT illness_NN ._. Symptoms_NNS of_IN hepatitis_NN A_NN infection_NN usually_RB do_VBP n't_RB appear_VB until_IN two_CD to_IN six_CD weeks_NNS after_IN a_DT person_NN has_VBZ been_VBN infected_VBN ,_, and_CC include_VBP fever_NN ,_, fatigue_NN ,_, nausea_NN ,_, vomiting_NN ,_, dark_JJ -_HYPH yellow_JJ urine_NN ,_, joint_JJ pain_NN and_CC jaundice_NN (_-LRB- a_DT yellowing_NN of_IN the_DT skin_NN and_CC eyes_NNS )_-RRB- ,_, according_VBG to_IN the_DT CDC_NNP ._. People_NNS with_IN the_DT infection_NN usually_RB get_VBP better_JJR on_IN their_PRP$ own_JJ without_IN a_DT specific_JJ treatment_NN ,_, but_CC in_IN some_DT cases_NNS ,_, the_DT infection_NN can_MD lead_VB to_IN liver_NN failure_NN ,_, particularly_RB in_IN older_JJR adults_NNS or_CC people_NNS who_WP have_VBP other_JJ liver_NN diseases_NNS ,_, according_VBG to_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._.","NNP NNP NNS may VB to VB some JJ NNS before VBG off to the NNS . The NNP NNP NNP of NNP VBZ VBG that its NNS VBP VBN against NN NN and VBP JJ NNS to VB themselves from the NN before VBG to NNP or NNP , both of which VBP VBG JJ NNS of the JJ NN . NNP VBZ VBN JJR than 300 NNS of NN NN since NNP 2017 , with 39 JJ NNS VBN in the JJ NN of NNP , VBG to the NNP NNP for NNP NNP . JJS NNS in the NN VBP VBN around NNP — the NN where the NNP NNP VBZ VBN . The JJ NN NN , which VBZ JJR than 150,000 NNS each NN , VBZ NN on the JJ NNP in NNP . "" With JJ NN NNS VBG up in JJ NNS , we VBP JJ NNPS will VB VBG to NNS VBN by NN NN , and we VBP them to VB JJ , "" NNP NNP , the NNP NN NN NN NN , VBD in a NN . "" VBG VBN and RB VBG your NNS before and after VBG NN and VBG and after VBG the NN VBP JJ , JJ and JJ NNS to VB the NN of NN NN . "" But VBP you RB VB to VB a NN NN NN if you VBP VBG to the NNP NNP ? NNP NNP NNP , a JJ NN at the NNP NNP NNP for NNP NNP , VBD the NNP NN VBZ an JJ NN to VB , and it VBZ RB a JJ NN . "" I can VB why they would VB it , "" NNP VBD . "" It VBZ NN that VBZ an JJ NN that can VB NN . "" [ 27 VBG JJ NNS ] At the JJ NN , NNP VBD NNP NNP that the NN of NN NN RB VBZ RB RB JJ for the JJ NN to the NNP . A NN of JJ NNP NN NN NNS , VBG the NN in NNP , VBP VBN RB among the JJ NN and JJ - NN NNS — a NN that may VB VBN NN to JJ NNS and NN NNS , which VBP JJ in VBG the NN of NN NN . But NN NN NNS can RB VB through VBN NN , NNP VBD — for NN , if NN NNS VBP the NN and VBP NN without RB VBG their NNS . ( The NNP NN NNP NN VBZ RB VBN VBN with VBN NN , although it VBD RB VBN that a NNP 's NN in NNP , NNP , RB of NNP , VBD the NN and could VB RB VBN it to NNS . ) If NNP NNP - NNS VBP to VB their NN of VBG the NN , "" the NN VBZ one NN to VB that , "" NNP VBD . NN NN VBZ a JJ NN NN VBN by the NN NN NN , VBG to the NNPS for NNP NNP and NNP . The NN VBZ VBN through the "" JJ - JJ "" NN — that VBZ , when JJ NNS of NN from an JJ NN VB NNS , NN or NNS that VBP RB VBN and VBN by another NN , the NNP VBZ . For this NN , JJ NN — RB after VBG the NN or VBG a NN 's NN , or before VBG — can VB VB a NN 's NN of VBG NN NN , VBG to the NNP NNP . It VBZ JJ to VB that the NNP NN VBZ RB a JJ NN . In JJ , the NNP VBZ the JJ NN for NNS at NN 1 , RB RB as NNS who may VB at JJR NN for NN NN or for NNS from the NN . These VBP NNS to NNS where NN NN VBZ JJ , NNS who VBP JJ NNS , NNS with JJ NN NN , NNS who VBP JJ NN with JJ NNS , and NNS who VBP JJ NN with NNS who VBP NN NN . The NNP VBZ that RB , a NN should VB the NN NN two NNS or JJR before VBG for their NN , but VBG the NN any NN before NN will VB some NN . NNP VBD that a NN of NNPS VBP RB VBN against NN NN . The NN VBD RB VBN in 1995 and VBD VBN for all NNP NNS VBG in 2006 . But that would RB VB JJ NNS NN VBN , unless they RB VBD the NN for NN or because they VBP into a NN that VBZ at JJR NN for VBG the NN . NNS of NN NN NN RB VBP RB VB until two to six NNS after a NN VBZ VBN VBN , and VBP NN , NN , NN , NN , JJ - JJ NN , JJ NN and NN ( a NN of the NN and NNS ) , VBG to the NNP . NNS with the NN RB VBP JJR on their JJ without a JJ NN , but in some NNS , the NN can VB to NN NN , RB in JJR NNS or NNS who VBP JJ NN NNS , VBG to the NNP NNPS of NNP ."
100,44,mainstream,M078bc,vaccine; vaccine.autism,"This_DT book_NN provides_VBZ clinicians_NNS and_CC their_PRP$ staff_NN with_IN essential_JJ information_NN on_IN the_DT vaccines_NNS that_WDT are_VBP recommended_VBN and_CC not_RB recommended_VBN for_IN their_PRP$ patients_NNS ,_, the_DT diseases_NNS these_DT vaccines_NNS prevent_VBP ,_, and_CC a_DT broad_JJ range_NN of_IN potential_JJ vaccine_NN safety_NN issues_NNS that_WDT may_MD be_VB brought_VBN up_RP by_IN their_PRP$ patients_NNS ._. Each_DT topic_NN ,_, from_IN specific_JJ vaccines_NNS to_IN safety_NN concerns_NNS ,_, is_VBZ covered_VBN succinctly_RB ,_, based_VBN upon_IN systematic_JJ reviews_NNS of_IN the_DT scientific_JJ literature_NN ,_, with_IN talking_NN points_NNS to_TO be_VB used_VBN with_IN patients_NNS ._. The_DT organization_NN of_IN the_DT information_NN makes_VBZ it_PRP easy_JJ to_TO reference_VB specific_JJ topics_NNS and_CC quickly_RB find_VB pertinent_JJ information_NN ,_, with_IN the_DT most_RBS practical_JJ details_NNS (_-LRB- such_JJ as_IN recommendations_NNS and_CC causality_NN conclusions_NNS )_-RRB- highlighted_VBN at_IN the_DT very_JJ beginning_NN of_IN the_DT respective_JJ sections_NNS ._. There_EX are_VBP also_RB sections_NNS outlining_VBG the_DT vaccine_NN safety_NN system_NN and_CC evidence_NN -_HYPH based_VBN strategies_NNS for_IN how_WRB to_TO talk_VB with_IN patients_NNS about_IN vaccines_NNS ._. This_DT book_NN aims_VBZ to_TO improve_VB the_DT efficiency_NN and_CC effectiveness_NN of_IN clinical_JJ vaccine_NN discussions_NNS with_IN patients_NNS ,_, leading_VBG to_IN more_RBR informed_VBN patients_NNS and_CC timely_JJ vaccination_NN ._. This_DT is_VBZ an_DT ideal_JJ resource_NN for_IN all_DT clinicians_NNS administering_VBG vaccines_NNS and_CC their_PRP$ healthcare_NN teams_NNS ._.","This NN VBZ NNS and their NN with JJ NN on the NNS that VBP VBN and RB VBN for their NNS , the NNS these NNS VBP , and a JJ NN of JJ NN NN NNS that may VB VBN up by their NNS . Each NN , from JJ NNS to NN NNS , VBZ VBN RB , VBN upon JJ NNS of the JJ NN , with NN NNS to VB VBN with NNS . The NN of the NN VBZ it JJ to VB JJ NNS and RB VB JJ NN , with the RBS JJ NNS ( JJ as NNS and NN NNS ) VBN at the JJ NN of the JJ NNS . There VBP RB NNS VBG the NN NN NN and NN - VBN NNS for how to VB with NNS about NNS . This NN VBZ to VB the NN and NN of JJ NN NNS with NNS , VBG to RBR VBN NNS and JJ NN . This VBZ an JJ NN for all NNS VBG NNS and their NN NNS ."
101,422,mainstream,M091ac,vaccine.autism,"The_DT hypothesis_NN that_IN MMR_NNP vaccine_NN can_MD cause_VB autism_NN and_CC Crohn_NNP 's_POS disease_NN ,_, mainly_RB suggested_VBN by_IN Wakefield_NNP ,_, has_VBZ been_VBN discussed_VBN at_IN length_NN (_-LRB- SED_NNP -_HYPH 14_CD ,_, 1079_CD ;_: SEDA_NNP -_SYM 25_CD ,_, 387_CD ;_: SEDA_NNP -_SYM 26_CD ,_, 359_CD ;_: SEDA_NNP -_SYM 27_CD ,_, 338_CD )_-RRB- ._. Subsequently_RB ,_, it_PRP became_VBD known_VBN that_IN Dr_NNP Wakefield_NNP was_VBD paid_VBN for_IN a_DT second_JJ study_NN into_IN whether_IN children_NNS allegedly_RB damaged_VBN by_IN the_DT MMR_NNP could_MD sue_VB ._. The_DT MMR_NNP research_NN was_VBD therefore_RB compromised_VBN by_IN a_DT financial_JJ conflict_NN of_IN interests_NNS ._. The_DT Editor_NNP of_IN the_DT Lancet_NNP concluded_VBD ,_, “_`` If_IN we_PRP knew_VBD then_RB what_WP we_PRP know_VBP now_RB ,_, we_PRP certainly_RB would_MD not_RB have_VB published_VBN the_DT part_NN of_IN the_DT paper_NN (_-LRB- 43_CD c_NN )_-RRB- that_WDT related_JJ to_IN MMR_NNP ”_'' (_-LRB- 44S_NN )_-RRB- ._. In_IN March_NNP 2004_CD ,_, 10_CD of_IN the_DT 12_CD authors_NNS of_IN the_DT article_NN in_IN question_NN issued_VBD a_DT “_`` Retraction_NN of_IN an_DT interpretation_NN ”_'' ._. The_DT authors_NNS made_VBD it_PRP clear_JJ that_IN in_IN this_DT paper_NN no_DT causal_JJ link_NN was_VBD established_VBN between_IN MMR_NN vaccine_NN and_CC autism_NN ,_, as_IN the_DT data_NNS were_VBD insufficient_JJ to_TO prove_VB the_DT hypothesis_NN (_-LRB- 45S_CD )_-RRB- ._. In_IN 2004_CD ,_, the_DT Vaccine_NNP Safety_NNP Committee_NNP of_IN the_DT Institute_NNP of_IN Medicine_NNP of_IN the_DT US_NNP National_NNP Academies_NNPS of_IN Sciences_NNPS published_VBD the_DT Immunization_NNP Safety_NNP Review_NNP on_IN Vaccines_NNPS and_CC Autism_NNP ._. The_DT Committee_NN examined_VBD the_DT hypothesis_NN that_IN vaccines_NNS ,_, specifically_RB the_DT MMR_NN vaccine_NN and_CC thiomersal_NN -_HYPH containing_VBG vaccines_NNS ,_, are_VBP causally_RB associated_VBN with_IN autism_NN ._. The_DT Committee_NNP concluded_VBD that_IN the_DT body_NN of_IN epidemiological_JJ evidence_NN favors_VBZ rejection_NN of_IN a_DT causal_JJ relation_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN as_RB well_RB as_IN a_DT causal_JJ relation_NN between_IN thiomersal_NN -_HYPH containing_VBG vaccines_NNS and_CC autism_NN ._. The_DT Committee_NN further_RB found_VBD that_IN potential_JJ biological_JJ mechanisms_NNS for_IN vaccine_NN -_HYPH induced_VBN autism_NN that_WDT have_VBP been_VBN generated_VBN to_IN date_NN are_VBP theoretical_JJ only_RB ._. In_IN addition_NN ,_, the_DT Committee_NN recommended_VBD that_IN available_JJ funding_NN for_IN autism_NN research_NN be_VBP channelled_VBN to_IN the_DT most_RBS promising_JJ areas_NNS (_-LRB- 46_CD M_NN )_-RRB- ._. The_DT results_NNS of_IN a_DT retrospective_JJ study_NN including_VBG 535_CD 544_CD children_NNS aged_VBN 1_CD –_SYM 7_CD years_NNS who_WP were_VBD immunized_VBN between_IN November_NNP 1982_CD and_CC June_NNP 1986_CD in_IN Finland_NNP ,_, based_VBN on_IN linkage_NN of_IN individual_JJ MMR_NN immunization_NN data_NNS to_IN a_DT hospital_NN discharge_NN register_NN ,_, have_VBP been_VBN published_VBN (_-LRB- 47C_CD )_-RRB- ._. The_DT numbers_NNS of_IN cases_NNS of_IN encephalitis_NN and_CC aseptic_JJ meningitis_NN within_IN a_DT 3_CD -_HYPH month_NN risk_NN interval_NN after_IN immunization_NN were_VBD compared_VBN with_IN the_DT estimated_VBN numbers_NNS of_IN naturally_RB occurring_VBG cases_NNS of_IN encephalitis_NN and_CC aseptic_JJ meningitis_NN during_IN the_DT subsequent_JJ 3_CD -_HYPH month_NN interval_NN ._. Changes_NNS in_IN the_DT overall_JJ number_NN of_IN hospitalizations_NNS because_IN of_IN autism_NN and_CC Crohn_NNP 's_POS disease_NN were_VBD also_RB checked_VBN throughout_IN the_DT study_NN period_NN ._. Of_IN the_DT 535_CD 544_CD immunized_VBN children_NNS ,_, 199_CD were_VBD hospitalized_VBN with_IN encephalitis_NN ,_, 161_CD with_IN aseptic_JJ meningitis_NN ,_, and_CC 352_CD with_IN autistic_JJ disorders_NNS ._. In_IN nine_CD children_NNS with_IN encephalitis_NN and_CC 10_CD with_IN meningitis_NN ,_, the_DT disease_NN developed_VBD within_IN 3_CD months_NNS of_IN immunization_NN ,_, revealing_VBG no_DT increased_VBN occurrence_NN within_IN this_DT designated_VBN risk_NN period_NN ._. Furthermore_RB ,_, in_IN eight_CD of_IN nine_CD cases_NNS of_IN encephalitis_NN ,_, a_DT very_RB short_JJ interval_NN of_IN 2_CD days_NNS or_CC an_DT interval_NN exceeding_VBG 1_CD month_NN between_IN immunization_NN and_CC hospitalization_NN makes_VBZ an_DT association_NN with_IN immunization_NN unlikely_JJ ._. As_IN with_IN encephalitis_NN ,_, an_DT association_NN between_IN immunization_NN and_CC meningitis_NN occurring_VBG on_IN day_NN 2_CD or_CC over_IN 1_CD month_NN after_IN immunization_NN is_VBZ unlikely_JJ ._. No_DT clustering_NN of_IN hospitalization_NN for_IN autism_NN has_VBZ been_VBN detected_VBN after_IN immunization_NN ;_, none_NN of_IN the_DT autistic_JJ children_NNS went_VBD into_IN hospital_NN because_IN of_IN Crohn_NNP 's_POS disease_NN ._. A_DT study_NN on_IN MMR_NN immunization_NN and_CC autism_NN has_VBZ been_VBN carried_VBN out_RP in_IN Denmark_NNP in_IN all_DT 537_CD 303_CD children_NNS born_VBN in_IN Denmark_NNP from_IN 1991_CD to_IN 1998_CD ._. Using_VBG national_JJ registry_NN data_NNS on_IN autistic_JJ disorders_NNS ,_, the_DT investigators_NNS found_VBD no_DT association_NN between_IN MMR_NN immunization_NN and_CC a_DT subsequent_JJ diagnosis_NN of_IN autism_NN (_-LRB- RR_NN =_SYM 0.92_CD ;_: 95_CD %_NN CI_NN =_SYM 0.68_CD ,_, 1.24_CD )_-RRB- or_CC a_DT related_JJ disorder_NN (_-LRB- RR_NN =_SYM 0.83_CD ;_: 95_CD %_NN CI_NN =_SYM 0.65_CD ,_, 1.07_CD )_-RRB- ._. This_DT national_JJ cohort_NN study_NN obviated_VBD the_DT problems_NNS of_IN selection_NN bias_NN and_CC misclassification_NN bias_NN (_-LRB- 48C_CD )_-RRB- ._. In_IN a_DT case_NN -_HYPH control_NN study_NN of_IN age_NN at_IN first_JJ MMR_NN immunization_NN in_IN children_NNS with_IN autism_NN (_-LRB- n_NN =_SYM 624_CD )_-RRB- and_CC children_NNS without_IN (_-LRB- n_NN =_SYM 1824_CD )_-RRB- ,_, including_VBG children_NNS with_IN regression_NN in_IN development_NN ,_, the_DT overall_JJ distribution_NN of_IN ages_NNS at_IN MMR_NNP immunization_NN among_IN children_NNS with_IN autism_NN was_VBD similar_JJ to_IN that_DT of_IN matched_VBN control_NN children_NNS (_-LRB- 49C_CD )_-RRB- ._. Most_JJS of_IN the_DT cases_NNS (_-LRB- 71_CD %_NN )_-RRB- and_CC control_NN children_NNS (_-LRB- 68_CD %_NN )_-RRB- were_VBD immunized_VBN at_IN 12_CD –_SYM 17_CD months_NNS of_IN age_NN ._. Similar_JJ proportions_NNS of_IN case_NN and_CC control_NN children_NNS had_VBD been_VBN immunized_VBN before_IN 18_CD or_CC before_IN 24_CD months_NNS of_IN age_NN ._. There_EX were_VBD no_DT significant_JJ associations_NNS for_IN either_DT of_IN these_DT age_NN cutoffs_NNS in_IN specific_JJ case_NN subgroups_NNS ,_, including_VBG those_DT with_IN evidence_NN of_IN developmental_JJ regression_NN ._. One_CD of_IN the_DT major_JJ reasons_NNS that_IN measles_NNS occurred_VBD among_IN bone_NN marrow_NN transplant_NN recipients_NNS during_IN an_DT outbreak_NN of_IN measles_NN in_IN Brazil_NNP was_VBD that_IN they_PRP had_VBD not_RB been_VBN immunized_VBN ._. In_IN Brazil_NNP ,_, a_DT 2_CD -_HYPH year_NN interval_NN between_IN bone_NN marrow_NN transplantation_NN and_CC measles_NNS immunization_NN was_VBD recommended_VBN ._. Following_VBG a_DT study_NN in_IN 79_CD patients_NNS the_DT investigators_NNS concluded_VBD that_IN MMR_NNP immunization_NN between_IN 12_CD and_CC 24_CD months_NNS after_IN bone_NN marrow_NN transplantation_NN is_VBZ safe_JJ and_CC will_MD therefore_RB be_VB recommended_VBN at_IN 15_CD months_NNS after_IN transplantation_NN ._. However_RB ,_, because_IN the_DT serocon-version_NN rate_NN to_IN measles_NN is_VBZ only_RB 46_CD %_NN (_-LRB- rubella_NN 91_CD %_NN )_-RRB- ,_, serology_NN should_MD be_VB performed_VBN after_IN immunization_NN to_TO confirm_VB protection_NN (_-LRB- 50_CD c_NN )_-RRB- ._.","The NN that NNP NN can VB NN and NNP 's NN , RB VBN by NNP , VBZ VBN VBN at NN ( NNP - 14 , 1079 ; NNP - 25 , 387 ; NNP - 26 , 359 ; NNP - 27 , 338 ) . RB , it VBD VBN that NNP NNP VBD VBN for a JJ NN into whether NNS RB VBN by the NNP could VB . The NNP NN VBD RB VBN by a JJ NN of NNS . The NNP of the NNP VBD , “ If we VBD RB what we VBP RB , we RB would RB VB VBN the NN of the NN ( 43 NN ) that JJ to NNP ” ( NN ) . In NNP 2004 , 10 of the 12 NNS of the NN in NN VBD a “ NN of an NN ” . The NNS VBD it JJ that in this NN no JJ NN VBD VBN between NN NN and NN , as the NNS VBD JJ to VB the NN ( 45S ) . In 2004 , the NNP NNP NNP of the NNP of NNP of the NNP NNP NNPS of NNPS VBD the NNP NNP NNP on NNPS and NNP . The NN VBD the NN that NNS , RB the NN NN and NN - VBG NNS , VBP RB VBN with NN . The NNP VBD that the NN of JJ NN VBZ NN of a JJ NN between the NN NN and NN RB RB as a JJ NN between NN - VBG NNS and NN . The NN RB VBD that JJ JJ NNS for NN - VBN NN that VBP VBN VBN to NN VBP JJ RB . In NN , the NN VBD that JJ NN for NN NN VBP VBN to the RBS JJ NNS ( 46 NN ) . The NNS of a JJ NN VBG 535 544 NNS VBN 1 – 7 NNS who VBD VBN between NNP 1982 and NNP 1986 in NNP , VBN on NN of JJ NN NN NNS to a NN NN NN , VBP VBN VBN ( 47C ) . The NNS of NNS of NN and JJ NN within a 3 - NN NN NN after NN VBD VBN with the VBN NNS of RB VBG NNS of NN and JJ NN during the JJ 3 - NN NN . NNS in the JJ NN of NNS because of NN and NNP 's NN VBD RB VBN throughout the NN NN . Of the 535 544 VBN NNS , 199 VBD VBN with NN , 161 with JJ NN , and 352 with JJ NNS . In nine NNS with NN and 10 with NN , the NN VBD within 3 NNS of NN , VBG no VBN NN within this VBN NN NN . RB , in eight of nine NNS of NN , a RB JJ NN of 2 NNS or an NN VBG 1 NN between NN and NN VBZ an NN with NN JJ . As with NN , an NN between NN and NN VBG on NN 2 or over 1 NN after NN VBZ JJ . No NN of NN for NN VBZ VBN VBN after NN ; NN of the JJ NNS VBD into NN because of NNP 's NN . A NN on NN NN and NN VBZ VBN VBN out in NNP in all 537 303 NNS VBN in NNP from 1991 to 1998 . VBG JJ NN NNS on JJ NNS , the NNS VBD no NN between NN NN and a JJ NN of NN ( NN = 0.92 ; 95 NN NN = 0.68 , 1.24 ) or a JJ NN ( NN = 0.83 ; 95 NN NN = 0.65 , 1.07 ) . This JJ NN NN VBD the NNS of NN NN and NN NN ( 48C ) . In a NN - NN NN of NN at JJ NN NN in NNS with NN ( NN = 624 ) and NNS without ( NN = 1824 ) , VBG NNS with NN in NN , the JJ NN of NNS at NNP NN among NNS with NN VBD JJ to that of VBN NN NNS ( 49C ) . JJS of the NNS ( 71 NN ) and NN NNS ( 68 NN ) VBD VBN at 12 – 17 NNS of NN . JJ NNS of NN and NN NNS VBD VBN VBN before 18 or before 24 NNS of NN . There VBD no JJ NNS for either of these NN NNS in JJ NN NNS , VBG those with NN of JJ NN . One of the JJ NNS that NNS VBD among NN NN NN NNS during an NN of NN in NNP VBD that they VBD RB VBN VBN . In NNP , a 2 - NN NN between NN NN NN and NNS NN VBD VBN . VBG a NN in 79 NNS the NNS VBD that NNP NN between 12 and 24 NNS after NN NN NN VBZ JJ and will RB VB VBN at 15 NNS after NN . RB , because the NN NN to NN VBZ RB 46 NN ( NN 91 NN ) , NN should VB VBN after NN to VB NN ( 50 NN ) ."
102,906,conspiracy,C00c7e,pharmaceutical.industry; vaccine,"As_IN the_DT Children_NNP ’s_POS Health_NNP Defense_NNP eBook_NNP ,_, Conflicts_NNPS of_IN Interest_NNP Undermine_NNP Children_NNPS ’s_POS Health_NNP ,_, tries_VBZ to_TO make_VB clear_JJ ,_, the_DT passage_NN of_IN the_DT National_NNP Childhood_NNP Vaccine_NNP Injury_NNP Act_NNP (_-LRB- NCVIA_NNP )_-RRB- in_IN 1986_CD was_VBD a_DT watershed_JJ event_NN that_WDT emboldened_VBD vaccine_NN manufacturers_NNS and_CC their_PRP$ public_JJ -_HYPH and_CC private_JJ -_HYPH sector_NN accomplices_NNS —_: notably_RB the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- —_: to_TO systematically_RB hide_VB the_DT serious_JJ damage_NN caused_VBN by_IN vaccines_NNS ._. In_IN addition_NN to_IN making_VBG a_DT mockery_NN of_IN pre-licensing_NN safety_NN testing_NN and_CC post_NN -_HYPH marketing_NN surveillance_NN ,_, these_DT entities_NNS have_VBP regularly_RB manipulated_VBN (_-LRB- or_CC destroyed_VBN )_-RRB- data_NNS to_TO exaggerate_VB both_CC the_DT benefits_NNS and_CC effectiveness_NN of_IN vaccination_NN ._. Manufacturers_NNS have_VBP also_RB used_VBN their_PRP$ money_NN and_CC power_NN to_TO subordinate_VB the_DT mainstream_JJ media_NN ,_, medical_JJ journals_NNS and_CC front_JJ groups_NNS ,_, making_VBG it_PRP possible_JJ to_TO publish_VB and_CC broadcast_VB deceptive_JJ studies_NNS that_WDT whitewash_VBP questions_NNS inconvenient_JJ to_IN the_DT financial_JJ bottom_JJ line_NN ._. From_IN multiple_JJ standpoints_NNS —_: not_RB least_JJS of_IN which_WDT is_VBZ children_NNS ’s_POS dismal_JJ state_NN of_IN health_NN —_: the_DT status_NN quo_NN is_VBZ untenable_JJ ._. Three_CD of_IN the_DT most_RBS urgent_JJ steps_NNS to_TO be_VB taken_VBN include_VBP repealing_VBG the_DT NCVIA_NNP ,_, eliminating_VBG vaccine_NN mandates_NNS (_-LRB- making_VBG both_CC childhood_NN and_CC adult_JJ vaccination_NN voluntary_JJ )_-RRB- and_CC addressing_VBG conflicts_NNS of_IN interest_NN by_IN establishing_VBG a_DT fully_RB transparent_JJ and_CC independent_JJ vaccine_NN safety_NN commission_NN ._. The_DT NCVIA_NNP has_VBZ been_VBN an_DT unmitigated_JJ disaster_NN ._. As_IN New_NNP York_NNP University_NNP law_NN professor_NN Mary_NNP Holland_NNP has_VBZ written_VBN ,_, the_DT Act_NN ’s_POS passage_NN has_VBZ allowed_VBN the_DT government_NN and_CC vaccine_NN manufacturers_NNS to_TO ride_VB roughshod_NNS over_IN three_CD important_JJ legal_JJ protections_NNS :_: •_NFP Free_JJ and_CC informed_VBN consent_NN to_IN an_DT invasive_JJ medical_JJ procedure_NN •_SYM Accurate_JJ and_CC complete_JJ information_NN about_IN vaccine_NN ingredients_NNS and_CC possible_JJ side_NN effects_NNS •_NFP The_DT right_NN to_TO sue_VB manufacturers_NNS and_CC medical_JJ practitioners_NNS directly_RB in_IN the_DT event_NN of_IN injury_NN ._. According_VBG to_IN Holland_NNP ,_, the_DT absence_NN of_IN these_DT legal_JJ protections_NNS for_IN vaccination_NN is_VBZ “_`` striking_JJ ”_'' compared_VBN to_IN “_`` almost_RB all_DT other_JJ medical_JJ interventions_NNS ._. ”_'' The_DT legal_JJ protections_NNS are_VBP interrelated_VBN ._. For_IN example_NN ,_, an_DT individual_NN cannot_MD exercise_VB truly_RB informed_VBN consent_NN unless_IN he_PRP or_CC she_PRP has_VBZ access_NN to_IN full_JJ and_CC unbiased_JJ information_NN ._. Recognizing_VBG this_DT ,_, one_CD provision_NN of_IN the_DT NCVIA_NNP was_VBD a_DT mandate_NN for_IN the_DT CDC_NNP to_TO develop_VB (_-LRB- and_CC health_NN care_NN providers_NNS to_TO distribute_VB )_-RRB- patient_JJ education_NN materials_NNS about_IN vaccine_NN risks_NNS and_CC benefits_NNS ._. However_RB ,_, not_RB only_RB has_VBZ the_DT CDC_NNP repeatedly_RB dumbed_VBN down_RP the_DT materials_NNS in_IN a_DT variety_NN of_IN ways_NNS ,_, but_CC research_NN suggests_VBZ that_IN many_JJ doctors_NNS do_VBP not_RB comply_VB with_IN the_DT legal_JJ requirement_NN to_TO hand_VB out_RP (_-LRB- much_RB less_RBR discuss_VB )_-RRB- them_PRP ._. Instead_RB ,_, providers_NNS and_CC the_DT media_NN continue_VBP to_TO blandly_RB assure_VB the_DT public_NN that_IN vaccine_NN injuries_NNS are_VBP a_DT “_`` one_CD in_IN a_DT million_CD ”_'' event_NN ,_, never_RB mentioning_VBG that_IN 99_CD %_NN of_IN vaccine_NN injuries_NNS go_VBP unreported_JJ ._. Under_IN the_DT circumstances_NNS ,_, no_DT meaningful_JJ assessment_NN of_IN vaccine_NN risks_NNS is_VBZ possible_JJ ._. Research_NN shows_VBZ that_IN by_IN eliminating_VBG consumers_NNS ’_POS ability_NN to_TO sue_VB ,_, the_DT NCVIA_NNP has_VBZ had_VBN a_DT tangibly_RB negative_JJ effect_NN on_IN vaccine_NN safety_NN ._. After_IN an_DT extensive_JJ analysis_NN of_IN nationwide_JJ and_CC state_NN -_HYPH level_NN U.S._NNP data_NNS ,_, a_DT researcher_NN reported_VBD in_IN 2017_CD that_IN vaccines_NNS licensed_VBN after_IN NCVIA_NNP ’s_POS passage_NN were_VBD associated_VBN with_IN “_`` a_DT significantly_RB higher_JJR incidence_NN of_IN adverse_JJ events_NNS ”_'' compared_VBN to_IN vaccines_NNS licensed_VBN prior_JJ to_IN the_DT law_NN ’s_POS passage_NN ._. The_DT researcher_NN concluded_VBD that_IN “_`` product_NN safety_NN deteriorates_VBZ when_WRB consumers_NNS are_VBP no_RB longer_RBR able_JJ to_TO sue_VB manufacturers_NNS ._. ”_'' Repealing_VBG the_DT NCVIA_NN and_CC reinstating_VBG product_NN liability_NN would_MD not_RB solve_VB all_DT of_IN the_DT ethical_JJ problems_NNS that_WDT permeate_VBP the_DT pharmaceutical_JJ industry_NN ’s_POS business_NN culture_NN ,_, but_CC it_PRP could_MD curtail_VB the_DT “_`` free_JJ -_HYPH for_IN -_HYPH all_DT ”_'' environment_NN that_WDT has_VBZ prevailed_VBN since_IN 1986_CD and_CC might_MD incentivize_VB manufacturers_NNS to_TO treat_VB vaccines_NNS in_IN the_DT same_JJ way_NN as_IN drugs_NNS and_CC put_VB safety_NN on_IN somewhat_RB of_IN a_DT more_RBR even_RB footing_NN with_IN profits_NNS …_: ._.","As the NNP ’s NNP NNP NNP , NNPS of NNP NNP NNPS ’s NNP , VBZ to VB JJ , the NN of the NNP NNP NNP NNP NNP ( NNP ) in 1986 VBD a JJ NN that VBD NN NNS and their JJ - and JJ - NN NNS — RB the NNPS for NNP NNP and NNP ( NNP ) — to RB VB the JJ NN VBN by NNS . In NN to VBG a NN of NN NN NN and NN - NN NN , these NNS VBP RB VBN ( or VBN ) NNS to VB both the NNS and NN of NN . NNS VBP RB VBN their NN and NN to VB the JJ NN , JJ NNS and JJ NNS , VBG it JJ to VB and VB JJ NNS that VBP NNS JJ to the JJ JJ NN . From JJ NNS — RB JJS of which VBZ NNS ’s JJ NN of NN — the NN NN VBZ JJ . Three of the RBS JJ NNS to VB VBN VBP VBG the NNP , VBG NN NNS ( VBG both NN and JJ NN JJ ) and VBG NNS of NN by VBG a RB JJ and JJ NN NN NN . The NNP VBZ VBN an JJ NN . As NNP NNP NNP NN NN NNP NNP VBZ VBN , the NN ’s NN VBZ VBN the NN and NN NNS to VB NNS over three JJ JJ NNS : • JJ and VBN NN to an JJ JJ NN • JJ and JJ NN about NN NNS and JJ NN NNS • The NN to VB NNS and JJ NNS RB in the NN of NN . VBG to NNP , the NN of these JJ NNS for NN VBZ “ JJ ” VBN to “ RB all JJ JJ NNS . ” The JJ NNS VBP VBN . For NN , an NN cannot VB RB VBN NN unless he or she VBZ NN to JJ and JJ NN . VBG this , one NN of the NNP VBD a NN for the NNP to VB ( and NN NN NNS to VB ) JJ NN NNS about NN NNS and NNS . RB , RB RB VBZ the NNP RB VBN down the NNS in a NN of NNS , but NN VBZ that JJ NNS VBP RB VB with the JJ NN to VB out ( RB RBR VB ) them . RB , NNS and the NN VBP to RB VB the NN that NN NNS VBP a “ one in a million ” NN , RB VBG that 99 NN of NN NNS VBP JJ . Under the NNS , no JJ NN of NN NNS VBZ JJ . NN VBZ that by VBG NNS ’ NN to VB , the NNP VBZ VBN a RB JJ NN on NN NN . After an JJ NN of JJ and NN - NN NNP NNS , a NN VBD in 2017 that NNS VBN after NNP ’s NN VBD VBN with “ a RB JJR NN of JJ NNS ” VBN to NNS VBN JJ to the NN ’s NN . The NN VBD that “ NN NN VBZ when NNS VBP RB RBR JJ to VB NNS . ” VBG the NN and VBG NN NN would RB VB all of the JJ NNS that VBP the JJ NN ’s NN NN , but it could VB the “ JJ - for - all ” NN that VBZ VBN since 1986 and might VB NNS to VB NNS in the JJ NN as NNS and VB NN on RB of a RBR RB NN with NNS … ."
103,1234,mainstream,M0815a,vaccine; vaccine.covid,"Brazil_NNP will_MD join_VB Oxford_NNP University_NNP ’s_POS coronavirus_NN vaccine_NN trial_NN ,_, the_DT university_NN announced_VBD this_DT week_NN ._. In_IN a_DT news_NN release_NN on_IN Thursday_NNP ,_, the_DT university_NN announced_VBD that_IN the_DT Brazilian_NNP Health_NNP Regulatory_NNP Agency_NNP (_-LRB- ANVISA_NNP )_-RRB- approved_VBD the_DT country_NN to_TO be_VB a_DT part_NN of_IN the_DT clinical_JJ trials_NNS conducted_VBN by_IN Oxford_NNP University_NNP and_CC supported_VBN by_IN AstraZeneca_NNP ,_, which_WDT makes_VBZ the_DT vaccine_NN ._. Some_DT 2,000_CD people_NNS will_MD be_VB recruited_VBN to_TO participate_VB ._. Brazil_NNP has_VBZ become_VBN an_DT epicenter_NN for_IN the_DT coronavirus_NN pandemic_NN ,_, with_IN the_DT country_NN reporting_VBG yet_RB another_DT record_JJ number_NN of_IN deaths_NNS on_IN Thursday_NNP –_SYM 1,473_CD –_: raising_VBG its_PRP$ toll_NN to_IN over_RB 34,000_CD ._. Brazil_NNP has_VBZ now_RB surpassed_VBN Italy_NNP for_IN the_DT world_NN 's_POS third_RB -_HYPH deadliest_JJS outbreak_NN ,_, even_RB though_IN it_PRP 's_VBZ still_RB considered_VBN by_IN experts_NNS a_DT significant_JJ undercount_NN due_IN to_IN insufficient_JJ testing_NN ._. Indeed_RB ,_, “_`` Brazil_NNP is_VBZ a_DT priority_NN for_IN the_DT study_NN because_IN of_IN the_DT ascendant_JJ curve_NN of_IN the_DT COVID_NNP -_HYPH 19_CD ,_, ”_'' officials_NNS said_VBD in_IN the_DT news_NN release_NN ._. ‘_`` SOCIAL_JJ GATHERINGS_NNS ’_'' BEHIND_JJ RISE_NN IN_IN CORONAVIRUS_NN CASES_NNS IN_IN PART_NN OF_IN IDAHO_NNP ,_, OFFICIALS_NNS SAY_VBP “_`` The_DT most_RBS important_JJ thing_NN is_VBZ to_TO carry_VB out_RP this_DT stage_NN of_IN the_DT study_NN now_RB when_WRB the_DT epidemiological_JJ curve_NN is_VBZ still_RB rising_VBG and_CC the_DT results_NNS may_MD be_VB more_RBR assertive_JJ ,_, ”_'' said_VBD Lily_NNP Yin_NNP Weckx_NNP ,_, coordinator_NN of_IN the_DT Reference_NNP Center_NNP for_IN Special_NNP Immunobiologicals_NNPS (_-LRB- CRIE_NNP )_-RRB- at_IN the_DT Federal_NNP University_NNP of_IN Sao_NNP Paulo_NNP ,_, in_IN a_DT statement_NN ._. More_JJR than_IN 6.6_CD million_CD people_NNS have_VBP been_VBN infected_VBN with_IN the_DT virus_NN and_CC more_JJR than_IN 389,000_CD have_VBP died_VBN from_IN COVID_NN -_HYPH 19_CD ,_, according_VBG to_IN the_DT Johns_NNP Hopkins_NNP count_NN ._. The_DT true_JJ toll_NN is_VBZ likely_RB much_RB higher_JJR ,_, due_IN to_IN limits_NNS on_IN testing_NN and_CC many_JJ asymptomatic_JJ cases_NNS ._. The_DT Associated_NNP Press_NNP contributed_VBD to_IN this_DT report_NN ._.","NNP will VB NNP NNP ’s NN NN NN , the NN VBD this NN . In a NN NN on NNP , the NN VBD that the NNP NNP NNP NNP ( NNP ) VBD the NN to VB a NN of the JJ NNS VBN by NNP NNP and VBN by NNP , which VBZ the NN . Some 2,000 NNS will VB VBN to VB . NNP VBZ VBN an NN for the NN NN , with the NN VBG RB another JJ NN of NNS on NNP – 1,473 – VBG its NN to RB 34,000 . NNP VBZ RB VBN NNP for the NN 's RB - JJS NN , RB though it VBZ RB VBN by NNS a JJ NN due to JJ NN . RB , “ NNP VBZ a NN for the NN because of the JJ NN of the NNP - 19 , ” NNS VBD in the NN NN . ‘ JJ NNS ’ JJ NN IN NN NNS IN NN OF NNP , NNS VBP “ The RBS JJ NN VBZ to VB out this NN of the NN RB when the JJ NN VBZ RB VBG and the NNS may VB RBR JJ , ” VBD NNP NNP NNP , NN of the NNP NNP for NNP NNPS ( NNP ) at the NNP NNP of NNP NNP , in a NN . JJR than 6.6 million NNS VBP VBN VBN with the NN and JJR than 389,000 VBP VBN from NN - 19 , VBG to the NNP NNP NN . The JJ NN VBZ RB RB JJR , due to NNS on NN and JJ JJ NNS . The NNP NNP VBD to this NN ."
104,382,conspiracy,C01344,coronavirus; vaccine; vaccine.covid,"A_DT Reuters_NNP /_, Ipsos_NNP poll_NN published_VBN Thursday_NNP has_VBZ revealed_VBN that_IN a_DT quarter_NN of_IN Americans_NNPS are_VBP not_RB interested_JJ in_IN taking_VBG a_DT coronavirus_NN vaccine_NN ._. The_DT poll_NN founds_VBZ that_IN 14_CD %_NN were_VBD not_RB interested_JJ at_IN all_DT ,_, and_CC 10_CD %_NN were_VBD not_RB very_RB interested_JJ in_IN the_DT vaccine_NN ._. However_RB ,_, while_IN that_IN 24_CD %_NN dismissed_VBD the_DT idea_NN ,_, two_CD thirds_NN ,_, 66_CD %_NN ,_, said_VBD they_PRP are_VBP either_CC “_`` very_RB ”_'' or_CC “_`` somewhat_RB ”_'' interested_JJ in_IN taking_VBG a_DT vaccine_NN when_WRB it_PRP is_VBZ produced_VBN ._. Dr._NNP William_NNP Schaffner_NNP ,_, an_DT infectious_JJ disease_NN expert_NN at_IN Vanderbilt_NNP University_NNP Medical_NNP Center_NNP in_IN Nashville_NNP ,_, said_VBD “_`` It_PRP ’s_VBZ a_DT little_JJ lower_JJR than_IN I_PRP thought_VBD it_PRP would_MD be_VB with_IN all_PDT the_DT attention_NN to_IN COVID_NNP -_HYPH 19_CD ,_, ”_'' adding_VBG “_'' I_PRP would_MD have_VB expected_VBN somewhere_RB around_IN 75_CD percent_NN ._. ”_'' The_DT Reuters_NNP report_NN notes_VBZ that_IN health_NN experts_NNS believe_VBP “_`` at_IN least_JJS 70_CD %_NN of_IN Americans_NNPS would_MD need_VB to_TO be_VB immune_JJ through_IN a_DT vaccine_NN or_CC prior_JJ infection_NN to_TO achieve_VB what_WP is_VBZ known_VBN as_IN “_`` herd_NN immunity_NN ,_, ”_'' when_WRB enough_JJ people_NNS are_VBP resistant_JJ to_IN an_DT infectious_JJ disease_NN to_TO prevent_VB its_PRP$ spread_NN ._. ”_'' Peter_NNP Hotez_NNP ,_, dean_NN of_IN the_DT National_NNP School_NNP of_IN Tropical_NNP Medicine_NNP at_IN Baylor_NNP College_NNP of_IN Medicine_NNP noted_VBD that_IN “_`` It_PRP ’s_VBZ not_RB surprising_JJ a_DT significant_JJ percentage_NN of_IN Americans_NNPS are_VBP not_RB going_VBG to_TO take_VB the_DT vaccine_NN because_IN of_IN the_DT terrible_JJ messaging_NN we_PRP ’ve_VBP had_VBN ,_, the_DT absence_NN of_IN a_DT communication_NN plan_NN around_IN the_DT vaccine_NN and_CC this_DT very_RB aggressive_JJ anti-vaccine_JJ movement_NN ._. ”_'' The_DT poll_NN also_RB found_VBD that_IN 36_CD %_NN of_IN respondents_NNS would_MD be_VB less_RBR willing_JJ to_TO take_VB a_DT vaccine_NN if_IN President_NNP Trump_NNP said_VBD it_PRP was_VBD safe_JJ ,_, with_IN just_RB 14_CD %_NN said_VBD they_PRP would_MD be_VB interested_JJ ._. A_DT week_NN ago_RB ,_, Trump_NNP announced_VBD “_`` Operation_NNP Warp_NNP Speed_NNP ,_, ”_'' to_TO fast_JJ -_HYPH track_VB the_DT development_NN and_CC distribution_NN of_IN a_DT coronavirus_NN vaccine_NN by_IN January_NNP 2021_CD ,_, tapping_VBG experts_NNS and_CC resources_NNS in_IN science_NN ,_, medicine_NN ,_, the_DT military_NN ,_, and_CC the_DT private_JJ sector_NN ._. Trump_NNP has_VBZ said_VBN that_IN the_DT military_NN will_MD be_VB deployed_VBN to_TO distribute_VB the_DT vaccine_NN ,_, but_CC has_VBZ suggested_VBN that_IN it_PRP will_MD remain_VB voluntary_JJ ,_, noting_VBG that_IN it_PRP will_MD be_VB for_IN those_DT “_`` who_WP want_VBP to_TO get_VB it_PRP ,_, ”_'' and_CC “_`` Not_RB everyone_NN is_VBZ going_VBG to_TO want_VB to_TO get_VB it_PRP ._. ”_'' The_DT platinum_NN standard_NN of_IN advanced_JJ multivitamin_NN formulations_NNS is_VBZ back_RB in_IN stock_NN !_. Order_VB Vitamin_NN Mineral_NN Fusion_NN at_IN 50_CD %_NN off_RP with_IN double_JJ Patriot_NN Points_NNS and_CC free_JJ shipping_NN today_NN !_.","A NNP / NNP NN VBN NNP VBZ VBN that a NN of NNPS VBP RB JJ in VBG a NN NN . The NN VBZ that 14 NN VBD RB JJ at all , and 10 NN VBD RB RB JJ in the NN . RB , while that 24 NN VBD the NN , two NN , 66 NN , VBD they VBP either “ RB ” or “ RB ” JJ in VBG a NN when it VBZ VBN . NNP NNP NNP , an JJ NN NN at NNP NNP NNP NNP in NNP , VBD “ It VBZ a JJ JJR than I VBD it would VB with all the NN to NNP - 19 , ” VBG “ I would VB VBN RB around 75 NN . ” The NNP NN VBZ that NN NNS VBP “ at JJS 70 NN of NNPS would VB to VB JJ through a NN or JJ NN to VB what VBZ VBN as “ NN NN , ” when JJ NNS VBP JJ to an JJ NN to VB its NN . ” NNP NNP , NN of the NNP NNP of NNP NNP at NNP NNP of NNP VBD that “ It VBZ RB JJ a JJ NN of NNPS VBP RB VBG to VB the NN because of the JJ NN we VBP VBN , the NN of a NN NN around the NN and this RB JJ JJ NN . ” The NN RB VBD that 36 NN of NNS would VB RBR JJ to VB a NN if NNP NNP VBD it VBD JJ , with RB 14 NN VBD they would VB JJ . A NN RB , NNP VBD “ NNP NNP NNP , ” to JJ - VB the NN and NN of a NN NN by NNP 2021 , VBG NNS and NNS in NN , NN , the NN , and the JJ NN . NNP VBZ VBN that the NN will VB VBN to VB the NN , but VBZ VBN that it will VB JJ , VBG that it will VB for those “ who VBP to VB it , ” and “ RB NN VBZ VBG to VB to VB it . ” The NN NN of JJ NN NNS VBZ RB in NN ! VB NN NN NN at 50 NN off with JJ NN NNS and JJ NN NN !"
105,700,mainstream,M0a841,vaccine; vaccine.covid,"Since_IN the_DT Covid_NNP -_HYPH 19_CD pandemic_NN began_VBD ,_, there_EX has_VBZ been_VBN a_DT sudden_JJ and_CC massive_JJ divergence_NN in_IN macroeconomic_JJ projections_NNS ._. For_IN example_NN ,_, in_IN early_JJ February_NNP ,_, the_DT spread_NN among_IN economic_JJ growth_NN forecasts_NNS for_IN Q2_NNP in_IN the_DT U.S._NNP was_VBD 3.5_CD percentage_NN points_NNS according_VBG to_IN FocusEconomics_NN data_NN ._. By_IN April_NNP 29_CD ,_, the_DT most_RBS optimistic_JJ forecast_NN among_IN the_DT 28_CD institutions_NNS in_IN our_PRP$ weekly_JJ coronavirus_NN survey_NN saw_VBD the_DT U.S._NNP economy_NN contracting_VBG 8.2_CD %_NN ._. The_DT most_RBS pessimistic_JJ projected_VBD a_DT huge_JJ 65.0_CD %_NN contraction_NN —_: a_DT spread_NN of_IN 56.8_CD percentage_NN points_NNS —_: with_IN an_DT average_NN of_IN -_SYM 31.4_CD %_NN ._. There_EX are_VBP three_CD reasons_NNS for_IN the_DT divergence_NN :_: First_RB ,_, the_DT economic_JJ impact_NN and_CC speed_NN of_IN policy_NN changes_NNS have_VBP never_RB been_VBN higher_JJR ._. Second_RB ,_, the_DT pandemic_NN is_VBZ undermining_VBG the_DT reliability_NN of_IN economic_JJ data_NNS ._. Finally_RB ,_, economic_JJ forecasters_NNS are_VBP having_VBG to_TO delve_VB into_IN the_DT unfamiliar_JJ world_NN of_IN epidemiology_NN ._. The_DT coronavirus_NN pandemic_NN has_VBZ introduced_VBN extreme_JJ uncertainty_NN into_IN nearly_RB every_DT aspect_NN of_IN society_NN ._. Will_MD health_NN care_NN systems_NNS hold_VB up_RP ?_. Will_MD scientists_NNS develop_VB a_DT vaccine_NN ?_. Are_VBP essential_JJ workers_NNS safe_JJ ?_. When_WRB can_MD regular_JJ employees_NNS go_VB back_RB to_IN the_DT office_NN ?_. The_DT answers_NNS to_IN these_DT questions_NNS —_: when_WRB there_EX are_VBP answers_NNS —_: seem_VB to_TO change_VB daily_RB ._. And_CC with_IN each_DT change_NN the_DT stock_NN market_NN (_-LRB- and_CC our_PRP$ hopes_NNS )_-RRB- rises_VBZ or_CC falls_VBZ ._. Since_IN the_DT Covid_NNP -_HYPH 19_CD pandemic_NN began_VBD ,_, we_PRP ’ve_VBP seen_VBN pervasive_JJ uncertainty_NN manifest_VBN in_IN a_DT sudden_JJ and_CC massive_JJ divergence_NN in_IN macroeconomic_JJ projections_NNS ._. For_IN example_NN ,_, in_IN early_JJ February_NNP ,_, the_DT spread_NN among_IN economic_JJ growth_NN forecasts_NNS for_IN Q2_NNP in_IN the_DT U.S._NNP was_VBD 3.5_CD percentage_NN points_NNS according_VBG to_IN FocusEconomics_NN data_NN ._. By_IN April_NNP 29_CD ,_, the_DT most_RBS optimistic_JJ forecast_NN among_IN the_DT 28_CD institutions_NNS in_IN our_PRP$ weekly_JJ coronavirus_NN survey_NN saw_VBD the_DT U.S._NNP economy_NN contracting_VBG 8.2_CD %_NN ._. The_DT most_RBS pessimistic_JJ projected_VBD a_DT huge_JJ 65.0_CD %_NN contraction_NN —_: a_DT spread_NN of_IN 56.8_CD percentage_NN points_NNS —_: with_IN an_DT average_NN of_IN -_SYM 31.4_CD %_NN ._. While_IN most_JJS institutions_NNS expected_VBD a_DT rebound_NN in_IN Q3_NNP ,_, some_DT saw_VBD further_JJR declines_NNS ._. And_CC in_IN Q4_NNP ,_, although_IN all_DT economists_NNS projected_VBD growth_NN of_IN some_DT form_NN ,_, forecasts_NNS ranged_VBD from_IN a_DT minimum_NN of_IN +1.1_CD %_NN and_CC a_DT maximum_NN of_IN +70.0_CD %_NN ._. The_DT spreads_NNS observed_VBD in_IN recent_JJ weeks_NNS are_VBP by_IN far_RB the_DT widest_JJS recorded_VBN since_IN we_PRP started_VBD covering_VBG the_DT U.S._NNP a_DT decade_NN ago_RB ._. Looking_VBG at_IN countries_NNS with_IN a_DT longer_JJR time_NN horizon_NN ,_, the_DT current_JJ forecast_NN spread_NN among_IN analysts_NNS is_VBZ far_RB larger_JJR than_IN at_IN any_DT point_NN during_IN the_DT past_JJ 20_CD years_NNS ,_, and_CC significantly_RB above_IN that_DT seen_VBN during_IN the_DT height_NN of_IN the_DT financial_JJ crisis_NN —_: the_DT last_JJ period_NN of_IN extreme_JJ ,_, prolonged_VBD global_JJ uncertainty_NN ._. For_IN example_NN ,_, during_IN the_DT 2008_CD financial_JJ crisis_NN ,_, both_CC Brazil_NNP and_CC Mexico_NNP saw_VBD the_DT spread_NN for_IN annual_JJ GDP_NN forecasts_NNS widen_VBP to_IN close_JJ to_IN six_CD percentage_NN points_NNS ,_, before_IN returning_VBG to_IN under_IN three_CD for_IN most_JJS of_IN the_DT 2010s_NNS ._. The_DT percentage_NN point_NN spread_NN is_VBZ now_RB well_RB over_RB seven_CD percentage_NN points_NNS ._. Why_WRB So_RB Much_JJ Divergence_NN ?_. The_DT short_JJ answer_NN to_IN why_WRB there_EX is_VBZ so_RB much_JJ divergence_NN is_VBZ because_IN no_DT one_NN knows_VBZ for_IN sure_JJ what_WP is_VBZ going_VBG to_TO happen_VB ._. Digging_VBG deeper_RBR ,_, three_CD key_JJ factors_NNS are_VBP causing_VBG forecasters_NNS particular_JJ difficulties_NNS ._. First_RB ,_, the_DT economic_JJ impact_NN and_CC speed_NN of_IN policy_NN changes_NNS have_VBP never_RB been_VBN higher_JJR ._. In_IN normal_JJ times_NNS ,_, most_JJS governments_NNS can_MD be_VB relied_VBN on_RP to_TO at_IN least_JJS attempt_VB to_TO encourage_VB economic_JJ growth_NN and_CC preserve_VB employment_NN ._. Today_NN ,_, however_RB ,_, they_PRP are_VBP deliberately_RB provoking_VBG recessions_NNS to_TO save_VB lives_NNS ,_, and_CC containment_NN measures_NNS are_VBP crushing_VBG domestic_JJ activity_NN ._. Simply_RB miscalculating_VBG the_DT end_NN date_NN of_IN a_DT nationwide_JJ lockdown_NN by_IN a_DT couple_NN of_IN weeks_NNS throws_VBZ annual_JJ GDP_NN forecasts_NNS completely_RB off_IN -_HYPH kilter_NN ._. Moreover_RB ,_, bills_NNS which_WDT generally_RB endure_VBP months_NNS of_IN parliamentary_JJ ping_NN -_HYPH pong_NN are_VBP being_VBG rushed_VBN through_IN legislatures_NNS in_IN days_NNS as_IN governments_NNS and_CC central_JJ banks_NNS race_VBP to_TO respond_VB to_IN the_DT rapid_JJ advance_NN of_IN the_DT virus_NN ._. Many_JJ governments_NNS have_VBP adopted_VBN emergency_NN powers_NNS allowing_VBG them_PRP to_TO rule_VB by_IN decree_NN ._. What_WP ’s_VBZ more_JJR ,_, the_DT fiscal_JJ and_CC monetary_JJ stimulus_NN being_VBG announced_VBN to_TO palliate_VB the_DT downturn_NN dwarfs_VBZ that_DT seen_VBN during_IN the_DT financial_JJ crisis_NN ._. For_IN economic_JJ forecasters_NNS ,_, keeping_VBG up_RP with_IN the_DT constant_JJ flurry_NN of_IN measures_NNS and_CC correctly_RB incorporating_VBG them_PRP into_IN models_NNS poses_VBZ challenges_NNS ._. Second_RB ,_, the_DT pandemic_NN is_VBZ undermining_VBG the_DT reliability_NN of_IN economic_JJ data_NNS —_: the_DT bedrock_NN of_IN any_DT good_JJ macroeconomic_JJ model_NN ._. In_IN particular_JJ ,_, survey_NN -_HYPH based_VBN data_NNS of_IN businesses_NNS and_CC households_NNS is_VBZ suffering_VBG as_IN lockdown_NN measures_NNS reduce_VBP response_NN rates_NNS ,_, amplifying_VBG sampling_NN error_NN ._. The_DT U.S._NNP Bureau_NNP of_IN Labor_NNP Statistics_NNP data_NNS for_IN March_NNP ,_, for_IN instance_NN ,_, saw_VBD establishments_NNS ’_POS and_CC households_NNS ’_POS response_NN rates_NNS fall_VBP by_IN nine_CD and_CC 10_CD percentage_NN points_NNS respectively_RB relative_RB to_IN their_PRP$ recent_JJ average_NN ._. Paul_NNP Donovan_NNP ,_, chief_JJ economist_NN at_IN UBS_NNP Global_NNP Wealth_NNP Management_NNP ,_, explained_VBD the_DT problem_NN this_DT way_NN :_: “_`` If_IN you_PRP are_VBP filling_VBG in_RP survey_NN forms_NNS in_IN a_DT lockdown_NN ,_, you_PRP are_VBP likely_JJ to_TO be_VB an_DT unusual_JJ person_NN ,_, and_CC possibly_RB not_RB representative_NN ._. Sentiment_NN affects_VBZ answers_NNS to_IN surveys_NNS ._. Data_NNS ,_, like_IN consumer_NN price_NN inflation_NN ,_, includes_VBZ restaurant_NN prices_NNS ,_, but_CC restaurants_NNS are_VBP closed_VBN ._. What_WP happens_VBZ when_WRB you_PRP survey_VBP something_NN that_WDT is_VBZ not_RB there_RB ?_. Online_JJ spending_NN is_VBZ likely_JJ to_TO have_VB increased_VBN in_IN lockdowns_NNS ._. Online_JJ spending_NN may_MD stay_VB higher_JJR after_IN the_DT lockdowns_NNS end_VBP ._. It_PRP may_MD not_RB be_VB properly_RB captured_VBN in_IN official_JJ data_NNS ._. ”_'' The_DT third_JJ reason_NN the_DT models_NNS are_VBP diverging_VBG so_RB much_RB is_VBZ because_IN economic_JJ forecasters_NNS are_VBP having_VBG to_TO delve_VB into_IN the_DT unfamiliar_JJ world_NN of_IN epidemiology_NN to_TO better_RBR understand_VB the_DT likely_JJ evolution_NN of_IN the_DT coronavirus_NN outbreak_NN in_IN each_DT country_NN ._. However_RB ,_, this_DT is_VBZ a_DT challenge_NN even_RB for_IN health_NN experts_NNS ._. Predicting_VBG the_DT scope_NN and_CC effectiveness_NN of_IN future_JJ public_JJ health_NN interventions_NNS ,_, or_CC how_WRB health_NN care_NN systems_NNS will_MD respond_VB under_IN pressure_NN ,_, is_VBZ tough_JJ —_: particularly_RB for_IN countries_NNS at_IN early_JJ stages_NNS of_IN their_PRP$ epidemics_NNS ._. There_EX is_VBZ no_DT firm_JJ timeline_NN for_IN the_DT arrival_NN of_IN game_NN -_HYPH changing_VBG treatments_NNS or_CC vaccines_NNS ,_, or_CC clarity_NN over_IN the_DT likelihood_NN or_CC severity_NN of_IN a_DT second_JJ wave_NN of_IN cases_NNS ._. The_DT divergence_NN in_IN economic_JJ forecasts_NNS should_MD narrow_VB somewhat_RB going_VBG forward_RB ._. Greater_JJR clarity_NN will_MD emerge_VB on_IN the_DT effectiveness_NN of_IN recent_JJ stimulus_NN ,_, and_CC any_DT further_JJR fiscal_JJ or_CC monetary_JJ measures_NNS will_MD likely_RB be_VB more_RBR modest_JJ in_IN scope_NN ._. The_DT gradual_JJ lifting_NN of_IN lockdowns_NNS will_MD facilitate_VB the_DT collection_NN of_IN economic_JJ data_NNS ._. Our_PRP$ knowledge_NN of_IN the_DT virus_NN and_CC its_PRP$ spread_NN will_MD improve_VB ._. But_CC a_DT return_NN to_IN pre-virus_JJ levels_NNS of_IN economic_JJ uncertainty_NN will_MD have_VB to_TO wait_VB until_IN a_DT lasting_VBG solution_NN to_IN the_DT pandemic_NN —_: likely_JJ in_IN the_DT form_NN of_IN a_DT vaccine_NN —_: is_VBZ found_VBN ._. While_IN the_DT coronavirus_NN pandemic_NN poses_VBZ a_DT unique_JJ challenge_NN to_IN macroeconomic_JJ forecasters_NNS ,_, the_DT profession_NN has_VBZ faced_VBN similarly_RB profound_JJ shocks_NNS in_IN the_DT past_NN and_CC emerged_VBD fortified_VBN ._. The_DT global_JJ financial_JJ crisis_NN of_IN 2008_CD caught_VBD most_JJS economists_NNS napping_VBG ._. But_CC the_DT insights_NNS gained_VBN in_IN areas_NNS such_JJ as_IN the_DT economics_NNS of_IN financial_JJ contagion_NN and_CC the_DT impact_NN of_IN unconventional_JJ monetary_JJ measures_NNS have_VBP improved_VBN the_DT quality_NN of_IN today_NN ’s_POS forecasting_NN models_NNS ._. In_IN the_DT same_JJ way_NN ,_, Covid_NNP -_HYPH 19_CD will_MD shine_VB new_JJ light_NN on_IN areas_NNS such_JJ as_IN behavioral_JJ economics_NN —_: how_WRB consumer_NN spending_NN is_VBZ affected_VBN by_IN fear_NN of_IN contagion_NN for_IN instance_NN —_: and_CC the_DT economic_JJ effects_NNS of_IN radical_JJ fiscal_JJ policy_NN ._. The_DT knowledge_NN gained_VBN could_MD make_VB the_DT uncertainty_NN of_IN future_JJ economic_JJ crises_NNS ,_, whenever_WRB and_CC however_IN they_PRP come_VBP ,_, that_DT bit_NN less_RBR extreme_JJ ._.","Since the NNP - 19 NN VBD , there VBZ VBN a JJ and JJ NN in JJ NNS . For NN , in JJ NNP , the NN among JJ NN NNS for NNP in the NNP VBD 3.5 NN NNS VBG to NN NN . By NNP 29 , the RBS JJ NN among the 28 NNS in our JJ NN NN VBD the NNP NN VBG 8.2 NN . The RBS JJ VBD a JJ 65.0 NN NN — a NN of 56.8 NN NNS — with an NN of - 31.4 NN . There VBP three NNS for the NN : RB , the JJ NN and NN of NN NNS VBP RB VBN JJR . RB , the NN VBZ VBG the NN of JJ NNS . RB , JJ NNS VBP VBG to VB into the JJ NN of NN . The NN NN VBZ VBN JJ NN into RB every NN of NN . Will NN NN NNS VB up ? Will NNS VB a NN ? VBP JJ NNS JJ ? When can JJ NNS VB RB to the NN ? The NNS to these NNS — when there VBP NNS — VB to VB RB . And with each NN the NN NN ( and our NNS ) VBZ or VBZ . Since the NNP - 19 NN VBD , we VBP VBN JJ NN VBN in a JJ and JJ NN in JJ NNS . For NN , in JJ NNP , the NN among JJ NN NNS for NNP in the NNP VBD 3.5 NN NNS VBG to NN NN . By NNP 29 , the RBS JJ NN among the 28 NNS in our JJ NN NN VBD the NNP NN VBG 8.2 NN . The RBS JJ VBD a JJ 65.0 NN NN — a NN of 56.8 NN NNS — with an NN of - 31.4 NN . While JJS NNS VBD a NN in NNP , some VBD JJR NNS . And in NNP , although all NNS VBD NN of some NN , NNS VBD from a NN of +1.1 NN and a NN of +70.0 NN . The NNS VBD in JJ NNS VBP by RB the JJS VBN since we VBD VBG the NNP a NN RB . VBG at NNS with a JJR NN NN , the JJ NN NN among NNS VBZ RB JJR than at any NN during the JJ 20 NNS , and RB above that VBN during the NN of the JJ NN — the JJ NN of JJ , VBD JJ NN . For NN , during the 2008 JJ NN , both NNP and NNP VBD the NN for JJ NN NNS VBP to JJ to six NN NNS , before VBG to under three for JJS of the NNS . The NN NN NN VBZ RB RB RB seven NN NNS . Why RB JJ NN ? The JJ NN to why there VBZ RB JJ NN VBZ because no NN VBZ for JJ what VBZ VBG to VB . VBG RBR , three JJ NNS VBP VBG NNS JJ NNS . RB , the JJ NN and NN of NN NNS VBP RB VBN JJR . In JJ NNS , JJS NNS can VB VBN on to at JJS VB to VB JJ NN and VB NN . NN , RB , they VBP RB VBG NNS to VB NNS , and NN NNS VBP VBG JJ NN . RB VBG the NN NN of a JJ NN by a NN of NNS VBZ JJ NN NNS RB off - NN . RB , NNS which RB VBP NNS of JJ NN - NN VBP VBG VBN through NNS in NNS as NNS and JJ NNS VBP to VB to the JJ NN of the NN . JJ NNS VBP VBN NN NNS VBG them to VB by NN . What VBZ JJR , the JJ and JJ NN VBG VBN to VB the NN VBZ that VBN during the JJ NN . For JJ NNS , VBG up with the JJ NN of NNS and RB VBG them into NNS VBZ NNS . RB , the NN VBZ VBG the NN of JJ NNS — the NN of any JJ JJ NN . In JJ , NN - VBN NNS of NNS and NNS VBZ VBG as NN NNS VBP NN NNS , VBG NN NN . The NNP NNP of NNP NNP NNS for NNP , for NN , VBD NNS ’ and NNS ’ NN NNS VBP by nine and 10 NN NNS RB RB to their JJ NN . NNP NNP , JJ NN at NNP NNP NNP NNP , VBD the NN this NN : “ If you VBP VBG in NN NNS in a NN , you VBP JJ to VB an JJ NN , and RB RB NN . NN VBZ NNS to NNS . NNS , like NN NN NN , VBZ NN NNS , but NNS VBP VBN . What VBZ when you VBP NN that VBZ RB RB ? JJ NN VBZ JJ to VB VBN in NNS . JJ NN may VB JJR after the NNS VBP . It may RB VB RB VBN in JJ NNS . ” The JJ NN the NNS VBP VBG RB RB VBZ because JJ NNS VBP VBG to VB into the JJ NN of NN to RBR VB the JJ NN of the NN NN in each NN . RB , this VBZ a NN RB for NN NNS . VBG the NN and NN of JJ JJ NN NNS , or how NN NN NNS will VB under NN , VBZ JJ — RB for NNS at JJ NNS of their NNS . There VBZ no JJ NN for the NN of NN - VBG NNS or NNS , or NN over the NN or NN of a JJ NN of NNS . The NN in JJ NNS should VB RB VBG RB . JJR NN will VB on the NN of JJ NN , and any JJR JJ or JJ NNS will RB VB RBR JJ in NN . The JJ NN of NNS will VB the NN of JJ NNS . Our NN of the NN and its NN will VB . But a NN to JJ NNS of JJ NN will VB to VB until a VBG NN to the NN — JJ in the NN of a NN — VBZ VBN . While the NN NN VBZ a JJ NN to JJ NNS , the NN VBZ VBN RB JJ NNS in the NN and VBD VBN . The JJ JJ NN of 2008 VBD JJS NNS VBG . But the NNS VBN in NNS JJ as the NNS of JJ NN and the NN of JJ JJ NNS VBP VBN the NN of NN ’s NN NNS . In the JJ NN , NNP - 19 will VB JJ NN on NNS JJ as JJ NN — how NN NN VBZ VBN by NN of NN for NN — and the JJ NNS of JJ JJ NN . The NN VBN could VB the NN of JJ JJ NNS , whenever and however they VBP , that NN RBR JJ ."
106,390,mainstream,M0adf3,vaccine,"The_DT Vaccines_NNPS are_VBP set_VBN to_TO support_VB the_DT Arctic_NNP Monkeys_NNPS on_IN their_PRP$ November_NNP UK_NNP arena_NN tour_NN ,_, it_PRP has_VBZ been_VBN confirmed_VBN today_NN ._. The_DT London_NNP quartet_NN ,_, who_WP also_RB supported_VBD the_DT ‘_`` Suck_VB It_PRP And_CC See_VB ’_POS rockers_NNS on_IN their_PRP$ recent_JJ North_NNP American_JJ tour_NN and_CC huge_JJ outdoor_JJ show_NN at_IN Sheffield_NNP ‘s_POS Don_NNP Valley_NNP Bowl_NNP ,_, will_MD provide_VB support_NN on_IN all_DT nine_CD of_IN the_DT Arctic_NNP Monkeys_NNPS ‘_`` arena_NN dates_NNS ._. The_DT shows_NNS kick_VBP off_RP at_IN Nottingham_NNP ‘s_POS Capital_NNP FM_NNP Arena_NNP on_IN October_NNP 28_CD and_CC end_NN at_IN Liverpool_NNP ‘s_POS Echo_NNP Arena_NNP on_IN November_NNP 9_CD ._. Arctic_NNP Monkeys_NNPS ,_, with_IN support_NN from_IN The_DT Vaccines_NNPS ,_, will_MD play_VB :_: Tickets_NNS go_VBP on_IN sale_NN on_IN Friday_NNP (_-LRB- June_NNP 17_CD )_-RRB- at_IN 9_CD am_NN (_-LRB- BST_NNP )_-RRB- ._. To_TO check_VB the_DT availability_NN of_IN Arctic_NNP Monkeys_NNPS tickets_NNS and_CC get_VB all_PDT the_DT latest_JJS listings_NNS ,_, go_VB to_IN NME._NNP COM_NN /_, TICKETS_NNPS now_RB ,_, or_CC call_VB 0871_CD 230_CD 1094_CD ._.","The NNPS VBP VBN to VB the NNP NNPS on their NNP NNP NN NN , it VBZ VBN VBN NN . The NNP NN , who RB VBD the ‘ VB It And VB ’ NNS on their JJ NNP JJ NN and JJ JJ NN at NNP ‘s NNP NNP NNP , will VB NN on all nine of the NNP NNPS ‘ NN NNS . The NNS VBP off at NNP ‘s NNP NNP NNP on NNP 28 and NN at NNP ‘s NNP NNP on NNP 9 . NNP NNPS , with NN from The NNPS , will VB : NNS VBP on NN on NNP ( NNP 17 ) at 9 NN ( NNP ) . To VB the NN of NNP NNPS NNS and VB all the JJS NNS , VB to NNP NN / NNPS RB , or VB 0871 230 1094 ."
107,113,mainstream,M084a3,vaccine.covid,"‘_`` It_PRP ’s_VBZ going_VBG to_TO be_VB hard_JJ ._. ’_'' We_PRP ’re_VBP also_RB perilously_RB far_RB behind_RB ._. The_DT number_NN of_IN new_JJ cases_NNS appearing_VBG each_DT day_NN is_VBZ swinging_VBG wildly_RB ,_, from_IN 13,000_CD on_IN May_NNP 19_CD to_IN 24,000_CD the_DT next_JJ day_NN ,_, even_RB though_IN much_JJ of_IN the_DT country_NN remains_VBZ locked_VBN down_RP ._. And_CC those_DT are_VBP just_RB the_DT cases_NNS we_PRP know_VBP about_IN ._. Until_IN the_DT U.S._NNP does_VBZ a_DT far_RB better_JJR job_NN of_IN quickly_RB figuring_VBG out_RP who_WP is_VBZ infected_VBN ,_, it_PRP simply_RB wo_MD n’t_RB be_VB possible_JJ to_TO keep_VB up_RP with_IN tracing_NN ._. Marc_NNP Lipsitch_NNP ,_, director_NN of_IN the_DT Center_NNP for_IN Communicable_NNP Disease_NNP Dynamics_NNP at_IN Harvard_NNP University_NNP 's_POS School_NNP of_IN Public_NNP Health_NNP ,_, is_VBZ pessimistic_JJ ._. Even_RB if_IN 80_CD percent_NN of_IN the_DT country_NN managed_VBD to_TO trace_VB cases_NNS effectively_RB —_: “_`` which_WDT would_MD be_VB miraculous_JJ ,_, ”_'' he_PRP said_VBD —_: the_DT remaining_VBG 20_CD percent_NN would_MD be_VB a_DT constant_JJ source_NN of_IN new_JJ infections_NNS ._. New_JJ research_NN ,_, not_RB yet_RB peer_NN reviewed_VBN ,_, suggests_VBZ tracing_NN would_MD have_VB to_TO catch_VB at_IN least_JJS half_NN of_IN all_DT new_JJ cases_NNS to_TO reduce_VB transmission_NN even_RB 10_CD percent_NN ._. “_`` My_PRP$ view_NN is_VBZ it_PRP ’s_VBZ probably_RB not_RB going_VBG to_TO work_VB ,_, ”_'' Lipsitch_NNP said_VBD ._. “_`` But_CC given_VBN the_DT lack_NN of_IN alternatives_NNS ,_, we_PRP have_VBP to_TO try_VB —_: and_CC hopefully_RB demonstrate_VB that_IN I_PRP ’m_VBP wrong_JJ ._. ”_'' Tracing_NN techniques_NNS have_VBP been_VBN honed_VBN over_IN decades_NNS Technology_NN may_MD help_VB some_DT this_DT time_NN around_RB ._. Apple_NNP and_CC Google_NNP and_CC a_DT half_NN dozen_CD other_JJ companies_NNS are_VBP developing_VBG cellphone_NN applications_NNS that_WDT use_VBP GPS_NN or_CC Bluetooth_NN technology_NN ._. These_DT apps_NNS can_MD alert_VB users_NNS that_IN they_PRP were_VBD recently_RB near_IN an_DT infectious_JJ person_NN or_CC allow_VB them_PRP to_TO retrace_VB their_PRP$ steps_NNS to_TO see_VB if_IN they_PRP crossed_VBD paths_NNS with_IN a_DT carrier_NN ._. But_CC most_JJS experts_NNS insist_VBP technology_NN will_MD merely_RB support_VB ,_, not_RB supplant_VB ,_, human_JJ tracing_NN ._. And_CC it_PRP may_MD never_RB be_VB as_RB effective_JJ in_IN the_DT U.S._NNP as_IN it_PRP has_VBZ been_VBN in_IN other_JJ countries_NNS ._. For_IN starters_NNS ,_, tech_NN solutions_NNS are_VBP valuable_JJ only_RB if_IN widely_RB adopted_VBN ,_, and_CC polls_NNS show_VBP Americans_NNPS are_VBP skeptical_JJ and_CC worry_VBP that_IN apps_NNS could_MD infringe_VB on_IN data_NN privacy_NN ._. The_DT U.S._NNP also_RB has_VBZ so_RB many_JJ cases_NNS that_IN it_PRP ca_MD n’t_RB rely_VB on_IN weak_JJ crowdsourcing_NN with_IN limited_JJ penetration_NN to_TO find_VB them_PRP all_DT ._. Meanwhile_RB ,_, in_IN much_JJ of_IN Asia_NNP ,_, previous_JJ viral_JJ outbreaks_NNS bred_VBD enough_JJ comfort_NN and_CC respect_NN for_IN tracing_NN that_IN there_EX is_VBZ less_JJR need_NN for_IN the_DT handholding_NN provided_VBN by_IN human_JJ tracers_NNS ._. In_IN a_DT few_JJ countries_NNS ,_, notably_RB China_NNP ,_, authoritarian_JJ governments_NNS also_RB leave_VBP citizens_NNS little_JJ choice_NN but_IN to_TO participate_VB ._.","‘ It VBZ VBG to VB JJ . ’ We VBP RB RB RB RB . The NN of JJ NNS VBG each NN VBZ VBG RB , from 13,000 on NNP 19 to 24,000 the JJ NN , RB though JJ of the NN VBZ VBN down . And those VBP RB the NNS we VBP about . Until the NNP VBZ a RB JJR NN of RB VBG out who VBZ VBN , it RB wo RB VB JJ to VB up with NN . NNP NNP , NN of the NNP for NNP NNP NNP at NNP NNP 's NNP of NNP NNP , VBZ JJ . RB if 80 NN of the NN VBD to VB NNS RB — “ which would VB JJ , ” he VBD — the VBG 20 NN would VB a JJ NN of JJ NNS . JJ NN , RB RB NN VBN , VBZ NN would VB to VB at JJS NN of all JJ NNS to VB NN RB 10 NN . “ My NN VBZ it VBZ RB RB VBG to VB , ” NNP VBD . “ But VBN the NN of NNS , we VBP to VB — and RB VB that I VBP JJ . ” NN NNS VBP VBN VBN over NNS NN may VB some this NN RB . NNP and NNP and a NN dozen JJ NNS VBP VBG NN NNS that VBP NN or NN NN . These NNS can VB NNS that they VBD RB near an JJ NN or VB them to VB their NNS to VB if they VBD NNS with a NN . But JJS NNS VBP NN will RB VB , RB VB , JJ NN . And it may RB VB RB JJ in the NNP as it VBZ VBN in JJ NNS . For NNS , NN NNS VBP JJ RB if RB VBN , and NNS VBP NNPS VBP JJ and VBP that NNS could VB on NN NN . The NNP RB VBZ RB JJ NNS that it ca RB VB on JJ NN with JJ NN to VB them all . RB , in JJ of NNP , JJ JJ NNS VBD JJ NN and NN for NN that there VBZ JJR NN for the NN VBN by JJ NNS . In a JJ NNS , RB NNP , JJ NNS RB VBP NNS JJ NN but to VB ."
108,594,mainstream,M0afd7,vaccine; vaccine.covid,"Get_VB breaking_VBG news_NN alerts_NNS and_CC special_JJ reports_NNS ._. The_DT news_NN and_CC stories_NNS that_WDT matter_VBP ,_, delivered_VBD weekday_NN mornings_NNS ._. An_DT experimental_JJ coronavirus_NN vaccine_NN from_IN Oxford_NNP University_NNP appears_VBZ to_TO be_VB effective_JJ at_IN preventing_VBG COVID_NN -_HYPH 19_CD ,_, according_VBG to_IN findings_NNS from_IN a_DT small_JJ study_NN in_IN six_CD monkeys_NNS ._. Oxford_NNP scientists_NNS posted_VBD the_DT preliminary_JJ findings_NNS on_IN the_DT vaccine_NN on_IN the_DT preprint_NN server_NN bioRxiv_NN early_JJ Thursday_NNP ._. Preprints_NNS are_VBP studies_NNS that_WDT have_VBP not_RB undergone_VBN a_DT rigorous_JJ peer_NN -_HYPH review_NN process_NN required_VBN for_IN publication_NN in_IN medical_JJ or_CC scientific_JJ journals_NNS ._. But_CC many_JJ scientists_NNS have_VBP been_VBN releasing_VBG results_NNS to_IN the_DT public_NN in_IN the_DT form_NN of_IN preprints_NNS because_IN of_IN the_DT high_JJ level_NN of_IN interest_NN surrounding_VBG potential_JJ treatments_NNS and_CC vaccines_NNS for_IN COVID_NN -_HYPH 19_CD ,_, the_DT disease_NN caused_VBN by_IN the_DT coronavirus_NN ._. The_DT new_JJ report_NN from_IN Oxford_NNP University_NNP is_VBZ based_VBN on_IN the_DT vaccination_NN of_IN six_CD rhesus_NN macaques_NNS ._. These_DT monkeys_NNS are_VBP considered_VBN to_TO be_VB good_JJ proxies_NNS for_IN how_WRB drugs_NNS could_MD work_VB in_IN people_NNS because_IN they_PRP share_VBP a_DT majority_NN of_IN their_PRP$ genes_NNS with_IN humans_NNS ._. The_DT animals_NNS were_VBD given_VBN half_NN of_IN the_DT dose_NN currently_RB being_VBG tested_VBN in_IN human_JJ ._. Those_DT trials_NNS began_VBD on_IN April_NNP 24_CD and_CC include_VBP about_RB 1,110_CD people_NNS ._. Researchers_NNS reported_VBD at_IN least_JJS some_DT of_IN the_DT monkeys_NNS developed_VBD antibodies_NNS to_IN the_DT virus_NN within_IN 14_CD days_NNS of_IN being_VBG vaccinated_VBN ,_, and_CC all_DT of_IN the_DT vaccinated_VBN animals_NNS had_VBD evidence_NN of_IN antibodies_NNS within_IN 28_CD days_NNS ._. Download_VB the_DT NBC_NNP News_NNP app_NN for_IN full_JJ coverage_NN of_IN the_DT coronavirus_NN outbreak_NN What_WP 's_VBZ more_RBR ,_, researchers_NNS said_VBD the_DT vaccine_NN appears_VBZ to_TO have_VB prevented_VBN pneumonia_NN and_CC other_JJ lung_NN problems_NNS in_IN the_DT animals_NNS after_IN they_PRP were_VBD exposed_VBN to_IN the_DT coronavirus_NN ._. Still_RB ,_, there_EX is_VBZ no_DT guarantee_NN the_DT Oxford_NNP vaccine_NN will_MD ultimately_RB prove_VB to_TO be_VB successful_JJ ._. Studies_NNS in_IN humans_NNS are_VBP ongoing_JJ ,_, and_CC this_DT research_NN team_NN is_VBZ one_CD of_IN several_JJ around_IN the_DT globe_NN working_VBG at_IN an_DT accelerated_VBN pace_NN to_TO find_VB a_DT safe_JJ and_CC effective_JJ vaccine_NN for_IN the_DT coronavirus_NN ._. But_CC so_RB far_RB ,_, the_DT Oxford_NNP vaccine_NN appears_VBZ to_TO hold_VB the_DT most_JJS promise_NN of_IN becoming_VBG the_DT first_JJ vaccine_NN to_TO be_VB widely_RB accessible_JJ ,_, if_IN proven_VBN to_TO work_VB ._. Oxford_NNP scientists_NNS previously_RB said_VBD they_PRP hope_VBP to_TO have_VB enough_JJ data_NNS to_TO show_VB the_DT vaccine_NN is_VBZ effective_JJ by_IN the_DT beginning_NN of_IN June_NNP ,_, and_CC predicted_VBD the_DT vaccine_NN could_MD be_VB produced_VBN by_IN September_NNP ._.","VB VBG NN NNS and JJ NNS . The NN and NNS that VBP , VBD NN NNS . An JJ NN NN from NNP NNP VBZ to VB JJ at VBG NN - 19 , VBG to NNS from a JJ NN in six NNS . NNP NNS VBD the JJ NNS on the NN on the NN NN NN JJ NNP . NNS VBP NNS that VBP RB VBN a JJ NN - NN NN VBN for NN in JJ or JJ NNS . But JJ NNS VBP VBN VBG NNS to the NN in the NN of NNS because of the JJ NN of NN VBG JJ NNS and NNS for NN - 19 , the NN VBN by the NN . The JJ NN from NNP NNP VBZ VBN on the NN of six NN NNS . These NNS VBP VBN to VB JJ NNS for how NNS could VB in NNS because they VBP a NN of their NNS with NNS . The NNS VBD VBN NN of the NN RB VBG VBN in JJ . Those NNS VBD on NNP 24 and VBP RB 1,110 NNS . NNS VBD at JJS some of the NNS VBD NNS to the NN within 14 NNS of VBG VBN , and all of the VBN NNS VBD NN of NNS within 28 NNS . VB the NNP NNP NN for JJ NN of the NN NN What VBZ RBR , NNS VBD the NN VBZ to VB VBN NN and JJ NN NNS in the NNS after they VBD VBN to the NN . RB , there VBZ no NN the NNP NN will RB VB to VB JJ . NNS in NNS VBP JJ , and this NN NN VBZ one of JJ around the NN VBG at an VBN NN to VB a JJ and JJ NN for the NN . But RB RB , the NNP NN VBZ to VB the JJS NN of VBG the JJ NN to VB RB JJ , if VBN to VB . NNP NNS RB VBD they VBP to VB JJ NNS to VB the NN VBZ JJ by the NN of NNP , and VBD the NN could VB VBN by NNP ."
109,861,mainstream,M0a887,bill.gates; vaccine,"Posts_NNS on_IN social_JJ media_NN claim_VBP Bill_NNP Gates_NNP is_VBZ facing_VBG a_DT trial_NN in_IN India_NNP for_IN allegedly_RB testing_VBG vaccines_NNS on_IN children_NNS illegally_RB ._. This_DT is_VBZ misleading_JJ ._. Some_DT iterations_NNS of_IN the_DT claim_NN ,_, titled_VBN “_`` Bill_NNP Gates_NNP Faces_NNPS Trial_NNP in_IN India_NNP for_IN Illegally_RB Testing_NNP Tribal_NNP Children_NNPS with_IN Vaccines_NNPS ”_'' ,_, can_MD be_VB seen_VBN here_RB and_CC here_RB ._. A_DT spokesperson_NN for_IN the_DT Gates_NNP Foundation_NNP confirmed_VBD to_IN Reuters_NNP via_IN email_NN that_IN the_DT allegations_NNS in_IN the_DT claim_NN are_VBP false_JJ ._. There_EX is_VBZ no_DT pending_VBG lawsuit_NN against_IN Gates_NNPS or_CC his_PRP$ foundation_NN in_IN relation_NN to_IN this_DT ._. The_DT vaccine_NN trial_NN in_IN question_NN was_VBD not_RB illegal_JJ ,_, though_IN it_PRP was_VBD later_RB halted_VBN and_CC has_VBZ been_VBN the_DT source_NN of_IN controversy_NN in_IN India_NNP ._. The_DT claims_NNS refer_VBP to_IN a_DT Human_NNP Papilloma_NNP Virus_NNP (_-LRB- HPV_NNP )_-RRB- vaccine_NN study_NN conducted_VBN by_IN the_DT U.S._NNP non-profit_JJ organization_NN Program_NNP for_IN Appropriate_NNP Technology_NNP in_IN Health_NNP (_-LRB- PATH_NNP )_-RRB- ._. The_DT study_NN ,_, which_WDT was_VBD financed_VBN by_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, was_VBD cancelled_VBN in_IN 2010_CD after_IN local_JJ media_NN reported_VBD the_DT death_NN of_IN seven_CD girls_NNS taking_VBG part_NN (_-LRB- here_RB ,_, here_RB )_-RRB- ._. The_DT study_NN was_VBD cancelled_VBN in_IN 2010_CD following_VBG local_JJ media_NN reports_NNS highlighting_VBG the_DT death_NN of_IN seven_CD girls_NNS taking_VBG part_NN ._. Science_NNP Magazine_NNP reported_VBD that_IN investigations_NNS carried_VBN out_RP by_IN a_DT committee_NN designated_VBN by_IN the_DT Indian_JJ Government_NN later_RBR determined_VBD the_DT deaths_NNS were_VBD unrelated_JJ to_IN the_DT vaccine_NN demonstration_NN :_: “_`` Five_CD were_VBD evidently_RB unrelated_JJ to_IN the_DT vaccine_NN :_: One_CD girl_NN drowned_VBD in_IN a_DT quarry_NN ;_, another_DT died_VBD from_IN a_DT snake_NN bite_NN ;_, two_CD committed_VBD suicide_NN by_IN ingesting_VBG pesticides_NNS ;_, and_CC one_CD died_VBD from_IN complications_NNS of_IN malaria_NN ._. The_DT causes_NNS of_IN death_NN for_IN the_DT other_JJ two_CD girls_NNS were_VBD less_RBR certain_JJ :_: one_CD possibly_RB from_IN pyrexia_NN ,_, or_CC high_JJ fever_NN ,_, and_CC a_DT second_NN from_IN a_DT suspected_VBN cerebral_JJ hemorrhage_NN ._. ”_'' (_-LRB- here_RB )_-RRB- On_IN August_NNP 29_CD ,_, 2013_CD the_DT Indian_JJ Parliament_NNP ’s_POS Standing_NNP Committee_NNP on_IN Health_NNP and_CC Family_NNP Welfare_NNP reported_VBD the_DT vaccination_NN trial_NN by_IN PATH_NNP committed_VBD several_JJ irregularities_NNS ,_, including_VBG a_DT “_`` gross_JJ violation_NN of_IN the_DT consent_NN and_CC legal_JJ requirement_NN of_IN consent_NN ”_'' (_-LRB- see_VB page_NN 14_CD here_RB )_-RRB- ._. After_IN the_DT report_NN was_VBD released_VBN ,_, PATH_NNP said_VBD they_PRP “_`` strongly_RB disagree_VBP with_IN the_DT findings_NNS ,_, conclusions_NNS ,_, and_CC tone_NN of_IN the_DT released_VBN report_NN and_CC its_PRP$ disregard_NN of_IN the_DT evidence_NN and_CC facts_NNS ._. ”_'' (_-LRB- here_RB )_-RRB- According_VBG to_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP ’s_POS website_NN ,_, they_PRP have_VBP been_VBN working_VBG in_IN India_NNP for_IN over_IN a_DT decade_NN ,_, with_IN a_DT focus_NN on_IN the_DT country_NN ’s_POS most_RBS vulnerable_JJ communities_NNS (_-LRB- here_RB )_-RRB- ._. As_IN of_IN May_NNP 18_CD ,_, 2020_CD the_DT Foundation_NNP faces_VBZ no_DT charges_NNS in_IN India_NNP and_CC continues_VBZ to_TO work_VB in_IN the_DT country_NN ._. False_JJ ._. Bill_NNP Gates_NNP is_VBZ not_RB facing_VBG trial_NN in_IN India_NNP for_IN an_DT illegal_JJ vaccination_NN study_NN ._. This_DT article_NN was_VBD produced_VBN by_IN the_DT Reuters_NNP Fact_NNP Check_NNP team_NN ._. Read_VB more_JJR about_IN our_PRP$ work_NN to_IN fact_NN -_HYPH check_VB social_JJ media_NN posts_NNS here_RB ._.","NNS on JJ NN VBP NNP NNP VBZ VBG a NN in NNP for RB VBG NNS on NNS RB . This VBZ JJ . Some NNS of the NN , VBN “ NNP NNP NNPS NNP in NNP for RB NNP NNP NNPS with NNPS ” , can VB VBN RB and RB . A NN for the NNP NNP VBD to NNP via NN that the NNS in the NN VBP JJ . There VBZ no VBG NN against NNPS or his NN in NN to this . The NN NN in NN VBD RB JJ , though it VBD RB VBN and VBZ VBN the NN of NN in NNP . The NNS VBP to a NNP NNP NNP ( NNP ) NN NN VBN by the NNP JJ NN NNP for NNP NNP in NNP ( NNP ) . The NN , which VBD VBN by the NNP & NNP NNP NNP , VBD VBN in 2010 after JJ NN VBD the NN of seven NNS VBG NN ( RB , RB ) . The NN VBD VBN in 2010 VBG JJ NN NNS VBG the NN of seven NNS VBG NN . NNP NNP VBD that NNS VBN out by a NN VBN by the JJ NN RBR VBD the NNS VBD JJ to the NN NN : “ Five VBD RB JJ to the NN : One NN VBD in a NN ; another VBD from a NN NN ; two VBD NN by VBG NNS ; and one VBD from NNS of NN . The NNS of NN for the JJ two NNS VBD RBR JJ : one RB from NN , or JJ NN , and a NN from a VBN JJ NN . ” ( RB ) On NNP 29 , 2013 the JJ NNP ’s NNP NNP on NNP and NNP NNP VBD the NN NN by NNP VBD JJ NNS , VBG a “ JJ NN of the NN and JJ NN of NN ” ( VB NN 14 RB ) . After the NN VBD VBN , NNP VBD they “ RB VBP with the NNS , NNS , and NN of the VBN NN and its NN of the NN and NNS . ” ( RB ) VBG to the NNP & NNP NNP NNP ’s NN , they VBP VBN VBG in NNP for over a NN , with a NN on the NN ’s RBS JJ NNS ( RB ) . As of NNP 18 , 2020 the NNP VBZ no NNS in NNP and VBZ to VB in the NN . JJ . NNP NNP VBZ RB VBG NN in NNP for an JJ NN NN . This NN VBD VBN by the NNP NNP NNP NN . VB JJR about our NN to NN - VB JJ NN NNS RB ."
110,843,mainstream,M07e78,vaccine.covid,"hen_UH Chloe_NNP Fu_NNP ,_, 24_CD ,_, went_VBD for_IN a_DT run_NN on_IN Monday_NNP evening_NN ,_, the_DT streets_NNS of_IN Stockholm_NNP were_VBD filled_VBN with_IN people_NNS drinking_VBG on_IN restaurant_NN patios_NNS ,_, enjoying_VBG the_DT first_JJ warm_JJ day_NN of_IN sunshine_NN after_IN a_DT long_JJ winter_NN ._. “_`` When_WRB you_PRP walk_VBP around_RB ,_, there_EX is_VBZ a_DT total_JJ and_CC utter_JJ absence_NN of_IN panic_NN ,_, ”_'' Fu_NNP says_VBZ ,_, who_WP moved_VBD to_IN Sweden_NNP from_IN the_DT United_NNP States_NNPS last_JJ year_NN ._. “_`` The_DT streets_NNS are_VBP just_RB as_RB busy_JJ as_IN they_PRP would_MD have_VB been_VBN last_JJ spring_NN ._. ”_'' As_IN many_JJ public_JJ spaces_NNS throughout_IN Europe_NNP empty_JJ out_RP —_: with_IN citizens_NNS only_RB leaving_VBG home_NN for_IN essential_JJ groceries_NNS or_CC medication_NN —_: life_NN in_IN Sweden_NNP is_VBZ carrying_VBG on_RP ,_, mostly_RB as_IN usual_JJ ._. Children_NNS walk_VBP to_IN school_NN while_IN adults_NNS meet_VBP up_RP for_IN dinner_NN at_IN their_PRP$ local_JJ bar_NN ._. Only_RB the_DT vulnerable_JJ have_VBP been_VBN advised_VBN to_TO isolate_VB and_CC some_DT are_VBP working_VBG from_IN home_NN ._. Yet_CC in_IN Sweden_NNP ,_, where_WRB there_EX are_VBP 9,141_CD confirmed_VBN cases_NNS and_CC 793_CD people_NNS have_VBP died_VBN ,_, experts_NNS worry_VBP weaker_JJR measures_NNS may_MD be_VB leading_VBG to_IN a_DT more_RBR severe_JJ outbreak_NN in_IN the_DT country_NN of_IN just_RB 10_CD million_CD citizens_NNS ._. Sweden_NNP has_VBZ a_DT relatively_RB high_JJ case_NN fatality_NN rate_NN :_: as_IN of_IN April_NNP 8_CD ,_, 7.68_CD %_NN of_IN the_DT Swedes_NNPS who_WP have_VBP tested_VBN positive_JJ for_IN COVID_NNP -_HYPH 19_CD have_VBP died_VBN of_IN the_DT virus_NN ._. Neighboring_VBG countries_NNS ,_, like_IN Norway_NNP and_CC Denmark_NNP ,_, have_VBP case_NN fatality_NN rates_NNS of_IN 1.46_CD %_NN and_CC 3.85_CD %_NN respectively_RB ._. (_-LRB- The_DT U.S._NNP case_NN fatality_NN rate_NN is_VBZ 3.21_CD %_NN ._. )_-RRB- While_IN Sweden_NNP ’s_POS elevated_VBN case_NN fatality_NN rate_NN could_MD be_VB a_DT result_NN of_IN its_PRP$ low_JJ testing_NN rates_NNS compared_VBN to_IN its_PRP$ neighbors_NNS ,_, experts_NNS say_VBP Sweden_NNP ’s_POS laissez_NN -_HYPH faire_NN approach_NN could_MD also_RB be_VB to_TO blame_VB ._. The_DT Swedish_JJ government_NN continues_VBZ to_TO advocate_VB for_IN relaxed_VBN measures_NNS ._. The_DT Swedish_NNP Public_NNP Health_NNP Agency_NNP cautions_VBZ citizens_NNS to_TO cover_VB their_PRP$ mouths_NNS when_WRB they_PRP cough_VBP or_CC sneeze_VB and_CC wash_VBP hands_NNS regularly_RB but_CC does_VBZ not_RB call_VB for_IN lockdown_NN measures_NNS ._. On_IN March_NNP 11_CD ,_, the_DT government_NN cut_VBD down_RP the_DT size_NN of_IN permitted_VBN gatherings_NNS to_IN 500_CD ,_, and_CC only_RB lowered_VBD that_DT down_RB to_IN 50_CD on_IN March_NNP 29_CD ._. Other_JJ countries_NNS ,_, like_IN Germany_NNP and_CC Australia_NNP ,_, have_VBP prohibited_VBN gathering_VBG in_IN groups_NNS larger_JJR than_IN two_CD ._. On_IN Monday_NNP ,_, Sweden_NNP declared_VBD that_IN domestic_JJ flights_NNS would_MD continue_VB running_VBG ,_, despite_IN the_DT risks_NNS domestic_JJ travel_NN poses_NNS for_IN spreading_VBG the_DT disease_NN ._. Anders_NNP Tegnell_NNP ,_, Sweden_NNP ’s_POS chief_JJ epidemiologist_NN overseeing_VBG the_DT government_NN ’s_POS response_NN to_IN COVID_NNP -_HYPH 19_CD has_VBZ said_VBN the_DT government_NN should_MD allow_VB the_DT virus_NN to_TO spread_VB slowly_RB through_IN the_DT population_NN ,_, an_DT approach_NN initially_RB employed_VBN by_IN the_DT United_NNP Kingdom_NNP and_CC the_DT Netherlands_NNPS before_IN both_DT countries_NNS rapidly_RB changed_VBD strategy_NN amid_IN mounting_VBG evidence_NN that_IN this_DT approach_NN would_MD still_RB overburden_VB health_NN care_NN systems_NNS ._. Tegnell_NNP told_VBD Swedish_JJ TV_NN on_IN April_NNP 5_CD that_IN COVID_NNP -_HYPH 19_CD could_MD be_VB stopped_VBN by_IN “_`` herd_NN immunity_NN or_CC a_DT combination_NN of_IN immunity_NN and_CC vaccination_NN ._. ”_'' (_-LRB- A_DT vaccine_NN for_IN COVID_NNP -_HYPH 19_CD is_VBZ likely_JJ at_IN least_JJS 14_CD months_NNS away_RB ._. )_-RRB- But_CC many_JJ experts_NNS throughout_IN Sweden_NNP say_VBP the_DT current_JJ strategy_NN is_VBZ dangerous_JJ ._. “_`` Herd_NN immunity_NN does_VBZ n’t_RB make_VB sense_NN because_IN we_PRP do_VBP n’t_RB know_VB whether_IN or_CC not_RB you_PRP can_MD become_VB immune_NN ,_, ”_'' says_VBZ Nele_NNP Brusselaers_NNP ,_, an_DT associate_NN professor_NN of_IN clinical_JJ epidemiology_NN ._. She_PRP added_VBD ,_, “_`` this_DT is_VBZ a_DT virus_NN that_WDT can_MD kill_VB anybody_NN ._. ”_'' Keep_VB up_RP to_IN date_NN with_IN our_PRP$ daily_JJ coronavirus_NN newsletter_NN by_IN clicking_VBG here_RB ._. At_IN the_DT end_NN of_IN March_NNP ,_, 2,300_CD doctors_NNS ,_, scientists_NNS and_CC academics_NNS signed_VBD an_DT open_JJ letter_NN to_IN the_DT government_NN calling_VBG for_IN stricter_JJR measures_NNS ._. “_`` We_PRP think_VBP there_EX is_VBZ no_DT scientific_JJ evidence_NN for_IN their_PRP$ strategy_NN ,_, ”_'' says_VBZ Cecilia_NNP Söderberg_NNP -_HYPH Nauclér_NNP ,_, an_DT expert_NN in_IN microbial_JJ pathogenesis_NN who_WP signed_VBD the_DT letter_NN ._. She_PRP says_VBZ the_DT government_NN has_VBZ been_VBN reluctant_JJ to_TO share_VB its_PRP$ data_NNS with_IN scientists_NNS ,_, leading_VBG her_PRP to_TO believe_VB that_IN the_DT government_NN ’s_POS strategy_NN is_VBZ “_`` not_RB based_VBN on_IN evidence_NN ._. ”_'' Carina_NNP King_NNP ,_, an_DT infectious_JJ diseases_NNS epidemiologist_NN ,_, agrees_VBZ that_IN the_DT government_NN ’s_POS lack_NN of_IN transparency_NN makes_VBZ it_PRP “_`` really_RB hard_JJ to_TO give_VB proper_JJ scientific_JJ thoughts_NNS on_IN their_PRP$ approach_NN because_IN they_PRP have_VBP n’t_RB released_VBN their_PRP$ science_NN ._. ”_'' She_PRP added_VBD that_IN the_DT government_NN has_VBZ made_VBN no_DT concrete_JJ efforts_NNS to_TO test_VB ,_, contact_VB trace_NN and_CC quarantine_NN —_: as_IN South_NNP Korea_NNP did_VBD —_: which_WDT is_VBZ standard_JJ protocol_NN to_TO stop_VB localized_VBN spread_NN at_IN the_DT beginning_NN of_IN an_DT outbreak_NN ._. Nevertheless_RB ,_, she_PRP says_VBZ Sweden_NNP could_MD be_VB a_DT rare_JJ case_NN where_WRB a_DT nationwide_JJ lockdown_NN may_MD not_RB be_VB necessary_JJ ._. “_`` Sweden_NNP is_VBZ unique_JJ ,_, ”_'' she_PRP says_VBZ ._. “_`` It_PRP does_VBZ n’t_RB have_VB many_JJ intergenerational_JJ households_NNS ._. It_PRP is_VBZ a_DT country_NN where_WRB you_PRP could_MD have_VB a_DT mixed_VBN approach_NN ._. ”_'' Though_IN interpersonal_JJ distance_NN is_VBZ valued_VBN in_IN Swedish_JJ culture_NN and_CC 40_CD %_NN of_IN Swedish_JJ households_NNS are_VBP single_JJ -_HYPH person_NN households_NNS without_IN children_NNS ,_, other_JJ experts_NNS say_VBP that_IN COVID_NNP -_HYPH 19_CD can_MD still_RB spread_VB rapidly_RB and_CC widely_RB in_IN these_DT conditions_NNS ._. Sweden_NNP has_VBZ the_DT second_RB lowest_JJS number_NN of_IN critical_JJ care_NN beds_NNS in_IN Europe_NNP after_IN Portugal_NNP ,_, with_IN only_RB 5_CD beds_NNS for_IN every_DT 100,000_CD inhabitants_NNS ._. The_DT healthcare_NN system_NN would_MD likely_RB be_VB unable_JJ to_TO handle_VB a_DT severe_JJ COVID_NN -_HYPH 19_CD outbreak_NN ._. Currently_RB ,_, experts_NNS say_VBP the_DT Swedish_JJ government_NN is_VBZ not_RB following_VBG the_DT World_NNP Health_NNP Organization_NNP ’s_POS (_-LRB- WHO_NNP )_-RRB- guidelines_NNS ,_, which_WDT advise_VBP countries_NNS with_IN COVID_NN -_HYPH 19_CD outbreaks_NNS to_TO contact_VB trace_NN where_WRB possible_JJ and_CC to_TO adopt_VB strict_JJ self_NN -_HYPH isolation_NN measures_NNS ._. “_`` I_PRP ’m_VBP surprised_JJ and_CC frustrated_JJ that_IN they_PRP still_RB have_VBP not_RB taken_VBN any_DT action_NN or_CC listened_VBN to_IN the_DT advice_NN of_IN organizations_NNS like_IN WHO_NNP ,_, ”_'' says_VBZ Brusselaers_NNPS ._. “_`` They_PRP disregard_VBP any_DT prediction_NN model_NN that_WDT has_VBZ been_VBN published_VBN by_IN experts_NNS in_IN the_DT field_NN and_CC they_PRP do_VBP n’t_RB even_RB give_VB a_DT defense_NN ._. ”_'' A_DT head_NN doctor_NN at_IN a_DT major_JJ hospital_NN in_IN Sweden_NNP says_VBZ the_DT current_JJ approach_NN will_MD “_`` probably_RB end_VB in_IN a_DT historical_JJ massacre_NN ._. ”_'' He_PRP says_VBZ healthcare_NN workers_NNS at_IN his_PRP$ hospital_NN who_WP have_VBP tested_VBN positive_JJ for_IN the_DT virus_NN but_CC are_VBP asymptomatic_JJ have_VBP been_VBN advised_VBN to_TO continue_VB working_VBG ._. He_PRP asked_VBD to_TO remain_VB anonymous_JJ because_IN “_`` it_PRP is_VBZ frowned_VBN upon_IN to_TO speak_VB of_IN the_DT epidemic_NN or_CC to_TO go_VB against_IN the_DT official_JJ vision_NN ”_'' but_CC said_VBD he_PRP felt_VBD a_DT need_NN to_TO speak_VB out_RP from_IN an_DT “_`` ethical_JJ and_CC medical_JJ point_NN of_IN view_NN ._. ”_'' The_DT Swedish_JJ legislature_NN will_MD meet_VB this_DT week_NN to_TO discuss_VB whether_IN tougher_JJR measures_NNS restricting_VBG business_NN and_CC travel_NN should_MD be_VB implemented_VBN ._. Söderberg_NNP -_HYPH Nauclér_NNP says_VBZ it_PRP ’s_VBZ already_RB too_RB late_JJ to_TO prevent_VB chaos_NN in_IN Stockholm_NNP but_CC that_IN preventative_JJ lockdown_NN measures_NNS could_MD still_RB be_VB taken_VBN throughout_IN other_JJ parts_NNS of_IN the_DT country_NN ._. “_`` If_IN they_PRP are_VBP right_JJ and_CC we_PRP are_VBP wrong_JJ ,_, I_PRP will_MD open_VB a_DT bottle_NN of_IN champagne_NN ,_, ”_'' Söderberg_NNP -_HYPH Nauclér_NNP says_VBZ ._. She_PRP notes_VBZ that_IN ,_, based_VBN on_IN the_DT modeling_NN she_PRP ’s_VBZ seen_VBN ,_, the_DT healthcare_NN system_NN in_IN Sweden_NNP will_MD collapse_VB if_IN stricter_JJR measures_NNS are_VBP not_RB adopted_VBN immediately_RB ._. “_`` But_CC I_PRP will_MD not_RB give_VB up_RP the_DT fight_NN until_IN the_DT government_NN shows_VBZ us_PRP evidence_NN for_IN their_PRP$ strategy_NN ._. ”_'' While_IN experts_NNS may_MD be_VB taking_VBG issue_NN with_IN the_DT government_NN ’s_POS approach_NN ,_, many_JJ Swedes_NNPS seem_VBP to_TO be_VB in_IN favor_NN of_IN it_PRP ._. Opinion_NN polls_NNS show_VBP that_IN citizens_NNS trust_VBP the_DT Public_NNP Health_NNP Authority_NNP ,_, with_IN 48_CD %_NN saying_VBG they_PRP have_VBP very_RB high_JJ or_CC high_JJ confidence_NN in_IN the_DT institution_NN ._. “_`` It_PRP ’s_VBZ rare_JJ for_IN Swedish_JJ society_NN to_TO loudly_RB disapprove_VB of_IN the_DT government_NN ,_, ”_'' says_VBZ Fu_NNP ._. “_'' Even_RB though_IN people_NNS are_VBP concerned_VBN about_IN losing_VBG loved_VBN ones_NNS ,_, they_PRP also_RB trust_VBP that_IN the_DT government_NN is_VBZ doing_VBG the_DT right_JJ thing_NN ._. ”_'' And_CC Swedes_NNPS have_VBP above_IN -_HYPH average_JJ confidence_NN in_IN their_PRP$ politicians_NNS ,_, who_WP in_IN turn_NN ,_, trust_VBP citizens_NNS to_TO follow_VB their_PRP$ advice_NN ._. “_`` In_IN Sweden_NNP ,_, the_DT approach_NN has_VBZ always_RB been_VBN to_TO make_VB suggestions_NNS and_CC let_VB the_DT public_NN decide_VB ,_, ”_'' says_VBZ Johan_NNP Erik_NNP Lallerstedt_NNP ,_, a_DT 23_CD -_HYPH year_NN -_HYPH old_JJ filmmaker_NN living_VBG in_IN Stockholm_NNP ._. “_`` Whatever_WDT guidelines_NNS the_DT government_NN may_MD give_VB are_VBP just_RB that_DT :_: suggestions_NNS ._. Nothing_NN is_VBZ enforced_VBN ._. ”_'' But_CC Söderberg_NNP -_HYPH Nauclér_NNP believes_VBZ this_DT outbreak_NN could_MD bring_VB an_DT end_NN to_IN a_DT long_JJ history_NN of_IN public_JJ trust_NN in_IN government_NN ._. “_`` If_IN you_PRP put_VBP people_NNS ’s_POS lives_NNS at_IN risk_NN in_IN democratic_JJ society_NN and_CC then_RB you_PRP do_VBP not_RB help_VB them_PRP ,_, how_WRB will_MD society_NN trust_VB politicians_NNS ?_. ”_'' she_PRP says_VBZ ._. “_`` I_PRP do_VBP n’t_RB want_VB to_TO live_VB in_IN a_DT society_NN that_WDT treats_VBZ people_NNS like_IN this_DT ._. ”_'' Please_UH send_VB any_DT tips_NNS ,_, leads_NNS ,_, and_CC stories_NNS to_IN virus@time.com_ADD ._.","hen NNP NNP , 24 , VBD for a NN on NNP NN , the NNS of NNP VBD VBN with NNS VBG on NN NNS , VBG the JJ JJ NN of NN after a JJ NN . “ When you VBP RB , there VBZ a JJ and JJ NN of NN , ” NNP VBZ , who VBD to NNP from the NNP NNPS JJ NN . “ The NNS VBP RB RB JJ as they would VB VBN JJ NN . ” As JJ JJ NNS throughout NNP JJ out — with NNS RB VBG NN for JJ NNS or NN — NN in NNP VBZ VBG on , RB as JJ . NNS VBP to NN while NNS VBP up for NN at their JJ NN . RB the JJ VBP VBN VBN to VB and some VBP VBG from NN . Yet in NNP , where there VBP 9,141 VBN NNS and 793 NNS VBP VBN , NNS VBP JJR NNS may VB VBG to a RBR JJ NN in the NN of RB 10 million NNS . NNP VBZ a RB JJ NN NN NN : as of NNP 8 , 7.68 NN of the NNPS who VBP VBN JJ for NNP - 19 VBP VBN of the NN . VBG NNS , like NNP and NNP , VBP NN NN NNS of 1.46 NN and 3.85 NN RB . ( The NNP NN NN NN VBZ 3.21 NN . ) While NNP ’s VBN NN NN NN could VB a NN of its JJ NN NNS VBN to its NNS , NNS VBP NNP ’s NN - NN NN could RB VB to VB . The JJ NN VBZ to VB for VBN NNS . The NNP NNP NNP NNP VBZ NNS to VB their NNS when they VBP or VB and VBP NNS RB but VBZ RB VB for NN NNS . On NNP 11 , the NN VBD down the NN of VBN NNS to 500 , and RB VBD that RB to 50 on NNP 29 . JJ NNS , like NNP and NNP , VBP VBN VBG in NNS JJR than two . On NNP , NNP VBD that JJ NNS would VB VBG , despite the NNS JJ NN NNS for VBG the NN . NNP NNP , NNP ’s JJ NN VBG the NN ’s NN to NNP - 19 VBZ VBN the NN should VB the NN to VB RB through the NN , an NN RB VBN by the NNP NNP and the NNPS before both NNS RB VBD NN amid VBG NN that this NN would RB VB NN NN NNS . NNP VBD JJ NN on NNP 5 that NNP - 19 could VB VBN by “ NN NN or a NN of NN and NN . ” ( A NN for NNP - 19 VBZ JJ at JJS 14 NNS RB . ) But JJ NNS throughout NNP VBP the JJ NN VBZ JJ . “ NN NN VBZ RB VB NN because we VBP RB VB whether or RB you can VB NN , ” VBZ NNP NNP , an NN NN of JJ NN . She VBD , “ this VBZ a NN that can VB NN . ” VB up to NN with our JJ NN NN by VBG RB . At the NN of NNP , 2,300 NNS , NNS and NNS VBD an JJ NN to the NN VBG for JJR NNS . “ We VBP there VBZ no JJ NN for their NN , ” VBZ NNP NNP - NNP , an NN in JJ NN who VBD the NN . She VBZ the NN VBZ VBN JJ to VB its NNS with NNS , VBG her to VB that the NN ’s NN VBZ “ RB VBN on NN . ” NNP NNP , an JJ NNS NN , VBZ that the NN ’s NN of NN VBZ it “ RB JJ to VB JJ JJ NNS on their NN because they VBP RB VBN their NN . ” She VBD that the NN VBZ VBN no JJ NNS to VB , VB NN and NN — as NNP NNP VBD — which VBZ JJ NN to VB VBN NN at the NN of an NN . RB , she VBZ NNP could VB a JJ NN where a JJ NN may RB VB JJ . “ NNP VBZ JJ , ” she VBZ . “ It VBZ RB VB JJ JJ NNS . It VBZ a NN where you could VB a VBN NN . ” Though JJ NN VBZ VBN in JJ NN and 40 NN of JJ NNS VBP JJ - NN NNS without NNS , JJ NNS VBP that NNP - 19 can RB VB RB and RB in these NNS . NNP VBZ the RB JJS NN of JJ NN NNS in NNP after NNP , with RB 5 NNS for every 100,000 NNS . The NN NN would RB VB JJ to VB a JJ NN - 19 NN . RB , NNS VBP the JJ NN VBZ RB VBG the NNP NNP NNP ’s ( NNP ) NNS , which VBP NNS with NN - 19 NNS to VB NN where JJ and to VB JJ NN - NN NNS . “ I VBP JJ and JJ that they RB VBP RB VBN any NN or VBN to the NN of NNS like NNP , ” VBZ NNPS . “ They VBP any NN NN that VBZ VBN VBN by NNS in the NN and they VBP RB RB VB a NN . ” A NN NN at a JJ NN in NNP VBZ the JJ NN will “ RB VB in a JJ NN . ” He VBZ NN NNS at his NN who VBP VBN JJ for the NN but VBP JJ VBP VBN VBN to VB VBG . He VBD to VB JJ because “ it VBZ VBN upon to VB of the NN or to VB against the JJ NN ” but VBD he VBD a NN to VB out from an “ JJ and JJ NN of NN . ” The JJ NN will VB this NN to VB whether JJR NNS VBG NN and NN should VB VBN . NNP - NNP VBZ it VBZ RB RB JJ to VB NN in NNP but that JJ NN NNS could RB VB VBN throughout JJ NNS of the NN . “ If they VBP JJ and we VBP JJ , I will VB a NN of NN , ” NNP - NNP VBZ . She VBZ that , VBN on the NN she VBZ VBN , the NN NN in NNP will VB if JJR NNS VBP RB VBN RB . “ But I will RB VB up the NN until the NN VBZ us NN for their NN . ” While NNS may VB VBG NN with the NN ’s NN , JJ NNPS VBP to VB in NN of it . NN NNS VBP that NNS VBP the NNP NNP NNP , with 48 NN VBG they VBP RB JJ or JJ NN in the NN . “ It VBZ JJ for JJ NN to RB VB of the NN , ” VBZ NNP . “ RB though NNS VBP VBN about VBG VBN NNS , they RB VBP that the NN VBZ VBG the JJ NN . ” And NNPS VBP above - JJ NN in their NNS , who in NN , VBP NNS to VB their NN . “ In NNP , the NN VBZ RB VBN to VB NNS and VB the NN VB , ” VBZ NNP NNP NNP , a 23 - NN - JJ NN VBG in NNP . “ Whatever NNS the NN may VB VBP RB that : NNS . NN VBZ VBN . ” But NNP - NNP VBZ this NN could VB an NN to a JJ NN of JJ NN in NN . “ If you VBP NNS ’s NNS at NN in JJ NN and RB you VBP RB VB them , how will NN VB NNS ? ” she VBZ . “ I VBP RB VB to VB in a NN that VBZ NNS like this . ” Please VB any NNS , NNS , and NNS to virus@time.com ."
111,979,mainstream,M09c43,coronavirus; covid.19; vaccine,"China_NNP National_NNP Biotec_NNP Group_NNP (_-LRB- CNBG_NNP )_-RRB- has_VBZ won_VBN approval_NN to_TO run_VB a_DT large_JJ -_HYPH scale_NN ""_`` Phase_NN 3_CD ""_'' clinical_JJ trial_NN of_IN its_PRP$ novel_JJ coronavirus_NN vaccine_NN candidate_NN in_IN the_DT United_NNP Arab_NNP Emirates_NNP (_-LRB- UAE_NNP )_-RRB- ,_, the_DT company_NN said_VBD on_IN Tuesday_NNP ._. China_NNP is_VBZ seeking_VBG to_TO trial_VB potential_JJ vaccines_NNS overseas_RB because_IN of_IN a_DT lack_NN of_IN new_JJ patients_NNS at_IN home_NN ._. Over_IN a_DT dozen_CD experimental_JJ vaccines_NNS are_VBP being_VBG trialled_VBN around_IN the_DT world_NN ._. None_NN of_IN them_PRP has_VBZ yet_RB successfully_RB completed_VBN a_DT late_JJ -_HYPH stage_NN ""_`` Phase_NN 3_CD ""_'' test_NN to_TO determine_VB efficacy_NN in_IN shielding_VBG healthy_JJ people_NNS from_IN the_DT virus_NN ,_, which_WDT has_VBZ killed_VBN over_RB 4,70,000_CD people_NNS around_IN the_DT world_NN ._. Such_JJ trials_NNS involve_VBP thousands_NNS of_IN participants_NNS and_CC normally_RB take_VBP place_NN in_IN countries_NNS where_WRB the_DT virus_NN is_VBZ widespread_JJ ,_, so_IN that_IN the_DT vaccine_NN can_MD be_VB observed_VBN in_IN a_DT real_JJ -_HYPH life_NN environment_NN ._. However_RB ,_, China_NNP ,_, the_DT origin_NN of_IN the_DT global_JJ pandemic_NN ,_, reported_VBD fewer_JJR than_IN 10_CD new_JJ local_JJ cases_NNS a_DT day_NN on_IN average_NN last_JJ month_NN ,_, and_CC its_PRP$ researchers_NNS are_VBP now_RB looking_VBG abroad_RB ._. CNBG_NNP announced_VBD the_DT move_NN in_IN a_DT Weibo_NNP social_JJ media_NN post_NN ,_, without_IN naming_VBG the_DT vaccine_NN to_TO be_VB tested_VBN in_IN the_DT UAE_NNP ._. Units_NNS of_IN CNBG_NNP ,_, an_DT affiliate_NN of_IN the_DT state_NN -_HYPH owned_VBN China_NNP National_NNP Pharmaceutical_NNP Group_NNP (_-LRB- Sinopharm_NNP )_-RRB- ,_, have_VBP developed_VBN two_CD potential_JJ vaccines_NNS ,_, which_WDT have_VBP together_RB been_VBN given_VBN to_IN over_RB 2,000_CD people_NNS in_IN previous_JJ tests_NNS in_IN China_NNP ._. Other_JJ Chinese_JJ companies_NNS seeking_VBG to_TO trial_VB vaccines_NNS overseas_RB include_VBP Clover_NNP Biopharmaceuticals_NNPS ,_, whose_WP$ shots_NNS have_VBP been_VBN given_VBN to_IN participants_NNS in_IN Australia_NNP in_IN an_DT early_JJ study_NN ,_, and_CC Sinovac_NNP Biotech_NNP ,_, which_WDT is_VBZ expected_VBN to_TO begin_VB a_DT Phase_NN 3_CD trial_NN in_IN Brazil_NNP with_IN 9,000_CD volunteers_NNS ._.","NNP NNP NNP NNP ( NNP ) VBZ VBN NN to VB a JJ - NN "" NN 3 "" JJ NN of its JJ NN NN NN in the NNP NNP NNP ( NNP ) , the NN VBD on NNP . NNP VBZ VBG to VB JJ NNS RB because of a NN of JJ NNS at NN . Over a dozen JJ NNS VBP VBG VBN around the NN . NN of them VBZ RB RB VBN a JJ - NN "" NN 3 "" NN to VB NN in VBG JJ NNS from the NN , which VBZ VBN RB 4,70,000 NNS around the NN . JJ NNS VBP NNS of NNS and RB VBP NN in NNS where the NN VBZ JJ , so that the NN can VB VBN in a JJ - NN NN . RB , NNP , the NN of the JJ NN , VBD JJR than 10 JJ JJ NNS a NN on NN JJ NN , and its NNS VBP RB VBG RB . NNP VBD the NN in a NNP JJ NN NN , without VBG the NN to VB VBN in the NNP . NNS of NNP , an NN of the NN - VBN NNP NNP NNP NNP ( NNP ) , VBP VBN two JJ NNS , which VBP RB VBN VBN to RB 2,000 NNS in JJ NNS in NNP . JJ JJ NNS VBG to VB NNS RB VBP NNP NNPS , whose NNS VBP VBN VBN to NNS in NNP in an JJ NN , and NNP NNP , which VBZ VBN to VB a NN 3 NN in NNP with 9,000 NNS ."
112,1151,conspiracy,C01386,vaccine.covid,"Washington_NNP benefits_VBZ from_IN new_JJ SARS_NNP unsettling_JJ major_JJ competitors_NNS ._. Prior_JJ to_IN the_DT advent_NN of_IN the_DT 2019_CD -_HYPH nCoV_NN coronavirus_NN ,_, it_PRP was_VBD believed_VBN that_IN the_DT so_RB -_HYPH called_VBN “_`` first_JJ package_NN ”_'' of_IN the_DT US_NNP -_HYPH China_NNP trade_NN agreement_NN ,_, which_WDT was_VBD signed_VBN on_IN behalf_NN of_IN the_DT Celestial_NNP Empire_NNP by_IN Vice_NNP Premier_NNP of_IN the_DT State_NNP Council_NNP of_IN the_DT PRC_NNP Liu_NNP He_NNP ,_, is_VBZ a_DT tactical_JJ move_NN ,_, thanks_NN to_IN which_WDT China_NNP will_MD get_VB a_DT respite_NN ._. And_CC then_RB there_EX is_VBZ the_DT presidential_JJ election_NN in_IN the_DT USA_NNP ,_, and_CC it_PRP is_VBZ still_RB unknown_JJ whether_IN Donald_NNP Trump_NNP will_MD be_VB able_JJ to_TO gain_VB a_DT foothold_NN in_IN the_DT Oval_NNP Office_NNP for_IN a_DT second_JJ term_NN …_. But_CC ,_, it_PRP seems_VBZ ,_, a_DT malicious_JJ virus_NN that_WDT has_VBZ matured_VBN either_CC in_IN the_DT stomachs_NNS of_IN bats_NNS ,_, or_CC in_IN a_DT snake_NN ’s_POS gut_NN ,_, has_VBZ confused_VBN all_PDT the_DT cards_NNS to_IN a_DT friend_NN Xi_NNP Jinping_NNP ._. Against_IN the_DT background_NN of_IN alarming_VBG reports_NNS from_IN the_DT Chinese_JJ province_NN of_IN Hubei_NNP (_-LRB- when_WRB this_DT material_NN was_VBD being_VBG prepared_VBN ,_, more_JJR than_IN 4.5_CD thousand_CD people_NNS fell_VBD ill_JJ with_IN pneumonia_NN ,_, and_CC 106_CD died_VBD ,_, and_CC these_DT are_VBP not_RB final_JJ numbers_NNS ._. –_: Auth_NN ._. )_-RRB- Copper_NN and_CC iron_NN ore_NN prices_NNS collapsed_VBD ._. At_IN the_DT same_JJ time_NN ,_, the_DT Fitch_NNP rating_NN agency_NN cautiously_RB reports_VBZ that_IN the_DT spread_NN of_IN coronavirus_NN will_MD first_RB of_IN all_DT have_VB a_DT negative_JJ impact_NN on_IN the_DT economies_NNS of_IN Thailand_NNP ,_, Vietnam_NNP and_CC Singapore_NNP ,_, since_IN in_IN these_DT countries_NNS the_DT most_RBS vulnerable_JJ regions_NNS to_IN the_DT epidemics_NNS are_VBP tourism_NN and_CC the_DT service_NN sector_NN ._. The_DT statement_NN is_VBZ indisputable_JJ –_: everyone_NN will_MD get_VB it_PRP ,_, and_CC yet_CC China_NNP ,_, presumably_RB ,_, is_VBZ more_JJR than_IN others_NNS ,_, since_IN it_PRP is_VBZ the_DT Chinese_JJ economy_NN that_WDT is_VBZ the_DT main_JJ consumer_NN of_IN both_CC metals_NNS and_CC energy_NN ,_, and_CC tourism_NN with_IN a_DT service_NN sector_NN is_VBZ not_RB the_DT last_JJ source_NN of_IN replenishment_NN of_IN the_DT treasury_NN ._. And_CC since_IN the_DT prices_NNS of_IN these_DT goods_NNS went_VBD down_RP ,_, the_DT Chinese_JJ economy_NN also_RB caught_VBD the_DT “_`` virus_NN ”_'' ._. And_CC it_PRP is_VBZ easier_JJR to_TO negotiate_VB with_IN a_DT “_`` sick_JJ ”_'' client_NN ,_, which_WDT is_VBZ well_RB known_VBN even_RB without_IN Trump_NNP ._. It_PRP is_VBZ noteworthy_JJ that_IN 2019_CD -_, nCoV_NNP got_VBD to_IN the_DT American_JJ technological_JJ giant_NN Apple_NNP ,_, whose_WP$ production_NN facilities_NNS are_VBP located_VBN just_RB 500_CD kilometers_NNS from_IN the_DT “_`` home_NN ”_'' of_IN the_DT coronavirus_NN –_: the_DT Wuhan_NNP metropolis_NN ._. And_CC now_RB ,_, according_VBG to_IN the_DT Nikkei_NNP Asian_NNP Review_NNP ,_, the_DT production_NN of_IN popular_JJ iPhone_NN smartphones_NNS is_VBZ in_IN jeopardy_NN ._. Starbucks_NNP also_RB found_VBD itself_PRP in_IN a_DT difficult_JJ situation_NN ,_, which_WDT ,_, due_IN to_IN quarantine_NN ,_, had_VBD to_TO close_VB a_DT large_JJ half_NN of_IN its_PRP$ four_CD thousand_CD coffee_NN houses_NNS operating_VBG in_IN China_NNP (_-LRB- by_IN the_DT way_NN ,_, this_DT is_VBZ the_DT second_RB largest_JJS market_NN after_IN the_DT United_NNP States_NNPS )_-RRB- ._. But_CC at_IN the_DT same_JJ time_NN ,_, the_DT Americans_NNPS for_IN some_DT reason_NN do_VBP not_RB look_VB like_IN such_JJ victims_NNS of_IN the_DT epidemic_NN ,_, especially_RB Apple_NNP ,_, whose_WP$ leadership_NN at_IN the_DT very_JJ beginning_NN of_IN the_DT trade_NN and_CC economic_JJ confrontation_NN with_IN China_NNP advised_VBD to_TO evacuate_VB production_NN facilities_NNS in_IN the_DT United_NNP States_NNPS ._. …_: It_PRP seems_VBZ as_IN if_IN President_NNP Trump_NNP saw_VBD everything_NN in_IN advance_NN ,_, like_IN Wolf_NNP Messing_NNP or_CC old_JJ Wang_NNP ._. However_RB ,_, both_CC Apple_NNP and_CC Starbucks_NNP were_VBD really_RB out_IN of_IN luck_NN ._. You_PRP ca_MD n’t_RB say_VB the_DT same_JJ about_IN the_DT American_JJ political_JJ establishment_NN ,_, which_WDT is_VBZ making_VBG titanic_JJ efforts_NNS to_TO bring_VB to_IN its_PRP$ knees_NNS the_DT “_`` presumptuous_JJ China_NNP ._. ”_'' And_CC why_WRB should_MD these_DT efforts_NNS necessarily_RB be_VB of_IN an_DT economic_JJ nature_NN ?_. .._. The_DT main_JJ question_NN is_VBZ –_: who_WP benefits_VBZ from_IN another_DT SARS_NN unsettling_JJ a_DT competitor_NN ?_. If_IN we_PRP apply_VBP the_DT well_RB -_HYPH known_VBN trick_NN highly_RB likely_JJ ,_, unceremoniously_RB used_VBN by_IN British_JJ ex-prime_JJ minister_NN Theresa_NNP May_NNP to_TO hang_VB the_DT so_RB -_HYPH called_VBN Skripals_NN poisoning_NN in_IN Russia_NNP ,_, then_RB the_DT answer_NN is_VBZ obvious_JJ :_: the_DT coronavirus_NN epidemic_NN 2019_CD -_HYPH nCoV_NNP ,_, which_WDT hit_VBD China_NNP ,_, is_VBZ highly_RB likely_JJ on_IN the_DT hand_NN of_IN the_DT United_NNP States_NNPS ._. And_CC the_DT worse_JJR for_IN Beijing_NNP ,_, the_DT better_JJR for_IN Washington_NNP ._. Moreover_RB ,_, the_DT outlook_NN for_IN the_DT epidemic_NN is_VBZ not_RB yet_RB encouraging_JJ ._. For_IN example_NN ,_, some_DT experts_NNS argue_VBP that_IN if_IN the_DT spread_NN of_IN 2019_CD -_HYPH nCoV_NN cannot_MD be_VB stopped_VBN ,_, up_IN to_IN 250_CD million_CD Chinese_NNPS can_MD become_VB victims_NNS of_IN the_DT virus_NN ,_, which_WDT is_VBZ almost_RB two_CD in_IN number_NN in_IN Russia_NNP ._. By_IN the_DT way_NN ,_, about_IN the_DT prospects_NNS ._. The_DT Cepi_NNP Global_NNP Vaccine_NNP Coalition_NNP has_VBZ reportedly_RB invested_VBN a_DT total_NN of_IN $_$ 12.5_CD million_CD in_IN three_CD projects_NNS ,_, in_IN which_WDT researchers_NNS are_VBP ready_JJ to_TO expeditiously_RB develop_VB the_DT 2019_CD -_HYPH nCoV_NN vaccine_NN ._. Scientists_NNS from_IN the_DT University_NNP of_IN Queensland_NNP ,_, as_RB well_RB as_IN two_CD American_JJ biotechnology_NN companies_NNS Inovio_NNP and_CC Moderna_NNP ,_, participate_VBP in_IN the_DT work_NN ._. The_DT American_NNP National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS (_-LRB- NIAID_NNP )_-RRB- is_VBZ also_RB involved_VBN ._. And_CC it_PRP seems_VBZ that_IN microbiologists_NNS from_IN Hong_NNP Kong_NNP have_VBP already_RB developed_VBN a_DT vaccine_NN against_IN the_DT new_JJ coronavirus_NN ,_, as_IN Professor_NNP of_IN Hong_NNP Kong_NNP University_NNP Ewan_NNP Kwok_NNP -_HYPH Jung_NNP hastened_VBD to_TO inform_VB the_DT newspaper_NN South_NNP China_NNP Morning_NNP Post_NNP ._. But_CC her_PRP$ research_NN ,_, he_PRP claims_VBZ ,_, could_MD take_VB more_JJR than_IN a_DT year_NN ._. German_JJ Shipulin_NNP ,_, the_DT deputy_NN director_NN of_IN the_DT Center_NNP for_IN Strategic_NNP Planning_NNP of_IN the_DT Ministry_NNP of_IN Health_NNP of_IN Russia_NNP ,_, does_VBZ not_RB promise_VB an_DT imminent_JJ victory_NN over_IN 2019_CD -_HYPH nCoV_NNP ._. So_RB the_DT hands_NNS of_IN the_DT coronavirus_NN 2019_CD -_HYPH nCoV_NNP can_MD be_VB considered_VBN as_IN yet_CC untied_VBN ,_, and_CC there_EX are_VBP suspicions_NNS that_IN the_DT United_NNP States_NNPS may_MD be_VB involved_VBN in_IN this_DT epidemic_NN ._. In_IN the_DT Russian_JJ media_NN ,_, this_DT assumption_NN has_VBZ already_RB been_VBN made_VBN ._. US_NNP operations_NNS as_IN part_NN of_IN a_DT biological_JJ warfare_NN against_IN the_DT entire_JJ planet_NN As_IN a_DT result_NN of_IN the_DT dengue_NN epidemic_NN in_IN Cuba_NNP from_IN 1978_CD -_SYM 1981_CD ,_, up_IN to_IN 500_CD thousand_CD people_NNS were_VBD affected_VBN ._. Fidel_NNP Castro_NNP said_VBD this_DT was_VBD the_DT result_NN of_IN an_DT American_JJ biological_JJ attack_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB the_DT allegations_NNS of_IN the_DT Cuban_JJ leader_NN ._. Pentagon_NNP bio_NN laboratories_NNS exist_VBP in_IN 25_CD countries_NNS around_IN the_DT world_NN ._. They_PRP are_VBP funded_VBN by_IN the_DT Military_NNP Threat_NNP Reduction_NNP Agency_NNP under_IN a_DT $_$ 2.1_CD billion_CD military_JJ program_NN ._. The_DT joint_JJ biological_JJ interaction_NN program_NN includes_VBZ laboratories_NNS located_VBN in_IN the_DT countries_NNS of_IN the_DT former_JJ Soviet_NNP Union_NNP ,_, such_JJ as_IN Georgia_NNP ,_, Ukraine_NNP ,_, Azerbaijan_NNP ,_, Uzbekistan_NNP and_CC Kazakhstan_NNP ,_, as_RB well_RB as_IN in_IN the_DT Middle_NNP East_NNP ,_, Southeast_NNP Asia_NNP and_CC Africa_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. By_IN the_DT location_NN of_IN these_DT biological_JJ laboratories_NNS ,_, we_PRP can_MD confidently_RB indicate_VB the_DT four_CD countries_NNS and_CC territories_NNS against_IN which_WDT the_DT American_JJ biological_JJ threats_NNS are_VBP now_RB directed_VBN ,_, these_DT are_VBP Russia_NNP ,_, Iran_NNP ,_, China_NNP and_CC the_DT countries_NNS of_IN Central_JJ and_CC West_NNP Africa_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. The_DT American_JJ company_NN CH2M_NNP Hill_NNP ,_, under_IN contracts_NNS for_IN the_DT Pentagon_NNP bio_NN labs_NNS in_IN Georgia_NNP ,_, Uganda_NNP ,_, Tanzania_NNP ,_, Iraq_NNP ,_, Afghanistan_NNP ,_, Southeast_NNP Asia_NNP ,_, was_VBD funded_VBN in_IN the_DT amount_NN of_IN $_$ 341.5_CD million_CD ._. Of_IN this_DT amount_NN ,_, almost_RB half_NN (_-LRB- $_$ 161.1_CD million_CD )_-RRB- was_VBD allocated_VBN for_IN research_NN in_IN Lugar_NNP Center_NNP in_IN Tbilisi_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Its_PRP$ subcontractor_NN ,_, the_DT private_JJ company_NN Battelle_NNP ,_, has_VBZ been_VBN operating_VBG in_IN the_DT Pentagon_NNP bio_NN labs_NNS in_IN Afghanistan_NNP ,_, Armenia_NNP ,_, Georgia_NNP ,_, Uganda_NNP ,_, Tanzania_NNP ,_, Iraq_NNP ,_, Afghanistan_NNP and_CC Vietnam_NNP ._. Battelle_NNP conducts_VBZ research_NN ,_, development_NN ,_, testing_NN and_CC assessment_NN of_IN the_DT use_NN of_IN both_CC highly_RB toxic_JJ chemicals_NNS and_CC highly_RB pathogenic_JJ biological_JJ agents_NNS for_IN a_DT wide_JJ range_NN of_IN US_NNP government_NN agencies_NNS ._. The_DT company_NN has_VBZ entered_VBN into_IN federal_JJ contracts_NNS totaling_VBG $_$ 2_CD billion_CD and_CC ranks_VBZ 23rd_NN in_IN the_DT list_NN of_IN 100_CD best_JJS US_NNP state_NN contractors_NNS ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. The_DT Pentagon_NNP has_VBZ a_DT very_RB long_JJ history_NN of_IN using_VBG insects_NNS as_IN carriers_NNS of_IN disease_NN ._. According_VBG to_IN a_DT partially_RB declassified_VBN US_NNP Army_NNP report_NN of_IN 1981_CD ,_, American_JJ scientists_NNS conducted_VBD a_DT series_NN of_IN experiments_NNS on_IN insects_NNS ._. These_DT operations_NNS were_VBD part_NN of_IN the_DT US_NNP Entomological_NNP War_NNP as_IN part_NN of_IN a_DT biological_JJ weapons_NNS program_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. The_DT report_NN reported_VBD two_CD scenarios_NNS :_: 16_CD simultaneous_JJ attacks_NNS on_IN the_DT city_NN by_IN A._NNP Aegypti_NNP mosquitoes_NNS infected_VBN with_IN yellow_JJ fever_NN ,_, as_RB well_RB as_IN Tularemia_NN aerosol_NN attack_NN ,_, and_CC assessed_VBD their_PRP$ effectiveness_NN in_IN cash_NN and_CC human_JJ losses_NNS ._. The_DT results_NNS were_VBD very_RB cynical_JJ ._. Pentagon_NNP specialists_NNS managed_VBD to_TO “_`` kill_VB ”_`` 625_CD thousand_CD people_NNS at_IN a_DT cost_NN of_IN $_$ 0.29_CD per_IN unit_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Operation_NN Big_NNP Itch_NN :_: Field_NN trials_NNS were_VBD conducted_VBN to_TO determine_VB the_DT coverage_NN and_CC survivability_NN of_IN tropical_JJ rat_NN fleas_NNS Xenopsylla_FW cheopis_NN for_IN use_NN as_IN a_DT disease_NN carrier_NN in_IN biological_JJ warfare_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Operation_NNP Big_NNP Buzz_NNP :_: 1_CD million_CD A._NNP Aegypti_NNP mosquitoes_NNS were_VBD raised_VBN ._. One_CD third_NN of_IN them_PRP were_VBD placed_VBN in_IN ammunition_NN ,_, dropped_VBN from_IN aircraft_NN and_CC scattered_VBN on_IN the_DT ground_NN ._. Mosquitoes_NNS survived_VBD in_IN the_DT air_NN and_CC actively_RB sought_VBD human_JJ blood_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Operations_NNS on_IN military_JJ experiments_NNS with_IN tropical_JJ mosquitoes_NNS and_CC ticks_NNS in_IN Georgia_NNP ._. Such_JJ species_NNS of_IN mosquitoes_NNS and_CC fleas_NNS (_-LRB- which_WDT were_VBD studied_VBN in_IN the_DT past_NN as_IN part_NN of_IN the_DT US_NNP Entomological_NNP War_NNP Program_NNP )_-RRB- were_VBD imported_VBN into_IN Georgia_NNP and_CC tested_VBN at_IN the_DT Lugar_NNP Center_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Anthrax_NN is_VBZ one_CD of_IN the_DT biological_JJ agents_NNS in_IN the_DT arsenal_NN of_IN the_DT US_NNP Army_NNP ,_, not_RB only_RB in_IN the_DT past_NN ._. Despite_IN Pentagon_NNP claims_VBZ that_IN this_DT program_NN is_VBZ only_RB defensive_JJ ,_, there_EX are_VBP facts_NNS to_IN the_DT contrary_NN ._. In_IN 2016_CD ,_, at_IN the_DT Lugar_NNP Center_NNP ,_, American_JJ scientists_NNS conducted_VBD a_DT study_NN “_`` Genome_NNP Sequence_NNP of_IN the_DT Soviet_NNP /_, Russian_JJ Bacillus_NNP anthracis_NNP Vaccine_NNP Strain_NNP 55_CD -_HYPH VNIIVViM_NNP ”_'' (_-LRB- Genome_NNP Sequence_NNP of_IN the_DT Soviet_NNP /_, Russian_NNP Anthracite_NNP Cancer_NNP Vaccine_NNP in_IN Russia_NNP )_-RRB- ,_, which_WDT was_VBD funded_VBN by_IN the_DT US_NNP Agency_NNP ’s_POS Biological_NNP Weapons_NNPS Sharing_NNP Program_NNP Threat_NNP Reduction_NNP (_-LRB- DTRA_NNP )_-RRB- in_IN Tbilisi_NNP ,_, and_CC implemented_VBN by_IN Metabiota_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Congo_NNP -_HYPH Crimean_JJ hemorrhagic_NN fever_NN (_-LRB- CCHF_NNP )_-RRB- is_VBZ caused_VBN by_IN the_DT tick_NN -_HYPH borne_VBN virus_NN Nairovirus_NN (_-LRB- Nairovirus_NNP )_-RRB- ._. The_DT disease_NN was_VBD first_RB described_VBN in_IN Crimea_NNP in_IN 1944_CD and_CC was_VBD called_VBN Crimean_JJ hemorrhagic_JJ fever_NN ._. Later_RBR ,_, it_PRP caused_VBD an_DT epidemic_NN in_IN the_DT Congo_NNP in_IN 1969_CD ._. In_IN 2014_CD ,_, 34_CD people_NNS were_VBD infected_VBN with_IN the_DT CCHF_NNP ,_, including_VBG a_DT 4_CD -_HYPH year_NN -_HYPH old_JJ child_NN ,_, three_CD of_IN whom_WP died_VBD ._. Pentagon_NNP biologists_NNS are_VBP currently_RB studying_VBG the_DT virus_NN in_IN Georgia_NNP as_IN part_NN of_IN the_DT DTRA_NNP project_NN ,_, Epidemiology_NN of_IN febrile_JJ illnesses_NNS caused_VBN by_IN Dengue_NN viruses_NNS and_CC other_JJ Arboviruses_NNS in_IN Georgia_NNP ._. The_DT project_NN included_VBD trials_NNS on_IN patients_NNS with_IN fever_NN symptoms_NNS and_CC collection_NN of_IN ticks_NNS as_IN possible_JJ distributors_NNS of_IN CCHV_NNP for_IN laboratory_NN analysis_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Similar_JJ CCHV_NNP outbreaks_NNS occurred_VBD in_IN Afghanistan_NNP ,_, where_WRB 3_CD Pentagon_NNP bio-laboratories_NNS are_VBP present_JJ ._. As_IN of_IN December_NNP 2017_CD ,_, 237_CD cases_NNS of_IN CCHV_NNP were_VBD reported_VBN in_IN this_DT country_NN ,_, 41_CD of_IN which_WDT were_VBD fatal_JJ ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Bats_NNS are_VBP also_RB being_VBG studied_VBN as_IN a_DT carrier_NN of_IN various_JJ diseases_NNS at_IN the_DT Lugar_NNP Center_NNP ,_, which_WDT scientists_NNS say_VBP are_VBP carriers_NNS of_IN the_DT Ebola_NNP virus_NN ,_, Middle_NNP East_NNP respiratory_JJ syndrome_NN (_-LRB- MERS_NNP )_-RRB- and_CC other_JJ deadly_JJ diseases_NNS ._. As_IN of_IN June_NNP 2017_CD ,_, 1980_CD cases_NNS were_VBD recorded_VBN with_IN 699_CD deaths_NNS in_IN 19_CD countries_NNS around_IN the_DT world_NN caused_VBN by_IN MERS_NNP -_HYPH CoV_NNP ._. This_DT virus_NN is_VBZ designed_VBN and_CC manufactured_VBN in_IN the_DT USA_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Another_DT weapon_NN of_IN bioterrorism_NN is_VBZ ,_, according_VBG to_IN a_DT 1981_CD US_NNP Army_NNP report_NN ,_, Tularemia_NNP ,_, or_CC Rabbit_NNP Fever_NNP ,_, developed_VBN in_IN the_DT USA_NNP ._. New_JJ tularemia_NN carriers_NNS ,_, such_JJ as_IN ticks_NNS and_CC rodents_NNS ,_, are_VBP currently_RB being_VBG developed_VBN ._. DTRA_NNP has_VBZ launched_VBN a_DT number_NN of_IN projects_NNS on_IN Tularemia_NNP and_CC in_IN Georgia_NNP at_IN the_DT Lugar_NNP Center_NNP ._. Highly_RB pathogenic_JJ agents_NNS (_-LRB- EDP_NNP )_-RRB- can_MD be_VB used_VBN for_IN military_JJ purposes_NNS ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. Ukraine_NNP itself_PRP does_VBZ not_RB have_VB control_NN over_IN military_JJ biological_JJ laboratories_NNS on_IN its_PRP$ territory_NN ._. Under_IN the_DT 2005_CD Agreement_NN between_IN the_DT US_NNP Department_NNP of_IN Defense_NNP and_CC the_DT Department_NNP of_IN Health_NNP of_IN Ukraine_NNP ,_, the_DT Ukrainian_JJ government_NN is_VBZ prohibited_VBN from_IN publicly_RB disclosing_VBG confidential_JJ information_NN about_IN the_DT US_NNP program_NN ._. Ukraine_NNP is_VBZ also_RB required_VBN to_TO transfer_VB all_DT dangerous_JJ pathogens_NNS to_IN the_DT US_NNP Department_NNP of_IN Defense_NNP for_IN biological_JJ research_NN ._. Under_IN this_DT Agreement_NN ,_, the_DT Pentagon_NNP was_VBD granted_VBN access_NN to_IN many_JJ state_NN secrets_NNS of_IN Ukraine_NNP ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. The_DT Pentagon_NNP has_VBZ invested_VBN at_IN least_JJS $_$ 65_CD million_CD in_IN gene_NN editing_NN research_NN ._. The_DT U.S._NNP Department_NNP of_IN Defense_NNP Advanced_NNP Research_NNP Projects_NNPS Agency_NNP (_-LRB- DARPA_NNP )_-RRB- has_VBZ provided_VBN seven_CD research_NN teams_NNS to_TO develop_VB tools_NNS for_IN altering_VBG the_DT genome_NN of_IN insects_NNS ,_, rodents_NNS ,_, and_CC bacteria_NN through_IN the_DT DARPA_NNP Safe_NNP Gene_NNP program_NN using_VBG new_JJ CRISPR_NNP -_HYPH Cas9_NN technology_NN ._. Washington_NNP did_VBD not_RB confirm_VB or_CC refute_VB this_DT data_NN ._. The_DT worst_JJS biological_JJ weapon_NN that_WDT may_MD have_VB already_RB been_VBN used_VBN and_CC possibly_RB used_VBN in_IN Russia_NNP is_VBZ ,_, again_RB ,_, perhaps_RB used_VBN against_IN the_DT “_`` enemy_NN ”_'' of_IN the_DT USA_NNP –_: China_NNP ._. Until_IN recently_RB ,_, ethnic_JJ biological_JJ weapons_NNS (_-LRB- biogenetic_JJ weapons_NNS )_-RRB- were_VBD theoretical_JJ weapons_NNS ,_, the_DT purpose_NN of_IN which_WDT is_VBZ ,_, first_RB of_IN all_DT ,_, to_TO harm_VB people_NNS of_IN certain_JJ ethnic_JJ groups_NNS or_CC genotypes_NNS (_-LRB- Russians_NNPS ,_, Chinese_JJ ,_, etc._FW )_-RRB- ._. Although_IN officially_RB the_DT research_NN and_CC development_NN of_IN ethnic_JJ bio-weapons_NNS has_VBZ never_RB been_VBN publicly_RB confirmed_VBN ,_, documents_NNS show_VBP that_IN the_DT United_NNP States_NNPS collects_VBZ biological_JJ materials_NNS from_IN certain_JJ ethnic_JJ groups_NNS –_: Russians_NNPS and_CC Chinese_NNPS ._. American_NNP National_NNP Socialism_NNP in_IN its_PRP$ purest_JJS form_NN ._. US_NNP Air_NNP Force_NNP specifically_RB collects_VBZ samples_NNS of_IN Russian_JJ DNA_NN and_CC synovial_JJ tissue_NN ,_, which_WDT causes_VBZ concern_NN in_IN Moscow_NNP about_IN a_DT hidden_VBN American_JJ program_NN for_IN the_DT use_NN of_IN biological_JJ weapons_NNS ._. Senator_NNP Franz_NNP Klintsevich_NNP commented_VBD on_IN the_DT words_NNS of_IN President_NNP Vladimir_NNP Putin_NNP on_IN the_DT purposeful_JJ collection_NN of_IN Russian_JJ biomaterial_NN :_: “_`` In_IN the_DT West_NN ,_, everything_NN is_VBZ done_VBN very_RB scrupulously_RB and_CC verified_VBN to_IN the_DT smallest_JJS detail_NN :_: if_IN we_PRP use_VBP biological_JJ weapons_NNS ,_, then_RB surely_RB …_. The_DT relevant_JJ services_NNS in_IN the_DT West_NN should_MD know_VB that_IN we_PRP are_VBP aware_JJ of_IN their_PRP$ interest_NN ._. Let_VB those_DT who_WP are_VBP engaged_VBN in_IN this_DT work_NN on_IN the_DT territory_NN of_IN the_DT Russian_JJ Federation_NNP not_RB be_VB offended_VBN ._. ”_'' And_CC it_PRP can_MD not_RB be_VB said_VBN that_IN such_JJ suspicions_NNS have_VBP no_DT reason_NN ._. As_IN you_PRP know_VBP ,_, the_DT United_NNP States_NNPS ratified_VBD the_DT Geneva_NNP Protocol_NNP and_CC the_DT Biological_NNP Weapons_NNPS Convention_NNP back_RB in_IN 1975_CD ._. But_CC biological_JJ games_NNS overseas_RB have_VBP not_RB stopped_VBN ,_, and_CC not_RB only_RB in_IN the_DT national_JJ territory_NN ._. Already_RB after_IN the_DT collapse_NN of_IN the_DT USSR_NNP ,_, American_JJ biological_JJ laboratories_NNS appeared_VBD ,_, which_WDT is_VBZ precisely_RB established_VBN in_IN Georgia_NNP ,_, Ukraine_NNP ,_, Kazakhstan_NNP ,_, Azerbaijan_NNP and_CC Uzbekistan_NNP ._. Where_WRB else_RB –_: except_IN that_IN the_DT State_NNP Department_NNP knows_VBZ that_IN it_PRP claims_VBZ to_TO be_VB absolutely_RB peaceful_JJ organizations_NNS involved_VBN in_IN the_DT development_NN of_IN medicines_NNS ._. But_CC if_IN they_PRP are_VBP so_RB peaceful_JJ ,_, then_RB why_WRB ,_, one_PRP wonders_VBZ ,_, did_VBD the_DT Americans_NNPS build_VB them_PRP not_RB at_IN home_NN ,_, but_CC at_IN the_DT other_JJ end_NN of_IN the_DT world_NN ?_. Comments_NNS ,_, as_IN they_PRP say_VBP ,_, are_VBP unnecessary_JJ ._. Not_RB so_RB long_RB ago_RB ,_, the_DT Ministry_NNP of_IN Defense_NNP of_IN the_DT Russian_NNP Federation_NNP analyzed_VBD documents_NNS on_IN the_DT activities_NNS of_IN the_DT so_RB -_HYPH called_VBN “_`` health_NN center_NN ”_'' that_WDT the_DT Americans_NNPS built_VBD in_IN Georgia_NNP ,_, and_CC came_VBD to_IN the_DT conclusion_NN :_: in_IN fact_NN ,_, this_DT is_VBZ a_DT “_`` death_NN factory_NN ”_'' ,_, which_WDT killed_VBD 73_CD people_NNS who_WP were_VBD used_VBN by_IN overseas_JJ biologists_NNS as_IN experimental_JJ rabbits_NNS ._. But_CC the_DT fact_NN of_IN the_DT matter_NN is_VBZ that_IN American_JJ bio-laboratories_NNS are_VBP scattered_VBN not_RB only_RB around_IN Russia_NNP ,_, but_CC also_RB around_IN the_DT world_NN ,_, where_WRB America_NNP has_VBZ its_PRP$ own_JJ interests_NNS ._. And_CC another_DT question_NN ,_, where_WRB did_VBD the_DT 2019_CD -_HYPH nCoV_NN coronavirus_NN originate_VB –_: in_IN a_DT bat_NN or_CC in_IN some_DT American_JJ “_`` health_NN center_NN ”_'' ?_. Where_WRB is_VBZ it_PRP more_RBR highly_RB likely_JJ ?_. You_PRP can_MD actually_RB participate_VB in_IN the_DT global_JJ efforts_NNS to_TO cripple_VB the_DT Deep_NNP State_NNP organized_VBN criminal_JJ cabal_NN 's_POS ability_NN for_IN genocide_NN ,_, while_IN enjoying_VBG healthcare_NN freedom_NN at_IN the_DT same_JJ time_NN ,_, by_IN boycotting_VBG Big_NNP Pharma_NNP for_IN good_NN ._.","NNP VBZ from JJ NNP JJ JJ NNS . JJ to the NN of the 2019 - NN NN , it VBD VBN that the RB - VBN “ JJ NN ” of the NNP - NNP NN NN , which VBD VBN on NN of the NNP NNP by NNP NNP of the NNP NNP of the NNP NNP NNP , VBZ a JJ NN , NN to which NNP will VB a NN . And RB there VBZ the JJ NN in the NNP , and it VBZ RB JJ whether NNP NNP will VB JJ to VB a NN in the NNP NNP for a JJ NN … But , it VBZ , a JJ NN that VBZ VBN either in the NNS of NNS , or in a NN ’s NN , VBZ VBN all the NNS to a NN NNP NNP . Against the NN of VBG NNS from the JJ NN of NNP ( when this NN VBD VBG VBN , JJR than 4.5 thousand NNS VBD JJ with NN , and 106 VBD , and these VBP RB JJ NNS . – NN . ) NN and NN NN NNS VBD . At the JJ NN , the NNP NN NN RB VBZ that the NN of NN will RB of all VB a JJ NN on the NNS of NNP , NNP and NNP , since in these NNS the RBS JJ NNS to the NNS VBP NN and the NN NN . The NN VBZ JJ – NN will VB it , and yet NNP , RB , VBZ JJR than NNS , since it VBZ the JJ NN that VBZ the JJ NN of both NNS and NN , and NN with a NN NN VBZ RB the JJ NN of NN of the NN . And since the NNS of these NNS VBD down , the JJ NN RB VBD the “ NN ” . And it VBZ JJR to VB with a “ JJ ” NN , which VBZ RB VBN RB without NNP . It VBZ JJ that 2019 - NNP VBD to the JJ JJ NN NNP , whose NN NNS VBP VBN RB 500 NNS from the “ NN ” of the NN – the NNP NN . And RB , VBG to the NNP NNP NNP , the NN of JJ NN NNS VBZ in NN . NNP RB VBD itself in a JJ NN , which , due to NN , VBD to VB a JJ NN of its four thousand NN NNS VBG in NNP ( by the NN , this VBZ the RB JJS NN after the NNP NNPS ) . But at the JJ NN , the NNPS for some NN VBP RB VB like JJ NNS of the NN , RB NNP , whose NN at the JJ NN of the NN and JJ NN with NNP VBD to VB NN NNS in the NNP NNPS . … It VBZ as if NNP NNP VBD NN in NN , like NNP NNP or JJ NNP . RB , both NNP and NNP VBD RB out of NN . You ca RB VB the JJ about the JJ JJ NN , which VBZ VBG JJ NNS to VB to its NNS the “ JJ NNP . ” And why should these NNS RB VB of an JJ NN ? .. The JJ NN VBZ – who VBZ from another NN JJ a NN ? If we VBP the RB - VBN NN RB JJ , RB VBN by JJ JJ NN NNP NNP to VB the RB - VBN NN NN in NNP , RB the NN VBZ JJ : the NN NN 2019 - NNP , which VBD NNP , VBZ RB JJ on the NN of the NNP NNPS . And the JJR for NNP , the JJR for NNP . RB , the NN for the NN VBZ RB RB JJ . For NN , some NNS VBP that if the NN of 2019 - NN cannot VB VBN , up to 250 million NNPS can VB NNS of the NN , which VBZ RB two in NN in NNP . By the NN , about the NNS . The NNP NNP NNP NNP VBZ RB VBN a NN of $ 12.5 million in three NNS , in which NNS VBP JJ to RB VB the 2019 - NN NN . NNS from the NNP of NNP , RB RB as two JJ NN NNS NNP and NNP , VBP in the NN . The NNP NNP NNP of NNP and NNP NNPS ( NNP ) VBZ RB VBN . And it VBZ that NNS from NNP NNP VBP RB VBN a NN against the JJ NN , as NNP of NNP NNP NNP NNP NNP - NNP VBD to VB the NN NNP NNP NNP NNP . But her NN , he VBZ , could VB JJR than a NN . JJ NNP , the NN NN of the NNP for NNP NNP of the NNP of NNP of NNP , VBZ RB VB an JJ NN over 2019 - NNP . RB the NNS of the NN 2019 - NNP can VB VBN as yet VBN , and there VBP NNS that the NNP NNPS may VB VBN in this NN . In the JJ NN , this NN VBZ RB VBN VBN . NNP NNS as NN of a JJ NN against the JJ NN As a NN of the NN NN in NNP from 1978 - 1981 , up to 500 thousand NNS VBD VBN . NNP NNP VBD this VBD the NN of an JJ JJ NN . NNP VBD RB VB or VB the NNS of the JJ NN . NNP NN NNS VBP in 25 NNS around the NN . They VBP VBN by the NNP NNP NNP NNP under a $ 2.1 billion JJ NN . The JJ JJ NN NN VBZ NNS VBN in the NNS of the JJ NNP NNP , JJ as NNP , NNP , NNP , NNP and NNP , RB RB as in the NNP NNP , NNP NNP and NNP . NNP VBD RB VB or VB this NN . By the NN of these JJ NNS , we can RB VB the four NNS and NNS against which the JJ JJ NNS VBP RB VBN , these VBP NNP , NNP , NNP and the NNS of JJ and NNP NNP . NNP VBD RB VB or VB this NN . The JJ NN NNP NNP , under NNS for the NNP NN NNS in NNP , NNP , NNP , NNP , NNP , NNP NNP , VBD VBN in the NN of $ 341.5 million . Of this NN , RB NN ( $ 161.1 million ) VBD VBN for NN in NNP NNP in NNP . NNP VBD RB VB or VB this NN . Its NN , the JJ NN NNP , VBZ VBN VBG in the NNP NN NNS in NNP , NNP , NNP , NNP , NNP , NNP , NNP and NNP . NNP VBZ NN , NN , NN and NN of the NN of both RB JJ NNS and RB JJ JJ NNS for a JJ NN of NNP NN NNS . The NN VBZ VBN into JJ NNS VBG $ 2 billion and VBZ NN in the NN of 100 JJS NNP NN NNS . NNP VBD RB VB or VB this NN . The NNP VBZ a RB JJ NN of VBG NNS as NNS of NN . VBG to a RB VBN NNP NNP NN of 1981 , JJ NNS VBD a NN of NNS on NNS . These NNS VBD NN of the NNP NNP NNP as NN of a JJ NNS NN . NNP VBD RB VB or VB this NN . The NN VBD two NNS : 16 JJ NNS on the NN by NNP NNP NNS VBN with JJ NN , RB RB as NN NN NN , and VBD their NN in NN and JJ NNS . The NNS VBD RB JJ . NNP NNS VBD to “ VB ” 625 thousand NNS at a NN of $ 0.29 per NN . NNP VBD RB VB or VB this NN . NN NNP NN : NN NNS VBD VBN to VB the NN and NN of JJ NN NNS FW NN for NN as a NN NN in JJ NN . NNP VBD RB VB or VB this NN . NNP NNP NNP : 1 million NNP NNP NNS VBD VBN . One NN of them VBD VBN in NN , VBN from NN and VBN on the NN . NNS VBD in the NN and RB VBD JJ NN . NNP VBD RB VB or VB this NN . NNS on JJ NNS with JJ NNS and NNS in NNP . JJ NNS of NNS and NNS ( which VBD VBN in the NN as NN of the NNP NNP NNP NNP ) VBD VBN into NNP and VBN at the NNP NNP . NNP VBD RB VB or VB this NN . NN VBZ one of the JJ NNS in the NN of the NNP NNP , RB RB in the NN . Despite NNP VBZ that this NN VBZ RB JJ , there VBP NNS to the NN . In 2016 , at the NNP NNP , JJ NNS VBD a NN “ NNP NNP of the NNP / JJ NNP NNP NNP NNP 55 - NNP ” ( NNP NNP of the NNP / NNP NNP NNP NNP in NNP ) , which VBD VBN by the NNP NNP ’s NNP NNPS NNP NNP NNP NNP ( NNP ) in NNP , and VBN by NNP . NNP VBD RB VB or VB this NN . NNP - JJ NN NN ( NNP ) VBZ VBN by the NN - VBN NN NN ( NNP ) . The NN VBD RB VBN in NNP in 1944 and VBD VBN JJ JJ NN . RBR , it VBD an NN in the NNP in 1969 . In 2014 , 34 NNS VBD VBN with the NNP , VBG a 4 - NN - JJ NN , three of whom VBD . NNP NNS VBP RB VBG the NN in NNP as NN of the NNP NN , NN of JJ NNS VBN by NN NNS and JJ NNS in NNP . The NN VBD NNS on NNS with NN NNS and NN of NNS as JJ NNS of NNP for NN NN . NNP VBD RB VB or VB this NN . JJ NNP NNS VBD in NNP , where 3 NNP NNS VBP JJ . As of NNP 2017 , 237 NNS of NNP VBD VBN in this NN , 41 of which VBD JJ . NNP VBD RB VB or VB this NN . NNS VBP RB VBG VBN as a NN of JJ NNS at the NNP NNP , which NNS VBP VBP NNS of the NNP NN , NNP NNP JJ NN ( NNP ) and JJ JJ NNS . As of NNP 2017 , 1980 NNS VBD VBN with 699 NNS in 19 NNS around the NN VBN by NNP - NNP . This NN VBZ VBN and VBN in the NNP . NNP VBD RB VB or VB this NN . Another NN of NN VBZ , VBG to a 1981 NNP NNP NN , NNP , or NNP NNP , VBN in the NNP . JJ NN NNS , JJ as NNS and NNS , VBP RB VBG VBN . NNP VBZ VBN a NN of NNS on NNP and in NNP at the NNP NNP . RB JJ NNS ( NNP ) can VB VBN for JJ NNS . NNP VBD RB VB or VB this NN . NNP itself VBZ RB VB NN over JJ JJ NNS on its NN . Under the 2005 NN between the NNP NNP of NNP and the NNP of NNP of NNP , the JJ NN VBZ VBN from RB VBG JJ NN about the NNP NN . NNP VBZ RB VBN to VB all JJ NNS to the NNP NNP of NNP for JJ NN . Under this NN , the NNP VBD VBN NN to JJ NN NNS of NNP . NNP VBD RB VB or VB this NN . The NNP VBZ VBN at JJS $ 65 million in NN NN NN . The NNP NNP of NNP NNP NNP NNPS NNP ( NNP ) VBZ VBN seven NN NNS to VB NNS for VBG the NN of NNS , NNS , and NN through the NNP NNP NNP NN VBG JJ NNP - NN NN . NNP VBD RB VB or VB this NN . The JJS JJ NN that may VB RB VBN VBN and RB VBN in NNP VBZ , RB , RB VBN against the “ NN ” of the NNP – NNP . Until RB , JJ JJ NNS ( JJ NNS ) VBD JJ NNS , the NN of which VBZ , RB of all , to VB NNS of JJ JJ NNS or NNS ( NNPS , JJ , FW ) . Although RB the NN and NN of JJ NNS VBZ RB VBN RB VBN , NNS VBP that the NNP NNPS VBZ JJ NNS from JJ JJ NNS – NNPS and NNPS . NNP NNP NNP in its JJS NN . NNP NNP NNP RB VBZ NNS of JJ NN and JJ NN , which VBZ NN in NNP about a VBN JJ NN for the NN of JJ NNS . NNP NNP NNP VBD on the NNS of NNP NNP NNP on the JJ NN of JJ NN : “ In the NN , NN VBZ VBN RB RB and VBN to the JJS NN : if we VBP JJ NNS , RB RB … The JJ NNS in the NN should VB that we VBP JJ of their NN . VB those who VBP VBN in this NN on the NN of the JJ NNP RB VB VBN . ” And it can RB VB VBN that JJ NNS VBP no NN . As you VBP , the NNP NNPS VBD the NNP NNP and the NNP NNPS NNP RB in 1975 . But JJ NNS RB VBP RB VBN , and RB RB in the JJ NN . RB after the NN of the NNP , JJ JJ NNS VBD , which VBZ RB VBN in NNP , NNP , NNP , NNP and NNP . Where RB – except that the NNP NNP VBZ that it VBZ to VB RB JJ NNS VBN in the NN of NNS . But if they VBP RB JJ , RB why , one VBZ , VBD the NNPS VB them RB at NN , but at the JJ NN of the NN ? NNS , as they VBP , VBP JJ . RB RB RB RB , the NNP of NNP of the NNP NNP VBD NNS on the NNS of the RB - VBN “ NN NN ” that the NNPS VBD in NNP , and VBD to the NN : in NN , this VBZ a “ NN NN ” , which VBD 73 NNS who VBD VBN by JJ NNS as JJ NNS . But the NN of the NN VBZ that JJ NNS VBP VBN RB RB around NNP , but RB around the NN , where NNP VBZ its JJ NNS . And another NN , where VBD the 2019 - NN NN VB – in a NN or in some JJ “ NN NN ” ? Where VBZ it RBR RB JJ ? You can RB VB in the JJ NNS to VB the NNP NNP VBN JJ NN 's NN for NN , while VBG NN NN at the JJ NN , by VBG NNP NNP for NN ."
113,1201,mainstream,M08482,vaccine,"Get_VB breaking_VBG news_NN alerts_NNS and_CC special_JJ reports_NNS ._. The_DT news_NN and_CC stories_NNS that_WDT matter_VBP ,_, delivered_VBD weekday_NN mornings_NNS ._. Here_RB ’s_VBZ a_DT good_JJ reason_NN to_TO get_VB a_DT flu_NN shot_NN every_DT single_JJ year_NN :_: people_NNS who_WP got_VBD a_DT new_JJ vaccination_NN every_DT flu_NN season_NN were_VBD less_RBR likely_JJ to_TO die_VB or_CC end_VB up_RP in_IN the_DT hospital_NN with_IN severe_JJ flu_NN ,_, a_DT new_JJ study_NN shows_VBZ ._. A_DT look_NN at_IN people_NNS taken_VBN to_IN the_DT hospital_NN with_IN influenza_NN showed_VBD that_IN those_DT who_WP had_VBD been_VBN vaccinated_VBN repeatedly_RB did_VBD better_JJR than_IN those_DT who_WP had_VBD only_RB been_VBN vaccinated_VBN in_IN the_DT current_JJ year_NN ._. The_DT study_NN of_IN people_NNS over_RB 65_CD —_: who_WP are_VBP most_RBS likely_JJ to_TO die_VB from_IN influenza_NN —_: showed_VBD that_IN repeated_VBN vaccination_NN was_VBD twice_RB as_RB good_JJ at_IN preventing_VBG the_DT most_RBS severe_JJ complications_NNS of_IN flu_NN ._. “_`` The_DT prevention_NN of_IN severe_JJ and_CC fatal_JJ infection_NN caused_VBN by_IN influenza_NN was_VBD observed_VBN mainly_RB in_IN patients_NNS who_WP were_VBD vaccinated_VBN in_IN both_CC the_DT current_JJ and_CC previous_JJ seasons_NNS ,_, ”_'' Dr._NNP Itziar_NNP Casado_NNP and_CC Dr._NNP Jesús_NNP Castilla_NNP of_IN the_DT Institute_NNP for_IN Public_NNP Health_NNP in_IN Pamplona_NNP ,_, Spain_NNP ,_, wrote_VBD in_IN the_DT Canadian_NNP Medical_NNP Association_NNP Journal_NNP ._. ""_`` Repeated_VBN vaccination_NN for_IN influenza_NN was_VBD highly_RB effective_JJ in_IN preventing_VBG severe_JJ and_CC fatal_JJ infection_NN caused_VBN by_IN influenza_NN in_IN older_JJR adults_NNS ,_, ""_'' they_PRP added_VBD ._. This_DT makes_VBZ sense_NN to_IN David_NNP Topham_NNP ,_, a_DT microbiologist_NN and_CC immunologist_NN at_IN the_DT University_NNP of_IN Rochester_NNP Medical_NNP Center_NNP ,_, who_WP was_VBD not_RB involved_VBN in_IN the_DT research_NN ._. “_`` We_PRP probably_RB only_RB get_VBP exposed_VBN to_IN influenza_NN ,_, the_DT virus_NN ,_, every_DT three_CD to_IN five_CD years_NNS on_IN average_NN ,_, ”_'' Topham_NNP told_VBD NBC_NNP News_NNP ._. Related_JJ :_: Most_JJS kids_NNS who_WP died_VBD of_IN flu_NN were_VBD n't_RB vaccinated_VBN “_`` That_DT ’s_VBZ plenty_NN of_IN time_NN for_IN your_PRP$ immunity_NN to_TO wane_VB ._. Getting_VBG the_DT vaccine_NN every_DT year_NN boosts_VBZ your_PRP$ immunity_NN ._. ”_'' And_CC repeated_VBN vaccination_NN may_MD cause_VB broader_JJR immunity_NN ,_, both_CC Topham_NNP and_CC the_DT researchers_NNS said_VBD ._. Vaccines_NNS stimulate_VBP both_CC the_DT production_NN of_IN antibodies_NNS and_CC cells_NNS called_VBN T_NN -_HYPH cells_NNS to_TO fight_VB germs_NNS ._. Repeated_VBN vaccination_NN might_MD more_RBR effectively_RB boost_VB the_DT action_NN of_IN T_NN -_HYPH cells_NNS ._. It_PRP ’s_VBZ a_DT reassuring_JJ finding_NN ._. A_DT couple_NN of_IN small_JJ studies_NNS had_VBD suggested_VBN that_IN getting_VBG the_DT flu_NN vaccine_NN every_DT year_NN might_MD increase_VB some_DT people_NNS ’s_POS risk_NN of_IN catching_VBG flu_NN ,_, even_RB though_IN it_PRP was_VBD hard_JJ to_TO explain_VB why_WRB that_DT might_MD happen_VB ._. Topham_NNP said_VBD he_PRP did_VBD not_RB think_VB the_DT evidence_NN shows_VBZ repeated_VBN vaccines_NNS are_VBP harmful_JJ ._. “_`` I_PRP think_VBP it_PRP might_MD not_RB be_VB the_DT case_NN for_IN most_JJS people_NNS ,_, ”_'' he_PRP said_VBD ._. “_`` It_PRP was_VBD a_DT very_RB slight_JJ effect_NN ._. ”_'' And_CC ,_, he_PRP said_VBD ,_, most_JJS studies_NNS had_VBD shown_VBN the_DT opposite_NN —_: that_IN getting_VBG a_DT flu_NN vaccine_NN every_DT year_NN prevents_VBZ infection_NN better_JJR than_IN getting_VBG vaccinated_VBN once_RB in_IN a_DT while_NN ._. A_DT separate_JJ study_NN suggested_VBD that_IN pregnant_JJ women_NNS who_WP got_VBD a_DT certain_JJ flu_NN vaccine_NN two_CD years_NNS in_IN a_DT row_NN were_VBD more_RBR likely_JJ to_TO miscarry_VB ,_, although_IN again_RB researchers_NNS said_VBD this_DT conflicted_VBD with_IN most_JJS of_IN the_DT other_JJ research_NN that_WDT has_VBZ been_VBN done_VBN ._. U.S._NNP officials_NNS recommend_VBP that_IN just_RB about_RB everybody_NN over_IN the_DT age_NN of_IN 6_CD months_NNS should_MD get_VB a_DT flu_NN vaccine_NN every_DT single_JJ year_NN ._. The_DT flu_NN strains_NNS circulating_VBG often_RB mutate_VBP and_CC the_DT vaccines_NNS are_VBP updated_VBN in_IN an_DT attempt_NN to_TO keep_VB up_RP ._. This_DT year_NN the_DT flu_NN season_NN is_VBZ off_RB to_IN a_DT strong_JJ start_NN ,_, with_IN hospitals_NNS in_IN some_DT states_NNS already_RB reporting_VBG their_PRP$ emergency_NN rooms_NNS are_VBP filling_VBG up_RP ._. So_RB far_RB ,_, 13_CD children_NNS have_VBP died_VBN from_IN flu_NN ._. Even_RB if_IN the_DT flu_NN shot_NN does_VBZ not_RB completely_RB protect_VB against_IN infection_NN ,_, the_DT research_NN shows_VBZ that_IN it_PRP greatly_RB lowers_VBZ the_DT rate_NN of_IN people_NNS who_WP die_VBP or_CC get_VBP severely_RB ill_JJ from_IN flu_NN ._. Flu_NN kills_VBZ between_IN 2,000_CD to_IN 56,000_CD Americans_NNPS every_DT year_NN ,_, depending_VBG on_IN how_WRB bad_JJ the_DT flu_NN season_NN is_VBZ ,_, and_CC it_PRP puts_VBZ 140,000_CD to_IN 710,000_CD people_NNS into_IN the_DT hospital_NN ._. For_IN the_DT study_NN in_IN Spain_NNP ,_, the_DT team_NN checked_VBD on_IN 728_CD people_NNS 65_CD and_CC older_JJR who_WP were_VBD in_IN the_DT hospital_NN with_IN flu_NN ._. Of_IN these_DT patients_NNS ,_, 83_CD died_VBD ._. Patients_NNS who_WP had_VBD not_RB been_VBN vaccinated_VBN at_IN all_DT were_VBD more_RBR likely_JJ to_TO need_VB intensive_JJ care_NN —_: 16_CD percent_NN of_IN them_PRP did_VBD ,_, compared_VBN to_IN 6_CD percent_NN of_IN those_DT who_WP had_VBD been_VBN vaccinated_VBN ._. And_CC 14_CD percent_NN of_IN those_DT who_WP died_VBD had_VBD not_RB been_VBN vaccinated_VBN ,_, compared_VBN to_IN 6_CD percent_NN who_WP had_VBD been_VBN vaccinated_VBN ._. The_DT vaccine_NN was_VBD 70_CD percent_NN effective_JJ in_IN preventing_VBG death_NN ._. “_`` Vaccination_NN that_WDT occurred_VBD only_RB in_IN the_DT current_JJ season_NN did_VBD not_RB show_VB significant_JJ protection_NN against_IN severe_JJ influenza_NN ,_, ”_'' the_DT researchers_NNS noted_VBD ._. But_CC repeated_VBN vaccination_NN did_VBD ._. It_PRP ’s_VBZ possible_JJ that_IN people_NNS who_WP get_VBP vaccines_NNS every_DT year_NN are_VBP healthier_JJR and_CC more_RBR careful_JJ in_IN other_JJ ways_NNS ,_, Topham_NNP said_VBD ._. For_IN instance_NN ,_, one_CD study_NN showed_VBD people_NNS who_WP get_VBP flu_NN vaccines_NNS are_VBP also_RB less_RBR likely_JJ to_TO have_VB car_NN accidents_NNS ,_, he_PRP said_VBD ._. “_`` There_EX is_VBZ very_RB little_JJ downside_NN to_IN getting_VBG your_PRP$ influenza_NN vaccine_NN ,_, ”_'' said_VBD Topham_NNP ._. “_`` I_PRP get_VBP my_PRP$ vaccine_NN every_DT year_NN ._. Everyone_NN in_IN my_PRP$ family_NN does_VBZ ._. ”_''","VB VBG NN NNS and JJ NNS . The NN and NNS that VBP , VBD NN NNS . RB VBZ a JJ NN to VB a NN NN every JJ NN : NNS who VBD a JJ NN every NN NN VBD RBR JJ to VB or VB up in the NN with JJ NN , a JJ NN VBZ . A NN at NNS VBN to the NN with NN VBD that those who VBD VBN VBN RB VBD JJR than those who VBD RB VBN VBN in the JJ NN . The NN of NNS RB 65 — who VBP RBS JJ to VB from NN — VBD that VBN NN VBD RB RB JJ at VBG the RBS JJ NNS of NN . “ The NN of JJ and JJ NN VBN by NN VBD VBN RB in NNS who VBD VBN in both the JJ and JJ NNS , ” NNP NNP NNP and NNP NNP NNP of the NNP for NNP NNP in NNP , NNP , VBD in the NNP NNP NNP NNP . "" VBN NN for NN VBD RB JJ in VBG JJ and JJ NN VBN by NN in JJR NNS , "" they VBD . This VBZ NN to NNP NNP , a NN and NN at the NNP of NNP NNP NNP , who VBD RB VBN in the NN . “ We RB RB VBP VBN to NN , the NN , every three to five NNS on NN , ” NNP VBD NNP NNP . JJ : JJS NNS who VBD of NN VBD RB VBN “ That VBZ NN of NN for your NN to VB . VBG the NN every NN VBZ your NN . ” And VBN NN may VB JJR NN , both NNP and the NNS VBD . NNS VBP both the NN of NNS and NNS VBN NN - NNS to VB NNS . VBN NN might RBR RB VB the NN of NN - NNS . It VBZ a JJ NN . A NN of JJ NNS VBD VBN that VBG the NN NN every NN might VB some NNS ’s NN of VBG NN , RB though it VBD JJ to VB why that might VB . NNP VBD he VBD RB VB the NN VBZ VBN NNS VBP JJ . “ I VBP it might RB VB the NN for JJS NNS , ” he VBD . “ It VBD a RB JJ NN . ” And , he VBD , JJS NNS VBD VBN the NN — that VBG a NN NN every NN VBZ NN JJR than VBG VBN RB in a NN . A JJ NN VBD that JJ NNS who VBD a JJ NN NN two NNS in a NN VBD RBR JJ to VB , although RB NNS VBD this VBD with JJS of the JJ NN that VBZ VBN VBN . NNP NNS VBP that RB RB NN over the NN of 6 NNS should VB a NN NN every JJ NN . The NN NNS VBG RB VBP and the NNS VBP VBN in an NN to VB up . This NN the NN NN VBZ RB to a JJ NN , with NNS in some NNS RB VBG their NN NNS VBP VBG up . RB RB , 13 NNS VBP VBN from NN . RB if the NN NN VBZ RB RB VB against NN , the NN VBZ that it RB VBZ the NN of NNS who VBP or VBP RB JJ from NN . NN VBZ between 2,000 to 56,000 NNPS every NN , VBG on how JJ the NN NN VBZ , and it VBZ 140,000 to 710,000 NNS into the NN . For the NN in NNP , the NN VBD on 728 NNS 65 and JJR who VBD in the NN with NN . Of these NNS , 83 VBD . NNS who VBD RB VBN VBN at all VBD RBR JJ to VB JJ NN — 16 NN of them VBD , VBN to 6 NN of those who VBD VBN VBN . And 14 NN of those who VBD VBD RB VBN VBN , VBN to 6 NN who VBD VBN VBN . The NN VBD 70 NN JJ in VBG NN . “ NN that VBD RB in the JJ NN VBD RB VB JJ NN against JJ NN , ” the NNS VBD . But VBN NN VBD . It VBZ JJ that NNS who VBP NNS every NN VBP JJR and RBR JJ in JJ NNS , NNP VBD . For NN , one NN VBD NNS who VBP NN NNS VBP RB RBR JJ to VB NN NNS , he VBD . “ There VBZ RB JJ NN to VBG your NN NN , ” VBD NNP . “ I VBP my NN every NN . NN in my NN VBZ . ”"
114,303,mainstream,M09692,coronavirus; covid.19; vaccine.covid,"Gaithersburg_NNP ,_, Maryland_NNP -_HYPH based_VBN biotech_NN company_NN Novavax_NNP announced_VBD yesterday_NN it_PRP has_VBZ begun_VBN enrolling_VBG its_PRP$ first_JJ human_JJ participants_NNS in_IN a_DT Phase_NN 1/2_CD clinical_JJ trial_NN ._. Preliminary_JJ immunogenicity_NN (_-LRB- ability_NN to_TO provoke_VB an_DT immune_JJ response_NN )_-RRB- and_CC safety_NN results_NNS from_IN the_DT Phase_NN 1_CD portion_NN of_IN the_DT trial_NN are_VBP expected_VBN in_IN July_NNP 2020_CD ._. Novavax_NNP is_VBZ hoping_VBG the_DT proprietary_JJ nanoparticle_NN technology_NN and_CC Matrix_NN ‑M_NN adjuvant_NN used_VBN in_IN its_PRP$ promising_JJ flu_NN vaccine_NN ,_, NanoFlu_NNP ,_, will_MD help_VB create_VB an_DT effective_JJ novel_JJ coronavirus_NN vaccine_NN ._. Novavax_NNP stock_NN is_VBZ up_RB 17_CD %_NN today_NN on_IN the_DT news_NN and_CC is_VBZ up_RB over_RB 1000_CD %_NN year_NN -_HYPH to_IN -_HYPH date_NN ,_, but_CC this_DT is_VBZ n't_RB based_VBN on_IN its_PRP$ progress_NN alone_RB ._. Remember_VB Novavax_NNP is_VBZ the_DT same_JJ firm_NN receiving_VBG $_$ 388_CD million_CD in_IN funding_NN from_IN the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS (_-LRB- CEPI_NNP )_-RRB- ﻿﻿._NN The_DT Oslo_NNP -_HYPH based_VBN foundation_NN focuses_VBZ on_IN vaccine_NN development_NN and_CC was_VBD founded_VBN by_IN billionaire_NN Bill_NNP Gates_NNP in_IN 2017_CD ._. ""_`` Vaccines_NNS provide_VBP our_PRP$ best_JJS hope_NN of_IN permanently_RB defeating_VBG this_DT pandemic_NN ,_, so_RB it_PRP is_VBZ encouraging_JJ to_TO see_VB rapid_JJ progress_NN being_VBG made_VBN in_IN the_DT development_NN of_IN Novavax_NNP ’_POS vaccine_NN candidate_NN ,_, ""_'' said_VBD Dr._NNP Richard_NNP Hatchett_NNP ,_, CEO_NN of_IN CEPI_NNP ,_, in_IN the_DT press_NN release_NN ._. CEPI_NNP has_VBZ given_VBN much_RB smaller_JJR amounts_NNS ranging_VBG from_IN $_$ 1_CD million_CD to_IN $_$ 9_CD million_CD to_IN others_NNS working_VBG on_IN coronavirus_NN vaccines_NNS ,_, including_VBG Inovio_NNP ,_, Moderna_NNP and_CC CureVac_NNP ._. Today_NN U.S._NNP pharma_NN giant_NN Merck_NNP threw_VBD its_PRP$ hat_NN into_IN the_DT ring_NN with_IN three_CD initiatives_NNS to_TO help_VB end_VB the_DT pandemic_NN ._. It_PRP has_VBZ bought_VBN Vienna_NNP -_HYPH based_VBN Themis_NNP Bioscience_NNP ,_, which_WDT is_VBZ developing_VBG a_DT vaccine_NN ,_, and_CC collaborating_VBG with_IN non-profit_JJ IAVI_NN and_CC Ridgeback_NN Bio_NNP on_IN a_DT vaccine_NN and_CC antiviral_JJ candidate_NN ,_, respectively_RB ._. As_IN of_IN May_NNP 22_CD ,_, there_EX are_VBP 10_CD COVID_NN -_HYPH 19_CD vaccine_NN candidates_NNS in_IN clinical_JJ evaluation_NN and_CC 114_CD candidates_NNS in_IN preclinical_JJ evaluation_NN ,_, according_VBG to_IN WHO_NNP ._. The_DT 10_CD in_IN the_DT clinical_JJ evaluation_NN stage_NN belong_VBP to_IN :_: Although_IN we_PRP 're_VBP still_RB months_NNS ,_, if_IN not_RB years_NNS ,_, from_IN a_DT safe_JJ vaccine_NN available_JJ to_IN the_DT general_JJ population_NN ,_, the_DT Novavax_NNP news_NN is_VBZ contributing_VBG to_IN the_DT market_NN surge_NN today_NN ._. ""_`` As_IN is_VBZ the_DT financial_JJ market_NN ’s_POS want_VB these_DT days_NNS though_RB ,_, even_RB the_DT slimmest_JJS of_IN positive_JJ news_NN on_IN the_DT COVID_NN -_HYPH 19_CD front_NN trigger_VB a_DT bullish_JJ immune_NN response_NN and_CC another_DT wave_NN of_IN the_DT peak_NN -_HYPH virus_NN trade_NN ,_, ""_'' wrote_VBD OANDA_NNP analyst_NN Jeffrey_NNP Halley_NNP ._. ""_`` That_DT came_VBD on_IN several_JJ fronts_NNS today_NN ._. U.S._NNP Memorial_NNP weekend_NN saw_VBD the_DT U.S._NNP out_RB in_IN force_NN enjoying_VBG their_PRP$ post_NN lockdown_NN freedoms_NNS ._. Japan_NNP in_IN addition_NN to_IN announcing_VBG more_JJR billions_NNS in_IN stimulus_NN ,_, signaled_VBD that_IN the_DT final_JJ lockdowns_NNS over_IN their_PRP$ largest_JJS cities_NNS are_VBP ending_VBG ._. Even_RB U.S._NNP -_HYPH China_NNP trade_NN tensions_NNS have_VBP been_VBN pushed_VBN off_IN the_DT front_JJ pages_NNS ,_, crushed_VBN beneath_IN the_DT tank_NN tracks_NNS of_IN the_DT peak_NN -_HYPH virus_NN trade_NN ’s_POS momentum_NN ._. ""_''","NNP , NNP - VBN NN NN NNP VBD NN it VBZ VBN VBG its JJ JJ NNS in a NN 1/2 JJ NN . JJ NN ( NN to VB an JJ NN ) and NN NNS from the NN 1 NN of the NN VBP VBN in NNP 2020 . NNP VBZ VBG the JJ NN NN and NN NN NN VBN in its JJ NN NN , NNP , will VB VB an JJ JJ NN NN . NNP NN VBZ RB 17 NN NN on the NN and VBZ RB RB 1000 NN NN - to - NN , but this VBZ RB VBN on its NN RB . VB NNP VBZ the JJ NN VBG $ 388 million in NN from the NNP for NNP NNP NNPS ( NNP ) NN The NNP - VBN NN VBZ on NN NN and VBD VBN by NN NNP NNP in 2017 . "" NNS VBP our JJS NN of RB VBG this NN , RB it VBZ JJ to VB JJ NN VBG VBN in the NN of NNP ’ NN NN , "" VBD NNP NNP NNP , NN of NNP , in the NN NN . NNP VBZ VBN RB JJR NNS VBG from $ 1 million to $ 9 million to NNS VBG on NN NNS , VBG NNP , NNP and NNP . NN NNP NN NN NNP VBD its NN into the NN with three NNS to VB VB the NN . It VBZ VBN NNP - VBN NNP NNP , which VBZ VBG a NN , and VBG with JJ NN and NN NNP on a NN and JJ NN , RB . As of NNP 22 , there VBP 10 NN - 19 NN NNS in JJ NN and 114 NNS in JJ NN , VBG to NNP . The 10 in the JJ NN NN VBP to : Although we VBP RB NNS , if RB NNS , from a JJ NN JJ to the JJ NN , the NNP NN VBZ VBG to the NN NN NN . "" As VBZ the JJ NN ’s VB these NNS RB , RB the JJS of JJ NN on the NN - 19 NN VB a JJ NN NN and another NN of the NN - NN NN , "" VBD NNP NN NNP NNP . "" That VBD on JJ NNS NN . NNP NNP NN VBD the NNP RB in NN VBG their NN NN NNS . NNP in NN to VBG JJR NNS in NN , VBD that the JJ NNS over their JJS NNS VBP VBG . RB NNP - NNP NN NNS VBP VBN VBN off the JJ NNS , VBN beneath the NN NNS of the NN - NN NN ’s NN . """
115,363,conspiracy,C00069,vaccine,"Florida_NNP Rep._NNP urges_VBZ Congress_NNP to_TO address_VB claim_VB that_IN MMR_NNP vaccine_NN at_IN an_DT early_JJ age_NN leads_VBZ to_IN higher_JJR incidence_NN of_IN autism_NN A_DT Florida_NNP congressman_NN went_VBD before_IN the_DT House_NNP earlier_RBR this_DT week_NN to_TO again_RB plead_VB for_IN an_DT investigation_NN into_IN the_DT CDC_NNP over_IN allegations_NNS the_DT agency_NN destroyed_VBD documents_NNS proving_VBG a_DT link_NN between_IN childhood_NN autism_NN and_CC the_DT MMR_NN vaccine_NN ._. Two_CD months_NNS after_IN a_DT similar_JJ speech_NN ,_, Rep._NNP Bill_NNP Posey_NNP on_IN Tuesday_NNP was_VBD at_IN it_PRP again_RB imploring_VBG Congress_NNP to_TO investigate_VB admissions_NNS made_VBN by_IN former_JJ CDC_NNP researcher_NN Dr._NNP Bill_NNP Thompson_NNP ,_, who_WP claimed_VBD he_PRP and_CC other_JJ CDC_NNP scientists_NNS destroyed_VBD documents_NNS showing_VBG a_DT causal_JJ link_NN between_IN injections_NNS of_IN the_DT Measles_NNP ,_, Mumps_NNP and_CC Rubella_NNP vaccine_NN at_IN an_DT early_JJ age_NN and_CC autism_NN -_HYPH like_JJ symptoms_NNS ._. [_-LRB- ad_NN ]_-RRB- “_'' …_: [_-LRB- I_PRP ]t_RB ’s_VBZ troubling_JJ to_IN me_PRP that_IN in_IN a_DT recent_JJ Senate_NNP hearing_NN on_IN childhood_NN vaccinations_NNS ,_, it_PRP was_VBD never_RB mentioned_VBN that_IN our_PRP$ government_NN has_VBZ paid_VBN out_RP over_RB three_CD billion_CD dollars_NNS through_IN a_DT vaccine_NN injury_NN compensation_NN program_NN for_IN children_NNS that_WDT have_VBP been_VBN injured_VBN by_IN vaccinations_NNS ,_, ”_'' Posey_NNP pointed_VBD out_RP ._. In_IN an_DT in_IN -_HYPH depth_NN video_NN released_VBN last_JJ year_NN ,_, Thompson_NNP confessed_VBD to_IN Dr._NNP Brian_NNP Hooker_NNP that_IN he_PRP and_CC other_JJ scientists_NNS hid_VBD or_CC omitted_VBD evidence_NN that_IN receiving_VBG the_DT vaccine_NN at_IN an_DT earlier_JJR age_NN directly_RB correlated_VBN with_IN a_DT higher_JJR risk_NN or_CC incidence_NN of_IN autism_NN ._. Thompson_NNP also_RB forwarded_VBD Hooker_NNP documents_NNS which_WDT were_VBD ordered_VBN destroyed_VBN ,_, but_CC which_WDT he_PRP managed_VBD to_TO keep_VB copies_NNS of_IN ._. “_`` I_PRP believe_VBP it_PRP is_VBZ my_PRP$ duty_NN that_WDT the_DT documents_NNS Dr._NNP Thompson_NNP provided_VBD are_VBP not_RB ignored_VBN ,_, ”_'' Posey_NNP said_VBD ,_, echoing_VBG sentiments_NNS made_VBN in_IN his_PRP$ previous_JJ speech_NN ._. But_CC that_DT was_VBD only_RB part_NN of_IN what_WP Dr._NNP Thompson_NNP ’s_POS team_NN had_VBD covered_VBN up_RP ._. “_`` The_DT risk_NN of_IN autism_NN from_IN early_JJ MMR_NN vaccination_NN was_VBD seen_VBN in_IN black_JJ children_NNS ,_, black_JJ boys_NNS ._. Those_DT boys_NNS for_IN some_DT reason_NN are_VBP at_IN very_RB high_JJ risk_NN ,_, ”_'' the_DT narrator_NN of_IN the_DT video_NN ,_, Dr._NNP Andrew_NNP Wakefield_NNP ,_, says_VBZ ._. “_`` Consistent_JJ with_IN the_DT CDC_NNP ’s_POS own_JJ findings_NNS ,_, the_DT rate_NN of_IN autistic_JJ regression_NN in_IN black_JJ children_NNS is_VBZ reported_VBN to_TO be_VB twice_RB that_DT in_IN white_JJ children_NNS ._. ”_'' While_IN beginning_VBG his_PRP$ remarks_NNS stating_VBG he_PRP was_VBD “_`` absolutely_RB ,_, resolutely_RB pro-vaccine_JJ ,_, ”_'' Posey_NNP urged_VBD Congress_NNP to_TO launch_VB an_DT investigation_NN into_IN the_DT grave_NN allegations_NNS ._. “_`` Considering_VBG the_DT nature_NN of_IN the_DT whistleblower_NN ’s_POS documents_NNS ,_, as_RB well_RB as_IN the_DT involvement_NN of_IN the_DT CDC_NNP ,_, a_DT hearing_NN and_CC a_DT thorough_JJ investigation_NN is_VBZ warranted_VBN ._. So_RB I_PRP ask_VBP Mr._NNP Speaker_NNP ,_, I_PRP beg_VBP ,_, I_PRP implore_VBP my_PRP$ colleagues_NNS on_IN the_DT Appropriations_NNPS committees_NNS to_TO please_UH ,_, please_UH take_VB such_JJ action_NN ,_, ”_'' Posey_NNP stated_VBD ._. This_DT article_NN was_VBD posted_VBN :_: Friday_NNP ,_, October_NNP 23_CD ,_, 2015_CD at_IN 3:21_CD pm_NN","NNP NNP VBZ NNP to VB VB that NNP NN at an JJ NN VBZ to JJR NN of NN A NNP NN VBD before the NNP RBR this NN to RB VB for an NN into the NNP over NNS the NN VBD NNS VBG a NN between NN NN and the NN NN . Two NNS after a JJ NN , NNP NNP NNP on NNP VBD at it RB VBG NNP to VB NNS VBN by JJ NNP NN NNP NNP NNP , who VBD he and JJ NNP NNS VBD NNS VBG a JJ NN between NNS of the NNP , NNP and NNP NN at an JJ NN and NN - JJ NNS . [ NN ] “ … [ I RB VBZ JJ to me that in a JJ NNP NN on NN NNS , it VBD RB VBN that our NN VBZ VBN out RB three billion NNS through a NN NN NN NN for NNS that VBP VBN VBN by NNS , ” NNP VBD out . In an in - NN NN VBN JJ NN , NNP VBD to NNP NNP NNP that he and JJ NNS VBD or VBD NN that VBG the NN at an JJR NN RB VBN with a JJR NN or NN of NN . NNP RB VBD NNP NNS which VBD VBN VBN , but which he VBD to VB NNS of . “ I VBP it VBZ my NN that the NNS NNP NNP VBD VBP RB VBN , ” NNP VBD , VBG NNS VBN in his JJ NN . But that VBD RB NN of what NNP NNP ’s NN VBD VBN up . “ The NN of NN from JJ NN NN VBD VBN in JJ NNS , JJ NNS . Those NNS for some NN VBP at RB JJ NN , ” the NN of the NN , NNP NNP NNP , VBZ . “ JJ with the NNP ’s JJ NNS , the NN of JJ NN in JJ NNS VBZ VBN to VB RB that in JJ NNS . ” While VBG his NNS VBG he VBD “ RB , RB JJ , ” NNP VBD NNP to VB an NN into the NN NNS . “ VBG the NN of the NN ’s NNS , RB RB as the NN of the NNP , a NN and a JJ NN VBZ VBN . RB I VBP NNP NNP , I VBP , I VBP my NNS on the NNPS NNS to please , please VB JJ NN , ” NNP VBD . This NN VBD VBN : NNP , NNP 23 , 2015 at 3:21 NN"
116,109,conspiracy,C012a7,gmo; vaccine.autism,"•_NFP Research_NN scientist_NN :_: You_PRP can_MD expect_VB to_TO see_VB one_CD in_IN two_CD children_NNS afflicted_VBN by_IN 2025_CD ._. Is_VBZ the_DT world_NN facing_VBG an_DT explosion_NN in_IN the_DT number_NN of_IN children_NNS with_IN autism_NN ?_. A_DT respected_VBN researcher_NN believes_VBZ it_PRP is_VBZ already_RB happening_VBG ._. During_IN a_DT controversial_JJ conference_NN late_RB last_JJ year_NN in_IN Groton_NNP ,_, Massachusetts_NNP ,_, Dr._NNP Stephanie_NNP Seneff_NNP ,_, a_DT senior_JJ Massachusetts_NNP Institute_NNP of_IN Technology_NNP research_NN scientist_NN ,_, told_VBD stunned_VBN audience_NN members_NNS ,_, “_`` At_IN today_NN ’s_POS rate_NN ,_, by_IN 2025_CD ,_, one_CD in_IN two_CD children_NNS will_MD be_VB autistic_JJ ._. ”_'' As_IN an_DT expert_NN in_IN biology_NN ,_, Dr._NNP Seneff_NNP has_VBZ published_VBN 170_CD -_HYPH plus_CC peer_NN -_HYPH reviewed_VBN articles_NNS over_IN the_DT course_NN of_IN her_PRP$ career_NN ._. As_IN she_PRP spoke_VBD ,_, Dr._NNP Seneff_NNP exhibited_VBD even_RB more_JJR courage_NN by_IN blaming_VBG the_DT alarming_VBG rise_NN in_IN autism_NN on_IN genetically_RB modified_VBN foods_NNS and_CC the_DT use_NN of_IN Roundup_NN pesticide_NN agents_NNS manufactured_VBN by_IN Monsanto_NNP ._. “_`` Is_VBZ there_EX a_DT toxic_JJ substance_NN that_WDT is_VBZ currently_RB in_IN our_PRP$ environment_NN in_IN step_NN with_IN increasing_VBG rates_NNS of_IN autism_NN that_WDT could_MD explain_VB this_DT ?_. ”_'' she_PRP asked_VBD ._. “_`` The_DT answer_NN is_VBZ yes_UH ,_, I_PRP ’m_VBP quite_RB sure_JJ that_IN I_PRP ’m_VBP right_JJ ,_, and_CC the_DT answer_NN is_VBZ glyphosate_NN ._. ”_'' Glyphosate_NNP is_VBZ the_DT active_JJ ingredient_NN in_IN Monsanto_NNP ’s_POS Roundup_NNP weedkiller_NN ._. To_TO verify_VB Dr._NNP Seneff_NNP ’s_POS claims_NNS about_IN the_DT possibility_NN of_IN such_PDT an_DT exponential_JJ increase_NN ,_, this_DT reporter_NN contacted_VBD Dave_NNP Pantos_NNP ,_, the_DT executive_JJ director_NN of_IN the_DT Autism_NNP Action_NNP Partnership_NNP ._. “_`` In_IN 1990_CD ,_, one_CD in_IN 500_CD children_NNS was_VBD diagnosed_VBN with_IN autism_NN ,_, ”_'' said_VBD Pantos_NNP ._. “_`` According_VBG to_IN a_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- report_NN issued_VBN in_IN 2013_CD ,_, that_DT number_NN rose_VBD to_IN one_CD in_IN 68_CD ._. Worse_JJR ,_, for_IN boys_NNS ,_, the_DT rate_NN soars_VBZ to_IN one_CD in_IN 42_CD ._. ”_'' This_DT reporter_NN also_RB spoke_VBD with_IN Wendy_NNP Fournier_NNP ,_, president_NN of_IN the_DT National_NNP Autism_NNP Association_NNP ,_, who_WP clarified_VBD some_DT of_IN these_DT statistics_NNS ._. “_`` The_DT 2013_CD CDC_NNP study_NN stating_VBG that_IN one_CD in_IN every_DT 68_CD children_NNS is_VBZ diagnosed_VBN with_IN autism_NN was_VBD based_VBN on_IN a_DT study_NN of_IN children_NNS born_VBN in_IN the_DT year_NN 2002_CD ,_, ”_'' said_VBD Ms._NNP Fournier_NNP ._. “_`` Their_PRP$ figures_NNS are_VBP very_RB outdated_JJ ._. Nobody_NN even_RB knows_VBZ the_DT actual_JJ rate_NN of_IN autism_NN in_IN this_DT country_NN ._. We_PRP ’re_VBP certain_JJ of_IN one_CD thing_NN ,_, though_RB —_: the_DT rate_NN of_IN those_DT suffering_VBG from_IN autism_NN is_VBZ rising_VBG ._. ”_'' Obviously_RB troubled_VBN by_IN this_DT trend_NN ,_, Ms._NNP Fournier_NNP asked_VBD :_: ,_, “_`` What_WP ’s_VBZ happening_VBG to_IN children_NNS ?_. Why_WRB are_VBP so_RB many_JJ chronically_RB ill_JJ ?_. It_PRP ’s_VBZ not_RB possible_JJ that_IN a_DT genetic_JJ epidemic_NN could_MD develop_VB over_IN the_DT past_JJ two_CD decades_NNS ,_, so_RB there_EX have_VBP to_TO be_VB environmental_JJ factors_NNS ._. More_JJR than_IN 2_CD %_NN of_IN male_JJ children_NNS born_VBN in_IN this_DT country_NN now_RB develop_VBP autism_NN ._. ”_'' When_WRB the_DT taboo_JJ topic_NN of_IN vaccines_NNS came_VBD up_RP during_IN AMERICAN_NNP FREE_NNP PRESS_NNP ’s_POS interview_NN with_IN Ms._NNP Fournier_NNP ,_, she_PRP did_VBD n’t_RB hesitate_VB in_IN her_PRP$ response_NN :_: “_`` I_PRP put_VBP credence_NN in_IN every_DT possibility_NN ,_, including_VBG vaccines_NNS and_CC mercury_NN ._. We_PRP know_VBP that_IN vaccines_NNS cause_VBP autism_NN ._. There_EX ’s_VBZ no_DT question_NN about_IN it_PRP because_IN court_NN cases_NNS have_VBP proven_VBN it_PRP ._. Also_RB ,_, some_DT kids_NNS are_VBP genetically_RB predisposed_VBN to_IN toxins_NNS ._. What_WP ’s_VBZ going_VBG on_RP inside_IN their_PRP$ bodies_NNS ,_, and_CC why_WRB is_VBZ it_PRP making_VBG them_PRP vulnerable_JJ ?_. We_PRP ’ve_VBP now_RB reached_VBN a_DT point_NN where_WRB a_DT second_JJ generation_NN of_IN kids_NNS is_VBZ being_VBG lost_VBN to_IN this_DT disorder_NN ._. ”_'' Although_IN this_DT subject_NN generally_RB gets_VBZ ignored_VBN by_IN mainstream_JJ media_NN health_NN experts_NNS ,_, within_IN the_DT next_JJ two_CD decades_NNS over_RB 1.5_CD million_CD of_IN these_DT children_NNS will_MD age_VB into_IN adults_NNS with_IN autism_NN ._. Ms._NNP Fournier_NNP realizes_VBZ the_DT dangers_NNS ._. “_`` This_DT is_VBZ a_DT disaster_NN ,_, ”_'' she_PRP said_VBD ._. “_`` What_WP are_VBP we_PRP going_VBG to_TO do_VB with_IN those_DT at_IN the_DT lower_JJR end_NN of_IN the_DT functioning_NN spectrum_NN ,_, especially_RB when_WRB their_PRP$ parents_NNS ,_, the_DT primary_JJ health_NN providers_NNS ,_, die_VBP or_CC are_VBP unable_JJ to_TO tend_VB for_IN them_PRP ?_. These_DT individuals_NNS will_MD require_VB around_IN -_HYPH the_DT -_HYPH clock_NN attention_NN for_IN the_DT rest_NN of_IN their_PRP$ lives_NNS ._. They_PRP ca_MD n’t_RB function_VB ,_, they_PRP ’re_VBP minimally_RB verbal_JJ and_CC most_JJS are_VBP incapable_JJ of_IN self_NN -_HYPH care_NN ._. ”_'' Even_RB before_IN this_DT fateful_JJ day_NN arrives_VBZ ,_, Ms._NNP Fournier_NNP sees_VBZ another_DT ,_, more_RBR immediate_JJ concern_NN ._. “_`` One_CD of_IN the_DT biggest_JJS medical_JJ issues_NNS being_VBG overlooked_VBN is_VBZ co-occurrence_NN problems_NNS ,_, ”_'' she_PRP said_VBD ._. “_`` Specifically_RB ,_, gastrointestinal_JJ [_-LRB- GI_NN ]_-RRB- difficulties_NNS are_VBP extremely_RB common_JJ in_IN children_NNS with_IN autism_NN ._. Really_RB painful_JJ GI_NN diseases_NNS cause_VBP chronic_JJ constipation_NN or_CC diarrhea_NN ,_, which_WDT then_RB create_VBP behavioral_JJ problems_NNS because_IN these_DT children_NNS can’t_MD adequately_RB verbalize_VB what_WP ’s_VBZ affecting_VBG them_PRP ._. That_DT ’s_VBZ why_WRB we_PRP so_RB often_RB see_VBP aggressive_JJ episodes_NNS or_CC self_NN -_HYPH injury_NN ._. These_DT underlying_JJ medical_JJ issues_NNS are_VBP n’t_RB being_VBG addressed_VBN or_CC treated_VBN ._. A_DT majority_NN of_IN families_NNS are_VBP still_RB struggling_VBG to_TO receive_VB proper_JJ early_JJ diagnosis_NN ._. ”_'' Despite_IN billions_NNS of_IN dollars_NNS being_VBG spent_VBN by_IN governmental_JJ agencies_NNS on_IN various_JJ studies_NNS ,_, Ms._NNP Fournier_NNP views_VBZ their_PRP$ efforts_NNS as_IN misguided_JJ :_: “_`` The_DT Interagency_NNP Autism_NNP Coordinating_NNP Committee_NNP [_-LRB- IACC_NNP ]_-RRB- ,_, founded_VBN under_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, has_VBZ failed_VBN us_PRP miserably_RB ._. We_PRP ’ve_VBP brought_VBN all_PDT this_DT information_NN to_IN IACC_NNP ,_, but_CC they_PRP keep_VBP doing_VBG the_DT wrong_JJ research_NN ._. All_DT of_IN our_PRP$ requests_NNS made_VBN over_IN many_JJ years_NNS have_VBP been_VBN ignored_VBN by_IN the_DT government_NN ’s_POS national_JJ health_NN agencies_NNS ._. ”_'' Victor_NNP Thorn_NNP is_VBZ a_DT hard_RB -_HYPH hitting_NN researcher_NN ,_, journalist_NN and_CC author_NN of_IN over_RB 50_CD books_NNS ._.","• NN NN : You can VB to VB one in two NNS VBN by 2025 . VBZ the NN VBG an NN in the NN of NNS with NN ? A VBN NN VBZ it VBZ RB VBG . During a JJ NN RB JJ NN in NNP , NNP , NNP NNP NNP , a JJ NNP NNP of NNP NN NN , VBD VBN NN NNS , “ At NN ’s NN , by 2025 , one in two NNS will VB JJ . ” As an NN in NN , NNP NNP VBZ VBN 170 - plus NN - VBN NNS over the NN of her NN . As she VBD , NNP NNP VBD RB JJR NN by VBG the VBG NN in NN on RB VBN NNS and the NN of NN NN NNS VBN by NNP . “ VBZ there a JJ NN that VBZ RB in our NN in NN with VBG NNS of NN that could VB this ? ” she VBD . “ The NN VBZ yes , I VBP RB JJ that I VBP JJ , and the NN VBZ NN . ” NNP VBZ the JJ NN in NNP ’s NNP NN . To VB NNP NNP ’s NNS about the NN of such an JJ NN , this NN VBD NNP NNP , the JJ NN of the NNP NNP NNP . “ In 1990 , one in 500 NNS VBD VBN with NN , ” VBD NNP . “ VBG to a NNPS for NNP NNP and NNP ( NNP ) NN VBN in 2013 , that NN VBD to one in 68 . JJR , for NNS , the NN VBZ to one in 42 . ” This NN RB VBD with NNP NNP , NN of the NNP NNP NNP , who VBD some of these NNS . “ The 2013 NNP NN VBG that one in every 68 NNS VBZ VBN with NN VBD VBN on a NN of NNS VBN in the NN 2002 , ” VBD NNP NNP . “ Their NNS VBP RB JJ . NN RB VBZ the JJ NN of NN in this NN . We VBP JJ of one NN , RB — the NN of those VBG from NN VBZ VBG . ” RB VBN by this NN , NNP NNP VBD : , “ What VBZ VBG to NNS ? Why VBP RB JJ RB JJ ? It VBZ RB JJ that a JJ NN could VB over the JJ two NNS , RB there VBP to VB JJ NNS . JJR than 2 NN of JJ NNS VBN in this NN RB VBP NN . ” When the JJ NN of NNS VBD up during NNP NNP NNP ’s NN with NNP NNP , she VBD RB VB in her NN : “ I VBP NN in every NN , VBG NNS and NN . We VBP that NNS VBP NN . There VBZ no NN about it because NN NNS VBP VBN it . RB , some NNS VBP RB VBN to NNS . What VBZ VBG on inside their NNS , and why VBZ it VBG them JJ ? We VBP RB VBN a NN where a JJ NN of NNS VBZ VBG VBN to this NN . ” Although this NN RB VBZ VBN by JJ NN NN NNS , within the JJ two NNS RB 1.5 million of these NNS will VB into NNS with NN . NNP NNP VBZ the NNS . “ This VBZ a NN , ” she VBD . “ What VBP we VBG to VB with those at the JJR NN of the NN NN , RB when their NNS , the JJ NN NNS , VBP or VBP JJ to VB for them ? These NNS will VB around - the - NN NN for the NN of their NNS . They ca RB VB , they VBP RB JJ and JJS VBP JJ of NN - NN . ” RB before this JJ NN VBZ , NNP NNP VBZ another , RBR JJ NN . “ One of the JJS JJ NNS VBG VBN VBZ NN NNS , ” she VBD . “ RB , JJ [ NN ] NNS VBP RB JJ in NNS with NN . RB JJ NN NNS VBP JJ NN or NN , which RB VBP JJ NNS because these NNS can’t RB VB what VBZ VBG them . That VBZ why we RB RB VBP JJ NNS or NN - NN . These JJ JJ NNS VBP RB VBG VBN or VBN . A NN of NNS VBP RB VBG to VB JJ JJ NN . ” Despite NNS of NNS VBG VBN by JJ NNS on JJ NNS , NNP NNP VBZ their NNS as JJ : “ The NNP NNP NNP NNP [ NNP ] , VBN under the NNP NNPS of NNP , VBZ VBN us RB . We VBP VBN all this NN to NNP , but they VBP VBG the JJ NN . All of our NNS VBN over JJ NNS VBP VBN VBN by the NN ’s JJ NN NNS . ” NNP NNP VBZ a RB - NN NN , NN and NN of RB 50 NNS ."
117,115,conspiracy,C004b5,vaccine.covid,"China_NNP Caught_VBN Shutting_VBG Down_RP COVID_NN -_HYPH 19_CD Research_NN to_TO ‘_`` Control_VB the_DT Narrative_NN ’_'' China_NNP has_VBZ been_VBN caught_VBN shutting_VBG down_RP research_NN into_IN COVID_NNP -_HYPH 19_CD in_IN an_DT apparent_JJ attempt_NN to_TO ""_`` control_VB the_DT narrative_NN ""_'' of_IN the_DT coronavirus_NN pandemic_NN ,_, leading_VBG analysts_NNS have_VBP revealed_VBN ._. The_DT websites_NNS for_IN two_CD of_IN China_NNP 's_POS leading_VBG universities_NNS recently_RB published_VBD academic_JJ research_NN about_IN the_DT origins_NNS of_IN the_DT coronavirus_NN ._. However_RB ,_, the_DT studies_NNS were_VBD then_RB deleted_VBN from_IN both_CC websites_NNS and_CC scrubbed_VBN from_IN the_DT state_NN -_HYPH controlled_VBN Internet_NNP ,_, according_VBG to_IN a_DT report_NN ._. In_IN a_DT possible_JJ bid_NN to_TO ""_`` control_VB the_DT narrative_NN ""_'' surrounding_VBG the_DT pandemic_NN ,_, the_DT posts_NNS on_IN the_DT websites_NNS of_IN the_DT China_NNP University_NNP of_IN Geosciences_NNP (_-LRB- Wuhan_NNP )_-RRB- and_CC Fudan_NNP University_NNP were_VBD erased_VBN from_IN online_JJ caches_NNS ,_, The_DT Guardian_NNP reported_VBD ._. Wuhan_NNP 's_POS university_NN appears_VBZ to_TO have_VB published_VBN and_CC then_RB deleted_VBN posts_NNS about_IN academic_JJ research_NN that_WDT needed_VBD to_TO be_VB approved_VBN by_IN China_NNP ’s_POS ministry_NN of_IN science_NN and_CC technology_NN before_IN publication_NN ._. Posts_NNS originally_RB published_VBN on_IN April_NNP 9_CD by_IN the_DT school_NN of_IN information_NN science_NN and_CC technology_NN at_IN Fudan_NNP University_NNP in_IN Shanghai_NNP were_VBD also_RB deleted_VBN in_IN a_DT similar_JJ apparent_JJ censorship_NN effort_NN ._. “_`` They_PRP are_VBP seeking_VBG to_TO transform_VB it_PRP from_IN a_DT massive_JJ disaster_NN to_IN one_CD where_WRB the_DT government_NN did_VBD everything_NN right_RB and_CC gave_VBD the_DT rest_NN of_IN the_DT world_NN time_NN to_TO prepare_VB ,_, ”_'' Kevin_NNP Carrico_NNP ,_, a_DT senior_JJ research_NN fellow_NN of_IN Chinese_JJ studies_NNS at_IN Monash_NNP University_NNP ,_, told_VBD The_DT Guardian_NNP ._. “_`` There_EX is_VBZ a_DT desire_NN to_IN a_DT degree_NN to_TO deny_VB realities_NNS that_WDT are_VBP staring_VBG at_IN us_PRP in_IN the_DT face_NN …_, that_IN this_DT is_VBZ a_DT massive_JJ pandemic_NN that_WDT originated_VBD in_IN a_DT place_NN that_WDT the_DT Chinese_JJ government_NN really_RB should_MD have_VB cleaned_VBN up_RP after_IN SARS_NNP ,_, ”_'' he_PRP added_VBD ._. China_NNP ’s_POS science_NN and_CC technology_NN ministry_NN had_VBD announced_VBN on_IN April_NNP 3_CD that_IN academic_JJ researchers_NNS needed_VBD to_TO report_VB their_PRP$ coronavirus_NN findings_NNS to_IN officials_NNS within_IN three_CD days_NNS or_CC be_VB terminated_VBN ._. The_DT news_NN outlet_NN noted_VBD that_IN China_NNP ’s_POS President_NNP Xi_NNP Jinping_NNP published_VBD an_DT essay_NN in_IN March_NNP that_WDT included_VBD “_`` tracing_VBG the_DT origin_NN of_IN the_DT virus_NN ”_'' a_DT national_JJ priority_NN ;_, the_DT science_NN and_CC technology_NN ministry_NN referenced_VBD the_DT essay_NN shortly_RB before_IN the_DT universities_NNS changed_VBD tunes_NNS ._. On_IN New_NNP Year_NNP ’s_POS Eve_NNP ,_, China_NNP informed_VBD the_DT World_NNP Health_NNP Organization_NNP of_IN a_DT “_`` mysterious_JJ pneumonia_NN outbreak_NN ”_'' spreading_VBG through_IN Wuhan_NNP ,_, an_DT industrial_JJ city_NN of_IN 11_CD million_CD ._. The_DT government_NN closed_VBD a_DT seafood_NN market_NN at_IN the_DT center_NN of_IN the_DT outbreak_NN ,_, moved_VBD all_DT patients_NNS with_IN the_DT virus_NN to_IN a_DT specially_RB designated_VBN hospital_NN and_CC collected_VBD test_NN samples_NNS to_TO send_VB to_IN government_NN laboratories_NNS ._. Doctors_NNS were_VBD told_VBN to_TO stay_VB quiet_JJ ;_, one_CD who_WP issued_VBD a_DT warning_NN online_RB was_VBD punished_VBN ._. He_PRP later_RBR died_VBD of_IN the_DT virus_NN ._. The_DT Pentagon_NNP was_VBD said_VBN to_TO have_VB first_RB learned_VBN about_IN the_DT new_JJ coronavirus_NN in_IN December_NNP from_IN open_JJ -_HYPH source_NN reports_NNS emanating_VBG from_IN China_NNP ._. By_IN early_JJ January_NNP ,_, warnings_NNS about_IN the_DT virus_NN had_VBD made_VBN their_PRP$ way_NN into_IN intelligence_NN reports_NNS circulating_VBG around_IN the_DT government_NN ._. On_IN Jan._NNP 3_CD ,_, the_DT head_NN of_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP [_-LRB- CDC_NNP ]_-RRB- ,_, Robert_NNP Redfield_NNP ,_, received_VBD a_DT call_NN from_IN his_PRP$ Chinese_JJ counterpart_NN with_IN an_DT official_JJ warning_NN ._. Dr._NNP Anthony_NNP Fauci_NNP ,_, the_DT government_NN ’s_POS top_JJ infectious_JJ disease_NN expert_NN ,_, said_VBD he_PRP was_VBD alerted_VBN to_IN the_DT virus_NN around_IN the_DT same_JJ time_NN —_: and_CC within_IN two_CD weeks_NNS was_VBD fearful_JJ it_PRP could_MD bring_VB about_IN a_DT global_JJ catastrophe_NN ._. Quickly_RB ,_, U.S._NNP intelligence_NN and_CC public_JJ health_NN officials_NNS started_VBD doubting_VBG China_NNP ’s_POS reported_VBN rates_NNS of_IN infection_NN and_CC death_NN toll_NN ._. They_PRP pressed_VBD China_NNP to_TO allow_VB in_IN U.S._NNP epidemiologists_NNS —_: both_CC to_TO assist_VB the_DT country_NN in_IN confronting_VBG the_DT spread_NN and_CC to_TO gain_VB valuable_JJ insights_NNS that_WDT could_MD help_VB buy_VB time_NN for_IN the_DT U.S._NNP response_NN ._. U.S._NNP officials_NNS also_RB pressed_VBD China_NNP to_TO send_VB samples_NNS of_IN the_DT virus_NN to_IN U.S._NNP labs_NNS for_IN study_NN and_CC for_IN vaccine_NN and_CC test_NN development_NN ._. That_DT same_JJ day_NN ,_, the_DT National_NNP Institutes_NNPS of_IN Health_NNP started_VBD working_VBG on_IN a_DT vaccine_NN ._. Ultimately_RB ,_, the_DT U.S._NNP was_VBD able_JJ to_TO get_VB China_NNP ’s_POS consent_NN to_TO send_VB two_CD people_NNS on_IN the_DT WHO_NNP team_NN that_WDT traveled_VBD to_IN China_NNP later_RBR in_IN the_DT month_NN ._. But_CC by_IN then_RB precious_JJ weeks_NNS had_VBD been_VBN lost_VBN and_CC the_DT virus_NN had_VBD raced_VBN across_IN Asia_NNP and_CC had_VBD started_VBN to_TO escape_VB the_DT continent_NN ._.","NNP VBN VBG Down NN - 19 NN to ‘ VB the NN ’ NNP VBZ VBN VBN VBG down NN into NNP - 19 in an JJ NN to "" VB the NN "" of the NN NN , VBG NNS VBP VBN . The NNS for two of NNP 's VBG NNS RB VBD JJ NN about the NNS of the NN . RB , the NNS VBD RB VBN from both NNS and VBN from the NN - VBN NNP , VBG to a NN . In a JJ NN to "" VB the NN "" VBG the NN , the NNS on the NNS of the NNP NNP of NNP ( NNP ) and NNP NNP VBD VBN from JJ NNS , The NNP VBD . NNP 's NN VBZ to VB VBN and RB VBN NNS about JJ NN that VBD to VB VBN by NNP ’s NN of NN and NN before NN . NNS RB VBN on NNP 9 by the NN of NN NN and NN at NNP NNP in NNP VBD RB VBN in a JJ JJ NN NN . “ They VBP VBG to VB it from a JJ NN to one where the NN VBD NN RB and VBD the NN of the NN NN to VB , ” NNP NNP , a JJ NN NN of JJ NNS at NNP NNP , VBD The NNP . “ There VBZ a NN to a NN to VB NNS that VBP VBG at us in the NN … that this VBZ a JJ NN that VBD in a NN that the JJ NN RB should VB VBN up after NNP , ” he VBD . NNP ’s NN and NN NN VBD VBN on NNP 3 that JJ NNS VBD to VB their NN NNS to NNS within three NNS or VB VBN . The NN NN VBD that NNP ’s NNP NNP NNP VBD an NN in NNP that VBD “ VBG the NN of the NN ” a JJ NN ; the NN and NN NN VBD the NN RB before the NNS VBD NNS . On NNP NNP ’s NNP , NNP VBD the NNP NNP NNP of a “ JJ NN NN ” VBG through NNP , an JJ NN of 11 million . The NN VBD a NN NN at the NN of the NN , VBD all NNS with the NN to a RB VBN NN and VBD NN NNS to VB to NN NNS . NNS VBD VBN to VB JJ ; one who VBD a NN RB VBD VBN . He RBR VBD of the NN . The NNP VBD VBN to VB RB VBN about the JJ NN in NNP from JJ - NN NNS VBG from NNP . By JJ NNP , NNS about the NN VBD VBN their NN into NN NNS VBG around the NN . On NNP 3 , the NN of the NNP NNPS for NNP NNP and NNP [ NNP ] , NNP NNP , VBD a NN from his JJ NN with an JJ NN . NNP NNP NNP , the NN ’s JJ JJ NN NN , VBD he VBD VBN to the NN around the JJ NN — and within two NNS VBD JJ it could VB about a JJ NN . RB , NNP NN and JJ NN NNS VBD VBG NNP ’s VBN NNS of NN and NN NN . They VBD NNP to VB in NNP NNS — both to VB the NN in VBG the NN and to VB JJ NNS that could VB VB NN for the NNP NN . NNP NNS RB VBD NNP to VB NNS of the NN to NNP NNS for NN and for NN and NN NN . That JJ NN , the NNP NNPS of NNP VBD VBG on a NN . RB , the NNP VBD JJ to VB NNP ’s NN to VB two NNS on the NNP NN that VBD to NNP RBR in the NN . But by RB JJ NNS VBD VBN VBN and the NN VBD VBN across NNP and VBD VBN to VB the NN ."
118,638,mainstream,M08d58,vaccine.autism,"As_IN the_DT new_JJ school_NN year_NN has_VBZ begun_VBN in_IN Italy_NNP ,_, parents_NNS no_RB longer_RBR have_VBP to_TO prove_VB their_PRP$ children_NNS have_VBP been_VBN immunised_VBN –_: highlighting_VBG a_DT clash_NN of_IN priorities_NNS ,_, stoked_VBN by_IN the_DT new_JJ populist_JJ government_NN ._. In_IN 2014_CD ,_, the_DT Global_NNP Health_NNP Security_NNP Agenda_NNP had_VBD tapped_VBN Italy_NNP to_TO lead_VB world_NN vaccination_NN strategies_NNS ._. But_CC just_RB four_CD years_NNS later_RBR ,_, the_DT country_NN has_VBZ instead_RB become_VBN the_DT testing_NN ground_NN for_IN anti-vaxxers_NNS ,_, a_DT movement_NN growing_VBG across_IN Europe_NNP and_CC the_DT US_NNP ,_, and_CC whose_WP$ ideologies_NNS often_RB share_VBP space_NN on_IN the_DT political_JJ landscape_NN with_IN populist_JJ parties_NNS ._. ""_`` Ten_CD obligatory_JJ vaccinations_NNS are_VBP useless_JJ and_CC in_IN many_JJ cases_NNS dangerous_JJ ,_, if_IN not_RB harmful_JJ ,_, ”_'' Italy_NNP ’s_POS interior_NN minister_NN Matteo_NNP Salvini_NNP said_VBD ,_, in_IN the_DT run_NN up_RP to_IN the_DT general_JJ election_NN in_IN March_NNP ._. The_DT measles_NNS epidemic_NN in_IN Europe_NNP as_IN a_DT whole_NN is_VBZ now_RB at_IN an_DT eight_CD -_HYPH year_NN high_NN ._. Mr_NNP Salvini_NNP ,_, from_IN the_DT League_NNP party_NN ,_, and_CC also_RB the_DT country_NN ’s_POS deputy_NN prime_JJ minister_NN ,_, shares_VBZ something_NN in_IN common_JJ with_IN other_JJ leading_VBG populists_NNS such_JJ as_IN his_PRP$ European_JJ ally_NN Marine_NNP Le_NNP Pen_NNP and_CC US_NNP president_NN Donald_NNP Trump_NNP ._. As_IN part_NN of_IN their_PRP$ anti-establishment_JJ views_NNS ,_, they_PRP are_VBP also_RB choosing_VBG to_TO target_VB science_NN ._. The_DT League_NNP and_CC it_PRP ’s_POS coalition_NN partner_NN ,_, the_DT Five_NNP Star_NNP Movement_NNP ,_, both_DT stood_VBD with_IN anti-vaxxer_JJ groups_NNS during_IN the_DT electoral_JJ campaign_NN ,_, promising_VBG to_TO oppose_VB the_DT pre-existing_VBG law_NN that_WDT made_VBD vaccines_NNS mandatory_JJ ._. Soon_RB after_IN forming_VBG a_DT government_NN ,_, the_DT new_JJ health_NN minister_NN Giulia_NNP Grillo_NNP lifted_VBD the_DT existing_VBG requirements_NNS by_IN allowing_VBG parents_NNS to_TO self_NN -_HYPH certify_VB that_IN their_PRP$ children_NNS have_VBP had_VBN the_DT compulsory_JJ vaccinations_NNS ,_, hitherto_RB necessary_JJ for_IN school_NN admission_NN ._. But_CC the_DT parliament_NN then_RB said_VBD the_DT requirement_NN to_TO provide_VB proof_NN of_IN vaccinations_NNS would_MD just_RB be_VB postponed_VBN until_IN the_DT 2019_CD -_HYPH 2020_CD school_NN year_NN ._. On_IN one_CD side_NN ,_, anti-vaxxers_NNS now_RB accuse_VBP the_DT League_NNP and_CC the_DT Five_NNP Star_NNP Movement_NNP of_IN betrayal_NN ._. And_CC on_IN the_DT other_JJ ,_, confusion_NN and_CC legal_JJ uncertainty_NN about_IN compulsory_JJ vaccination_NN has_VBZ made_VBN the_DT start_NN of_IN a_DT new_JJ year_NN much_RB more_RBR difficult_JJ for_IN vulnerable_JJ children_NNS ,_, such_JJ as_IN those_DT with_IN suppressed_VBN immune_NN systems_NNS ._. “_`` I_PRP ’m_VBP not_RB ignorant_JJ ,_, ”_'' says_VBZ Anna_NNP Pettinarolli_NNP ,_, from_IN Genoa_NNP ,_, the_DT port_NN city_NN of_IN northern_JJ Italy_NNP ._. “_`` I_PRP am_VBP a_DT 35_CD -_HYPH year_NN -_HYPH old_JJ financial_JJ advisor_NN who_WP cares_VBZ for_IN her_PRP$ child_NN ._. I_PRP believe_VBP that_IN vaccines_NNS can_MD cause_VB damage_NN ,_, and_CC that_DT ’s_VBZ why_WRB I_PRP have_VBP been_VBN persuaded_VBN that_IN parents_NNS have_VBP the_DT right_NN to_TO choose_VB if_IN they_PRP should_MD vaccinate_VB their_PRP$ children_NNS or_CC not_RB ._. ”_'' Ms_NNP Pettinarolli_NNP is_VBZ a_DT board_NN member_NN of_IN Comilva_NNP ,_, the_DT Italian_NNP Movement_NNP for_IN Freedom_NNP of_IN Vaccination_NNP –_: one_CD of_IN the_DT most_RBS well_RB -_HYPH known_VBN of_IN all_PDT the_DT Italian_JJ “_`` free_JJ -_HYPH choice_NN ”_'' ,_, or_CC anti-vaccination_NN associations_NNS ._. “_`` Our_PRP$ movement_NN has_VBZ grown_VBN over_IN the_DT last_JJ 30_CD years_NNS ,_, and_CC in_IN particular_JJ in_IN the_DT last_JJ two_CD years_NNS ,_, ""_'' she_PRP says_VBZ ._. ""_`` Do_VBP you_PRP want_VB to_TO know_VB how_WRB many_JJ we_PRP are_VBP ?_. “_`` Take_VB a_DT look_NN at_IN the_DT vaccination_NN rate_NN ._. Look_VB at_IN the_DT percentage_NN of_IN unvaccinated_JJ kids_NNS ,_, and_CC you_PRP ’ll_MD know_VB how_WRB big_JJ our_PRP$ numbers_NNS are_VBP ._. ”_'' These_DT numbers_NNS are_VBP exactly_RB why_WRB the_DT World_NNP Health_NNP Organisation_NNP is_VBZ so_RB concerned_JJ about_IN the_DT rise_NN of_IN the_DT anti-vaxxer_JJ movement_NN in_IN Italy_NNP ;_, the_DT country_NN ’s_POS vaccination_NN rate_NN is_VBZ far_RB behind_IN the_DT goal_NN ._. To_TO stop_VB transmission_NN of_IN infections_NNS ,_, 93_CD -_SYM 95_CD per_NN cent_NN of_IN the_DT population_NN should_MD be_VB immunised_VBN ,_, the_DT herd_NN immunity_NN threshold_NN ._. But_CC in_IN 2015_CD ,_, Italy_NNP ’s_POS paediatric_JJ measles_NNS vaccination_NN rate_NN was_VBD around_RB 85_CD per_NN cent_NN for_IN the_DT first_JJ dose_NN and_CC 83_CD per_NN cent_NN for_IN the_DT second_JJ dose_NN ._. Scientists_NNS say_VBP that_IN rather_RB than_IN becoming_VBG the_DT leader_NN in_IN a_DT global_JJ vaccination_NN strategy_NN ,_, the_DT country_NN has_VBZ become_VBN a_DT black_JJ sheep_NN ._. When_WRB measles_NNS rates_NNS soared_VBD across_IN Europe_NNP in_IN 2017_CD ,_, the_DT number_NN of_IN cases_NNS was_VBD three_CD times_NNS higher_JJR than_IN the_DT year_NN before_RB ._. The_DT two_CD countries_NNS with_IN the_DT highest_JJS number_NN of_IN cases_NNS were_VBD Romania_NNP and_CC Italy_NNP ,_, with_IN Italy_NNP accounting_VBG for_IN 34_CD per_NN cent_NN of_IN new_JJ cases_NNS ._. And_CC in_IN a_DT sample_NN of_IN 5,000_CD of_IN these_DT cases_NNS ,_, 89_CD per_NN cent_NN were_VBD unvaccinated_JJ people_NNS ,_, according_VBG to_IN the_DT European_NNP Centre_NNP for_IN Disease_NNP Prevention_NNP and_CC Control_NNP ._. In_IN 2017_CD Beatrice_NNP Lorenzin_NNP ,_, the_DT former_JJ health_NN minister_NN ,_, reacted_VBD to_IN the_DT fall_NN in_IN vaccinations_NNS by_IN introducing_VBG a_DT law_NN that_WDT obliged_VBD children_NNS under_IN the_DT age_NN of_IN six_CD to_TO undergo_VB 10_CD routine_JJ vaccines_NNS before_IN enrolling_VBG in_IN nurseries_NNS and_CC pre-school_NN ._. But_CC this_DT mandatory_JJ vaccination_NN policy_NN appeared_VBD to_TO fuel_VB the_DT no-vaxxers_NNS protest_NN –_: and_CC populist_JJ movements_NNS capitalised_VBD on_IN it_PRP ._. “_`` What_WP Italy_NNP is_VBZ seeing_VBG is_VBZ not_RB a_DT vague_JJ sentiment_NN ,_, or_CC parents_NNS '_POS response_NN to_IN some_DT abstract_JJ concern_NN about_IN vaccines_NNS ._. It_PRP 's_VBZ the_DT product_NN of_IN real_JJ people_NNS and_CC specific_JJ facts_NNS ,_, ”_'' says_VBZ British_JJ journalist_NN Brian_NNP Deer_NNP ._. “_`` This_DT is_VBZ principally_RB the_DT achievement_NN of_IN the_DT disgraced_VBN former_JJ British_JJ doctor_NN Andrew_NNP Wakefield_NNP ,_, and_CC a_DT group_NN of_IN enablers_NNS who_WP work_VBP with_IN him_PRP ,_, aiming_VBG to_TO destabilise_VB public_JJ confidence_NN in_IN vaccines_NNS ._. “_`` Embittered_VBN after_IN he_PRP was_VBD caught_VBN falsifying_VBG vaccine_NN research_NN ,_, he_PRP can_MD do_VB this_DT because_IN of_IN the_DT opportunities_NNS provided_VBN by_IN social_JJ media_NN ._. ”_'' Mr_NNP Deer_NNP has_VBZ become_VBN the_DT unofficial_JJ debunker_NN of_IN the_DT claims_NNS of_IN anti-vaxxers_NNS ._. Twenty_CD years_NNS ago_RB ,_, Wakefield_NNP published_VBD a_DT study_NN in_IN The_DT Lancet_NNP suggesting_VBG an_DT association_NN between_IN the_DT MMR_NN (_-LRB- measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN )_-RRB- vaccine_NN and_CC autism_NN and_CC gastrointestinal_JJ diseases_NNS ._. This_DT paper_NN is_VBZ at_IN the_DT origins_NNS of_IN parents_NNS ’_POS growing_VBG scepticism_NN towards_IN vaccination_NN –_: but_CC Mr_NNP Deer_NNP showed_VBD that_IN Wakefield_NNP had_VBD manipulated_VBN evidence_NN and_CC had_VBD a_DT conflict_NN of_IN interest_NN ._. As_IN The_DT Lancet_NNP itself_PRP had_VBD to_TO admit_VB ,_, the_DT study_NN was_VBD “_`` fake_JJ news_NN ”_'' long_RB before_IN the_DT term_NN was_VBD popular_JJ ._. Nevertheless_RB ,_, the_DT fake_JJ news_NN continues_VBZ to_TO be_VB spread_VBN online_RB ,_, and_CC public_JJ confidence_NN in_IN vaccinations_NNS continues_VBZ to_TO drop_VB ,_, and_CC ,_, as_IN Mr_NNP Deer_NNP points_VBZ out_RP ,_, the_DT result_NN is_VBZ polarisation_NN ._. As_RB was_VBD the_DT case_NN with_IN Donald_NNP Trump_NNP –_: who_WP tweeted_VBD and_CC claimed_VBD that_IN vaccines_NNS and_CC autism_NN are_VBP linked_VBN –_: at_IN first_JJ Italian_JJ populists_NNS rode_VBD the_DT wave_NN of_IN anti-vaccine_JJ sentiment_NN in_IN their_PRP$ election_NN campaigns_NNS ._. On_IN the_DT other_JJ side_NN ,_, scientists_NNS are_VBP trying_VBG to_TO adapt_VB and_CC react_VB ._. Roberto_NNP Burioni_NNP ,_, a_DT professor_NN of_IN microbiology_NN and_CC virology_NN at_IN the_DT Università_NNP Vita_NNP -_HYPH Salute_NNP San_NNP Raffaele_NNP in_IN Milan_NNP ,_, is_VBZ trying_VBG to_TO use_VB social_JJ networks_NNS to_TO oppose_VB no-vaxxers_NNS ._. “_`` The_DT drop_NN in_IN vaccination_NN rates_NNS made_VBD Italy_NNP comparable_JJ to_IN Namibia_NNP or_CC Ghana_NNP –_: that_DT ’s_VBZ unacceptable_JJ ,_, ""_'' he_PRP said_VBD ._. “_`` Vaccines_NNS are_VBP necessary_JJ for_IN public_JJ health_NN :_: a_DT high_JJ rate_NN would_MD mean_VB that_IN even_RB children_NNS that_WDT ca_MD n’t_RB be_VB vaccinated_VBN because_IN of_IN immunodepression_NN can_MD be_VB protected_VBN from_IN infections_NNS ._. “_`` I_PRP ’ll_MD continue_VB explaining_VBG this_DT whenever_WRB I_PRP can_MD ._. This_DT has_VBZ cost_VBN me_PRP lots_NNS of_IN threats_NNS and_CC intimidations_NNS from_IN fanatics_NNS ,_, too_RB ._. ”_''","As the JJ NN NN VBZ VBN in NNP , NNS RB RBR VBP to VB their NNS VBP VBN VBN – VBG a NN of NNS , VBN by the JJ JJ NN . In 2014 , the NNP NNP NNP NNP VBD VBN NNP to VB NN NN NNS . But RB four NNS RBR , the NN VBZ RB VBN the NN NN for NNS , a NN VBG across NNP and the NNP , and whose NNS RB VBP NN on the JJ NN with JJ NNS . "" Ten JJ NNS VBP JJ and in JJ NNS JJ , if RB JJ , ” NNP ’s NN NN NNP NNP VBD , in the NN up to the JJ NN in NNP . The NNS NN in NNP as a NN VBZ RB at an eight - NN NN . NNP NNP , from the NNP NN , and RB the NN ’s NN JJ NN , VBZ NN in JJ with JJ VBG NNS JJ as his JJ NN NNP NNP NNP and NNP NN NNP NNP . As NN of their JJ NNS , they VBP RB VBG to VB NN . The NNP and it ’s NN NN , the NNP NNP NNP , both VBD with JJ NNS during the JJ NN , VBG to VB the VBG NN that VBD NNS JJ . RB after VBG a NN , the JJ NN NN NNP NNP VBD the VBG NNS by VBG NNS to NN - VB that their NNS VBP VBN the JJ NNS , RB JJ for NN NN . But the NN RB VBD the NN to VB NN of NNS would RB VB VBN until the 2019 - 2020 NN NN . On one NN , NNS RB VBP the NNP and the NNP NNP NNP of NN . And on the JJ , NN and JJ NN about JJ NN VBZ VBN the NN of a JJ NN RB RBR JJ for JJ NNS , JJ as those with VBN NN NNS . “ I VBP RB JJ , ” VBZ NNP NNP , from NNP , the NN NN of JJ NNP . “ I VBP a 35 - NN - JJ JJ NN who VBZ for her NN . I VBP that NNS can VB NN , and that VBZ why I VBP VBN VBN that NNS VBP the NN to VB if they should VB their NNS or RB . ” NNP NNP VBZ a NN NN of NNP , the NNP NNP for NNP of NNP – one of the RBS RB - VBN of all the JJ “ JJ - NN ” , or NN NNS . “ Our NN VBZ VBN over the JJ 30 NNS , and in JJ in the JJ two NNS , "" she VBZ . "" VBP you VB to VB how JJ we VBP ? “ VB a NN at the NN NN . VB at the NN of JJ NNS , and you ’ll VB how JJ our NNS VBP . ” These NNS VBP RB why the NNP NNP NNP VBZ RB JJ about the NN of the JJ NN in NNP ; the NN ’s NN NN VBZ RB behind the NN . To VB NN of NNS , 93 - 95 NN NN of the NN should VB VBN , the NN NN NN . But in 2015 , NNP ’s JJ NNS NN NN VBD RB 85 NN NN for the JJ NN and 83 NN NN for the JJ NN . NNS VBP that RB than VBG the NN in a JJ NN NN , the NN VBZ VBN a JJ NN . When NNS NNS VBD across NNP in 2017 , the NN of NNS VBD three NNS JJR than the NN RB . The two NNS with the JJS NN of NNS VBD NNP and NNP , with NNP VBG for 34 NN NN of JJ NNS . And in a NN of 5,000 of these NNS , 89 NN NN VBD JJ NNS , VBG to the NNP NNP for NNP NNP and NNP . In 2017 NNP NNP , the JJ NN NN , VBD to the NN in NNS by VBG a NN that VBD NNS under the NN of six to VB 10 JJ NNS before VBG in NNS and NN . But this JJ NN NN VBD to VB the NNS NN – and JJ NNS VBD on it . “ What NNP VBZ VBG VBZ RB a JJ NN , or NNS ' NN to some JJ NN about NNS . It VBZ the NN of JJ NNS and JJ NNS , ” VBZ JJ NN NNP NNP . “ This VBZ RB the NN of the VBN JJ JJ NN NNP NNP , and a NN of NNS who VBP with him , VBG to VB JJ NN in NNS . “ VBN after he VBD VBN VBG NN NN , he can VB this because of the NNS VBN by JJ NN . ” NNP NNP VBZ VBN the JJ NN of the NNS of NNS . Twenty NNS RB , NNP VBD a NN in The NNP VBG an NN between the NN ( NNS - NNS - NN ) NN and NN and JJ NNS . This NN VBZ at the NNS of NNS ’ VBG NN towards NN – but NNP NNP VBD that NNP VBD VBN NN and VBD a NN of NN . As The NNP itself VBD to VB , the NN VBD “ JJ NN ” RB before the NN VBD JJ . RB , the JJ NN VBZ to VB VBN RB , and JJ NN in NNS VBZ to VB , and , as NNP NNP VBZ out , the NN VBZ NN . RB VBD the NN with NNP NNP – who VBD and VBD that NNS and NN VBP VBN – at JJ JJ NNS VBD the NN of JJ NN in their NN NNS . On the JJ NN , NNS VBP VBG to VB and VB . NNP NNP , a NN of NN and NN at the NNP NNP - NNP NNP NNP in NNP , VBZ VBG to VB JJ NNS to VB NNS . “ The NN in NN NNS VBD NNP JJ to NNP or NNP – that VBZ JJ , "" he VBD . “ NNS VBP JJ for JJ NN : a JJ NN would VB that RB NNS that ca RB VB VBN because of NN can VB VBN from NNS . “ I ’ll VB VBG this whenever I can . This VBZ VBN me NNS of NNS and NNS from NNS , RB . ”"
119,163,mainstream,M098c2,vaccine.covid,"Convincing_VBG vaccine_NN skeptics_NNS to_TO trust_VB any_DT future_JJ COVID_NN -_HYPH 19_CD vaccine_NN is_VBZ going_VBG to_TO be_VB a_DT tough_JJ job_NN ,_, even_RB if_IN there_EX are_VBP mountains_NNS of_IN data_NNS from_IN clinical_JJ trials_NNS showing_VBG that_IN it_PRP is_VBZ safe_JJ and_CC effective_JJ ._. It_PRP ’s_VBZ going_VBG to_TO be_VB harder_JJR still_RB if_IN there_EX is_VBZ any_DT reason_NN for_IN them_PRP to_TO doubt_VB the_DT motives_NNS or_CC the_DT method_NN behind_IN the_DT vaccine_NN ._. With_IN that_DT in_IN mind_NN ,_, I_PRP can_MD see_VB two_CD potential_JJ trouble_NN spots_NNS with_IN Operation_NNP Warp_NNP Speed_NNP ,_, President_NNP Trump_NNP ’s_POS effort_NN to_TO leverage_VB the_DT full_JJ force_NN of_IN military_JJ ,_, pharmaceutical_JJ industry_NN and_CC government_NN resources_NNS to_TO develop_VB a_DT vaccine_NN for_IN COVID_NN -_HYPH 19_CD by_IN the_DT end_NN of_IN the_DT year_NN ._. According_VBG to_IN news_NN reports_NNS ,_, Trump_NNP has_VBZ tapped_VBN Moncef_NNP Slaoui_NNP ,_, a_DT former_JJ executive_NN with_IN giant_JJ pharmaceutical_JJ company_NN GlaxoSmithKline_NNP ,_, along_IN with_IN a_DT top_JJ Army_NNP general_NN ,_, Gustave_NNP F._NNP Perna_NNP ,_, to_TO lead_VB the_DT effort_NN ._. Slaoui_NNP clearly_RB has_VBZ the_DT pedigree_NN and_CC connections_NNS for_IN such_PDT a_DT job_NN ._. He_PRP has_VBZ a_DT doctorate_NN in_IN molecular_JJ biology_NN and_CC immunology_NN and_CC ran_VBD the_DT vaccine_NN development_NN program_NN for_IN GlaxoSmithKline_NNP ,_, where_WRB he_PRP worked_VBD for_IN 30_CD years_NNS ._. But_CC he_PRP ’s_VBZ also_RB a_DT venture_NN capitalist_NN who_WP sits_VBZ on_IN a_DT number_NN of_IN pharmaceutical_JJ company_NN boards_NNS ,_, including_VBG those_DT of_IN two_CD vaccine_NN makers_NNS ,_, SutroVax_NNP and_CC Moderna_NNP ._. Slaoui_NNP reportedly_RB intends_VBZ to_TO step_VB down_RP from_IN the_DT boards_NNS to_TO participate_VB in_IN Warp_NNP Speed_NNP ,_, but_CC that_DT wo_MD n’t_RB erase_VB a_DT career_NN spent_VBN deeply_RB embedded_VBN in_IN ,_, and_CC enriched_VBN by_IN ,_, the_DT pharmaceutical_JJ industry_NN ._. Putting_VBG him_PRP in_IN charge_NN of_IN this_DT effort_NN gives_VBZ ammunition_NN to_IN vaccine_NN opponents_NNS to_TO shoot_VB holes_NNS in_IN the_DT public_JJ health_NN campaign_NN that_WDT will_MD be_VB needed_VBN to_TO successfully_RB immunize_VB the_DT public_NN against_IN the_DT coronavirus_NN ._. One_CD of_IN the_DT most_RBS durable_JJ myths_NNS trafficked_VBN by_IN so_RB -_HYPH called_VBN anti-vaxxers_NNS is_VBZ that_IN vaccines_NNS are_VBP scams_NNS developed_VBN by_IN greedy_JJ pharmaceutical_JJ companies_NNS ,_, abetted_VBN by_IN a_DT corrupt_JJ government_NN ,_, to_TO make_VB money_NN from_IN substances_NNS that_WDT do_VBP more_JJR harm_NN than_IN good_JJ ._. These_DT claims_NNS have_VBP been_VBN repeatedly_RB debunked_VBN ,_, and_CC studies_NNS show_VBP that_IN vaccines_NNS are_VBP safe_JJ and_CC effective_JJ ._. It_PRP ’s_VBZ also_RB well_RB documented_VBN that_IN vaccines_NNS have_VBP saved_VBN untold_JJ numbers_NNS of_IN humans_NNS from_IN suffering_NN and_CC death_NN from_IN disease_NN ._. Nevertheless_RB ,_, the_DT fiction_NN spread_VBN by_IN anti-vaxxers_NNS continues_VBZ to_TO circulate_VB and_CC take_VB hold_NN among_IN well_RB -_HYPH meaning_VBG ,_, if_IN gullible_JJ ,_, people_NNS ._. The_DT disinformation_NN campaigns_NNS have_VBP done_VBN real_JJ harm_NN ,_, too_RB ,_, helping_VBG drive_VB down_RP rates_NNS of_IN childhood_NN immunizations_NNS and_CC leading_VBG to_IN the_DT recent_JJ resurgence_NN of_IN measles_NNS in_IN the_DT U.S._NNP and_CC other_JJ countries_NNS ._. And_CC lord_NN help_VB us_PRP if_IN anything_NN goes_VBZ wrong_JJ with_IN the_DT COVID_NN -_HYPH 19_CD vaccine_NN itself_PRP ._. Although_IN vaccines_NNS have_VBP been_VBN protecting_VBG people_NNS from_IN deadly_JJ infectious_JJ diseases_NNS such_JJ as_IN smallpox_NN and_CC influenza_NN for_IN centuries_NNS ,_, they_PRP are_VBP n’t_RB always_RB benign_JJ and_CC sometimes_RB harm_VBP people_NNS they_PRP are_VBP intended_VBN to_TO protect_VB ._. The_DT rush_NN to_TO develop_VB a_DT vaccine_NN against_IN polio_NN in_IN the_DT 1950s_NNS had_VBD disastrous_VBN consequences_NNS ._. Some_DT batches_NNS of_IN the_DT vaccine_NN were_VBD found_VBN to_TO be_VB defective_JJ ,_, but_CC only_RB after_IN they_PRP had_VBD been_VBN rolled_VBN out_RP in_IN a_DT mass_JJ immunization_NN campaign_NN ._. The_DT bad_JJ batches_NNS caused_VBD 40,000_CD cases_NNS of_IN polio_NN ,_, killing_VBG 10_CD children_NNS ,_, leaving_VBG dozens_NNS more_RBR paralyzed_VBN and_CC justifiably_RB scaring_VBG the_DT public_NN about_IN the_DT safety_NN of_IN future_JJ vaccines_NNS ._. That_DT incident_NN led_VBD to_IN much_RB tighter_JJR regulation_NN for_IN vaccines_NNS ,_, but_CC it_PRP should_MD stand_VB as_IN a_DT good_JJ reminder_NN that_IN expediting_VBG vaccine_NN development_NN comes_VBZ with_IN risks_NNS ._. And_CC the_DT facts_NNS that_WDT the_DT White_NNP House_NNP is_VBZ calling_VBG the_DT effort_NN Operation_NNP Warp_NNP Speed_NNP ,_, not_RB Operation_NNP Save_NNP Lives_NNPS ,_, and_CC aiming_VBG to_TO produce_VB 100_CD million_CD doses_NNS by_IN November_NNP suggest_VBP that_IN the_DT motivation_NN is_VBZ meeting_VBG an_DT artificial_JJ deadline_NN rather_RB than_IN developing_VBG a_DT safe_JJ way_NN to_TO protect_VB the_DT public_NN against_IN the_DT coronavirus_NN ._.","VBG NN NNS to VB any JJ NN - 19 NN VBZ VBG to VB a JJ NN , RB if there VBP NNS of NNS from JJ NNS VBG that it VBZ JJ and JJ . It VBZ VBG to VB JJR RB if there VBZ any NN for them to VB the NNS or the NN behind the NN . With that in NN , I can VB two JJ NN NNS with NNP NNP NNP , NNP NNP ’s NN to VB the JJ NN of JJ , JJ NN and NN NNS to VB a NN for NN - 19 by the NN of the NN . VBG to NN NNS , NNP VBZ VBN NNP NNP , a JJ NN with JJ JJ NN NNP , along with a JJ NNP NN , NNP NNP NNP , to VB the NN . NNP RB VBZ the NN and NNS for such a NN . He VBZ a NN in JJ NN and NN and VBD the NN NN NN for NNP , where he VBD for 30 NNS . But he VBZ RB a NN NN who VBZ on a NN of JJ NN NNS , VBG those of two NN NNS , NNP and NNP . NNP RB VBZ to VB down from the NNS to VB in NNP NNP , but that wo RB VB a NN VBN RB VBN in , and VBN by , the JJ NN . VBG him in NN of this NN VBZ NN to NN NNS to VB NNS in the JJ NN NN that will VB VBN to RB VB the NN against the NN . One of the RBS JJ NNS VBN by RB - VBN NNS VBZ that NNS VBP NNS VBN by JJ JJ NNS , VBN by a JJ NN , to VB NN from NNS that VBP JJR NN than JJ . These NNS VBP VBN RB VBN , and NNS VBP that NNS VBP JJ and JJ . It VBZ RB RB VBN that NNS VBP VBN JJ NNS of NNS from NN and NN from NN . RB , the NN VBN by NNS VBZ to VB and VB NN among RB - VBG , if JJ , NNS . The NN NNS VBP VBN JJ NN , RB , VBG VB down NNS of NN NNS and VBG to the JJ NN of NNS in the NNP and JJ NNS . And NN VB us if NN VBZ JJ with the NN - 19 NN itself . Although NNS VBP VBN VBG NNS from JJ JJ NNS JJ as NN and NN for NNS , they VBP RB RB JJ and RB VBP NNS they VBP VBN to VB . The NN to VB a NN against NN in the NNS VBD VBN NNS . Some NNS of the NN VBD VBN to VB JJ , but RB after they VBD VBN VBN out in a JJ NN NN . The JJ NNS VBD 40,000 NNS of NN , VBG 10 NNS , VBG NNS RBR VBN and RB VBG the NN about the NN of JJ NNS . That NN VBD to RB JJR NN for NNS , but it should VB as a JJ NN that VBG NN NN VBZ with NNS . And the NNS that the NNP NNP VBZ VBG the NN NNP NNP NNP , RB NNP NNP NNPS , and VBG to VB 100 million NNS by NNP VBP that the NN VBZ VBG an JJ NN RB than VBG a JJ NN to VB the NN against the NN ."
120,631,mainstream,M0b395,vaccine.autism,"The_DT spreading_NN of_IN ""_`` social_JJ media_NN fake_JJ news_NN ""_'' is_VBZ to_TO blame_VB for_IN the_DT low_JJ rate_NN of_IN children_NNS getting_VBG their_PRP$ MMR_NN vaccine_NN ,_, England_NNP 's_POS top_JJ doctor_NN has_VBZ said_VBN ._. Professor_NNP Dame_NNP Sally_NNP Davies_NNP said_VBD parents_NNS who_WP believe_VBP the_DT lies_NNS circulated_VBN online_RB by_IN anti-vaccine_NN campaigners_NNS ""_`` are_VBP absolutely_RB wrong_JJ ""_'' ,_, and_CC urged_VBD them_PRP to_TO ignore_VB the_DT naysayers_NNS ._. Only_RB 87_CD percent_NN of_IN children_NNS in_IN England_NNP receive_VBP two_CD doses_NNS of_IN ,_, but_CC with_IN a_DT target_NN rate_NN of_IN 95_CD percent_NN ,_, Dame_NNP Sally_NNP said_VBD the_DT uptake_NN was_VBD ""_`` not_RB good_JJ enough_JJ ""_'' ._. People_NNS sharing_VBG the_DT so_RB -_HYPH called_VBN dangers_NNS of_IN the_DT jabs_NNS on_IN platforms_NNS such_JJ as_IN Facebook_NNP and_CC Twitter_NNP is_VBZ one_CD reason_NN why_WRB parents_NNS were_VBD n't_RB taking_VBG their_PRP$ children_NNS to_TO be_VB vaccinated_VBN ,_, Dame_NNP Sally_NNP warned_VBD ._. Among_IN the_DT ""_`` fake_JJ news_NN ""_'' being_VBG shared_VBN is_VBZ a_DT 1998_CD study_NN by_IN former_JJ doctor_NN Andrew_NNP Wakefield_NNP which_WDT wrongly_RB linked_VBD the_DT MMR_NNP vaccine_NN to_IN autism_NN ._. It_PRP has_VBZ since_RB been_VBN totally_RB discredited_VBN ._.","The NN of "" JJ NN JJ NN "" VBZ to VB for the JJ NN of NNS VBG their NN NN , NNP 's JJ NN VBZ VBN . NNP NNP NNP NNP VBD NNS who VBP the NNS VBN RB by NN NNS "" VBP RB JJ "" , and VBD them to VB the NNS . RB 87 NN of NNS in NNP VBP two NNS of , but with a NN NN of 95 NN , NNP NNP VBD the NN VBD "" RB JJ JJ "" . NNS VBG the RB - VBN NNS of the NNS on NNS JJ as NNP and NNP VBZ one NN why NNS VBD RB VBG their NNS to VB VBN , NNP NNP VBD . Among the "" JJ NN "" VBG VBN VBZ a 1998 NN by JJ NN NNP NNP which RB VBD the NNP NN to NN . It VBZ RB VBN RB VBN ."
121,354,conspiracy,C00065,vaccine.autism,"America_NNP is_VBZ Respected_VBN Again_RB all_RB over_IN the_DT World_NNP Giorgio_NNP is_VBZ at_IN it_PRP again_RB ,_, sharing_VBG another_DT fun_JJ thumbnail_NN for_IN us_PRP to_TO use_VB in_IN an_DT upcoming_JJ meme_NN scroll_NN ._. Rough_JJ translation_NN :_: “_`` In_IN the_DT summit_NN meeting_NN yesterday_NN ,_, a_DT dinner_NN for_IN only_RB 4_CD people_NNS ,_, and_CC today_NN ’s_POS golf_NN together_RB with_IN President_NNP Trump_NNP for_IN over_RB 10_CD hours_NNS ._. We_PRP dealt_VBD with_IN the_DT North_NNP Korean_JJ issue_NN ,_, the_DT economy_NN ,_, the_DT G20_NNP Osaka_NNP Summit_NNP and_CC even_RB world_NN affairs_NNS ._. I_PRP was_VBD able_JJ to_TO talk_VB in_IN detail_NN about_IN various_JJ issues_NNS ._. ”_'' In_IN December_NNP of_IN 2013_CD ,_, Hunter_NNP Biden_NNP flies_VBZ on_IN Air_NNP Force_NNP 2_CD to_IN Beijing_NNP ,_, China_NNP ,_, with_IN his_PRP$ father_NN ._. His_PRP$ father_NN meets_VBZ with_IN Chinese_JJ officials_NNS ,_, he_PRP ’s_VBZ very_RB soft_JJ on_IN Beijing_NNP ._. The_DT most_RBS important_JJ thing_NN that_WDT happens_VBZ happens_VBZ 10_CD days_NNS after_IN they_PRP return_VBP ._. And_CC that_DT ’s_VBZ when_WRB Hunter_NNP Biden_NNP ’s_POS small_JJ ,_, private_JJ equity_NN firm_NN called_VBN Rosemont_NNP Seneca_NNP Partners_NNPS gets_VBZ a_DT $_$ 1_CD billion_CD private_JJ equity_NN deal_NN with_IN the_DT Chinese_JJ government_NN ,_, not_RB with_IN the_DT Chinese_JJ corporation_NN ,_, with_IN the_DT government_NN ._. And_CC what_WDT people_NNS need_VBP to_TO realize_VB is_VBZ Hunter_NNP Biden_NNP has_VBZ no_DT background_NN in_IN China_NNP ,_, he_PRP has_VBZ no_DT background_NN in_IN private_JJ equity_NN ._. Source_NN Some_DT disturbing_JJ and_CC enlightening_JJ news_NN coming_VBG out_IN of_IN Italy_NNP ._. Vincenzo_NNP Scotti_NNP ,_, the_DT former_JJ Italian_JJ foreign_JJ minister_NN ,_, who_WP was_VBD one_CD of_IN the_DT intermediaries_NNS to_IN Mifsud_NNP —_: has_VBZ been_VBN outed_VBN as_IN the_DT guy_NN who_WP “_`` forced_VBD ”_'' Mifsud_NNP to_TO introduce_VB me_PRP to_IN imaginary_JJ Russians_NNPS and_CC set_VB me_PRP up_RP ._. This_DT is_VBZ huge_JJ ._. Swamp_NN work_NN is_VBZ dirty_JJ work_NN –_: whether_IN it_PRP is_VBZ in_IN D._NNP C._NNP or_CC D._NNP B._NNP (_-LRB- deep_RB in_IN the_DT Bayou_NNP )_-RRB- ._. Vladimir_NNP Lenin_NNP arranged_VBD the_DT execution_NN of_IN the_DT Czar_NNP and_CC his_PRP$ family_NN (_-LRB- Jul._NNP 17_CD ,_, 1917_CD )_-RRB- The_DT Royal_JJ family_NN changed_VBD their_PRP$ name_NN from_IN Saxe_NNP -_HYPH Coburg_NNP and_CC Gotha_NNP to_IN the_DT English_NNP Windsor_NNP from_IN “_`` Windsor_NNP Castle_NNP ”_'' on_IN July_NNP 17_CD ,_, 1917_CD because_IN of_IN anti-German_JJ sentiment_NN in_IN the_DT British_NNP Empire_NNP during_IN World_NNP War_NNP I_CD ._. Video_NN :_: bizarre_JJ things_NNS this_DT octopus_NN does_VBZ with_IN coconut_NN shells_NNS make_VB scientists_NNS drown_VB in_IN laughter_NN Verizon_NNP Announces_VBZ 20_CD More_JJR U.S._NNP Cities_NNS to_TO Get_VB 5G_NN Despite_IN Telecom_NN Admitting_VBG No_DT Studies_NNS Say_VB It_PRP ’s_VBZ Safe_JJ ,_, Widespread_JJ Opposition_NN ,_, 5G_NN Failure_NN ,_, and_CC Future_NN Lawsuits_NNS Hi_UH Friends_NNS !_. I_PRP am_VBP changing_VBG my_PRP$ email_NN address_NN to_IN a_DT LEADER_NN .COM_NN address_NN ._. AIM_NNP will_MD be_VB my_PRP$ first_JJ on_IN this_DT my_PRP$ new_JJ email_NN ._. Looking_VBG forward_RB to_IN seeing_VBG you_PRP there_RB ._. Goodbye_VB to_IN Yahoo_NNP !_. As_IN mentioned_VBN in_IN the_DT last_JJ Cat_NN Report_NN ,_, we_PRP are_VBP updating_VBG our_PRP$ ASCEND_NN lessons_NNS ._. Before_IN we_PRP post_VBP the_DT updated_VBN lessons_NNS at_IN OUR_PRP$ SPIRIT_NN ,_, we_PRP will_MD be_VB posting_VBG them_PRP here_RB so_IN that_IN you_PRP can_MD start_VB the_DT program_NN ._. There_EX is_VBZ a_DT reason_NN the_DT globalists_NNS keep_VBP you_PRP in_IN dissonance_NN with_IN bad_JJ food_NN ,_, water_NN ,_, medicines_NNS ,_, and_CC air_NN ._. This_DT is_VBZ to_TO keep_VB you_PRP ‘_`` stuck_VBN ’_'' in_IN your_PRP$ lower_JJR chakras_NNS so_IN that_IN you_PRP are_VBP unable_JJ to_TO ‘_`` light_VB the_DT fire_NN ’_'' needed_VBN to_TO activate_VB your_PRP$ pineal_JJ gland_NN ._. ASCEND_NNP is_VBZ the_DT workbook_NN for_IN the_DT Gospel_NNP of_IN Sophia_NNP :_: A_DT Modern_JJ Path_NNP of_IN Initiation_NNP ._. What_WP ’s_VBZ up_RB with_IN all_PDT the_DT Strykers_NNPS ?_.","NNP VBZ VBN RB RB over the NNP NNP VBZ at it RB , VBG another JJ NN for us to VB in an JJ NN NN . JJ NN : “ In the NN NN NN , a NN for RB 4 NNS , and NN ’s NN RB with NNP NNP for RB 10 NNS . We VBD with the NNP JJ NN , the NN , the NNP NNP NNP and RB NN NNS . I VBD JJ to VB in NN about JJ NNS . ” In NNP of 2013 , NNP NNP VBZ on NNP NNP 2 to NNP , NNP , with his NN . His NN VBZ with JJ NNS , he VBZ RB JJ on NNP . The RBS JJ NN that VBZ VBZ 10 NNS after they VBP . And that VBZ when NNP NNP ’s JJ , JJ NN NN VBN NNP NNP NNPS VBZ a $ 1 billion JJ NN NN with the JJ NN , RB with the JJ NN , with the NN . And what NNS VBP to VB VBZ NNP NNP VBZ no NN in NNP , he VBZ no NN in JJ NN . NN Some JJ and JJ NN VBG out of NNP . NNP NNP , the JJ JJ JJ NN , who VBD one of the NNS to NNP — VBZ VBN VBN as the NN who “ VBD ” NNP to VB me to JJ NNPS and VB me up . This VBZ JJ . NN NN VBZ JJ NN – whether it VBZ in NNP NNP or NNP NNP ( RB in the NNP ) . NNP NNP VBD the NN of the NNP and his NN ( NNP 17 , 1917 ) The JJ NN VBD their NN from NNP - NNP and NNP to the NNP NNP from “ NNP NNP ” on NNP 17 , 1917 because of JJ NN in the NNP NNP during NNP NNP I . NN : JJ NNS this NN VBZ with NN NNS VB NNS VB in NN NNP VBZ 20 JJR NNP NNS to VB NN Despite NN VBG No NNS VB It VBZ JJ , JJ NN , NN NN , and NN NNS Hi NNS ! I VBP VBG my NN NN to a NN NN NN . NNP will VB my JJ on this my JJ NN . VBG RB to VBG you RB . VB to NNP ! As VBN in the JJ NN NN , we VBP VBG our NN NNS . Before we VBP the VBN NNS at OUR NN , we will VB VBG them RB so that you can VB the NN . There VBZ a NN the NNS VBP you in NN with JJ NN , NN , NNS , and NN . This VBZ to VB you ‘ VBN ’ in your JJR NNS so that you VBP JJ to ‘ VB the NN ’ VBN to VB your JJ NN . NNP VBZ the NN for the NNP of NNP : A JJ NNP of NNP . What VBZ RB with all the NNPS ?"
122,762,mainstream,M0b407,vaccine; vaccine.autism,"Most_JJS Americans_NNPS think_VBP vaccines_NNS are_VBP beneficial_JJ for_IN health_NN ,_, and_CC that_IN children_NNS should_MD be_VB required_VBN to_TO get_VB them_PRP ,_, according_VBG to_IN a_DT new_JJ poll_NN ._. The_DT poll_NN ,_, from_IN Pew_NNP Research_NNP Center_NNP ,_, found_VBD 82_CD percent_NN of_IN U.S._NNP adults_NNS say_VB healthy_JJ children_NNS should_MD be_VB required_VBN to_TO get_VB the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NN )_-RRB- vaccine_NN in_IN order_NN to_TO attend_VB school_NN ,_, while_IN just_RB 17_CD percent_NN say_VBP parents_NNS should_MD be_VB able_JJ to_TO decide_VB not_RB to_TO vaccine_VB their_PRP$ kids_NNS ._. In_IN addition_NN ,_, nearly_RB three_CD -_HYPH quarters_NNS of_IN respondents_NNS (_-LRB- 73_CD percent_NN )_-RRB- rated_VBD the_DT health_NN benefits_NNS of_IN the_DT MMR_NNP vaccine_NN as_IN ""_`` high_JJ ""_'' or_CC ""_`` very_RB high_JJ ,_, ""_'' while_IN just_RB 7_CD percent_NN rated_VBD the_DT benefits_NNS as_IN ""_`` low_JJ ._. ""_'' Overall_RB ,_, 88_CD percent_NN of_IN Americans_NNPS said_VBD the_DT benefits_NNS of_IN the_DT MMR_NN vaccine_NN outweigh_VBP the_DT risks_NNS ,_, the_DT poll_NN found_VBD ._. [_-LRB- Just_RB How_WRB Safe_JJ Are_VBP Vaccines_NNS ?_. Here_RB Are_VBP the_DT Numbers_NNS ]_-RRB- Still_RB ,_, parents_NNS with_IN young_JJ children_NNS were_VBD slightly_RB more_RBR concerned_JJ about_IN the_DT safety_NN of_IN the_DT MMR_NN vaccine_NN ._. The_DT poll_NN found_VBD that_IN about_RB 43_CD percent_NN of_IN parents_NNS with_IN children_NNS ages_NNS 0_CD to_IN 4_CD years_NNS rated_VBD the_DT risks_NNS of_IN the_DT MMR_NNP vaccine_NN as_IN ""_`` medium_JJ ""_'' or_CC ""_`` high_JJ ,_, ""_'' compared_VBN with_IN 29_CD percent_NN of_IN parents_NNS with_IN no_DT children_NNS under_IN 18_CD ._. Some_DT reports_NNS have_VBP found_VBN that_IN people_NNS in_IN more_RBR affluent_JJ communities_NNS are_VBP less_RBR likely_JJ to_TO vaccinate_VB their_PRP$ children_NNS ,_, which_WDT has_VBZ led_VBN to_IN speculation_NN that_IN people_NNS with_IN higher_JJR incomes_NNS are_VBP more_RBR concerned_JJ about_IN vaccine_NN safety_NN ,_, Pew_NNP said_VBD ._. But_CC the_DT new_JJ poll_NN found_VBD people_NNS with_IN higher_JJR incomes_NNS tended_VBD to_TO have_VB a_DT positive_JJ view_NN of_IN vaccines_NNS —_: 97_CD percent_NN of_IN those_DT with_IN a_DT family_NN income_NN of_IN $_$ 100,000_CD a_DT year_NN or_CC more_JJR said_VBD that_IN the_DT benefits_NNS of_IN the_DT MMR_NN vaccine_NN outweigh_VBP the_DT risks_NNS ,_, and_CC 78_CD percent_NN rated_VBD the_DT risks_NNS of_IN the_DT vaccine_NN as_IN low_JJ ._. Among_IN those_DT with_IN a_DT family_NN income_NN of_IN less_JJR than_IN $_$ 30,000_CD a_DT year_NN ,_, 60_CD percent_NN rated_VBD the_DT risks_NNS of_IN the_DT MMR_NNP vaccine_NN as_IN low_JJ ,_, and_CC 79_CD percent_NN said_VBD the_DT benefits_NNS outweigh_VBP the_DT risks_NNS ._. The_DT poll_NN also_RB looked_VBD at_IN Americans_NNPS '_POS views_NNS on_IN the_DT MMR_NNP vaccine_NN among_IN different_JJ ideologies_NNS ._. It_PRP found_VBD that_IN 25_CD percent_NN of_IN people_NNS who_WP identify_VBP as_IN conservative_JJ said_VBD that_IN parents_NNS should_MD be_VB able_JJ to_TO decide_VB not_RB to_TO vaccine_VB their_PRP$ children_NNS ,_, compared_VBN with_IN 15_CD percent_NN of_IN people_NNS who_WP identify_VBP as_IN moderate_JJ ,_, and_CC 9_CD percent_NN of_IN people_NNS who_WP identify_VBP as_IN liberal_JJ ._. Still_RB ,_, the_DT majority_NN of_IN conservatives_NNS (_-LRB- 73_CD percent_NN )_-RRB- said_VBD that_IN healthy_JJ children_NNS should_MD be_VB required_VBN to_TO get_VB the_DT MMR_NN vaccine_NN to_TO attend_VB school_NN ,_, and_CC 90_CD percent_NN of_IN liberals_NNS agreed_VBD with_IN this_DT statement_NN ._. Historically_RB ,_, some_DT people_NNS with_IN concerns_NNS about_IN vaccines_NNS have_VBP cited_VBN a_DT now_RB -_HYPH widely_RB discredited_VBN study_NN linking_VBG the_DT MMR_NNP vaccine_NN to_IN autism_NN ._. There_EX are_VBP now_RB more_JJR than_IN 20_CD rigorous_JJ scientific_JJ studies_NNS that_WDT have_VBP failed_VBN to_TO find_VB a_DT link_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ,_, and_CC the_DT original_JJ study_NN was_VBD retracted_VBN ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. The_DT poll_NN results_NNS are_VBP based_VBN on_IN interviews_NNS with_IN 1,549_CD Americans_NNPS ages_NNS 18_CD or_CC older_JJR ,_, which_WDT took_VBD place_NN from_IN May_NNP to_IN June_NNP 2016_CD ._. The_DT survey_NN sample_NN is_VBZ nationally_RB representative_JJ ,_, and_CC the_DT poll_NN 's_POS margin_NN of_IN error_NN is_VBZ 4_CD percent_NN ,_, Pew_NNP said_VBD ._.","JJS NNPS VBP NNS VBP JJ for NN , and that NNS should VB VBN to VB them , VBG to a JJ NN . The NN , from NNP NNP NNP , VBD 82 NN of NNP NNS VB JJ NNS should VB VBN to VB the NNS , NNS and NN ( NN ) NN in NN to VB NN , while RB 17 NN VBP NNS should VB JJ to VB RB to VB their NNS . In NN , RB three - NNS of NNS ( 73 NN ) VBD the NN NNS of the NNP NN as "" JJ "" or "" RB JJ , "" while RB 7 NN VBD the NNS as "" JJ . "" RB , 88 NN of NNPS VBD the NNS of the NN NN VBP the NNS , the NN VBD . [ RB How JJ VBP NNS ? RB VBP the NNS ] RB , NNS with JJ NNS VBD RB RBR JJ about the NN of the NN NN . The NN VBD that RB 43 NN of NNS with NNS NNS 0 to 4 NNS VBD the NNS of the NNP NN as "" JJ "" or "" JJ , "" VBN with 29 NN of NNS with no NNS under 18 . Some NNS VBP VBN that NNS in RBR JJ NNS VBP RBR JJ to VB their NNS , which VBZ VBN to NN that NNS with JJR NNS VBP RBR JJ about NN NN , NNP VBD . But the JJ NN VBD NNS with JJR NNS VBD to VB a JJ NN of NNS — 97 NN of those with a NN NN of $ 100,000 a NN or JJR VBD that the NNS of the NN NN VBP the NNS , and 78 NN VBD the NNS of the NN as JJ . Among those with a NN NN of JJR than $ 30,000 a NN , 60 NN VBD the NNS of the NNP NN as JJ , and 79 NN VBD the NNS VBP the NNS . The NN RB VBD at NNPS ' NNS on the NNP NN among JJ NNS . It VBD that 25 NN of NNS who VBP as JJ VBD that NNS should VB JJ to VB RB to VB their NNS , VBN with 15 NN of NNS who VBP as JJ , and 9 NN of NNS who VBP as JJ . RB , the NN of NNS ( 73 NN ) VBD that JJ NNS should VB VBN to VB the NN NN to VB NN , and 90 NN of NNS VBD with this NN . RB , some NNS with NNS about NNS VBP VBN a RB - RB VBN NN VBG the NNP NN to NN . There VBP RB JJR than 20 JJ JJ NNS that VBP VBN to VB a NN between the NN NN and NN , and the JJ NN VBD VBN , VBG to the NNPS for NNP NNP and NNP . The NN NNS VBP VBN on NNS with 1,549 NNPS NNS 18 or JJR , which VBD NN from NNP to NNP 2016 . The NN NN VBZ RB JJ , and the NN 's NN of NN VBZ 4 NN , NNP VBD ."
123,243,mainstream,M084ea,vaccine,"Pregnant_JJ women_NNS can_MD breathe_VB easy_JJ about_IN getting_VBG flu_NN and_CC whooping_VBG cough_NN vaccines_NNS during_IN pregnancy_NN ,_, and_CC there_EX 's_VBZ no_DT reason_NN to_TO be_VB concerned_JJ about_IN getting_VBG them_PRP both_CC at_IN the_DT same_JJ time_NN ,_, experts_NNS say_VBP ._. Doctors_NNS previously_RB recommended_VBD the_DT two_CD vaccines_NNS be_VB given_VBN weeks_NNS apart_RB ._. But_CC a_DT new_JJ ,_, six_CD -_HYPH year_NN study_NN published_VBN Wednesday_NNP in_IN the_DT journal_NN Obstetrics_NNP and_CC Gynecology_NNP reports_VBZ that_IN getting_VBG the_DT shots_NNS at_IN the_DT same_JJ time_NN is_VBZ just_RB as_RB safe_JJ as_IN spacing_VBG them_PRP out_RP ._. The_DT researchers_NNS analyzed_VBD data_NNS on_IN 36,844_CD women_NNS ,_, ages_NNS 14_CD to_IN 49_CD ,_, who_WP received_VBD flu_NN and_CC whooping_VBG cough_NN vaccines_NNS during_IN pregnancy_NN between_IN 2007_CD and_CC 2013_CD ._. In_IN 23_CD percent_NN of_IN pregnancies_NNS the_DT vaccines_NNS were_VBD given_VBN at_IN the_DT same_JJ time_NN and_CC in_IN the_DT other_JJ 77_CD percent_NN the_DT vaccines_NNS were_VBD administered_VBN at_IN separate_JJ times_NNS ._. Vaccine_NN research_NN scientist_NN and_CC study_NN co-author_NN Marlene_NNP Lugg_NNP said_VBD they_PRP found_VBD no_DT significant_JJ increased_VBN risk_NN of_IN fever_NN or_CC other_JJ adverse_JJ effects_NNS to_IN mother_NN or_CC baby_NN ._. ""_`` There_EX was_VBD no_DT difference_NN in_IN early_JJ birth_NN ,_, low_JJ birth_NN weight_NN ,_, in_IN any_DT of_IN the_DT babies_NNS '_POS outcomes_NNS ,_, ""_'' said_VBD Lugg_NNP ._. Dr._NNP Richard_NNP Beigi_NNP ,_, Chief_NNP Medical_NNP Officer_NNP and_CC Vice_NNP President_NNP of_IN Medical_NNP Affairs_NNPS at_IN Magee_NNP -_HYPH Womens_NNP Hospital_NNP at_IN the_DT University_NNP of_IN Pittsburgh_NNP Medical_NNP Center_NNP ,_, told_VBD CBS_NNP News_NNP there_EX was_VBD no_DT reason_NN to_TO believe_VB getting_VBG the_DT two_CD vaccines_NNS together_RB would_MD be_VB unsafe_JJ in_IN pregnant_JJ women_NNS ,_, but_CC it_PRP had_VBD never_RB been_VBN addressed_VBN before_RB in_IN research_NN ._. ""_`` This_DT study_NN is_VBZ reassuring_JJ in_IN that_IN it_PRP involved_VBD thousands_NNS of_IN women_NNS at_IN multiple_JJ centers_NNS ,_, ""_'' said_VBD Beigi_NNP ,_, who_WP is_VBZ also_RB a_DT spokesperson_NN for_IN the_DT American_NNP Congress_NNP of_IN Obstetricians_NNPS and_CC Gynecologists_NNPS ._. ""_`` It_PRP validates_VBZ what_WP we_PRP 've_VBP already_RB known_VBN for_IN years_NNS but_CC it_PRP 's_VBZ really_RB nice_JJ to_TO see_VB this_DT ._. It_PRP provides_VBZ reassurance_NN that_IN when_WRB you_PRP give_VBP them_PRP together_RB it_PRP 's_VBZ very_RB safe_JJ ._. There_EX 's_VBZ no_DT signal_NN in_IN study_NN that_WDT would_MD be_VB of_IN concern_NN for_IN an_DT OB_NN care_NN provider_NN ._. ""_'' Beigi_NNP said_VBD this_DT study_NN does_VBZ n't_RB delve_VB into_IN how_WRB the_DT vaccines_NNS impact_VBP the_DT unborn_JJ baby_NN after_IN birth_NN ,_, but_CC he_PRP said_VBD ,_, ""_`` There_EX 's_VBZ no_DT reason_NN to_TO believe_VB there_EX would_MD be_VB an_DT issue_NN ._. ""_'' He_PRP said_VBD research_NN suggests_VBZ that_IN if_IN you_PRP immunize_VBP a_DT mother_NN with_IN the_DT flu_NN vaccine_NN it_PRP protects_VBZ the_DT baby_NN as_RB well_RB ._. ""_`` Numerous_JJ studies_NNS show_VBP immunizing_VBG the_DT mother_NN protects_VBZ the_DT baby_NN ._. ""_'' Pregnant_JJ women_NNS who_WP catch_VBP the_DT flu_NN are_VBP at_IN risk_NN for_IN serious_JJ complications_NNS and_CC hospitalization_NN ,_, according_VBG to_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. Beigi_NNP said_VBD it_PRP 's_VBZ not_RB clear_JJ why_WRB they_PRP 're_VBP more_RBR vulnerable_JJ but_CC it_PRP may_MD be_VB linked_VBN to_IN immunological_JJ or_CC anatomical_JJ changes_NNS during_IN pregnancy_NN ._. Lugg_NNP said_VBD pregnant_JJ women_NNS need_VBP to_TO ""_`` understand_VB that_IN it_PRP 's_VBZ extremely_RB safe_JJ and_CC it_PRP protects_VBZ them_PRP and_CC the_DT baby_NN ._. ""_'' Protection_NN against_IN whooping_NN cough_NN is_VBZ also_RB important_JJ for_IN pregnant_JJ women_NNS and_CC others_NNS who_WP spend_VBP time_NN around_IN newborns_NNS since_IN the_DT illness_NN can_MD be_VB extremely_RB serious_JJ for_IN infants_NNS ._. Expectant_JJ mom_NN Emily_NNP Whitehead_NNP ,_, 32_CD ,_, is_VBZ due_JJ in_IN seven_CD weeks_NNS and_CC said_VBD she_PRP plans_VBZ to_TO get_VB vaccinated_VBN against_IN flu_NN and_CC whooping_NN cough_NN ._. The_DT DTaP_NNP vaccine_NN includes_VBZ tetanus_NN ,_, diphtheria_NN ,_, and_CC pertussis_NN ,_, commonly_RB known_VBN as_IN whooping_NN cough_NN ._. ""_`` We_PRP definitely_RB are_VBP mindful_JJ about_IN vaccinations_NNS ._. I_PRP 've_VBP heard_VBN that_IN the_DT whooping_NN cough_NN is_VBZ ,_, like_UH ,_, a_DT really_RB good_JJ one_NN to_TO get_VB ,_, ""_'' she_PRP said_VBD ._.","JJ NNS can VB JJ about VBG NN and VBG NN NNS during NN , and there VBZ no NN to VB JJ about VBG them both at the JJ NN , NNS VBP . NNS RB VBD the two NNS VB VBN NNS RB . But a JJ , six - NN NN VBN NNP in the NN NNP and NNP VBZ that VBG the NNS at the JJ NN VBZ RB RB JJ as VBG them out . The NNS VBD NNS on 36,844 NNS , NNS 14 to 49 , who VBD NN and VBG NN NNS during NN between 2007 and 2013 . In 23 NN of NNS the NNS VBD VBN at the JJ NN and in the JJ 77 NN the NNS VBD VBN at JJ NNS . NN NN NN and NN NN NNP NNP VBD they VBD no JJ VBN NN of NN or JJ JJ NNS to NN or NN . "" There VBD no NN in JJ NN , JJ NN NN , in any of the NNS ' NNS , "" VBD NNP . NNP NNP NNP , NNP NNP NNP and NNP NNP of NNP NNPS at NNP - NNP NNP at the NNP of NNP NNP NNP , VBD NNP NNP there VBD no NN to VB VBG the two NNS RB would VB JJ in JJ NNS , but it VBD RB VBN VBN RB in NN . "" This NN VBZ JJ in that it VBD NNS of NNS at JJ NNS , "" VBD NNP , who VBZ RB a NN for the NNP NNP of NNPS and NNPS . "" It VBZ what we VBP RB VBN for NNS but it VBZ RB JJ to VB this . It VBZ NN that when you VBP them RB it VBZ RB JJ . There VBZ no NN in NN that would VB of NN for an NN NN NN . "" NNP VBD this NN VBZ RB VB into how the NNS VBP the JJ NN after NN , but he VBD , "" There VBZ no NN to VB there would VB an NN . "" He VBD NN VBZ that if you VBP a NN with the NN NN it VBZ the NN RB RB . "" JJ NNS VBP VBG the NN VBZ the NN . "" JJ NNS who VBP the NN VBP at NN for JJ NNS and NN , VBG to the NNP NNPS for NNP NNP and NNP . NNP VBD it VBZ RB JJ why they VBP RBR JJ but it may VB VBN to JJ or JJ NNS during NN . NNP VBD JJ NNS VBP to "" VB that it VBZ RB JJ and it VBZ them and the NN . "" NN against NN NN VBZ RB JJ for JJ NNS and NNS who VBP NN around NNS since the NN can VB RB JJ for NNS . JJ NN NNP NNP , 32 , VBZ JJ in seven NNS and VBD she VBZ to VB VBN against NN and NN NN . The NNP NN VBZ NN , NN , and NN , RB VBN as NN NN . "" We RB VBP JJ about NNS . I VBP VBN that the NN NN VBZ , like , a RB JJ NN to VB , "" she VBD ."
124,101,mainstream,M0b6b6,vaccine.covid,"There_EX is_VBZ no_DT guarantee_NN a_DT vaccine_NN for_IN coronavirus_NN will_MD be_VB found_VBN ,_, the_DT Health_NNP Secretary_NNP has_VBZ warned_VBN ._. Speaking_VBG as_IN the_DT UK_NNP has_VBZ the_DT second_JJ highest_JJS death_NN toll_NN in_IN the_DT world_NN ,_, Matt_NNP Hancock_NNP said_VBD Britons_NNPS may_MD have_VB to_TO ""_`` find_VB a_DT way_NN to_TO live_VB with_IN the_DT virus_NN ""_'' if_IN the_DT race_NN to_TO develop_VB a_DT vaccine_NN fails_VBZ ._. However_RB ,_, he_PRP said_VBD some_DT of_IN the_DT restrictions_NNS on_IN the_DT 1.5_CD million_CD vulnerable_JJ people_NNS who_WP have_VBP been_VBN told_VBN to_TO ""_`` shield_VB ""_'' themselves_PRP for_IN 12_CD weeks_NNS could_MD be_VB lifted_VBN ,_, even_RB if_IN there_EX was_VBD not_RB a_DT vaccine_NN ._. Mr_NNP Hancock_NNP told_VBD Sky_NNP News_NNP :_: ""_`` If_IN a_DT vaccine_NN can't_MD be_VB found_VBN then_RB we_PRP have_VBP to_TO learn_VB to_TO find_VB a_DT way_NN to_TO live_VB with_IN this_DT virus_NN so_RB that_DT means_VBZ getting_VBG the_DT numbers_NNS down_RP and_CC holding_VBG them_PRP down_RP through_IN ,_, for_IN instance_NN ,_, mass_NN -_HYPH scale_NN testing_NN and_CC then_RB tracing_VBG the_DT virus_NN through_IN a_DT combination_NN of_IN technology_NN and_CC human_JJ contact_NN tracers_NNS ._. ""_'' Sign_VB up_RP to_TO get_VB the_DT Mirror_NNP ’s_POS daily_JJ coronavirus_NN briefing_NN email_NN at_IN mirror_NN ._. co.uk_NN /_, email_NN -_, in_IN your_PRP$ inbox_NN after_IN the_DT press_NN conference_NN every_DT evening_NN ._. He_PRP added_VBD :_: ""_`` We_PRP may_MD well_RB be_VB able_JJ to_TO release_VB some_DT of_IN those_DT measures_NNS before_IN a_DT vaccine_NN is_VBZ available_JJ if_IN we_PRP can_MD get_VB the_DT number_NN of_IN new_JJ cases_NNS right_RB down_RB ._. ""_'' ""_`` If_IN we_PRP succeed_VBP in_IN doing_VBG that_DT we_PRP will_MD be_VB able_JJ to_TO take_VB clinical_JJ advice_NN on_IN whether_IN it_PRP is_VBZ safe_JJ for_IN those_DT who_WP are_VBP shielded_VBN to_IN ,_, for_IN instance_NN ,_, to_TO hug_VB their_PRP$ grandchildren_NNS ._. That_DT is_VBZ right_JJ at_IN the_DT front_NN of_IN my_PRP$ mind_NN ._. ""_'' Mr_NNP Hancock_NNP was_VBD answering_VBG Britons_NNPS questions_NNS about_IN coronavirus_NN ,_, the_DT government_NN 's_POS handling_NN of_IN the_DT outbreak_NN and_CC how_WRB and_CC when_WRB lockdown_NN restrictions_NNS will_MD be_VB eased_VBN ._. He_PRP rejected_VBD claims_NNS the_DT Government_NN had_VBD sacrificed_VBN people_NNS in_IN care_NN homes_NNS in_IN order_NN to_TO protect_VB the_DT NHS_NNP during_IN the_DT pandemic_NN ._. But_CC he_PRP acknowledged_VBD that_IN a_DT lack_NN of_IN capacity_NN meant_VBD it_PRP had_VBD not_RB been_VBN possible_JJ to_TO test_VB everyone_NN leaving_VBG hospitals_NNS for_IN Covid_NNP -_HYPH 19_CD before_IN they_PRP went_VBD into_IN a_DT care_NN home_NN ._. The_DT Health_NNP Secretary_NNP claimed_VBD the_DT UK_NNP is_VBZ now_RB a_DT world_NN leader_NN in_IN testing_NN for_IN Covid_NNP -_HYPH 19_CD ._. He_PRP dmitted_VBD that_IN it_PRP would_MD have_VB been_VBN ""_`` wonderful_JJ ""_'' to_TO have_VB a_DT diagnostics_NN industry_NN like_IN Germany_NNP to_TO tackle_VB the_DT coronavirus_NN crisis_NN -_, but_CC insisted_VBD the_DT UK_NNP has_VBZ now_RB caught_VBN up_RP with_IN the_DT Germans_NNPS in_IN terms_NNS of_IN testing_NN ._. It_PRP came_VBD after_IN Security_NNP Minister_NNP James_NNP Brokenshire_NNP said_VBD ""_`` capacity_NN constraints_NNS ""_'' meant_VBD widespread_JJ checks_NNS in_IN the_DT community_NN were_VBD scrapped_VBN in_IN mid-March_NNP ._. Mr_NNP Hancock_NNP also_RB said_VBD it_PRP is_VBZ too_RB soon_RB to_TO say_VB when_WRB schools_NNS are_VBP able_JJ to_TO return_VB ._. He_PRP said_VBD he_PRP was_VBD left_VBN speechless_JJ by_IN Professor_NNP Neil_NNP Ferguson_NNP 's_POS breach_NN of_IN lockdown_NN rules_NNS and_CC subsequent_JJ resignation_NN from_IN Sage_NNP ._. Professor_NNP Ferguson_NNP was_VBD right_JJ to_TO resign_VB from_IN the_DT scientific_JJ advice_NN board_NN and_CC social_JJ distancing_NN rules_NNS are_VBP in_IN place_NN for_IN everyone_NN ._. he_PRP added_VBD ._. Mr_NNP Hancock_NNP said_VBD it_PRP was_VBD a_DT matter_NN for_IN the_DT police_NNS whether_IN they_PRP would_MD take_VB any_DT action_NN against_IN Professor_NNP Ferguson_NNP for_IN breaching_VBG the_DT rules_NNS ._. Asked_VBN by_IN a_DT viewer_NN during_IN a_DT Q&_NN A_NN how_WRB they_PRP could_MD safely_RB reopen_VB their_PRP$ cafe_NN once_IN the_DT lockdown_NN is_VBZ lifted_VBN ,_, Mr_NNP Hancock_NNP said_VBD some_DT businesses_NNS could_MD utilise_VB more_JJR outdoor_JJ working_VBG during_IN the_DT summer_NN months_NNS ._. The_DT Health_NNP Secretary_NNP suggested_VBD the_DT Government_NN was_VBD unlikely_JJ to_TO reduce_VB the_DT distance_NN people_NNS should_MD remain_VB away_RB from_IN each_DT other_JJ ,_, with_IN the_DT risk_NN of_IN infection_NN increasing_VBG ""_`` exponentially_RB ""_'' once_IN the_DT two_CD -_HYPH metre_NN recommended_VBN distance_NN is_VBZ shortened_VBN ,_, he_PRP said_VBD ._.","There VBZ no NN a NN for NN will VB VBN , the NNP NNP VBZ VBN . VBG as the NNP VBZ the JJ JJS NN NN in the NN , NNP NNP VBD NNPS may VB to "" VB a NN to VB with the NN "" if the NN to VB a NN VBZ . RB , he VBD some of the NNS on the 1.5 million JJ NNS who VBP VBN VBN to "" VB "" themselves for 12 NNS could VB VBN , RB if there VBD RB a NN . NNP NNP VBD NNP NNP : "" If a NN can't VB VBN RB we VBP to VB to VB a NN to VB with this NN RB that VBZ VBG the NNS down and VBG them down through , for NN , NN - NN NN and RB VBG the NN through a NN of NN and JJ NN NNS . "" VB up to VB the NNP ’s JJ NN NN NN at NN . NN / NN - in your NN after the NN NN every NN . He VBD : "" We may RB VB JJ to VB some of those NNS before a NN VBZ JJ if we can VB the NN of JJ NNS RB RB . "" "" If we VBP in VBG that we will VB JJ to VB JJ NN on whether it VBZ JJ for those who VBP VBN to , for NN , to VB their NNS . That VBZ JJ at the NN of my NN . "" NNP NNP VBD VBG NNPS NNS about NN , the NN 's NN of the NN and how and when NN NNS will VB VBN . He VBD NNS the NN VBD VBN NNS in NN NNS in NN to VB the NNP during the NN . But he VBD that a NN of NN VBD it VBD RB VBN JJ to VB NN VBG NNS for NNP - 19 before they VBD into a NN NN . The NNP NNP VBD the NNP VBZ RB a NN NN in NN for NNP - 19 . He VBD that it would VB VBN "" JJ "" to VB a NN NN like NNP to VB the NN NN - but VBD the NNP VBZ RB VBN up with the NNPS in NNS of NN . It VBD after NNP NNP NNP NNP VBD "" NN NNS "" VBD JJ NNS in the NN VBD VBN in NNP . NNP NNP RB VBD it VBZ RB RB to VB when NNS VBP JJ to VB . He VBD he VBD VBN JJ by NNP NNP NNP 's NN of NN NNS and JJ NN from NNP . NNP NNP VBD JJ to VB from the JJ NN NN and JJ NN NNS VBP in NN for NN . he VBD . NNP NNP VBD it VBD a NN for the NNS whether they would VB any NN against NNP NNP for VBG the NNS . VBN by a NN during a NN NN how they could RB VB their NN once the NN VBZ VBN , NNP NNP VBD some NNS could VB JJR JJ VBG during the NN NNS . The NNP NNP VBD the NN VBD JJ to VB the NN NNS should VB RB from each JJ , with the NN of NN VBG "" RB "" once the two - NN VBN NN VBZ VBN , he VBD ."
125,198,mainstream,M0a9d7,vaccine,"See_VB also_RB a_DT list_NN of_IN vaccines_NNS by_IN disease_NN ._. Vaccines_NNS are_VBP available_JJ for_IN these_DT 18_CD dangerous_JJ or_CC deadly_JJ diseases_NNS ._. Over_IN the_DT years_NNS ,_, these_DT vaccines_NNS have_VBP prevented_VBN countless_JJ cases_NNS of_IN disease_NN and_CC saved_VBD millions_NNS of_IN lives_NNS ._. Infants_NNS ,_, children_NNS ,_, adolescents_NNS ,_, teens_NNS and_CC adults_NNS need_VBP different_JJ vaccinations_NNS ,_, depending_VBG on_IN their_PRP$ age_NN ,_, location_NN ,_, job_NN ,_, lifestyle_NN ,_, travel_NN schedule_NN ,_, health_NN conditions_NNS or_CC previous_JJ vaccinations_NNS ._. Click_VB on_IN a_DT disease_NN name_NN to_TO learn_VB more_JJR about_IN the_DT diseases_NNS and_CC the_DT vaccines_NNS that_WDT prevent_VBP them_PRP ._. Vaccines_NNS Recommended_VBN for_IN Travel_NN and_CC Some_DT Specific_JJ Groups_NNS People_NNS in_IN certain_JJ research_NN jobs_NNS and_CC travel_NN situations_NNS may_MD be_VB exposed_VBN to_IN dangerous_JJ or_CC deadly_JJ diseases_NNS that_WDT are_VBP no_RB longer_RBR common_JJ in_IN the_DT U.S._NNP Because_IN of_IN the_DT increased_VBN risk_NN of_IN disease_NN exposure_NN in_IN these_DT instances_NNS ,_, these_DT 9_CD non-routine_JJ vaccines_NNS are_VBP available_JJ ,_, listed_VBN below_RB by_IN disease_NN ._. These_DT are_VBP considered_VBN non-routine_JJ vaccines_NNS because_IN they_PRP are_VBP not_RB part_NN of_IN the_DT recommended_VBN immunization_NN schedules_NNS for_IN children_NNS ,_, adolescents_NNS and_CC adults_NNS ._.","VB RB a NN of NNS by NN . NNS VBP JJ for these 18 JJ or JJ NNS . Over the NNS , these NNS VBP VBN JJ NNS of NN and VBD NNS of NNS . NNS , NNS , NNS , NNS and NNS VBP JJ NNS , VBG on their NN , NN , NN , NN , NN NN , NN NNS or JJ NNS . VB on a NN NN to VB JJR about the NNS and the NNS that VBP them . NNS VBN for NN and Some JJ NNS NNS in JJ NN NNS and NN NNS may VB VBN to JJ or JJ NNS that VBP RB RBR JJ in the NNP Because of the VBN NN of NN NN in these NNS , these 9 JJ NNS VBP JJ , VBN RB by NN . These VBP VBN JJ NNS because they VBP RB NN of the VBN NN NNS for NNS , NNS and NNS ."
126,433,mainstream,M0a427,vaccine.covid,"We_PRP do_VBP n’t_RB have_VB enough_JJ evidence_NN yet_RB to_TO know_VB if_IN recovering_VBG from_IN covid_NN -_HYPH 19_CD induces_VBZ immunity_NN ,_, or_CC whether_IN any_DT immunity_NN would_MD give_VB long_RB -_HYPH lasting_VBG protection_NN against_IN the_DT coronavirus_NN SAY_VB you_PRP have_VBP caught_VBN covid_NN -_HYPH 19_CD and_CC recovered_VBD –_: are_VBP you_PRP now_RB immune_JJ for_IN life_NN ,_, or_CC could_MD you_PRP catch_VB it_PRP again_RB ?_. We_PRP just_RB do_VBP n’t_RB know_VB yet_RB ._. In_IN February_NNP ,_, reports_NNS emerged_VBD of_IN a_DT woman_NN in_IN Japan_NNP who_WP had_VBD been_VBN given_VBN the_DT all_DT -_HYPH clear_JJ after_IN having_VBG covid_NN -_HYPH 19_CD but_CC then_RB tested_VBN positive_JJ for_IN the_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD virus_NN a_DT second_JJ time_NN ._. There_EX have_VBP also_RB been_VBN reports_NNS of_IN a_DT man_NN in_IN Japan_NNP testing_VBG positive_JJ after_IN being_VBG given_VBN the_DT all_DT -_HYPH clear_JJ ,_, and_CC anecdotal_JJ cases_NNS of_IN second_JJ positives_NNS have_VBP emerged_VBN from_IN China_NNP ,_, too_RB ._. This_DT has_VBZ raised_VBN fears_NNS that_IN people_NNS may_MD not_RB develop_VB immunity_NN to_IN the_DT virus_NN ._. This_DT would_MD mean_VB that_IN ,_, until_IN we_PRP have_VBP an_DT effective_JJ vaccine_NN ,_, we_PRP could_MD all_RB experience_VB repeated_VBN rounds_NNS of_IN infection_NN ._. But_CC the_DT science_NN is_VBZ still_RB uncertain_JJ ._. “_`` There_EX is_VBZ some_DT anecdotal_JJ evidence_NN of_IN reinfections_NNS ,_, but_CC we_PRP really_RB do_VBP n’t_RB know_VB ,_, ”_'' says_VBZ Ira_NNP Longini_NNP at_IN the_DT University_NNP of_IN Florida_NNP ._. It_PRP may_MD be_VB that_IN the_DT tests_NNS used_VBN were_VBD unreliable_JJ ,_, which_WDT is_VBZ a_DT problem_NN with_IN tests_NNS for_IN other_JJ respiratory_JJ viruses_NNS ,_, says_VBZ Jeffrey_NNP Shaman_NNP at_IN Columbia_NNP University_NNP in_IN New_NNP York_NNP ._. Early_JJ signs_NNS from_IN small_JJ animal_NN experiments_NNS are_VBP reassuring_JJ ._. A_DT team_NN from_IN the_DT Chinese_NNP Academy_NNP of_IN Medical_NNP Sciences_NNPS in_IN Beijing_NNP exposed_VBD four_CD rhesus_NN macaques_NNS to_IN the_DT virus_NN ._. A_DT week_NN later_RBR ,_, all_DT four_CD were_VBD ill_JJ with_IN covid_NN -_HYPH 19_CD -_HYPH like_JJ symptoms_NNS and_CC had_VBD high_JJ virus_NN loads_NNS ._. Two_CD weeks_NNS later_RBR ,_, the_DT macaques_NNS had_VBD recovered_VBN and_CC were_VBD confirmed_VBN to_TO have_VB antibodies_NNS to_IN the_DT virus_NN in_IN their_PRP$ bloodstream_NN ._. “_`` You_PRP can_MD be_VB infected_VBN with_IN other_JJ coronaviruses_NNS over_RB and_CC over_RB ._. We_PRP do_VBP n’t_RB know_VB if_IN that_DT ’s_VBZ true_JJ for_IN this_DT virus_NN ”_'' The_DT researchers_NNS then_RB tried_VBD to_TO reinfect_VB two_CD of_IN them_PRP but_CC failed_VBD ,_, which_WDT suggests_VBZ the_DT animals_NNS were_VBD immune_NN (_-LRB- bioRxiv_NNP ,_, doi.org/ggn8r8_NNP )_-RRB- ._. “_`` That_DT finding_NN is_VBZ very_RB encouraging_JJ ,_, as_IN it_PRP suggests_VBZ that_IN it_PRP is_VBZ possible_JJ to_TO induce_VB protective_JJ immunity_NN against_IN the_DT virus_NN ,_, ”_'' says_VBZ Alfredo_NNP Garzino_NNP -_HYPH Demo_NNP at_IN the_DT University_NNP of_IN Maryland_NNP School_NNP of_IN Medicine_NNP ._. But_CC that_DT does_VBZ n’t_RB necessarily_RB mean_VB long_JJ -_HYPH term_NN immunity_NN ._. There_EX are_VBP other_JJ coronaviruses_NNS circulating_VBG among_IN humans_NNS and_CC although_IN they_PRP induce_VBP immunity_NN ,_, this_DT does_VBZ n’t_RB last_VB ._. “_`` Some_DT other_JJ viruses_NNS in_IN the_DT coronavirus_NN family_NN ,_, such_JJ as_IN those_DT that_WDT cause_VBP common_JJ colds_NNS ,_, tend_VBP to_TO induce_VB immunity_NN that_WDT is_VBZ relatively_RB short_JJ -_HYPH lived_VBN ,_, at_IN around_RB three_CD months_NNS ,_, ”_'' says_VBZ Peter_NNP Openshaw_NNP at_IN Imperial_NNP College_NNP London_NNP ._. “_`` Because_IN [_-LRB- the_DT virus_NN ]_-RRB- is_VBZ so_RB new_JJ ,_, we_PRP do_VBP not_RB yet_RB know_VB how_WRB long_RB any_DT protection_NN generated_VBN through_IN infection_NN will_MD last_VB ._. We_PRP urgently_RB need_VBP more_JJR research_NN looking_VBG at_IN the_DT immune_JJ responses_NNS of_IN people_NNS who_WP have_VBP recovered_VBN from_IN infection_NN to_TO be_VB sure_JJ ,_, ”_'' says_VBZ Openshaw_NNP ._. Other_JJ immunologists_NNS agree_VBP ._. “_`` Immunity_NN to_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD is_VBZ not_RB yet_RB well_RB understood_VBN and_CC we_PRP do_VBP not_RB know_VB how_WRB protective_JJ the_DT antibody_NN response_NN will_MD be_VB in_IN the_DT long_JJ -_HYPH term_NN ,_, ”_'' says_VBZ Erica_NNP Bickerton_NNP at_IN the_DT Pirbright_NNP Institute_NNP in_IN the_DT UK_NNP ._. “_`` For_IN ordinary_JJ coronavirus_NN infections_NNS ,_, you_PRP do_VBP not_RB get_VB lasting_VBG immunity_NN ,_, ”_'' says_VBZ Longini_NNP ._. “_`` You_PRP can_MD be_VB infected_VBN over_RB and_CC over_RB ,_, and_CC we_PRP really_RB do_VBP n’t_RB know_VB for_IN this_DT novel_JJ coronavirus_NN if_IN that_DT ’s_VBZ also_RB true_JJ ._. ”_'' Other_JJ infectious_JJ disease_NN specialists_NNS are_VBP more_RBR optimistic_JJ ._. “_`` The_DT evidence_NN is_VBZ increasingly_RB convincing_JJ that_IN infection_NN with_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD leads_VBZ to_IN an_DT antibody_NN response_NN that_WDT is_VBZ protective_JJ ._. Most_RBS likely_JJ this_DT protection_NN is_VBZ for_IN life_NN ,_, ”_'' says_VBZ Martin_NNP Hibberd_NNP at_IN the_DT London_NNP School_NNP of_IN Hygiene_NNP &_CC Tropical_NNP Medicine_NNP ._. “_`` Although_IN we_PRP need_VBP more_JJR evidence_NN to_TO be_VB sure_JJ of_IN this_DT ,_, people_NNS who_WP have_VBP recovered_VBN are_VBP unlikely_JJ to_TO be_VB infected_VBN with_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD again_RB ._. ”_'' Health_NN Check_NN newsletter_NN Get_VB the_DT latest_JJS health_NN news_NN in_IN your_PRP$ inbox_NN every_DT week_NN newscientist.com_NN /_, healthcheck_NN","We VBP RB VB JJ NN RB to VB if VBG from NN - 19 VBZ NN , or whether any NN would VB RB - VBG NN against the NN VB you VBP VBN NN - 19 and VBD – VBP you RB JJ for NN , or could you VB it RB ? We RB VBP RB VB RB . In NNP , NNS VBD of a NN in NNP who VBD VBN VBN the all - JJ after VBG NN - 19 but RB VBN JJ for the NNP - NNP - 2 NN a JJ NN . There VBP RB VBN NNS of a NN in NNP VBG JJ after VBG VBN the all - JJ , and JJ NNS of JJ NNS VBP VBN from NNP , RB . This VBZ VBN NNS that NNS may RB VB NN to the NN . This would VB that , until we VBP an JJ NN , we could RB VB VBN NNS of NN . But the NN VBZ RB JJ . “ There VBZ some JJ NN of NNS , but we RB VBP RB VB , ” VBZ NNP NNP at the NNP of NNP . It may VB that the NNS VBN VBD JJ , which VBZ a NN with NNS for JJ JJ NNS , VBZ NNP NNP at NNP NNP in NNP NNP . JJ NNS from JJ NN NNS VBP JJ . A NN from the NNP NNP of NNP NNPS in NNP VBD four NN NNS to the NN . A NN RBR , all four VBD JJ with NN - 19 - JJ NNS and VBD JJ NN NNS . Two NNS RBR , the NNS VBD VBN and VBD VBN to VB NNS to the NN in their NN . “ You can VB VBN with JJ NNS RB and RB . We VBP RB VB if that VBZ JJ for this NN ” The NNS RB VBD to VB two of them but VBD , which VBZ the NNS VBD NN ( NNP , NNP ) . “ That NN VBZ RB JJ , as it VBZ that it VBZ JJ to VB JJ NN against the NN , ” VBZ NNP NNP - NNP at the NNP of NNP NNP of NNP . But that VBZ RB RB VB JJ - NN NN . There VBP JJ NNS VBG among NNS and although they VBP NN , this VBZ RB VB . “ Some JJ NNS in the NN NN , JJ as those that VBP JJ NNS , VBP to VB NN that VBZ RB JJ - VBN , at RB three NNS , ” VBZ NNP NNP at NNP NNP NNP . “ Because [ the NN ] VBZ RB JJ , we VBP RB RB VB how RB any NN VBN through NN will VB . We RB VBP JJR NN VBG at the JJ NNS of NNS who VBP VBN from NN to VB JJ , ” VBZ NNP . JJ NNS VBP . “ NN to NN - NN - 2 VBZ RB RB RB VBN and we VBP RB VB how JJ the NN NN will VB in the JJ - NN , ” VBZ NNP NNP at the NNP NNP in the NNP . “ For JJ NN NNS , you VBP RB VB VBG NN , ” VBZ NNP . “ You can VB VBN RB and RB , and we RB VBP RB VB for this JJ NN if that VBZ RB JJ . ” JJ JJ NN NNS VBP RBR JJ . “ The NN VBZ RB JJ that NN with NNP - NNP - 2 VBZ to an NN NN that VBZ JJ . RBS JJ this NN VBZ for NN , ” VBZ NNP NNP at the NNP NNP of NNP & NNP NNP . “ Although we VBP JJR NN to VB JJ of this , NNS who VBP VBN VBP JJ to VB VBN with NN - NN - 2 RB . ” NN NN NN VB the JJS NN NN in your NN every NN NN / NN"
127,1311,mainstream,M0b023,vaccine,"Richard_NNP Bright_NNP ,_, former_JJ director_NN of_IN the_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP ,_, arrives_VBZ for_IN a_DT House_NNP Energy_NNP and_CC Commerce_NNP Subcommittee_NNP on_IN Health_NNP hearing_NN to_TO discuss_VB protecting_VBG scientific_JJ integrity_NN in_IN response_NN to_IN the_DT coronavirus_NN outbreak_NN ,_, Thursday_NNP ,_, May_NNP 14_CD ,_, 2020_CD on_IN Capitol_NNP Hill_NNP in_IN Washington_NNP ._. (_-LRB- Greg_NNP Nash_NNP /_, Pool_NNP via_IN AP_NNP )_-RRB- Richard_NNP Bright_NNP ,_, former_JJ director_NN of_IN the_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP ,_, arrives_VBZ for_IN a_DT House_NNP Energy_NNP and_CC Commerce_NNP Subcommittee_NNP on_IN Health_NNP hearing_NN to_TO discuss_VB protecting_VBG scientific_JJ integrity_NN in_IN response_NN to_IN the_DT coronavirus_NN outbreak_NN ,_, Thursday_NNP ,_, May_NNP 14_CD ,_, 2020_CD on_IN Capitol_NNP Hill_NNP in_IN Washington_NNP ._. (_-LRB- Greg_NNP Nash_NNP /_, Pool_NNP via_IN AP_NNP )_-RRB- WASHINGTON_NNP (_-LRB- AP_NN )_-RRB- —_: Despite_IN White_NNP House_NNP claims_NNS ,_, the_DT U.S._NNP still_RB lacks_VBZ a_DT comprehensive_JJ battle_NN plan_NN against_IN the_DT coronavirus_NN in_IN critical_JJ areas_NNS including_VBG masks_NNS ,_, testing_NN ,_, treatments_NNS and_CC vaccines_NNS ,_, whistleblower_NN Rick_NNP Bright_NNP warned_VBD Thursday_NNP in_IN testimony_NN before_IN a_DT House_NNP committee_NN ._. “_`` Our_PRP$ window_NN of_IN opportunity_NN is_VBZ closing_VBG ,_, ”_'' he_PRP declared_VBD ._. The_DT nation_NN could_MD face_VB “_`` the_DT darkest_JJS winter_NN in_IN modern_JJ history_NN ”_'' if_IN the_DT virus_NN rebounds_VBZ ,_, the_DT government_NN vaccine_NN scientist_NN told_VBD lawmakers_NNS ._. Bright_NNP ’s_POS appearance_NN came_VBD after_IN his_PRP$ ouster_NN last_JJ month_NN as_IN head_NN of_IN a_DT Health_NNP and_CC Human_NNP Services_NNPS biodefense_NN agency_NN ,_, an_DT action_NN he_PRP alleges_VBZ was_VBD retaliation_NN by_IN the_DT Trump_NNP administration_NN ._. “_`` We_PRP need_VBP still_RB a_DT comprehensive_JJ plan_NN ,_, and_CC everyone_NN across_IN the_DT government_NN and_CC everyone_NN in_IN America_NNP needs_VBZ to_TO know_VB what_WP that_DT plan_NN is_VBZ ,_, and_CC what_WDT role_NN they_PRP play_VBP ,_, ”_'' he_PRP told_VBD the_DT House_NNP Energy_NNP and_CC Commerce_NNP Committee_NNP ._. “_`` There_EX are_VBP critical_JJ steps_NNS that_WDT we_PRP need_VBP to_TO do_VB to_TO prepare_VB ..._, we_PRP do_VBP not_RB still_RB have_VB enough_JJ personal_JJ protective_JJ equipment_NN to_TO manage_VB our_PRP$ health_NN care_NN workers_NNS ..._, we_PRP still_RB do_VBP not_RB have_VB the_DT supply_NN chains_NNS ramped_VBN up_RP for_IN the_DT drugs_NNS and_CC vaccines_NNS ,_, and_CC we_PRP still_RB do_VBP n’t_RB have_VB plans_NNS in_IN place_NN for_IN how_WRB we_PRP distribute_VBP those_DT drugs_NNS and_CC vaccines_NNS ._. We_PRP still_RB do_VBP not_RB have_VB a_DT comprehensive_JJ testing_NN strategy_NN ._. ”_'' At_IN the_DT White_NNP House_NNP ,_, President_NNP Donald_NNP Trump_NNP said_VBD Bright_NNP looked_VBD like_IN an_DT “_`` angry_JJ ,_, disgruntled_JJ employee_NN ,_, ”_'' and_CC Bright_NNP ’s_POS boss_NN ,_, HHS_NNP Secretary_NNP Alex_NNP Azar_NNP ,_, said_VBD ,_, “_`` Everything_NN he_PRP is_VBZ complaining_VBG about_IN was_VBD achieved_VBN ._. ”_'' “_`` So_RB this_DT is_VBZ like_IN somebody_NN who_WP was_VBD in_IN a_DT choir_NN and_CC is_VBZ now_RB trying_VBG to_TO say_VB he_PRP was_VBD a_DT soloist_NN back_RB then_RB ,_, ”_'' Azar_NNP added_VBD ._. Trump_NNP ,_, said_VBD later_RBR ,_, at_IN a_DT Pennsylvania_NNP medical_JJ equipment_NN distributor_NN ,_, that_IN the_DT U.S._NNP is_VBZ ramping_VBG up_RP production_NN of_IN COVID_NN -_HYPH 19_CD -_HYPH related_JJ items_NNS and_CC that_IN his_PRP$ goal_NN “_'' is_VBZ to_TO produce_VB everything_NN America_NNP needs_VBZ for_IN ourselves_PRP and_CC then_RB export_VB to_IN the_DT world_NN ,_, including_VBG medicines_NNS ._. ”_'' Bright_NNP spoke_VBD in_IN measured_VBN tones_NNS and_CC rarely_RB raised_VBD his_PRP$ voice_NN during_IN five_CD hours_NNS of_IN questioning_NN ._. He_PRP did_VBD n’t_RB question_VB the_DT fact_NN that_IN there_EX ’s_VBZ now_RB an_DT all_DT -_HYPH out_NN effort_NN ,_, financed_VBN by_IN billions_NNS in_IN taxpayer_NN dollars_NNS ,_, to_TO procure_VB masks_NNS and_CC other_JJ supplies_NNS ,_, develop_VB better_JJR tests_NNS and_CC treatments_NNS and_CC discover_VB an_DT effective_JJ vaccine_NN ._. His_PRP$ point_NN was_VBD that_IN those_DT efforts_NNS are_VBP n’t_RB being_VBG fitted_VBN together_RB in_IN a_DT coherent_JJ strategy_NN that_WDT will_MD get_VB supplies_NNS and_CC medicines_NNS to_IN where_WRB they_PRP ’re_VBP most_RBS needed_VBN to_TO protect_VB people_NNS and_CC prevent_VB shortages_NNS and_CC price_NN gouging_NN ._. Asked_VBN by_IN Rep._NNP Joe_NNP Kennedy_NNP ,_, D_NNP -_HYPH Mass._NNP ,_, if_IN administration_NN officials_NNS have_VBP prepared_VBN the_DT country_NN for_IN the_DT “_`` moment_NN we_PRP are_VBP in_IN ”_'' and_CC the_DT months_NNS ahead_RB ,_, Bright_NNP responded_VBD ,_, “_`` I_PRP think_VBP we_PRP have_VBP a_DT lot_NN of_IN work_NN to_TO do_VB to_TO be_VB prepared_VBN ._. ”_'' Rep._NNP Frank_NNP Pallone_NNP ,_, D_NNP -_HYPH N.J._NNP ,_, asked_VBD if_IN he_PRP should_MD be_VB concerned_VBN that_IN Americans_NNPS will_MD have_VB problems_NNS getting_VBG access_NN to_IN a_DT vaccine_NN when_WRB it_PRP ’s_VBZ available_JJ ._. Bright_NNP responded_VBD ,_, “_`` Absolutely_RB ,_, sir_NNP ._. ”_'' Bright_NNP ,_, a_DT career_NN official_NN ,_, alleges_VBZ he_PRP was_VBD removed_VBN as_IN head_NN of_IN the_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP after_IN repeatedly_RB warning_VBG higher_JJR -_HYPH ups_NNS the_DT virus_NN outbreak_NN was_VBD going_VBG to_TO be_VB worse_JJR than_IN the_DT public_NN was_VBD being_VBG led_VBN to_TO believe_VB ._. He_PRP said_VBD the_DT breaking_NN point_NN came_VBD when_WRB he_PRP opposed_VBD a_DT White_NNP House_NNP directive_NN to_TO allow_VB widespread_JJ access_NN to_IN hydroxychloroquine_NN ,_, a_DT malaria_NN drug_NN Trump_NNP was_VBD touting_VBG as_IN an_DT effective_JJ treatment_NN ._. The_DT FDA_NNP recently_RB warned_VBD against_IN its_PRP$ use_NN for_IN COVID_NNP -_HYPH 19_CD ,_, except_IN in_IN limited_JJ circumstances_NNS ._. But_CC at_IN the_DT White_NNP House_NNP on_IN Thursday_NNP ,_, the_DT president_NN was_VBD still_RB bullish_JJ ._. “_`` We_PRP ’ve_VBP had_VBN tremendous_JJ response_NN to_IN the_DT hydroxy_NN ,_, ”_'' Trump_NNP said_VBD ._. “_`` So_RB ,_, a_DT lot_NN of_IN people_NNS have_VBP sworn_VBN by_IN it_PRP ,_, and_CC we_PRP ’ll_MD see_VB ._. ”_'' Republican_JJ lawmakers_NNS for_IN the_DT most_JJS part_NN were_VBD careful_JJ not_RB to_TO attack_VB Bright_NNP directly_RB ._. But_CC Rep._NNP Markwayne_NNP Mullin_NNP of_IN Oklahoma_NNP criticized_VBD him_PRP for_IN continuing_VBG to_TO collect_VB his_PRP$ $_$ 285,000_CD salary_NN while_IN first_RB on_IN sick_JJ leave_NN for_IN a_DT spike_NN in_IN blood_NN pressure_NN ,_, and_CC now_RB on_IN vacation_NN as_IN he_PRP tries_VBZ to_TO straighten_VB out_RP his_PRP$ work_NN situation_NN ._. “_`` You_PRP ’re_VBP too_RB sick_JJ to_TO go_VB into_IN work_NN ,_, but_CC you_PRP ’re_VBP well_RB enough_JJ to_TO come_VB here_RB while_IN getting_VBG paid_VBN ,_, ”_'' said_VBD Mullin_NNP ._. “_`` I_PRP have_VBP a_DT hard_JJ time_NN understanding_VBG that_DT ._. ”_'' Bright_NNP said_VBD one_CD of_IN the_DT worst_JJS moments_NNS as_IN he_PRP tried_VBD to_TO raise_VB alarms_NNS came_VBD when_WRB repeated_VBN efforts_NNS to_TO jump_VB -_HYPH start_VB U.S._NNP production_NN of_IN respirator_NN masks_NNS went_VBD nowhere_RB ._. He_PRP recalled_VBD getting_VBG emails_NNS in_IN late_JJ January_NNP from_IN Mike_NNP Bowen_NNP ,_, an_DT executive_NN at_IN a_DT medical_JJ supply_NN company_NN called_VBN Prestige_NNP Ameritech_NNP ,_, indicating_VBG that_IN its_PRP$ N95_NN mask_NN supply_NN was_VBD “_`` completely_RB decimated_VBN ._. ”_'' “_`` And_CC he_PRP said_VBD :_: ‘_`` We_PRP ’re_VBP in_IN deep_JJ shit_NN ._. The_DT world_NN is_VBZ ._. And_CC we_PRP need_VBP to_TO act_VB ,_, ’_'' ”_'' Bright_NNP said_VBD ._. “_`` And_CC I_PRP pushed_VBD that_DT forward_RB to_IN the_DT highest_JJS levels_NNS I_PRP could_MD in_IN HHS_NNP and_CC got_VBD no_DT response_NN ._. From_IN that_DT moment_NN I_PRP knew_VBD that_IN we_PRP were_VBD going_VBG to_TO have_VB a_DT crisis_NN for_IN our_PRP$ health_NN care_NN workers_NNS because_IN we_PRP were_VBD not_RB taking_VBG action_NN ._. ”_'' Following_VBG Bright_NNP to_IN the_DT witness_NN table_NN ,_, Bowen_NNP told_VBD lawmakers_NNS he_PRP ’s_VBZ a_DT Republican_NNP who_WP voted_VBD for_IN Trump_NNP ._. He_PRP paused_VBD then_RB ,_, and_CC added_VBD that_IN he_PRP admires_VBZ Bright_NNP ._. As_IN part_NN of_IN his_PRP$ whistleblower_NN complaint_NN ,_, Bright_NNP is_VBZ seeking_VBG to_TO be_VB reinstated_VBN in_IN his_PRP$ old_JJ job_NN ._. A_DT federal_JJ watchdog_NN agency_NN has_VBZ found_VBN “_`` reasonable_JJ grounds_NNS ”_'' that_IN he_PRP was_VBD removed_VBN as_IN a_DT reprisal_NN ._. HHS_NNP ,_, Bright_NNP ’s_POS employer_NN ,_, says_VBZ it_PRP strongly_RB disagrees_VBZ with_IN his_PRP$ allegations_NNS and_CC says_VBZ it_PRP reassigned_VBD him_PRP to_IN a_DT high_JJ -_HYPH profile_NN position_NN helping_VBG to_TO lead_VB the_DT development_NN of_IN new_JJ coronavirus_NN tests_NNS at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._. Nearly_RB 85,000_CD people_NNS have_VBP died_VBN from_IN COVID_NN -_HYPH 19_CD in_IN the_DT U.S._NNP ,_, representing_VBG more_JJR than_IN one_CD -_HYPH fourth_NN of_IN global_JJ deaths_NNS and_CC the_DT world_NN ’s_POS highest_JJS toll_NN ,_, according_VBG to_IN figures_NNS compiled_VBN by_IN Johns_NNP Hopkins_NNP University_NNP ._. Worldwide_RB more_JJR than_IN 4.4_CD million_CD have_VBP been_VBN infected_VBN and_CC about_RB 300,000_CD have_VBP died_VBN ._. Bright_NNP ’s_POS testimony_NN followed_VBD this_DT week_NN ’s_POS warning_NN by_IN Dr._NNP Anthony_NNP Fauci_NNP ,_, the_DT government_NN ’s_POS top_JJ infectious_JJ disease_NN expert_NN ,_, that_IN a_DT rushed_VBN lifting_NN of_IN store_NN -_HYPH closing_NN and_CC stay_VB -_HYPH at_IN -_HYPH home_NN restrictions_NNS could_MD “_`` turn_VB back_RP the_DT clock_NN ,_, ”_'' seeding_VBG more_JJR suffering_NN and_CC death_NN and_CC complicating_VBG efforts_NNS to_TO get_VB the_DT economy_NN rolling_VBG again_RB ._. Eager_JJ to_TO restart_VB the_DT U.S._NNP economy_NN ,_, Trump_NNP has_VBZ been_VBN urging_VBG states_NNS to_TO lift_VB restrictions_NNS ,_, and_CC many_JJ governors_NNS are_VBP doing_VBG so_RB gradually_RB ,_, though_IN consumers_NNS remain_VBP leery_JJ of_IN going_VBG back_RB to_IN restaurants_NNS ,_, social_JJ events_NNS and_CC sporting_NN competitions_NNS ._. Bright_NNP ,_, who_WP has_VBZ a_DT doctoral_JJ degree_NN in_IN immunology_NN ,_, said_VBD the_DT nation_NN ’s_POS path_NN forward_RB should_MD be_VB based_VBN on_IN science_NN ._. The_DT steps_NNS include_VBP :_: —_: Establishing_VBG a_DT national_JJ testing_NN strategy_NN ._. The_DT White_NNP House_NNP has_VBZ urged_VBN states_NNS to_TO take_VB the_DT lead_NN on_IN testing_NN ,_, even_RB as_IN the_DT federal_JJ government_NN pushes_VBZ to_TO make_VB more_JJR tests_NNS and_CC better_JJR ones_NNS widely_RB available_JJ ._. Trump_NNP says_VBZ the_DT U.S._NNP has_VBZ “_`` prevailed_VBN ”_'' on_IN testing_NN through_IN this_DT strategy_NN ,_, but_CC in_IN Congress_NNP Democrats_NNPS are_VBP demanding_VBG a_DT federal_JJ framework_NN to_TO encompass_VB the_DT whole_JJ nation_NN ._. —_: Doubling_VBG down_RP on_IN educating_VBG the_DT public_NN about_IN basic_JJ safety_NN measures_NNS such_JJ as_IN frequent_JJ hand_NN -_HYPH washing_NN and_CC wearing_VBG masks_NNS in_IN public_JJ places_NNS ._. “_`` Frankly_RB ,_, our_PRP$ leaders_NNS must_MD lead_VB by_IN modeling_VBG the_DT behavior_NN ,_, ”_'' said_VBD Bright_NNP ,_, in_IN a_DT not_RB -_HYPH too_RB -_HYPH subtle_JJ reference_NN to_IN a_DT president_NN who_WP conspicuously_RB goes_VBZ maskless_JJ ._. —_: Setting_VBG up_RP a_DT system_NN to_TO fairly_RB distribute_VB equipment_NN and_CC supplies_NNS that_WDT are_VBP scarce_JJ and_CC highly_RB sought_VBN ._. Eliminating_VBG state_NN vs._IN state_NN competition_NN would_MD increase_VB efficiency_NN and_CC reduce_VB costs_NNS ._.","NNP NNP , JJ NN of the NNP NNP NNP and NNP NNP , VBZ for a NNP NNP and NNP NNP on NNP NN to VB VBG JJ NN in NN to the NN NN , NNP , NNP 14 , 2020 on NNP NNP in NNP . ( NNP NNP / NNP via NNP ) NNP NNP , JJ NN of the NNP NNP NNP and NNP NNP , VBZ for a NNP NNP and NNP NNP on NNP NN to VB VBG JJ NN in NN to the NN NN , NNP , NNP 14 , 2020 on NNP NNP in NNP . ( NNP NNP / NNP via NNP ) NNP ( NN ) — Despite NNP NNP NNS , the NNP RB VBZ a JJ NN NN against the NN in JJ NNS VBG NNS , NN , NNS and NNS , NN NNP NNP VBD NNP in NN before a NNP NN . “ Our NN of NN VBZ VBG , ” he VBD . The NN could VB “ the JJS NN in JJ NN ” if the NN VBZ , the NN NN NN VBD NNS . NNP ’s NN VBD after his NN JJ NN as NN of a NNP and NNP NNPS NN NN , an NN he VBZ VBD NN by the NNP NN . “ We VBP RB a JJ NN , and NN across the NN and NN in NNP VBZ to VB what that NN VBZ , and what NN they VBP , ” he VBD the NNP NNP and NNP NNP . “ There VBP JJ NNS that we VBP to VB to VB ... we VBP RB RB VB JJ JJ JJ NN to VB our NN NN NNS ... we RB VBP RB VB the NN NNS VBN up for the NNS and NNS , and we RB VBP RB VB NNS in NN for how we VBP those NNS and NNS . We RB VBP RB VB a JJ NN NN . ” At the NNP NNP , NNP NNP NNP VBD NNP VBD like an “ JJ , JJ NN , ” and NNP ’s NN , NNP NNP NNP NNP , VBD , “ NN he VBZ VBG about VBD VBN . ” “ RB this VBZ like NN who VBD in a NN and VBZ RB VBG to VB he VBD a NN RB RB , ” NNP VBD . NNP , VBD RBR , at a NNP JJ NN NN , that the NNP VBZ VBG up NN of NN - 19 - JJ NNS and that his NN “ VBZ to VB NN NNP VBZ for ourselves and RB VB to the NN , VBG NNS . ” NNP VBD in VBN NNS and RB VBD his NN during five NNS of NN . He VBD RB VB the NN that there VBZ RB an all - NN NN , VBN by NNS in NN NNS , to VB NNS and JJ NNS , VB JJR NNS and NNS and VB an JJ NN . His NN VBD that those NNS VBP RB VBG VBN RB in a JJ NN that will VB NNS and NNS to where they VBP RBS VBN to VB NNS and VB NNS and NN NN . VBN by NNP NNP NNP , NNP - NNP , if NN NNS VBP VBN the NN for the “ NN we VBP in ” and the NNS RB , NNP VBD , “ I VBP we VBP a NN of NN to VB to VB VBN . ” NNP NNP NNP , NNP - NNP , VBD if he should VB VBN that NNPS will VB NNS VBG NN to a NN when it VBZ JJ . NNP VBD , “ RB , NNP . ” NNP , a NN NN , VBZ he VBD VBN as NN of the NNP NNP NNP and NNP NNP after RB VBG JJR - NNS the NN NN VBD VBG to VB JJR than the NN VBD VBG VBN to VB . He VBD the NN NN VBD when he VBD a NNP NNP NN to VB JJ NN to NN , a NN NN NNP VBD VBG as an JJ NN . The NNP RB VBD against its NN for NNP - 19 , except in JJ NNS . But at the NNP NNP on NNP , the NN VBD RB JJ . “ We VBP VBN JJ NN to the NN , ” NNP VBD . “ RB , a NN of NNS VBP VBN by it , and we ’ll VB . ” JJ NNS for the JJS NN VBD JJ RB to VB NNP RB . But NNP NNP NNP of NNP VBD him for VBG to VB his $ 285,000 NN while RB on JJ NN for a NN in NN NN , and RB on NN as he VBZ to VB out his NN NN . “ You VBP RB JJ to VB into NN , but you VBP RB JJ to VB RB while VBG VBN , ” VBD NNP . “ I VBP a JJ NN VBG that . ” NNP VBD one of the JJS NNS as he VBD to VB NNS VBD when VBN NNS to VB - VB NNP NN of NN NNS VBD RB . He VBD VBG NNS in JJ NNP from NNP NNP , an NN at a JJ NN NN VBN NNP NNP , VBG that its NN NN NN VBD “ RB VBN . ” “ And he VBD : ‘ We VBP in JJ NN . The NN VBZ . And we VBP to VB , ’ ” NNP VBD . “ And I VBD that RB to the JJS NNS I could in NNP and VBD no NN . From that NN I VBD that we VBD VBG to VB a NN for our NN NN NNS because we VBD RB VBG NN . ” VBG NNP to the NN NN , NNP VBD NNS he VBZ a NNP who VBD for NNP . He VBD RB , and VBD that he VBZ NNP . As NN of his NN NN , NNP VBZ VBG to VB VBN in his JJ NN . A JJ NN NN VBZ VBN “ JJ NNS ” that he VBD VBN as a NN . NNP , NNP ’s NN , VBZ it RB VBZ with his NNS and VBZ it VBD him to a JJ - NN NN VBG to VB the NN of JJ NN NNS at the NNP NNPS of NNP . RB 85,000 NNS VBP VBN from NN - 19 in the NNP , VBG JJR than one - NN of JJ NNS and the NN ’s JJS NN , VBG to NNS VBN by NNP NNP NNP . RB JJR than 4.4 million VBP VBN VBN and RB 300,000 VBP VBN . NNP ’s NN VBD this NN ’s NN by NNP NNP NNP , the NN ’s JJ JJ NN NN , that a VBN NN of NN - NN and VB - at - NN NNS could “ VB back the NN , ” VBG JJR NN and NN and VBG NNS to VB the NN VBG RB . JJ to VB the NNP NN , NNP VBZ VBN VBG NNS to VB NNS , and JJ NNS VBP VBG RB RB , though NNS VBP JJ of VBG RB to NNS , JJ NNS and NN NNS . NNP , who VBZ a JJ NN in NN , VBD the NN ’s NN RB should VB VBN on NN . The NNS VBP : — VBG a JJ NN NN . The NNP NNP VBZ VBN NNS to VB the NN on NN , RB as the JJ NN VBZ to VB JJR NNS and JJR NNS RB JJ . NNP VBZ the NNP VBZ “ VBN ” on NN through this NN , but in NNP NNPS VBP VBG a JJ NN to VB the JJ NN . — VBG down on VBG the NN about JJ NN NNS JJ as JJ NN - NN and VBG NNS in JJ NNS . “ RB , our NNS must VB by VBG the NN , ” VBD NNP , in a RB - RB - JJ NN to a NN who RB VBZ JJ . — VBG up a NN to RB VB NN and NNS that VBP JJ and RB VBN . VBG NN vs. NN NN would VB NN and VB NNS ."
128,798,mainstream,M086c8,vaccine.covid,"It_PRP is_VBZ an_DT everyday_JJ miracle_NN ,_, mysterious_JJ and_CC beguiling_JJ ,_, and_CC it_PRP is_VBZ replicated_VBN several_JJ thousand_CD times_NNS over_RB ,_, at_IN all_DT hours_NNS ,_, in_IN churches_NNS that_WDT are_VBP beautiful_JJ and_CC churches_NNS that_WDT are_VBP not_RB ._. The_DT priest_NN consecrates_VBZ the_DT bread_NN ,_, and_CC then_RB he_PRP consecrates_VBZ the_DT wine_NN ,_, and_CC there_RB on_IN the_DT altar_NN the_DT meal_NN becomes_VBZ the_DT body_NN and_CC blood_NN of_IN Christ_NNP ._. Then_RB ,_, just_RB as_IN Jesus_NNP broke_VBD bread_NN and_CC shared_VBD wine_NN with_IN the_DT apostles_NNS at_IN the_DT Last_NNP Supper_NNP ,_, believers_NNS rise_VBP from_IN the_DT pews_NNS ,_, receive_VBP the_DT host_NN ,_, eat_VBP it_PRP ,_, and_CC ,_, one_CD by_IN one_CD ,_, drink_VBP the_DT Precious_NNP Blood_NNP ,_, putting_VBG their_PRP$ lips_NNS to_IN the_DT same_JJ cup_NN ._. That_DT last_JJ part_NN does_VBZ n’t_RB happen_VB these_DT days_NNS ._. Churches_NNS are_VBP closed_VBN and_CC services_NNS have_VBP been_VBN moved_VBN online_RB ,_, for_IN one_CD ,_, but_CC the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP has_VBZ also_RB advised_VBN against_IN it_PRP ._. Before_IN the_DT pandemic_NN ,_, William_NNP Ouweleen_NNP had_VBD drunk_JJ from_IN such_PDT a_DT cup_NN countless_JJ times_NNS ._. A_DT vintner_NN in_IN the_DT Finger_NNP Lakes_NNP region_NN of_IN New_NNP York_NNP ,_, he_PRP used_VBD to_TO attend_VB mass_NN and_CC receive_VB communion_NN at_IN St._NNP Matthew_NNP Church_NNP ,_, in_IN Livonia_NNP ,_, where_WRB the_DT Precious_NNP Blood_NNP in_IN the_DT chalice_NN had_VBD been_VBN a_DT blush_NN -_HYPH colored_VBN wine_NN that_WDT he_PRP ’d_VBD made_VBN ._. Ouweleen_NNP runs_VBZ a_DT winery_NN named_VBN O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP ,_, which_WDT makes_VBZ sacramental_JJ wine_NN that_WDT churches_NNS use_VBP to_TO celebrate_VB the_DT Eucharist_NNP ._. The_DT winery_NN ,_, which_WDT is_VBZ next_RB to_IN Hemlock_NNP Lake_NNP —_: “_`` o_IN -_HYPH neh_NNP -_HYPH da_NNP ”_'' is_VBZ the_DT Seneca_NNP word_NN for_IN “_`` hemlock_NN ”_'' —_: is_VBZ the_DT go_NN -_HYPH to_IN for_IN Catholics_NNPS in_IN the_DT Northeast_NNP ._. When_WRB Pope_NNP Francis_NNP visited_VBD New_NNP York_NNP City_NNP ,_, in_IN 2015_CD ,_, he_PRP used_VBD O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP wine_NN for_IN a_DT mass_NN at_IN Madison_NNP Square_NNP Garden_NNP ._. In_IN contrast_NN to_IN regular_JJ wine_NN ,_, which_WDT might_MD be_VB made_VBN with_IN extra_JJ yeast_NN ,_, tannin_NN powders_NNS ,_, and_CC flavorings_NNS ,_, Communion_NN wine_NN must_MD be_VB “_`` natural_JJ ,_, from_IN the_DT fruit_NN of_IN the_DT grape_NN ,_, pure_JJ and_CC incorrupt_JJ ,_, not_RB mixed_VBN with_IN other_JJ substances_NNS ,_, ”_'' according_VBG to_IN Vatican_NNP instructions_NNS ._. So_RB ,_, last_JJ fall_NN ,_, Ouweleen_NNP ,_, a_DT self_NN -_HYPH described_VBN “_`` hippie_NN ”_'' who_WP is_VBZ fifty_CD -_HYPH eight_CD and_CC wears_VBZ his_PRP$ hair_NN in_IN dreadlocks_NNS ,_, did_VBD what_WP he_PRP does_VBZ every_DT fall_NN :_: he_PRP harvested_VBD forty_CD acres_NNS ’_POS worth_NN of_IN grapes_NNS ,_, trucked_VBD them_PRP to_IN his_PRP$ winery_NN ,_, crushed_VBD them_PRP ,_, and_CC allowed_VBD them_PRP to_TO ferment_VB with_IN no_DT additives_NNS ._. (_-LRB- Except_IN ,_, that_DT is_VBZ ,_, for_IN some_DT added_VBN sulfites_NNS ,_, just_RB before_IN bottling_VBG —_: a_DT preservative_NN sanctioned_VBN by_IN the_DT Vatican_NNP ._. )_-RRB- By_IN springtime_NN ,_, he_PRP had_VBD fifty_CD thousand_CD gallons_NNS of_IN wine_NN in_IN his_PRP$ cellar_NN ._. This_DT time_NN of_IN year_NN ,_, he_PRP would_MD usually_RB be_VB filling_VBG fifteen_CD hundred_CD wine_NN bottles_NNS per_IN day_NN ,_, in_IN order_NN to_TO deliver_VB them_PRP to_IN churches_NNS in_IN New_NNP York_NNP and_CC Pennsylvania_NNP ,_, and_CC to_IN religious_JJ -_HYPH goods_NNS stores_NNS as_RB far_RB away_RB as_IN Florida_NNP and_CC Guam_NNP ._. But_CC he_PRP is_VBZ n’t_RB doing_VBG that_DT this_DT year_NN ,_, because_IN it_PRP would_MD mean_VB purchasing_VBG glass_NN bottles_NNS to_TO fill_VB with_IN wine_NN that_WDT might_MD not_RB sell_VB ._. Ouweleen_NNP does_VBZ n’t_RB know_VB when_WRB the_DT churches_NNS will_MD reopen_VB ._. This_DT past_JJ Friday_NNP ,_, President_NNP Trump_NNP deemed_VBD houses_NNS of_IN worship_NN “_`` essential_JJ ”_'' and_CC asked_VBD all_DT governors_NNS to_TO allow_VB them_PRP “_`` to_TO open_VB right_RB now_RB ,_, for_IN this_DT weekend_NN ,_, ”_'' but_CC ,_, in_IN New_NNP York_NNP ,_, houses_NNS of_IN worship_NN can_MD only_RB fully_RB reopen_VB in_IN the_DT last_JJ phase_NN of_IN the_DT state_NN ’s_POS four_CD -_HYPH part_NN reopening_NN plan_NN ,_, along_IN with_IN stadiums_NNS and_CC amusement_NN parks_NNS ._. Ouweleen_NNP is_VBZ also_RB not_RB sure_JJ that_IN ,_, when_WRB they_PRP do_VBP reopen_VB ,_, they_PRP will_MD continue_VB to_TO serve_VB consecrated_VBN wine_NN ,_, which_WDT ,_, in_IN most_JJS of_IN the_DT country_NN ’s_POS Catholic_JJ churches_NNS ,_, is_VBZ drunk_JJ from_IN a_DT chalice_NN that_WDT is_VBZ shared_VBN by_IN the_DT entire_JJ congregation_NN ._. So_RB he_PRP decided_VBD to_TO ask_VB them_PRP ._. Last_JJ month_NN ,_, Ouweleen_NNP typed_VBD up_RP a_DT letter_NN to_IN the_DT bishop_NN in_IN Albany_NNP ,_, to_TO ask_VB if_IN he_PRP had_VBD any_DT foresight_NN on_IN the_DT future_NN of_IN sacramental_JJ wine_NN ._. A_DT week_NN later_RBR ,_, still_RB awaiting_VBG a_DT reply_NN ,_, Ouweleen_NNP broadened_VBD his_PRP$ query_NN ,_, writing_VBG to_IN more_JJR than_IN a_DT thousand_CD parishes_NNS —_: all_DT customers_NNS of_IN his_PRP$ —_: to_TO ask_VB if_IN they_PRP plan_VBP to_TO distribute_VB the_DT Eucharist_NNP by_IN chalice_NN ,_, once_IN church_NN services_NNS resume_VBP ._. In_IN his_PRP$ letter_NN to_IN the_DT priests_NNS ,_, Ouweleen_NNP explained_VBD that_IN O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP had_VBD survived_VBN —_: by_IN God_NNP ’s_POS grace_NN —_: several_JJ wars_NNS ,_, the_DT Great_NNP Depression_NNP ,_, and_CC Prohibition_NNP ,_, but_CC ,_, “_`` the_DT Good_NNP Lord_NNP helps_VBZ those_DT who_WP help_VBP themselves_PRP ,_, so_RB we_PRP are_VBP taking_VBG an_DT active_JJ role_NN in_IN planning_VBG for_IN the_DT other_JJ side_NN of_IN this_DT pandemic_NN ._. ”_'' Ouweleen_NNP figured_VBD that_IN the_DT wine_NN in_IN his_PRP$ cellar_NN would_MD last_VB for_IN about_RB a_DT year_NN before_IN its_PRP$ taste_NN started_VBD to_TO fade_VB ._. “_`` I_PRP ’ll_MD know_VB what_WP to_TO do_VB with_IN that_DT wine_NN when_WRB I_PRP know_VBP what_WP to_TO do_VB ,_, ”_'' he_PRP said_VBD ._. “_`` This_DT graceful_JJ hand_NN of_IN the_DT unseen_NN has_VBZ been_VBN very_RB present_JJ in_IN my_PRP$ life_NN ,_, and_CC I_PRP respect_VBP that_DT ._. ”_'' In_IN the_DT meantime_NN ,_, he_PRP continued_VBD checking_VBG in_RP on_IN his_PRP$ vineyard_NN ._. By_IN September_NNP ,_, his_PRP$ vines_NNS will_MD have_VB produced_VBN two_CD hundred_CD tons_NNS of_IN grapes_NNS ,_, which_WDT will_MD yield_VB another_DT forty_CD thousand_CD gallons_NNS of_IN wine_NN ._. It_PRP was_VBD getting_VBG warm_JJ ,_, and_CC the_DT vines_NNS were_VBD about_RB to_TO bud_VB ._. There_EX are_VBP three_CD major_JJ sacramental_JJ wineries_NNS in_IN the_DT United_NNP States_NNPS :_: Mont_NNP La_NNP Salle_NNP and_CC Cribari_NNP ,_, both_CC in_IN California_NNP ,_, and_CC O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP ,_, in_IN New_NNP York_NNP ,_, which_WDT is_VBZ the_DT smallest_JJS and_CC the_DT oldest_JJS ._. Established_VBN in_IN 1872_CD by_IN Bishop_NNP Bernard_NNP McQuaid_NNP ,_, the_DT first_JJ bishop_NN of_IN Rochester_NNP ,_, O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP was_VBD originally_RB run_VBN by_IN seminarians_NNS ,_, and_CC ,_, later_RBR ,_, by_IN monks_NNS ._. In_IN 2002_CD ,_, it_PRP was_VBD purchased_VBN by_IN Steven_NNP Goldstone_NNP ,_, who_WP ’d_VBD recently_RB retired_VBN as_IN the_DT C.E.O._NNP of_IN RJR_NNP Nabisco_NNP ,_, the_DT food_NN and_CC tobacco_NN conglomerate_NN ,_, and_CC who_WP ’d_VBD seen_VBN a_DT notice_NN in_IN the_DT Wall_NNP Street_NNP Journal_NNP advertising_VBG a_DT winery_NN for_IN sale_NN in_IN the_DT Finger_NNP Lakes_NNPS ._. (_-LRB- Goldstone_NNP ,_, a_DT private_JJ pilot_NN ,_, liked_VBD to_TO fly_VB over_IN the_DT region_NN in_IN his_PRP$ plane_NN ._. )_-RRB- In_IN 2007_CD ,_, there_EX was_VBD another_DT ad_NN —_: this_DT time_NN ,_, in_IN the_DT PennySaver_NNP ,_, for_IN a_DT rental_JJ house_NN on_IN the_DT O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP Winery_NNP ’s_POS property_NN ,_, which_WDT would_MD cost_VB eight_CD hundred_CD and_CC fifty_CD dollars_NNS a_DT month_NN ._. Ouweleen_NNP responded_VBD to_IN it_PRP ;_, he_PRP and_CC his_PRP$ wife_NN ,_, Lisa_NNP Woodhams_NNP ,_, and_CC his_PRP$ stepson_NN ,_, Jacob_NNP ,_, were_VBD facing_VBG eviction_NN from_IN their_PRP$ home_NN in_IN Conesus_NNP ._. The_DT family_NN was_VBD continuously_RB hard_JJ up_RP —_: Ouweleen_NNP was_VBD the_DT manager_NN of_IN an_DT organic_JJ market_NN that_WDT was_VBD trying_VBG (_-LRB- and_CC failing_VBG )_-RRB- to_TO compete_VB with_IN Wegmans_NNPS —_: and_CC they_PRP were_VBD searching_VBG for_IN a_DT gentler_JJR ,_, more_RBR Christ_NN -_HYPH like_IN life_NN ._. (_-LRB- They_PRP wrote_VBD a_DT prayer_NN :_: “_`` Land_NN with_IN a_DT view_NN /_, a_DT ridge_NN line_NN or_CC two_CD …_: a_DT place_NN to_TO grow_VB /_, with_IN maintenance_NN kept_VBN low_JJ /_, sanctuary_NN where_WRB /_, we_PRP reap_VBP what_WP we_PRP sow_VBP ._. ”_'' “_`` Divinity_NNP ,_, ”_'' it_PRP concluded_VBD ,_, “_`` make_VB it_PRP so_RB ._. ”_'' )_-RRB- The_DT rental_NN ,_, an_DT old_JJ winemaker_NN ’s_POS house_NN built_VBN in_IN the_DT twenties_NNS ,_, with_IN three_CD bedrooms_NNS ,_, and_CC a_DT lot_NN of_IN bats_NNS in_IN the_DT attic_NN ,_, felt_VBD fated_JJ ._. The_DT family_NN moved_VBD in_RB and_CC learned_VBD ,_, upon_IN their_PRP$ arrival_NN ,_, that_IN the_DT winery_NN on_IN the_DT grounds_NNS was_VBD n’t_RB doing_VBG too_RB well_RB ._. (_-LRB- They_PRP had_VBD regular_JJ encounters_NNS with_IN the_DT winemaker_NN ,_, who_WP kept_VBD knocking_VBG on_IN their_PRP$ door_NN ,_, asking_VBG if_IN they_PRP had_VBD any_DT spare_NN trash_NN bags_NNS or_CC light_NN bulbs_NNS ._. )_-RRB- Ouweleen_NNP was_VBD also_RB looking_VBG for_IN a_DT new_JJ job_NN ,_, so_RB he_PRP called_VBD Goldstone_NNP and_CC told_VBD him_PRP ,_, “_`` I_PRP think_VBP I_PRP ’m_VBP supposed_VBN to_TO be_VB here_RB to_TO help_VB you_PRP with_IN this_DT winery_NN ._. ”_'' Goldstone_NNP flew_VBD north_RB to_TO meet_VB with_IN Ouweleen_NNP ,_, who_WP had_VBD prepared_VBN a_DT PowerPoint_NNP presentation_NN on_IN what_WP he_PRP described_VBD as_IN the_DT brand_NN ’s_POS “_`` natural_JJ assets_NNS ,_, ”_'' such_JJ as_IN its_PRP$ long_JJ ,_, almost_RB romantic_JJ history_NN of_IN sequestered_VBN religious_JJ men_NNS ministering_VBG to_IN its_PRP$ grapes_NNS ._. Ouweleen_NNP had_VBD no_DT experience_NN in_IN wine_NN -_HYPH making_VBG ,_, but_CC ,_, Goldstone_NNP said_VBD later_RBR ,_, “_`` It_PRP ’s_VBZ not_RB like_IN I_PRP had_VBD a_DT long_JJ line_NN of_IN prestigious_JJ winemakers_NNS waiting_VBG to_TO be_VB interviewed_VBN for_IN the_DT job_NN ._. ”_'' Goldstone_NNP decided_VBD ,_, of_IN Ouweleen_NNP and_CC his_PRP$ family_NN ,_, that_IN “_`` they_PRP belong_VBP there_RB ._. ”_'' The_DT two_CD men_NNS worked_VBD out_RP an_DT arrangement_NN in_IN which_WDT Ouweleen_NNP would_MD run_VB O_NNP -_HYPH Neh_NNP -_HYPH Dah_NNP ._. A_DT year_NN later_RBR ,_, Woodhams_NNP joined_VBD him_PRP ._. (_-LRB- She_PRP ’d_VBD been_VBN bartending_VBG and_CC waiting_VBG tables_NNS until_IN she_PRP was_VBD sure_JJ that_IN this_DT sacramental_JJ winery_NN gig_NN was_VBD going_VBG to_TO work_VB out_RP ._. )_-RRB- Together_RB with_IN one_CD other_JJ full_JJ -_HYPH time_NN employee_NN and_CC several_JJ part_NN -_HYPH time_NN staff_NN ,_, Ouweleen_NNP and_CC Woodhams_NNP do_VBP the_DT work_NN of_IN a_DT hundred_CD unpaid_JJ monks_NNS ._. Ouweleen_NNP plays_VBZ Reggae_NNP for_IN the_DT fermenting_VBG grapes_NNS —_: “_`` conscious_JJ music_NN ,_, ”_'' he_PRP said_VBD ,_, “_`` to_TO encourage_VB them_PRP ”_'' —_: and_CC tastes_NNS and_CC adjusts_VBZ the_DT wine_NN ._. He_PRP also_RB fixes_VBZ the_DT bottle_NN -_HYPH capper_NN ,_, and_CC the_DT crusher_NN ,_, and_CC the_DT labeller_NN ,_, and_CC the_DT filler_NN ,_, and_CC the_DT air_NN -_HYPH compressor_NN ,_, and_CC the_DT tractor_NN ,_, when_WRB they_PRP break_VBP ._. Woodhams_NNP pays_VBZ the_DT bills_NNS ,_, answers_VBZ the_DT phones_NNS ,_, puts_VBZ together_RP wholesale_JJ orders_NNS ,_, and_CC coördinates_VBZ the_DT family_NN ’s_POS appearances_NNS at_IN wine_NN tastings_NNS ._. Friends_NNS help_VBP them_PRP bottle_VB the_DT wine_NN ._. “_`` It_PRP ’s_VBZ like_UH if_IN a_DT Catholic_JJ school_NN lost_VBD all_PDT their_PRP$ nuns_NNS ,_, ”_'' Ouweleen_NNP said_VBD ._. “_`` It_PRP ’s_VBZ noble_JJ but_CC unprofitable_JJ work_NN ._. ”_'' This_DT is_VBZ true_JJ even_RB when_WRB there_EX ’s_VBZ no_DT pandemic_NN ._. (_-LRB- O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP charges_VBZ about_RB eighty_CD dollars_NNS for_IN a_DT case_NN of_IN twelve_CD bottles_NNS of_IN sacramental_JJ wine_NN ,_, and_CC the_DT average_JJ church_NN customer_NN orders_VBZ twenty_CD cases_NNS of_IN wine_NN a_DT year_NN ._. )_-RRB- But_CC it_PRP has_VBZ been_VBN a_DT reliable_JJ source_NN of_IN income_NN ,_, which_WDT ,_, for_IN Ouweleen_NNP ,_, feels_VBZ nothing_NN short_JJ of_IN miraculous_JJ ._. In_IN the_DT spring_NN ,_, when_WRB the_DT grapevines_NNS begin_VBP to_TO sprout_VB ,_, the_DT robins_NNS are_VBP loudest_JJS in_IN the_DT mornings_NNS and_CC the_DT woodpeckers_NNS are_VBP busiest_JJS in_IN the_DT evenings_NNS ._. In_IN the_DT fall_NN ,_, when_WRB the_DT grapes_NNS are_VBP harvested_VBN —_: first_RB the_DT Rosette_NNP ,_, then_RB the_DT Delaware_NNP —_: the_DT lake_NN reflects_VBZ the_DT orange_NN of_IN the_DT trees_NNS ._. Every_DT year_NN is_VBZ different_JJ but_CC also_RB the_DT same_JJ ._. The_DT family_NN has_VBZ been_VBN able_JJ to_TO count_VB on_IN it_PRP ._.","It VBZ an JJ NN , JJ and JJ , and it VBZ VBN JJ thousand NNS RB , at all NNS , in NNS that VBP JJ and NNS that VBP RB . The NN VBZ the NN , and RB he VBZ the NN , and RB on the NN the NN VBZ the NN and NN of NNP . RB , RB as NNP VBD NN and VBD NN with the NNS at the NNP NNP , NNS VBP from the NNS , VBP the NN , VBP it , and , one by one , VBP the NNP NNP , VBG their NNS to the JJ NN . That JJ NN VBZ RB VB these NNS . NNS VBP VBN and NNS VBP VBN VBN RB , for one , but the NNPS for NNP NNP and NNP VBZ RB VBN against it . Before the NN , NNP NNP VBD JJ from such a NN JJ NNS . A NN in the NNP NNP NN of NNP NNP , he VBD to VB NN and VB NN at NNP NNP NNP , in NNP , where the NNP NNP in the NN VBD VBN a NN - VBN NN that he VBD VBN . NNP VBZ a NN VBN NNP - NNP - NNP , which VBZ JJ NN that NNS VBP to VB the NNP . The NN , which VBZ RB to NNP NNP — “ o - NNP - NNP ” VBZ the NNP NN for “ NN ” — VBZ the NN - to for NNPS in the NNP . When NNP NNP VBD NNP NNP NNP , in 2015 , he VBD NNP - NNP - NNP NN for a NN at NNP NNP NNP . In NN to JJ NN , which might VB VBN with JJ NN , NN NNS , and NNS , NN NN must VB “ JJ , from the NN of the NN , JJ and JJ , RB VBN with JJ NNS , ” VBG to NNP NNS . RB , JJ NN , NNP , a NN - VBN “ NN ” who VBZ fifty - eight and VBZ his NN in NNS , VBD what he VBZ every NN : he VBD forty NNS ’ NN of NNS , VBD them to his NN , VBD them , and VBD them to VB with no NNS . ( Except , that VBZ , for some VBN NNS , RB before VBG — a NN VBN by the NNP . ) By NN , he VBD fifty thousand NNS of NN in his NN . This NN of NN , he would RB VB VBG fifteen hundred NN NNS per NN , in NN to VB them to NNS in NNP NNP and NNP , and to JJ - NNS NNS RB RB RB as NNP and NNP . But he VBZ RB VBG that this NN , because it would VB VBG NN NNS to VB with NN that might RB VB . NNP VBZ RB VB when the NNS will VB . This JJ NNP , NNP NNP VBD NNS of NN “ JJ ” and VBD all NNS to VB them “ to VB RB RB , for this NN , ” but , in NNP NNP , NNS of NN can RB RB VB in the JJ NN of the NN ’s four - NN NN NN , along with NNS and NN NNS . NNP VBZ RB RB JJ that , when they VBP VB , they will VB to VB VBN NN , which , in JJS of the NN ’s JJ NNS , VBZ JJ from a NN that VBZ VBN by the JJ NN . RB he VBD to VB them . JJ NN , NNP VBD up a NN to the NN in NNP , to VB if he VBD any NN on the NN of JJ NN . A NN RBR , RB VBG a NN , NNP VBD his NN , VBG to JJR than a thousand NNS — all NNS of his — to VB if they VBP to VB the NNP by NN , once NN NNS VBP . In his NN to the NNS , NNP VBD that NNP - NNP - NNP VBD VBN — by NNP ’s NN — JJ NNS , the NNP NNP , and NNP , but , “ the NNP NNP VBZ those who VBP themselves , RB we VBP VBG an JJ NN in VBG for the JJ NN of this NN . ” NNP VBD that the NN in his NN would VB for RB a NN before its NN VBD to VB . “ I ’ll VB what to VB with that NN when I VBP what to VB , ” he VBD . “ This JJ NN of the NN VBZ VBN RB JJ in my NN , and I VBP that . ” In the NN , he VBD VBG in on his NN . By NNP , his NNS will VB VBN two hundred NNS of NNS , which will VB another forty thousand NNS of NN . It VBD VBG JJ , and the NNS VBD RB to VB . There VBP three JJ JJ NNS in the NNP NNPS : NNP NNP NNP and NNP , both in NNP , and NNP - NNP - NNP , in NNP NNP , which VBZ the JJS and the JJS . VBN in 1872 by NNP NNP NNP , the JJ NN of NNP , NNP - NNP - NNP VBD RB VBN by NNS , and , RBR , by NNS . In 2002 , it VBD VBN by NNP NNP , who VBD RB VBN as the NNP of NNP NNP , the NN and NN NN , and who VBD VBN a NN in the NNP NNP NNP VBG a NN for NN in the NNP NNPS . ( NNP , a JJ NN , VBD to VB over the NN in his NN . ) In 2007 , there VBD another NN — this NN , in the NNP , for a JJ NN on the NNP - NNP - NNP NNP ’s NN , which would VB eight hundred and fifty NNS a NN . NNP VBD to it ; he and his NN , NNP NNP , and his NN , NNP , VBD VBG NN from their NN in NNP . The NN VBD RB JJ up — NNP VBD the NN of an JJ NN that VBD VBG ( and VBG ) to VB with NNPS — and they VBD VBG for a JJR , RBR NN - like NN . ( They VBD a NN : “ NN with a NN / a NN NN or two … a NN to VB / with NN VBN JJ / NN where / we VBP what we VBP . ” “ NNP , ” it VBD , “ VB it RB . ” ) The NN , an JJ NN ’s NN VBN in the NNS , with three NNS , and a NN of NNS in the NN , VBD JJ . The NN VBD RB and VBD , upon their NN , that the NN on the NNS VBD RB VBG RB RB . ( They VBD JJ NNS with the NN , who VBD VBG on their NN , VBG if they VBD any NN NN NNS or NN NNS . ) NNP VBD RB VBG for a JJ NN , RB he VBD NNP and VBD him , “ I VBP I VBP VBN to VB RB to VB you with this NN . ” NNP VBD RB to VB with NNP , who VBD VBN a NNP NN on what he VBD as the NN ’s “ JJ NNS , ” JJ as its JJ , RB JJ NN of VBN JJ NNS VBG to its NNS . NNP VBD no NN in NN - VBG , but , NNP VBD RBR , “ It VBZ RB like I VBD a JJ NN of JJ NNS VBG to VB VBN for the NN . ” NNP VBD , of NNP and his NN , that “ they VBP RB . ” The two NNS VBD out an NN in which NNP would VB NNP - NNP - NNP . A NN RBR , NNP VBD him . ( She VBD VBN VBG and VBG NNS until she VBD JJ that this JJ NN NN VBD VBG to VB out . ) RB with one JJ JJ - NN NN and JJ NN - NN NN , NNP and NNP VBP the NN of a hundred JJ NNS . NNP VBZ NNP for the VBG NNS — “ JJ NN , ” he VBD , “ to VB them ” — and NNS and VBZ the NN . He RB VBZ the NN - NN , and the NN , and the NN , and the NN , and the NN - NN , and the NN , when they VBP . NNP VBZ the NNS , VBZ the NNS , VBZ together JJ NNS , and VBZ the NN ’s NNS at NN NNS . NNS VBP them VB the NN . “ It VBZ like if a JJ NN VBD all their NNS , ” NNP VBD . “ It VBZ JJ but JJ NN . ” This VBZ JJ RB when there VBZ no NN . ( NNP - NNP - NNP VBZ RB eighty NNS for a NN of twelve NNS of JJ NN , and the JJ NN NN VBZ twenty NNS of NN a NN . ) But it VBZ VBN a JJ NN of NN , which , for NNP , VBZ NN JJ of JJ . In the NN , when the NNS VBP to VB , the NNS VBP JJS in the NNS and the NNS VBP JJS in the NNS . In the NN , when the NNS VBP VBN — RB the NNP , RB the NNP — the NN VBZ the NN of the NNS . Every NN VBZ JJ but RB the JJ . The NN VBZ VBN JJ to VB on it ."
129,820,mainstream,M08d1f,vaccine.autism,"In_IN December_NNP ,_, 1962_CD ,_, Esquire_NNP magazine_NN established_VBD what_WP it_PRP called_VBD its_PRP$ Dubious_NNP Achievement_NNP Awards_NNP ._. These_DT were_VBD a_DT series_NN of_IN fictional_JJ prizes_NNS given_VBN to_IN celebrities_NNS ,_, politicians_NNS ,_, and_CC business_NN leaders_NNS who_WP committed_VBD some_DT egregious_JJ blunder_NN that_DT year_NN ,_, a_DT gaffe_NN worthy_JJ of_IN a_DT kind_NN of_IN Hall_NNP of_IN Shame_NNP ._. The_DT annual_JJ event_NN became_VBD so_RB popular_JJ that_IN readers_NNS and_CC media_NNS hungered_VBD for_IN it_PRP year_NN after_IN year_NN ._. Now_RB there_EX are_VBP dubious_JJ awards_NNS everywhere_RB ,_, across_IN all_DT genres_NNS —_: movies_NNS ,_, television_NN ,_, commercials_NNS ._. Every_DT news_NN organization_NN hungers_VBZ to_TO win_VB awards_NNS ._. They_PRP display_VBP them_PRP in_IN glass_NN cases_NNS in_IN the_DT lobby_NN ._. They_PRP write_VBP stories_NNS about_IN the_DT individual_JJ winners_NNS ._. Your_PRP$ public_JJ broadcaster_NN is_VBZ no_RB different_JJ ._. We_PRP love_VBP getting_VBG awards_NNS ._. The_DT award_NN season_NN is_VBZ about_JJ to_TO begin_VB ,_, with_IN various_JJ programs_NNS submitting_VBG entries_NNS to_IN award_NN -_HYPH conferring_VBG bodies_NNS ._. Over_IN the_DT years_NNS ,_, the_DT CBC_NNP —_: radio_NN and_CC television_NN —_: has_VBZ received_VBN hundreds_NNS of_IN plaques_NNS ,_, statuettes_NNS ,_, proclamations_NNS recognizing_VBG significant_JJ achievements_NNS in_IN reporting_VBG and_CC broadcasting_NN ._. At_IN the_DT tail_NN end_NN of_IN 2016_CD ,_, we_PRP received_VBD an_DT official_JJ looking_VBG envelope_NN containing_VBG an_DT official_JJ ,_, suitable_JJ -_HYPH for_IN -_HYPH framing_NN ,_, award_NN certificate_NN ._. Because_IN of_IN its_PRP$ importance_NN ,_, I_PRP want_VBP to_TO read_VB the_DT official_JJ proclamation_NN word_NN for_IN word_NN :_: To_TO wit_VB -_, ""_`` The_DT 2016_CD Adding_NNP Insult_NNP to_IN Injury_NNP Award_NNP ,_, recognizing_VBG deception_NN ,_, distortion_NN and_CC dishonesty_NN in_IN Media_NN ,_, awarded_VBN to_IN CBC_NNP Radio_NNP —_: The_DT Sunday_NNP Edition_NNP ._. ""_'' The_DT award_NN was_VBD presented_VBN by_IN the_DT Board_NN of_IN Directors_NNS of_IN Vaccine_NNP Choice_NNP Canada_NNP ._. For_IN those_DT unaware_JJ of_IN Vaccine_NNP Choice_NNP Canada_NNP ,_, it_PRP is_VBZ an_DT organization_NN opposed_VBN to_IN the_DT compulsory_JJ vaccination_NN of_IN children_NNS ._. Its_PRP$ argument_NN is_VBZ that_IN ordinary_JJ vaccinations_NNS can_MD neurologically_RB wound_VB children_NNS or_CC kill_VB them_PRP outright_RB ._. It_PRP blames_VBZ vaccination_NN for_IN seeming_VBG increases_NNS in_IN autism_NN spectrum_NN disorder_NN ._. It_PRP assiduously_RB ignores_VBZ the_DT burden_NN of_IN evidence_NN from_IN the_DT World_NNP Health_NNP Organization_NNP at_IN the_DT top_NN of_IN the_DT health_NN chain_NN ,_, down_RB to_IN your_PRP$ local_JJ family_NN physician_NN and_CC pharmacist_NN ,_, that_IN this_DT is_VBZ not_RB the_DT case_NN ._. Measles_NN is_VBZ one_CD of_IN the_DT most_RBS contagious_JJ and_CC deadly_JJ diseases_NNS on_IN the_DT planet_NN ._. It_PRP kills_VBZ about_RB 100,000_CD children_NNS every_DT year_NN ._. What_WDT Vaccine_NN Choice_NNP Canada_NNP objects_VBZ to_IN is_VBZ a_DT story_NN we_PRP broadcast_VBD on_IN last_JJ June_NNP on_IN the_DT backfire_NN effect_NN ._. I_PRP interviewed_VBD an_DT American_JJ professor_NN named_VBN Brendan_NNP Nyhan_NNP ._. He_PRP explained_VBD the_DT backfire_NN effect_NN as_IN the_DT inability_NN of_IN many_JJ people_NNS to_TO change_VB their_PRP$ opinions_NNS ,_, even_RB after_IN presented_VBN with_IN irrefutable_JJ facts_NNS to_IN the_DT contrary_NN ._. It_PRP matters_VBZ not_RB how_WRB many_JJ facts_NNS are_VBP marshalled_VBN to_TO contradict_VB them_PRP ._. They_PRP are_VBP resolute_JJ ,_, even_RB reinforced_VBN ,_, in_IN their_PRP$ views_NNS ._. During_IN the_DT interview_NN ,_, Professor_NNP Nyhan_NNP used_VBD the_DT anti-vaccine_JJ movement_NN as_IN another_DT example_NN of_IN the_DT intransigence_NN of_IN people_NNS holding_VBG views_NNS which_WDT are_VBP contradicted_VBN by_IN evidence_NN ._. With_IN the_DT anti-vaccine_NN movement_NN ,_, it_PRP is_VBZ especially_RB difficult_JJ ._. As_IN the_DT New_NNP York_NNP Times_NNP pointed_VBD out_RP in_IN early_JJ January_NNP ,_, the_DT anti-vaccine_JJ group_NN ""_`` is_VBZ not_RB a_DT bastion_NN of_IN rationality_NN ._. ""_'' Although_IN study_NN after_IN study_NN has_VBZ demonstrated_VBN there_EX is_VBZ no_DT link_NN between_IN vaccination_NN and_CC such_JJ diseases_NNS as_IN autism_NN ,_, the_DT anti-vaxxers_NNS continue_VBP their_PRP$ crusade_NN ._. You_PRP have_VBP to_TO be_VB an_DT automaton_NN not_RB to_TO feel_VB sorry_JJ for_IN parents_NNS dealing_VBG with_IN autism_NN ,_, who_WP search_VBP for_IN some_DT explanation_NN for_IN their_PRP$ child_NN 's_POS disorder_NN ._. In_IN desperation_NN they_PRP turn_VBP to_IN garbage_NN science_NN and_CC conspiracy_NN theories_NNS ._. The_DT American_NNP Academy_NNP of_IN Pediatrics_NNP has_VBZ issued_VBN a_DT 21_CD page_NN document_NN listing_VBG all_PDT the_DT studies_NNS showing_VBG that_IN there_EX is_VBZ no_DT link_NN between_IN vaccines_NNS and_CC autism_NN ._. Nevertheless_RB ,_, the_DT arguments_NNS put_VBN out_RP by_IN the_DT anti-vaxxers_NNS seems_VBZ to_TO be_VB gaining_VBG ground_NN in_IN the_DT United_NNP State_NNP ,_, especially_RB in_IN the_DT south_NN and_CC especially_RB in_IN Texas_NNP ._. Peter_NNP Hotez_NNP is_VBZ a_DT pediatrician_NN with_IN the_DT Baylor_NNP College_NNP of_IN Medicine_NNP in_IN Texas_NNP ._. Dr._NNP Hotez_NNP ,_, writing_VBG in_IN the_DT New_NNP York_NNP Times_NNP ,_, said_VBD that_IN because_IN the_DT number_NN of_IN unvaccinated_JJ children_NNS is_VBZ rising_VBG ,_, there_EX could_MD be_VB serious_JJ outbreaks_NNS of_IN measles_NNS in_IN his_PRP$ state_NN ._. It_PRP does_VBZ n't_RB help_VB things_NNS when_WRB the_DT sitting_NN president_NN believes_VBZ that_IN vaccines_NNS cause_VBP autism_NN ._. Dr._NNP Hotez_NNP said_VBD :_: ""_`` I_PRP 'm_VBP worried_JJ that_IN our_PRP$ nation_NN 's_POS health_NN will_MD soon_RB be_VB threatened_VBN because_IN we_PRP have_VBP not_RB stood_VBN up_RP to_IN the_DT pseudoscience_NN and_CC fake_JJ conspiracy_NN claims_NNS of_IN this_DT movement_NN ._. ""_'' In_IN 2000_CD ,_, the_DT US_NNP Centres_NNPS for_IN Disease_NNP Control_NNP announced_VBD that_IN measles_NNS had_VBD been_VBN eliminated_VBN in_IN the_DT United_NNP States_NNPS ,_, meaning_VBG it_PRP was_VBD no_RB longer_RBR endemic_JJ to_IN the_DT US_NNP ._. Now_RB it_PRP appears_VBZ to_TO be_VB coming_VBG back_RB ._. Which_WDT means_VBZ a_DT renewed_VBN attention_NN on_IN the_DT importance_NN of_IN vaccination_NN and_CC the_DT skeptics_NNS who_WP oppose_VBP it_PRP ._. So_RB on_IN behalf_NN of_IN The_DT Sunday_NNP Edition_NNP ,_, I_PRP humbly_RB accept_VBP the_DT 2016_CD Adding_NNP Insult_NNP to_IN Injury_NNP Award_NNP ,_, and_CC give_VBP it_PRP pride_NN of_IN place_NN in_IN our_PRP$ office_NN ._. Click_VB the_DT button_NN above_RB to_TO hear_VB Michael_NNP 's_POS essay_NN ._.","In NNP , 1962 , NNP NN VBD what it VBD its NNP NNP NNP . These VBD a NN of JJ NNS VBN to NNS , NNS , and NN NNS who VBD some JJ NN that NN , a NN JJ of a NN of NNP of NNP . The JJ NN VBD RB JJ that NNS and NNS VBD for it NN after NN . RB there VBP JJ NNS RB , across all NNS — NNS , NN , NNS . Every NN NN VBZ to VB NNS . They VBP them in NN NNS in the NN . They VBP NNS about the JJ NNS . Your JJ NN VBZ RB JJ . We VBP VBG NNS . The NN NN VBZ JJ to VB , with JJ NNS VBG NNS to NN - VBG NNS . Over the NNS , the NNP — NN and NN — VBZ VBN NNS of NNS , NNS , NNS VBG JJ NNS in VBG and NN . At the NN NN of 2016 , we VBD an JJ VBG NN VBG an JJ , JJ - for - NN , NN NN . Because of its NN , I VBP to VB the JJ NN NN for NN : To VB - "" The 2016 NNP NNP to NNP NNP , VBG NN , NN and NN in NN , VBN to NNP NNP — The NNP NNP . "" The NN VBD VBN by the NN of NNS of NNP NNP NNP . For those JJ of NNP NNP NNP , it VBZ an NN VBN to the JJ NN of NNS . Its NN VBZ that JJ NNS can RB VB NNS or VB them RB . It VBZ NN for VBG NNS in NN NN NN . It RB VBZ the NN of NN from the NNP NNP NNP at the NN of the NN NN , RB to your JJ NN NN and NN , that this VBZ RB the NN . NN VBZ one of the RBS JJ and JJ NNS on the NN . It VBZ RB 100,000 NNS every NN . What NN NNP NNP VBZ to VBZ a NN we VBD on JJ NNP on the NN NN . I VBD an JJ NN VBN NNP NNP . He VBD the NN NN as the NN of JJ NNS to VB their NNS , RB after VBN with JJ NNS to the NN . It VBZ RB how JJ NNS VBP VBN to VB them . They VBP JJ , RB VBN , in their NNS . During the NN , NNP NNP VBD the JJ NN as another NN of the NN of NNS VBG NNS which VBP VBN by NN . With the NN NN , it VBZ RB JJ . As the NNP NNP NNP VBD out in JJ NNP , the JJ NN "" VBZ RB a NN of NN . "" Although NN after NN VBZ VBN there VBZ no NN between NN and JJ NNS as NN , the NNS VBP their NN . You VBP to VB an NN RB to VB JJ for NNS VBG with NN , who VBP for some NN for their NN 's NN . In NN they VBP to NN NN and NN NNS . The NNP NNP of NNP VBZ VBN a 21 NN NN VBG all the NNS VBG that there VBZ no NN between NNS and NN . RB , the NNS VBN out by the NNS VBZ to VB VBG NN in the NNP NNP , RB in the NN and RB in NNP . NNP NNP VBZ a NN with the NNP NNP of NNP in NNP . NNP NNP , VBG in the NNP NNP NNP , VBD that because the NN of JJ NNS VBZ VBG , there could VB JJ NNS of NNS in his NN . It VBZ RB VB NNS when the NN NN VBZ that NNS VBP NN . NNP NNP VBD : "" I VBP JJ that our NN 's NN will RB VB VBN because we VBP RB VBN up to the NN and JJ NN NNS of this NN . "" In 2000 , the NNP NNPS for NNP NNP VBD that NNS VBD VBN VBN in the NNP NNPS , VBG it VBD RB RBR JJ to the NNP . RB it VBZ to VB VBG RB . Which VBZ a VBN NN on the NN of NN and the NNS who VBP it . RB on NN of The NNP NNP , I RB VBP the 2016 NNP NNP to NNP NNP , and VBP it NN of NN in our NN . VB the NN RB to VB NNP 's NN ."
130,514,mainstream,M09741,vaccine; vaccine.covid,"WASHINGTON_NNP —_: Dr._NNP Anthony_NNP Fauci_NNP says_VBZ the_DT government_NN is_VBZ working_VBG on_IN several_JJ potential_JJ vaccines_NNS for_IN COVID_NN -_HYPH 19_CD ._. “_`` We_PRP have_VBP many_JJ candidates_NNS and_CC hope_VBP to_TO have_VB many_JJ winners_NNS ,_, ”_'' he_PRP told_VBD the_DT Senate_NNP Health_NNP ,_, Education_NNP ,_, Labor_NNP and_CC Pension_NNP committee_NNP ._. “_`` In_IN other_JJ words_NNS ,_, it_PRP is_VBZ many_JJ shots_NNS on_IN goal_NN ._. ”_'' Despite_IN the_DT rapid_JJ pace_NN of_IN work_NN on_IN vaccines_NNS ,_, Fauci_NNP was_VBD offering_VBG no_DT guarantees_NNS ._. He_PRP says_VBZ ,_, “_`` The_DT big_JJ unknown_JJ is_VBZ efficacy_NN ._. ”_'' Fauci_NNP heads_VBZ the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS and_CC is_VBZ the_DT government_NN ’s_POS leading_VBG expert_NN on_IN the_DT pandemic_NN ._. He_PRP says_VBZ he_PRP hopes_VBZ to_TO have_VB a_DT vaccine_NN in_IN advanced_JJ trials_NNS by_IN late_JJ fall_NN or_CC early_JJ winter_NN ._. WATCH_VB LIVE_NN :_: Fauci_NNP ,_, CDC_NNP director_NN testify_VB in_IN Senate_NNP hearing_NN on_IN how_WRB to_TO safely_RB return_VB to_IN work_NN and_CC school_NN","NNP — NNP NNP NNP VBZ the NN VBZ VBG on JJ JJ NNS for NN - 19 . “ We VBP JJ NNS and VBP to VB JJ NNS , ” he VBD the NNP NNP , NNP , NNP and NNP NNP . “ In JJ NNS , it VBZ JJ NNS on NN . ” Despite the JJ NN of NN on NNS , NNP VBD VBG no NNS . He VBZ , “ The JJ JJ VBZ NN . ” NNP VBZ the NNP NNP of NNP and NNP NNPS and VBZ the NN ’s VBG NN on the NN . He VBZ he VBZ to VB a NN in JJ NNS by JJ NN or JJ NN . VB NN : NNP , NNP NN VB in NNP NN on how to RB VB to NN and NN"
131,746,mainstream,M078be,vaccine,"Well_UH ,_, it_PRP gets_VBZ very_RB technical_JJ ,_, and_CC I_PRP do_VBP n’t_RB want_VB to_TO get_VB into_IN the_DT technicalities_NNS of_IN this_DT ._. But_CC basically_RB ,_, these_DT were_VBD futures_NNS contracts_NNS that_WDT rolled_VBD over_RP ._. And_CC so_RB this_DT was_VBD a_DT phenomena_NN that_WDT occurred_VBD over_IN a_DT 12_CD to_IN 24_CD -_HYPH hour_NN period_NN ._. So_RB there_EX ’s_VBZ something_NN a_DT bit_NN artificial_JJ about_IN it_PRP ._. But_CC it_PRP does_VBZ reflect_VB something_NN that_WDT ’s_VBZ real_JJ ._. Nobody_NN wants_VBZ the_DT oil_NN ._. It_PRP is_VBZ not_RB a_DT precious_JJ commodity_NN right_RB now_RB because_IN people_NNS are_VBP not_RB driving_VBG ,_, people_NNS are_VBP not_RB flying_VBG ,_, cruise_NN ships_NNS are_VBP not_RB cruising_VBG ,_, and_CC industry_NN is_VBZ not_RB burning_VBG as_RB much_JJ fuel_NN as_IN it_PRP was_VBD ._. And_CC yet_CC the_DT world_NN is_VBZ still_RB producing_VBG this_DT oil_NN ._. That_DT ’s_VBZ right_JJ ._. So_RB all_DT of_IN those_DT things_NNS were_VBD done_VBN ._. But_CC all_DT that_WDT was_VBD accomplished_VBN ,_, and_CC it_PRP was_VBD something_NN ,_, was_VBD to_TO stem_VB the_DT bleeding_NN ._. And_CC that_DT brings_VBZ us_PRP to_IN the_DT second_JJ trauma_NN ,_, which_WDT is_VBZ the_DT early_JJ years_NNS of_IN the_DT current_JJ century_NN ._. When_WRB suddenly_RB ,_, our_PRP$ production_NN is_VBZ in_IN decline_NN again_RB ._. China_NNP is_VBZ growing_VBG by_IN leaps_NNS and_CC bounds_NNS ._. India_NNP is_VBZ starting_VBG to_TO grow_VB by_IN leaps_NNS and_CC bounds_NNS ._. A_DT middle_JJ class_NN is_VBZ growing_VBG around_IN the_DT developing_VBG world_NN ._. So_RB demand_NN is_VBZ going_VBG up_RP ,_, like_UH ,_, 5_CD million_CD barrels_NNS a_DT day_NN around_IN the_DT world_NN ._. And_CC the_DT Middle_NNP East_NNP is_VBZ suddenly_RB more_RBR unstable_JJ ._. And_CC so_RB prices_NNS skyrocket_VBP between_IN the_DT years_NNS of_IN about_IN 2004_CD and_CC 2007_CD ._. Economically_RB speaking_VBG ,_, no_DT question_NN about_IN it_PRP ._. By_IN 2014_CD ,_, we_PRP were_VBD bringing_VBG down_RP gasoline_NN prices_NNS for_IN consumers_NNS ._. It_PRP was_VBD part_NN of_IN our_PRP$ recovery_NN from_IN the_DT recession_NN ._. And_CC all_DT of_IN this_DT American_JJ production_NN puts_VBZ the_DT United_NNP States_NNPS in_IN a_DT extremely_RB powerful_JJ position_NN economically_RB ,_, employing_VBG millions_NNS of_IN people_NNS and_CC producing_VBG revenues_NNS for_IN state_NN and_CC local_JJ governments_NNS across_IN much_JJ of_IN the_DT country_NN ._. Also_RB giving_VBG the_DT United_NNP States_NNPS the_DT freedom_NN to_TO act_VB in_IN foreign_JJ policy_NN in_IN ways_NNS that_WDT would_MD have_VB been_VBN unheard_JJ -_HYPH of_IN years_NNS before_RB ,_, such_JJ as_IN putting_VBG pressure_NN on_IN Iran_NNP without_IN endangering_VBG our_PRP$ energy_NN supply_NN ._. It_PRP was_VBD basically_RB the_DT culmination_NN of_IN the_DT dream_NN from_IN the_DT 1970s_NNS ._. And_CC it_PRP was_VBD hard_JJ to_TO imagine_VB ,_, just_RB a_DT few_JJ months_NNS ago_RB ,_, what_WP could_MD happen_VB that_WDT could_MD undercut_VB that_DT dream_NN ._. So_RB the_DT oil_NN has_VBZ no_DT place_NN to_TO go_VB ._. And_CC it_PRP ’s_VBZ rapidly_RB filling_VBG up_RP tank_NN farms_NNS ,_, strategic_JJ reserves_NNS around_IN the_DT world_NN ._. Refineries_NNS are_VBP running_VBG out_IN of_IN space_NN to_TO put_VB the_DT oil_NN ._. And_CC so_RB the_DT inventories_NNS are_VBP building_VBG to_IN a_DT point_NN where_WRB there_EX ’ll_MD be_VB no_DT physical_JJ space_NN to_TO put_VB the_DT oil_NN ._. You_PRP now_RB have_VBP tankers_NNS which_WDT ,_, you_PRP know_VBP ,_, used_VBD to_TO ship_VB oil_NN from_IN place_NN to_IN place_NN ,_, just_RB storing_VBG the_DT oil_NN and_CC sitting_VBG out_RP off_IN of_IN the_DT shores_NNS of_IN Los_NNP Angeles_NNP ,_, for_IN instance_NN ,_, and_CC other_JJ places_NNS ._. And_CC these_DT are_VBP the_DT people_NNS who_WP are_VBP making_VBG a_DT lot_NN of_IN money_NN ._. They_PRP ’re_VBP getting_VBG paid_VBN to_TO just_RB hold_VB the_DT oil_NN ._. Well_UH ,_, that_DT ’s_VBZ beginning_VBG to_TO happen_VB ,_, but_CC it_PRP ’s_VBZ a_DT cumbersome_JJ ,_, complex_JJ process_NN ._. First_RB of_IN all_DT ,_, you_PRP have_VBP thousands_NNS of_IN producers_NNS in_IN the_DT United_NNP States_NNPS ._. We_PRP do_VBP n’t_RB have_VB a_DT national_JJ oil_NN company_NN which_WDT is_VBZ taking_VBG orders_NNS from_IN the_DT government_NN ,_, such_JJ as_IN in_IN Saudi_NNP Arabia_NNP ._. And_CC then_RB there_EX are_VBP complications_NNS that_WDT go_VBP along_RB with_IN shutting_VBG in_IN wells_NNS ._. It_PRP ’s_VBZ an_DT expensive_JJ process_NN ._. You_PRP can_MD actually_RB damage_VB the_DT resource_NN to_IN the_DT point_NN where_WRB ,_, when_WRB you_PRP restart_VBP the_DT oil_NN ,_, you_PRP ’ll_MD actually_RB pump_VB less_JJR oil_NN out_RP ._. And_CC then_RB ,_, you_PRP have_VBP all_DT of_IN these_DT companies_NNS that_WDT ,_, even_RB when_WRB they_PRP ’re_VBP losing_VBG money_NN ,_, they_PRP need_VBP cash_NN flow_NN ._. They_PRP need_VBP cash_NN flow_NN to_TO meet_VB their_PRP$ payroll_NN ,_, to_TO meet_VB their_PRP$ debt_NN responsibilities_NNS ._. So_RB what_WDT oil_NN companies_NNS prefer_VBP to_TO do_VB ,_, you_PRP let_VBP the_DT well_RB ,_, basically_RB ,_, slowly_RB decline_VB ._.","Well , it VBZ RB JJ , and I VBP RB VB to VB into the NNS of this . But RB , these VBD NNS NNS that VBD over . And RB this VBD a NN that VBD over a 12 to 24 - NN NN . RB there VBZ NN a NN JJ about it . But it VBZ VB NN that VBZ JJ . NN VBZ the NN . It VBZ RB a JJ NN RB RB because NNS VBP RB VBG , NNS VBP RB VBG , NN NNS VBP RB VBG , and NN VBZ RB VBG RB JJ NN as it VBD . And yet the NN VBZ RB VBG this NN . That VBZ JJ . RB all of those NNS VBD VBN . But all that VBD VBN , and it VBD NN , VBD to VB the NN . And that VBZ us to the JJ NN , which VBZ the JJ NNS of the JJ NN . When RB , our NN VBZ in NN RB . NNP VBZ VBG by NNS and NNS . NNP VBZ VBG to VB by NNS and NNS . A JJ NN VBZ VBG around the VBG NN . RB NN VBZ VBG up , like , 5 million NNS a NN around the NN . And the NNP NNP VBZ RB RBR JJ . And RB NNS VBP between the NNS of about 2004 and 2007 . RB VBG , no NN about it . By 2014 , we VBD VBG down NN NNS for NNS . It VBD NN of our NN from the NN . And all of this JJ NN VBZ the NNP NNPS in a RB JJ NN RB , VBG NNS of NNS and VBG NNS for NN and JJ NNS across JJ of the NN . RB VBG the NNP NNPS the NN to VB in JJ NN in NNS that would VB VBN JJ - of NNS RB , JJ as VBG NN on NNP without VBG our NN NN . It VBD RB the NN of the NN from the NNS . And it VBD JJ to VB , RB a JJ NNS RB , what could VB that could VB that NN . RB the NN VBZ no NN to VB . And it VBZ RB VBG up NN NNS , JJ NNS around the NN . NNS VBP VBG out of NN to VB the NN . And RB the NNS VBP VBG to a NN where there ’ll VB no JJ NN to VB the NN . You RB VBP NNS which , you VBP , VBD to VB NN from NN to NN , RB VBG the NN and VBG out off of the NNS of NNP NNP , for NN , and JJ NNS . And these VBP the NNS who VBP VBG a NN of NN . They VBP VBG VBN to RB VB the NN . Well , that VBZ VBG to VB , but it VBZ a JJ , JJ NN . RB of all , you VBP NNS of NNS in the NNP NNPS . We VBP RB VB a JJ NN NN which VBZ VBG NNS from the NN , JJ as in NNP NNP . And RB there VBP NNS that VBP RB with VBG in NNS . It VBZ an JJ NN . You can RB VB the NN to the NN where , when you VBP the NN , you ’ll RB VB JJR NN out . And RB , you VBP all of these NNS that , RB when they VBP VBG NN , they VBP NN NN . They VBP NN NN to VB their NN , to VB their NN NNS . RB what NN NNS VBP to VB , you VBP the RB , RB , RB VB ."
132,673,mainstream,M07d41,vaccine; vaccine.covid,"Humans_NNS are_VBP hard_RB -_HYPH wired_VBN to_TO avoid_VB uncertainty_NN ._. But_CC when_WRB it_PRP comes_VBZ to_IN the_DT coronavirus_NN crisis_NN ,_, uncertainty_NN is_VBZ unavoidable_JJ ._. Every_DT day_NN ,_, we_PRP ’re_VBP bombarded_VBN with_IN ambiguous_JJ ,_, complex_JJ ,_, and_CC often_RB conflicting_VBG information_NN ._. To_TO make_VB sense_NN out_IN of_IN all_PDT this_DT noise_NN ,_, the_DT authors_NNS describe_VBP a_DT framework_NN for_IN understanding_VBG different_JJ types_NNS of_IN informational_JJ uncertainty_NN ._. They_PRP then_RB suggest_VBP several_JJ strategies_NNS for_IN coping_VBG with_IN that_DT uncertainty_NN ,_, both_CC cognitively_RB (_-LRB- to_TO more_RBR effectively_RB process_VB and_CC make_VB sense_NN of_IN information_NN )_-RRB- and_CC emotionally_RB (_-LRB- to_TO mitigate_VB the_DT stress_NN and_CC anxiety_NN that_WDT result_VBP from_IN uncertainty_NN )_-RRB- ._. Will_MD colleges_NNS and_CC universities_NNS restart_VB in_IN -_HYPH person_NN classes_NNS this_DT fall_NN ?_. Will_MD there_EX be_VB a_DT vaccine_NN for_IN the_DT novel_JJ coronavirus_NN soon_RB ?_. Will_MD there_EX be_VB second_JJ wave_NN of_IN the_DT virus_NN ?_. Do_VBP I_PRP wear_VB a_DT mask_NN outside_RB even_RB if_IN I_PRP plan_VBP to_TO socially_RB distance_NN ?_. How_WRB can_MD I_PRP figure_VB out_RP which_WDT news_NN sources_NNS and_CC leaders_NNS to_TO trust_VB ?_. Every_DT day_NN we_PRP are_VBP faced_VBN with_IN a_DT torrent_NN of_IN information_NN from_IN news_NN articles_NNS ,_, cable_NN networks_NNS ,_, social_JJ media_NN ,_, the_DT White_NNP House_NNP ,_, the_DT Center_NNP for_IN Disease_NNP Control_NNP –_: and_CC yet_RB ,_, there_EX are_VBP no_DT clear_JJ answers_NNS ._. As_IN humans_NNS ,_, we_PRP innately_RB find_VBP uncertainty_NN to_TO be_VB an_DT aversive_JJ state_NN and_CC are_VBP motivated_VBN to_TO reduce_VB it_PRP ,_, even_RB at_IN a_DT cost_NN ._. Research_NN has_VBZ shown_VBN that_IN people_NNS are_VBP calmer_JJR and_CC less_RBR agitated_JJ when_WRB they_PRP know_VBP they_PRP are_VBP going_VBG to_TO receive_VB an_DT electric_JJ shock_NN than_IN when_WRB they_PRP know_VBP there_EX is_VBZ a_DT 50_CD %_NN chance_NN they_PRP might_MD receive_VB an_DT electric_JJ shock_NN ._. Similarly_RB ,_, the_DT threat_NN of_IN perceived_VBN job_NN insecurity_NN has_VBZ more_RBR detrimental_JJ health_NN effects_NNS than_IN actually_RB losing_VBG a_DT job_NN ._. Feeling_VBG uncertain_JJ is_VBZ not_RB a_DT natural_JJ state_NN of_IN being_VBG for_IN us_PRP —_: it_PRP signals_VBZ to_IN the_DT brain_NN that_IN things_NNS are_VBP not_RB right_JJ ._. The_DT brain_NN then_RB seeks_VBZ out_RP information_NN to_TO resolve_VB the_DT uncertainty_NN ._. This_DT desire_NN for_IN resolution_NN is_VBZ why_WRB feelings_NNS of_IN uncertainty_NN lead_VBP us_PRP to_TO process_VB information_NN more_RBR systematically_RB and_CC deeply_RB in_IN the_DT hope_NN of_IN finding_VBG answers_NNS ._. But_CC the_DT coronavirus_NN pandemic_NN leaves_VBZ us_PRP in_IN a_DT quandary_NN :_: Our_PRP$ natural_JJ instinct_NN is_VBZ to_TO try_VB to_TO resolve_VB our_PRP$ intense_JJ feelings_NNS of_IN uncertainty_NN ,_, but_CC there_EX is_VBZ so_RB much_JJ uncertainty_NN around_IN the_DT virus_NN and_CC its_PRP$ effects_NNS that_IN a_DT quest_NN for_IN complete_JJ resolution_NN is_VBZ futile_JJ ._. So_RB what_WP can_MD we_PRP do_VB ?_. First_RB ,_, it_PRP is_VBZ important_JJ to_TO understand_VB that_IN uncertainty_NN is_VBZ multi-dimensional_JJ ._. There_EX are_VBP at_IN least_JJS three_CD types_NNS of_IN uncertainty_NN :_: probability_NN ,_, ambiguity_NN ,_, and_CC complexity_NN ._. To_TO cope_VB with_IN each_DT ,_, we_PRP have_VBP identified_VBN several_JJ strategies_NNS ,_, both_CC cognitive_JJ (_-LRB- to_TO more_RBR effectively_RB process_VB and_CC make_VB sense_NN of_IN information_NN )_-RRB- and_CC emotional_JJ (_-LRB- to_TO mitigate_VB the_DT stress_NN and_CC anxiety_NN that_WDT result_VBP from_IN uncertainty_NN )_-RRB- ._. Probability_NN uncertainty_NN refers_VBZ to_IN situations_NNS in_IN which_WDT it_PRP is_VBZ difficult_JJ to_TO ascertain_VB risk_NN levels_NNS :_: Not_RB only_RB do_VBP you_PRP not_RB know_VB what_WP will_MD happen_VB ,_, you_PRP also_RB do_VBP n’t_RB know_VB how_WRB likely_JJ each_DT outcome_NN is_VBZ ._. For_IN example_NN ,_, how_WRB much_JJ am_VBP I_PRP really_RB at_IN risk_NN compared_VBN to_IN others_NNS in_IN my_PRP$ group_NN ?_. People_NNS of_IN my_PRP$ age_NN ?_. People_NNS where_WRB I_PRP live_VBP ?_. People_NNS who_WP behave_VBP like_IN me_PRP ?_. As_IN a_DT cognitive_JJ coping_NN mechanism_NN ,_, the_DT first_JJ thing_NN to_TO do_VB is_VBZ to_TO understand_VB that_IN you_PRP are_VBP at_IN risk_NN as_RB much_RB as_IN any_DT other_JJ member_NN of_IN your_PRP$ group_NN ._. Research_NN shows_VBZ that_IN people_NNS tend_VBP to_TO underestimate_VB their_PRP$ own_JJ risk_NN of_IN contracting_VBG a_DT disease_NN or_CC encountering_VBG a_DT negative_JJ event_NN ._. This_DT is_VBZ a_DT self_NN -_HYPH positivity_NN bias_NN ,_, that_DT needs_VBZ to_TO be_VB overcome_VBN ._. Recognize_VB that_IN you_PRP are_VBP as_RB much_RB at_IN risk_NN as_IN everyone_NN else_JJ ,_, and_CC focus_VB on_IN what_WP you_PRP know_VBP you_PRP can_MD do_VB to_TO reduce_VB risk_NN by_IN complying_VBG with_IN expert_NN recommendations_NNS (_-LRB- e.g._FW ,_, wash_VB hands_NNS often_RB ,_, wear_VB facial_JJ coverings_NNS in_IN public_NN ,_, maintain_VB social_JJ distancing_NN )_-RRB- ._. Do_VB n’t_RB be_VB that_DT person_NN who_WP gets_VBZ yelled_VBN at_IN in_IN a_DT grocery_NN store_NN for_IN not_RB wearing_VBG a_DT mask_NN !_. Emotionally_RB ,_, it_PRP is_VBZ important_JJ to_TO embrace_VB that_IN you_PRP are_VBP at_IN as_RB much_JJ risk_NN as_IN the_DT people_NNS around_IN you_PRP and_CC empathize_VBP with_IN them_PRP on_IN this_DT common_JJ ground_NN ._. Connect_VB virtually_RB (_-LRB- or_CC in_IN person_NN with_IN appropriate_JJ social_JJ distance_NN ,_, if_IN allowed_VBN )_-RRB- with_IN people_NNS you_PRP care_VBP about_IN ,_, whether_IN they_PRP are_VBP friends_NNS ,_, family_NN or_CC neighbors_NNS ._. Accept_VB that_IN we_PRP ’re_VBP all_RB in_IN the_DT same_JJ boat_NN and_CC we_PRP ’re_VBP all_RB doing_VBG our_PRP$ best_JJS to_TO get_VB through_IN this_DT together_RB ._. Ambiguity_NN uncertainty_NN refers_VBZ to_IN situations_NNS in_IN which_WDT we_PRP are_VBP faced_VBN with_IN imprecise_JJ ,_, insufficient_JJ ,_, or_CC conflicting_JJ information_NN ._. For_IN example_NN ,_, we_PRP were_VBD told_VBN that_IN the_DT virus_NN could_MD be_VB transmitted_VBN through_IN hard_JJ surfaces_NNS such_JJ as_IN cardboard_NN ,_, plastic_NN ,_, metal_NN ,_, etc_FW ._. Now_RB the_DT CDC_NNP believes_VBZ that_IN the_DT virus_NN is_VBZ mostly_RB airborne_JJ and_CC that_IN the_DT chances_NNS of_IN contracting_VBG the_DT virus_NN through_IN surfaces_NNS is_VBZ very_RB small_JJ ._. What_WP does_VBZ that_DT mean_VB for_IN my_PRP$ behavior_NN ?_. Can_MD I_PRP get_VB the_DT virus_NN from_IN not_RB just_RB someone_NN ’s_POS cough_NN ,_, but_CC if_IN they_PRP speak_VBP to_IN me_PRP ?_. Is_VBZ six_CD feet_NNS of_IN social_JJ distancing_NN enough_RB to_TO protect_VB myself_PRP ?_. As_IN a_DT cognitive_JJ coping_NN mechanism_NN ,_, consolidate_VB the_DT different_JJ sources_NNS of_IN information_NN and_CC try_VB to_TO get_VB clarity_NN through_IN what_WP social_JJ scientists_NNS call_VBP triangulation_NN (_-LRB- i.e._FW ,_, using_VBG multiple_JJ measures_NNS or_CC methods_NNS to_TO ensure_VB that_IN they_PRP all_DT converge_VBP on_IN the_DT same_JJ result_NN )_-RRB- ._. Rely_VB most_JJS on_IN information_NN that_WDT is_VBZ reported_VBN consistently_RB through_IN multiple_JJ reliable_JJ sources_NNS ._. But_CC also_RB understand_VB that_IN the_DT coronavirus_NN is_VBZ novel_JJ ,_, and_CC that_IN the_DT science_NN around_IN it_PRP keeps_VBZ evolving_VBG ._. So_RB sometimes_RB we_PRP need_VBP to_TO find_VB a_DT non-cognitive_JJ approach_NN that_WDT does_VBZ not_RB involve_VB trying_VBG to_TO resolve_VB uncertainty_NN ._. Cope_VB emotionally_RB by_IN knowing_VBG when_WRB it_PRP ’s_VBZ time_NN to_TO end_VB the_DT search_NN for_IN more_JJR information_NN ._. Sources_NNS such_JJ as_IN the_DT CDC_NNP warn_VBP against_IN information_NN overload_NN :_: “_`` Take_VB breaks_NNS from_IN watching_VBG ,_, reading_NN ,_, or_CC listening_VBG to_IN news_NN stories_NNS ,_, including_VBG social_JJ media_NN ._. Hearing_VBG about_IN the_DT pandemic_NN repeatedly_RB can_MD be_VB upsetting_JJ ._. ”_'' Recognize_VB that_IN the_DT endless_JJ search_NN for_IN clarity_NN can_MD create_VB more_JJR stress_NN than_IN it_PRP alleviates_VBZ ,_, and_CC sometimes_RB enough_RB is_VBZ enough_JJ ._. This_DT occurs_VBZ when_WRB an_DT issue_NN is_VBZ technically_RB complex_JJ and_CC difficult_JJ to_TO understand_VB :_: For_IN example_NN ,_, for_IN non-statisticians_NNS ,_, it_PRP can_MD be_VB hard_JJ to_TO understand_VB what_WP “_`` flattening_VBG the_DT curve_NN ”_'' really_RB means_VBZ ,_, why_WRB it_PRP ’s_VBZ important_JJ ,_, and_CC how_WRB to_TO balance_VB different_JJ factors_NNS such_JJ as_IN resource_NN constraints_NNS ,_, geographical_JJ variances_NNS ,_, and_CC economic_JJ considerations_NNS ._. Is_VBZ it_PRP true_JJ that_IN a_DT week_NN ’s_POS delay_NN in_IN lockdown_NN in_IN March_NNP led_VBD to_IN a_DT loss_NN of_IN 36,000_CD lives_NNS ?_. And_CC now_RB ,_, how_WRB is_VBZ each_DT state_NN or_CC county_NN making_VBG the_DT decision_NN to_TO reopen_VB ,_, and_CC how_WRB are_VBP they_PRP balancing_VBG economic_JJ loss_NN against_IN the_DT loss_NN of_IN human_JJ life_NN ?_. As_IN a_DT cognitive_JJ coping_NN mechanism_NN ,_, consult_VB an_DT expert_NN source_NN well_RB versed_VBN in_IN the_DT field_NN to_TO break_VB down_RP complex_JJ information_NN into_IN understandable_JJ nuggets_NNS ._. Make_VB sure_JJ to_TO find_VB sources_NNS grounded_VBN in_IN science_NN ,_, not_RB partisanship_NN ._. And_CC again_RB ,_, recognize_VB when_WRB the_DT quest_NN for_IN information_NN is_VBZ helpful_JJ ,_, and_CC when_WRB it_PRP is_VBZ n’t_RB ._. Maybe_RB what_WP ’s_VBZ needed_VBN right_RB now_RB is_VBZ not_RB to_TO understand_VB the_DT details_NNS of_IN each_DT epidemiological_JJ model_NN ,_, but_CC instead_RB to_TO just_RB understand_VB what_WDT actions_NNS we_PRP need_VBP to_TO take_VB to_TO be_VB safe_JJ ._. Simplify_VB the_DT complexity_NN into_IN an_DT actionable_JJ piece_NN of_IN information_NN (_-LRB- e.g._FW ,_, wear_VB a_DT mask_NN when_WRB going_VBG outside_RB )_-RRB- ._. If_IN this_DT gets_VBZ too_RB overwhelming_JJ ,_, cope_VB emotionally_RB by_IN finding_VBG ways_NNS to_TO escape_VB the_DT complexity_NN :_: Re-watch_VB a_DT favorite_JJ TV_NN show_NN ,_, knit_VB a_DT blanket_NN ,_, or_CC organize_VB your_PRP$ closet_NN by_IN color_NN ._. Or_CC if_IN you_PRP can_MD ,_, escape_VB your_PRP$ own_JJ stresses_NNS by_IN making_VBG this_DT world_NN a_DT little_JJ less_RBR stressful_JJ for_IN others_NNS :_: Donate_VB to_IN your_PRP$ local_JJ food_NN bank_NN ,_, support_VB your_PRP$ local_JJ businesses_NNS ,_, or_CC even_RB bail_VB someone_NN out_IN of_IN jail_NN ._. Taking_VBG these_DT steps_NNS to_TO mitigate_VB informational_JJ uncertainty_NN will_MD leave_VB you_PRP with_IN the_DT mental_JJ bandwidth_NN to_TO cope_VB with_IN the_DT many_JJ other_JJ important_JJ issues_NNS we_PRP all_DT face_VBP ._. And_CC in_IN these_DT trying_VBG times_NNS ,_, it_PRP ’s_VBZ best_JJS to_TO take_VB every_DT chance_NN you_PRP get_VBP to_TO unwind_VB and_CC find_VB some_DT moments_NNS of_IN zen_NN ._.","NNS VBP RB - VBN to VB NN . But when it VBZ to the NN NN , NN VBZ JJ . Every NN , we VBP VBN with JJ , JJ , and RB VBG NN . To VB NN out of all this NN , the NNS VBP a NN for VBG JJ NNS of JJ NN . They RB VBP JJ NNS for VBG with that NN , both RB ( to RBR RB VB and VB NN of NN ) and RB ( to VB the NN and NN that VBP from NN ) . Will NNS and NNS VB in - NN NNS this NN ? Will there VB a NN for the JJ NN RB ? Will there VB JJ NN of the NN ? VBP I VB a NN RB RB if I VBP to RB NN ? How can I VB out which NN NNS and NNS to VB ? Every NN we VBP VBN with a NN of NN from NN NNS , NN NNS , JJ NN , the NNP NNP , the NNP for NNP NNP – and RB , there VBP no JJ NNS . As NNS , we RB VBP NN to VB an JJ NN and VBP VBN to VB it , RB at a NN . NN VBZ VBN that NNS VBP JJR and RBR JJ when they VBP they VBP VBG to VB an JJ NN than when they VBP there VBZ a 50 NN NN they might VB an JJ NN . RB , the NN of VBN NN NN VBZ RBR JJ NN NNS than RB VBG a NN . VBG JJ VBZ RB a JJ NN of VBG for us — it VBZ to the NN that NNS VBP RB JJ . The NN RB VBZ out NN to VB the NN . This NN for NN VBZ why NNS of NN VBP us to VB NN RBR RB and RB in the NN of VBG NNS . But the NN NN VBZ us in a NN : Our JJ NN VBZ to VB to VB our JJ NNS of NN , but there VBZ RB JJ NN around the NN and its NNS that a NN for JJ NN VBZ JJ . RB what can we VB ? RB , it VBZ JJ to VB that NN VBZ JJ . There VBP at JJS three NNS of NN : NN , NN , and NN . To VB with each , we VBP VBN JJ NNS , both JJ ( to RBR RB VB and VB NN of NN ) and JJ ( to VB the NN and NN that VBP from NN ) . NN NN VBZ to NNS in which it VBZ JJ to VB NN NNS : RB RB VBP you RB VB what will VB , you RB VBP RB VB how JJ each NN VBZ . For NN , how JJ VBP I RB at NN VBN to NNS in my NN ? NNS of my NN ? NNS where I VBP ? NNS who VBP like me ? As a JJ NN NN , the JJ NN to VB VBZ to VB that you VBP at NN RB RB as any JJ NN of your NN . NN VBZ that NNS VBP to VB their JJ NN of VBG a NN or VBG a JJ NN . This VBZ a NN - NN NN , that VBZ to VB VBN . VB that you VBP RB RB at NN as NN JJ , and VB on what you VBP you can VB to VB NN by VBG with NN NNS ( FW , VB NNS RB , VB JJ NNS in NN , VB JJ NN ) . VB RB VB that NN who VBZ VBN at in a NN NN for RB VBG a NN ! RB , it VBZ JJ to VB that you VBP at RB JJ NN as the NNS around you and VBP with them on this JJ NN . VB RB ( or in NN with JJ JJ NN , if VBN ) with NNS you VBP about , whether they VBP NNS , NN or NNS . VB that we VBP RB in the JJ NN and we VBP RB VBG our JJS to VB through this RB . NN NN VBZ to NNS in which we VBP VBN with JJ , JJ , or JJ NN . For NN , we VBD VBN that the NN could VB VBN through JJ NNS JJ as NN , NN , NN , FW . RB the NNP VBZ that the NN VBZ RB JJ and that the NNS of VBG the NN through NNS VBZ RB JJ . What VBZ that VB for my NN ? Can I VB the NN from RB RB NN ’s NN , but if they VBP to me ? VBZ six NNS of JJ NN RB to VB myself ? As a JJ NN NN , VB the JJ NNS of NN and VB to VB NN through what JJ NNS VBP NN ( FW , VBG JJ NNS or NNS to VB that they all VBP on the JJ NN ) . VB JJS on NN that VBZ VBN RB through JJ JJ NNS . But RB VB that the NN VBZ JJ , and that the NN around it VBZ VBG . RB RB we VBP to VB a JJ NN that VBZ RB VB VBG to VB NN . VB RB by VBG when it VBZ NN to VB the NN for JJR NN . NNS JJ as the NNP VBP against NN NN : “ VB NNS from VBG , NN , or VBG to NN NNS , VBG JJ NN . VBG about the NN RB can VB JJ . ” VB that the JJ NN for NN can VB JJR NN than it VBZ , and RB RB VBZ JJ . This VBZ when an NN VBZ RB JJ and JJ to VB : For NN , for NNS , it can VB JJ to VB what “ VBG the NN ” RB VBZ , why it VBZ JJ , and how to VB JJ NNS JJ as NN NNS , JJ NNS , and JJ NNS . VBZ it JJ that a NN ’s NN in NN in NNP VBD to a NN of 36,000 NNS ? And RB , how VBZ each NN or NN VBG the NN to VB , and how VBP they VBG JJ NN against the NN of JJ NN ? As a JJ NN NN , VB an NN NN RB VBN in the NN to VB down JJ NN into JJ NNS . VB JJ to VB NNS VBN in NN , RB NN . And RB , VB when the NN for NN VBZ JJ , and when it VBZ RB . RB what VBZ VBN RB RB VBZ RB to VB the NNS of each JJ NN , but RB to RB VB what NNS we VBP to VB to VB JJ . VB the NN into an JJ NN of NN ( FW , VB a NN when VBG RB ) . If this VBZ RB JJ , VB RB by VBG NNS to VB the NN : VB a JJ NN NN , VB a NN , or VB your NN by NN . Or if you can , VB your JJ NNS by VBG this NN a JJ RBR JJ for NNS : VB to your JJ NN NN , VB your JJ NNS , or RB VB NN out of NN . VBG these NNS to VB JJ NN will VB you with the JJ NN to VB with the JJ JJ JJ NNS we all VBP . And in these VBG NNS , it VBZ JJS to VB every NN you VBP to VB and VB some NNS of NN ."
